PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Salomon-Torres, R; Matukumalli, LK; Van Tassell, CP; Villa-Angulo, C; Gonzalez-Vizcarra, VM; Villa-Angulo, R				Salomon-Torres, Ricardo; Matukumalli, Lakshmi K.; Van Tassell, Curtis P.; Villa-Angulo, Carlos; Gonzalez-Vizcarra, Victor M.; Villa-Angulo, Rafael			High Density LD-Based Structural Variations Analysis in Cattle Genome	PLOS ONE			English	Article							COPY-NUMBER VARIATION; HIDDEN-MARKOV MODEL	Genomic structural variations represent an important source of genetic variation in mammal genomes, thus, they are commonly related to phenotypic expressions. In this work, similar to 770,000 single nucleotide polymorphism genotypes from 506 animals from 19 cattle breeds were analyzed. A simple LD-based structural variation was defined, and a genome-wide analysis was performed. After applying some quality control filters, for each breed and each chromosome we calculated the linkage disequilibrium (r(2)) of short range (<= 100 Kb). We sorted SNP pairs by distance and obtained a set of LD means (called the expected means) using bins of 5 Kb. We identified 15,246 segments of at least 1 Kb, among the 19 breeds, consisting of sets of at least 3 adjacent SNPs so that, for each SNP, r(2) within its neighbors in a 100 Kb range, to the right side of that SNP, were all bigger than, or all smaller than, the corresponding expected mean, and their P-value were significant after a Benjamini-Hochberg multiple testing correction. In addition, to account just for homogeneously distributed regions we considered only SNPs having at least 15 SNP neighbors within 100 Kb. We defined such segments as structural variations. By grouping all variations across all animals in the sample we defined 9,146 regions, involving a total of 53,137 SNPs; representing the 6.40% (160.98 Mb) from the bovine genome. The identified structural variations covered 3,109 genes. Clustering analysis showed the relatedness of breeds given the geographic region in which they are evolving. In summary, we present an analysis of structural variations based on the deviation of the expected short range LD between SNPs in the bovine genome. With an intuitive and simple definition based only on SNPs data it was possible to discern closeness of breeds due to grouping by geographic region in which they are evolving.	[Salomon-Torres, Ricardo; Villa-Angulo, Carlos; Villa-Angulo, Rafael] Autonomous Univ Baja California, Engn Inst, Lab Bioinformat & Biofoton, Ensenada, Baja California, Mexico; [Matukumalli, Lakshmi K.] NIFA, Anim Breeding Genet & Genom USDA, Washington, DC USA; [Van Tassell, Curtis P.] USDA ARS, Bovine Funct Genom Labs, Beltsville, MD USA; [Gonzalez-Vizcarra, Victor M.] Autonomous Univ Baja California, Res Inst Vet Sci, Ensenada, Baja California, Mexico	Universidad Autonoma de Baja California; United States Department of Agriculture (USDA); Universidad Autonoma de Baja California	Salomon-Torres, R (corresponding author), Autonomous Univ Baja California, Engn Inst, Lab Bioinformat & Biofoton, Ensenada, Baja California, Mexico.	ricardo.salomon@uabc.edu.mx	Villa-Angulo, Rafael/I-5937-2015; Torres, Ricardo Salomon/F-8056-2015; Van Tassell, Curtis P./O-4247-2019; Salomon-Torres, Ricardo/H-4773-2019; vizcarra, victor manuel gonzalez/L-3079-2019	Villa-Angulo, Rafael/0000-0002-7698-6617; Torres, Ricardo Salomon/0000-0002-6486-2131; Van Tassell, Curtis P./0000-0002-8416-2087; Salomon-Torres, Ricardo/0000-0002-6486-2131; villa-angulo, carlos/0000-0001-6940-3711	National Scholarship Program for Postgraduate Studies, the National Council of Science and Technology of Mexico (CONACYT)	National Scholarship Program for Postgraduate Studies, the National Council of Science and Technology of Mexico (CONACYT)	The authors appreciate the financial support provided by the National Scholarship Program for Postgraduate Studies, the National Council of Science and Technology of Mexico (CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cicconardi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-124; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Hou YL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-376; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048732; Jolliffe I.T., 2002, SPRINGER SERIES STAT; Kadri NK, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-7; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matukumalli L. K., 2011, PUB ILLUMINA INC; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Seroussi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-673; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Wain LV, 2011, METHODS MOL BIOL, V713, P167, DOI 10.1007/978-1-60327-416-6_13; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wineinger Nathan E., 2011, Frontiers in Genetics, V2, P17, DOI 10.3389/fgene.2011.00017; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	28	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103046	10.1371/journal.pone.0103046	http://dx.doi.org/10.1371/journal.pone.0103046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050984	gold, Green Submitted, Green Published			2022-12-27	WOS:000339551100081
J	Scholzen, A; Nahrendorf, W; Langhorne, J; Sauerwein, RW				Scholzen, Anja; Nahrendorf, Wiebke; Langhorne, Jean; Sauerwein, Robert W.			Expansion of IgG plus B-Cells during Mitogen Stimulation for Memory B-Cell ELISpot Analysis Is Influenced by Size and Composition of the B-Cell Pool	PLOS ONE			English	Article							MALARIA; ASSAY	The memory B-cell (MBC) ELISpot assay is the main technique used to measure antigen-specific MBCs as a readout of humoral immune memory. This assay relies on the ability of MBCs to differentiate into antibody-secreting cells (ASC) upon polyclonal stimulation. The total number of IgG+ ASCs generated by mitogen-stimulation is often used as a reference point; alternatively antigen-specific MBCs are expressed as a frequency of post-culture peripheral blood mononuclear cells (PBMC) as a surrogate for absolute frequencies. Therefore, it is important to know whether IgG+ B-cells are uniformly expanded during the preceding mitogen-culture as a true reflection of MBC frequencies ex vivo. We systematically compared B-cell phenotype and proportions before and after mitogen stimulation in cultures of 269 peripheral blood mononuclear cell samples from 62 volunteers by flow cytometry and analyzed the number of resulting ASCs. Our data show that the number of total IgG+ ASCs detected by ELISpot after mitogen stimulation correlates with the proportion of IgG+ MBCs ex vivo, highlighting its general robustness for comparisons of study cohorts at group level. The expansion of total and IgG+ B-cells during mitogen-stimulation, however, was not identical in all cultures, but influenced by size and composition of the ex vivo B-cell compartment. The uncorrected readout of antigen-specific MBCs per million post-culture PBMCs therefore only preserves the quality, but not the magnitude of differences in the ex vivo MBC response between groups or time points, particularly when comparing samples where the B-cell compartment substantially differs between cohorts or over time. Therefore, expressing antigen-specific cells per total IgG+ ASCs is currently the best measure to correct for mitogen-culture effects. Additionally, baseline information on the size and composition of the ex vivo B-cell compartment should be supplied to additionally inform about differences or changes in the size and composition of the ex vivo MBC compartment.	[Scholzen, Anja; Nahrendorf, Wiebke; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Nahrendorf, Wiebke; Langhorne, Jean] MRC Natl Inst Med Res, Div Parasitol, London, England	Radboud University Nijmegen; MRC National Institute for Medical Research	Scholzen, A (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.	anja.scholzen@radboudumc.nl; robert.sauerwein@radboudumc.nl	Sauerwein, Robert/C-8519-2013; Scholzen, Anja/D-1046-2013	Scholzen, Anja/0000-0001-6481-6090; Nahrendorf, Wiebke/0000-0002-4503-8761; Langhorne, Jean/0000-0002-2257-9733	European FP6 integrated project grant (European Malaria Vaccine Development Association (EMVDA)) [LSHP-CT-2007-037506]; ZonMw grant [95110086]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO, Dutch organisation for scientific research); FP7 founded European Virtual Institute of Malaria Research (EVIMalaR) [242095]; EVIMalaR PhD scholarship; European Molecular Biology Organization (EMBO); UK Medical Research Council [U117584248]; Medical Research Council [MC_U117584248] Funding Source: researchfish; MRC [MC_U117584248] Funding Source: UKRI	European FP6 integrated project grant (European Malaria Vaccine Development Association (EMVDA)); ZonMw grant; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO, Dutch organisation for scientific research); FP7 founded European Virtual Institute of Malaria Research (EVIMalaR); EVIMalaR PhD scholarship; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a European FP6 integrated project grant (European Malaria Vaccine Development Association (EMVDA), agreement number LSHP-CT-2007-037506), a ZonMw grant (project number 95110086) by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO, Dutch organisation for scientific research), and the FP7 founded European Virtual Institute of Malaria Research (EVIMalaR, grant agreement number 242095). WN received an EVIMalaR PhD scholarship and AS was supported by a long-term post-doctoral fellowship of the European Molecular Biology Organization (EMBO). JL and WN were supported by the UK Medical Research Council (U117584248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Bijker EM, 2013, P NATL ACAD SCI USA, V110, P7862, DOI 10.1073/pnas.1220360110; Bijker EM, 2014, J INFECT DI IN PRESS; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Esen M, 2012, J IMMUNOL METHODS, V375, P7, DOI 10.1016/j.jim.2011.08.020; Franz B, 2011, BLOOD, V118, P348, DOI 10.1182/blood-2011-03-341917; Hendrikx LH, 2011, VACCINE, V29, P1431, DOI 10.1016/j.vaccine.2010.12.033; Henn AD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00345; Henn AD, 2009, J IMMUNOL, V183, P3177, DOI 10.4049/jimmunol.0804233; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moody MA, 2008, CYTOM PART A, V73A, P1086, DOI 10.1002/cyto.a.20599; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Morimoto S, 2000, J IMMUNOL, V164, P4097, DOI 10.4049/jimmunol.164.8.4097; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Scholzen A, 2014, J IMMUNOL, V192, P3719, DOI 10.4049/jimmunol.1302960; Weiss GE, 2012, J IMMUNOL METHODS, V375, P68, DOI 10.1016/j.jim.2011.09.006; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297	24	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102885	10.1371/journal.pone.0102885	http://dx.doi.org/10.1371/journal.pone.0102885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050555	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100065
J	Choon, YW; Mohamad, MS; Deris, S; Illias, RM; Chong, CK; Chai, LE; Omatu, S; Corchado, JM				Choon, Yee Wen; Mohamad, Mohd Saberi; Deris, Safaai; Illias, Rosli Md; Chong, Chuii Khim; Chai, Lian En; Omatu, Sigeru; Manuel Corchado, Juan			Differential Bees Flux Balance Analysis with OptKnock for In Silico Microbial Strains Optimization	PLOS ONE			English	Article							GENE KNOCKOUT STRATEGIES; RECONSTRUCTION; ALGORITHM	Microbial strains optimization for the overproduction of desired phenotype has been a popular topic in recent years. The strains can be optimized through several techniques in the field of genetic engineering. Gene knockout is a genetic engineering technique that can engineer the metabolism of microbial cells with the objective to obtain desirable phenotypes. However, the complexities of the metabolic networks have made the process to identify the effects of genetic modification on the desirable phenotypes challenging. Furthermore, a vast number of reactions in cellular metabolism often lead to the combinatorial problem in obtaining optimal gene deletion strategy. Basically, the size of a genome-scale metabolic model is usually large. As the size of the problem increases, the computation time increases exponentially. In this paper, we propose Differential Bees Flux Balance Analysis (DBFBA) with OptKnock to identify optimal gene knockout strategies for maximizing the production yield of desired phenotypes while sustaining the growth rate. This proposed method functions by improving the performance of a hybrid of Bees Algorithm and Flux Balance Analysis (BAFBA) by hybridizing Differential Evolution (DE) algorithm into neighborhood searching strategy of BAFBA. In addition, DBFBA is integrated with OptKnock to validate the results for improving the reliability the work. Through several experiments conducted on Escherichia coli, Bacillus subtilis, and Clostridium thermocellum as the model organisms, DBFBA has shown a better performance in terms of computational time, stability, growth rate, and production yield of desired phenotypes compared to the methods used in previous works.	[Choon, Yee Wen; Mohamad, Mohd Saberi; Deris, Safaai; Chong, Chuii Khim; Chai, Lian En] Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Grp, Johor Baharu, Malaysia; [Illias, Rosli Md] Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Skudai, Johor, Malaysia; [Omatu, Sigeru] Osaka Inst Technol, Dept Elect Informat & Commun Engn, Osaka 535, Japan; [Manuel Corchado, Juan] Univ Salamanca, Biomed Res Inst Salamanca, BISITE Res Grp, E-37008 Salamanca, Spain	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Osaka Institute of Technology; University of Salamanca	Mohamad, MS (corresponding author), Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Grp, Johor Baharu, Malaysia.	saberi@utm.my	Mohamad, Mohd Saberi/J-3201-2014; Choon, Yee Wen/R-4865-2019; Corchado Rodríguez, Juan/D-3229-2013; MOHAMAD, MOHD SABERI/AAA-1929-2022	Mohamad, Mohd Saberi/0000-0002-1079-4559; Corchado Rodríguez, Juan/0000-0002-2829-1829; MOHAMAD, MOHD SABERI/0000-0002-1079-4559	Malaysian Ministry of Science, Technology and Innovation [06-01-06-SF1029, 01-01-06-SF1234]; Exploratory Research Grant [R.J130000.7807.4L096]; Fundamental Research Grant from Malaysian Ministry of Higher Education [R.J130000.7807.4F190]	Malaysian Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Exploratory Research Grant; Fundamental Research Grant from Malaysian Ministry of Higher Education	The authors would like to thank Malaysian Ministry of Science, Technology and Innovation for supporting this research by two e-science research grants (Grant numbers: 06-01-06-SF1029 and 01-01-06-SF1234). This research is also funded by an Exploratory Research Grant Scheme (Grant number: R.J130000.7807.4L096) and a Fundamental Research Grant Scheme (Grant number: R.J130000.7807.4F190) from Malaysian Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt W, 2009, J MATH BIOL, V58, P1, DOI 10.1007/s00285-008-0207-x; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Cheng MY, 2011, P 28 ISARC SEOUL, P898; Choon YW, 2012, ADV INTEL SOFT COMPU, V151, P371; Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Sanchez CEG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043006; Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69; Kim JW, 2012, BIOPROC BIOSYST ENG, V35, P49, DOI 10.1007/s00449-011-0590-3; Olague G, 2006, LECT NOTES COMPUT SC, V3907, P427; Pagliardini J, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-29; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pham D.T., 2007, 3 INT VIRT C INT PRO; Pham DT, 2006, INT J COMPUTER AIDED, V1, P250; Pham DT, 2006, INTELLIGENT PRODUCTI; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Roberts SB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-31; Rocha M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-499; Soons ZITA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061648; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200	21	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102744	10.1371/journal.pone.0102744	http://dx.doi.org/10.1371/journal.pone.0102744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047076	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100067
J	Hu, C; Wang, FX; Dong, YH; Dai, JC				Hu, Chao; Wang, Feixiang; Dong, Yehao; Dai, Jican			A Novel Method to Establish a Rat ED Model Using Internal Iliac Artery Ligation Combined with Hyperlipidemia	PLOS ONE			English	Article							INDUCED ERECTILE DYSFUNCTION; ENDOTHELIAL GROWTH-FACTOR; CAVERNOSAL SMOOTH-MUSCLE; EXPERIMENTAL HYPERCHOLESTEROLEMIA; STEM-CELLS; HYPERPLASIA; MECHANISMS; EXPRESSION; ISCHEMIA; TISSUE	Objective: To investigate a novel method, namely using bilateral internal iliac artery ligation combined with a high-fat diet (BCH), for establishing a rat model of erectile dysfunction (ED) that, compared to classical approaches, more closely mimics the chronic pathophysiology of human ED after acute ischemic insult. Materials and Methods: Forty 4-month-old male Sprague Dawley rats were randomly placed into five groups (n = 8 per group): normal control (NC), bilateral internal iliac artery ligation (BIIAL), high-fat diet (HFD), BCH, and mock surgery (MS). All rats were induced for 12 weeks. Copulatory behavior, intracavernosal pressure (ICP), ICP/mean arterial pressure, hematoxylin-eosin staining, Masson's trichrome staining, serum lipid levels, and endothelial and neuronal nitric oxide synthase immunohistochemical staining of the cavernous smooth muscle and endothelium were assessed. Data were analyzed by SAS 8.0 for Windows. Results: Serum total cholesterol and triglyceride levels were significantly higher in the HFD and BCH groups than the NC and MS groups. High density lipoprotein levels were significantly lower in the HFD and BCH groups than the NC and MS groups. The ICP values and mount and intromission numbers were significantly lower in the BIIAL, HFD, and BCH groups than in the NC and MS groups. ICP was significantly lower in the BCH group than in the BIIAL and HFD groups. Cavernous smooth muscle and endothelial damage increased in the HFD and BCH groups. Cavernous smooth muscle to collagen ratio, nNOS and eNOS staining decreased significantly in the BIIAL, HFD, and BCH groups compared to the NC and MS groups. Conclusions: The novel BCH model mimics the chronic pathophysiology of ED in humans and avoids the drawbacks of traditional ED models.	[Hu, Chao; Dong, Yehao; Dai, Jican] Shanghai Jiao Tong Univ, Affiliated Ren Ji Hosp, Dept Urol, Sch Med, Shanghai 200030, Peoples R China; [Wang, Feixiang] Shanghai Key Lab Forens Med, Inst Forens Sci, Natl Minist Justice, Shanghai, Peoples R China	Shanghai Jiao Tong University; Institute of Forensic Science Ministry of Justice PRC	Dai, JC (corresponding author), Shanghai Jiao Tong Univ, Affiliated Ren Ji Hosp, Dept Urol, Sch Med, Shanghai 200030, Peoples R China.	jican_dai@aliyun.com		Hu, Chao/0000-0001-5895-6038	science and technology commission of Shanghai municipality [08411951800]	science and technology commission of Shanghai municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The projects were supported by major scientific and technological issues (science and technology commission of Shanghai municipality, reference No. 08411951800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, J PHARMACOL SCI, V120, P250, DOI 10.1254/jphs.12113SC; Alvarenga TA, 2010, J SEX MED, V7, P2435, DOI 10.1111/j.1743-6109.2010.01851.x; Amany S, 2013, EXP CLIN ENDOCR DIAB, V121, P230, DOI 10.1055/s-0033-1341428; AZADZOI KM, 1992, J UROLOGY, V147, P1675, DOI 10.1016/S0022-5347(17)37676-0; Azadzoi KM, 1998, J UROLOGY, V160, P2216, DOI 10.1016/S0022-5347(01)62299-7; Bakircioglu ME, 2000, J UROLOGY, V164, P1798, DOI 10.1016/S0022-5347(05)67109-1; Chitaley K, 2008, J SEX MED, V5, P1149, DOI 10.1111/j.1743-6109.2008.00787.x; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Feng XT, 2012, BIOSCI BIOTECH BIOCH, V76, P257, DOI 10.1271/bbb.110568; Gaudreault N, 2012, ARTERIOSCL THROM VAS, V32, P264, DOI 10.1161/ATVBAHA.111.238964; Gholami SS, 2003, J UROLOGY, V169, P1577, DOI 10.1097/01.ju.0000055120.73261.76; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Hotta Y, 2011, J SEX MED, V8, P705, DOI 10.1111/j.1743-6109.2010.02153.x; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Iacono F, 2005, J UROLOGY, V173, P1673, DOI 10.1097/01.ju.0000154356.76027.4f; Karaboga R, 2006, UROLOGY, V67, P431, DOI 10.1016/j.urology.2005.08.049; Kendirci M, 2007, EUR UROL, V52, P555, DOI 10.1016/j.eururo.2007.03.022; Kimura M, 2011, J SEX MED, V8, P2215, DOI 10.1111/j.1743-6109.2011.02351.x; Kovanecz I, 2012, J SEX MED, V9, P2814, DOI 10.1111/j.1743-6109.2012.02913.x; Labazi H, 2013, J SEX MED, V10, P2154, DOI 10.1111/jsm.12245; Lee MC, 2002, J UROLOGY, V167, P761, DOI 10.1016/S0022-5347(01)69141-9; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Metze M, 2007, J TRAUMA, V63, P394, DOI 10.1097/01.ta.0000241145.02748.df; Nash M S, 2001, J Spinal Cord Med, V24, P2; Oudot A, 2010, J SEX MED, V7, P406; Prieto Castro Rafael, 2010, Archivos Espanoles de Urologia, V63, P637; Qiu XF, 2011, BJU INT, V108, P1866, DOI 10.1111/j.1464-410X.2011.10162.x; Wang J, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.08.026; White S, 2003, J UROLOGY, V169, P363; Xie DH, 2007, J SEX MED, V4, P898, DOI 10.1111/j.1743-6109.2007.00518.x; Yesilli C, 2001, UROLOGY, V57, P1184, DOI 10.1016/S0090-4295(01)00974-8; Zanoli P, 2009, J ETHNOPHARMACOL, V126, P308, DOI 10.1016/j.jep.2009.08.021	33	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102583	10.1371/journal.pone.0102583	http://dx.doi.org/10.1371/journal.pone.0102583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047124	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100048
J	Lopes, APY; Lopes, LM; Fraga, TR; Chura-Chambi, RM; Sanson, AL; Cheng, E; Nakajima, E; Morganti, L; Martins, EAL				Lopes, Alexandre P. Y.; Lopes, Luana M.; Fraga, Tatiana R.; Chura-Chambi, Rosa M.; Sanson, Andre L.; Cheng, Elisabeth; Nakajima, Erika; Morganti, Ligia; Martins, Elizabeth A. L.			VapC from the Leptospiral VapBC Toxin-Antitoxin Module Displays Ribonuclease Activity on the Initiator tRNA	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; CRYSTAL-STRUCTURE; INCLUSION-BODIES; MULTIDRUG TOLERANCE; MESSENGER-RNAS; PROTEIN; INTERROGANS; GENOME; REVEALS; TRANSLATION	The prokaryotic ubiquitous Toxin-Antitoxin (TA) operons encode a stable toxin and an unstable antitoxin. The most accepted hypothesis of the physiological function of the TA system is the reversible cessation of cellular growth under stress conditions. The major TA family, VapBC is present in the spirochaete Leptospira interrogans. VapBC modules are classified based on the presence of a predicted ribonucleasic PIN domain in the VapC toxin. The expression of the leptospiral VapC in E. coli promotes a strong bacterial growth arrestment, making it difficult to express the recombinant protein. Nevertheless, we showed that long term induction of expression in E. coli enabled the recovery of VapC in inclusion bodies. The recombinant protein was successfully refolded by high hydrostatic pressure, providing a new method to obtain the toxin in a soluble and active form. The structural integrity of the recombinant VapB and VapC proteins was assessed by circular dichroism spectroscopy. Physical interaction between the VapC toxin and the VapB antitoxin was demonstrated in vivo and in vitro by pull down and ligand affinity blotting assays, respectively, thereby indicating the ultimate mechanism by which the activity of the toxin is regulated in bacteria. The predicted model of the leptospiral VapC structure closely matches the Shigella's VapC X-ray structure. In agreement, the ribonuclease activity of the leptospiral VapC was similar to the activity described for Shigella's VapC, as demonstrated by the cleavage of tRNA fMet and by the absence of unspecific activity towards E. coli rRNA. This finding suggests that the cleavage of the initiator transfer RNA may represent a common mechanism to a larger group of bacteria and potentially configures a mechanism of post-transcriptional regulation leading to the inhibition of global translation.	[Lopes, Alexandre P. Y.; Lopes, Luana M.; Fraga, Tatiana R.; Sanson, Andre L.; Cheng, Elisabeth; Nakajima, Erika; Martins, Elizabeth A. L.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Chura-Chambi, Rosa M.; Morganti, Ligia] Comissao Nacl Energia Nucl, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, Brazil	Instituto Butantan; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN)	Lopes, APY (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	alexandre.lopes@butantan.gov.br	lopes, alexandre py/A-4270-2015; FRAGA, TATIANA RODRIGUES/ABD-8152-2020; Morganti, Ligia/K-4352-2014; Chura-Chambi, Rosa Maria/H-9598-2012; Nakajima, Erika/M-9124-2018; Martins, Elizabeth AL/B-7135-2015; Cheng, Elisabeth/I-2538-2012	Morganti, Ligia/0000-0002-7870-1793; Martins, Elizabeth AL/0000-0002-2333-9379; Rodrigues Fraga, Tatiana/0000-0002-5896-5994; Cheng, Elisabeth/0000-0002-0327-3368	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CAPES/CNPq); Fundacao Butantan and Programa de Aprimoramento Profissional - Fundacao do Desenvolvimento Administrativo (PAP-FUNDAP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CAPES/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao Butantan and Programa de Aprimoramento Profissional - Fundacao do Desenvolvimento Administrativo (PAP-FUNDAP)	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CAPES/CNPq), Fundacao Butantan and Programa de Aprimoramento Profissional - Fundacao do Desenvolvimento Administrativo (PAP-FUNDAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Balduino KN, 2011, MOL BIOTECHNOL, V48, P228, DOI 10.1007/s12033-010-9363-5; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875; Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Fraga TR, 2010, J BIOTECHNOL, V148, P156, DOI 10.1016/j.jbiotec.2010.04.007; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gomez FA, 2011, FEMS MICROBIOL LETT, V317, P83, DOI 10.1111/j.1574-6968.2011.02218.x; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Ishibashi MI, 2005, PROTEIN PEPTIDE LETT, V12, P649, DOI 10.2174/0929866054696136; Levin I, 2004, PROTEINS, V56, P404, DOI 10.1002/prot.20090; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Maezato Y, 2011, RNA, V17, P1381, DOI 10.1261/rna.2679911; Malavasi NV, 2011, PROCESS BIOCHEM, V46, P512, DOI 10.1016/j.procbio.2010.10.002; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; McKenzie JL, 2012, J BACTERIOL, V194, P2189, DOI 10.1128/JB.06790-11; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Picardeau M, 2003, FEMS MICROBIOL LETT, V229, P277, DOI 10.1016/S0378-1097(03)00848-6; Picardeau M, 2001, J BACTERIOL, V183, P6494, DOI 10.1128/JB.183.21.6494-6497.2001; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seefeldt MB, 2009, CURR PHARM BIOTECHNO, V10, P447, DOI 10.2174/138920109788488914; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Tan QA, 2011, MOL MICROBIOL, V79, P109, DOI 10.1111/j.1365-2958.2010.07433.x; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Wolff DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081818; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yuan J, 2010, J BIOL CHEM, V285, P40397, DOI 10.1074/jbc.M110.138776; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YX, 2004, CELL RES, V14, P208, DOI 10.1038/sj.cr.7290221	57	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101678	10.1371/journal.pone.0101678	http://dx.doi.org/10.1371/journal.pone.0101678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047537	gold, Green Published			2022-12-27	WOS:000339558100011
J	Lumjuan, N; Wicheer, J; Leelapat, P; Choochote, W; Somboon, P				Lumjuan, Nongkran; Wicheer, Jureeporn; Leelapat, Posri; Choochote, Wej; Somboon, Pradya			Identification and Characterisation of Aedes aegypti Aldehyde Dehydrogenases Involved in Pyrethroid Metabolism	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; DENGUE VECTOR; DROSOPHILA-MELANOGASTER; MOLECULAR-BASIS; DETOXIFICATION GENES; ANOPHELES-GAMBIAE; DIETARY ETHANOL; SELECTION; PERMETHRIN	Background: Pyrethroid insecticides, especially permethrin and deltamethrin, have been used extensively worldwide for mosquito control. However, insecticide resistance can spread through a population very rapidly under strong selection pressure from insecticide use. The upregulation of aldehyde dehydrogenase (ALDH) has been reported upon pyrethroid treatment. In Aedes aegypti, the increase in ALDH activity against the hydrolytic product of pyrethroid has been observed in DDT/permethrin-resistant strains. The objective of this study was to identify the role of individual ALDHs involved in pyrethroid metabolism. Methodology/Principal Findings: Three ALDHs were identified; two of these, ALDH9948 and ALDH14080, were upregulated in terms of both mRNA and protein levels in a DDT/pyrethroid-resistant strain of Ae. aegypti. Recombinant ALDH9948 and ALDH14080 exhibited oxidase activities to catalyse the oxidation of a permethrin intermediate, phenoxybenzyl aldehyde (PBald), to phenoxybenzoic acid (PBacid). Conclusions/Significance: ALDHs have been identified in association with permethrin resistance in Ae. aegypti. Characterisation of recombinant ALDHs confirmed the role of this protein in pyrethroid metabolism. Understanding the biochemical and molecular mechanisms of pyrethroid resistance provides information for improving vector control strategies.	[Lumjuan, Nongkran; Wicheer, Jureeporn; Leelapat, Posri] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Choochote, Wej; Somboon, Pradya] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Lumjuan, N (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	nklumjuan@yahoo.com	Somboon, Pradya/AAL-3458-2020	Somboon, Pradya/0000-0002-0760-4363; Lumjuan, Nongkran/0000-0001-9663-3328	National Research Council of Thailand (NRTC); Thailand Research Fund (TRF) [RTA5480006]	National Research Council of Thailand (NRTC); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This study was supported by grants from the National Research Council of Thailand (NRTC) to NL and Thailand Research Fund (TRF) to WC and NL (TRF Senior Research Scholar: RTA5480006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280; Choi J, 2002, PEST BIOCH PHYSL, V22, P249; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Ding YC, 2005, BIOCHEM J, V387, P879, DOI 10.1042/BJ20041850; Feyereisen R., 2005, P1; Fry JD, 2008, EVOLUTION, V62, P66, DOI 10.1111/j.1558-5646.2007.00288.x; Fry JD, 2006, GENET RES, V87, P87, DOI 10.1017/S0016672306008032; Fry JD, 2004, INTEGR COMP BIOL, V44, P275, DOI 10.1093/icb/44.4.275; Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hodgson E, 2003, J BIOCHEM MOL TOXIC, V17, P201, DOI 10.1002/jbt.10080; Ismail HM, 2013, P NATL ACAD SCI USA, V110, P19766, DOI 10.1073/pnas.1320185110; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; MAHARAJ R, 2011, OPEN ACCESS INSECT P, V3, P27, DOI DOI 10.2147/OAIP.S8620; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; MORSE D, 1984, SCIENCE, V226, P1434, DOI 10.1126/science.226.4681.1434; Nakamura Y, 2007, TOXICOLOGY, V235, P176, DOI 10.1016/j.tox.2007.03.016; Nishi K, 2006, ARCH BIOCHEM BIOPHYS, V445, P115, DOI 10.1016/j.abb.2005.11.005; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004; Ranson H., 2005, P383; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Somwang P, 2011, PARASITOL RES, V109, P531, DOI 10.1007/s00436-011-2280-0; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Strode C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044578, 10.1371/journal.pone.0039439]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Yoon M, 2006, TOXICOL SCI, V89, P386, DOI 10.1093/toxsci/kfj045	48	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102746	10.1371/journal.pone.0102746	http://dx.doi.org/10.1371/journal.pone.0102746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047125	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100068
J	Tzeng, HT; Tsai, HF; Chyuan, IT; Liao, HJ; Chen, CJ; Chen, PJ; Hsu, PN				Tzeng, Horng-Tay; Tsai, Hwei-Fang; Chyuan, I-Tsu; Liao, Hsiu-Jung; Chen, Chun-Jen; Chen, Pei-Jer; Hsu, Ping-Ning			Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model	PLOS ONE			English	Article							T-CELL DYSFUNCTION; HUMAN HEPATOCYTES; GENE-EXPRESSION; INTERFERON; ACTIVATION; INFECTION; LIVER; REACTIVATION; PATHWAY; INNATE	Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). An efficient control of virus infections requires the coordinated actions of both innate and adaptive immune responses. In order to define the role of innate immunity effectors against HBV, viral clearance was studied in a panel of immunodeficient mouse strains by the hydrodynamic injection approach. Our results demonstrate that HBV viral clearance is not changed in IFN-alpha/beta receptor (IFNAR), RIG-I, MDA5, MYD88, NLRP3, ASC, and IL-1R knock-out mice, indicating that these innate immunity effectors are not required for HBV clearance. In contrast, HBV persists in the absence of tumor necrosis factor-alpha (TNF-alpha) or in mice treated with the soluble TNF receptor blocker, Etanercept. In these mice, there was an increase in PD-1-expressing CD8(+) T-cells and an increase of serum HBV DNA, HBV core, and surface antigen expression as well as viral replication within the liver. Furthermore, the induction of TNF-alpha in clearing HBV is dependent on the HBV core, and TNF blockage eliminated HBV core-induced viral clearance effects. Finally, the intra-hepatic leukocytes (IHLs), but not the hepatocytes, are the cell source responsible for TNF-alpha production induced by HBcAg. These results provide evidences for TNF-alpha mediated innate immune mechanisms in HBV clearance and explain the mechanism of HBV reactivation during therapy with TNF blockage agents.	[Tzeng, Horng-Tay; Liao, Hsiu-Jung; Hsu, Ping-Ning] Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Taipei, Taiwan; [Tsai, Hwei-Fang] Taipei Med Univ, Inst Clin Med, Coll Med, Taipei, Taiwan; [Chyuan, I-Tsu; Hsu, Ping-Ning] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Chun-Jen] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Chen, Pei-Jer] Natl Taiwan Univ, Dept Microbiol, Coll Med, Taipei 10764, Taiwan; [Chen, Pei-Jer] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Hsu, PN (corresponding author), Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan.	phsu8635@ntu.edu.tw	Chen, Chun-Jen/D-9647-2013; Hsiao, Wei-Hung/B-9931-2013	Chen, Chun-Jen/0000-0002-9211-8641; Chen, Pei-Jer/0000-0001-8316-3785; HSU, PING-NING/0000-0003-4479-3391	National Science Council, Taiwan [NSC98-3112-B-002-047, NSC101-2320-B-038-019-, NSC 101-2321-B002-008-]; National Taiwan University Hospital [VN-9801]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by grants from the National Science Council, Taiwan (NSC98-3112-B-002-047, NSC101-2320-B-038-019-, and NSC 101-2321-B002-008-), and National Taiwan University Hospital (VN-9801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; Bertoletti A, 2013, POSTGRAD MED J, V89, P294, DOI 10.1136/postgradmedj-2011-301073rep; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; BRUNDA MJ, 1984, CANCER RES, V44, P597; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Durantel D, 2009, HEPATOLOGY, V50, P1692, DOI 10.1002/hep.23361; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; GILLES PN, 1992, J VIROL, V66, P3955, DOI 10.1128/JVI.66.6.3955-3960.1992; Guo H, 2009, J VIROL, V83, P847, DOI 10.1128/JVI.02008-08; Heise T, 1999, J VIROL, V73, P474, DOI 10.1128/JVI.73.1.474-481.1999; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; HUSSAIN MJ, 1994, J CLIN PATHOL, V47, P1112, DOI 10.1136/jcp.47.12.1112; Lan JL, 2011, ANN RHEUM DIS, V70, P1719, DOI 10.1136/ard.2010.148783; Lin YJ, 2012, J VIROL, V86, P9266, DOI 10.1128/JVI.00608-12; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Lutgehetmann M, 2011, GASTROENTEROLOGY, V140, P2074, DOI 10.1053/j.gastro.2011.02.057; NETA R, 1988, J IMMUNOL, V140, P108; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Penna A, 1996, J CLIN INVEST, V98, P1185, DOI 10.1172/JCI118902; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Perez-Alvarez R, 2011, MEDICINE, V90, P359, DOI 10.1097/MD.0b013e3182380a76; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Tzeng HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039179; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Xu L, 2013, HEPATOLOGY IN PRESS, DOI [10.1002/hep.26668, DOI 10.1002/HEP.26668]; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yang ST, 2013, J HEPATOL, V58, P1157, DOI 10.1016/j.jhep.2013.01.025; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0	38	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103008	10.1371/journal.pone.0103008	http://dx.doi.org/10.1371/journal.pone.0103008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047809	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100096
J	Walther, LE; Blodow, A; Buder, J; Kniep, R				Walther, Leif Erik; Bloedow, Alexander; Buder, Jana; Kniep, Ruediger			Principles of Calcite Dissolution in Human and Artificial Otoconia	PLOS ONE			English	Article							GELATIN NANOCOMPOSITES; STREPTOMYCIN; MINERALIZATION; MECHANISMS; UTRICLE; DAMAGE; SHAPE	Human otoconia provide mechanical stimuli to deflect hair cells of the vestibular sensory epithelium for purposes of detecting linear acceleration and head tilts. During lifetime, the volume and number of otoconia are gradually reduced. In a process of degeneration morphological changes occur. Structural changes in human otoconia are assumed to cause vertigo and balance disorders such as benign paroxysmal positional vertigo (BPPV). The aim of this study was to investigate the main principles of morphological changes in human otoconia in dissolution experiments by exposure to hydrochloric acid, EDTA, demineralized water and completely purified water respectively. For comparison reasons artificial (biomimetic) otoconia (calcite gelatin nanocomposits) and natural calcite were used. Morphological changes were detected in time steps by the use of environmental scanning electron microscopy (ESEM). Under in vitro conditions three main dissolution mechanisms were identified as causing characteristic morphological changes of the specimen under consideration: pH drops in the acidic range, complex formation with calcium ions and changes of ion concentrations in the vicinity of otoconia. Shifts in pH cause a more uniform reduction of otoconia size (isotropic dissolution) whereas complexation reactions and changes of the ionic concentrations within the surrounding medium bring about preferred attacks at specific areas (anisotropic dissolution) of human and artificial otoconia. Owing to successive reduction of material, all the dissolution mechanisms finally produce fragments and remnants of otoconia. It can be assumed that the organic component of otoconia is not significantly attacked under the given conditions. Artificial otoconia serve as a suitable model system mimicking chemical attacks on biogenic specimens. The underlying principles of calcite dissolution under in vitro conditions may play a role in otoconia degeneration processes such as BPPV.	[Walther, Leif Erik] Heidelberg Univ, Univ Med Mannheim, Dept Otorhinolaryngol & Head & Neck Surg, Mannheim, Germany; [Bloedow, Alexander] Helios Clin Berlin Buch, Dept Otorhinolaryngol, Berlin, Germany; [Buder, Jana; Kniep, Ruediger] Max Planck Inst Chem Phys Solids, Dresden, Germany	Ruprecht Karls University Heidelberg; Max Planck Society	Walther, LE (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Otorhinolaryngol & Head & Neck Surg, Mannheim, Germany.	Leif.Walther@hno-praxis-sulzbach.de		Kniep, Rudiger/0000-0003-0679-5468				Andrade LR, 2012, HEARING RES, V292, P14, DOI 10.1016/j.heares.2012.07.003; Black FO, 2004, OTOL NEUROTOL, V25, P353, DOI 10.1097/00129492-200405000-00025; Bremova T, 2013, ACTA OTO-LARYNGOL, V133, P1297, DOI 10.3109/00016489.2013.829922; Calzada AP, 2012, OTOL NEUROTOL, V33, P1593, DOI 10.1097/MAO.0b013e318271c48b; CAMPOS A, 1990, ADV OTO-RHINO-LARYNG, V45, P143; CARLSTROM D., 1955, ACTA OTO LARYNGOL, V45, P14, DOI 10.3109/00016485509118139; Duchstein P, 2013, CRYST GROWTH DES, V13, P4885, DOI 10.1021/cg401070h; HARADA Y, 1977, ACTA OTO-LARYNGOL, V84, P65, DOI 10.3109/00016487709123943; Huang YX, 2008, ANGEW CHEM INT EDIT, V47, P8280, DOI 10.1002/anie.200800968; Jang YS, 2006, LARYNGOSCOPE, V116, P996, DOI 10.1097/01.mlg.0000217238.84401.03; JOHNSSON LG, 1972, ANN OTO RHINOL LARYN, V81, P179, DOI 10.1177/000348947208100203; JOHNSSON LG, 1980, ACTA OTO-LARYNGOL, V89, P401, DOI 10.3109/00016488009127155; Jones SM, 2004, HEARING RES, V191, P34, DOI 10.1016/j.heares.2004.01.008; Kollen L, 2012, AGING CLIN EXP RES, V24, P317; Kollmann T, 2010, CHEM MATER, V22, P5137, DOI 10.1021/cm101755j; KOMUNE S, 1995, ANN OTO RHINOL LARYN, V104, P149, DOI 10.1177/000348949510400212; Kusunoki T, 2005, J LARYNGOL OTOL, V119, P87, DOI 10.1258/0022215053420040; Lee JD, 2013, ACTA OTO-LARYNGOL, V133, P150, DOI 10.3109/00016489.2012.723823; Lindeman H H, 1973, Adv Otorhinolaryngol, V20, P405; Lins U, 2000, J STRUCT BIOL, V131, P67, DOI 10.1006/jsbi.2000.4260; Lu WF, 2010, HEARING RES, V268, P172, DOI 10.1016/j.heares.2010.05.019; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Moreland KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095333; Nakahara H, 2013, ACTA OTO-LARYNGOL, V133, P144, DOI 10.3109/00016489.2012.720030; ROSS MD, 1984, PHILOS T ROY SOC B, V304, P445, DOI 10.1098/rstb.1984.0038; ROSS MD, 1976, ANN OTO RHINOL LARYN, V85, P310, DOI 10.1177/000348947608500302; Rosseeva EV, 2008, CHEM MATER, V20, P6003, DOI 10.1021/cm8005748; Schuknecht H F, 1973, Adv Otorhinolaryngol, V20, P434; SCHUKNECHT HF, 1969, ARCH OTOLARYNGOL, V90, P765; Seo T, 2013, NEUROSCI LETT, V550, P12, DOI 10.1016/j.neulet.2013.06.041; Simon P, 2011, EUR J INORG CHEM, P5370, DOI 10.1002/ejic.201100756; STYPULKOWSKI PH, 1990, HEARING RES, V46, P113, DOI 10.1016/0378-5955(90)90144-E; Takano S, 2013, ACTA OTO-LARYNGOL, V133, P692, DOI 10.3109/00016489.2013.771409; Takumida M, 1997, ACTA OTO-LARYNGOL, V117, P538, DOI 10.3109/00016489709113434; Takumida M, 1997, ORL J OTO-RHINO-LARY, V59, P263, DOI 10.1159/000276950; Thalmann I, 2006, ELECTROPHORESIS, V27, P1598, DOI 10.1002/elps.200500768; Thalmann R, 2001, ANN NY ACAD SCI, V942, P162; Walther LE, 2007, J VESTIBUL RES-EQUIL, V17, P89; Walther LE, 2014, EUR ARCH OTO-RHINO-L, V271, P3133, DOI 10.1007/s00405-013-2784-6; Walther LE, 2014, OTOL NEUROTOL, V35, P686, DOI 10.1097/MAO.0000000000000206; Walther LE, 2014, ACTA OTO-LARYNGOL, V134, P111, DOI 10.3109/00016489.2013.849384; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Yamane H, 2012, ACTA OTO-LARYNGOL, V132, P1054, DOI 10.3109/00016489.2012.680980; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	45	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102516	10.1371/journal.pone.0102516	http://dx.doi.org/10.1371/journal.pone.0102516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048115	gold, Green Submitted, Green Published			2022-12-27	WOS:000339558100039
J	Czarnecki, O; Yang, J; Wang, XP; Wang, SC; Muchero, W; Tuskan, GA; Chen, JG				Czarnecki, Olaf; Yang, Jun; Wang, Xiaoping; Wang, Shucai; Muchero, Wellington; Tuskan, Gerald A.; Chen, Jin-Gui			Characterization of MORE AXILLARY GROWTH Genes in Populus	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; PHOSPHORUS DEFICIENCY; PHOSPHATE DEFICIENCY; STRIGOLACTONE; ARABIDOPSIS; INHIBITION; SIGNAL; RICE; MAX1; ACTS	Background: Strigolactones are a new class of plant hormones that play a key role in regulating shoot branching. Studies of branching mutants in Arabidopsis, pea, rice and petunia have identified several key genes involved in strigolactone biosynthesis or signaling pathway. In the model plant Arabidopsis, MORE AXILLARY GROWTH1 (MAX1), MAX2, MAX3 and MAX4 are four founding members of strigolactone pathway genes. However, little is known about the strigolactone pathway genes in the woody perennial plants. Methodology/Principal Finding: Here we report the identification of MAX homologues in the woody model plant Populus trichocarpa. We identified the sequence homologues for each MAX protein in P. trichocarpa. Gene expression analysis revealed that Populus MAX paralogous genes are differentially expressed across various tissues and organs. Furthermore, we showed that Populus MAX genes could complement or partially complement the shoot branching phenotypes of the corresponding Arabidopsis max mutants. Conclusion/Significance: This study provides genetic evidence that strigolactone pathway genes are likely conserved in the woody perennial plants and lays a foundation for further characterization of strigolactone pathway and its functions in the woody perennial plants.	[Czarnecki, Olaf; Yang, Jun; Wang, Xiaoping; Muchero, Wellington; Tuskan, Gerald A.; Chen, Jin-Gui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Yang, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Wang, Xiaoping; Wang, Shucai] NE Normal Univ, Inst Cytol & Genet, Key Lab Mol Epigenet MOE, Changchun, Peoples R China	United States Department of Energy (DOE); Oak Ridge National Laboratory; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Northeast Normal University - China	Chen, JG (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	chenj@ornl.gov	Wang, Xiaoping/P-1077-2017; Chen, Jin-Gui/AFV-6337-2022; Czarnecki, Olaf/AAV-1638-2021; Tuskan, Gerald/A-6225-2011; Chen, Jin-Gui/A-4773-2011	Wang, Xiaoping/0000-0002-5032-3671; Chen, Jin-Gui/0000-0002-1752-4201; Tuskan, Gerald/0000-0003-0106-1289; Chen, Jin-Gui/0000-0002-1752-4201; Czarnecki, Olaf/0000-0001-5726-9586; muchero, wellington/0000-0002-0200-9856; Wang, Shucai/0000-0001-7619-2385	United States Department of Energy, Office of Science, Biological and Environmental Research; United States Department of Energy [DE-AC05-00OR22725]; Laboratory Directed Research and Development Program (Seed Money Fund) of Oak Ridge National Laboratory; Chinese Academy of Sciences [201019]; China Scholarship Council	United States Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program (Seed Money Fund) of Oak Ridge National Laboratory; Chinese Academy of Sciences(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council)	This work was supported by the Plant-Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov:8080/pmi/index.jsp) in the Genomic Science Program, United States Department of Energy, Office of Science, Biological and Environmental Research (http://science.energy.gov/ber/). Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the United States Department of Energy under contract DE-AC05-00OR22725. The early phase of this work was supported by the Laboratory Directed Research and Development Program (Seed Money Fund) of Oak Ridge National Laboratory (http://www.ornl.gov/). J.Y. was partially supported by a visiting scholarship from the Chinese Academy of Sciences (http://english.cas.cn/) (grant number: 201019). X.W. was partially supported by a visiting scholarship from the China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Brewer PB, 2013, MOL PLANT, V6, P18, DOI 10.1093/mp/sss130; Ha CV, 2014, P NATL ACAD SCI USA, V111, P851, DOI 10.1073/pnas.1322135111; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czarnecki O, 2013, INT J MOL SCI, V14, P7681, DOI 10.3390/ijms14047681; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Foo E, 2013, MOL PLANT, V6, P76, DOI 10.1093/mp/sss115; Gaiji Noura, 2012, BMC Res Notes, V5, P307, DOI 10.1186/1756-0500-5-307; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Janssen BJ, 2014, CURR OPIN PLANT BIOL, V17, P28, DOI 10.1016/j.pbi.2013.11.004; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li Z, 2014, J PROTEOME RES, V13, P1359, DOI 10.1021/pr400925t; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Mason MG, 2013, NEW PHYTOL, V198, P975, DOI 10.1111/nph.12268; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Rasmussen A, 2013, PLANTA, V238, P615, DOI 10.1007/s00425-013-1911-3; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Salmon J, 2014, PLANT BIOTECHNOL J, V12, P480, DOI 10.1111/pbi.12154; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Tsuchiya Y, 2012, MOL BIOSYST, V8, P464, DOI 10.1039/c1mb05195d; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Wang YH, 2011, CURR OPIN PLANT BIOL, V14, P94, DOI 10.1016/j.pbi.2010.11.002; Wang Y, 2013, DEV CELL, V27, P681, DOI 10.1016/j.devcel.2013.11.010; Ward SP, 2013, PLANT PHYSIOL, V162, P800, DOI 10.1104/pp.113.218461; Waters MT, 2012, PLANT PHYSIOL, V159, P1073, DOI 10.1104/pp.112.196253; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1; Yoneyama K, 2012, PLANTA, V235, P1197, DOI 10.1007/s00425-011-1568-8; Zheng ZY, 2014, MOL PLANT, V7, P934, DOI 10.1093/mp/ssu021; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	56	21	23	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102757	10.1371/journal.pone.0102757	http://dx.doi.org/10.1371/journal.pone.0102757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036388	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200083
J	Liu, LB; Hansen, CG; Honeyman, BJ; Nichols, BJ; Pilch, PF				Liu, Libin; Hansen, Carsten G.; Honeyman, Brian J.; Nichols, Benjamin J.; Pilch, Paul F.			Cavin-3 Knockout Mice Show that Cavin-3 Is Not Essential for Caveolae Formation, for Maintenance of Body Composition, or for Glucose Tolerance	PLOS ONE			English	Article							TRANSCRIPTION COMPLEXES; ADIPOCYTE CAVEOLAE; LIPID-METABOLISM; POLYMERASE-I; PROTEIN; PTRF; DISSOCIATION; DELETION; MOUSE	The cavins are a family of proteins associated with caveolae, cavin-1, -2 and -3 being widely expressed while cavin-4 is restricted to striated muscle. Deletion of cavin-1 results in phenotypes including metabolic changes consistent with adipocyte dysfunction, and caveolae are completely absent. Deletion of cavin-2 causes tissue-specific loss of caveolae. The consequences of cavin-3 deletion are less clear, as there are divergent data on the abundance of caveolae in cavin-3 null mice. Here we examine the consequences of cavin-3 deficiency in vivo by making cavin-3 knockout mice. We find that loss of cavin-3 has minimal or no effects on the levels of other caveolar proteins, does not appear to play a major role in formation of protein complexes important for caveolar morphogenesis, and has no significant effect on caveolae abundance. Cavin-3 null mice have the same body weight and fat mass as wild type animals at ages 8 through 30 weeks on both normal chow and high fat diets. Likewise, the two mouse strains exhibit identical glucose tolerance tests on both diets. Microarray analysis from adipose tissue shows that the changes in mRNA expression between cavin-3 null and wild type mouse are minimal. We conclude that cavin-3 is not absolutely required for making caveolae, and suggest that the mechanistic link between cavin-3 and metabolic regulation remains uncertain.	[Liu, Libin; Honeyman, Brian J.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Hansen, Carsten G.; Nichols, Benjamin J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; MRC Laboratory Molecular Biology; Boston University	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	ppilch@bu.edu	Liu, Libin/ABH-6019-2020	Hansen, Carsten/0000-0003-0746-7482; Pilch, Paul/0000-0003-1997-0499; Liu, Libin/0000-0001-5056-1517	United States National Institutes of Health [DK097708, DK092942]; National Institutes of Health (NIH) [UL1-TR000157]; NIH [U01HG004085, U01HG004080, U42RR024244]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097708, R01DK092942] Funding Source: NIH RePORTER; MRC [MC_U105178778] Funding Source: UKRI; Medical Research Council [MC_U105178778] Funding Source: researchfish	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the United States National Institutes of Health DK097708 and DK092942 to PFP and National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program UL1-TR000157 to CTSI at the Boston University. The ES cells used for this research project were generated by the trans-NIH Knock-Out Mouse Project (KOMP) and obtained from the KOMP Repository. NIH grants to Velocigene at Regeneron Inc (U01HG004085) and the CSD Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program and archived and distributed by the KOMP Repository at University of California Davis and CHORI (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Ding SY, 2014, J BIOL CHEM, V289, P8473, DOI 10.1074/jbc.M113.546242; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; GUSTINCICH S, 1993, CELL GROWTH DIFFER, V4, P753; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hernandez VJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00905; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Schneider K, 2012, EMBO REP, V13, P1138, DOI 10.1038/embor.2012.158; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102935	10.1371/journal.pone.0102935	http://dx.doi.org/10.1371/journal.pone.0102935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036884	gold, Green Submitted, Green Published			2022-12-27	WOS:000339615200100
J	Ning, DF; Song, AL; Fan, FL; Li, ZJ; Liang, YC				Ning, Dongfeng; Song, Alin; Fan, Fenliang; Li, Zhaojun; Liang, Yongchao			Effects of Slag-Based Silicon Fertilizer on Rice Growth and Brown-Spot Resistance	PLOS ONE			English	Article							SHEATH BLIGHT; BIPOLARIS-ORYZAE; STEEL SLAG; BLAST; ACCUMULATION; COMPONENTS; PLANTS; DEFICIENCY; MECHANISMS; MANAGEMENT	It is well documented that slag-based silicon fertilizers have beneficial effects on the growth and disease resistance of rice. However, their effects vary greatly with sources of slag and are closely related to availability of silicon (Si) in these materials. To date, few researches have been done to compare the differences in plant performance and disease resistance between different slag-based silicon fertilizers applied at the same rate of plant-available Si. In the present study both steel and iron slags were chosen to investigate their effects on rice growth and disease resistance under greenhouse conditions. Both scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used to examine the effects of slags on ultrastructural changes in leaves of rice naturally infected by Bipolaris oryaze, the causal agent of brown spot. The results showed that both slag-based Si fertilizers tested significantly increased rice growth and yield, but decreased brown spot incidence, with steel slag showing a stronger effect than iron slag. The results of SEM analysis showed that application of slags led to more pronounced cell silicification in rice leaves, more silica cells, and more pronounced and larger papilla as well. The results of TEM analysis showed that mesophyll cells of slag-untreated rice leaf were disorganized, with colonization of the fungus (Bipolaris oryzae), including chloroplast degradation and cell wall alterations. The application of slag maintained mesophyll cells relatively intact and increased the thickness of silicon layer. It can be concluded that applying slag-based fertilizer to Si-deficient paddy soil is necessary for improving both rice productivity and brown spot resistance. The immobile silicon deposited in host cell walls and papillae sites is the first physical barrier for fungal penetration, while the soluble Si in the cytoplasm enhances physiological or induced resistance to fungal colonization.	[Ning, Dongfeng; Song, Alin; Fan, Fenliang; Li, Zhaojun; Liang, Yongchao] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100193, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecol Hlth, Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Liang, YC (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100193, Peoples R China.	ycliang@zju.edu.cn	Ning, dongfeng/P-2697-2014; Liang, Yongchao/D-5809-2012; Fan, Fenliang/G-6090-2012; Liang, Yongchao/S-9281-2019; Li, zhaojun/E-5735-2012	Ning, dongfeng/0000-0001-6899-9453; Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823; 	Ministry of Science and Technology, China; National Natural Science Foundation of China [41301310]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by The 12th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration" and "Study of Key Technologies for Alleviating Obstacle Factors and Improving Productivity of Low-Yield Cropland" supported by Ministry of Science and Technology, China and The National Natural Science Foundation of China entitled "The quantitative study of influence of straw returning on silicon releasing in typical rice soil of Southern China (41301310)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2001, CROP PROT, V20, P43, DOI 10.1016/S0261-2194(00)00051-X; Bocharnikova E. A., 2010, Russian Agricultural Sciences, V36, P446, DOI 10.3103/S1068367410060157; Buck GB, 2010, J PLANT NUTR, V34, P272, DOI 10.1080/01904167.2011.533327; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Cha W, 2006, WATER RES, V40, P1034, DOI 10.1016/j.watres.2005.12.039; Dai WeiMin, 2005, Chinese Journal of Rice Science, V19, P460; Dallagnol LJ, 2011, PHYTOPATHOLOGY, V101, P92, DOI 10.1094/PHYTO-04-10-0105; Dallagnol LJ, 2009, PHYTOPATHOLOGY, V99, P116, DOI 10.1094/PHYTO-99-1-0116; Datnoff LE, 1997, CROP PROT, V16, P525, DOI 10.1016/S0261-2194(97)00033-1; DATNOFF LE, 1991, PLANT DIS, V75, P729, DOI 10.1094/PD-75-0729; DEREN CW, 1994, CROP SCI, V34, P733, DOI 10.2135/cropsci1994.0011183X003400030024x; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Foy C.D., 1992, ADV SOIL SCI, P97, DOI DOI 10.1007/978-1-4612-2894-3_5; Guntzer F, 2012, AGRON SUSTAIN DEV, V32, P201, DOI 10.1007/s13593-011-0039-8; Hayasaka T, 2008, PHYTOPATHOLOGY, V98, P1038, DOI 10.1094/PHYTO-98-9-1038; Kato N, 1997, SOIL SCI PLANT NUTR, V43, P329, DOI 10.1080/00380768.1997.10414757; Kim SG, 2002, PHYTOPATHOLOGY, V92, P1095, DOI 10.1094/PHYTO.2002.92.10.1095; Lee T. S., 1981, Journal of Agricultural Research of China, V30, P35; Liang YC, 2005, PLANT PATHOL, V54, P678, DOI 10.1111/j.1365-3059.2005.01246.x; LIANG YC, 1994, COMMUN SOIL SCI PLAN, V25, P2285, DOI 10.1080/00103629409369189; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Lu RK, 2000, ANAL METHODS SOIL AG, P201; Ma J.F., 2002, SOIL FERTILIZER PLAN, V1st, P1; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; MARCHETTI MA, 1984, PLANT DIS, V68, P288, DOI 10.1094/PD-69-288; Motlagh M. R. S., 2008, International Journal of Agriculture and Biology, V10, P638; Motz H, 2001, WASTE MANAGE, V21, P285, DOI 10.1016/S0956-053X(00)00102-1; Nanayakkara UN, 2008, PLANT DIS, V92, P870, DOI 10.1094/PDIS-92-6-0870; Nguyen NV, 2006, PADDY WATER ENVIRON, V4, P1, DOI 10.1007/s10333-005-0031-5; Ou SH, 1985, RICE DIS; Raven JA, 2003, NEW PHYTOL, V158, P419, DOI 10.1046/j.1469-8137.2003.00778.x; Rodrigues F. A., 2005, Fitopatologia Brasileira, V30, P457, DOI 10.1590/S0100-41582005000500001; Rodrigues FA, 2005, PHYSIOL MOL PLANT P, V66, P144, DOI 10.1016/j.pmpp.2005.06.002; Rodrigues FA, 2004, PHYTOPATHOLOGY, V94, P177, DOI 10.1094/PHYTO.2004.94.2.177; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P256, DOI 10.1094/PHYTO.2003.93.3.256; Rodrigues FA, 2003, CROP PROT, V22, P23, DOI 10.1016/S0261-2194(02)00084-4; Savant NK, 1997, ADV AGRON, V58, P151; Seebold KW, 2004, PLANT DIS, V88, P253, DOI 10.1094/PDIS.2004.88.3.253; Seebold KW, 2001, PHYTOPATHOLOGY, V91, P63, DOI 10.1094/PHYTO.2001.91.1.63; Shen HT, 2003, WASTE MANAGE, V23, P933, DOI 10.1016/S0956-053X(02)00164-2; Sun WC, 2010, EUR J PLANT PATHOL, V128, P39, DOI 10.1007/s10658-010-9625-x; TAKAHASHI K, 1981, Bulletin of the Shikoku National Agricultural Experiment Station, P75; Wailes E. J., 1997, ARKANSAS AGR EXP STA, P177; Wang H., 2001, STUD PLANT SCI, V8, P343, DOI [10.1016/S0928-3420(01)80025-2, DOI 10.1016/S0928-3420(01)80025-2]; Winslow MD, 1997, PLANT SOIL, V188, P239, DOI 10.1023/A:1004298817861; Wu SP, 2007, BUILD ENVIRON, V42, P2580, DOI 10.1016/j.buildenv.2006.06.008; YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1; Zhang Guo-Liang, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P600; Zhu GL, 2010, IRON STEEL SCRAP, V1, P12	52	59	64	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102681	10.1371/journal.pone.0102681	http://dx.doi.org/10.1371/journal.pone.0102681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036893	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200079
J	Caspani, EM; Crossley, PH; Redondo-Garcia, C; Martinez, S				Caspani, Elisabetta M.; Crossley, Philip H.; Redondo-Garcia, Carolina; Martinez, Salvador			Glioblastoma: A Pathogenic Crosstalk between Tumor Cells and Pericytes	PLOS ONE			English	Article							MICROVASCULAR PERICYTES; SMOOTH-MUSCLE; STEM-CELLS; CO-OPTION; BRAIN; ACTIVATION; GLIOMA; MARKER; CDC42; MACROPHAGES	Cancers likely originate in progenitor zones containing stem cells and perivascular stromal cells. Much evidence suggests stromal cells play a central role in tumor initiation and progression. Brain perivascular cells (pericytes) are contractile and function normally to regulate vessel tone and morphology, have stem cell properties, are interconvertible with macrophages and are involved in new vessel formation during angiogenesis. Nevertheless, how pericytes contribute to brain tumor infiltration is not known. In this study we have investigated the underlying mechanism by which the most lethal brain cancer, Glioblastoma Multiforme (GBM) interacts with pre-existing blood vessels (co-option) to promote tumor initiation and progression. Here, using mouse xenografts and laminin-coated silicone substrates, we show that GBM malignancy proceeds via specific and previously unknown interactions of tumor cells with brain pericytes. Two-photon and confocal live imaging revealed that GBM cells employ novel, Cdc42-dependent and actin-based cytoplasmic extensions, that we call flectopodia, to modify the normal contractile activity of pericytes. This results in the co-option of modified preexisting blood vessels that support the expansion of the tumor margin. Furthermore, our data provide evidence for GBM cell/pericyte fusion-hybrids, some of which are located on abnormally constricted vessels ahead of the tumor and linked to tumor-promoting hypoxia. Remarkably, inhibiting Cdc42 function impairs vessel co-option and converts pericytes to a phagocytic/macrophage-like phenotype, thus favoring an innate immune response against the tumor. Our work, therefore, identifies for the first time a key GBM contact-dependent interaction that switches pericyte function from tumor-suppressor to tumor-promoter, indicating that GBM may harbor the seeds of its own destruction. These data support the development of therapeutic strategies directed against co-option (preventing incorporation and modification of pre-existing blood vessels), possibly in combination with anti-angiogenesis (blocking new vessel formation), which could lead to improved vascular targeting not only in Glioblastoma but also for other cancers.	[Caspani, Elisabetta M.; Crossley, Philip H.; Redondo-Garcia, Carolina; Martinez, Salvador] Univ Miguel Hernandez, Spanish Natl Res Council, Inst Neurosci, Lab Expt Embryol, Alicante, Spain; [Martinez, Salvador] Ctr Invest Biosanitaria Red Salud Mental, Murcia, Spain; [Martinez, Salvador] Inst Murciano Invest Biosanitaria Arrixaca, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Caspani, EM (corresponding author), Univ Miguel Hernandez, Spanish Natl Res Council, Inst Neurosci, Lab Expt Embryol, Alicante, Spain.	elisabetta_caspani@yahoo.it	Caspani, Elisabetta/AHD-8211-2022; Martinez, Salvador/L-4896-2014	Martinez, Salvador/0000-0002-2910-8926; Martinez, Salvador/0000-0002-9320-4103	Spanish Ministry of Science and Innovation: FEDER [BFU-2010-27326]; Consolider [CSD2007-00023]; Health Institute Carlos III: Red TERCEL [RD12/0019/0024]; Marie Curie Intra-European Fellowship	Spanish Ministry of Science and Innovation: FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Health Institute Carlos III: Red TERCEL; Marie Curie Intra-European Fellowship(European Commission)	This work was funded by Spanish Ministry of Science and Innovation: FEDER (BFU-2010-27326) and Consolider (CSD2007-00023); Health Institute Carlos III: Red TERCEL (RD12/0019/0024); P.H.C was also supported by Marie Curie Intra-European Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard B, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/485156; Anfuso CD, 2014, BIOCHIMIE, V99, P77, DOI 10.1016/j.biochi.2013.11.013; Appaix Florence, 2014, World J Stem Cells, V6, P134, DOI 10.4252/wjsc.v6.i2.134; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Bageritz J, 2014, CELL DEATH DIFFER, V21, P929, DOI 10.1038/cdd.2014.12; Balabanov R, 1996, MICROVASC RES, V52, P127, DOI 10.1006/mvre.1996.0049; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Budde MD, 2012, NMR BIOMED, V25, P726, DOI 10.1002/nbm.1786; Burger PC, 2007, TUMORS CENTRAL NER 4, P65; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Corselli M, 2013, CYTOM PART A, V83A, P714, DOI [10.1002/cyto.22313, 10.1002/cyto.a.22313]; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; De Sanctis F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00069; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Ding YP, 2012, CANCER MICROENVIRON, V5, P225, DOI 10.1007/s12307-012-0106-y; Dome B, 2003, J NEUROPATH EXP NEUR, V62, P655; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Franco M, 2011, HORM METAB RES, V43, P884, DOI 10.1055/s-0031-1284381; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Goding JW, 2000, J LEUKOCYTE BIOL, V67, P285, DOI 10.1002/jlb.67.3.285; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hurtado-Alvarado G, 2014, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00080; Li N, 2007, J PROTEOME RES, V6, P3304, DOI 10.1021/pr0702363; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mravic M, 2014, INT ORTHOP, V38, P1819, DOI 10.1007/s00264-014-2295-0; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Ochs K, 2013, J NEUROIMMUNOL, V265, P106, DOI 10.1016/j.jneuroim.2013.09.011; Oishi K, 2007, MICROVASC RES, V73, P20, DOI 10.1016/j.mvr.2006.08.004; Oser M, 2011, EUR J CELL BIOL, V90, P181, DOI 10.1016/j.ejcb.2010.08.006; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pieper C, 2014, BRAIN RES, V1550, P1, DOI 10.1016/j.brainres.2014.01.004; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian CN, 2013, NAT REV UROL, V10, P300, DOI 10.1038/nrurol.2013.26; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rupp C, 2015, ONCOGENE, V34, P815, DOI 10.1038/onc.2014.18; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; Travaglione S, 2002, TOXICOL IN VITRO, V16, P405, DOI 10.1016/S0887-2333(02)00028-0; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Xu S, 2013, NEURO-ONCOLOGY, V15, P1160, DOI 10.1093/neuonc/not067; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	69	76	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101402	10.1371/journal.pone.0101402	http://dx.doi.org/10.1371/journal.pone.0101402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032689	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300015
J	Choi, KS; Kim, SH; Kim, ED; Lee, SH; Han, SJ; Yoon, S; Chang, KT; Seo, KY				Choi, Kyoung Sub; Kim, Sang-Hyun; Kim, Eun-Do; Lee, Sang-Ho; Han, Soo Jung; Yoon, Sangchul; Chang, Kyu-Tae; Seo, Kyoung Yul			Protection from Hemolytic Uremic Syndrome by Eyedrop Vaccination with Modified Enterohemorrhagic E-coli Outer Membrane Vesicles	PLOS ONE			English	Article							SHIGA-TOXIN; MUCOSAL VACCINE; B-SUBUNIT; LIPOPOLYSACCHARIDE; IMMUNITY; INFECTION; ANTIGEN; VIRULENCE; RESPONSES; PROTEINS	We investigated whether eyedrop vaccination using modified outer membrane vesicles (mOMVs) is effective for protecting against hemolytic uremic syndrome (HUS) caused by enterohemorrhagic E. coli (EHEC) O157:H7 infection. Modified OMVs and waaJ-mOMVs were prepared from cultures of MsbB- and Shiga toxin A subunit (STxA)-deficient EHEC O157:H7 bacteria with or without an additional waaJ mutation. BALB/c mice were immunized by eyedrop mOMVs, waaJ-mOMVs, and mOMVs plus polymyxin B (PMB). Mice were boosted at 2 weeks, and challenged peritoneally with wild-type OMVs (wtOMVs) at 4 weeks. As parameters for evaluation of the OMV-mediated immune protection, serum and mucosal immunoglobulins, body weight change and blood urea nitrogen (BUN)/Creatinin (Cr) were tested, as well as histopathology of renal tissue. In order to confirm the safety of mOMVs for eyedrop use, body weight and ocular histopathological changes were monitored in mice. Modified OMVs having penta-acylated lipid A moiety did not contain STxA subunit proteins but retained non-toxic Shiga toxin B (STxB) subunit. Removal of the polymeric O-antigen of O157 LPS was confirmed in waaJ-mOMVs. The mice group vaccinated with mOMVs elicited greater humoral and mucosal immune responses than did the waaJ-mOMVs and PBS-treated groups. Eyedrop vaccination of mOMVs plus PMB reduced the level of humoral and mucosal immune responses, suggesting that intact O157 LPS antigen can be a critical component for enhancing the immunogenicity of the mOMVs. After challenge, mice vaccinated with mOMVs were protected from a lethal dose of wtOMVs administered intraperitoneally, conversely mice in the PBS control group were not. Collectively, for the first time, EHEC O157-derived mOMV eyedrop vaccine was experimentally evaluated as an efficient and safe means of vaccine development against EHEC O157:H7 infection-associated HUS.	[Choi, Kyoung Sub; Kim, Eun-Do] Yonsei Univ, Grad Sch, Seoul 120749, South Korea; [Choi, Kyoung Sub] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Ophthalmol, Goyang City, South Korea; [Kim, Sang-Hyun; Lee, Sang-Ho] Korea Res Inst Biosci & Biotechnol, Viral Infect Dis Res Ctr, Taejon, South Korea; [Kim, Eun-Do; Han, Soo Jung; Yoon, Sangchul; Seo, Kyoung Yul] Yonsei Univ, Coll Med, Eye & Ear Hosp, Dept Ophthalmol,Severance Hosp,Inst Vis Res, Seoul, South Korea; [Kim, Eun-Do] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongwon, Chungbuk, South Korea	Yonsei University; National Health Insurance Service; NHIS Ilsan Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University; Yonsei University Health System; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Chang, KT (corresponding author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongwon, Chungbuk, South Korea.	changkt@kribb.re.kr; seoky@yuhs.ac	Seo, Kyoung Yul/I-5484-2019	Yoon, Sangchul/0000-0003-0454-9597; Seo, Kyoung Yul/0000-0002-9855-1980	Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A121861]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3A9D5072551]	Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This study was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Grant No.: A121861). Additional funding was received from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9D5072551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotevi O, 2007, J IMMUNOL, V179, P3371, DOI 10.4049/jimmunol.179.5.3371; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Camacho AI, 2011, VACCINE, V29, P8222, DOI 10.1016/j.vaccine.2011.08.121; Domingues MM, 2012, BIOPOLYMERS, V98, P338, DOI 10.1002/bip.22095; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hu K, 2011, VACCINE, V29, P1455, DOI 10.1016/j.vaccine.2010.12.031; JAYAWARDANE GWL, 1995, VET MICROBIOL, V46, P69, DOI 10.1016/0378-1135(95)00073-J; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Kim SH, 2011, FEMS IMMUNOL MED MIC, V63, P427, DOI 10.1111/j.1574-695X.2011.00869.x; Kim SH, 2010, FEMS IMMUNOL MED MIC, V58, P412, DOI 10.1111/j.1574-695X.2010.00654.x; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; Kim SH, 2004, INFECT IMMUN, V72, P1174, DOI 10.1128/IAI.72.2.1174-1180.2004; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee DH, 2011, VACCINE, V29, P8293, DOI 10.1016/j.vaccine.2011.08.102; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; Nagy G, 2008, BIOL CHEM, V389, P513, DOI 10.1515/BC.2008.056; Nieves W, 2011, VACCINE, V29, P8381, DOI 10.1016/j.vaccine.2011.08.058; Okada K, 2011, ADV OTO-RHINO-LARYNG, V72, P31, DOI 10.1159/000324591; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Roy K, 2011, CLIN VACCINE IMMUNOL, V18, P1803, DOI 10.1128/CVI.05217-11; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tsuji T, 2008, VACCINE, V26, P2092, DOI 10.1016/j.vaccine.2008.02.034; Tsuji T, 2008, VACCINE, V26, P469, DOI 10.1016/j.vaccine.2007.11.038; van de Waterbeemd B, 2010, VACCINE, V28, P4810, DOI 10.1016/j.vaccine.2010.04.082; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Yoon JW, 2008, J VET SCI, V9, P219, DOI 10.4142/jvs.2008.9.3.219; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007; ZUNDEL E, 1992, ANN RECH VET, V23, P177	36	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100229	10.1371/journal.pone.0100229	http://dx.doi.org/10.1371/journal.pone.0100229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032703	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300007
J	Gianoarli, L; Luiselli, D; Crivello, AM; Lang, M; Ferraretti, AP; De Fanti, S; Magli, MC; Romeo, G				Gianoarli, Luca; Luiselli, Donata; Crivello, Anna Maria; Lang, Martin; Ferraretti, Anna Pia; De Fanti, Sara; Magli, M. Cristina; Romeo, Giovanni			Mitogenomes of Polar Bodies and Corresponding Oocytes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HETEROPLASMY; SELECTION; MUTATIONS; DISEASE; MTDNA	The objective of the present study was to develop an approach that could assess the chromosomal status and the mitochondrial DNA (mtDNA) content of oocytes and their corresponding polar bodies (PBs) with the goal of obtaining a comparative picture of the segregation process both for nuclear and mtDNA. After Whole Genome Amplification (WGA), sequencing of the whole mitochondrial genome was attempted to analyze the segregation of mutant and wild-type mtDNA during human meiosis. Three triads, composed of oocyte and corresponding PBs, were analyzed and their chromosome status was successfully assessed. The complete mitochondrial genome (mitogenome) was almost entirely sequenced in the oocytes (95.99% compared to 98.43% in blood), while the percentage of sequences obtained in the corresponding PB1 and PB2 was lower (69.70% and 69.04% respectively). The comparison with the mtDNA sequence in blood revealed no changes in the D-loop region for any of the cells of each triad. In the coding region of blood mtDNA and oocyte mtDNA sequences showed full correspondence, whereas all PBs had at least one change with respect to the blood-oocyte pairs. In all, 9 changes were found, either in PB1 or PB2: 4 in MT-ND5, 2 in MT-RNR2, and 1 each in MT-ATP8, MT-ND4, MT-CYTB. The full concordance between oocyte and blood in the 3 triads, and the relegation of changes to PBs, revealed the unexpected coexistence of different variants, giving a refined estimation of mitochondrial heteroplasmy. Should these findings be confirmed by additional data, an active mechanism could be postulated in the oocyte to preserve a condition of 'normality'.	[Gianoarli, Luca; Crivello, Anna Maria; Ferraretti, Anna Pia; Magli, M. Cristina] SISMER Reprod Med Unit, Bologna, Italy; [Luiselli, Donata; Lang, Martin; De Fanti, Sara; Romeo, Giovanni] Univ Bologna, Bologna, Italy; [Romeo, Giovanni] European Sch Genet Med, Bologna, Italy	University of Bologna	Gianoarli, L (corresponding author), SISMER Reprod Med Unit, Bologna, Italy.	luca.gianaroli@sismer.it	Lang, Martin/AAW-8645-2021	Lang, Martin/0000-0002-0242-6713; Crivello, Anna Maria/0000-0002-2836-5752				Cummins J M, 2002, Reprod Biomed Online, V4, P176; Eichenlaub-Ritter U, 2011, MITOCHONDRION, V11, P783, DOI 10.1016/j.mito.2010.08.011; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; Gigarel N, 2011, AM J HUM GENET, V88, P494, DOI 10.1016/j.ajhg.2011.03.010; Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Maragh S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-7; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Nara Akina, 2009, Leg Med (Tokyo), V11 Suppl 1, pS115, DOI 10.1016/j.legalmed.2009.01.114; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267	15	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102182	10.1371/journal.pone.0102182	http://dx.doi.org/10.1371/journal.pone.0102182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032828	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300040
J	Hirai, S; Endo, S; Saito, R; Hirose, M; Ueno, T; Suzuki, H; Yamato, K; Abei, M; Hyodo, I				Hirai, Sachiko; Endo, Shinji; Saito, Rie; Hirose, Mitsuaki; Ueno, Takunori; Suzuki, Hideo; Yamato, Kenji; Abei, Masato; Hyodo, Ichinosuke			Antitumor Effects of a Sirtuin Inhibitor, Tenovin-6, against Gastric Cancer Cells via Death Receptor 5 Up-Regulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; TRAIL-INDUCED APOPTOSIS; P53; EXPRESSION; SENESCENCE; CHEMOSENSITIVITY; ADENOCARCINOMA; TRICHOSTATIN; COMBINATION; METABOLISM	Up-regulated sirtuin 1 (SIRT1), an NAD(+)-dependent class III histone deacetylase, deacetylates p53 and inhibits its transcriptional activity, leading to cell survival. SIRT1 overexpression has been reported to predict poor survival in some malignancies, including gastric cancer. However, the antitumor effect of SIRT1 inhibition remains elusive in gastric cancer. Here, we investigated the antitumor mechanisms of a sirtuin inhibitor, tenovin-6, in seven human gastric cancer cell lines (four cell lines with wild-type TP53, two with mutant-type TP53, and one with null TP53). Interestingly, tenovin-6 induced apoptosis in all cell lines, not only those with wild-type TP53, but also mutant-type and null versions, accompanied by up-regulation of death receptor 5 (DR5). In the KatoIII cell line (TP53-null), DR5 silencing markedly attenuated tenovin-6-induced apoptosis, suggesting that the pivotal mechanism behind its antitumor effects is based on activation of the death receptor signal pathway. Although endoplasmic reticulum stress caused by sirtuin inhibitors was reported to induce DR5 up-regulation in other cancer cell lines, we could not find marked activation of its related molecules, such as ATF6, PERK, and CHOP, in gastric cancer cells treated with tenovin-6. Tenovin-6 in combination with docetaxel or SN-38 exerted a slight to moderate synergistic cytotoxicity against gastric cancer cells. In conclusion, tenovin-6 has potent antitumor activity against human gastric cancer cells via DR5 up-regulation. Our results should be helpful for the future clinical development of sirtuin inhibitors.	[Hirai, Sachiko; Endo, Shinji; Saito, Rie; Hirose, Mitsuaki; Ueno, Takunori; Suzuki, Hideo; Yamato, Kenji; Abei, Masato; Hyodo, Ichinosuke] Univ Tsukuba, Inst Clin Med, Dept Gastroenterol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan	University of Tsukuba	Endo, S (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Gastroenterol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan.	shinj.endo@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to IH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P283, DOI 10.1517/13543770902755111; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Bruzzese F, 2009, MOL CANCER THER, V8, P3075, DOI 10.1158/1535-7163.MCT-09-0254; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chang H, 2010, J CANCER RES CLIN, V136, P1901, DOI 10.1007/s00432-010-0849-0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x; Engel D, 2006, J CANCER RES CLIN, V132, P673, DOI 10.1007/s00432-006-0116-6; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Groves MJ, 2013, BRIT J CANCER, V109, P2434, DOI 10.1038/bjc.2013.601; Guo F, 2005, BLOOD, V105, P1246, DOI 10.1182/blood-2004-05-2041; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JJ, 2012, INVEST NEW DRUG, V30, P1434, DOI 10.1007/s10637-011-9718-1; Iida S, 2000, INT J CANCER, V87, P654, DOI 10.1002/1097-0215(20000901)87:5<654::AID-IJC6>3.0.CO;2-P; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Kim SY, 2009, ANN NY ACAD SCI, V1171, P270, DOI 10.1111/j.1749-6632.2009.04721.x; Kong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037222; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Malago JJ, 2003, CELL STRESS CHAPERON, V8, P194, DOI 10.1379/1466-1268(2003)008<0194:ELOHSP>2.0.CO;2; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; Musch MW, 2001, CELL GROWTH DIFFER, V12, P419; Na YS, 2011, CANCER CHEMOTH PHARM, V68, P389, DOI 10.1007/s00280-010-1495-6; Na YS, 2010, ONCOL REP, V24, P1509, DOI 10.3892/or_00001012; Nishiyama M, 2009, GASTRIC CANCER, V12, P132, DOI 10.1007/s10120-009-0521-z; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roth M., 2013, ONCOGENE, DOI 10. 1038/onc. 2013. 120; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soussi T, 2006, CLIN CANCER RES, V12, P62, DOI 10.1158/1078-0432.CCR-05-0413; Sunami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057633; Sung B, 2012, FREE RADICAL BIO MED, V53, P1977, DOI 10.1016/j.freeradbiomed.2012.08.012; Tiwary R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011865; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Ueno T, 2013, ONCOL RES, V21, P155, DOI 10.3727/096504013X13854886566598; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang DG, 2013, ONCOL LETT, V6, P1492, DOI 10.3892/ol.2013.1565; Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076662; Woo JS, 2013, BIOCHEM BIOPH RES CO, V431, P354, DOI 10.1016/j.bbrc.2012.11.134; Yamato K, 2008, CANCER GENE THER, V15, P140, DOI 10.1038/sj.cgt.7701118; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang QC, 2012, ASIAN PAC J CANCER P, V13, P3471, DOI 10.7314/APJCP.2012.13.7.3471; Zhang XT, 2006, ONCOL REP, V16, P563; Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	57	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102831	10.1371/journal.pone.0102831	http://dx.doi.org/10.1371/journal.pone.0102831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033286	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300100
J	Lai, CH; Chang, LL; Lin, JN; Chen, WF; Wei, YF; Chiu, CT; Wu, JT; Hsu, CK; Chen, JY; Lee, HS; Lin, HH; Chen, YH				Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Chen, Wei-Fang; Wei, Yu-Feng; Chiu, Chien-Tung; Wu, Jiun-Ting; Hsu, Chi-Kuei; Chen, Jung-Yueh; Lee, Ho-Sheng; Lin, Hsi-Hsun; Chen, Yen-Hsu			Clinical Characteristics of Q Fever and Etiology of Community-Acquired Pneumonia in a Tropical Region of Southern Taiwan: A Prospective Observational Study	PLOS ONE			English	Article							COXIELLA-BURNETII INFECTION; ADULT PATIENTS; RISK-FACTORS; EPIDEMIOLOGY; PREVALENCE; SEVERITY; HOSPITALIZATION; SURVEILLANCE; OUTPATIENT; PATHOGENS	Background: The clinical characteristics of Q fever are poorly identified in the tropics. Fever with pneumonia or hepatitis are the dominant presentations of acute Q fever, which exhibits geographic variability. In southern Taiwan, which is located in a tropical region, the role of Q fever in community-acquired pneumonia (CAP) has never been investigated. Methodology/Principal Findings: During the study period, May 2012 to April 2013, 166 cases of adult CAP and 15 cases of acute Q fever were prospectively investigated. Cultures of clinical specimens, urine antigen tests for Streptococcus pneumoniae and Legionella pneumophila, and paired serologic assessments for Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Q fever (Coxiella burnetii) were used for identifying pathogens associated with CAP. From April 2004 to April 2013 (the pre-study period), 122 cases of acute Q fever were also included retrospectively for analysis. The geographic distribution of Q fever and CAP cases was similar. Q fever cases were identified in warmer seasons and younger ages than CAP. Based on multivariate analysis, male gender, chills, thrombocytopenia, and elevated liver enzymes were independent characteristics associated with Q fever. In patients with Q fever, 95% and 13.5% of cases presented with hepatitis and pneumonia, respectively. Twelve (7.2%) cases of CAP were seropositive for C. burnetii antibodies, but none of them had acute Q fever. Among CAP cases, 22.9% had a CURB-65 score >= 2, and 45.8% had identifiable pathogens. Haemophilus parainfluenzae (14.5%), S. pneumoniae (6.6%), Pseudomonas aeruginosa (4.8%), and Klebsiella pneumoniae (3.0%) were the most common pathogens identified by cultures or urine antigen tests. Moreover, M. pneumoniae, C. pneumoniae, and co-infection with 2 pathogens accounted for 9.0%, 7.8%, and 1.8%, respectively. Conclusions: In southern Taiwan, Q fever is an endemic disease with hepatitis as the major presentation and is not a common etiology of CAP.	[Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Lin, Jiun-Nong; Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Chen, Wei-Fang] I Shou Univ, E Da Hosp, Div Infect Control Lab, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Microbiol, Kaohsiung, Taiwan; [Wei, Yu-Feng; Chiu, Chien-Tung; Wu, Jiun-Ting; Hsu, Chi-Kuei; Chen, Jung-Yueh; Lee, Ho-Sheng] I Shou Univ, E Da Hosp, Dept Internal Med, Div Pulm Med, Dashu District, Kaohsiung Count, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Kaohsiung Medical University; E-Da Hospital; I Shou University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	infchen@gmail.com		Chen, Yen-hsu/0000-0002-8667-4844	E-Da Hospital [EDAHP100001]	E-Da Hospital	This work was supported by a research grant from E-Da Hospital [EDAHP100001]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RF, 2007, EUR J CLIN MICROBIOL, V26, P495, DOI 10.1007/s10096-007-0323-3; Amitai Z, 2010, CLIN INFECT DIS, V50, P1433, DOI 10.1086/652442; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bhatty M, 2011, ALCOHOL, V45, P523, DOI 10.1016/j.alcohol.2011.02.305; Bochud PY, 2001, MEDICINE, V80, P75, DOI 10.1097/00005792-200103000-00001; Capelastegui A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-134; Carratala J, 2005, ANN INTERN MED, V142, P165, DOI 10.7326/0003-4819-142-3-200502010-00006; Centers for Disease Control Taiwan, Q FEV; Chan Jasper F. W., 2010, Hong Kong Medical Journal, V16, P56; Chang CC, 2010, ZOONOSES PUBLIC HLTH, V57, pE95, DOI 10.1111/j.1863-2378.2009.01290.x; CLARK WH, 1951, ARCH INTERN MED, V88, P155, DOI 10.1001/archinte.1951.03810080023003; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Cunha BA, 2006, CLIN MICROBIOL INFEC, V12, P12, DOI 10.1111/j.1469-0691.2006.01393.x; de Alarcon A, 2003, J INFECTION, V47, P110, DOI 10.1016/S0163-4453(03)00013-6; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; DUPONT HT, 1992, AM J MED, V93, P427, DOI 10.1016/0002-9343(92)90173-9; Epelboin L, 2012, CLIN INFECT DIS, V55, P67, DOI 10.1093/cid/cis288; Falguera M, 2001, ARCH INTERN MED, V161, P1866, DOI 10.1001/archinte.161.15.1866; Georgiev M, 2013, EURO SURVEILL, V18; Gutierrez F, 2005, CLIN MICROBIOL INFEC, V11, P788, DOI 10.1111/j.1469-0691.2005.01226.x; Harris P, 2013, EPIDEMIOL INFECT, V141, P1034, DOI 10.1017/S0950268812001495; Hou MY, 2011, JPN J INFECT DIS, V64, P161; Knobel DL, 2013, AM J TROP MED HYG, V88, P513, DOI 10.4269/ajtmh.12-0169; Ko WC, 2000, J FORMOS MED ASSOC, V99, P33; Kwak Wooseok, 2013, Osong Public Health Res Perspect, V4, P34, DOI 10.1016/j.phrp.2012.12.006; Lai CH, 2008, SCAND J INFECT DIS, V40, P105, DOI 10.1080/00365540701558722; Lai CH, 2007, CLIN INFECT DIS, V45, pE52, DOI 10.1086/520680; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077640; LaScola B, 1997, INFECT IMMUN, V65, P2443, DOI 10.1128/IAI.65.6.2443-2447.1997; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; Lee SJ, 2002, JPN J INFECT DIS, V55, P157; Leone M, 2004, J INFECT DIS, V189, P339, DOI 10.1086/380798; LEVY P, 1989, EUR J EPIDEMIOL, V5, P447, DOI 10.1007/BF00140139; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Lowbridge Chris P, 2012, N S W Public Health Bull, V23, P31, DOI 10.1071/NB11037; Lui G, 2009, RESPIROLOGY, V14, P1098, DOI 10.1111/j.1440-1843.2009.01637.x; Luna CM, 2000, CHEST, V118, P1344, DOI 10.1378/chest.118.5.1344; Marrie TJ, 2008, EMERG INFECT DIS, V14, P67, DOI 10.3201/eid1401.071256; Marrie Thomas J, 2002, Can J Infect Dis, V13, P164; Marrie TJ, 1996, J INFECT DIS, V173, P484, DOI 10.1093/infdis/173.2.484; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McQuiston JH, 2006, AM J TROP MED HYG, V75, P36, DOI 10.4269/ajtmh.2006.75.1.0750036; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Montes M, 2006, ANN NY ACAD SCI, V1078, P129, DOI 10.1196/annals.1374.020; ORDIROS J, 1994, CLIN INFECT DIS, V18, P213, DOI 10.1093/clinids/18.2.213; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Porter SR, 2011, VET MICROBIOL, V149, P298, DOI 10.1016/j.vetmic.2010.11.017; RAOULT D, 1990, ANN NY ACAD SCI, V590, P33, DOI 10.1111/j.1749-6632.1990.tb42204.x; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; SCHACK M, 2013, EPIDEMIOL INFECT, P1; SIMOR AE, 1987, CAN VET J, V28, P264; Song JH, 2008, INT J ANTIMICROB AG, V31, P107, DOI 10.1016/j.ijantimicag.2007.09.014; Sopena N, 1999, EUR J CLIN MICROBIOL, V18, P852, DOI 10.1007/s100960050419; Suputtamongkol Y, 2003, EMERG INFECT DIS, V9, P1186; Takahashi H, 2004, DIAGN MICR INFEC DIS, V48, P247, DOI 10.1016/j.diagmicrobio.2003.11.002; Torres A, 2014, EUR J CLIN MICROBIOL; Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787; Wielders CCH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091764; Yen MY, 2005, J FORMOS MED ASSOC, V104, P724	62	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102808	10.1371/journal.pone.0102808	http://dx.doi.org/10.1371/journal.pone.0102808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033402	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300093
J	Drichoutis, AC; Lusk, JL				Drichoutis, Andreas C.; Lusk, Jayson L.			Judging Statistical Models of Individual Decision Making under Risk Using In- and Out-of-Sample Criteria	PLOS ONE			English	Article							GENERALIZED EXPECTED UTILITY; PROSPECT-THEORY; SELECTION; AVERSION; CHOICE; ERROR	Despite the fact that conceptual models of individual decision making under risk are deterministic, attempts to econometrically estimate risk preferences require some assumption about the stochastic nature of choice. Unfortunately, the consequences of making different assumptions are, at present, unclear. In this paper, we compare three popular error specifications (Fechner, contextual utility, and Luce error) for three different preference functionals (expected utility, rank-dependent utility, and a mixture of those two) using in-and out-of-sample selection criteria. We find drastically different inferences about structural risk preferences across the competing functionals and error specifications. Expected utility theory is least affected by the selection of the error specification. A mixture model combining the two conceptual models assuming contextual utility provides the best fit of the data both in-and out-of-sample.	[Drichoutis, Andreas C.] Agr Univ Athens, GR-11855 Athens, Greece; [Lusk, Jayson L.] Oklahoma State Univ, Stillwater, OK 74078 USA	Agricultural University of Athens; Oklahoma State University System; Oklahoma State University - Stillwater	Drichoutis, AC (corresponding author), Agr Univ Athens, GR-11855 Athens, Greece.	adrihout@aua.gr	Drichoutis, Andreas/AAM-6580-2020	Drichoutis, Andreas/0000-0002-4082-4560	Willard Sparks Endowed Chair	Willard Sparks Endowed Chair	Jayson Lusk is the Regents Professor and Willard Sparks Endowed Chair. Funding for the research described in the paper has been provided from his endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen S, 2011, 201103 GEORG STAT U; Andersen S, 2008, ECONOMETRICA, V76, P583, DOI 10.1111/j.1468-0262.2008.00848.x; Blavatskyy PR, 2007, J RISK UNCERTAINTY, V34, P259, DOI 10.1007/s11166-007-9009-6; Blavatskyy PR, 2010, J APPL ECONOMET, V25, P963, DOI 10.1002/jae.1116; Buschena D, 2000, J RISK UNCERTAINTY, V20, P67, DOI 10.1023/A:1007814719863; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Carbone E, 2000, J RISK UNCERTAINTY, V20, P161, DOI 10.1023/A:1007829024107; Carbone E, 1997, ECON LETT, V57, P305, DOI 10.1016/S0165-1765(97)00244-9; Clarke KA, 2003, J CONFLICT RESOLUT, V47, P72, DOI 10.1177/0022002702239512; Conte A, 2011, J ECONOMETRICS, V162, P79, DOI 10.1016/j.jeconom.2009.10.011; Drichoutis Andreas C., 2014, 55386 MUN PERS REPEC; Erdem T, 1996, MARKET SCI, V15, P359, DOI 10.1287/mksc.15.4.359; Fechner G., 1860, ELEMENTS PSYCHOPHYSI; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Ghirardato P, 2004, J ECON THEORY, V118, P133, DOI 10.1016/j.jet.2003.12.004; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Greiner B., 2004, FORSCHUNG WISSENSCHA, V63, P79; HARLESS DW, 1994, ECONOMETRICA, V62, P1251, DOI 10.2307/2951749; Harrison GW, 2009, EXP ECON, V12, P133, DOI 10.1007/s10683-008-9203-7; Harrison GW, 2009, J ECON BEHAV ORGAN, V70, P498, DOI 10.1016/j.jebo.2008.02.011; Harrison GW, 2005, AM ECON REV, V95, P897, DOI 10.1257/0002828054201378; Harrison GW, 2012, METHODS MODERN EXPT; Hey JD, 2005, EXP ECON, V8, P325, DOI 10.1007/s10683-005-5373-8; HEY JD, 1994, ECONOMETRICA, V62, P1291, DOI 10.2307/2951750; Hey JD, 2010, J RISK UNCERTAINTY, V41, P81, DOI 10.1007/s11166-010-9102-0; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Loomes G, 2005, EXP ECON, V8, P301, DOI 10.1007/s10683-005-5372-9; Loomes G, 2002, J RISK UNCERTAINTY, V24, P103, DOI 10.1023/A:1014094209265; Luce R, 1959, INDIVIDUAL CHOICE BE; Luce R. D., 1965, HDB MATH PSYCHOL, VIII, P249; Maddala G.S., 1986, LTD DEPENDENT QUALIT; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Norwood B, 2004, AM J AGR ECON, V86, P1032, DOI 10.1111/j.0002-9092.2004.00651.x; Norwood FB, 2004, J AGR RESOUR ECON, V29, P404; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; Roy R, 1996, MARKET SCI, V15, P280, DOI 10.1287/mksc.15.3.280; StataCorp, 2011, STAT 12 BAS REF MAN; Stott HP, 2006, J RISK UNCERTAINTY, V32, P101, DOI 10.1007/s11166-006-8289-6; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wilcox N. T, 2007, WORKING PAPER; Wilcox NT, 2011, J ECONOMETRICS, V162, P89, DOI 10.1016/j.jeconom.2009.10.012; Wilcox NT, 2008, RES EXP ECON, V12, P197, DOI 10.1016/S0193-2306(08)00004-5	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102269	10.1371/journal.pone.0102269	http://dx.doi.org/10.1371/journal.pone.0102269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029467	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600054
J	Louf, R; Roth, C; Barthelemy, M				Louf, Remi; Roth, Camille; Barthelemy, Marc			Scaling in Transportation Networks	PLOS ONE			English	Article								Subway systems span most large cities, and railway networks most countries in the world. These networks are fundamental in the development of countries and their cities, and it is therefore crucial to understand their formation and evolution. However, if the topological properties of these networks are fairly well understood, how they relate to population and socio-economical properties remains an open question. We propose here a general coarse-grained approach, based on a cost-benefit analysis that accounts for the scaling properties of the main quantities characterizing these systems (the number of stations, the total length, and the ridership) with the substrate's population, area and wealth. More precisely, we show that the length, number of stations and ridership of subways and rail networks can be estimated knowing the area, population and wealth of the underlying region. These predictions are in good agreement with data gathered for about 140 subway systems and more than 50 railway networks in the world. We also show that train networks and subway systems can be described within the same framework, but with a fundamental difference: while the interstation distance seems to be constant and determined by the typical walking distance for subways, the interstation distance for railways scales with the number of stations.	[Louf, Remi; Barthelemy, Marc] CEA, CNRS, URA 2306, Inst Phys Theor, F-91198 Gif Sur Yvette, France; [Roth, Camille] Ctr Marc Bloch Berlin, UMIFRE, CNRS, MAE, Berlin, Germany; [Roth, Camille; Barthelemy, Marc] EHESS, CNRS, UMR 8557, Ctr Anal & Math Sociales, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Barthelemy, M (corresponding author), CEA, CNRS, URA 2306, Inst Phys Theor, F-91198 Gif Sur Yvette, France.	marc.barthelemy@cea.fr	Roth, Camille/AFB-9056-2022	Roth, Camille/0000-0003-3925-7957; Louf, Remi/0000-0001-7929-5507				[Anonymous], 1963, THESIS U CHICAGO CHI; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; BENGUIGUI L, 1992, J PHYS I, V2, P385, DOI 10.1051/jp1:1992151; BENGUIGUI L, 1995, ENVIRON PLANN A, V27, P1147, DOI 10.1068/a271147; Black WR, 1971, GEOGR ANAL, V3; Derrible S, 2009, TRANSPORT RES REC, P17, DOI 10.3141/2112-03; Kuby M, 2004, TRANSPORT RES A-POL, V38, P223, DOI 10.1016/j.tra.2003.10.006; Leng B, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/58004; Levinson D, 2008, J ECON GEOGR, V8, P5577; Levinson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029721; Louf R, 2014, SCI REPORTS IN PRESS; Louf R, 2013, P NATL ACAD SCI USA, V110, P8824, DOI 10.1073/pnas.1222441110; Matsunaka R, 2013, TRANSPORT POLICY, V30, P26, DOI 10.1016/j.tranpol.2013.06.008; Roth C, 2012, J ROYAL SOC INTERFAC, V9; Sienkiewicz J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046127; Von Ferber C, 2009, TRAFFIC GRANULAR FLO; Xie F, 2009, COMPUT ENVIRON URBAN, V33, P211, DOI 10.1016/j.compenvurbsys.2008.09.009	17	50	50	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102007	10.1371/journal.pone.0102007	http://dx.doi.org/10.1371/journal.pone.0102007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029528	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600030
J	Kusner, LL; Ciesielski, MJ; Marx, A; Kaminski, HJ; Fenstermaker, RA				Kusner, Linda L.; Ciesielski, Michael J.; Marx, Alexander; Kaminski, Henry J.; Fenstermaker, Robert A.			Survivin as a Potential Mediator to Support Autoreactive Cell Survival in Myasthenia Gravis: A Human and Animal Model Study	PLOS ONE			English	Article							ACTIVATED T-LYMPHOCYTES; RHEUMATOID-ARTHRITIS; ACETYLCHOLINE-RECEPTOR; MULTIPLE-SCLEROSIS; PROTEIN SURVIVIN; APOPTOSIS; CANCER; INHIBITOR; EXPRESSION; THYMUS	The mechanisms that underlie the development and maintenance of autoimmunity in myasthenia gravis are poorly understood. In this investigation, we evaluate the role of survivin, a member of the inhibitor of apoptosis protein family, in humans and in two animal models. We identified survivin expression in cells with B lymphocyte and plasma cells markers, and in the thymuses of patients with myasthenia gravis. A portion of survivin-expressing cells specifically bound a peptide derived from the alpha subunit of acetylcholine receptor indicating that they recognize the peptide. Thymuses of patients with myasthenia gravis had large numbers of survivin-positive cells with fewer cells in the thymuses of corticosteroid-treated patients. Application of a survivin vaccination strategy in mouse and rat models of myasthenia gravis demonstrated improved motor assessment, a reduction in acetylcholine receptor specific autoantibodies, and a retention of acetylcholine receptor at the neuromuscular junction, associated with marked reduction of survivin-expressing circulating CD20+ cells. These data strongly suggest that survivin expression in cells with lymphocyte and plasma cell markers occurs in patients with myasthenia gravis and in two animal models of myasthenia gravis. Survivin expression may be part of a mechanism that inhibits the apoptosis of autoreactive B cells in myasthenia gravis and other autoimmune disorders.	[Kusner, Linda L.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20037 USA; [Kaminski, Henry J.] George Washington Univ, Dept Neurol, Washington, DC USA; [Ciesielski, Michael J.; Fenstermaker, Robert A.] Roswell Pk Canc Inst, Dept Neurosurg, Buffalo, NY 14263 USA; [Ciesielski, Michael J.; Fenstermaker, Robert A.] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany	George Washington University; George Washington University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Ruprecht Karls University Heidelberg	Kusner, LL (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20037 USA.	lkusner@gwu.edu		Kusner, Linda/0000-0002-5530-2140; Kaminski, Henry/0000-0002-8195-0141	Roswell Park Cancer Institute, Cancer Center Support Grant [NIH-CCSG-CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Roswell Park Cancer Institute, Cancer Center Support Grant; NIH-CCSG-CA016056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, AM J PATHOL, V152, P43; Aguilar LK, 2011, J CELL BIOCHEM, V112, P1969, DOI 10.1002/jcb.23126; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Andersen MH, 2001, CANCER RES, V61, P869; Baggi F, 2012, ARCH IMMUNOL THER EX, V60, P19, DOI 10.1007/s00005-011-0158-6; Benatar M, 2012, MUSCLE NERVE, V45, P909, DOI 10.1002/mus.23330; Bokarewa M, 2005, ARTHRITIS RES THER, V7, pR349, DOI 10.1186/ar1498; Cavalcante P, 2013, AUTOIMMUN REV, V12, P863, DOI 10.1016/j.autrev.2013.03.010; Christadoss P, 2000, CLIN IMMUNOL, V94, P75, DOI 10.1006/clim.1999.4807; Ciesielski MJ, 2008, CANCER IMMUNOL IMMUN, V57, P1827, DOI 10.1007/s00262-008-0510-9; Ciesielski MJ, 2006, CANCER IMMUNOL IMMUN, V55, P1491, DOI 10.1007/s00262-006-0138-6; Ciesielski MJ, 2010, CANCER IMMUNOL IMMUN, V59, P1211, DOI 10.1007/s00262-010-0845-x; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Conway EM, 2000, BLOOD, V95, P1435, DOI 10.1182/blood.V95.4.1435.004k01_1435_1442; Fenstermaker RA, 2014, EXPERT REV VACCINES, V13, P377, DOI 10.1586/14760584.2014.881255; FUJII Y, 1986, J IMMUNOL, V136, P887; Galeotti L, 2008, CLIN EXP RHEUMATOL, V26, P373; Hebb ALO, 2008, MULT SCLER J, V14, P577, DOI 10.1177/1352458507087468; Isgren A, 2012, SEMIN ARTHRITIS RHEU, V41, P652, DOI 10.1016/j.semarthrit.2011.08.005; Khan WN, 2013, IMMUNOL RES, V57, P335, DOI 10.1007/s12026-013-8466-z; Kusner LL, 2013, MUSCLE NERVE, V47, P33, DOI 10.1002/mus.23448; Kyewski B, 2008, ANN NY ACAD SCI, V1132, P157, DOI 10.1196/annals.1405.026; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lang B, 2009, CURR OPIN PHARMACOL, V9, P336, DOI 10.1016/j.coph.2009.04.005; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Marx A, 2012, ANN NY ACAD SCI, V1275, P92, DOI 10.1111/j.1749-6632.2012.06799.x; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; Morgan BP, 2006, CLIN EXP IMMUNOL, V146, P294, DOI 10.1111/j.1365-2249.2006.03205.x; Piddlesden SJ, 1996, J NEUROIMMUNOL, V71, P173, DOI 10.1016/S0165-5728(96)00144-0; Ragheb S, 2008, ARCH NEUROL-CHICAGO, V65, P1358, DOI 10.1001/archneur.65.10.1358; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Sharief MK, 2002, EUR J NEUROL, V9, P503, DOI 10.1046/j.1468-1331.2002.00454.x; Sharief MK, 2001, J NEUROIMMUNOL, V119, P358, DOI 10.1016/S0165-5728(01)00389-7; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Simon-Keller K, 2013, AM J PATHOL, V182, P2121, DOI 10.1016/j.ajpath.2013.02.017; Smith MD, 2010, RHEUMATOLOGY, V49, P862, DOI 10.1093/rheumatology/kep467; Soltys J, 2009, ANN NEUROL, V65, P67, DOI 10.1002/ana.21536; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Tamm I, 1998, CANCER RES, V58, P5315; Thangarajh M, 2006, J NEUROIMMUNOL, V178, P161, DOI 10.1016/j.jneuroim.2006.05.023; Tuzun E, 2003, J IMMUNOL, V171, P3847, DOI 10.4049/jimmunol.171.7.3847; Wu B, 2001, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1508s21	44	27	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102231	10.1371/journal.pone.0102231	http://dx.doi.org/10.1371/journal.pone.0102231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050620	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100022
J	Lamina, C; Haun, M; Coassin, S; Kloss-Brandstatter, A; Gieger, C; Peters, A; Grallert, H; Strauch, K; Meitinger, T; Kedenko, L; Paulweber, B; Kronenberg, F				Lamina, Claudia; Haun, Margot; Coassin, Stefan; Kloss-Brandstaetter, Anita; Gieger, Christian; Peters, Annette; Grallert, Harald; Strauch, Konstantin; Meitinger, Thomas; Kedenko, Lyudmyla; Paulweber, Bernhard; Kronenberg, Florian			A Systematic Evaluation of Short Tandem Repeats in Lipid Candidate Genes: Riding on the SNP-Wave	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION-GENETICS; GILBERTS-SYNDROME; HEART-DISEASE; SHADOW BANDS; CETP GENE; POLYMORPHISM; CAUCASIANS; IMPUTATION; EVOLUTION	Structural genetic variants as short tandem repeats (STRs) are not targeted in SNP-based association studies and thus, their possible association signals are missed. We systematically searched for STRs in gene regions known to contribute to total cholesterol, HDL cholesterol, LDL cholesterol and triglyceride levels in two independent studies (KORA F4, n = 2553 and SAPHIR, n = 1648), resulting in 16 STRs that were finally evaluated. In a combined dataset of both studies, the sum of STR alleles was regressed on each phenotype, adjusted for age and sex. The association analyses were repeated for SNPs in a 200 kb region surrounding the respective STRs in the KORA F4 Study. Three STRs were significantly associated with total cholesterol (within LDLR, the APOA1/C3/A4/A5/BUD13 gene region and ABCG5/8), five with HDL cholesterol (3 within CETP, one in LPL and one inAPOA1/C3/A4/A5/BUD13), three with LDL cholesterol (LDLR, ABCG5/8 and CETP) and two with triglycerides (APOA1/C3/A4/A5/BUD13 and LPL). None of the investigated STRs, however, showed a significant association after adjusting for the lead or adjacent SNPs within that gene region. The evaluated STRs were found to be well tagged by the lead SNP within the respective gene regions. Therefore, the STRs reflect the association signals based on surrounding SNPs. In conclusion, none of the STRs contributed additionally to the SNP-based association signals identified in GWAS on lipid traits.	[Lamina, Claudia; Haun, Margot; Coassin, Stefan; Kloss-Brandstaetter, Anita; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Mol Epidemiol, Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Kedenko, Lyudmyla; Paulweber, Bernhard] Paracelsus Private Med Univ Salzburg, Dept Internal Med 1, Salzburg, Austria	Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Paracelsus Private Medical University	Kronenberg, F (corresponding author), Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	Florian.Kronenberg@i-med.ac.at	Meitinger, Thomas/O-1318-2015; Grallert, Harald/B-3424-2013; Kronenberg, Florian/B-1736-2008; Lamina, Claudia/F-7608-2010; Coassin, Stefan/J-2611-2018; Peters, Annette/A-6117-2011	Kronenberg, Florian/0000-0003-2229-1120; Lamina, Claudia/0000-0002-5398-5806; Coassin, Stefan/0000-0001-5677-8979; Peters, Annette/0000-0001-6645-0985; Meitinger, Thomas/0000-0002-8838-8403; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Gieger, Christian/0000-0001-6986-9554	"Genomics of Lipid-associated Disorders - GOLD" of the "Austrian Genome Research Programme GEN-AU"; Austrian Science Fund (FWF) [P 26660-B13]	"Genomics of Lipid-associated Disorders - GOLD" of the "Austrian Genome Research Programme GEN-AU"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the "Genomics of Lipid-associated Disorders - GOLD" of the "Austrian Genome Research Programme GEN-AU" to FK and by a grant from the Austrian Science Fund (FWF) P 26660-B13 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BODOWLE B, 1995, J FORENSIC SCI, V40, P45; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gulcher Jeffrey, 2012, Cold Spring Harb Protoc, V2012, P425, DOI 10.1101/pdb.top068510; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Hersberger M, 2010, HUM IMMUNOL, V71, P1154, DOI 10.1016/j.humimm.2010.08.008; Hsieh TY, 2007, PHARMACOGENET GENOM, V17, P229, DOI 10.1097/FPC.0b013e328012d0da; Kamstrup PR, 2008, J CLIN ENDOCR METAB, V93, P3769, DOI 10.1210/jc.2008-0830; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Lamina C, 2012, ATHEROSCLEROSIS, V225, P363, DOI 10.1016/j.atherosclerosis.2012.09.016; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lira ME, 2004, BBA-MOL CELL BIOL L, V1684, P38, DOI 10.1016/j.bbalip.2004.06.002; LITT M, 1993, BIOTECHNIQUES, V15, P280; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; MURRAY V, 1993, NUCLEIC ACIDS RES, V21, P2395, DOI 10.1093/nar/21.10.2395; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; PESTONI C, 1995, INT J LEGAL MED, V107, P283, DOI 10.1007/BF01246874; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rosby O, 2000, J INTERN MED, V247, P139, DOI 10.1046/j.1365-2796.2000.00628.x; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Talmud PJ, 2000, CIRCULATION, V101, P2461, DOI 10.1161/01.CIR.101.21.2461; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson JF, 2003, ATHEROSCLEROSIS, V167, P195, DOI 10.1016/S0021-9150(03)00005-4; TROMMSDORFF M, 1995, J CLIN INVEST, V96, P150, DOI 10.1172/JCI118015; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102113	10.1371/journal.pone.0102113	http://dx.doi.org/10.1371/journal.pone.0102113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050552	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100021
J	Lu, X; Deng, YS; Yu, DH; Cao, HM; Wang, L; Liu, L; Yu, CJ; Zhang, YP; Guo, XM; Yu, G				Lu, Xi; Deng, Yushuang; Yu, Daohai; Cao, Huiming; Wang, Li; Liu, Li; Yu, Caijia; Zhang, Yuping; Guo, Xiuming; Yu, Gang			Histone Acetyltransferase p300 Mediates Histone Acetylation of PS1 and BACE1 in a Cellular Model of Alzheimer's Disease	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; EPIGENETIC MECHANISMS; PRECURSOR PROTEIN; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSGENIC MICE; BETA PRODUCTION; SH-SY5Y CELLS; MEMORY; CURCUMIN	Epigenetic modifications, particularly histone acetylation, have been implicated in Alzheimer's disease (AD). While previous studies have suggested that histone hypoacetylation may regulate the expression of genes associated with memory and learning in AD, little is known about histone regulation of AD-related genes such as Presenilin 1(PS1) and beta-site amyloid precursor protein cleaving enzyme 1(BACE1). By utilizing neuroblastoma N2a cells transfected with Swedish mutated human amyloid precursor protein (APP) (N2a/APPswe) and wild-type APP (N2a/APPwt) as cellular models of AD, we examined the alterations of histone acetylation at the promoter regions of PS1 and BACE1 in these cells. Our results revealed that histone H3 acetylation in PS1 and BACE1 promoters is markedly increased in N2a/APPswe cells when compared to N2a/APPwt cells and control cells (vector-transfected), respectively, causing the elevated expression of PS1 and BACE1. In addition, expression of histone acetyltransferase (HAT) adenoviral E1A-associated 300-kDa protein (p300) is dramatically enhanced in N2a/APPswe cells compared to N2a/APPwt and control cells. We have further demonstrated the direct binding of p300 protein to the PS1 and BACE1 promoters in N2a/APPswe cells. The expression levels of H3 acetylation of the PS1 and BACE1 promoters and p300 protein, however, were found to be not significantly different in N2a/APPwt cells when compared to controls in our studies. Furthermore, curcumin, a natural selective inhibitor of p300 in HATs, significantly suppressed the expression of PS1 and BACE1 through inhibition of H3 acetylation in their promoter regions in N2a/APPswe cells. These findings indicated that histone acetyltransferase p300 plays a critical role in controlling the expression of AD-related genes through regulating the acetylation of their promoter regions, suggesting that p300 may represent a novel potential therapeutic target for AD.	[Lu, Xi; Deng, Yushuang; Cao, Huiming; Zhang, Yuping; Guo, Xiuming; Yu, Gang] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Lu, Xi; Deng, Yushuang; Cao, Huiming] Chongqing Med Univ, Affiliated Hosp 1, Lab Res Ctr, Chongqing, Peoples R China; [Yu, Daohai] Temple Univ, Sch Med, Dept Clin Sci, Philadelphia, PA 19122 USA; [Wang, Li] Chingqing Canc Inst, Dept Biotherapy & Hematooncol, Chongqing, Peoples R China; [Liu, Li] Chongqing Hosp Tradit Chinese Med, Dept Neurol, Chongqing, Peoples R China; [Yu, Caijia] Northwestern Univ, Evanston, IL USA	Chongqing Medical University; Chongqing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Northwestern University	Yu, G (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	gangyuw2013@126.com			Chongqing Natural Science Foundation [CSTC, 2012JJA10044]	Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was supported by the Chongqing Natural Science Foundation (No. CSTC, 2012JJA10044; http://www.cstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Belkacemi A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002055; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Coulson DTR, 2010, J ALZHEIMERS DIS, V22, P1111, DOI 10.3233/JAD-2010-101254; Goodman RH, 2000, GENE DEV, V14, P1553; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graff J, 2009, EUR J NEUROSCI, V30, P1, DOI 10.1111/j.1460-9568.2009.06787.x; Gu XL, 2013, NEUROBIOL AGING, V34, P1069, DOI 10.1016/j.neurobiolaging.2012.10.013; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guo X, 2011, NEUROSCIENCE, V194, P272, DOI 10.1016/j.neuroscience.2011.07.012; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Liu RG, 2012, NEUROBIOL DIS, V45, P902, DOI 10.1016/j.nbd.2011.12.007; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marques SCF, 2012, NEUROSCIENCE, V220, P256, DOI 10.1016/j.neuroscience.2012.06.029; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miller G, 2010, SCIENCE, V329, P27, DOI 10.1126/science.329.5987.27; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Sun HC, 2010, LIFE SCI, V87, P707, DOI 10.1016/j.lfs.2010.10.009; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019229; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xia XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048673; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Zhang C, 2010, J BIOL CHEM, V285, P28472, DOI 10.1074/jbc.M110.133520	33	36	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103067	10.1371/journal.pone.0103067	http://dx.doi.org/10.1371/journal.pone.0103067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051175	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100083
J	Zhou, J; Zheng, GY; Zhang, XY; Zhou, LX				Zhou, Jun; Zheng, Guanyu; Zhang, Xueying; Zhou, Lixiang			Influences of Extracellular Polymeric Substances on the Dewaterability of Sewage Sludge during Bioleaching	PLOS ONE			English	Article							WASTE-WATER SLUDGE; ACTIVATED-SLUDGE; AEROBIC DIGESTION; HEAVY-METALS; BORNE METALS; EPS; IRON; PH; SETTLEABILITY; THIOBACILLUS	Extracellular polymeric substances (EPS) play important roles in regulating the dewaterability of sludge. This study sought to elucidate the influence of EPS on the dewaterability of sludge during bioleaching process. Results showed that, in bioleaching system with the co-inoculation of Acidithiobacillus thiooxidans TS6 and Acidithiobacillus ferrooxidans LX5 (A. t+A. f system), the capillary suction time (CST) of sludge reduced from 255.9 s to 25.45 s within 48 h, which was obviously better than the controls. The correlation analysis between sludge CST and sludge EPS revealed that the sludge EPS significantly impacted the dewaterability of sludge. Sludge CST had correlation with protein content in slime and both protein and polysaccharide contents in TB-EPS and Slime+LB+TB layers, and the decrease of protein content in slime and decreases of both protein and polysaccharide contents in TB-EPS and Slime+LB+TB layers improved sludge dewaterability during sludge bioleaching process. Moreover, the low sludge pH (2.92) and the increasing distribution of Fe in the solid phase were another two factors responsible for the improvement of sludge dewaterability during bioleaching. This study suggested that during sludge bioleaching the growth of Acidithiobacillus species resulted in the decrease of sludge pH, the increasing distribution of Fe in the solid phase, and the decrease of EPS content (mainly including protein and/or polysaccharide) in the slime, TB-EPS, and Slime+LB+TB layers, all of which are helpful for sludge dewaterability enhancement.	[Zhou, Jun; Zheng, Guanyu; Zhou, Lixiang] Nanjing Agr Univ, Coll Resources & Environm Sci, Dept Environm Engn, Nanjing, Jiangsu, Peoples R China; [Zhou, Jun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Zheng, Guanyu; Zhou, Lixiang] Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Nanjing, Jiangsu, Peoples R China; [Zhang, Xueying] Nanjing Tech Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Tech University; Nanjing Tech University	Zhou, LX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Dept Environm Engn, Nanjing, Jiangsu, Peoples R China.	lxzhou@njau.edu.cn	Zhou, Li/GSE-4531-2022		National Natural Science Foundation of China [21177060, 21207065]; Jiangsu Province Science Foundation for Youths [BK20130931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science Foundation for Youths	This work was supported by National Natural Science Foundation of China (21177060, 21207065), and the Jiangsu Province Science Foundation for Youths (BK20130931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MZ, 2003, WATER RES, V37, P1118, DOI 10.1016/S0043-1354(02)00452-9; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Cetin S, 2004, WATER SCI TECHNOL, V50, P49, DOI 10.2166/wst.2004.0532; Chen YG, 2001, WATER RES, V35, P2615, DOI 10.1016/S0043-1354(00)00565-0; Comte S, 2007, J HAZARD MATER, V140, P129, DOI 10.1016/j.jhazmat.2006.06.058; Deveci H, 2004, HYDROMETALLURGY, V73, P293, DOI 10.1016/j.hydromet.2003.12.001; Fang D, 2006, WATER AIR SOIL POLL, V171, P81, DOI 10.1007/s11270-005-9014-9; FROLUND B, 1995, APPL MICROBIOL BIOT, V43, P755, DOI 10.1007/s002530050481; Gaudy A.F., 1962, IND WATER WASTES, V7, P17; Houghton JI, 2001, WATER SCI TECHNOL, V44, P373, DOI 10.2166/wst.2001.0792; Jin B, 2004, CHEM ENG J, V98, P115, DOI 10.1016/j.cej.2003.05.002; Lee CH, 2000, WATER RES, V34, P4430, DOI 10.1016/S0043-1354(00)00209-8; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liao BQ, 2001, WATER RES, V35, P339, DOI 10.1016/S0043-1354(00)00277-3; Liao YH, 2009, APPL GEOCHEM, V24, P1739, DOI 10.1016/j.apgeochem.2009.05.003; Liu Fen-wu, 2011, Huanjing Kexue, V32, P2993; Liu FW, 2012, J HAZARD MATER, V221, P170, DOI 10.1016/j.jhazmat.2012.04.028; Liu XM, 2010, ENVIRON SCI TECHNOL, V44, P4355, DOI 10.1021/es9016766; Lo IMC, 2001, ENVIRON SCI TECHNOL, V35, P4691, DOI 10.1021/es010834x; Lombardi AT, 2002, WATER RES, V36, P3193, DOI 10.1016/S0043-1354(02)00008-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmoud A, 2011, WATER RES, V45, P2795, DOI 10.1016/j.watres.2011.02.029; Neyens E, 2004, J HAZARD MATER, V106, P83, DOI 10.1016/j.jhazmat.2003.11.014; Novak JT, 2003, WATER RES, V37, P3136, DOI 10.1016/S0043-1354(03)00171-4; Olson GJ, 2003, APPL MICROBIOL BIOT, V63, P249, DOI 10.1007/s00253-003-1404-6; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Subramanian SB, 2010, WATER RES, V44, P2253, DOI 10.1016/j.watres.2009.12.046; Sun YD, 1999, VET MICROBIOL, V65, P153, DOI 10.1016/S0378-1135(98)00286-7; Wang SM, 2010, WATER RES, V44, P5423, DOI 10.1016/j.watres.2010.06.055; Wong JWC, 2002, WATER AIR SOIL POLL, V138, P25, DOI 10.1023/A:1015503828607; Yu GH, 2008, ENVIRON SCI TECHNOL, V42, P7944, DOI 10.1021/es8016717; Yu GH, 2008, WATER RES, V42, P1925, DOI 10.1016/j.watres.2007.11.022; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhang ZQ, 2010, WATER RES, V44, P3087, DOI 10.1016/j.watres.2010.02.033; Zheng GY, 2011, WATER RES, V45, P5295, DOI 10.1016/j.watres.2011.07.031; Zheng GY, 2009, ENVIRON SCI TECHNOL, V43, P4151, DOI 10.1021/es803062r; Zhou J, 2012, ENVIRON TECHNOL, V33, P2553, DOI 10.1080/09593330.2012.668944	37	16	21	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102688	10.1371/journal.pone.0102688	http://dx.doi.org/10.1371/journal.pone.0102688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050971	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100048
J	Ali, BH; Al-Salam, S; Al Za'abi, M; Al Balushi, KA; Ramkumar, A; Waly, MI; Yasin, J; Adham, SA; Nemmar, A				Ali, Badreldin H.; Al-Salam, Suhail; Al Za'abi, Mohammed; Al Balushi, Khalid A.; Ramkumar, Aishwarya; Waly, Mostafa I.; Yasin, Javid; Adham, Sirin A.; Nemmar, Abderrahim			Does Swimming Exercise Affect Experimental Chronic Kidney Disease in Rats Treated with Gum Acacia?	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; OXIDATIVE STRESS BIOMARKERS; WATER-BASED EXERCISE; DAMAGE; HEMODIALYSIS; HEALTH; CKD	Different modes of exercise are reported to be beneficial in subjects with chronic kidney disease (CKD). Similar benefits have also been ascribed to the dietary supplement gum acacia (GA). Using several physiological, biochemical, immunological, and histopathological measurements, we assessed the effect of swimming exercise (SE) on adenine -induced CKD, and tested whether SE would influence the salutary action of GA in rats with CKD. Eight groups of rats were used, the first four of which were fed normal chow for 5 weeks, feed mixed with adenine (0.25% w/w) to induce CKD, GA in the drinking water (15% w/v), or were given adenine plus GA, as above. Another four groups were similarly treated, but were subjected to SE during the experimental period, while the first four groups remained sedentary. The pre-SE program lasted for four days (before the start of the experimental treatments), during which the rats were made to swim for 5 to 10 min, and then gradually extended to 20 min per day. Thereafter, the rats in the 5th, 6th, 7th, and 8th groups started to receive their respective treatments, and were subjected to SE three days a week for 45 min each. Adenine induced the typical signs of CKD as confirmed by histopathology, and the other measurements, and GA significantly ameliorated all these signs. SE did not affect the salutary action of GA on renal histology, but it partially improved some of the above biochemical and physiological analytes, suggesting that addition of this mode of exercise to GA supplementation may improve further the benefits of GA supplementation.	[Ali, Badreldin H.; Al Za'abi, Mohammed; Al Balushi, Khalid A.; Ramkumar, Aishwarya] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman; [Al-Salam, Suhail] Coll Med & Hlth Sci, Dept Pathol, Alin, U Arab Emirates; [Waly, Mostafa I.] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Food Sci & Nutr, Muscat, Oman; [Yasin, Javid] Coll Med & Hlth Sci, Dept Med, Alin, U Arab Emirates; [Adham, Sirin A.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Nemmar, Abderrahim] Coll Med & Hlth Sci, Dept Physiol, Alin, U Arab Emirates	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University	Ali, BH (corresponding author), Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman.	alibadreldin@hotmail.com	Za'abi, Mohammed Al/C-6591-2013; Adham, Sirin A/ABB-8842-2020; PATHAN, JAVED YASIN/GOE-4396-2022; Waly, Mostafa/P-7516-2016	Za'abi, Mohammed Al/0000-0002-2019-1022; Adham, Sirin A/0000-0002-8349-6202; Waly, Mostafa/0000-0002-8197-3378; PATHAN, JAVED YASIN/0000-0002-5867-2833; Al-Salam, Suhail/0000-0003-0109-5964; Al Balushi, Khalid/0000-0003-4638-8787	Research Council of Oman [RC/Med/Phar/10/01]; Sultan Qaboos University (SQU)	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Sultan Qaboos University (SQU)	This work was financially supported by a grant from the Research Council of Oman (RC/Med/Phar/10/01), and the Sultan Qaboos University (SQU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Za'abi M, 2013, J CHROMATOGR SCI, V51, P40, DOI 10.1093/chromsci/bms103; Ali AA, 2008, NAT PROD RES, V22, P12, DOI 10.1080/14786410500463544; Ali BH, 2014, PHYSIOL RES, V63, P351, DOI 10.33549/physiolres.932685; Ali BH, 2013, J PHARMACOL TOX MET, V68, P384, DOI 10.1016/j.vascn.2013.05.001; Ali BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055242; Ali BH, 2011, PHYTOMEDICINE, V18, P1176, DOI 10.1016/j.phymed.2011.03.005; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali BH, 2009, FOOD CHEM TOXICOL, V47, P1, DOI 10.1016/j.fct.2008.07.001; Babiker R, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-111; Neto OB, 2013, J SPORT SCI MED, V12, P52; Briasoulis A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0340-4; Bronas UG, 2009, ADV CHRONIC KIDNEY D, V16, P449, DOI 10.1053/j.ackd.2009.07.005; Cechella JL, 2014, AMINO ACIDS IN PRESS; Clapp EL, 2012, PEDIATR NEPHROL, V27, P165, DOI 10.1007/s00467-010-1753-1; Deminice R, 2010, J SPORT MED PHYS FIT, V50, P356; Deminice R, 2012, AMINO ACIDS, V43, P709, DOI 10.1007/s00726-011-1121-x; Diwan V, 2013, J PHARMACOL TOX MET, V68, P197, DOI 10.1016/j.vascn.2013.05.006; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Gegentonglaga, 2013, LIFE SCI, V93, P773, DOI 10.1016/j.lfs.2013.09.022; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; Heiwe S, 2011, COCHRANE DB SYST REV, V5; Heiwe S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003236.pub2; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Howden EJ, 2012, SPORTS MED, V42, P473, DOI 10.2165/11630800-000000000-00000; Ishikawa Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/702948; Johansen KL, 2012, AM J KIDNEY DIS, V59, P126, DOI 10.1053/j.ajkd.2011.10.008; Knight SF, 2010, AM J PHYSIOL-RENAL, V298, pF86, DOI 10.1152/ajprenal.00351.2009; Koufaki P, 2002, CLIN PHYSIOL FUNCT I, V22, P115, DOI 10.1046/j.1365-2281.2002.00405.x; Kucukkoylu S, 2013, DEUT MED WOCHENSCHR, V138, P721, DOI 10.1055/s-0032-1332979; Kutner NG, 2007, INT UROL NEPHROL, V39, P1281, DOI 10.1007/s11255-007-9281-z; Luiz Rda S, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0055363; Meredith-Jones K, 2011, COMPLEMENT THER MED, V19, P93, DOI 10.1016/j.ctim.2011.02.002; Mosawi AJ, 2009, CLIN EXP NEPHROL, V13, P494, DOI 10.1007/s10157-009-0181-7; Pechter U, 2003, INT J REHABIL RES, V26, P153, DOI 10.1097/01.mrr.0000070755.63544.5a; Peng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037388; Ranadive SM, 2014, EXP PHYSL IN PRESS; Sakr HF, 2013, J PHYSIOL PHARMACOL, V64, P231; Segura-Orti E, 2010, SEMIN DIALYSIS, V23, P422, DOI 10.1111/j.1525-139X.2010.00766.x; Smart N, 2011, NEPHROLOGY, V16, P626, DOI 10.1111/j.1440-1797.2011.01471.x; Tanaka H, 2009, SPORTS MED, V39, P377, DOI 10.2165/00007256-200939050-00004	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102528	10.1371/journal.pone.0102528	http://dx.doi.org/10.1371/journal.pone.0102528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048380	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100041
J	Finn, AS; Lee, T; Kraus, A; Kam, CLH				Finn, Amy S.; Lee, Taraz; Kraus, Allison; Kam, Carla L. Hudson			When It Hurts (and Helps) to Try: The Role of Effort in Language Learning	PLOS ONE			English	Article							WORKING-MEMORY; SPEECH SEGMENTATION; COGNITIVE CONTROL; CRITICAL PERIOD; IMPLICIT; ACQUISITION; ATTENTION; CONSTRAINTS; BRAIN; INFORMATION	Compared to children, adults are bad at learning language. This is counterintuitive; adults outperform children on most measures of cognition, especially those that involve effort (which continue to mature into early adulthood). The present study asks whether these mature effortful abilities interfere with language learning in adults and further, whether interference occurs equally for aspects of language that adults are good (word-segmentation) versus bad (grammar) at learning. Learners were exposed to an artificial language comprised of statistically defined words that belong to phonologically defined categories (grammar). Exposure occurred under passive or effortful conditions. Passive learners were told to listen while effortful learners were instructed to try to 1) learn the words, 2) learn the categories, or 3) learn the category-order. Effortful learners showed an advantage for learning words while passive learners showed an advantage for learning the categories. Effort can therefore hurt the learning of categories.	[Finn, Amy S.] MIT, Dept Brain & Cognit Sci, Boston, MA USA; [Lee, Taraz] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Kraus, Allison] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Kam, Carla L. Hudson] Univ British Columbia, Dept Linguist, Vancouver, BC V5Z 1M9, Canada	Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; Stanford University; University of British Columbia	Finn, AS (corresponding author), MIT, Dept Brain & Cognit Sci, Boston, MA USA.	amyfinn@mit.edu		Lee, Taraz/0000-0002-3186-8625; Hudson Kam, Carla/0000-0002-7638-3656	National Institute of Child Health and Human Development [048572]; National Science Foundation (GRFP)	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation (GRFP)(National Science Foundation (NSF))	This research was funded by the National Institute of Child Health and Human Development (048572 to C.L.H.K.) and the National Science Foundation (GRFP to A.S.F.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amso D, 2012, DEV PSYCHOBIOL, V54, P664, DOI 10.1002/dev.20587; Arnon I, 2012, COGNITION, V122, P292, DOI 10.1016/j.cognition.2011.10.009; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Cochran BP, 1999, J MEM LANG, V41, P30, DOI 10.1006/jmla.1999.2633; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cowan N, 1999, INT J PSYCHOL, V34, P353, DOI 10.1080/002075999399684; Cowan Nelson, 2005, WORKING MEMORY CAPAC; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; ELMAN JL, 1993, COGNITION, V48, P71, DOI 10.1016/0010-0277(93)90058-4; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Fernandes T, 2010, ATTEN PERCEPT PSYCHO, V72, P1522, DOI 10.3758/APP.72.6.1522; Finn AS, 2008, COGNITION, V108, P477, DOI 10.1016/j.cognition.2008.04.002; Finn AS, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00085; FLEGE JE, 1995, J ACOUST SOC AM, V97, P3125, DOI 10.1121/1.413041; Fletcher PC, 2005, CEREB CORTEX, V15, P1002, DOI 10.1093/cercor/bhh201; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Ghetti S, 2008, CHILD DEV, V79, P339, DOI 10.1111/j.1467-8624.2007.01129.x; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Howard DV, 2001, PSYCHON B REV, V8, P798, DOI 10.3758/BF03196220; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Katz J., 2005, SOFTVOICE DEMO PROGR; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Leow RP, 2008, LANG LEARN, V58, P665, DOI 10.1111/j.1467-9922.2008.00453.x; Leow RP, 2001, LANG LEARN, V51, P113, DOI 10.1111/j.1467-1770.2001.tb00016.x; MARCHMAN VA, 1993, J COGNITIVE NEUROSCI, V5, P215, DOI 10.1162/jocn.1993.5.2.215; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; Mintz TH, 2002, MEM COGNITION, V30, P678, DOI 10.3758/BF03196424; Munakata Y, 2012, CURR DIR PSYCHOL SCI, V21, P71, DOI 10.1177/0963721412436807; Newman R, 2006, DEV PSYCHOL, V42, P643, DOI 10.1037/0012-1649.42.4.643; Newport E. L., 2001, LANGUAGE BRAIN COGNI, P481, DOI DOI 10.1067/MHN.2001.115372; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Ramscar M, 2007, TRENDS COGN SCI, V11, P274, DOI 10.1016/j.tics.2007.05.007; Ramscar M, 2013, PSYCHOL SCI, V24, P1017, DOI 10.1177/0956797612460691; REBER AS, 1976, J EXP PSYCHOL-HUM L, V2, P88, DOI 10.1037/0278-7393.2.1.88; Reeder PA, 2013, COGNITIVE PSYCHOL, V66, P30, DOI 10.1016/j.cogpsych.2012.09.001; Rohde DLT, 2003, STUD DEV PSYCHOL, P160; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; Saffran JR, 2003, INFANCY, V4, P273, DOI 10.1207/S15327078IN0402_07; Saffran JR, 2001, J MEM LANG, V44, P493, DOI 10.1006/jmla.2000.2759; Schneider W., 2002, E PRIME USERS GUIDE; Singh L, 2012, DEVELOPMENTAL SCI, V15, P482, DOI 10.1111/j.1467-7687.2012.01141.x; Singleton JL, 2004, COGNITIVE PSYCHOL, V49, P370, DOI 10.1016/j.cogpsych.2004.05.001; SNOW CE, 1978, CHILD DEV, V49, P1114, DOI 10.2307/1128751; Thompson SP, 2007, LANG LEARN DEV, V3, P1, DOI 10.1080/15475440709336999; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Toro JM, 2005, PERCEPTION PSYCHOPHY, V67; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Wainwright A, 2005, DEV NEUROPSYCHOL, V27, P237, DOI 10.1207/s15326942dn2702_3; Willingham DB, 1999, PSYCHOL SCI, V10, P531, DOI 10.1111/1467-9280.00201; Wilson S. T., 2013, LEARNING SYNTAX STAT; Yurovsky D, 2013, DEVELOPMENTAL SCI, V16, P149, DOI 10.1111/desc.12011	63	30	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101806	10.1371/journal.pone.0101806	http://dx.doi.org/10.1371/journal.pone.0101806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25047901	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100016
J	Hill, KR; Wood, BM; Baggio, J; Hurtado, AM; Boyd, RT				Hill, Kim R.; Wood, Brian M.; Baggio, Jacopo; Hurtado, A. Magdalena; Boyd, Robert T.			Hunter-Gatherer Inter-Band Interaction Rates: Implications for Cumulative Culture	PLOS ONE			English	Article							SOCIAL NETWORKS; EVOLUTION; COOPERATION; DEMOGRAPHY	Our species exhibits spectacular success due to cumulative culture. While cognitive evolution of social learning mechanisms may be partially responsible for adaptive human culture, features of early human social structure may also play a role by increasing the number potential models from which to learn innovations. We present interview data on interactions between same-sex adult dyads of Ache and Hadza hunter-gatherers living in multiple distinct residential bands (20 Ache bands; 42 Hadza bands; 1201 dyads) throughout a tribal home range. Results show high probabilities (5%-29% per year) of cultural and cooperative interactions between randomly chosen adults. Multiple regression suggests that ritual relationships increase interaction rates more than kinship, and that affinal kin interact more often than dyads with no relationship. These may be important features of human sociality. Finally, yearly interaction rates along with survival data allow us to estimate expected lifetime partners for a variety of social activities, and compare those to chimpanzees. Hadza and Ache men are estimated to observe over 300 men making tools in a lifetime, whereas male chimpanzees interact with only about 20 other males in a lifetime. High intergroup interaction rates in ancestral humans may have promoted the evolution of cumulative culture.	[Hill, Kim R.; Baggio, Jacopo; Hurtado, A. Magdalena; Boyd, Robert T.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Wood, Brian M.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	Arizona State University; Arizona State University-Tempe; Yale University	Hill, KR (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	Kim.Hill@asu.edu	Baggio, Jacopo/AAE-8674-2019; Wood, Brian/AAQ-4410-2020	Baggio, Jacopo/0000-0002-9616-4143; Wood, Brian/0000-0002-8187-9429	National Science Foundation [BCS1062879]; Arizona State University; Division Of Behavioral and Cognitive Sci [1062879] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Arizona State University; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was funded by a Late Lessons Grant from Arizona State University and National Science Foundation Grant BCS1062879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MANY FRIENDS DOES ON; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Guemple DL, 1972, ALLIANCE ESKIMO SOC; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Hill K, 2002, HUM NATURE-INT BIOS, V13, P105, DOI 10.1007/s12110-002-1016-3; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hrdy S., 2009, MOTHERS OTHERS; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; MCMILLAN G, 2001, THESIS U NEW MEXICO; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Radcliffe-Brown A. R., 1952, STRUCTURE FUNCTION P; Service E.R., 1962, PRIMITIVE SOCIAL ORG; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wiessner P, 1998, CURR ANTHROPOL, V39, P514, DOI 10.1086/204763; Wiessner P., 1977, THESIS U MICHIGAN; Wiessner P, 2014, P NATL ACAD IN PRESS; Wiessner P, 2009, ORIG HUM BEHAV, V2, P251; Yengoyan AA., 1968, MAN HUNTER, P185	29	116	116	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102806	10.1371/journal.pone.0102806	http://dx.doi.org/10.1371/journal.pone.0102806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25047714	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100075
J	Olivola, E; Pierantozzi, M; Imbriani, P; Liguori, C; Bassi, MS; Conti, M; D'Angelo, V; Mercuri, NB; Stefani, A				Olivola, Enrica; Pierantozzi, Mariangela; Imbriani, Paola; Liguori, Claudio; Bassi, Mario Stampanoni; Conti, Marco; D'Angelo, Vincenza; Mercuri, Nicola Biagio; Stefani, Alessandro			Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart	PLOS ONE			English	Article							DOPA-INDUCED DYSKINESIAS; PARKINSONS-DISEASE; DEPRESSIVE SYMPTOMS; CEREBROSPINAL-FLUID; DYSFUNCTION; MOTOR; METABOLISM; BINDING; SYSTEM; PET	In Parkinson's disease (PD), several studies have detected an impaired serotonin (5-HT) pathway, likely affecting both motor and non-motor domains. However, the precise impact of 5-HT impairment is far from established. Here, we have used a HPLC chromatographic method, in a homogenous cohort (n = 35) of non fluctuating, non dyskinetic PD patients, to assess the concentration of 5-HT and its metabolite 5-HIAA in peripheral cerebrospinal fluid (CSF) obtained from lumbar puncture (LP). LP was performed following three days of therapy withdrawal, in order to vanish the effects of prolonged released dopamine agonists (DA), and in absence of any serotonergic agent. The PD patient group showed a significantly reduced CSF level of both 5-HT and 5-HIAA compared to either age-matched control subjects (n = 18), or Alzheimer's disease patients (n = 20). However, no correlation emerged between 5-HT/5-HIAA concentrations and UPDRS-III (r = -0.12), disease duration (r = -0.1), age (r = -0.27) and MMSE (r = 0.11). Intriguingly, low CSF 5-HT levels did not differ for gender or for motor phenotype (in terms of non-tremor dominant subtype and tremor dominant subtype). Further, low CSF 5-HT levels did not correlate with the presence of depression, apathy or sleep disturbance. Our findings support the contention that 5-HT impairment is a cardinal feature of stable PD, probably representing a hallmark of diffuse Lewy bodies deposition in the brainstem. However, clinical relevance remains uncertain. Given these findings, an add-on therapy with serotonergic agents seems questionable in PD patients, or should be individually tailored, unless severe depression is present.	[Olivola, Enrica; Pierantozzi, Mariangela; Imbriani, Paola; Bassi, Mario Stampanoni; Conti, Marco; D'Angelo, Vincenza; Stefani, Alessandro] Univ Roma Tor Vergata, Movement Disorder Ctr, Dept Syst Med, Rome, Italy; [Imbriani, Paola; Mercuri, Nicola Biagio; Stefani, Alessandro] IRCCS Fdn, Rome, Italy; [Liguori, Claudio; Mercuri, Nicola Biagio] Univ Roma Tor Vergata, Dept Syst Med, Neurophysiopathol Unit, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Stefani, A (corresponding author), Univ Roma Tor Vergata, Movement Disorder Ctr, Dept Syst Med, Rome, Italy.	stefani@uniroma2.it	Imbriani, Paola/J-2984-2018; Pierantozzi, Mariangela/J-6905-2018; Imbriani, Paola/AAY-8754-2020; Stampanoni Bassi, Mario/ABI-7367-2020; Olivola, Enrica/AAB-3554-2019; Mercuri, Nicola Biagio/K-5348-2016	Imbriani, Paola/0000-0003-3373-5073; Stampanoni Bassi, Mario/0000-0003-4664-850X; Mercuri, Nicola Biagio/0000-0001-6700-7491; Olivola, Enrica/0000-0002-6530-8132; STEFANI, ALESSANDRO/0000-0002-1806-8922; PIERANTOZZI, MARIANGELA/0000-0002-4507-4666; Conti, Marco/0000-0001-8260-4753; D'Angelo, Vincenza/0000-0002-7720-8913	Lundbeck; Medtronic	Lundbeck(Lundbeck Corporation); Medtronic(Medtronic)	The author(s) received no specific funding for this work, asides personnel grants to AS; the grants to AS were liberal contribution from Lundbeck and Medtronic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo WF, 2004, MOVEMENT DISORD, V19, P571, DOI 10.1002/mds.10714; Ballanger B, 2012, MOVEMENT DISORD, V27, P84, DOI 10.1002/mds.23895; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Bedard C, 2011, PARKINSONISM RELAT D, V17, P593, DOI 10.1016/j.parkreldis.2011.05.012; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; CHIA LG, 1993, J NEUROL SCI, V116, P125, DOI 10.1016/0022-510X(93)90316-Q; Engelborghs S, 2004, J NEUROL NEUROSUR PS, V75, P1080; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Guttman M, 2007, EUR J NEUROL, V14, P523, DOI 10.1111/j.1468-1331.2007.01727.x; Huot P., 2012, NEUROBIOL AGING, V33; Huot P, 2011, PROG NEUROBIOL, V95, P163, DOI 10.1016/j.pneurobio.2011.08.004; Kerenyi L, 2003, ARCH NEUROL-CHICAGO, V60, P1223, DOI 10.1001/archneur.60.9.1223; Kish SJ, 2003, ADV NEUROL, V91, P39; KOSTIC VS, 1987, J NEUROL, V234, P94, DOI 10.1007/BF00314109; Kuhn W, 1996, J NEURAL TRANSM, V103, P1441, DOI 10.1007/BF01271258; LEWITT PA, 1992, NEUROLOGY, V42, P2111, DOI 10.1212/WNL.42.11.2111; Loane C, 2013, NEUROLOGY, V80, P1850, DOI 10.1212/WNL.0b013e318292a31d; Lunardi G, 2009, PARKINSONISM RELAT D, V15, P383, DOI 10.1016/j.parkreldis.2008.10.001; MAYEUX R, 1984, NEUROLOGY, V34, P642, DOI 10.1212/WNL.34.5.642; Meco G, 2003, CLIN NEUROPHARMACOL, V26, P179, DOI 10.1097/00002826-200307000-00005; Navailles S, 2012, MOL NEUROBIOL, V45, P173, DOI 10.1007/s12035-011-8230-0; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Roselli F, 2010, MOVEMENT DISORD, V25, P1853, DOI 10.1002/mds.23179; Rylander Daniella, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS126, DOI 10.1016/S1353-8020(11)70039-6; Solla P, 2012, J NEUROL SCI, V323, P33, DOI 10.1016/j.jns.2012.07.026; Stefani A, 2012, J NEURAL TRANSM, V119, P861, DOI 10.1007/s00702-012-0820-0	28	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101763	10.1371/journal.pone.0101763	http://dx.doi.org/10.1371/journal.pone.0101763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036938	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200023
J	Stutz, WE; Bolnick, DI				Stutz, William E.; Bolnick, Daniel I.			Stepwise Threshold Clustering: A New Method for Genotyping MHC Loci Using Next-Generation Sequencing Technology	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREQUENCY-DEPENDENT SELECTION; CLASS-II GENES; HIGH-THROUGHPUT; NUCLEOTIDE SUBSTITUTION; MULTIVARIATE ANALYSES; COMPARATIVE GENOMICS; GEL-ELECTROPHORESIS; PARASITE RESISTANCE; SEXUAL SELECTION	Genes of the vertebrate major histocompatibility complex (MHC) are of great interest to biologists because of their important role in immunity and disease, and their extremely high levels of genetic diversity. Next generation sequencing (NGS) technologies are quickly becoming the method of choice for high-throughput genotyping of multi-locus templates like MHC in non-model organisms. Previous approaches to genotyping MHC genes using NGS technologies suffer from two problems: 1) a "gray zone" where low frequency alleles and high frequency artifacts can be difficult to disentangle and 2) a similar sequence problem, where very similar alleles can be difficult to distinguish as two distinct alleles. Here were present a new method for genotyping MHC loci - Stepwise Threshold Clustering (STC) - that addresses these problems by taking full advantage of the increase in sequence data provided by NGS technologies. Unlike previous approaches for genotyping MHC with NGS data that attempt to classify individual sequences as alleles or artifacts, STC uses a quasi-Dirichlet clustering algorithm to cluster similar sequences at increasing levels of sequence similarity. By applying frequency and similarity based criteria to clusters rather than individual sequences, STC is able to successfully identify clusters of sequences that correspond to individual or similar alleles present in the genomes of individual samples. Furthermore, STC does not require duplicate runs of all samples, increasing the number of samples that can be genotyped in a given project. We show how the STC method works using a single sample library. We then apply STC to 295 threespine stickleback (Gasterosteus aculeatus) samples from four populations and show that neighboring populations differ significantly in MHC allele pools. We show that STC is a reliable, accurate, efficient, and flexible method for genotyping MHC that will be of use to biologists interested in a variety of downstream applications.	[Stutz, William E.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Bolnick, Daniel I.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Bolnick, Daniel I.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Stutz, WE (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	william.stutz@colorado.edu	Bolnick, Daniel I./G-4440-2015	Bolnick, Daniel I./0000-0003-3148-6296	Howard Hughes Medical Institute; Division Of Environmental Biology [1144773] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding comes from the Howard Hughes Medical Institute (www.hhmi.org). Dan Bolnick (co-author) is an HHMI young investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer Sonia, 2008, P259; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arguello JR, 1998, TISSUE ANTIGENS, V52, P57, DOI 10.1111/j.1399-0039.1998.tb03024.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bos DH, 2008, EVOLUTION, V62, P1458, DOI 10.1111/j.1558-5646.2008.00364.x; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Bryja J, 2005, MOL ECOL NOTES, V5, P173, DOI 10.1111/j.1471-8286.2004.00855.x; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dijkstra JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-260; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunn PO, 2013, EVOLUTION, V67, P679, DOI 10.1111/j.1558-5646.2012.01799.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Hedrick PW, 2000, EVOLUTION, V54, P2145; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; KLEIN J, 1986, NATURAL HIST MAJOR H; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Lenz TL, 2013, EVOLUTION, V67, P2400, DOI 10.1111/evo.12124; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-57; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Livant EJ, 2005, ANIM GENET, V36, P432, DOI 10.1111/j.1365-2052.2005.01331.x; Longeri M, 2002, EUR J IMMUNOGENET, V29, P517, DOI 10.1046/j.1365-2370.2002.00356.x; Malaga-Trillo E, 1998, GENETICS, V149, P1527; MCGINNIS MD, 1995, TISSUE ANTIGENS, V46, P173, DOI 10.1111/j.1399-0039.1995.tb03116.x; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nadachowska-Brzyska K, 2012, MOL ECOL, V21, P887, DOI 10.1111/j.1365-294X.2011.05347.x; Ohta T, 1999, IMMUNOL REV, V167, P319, DOI 10.1111/j.1600-065X.1999.tb01401.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Pavey SA, 2013, MOL ECOL, V22, P3833, DOI 10.1111/mec.12358; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; POTTS WK, 1990, TRENDS ECOL EVOL, V5, P181, DOI 10.1016/0169-5347(90)90207-T; Promerova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069135; Promerova M, 2012, MOL ECOL RESOUR, V12, P285, DOI 10.1111/j.1755-0998.2011.03082.x; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013619; R Core Team, 2012, R LANG ENV STAT COMP; Radwan J, 2012, MOL ECOL, V21, P2469, DOI 10.1111/j.1365-294X.2012.05547.x; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Reusch TBH, 2004, IMMUNOGENETICS, V56, P427, DOI 10.1007/s00251-004-0704-z; Richman AD, 2003, GENET RES, V82, P89, DOI 10.1017/S0016672303006347; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; SLADE RW, 1992, GENETICS, V132, P861; SNELL GD, 1968, FOLIA BIOL-PRAGUE, V14, P335; Sommer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-542; Spurgin LG, 2011, MOL ECOL, V20, P5213, DOI 10.1111/j.1365-294X.2011.05367.x; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Strandh M, 2012, P ROY SOC B-BIOL SCI, V279, P4457, DOI 10.1098/rspb.2012.1562; Stuglik MT, 2011, MOL ECOL RESOUR, V11, P739, DOI 10.1111/j.1755-0998.2011.02997.x; TAKAHATA N, 1990, GENETICS, V124, P967; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	86	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100587	10.1371/journal.pone.0100587	http://dx.doi.org/10.1371/journal.pone.0100587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036866	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200009
J	Veijola, J; Guo, JY; Moilanen, JS; Jaaskelainen, E; Miettunen, J; Kyllonen, M; Haapea, M; Huhtaniska, S; Alaraisanen, A; Maki, P; Kiviniemi, V; Nikkinen, J; Starck, T; Remes, JJ; Tanskanen, P; Tervonen, O; Wink, AM; Kehagia, A; Suckling, J; Kobayashi, H; Barnett, JH; Barnes, A; Koponen, HJ; Jones, PB; Isohanni, M; Murray, GK				Veijola, Juha; Guo, Joyce Y.; Moilanen, Jani S.; Jaaskelainen, Erika; Miettunen, Jouko; Kyllonen, Merja; Haapea, Marianne; Huhtaniska, Sanna; Alaraisanen, Antti; Maki, Pirjo; Kiviniemi, Vesa; Nikkinen, Juha; Starck, Tuomo; Remes, Jukka J.; Tanskanen, Paivikki; Tervonen, Osmo; Wink, Alle-Meije; Kehagia, Angie; Suckling, John; Kobayashi, Hiroyuki; Barnett, Jennifer H.; Barnes, Anna; Koponen, Hannu J.; Jones, Peter B.; Isohanni, Matti; Murray, Graham K.			Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication	PLOS ONE			English	Article							NEGATIVE-SYNDROME-SCALE; VENTRICULAR SIZE; BIRTH COHORT; METAANALYSIS; EXPOSURE; ACCURATE; PANSS	Studies show evidence of longitudinal brain volume decreases in schizophrenia. We studied brain volume changes and their relation to symptom severity, level of function, cognition, and antipsychotic medication in participants with schizophrenia and control participants from a general population based birth cohort sample in a relatively long follow-up period of almost a decade. All members of the Northern Finland Birth Cohort 1966 with any psychotic disorder and a random sample not having psychosis were invited for a MRI brain scan, and clinical and cognitive assessment during 1999-2001 at the age of 33-35 years. A follow-up was conducted 9 years later during 2008-2010. Brain scans at both time points were obtained from 33 participants with schizophrenia and 71 control participants. Regression models were used to examine whether brain volume changes predicted clinical and cognitive changes over time, and whether antipsychotic medication predicted brain volume changes. The mean annual whole brain volume reduction was 0.69% in schizophrenia, and 0.49% in controls (p = 0.003, adjusted for gender, educational level, alcohol use and weight gain). The brain volume reduction in schizophrenia patients was found especially in the temporal lobe and periventricular area. Symptom severity, functioning level, and decline in cognition were not associated with brain volume reduction in schizophrenia. The amount of antipsychotic medication (dose years of equivalent to 100 mg daily chlorpromazine) over the follow-up period predicted brain volume loss (p = 0.003 adjusted for symptom level, alcohol use and weight gain). In this population based sample, brain volume reduction continues in schizophrenia patients after the onset of illness, and antipsychotic medications may contribute to these reductions.	[Veijola, Juha; Moilanen, Jani S.; Jaaskelainen, Erika; Miettunen, Jouko; Kyllonen, Merja; Haapea, Marianne; Huhtaniska, Sanna; Alaraisanen, Antti; Maki, Pirjo; Isohanni, Matti] Univ Oulu, Inst Clin Med, Dept Psychiat, Oulu, Finland; [Veijola, Juha; Moilanen, Jani S.; Jaaskelainen, Erika; Haapea, Marianne; Huhtaniska, Sanna; Alaraisanen, Antti; Maki, Pirjo; Isohanni, Matti] Oulu Univ, Cent Hosp, Dept Psychiat, SF-90220 Oulu, Finland; [Guo, Joyce Y.; Wink, Alle-Meije; Suckling, John; Kobayashi, Hiroyuki; Barnett, Jennifer H.; Barnes, Anna; Jones, Peter B.; Murray, Graham K.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Wink, Alle-Meije; Suckling, John; Murray, Graham K.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Miettunen, Jouko] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Miettunen, Jouko] Oulu Univ, Cent Hosp, Unit Gen Practice, SF-90220 Oulu, Finland; [Kiviniemi, Vesa; Nikkinen, Juha; Starck, Tuomo; Remes, Jukka J.; Tanskanen, Paivikki; Tervonen, Osmo] Oulu Univ, Cent Hosp, Dept Diagnost Radiol, SF-90220 Oulu, Finland; [Wink, Alle-Meije] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Kehagia, Angie] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London, England; [Kobayashi, Hiroyuki] Toho Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Barnett, Jennifer H.] Cambridge Cognit Ltd, Cambridge, England; [Barnes, Anna] Univ Coll London Hosp, NHS Fdn Trust, Inst Nucl Med, London, England; [Koponen, Hannu J.] Univ Eastern Finland, Fac Hlth Sci, Inst Clin Med, Kuopio, Finland; [Koponen, Hannu J.] Univ Kuopio, Cent Hosp, Dept Psychiat, Kuopio, Finland	University of Oulu; University of Oulu; University of Cambridge; University of Cambridge; University of Oulu; University of Oulu; University of Oulu; Vrije Universiteit Amsterdam; University of London; King's College London; Toho University; Oxford University Hospitals NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Veijola, J (corresponding author), Univ Oulu, Inst Clin Med, Dept Psychiat, Oulu, Finland.	juha.veijola@oulu.fi	Haapea, Marianne/I-3291-2016; Guo, Joyce/AAY-2946-2020; Miettunen, Jouko/AAC-4334-2019; Barnes, Anna/AAV-8780-2021; Wink, Alle Meije/R-6403-2017; Remes, Jukka J/E-4217-2015; Suckling, John/ABD-7246-2021	Haapea, Marianne/0000-0002-3989-9354; Guo, Joyce/0000-0001-9388-6688; Miettunen, Jouko/0000-0003-0575-2669; Barnes, Anna/0000-0002-6902-214X; Wink, Alle Meije/0000-0002-8197-0118; Remes, Jukka J/0000-0003-1685-8346; Suckling, John/0000-0002-5098-1527; Koponen, Hannu/0000-0002-7368-1869; Nikkinen, Juha/0000-0001-6355-3444; Murray, Graham/0000-0001-8296-1742; Jones, Peter Brian/0000-0002-0387-880X	Academy of Finland; Medical Research Council; Sigrid Juselius Foundation; Stanley Foundation; NARSAD; Brain and Behavior Research Fund; MRC [G0701911] Funding Source: UKRI; Medical Research Council [G0001354B, G0701911, G0001354, G1000183B] Funding Source: researchfish	Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Stanley Foundation; NARSAD(NARSAD); Brain and Behavior Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following sources of funding: Academy of Finland, Medical Research Council, Sigrid Juselius Foundation, Stanley Foundation, NARSAD, and the Brain and Behavior Research Fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreasen NC, 2013, AM J PSYCHIAT, V170, P609, DOI 10.1176/appi.ajp.2013.12050674; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Arajarvi R, 2005, SOC PSYCH PSYCH EPID, V40, P808, DOI 10.1007/s00127-005-0951-9; de Bresser J, 2011, NEUROIMAGE, V54, P760, DOI 10.1016/j.neuroimage.2010.09.060; Delis DC., 2000, CALIFORNIA VERBAL LE; Dorph-Petersen KA, 2005, NEUROPSYCHOPHARMACOL, V30, P1649, DOI 10.1038/sj.npp.1300710; First M, 2002, COMMUNICATION; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Glahn D, 2008, EUR PSYCHIAT, V23, P315, DOI 10.1016/j.eurpsy.2007.09.014; Glahn DC, 2000, BIOL PSYCHIAT, V47, P34, DOI 10.1016/S0006-3223(99)00187-0; Glahn DC, 1997, NEUROPSYCHOLOGY, V11, P602, DOI 10.1037/0894-4105.11.4.602; Haapea M, 2007, SOC PSYCH PSYCH EPID, V42, P403, DOI 10.1007/s00127-007-0178-z; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; JOHNSTONE EC, 1976, LANCET, V2, P924; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E, 1986, PSYCHIAT LEHRBUCH ST; Lauronen E, 2005, J CLIN PSYCHIAT, V66, P375, DOI 10.4088/JCP.v66n0315; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Lewis DA, 2011, ARCH GEN PSYCHIAT, V68, P126, DOI 10.1001/archgenpsychiatry.2010.187; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Lieberman JA, 1999, BIOL PSYCHIAT, V46, P729, DOI 10.1016/S0006-3223(99)00147-X; MARSDEN CD, 1976, LANCET, V2, P1079; McCormick L, 2005, SCHIZOPHR RES, V80, P73, DOI 10.1016/j.schres.2005.06.022; Moilanen K, 2003, SOC PSYCH PSYCH EPID, V38, P305, DOI 10.1007/s00127-003-0638-z; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Poikolainen K, 1996, AM J EPIDEMIOL, V144, P346, DOI 10.1093/oxfordjournals.aje.a008935; Pol HEH, 2008, SCHIZOPHRENIA BULL, V34, P354, DOI 10.1093/schbul/sbm168; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; SMITH GN, 1986, LANCET, V1, P1450; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Soreca I, 2009, PSYCHOSOM MED, V71, P485, DOI 10.1097/PSY.0b013e3181a5429d; Spitzer L, 1989, COMMUNICATION; Spitzer RL, 2000, HDB PSYCHIAT MEASURE; Tanskanen P, 2009, PSYCHIAT RES-NEUROIM, V174, P116, DOI 10.1016/j.pscychresns.2009.04.009; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; van Haren NEM, 2011, ARCH GEN PSYCHIAT, V68, P871, DOI 10.1001/archgenpsychiatry.2011.88; Verbaten MN, 2009, HUM PSYCHOPHARM CLIN, V24, P199, DOI 10.1002/hup.1022; Vernon AC, 2011, BIOL PSYCHIAT, V69, P936, DOI 10.1016/j.biopsych.2010.11.010	45	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101689	10.1371/journal.pone.0101689	http://dx.doi.org/10.1371/journal.pone.0101689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036617	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200021
J	Kamoi, S; Pretty, C; Docherty, P; Squire, D; Revie, J; Chiew, YS; Desaive, T; Shaw, GM; Chase, G				Kamoi, Shun; Pretty, Christopher; Docherty, Paul; Squire, Dougie; Revie, James; Chiew, Yeong Shiong; Desaive, Thomas; Shaw, Geoffrey M.; Chase, Geoffrey			Continuous Stroke Volume Estimation from Aortic Pressure Using Zero Dimensional Cardiovascular Model: Proof of Concept Study from Porcine Experiments	PLOS ONE			English	Article							CARDIAC-OUTPUT MEASUREMENT; HEART-FAILURE; ARTERIAL; PULSE; EPIDEMIOLOGY; INDICATOR; DIAGNOSIS; RESERVOIR; PATIENT; SHAPE	Introduction: Accurate, continuous, left ventricular stroke volume (SV) measurements can convey large amounts of information about patient hemodynamic status and response to therapy. However, direct measurements are highly invasive in clinical practice, and current procedures for estimating SV require specialized devices and significant approximation. Method: This study investigates the accuracy of a three element Windkessel model combined with an aortic pressure waveform to estimate SV. Aortic pressure is separated into two components capturing; 1) resistance and compliance, 2) characteristic impedance. This separation provides model-element relationships enabling SV to be estimated while requiring only one of the three element values to be known or estimated. Beat-to-beat SV estimation was performed using population-representative optimal values for each model element. This method was validated using measured SV data from porcine experiments (N = 3 female Pietrain pigs, 29-37 kg) in which both ventricular volume and aortic pressure waveforms were measured simultaneously. Results: The median difference between measured SV from left ventricle (LV) output and estimated SV was 0.6 ml with a 90% range (5th-95th percentile) -12.4 ml-14.3 ml. During periods when changes in SV were induced, cross correlations in between estimated and measured SV were above R = 0.65 for all cases. Conclusion: The method presented demonstrates that the magnitude and trends of SV can be accurately estimated from pressure waveforms alone, without the need for identification of complex physiological metrics where strength of correlations may vary significantly from patient to patient.	[Kamoi, Shun; Pretty, Christopher; Docherty, Paul; Squire, Dougie; Revie, James; Chiew, Yeong Shiong; Chase, Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand; [Desaive, Thomas] Univ Liege, GIGA Cardiovasc Sci, Liege, Belgium; [Shaw, Geoffrey M.] Christchurch Hosp, Intens Care Unit, Christchurch, New Zealand	University of Canterbury; University of Liege; Christchurch Hospital New Zealand	Kamoi, S (corresponding author), Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand.	shun.kamoi@pg.canterbury.ac.nz	Squire, Dougie/AAI-6207-2021; Pretty, Christopher G/B-6300-2014; Chiew, Yeong Shiong/AAL-8505-2021; Chiew, Yeong Shiong/M-7028-2016	Squire, Dougie/0000-0003-3271-6874; Pretty, Christopher G/0000-0002-2265-6065; Chiew, Yeong Shiong/0000-0003-3222-2006; Chiew, Yeong Shiong/0000-0003-3222-2006; Docherty, Paul/0000-0003-1661-2573	Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium); University of Liege research grant (Belgium)	Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); University of Liege research grant (Belgium)	Funding provided by Fonds National de la Recherche Scientifique (F.R.S.-FNRS, Belgium), University of Liege research grant for foreign doctoral student (Belgium). (Both non-commercial source). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL FL, 1981, AM J PHYSIOL, V240, pH676, DOI 10.1152/ajpheart.1981.240.4.H676; Aguado-Sierra J, 2008, P I MECH ENG H, V222, P403, DOI 10.1243/09544119JEIM315; Alastruey J, 2009, J ENG MATH, V64, P331, DOI 10.1007/s10665-009-9275-1; Alhashemi JA, 2011, CRIT CARE, V15, DOI 10.1186/cc9996; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Asfar P, 2014, NEW ENGLAND J MED; Band DM, 1997, J PHYSIOL-LONDON, V498, P225, DOI 10.1113/jphysiol.1997.sp021853; Bridges E, 2013, AM J NURS, V113, P42, DOI 10.1097/01.NAJ.0000429754.15255.eb; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Chase JG, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-11; Cousins TR, 2004, AANA J, V72; Dickstein K, 2005, EUR J HEART FAIL, V7, P303, DOI 10.1016/j.ejheart.2005.01.003; Docherty PD, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-39; Ellender TJ, 2008, EMERG MED CLIN N AM, V26, P759, DOI 10.1016/j.emc.2008.04.001; Felker G M, 2001, Curr Cardiol Rep, V3, P108, DOI 10.1007/s11886-001-0035-8; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Kruger Grant H, 2011, Anesthesiol Clin, V29, P487, DOI 10.1016/j.anclin.2011.05.004; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Massoud TF, 1998, FASEB J, V12, P275, DOI 10.1096/fasebj.12.3.275; Montenij LJ, 2011, CURR OPIN ANESTHESIO, V24, P651, DOI 10.1097/ACO.0b013e32834cd2d9; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; OROURKE M, 1990, HYPERTENSION, V15, P339, DOI 10.1161/01.HYP.15.4.339; Parker KH, 2012, MED BIOL ENG COMPUT, V50, P419, DOI 10.1007/s11517-012-0872-1; Perkins GD, 2003, CRIT CARE, V7, pR129, DOI 10.1186/cc2359; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Revie JA, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-33; SAGAWA K, 1990, J MOL CELL CARDIOL, V22, P253, DOI 10.1016/0022-2828(90)91459-K; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; SIEGEL LC, 1992, ANESTH ANALG, V74, P790; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Taylor C A, 1999, Comput Aided Surg, V4, P231, DOI 10.3109/10929089909148176; Thiele RH, 2011, ANESTH ANALG, V113, P766, DOI 10.1213/ANE.0b013e31822773ec; Thom O, 2009, BRIT J ANAESTH, V103, P800, DOI 10.1093/bja/aep296; Tibby SM, 2003, ARCH DIS CHILD, V88, P46, DOI 10.1136/adc.88.1.46; Trankina MF, 1999, SEMINARS ANESTHESIA, V18, P44; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; van Drunen EJ, 2013, BIOMED TECH BERL; van Lieshout JJ, 2003, EUR J APPL PHYSIOL, V90, P131, DOI 10.1007/s00421-003-0901-8; Wang JJ, 2003, AM J PHYSIOL-HEART C, V284, pH1358, DOI 10.1152/ajpheart.00175.2002; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	43	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102476	10.1371/journal.pone.0102476	http://dx.doi.org/10.1371/journal.pone.0102476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033442	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300054
J	Chen, LM; Luo, LF; Lu, JY; Li, LC; Liu, YF; Wang, J; Liu, H; Song, H; Jiang, HL; Chen, SJ; Luo, C; Li, KK				Chen, Limin; Luo, Liu-Fei; Lu, Junyan; Li, Lianchun; Liu, Yuan-Fang; Wang, Jiang; Liu, Hong; Song, Heng; Jiang, Hualiang; Chen, Sai-Juan; Luo, Cheng; Li, Keqin Kathy			FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels	PLOS ONE			English	Article							NEUTRAL SPHINGOMYELINASE; LYMPHOCYTIC-LEUKEMIA; CANCER-CELLS; INHIBITOR; FINGOLIMOD; PATHWAY; DEATH; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; TRANSLOCATION	The M2 subtype Acute Myeloid Leukemia (AML-M2) with t(8;21) represents an unmet challenge because of poor clinical outcomes in a sizable portion of patients. In this study, we report that FTY720 (Fingolimod), a sphingosine analogue and an FDA approved drug for treating of multiple sclerosis, shows antitumorigenic activity against the Kasumi-1 cell line, xenograft mouse models and leukemic blasts isolated from AML-M2 patients with t(8; 21) translocation. Primary investigation indicated that FTY720 caused cell apoptosis through caspases and protein phosphatase 2A (PP2A) activation. Transcriptomic profiling further revealed that FTY720 treatment could upregulate AML1 target genes and interfere with genes involved in ceramide synthesis. Treatment with FTY720 led to the elimination of AML1-ETO oncoprotein and caused cell cycle arrest. More importantly, FTY720 treatment resulted in rapid and significant increase of pro-apoptotic ceramide levels, determined by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry based lipidomic approaches. Structural simulation model had also indicated that the direct binding of ceramide to inhibitor 2 of PP2A (I2PP2A) could reactivate PP2A and cause cell death. This study demonstrates, for the first time, that accumulation of ceramide plays a central role in FTY720 induced cell death of AML-M2 with t(8; 21). Targeting sphingolipid metabolism by using FTY720 may provide novel insight for the drug development of treatment for AML-M2 leukemia.	[Chen, Limin; Luo, Liu-Fei; Liu, Yuan-Fang; Chen, Sai-Juan; Li, Keqin Kathy] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Chen, Limin; Lu, Junyan; Li, Lianchun; Wang, Jiang; Liu, Hong; Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Song, Heng] E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology	Luo, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China.	cluo@simm.ac.cn; kli@epigenetic.us		Lu, Junyan/0000-0002-9211-0746	China 973 Program [2013CB733700, 2011CB510102, 2009CB918502]; National Natural Science Foundation of China [81270622, 91029704, 91229204, 21210003, 81230076, 21021063, 81200373]; National High Technology Research and Development Program of China [2012AA020302]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2013ZX09507-004]	China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"	This work was supported by China 973 Program (2013CB733700, 2011CB510102, and 2009CB918502), the National Natural Science Foundation of China grants (81270622, 91029704, 91229204, 21210003, 81230076, 21021063 and 81200373), the National High Technology Research and Development Program of China (2012AA020302), and the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2013ZX09507-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banker DE, 2004, BLOOD, V104, P1816, DOI 10.1182/blood-2004-01-0395; Bezombes C, 2001, FASEB J, V15, P297; Billstrom R, 1997, EUR J HAEMATOL, V59, P47; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dewson G, 2003, ONCOGENE, V22, P2643, DOI 10.1038/sj.onc.1206326; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Gardini A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000275; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Liao AJ, 2012, EUR J PHARM SCI, V45, P600, DOI 10.1016/j.ejps.2011.12.014; Liao AJ, 2011, BLOOD, V118, P2793, DOI 10.1182/blood-2011-01-331447; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Martinez N, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-44; Matsuda S, 1999, J IMMUNOL, V162, P3321; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Nagahara Y, 2000, J IMMUNOL, V165, P3250, DOI 10.4049/jimmunol.165.6.3250; Nagahara Y, 2001, JPN J CANCER RES, V92, P680, DOI 10.1111/j.1349-7006.2001.tb01148.x; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Pchejetski D, 2010, CANCER RES, V70, P8651, DOI 10.1158/0008-5472.CAN-10-1388; Perera MN, 2012, BBA-BIOMEMBRANES, V1818, P1291, DOI 10.1016/j.bbamem.2012.02.010; Petrie K, 2007, BLOOD, V109, P4109, DOI 10.1182/blood-2007-02-075804; Pitman MR, 2012, CURR MOL MED, V12, P1207, DOI 10.2174/156652412803833599; Ptasinska A, 2012, LEUKEMIA, V26, P1829, DOI 10.1038/leu.2012.49; Rosales KR, 2011, BIOCHEM J, V439, P299, DOI 10.1042/BJ20110853; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Shah MV, 2008, BLOOD, V112, P770, DOI 10.1182/blood-2007-11-121871; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKAHASHI T, 1992, J BIOL CHEM, V267, P12552; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wallington-Beddoe CT, 2011, AUTOPHAGY, V7, P707, DOI 10.4161/auto.7.7.15154; Wang W, 2010, BLOOD, V116, P254, DOI 10.1182/blood-2009-11-254664; Yang Y, 2012, J CELL BIOCHEM, V113, P1314, DOI 10.1002/jcb.24003; Yoshino T, 2011, CELL MOL NEUROBIOL, V31, P1009, DOI 10.1007/s10571-011-9698-x	47	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103033	10.1371/journal.pone.0103033	http://dx.doi.org/10.1371/journal.pone.0103033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050888	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100080
J	Roshyara, NR; Scholz, M				Roshyara, Nab Raj; Scholz, Markus			fcGENE: A Versatile Tool for Processing and Transforming SNP Datasets	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMPUTATION; GENOTYPES	Background: Modern analysis of high-dimensional SNP data requires a number of biometrical and statistical methods such as pre-processing, analysis of population structure, association analysis and genotype imputation. Software used for these purposes often rely on specific and incompatible input and output data formats. Therefore extensive data management including multiple format conversions is necessary during analyses. Methods: In order to support fast and efficient management and bio-statistical quality control of high-dimensional SNP data, we developed the publically available software fcGENE using C++ object-oriented programming language. This software simplifies and automates the use of different existing analysis packages, especially during the workflow of genotype imputations and corresponding analyses. Results: fcGENE transforms SNP data and imputation results into different formats required for a large variety of analysis packages such as PLINK, SNPTEST, HAPLOVIEW, EIGENSOFT, GenABEL and tools used for genotype imputation such as MaCH, IMPUTE, BEAGLE and others. Data Management tasks like merging, splitting, extracting SNP and pedigree information can be performed. fcGENE also supports a number of bio-statistical quality control processes and quality based filtering processes at SNP-and sample-wise level. The tool also generates templates of commands required to run specific software packages, especially those required for genotype imputation. We demonstrate the functionality of fcGENE by example workflows of SNP data analyses and provide a comprehensive manual of commands, options and applications. Conclusions: We have developed a user-friendly open-source software fcGENE, which comprehensively supports SNP data management, quality control and analysis workflows. Download statistics and corresponding feedbacks indicate that software is highly recognised and extensively applied by the scientific community.	[Roshyara, Nab Raj; Scholz, Markus] Univ Leipzig, Dept Med, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Roshyara, Nab Raj; Scholz, Markus] Univ Leipzig, Dept Med, LIFE Res Ctr, Leipzig Interdisciplinary Res Cluster Genet Facto, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Roshyara, NR (corresponding author), Univ Leipzig, Dept Med, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany.	roshyara@yahoo.com			Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig); European Union; European Regional Development Fund (ERFD); European Social Fund; Free State of Saxony within the framework of the excellence initiative	Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig); European Union(European Commission); European Regional Development Fund (ERFD)(European Commission); European Social Fund(European Social Fund (ESF)); Free State of Saxony within the framework of the excellence initiative	Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig) (http://life.uni-leipzig.de/en/life_health_care_study.html). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERFD), the European Social Fund and by means of the Free State of Saxony within the framework of the excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chambers J, R LANG ENV STAT COMP; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roshyara NR, FCGENE FORMAT CONVER; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	19	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e97589	10.1371/journal.pone.0097589	http://dx.doi.org/10.1371/journal.pone.0097589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050709	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100001
J	Song, ZF; Zhu, XL; Jin, R; Wang, CP; Yan, JC; Zheng, QC; Nanda, A; Granger, DN; Li, GH				Song, Zifang; Zhu, Xiaolei; Jin, Rong; Wang, Cuiping; Yan, Jinchuan; Zheng, Qichang; Nanda, Anil; Granger, D. Neil; Li, Guohong			Roles of the Kinase TAK1 in CD40-Mediated Effects on Vascular Oxidative Stress and Neointima Formation after Vascular Injury	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; NADPH OXIDASE; LEUKOCYTE RECRUITMENT; ACTIVATION; DYSFUNCTION; RESTENOSIS; PROTEIN; CELLS; NEUTROPHILS	Although TAK1 has been implicated in inflammation and oxidative stress, its roles in vascular smooth muscle cells (VSMCs) and in response to vascular injury have not been investigated. The present study aimed to investigate the role of TAK1 in modulating oxidative stress in VSMCs and its involvement in neointima formation after vascular injury. Double immunostaining reveals that vascular injury induces a robust phosphorylation of TAK1 (Thr187) in the medial VSMCs of injured arteries in wildtype mice, but this effect is blocked in CD40-deficient mice. Upregulation of TAK1 in VSMCs is functionally important, as it is critically involved in pro-oxidative and pro-inflammatory effects on VSMCs and eventual neointima formation. In vivo, pharmacological inhibition of TAK1 with 5Z-7-oxozeaenol blocked the injury-induced phosphorylation of both TAK1 (Thr187) and NF-kB/p65 (Ser536), associated with marked inhibition of superoxide production, 3-nitrotyrosine, and MCP-1 in the injured arteries. Cell culture experiments demonstrated that either siRNA knockdown or 5Z-7-oxozeaenol inhibition of TAK1 significantly attenuated NADPH oxidase activation and superoxide production induced by CD40L/CD40 stimulation. Co-immunoprecipitation experiments indicate that blockade of TAK1 disrupted the CD40L-induced complex formation of p22phox with p47phox, p67phox, or Nox4. Blockade of TAK1 also inhibited CD40L-induced NF-kB activation by modulating IKK alpha/beta and NF-kB p65 phosphorylation and this was related to reduced expression of proinflammatory genes (IL-6, MCP-1 and ICAM-1) in VSMCs. Lastly, treatment with 5Z-7-oxozeaenol attenuated neointimal formation in wire-injured femoral arteries. Our findings demonstrate previously uncharacterized roles of TAK1 in vascular oxidative stress and the contribution to neointima formation after vascular injury.	[Song, Zifang; Zhu, Xiaolei; Jin, Rong; Wang, Cuiping; Nanda, Anil; Li, Guohong] LSU Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA 71103 USA; [Granger, D. Neil; Li, Guohong] LSU Hlth Sci Ctr Shreveport, Dept Physiol, Shreveport, LA USA; [Song, Zifang; Zheng, Qichang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China; [Wang, Cuiping; Yan, Jinchuan] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Huazhong University of Science & Technology; Jiangsu University	Li, GH (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA 71103 USA.	gli@lsuhsc.edu	Song, Zifang/AAA-8467-2022	Song, Zifang/0000-0003-3642-2531	National Institutes of Health [HL087990]; American Heart Association [0530166N]; National Heart Lung & Blood Institute [HL26441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990, R01HL026441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Heart Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL087990 (GL) and by a scientist development grant (0530166N, GL) from the American Heart Association. DNG is funded by the National Heart Lung & Blood Institute (HL26441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI 10.1089/ARS.2008.2390; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Chen ZP, 2004, P NATL ACAD SCI USA, V101, P13014, DOI 10.1073/pnas.0405389101; Cipollone F, 2003, CIRCULATION, V108, P2776, DOI 10.1161/01.CIR.0000103700.05109.0D; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Hostager BS, 2007, IMMUNOL RES, V39, P105, DOI 10.1007/s12026-007-0082-3; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kappert K, 2006, ARTERIOSCL THROM VAS, V26, P2644, DOI 10.1161/01.ATV.0000246777.30819.85; Kefer JM, 2005, CORONARY ARTERY DIS, V16, P505, DOI 10.1097/00019501-200512000-00009; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Li GH, 2007, ARTERIOSCL THROM VAS, V27, P1850, DOI 10.1161/ATVBAHA.107.144576; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Liu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037168; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P29, DOI 10.1161/01.ATV.0000150649.39934.13; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Saxena A, 2011, CARDIOVASC RES, V91, P350, DOI 10.1093/cvr/cvr075; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Song ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023239; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Szocs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zippel N, 2013, ARTERIOSCL THROM VAS, V33, P2792, DOI 10.1161/ATVBAHA.113.301848	43	18	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101671	10.1371/journal.pone.0101671	http://dx.doi.org/10.1371/journal.pone.0101671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050617	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100011
J	Kikkas, I; Mallone, R; Larger, E; Volland, H; Morel, N				Kikkas, Ingrid; Mallone, Roberto; Larger, Etienne; Volland, Herve; Morel, Nathalie			A Rapid Lateral Flow Immunoassay for the Detection of Tyrosine Phosphatase-Like Protein IA-2 Autoantibodies in Human Serum	PLOS ONE			English	Article							ASSAYS; DIAGNOSIS; RISK	Type 1 diabetes (T1D) results from the destruction of pancreatic insulin-producing beta cells and is strongly associated with the presence of islet autoantibodies. Autoantibodies to tyrosine phosphatase-like protein IA-2 (IA-2As) are considered to be highly predictive markers of T1D. We developed a novel lateral flow immunoassay (LFIA) based on a bridging format for the rapid detection of IA-2As in human serum samples. In this assay, one site of the IA-2As is bound to HA-tagged-IA-2, which is subsequently captured on the anti-HA-Tag antibody-coated test line on the strip. The other site of the IA-2As is bound to biotinylated IA-2, allowing the complex to be visualized using colloidal gold nanoparticle-conjugated streptavidin. For this study, 35 serum samples from T1D patients and 44 control sera from non-diabetic individuals were analyzed with our novel assay and the results were correlated with two IA-2A ELISAs. Among the 35 serum samples from T1D patients, the IA-2A LFIA, the in-house IA-2A ELISA and the commercial IA-2A ELISA identified as positive 21, 29 and 30 IA-2A-positive sera, respectively. The major advantages of the IA-2A LFIA are its rapidity and simplicity.	[Kikkas, Ingrid; Volland, Herve; Morel, Nathalie] CEA, iBiTec S, Serv Pharmacol & Immunoanal, Lab Etud & Rech Immunoanal, Gif Sur Yvette, France; [Mallone, Roberto] INSERM, U1016, Cochin Inst, DeAR Lab, Paris, France; [Mallone, Roberto; Larger, Etienne] Paris Descartes Univ, Sorbonne Paris Cite, Fac Med, Paris, France; [Mallone, Roberto; Larger, Etienne] Hop Cochin, AP HP, Serv Diabetol, F-75674 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Morel, N (corresponding author), CEA, iBiTec S, Serv Pharmacol & Immunoanal, Lab Etud & Rech Immunoanal, Gif Sur Yvette, France.	nathalie.morel@cea.fr	Mallone, Roberto/H-4430-2013	Mallone, Roberto/0000-0002-9846-8861				Achenbach P, 2013, DIABETOLOGIA, V56, P1615, DOI 10.1007/s00125-013-2896-y; Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Biagini RE, 2006, CLIN VACCINE IMMUNOL, V13, P541, DOI 10.1128/CVI.13.5.541-546.2006; Chen S, 2005, CLIN CHIM ACTA, V357, P74, DOI 10.1016/j.cccn.2005.02.006; Decochez K, 2002, DIABETOLOGIA, V45, P1658, DOI 10.1007/s00125-002-0949-8; Jahromi MM, 2007, CELL MOL LIFE SCI, V64, P865, DOI 10.1007/s00018-007-6469-4; Kikkas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069021; Knip M, 2003, REV ENDOCR METAB DIS, V4, P213, DOI 10.1023/A:1025121510678; Lampasona V, 1996, J IMMUNOL, V157, P2707; Larsson HE, 2014, PEDIATR DIABETES, V15, P118, DOI 10.1111/pedi.12066; Lobner K, 1999, HORM METAB RES, V31, P686, DOI 10.1055/s-2007-978821; Masuda M, 2000, CLIN CHIM ACTA, V291, P53, DOI 10.1016/S0009-8981(99)00199-0; Mdluli P, 2014, BIOSENS BIOELECTRON, V54, P1, DOI 10.1016/j.bios.2013.10.019; Morgenthaler NG, 1998, HORM METAB RES, V30, P559, DOI 10.1055/s-2007-978933; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Renger F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3057; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Silpasakorn S, 2012, AM J TROP MED HYG, V87, P148, DOI 10.4269/ajtmh.2012.11-0583; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Westerlund-Karlsson A, 2003, CLIN CHEM, V49, P916, DOI 10.1373/49.6.916; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	22	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103088	10.1371/journal.pone.0103088	http://dx.doi.org/10.1371/journal.pone.0103088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047039	gold, Green Submitted, Green Published			2022-12-27	WOS:000339558100106
J	Lui, YLE; Tan, TL; Woo, WH; Timms, P; Hafner, LM; Tan, KH; Tan, EL				Lui, Yan Long Edmund; Tan, Tuan Lin; Woo, Wee Hong; Timms, Peter; Hafner, Louise Marie; Tan, Kian Hwa; Tan, Eng Lee			Enterovirus71 (EV71) Utilise Host microRNAs to Mediate Host Immune System Enhancing Survival during Infection	PLOS ONE			English	Article							CELLULAR MICRORNA; MOLECULAR EPIDEMIOLOGY; ANTIVIRAL RESPONSES; PROTEIN EXPRESSION; VIRUS-INFECTION; VIRAL EVASION; INTERFERONS; RECEPTORS; HIV-1; RNAS	Hand, Foot and Mouth Disease (HFMD) is a self-limiting viral disease that mainly affects infants and children. In contrast with other HFMD causing enteroviruses, Enterovirus71 (EV71) has commonly been associated with severe clinical manifestation leading to death. Currently, due to a lack in understanding of EV71 pathogenesis, there is no antiviral therapeutics for the treatment of HFMD patients. Therefore the need to better understand the mechanism of EV71 pathogenesis is warranted. We have previously reported a human colorectal adenocarcinoma cell line (HT29) based model to study the pathogenesis of EV71. Using this system, we showed that knockdown of DGCR8, an essential cofactor for microRNAs biogenesis resulted in a reduction of EV71 replication. We also demonstrated that there are miRNAs changes during EV71 pathogenesis and EV71 utilise host miRNAs to attenuate antiviral pathways during infection. Together, data from this study provide critical information on the role of miRNAs during EV71 infection.	[Lui, Yan Long Edmund; Timms, Peter; Hafner, Louise Marie] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Lui, Yan Long Edmund; Timms, Peter; Hafner, Louise Marie] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Lui, Yan Long Edmund; Tan, Tuan Lin; Woo, Wee Hong; Tan, Kian Hwa] Singapore Polytech, Sch Chem & Life Sci, Singapore, Singapore; [Lui, Yan Long Edmund; Tan, Eng Lee] Singapore Polytech, Ctr Biomed & Life Sci, Singapore, Singapore; [Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4556, Australia; [Tan, Eng Lee] Natl Univ Singapore Hosp, Dept Paediat, Univ Childrens Med Inst, Singapore 117548, Singapore	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Singapore Polytechnic; Singapore Polytechnic; University of the Sunshine Coast; National University of Singapore	Lui, YLE (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia.	edmundyanlong.lui@student.qut.edu.au; l.hafner@qut.edu.au		Timms, Peter/0000-0002-1682-0025	Singapore Polytechnic; Queensland University of Technology	Singapore Polytechnic; Queensland University of Technology	This research was supported by Singapore Polytechnic. Yan Long Edmund Lui was supported by Queensland University of Technology Higher Degree Research Award Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkhout B, 2007, J BIOL CHEM, V282, P26641, DOI 10.1074/jbc.R700023200; Boss IW, 2011, BBA-GENE REGUL MECH, V1809, P708, DOI 10.1016/j.bbagrm.2011.06.012; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Ho BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4344; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Huang HI, 2012, FUTURE MICROBIOL, V7, P467, DOI [10.2217/FMB.12.22, 10.2217/fmb.12.22]; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee JJ, 2011, J PROTEOMICS, V74, P2018, DOI 10.1016/j.jprot.2011.05.022; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lui YLE, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-267; Lui YLE, 2014, FEBS OPEN BIO, V4, P426, DOI 10.1016/j.fob.2014.04.005; Lui YLE, 2013, BIOCHEM BIOPH RES CO, V433, P607, DOI 10.1016/j.bbrc.2013.03.044; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Munday DC, 2012, PROTEOMICS, V12, P666, DOI 10.1002/pmic.201100488; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Oudshoorn D, 2012, CYTOKINE GROWTH F R, V23, P273, DOI 10.1016/j.cytogfr.2012.08.003; Patel KP, 2009, NAT MED, V15, P728, DOI 10.1038/nm0709-728; Rajsbaum R, 2013, TRENDS MICROBIOL, V21, P421, DOI 10.1016/j.tim.2013.06.006; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roberts APE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-201; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sullivan CS, 2008, NAT REV GENET, V9, P503, DOI 10.1038/nrg2349; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Tan EL, 2008, DIAGN MICR INFEC DIS, V61, P294, DOI 10.1016/j.diagmicrobio.2008.02.009; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Wen BP, 2013, INTERVIROLOGY, V56, P195, DOI 10.1159/000348504; Wiertz E, 1997, IMMUNOL LETT, V57, P213, DOI 10.1016/S0165-2478(97)00073-4; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zheng Z, 2013, J VIROL	66	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102997	10.1371/journal.pone.0102997	http://dx.doi.org/10.1371/journal.pone.0102997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047717	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100095
J	Cai, YH; Chen, XJ; Xie, K; Xing, QK; Wu, YW; Li, J; Du, CH; Sun, ZX; Guo, ZJ				Cai, Yuhui; Chen, Xujun; Xie, Ke; Xing, Qikai; Wu, Yawen; Li, Jing; Du, Caihong; Sun, Zongxiu; Guo, Zejian			Dlf1, a WRKY Transcription Factor, Is Involved in the Control of Flowering Time and Plant Height in Rice	PLOS ONE			English	Article							DISEASE RESISTANCE; NATURAL VARIATION; DWARF MUTANT; HEADING DATE; GENE; ARABIDOPSIS; ENCODES; EXPRESSION; PROTEIN; TOLERANCE	Flowering time and plant height are important agronomic traits for crop production. In this study, we characterized a semi-dwarf and late flowering (dlf1) mutation of rice that has pleiotropic effects on these traits. The dlf1 mutation was caused by a T-DNA insertion and the cloned Dlf1 gene was found to encode a WRKY transcription factor (OsWRKY11). The dlf1 mutant contains a T-DNA insertion at the promoter region, leading to enhanced accumulation of Dlf1 transcripts, resulting in a semidominant mutation. The dlf1 mutation suppressed the transcription of Ehd2/RID1/OsId1 and its downstream flowering-time genes including Hd1, Ehd1 and Hd3a under both long-day (LD) and short-day (SD) conditions. Knock-down of Dlf1 expression exhibited early flowering at LD condition related to the wild-type plants. Accumulation of Dlf1 mRNA was observed in most tissues, and two splicing forms of Dlf1 cDNAs were obtained (OsWRKY11.1 and OsWRKY11.2). These two proteins showed transactivation activity in yeast cells. Dlf1 protein was found to be localized in the nucleus. Enhanced expression of OsWRKY11.2 or its 59 truncated gene showed similar phenotypes to the dlf1 mutant, suggesting that it might function as a negative regulator. We conclude that Dlf1 acts as a transactivator to downregulate Ehd2/RID1/OsId1 in the signal transduction pathway of flowering and plays an important role in the regulation of plant height in rice.	[Cai, Yuhui; Chen, Xujun; Xing, Qikai; Guo, Zejian] China Agr Univ, Key Lab Plant Pathol, Beijing 100094, Peoples R China; [Wu, Yawen; Sun, Zongxiu] China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Xie, Ke; Li, Jing; Du, Caihong; Guo, Zejian] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Guo, ZJ (corresponding author), China Agr Univ, Key Lab Plant Pathol, Beijing 100094, Peoples R China.	sunzx405@163.com; guozj@cau.edu.cn	Li, Jing/F-5934-2014	Li, Jing/0000-0002-0989-7622	National Nature Science of Foundation [31171833, 31272025]; Program for Changjiang Scholars and Innovative Research Team in University [IRT042]; 111 project [B13006]	National Nature Science of Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 project(Ministry of Education, China - 111 Project)	This research was financially supported by National Nature Science of Foundation (31171833 and 31272025), the Program for Changjiang Scholars and Innovative Research Team in University (IRT042), and the 111 project (B13006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; EIMERT K, 1995, PLANT CELL, V7, P1703, DOI 10.1105/tpc.7.10.1703; Franco-Zorrilla JM, 2009, PLANT J, V59, P840, DOI 10.1111/j.1365-313X.2009.03904.x; Fujino K, 2013, THEOR APPL GENET, V126, P611, DOI 10.1007/s00122-012-2005-5; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; Kim WY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2357; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kurepa J, 1998, PLANT GROWTH REGUL, V26, P91, DOI 10.1023/A:1006043914056; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Matsubara K, 2008, PLANT PHYSIOL, V148, P1425, DOI 10.1104/pp.108.125542; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Park SJ, 2008, PLANT J, V56, P1018, DOI 10.1111/j.1365-313X.2008.03667.x; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Riboni M, 2013, PLANT PHYSIOL, V162, P1706, DOI 10.1104/pp.113.217729; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Wu CF, 2008, J NEUROGENET, V22, P1, DOI 10.1080/01677060801918016; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104	45	55	76	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102529	10.1371/journal.pone.0102529	http://dx.doi.org/10.1371/journal.pone.0102529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036785	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200065
J	Droguett, A; Krall, P; Burgos, ME; Valderrama, G; Carpio, D; Ardiles, L; Rodriguez-Diez, R; Kerr, B; Walz, K; Ruiz-Ortega, M; Egido, J; Mezzano, S				Droguett, Alejandra; Krall, Paola; Burgos, M. Eugenia; Valderrama, Graciela; Carpio, Daniel; Ardiles, Leopoldo; Rodriguez-Diez, Raquel; Kerr, Bredford; Walz, Katherina; Ruiz-Ortega, Marta; Egido, Jesus; Mezzano, Sergio			Tubular Overexpression of Gremlin Induces Renal Damage Susceptibility in Mice	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; MORPHOGENETIC PROTEIN ANTAGONIST; TRANSGENIC MICE; DIABETIC-NEPHROPATHY; PROXIMAL TUBULE; ANGIOTENSINOGEN GENE; BLOOD-PRESSURE; HIGH GLUCOSE; FACTOR-BETA; EXPRESSION	A growing number of patients are recognized worldwide to have chronic kidney disease. Glomerular and interstitial fibrosis are hallmarks of renal progression. However, fibrosis of the kidney remains an unresolved challenge, and its molecular mechanisms are still not fully understood. Gremlin is an embryogenic gene that has been shown to play a key role in nephrogenesis, and its expression is generally low in the normal adult kidney. However, gremlin expression is elevated in many human renal diseases, including diabetic nephropathy, pauci-immune glomerulonephritis and chronic allograft nephropathy. Several studies have proposed that gremlin may be involved in renal damage by acting as a downstream mediator of TGF-beta. To examine the in vivo role of gremlin in kidney pathophysiology, we generated seven viable transgenic mouse lines expressing human gremlin (GREM1) specifically in renal proximal tubular epithelial cells under the control of an androgen-regulated promoter. These lines demonstrated 1.2- to 200-fold increased GREM1 expression. GREM1 transgenic mice presented a normal phenotype and were without proteinuria and renal function involvement. In response to the acute renal damage cause by folic acid nephrotoxicity, tubule-specific GREM1 transgenic mice developed increased proteinuria after 7 and 14 days compared with wild-type treated mice. At 14 days tubular lesions, such as dilatation, epithelium flattening and hyaline casts, with interstitial cell infiltration and mild fibrosis were significantly more prominent in transgenic mice than wild-type mice. Tubular GREM1 overexpression was correlated with the renal upregulation of profibrotic factors, such as TGF-beta and alpha SMA, and with increased numbers of monocytes/macrophages and lymphocytes compared to wild-type mice. Taken together, our results suggest that GREM1-overexpressing mice have an increased susceptibility to renal damage, supporting the involvement of gremlin in renal damage progression. This transgenic mouse model could be used as a new tool for enhancing the knowledge of renal disease progression.	[Droguett, Alejandra; Krall, Paola; Burgos, M. Eugenia; Valderrama, Graciela; Ardiles, Leopoldo; Mezzano, Sergio] Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile; [Kerr, Bredford; Walz, Katherina] Ctr Estudios Cient, Valdivia, Chile; [Carpio, Daniel] Univ Austral Chile, Sch Med, Hystopathol Div, Valdivia, Chile; [Rodriguez-Diez, Raquel; Ruiz-Ortega, Marta; Egido, Jesus] Univ Autonoma Madrid, Cellular Biol Renal Dis Lab, Madrid, Spain	Universidad Austral de Chile; Universidad Austral de Chile; Autonomous University of Madrid	Mezzano, S (corresponding author), Univ Austral Chile, Sch Med, Div Nephrol, Valdivia, Chile.	smezzano@uach.cl	Ortega, Marta Ruiz/AAN-2136-2020; Ardiles, Leopoldo/K-8238-2019; Díez, Raquel Rodrigues/ABE-9703-2020; Ardiles, Leopoldo/AAR-3058-2020; Ruiz-Ortega, Marta/D-3584-2012; ruiz-ortega, marta/D-3584-2012	Ortega, Marta Ruiz/0000-0002-1495-6535; Díez, Raquel Rodrigues/0000-0002-6348-1505; Ardiles, Leopoldo/0000-0002-6197-0954; Ruiz-Ortega, Marta/0000-0002-1495-6535; Droguett, Alejandra/0000-0002-4782-650X; ruiz-ortega, marta/0000-0002-1403-2690; Kerr, Bredford/0000-0001-8714-8726	Ciberdem; Redinren; Fondecyt [1120480, 1080083]; Fondecyt, Chile [1100821]	Ciberdem; Redinren; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Supported by Ciberdem, Redinren, Fondecyt 1120480, Fondecyt 1080083, Fondecyt 1100821, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2013, LAB INVEST, V93, P81, DOI 10.1038/labinvest.2012.162; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Carvajal G, 2008, TRANSPL P, V40, P734, DOI 10.1016/j.transproceed.2008.02.064; Costello CM, 2010, AM J RESP CELL MOL, V42, P517, DOI 10.1165/rcmb.2009-0101TR; Ding YM, 2001, AM J PHYSIOL-RENAL, V280, pF54, DOI 10.1152/ajprenal.2001.280.1.F54; Ding YM, 1997, J BIOL CHEM, V272, P28142, DOI 10.1074/jbc.272.44.28142; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Guimei Maha, 2012, BMC Res Notes, V5, P390, DOI 10.1186/1756-0500-5-390; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Karagiannis GS, 2013, MOL ONCOL, V7, P826, DOI 10.1016/j.molonc.2013.04.002; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lappin DWP, 2002, NEPHROL DIAL TRANSPL, V17, P65, DOI 10.1093/ndt/17.suppl_9.65; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Li GY, 2013, J CELL BIOCHEM, V114, P2101, DOI 10.1002/jcb.24559; Li HP, 2008, AM J PHYSIOL-RENAL, V294, pF1481, DOI 10.1152/ajprenal.00064.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMahon R, 2000, J BIOL CHEM, V275, P9901, DOI 10.1074/jbc.275.14.9901; Mezzano S, 2007, NEPHROL DIAL TRANSPL, V22, P1882, DOI 10.1093/ndt/gfm145; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rodrigues-Diez R, 2012, NEPHRON EXP NEPHROL, V122, P62, DOI 10.1159/000346575; Roxburgh SA, 2006, NEPHRON PHYSIOL, V103, P139, DOI 10.1159/000092453; Roxburgh SA, 2009, DIABETES, V58, P1641, DOI 10.2337/db08-1365; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722; Zhang QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011709; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	35	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101879	10.1371/journal.pone.0101879	http://dx.doi.org/10.1371/journal.pone.0101879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036148	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200026
J	Gleicher, N; McAlpine, JN; Gilks, CB; Kushnir, VA; Lee, HJ; Wu, YG; Lazzaroni-Tealdi, E; Barad, DH				Gleicher, Norbert; McAlpine, Jessica N.; Gilks, C. Blake; Kushnir, Vitaly A.; Lee, Ho-Joon; Wu, Yan-Guang; Lazzaroni-Tealdi, Emanuela; Barad, David H.			Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers	PLOS ONE			English	Article							BRCA1/2 MUTATIONS; ALLELES; BREAST; CARRIERS; RESCUE; RISKS; P53	Previously reported findings in Austrian BRCA1/2 mutation carriers suggested a possible dependency of embryos with BRCA1/2 mutations on so-called low alleles of the fragile X mental retardation 1 (FMR1) gene, characterized by less than 26 CGG repeats (CGGn, 26). The hypothesis arose from a study reporting highly statistically significant enrichment of low FMR1 alleles, significantly exceeding low allele prevalence in a general population, suggesting embryo lethality of BRCA1/2 mutations, "rescued" by presence of low FMR1 alleles. Such a dependency would also offer an explanation for the so-called "BRCA-paradox," characterized by BRCA1/2 deficient embryonic tissues being anti-proliferative (thereby potentially causing embryo-lethality) but proliferative in malignant tumors, including breast and ovarian cancers. Follow up investigations by other investigators, however, at most demonstrated trends towards enrichment but, mostly, no enrichment at all, raising questions about the original observation and hypothesis. We in this study, therefore, investigated CGGn of the FMR1 gene of 86 anonymized DNA samples from women with various forms of ovarian cancer, and were unable to demonstrate differences in prevalence of low FMR1 alleles either between positive and negative ovarian cancer patients for BRCA1/2 or between ovarian cancer patients and reported rates in non-cancer populations. This raises further questions about a suggested dependency between BRCA1/2 and FMR1, but also raises the possibility that investigated Austrian BRCA1/2 carrier populations differ from those in other countries. Either only selected BRCA1/2 mutations, therefore, interact with low FMR1 alleles or the Austrian data reflect only coincidental observations.	[Gleicher, Norbert; Kushnir, Vitaly A.; Lee, Ho-Joon; Wu, Yan-Guang; Lazzaroni-Tealdi, Emanuela; Barad, David H.] Ctr Human Reprod, New York, NY 10021 USA; [Gleicher, Norbert; Barad, David H.] Fdn Reprod Med, New York, NY USA; [McAlpine, Jessica N.] Univ British Columbia, Dept Gynecol & Obstet, Div Gynecol Oncol, Vancouver, BC V5Z 1M9, Canada; [McAlpine, Jessica N.; Gilks, C. Blake] BC Canc Agcy, OvCaRe Gynecol Tissue Bank, Vancouver, BC, Canada; [Gilks, C. Blake] Univ British Columbia, Dept Pathol & Lab Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Gleicher, N (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.	ngleicher@thechr.com	Barad, David/AAF-4332-2021		not-for-profit Foundation for Reproductive Medicine (FRM), New York, N.Y., USA; Center for Human Reproduction (CHR) - New York, N.Y., USA	not-for-profit Foundation for Reproductive Medicine (FRM), New York, N.Y., USA; Center for Human Reproduction (CHR) - New York, N.Y., USA	This study was supported by funds from the not-for-profit Foundation for Reproductive Medicine (FRM), New York, N.Y. 10021, USA, and intramural funds from the Center for Human Reproduction (CHR) - New York, N.Y. 10021, USA, a for-profit fertility and research center. The FRM had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript, even though N. G. and D. H. B. are members of the foundation's Board. Since staff makes funding decisions at CHR, independent of CHR's ownership, funders at CHR had also no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. All of those responsibilities were exclusively the authors', among which N. G., CHR's owner, is one. The funders at CHR only provided support in form of salaries to N. G., V. A. K. and D. H. B. The specific roles of these authors are articulated in the author contribution section.	Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Brandao RD, 2013, HUM REPROD, V28, P2308, DOI 10.1093/humrep/det254; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Crook T, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63327-2; Dagan E, 2014, EUR J HUM GENET, V22, P277, DOI 10.1038/ejhg.2013.281; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Gleicher N, 2014, EUR J HUM GENET, V22, P155, DOI 10.1038/ejhg.2013.213; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Janavivicius R, 2010, EPMA J, V1, P297; Lose F, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn345; Ludwig T, 1997, GENE DEV, V97, P764; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Ramus SJ, 2012, HUM MUTAT, V33, P690, DOI 10.1002/humu.22025; Ricci MT, 2014, EUR J HUM GENET, V22, P280, DOI 10.1038/ejhg.2013.193; Stone C, 2003, CURR BIOL, V13, pR63, DOI 10.1016/S0960-9822(02)01430-6; Tea MK, 2013, MATURITAS, V75; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; Verhoog LC, 2001, EUR J CANCER, V37, P2082, DOI 10.1016/S0959-8049(01)00244-1; Weghofer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044753; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102370	10.1371/journal.pone.0102370	http://dx.doi.org/10.1371/journal.pone.0102370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036526	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200049
J	Patel, EU; Frank, MA; Hsieh, YH; Rothman, RE; Baker, AEO; Kraus, CK; Shahan, J; Gaydos, CA; Kelen, GD; Quinn, TC; Laeyendecker, O				Patel, Eshan U.; Frank, Melanie A.; Hsieh, Yu-Hsiang; Rothman, Richard E.; Baker, Amy E. O.; Kraus, Chadd K.; Shahan, Judy; Gaydos, Charlotte A.; Kelen, Gabor D.; Quinn, Thomas C.; Laeyendecker, Oliver			Prevalence and Factors Associated with Herpes Simplex Virus Type 2 Infection in Patients Attending a Baltimore City Emergency Department	PLOS ONE			English	Article							GENITAL HERPES; UNITED-STATES; INNER-CITY; SEROPREVALENCE; TRENDS; EPIDEMIOLOGY; TRANSMISSION; VALACYCLOVIR; SUPPRESSION; POPULATION	Objectives: Herpes simplex virus type 2 (HSV-2) is a common sexually transmitted disease, but there is limited data on its epidemiology among urban populations. The urban Emergency Department (ED) is a potential venue for surveillance as it predominantly serves an inner city minority population. We evaluate the seroprevalence and factors associated with HSV-2 infection among patients attending the Johns Hopkins Hospital Adult Emergency Department (JHH ED). Methods: An identity unlinked-serosurvey was conducted between 6/2007 and 9/2007 in the JHH ED; sera were tested by the Focus HerpeSelect ELISA. Prevalence risk ratios (PRR) were used to determine factors associated with HSV-2 infection. Results: Of 3,408 serum samples, 1,853 (54.4%) were seropositive for HSV-2. Females (adjPRR = 1.47, 95% CI 1.38-1.56), non-Hispanic blacks (adjPRR = 2.03, 95% CI 1.82-2.27), single (adjPRR = 1.15, 95% CI 1.07-1.25), divorced (adjPRR = 1.28, 95% CI 1.15-1.41), and unemployed patients (adjPRR = 1.13, 95% CI 1.05-1.21) had significantly higher rates of HSV-2 infection. Though certain zip codes had significantly higher seroprevalence of HSV-2, this effect was completely attenuated when controlling for age and gender. Conclusions: Seroprevalence of HSV-2 in the JHH ED was higher than U. S. national estimates; however, factors associated with HSV-2 infection were similar. The high seroprevalence of HSV-2 in this urban ED highlights the need for targeted testing and treatment. Cross-sectional serosurveys in the urban ED may help to examine the epidemiology of HSV-2.	[Patel, Eshan U.; Frank, Melanie A.; Quinn, Thomas C.; Laeyendecker, Oliver] NIAID, Div Intramural Res, NIH, Baltimore, MD 21201 USA; [Hsieh, Yu-Hsiang; Rothman, Richard E.; Baker, Amy E. O.; Kraus, Chadd K.; Shahan, Judy; Gaydos, Charlotte A.; Kelen, Gabor D.; Quinn, Thomas C.; Laeyendecker, Oliver] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University	Laeyendecker, O (corresponding author), NIAID, Div Intramural Res, NIH, Baltimore, MD 21201 USA.	olaeyen1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010	Kiener, Melanie/0000-0001-6456-4313; Kelen, Gabor/0000-0002-3236-8286; Laeyendecker, Oliver/0000-0002-6429-4760; Patel, Eshan/0000-0003-2174-5004; Rothman, Richard/0000-0002-1017-9505	Division of Intramural Research; NIH Award from NIAID [5K01AI100681]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI100681, ZIAAI000361] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Award from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by the Division of Intramural Research and Dr. Hsieh is supported in part by an NIH Award, 5K01AI100681 from NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; Corey Lawrence, 2004, Herpes, V11 Suppl 3, p170A; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Dickson N, 2013, SEX TRANSM INFECT; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Force USPST, 2005, SCREEN GEN HERP REC; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Jenkins WD, 2013, SEX TRANSM INFECT; KELEN GD, 1989, JAMA-J AM MED ASSOC, V262, P516, DOI 10.1001/jama.262.4.516; KELEN GD, 1995, CLIN INFECT DIS, V21, P867, DOI 10.1093/clinids/21.4.867; KELEN GD, 1988, NEW ENGL J MED, V318, P1645, DOI 10.1056/NEJM198806233182503; Mehta SD, 2003, SEX TRANSM DIS, V30, P143, DOI 10.1097/00007435-200302000-00010; Page WF, 2012, SEX TRANSM DIS, V39, P241, DOI 10.1097/OLQ.0b013e3182401a17; Schillinger JA, 2008, SEX TRANSM DIS, V35, P599, DOI 10.1097/OLQ.0b013e3181666fb1; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V268, P1702, DOI 10.1001/jama.268.13.1702; Summerton J, 2007, CLIN VACCINE IMMUNOL, V14, P1545, DOI 10.1128/CVI.00120-07; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	26	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102422	10.1371/journal.pone.0102422	http://dx.doi.org/10.1371/journal.pone.0102422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036862	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200058
J	Wasowicz, P; Pasierbinski, A; Przedpelska-Wasowicz, EM; Kristinsson, H				Wasowicz, Pawel; Pasierbinski, Andrzej; Przedpelska-Wasowicz, Ewa Maria; Kristinsson, Hordur			Distribution Patterns in the Native Vascular Flora of Iceland	PLOS ONE			English	Article							VACCINIUM MYRTILLUS; CLIMATE; BRITISH	The aim of our study was to reveal biogeographical patterns in the native vascular flora of Iceland and to define ecological factors responsible for these patterns. We analysed dataset of more than 500,000 records containing information on the occurrence of vascular plants. Analysis of ecological factors included climatic (derived from WORLDCLIM data), topographic (calculated from digital elevation model) and geological (bedrock characteristics) variables. Spherical k-means clustering and principal component analysis were used to detect biogeographical patterns and to study the factors responsible for them. We defined 10 biotic elements exhibiting different biogeographical patterns. We showed that climatic (temperature-related) and topographic variables were the most important factors contributing to the spatial patterns within the Icelandic vascular flora and that these patterns are almost completely independent of edaphic factors (bedrock type). Our study is the first one to analyse the biogeographical differentiation of the native vascular flora of Iceland.	[Wasowicz, Pawel; Kristinsson, Hordur] Iceland Inst Nat Hist, Akureyri, Iceland; [Pasierbinski, Andrzej] Silesian Univ, Fac Biol & Environm Protect, Dept Plant Systemat, Katowice, Poland; [Przedpelska-Wasowicz, Ewa Maria] Univ Warsaw, Inst Bot, Warsaw, Poland	University of Silesia in Katowice; University of Warsaw	Wasowicz, P (corresponding author), Iceland Inst Nat Hist, Akureyri, Iceland.	pawel@ni.is	Wasowicz, Pawel/A-7295-2013; Przedpelska-Wasowicz, Ewa/AAP-9310-2021	Wasowicz, Pawel/0000-0002-6864-6786; Przedpelska-Wasowicz, Ewa Maria/0000-0002-0481-7953	Icelandic Institute of Natural History	Icelandic Institute of Natural History	Study was funded by Icelandic Institute of Natural History. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babington CC., 1871, J LINNEAN SOC BOT, V11, P282, DOI [10.1111/j.1095-8339.1870.tb00067.x, DOI 10.1111/J.1095-8339.1870.TB00067.X]; Beck PSA, 2005, REMOTE SENS ENVIRON, V98, P110, DOI 10.1016/j.rse.2005.07.002; BIRKS HJB, 1976, NEW PHYTOL, V77, P257, DOI 10.1111/j.1469-8137.1976.tb01517.x; BIRKS HJB, 1987, ANN ZOOL FENN, V24, P165; Bohner J, 2009, DEV SOIL SCI, V33, P195, DOI 10.1016/S0166-2481(08)00008-1; Bohner J., 2002, EUR SOIL BUR, V7, P213; CAFF, 2013, ARCTIC BIODIVERSITY; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Crawford R.M.M., 1989, STUDIES PLANT SURVIV; CURL H, 1972, ECOLOGY, V53, P1189, DOI 10.2307/1935433; Elven R, 2011, CHECKLIST PANARCTIC; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Gronlund Ch., 1881, ISLANDS FLORA; Hallgrimsson H, 1971, NATTURUFRAEDINGURINN, V40, P233; Hallgrimsson H, 1969, NATTURUFRAEDINGURINN, V39, P17; Heino J, 2001, J BIOGEOGR, V28, P69, DOI 10.1046/j.1365-2699.2001.00538.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, DIVA GIS VERS 7 5 MA; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hill M.O., 2004, ATTRIBUTES BRIT IRIS; HILL MO, 1991, J BIOGEOGR, V18, P247, DOI 10.2307/2845395; Hill MO, 1979, DECORANA A FORTRAN P; Hugo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036269; Ingadottir A, 1996, PLONTUR; Jakobsson S, 1980, JOKULL, V29, P57; Jakobsson SP, 2008, JOKULL, V58, P117; Jaleska SD, 2009, GEOMORPHOMETRY CONCE; Kristinsson H., 2008, FJOLRIT NATTURUFRAEO, V51, P1; Kristinsson H, 1998, KVISKERKJABOK, P82; Kristinsson H, 1986, GUIDE FLOWERING PLAN; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Nucci A, 2012, PLANT BIOSYST, V146, P564, DOI 10.1080/11263504.2012.670669; Ogren E, 1996, FUNCT ECOL, V10, P724, DOI 10.2307/2390507; Ogren E, 1997, TREE PHYSIOL, V17, P724; Pawlowska S, 1966, VEGETATION POLAND, P138; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; Preston C. D., 2013, New Journal of Botany, V3, P96, DOI 10.1179/2042349713Y.0000000024; Preston CD, 1997, BOT J LINN SOC, V124, P1, DOI 10.1006/bojl.1996.0084; Preston CD, 2013, J BRYOL, V35, P71, DOI 10.1179/1743282012Y.0000000045; R Core Team, 2021, R LANGUAGE ENV STAT; RAUNKIAER C., 1934; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; SALISBURY EJ, 1932, T NORFOLK NORWICH NA, V13, P191; Stefansson S., 1901, FLORA ISLANDS; Steindorsson S, 1962, SOCIETAS SCIENTIARUM, V35, P5; Sveinbjornsson J, 2002, AMBIO, P23; Taulavuori K, 1997, ENVIRON POLLUT, V98, P91, DOI 10.1016/S0269-7491(97)00115-2; Trueman I, 1995, FLORA MONTGOMERYSHIR; Van de Ven CM, 2007, EARTH INTERACT, V11, DOI 10.1175/EI205.1; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wasowicz P, 2013, FLORA, V208, P648, DOI 10.1016/j.flora.2013.09.009; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; YURTSEV BA, 1994, J VEG SCI, V5, P765, DOI 10.2307/3236191	57	9	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102916	10.1371/journal.pone.0102916	http://dx.doi.org/10.1371/journal.pone.0102916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036368	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200097
J	Boonstra, TA; van Vugt, JPP; van der Kooij, H; Bloem, BR				Boonstra, Tjitske A.; van Vugt, Jeroen P. P.; van der Kooij, Herman; Bloem, Bastiaan R.			Balance Asymmetry in Parkinson's Disease and Its Contribution to Freezing of Gait	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; BILATERAL COORDINATION; SYSTEM-IDENTIFICATION; STANDING BALANCE; POSTURAL SWAY; LEVODOPA; STANCE; RHYTHMICITY; DYNAMICS; WALKING	Balance control (the ability to maintain an upright posture) is asymmetrically controlled in a proportion of patients with Parkinson's disease. Gait asymmetries have been linked to the pathophysiology of freezing of gait. We speculate that asymmetries in balance could contribute to freezing by a) hampering the unloading of the stepping leg and/or b) leading to a preferred stance leg during gait, which then results in asymmetric gait. To investigate this, we examined the relationship between balance control and weight-bearing asymmetries and freezing. We included 20 human patients with Parkinson (tested OFF medication; nine freezers) and nine healthy controls. Balance was perturbed in the sagittal plane, using continuous multi-sine perturbations, applied by a motion platform and by a force at the sacrum. Applying closed-loop system identification techniques, relating the body sway angle to the joint torques of each leg separately, determined the relative contribution of each ankle and hip joint to the total amount of joint torque. We also calculated weight-bearing asymmetries. We determined the 99-percent confidence interval of weight-bearing and balance-control asymmetry using the responses of the healthy controls. Freezers did not have larger asymmetries in weight bearing (p = 0.85) nor more asymmetrical balance control compared to non-freezers (p = 0.25). The healthy linear one-to-one relationship between weight bearing and balance control was significantly different for freezers and non-freezers (p = 0.01). Specifically, non-freezers had a significant relationship between weight bearing and balance control (p = 0.02), whereas this relation was not significant for freezers (p = 0.15). Balance control is asymmetrical in most patients (about 75 percent) with Parkinson's disease, but this asymmetry is not related to freezing. The relationship between weight bearing and balance control seems to be less pronounced in freezers, compared to healthy controls and non-freezers. However, this relationship should be investigated further in larger groups of patients.	[Boonstra, Tjitske A.; van der Kooij, Herman] Univ Twente, Dept Biomech Engn, MIRA Inst Biomech Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Vugt, Jeroen P. P.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [van der Kooij, Herman] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Twente; Medical Spectrum Twente; Delft University of Technology; Radboud University Nijmegen	Boonstra, TA (corresponding author), Univ Twente, Dept Biomech Engn, MIRA Inst Biomech Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	t.a.boonstra@gmail.com	Bloem, Bastiaan/H-8013-2014	Bloem, Bastiaan/0000-0002-6371-3337; van der kooij, herman/0000-0002-7926-3262	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Dutch Parkinson Patient Foundation; Netherlands Organization for Scientific Research (NWO) [016076352]	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; Dutch Parkinson Patient Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (www.nici.ru.nl/braingain); the Dutch Parkinson Patient Foundation (http://www.parkinson-vereniging.nl/; to T.A.B.) and the Netherlands Organization for Scientific Research (NWO) (#016076352 to B.R.B.; www.nwo.nl). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker LC, 2008, GAIT POSTURE, V27, P471, DOI 10.1016/j.gaitpost.2007.06.002; Asai Y, 2003, BIOL CYBERN, V88, P152, DOI 10.1007/s00422-002-0371-9; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; BECKLEY DJ, 1995, J NEUROL SCI, V132, P133, DOI 10.1016/0022-510X(95)00130-T; Bloem BR, 2008, TREATMENT GAIT BALAN; Boonstra TA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-23; BurleighJacobs A, 1997, MOVEMENT DISORD, V12, P206, DOI 10.1002/mds.870120211; Cohen OS, 2012, J GERIATR PSYCH NEUR, V25, P71, DOI 10.1177/0891988712445087; Cook RD, 1982, RESIDUALS INFLUENCE; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Danoudis M, 2012, PARKINSONISM RELAT D, V18, P543, DOI 10.1016/j.parkreldis.2012.02.005; de Vlugt E, 2003, J NEUROSCI METH, V122, P123, DOI 10.1016/S0165-0270(02)00303-5; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Doherty KM, 2011, LANCET NEUROL; Engelhart D, 2013, J AM MED DIR ASS; Fasano A, 2011, MOVEMENT DISORD, V26, P844, DOI 10.1002/mds.23583; Fling BW, 2013, BRAIN; Frazzitta G, 2012, J NEUROL; Geurts ACH, 2011, GAIT POSTURE, V33, P143, DOI 10.1016/j.gaitpost.2010.09.018; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hendrickson J, 2014, GAIT POSTURE, V39, P177, DOI 10.1016/j.gaitpost.2013.06.022; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Jacobs JV, 2009, EXP NEUROL, V215, P334, DOI 10.1016/j.expneurol.2008.10.019; Jenkins G. M., 1969, SPECTRAL ANAL ITS AP; Kiemel T, 2008, J NEUROPHYSIOL, V100, P3394, DOI 10.1152/jn.01272.2007; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; KOOPMAN B, 1995, J BIOMECH, V28, P1369, DOI 10.1016/0021-9290(94)00185-7; Koopman HFJM, 1989, 3 DIMENSIONAL ANAL P; Lewek MD, 2010, GAIT POSTURE, V31, P256, DOI 10.1016/j.gaitpost.2009.10.013; Mancini M, 2008, CLIN BIOMECH, V23, P450, DOI 10.1016/j.clinbiomech.2007.11.007; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Pasma JH, 2014, NEUROSCIENCE, V267, P157, DOI 10.1016/j.neuroscience.2014.02.030; Pasma JH, 2012, J NEUROPHYSIOL, V108, P1138, DOI 10.1152/jn.01008.2011; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090634; Peterson DS, 2012, PARKINSONISM RELAT D; Pintelon R., 2001, SYSTEM IDENTIFICATIO; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Preuss R, 2004, J BIOMECH, V37, P1177, DOI 10.1016/j.jbiomech.2003.12.007; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Royall DR, 2001, NEUROLOGY, V57, P565, DOI 10.1212/WNL.57.3.565; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Singh NB, 2012, J ELECTROMYOGR KINES, V22, P131, DOI 10.1016/j.jelekin.2011.10.007; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Spildooren J, 2012, NEUROSCIENCE, V207, P298, DOI 10.1016/j.neuroscience.2012.01.024; Uitti RJ, 2005, PARKINSONISM RELAT D, V11, P139, DOI 10.1016/j.parkreldis.2004.10.007; van Asseldonk EHF, 2006, EXP NEUROL, V201, P441, DOI 10.1016/j.expneurol.2006.04.036; van der Kooij H, 2007, J NEURAL TRANSM, V114, P1333, DOI 10.1007/s00702-007-0801-x; van der Kooij H, 2005, J PHYSIOL-LONDON, V569, P705, DOI 10.1113/jphysiol.2005.569001; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Wright WG, 2010, EXP NEUROL, V225, P202, DOI 10.1016/j.expneurol.2010.06.016	58	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102493	10.1371/journal.pone.0102493	http://dx.doi.org/10.1371/journal.pone.0102493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032994	Green Published, gold			2022-12-27	WOS:000339418300057
J	Li, JW; Xu, C; Fan, Y; Wang, Y; Xiao, YB				Li, Jing-Wei; Xu, Cui; Fan, Ye; Wang, Yong; Xiao, Ying-Bin			Can Serum Levels of Alkaline Phosphatase and Phosphate Predict Cardiovascular Diseases and Total Mortality in Individuals with Preserved Renal Function? A Systemic Review and Meta-Analysis	PLOS ONE			English	Review							STATES NATIONAL-HEALTH; C-REACTIVE PROTEIN; GROWTH-FACTOR 23; PARATHYROID-HORMONE; ALL-CAUSE; MYOCARDIAL-INFARCTION; PHOSPHORUS LEVELS; RISK-FACTOR; ASSOCIATION; CALCIUM	It is demonstrated that elevated serum levels of alkaline phosphatase (ALP) and phosphate indicate a higher risks of cardiovascular disease (CVD) and total mortality in population with chronic kidney disease (CKD), but it remains unclear whether this association exists in people with normal or preserved renal function. Method: Clinical trials were searched from Embase and PubMed from inception to 2013 December using the keywords "ALP'', "phosphate'', "CVD'', "mortality'' and so on, and finally 24 trials with a total of 147634 patients were included in this study. Dose-response and semi-parametric meta-analyses were performed. Results: A linear association of serum levels of ALP and phosphate with risks of coronary heart disease (CHD) events, CVD events and deaths was identified. The relative risk(RR) of ALP for CVD deaths was 1.02 (95% confidence interval [CI], 1.01-1.04). The RR of phosphate for CVD deaths and events was 1.05 (95% CI, 1.02-1.09) and 1.04 (95% CI: 1.03-1.06), respectively. A non-linear association of ALP and phosphate with total mortality was identified. Compared with the reference category of ALP and phosphate, the pooled RR of ALP for total mortality was 1.57 (95% CI, 1.27-1.95) for the high ALP group, while the RR of phosphate for total mortality was 1.33 (95% CI, 1.21-1.46) for the high phosphate group. It was observed in subgroup analysis that higher levels of serum ALP and phosphate seemed to indicate a higher mortality rate in diabetic patients and those having previous CVD. The higher total mortality rate was more obvious in the men and Asians with high ALP. Conclusion: A non-linear relationship exists between serum levels of ALP and phosphate and risk of total mortality. There appears to be a positive association of serum levels of ALP/phosphate with total mortality in people with normal or preserved renal function, while the relationship between ALP and CVD is still ambiguous.	[Li, Jing-Wei; Wang, Yong; Xiao, Ying-Bin] Third Mil Med Univ, Xinqiao Hosp, Inst Cardiovasc Surg, Chongqing, Peoples R China; [Xu, Cui] 305 Hosp PLA, Dept Med, Beijing, Peoples R China; [Fan, Ye] Third Mil Med Univ, Xinqiao Hosp, Inst Resp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xiao, YB (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Inst Cardiovasc Surg, Chongqing, Peoples R China.	xiaoyb@vip.sina.com		Li, Jing-Wei/0000-0003-1638-2317				Abramowitz M, 2010, CLIN J AM SOC NEPHRO, V5, P1064, DOI 10.2215/CJN.08621209; Aronson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058348; Babaev VR, 2013, CIRCULATION, V128; Bates CJ, 2012, OSTEOPOROSIS INT, V23, P457, DOI 10.1007/s00198-011-1543-z; Cancela AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036883; Celik E, 2013, MINERVA MED, V104, P497; Cheung BMY, 2008, CLIN CHEM LAB MED, V46, P523, DOI 10.1515/CCLM.2008.111; Cheung BMY, 2009, INT J CARDIOL, V135, P156, DOI 10.1016/j.ijcard.2008.03.039; Chonchol M, 2009, AM J MED, V122, P380, DOI 10.1016/j.amjmed.2008.09.039; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Cupisti A, 2013, INT J NEPHROL RENOV, V6, P193, DOI 10.2147/IJNRD.S35632; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dominguez JR, 2013, AM J KIDNEY DIS, V61, P555, DOI 10.1053/j.ajkd.2012.11.033; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; EASTMAN JR, 1977, CLIN CHEM, V23, P1769; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Ess M, 2013, J CARD FAIL, V19, P25, DOI 10.1016/j.cardfail.2012.11.008; Figueiredo CP, 2013, BONE, V52, P354, DOI 10.1016/j.bone.2012.10.019; Fleming KM, 2011, ALIMENT PHARM THER, V34, P324, DOI 10.1111/j.1365-2036.2011.04718.x; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Grandi NC, 2012, HEART, V98, P926, DOI 10.1136/heartjnl-2011-300806; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Iqbal MP, 2013, CLIN CHIM ACTA, V425, P192, DOI 10.1016/j.cca.2013.08.009; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kim J, 2013, STROKE; Koehler EM, 2013, LIVER INT; Krishnamurthy VR, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.11.030; Larsson TE, 2010, ARTERIOSCL THROM VAS, V30, P333, DOI 10.1161/ATVBAHA.109.196675; Lau WL, 2011, ADV CHRONIC KIDNEY D, V18, P105, DOI 10.1053/j.ackd.2010.12.002; Linefsky JP, 2011, J AM COLL CARDIOL, V58, P291, DOI 10.1016/j.jacc.2010.11.073; Lippi Giuseppe, 2009, Diabetes Res Clin Pract, V84, pe3, DOI 10.1016/j.diabres.2009.01.003; Liu X, 2014, CLIN J AM SOC NEPHRO; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; MAXWELL DB, 1986, J AM COLL NUTR, V5, P55; McGovern AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074996; Natoli JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-88; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Onufrak SJ, 2009, AM J EPIDEMIOL, V169, P67, DOI 10.1093/aje/kwn285; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Park JB, 2013, EUR HEART J, V34, P920, DOI 10.1093/eurheartj/ehs419; Rajamannan NM, 2011, J AM COLL CARDIOL, V58, P298, DOI 10.1016/j.jacc.2011.01.047; Regidor DL, 2008, J AM SOC NEPHROL, V19, P2193, DOI 10.1681/ASN.2008010014; Ryu WS, 2010, NEUROLOGY, V75, P1995, DOI 10.1212/WNL.0b013e3181ff966a; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shin S, 2012, EUR HEART J, V33, P2873, DOI 10.1093/eurheartj/ehs152; Slinin Y, 2011, INT J CARDIOL, V149, P335, DOI 10.1016/j.ijcard.2010.02.013; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tanhauserova V, 2014, CLIN CHEM LAB MED, V52, P77, DOI 10.1515/cclm-2012-0833; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; van Kuijk JP, 2010, AM J NEPHROL, V32, P163, DOI 10.1159/000315856; Vyssoulis G, 2010, HYPERTENS RES, V33, P825, DOI 10.1038/hr.2010.86; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Webber M, 2010, CLIN CHEM LAB MED, V48, P167, DOI 10.1515/CCLM.2010.052; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Westerberg PA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-85; Yousaf F, 2014, RENAL FAILURE, V36, P131, DOI 10.3109/0886022X.2013.832319	60	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102276	10.1371/journal.pone.0102276	http://dx.doi.org/10.1371/journal.pone.0102276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033287	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300044
J	Yehia, BR; Herati, RS; Fleishman, JA; Gallant, JE; Agwu, AL; Berry, SA; Korthuis, PT; Moore, RD; Metlay, JP; Gebo, KA				Yehia, Baligh R.; Herati, Ramin S.; Fleishman, John A.; Gallant, Joel E.; Agwu, Allison L.; Berry, Stephen A.; Korthuis, P. Todd; Moore, Richard D.; Metlay, Joshua P.; Gebo, Kelly A.		HIV Res Network	Hepatitis C Virus Testing in Adults Living with HIV: A Need for Improved Screening Efforts	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; MEDICINE ASSOCIATION; FREQUENT ATTENDERS; PRIMARY-CARE; HEALTH; INTERVENTION; GUIDELINES; RECOMMENDATIONS; PREVENTION; ADHERENCE	Objectives: Guidelines recommend hepatitis C virus (HCV) screening for all people living with HIV (PLWH). Understanding HCV testing practices may improve compliance with guidelines and can help identify areas for future intervention. Methods: We evaluated HCV screening and unnecessary repeat HCV testing in 8,590 PLWH initiating care at 12 U.S. HIV clinics between 2006 and 2010, with follow-up through 2011. Multivariable logistic regression examined the association between patient factors and the outcomes: HCV screening (>= 1 HCV antibody tests during the study period) and unnecessary repeat HCV testing (>= 1 HCV antibody tests in patients with a prior positive test result). Results: Overall, 82% of patients were screened for HCV, 18% of those screened were HCV antibody-positive, and 40% of HCV antibody-positive patients had unnecessary repeat HCV testing. The likelihood of being screened for HCV increased as the number of outpatient visits rose (adjusted odds ratio 1.02, 95% confidence interval 1.01-1.03). Compared to men who have sex with men (MSM), patients with injection drug use (IDU) were less likely to be screened for HCV (0.63, 0.52-0.78); while individuals with Medicaid were more likely to be screened than those with private insurance (1.30, 1.04-1.62). Patients with heterosexual (1.78, 1.20-2.65) and IDU (1.58, 1.06-2.34) risk compared to MSM, and those with higher numbers of outpatient (1.03, 1.01-1.04) and inpatient (1.09, 1.01-1.19) visits were at greatest risk of unnecessary HCV testing. Conclusions: Additional efforts to improve compliance with HCV testing guidelines are needed. Leveraging health information technology may increase HCV screening and reduce unnecessary testing.	[Yehia, Baligh R.; Herati, Ramin S.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Yehia, Baligh R.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Fleishman, John A.] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA; [Gallant, Joel E.] Southwest Care Ctr, Santa Fe, NM USA; [Agwu, Allison L.; Berry, Stephen A.; Moore, Richard D.; Gebo, Kelly A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Metlay, Joshua P.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Agency for Healthcare Research & Quality; Johns Hopkins University; Oregon Health & Science University; Harvard University; Massachusetts General Hospital	Yehia, BR (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.	byehia@upenn.edu	Gebo, Kelly/AHA-7533-2022	Gebo, Kelly/0000-0003-4010-398X; Sedaghat Herati, Ramin/0000-0001-7713-2587; Herati, Ramin/0000-0003-2613-4050; Korthuis, Philip/0000-0001-5556-3597	Agency for Healthcare Research and Quality [HHSA290201100007C]; National Institutes of Health [K23-MH097647-01A1, K23AI084854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069918, K23AI084854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Agency for Healthcare Research and Quality, www.ahrq.gov, [HHSA290201100007C] and the National Institutes of Health, www.nih.gov, [K23-MH097647-01A1 to BRY, K23AI084854 to SAB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Asonganyi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072712; Baron RC, 2010, AM J PREV MED, V38, P110, DOI 10.1016/j.amepre.2009.09.031; Bates DW, 1999, AM J MED, V106, P144, DOI 10.1016/S0002-9343(98)00410-0; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Boohaker EA, 1996, ARCH INTERN MED, V156, P327, DOI 10.1001/archinte.156.3.327; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Community Preventive Serv Task, 2012, AM J PREV MED, V43, P92, DOI [10.1016/j.amepre.2012.04.008, 10.1016/j.amepre.2012.08.013]; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Groom H, 2008, J CLIN GASTROENTEROL, V42, P97, DOI 10.1097/MCG.0b013e31802dc56f; Hoover KW, 2012, SEX TRANSM DIS, V39, P349, DOI 10.1097/OLQ.0b013e318244a923; Jonckheere S, 2013, AIDS PATIENT CARE ST, V27, P317, DOI 10.1089/apc.2013.0096; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Kim AY, 2007, J INFECT DIS S1, V1, pS1; Knowlton AR, 2001, DRUG ALCOHOL DEPEN, V64, P55, DOI 10.1016/S0376-8716(00)00228-3; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Kwok J, 2005, J CLIN PATHOL, V58, P457, DOI 10.1136/jcp.2004.021691; Lambers FAE, 2014, AIDS CARE, V26, P416, DOI 10.1080/09540121.2013.832721; Lefevre F, 1999, J GEN INTERN MED, V14, P425, DOI 10.1046/j.1525-1497.1999.07238.x; Legorreta AP, 1997, DIABETES CARE, V20, P520, DOI 10.2337/diacare.20.4.520; Linas BP, 2014, AM J MED, V127, P398, DOI 10.1016/j.amjmed.2014.01.012; Liu P, 1997, TRANSFUSION, V37, P732, DOI 10.1046/j.1537-2995.1997.37797369450.x; McGregor MJ, 2012, CAN FAM PHYSICIAN, V58, P1191; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Neal RD, 2000, BRIT J GEN PRACT, V50, P972; Nies J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-70; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2009, GUIDELINES USE ANTIR, P1; Reed M, 2013, JAMA-J AM MED ASSOC, V310, P1060, DOI 10.1001/jama.2013.276733; Scaife B, 2000, FAM PRACT, V17, P298, DOI 10.1093/fampra/17.4.298; Taylor LE, 2011, AIDS PATIENT CARE ST, V25, P571, DOI 10.1089/apc.2011.0106; Valenstein P, 1998, ARCH PATHOL LAB MED, V112, P238; Veterans Health Administration, 2009, STAT CAR VET HIV AID; White P, 2013, J LOW GENIT TRACT DI, V17, P175, DOI 10.1097/LGT.0b013e3182607137; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Yehia BR, 2013, AIDS, V27, P1529, DOI 10.1097/QAD.0b013e328360104e; Yehia BR, 2013, AIDS PATIENT CARE ST, V27, P272, DOI 10.1089/apc.2013.0007; Yehia BR, 2008, AIDS PATIENT CARE ST, V22, P1007, DOI 10.1089/apc.2008.0093; Yehia BR, 2013, AIDS BEHAV	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102766	10.1371/journal.pone.0102766	http://dx.doi.org/10.1371/journal.pone.0102766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032989	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300089
J	Kang, YY; Hodges, A; Ong, E; Roberts, W; Piermarocchi, C; Paternostro, G				Kang, Yunyi; Hodges, Andrew; Ong, Edison; Roberts, William; Piermarocchi, Carlo; Paternostro, Giovanni			Identification of Drug Combinations Containing Imatinib for Treatment of BCR-ABL plus Leukemias	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; PHILADELPHIA-CHROMOSOME; POSITIVE LEUKEMIA; CANCER-CELLS; STEM-CELLS; IN-VITRO; RESISTANCE	The BCR-ABL translocation is found in chronic myeloid leukemia (CML) and in Ph+ acute lymphoblastic leukemia (ALL) patients. Although imatinib and its analogues have been used as front-line therapy to target this mutation and control the disease for over a decade, resistance to the therapy is still observed and most patients are not cured but need to continue the therapy indefinitely. It is therefore of great importance to find new therapies, possibly as drug combinations, which can overcome drug resistance. In this study, we identified eleven candidate anti-leukemic drugs that might be combined with imatinib, using three approaches: a kinase inhibitor library screen, a gene expression correlation analysis, and literature analysis. We then used an experimental search algorithm to efficiently explore the large space of possible drug and dose combinations and identified drug combinations that selectively kill a BCR-ABL+ leukemic cell line (K562) over a normal fibroblast cell line (IMR-90). Only six iterations of the algorithm were needed to identify very selective drug combinations. The efficacy of the top forty-nine combinations was further confirmed using Ph+ and Ph- ALL patient cells, including imatinib-resistant cells. Collectively, the drug combinations and methods we describe might be a first step towards more effective interventions for leukemia patients, especially those with the BCR-ABL translocation.	[Kang, Yunyi; Hodges, Andrew; Paternostro, Giovanni] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ong, Edison] Salgomed Inc, Del Mar, CA USA; [Roberts, William] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, San Diego, CA 92103 USA; [Piermarocchi, Carlo] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Sanford Burnham Prebys Medical Discovery Institute; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Michigan State University	Paternostro, G (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	giovanni@burnham.org	Piermarocchi, Carlo/AAH-2162-2019	Piermarocchi, Carlo/0000-0003-2762-8562; Ong, Edison/0000-0002-5159-414X	National Science Foundation [0829891]; NATIONAL CANCER INSTITUTE [P30CA023100, P30CA030199] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Science Foundation (Grant No. 0829891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Feala JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029374; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goff DJ, 2013, CELL STEM CELL, V12, P316, DOI 10.1016/j.stem.2012.12.011; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Hawkins LM, 2005, PEDIATR RES, V57, P430, DOI 10.1203/01.PDR.0000153871.45184.19; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hwang SH, 2008, MOL CANCER THER, V7, P559, DOI 10.1158/1535-7163.MCT-07-0548; Kuroda J, 2007, CELL DEATH DIFFER, V14, P1667, DOI 10.1038/sj.cdd.4402168; Kuroda J, 2008, BRIT J HAEMATOL, V140, P181, DOI 10.1111/j.1365-2141.2007.06899.x; La Rosee P, 2002, EXP HEMATOL, V30, P729, DOI 10.1016/S0301-472X(02)00836-6; Lancet JE, 2010, LEUKEMIA, V24, P699, DOI 10.1038/leu.2009.292; Melo JV, 1996, LEUKEMIA, V10, P751; Nguyen TK, 2006, CLIN CANCER RES, V12, P2239, DOI 10.1158/1078-0432.CCR-05-2282; Packer LM, 2011, CANCER CELL, V20, P715, DOI 10.1016/j.ccr.2011.11.004; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Radujkovic A, 2005, LEUKEMIA, V19, P1198, DOI 10.1038/sj.leu.2403764; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schneider J. J., 2006, STOCHASTIC OPTIMIZAT; Schrag D, 2004, J CLIN ONCOL, V22, P3631, DOI 10.1200/JCO.2004.05.065; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Tipping AJ, 2002, LEUKEMIA, V16, P2349, DOI 10.1038/sj.leu.2402775; Tiziani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082859; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; Wang H, 2006, CANCER RES, V66, P9722, DOI 10.1158/0008-5472.CAN-05-4602; WESTBROOK CA, 1992, BLOOD, V80, P2983; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102221	10.1371/journal.pone.0102221	http://dx.doi.org/10.1371/journal.pone.0102221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029499	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600047
J	Prufer, J; Schuchardt, M; Tolle, M; Prufer, N; Hohne, M; Zidek, W; van der Giet, M				Pruefer, Jasmin; Schuchardt, Mirjam; Toelle, Markus; Pruefer, Nicole; Hoehne, Matthias; Zidek, Walter; van der Giet, Markus			Harmful Effects of the Azathioprine Metabolite 6-Mercaptopurine in Vascular Cells: Induction of Mineralization	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; PREDICTS CARDIOVASCULAR EVENTS; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; OXIDATIVE STRESS; RISK-FACTORS; OSTEOBLASTIC DIFFERENTIATION; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; DISEASE	Vascular mineralization contributes to the high cardiovascular morbidity and mortality in patients who suffer from chronic kidney disease and in individuals who have undergone solid organ transplantation. The immunosuppressive regimen used to treat these patients appears to have an impact on vascular alterations. The effect of 6-mercaptopurine (6-MP) on vascular calcification has not yet been determined. This study investigates the effect of 6-MP on vascular mineralization by the induction of trans-differentiation of rat vascular smooth muscle cells in vitro. 6-MP not only induces the expression of osteochondrocyte-like transcription factors and proteins but also activates alkaline phosphatase enzyme activity and produces calcium deposition in in vitro and ex vivo models. These processes are dependent on 6-MP-induced production of reactive oxygen species, intracellular activation of mitogen-activated kinases and phosphorylation of the transcription factor Cbfa1. Furthermore, the metabolic products of 6-MP, 6-thioguanine nucleotides and 6-methyl-thio-inosine monophosphate have major impacts on cellular calcification. These data provide evidence for a possible harmful effect of the immunosuppressive drug 6-MP in vascular diseases, such as arteriosclerosis.	[Pruefer, Jasmin; Schuchardt, Mirjam; Toelle, Markus; Pruefer, Nicole; Zidek, Walter; van der Giet, Markus] Charite, Charite Ctr 13, Dept Nephrol, D-13353 Berlin, Germany; [Pruefer, Jasmin] Free Univ Berlin, Fachbereich Biochem, Berlin, Germany; [Pruefer, Nicole] Univ Potsdam, Dept Nutr Sci, Potsdam, Germany; [Hoehne, Matthias] Novartis Germany GmbH, Nurnberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; University of Potsdam	van der Giet, M (corresponding author), Charite, Charite Ctr 13, Dept Nephrol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	Markus.vanderGiet@charite.de	Schuchardt, Mirjam/AAS-3704-2021; Tölle, Markus/GPP-7157-2022	Schuchardt, Mirjam/0000-0001-7388-9611; van der Giet, Markus/0000-0003-3590-5451	Else Kroner-Fresenius-Stiftung; Sonnenfeld Stiftung; Peter and Traudl Engelhorn Stiftung	Else Kroner-Fresenius-Stiftung; Sonnenfeld Stiftung; Peter and Traudl Engelhorn Stiftung	This work was supported by grants from Else Kroner-Fresenius-Stiftung [M.vdG], Sonnenfeld Stiftung [J.P, M. S, M. T] and Peter and Traudl Engelhorn Stiftung [M. S]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnol M, 2008, TRANSPLANTATION, V86, P1844, DOI 10.1097/TP.0b013e31818ffec0; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Bottomley MJ, 2013, BRIT MED BULL, V106, P117, DOI 10.1093/bmb/ldt012; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; DeLoach SS, 2009, NEPHROL DIAL TRANSPL, V24, P1314, DOI 10.1093/ndt/gfn753; Deshpande AJ, 2010, MOL PATHOL LIB, P3, DOI 10.1007/978-1-4419-5698-9_1; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Gearry RB, 2005, J GASTROEN HEPATOL, V20, P1149, DOI 10.1111/j.1440-1746.2005.03832.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Haque S, 2010, J RHEUMATOL, V37, P322, DOI 10.3899/jrheum.090306; Jardine AG, 2011, LANCET, V378, P1419, DOI 10.1016/S0140-6736(11)61334-2; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; Liefeldt L, 2010, TRANSPL INT, V23, P1191, DOI 10.1111/j.1432-2277.2010.01159.x; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Mardini HE, 2003, J CLIN GASTROENTEROL, V36, P390, DOI 10.1097/00004836-200305000-00005; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; McGrath LT, 1997, CLIN CHIM ACTA, V264, P1, DOI 10.1016/S0009-8981(97)00088-0; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112; Nguyen PTH, 2010, NEPHROL DIAL TRANSPL, V25, P3773, DOI 10.1093/ndt/gfq268; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Polifka JE, 2002, TERATOLOGY, V65, P240, DOI 10.1002/tera.10043; Pols TWH, 2010, ARTERIOSCL THROM VAS, V30, P1591, DOI 10.1161/ATVBAHA.110.205674; Roe P, 2010, ATHEROSCLEROSIS, V212, P589, DOI 10.1016/j.atherosclerosis.2010.05.016; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Schuchardt M, 2012, KIDNEY INT, V81, P256, DOI 10.1038/ki.2011.326; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Taverne YJHJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/862423; van den Dorpel MA, 1999, ARTERIOSCL THROM VAS, V19, P1555, DOI 10.1161/01.ATV.19.6.1555; vandenDorpel MA, 1997, KIDNEY INT, V51, P1608, DOI 10.1038/ki.1997.221; Vanrenterghem YFC, 2008, TRANSPLANTATION, V85, P209, DOI 10.1097/TP.0b013e318160254f; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101709	10.1371/journal.pone.0101709	http://dx.doi.org/10.1371/journal.pone.0101709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029363	Green Published, gold			2022-12-27	WOS:000341306600021
J	Berod, L; Stuve, P; Varela, F; Behrends, J; Swallow, M; Kruse, F; Krull, F; Ghorbani, P; Mayer, CT; Holscher, C; Sparwasser, T				Berod, Luciana; Stueve, Philipp; Varela, Filipa; Behrends, Jochen; Swallow, Maxine; Kruse, Friederike; Krull, Freyja; Ghorbani, Peyman; Mayer, Christian T.; Hoelscher, Christoph; Sparwasser, Tim			Rapid Rebound of the Treg Compartment in DEREG Mice Limits the Impact of Treg Depletion on Mycobacterial Burden, but Prevents Autoimmunity	PLOS ONE			English	Article							REGULATORY T-CELLS; SUPPRESS IMMUNE-RESPONSES; PULMONARY TUBERCULOSIS; SELECTIVE DEPLETION; INTERFERON-GAMMA; IFN-GAMMA; INFECTION; MECHANISMS; EXPANSION; BLOOD	The development of an effective vaccine against tuberculosis (Tb) represents one of the major medical challenges of this century. Mycobacterium bovis Bacille Calmette-Guerin (BCG), the only vaccine available at present, is mostly effective at preventing disseminated Tb in children, but shows variable protection against pulmonary Tb, the most common form in adults. The reasons for this poor efficacy are not completely understood, but there is evidence that T regulatory cells (Tregs) might be involved. Similarly, Tregs have been associated with the immunosuppression observed in patients infected with Tb and are therefore believed to play a role in pathogen persistence. Thus, Treg depletion has been postulated as a novel strategy to potentiate M. bovis BCG vaccination on one side, while on the other, employed as a therapeutic approach during chronic Tb infection. Yet since Tregs are critically involved in controlling autoimmune inflammation, elimination of Tregs may therefore also incur the danger of an excessive inflammatory immune response. Thus, understanding the dynamics and function of Tregs during mycobacterial infection is crucial to evaluate the potential of Treg depletion as a medical option. To address this, we depleted Tregs after infection with M. bovis BCG or Mycobacterium tuberculosis (Mtb) using DEREG mice, which express the diphtheria toxin (DT) receptor under the control of the FoxP3 locus, thereby allowing the selective depletion of FoxP3(+) Tregs. Our results show that after depletion, the Treg niche is rapidly refilled by a population of DT-insensitive Tregs (diTregs) and bacterial load remains unchanged. On the contrary, impaired rebound of Tregs in DEREG x FoxP3(GFP) mice improves pathogen burden, but is accompanied by detrimental autoimmune inflammation. Therefore, our study provides the proof-of-principle that, although a high degree of Treg depletion may contribute to the control of mycobacterial infection, it carries the risk of autoimmunity.	[Berod, Luciana; Stueve, Philipp; Swallow, Maxine; Kruse, Friederike; Krull, Freyja; Ghorbani, Peyman; Mayer, Christian T.; Sparwasser, Tim] Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Varela, Filipa; Hoelscher, Christoph] Res Ctr Borstel, Prior Res Area Infect, Div Infect Immunol, Borstel, Germany; [Behrends, Jochen] Res Ctr Borstel, Core Facil Fluorescence Cytometry, Borstel, Germany; [Hoelscher, Christoph] Univ Kiel, Cluster Excellence Inflammat Interfaces, Kiel, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Kiel	Sparwasser, T (corresponding author), Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, Hannover, Germany.	Sparwasser.Office@mh-hannover.de	Berod, Luciana/AAG-8095-2019; Sparwasser, Tim D/AAA-4306-2022; Hölscher, Christoph/O-1732-2018; Varela, Filipa Alexandra Pereira Rosa/V-8718-2019; Sparwasser, Tim/AAF-7085-2019	Berod, Luciana/0000-0002-9677-3483; Hölscher, Christoph/0000-0002-7520-9146; Sparwasser, Tim/0000-0001-5645-902X; Ghorbani, Peyman/0000-0002-7398-5141	German Research Foundation (DFG) [SFB900]; BMBF [01KI0784]; German Center for Infection Research (DZIF); DZIF; German National Academic Foundation; International Research Training Groups (IRTG) - DFG [1273, 1911]; Braukmann-Wittenberg-Herz-Stiftung; DFG	German Research Foundation (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); German Center for Infection Research (DZIF); DZIF; German National Academic Foundation; International Research Training Groups (IRTG) - DFG(German Research Foundation (DFG)); Braukmann-Wittenberg-Herz-Stiftung; DFG(German Research Foundation (DFG))	This work was partly supported by the German Research Foundation (DFG, SFB900, Project B7, www.mh-hannover.de/sfb900) to T. S. and by the BMBF (01KI0784) and the German Center for Infection Research (DZIF, www.dzif.de) to C. H. F. Krull was also supported by the DZIF. C. T. M. was supported by the German National Academic Foundation. P. S. and F. V. were supported by the International Research Training Groups (IRTG) 1273 and 1911, respectively, funded by the DFG. The Cell Sorting Core Facility of the Hannover Medical School was supported in part by Braukmann-Wittenberg-Herz-Stiftung and DFG. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abel S, 2012, J IMMUNOL, V188, P5467, DOI 10.4049/jimmunol.1102223; Belkaid Y, 2008, EUR J IMMUNOL, V38, P918, DOI 10.1002/eji.200738120; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Berod L, 2012, MICROB BIOTECHNOL, V5, P260, DOI 10.1111/j.1751-7915.2011.00299.x; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Fernandez MA, 2013, VIROLOGY, V447, P9, DOI 10.1016/j.virol.2013.08.027; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Ho PY, 2010, J LEUKOCYTE BIOL, V88, P1073, DOI 10.1189/jlb.0809582; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hougardy JM, 2007, MICROBES INFECT, V9, P1325, DOI 10.1016/j.micinf.2007.06.004; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Marabelle A, 2013, CLIN CANCER RES, V19, P5261, DOI 10.1158/1078-0432.CCR-13-1923; Mayer CT, 2014, EUR J IMMUN IN PRESS; McBride A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003397; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray PJ, 1997, J IMMUNOL, V158, P315; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Othieno C, 1999, INFECT IMMUN, V67, P5730, DOI 10.1128/IAI.67.11.5730-5735.1999; Ozeki Y, 2010, INT IMMUNOL, V22, P179, DOI 10.1093/intimm/dxp126; Pace L, 2012, SCIENCE, V338, P532, DOI 10.1126/science.1227049; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Rausch S, 2009, EUR J IMMUNOL, V39, P3066, DOI 10.1002/eji.200939644; Reuter D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033989; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; van Maren WWC, 2008, IMMUNOLOGY, V124, P445, DOI 10.1111/j.1365-2567.2008.02871.x; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Wilczynski JR, 2008, FRONT BIOSCI-LANDMRK, V13, P2266, DOI 10.2741/2840; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert E, 2010, MUCOSAL IMMUNOL, V3, P213, DOI 10.1038/mi.2010.11; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	61	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102804	10.1371/journal.pone.0102804	http://dx.doi.org/10.1371/journal.pone.0102804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050936	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100058
J	Barentsz, MW; Wessels, H; van Diest, PJ; Pijnappel, RM; van der Pol, CC; Witkamp, AJ; van den Bosch, MAAJ; Verkooijen, HM				Barentsz, Maarten W.; Wessels, Hester; van Diest, Paul J.; Pijnappel, Ruud M.; van der Pol, Carmen C.; Witkamp, Arjen J.; van den Bosch, Maurice A. A. J.; Verkooijen, Helena M.			Same-Day Diagnosis Based on Histology for Women Suspected of Breast Cancer: High Diagnostic Accuracy and Favorable Impact on the Patient	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; FINE-NEEDLE; ASPIRATION-CYTOLOGY; DISTRESS; ANXIETY; COSTS	Background: Same-day diagnosis based on histology is increasingly being offered to patients suspected of breast cancer. We evaluated to which extent same-day diagnosis affected diagnostic accuracy and patients' anxiety levels during the diagnostic phase. Patients and methods: All 759 women referred for same-day evaluation of suspicious breast lesions between November 2011-March 2013 were included. Diagnostic accuracy was assessed by linking all patients to the national pathology database to identify diagnostic discrepancies, in which case slides were reviewed. Patients' anxiety was measured in 127 patients by the State Trait and Anxiety Inventory on six moments during the diagnostic workup and changes over time (, = 1 week) were analyzed by mixed effect models. Results: Core-needle biopsy was indicated in 374/759 patients (49.3%) and in 205/759 (27%) patients, invasive or in situ cancer was found. Final diagnosis on the same day was provided for 606/759 (79.8%) patients. Overall, 3/759 (0.4%) discordant findings were identified. Anxiety levels decreased significantly over time from 45.2 to 30.0 (P =, 0.001). Anxiety levels decreased from 44.4 to 25.9 (P = <0.001) for patients with benign disease, and remained unchanged for patients diagnosed with malignancies (48.6 to 46.7, P = 0.933). Time trends in anxiety were not affected by other patient or disease characteristics like age, education level or (family) history of breast cancer. Conclusion: Same-day histological diagnosis is feasible in the vast majority of patients, without impairing diagnostic accuracy. Patients' anxiety rapidly decreased in patients with a benign diagnosis and remained constant in patients with malignancy.	[Barentsz, Maarten W.; Pijnappel, Ruud M.; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Wessels, Hester] Univ Med Ctr Utrecht, Dept Corp Commun, Utrecht, Netherlands; [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Pol, Carmen C.; Witkamp, Arjen J.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Barentsz, MW (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	m.barentsz@umcutrecht.nl		Pijnappel, Ruud/0000-0002-6912-9414	Alpe d'HuZes; Dutch Cancer Society	Alpe d'HuZes; Dutch Cancer Society(KWF Kankerbestrijding)	Same-day diagnosis for breast cancer was implemented in the University Medical Center Utrecht with the financial support of Alpe d'HuZes, partner of the Dutch Cancer Society. http://www.opgevenisgeenoptie.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, IARC CANCERBASE; Brancato B, 2012, BREAST, V21, P449, DOI 10.1016/j.breast.2011.10.008; Bulte JP, 2013, BREAST CANCER RES TR, V137, P609, DOI 10.1007/s10549-012-2372-2; Clarke D, 2001, ANN ROY COLL SURG, V83, P110; Crystal P, 2005, J CLIN ULTRASOUND, V33, P47, DOI 10.1002/jcu.20089; Dey P, 2002, BRIT MED J, V324, P507, DOI 10.1136/bmj.324.7336.507; Flory N, 2011, RADIOLOGY, V260, P166, DOI 10.1148/radiol.11102211; Harcourt D, 1999, PSYCHOL HEALTH MED, V4, P14; Hatada T, 2000, J AM COLL SURGEONS, V190, P299, DOI 10.1016/S1072-7515(99)00300-2; Hedeker D., 2006, LONGITUDINAL DATA AN; Henselmans Inge, 2010, Ned Tijdschr Geneeskd, V154, pB491; Hukkinen K, 2008, ACTA ONCOL, V47, P1037, DOI 10.1080/02841860802001442; Kerlikowske K, 2003, ANN INTERN MED, V139, P274, DOI 10.7326/0003-4819-139-4-200308190-00010; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Strong V, 2007, BRIT J CANCER, V96, P868, DOI 10.1038/sj.bjc.6603626; Ubhi SS, 1996, ANN ROY COLL SURG, V78, P466; van der Bij Akke K, 2003, Community Genet, V6, P84, DOI 10.1159/000073003; Willems SM, 2012, J CLIN PATHOL, V65, P287, DOI 10.1136/jclinpath-2011-200410; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y	19	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103105	10.1371/journal.pone.0103105	http://dx.doi.org/10.1371/journal.pone.0103105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047134	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100108
J	Bharathkumar, H; Sundaram, MS; Jagadish, S; Paricharak, S; Hemshekhar, M; Mason, D; Kemparaju, K; Girish, KS; Basappa; Bender, A; Rangappa, KS				Bharathkumar, Hanumantharayappa; Sundaram, Mahalingam S.; Jagadish, Swamy; Paricharak, Shardul; Hemshekhar, Mahadevappa; Mason, Daniel; Kemparaju, Kempaiah; Girish, Kesturu S.; Basappa; Bender, Andreas; Rangappa, Kanchugarakoppal S.			Novel Benzoxazine-Based Aglycones Block Glucose Uptake In Vivo by Inhibiting Glycosidases	PLOS ONE			English	Article							ALPHA-AMYLASE ACTIVITY; DRUG DESIGN; DERIVATIVES; POTENT	Glycoside hydrolases catalyze the selective hydrolysis of glycosidic bonds in oligosaccharides, polysaccharides, and their conjugates. beta-glucosidases occur in all domains of living organisms and constitute a major group among glycoside hydrolases. On the other hand, the benzoxazinoids occur in living systems and act as stable b-glucosides, such as 2-(2,4-dihydroxy- 7-methoxy-2H-1,4-benzoxazin-3(4H)-one)-b-D-gluco-pyranose, which hydrolyse to an aglycone DIMBOA. Here, we synthesized the library of novel 1,3-benzoxazine scaffold based aglycones by using 2-aminobenzyl alcohols and aldehydes from one-pot reaction in a chloroacetic acid catalytic system via aerobic oxidative synthesis. Among the synthesized benzoxazines, 4-(7-chloro-2,4-dihydro-1H-benzo[d][1,3] oxazin-2-yl) phenol (compound 7) exhibit significant inhibition towards glucosidase compared to acarbose, with a IC50 value of 11.5 mM. Based upon results generated by in silico target prediction algorithms (Nai " ve Bayesian classifier), these aglycones potentially target the additional sodium/glucose cotransporter 1 (where a log likelihood score of 2.70 was observed). Furthermore, the in vitro glucosidase activity was correlated with the in silico docking results, with a high docking score for the aglycones towards the substrate binding site of glycosidase. Evidently, the in vitro and in vivo experiments clearly suggest an anti-hyperglycemic effect via glucose uptake inhibition by 4-(7-chloro-2,4-dihydro-1H-benzo[d][1,3] oxazin-2-yl) phenol in the starved rat model. These synthetic aglycones could constitute a novel pharmacological approach for the treatment, or re-enforcement of existing treatments, of type 2 diabetes and associated secondary complications.	[Bharathkumar, Hanumantharayappa; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India; [Sundaram, Mahalingam S.; Hemshekhar, Mahadevappa; Kemparaju, Kempaiah; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore, Karnataka, India; [Jagadish, Swamy; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Chem, Mysore, Karnataka, India; [Paricharak, Shardul; Mason, Daniel; Bender, Andreas] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Paricharak, Shardul] Leiden Univ, Leiden Acad Ctr Drug Res, Div Med Chem, Leiden, Netherlands	Bangalore University; University of Mysore; University of Mysore; University of Cambridge; Leiden University; Leiden University - Excl LUMC	Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560056, Karnataka, India.	salundibasappa@gmail.com; ab454@cam.ac.uk; rangappaks@gmail.com	Bender, Andreas/C-6942-2009; KS, Girish/GWZ-7128-2022	Bender, Andreas/0000-0002-6683-7546; /0000-0001-6121-0771; KS, Girish/0000-0002-7284-3707; Basappa, Basappa/0000-0002-8844-468X	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]; Basappa thanks Karnataka University, INDIA; UGC; DST	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology, Department of Science and Technology; Basappa thanks Karnataka University, INDIA; UGC(University Grants Commission, India); DST(Department of Science & Technology (India))	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, Department of Science and Technology (NO. SR/FT/LS-142/2012) to Basappa. Basappa thanks Karnataka University, INDIA for PAVATE fellowship. KSR thanks DST and UGC for funding. AB thanks Unilever and SP the Netherlands Organisation for Scientific Research (NWO) and the Prins Bernhard cultuurfonds for funding. MSS thanks UGC-BSR-SAP for the research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisakwattana S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-110; Adisakwattana S, 2009, J ENZYM INHIB MED CH, V24, P1194, DOI 10.1080/14756360902779326; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Boyer S, 2007, J CHEM INF MODEL, V47, P583, DOI 10.1021/ci600376q; Cazarolli LH, 2013, EUR J PHARMACOL, V712, P1, DOI 10.1016/j.ejphar.2013.02.029; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Chandramohanadas R, 2014, J INFECT DI IN PRESS; Israili ZH, 2011, AM J THER, V18, P117, DOI 10.1097/MJT.0b013e3181afbf51; Kato-Noguchi H, 2008, J PLANT PHYSIOL, V165, P1889, DOI 10.1016/j.jplph.2008.04.006; Kato-Noguchi H, 2010, J PLANT PHYSIOL, V167, P1221, DOI 10.1016/j.jplph.2010.04.006; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Li JM, 2007, J PHARMACOL EXP THER, V320, P38, DOI 10.1124/jpet.106.111526; Macias FA, 2009, NAT PROD REP, V26, P478, DOI 10.1039/b700682a; Moorthy NSHN, 2012, MINI-REV MED CHEM, V12, P713; Panahi F, 2013, CARBOHYD RES, V380, P81, DOI 10.1016/j.carres.2013.07.008; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Semighini EP, 2011, J BIOMOL STRUCT DYN, V28, P787, DOI 10.1080/07391102.2011.10508606; Sukhorukov AY, 2014, BIOORG MED IN PRESS; Tsujii E, 1996, BIOCHEM BIOPH RES CO, V220, P459, DOI 10.1006/bbrc.1996.0427; Wardrop DJ, 2010, NAT PROD REP, V27, P1431, DOI 10.1039/b914958a	22	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102759	10.1371/journal.pone.0102759	http://dx.doi.org/10.1371/journal.pone.0102759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047583	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000339558100073
J	Chen, CP; Fushing, H; Atwill, R; Koehl, P				Chen, Chia-Pei; Fushing, Hsieh; Atwill, Rob; Koehl, Patrice			biDCG: A New Method for Discovering Global Features of DNA Microarray Data via an Iterative Re-Clustering Procedure	PLOS ONE			English	Article							GENE-EXPRESSION DATA; BREAST-CANCER; MOLECULAR CLASSIFICATION; BICLUSTERING ALGORITHMS; PATTERNS; BIOLOGY	Biclustering techniques have become very popular in cancer genetics studies, as they are tools that are expected to connect phenotypes to genotypes, i.e. to identify subgroups of cancer patients based on the fact that they share similar gene expression patterns as well as to identify subgroups of genes that are specific to these subtypes of cancer and therefore could serve as biomarkers. In this paper we propose a new approach for identifying such relationships or biclusters between patients and gene expression profiles. This method, named biDCG, rests on two key concepts. First, it uses a new clustering technique, DCG-tree [Fushing et al, PLos One, 8, e56259 (2013)] that generates ultrametric topological spaces that capture the geometries of both the patient data set and the gene data set. Second, it optimizes the definitions of bicluster membership through an iterative two-way reclustering procedure in which patients and genes are reclustered in turn, based respectively on subsets of genes and patients defined in the previous round. We have validated biDCG on simulated and real data. Based on the simulated data we have shown that biDCG compares favorably to other biclustering techniques applied to cancer genomics data. The results on the real data sets have shown that biDCG is able to retrieve relevant biological information.	[Chen, Chia-Pei; Fushing, Hsieh] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Atwill, Rob] Univ Calif Davis, Dept Populat Hlth & Reprod Vet Med Extens, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Koehl, P (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.	koehl@cs.ucdavis.edu			National Science Foundation [DMS-1007219]; National Institute of Health [GM080399]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080399] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Science Foundation: Grant DMS-1007219 and National Institute of Health: Grant GM080399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belacel N, 2006, OMICS, V10, P507, DOI 10.1089/omi.2006.10.507; Ben-Dor A., 2002, P 6 ANN INT C COMP B, P49, DOI [10.1145/565196.565203, DOI 10.1145/565196.565203]; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; CHANDRA B, 2006, STAT METHODOL, V3, P93; Cheeseman P., 1996, ADV KNOWLEDGE DISCOV, ppp153; Chen C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041120; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clarke PA, 2001, BIOCHEM PHARMACOL, V62, P1311, DOI 10.1016/S0006-2952(01)00785-7; Cummings MC, 2011, PATHOLOGY, V43, P1, DOI 10.1097/PAT.0b013e328341e0b5; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeRisi J, 1996, NAT GENET, V14, P457; DiMaggio PA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-458; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Flores JL, 2013, COMPUT METH PROG BIO, V112, P367, DOI 10.1016/j.cmpb.2013.07.025; Fushing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056259; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Getz G, 2003, BIOINFORMATICS, V19, P1079, DOI 10.1093/bioinformatics/btf876; Getz G, 2003, BIOINFORMATICS, V19, P1153, DOI 10.1093/bioinformatics/btg143; Gollub J, 2006, METHOD ENZYMOL, V411, P194, DOI 10.1016/S0076-6879(06)11010-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hartigan J., 1975, CLUSTERING ALGORITHM; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045502; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Kossenkov AV, 2010, INT J DATA MIN BIOIN, V4, P72, DOI 10.1504/IJDMB.2010.030968; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lazzeroni L, 2002, STAT SINICA, V12, P61; Macgregor PF, 2002, CLIN CHEM, V48, P1170; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Murali T M, 2003, Pac Symp Biocomput, P77; Nugent R, 2010, METHODS MOL BIOL, V620, P369, DOI 10.1007/978-1-60761-580-4_12; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Serin A, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-18; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tang C, 2001, 2ND ANNUAL IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P41, DOI 10.1109/BIBE.2001.974410; Tchagang AB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-229; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wiltgen M, 2007, HEMATOLOGY, V12, P271, DOI 10.1080/10245330701283967; Xu Rui, 2010, IEEE Rev Biomed Eng, V3, P120, DOI 10.1109/RBME.2010.2083647	51	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102445	10.1371/journal.pone.0102445	http://dx.doi.org/10.1371/journal.pone.0102445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047553	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100032
J	Marshall, PWM; Lovell, R; Jeppesen, GK; Andersen, K; Siegler, JC				Marshall, Paul W. M.; Lovell, Ric; Jeppesen, Gitte K.; Andersen, Kristoffer; Siegler, Jason C.			Hamstring Muscle Fatigue and Central Motor Output during a Simulated Soccer Match	PLOS ONE			English	Article							PERFORMANCE RESPONSES; PROFESSIONAL FOOTBALL; INJURIES; EXERCISE; SPEED; ACTIVATION; KINEMATICS; STRATEGIES; RECOVERY; JOINT	Purpose: To examine changes in hamstring muscle fatigue and central motor output during a 90-minute simulated soccer match, and the concomitant changes in hamstring maximal torque and rate of torque development. Method: Eight amateur male soccer players performed a 90-minute simulated soccer match, with measures performed at the start of and every 15-minutes during each half. Maximal torque (Nm) and rate of torque development (RTD; Nm.s(-1)) were calculated from maximal isometric knee flexor contractions performed at 10 degrees of flexion. Hamstring peripheral fatigue was assessed from changes in the size and shape of the resting twitch (RT). Hamstring central motor output was quantified from voluntary activation (%) and normalized biceps femoris (BF) and medial hamstrings (MH) electromyographic amplitudes (EMG/M). Results: Maximal torque was reduced at 45-minutes by 7.6 +/- 9.4% (p<0.05). RTD in time intervals of 0-25, 0-50, and 0-75 ms post-contraction onset were reduced after 15-minutes in the first-half between 29.6 to 46.2% (p<0.05), and were further reduced at the end of the second-half (p<0.05). Maximal EMG/M was reduced for biceps femoris only concomitant to the time-course of reductions in maximal torque (p = 0.007). The rate of EMG rise for BF and MH was reduced in early time periods (0-75 ms) post-contraction onset (p<0.05). No changes were observed for the size and shape of the RT, indicating no hamstring peripheral fatigue. Conclusion: Centrally mediated reductions in maximal torque and rate of torque development provide insight into factors that may explain hamstring injury risk during soccer. Of particular interest were early reductions during the first-half of hamstring rate of torque development, and the decline in maximal EMG/M of biceps femoris in the latter stages of the half. These are important findings that may help explain why the hamstrings are particularly vulnerable to strain injury during soccer.	[Marshall, Paul W. M.; Lovell, Ric; Siegler, Jason C.] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Jeppesen, Gitte K.; Andersen, Kristoffer] Aalborg Univ, Sch Med & Hlth, Aalborg, Denmark	Western Sydney University; Aalborg University	Marshall, PWM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia.	p.marshall@uws.edu.au	Lovell, Ric/I-9973-2019	Lovell, Ric/0000-0001-5859-0267; Siegler, Jason/0000-0003-1346-4982	NSW	NSW	This study was supported by the NSW Sports Research and Injury Prevention Scheme. http://www.sportinginjuries.nsw.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allison GT, 2003, J ELECTROMYOGR KINES, V13, P209, DOI 10.1016/S1050-6411(03)00019-1; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Andersson H, 2008, MED SCI SPORT EXER, V40, P372, DOI 10.1249/mss.0b013e31815b8497; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Behm DG, 1996, J APPL PHYSIOL, V81, P2267, DOI 10.1152/jappl.1996.81.5.2267; Bizzini M, 2013, J SPORT SCI, V31, P1481, DOI 10.1080/02640414.2013.802922; Buckthorpe M, 2014, EXP PHYSL; Chumanov ES, 2007, J BIOMECH, V40, P3555, DOI 10.1016/j.jbiomech.2007.05.026; Delextrat A, 2010, INT J SPORTS MED, V31, P192, DOI 10.1055/s-0029-1243642; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Heiderscheit BC, 2005, CLIN BIOMECH, V20, P1072, DOI 10.1016/j.clinbiomech.2005.07.005; Impellizzeri FM, 2013, J SPORT SCI, V31, P1491, DOI 10.1080/02640414.2013.802926; Koulouris G, 2003, SKELETAL RADIOL, V32, P582, DOI 10.1007/s00256-003-0674-5; Koulouris G, 2007, AM J SPORTS MED, V35; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Lovell R, 2013, SCAND J MED SCI SPOR, V23, P105, DOI 10.1111/j.1600-0838.2011.01353.x; Lovell R, 2008, COACH SPORTS SCI, P3; Magalhaes J, 2010, EUR J APPL PHYSIOL, V108, P39, DOI 10.1007/s00421-009-1161-z; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nybo L, 2013, MED SCI SPORT EXER, V45, P860, DOI 10.1249/MSS.0b013e31827ded04; Onishi H, 2002, J ELECTROMYOGR KINES, V12, P399, DOI 10.1016/S1050-6411(02)00033-0; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Petersen J, 2011, AM J SPORT MED, V39, P2296, DOI 10.1177/0363546511419277; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Rampinini E, 2011, MED SCI SPORT EXER, V43, P2161, DOI 10.1249/MSS.0b013e31821e9c5c; Scaglioni G, 2009, EUR J APPL PHYSIOL, V106, P563, DOI 10.1007/s00421-009-1049-y; Schache AG, 2009, GAIT POSTURE, V29, P332, DOI 10.1016/j.gaitpost.2008.10.054; Shield A, 2004, SPORTS MED, V34, P253, DOI 10.2165/00007256-200434040-00005; Sidhu SK, 2013, SPORTS MED, V43, P437, DOI 10.1007/s40279-013-0020-6; Small K, 2010, J SCI MED SPORT, V13, P120, DOI 10.1016/j.jsams.2008.08.005; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P605, DOI 10.1111/j.1600-0838.2007.00703.x; Thelen DG, 2005, MED SCI SPORT EXER, V37, P1931, DOI 10.1249/01.mss.0000176674.42929.de; Thorlund JB, 2009, INT J SPORTS MED, V30, P273, DOI 10.1055/s-0028-1104587; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Verrall GM, 2003, AM J SPORT MED, V31, P969, DOI 10.1177/03635465030310063701; VONDURING M, 1990, PRIMARY AFFERENT NEURON, P35; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; Yu B, 2008, J BIOMECH, V41, P3121, DOI 10.1016/j.jbiomech.2008.09.005	44	56	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102753	10.1371/journal.pone.0102753	http://dx.doi.org/10.1371/journal.pone.0102753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047547	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100072
J	Olufsen, M; Cangialosi, MV; Arukwe, A				Olufsen, Marianne; Cangialosi, Maria V.; Arukwe, Augustine			Modulation of Membrane Lipid Composition and Homeostasis in Salmon Hepatocytes Exposed to Hypoxia and Perfluorooctane Sulfonamide, Given Singly or in Combination	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; POLYUNSATURATED FATTY-ACIDS; OXIDATIVE STRESS RESPONSES; NUCLEAR RECEPTORS; METABOLIC-RESPONSES; INDUCIBLE FACTORS; FISH-OIL; ALPHA; OXYGEN; GENE	The relative importance of environmental hypoxia due to global climate change on organismal ability to adapt to chemical insult and/or mechanisms of these responses is not well understood. Therefore, we have studied the effects of combined exposure to perfluorooctane sulfonamide (PFOSA) and chemically induced hypoxia on membrane lipid profile and homeostasis. Primary salmon hepatocytes were exposed to PFOSA at 0, 25 and 50 mu M singly or in combination with either cobalt chloride (CoCl2: 0 and 150 mu M) or deferroxamine (DFO: 0 and 100 mu M) for 24 and 48 h. CoCl2 and DFO were used to induce cellular hypoxia because these two chemicals have been commonly used in animal experiments for this purpose and have been shown to increase hypoxia-inducible factor 1-alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) levels. Fatty acid (FA) profiles were determined by GC-MS, while gene expression patterns were determined by quantitative PCR. Hypoxic condition was confirmed with time-related increases of HIF-1 alpha mRNA levels in CoCl2 and DFO exposed cells. In general, significant alterations of genes involved in lipid homeostasis were predominantly observed after 48 h exposure. Gene expression analysis showed that biological responses related to peroxisome proliferation (peroxisome proliferator-activated receptors (PPARs) and acyl coenzyme A (ACOX)) and FA desaturation (Delta(5)- and Delta(6)-desaturases: FAD5 and FAD6, respectively) and elongation (FAE) were elevated slightly by single exposure (i.e. either PFOSA, CoCl2 or DFO exposure alone), and these responses were potentiated in combined exposure conditions. Principal component analysis (PCA) showed a clustering of peroxisome proliferation responses at transcript levels and FA desaturation against membrane FAs levels whose changes were explained by PFOSA and chemically induced hypoxia exposures. Overall, our data show that most of the observed responses were stronger in combined stressor exposure conditions, compared to individual stressor exposure. In general, our data show that hypoxia may, singly or in combination with PFOSA produce deleterious health, physiological and developmental consequences through the alteration of membrane lipid profile in organisms.	[Olufsen, Marianne; Arukwe, Augustine] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Cangialosi, Maria V.] Univ Messina, Dept Food & Environm Sci Prof G Stagno dAlcontres, Messina, Italy	Norwegian University of Science & Technology (NTNU); University of Messina	Arukwe, A (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	arukwe@bio.ntnu.no	Arukwe, Augustine/ABD-4927-2020; Arukwe, Augustine/H-8497-2014	Arukwe, Augustine/0000-0002-2134-4799; 	Norwegian Research Council [1964442/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council project number 1964442/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2008, MITOCHONDRION, V8, P329, DOI 10.1016/j.mito.2008.02.001; Ankley GT, 2005, ENVIRON TOXICOL CHEM, V24, P2316, DOI 10.1897/04-634R.1; Arukwe A, 2006, ENVIRON SCI TECHNOL, V40, P7944, DOI 10.1021/es0615223; Arukwe A, 2011, COMP BIOCHEM PHYS C, V154, P288, DOI 10.1016/j.cbpc.2011.06.012; Asakawa A, 2008, INT J MOL MED, V21, P439; Austin ME, 2003, ENVIRON HEALTH PERSP, V111, P1485, DOI 10.1289/ehp.6128; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Bell JG, 2003, J NUTR, V133, P2793, DOI 10.1093/jn/133.9.2793; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Braune BM, 2013, ENVIRON SCI TECHNOL, V47, P616, DOI 10.1021/es303733d; CAVE WT, 1991, FASEB J, V5, P2160, DOI 10.1096/fasebj.5.8.1673664; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dulf FV, 2013, MOLECULES, V18, P11768, DOI 10.3390/molecules181011768; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Eggen T, 2010, SCI TOTAL ENVIRON, V408, P5147, DOI 10.1016/j.scitotenv.2010.07.049; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Farooqui AA, 2000, J MOL NEUROSCI, V14, P123, DOI 10.1385/JMN:14:3:123; FLATMARK T, 1983, BIOCHIM BIOPHYS ACTA, V753, P460, DOI 10.1016/0005-2760(83)90071-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Goda N, 2012, INT J HEMATOL, V95, P457, DOI 10.1007/s12185-012-1069-y; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Hahn ME, 2005, XENOBIOTIC RECEPTORS, P191; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Hardy J.T., 2003, CLIMATE CHANGE CAUSE; HAUGHOM B, 1992, BIOCHIM BIOPHYS ACTA, V1128, P65, DOI 10.1016/0005-2760(92)90258-W; He WS, 2002, BIOCHEM BIOPH RES CO, V299, P832, DOI 10.1016/S0006-291X(02)02743-2; Hlavackova M, 2007, EXP BIOL MED, V232, P823; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huss JM, 2001, J BIOL CHEM, V276, P27605, DOI 10.1074/jbc.M100277200; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Jones PD, 2003, ENVIRON TOXICOL CHEM, V22, P2639, DOI 10.1897/02-553; Jun JC, 2013, AM J PHYSIOL-ENDOC M, V304, pE424, DOI 10.1152/ajpendo.00515.2012; Kaelin WG, 2002, GENE DEV, V16, P1441, DOI 10.1101/gad.1003602; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kelly DP, 2008, NAT GENET, V40, P132, DOI 10.1038/ng0208-132; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; KOGEL D, 2008, 38 ANN M SOC NEUR WA; Li JG, 2006, PHYSIOL GENOMICS, V25, P450, DOI 10.1152/physiolgenomics.00293.2005; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Liu Y, 2008, AQUAT TOXICOL, V89, P242, DOI 10.1016/j.aquatox.2008.07.009; Liu YL, 2014, TOXICOL LETT, V226, P117, DOI 10.1016/j.toxlet.2014.01.033; Lou PH, 2013, CARDIOVASC RES, V97, P251, DOI 10.1093/cvr/cvs323; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mazurais D, 2013, MAR BIOTECHNOL NY; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; MILLER MJ, 1989, CHEM REV, V89, P1563, DOI 10.1021/cr00097a011; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; Mortensen Anne S, 2007, Comp Hepatol, V6, P2, DOI 10.1186/1476-5926-6-2; Mortensen AS, 2011, CHEMOSPHERE, V83, P1035, DOI 10.1016/j.chemosphere.2011.01.067; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Razeghi P, 2001, BIOCHEM BIOPH RES CO, V287, P5, DOI 10.1006/bbrc.2001.5541; Rizvi YQ, 2013, VASC PHARMACOL, V59, P144, DOI 10.1016/j.vph.2013.09.001; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Ruyter B, 1997, BBA-LIPID LIPID MET, V1348, P331, DOI 10.1016/S0005-2760(97)00080-5; Ruyter B, 1999, LIPIDS, V34, P1167, DOI 10.1007/s11745-999-0468-3; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P716, DOI 10.1289/ehp.11253; Stephensen CB, 2004, NUTR REV, V62, P486, DOI [10.1111/j.1753-4887.2004.tb00021.x, 10.1301/nr.2004.000-000]; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; Wagbo AM, 2012, CHEM RES TOXICOL, V25, P1253, DOI 10.1021/tx300110u; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Wu RSS, 2009, FISH PHYSIOL, V27, P79, DOI 10.1016/S1546-5098(08)00003-4; Xu L, 2004, CHEM RES TOXICOL, V17, P767, DOI 10.1021/tx034222x; Zheng L, 2009, ARCH TOXICOL, V83, P679, DOI 10.1007/s00204-008-0361-3	88	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102485	10.1371/journal.pone.0102485	http://dx.doi.org/10.1371/journal.pone.0102485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047721	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100035
J	Wang, C; Hu, L; Zhao, L; Yang, P; Moorhead, JF; Varghese, Z; Chen, YX; Ruan, XZ				Wang, Chuan; Hu, Lin; Zhao, Lei; Yang, Ping; Moorhead, John F.; Varghese, Zac; Chen, Yaxi; Ruan, Xiong Z.			Inflammatory Stress Increases Hepatic CD36 Translational Efficiency via Activation of the mTOR Signalling Pathway	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MESSENGER-RNA TRANSLATION; FATTY-ACID UPTAKE; CHOLESTEROL ACCUMULATION; LIPID-ACCUMULATION; GENE-EXPRESSION; CELLS; RECEPTOR; LIVER; MECHANISMS	Inflammatory stress is an independent risk factor for the development of non-alcoholic fatty liver disease (NAFLD). Although CD36 is known to facilitate long-chain fatty acid uptake and contributes to NAFLD progression, the mechanisms that link inflammatory stress to hepatic CD36 expression and steatosis remain unclear. As the mammalian target of rapamycin (mTOR) signalling pathway is involved in CD36 translational activation, this study was undertaken to investigate whether inflammatory stress enhances hepatic CD36 expression via mTOR signalling pathway and the underlying mechanisms. To induce inflammatory stress, we used tumour necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) stimulation of the human hepatoblastoma HepG2 cells in vitro and casein injection in C57BL/6J mice in vivo. The data showed that inflammatory stress increased hepatic CD36 protein levels but had no effect on mRNA expression. A protein degradation assay revealed that CD36 protein stability was not different between HepG2 cells treated with or without TNF-alpha or IL-6. A polysomal analysis indicated that CD36 translational efficiency was significantly increased by inflammatory stress. Additionally, inflammatory stress enhanced the phosphorylation of mTOR and its downstream translational regulators including p70S6K, 4E-BP1 and eIF4E. Rapamycin, an mTOR-specific inhibitor, reduced the phosphorylation of mTOR signalling pathway and decreased the CD36 translational efficiency and protein level even under inflammatory stress resulting in the alleviation of inflammatory stress-induced hepatic lipid accumulation. This study demonstrates that the activation of the mTOR signalling pathway increases hepatic CD36 translational efficiency, resulting in increased CD36 protein expression under inflammatory stress.	[Wang, Chuan; Hu, Lin; Zhao, Lei; Yang, Ping; Chen, Yaxi; Ruan, Xiong Z.] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Ctr Lipid Res,Minist Educ, Chongqing, Peoples R China; [Moorhead, John F.; Varghese, Zac] UCL, John Moorhead Res Lab, Ctr Nephrol, Univ Coll London UCL Med Sch, London WC1E 6BT, England	Chongqing Medical University; University of London; University College London	Chen, YX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Ctr Lipid Res,Minist Educ, Chongqing, Peoples R China.	chenyaxi@cqmu.edu.cn; x.ruan@ucl.ac.uk	Moorhead, John/M-7404-2014; Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	National Natural Science Foundation of China [81270493, 81200567, 81270789, 81030008, 81390354]; National Basic Research Program of China (973 Program) [2012CB517700, 2012CB517500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (81270493, 81200567, 81270789 and Key Program, no. 81030008, 81390354), National Basic Research Program of China (973 Program, NO. 2012CB517700 & 2012CB517500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Brunt EM, 2009, HEPATOLOGY, V49, P809, DOI 10.1002/hep.22724; Carroll M, 2013, J INTERF CYTOK RES, V33, P227, DOI 10.1089/jir.2012.0142; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; Chen YY, 2012, J GASTROEN HEPATOL, V27, P974, DOI 10.1111/j.1440-1746.2011.06986.x; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Crozier SJ, 2005, AM J PHYSIOL-HEART C, V289, pH1242, DOI 10.1152/ajpheart.00859.2004; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Jung EJ, 2011, J LIPID RES, V52, P1617, DOI 10.1194/jlr.M015263; Ka K, 2013, J CLIN PERIODONTOL, V40, P986, DOI 10.1111/jcpe.12146; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Lauzier B, 2011, J MOL CELL CARDIOL, V51, P99, DOI 10.1016/j.yjmcc.2011.04.001; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Ma KL, 2007, TRANSPLANTATION, V84, P1029, DOI 10.1097/01.tp.0000286095.55685.e9; Ma KL, 2013, CARDIOVASC RES, V100, P450, DOI 10.1093/cvr/cvt203; Martin-Vilchez S, 2008, BRIT J PHARMACOL, V154, P698, DOI 10.1038/bjp.2008.87; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Mei M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-110; Noushmehr H, 2005, DIABETES, V54, P472, DOI 10.2337/diabetes.54.2.472; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Ruan XZ, 2001, KIDNEY INT, V60, P1716, DOI 10.1046/j.1523-1755.2001.00025.x; Shah P, 2014, DRUG METAB DISPOS, V42, P172, DOI 10.1124/dmd.113.053850; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Tanti JF., 2012, FRONT ENDOCRINOL, V3, P181, DOI [DOI 10.3389/FENDO.2012.00181, 10.3389/fendo.2012.00181]; Tilg H, 2011, J HEPATOL, V55, P960, DOI 10.1016/j.jhep.2011.04.007; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x; Zhou FH, 2013, CELL STRESS CHAPERON, V18, P643, DOI 10.1007/s12192-013-0417-z; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	42	30	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103071	10.1371/journal.pone.0103071	http://dx.doi.org/10.1371/journal.pone.0103071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048611	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100103
J	Wang, CR; Zhang, YN; Zhang, L; Hou, XH; Lu, HJ; Shen, YX; Chen, RH; Fang, PY; Yu, H; Li, M; Zhang, F; Chen, HB; Yu, HY; Zhou, J; Liu, F; Bao, YQ; Jia, WP				Wang, Congrong; Zhang, Yinan; Zhang, Lei; Hou, Xuhong; Lu, Huijuan; Shen, Yixie; Chen, Ruihua; Fang, Pingyan; Yu, Hong; Li, Ming; Zhang, Feng; Chen, Haibing; Yu, Haoyong; Zhou, Jian; Liu, Fang; Bao, Yuqian; Jia, Weiping			Prevalence of Type 2 Diabetes among High-Risk Adults in Shanghai from 2002 to 2012	PLOS ONE			English	Article							CHINESE ADULTS; POPULATION; TRENDS	Objective: The objective of this study was to evaluate the trend and prevalence of prediabetes and diabetes among high-risk adults in Shanghai from 2002 to 2012. Methods: From 2002 to 2012, 10043 subjects with known risk factors for diabetes participated in the diabetes-screening project at the Shanghai Sixth People's Hospital of Shanghai Jiao Tong University. All participants were asked to complete a nurse-administered standard questionnaire concerning age, sex, smoking status, and personal and family histories of diabetes, cardiovascular disease, stroke, hypertension and other diseases. The participants' body mass index scores, blood pressures and blood glucose levels at 0, 30, 60, 120 and 180 min were measured in response to a 75 g oral glucose tolerance test. Results: The overall prevalence of diabetes increased from 27.93% to 34.78% between 2002 and 2012 in high-risk subjects. The study also showed that the prevalence increased much faster in male compared to female subjects. Specifically, an increased rate was seen in middle-aged men, with no change observed in middle-aged females over the eleven-year period. Conclusion: This study showed that sex, age, parental diabetic history, and being overweight were associated with an increased risk for diabetes in high-risk people. Therefore, as prediabetes and diabetes are highly prevalent in people with multiple diabetes risk factors in Shanghai, screening programs targeting these individuals may be beneficial.	[Wang, Congrong; Hou, Xuhong; Lu, Huijuan; Shen, Yixie; Chen, Ruihua; Fang, Pingyan; Yu, Hong; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Clin Med Ctr Di, Shanghai Key Clin Ctr Diabet,Shanghai Key Lab Dia, Dept Endocrinol & Metab,Metab Dis Biobank, Shanghai 200030, Peoples R China; [Zhang, Yinan] Shanghai Jiao Tong Univ, Shanghai Key Lab Diabet, Dept Endocrinol & Metab,Metab Dis Biobank, Ctr Translat Med,Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Zhang, Lei; Li, Ming; Zhang, Feng; Chen, Haibing; Yu, Haoyong; Zhou, Jian; Liu, Fang; Bao, Yuqian] Shanghai Jiao Tong Univ, Shanghai Clin Med Ctr Diabet,Shanghai Diabet Inst, Shanghai Key Clin Ctr Diabet,Shanghai Key Lab Dia, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Clin Med Ctr Di, Shanghai Key Clin Ctr Diabet,Shanghai Key Lab Dia, Dept Endocrinol & Metab,Metab Dis Biobank, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; Wang, Congrong/AAL-8178-2020; 王, 从容/HDM-0959-2022	王, 从容/0000-0002-8645-1114	Drug Innovation Program of National Science and Technology Project [2011ZX09307-001-02]; Shanghai Science and Technology funds [12DZ2295004]	Drug Innovation Program of National Science and Technology Project; Shanghai Science and Technology funds	Funding provided by Drug Innovation Program of National Science and Technology Project (2011ZX09307-001-02) WPJ and Shanghai Science and Technology funds (12DZ2295004) CRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4; Li R, 2012, DIABETES CARE, V35, P1028, DOI 10.2337/dc11-1212; Lin CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-318; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Liu SQ, 2011, PREV CHRONIC DIS, V8; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Redondo-Sendino A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-155; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	19	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102926	10.1371/journal.pone.0102926	http://dx.doi.org/10.1371/journal.pone.0102926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047241	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100089
J	Werblow, A; Klimpel, S; Bolius, S; Dorresteijn, AWC; Sauer, J; Melaun, C				Werblow, Antje; Klimpel, Sven; Bolius, Sarah; Dorresteijn, Adriaan W. C.; Sauer, Jan; Melaun, Christian			Population Structure and Distribution Patterns of the Sibling Mosquito Species Culex pipiens and Culex torrentium (Diptera: Culicidae) Reveal Different Evolutionary Paths	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; MITOCHONDRIAL-DNA; CYTOPLASMIC INCOMPATIBILITY; NUCLEOTIDE SUBSTITUTIONS; ANOPHELINAE DIPTERA; FEEDING PATTERNS; WESTERN-EUROPE; BORNE VIRUSES; COMPLEX; WOLBACHIA	Nowadays a number of endemic mosquito species are known to possess vector abilities for various diseases, as e. g. the sibling species Culex pipiens and Culex torrentium. Due to their morphological similarity, ecology, distribution and vector abilities, knowledge about these species' population structure is essential. Culicidae from 25 different sampling sites were collected from March till October 2012. All analyses were performed with aligned cox1 sequences with a total length of 658 bp. Population structure as well as distribution patterns of both species were analysed using molecular methods and different statistical tests like distance based redundancy analysis (dbDRA), analysis of molecular variances (AMOVA) or McDonald & Kreitman test and Tajima's D. Within both species, we could show a genetic variability among the cox1 fragment. The construction of haplotype networks revealed one dominating haplotype for Cx. pipiens, widely distributed within Germany and a more homogeneous pattern for Cx. torrentium. The low genetic differences within Cx. pipiens could be a result of an infection with Wolbachia which can induce a sweep through populations by passively taking the also maternally inherited mtDNA through the population, thereby reducing the mitochondrial diversity as an outcome of reproductive incompatibility. Pairwise population genetic differentiation (F-ST) ranged significantly from moderate to very great between populations of Cx. pipiens and Cx. torrentium. Analyses of molecular variances revealed for both species that the main genetic variability exists within the populations (Cx. pipiens [88.38%]; Cx. torrentium [66.54%]). Based on a distance based redundancy analysis geographical origin explained a small but significant part of the species' genetic variation. Overall, the results confirm that Cx. pipiens and Cx. torrentium underlie different factors regarding their mitochondrial differentiation, which could be a result of endosymbiosis, dispersal between nearly located populations or human introduction.	[Werblow, Antje; Klimpel, Sven; Melaun, Christian] Goethe Univ, Inst Ecol Evolut & Divers, Frankfurt, Germany; [Werblow, Antje; Klimpel, Sven; Melaun, Christian] SGN, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Bolius, Sarah; Dorresteijn, Adriaan W. C.] Univ Giessen, Inst Gen Zool & Dev Biol, D-35390 Giessen, Germany; [Sauer, Jan] Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Justus Liebig University Giessen; University of Bielefeld	Melaun, C (corresponding author), Goethe Univ, Inst Ecol Evolut & Divers, Frankfurt, Germany.	christian.melaun@senckenberg.de		Dorresteijn, Adriaan/0000-0003-2314-1634; Bolius, Sarah/0000-0003-3542-6004	program "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich- "okonomischer Exzellenz'' of Hesse's Ministry of Higher Education, Research; SAW (Senate Competition Committee) [SAW-2011-BNI-3, SAW-2014-SGN-3]; German Research Council [DFG BiodivERsA KL 2087/6-1]; German Research Council (DFG) [SA2228/1-1]	program "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich- "okonomischer Exzellenz'' of Hesse's Ministry of Higher Education, Research; SAW (Senate Competition Committee); German Research Council(German Research Foundation (DFG)); German Research Council (DFG)(German Research Foundation (DFG))	The present study was financially supported by the research funding program "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich- "okonomischer Exzellenz'' of Hesse's Ministry of Higher Education, Research, and the Arts, by the SAW (Senate Competition Committee) grant (SAW-2011-BNI-3; SAW-2014-SGN-3) of the Leibniz Association as well as the German Research Council (grant no. DFG BiodivERsA KL 2087/6-1). Jan Sauer is funded by a research grant of the German Research Council (DFG) (SA2228/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; Avsic-Zupanc T, 2013, CLIN MICROBIOL INFEC, V19, P683, DOI 10.1111/1469-0691.12215; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; BANDELT HJ, 1995, GENETICS, V141, P743; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; CHEVILLON C, 1995, GENET RES, V66, P147, DOI 10.1017/S0016672300034492; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dahl C., 1988, Systematics Association Special Volume Series, P149; Dreyer G, 2000, PARASITOL TODAY, V16, P544, DOI 10.1016/S0169-4758(00)01778-6; Engdahl C, 2014, MOL ECOL RESOUR, V14, P478, DOI 10.1111/1755-0998.12202; Estep LK, 2010, J MED ENTOMOL, V47, P977, DOI 10.1603/ME10056; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hesson JC, 2014, MED VET ENTOMOL, V28, P179, DOI 10.1111/mve.12024; Hesson JC, 2011, VECTOR-BORNE ZOONOT, V11, P1383, DOI 10.1089/vbz.2011.0630; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JAENSON TGT, 1986, B ENTOMOL RES, V76, P375, DOI 10.1017/S0007485300014863; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248; Jost H, 2011, AM J TROP MED HYG, V84, P241, DOI 10.4269/ajtmh.2011.10-0483; Jost H, 2010, J CLIN MICROBIOL, V48, P1900, DOI 10.1128/JCM.00037-10; Khrabrova Natalia V., 2009, European Mosquito Bulletin, V27, P18; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Lapointe DA, 2008, J MED ENTOMOL, V45, P600, DOI 10.1603/0022-2585(2008)45[600:DOCQDC]2.0.CO;2; LAVEN H, 1951, EVOLUTION, V5, P370, DOI 10.2307/2405682; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINDQUIST AW, 1967, B WORLD HEALTH ORGAN, V36, P21; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; LUNDSTROM JO, 1990, J MED ENTOMOL, V27, P561, DOI 10.1093/jmedent/27.4.561; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Melaun C, 2014, PARASITOL RES MG, V5, P25, DOI 10.1007/978-3-642-39333-4_3; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller BR, 1996, INSECT MOL BIOL, V5, P93, DOI 10.1111/j.1365-2583.1996.tb00044.x; Mirabello L, 2008, MED VET ENTOMOL, V22, P109, DOI 10.1111/j.1365-2915.2008.00731.x; Mohrig W, 1969, CULICIDEN DEUTSCHLAN; Osorio HC, 2014, MED VET ENTOMOL, V28, P103, DOI 10.1111/mve.12020; Pedro PM, 2009, BIOL J LINN SOC, V97, P854, DOI 10.1111/j.1095-8312.2009.01226.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raymond Michel, 1995, Entomologisk Tidskrift, V116, P65; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; REISEN WK, 1991, J MED ENTOMOL, V28, P357, DOI 10.1093/jmedent/28.3.357; ROUSSET F, 1991, TRENDS ECOL EVOL, V6, P54, DOI 10.1016/0169-5347(91)90123-F; Rudolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071832; Saeung A, 2008, PARASITOL RES, V102, P499, DOI 10.1007/s00436-007-0788-0; Sallum MAM, 2008, J MED ENTOMOL, V45, P970, DOI 10.1603/0022-2585(2008)45[970:IIANDC]2.0.CO;2; Sallum MAM, 2002, SYST ENTOMOL, V27, P361, DOI 10.1046/j.1365-3113.2002.00182.x; Scherpner C., 1960, Mitteilungen aus dem Zoologischen Museum in Berlin, V36, P49; Shaikevich E. V., 2007, European Mosquito Bulletin, P25; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Straetemans M, 2008, Euro Surveill, V13; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Tsuda Y, 2008, J AM MOSQUITO CONTR, V24, P339, DOI 10.2987/5754.1; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Ventim R, 2012, PARASITOL RES, V111, P637, DOI 10.1007/s00436-012-2880-3; Vinogradova EB, 2007, COMP CYTOGENET, V1, P129; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Vinogradova Elena B., 2007, European Mosquito Bulletin, V22, P17; Weitzel Thomas, 2011, European Mosquito Bulletin, V29, P22; Weitzel T, 2009, J AM MOSQUITO CONTR, V25, P6, DOI 10.2987/08-5699.1; Werblow A, 2013, PARASITOL RES, V112, P2495, DOI 10.1007/s00436-013-3418-z; WHO, 2013, REG COMM EUR 63 SESS; Wiwatanaratanabutr I, 2009, J INVERTEBR PATHOL, V102, P220, DOI 10.1016/j.jip.2009.08.009; Zittra C, 2012, WISSENSCHAFTL REIHE, V27	86	17	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102158	10.1371/journal.pone.0102158	http://dx.doi.org/10.1371/journal.pone.0102158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048456	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100021
J	McCormack, SW; Witzel, U; Watson, PJ; Fagan, MJ; Groning, F				McCormack, Steven W.; Witzel, Ulrich; Watson, Peter J.; Fagan, Michael J.; Groening, Flora			The Biomechanical Function of Periodontal Ligament Fibres in Orthodontic Tooth Movement	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; MECHANICAL-PROPERTIES; PAGES 1831-1838; VOLUME 44; ISSUE 10; BONE; BEHAVIOR; STRESS; STRAIN; SIMPLIFICATIONS	Orthodontic tooth movement occurs as a result of resorption and formation of the alveolar bone due to an applied load, but the stimulus responsible for triggering orthodontic tooth movement remains the subject of debate. It has been suggested that the periodontal ligament (PDL) plays a key role. However, the mechanical function of the PDL in orthodontic tooth movement is not well understood as most mechanical models of the PDL to date have ignored the fibrous structure of the PDL. In this study we use finite element (FE) analysis to investigate the strains in the alveolar bone due to occlusal and orthodontic loads when PDL is modelled as a fibrous structure as compared to modelling PDL as a layer of solid material. The results show that the tension-only nature of the fibres essentially suspends the tooth in the tooth socket and their inclusion in FE models makes a significant difference to both the magnitude and distribution of strains produced in the surrounding bone. The results indicate that the PDL fibres have a very important role in load transfer between the teeth and alveolar bone and should be considered in FE studies investigating the biomechanics of orthodontic tooth movement.	[McCormack, Steven W.; Watson, Peter J.; Fagan, Michael J.] Univ Hull, Sch Engn, Med & Biol Engn Res Grp, Kingston Upon Hull HU6 7RX, N Humberside, England; [Witzel, Ulrich] Ruhr Univ Bochum, Fak Maschinenbau, Bochum, Germany; [Groening, Flora] Univ Aberdeen, Sch Med & Dent, Musculoskeletal Res Programme, Aberdeen AB9 1FX, Scotland	University of Hull; Ruhr University Bochum; University of Aberdeen	Groning, F (corresponding author), Univ Aberdeen, Sch Med & Dent, Musculoskeletal Res Programme, Aberdeen AB9 1FX, Scotland.	f.groening@abdn.ac.uk	Groning, Flora/C-2220-2012	Groning, Flora/0000-0002-8127-4112	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I008462/1]; Marie Curie Actions Integration Grant [FP7-PEOPLE PERG7-GA-2010-268430]; Biotechnology and Biological Sciences Research Council [BB/I008462/1] Funding Source: researchfish; BBSRC [BB/I008462/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Actions Integration Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk; BB/I008462/1) and Marie Curie Actions Integration Grant (ec.europa.eu/research/mariecurieactions; FP7-PEOPLE PERG7-GA-2010-268430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATMARAM GH, 1981, J DENT RES, V60, P873, DOI 10.1177/00220345810600050301; BAUMRIND S, 1969, AMER J ORTHODONTICS, V55, P12, DOI 10.1016/S0002-9416(69)90170-5; BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51; Borak L, 2011, DENT MATER J, V30, P448, DOI 10.4012/dmj.2010-170; Boryor A, 2008, J BIOMECH, V41, P376, DOI 10.1016/j.jbiomech.2007.08.016; Bourauel C, 1999, J Orofac Orthop, V60, P136, DOI 10.1007/BF01298963; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; Cattaneo PM, 2009, ORTHOD CRANIOFAC RES, V12, P120, DOI 10.1111/j.1601-6343.2009.01445.x; Cattaneo PM, 2008, AM J ORTHOD DENTOFAC, V133, P681, DOI 10.1016/j.ajodo.2006.05.038; Cattaneo PM, 2005, J DENT RES, V84, P428, DOI 10.1177/154405910508400506; Chen JN, 2014, J BIOMECH, V47, P1689, DOI 10.1016/j.jbiomech.2014.02.030; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 1984, CALCIFIED TISSUE INT, V36, pS7, DOI 10.1007/BF02406127; CURREY JD, 1968, J THEOR BIOL, V20, P91, DOI 10.1016/0022-5193(68)90094-5; Daegling DJ, 1997, J HUM EVOL, V33, P705, DOI 10.1006/jhev.1997.0164; Dorow Christina, 2003, J Orofac Orthop, V64, P100, DOI 10.1007/s00056-003-0225-7; Dorow Christina, 2002, J Orofac Orthop, V63, P94, DOI 10.1007/s00056-002-0107-4; Fill TS, 2012, J BIOMECH, V45, P9, DOI 10.1016/j.jbiomech.2011.09.020; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM., 1964, LAWS BONE STRUCTURE; Gautieri A, 2012, MATRIX BIOL, V31, P141, DOI 10.1016/j.matbio.2011.11.005; Groning F, 2012, J BIOMECH, V45, P1749, DOI 10.1016/j.jbiomech.2011.10.042; Groning F, 2012, J BIOMECH, V45, P1498, DOI 10.1016/j.jbiomech.2012.02.009; Groning F, 2011, J BIOMECH, V44, P1304, DOI 10.1016/j.jbiomech.2011.01.008; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; Groning F, 2009, J BIOMECH, V42, P1224, DOI 10.1016/j.jbiomech.2009.03.025; Grosse IR, 2012, J BIOMECH, V45, P1750, DOI 10.1016/j.jbiomech.2012.01.047; Hall Brian K., 2005, P338, DOI 10.1016/B978-012319060-4/50027-0; Jones M L, 2001, J Orthod, V28, P29; Kato H, 1982, J JPN PROSTHODONT SO, V26, P133; Katona TR, 2001, AM J ORTHOD DENTOFAC, V120, P263, DOI 10.1067/mod.2001.116086; Limbert Georges, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P337, DOI 10.1080/10255840310001637572; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Melsen B, 2001, EUR J ORTHODONT, V23, P671, DOI 10.1093/ejo/23.6.671; Meyer BN, 2010, AM J ORTHOD DENTOFAC, V137, P354, DOI 10.1016/j.ajodo.2008.03.029; Middleton J, 1996, AM J ORTHOD DENTOFAC, V109, P155, DOI 10.1016/S0889-5406(96)70176-2; Misch CE, 1999, J ORAL MAXIL SURG, V57, P700, DOI 10.1016/S0278-2391(99)90437-8; O'Connor CF, 2005, AM J PHYS ANTHROPOL, V127, P129, DOI 10.1002/ajpa.20025; Poppe Mathias, 2002, J Orofac Orthop, V63, P358, DOI 10.1007/s00056-002-0067-8; Provatidis CG, 2000, MED ENG PHYS, V22, P359, DOI 10.1016/S1350-4533(00)00055-2; Qian HH, 2001, AM J ORTHOD DENTOFAC, V120, P272, DOI 10.1067/mod.2001.116085; Qian YL, 2010, INT J NUMER METH BIO, V26, P157, DOI 10.1002/cnm.1179; Rees JS, 1997, BIOMATERIALS, V18, P995, DOI 10.1016/S0142-9612(97)00021-5; SLOAN P, 1979, J ROY SOC MED, V72, P188, DOI 10.1177/014107687907200308; Toms SR, 2002, J BIOMECH, V35, P1411, DOI 10.1016/S0021-9290(02)00166-5; Toms SR, 2002, AM J ORTHOD DENTOFAC, V122, P174, DOI 10.1067/mod.2002.124997; van Driel WD, 2000, P I MECH ENG H, V214, P497, DOI 10.1243/0954411001535525; Witzel U, 1998, TARGET, V1, P10	49	47	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102387	10.1371/journal.pone.0102387	http://dx.doi.org/10.1371/journal.pone.0102387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036099	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200053
J	Chen, YX; Williams, E; Kirk, M				Chen, Yingxi; Williams, Emlyn; Kirk, Martyn			Risk Factors for Acute Respiratory Infection in the Australian Community	PLOS ONE			English	Article							VIRAL-INFECTIONS; DAY-CARE; CHILDREN; ILLNESS; INFLUENZA; TRANSMISSION; EPIDEMIOLOGY; SEASONALITY; RHINOVIRUS; MORTALITY	Objectives: The objective of this study was to identify the risk factors for ARI in the Australian community. Methods: We used a national survey of 7578 randomly selected respondents in 2008-2009 to identify the risk factors of ARI. A case was defined as a person experiencing cold or flu with one or more symptoms of: fever, chills, sore throat, runny nose, or cough in the previous four weeks. Results: There were 19.8% (1505/7578) of respondents who reported ARI in the four weeks prior to the survey. Age was an independent risk factor for ARI, with the risk of acquiring ARI decreasing as age increased. Respondents reporting asthma (OR 1.4, 95% CI: 1.2-1.7) or having someone in their house attending childcare (OR 1.6, 95% CI: 1.2-2.1) were more likely to report ARI. Conclusions: It is important to identify ways of interrupting transmission of ARI amongst children. Improving identification of risk factors will enable targeted interventions for this exceedingly common syndrome.	[Chen, Yingxi; Kirk, Martyn] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Williams, Emlyn] Australian Natl Univ, Stat Consulting Unit, Canberra, ACT, Australia	Australian National University; Australian National University	Kirk, M (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	martyn.kirk@anu.edu.au	Chen, Yingxi/ABF-2593-2020	Chen, Yingxi/0000-0002-3565-1052; Kirk, Martyn/0000-0001-5432-5984	Commonwealth Department of Health	Commonwealth Department of Health	The study was funded by the Commonwealth Department of Health, and study conduct was overseen by a committee comprised of representatives from Australian government agencies and departments. The funding agency had no role in data collection or analysis, decision to publish or preparation of the manuscript.	Albarbi S, 2012, BMC INFECT DIS, V12, P55; Azizi B. H. O., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P280; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Chen Y, 2013, EPIDEMIOL INFECT, P1; DENNY FW, 1986, REV INFECT DIS, V8, P527; EDWARDS B, RESP INFECT DIS BURD; Einarsson O, 1996, J CLIN INVEST, V97, P915, DOI 10.1172/JCI118514; Fleming DM, 2005, ARCH DIS CHILD, V90, P741, DOI 10.1136/adc.2004.063461; Fuhrmann C, 2010, GEOGR COMPASS, V4, DOI 10.1111/j.1749-8198.2010.00343.x; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hall GV, 2006, EPIDEMIOL INFECT, V134, P111, DOI 10.1017/S0950268805004656; Hope-Simpson RE, 1992, TRANSMISSION EPIDEMI, V275; Hu XJ, 2005, CHIN J DIS PREV, V9, P166; HURWITZ ES, 1991, PEDIATRICS, V87, P62; Johnson C, 2005, FAM PRACT, V22, P608, DOI 10.1093/fampra/cmi072; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; KamperJorgensen M, 2006, PEDIATRICS, V118, P8; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambert SB, 2005, J PAEDIATR CHILD H, V41, P125, DOI 10.1111/j.1440-1754.2005.00561.x; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Lee SL, 2011, EUR J PEDIATR, V170, P1317, DOI 10.1007/s00431-011-1446-1; Lofgren E, 2007, J VIROL, V13, P220; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McCaw JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-345; Monto AS, 1995, AM J MED, V99, pS24, DOI 10.1016/S0002-9343(99)80307-6; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Rakes GP, 1999, AM J RESP CRIT CARE, V12, P321; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; SMYTH AR, 1995, ARCH DIS CHILD, V73, P117, DOI 10.1136/adc.73.2.117; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; WANG JB, 1994, CHINESE J EPIDEMIOLO, V15, P141; Weber MW, 1999, INT J EPIDEMIOL, V28, P157, DOI 10.1093/ije/28.1.157; WOODWARD A, 1990, J EPIDEMIOL COMMUN H, V44, P224, DOI 10.1136/jech.44.3.224; Zhang GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044568; Zomer TP, 2013, AM J INFECT CONTROL, V41, P497, DOI 10.1016/j.ajic.2012.06.005; 2010, ASTHMA SERIES	44	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101440	10.1371/journal.pone.0101440	http://dx.doi.org/10.1371/journal.pone.0101440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032810	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300016
J	Fujii, T; Matsuo, K; Abe, Y; Yukawa, J; Tokuda, M				Fujii, Tomohisa; Matsuo, Kazunori; Abe, Yoshihisa; Yukawa, Junichi; Tokuda, Makoto			An Endoparasitoid Avoids Hyperparasitism by Manipulating Immobile Host Herbivore to Modify Host Plant Morphology	PLOS ONE			English	Article							BEHAVIORAL MANIPULATION; PARASITOIDS; CATERPILLARS; USURPATION; DIPTERA; GALLS	Many parasitic organisms have an ability to manipulate their hosts to increase their own fitness. In parasitoids, behavioral changes of mobile hosts to avoid or protect against predation and hyperparasitism have been intensively studied, but host manipulation by parasitoids associated with endophytic or immobile hosts has seldom been investigated. We examined the interactions between a gall inducer Masakimyia pustulae (Diptera: Cecidomyiidae) and its parasitoids. This gall midge induces dimorphic leaf galls, thick and thin types, on Euonymus japonicus (Celastraceae). Platygaster sp. was the most common primary parasitoid of M. pustulae. In galls attacked by Platygaster sp., whole gall thickness as well as thicknesses of upper and lower gall wall was significantly larger than unparasitized galls, regardless of the gall types, in many localities. In addition, localities and tree individuals significantly affected the thickness of gall. Galls attacked by Platygaster sp. were seldom hyperparasitized in the two gall types. These results strongly suggest that Platygaster sp. manipulates the host plant's development to avoid hyperparasitism by thickening galls.	[Fujii, Tomohisa; Abe, Yoshihisa] Kyushu Univ, Biosyst Lab, Grad Sch Social & Cultural Studies, Fukuoka 812, Japan; [Fujii, Tomohisa; Matsuo, Kazunori] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Matsuo, Kazunori] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Entomol Lab, Fukuoka 812, Japan; [Yukawa, Junichi] Kyushu Univ, Fac Agr, Entomol Lab, Fukuoka 812, Japan; [Tokuda, Makoto] Saga Univ, Fac Agr, Lab Syst Ecol, Saga 840, Japan	Kyushu University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University; Saga University	Tokuda, M (corresponding author), Saga Univ, Fac Agr, Lab Syst Ecol, Saga 840, Japan.	tokudam@cc.saga-u.ac.jp		Tokuda, Makoto/0000-0001-7162-0715	Robert T. Huang Entrepreneurship Center of Kyushu University, Japan; JSPS fellows [24-6016]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21780052]; New Technology Development Foundation	Robert T. Huang Entrepreneurship Center of Kyushu University, Japan; JSPS fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Technology Development Foundation	This study was supported in part by the Academic Challenge 2010 from Robert T. Huang Entrepreneurship Center of Kyushu University, Japan to TF, a Grant-in-aid for JSPS fellows (24-6016) to TF, a Grant-in-aid for Young Scientists (B, 21780052) from Ministry of Education, Culture, Sports, Science and Technology, Japan to MT and Research Grant for Plant Science from The New Technology Development Foundation to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2012, HOST MANIPULATION BY PARASITES, P36; Askew R.R., 1975, P130; Askew R. R., 1961, Proceedings of the Royal Entomological Society of London, V36, P103; BRODEUR J, 1992, ECOL ENTOMOL, V17, P97, DOI 10.1111/j.1365-2311.1992.tb01164.x; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; Buhl Peter Neerup, 2006, Steenstrupia, V29, P127; CORNELL HV, 1983, AM MIDL NAT, V110, P225, DOI 10.2307/2425263; Grandgirard J, 2002, ENTOMOL EXP APPL, V103, P239, DOI 10.1023/A:1021193329749; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Harvey JA, 2008, ANIM BEHAV, V76, P701, DOI 10.1016/j.anbehav.2008.03.016; HOLM S, 1979, SCAND J STAT, V6, P65; Ito M, 2005, J FOR RES, V9, P355; Janssen A, 2010, BEHAV ECOL, V21, P33, DOI 10.1093/beheco/arp153; Langellotto GA, 2006, OECOLOGIA, V150, P291, DOI 10.1007/s00442-006-0514-0; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; MAEDA N, 1982, Kontyu, V50, P44; Marchosky RJ, 2004, ENVIRON ENTOMOL, V33, P709, DOI 10.1603/0046-225X-33.3.709; Maure F, 2013, J EXP BIOL, V216, P36, DOI 10.1242/jeb.073130; Moore J., 2002, PARASITES BEHAV ANIM; Paik Jong-Cheol, 2004, Esakia, V44, P57; Poelman EH, 2011, ECOL LETT, V14, P670, DOI 10.1111/j.1461-0248.2011.01629.x; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; R Development Core Team, 2010, R VERS 2 12 1 LANG E; Seyahooei MA, 2009, OIKOS, V118, P1148, DOI 10.1111/j.1600-0706.2009.17508.x; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; SUNOSE T, 1985, Kontyu, V53, P677; SUNOSE T, 1984, Kontyu, V52, P557; SUNOSE T, 1985, RES POPUL ECOL, V27, P287, DOI 10.1007/BF02515467; Tabuchi K, 2004, EVOL ECOL RES, V6, P695; Tanaka S, 2006, ECOL RES, V21, P570, DOI 10.1007/s11284-006-0153-2; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; VINSON SB, 1980, Q REV BIOL, V55, P143, DOI 10.1086/411731; YUKAWA J, 1976, Kontyu, V44, P159; Yukawa J, 1996, INSECT MITE GALLS JA; Yukawa J, 1983, MEM FAC AGR KAGOSHIM, V19, P89	37	10	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102508	10.1371/journal.pone.0102508	http://dx.doi.org/10.1371/journal.pone.0102508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033216	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300059
J	Oslund, KL; Zhou, X; Lee, B; Zhu, LX; Duong, T; Shih, R; Baumgarth, N; Hung, LY; Wu, R; Chen, Y				Oslund, Karen L.; Zhou, Xu; Lee, Boram; Zhu, Lingxiang; Trang Duong; Shih, Robert; Baumgarth, Nicole; Hung, Li-Yin; Wu, Reen; Chen, Yin			Synergistic Up-Regulation of CXCL10 by Virus and IFN gamma in Human Airway Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERON-GAMMA; GENE-EXPRESSION; TNF-ALPHA; HUMAN KERATINOCYTES; 10 KDA; MACROPHAGES; INDUCTION; INFECTION; IP-10	Airway epithelial cells are the first line of defense against viral infections and are instrumental in coordinating the inflammatory response. In this study, we demonstrate the synergistic stimulation of CXCL10 mRNA and protein, a key chemokine responsible for the early immune response to viral infection, following treatment of airway epithelial cells with IFN gamma and influenza virus. The synergism also occurred when the cells were treated with IFN gamma and a viral replication mimicker (dsRNA) both in vitro and in vivo. Despite the requirement of type I interferon (IFNAR) signaling in dsRNA-induced CXCL10, the synergism was independent of the IFNAR pathway since it wasn't affected by the addition of a neutralizing IFNAR antibody or the complete lack of IFNAR expression. Furthermore, the same synergistic effect was also observed when a CXCL10 promoter reporter was examined. Although the responsive promoter region contains both ISRE and NF kappa B sites, western blot analysis indicated that the combined treatment of IFN gamma and dsRNA significantly augmented NF kappa B but not STAT1 activation as compared to the single treatment. Therefore, we conclude that IFN gamma and dsRNA act in concert to potentiate CXCL10 expression in airway epithelial cells via an NF kappa B-dependent but IFNAR-STAT independent pathway and it is at least partly regulated at the transcriptional level.	[Oslund, Karen L.; Trang Duong; Shih, Robert; Hung, Li-Yin; Wu, Reen] Univ Calif Davis, Dept Internal Med, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Oslund, Karen L.; Trang Duong; Baumgarth, Nicole] Univ Calif Davis, Sch Vet Med, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Zhou, Xu; Lee, Boram; Zhu, Lingxiang; Chen, Yin] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona	Chen, Y (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	ychen@pharmacy.arizona.edu	Baumgarth, Nicole/AAI-6949-2020; Hung, Li-Yin/L-6758-2019	Hung, Li-Yin/0000-0001-7623-1946	National Institute of Health [AI061695, HL077902, HL077315, HL096373, ES00628]; American Lung Association; Fly Attendant Medical Research Institute [123055_CIA]; Arizona Biomedical Research Commission;  [ES012441]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096373, R01HL077902, R01HL077315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061695, R21AI113526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES012441] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Fly Attendant Medical Research Institute; Arizona Biomedical Research Commission; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by R01 grants from National Institute of Health (AI061695 to YC; HL077902, HL077315, HL096373, ES00628 to RW), a KO8 (ES012441) to KLO, a grant from the American Lung Association to KLO, a Fly Attendant Medical Research Institute grant (123055_CIA) to YC, and an Arizona Biomedical Research Commission grant to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus JL, 2006, EXP BIOL MED, V231, P1283, DOI 10.1177/153537020623100801; Butowski N, 2009, J NEURO-ONCOL, V91, P183, DOI 10.1007/s11060-008-9705-3; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Dhillon N, 2008, J NEUROVIROL, V14, P196, DOI 10.1080/13550280801993648; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Horton MR, 1998, J BIOL CHEM, V273, P35088, DOI 10.1074/jbc.273.52.35088; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Kanda N, 2002, J INVEST DERMATOL, V119, P1290, DOI 10.1046/j.1523-1747.2002.19626.x; Kanda N, 2007, ENDOCRINOLOGY, V148, P2317, DOI 10.1210/en.2006-1639; Kraft M, 2001, CLIN EXP IMMUNOL, V126, P474, DOI 10.1046/j.1365-2249.2001.01634.x; Lindell DM, 2008, EUR J IMMUNOL, V38, P2168, DOI 10.1002/eji.200838155; Lombardi A, 2009, EUR J CELL BIOL, V88, P731, DOI 10.1016/j.ejcb.2009.07.004; Majumder S, 1998, J IMMUNOL, V161, P4736; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Tao SS, 2012, AM J RESP CELL MOL, V46, P660, DOI 10.1165/rcmb.2011-0340OC; Williams R, 2009, GLIA, V57, P734, DOI 10.1002/glia.20801; Wong JP, 2009, CURR PHARM DESIGN, V15, P1269, DOI 10.2174/138161209787846775; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; Yu DF, 2011, AM J PHYSIOL-LUNG C, V301, pL31, DOI 10.1152/ajplung.00301.2010; Zeng XY, 2005, J INTERF CYTOK RES, V25, P103, DOI 10.1089/jir.2005.25.103; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	28	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100978	10.1371/journal.pone.0100978	http://dx.doi.org/10.1371/journal.pone.0100978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033426	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300013
J	Shapiro, LJ; Cole, WG; Young, JW; Raichlen, DA; Robinson, SR; Adolph, KE				Shapiro, Liza J.; Cole, Whitney G.; Young, Jesse W.; Raichlen, David A.; Robinson, Scott R.; Adolph, Karen E.			Human Quadrupeds, Primate Quadrupedalism, and Uner Tan Syndrome	PLOS ONE			English	Article							DIAGONAL-SEQUENCE WALKING; SYMMETRICAL GAITS; INTERLIMB COORDINATION; CEREBELLAR HYPOPLASIA; MENTAL-RETARDATION; MONKEY LOCOMOTION; FOOTFALL PATTERNS; TREADMILL; EVOLUTION; MUTATIONS	Since 2005, an extensive literature documents individuals from several families afflicted with "Uner Tan Syndrome (UTS)," a condition that in its most extreme form is characterized by cerebellar hypoplasia, loss of balance and coordination, impaired cognitive abilities, and habitual quadrupedal gait on hands and feet. Some researchers have interpreted habitual use of quadrupedalism by these individuals from an evolutionary perspective, suggesting that it represents an atavistic expression of our quadrupedal primate ancestry or "devolution." In support of this idea, individuals with "UTS" are said to use diagonal sequence quadrupedalism, a type of quadrupedal gait that distinguishes primates from most other mammals. Although the use of primate-like quadrupedal gait in humans would not be sufficient to support the conclusion of evolutionary "reversal," no quantitative gait analyses were presented to support this claim. Using standard gait analysis of 518 quadrupedal strides from video sequences of individuals with "UTS", we found that these humans almost exclusively used lateral sequence-not diagonal sequence-quadrupedal gaits. The quadrupedal gait of these individuals has therefore been erroneously described as primate-like, further weakening the "devolution" hypothesis. In fact, the quadrupedalism exhibited by individuals with UTS resembles that of healthy adult humans asked to walk quadrupedally in an experimental setting. We conclude that quadrupedalism in healthy adults or those with a physical disability can be explained using biomechanical principles rather than evolutionary assumptions.	[Shapiro, Liza J.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Cole, Whitney G.; Robinson, Scott R.; Adolph, Karen E.] NYU, Dept Psychol, New York, NY 10003 USA; [Young, Jesse W.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Raichlen, David A.] Univ Arizona, Sch Anthropol, Tucson, AZ USA	University of Texas System; University of Texas Austin; New York University; Northeast Ohio Medical University (NEOMED); University of Arizona	Shapiro, LJ (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.	liza.shapiro@austin.utexas.edu		Cole, Whitney/0000-0002-0637-4738	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R37-HD033486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033486] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by Award Number R37-HD033486 to KEA from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph KE, 1998, CHILD DEV, V69, P1299, DOI 10.2307/1132267; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; [Anonymous], 1966, FOLIA BIOTHEORETICA; BLASZCZYK J, 1993, PHYSIOL BEHAV, V53, P501, DOI 10.1016/0031-9384(93)90144-5; Blumberg MS, 2010, FREAKS NATURE WHAT A; Boycott KM, 2009, J CHILD NEUROL, V24, P1310, DOI 10.1177/0883073809332696; BUCHNER HHF, 1994, VET QUART, V16, pS87; Burnside LH, 1927, GENET PSYCHOL MONOGR, V2; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; Cartmill Matt, 2007, P403, DOI 10.1007/978-0-387-33507-0_12; FREEDLAND RL, 1994, PSYCHOL SCI, V5, P26, DOI 10.1111/j.1467-9280.1994.tb00609.x; Gulsuner S, 2011, GENOME RES, V21, P1995, DOI 10.1101/gr.126110.111; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Herbin M, 2007, BEHAV BRAIN RES, V181, P173, DOI 10.1016/j.bbr.2007.04.001; Herz Joachim, 2008, Proc Natl Acad Sci U S A, V105, pE25, DOI 10.1073/pnas.0802584105; HILDEBRAND M, 1967, AM J PHYS ANTHROPOL, V26, P119, DOI 10.1002/ajpa.1330260203; HILDEBRAND M, 1968, J MORPHOL, V124, P353, DOI 10.1002/jmor.1051240308; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Hildebrand M., 1976, NEURAL CONTROL LOCOM, V18, P202, DOI DOI 10.1007/978-1-4757-0964-3_9; Hirasaki E, 2004, J HUM EVOL, V46, P739, DOI 10.1016/j.jhevol.2004.04.004; Humphrey Nicholas, 2008, Proc Natl Acad Sci U S A, V105, pE26, DOI 10.1073/pnas.0802839105; HUROV JR, 1982, AM J PRIMATOL, V2, P211, DOI 10.1002/ajp.1350020210; Ivanenko YP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00020; Karaca S, 2013, DEV DISABILITIES MOL; Karaca Sibel, 2012, Front Neurol, V3, P154, DOI 10.3389/fneur.2012.00154; Larson SG, 1998, PRIMATE LOCOMOTION, P157; Lemelin P, 2003, J ZOOL, V260, P423, DOI 10.1017/S0952836903003856; Lemelin Pierre, 2007, P329, DOI 10.1007/978-0-387-33507-0_10; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Muybridge E, 1955, HUMAN FIGURE MOTION; Muybridge E., 1887, ANIMAL LOCOMOTION EL; Muybridge Eadweard, 1902, ANIMALS MOTION, P20; Nakano Y, 1996, FOLIA PRIMATOL, V66, P113, DOI 10.1159/000157189; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nyakatura JA, 2008, AM J PHYS ANTHROPOL, V135, P13, DOI 10.1002/ajpa.20699; Nyakatura JA, 2010, J HUM EVOL, V58, P242, DOI 10.1016/j.jhevol.2009.11.010; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Patrick SK, 2009, J NEUROPHYSIOL, V101, P603, DOI 10.1152/jn.91125.2008; Pereira JE, 2006, BEHAV BRAIN RES, V172, P212, DOI 10.1016/j.bbr.2006.04.027; PRIDMORE PA, 1994, AUST J ZOOL, V42, P679, DOI 10.1071/ZO9940679; PROST JH, 1969, AM J PHYS ANTHROPOL, V31, P53, DOI 10.1002/ajpa.1330310107; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; REYNOLDS TR, 1987, AM J PHYS ANTHROPOL, V72, P101, DOI 10.1002/ajpa.1330720113; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Shapiro LJ, 2006, J ZOOL, V269, P191, DOI 10.1111/j.1469-7998.2006.00082.x; Shapiro LJ, 2011, DEV PRIMATOL-PROG PR, P335, DOI 10.1007/978-1-4419-1420-0_17; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V126, P205, DOI 10.1002/ajpa.20049; Slijper EJ, 1942, P K NED AKAD WETENSC, V45, P288; SPARROW WA, 1989, AM J PHYS ANTHROPOL, V78, P387, DOI 10.1002/ajpa.1330780307; Stevens NJ, 2008, AM J PRIMATOL, V70, P356, DOI 10.1002/ajp.20499; Stevens NJ, 2006, J EXP ZOOL PART A, V305A, P953, DOI 10.1002/jez.a.336; STEVENS NJ, 2003, THESIS STONY BROOK U; Tan M, 2010, MOVEMENT DISORD, V25, P652, DOI 10.1002/mds.22951; Tan ner, 2012, LATEST FIND INTELLEC, V1, P1; Tan U, 2006, INT J NEUROSCI, V116, P361, DOI 10.1080/00207450500455330; Tan U, 2005, NEUROQUANTOLOGY, V4, P250; Tan U, 2010, WEBMEDCENTRAL NEUROL, V1, P1; Tan U, 2008, INT J NEUROSCI, V118, P1, DOI 10.1080/00207450701667857; Tan U, 2008, INT J NEUROSCI, V118, P313, DOI 10.1080/00207450701667766; Tan U, 2008, INT J NEUROSCI, V118, P211, DOI 10.1080/00207450701667808; Tan U, 2006, INT J NEUROSCI, V116, P1539, DOI 10.1080/10623320600934325; Tan U, 2006, INT J NEUROSCI, V116, P763, DOI 10.1080/00207450600588733; Tan U, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00084; Tan Uner, 2010, Open Neurol J, V4, P78, DOI 10.2174/1874205X01004010078; Tan U, 2009, INT J NEUROSCI, V119, P909, DOI 10.1080/00207450902828050; Turkmen S, 2008, EUR J HUM GENET, V16, P1070, DOI 10.1038/ejhg.2008.73; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; VILENSKY JA, 1989, ANNU REV ANTHROPOL, V18, P17, DOI 10.1146/annurev.an.18.100189.000313; VILENSKY JA, 1989, AM J PRIMATOL, V17, P11, DOI 10.1002/ajp.1350170103; VILENSKY JA, 1994, J HUM EVOL, V26, P375, DOI 10.1006/jhev.1994.1024; Wallace IJ, 2008, J HUM EVOL, V54, P783, DOI 10.1016/j.jhevol.2007.10.008; Webb D, 2007, PRIMATES, V48, P277, DOI 10.1007/s10329-007-0043-4; West-Eberhard Mary Jane, 2003, pi; WHITE TD, 1990, J MAMMAL, V71, P79, DOI 10.2307/1381321; Young JW, 2007, J HUM EVOL, V53, P26, DOI 10.1016/j.jhevol.2007.01.005; Young JW, 2012, AM J PHYS ANTHROPOL, V147, P580, DOI 10.1002/ajpa.22016	78	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101758	10.1371/journal.pone.0101758	http://dx.doi.org/10.1371/journal.pone.0101758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029457	Green Submitted, Green Published			2022-12-27	WOS:000341306600022
J	Thorn, S; Bassler, C; Gottschalk, T; Hothorn, T; Bussler, H; Raffa, K; Muller, J				Thorn, Simon; Baessler, Claus; Gottschalk, Thomas; Hothorn, Torsten; Bussler, Heinz; Raffa, Kenneth; Mueller, Joerg			New Insights into the Consequences of Post-Windthrow Salvage Logging Revealed by Functional Structure of Saproxylic Beetles Assemblages	PLOS ONE			English	Article							IPS-TYPOGRAPHUS L.; COARSE WOODY DEBRIS; NATURAL DISTURBANCES; BOREAL FORESTS; NORWAY SPRUCE; BLACK SPRUCE; DEAD WOOD; MANAGEMENT; DIVERSITY; COMMUNITIES	Windstorms, bark beetle outbreaks and fires are important natural disturbances in coniferous forests worldwide. Windthrown trees promote biodiversity and restoration within production forests, but also cause large economic losses due to bark beetle infestation and accelerated fungal decomposition. Such damaged trees are often removed by salvage logging, which leads to decreased biodiversity and thus increasingly evokes discussions between economists and ecologists about appropriate strategies. To reveal the reasons behind species loss after salvage logging, we used a functional approach based on four habitat-related ecological traits and focused on saproxylic beetles. We predicted that salvage logging would decrease functional diversity (measured as effect sizes of mean pairwise distances using null models) as well as mean values of beetle body size, wood diameter niche and canopy cover niche, but would increase decay stage niche. As expected, salvage logging caused a decrease in species richness, but led to an increase in functional diversity by altering the species composition from habitat-filtered assemblages toward random assemblages. Even though salvage logging removes tree trunks, the most negative effects were found for small and heliophilous species and for species specialized on wood of small diameter. Our results suggested that salvage logging disrupts the natural assembly process on windthrown trees and that negative ecological impacts are caused more by microclimate alteration of the dead-wood objects than by loss of resource amount. These insights underline the power of functional approaches to detect ecosystem responses to anthropogenic disturbance and form a basis for management decisions in conservation. To mitigate negative effects on saproxylic beetle diversity after windthrows, we recommend preserving single windthrown trees or at least their tops with exposed branches during salvage logging. Such an extension of the green-tree retention approach to windthrown trees will preserve natural succession and associated communities of disturbed spruce forests.	[Thorn, Simon; Baessler, Claus; Mueller, Joerg] Nal Pk Verwaltung Bayer Wald, Sachgebiet Forsch & Dokumentat, Grafenau, Germany; [Gottschalk, Thomas] Hsch Forstwirtschaft Rottenburg, Rottenburg, Germany; [Hothorn, Torsten] Univ Zurich, Biostat Abt, Zurich, Switzerland; [Bussler, Heinz] Bavarian State Inst Forestry, Freising Weihenstephan, Germany; [Raffa, Kenneth] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Mueller, Joerg] Tech Univ Munich, Dept Ecol & Ecosyst Management, Chair Terr Ecol, Freising Weihenstephan, Germany	University of Zurich; University of Wisconsin System; University of Wisconsin Madison; Technical University of Munich	Thorn, S (corresponding author), Nal Pk Verwaltung Bayer Wald, Sachgebiet Forsch & Dokumentat, Grafenau, Germany.	simon@thornonline.de	Thorn, Simon/ABD-9917-2020	Thorn, Simon/0000-0002-3062-3060; Muller, Jorg/0000-0002-1409-1586; Bassler, Claus/0000-0001-8177-8997; Gottschalk, Thomas/0000-0002-8951-386X	German Federal Environmental Foundation	German Federal Environmental Foundation	ST was funded by the Scholarship Programme of the German Federal Environmental Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KNA, 2008, REV ECOL-TERRE VIE, P9; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Azeria ET, 2012, OECOLOGIA, V168, P1123, DOI 10.1007/s00442-011-2180-0; Bassler C, 2010, FOLIA GEOBOT, V45, P163, DOI 10.1007/s12224-010-9059-4; Black S.H., 2005, LOGGING CONTROL INSE; Bouget C, 2004, BIOL CONSERV, V118, P281, DOI 10.1016/j.biocon.2003.09.009; Brin A, 2013, INSECT CONSERV DIVER, V6, P255, DOI 10.1111/j.1752-4598.2012.00209.x; Brin A, 2011, J INSECT CONSERV, V15, P653, DOI 10.1007/s10841-010-9364-5; Brown M, 2009, JFSP BRIEFS, P1; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Bussler H, 2011, FOREST ECOL MANAG, V262, P1887, DOI 10.1016/j.foreco.2011.08.011; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Castro J, 2010, CONSERV BIOL, V24, P810, DOI 10.1111/j.1523-1739.2009.01382.x; Chambers JQ, 2009, OECOLOGIA, V160, P107, DOI 10.1007/s00442-008-1274-9; Cobb TP, 2011, CONSERV BIOL, V25, P94, DOI 10.1111/j.1523-1739.2010.01566.x; Ding Y, 2012, OIKOS, V121, P1263, DOI 10.1111/j.1600-0706.2011.19992.x; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Ernst R, 2006, BIOL CONSERV, V133, P143, DOI 10.1016/j.biocon.2006.05.028; Fettig CJ, 2006, EFFECTIVENESS VEGETA; Fischer A, 2012, EUR J FOREST RES, V131, P493, DOI 10.1007/s10342-011-0524-2; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Foit J, 2010, AGR FOREST ENTOMOL, V12, P133, DOI 10.1111/j.1461-9563.2009.00461.x; Freude H., 1964, KAFER MITTELEUROPAS; Gautam S, 2010, BIOMASS BIOENERG, V34, P1562, DOI 10.1016/j.biombioe.2010.06.001; Gibb H, 2005, SCAND J FOREST RES, V20, P213, DOI 10.1080/02827580510008392; Gossner MM, 2013, CONSERV BIOL, V27, P605, DOI 10.1111/cobi.12023; Grodzki W, 2006, ANN FOREST SCI, V63, P55, DOI 10.1051/forest:2005097; Hebblewhite M, 2009, FOREST ECOL MANAG, V257, P1053, DOI 10.1016/j.foreco.2008.11.009; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hothorn T, 2011, ECOL MONOGR, V81, P329, DOI 10.1890/10-0602.1; Hyvarinen E, 2006, CONSERV BIOL, V20, P1711, DOI 10.1111/j.1523-1739.2006.00511.x; Jacobs JM, 2012, CAN J FOREST RES, V42, P1477, DOI [10.1139/X2012-075, 10.1139/x2012-075]; Jakus R, 2011, TREES-STRUCT FUNCT, V25, P965, DOI 10.1007/s00468-011-0571-9; Jarzabek-Mueller Andrea, 2008, Elateridarium, V2, P199; Jonsell Mats, 2001, Ecological Bulletins, V49, P173; Kouki J, 2012, DIVERS DISTRIB, V18, P348, DOI 10.1111/j.1472-4642.2011.00839.x; Kroll AJ, 2012, J WILDLIFE MANAGE, V76, P1188, DOI 10.1002/jwmg.353; Lain EJ, 2008, FOREST ECOL MANAG, V256, P863, DOI 10.1016/j.foreco.2008.05.018; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lassauce A, 2012, BIOL CONSERV, V147, P204, DOI 10.1016/j.biocon.2012.01.001; Lassauce A, 2011, ECOL INDIC, V11, P1027, DOI 10.1016/j.ecolind.2011.02.004; Lindenmayer D, 2006, FOREST CHRON, V82, P48, DOI 10.5558/tfc82048-1; Lindenmayer DB, 2004, SCIENCE, V303, P1303, DOI 10.1126/science.1093438; McFarlane BL, 2012, CAN J FOREST RES, V42, P710, DOI [10.1139/X2012-030, 10.1139/x2012-030]; Morissette JL, 2002, CAN J FOREST RES, V32, P2169, DOI 10.1139/X02-134; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Muller J, 2010, BIOL CONSERV, V143, P2559, DOI 10.1016/j.biocon.2010.06.024; Noss RF, 2006, CONSERV BIOL, V20, P946, DOI 10.1111/j.1523-1739.2006.00498.x; Olsson J, 2011, BIOL CONSERV, V144, P1100, DOI 10.1016/j.biocon.2010.12.029; Overbeck M, 2012, FOREST ECOL MANAG, V266, P115, DOI 10.1016/j.foreco.2011.11.011; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Pitkdnen A, 2008, FOREST ECOL MANAG, V255, P522, DOI 10.1016/j.foreco.2007.09.024; Priewasser K, 2013, FACTORS INFLUENCING, P157; Priewasser K, 2013, EUR J FOREST RES, V132, P231, DOI 10.1007/s10342-012-0670-1; Purves DW, 2010, J ANIM ECOL, V79, P1215, DOI 10.1111/j.1365-2656.2010.01738.x; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Russo D, 2011, J INSECT CONSERV, V15, P685, DOI 10.1007/s10841-010-9366-3; Saint-Germain M, 2007, ECOGRAPHY, V30, P737, DOI 10.1111/j.2007.0906-7590.05080.x; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schroeder LM, 2010, AGR FOREST ENTOMOL, V12, P29, DOI 10.1111/j.1461-9563.2009.00447.x; Seidl R, 2011, GLOBAL CHANGE BIOL, V17, P2842, DOI 10.1111/j.1365-2486.2011.02452.x; Shorohova E, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008083; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Stokstad E, 2006, SCIENCE, V311, P761, DOI 10.1126/science.311.5762.761; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Victorsson J, 2013, INSECT CONSERV DIVER, V6, P483, DOI 10.1111/icad.12005; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WESLIEN J, 1992, ENTOMOL FENNICA, V3, P205, DOI 10.33338/ef.83730; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Yang Q, 2013, SOIL SCI PLANT NUTR, V59, P311, DOI 10.1080/00380768.2013.775004; Zmihorski M, 2010, BIODIVERS CONSERV, V19, P1871, DOI 10.1007/s10531-010-9809-x	77	49	49	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101757	10.1371/journal.pone.0101757	http://dx.doi.org/10.1371/journal.pone.0101757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050914	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100015
J	Zhang, WJ; Zhu, C; Ye, DX; Xu, L; Zhang, XC; Wu, QJ; Zhang, XL; Kaplan, DL; Jiang, XQ				Zhang, Wenjie; Zhu, Chao; Ye, Dongxia; Xu, Ling; Zhang, Xiaochen; Wu, Qianju; Zhang, Xiuli; Kaplan, David L.; Jiang, Xinquan			Porous Silk Scaffolds for Delivery of Growth Factors and Stem Cells to Enhance Bone Regeneration	PLOS ONE			English	Article							TISSUE-ENGINEERED BONE; MORPHOGENETIC PROTEIN-2; OSTEOGENIC-DIFFERENTIATION; BMP-2 DELIVERY; 3-D SCAFFOLDS; FIBROIN; TRACKING; REPAIR; VEGF; ANGIOGENESIS	Stem cell-based tissue engineering shows promise for bone regeneration and requires artificial microenvironments to enhance the survival, proliferation and differentiation of the seeded cells. Silk fibroin, as a natural protein polymer, has unique properties for tissue regeneration. The present study aimed to evaluate the influence of porous silk scaffolds on rat bone marrow stem cells (BMSCs) by lenti-GFP tracking both in vitro and in vivo in cranial bone defects. The number of cells seeded within silk scaffolds in rat cranial bone defects increased from 2 days to 2 weeks after implantation, followed by a decrease at eight weeks. Importantly, the implanted cells survived for 8 weeks in vivo and some of the cells might differentiate into endothelial cells and osteoblasts induced by the presence of VEGF and BMP-2 in the scaffolds to promote angiogenesis and osteogenesis. The results demonstrate that porous silk scaffolds provide a suitable niche to maintain long survival and function of the implanted cells for bone regeneration.	[Zhang, Wenjie; Xu, Ling; Wu, Qianju; Jiang, Xinquan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, Shanghai 200030, Peoples R China; [Zhang, Wenjie; Wu, Qianju; Zhang, Xiuli; Jiang, Xinquan] Shanghai Jiao Tong Univ, Oral Bioengn & Regenerat Med Lab, Shanghai Res Inst Stomatol, Sch Med,Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Zhu, Chao] Linyi Peoples Hosp, Dept Oral & Stomatol, Linyi, Peoples R China; [Ye, Dongxia; Zhang, Xiaochen] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China; [Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu; xinquanj@aliyun.com	Ye, Dongxia/AAF-2877-2019; Ye, Dongxia/S-4804-2018; Zhang, Wenjie/O-5336-2014	Ye, Dongxia/0000-0001-8260-4569; 	National Basic Research Program of China (973 Program) [2012CB933604]; Ph.D innovation fund from Shanghai Jiao Tong University School of Medicine [BXJ201331]; National Science Fund for Distinguished Young Scholars of China [81225006]; National Natural Science Foundation of China [81170939]; National Institutes of Health [NIH P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D innovation fund from Shanghai Jiao Tong University School of Medicine; National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was jointly supported by the National Basic Research Program of China (973 Program, 2012CB933604), Ph.D innovation fund from Shanghai Jiao Tong University School of Medicine (BXJ201331), the National Science Fund for Distinguished Young Scholars of China (No. 81225006), the National Natural Science Foundation of China (No. 81170939) and the National Institutes of Health (NIH P41 EB002520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Colnot C, 2011, TISSUE ENG PART B-RE, V17, P449, DOI [10.1089/ten.teb.2011.0243, 10.1089/ten.TEB.2011.0243]; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107; Egusa H, 2012, J PROSTHODONT RES, V56, P229, DOI 10.1016/j.jpor.2012.10.001; Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Jing XH, 2008, JOINT BONE SPINE, V75, P432, DOI 10.1016/j.jbspin.2007.09.013; Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059; Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728; Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031; Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pieri F, 2010, BIOMATERIALS, V31, P3527, DOI 10.1016/j.biomaterials.2010.01.066; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raida M, 2006, INT J MOL MED, V18, P735; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Vacanti JP, 1999, LANCET, V354, pSI32; Villa C, 2011, TISSUE ENG PART B-RE, V17, P1, DOI 10.1089/ten.TEB.2010.0362; Vogel G, 2011, SCIENCE, V333, P1088, DOI 10.1126/science.333.6046.1088; Wagers AJ, 2012, CELL STEM CELL; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Yamada Y, 2011, CELL TRANSPLANT, V20, P1003, DOI 10.3727/096368910X539128; Zhang W, 2013, J DENT RES, V92, P1136, DOI 10.1177/0022034513507581; Zhang WJ, 2014, EUR CELLS MATER, V27, P1; Zhang WJ, 2012, INT J NANOMED, V7, P4459, DOI 10.2147/IJN.S33575; Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Zhu C, 2011, J MATER SCI-MATER M, V22, P1965, DOI 10.1007/s10856-011-4376-6; Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]; Zou DH, 2012, BIOMATERIALS, V33, P2097, DOI 10.1016/j.biomaterials.2011.11.053; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	54	43	45	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102371	10.1371/journal.pone.0102371	http://dx.doi.org/10.1371/journal.pone.0102371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050556	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100032
J	Passaes, CPB; Cardoso, CC; Caetano, DG; Teixeira, SLM; Guimaraes, ML; Campos, DP; Veloso, VG; Babic, DZ; Stevenson, M; Moraes, MO; Morgado, MG				Bittencourt Passaes, Caroline Pereira; Cardoso, Cynthia Chester; Caetano, Diogo Gama; Maia Teixeira, Sylvia Lopes; Guimaraes, Monick Lindenmeyer; Campos, Dayse Pereira; Veloso, Valdilea Goncalves; Babic, Dunja Z.; Stevenson, Mario; Moraes, Milton Ozorio; Morgado, Mariza Goncalves			Association of Single Nucleotide Polymorphisms in the Lens Epithelium-Derived Growth Factor (LEDGF/p75) with HIV-1 Infection Outcomes in Brazilian HIV-1+Individuals	PLOS ONE			English	Article							LONG-TERM SURVIVOR; T-CELL RESPONSES; ELITE CONTROLLERS; GENETIC-VARIANTS; CLASS-I; INTEGRASE; RESTRICTION; NONPROGRESSORS; DETERMINANTS; REPLICATION	The lens epithelium-derived growth factor p75 (LEDGF/p75), coded by the PSIP1 gene, is an important host co-factor that interacts with HIV-1 integrase to target integration of viral cDNA into active genes. The aim of this study was to investigate the association of SNPs in the PSIP1 gene with disease outcome in HIV-1 infected patients. We performed a genetic association study in a cohort of 171 HIV-1 seropositive Brazilian individuals classified as rapid progressors (RP, n = 69), typical progressors (TP, n = 79) and long-term nonprogressors (LTNP, n = 23). The exonic SNP rs61744944 and 9 tag SNPs were genotyped. A group of 192 healthy subjects was analyzed to determine the frequency of SNPs and haplotypes in the general population. Linkage disequilibrium (LD) analyses indicated that the SNPs analyzed were not in high LD (r(2)<0.8). Logistic regression models suggested that patients carrying the T allele rs61744944 (472L) were more likely to develop a LTNP phenotype (OR = 4.98; p = 0.05) as compared to TP group. The same trend was observed when LTNPs were compared to the RP group (OR = 3.26). Results of haplotype analyses reinforced this association, since the OR values obtained for the haplotype carrying allele T at rs61744944 also reflected an association with LTNP status (OR = 6.05; p = 0.08 and OR = 3.44; p = 0.12 for comparisons to TP and RP, respectively). The rare missense variations IIe436Ser and Thr473IIe were not identified in the patients enrolled in this study. Gene expression analyses showed lower LEDGF/p75 mRNA levels in peripheral blood mononuclear cells obtained from HIV-1 infected individuals. However, these levels were not influenced by any of the SNPs investigated. In spite of the limited number of LTNPs, these data suggest that the PSIP1 gene could be associated with the outcome of HIV-1 infection. Further analyses of this gene may guide the identification of causative variants to help predict disease course.	[Bittencourt Passaes, Caroline Pereira; Caetano, Diogo Gama; Maia Teixeira, Sylvia Lopes; Guimaraes, Monick Lindenmeyer; Morgado, Mariza Goncalves] IOC FIOCRUZ, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Cardoso, Cynthia Chester] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol Anim, Rio De Janeiro, Brazil; [Campos, Dayse Pereira; Veloso, Valdilea Goncalves] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil; [Babic, Dunja Z.; Stevenson, Mario] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA; [Moraes, Milton Ozorio] IOC FIOCRUZ, Lab Hanseniase, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Miami; Fundacao Oswaldo Cruz	Cardoso, CC (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol Anim, Rio De Janeiro, Brazil.	cynthiac@biologia.ufrj.br	Passaes, Caroline/AAH-3392-2020; Cardoso, Cynthia/K-5824-2012; Moraes, Milton/AFF-1842-2022; Moraes, Milton Ozório/G-9753-2011	Passaes, Caroline/0000-0002-0813-2521; Cardoso, Cynthia/0000-0003-0565-7047; Moraes, Milton Ozório/0000-0003-2653-0037	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [305592/2010-6, 480875/2010-3]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [100.299/2011, 103.095/2011]; NIH [MH093306, AI096109]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106701] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq [grant numbers 305592/2010-6 and 480875/2010-3 to MGM], Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [grant number 100.299/2011 to CPBP and 103.095/2011 to MGM] and NIH grants MH093306 and AI096109 to M. Stevenson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Ballana E, 2012, AIDS, V26, P527, DOI 10.1097/QAD.0b013e32834fa194; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Falkenberg Virginia R, 2011, BMC Res Notes, V4, P324, DOI 10.1186/1756-0500-4-324; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711; Guergnon J, 2012, J INFECT DIS, V205, P718, DOI 10.1093/infdis/jir833; Hare S, 2009, VIRUSES-BASEL, V1, P780, DOI 10.3390/v1030780; Koh Y, 2013, AIDS, V27, P665, DOI 10.1097/QAD.0b013e32835af34c; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Machmach K, 2012, J VIROL, V86, P4245, DOI 10.1128/JVI.07114-11; Madlala P, 2011, AIDS, V25, P1711, DOI 10.1097/QAD.0b013e328349c693; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Messiaen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050204; MICHAEL NL, 1995, J VIROL, V69, P4228, DOI 10.1128/JVI.69.7.4228-4236.1995; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033934; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Schrijvers R, 2013, AIDS, V27, P539, DOI 10.1097/QAD.0b013e32835d0d86; Shea PR, 2013, ANNU REV MED, V64, P203, DOI 10.1146/annurev-med-052511-135400; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Tsutsui KM, 2011, NUCLEIC ACIDS RES, V39, P5067, DOI 10.1093/nar/gkr088; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4	54	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101780	10.1371/journal.pone.0101780	http://dx.doi.org/10.1371/journal.pone.0101780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047784	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100015
J	Finne, LB; Christensen, JO; Knardahl, S				Finne, Live Bakke; Christensen, Jan Olav; Knardahl, Stein			Psychological and Social Work Factors as Predictors of Mental Distress: A Prospective Study	PLOS ONE			English	Article							DEMANDS-RESOURCES MODEL; PSYCHOSOCIAL FACTORS; ORGANIZATIONAL JUSTICE; DEPRESSIVE SYMPTOMS; ROLE STRESSORS; HEALTH; RISK; METAANALYSIS; ENVIRONMENT; DISORDERS	Studies exploring psychological and social work factors in relation to mental health problems (anxiety and depression) have mainly focused on a limited set of exposures. The current study investigated prospectively a broad set of specific psychological and social work factors as predictors of potentially clinically relevant mental distress (anxiety and depression), i.e. "caseness'' level of distress. Employees were recruited from 48 Norwegian organizations, representing a wide variety of job types. A total of 3644 employees responded at both baseline and at follow-up two years later. Respondents were distributed across 832 departments within the 48 organizations. Nineteen work factors were measured. Two prospective designs were tested: (i) with baseline predictors and (ii) with average exposure over time ([T1+ T2]/2) as predictors. Random intercept logistic regressions were conducted to account for clustering of the data. Baseline "cases'' were excluded (n = 432). Age, sex, skill level, and mental distress as a continuous variable at T1 were adjusted for. Fourteen of 19 factors showed some prospective association with mental distress. The most consistent risk factor was role conflict (highest odds ratio [OR] 2.08, 99% confidence interval [CI]: 1.45-3.00). The most consistent protective factors were support from immediate superior (lowest OR 0.56, 99% CI: 0.43-0.72), fair leadership (lowest OR 0.52, 99% CI: 0.40-0.68), and positive challenge (lowest OR 0.60, 99% CI: 0.41-0.86). The present study demonstrated that a broad set of psychological and social work factors predicted mental distress of potential clinical relevance. Some of the most consistent predictors were different from those traditionally studied. This highlights the importance of expanding the range of factors beyond commonly studied concepts like the demand-control model and the effort-reward imbalance model.	[Finne, Live Bakke; Christensen, Jan Olav; Knardahl, Stein] Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway; [Finne, Live Bakke] Norwegian Univ Sci & Technol, Dept Psychol, N-7034 Trondheim, Norway; [Christensen, Jan Olav] Univ Oslo, Dept Psychol, Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo	Finne, LB (corresponding author), Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway.	live.b.finne@stami.no	Christensen, Jan Olav/AAS-1031-2020	Christensen, Jan Olav/0000-0001-5530-7526	Norwegian Research Council [185209]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council (grant number: 185209), http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Babyak MA, 2009, EVID-BASED MENT HEAL, V12, P68, DOI 10.1136/ebmh.12.3.68; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bliese PD, 2004, ORGAN RES METHODS, V7, P400, DOI 10.1177/1094428104268542; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Bowling NA, 2006, J APPL PSYCHOL, V91, P998, DOI 10.1037/0021-9010.91.5.998; Butterworth P, 2011, OCCUP ENVIRON MED, V68, P806, DOI 10.1136/oem.2010.059030; Christensen JO, 2012, EUR J PAIN, V16, P921, DOI 10.1002/j.1532-2149.2011.00091.x; Christensen JO, 2010, PAIN, V151, P162, DOI 10.1016/j.pain.2010.07.001; Cole Donald C, 2002, Chronic Dis Can, V23, P91; Dalgard OS, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-27; Dallner M., 2000, VALIDATION GEN NORDI; De Lange AH, 2004, WORK STRESS, V18, P149, DOI 10.1080/02678370412331270860; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2011, SA J IND PSYCHOL, DOI [10.4102/sajip.v37i2.974., DOI 10.4102/sajip.v37i2.974, 10.4102/ajip.v37i2.974]; Derogatis LR, 1976, BEHAV SCI, V19, P1; Dormann C, 2002, J OCCUP ORGAN PSYCH, V75, P33, DOI 10.1348/096317902167630; Einarsen S, 2000, AGGRESS VIOLENT BEH, V5, P379, DOI 10.1016/S1359-1789(98)00043-3; Embad R, 2013, INT ARCH OCC ENV HEA, V86, P709; ERIKSEN W, 2006, BMC PUBLIC HEALTH, V6, DOI DOI 10.1186/1471-2458-6-290; Eriksen W, 2008, INT ARCH OCC ENV HEA, V81, P301, DOI 10.1007/s00420-007-0214-z; Finne LB, 2011, SCAND J WORK ENV HEA, V37, P276, DOI 10.5271/sjweh.3156; Ford MT, 2014, WORK STRESS, V28, P9, DOI 10.1080/02678373.2013.877096; Foss L, 2010, J OCCUP ENVIRON MED, V52, P698, DOI 10.1097/JOM.0b013e3181e98731; Furlan AD, 2012, J OCCUP REHABIL, V22, P312, DOI 10.1007/s10926-011-9340-2; Griffin JM, 2007, J OCCUP HEALTH PSYCH, V12, P334, DOI 10.1037/1076-8998.12.4.334; Hakanen JJ, 2008, WORK STRESS, V22, P224, DOI 10.1080/02678370802379432; Hauge LJ, 2011, INT J STRESS MANAGE, V18, P305, DOI 10.1037/a0025396; Hauke A, 2011, WORK STRESS, V25, P243, DOI 10.1080/02678373.2011.614069; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Johannessen HA, 2013, J OCCUP ENVIRON MED, V55, P605, DOI 10.1097/JOM.0b013e3182917899; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Kaschka WP, 2011, DTSCH ARZTEBL INT, V108, P781, DOI 10.3238/arztebl.2011.0781; Lindstrom K, 1997, 1997015 NORD NORD CO; Lohela M, 2009, J OCCUP ENVIRON MED, V51, P195, DOI 10.1097/JOM.0b013e318192bd2c; Maslach C, 2016, MASLACH BURNOUT INVE; Maslach C., 1982, JOB STRESS BURNOUT, P29, DOI DOI 10.1371/JOURNAL.PONE.0102514; MOORMAN RH, 1991, J APPL PSYCHOL, V76, P845, DOI 10.1037/0021-9010.76.6.845; Munir F, 2010, J AFFECT DISORDERS, V120, P235, DOI 10.1016/j.jad.2009.03.020; Muthen L.K., 2010, MPLUS USERS GUIDE; Ndjaboue R, 2012, OCCUP ENVIRON MED, V69, P694, DOI 10.1136/oemed-2011-100595; NETTELBLADT P, 1993, SOC PSYCH PSYCH EPID, V28, P130, DOI 10.1007/BF00801743; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Nielsen MB, 2013, INT ARCH OCC ENV HEA, V86, P717, DOI 10.1007/s00420-013-0868-7; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Nixon AE, 2011, WORK STRESS, V25, P1, DOI 10.1080/02678373.2011.569175; Paterniti S, 2002, BRIT J PSYCHIAT, V181, P111; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Reknes I, 2014, SCAND J PSYCHOL, V55, P45, DOI 10.1111/sjop.12092; Rickels K, 1976, Prim Care, V3, P751; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 2008, EUR ARCH PSY CLIN N, V258, P115, DOI 10.1007/s00406-008-5024-0; Stansfeld SA, 1999, OCCUP ENVIRON MED, V56, P302, DOI 10.1136/oem.56.5.302; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; Waldenstrom K, 2008, OCCUP ENVIRON MED, V65, P90, DOI 10.1136/oem.2006.031252; Wannstrom I, 2009, SCAND J PSYCHOL, V50, P231, DOI 10.1111/j.1467-9450.2008.00697.x; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 2008, GLOBAL BURDEN DIS; Ylipaavalniemi J, 2005, SOC SCI MED, V61, P111, DOI 10.1016/j.socscimed.2004.11.038	65	58	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102514	10.1371/journal.pone.0102514	http://dx.doi.org/10.1371/journal.pone.0102514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25048033	Green Published, gold			2022-12-27	WOS:000339558100038
J	Perraut, R; Joos, C; Sokhna, C; Polson, HEJ; Trape, JF; Tall, A; Marrama, L; Mercereau-Puijalon, O; Richard, V; Longacre, S				Perraut, Ronald; Joos, Charlotte; Sokhna, Cheikh; Polson, Hannah E. J.; Trape, Jean-Francois; Tall, Adama; Marrama, Laurence; Mercereau-Puijalon, Odile; Richard, Vincent; Longacre, Shirley			Association of Antibody Responses to the Conserved Plasmodium falciparum Merozoite Surface Protein 5 with Protection against Clinical Malaria	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; HOLOENDEMIC AREA; BLOOD STAGES; IN-VITRO; VACCINE; IMMUNE; TRANSMISSION; INDIVIDUALS; COMMUNITY; INVASION	Background: Plasmodium falciparum merozoite surface protein 5 (PfMSP5) is an attractive blood stage vaccine candidate because it is both exposed to the immune system and well conserved. To evaluate its interest, we investigated the association of anti-PfMSP5 IgG levels, in the context of responses to two other conserved Ags PfMSP1p19 and R23, with protection from clinical episodes of malaria in cross-sectional prospective studies in two different transmission settings. Methods: Ndiop (mesoendemic) and Dielmo (holoendemic) are two Senegalese villages participating in an on-going long-term observational study of natural immunity to malaria. Blood samples were taken before the transmission season (Ndiop) or before peak transmission (Dielmo) and active clinical surveillance was carried out during the ensuing 5.5-month follow-up. IgG responses to recombinant PfMSP5, PfMSP1p19 and R23 were quantified by ELISA in samples from surveys carried out in Dielmo (186 subjects) and Ndiop (221 subjects) in 2002, and Ndiop in 2000 (204 subjects). In addition, 236 sera from the Dielmo and Ndiop-2002 surveys were analyzed for relationships between the magnitude of anti-PfMSP5 response and neutrophil antibody dependent respiratory burst (ADRB) activity. Results: Anti-PfMSP5 antibodies predominantly IgG1 were detected in 60-74% of villagers, with generally higher levels in older age groups. PfMSP5 IgG responses were relatively stable for Ndiop subjects sampled both in 2000 and 2002. ADRB activity correlated with age and anti-PfMSP5 IgG levels. Importantly, PfMSP5 antibody levels were significantly associated with reduced incidence of clinical malaria in all three cohorts. Inclusion of IgG to PfMSP1p19 in the poisson regression model did not substantially modify results. Conclusion: These results indicate that MSP5 is recognized by naturally acquired Ab. The large seroprevalence and association with protection against clinical malaria in two settings with differing transmission conditions and stability over time demonstrated in Ndiop argue for further evaluation of baculovirus PfMSP5 as a vaccine candidate.	[Perraut, Ronald; Joos, Charlotte] Inst Pasteur, Unite Immunol, Dakar, Senegal; [Joos, Charlotte; Polson, Hannah E. J.; Longacre, Shirley] Inst Pasteur, Lab Vaccinol Parasitaire, Paris, France; [Sokhna, Cheikh; Trape, Jean-Francois] IRD, Lab Paludol Zool Med, Dakar, Senegal; [Tall, Adama; Marrama, Laurence; Richard, Vincent] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Mercereau-Puijalon, Odile] Inst Pasteur, CNRS URA 2581, Unite Immunol Mol Parasites, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Perraut, R (corresponding author), Inst Pasteur, Unite Immunol, Dakar, Senegal.	perraut@pasteur.sn	Mercereau-Puijalon, Odile/AAA-2242-2020	Vincent, RICHARD/0000-0002-6961-1753	Institut Pasteur Foundation; French Ministry of Research and Technology; European Union [QLRT-2002-01197]; EUROMALVAC2 funds; Fonds dedies program: fight against Parasitic Diseases (Sanofi Aventis/Ministere de l'Enseignement Superieur et de la Recherche); AUF (Agence Universitaire de la Francophonie); PSF (Pharmacien Sans Frontiere)	Institut Pasteur Foundation; French Ministry of Research and Technology; European Union(European Commission); EUROMALVAC2 funds; Fonds dedies program: fight against Parasitic Diseases (Sanofi Aventis/Ministere de l'Enseignement Superieur et de la Recherche); AUF (Agence Universitaire de la Francophonie); PSF (Pharmacien Sans Frontiere)	This work was supported by grants from the Institut Pasteur Foundation, the French Ministry of Research and Technology (Programme VIHPAL/PAL+), the European Union (EUROMALVAC2 Consortium; project QLRT-2002-01197). HEJ Polson was supported by EUROMALVAC2 funds and Fonds dedies program: fight against Parasitic Diseases (Sanofi Aventis/Ministere de l'Enseignement Superieur et de la Recherche). C Joos was supported by PhD grants from AUF (Agence Universitaire de la Francophonie) and PSF (Pharmacien Sans Frontiere). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LANCET INFECT DIS; Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; BONNEFOY S, 1992, EXP PARASITOL, V74, P441, DOI 10.1016/0014-4894(92)90206-P; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Garraud O, 2003, TRENDS IMMUNOL, V24, P30, DOI 10.1016/S1471-4906(02)00012-1; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Holm I, 1997, MOL BIOCHEM PARASIT, V89, P313, DOI 10.1016/S0166-6851(97)00128-X; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Marshall VM, 1998, MOL BIOCHEM PARASIT, V94, P13, DOI 10.1016/S0166-6851(98)00045-0; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Nguer CM, 1997, INFECT IMMUN, V65, P4873, DOI 10.1128/IAI.65.11.4873-4876.1997; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Perraut R, 2000, VACCINE, V19, P59, DOI 10.1016/S0264-410X(00)00158-4; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Perraut R, 2003, J INFECT DIS, V188, P1940, DOI 10.1086/379838; Perraut R, 2002, MICROBES INFECT, V4, P31, DOI 10.1016/S1286-4579(01)01506-4; Perraut R, 2000, AM J TROP MED HYG, V62, P746, DOI 10.4269/ajtmh.2000.62.746; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; Polson HEJ, 2005, MOL BIOCHEM PARASIT, V142, P110, DOI 10.1016/j.molbiopara.2005.02.009; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; ROGIER C, 1993, T ROY SOC TROP MED H, V87, P245, DOI 10.1016/0035-9203(93)90110-C; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; WHO, 2012, WHO WORLD MALARIA RE; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Wu TQ, 1999, MOL BIOCHEM PARASIT, V103, P243, DOI 10.1016/S0166-6851(99)00134-6	43	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101737	10.1371/journal.pone.0101737	http://dx.doi.org/10.1371/journal.pone.0101737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047634	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100013
J	Williams, JR; Alary, M; Lowndes, CM; Behanzin, L; Labbe, AC; Anagonou, S; Ndour, M; Minani, I; Ahoussinou, C; Zannou, DM; Boily, MC				Williams, John R.; Alary, Michel; Lowndes, Catherine M.; Behanzin, Luc; Labbe, Annie-Claude; Anagonou, Severin; Ndour, Marguerite; Minani, Isaac; Ahoussinou, Clement; Zannou, Djimon Marcel; Boily, Marie-Claude			Positive Impact of Increases in Condom Use among Female Sex Workers and Clients in a Medium HIV Prevalence Epidemic: Modelling Results from Project SIDA1/2/3 in Cotonou, Benin	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; POLLING BOOTH SURVEYS; PREVENTION PROGRAM; TRANSMISSION; INTERVENTIONS; INFECTIONS; POPULATION; INSIGHTS; BEHAVIOR; DECLINE	Background: A comprehensive, HIV prevention programme (Projet Sida1/2/3) was implemented among female sex workers (FSWs) in Cotonou, Benin, in 1993 following which condom use among FSWs increased threefold between 1993 and 2008 while FSW HIV prevalence declined from 53.3% to 30.4%. Objective: Estimate the potential impact of the intervention on HIV prevalence/incidence in FSWs, clients and the general population in Cotonou, Benin. Methods and Findings: A transmission dynamics model parameterised with setting-specific bio-behavioural data was used within a Bayesian framework to fit the model and simulate HIV transmission in the high and low-risk population of Cotonou and to estimate HIV incidence and infections averted by SIDA1/2/3. Our model results suggest that prior to SIDA1/2/3 commercial sex had contributed directly or indirectly to 93% (84-98%) of all cumulative infections and that the observed decline in FSWs HIV prevalence was more consistent with the self-reported post-intervention increase in condom use by FSWs than a counterfactual assuming no change in condom use after 1993 (CF-1). Compared to the counterfactual (CF-1), the increase in condom use may have prevented 62% (52-71%) of new HIV infections among FSWs between 1993 and 2008 and 33% (20-46%) in the overall population. Conclusions: Our analysis provides plausible evidence that the post-intervention increase in condom use during commercial sex significantly reduced HIV prevalence and incidence among FSWs and general population. Sex worker interventions can be effective even in medium HIV prevalence epidemics and need to be sustained over the long-term.	[Williams, John R.; Boily, Marie-Claude] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Alary, Michel; Behanzin, Luc; Boily, Marie-Claude] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Ctr Hosp Univ Quebec,Unite Rech Sante Populat, Quebec City, PQ G1K 7P4, Canada; [Lowndes, Catherine M.] London Sch Hyg & Trop Med, London WC1, England; [Lowndes, Catherine M.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London, England; [Labbe, Annie-Claude] Hop Maison Neuve Rosemont, Dept Microbiol, Montreal, PQ H1T 2M4, Canada; [Anagonou, Severin; Zannou, Djimon Marcel] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Anagonou, Severin; Zannou, Djimon Marcel] Ctr Natl Hosp Univ, Cotonou, Benin; [Ndour, Marguerite] Populat Serv Int, Cotonou, Benin; [Minani, Isaac] Dispensaire Infect Sexuellement Transmissibles, Cotonou, Benin; [Ahoussinou, Clement] Programme Natl Lutte Syndrome Immunodeficience Ac, Cotonou, Benin	Imperial College London; Laval University; University of London; London School of Hygiene & Tropical Medicine; Public Health England; Universite de Montreal; University of Abomey Calavi	Boily, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England.	mc.boily@imperial.ac.uk		Boily, Marie-Claude/0000-0003-3919-006X; Williams, John/0000-0002-9274-6824	Canadian Institutes of Health Research [HCB-82159]; Canadian International Development Agency	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian International Development Agency	Funding was provided by Canadian Institutes of Health Research (grant no. HCB-82159) (URL http://www.cihr-irsc.gc.ca/). MA was funded by the Canadian International Development Agency to implement the intervention programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomagni Lazarre, 2006, MONOGRAPHIE COMMUNE; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Alkema L, 2007, ANN APPL STAT, V1, P229, DOI 10.1214/07-AOAS111; ANDERSON R M, 1991; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Behanzin L, 2013, SEX TRANSM INFECT, V89, P595, DOI 10.1136/sextrans-2012-050884; Behanzin L, 2013, JAIDS-J ACQ IMM DEF, V63, P126, DOI 10.1097/QAI.0b013e318286b9d4; Behanzin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043818; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2014, CURR OPIN HIV AIDS, V9, P134, DOI [10., 10.1097/COH.0000000000000036]; Boily MC, 2013, AIDS, V27, P1449, DOI 10.1097/QAD.0b013e32835fba81; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Boily MC, 2011, 19 ISSTDR QUEB JUL; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Diabate S, 2011, WORLD J AIDS, V1, P94, DOI [10.4236/wja.2011.13014, DOI 10.4236/WJA.2011.13014]; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Hofler M, 2005, BMC Med Res Methodol, V5, P28, DOI 10.1186/1471-2288-5-28; Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441; Lowndes CM, 2012, AIDS BEHAV, V16, P1054, DOI 10.1007/s10461-011-0004-1; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Lowndes CM, 2008, CHARACTERISATION HIV; Mishra S, 2014, SEX TRANSM INFECT, V90, P19, DOI 10.1136/sextrans-2013-051250; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pickles M, 2010, SEX TRANSM INFECT, V86, pI33, DOI 10.1136/sti.2009.038950; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Population Division U.S. Census Bureau, 2013, DAT HIV AIDS SURV DA; Prudden HJ, 2013, AIDS, V27; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Semini I, 2013, AIDS CARE, V25, pS30, DOI 10.1080/09540121.2013.784392; Steen R, 2014, AIDS, V28, P891, DOI 10.1097/QAD.0000000000000176; Stigum H, 1997, AM J EPIDEMIOL, V145, P644, DOI 10.1093/oxfordjournals.aje.a009162; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2000, 2 GEN SURV HIV NEXT; United Nations Human Settlements Programme, 2008, STAT AFR CIT 2008 FR; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2010, UN ACC SCAL PRIOR HI	39	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102643	10.1371/journal.pone.0102643	http://dx.doi.org/10.1371/journal.pone.0102643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047804	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100056
J	Zou, Y; Zhan, WJ; Shao, Y				Zou, Yi; Zhan, Wenjie; Shao, Yuan			Evolution with Reinforcement Learning in Negotiation	PLOS ONE			English	Article							AGENT; MODEL	Adaptive behavior depends less on the details of the negotiation process and makes more robust predictions in the long term as compared to in the short term. However, the extant literature on population dynamics for behavior adjustment has only examined the current situation. To offset this limitation, we propose a synergy of evolutionary algorithm and reinforcement learning to investigate long-term collective performance and strategy evolution. The model adopts reinforcement learning with a tradeoff between historical and current information to make decisions when the strategies of agents evolve through repeated interactions. The results demonstrate that the strategies in populations converge to stable states, and the agents gradually form steady negotiation habits. Agents that adopt reinforcement learning perform better in payoff, fairness, and stableness than their counterparts using classic evolutionary algorithm.	[Zou, Yi; Zhan, Wenjie; Shao, Yuan] Huazhong Univ Sci & Technol, Sch Management, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zou, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Management, Wuhan 430074, Peoples R China.	mail_zou@126.com			National Natural Science Foundation of China [70871045, 71232001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported in part by the National Natural Science Foundation of China (Grant No. 70871045) and the Key Program of National Natural Science Foundation of China (Grant No. 71232001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, THEORY LEARNING GAME; Borgers T, 1997, J ECON THEORY, V77, P1, DOI 10.1006/jeth.1997.2319; Brede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067056; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Erev I, 1998, AM ECON REV, V88, P848; Gimenez-Funes E, 1998, INTERNATIONAL CONFERENCE ON MULTI-AGENT SYSTEMS, PROCEEDINGS, P136, DOI 10.1109/ICMAS.1998.699042; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Han J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061542; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Krovi R, 1999, IEEE T SYST MAN CY C, V29, P15, DOI 10.1109/5326.740666; Lau RY, 2005, P 38 ANN HAW INT C S, p35c; Lau RYK, 2006, INT J INTELL SYST, V21, P41, DOI 10.1002/int.20120; Li CH, 2006, IEEE T SYST MAN CY C, V36, P31, DOI 10.1109/TSMCC.2005.860573; MAHADEVAN S, 1992, ARTIF INTELL, V55, P311, DOI 10.1016/0004-3702(92)90058-6; Matos N, 1998, INTERNATIONAL CONFERENCE ON MULTI-AGENT SYSTEMS, PROCEEDINGS, P182, DOI 10.1109/ICMAS.1998.699048; Maynard Smith J., 1982, pi; Miyaji K, 2013, CHAOS SOLITON FRACT, V56, P13, DOI 10.1016/j.chaos.2013.05.007; Oliver J. R., 1996, Journal of Management Information Systems, V13, P83; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Ren FH, 2009, DECIS SUPPORT SYST, V46, P704, DOI 10.1016/j.dss.2008.11.005; Sarin R, 1999, GAME ECON BEHAV, V28, P294, DOI 10.1006/game.1998.0702; Sim KM, 2004, IEEE T SYST MAN CY B, V34, P1602, DOI 10.1109/TSMCB.2004.825935; Sim KM, 2009, IEEE T SYST MAN CY B, V39, P198, DOI 10.1109/TSMCB.2008.2004501; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sycara K., 1997, P AAAI NAT C ART INT, P36; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Weibull J W, 1997, EVOLUTIONARY GAME TH; Williams CR, 2011, P 21 INT JOINT C ART, V22, P432, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-080; Xia CY, 2013, PHYSICA A, V392, P1577, DOI 10.1016/j.physa.2012.11.043; YOUNG HP, 1993, J ECON THEORY, V59, P145, DOI 10.1006/jeth.1993.1009	36	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102840	10.1371/journal.pone.0102840	http://dx.doi.org/10.1371/journal.pone.0102840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25048108	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100079
J	Allen, RM; Marshall, D				Allen, Richard M.; Marshall, Dustin			Egg Size Effects across Multiple Life-History Stages in the Marine Annelid Hydroides diramphus	PLOS ONE			English	Article							OFFSPRING SIZE; LARVAL DEVELOPMENT; PROPAGULE SIZE; REPRODUCTIVE STRATEGIES; BENTHIC INVERTEBRATES; VARIABLE ENVIRONMENTS; FERTILIZATION SUCCESS; EVOLUTIONARY ECOLOGY; DIANTHUS POLYCHAETA; MATERNAL INVESTMENT	The optimal balance of reproductive effort between offspring size and number depends on the fitness of offspring size in a particular environment. The variable environments offspring experience, both among and within life-history stages, are likely to alter the offspring size/fitness relationship and favor different offspring sizes. Hence, the many environments experienced throughout complex life-histories present mothers with a significant challenge to optimally allocate their reproductive effort. In a marine annelid, we tested the relationship between egg size and performance across multiple life-history stages, including: fertilization, larval development, and post-metamorphosis survival and size in the field. We found evidence of conflicting effects of egg size on performance: larger eggs had higher fertilization under sperm-limited conditions, were slightly faster to develop pre-feeding, and were larger post-metamorphosis; however, smaller eggs had higher fertilization when sperm was abundant, and faster planktonic development; and egg size did not affect post-metamorphic survival. The results indicate that egg size effects are conflicting in H. diramphus depending on the environments within and among life-history stages. We suggest that offspring size in this species may be a compromise between the overall costs and benefits of egg sizes in each stage and that performance in any one stage is not maximized.	[Allen, Richard M.; Marshall, Dustin] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	Allen, RM (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	richard.allen@uqconnect.edu.au	Allen, Richard/B-7373-2015	Marshall, Dustin/0000-0001-6651-6219	Australian Research Council [DPO556552]; Australian Post-Graduate Award	Australian Research Council(Australian Research Council); Australian Post-Graduate Award(Australian Government)	This project was funded by Australian Research Council (DPO556552) to Dustin J. Marshall. R. M. A. was supported by an Australian Post-Graduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Allen RM, 2013, FUNCT ECOL, V27, P1358, DOI 10.1111/1365-2435.12117; Allen RM, 2010, OIKOS, V119, P1977, DOI 10.1111/j.1600-0706.2010.18682.x; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Bernardo J, 1996, AM ZOOL, V36, P216; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Crean AJ, 2011, EVOLUTION, V65, P3079, DOI 10.1111/j.1558-5646.2011.01372.x; Dias GM, 2010, OIKOS, V119, P154, DOI 10.1111/j.1600-0706.2009.17725.x; Einum S, 2003, ENVIRON BIOL FISH, V67, P263, DOI 10.1023/A:1025818627731; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Fox CW, 1997, EVOLUTION, V51, P1005, DOI 10.1111/j.1558-5646.1997.tb03683.x; FOX CW, 1994, HEREDITY, V73, P509, DOI 10.1038/hdy.1994.149; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; HART MW, 1995, AM NAT, V146, P415, DOI 10.1086/285807; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Hendry AP, 2003, EVOL ECOL RES, V5, P421; Hendry AP, 2001, AM NAT, V157, P387, DOI 10.1086/319316; Hollows CF, 2007, MAR ECOL PROG SER, V333, P51, DOI 10.3354/meps333051; Jaeckle William B., 1995, P49; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kiflawi M, 2006, OIKOS, V113, P168, DOI 10.1111/j.0030-1299.2001.14378.x; KINGHORN BP, 1983, AQUACULTURE, V31, P283, DOI 10.1016/0044-8486(83)90320-4; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; LEVITAN DR, 1993, AM NAT, V141, P517, DOI 10.1086/285489; Lindholm AK, 2006, BIOL LETTERS, V2, P586, DOI 10.1098/rsbl.2006.0546; Marshall DJ, 2006, ECOLOGY, V87, P214, DOI 10.1890/05-0350; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2002, ECOL LETT, V5, P173, DOI 10.1046/j.1461-0248.2002.00257.x; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Marshall DJ, 2011, CURR BIOL, V21, pR718, DOI 10.1016/j.cub.2011.08.022; McEdward LR, 2003, MAR ECOL PROG SER, V256, P111, DOI 10.3354/meps256111; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Miles CM, 2009, GENETICA, V135, P289, DOI 10.1007/s10709-008-9277-3; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; Moran AL, 2009, BIOL BULL-US, V216, P226, DOI 10.1086/BBLv216n3p226; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; Morgan Steven G., 1995, P279; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Phillips NE, 2002, ECOLOGY, V83, P2562, DOI 10.2307/3071815; Podolsky RD, 2006, INTEGR COMP BIOL, V46, P577, DOI 10.1093/icb/icl026; Qian PY, 1998, J EXP MAR BIOL ECOL, V227, P169, DOI 10.1016/S0022-0981(97)00267-0; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rius M, 2010, FUNCT ECOL, V24, P685, DOI 10.1111/j.1365-2435.2009.01668.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; SCHELTEMA RS, 1981, MAR ECOL PROG SER, V5, P69, DOI 10.3354/meps005069; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; SEWELL MA, 1992, B MAR SCI, V51, P161; SIBLY R, 1988, J THEOR BIOL, V133, P13, DOI 10.1016/S0022-5193(88)80021-3; SINERVO B, 1988, EVOLUTION, V42, P885, DOI 10.1111/j.1558-5646.1988.tb02509.x; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; STANTON ML, 1984, ECOLOGY, V65, P1105, DOI 10.2307/1938318; STRATHMANN RR, 1977, AM NAT, V111, P373, DOI 10.1086/283168; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Toonen RJ, 2001, MAR ECOL PROG SER, V224, P115, DOI 10.3354/meps224115; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; VANCE RR, 1973, AM NAT, V107, P339, DOI 10.1086/282838; VOGEL H, 1982, MATH BIOSCI, V58, P189, DOI 10.1016/0025-5564(82)90073-6; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; YUND PO, 1990, J EXP ZOOL, V253, P102, DOI 10.1002/jez.1402530114	67	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102253	10.1371/journal.pone.0102253	http://dx.doi.org/10.1371/journal.pone.0102253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036850	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200044
J	Engel, AS; Gupta, AA				Engel, Annette Summers; Gupta, Axita A.			Regime Shift in Sandy Beach Microbial Communities following Deepwater Horizon Oil Spill Remediation Efforts	PLOS ONE			English	Article							HYDROCARBON-DEGRADING BACTERIA; GRAIN-SIZE DISTRIBUTION; BARRIER-ISLAND; AROMATIC-HYDROCARBONS; MULTIVARIATE ANALYSES; MARINE-SEDIMENTS; FRESH-WATER; DIVERSITY; BIODEGRADATION; VARIABILITY	Sandy beaches support a wide variety of underappreciated biodiversity that is critical to coastal ecosystems. Prior to the 2010 Deepwater Horizon oil spill, the diversity and function of supratidal beach sediment microbial communities along Gulf of Mexico coastlines were not well understood. As such, it was unclear if microbial community compositional changes would occur following exposure to beached oil, if indigenous communities could biodegrade oil, or how cleanup efforts, such as sand washing and sediment redistribution, would impact microbial ecosystem resiliency. Transects perpendicular to the shoreline were sampled from public beaches on Grand Isle, Louisiana, and Dauphin Island, Alabama, over one year. Prior to oil coming onshore, elevated levels of bacteria associated with fecal contamination were detected (e.g., Enterobacteriales and Campylobacterales). Over time, significant shifts within major phyla were identified (e.g., Proteobacteria, Firmicutes, Actinobacteria) and fecal indicator groups were replaced by taxa affiliated with open-ocean and marine systems (e.g., Oceanospirillales, Rhodospirillales, and Rhodobacterales). These new bacterial groups included putative hydrocarbon degraders, similar to those identified near the oil plume offshore. Shifts in the microbial community composition strongly correlated to more poorly sorted sediment and grain size distributional changes. Natural oceanographic processes could not account for the disrupted sediment, especially from the backshore well above the maximum high-tide levels recorded at these sites. Sand washing and tilling occurred on both open beaches from August through at least December 2010, which were mechanisms that could replace fecal indicator groups with open-ocean groups. Consequently, remediation efforts meant to return beaches to pre-spill compositions caused a regime shift that may have added potential ecosystem function, like hydrocarbon degradation, to the sediment. Future research will need to assess the persistence and impact of the newly formed microbial communities to the overall sandy beach ecosystems.	[Engel, Annette Summers; Gupta, Axita A.] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA; [Engel, Annette Summers] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA	Louisiana State University System; Louisiana State University; University of Tennessee System; University of Tennessee Knoxville	Engel, AS (corresponding author), Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA.	aengel1@utk.edu	Engel, Annette Summers/GNM-8161-2022; Engel, Annette S/E-3662-2016	Engel, Annette Summers/0000-0003-2469-744X; Engel, Annette S/0000-0003-2469-744X	Louisiana State University Gulf of Mexico Oil Spill Research Program; BP Exploration and Production Inc.; National Science Foundation [DEB-1044599]; Jones Endowment fund at the University of Tennessee-Knoxville	Louisiana State University Gulf of Mexico Oil Spill Research Program; BP Exploration and Production Inc.; National Science Foundation(National Science Foundation (NSF)); Jones Endowment fund at the University of Tennessee-Knoxville	This research was financially supported by the Louisiana State University Gulf of Mexico Oil Spill Research Program (funded by BP Exploration and Production Inc.) and the National Science Foundation (DEB-1044599). Continued support has been provided by the BP/Gulf of Mexico Research Initiative through the Coastal Waters Consortium and the Jones Endowment fund at the University of Tennessee-Knoxville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuodha JOZ, 2003, J AFR EARTH SCI, V36, P41, DOI 10.1016/S0899-5362(03)00016-2; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bascom WN, 1959, T AM GEOPHYS UNION, V32, P866; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bolton FJ, 1999, EPIDEMIOL INFECT, V122, P7, DOI 10.1017/S0950268898001915; Boudreau BP., 2001, EOS T AM GEOPHYS UNI, V82, P133; Chakraborty R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00357; CHAO A, 1984, SCAND J STAT, V11, P265; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; CONATSER WE, 1971, GEOL SOC AM BULL, V82, P3049, DOI 10.1130/0016-7606(1971)82[3049:GIABII]2.0.CO;2; CPRA, 2010, INT ECOS REST HURR P; Dave D., 2011, American Journal of Environmental Sciences, V7, P423, DOI 10.3844/ajessp.2011.424.440; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Delille D, 2000, MAR ENVIRON RES, V49, P403, DOI 10.1016/S0141-1136(99)00080-X; Devine J, 2012, TESTING WATERS GUIDE; Dixon CR, 2011, DAUPHM ISL BEACH BAR; Dorfman M., 2011, TESTING WATERS GUIDE; Dorfman M, 2010, TESTING WATERS GUIDE; DOUGLASS SL, 1994, J COASTAL RES, V10, P306; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; EPA U, 2012, EPAS BEACH REP AL 20; EPA U, 2011, EPAS BEACH REP AL 20; EPA U, 2010, EPAS BEACH REP AL 20; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; Foght J, 2008, J MOL MICROB BIOTECH, V15, P93, DOI 10.1159/000121324; Garrity GM., 2005, BERGEYS MANUAL SYSTE, P270, DOI DOI 10.1007/0-387-28022-7_8; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Glasby TM, 1996, ENVIRON MONIT ASSESS, V42, P241, DOI 10.1007/BF00414371; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Gopalakrishnan S, 2011, J ENVIRON ECON MANAG, V61, P297, DOI 10.1016/j.jeem.2010.09.003; GUNDLACH ER, 1978, MAR TECHNOL SOC J, V12, P18; Halliday E, 2011, ENVIRON SCI TECHNOL, V45, P370, DOI 10.1021/es102747s; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heaney CD, 2012, EPIDEMIOLOGY, V23, P95, DOI 10.1097/EDE.0b013e31823b504c; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hernandez RJ, 2014, WATER RES, V48, P579, DOI 10.1016/j.watres.2013.10.020; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Horel A, 2012, WATER AIR SOIL POLL, V223, P3145, DOI 10.1007/s11270-012-1097-5; Horel A, 2012, ENVIRON TOXICOL CHEM, V31, P1004, DOI 10.1002/etc.1770; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; IMHOFF JF, 2005, BERGEYS MANUAL SYSTE, V2, P1, DOI DOI 10.1099/00207713-34-3-338; Komar P., 1997, BEACH PROCESSES SEDI; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Labud V, 2007, CHEMOSPHERE, V66, P1863, DOI 10.1016/j.chemosphere.2006.08.021; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lisle J, 2011, 2011115 USGS; Lisle J. T., 2011, 20111059 USGS; Looper JK, 2013, ENVIRON SCI-PROC IMP, V15, P2068, DOI 10.1039/c3em00200d; Louisiana Department of Health and Hospitals (LDHH), 2011, LOU BEACH PROGR QUAL; Louisiana Department of Health and Hospitals (LDHH), 2012, LOU BEACH GRANT REP; Louisiana Department of Health and Hospitals (LDHH), 2010, LOU BEACH GRANT REP; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Martinez ML, 2011, FRONT ECOL ENV; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McLachlan A., 1983, Developments in Hydrobiology, V19, P321; McLachlan A, 1996, MAR ECOL PROG SER, V131, P205, DOI 10.3354/meps131205; MEADOWS PS, 1966, NATURE, V212, P1059, DOI 10.1038/2121059a0; Michel J, 1999, P 1999 INT OIL SPILL; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Mills HJ, 2008, APPL ENVIRON MICROB, V74, P4440, DOI 10.1128/AEM.02692-07; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Mortazavi B, 2013, J HAZARD MATER, V244, P537, DOI 10.1016/j.jhazmat.2012.10.038; Morton R.A., 2004, US GEOLOGICAL SURVEY, V1043, P45, DOI [10.3133/ofr20041043, DOI 10.3133/OFR20041043]; Morton RA, 2008, J COASTAL RES, V24, P1587, DOI 10.2112/07-0953.1; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Newton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074265; NOAA, 2000, 20001 HAZMAT NOAA; Owens E. H., 2011, INT OIL SPILL C P, V2011, P265, DOI DOI 10.7901/2169-3358-2011-1-265; PALACAS JG, 1976, GEOLOGY, V4, P81, DOI 10.1130/0091-7613(1976)4<81:BCOHIB>2.0.CO;2; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Petersen J, 2002, NOSORR11 NOAA; Phillips MC, 2011, WATER RES, V45, P6763, DOI 10.1016/j.watres.2011.10.028; Piggot AM, 2012, APPL ENVIRON MICROB, V78, P5973, DOI 10.1128/AEM.00603-12; Podgorska B, 2007, POL J ECOL, V55, P15; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18; Schlacher TA, 2007, DIVERS DISTRIB, V13, P556, DOI 10.1111/j.1472-4642.2007.00363.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Tao Z, 2011, ECOHEALTH, V8, P507, DOI 10.1007/s10393-011-0720-z; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; US EPA, 2011, EPAS BEACH REP LOU 2; US EPA, 2010, NAT LIST BEACH, P165; US EPS, 1999, 600R98079 US EPS, P27; Wang P, 2013, J COASTAL RES, V29, P144, DOI 10.2112/JCOASTRES-D-12-00198.1; Zhang CL, 1998, GEOMICROBIOL J, V15, P171, DOI 10.1080/01490459809378074; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	106	20	21	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102934	10.1371/journal.pone.0102934	http://dx.doi.org/10.1371/journal.pone.0102934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036744	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200099
J	Franciosi, L; Postma, DS; Van den Berge, M; Govorukhina, N; Horvatovich, PL; Fusetti, F; Poolman, B; Lodewijk, ME; Timens, W; Bischoff, R; Ten Hacken, NHT				Franciosi, Lorenza; Postma, Dirkje S.; Van den Berge, Maarten; Govorukhina, Natalia; Horvatovich, Peter L.; Fusetti, Fabrizia; Poolman, Bert; Lodewijk, Monique E.; Timens, Wim; Bischoff, Rainer; Ten Hacken, Nick H. T.			Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE; PROTEIN EXPRESSION; SPUTUM PROTEOMICS; OXIDATIVE STRESS; SMOKERS; SERUM; BIOMARKERS; CELLS; FLUID	Cigarette smoking is the main risk factor for COPD (Chronic Obstructive Pulmonary Disease), yet only a subset of smokers develops COPD. Family members of patients with severe early-onset COPD have an increased risk to develop COPD and are therefore defined as "susceptible individuals". Here we perform unbiased analyses of proteomic profiles to assess how "susceptible individuals" differ from age-matched "non-susceptible individuals" in response to cigarette smoking. Epithelial lining fluid (ELF) was collected at baseline and 24 hours after smoking 3 cigarettes in young individuals susceptible or non-susceptible to develop COPD and older subjects with established COPD. Controls at baseline were older healthy smoking and non-smoking individuals. Five samples per group were pooled and analysed by stable isotope labelling (iTRAQ) in duplicate. Six proteins were selected and validated by ELISA or immunohistochemistry. After smoking, 23 proteins increased or decreased in young susceptible individuals, 7 in young non-susceptible individuals, and 13 in COPD in the first experiment; 23 proteins increased or decreased in young susceptible individuals, 32 in young non-susceptible individuals, and 11 in COPD in the second experiment. SerpinB3 and Uteroglobin decreased after acute smoke exposure in young non-susceptible individuals exclusively, whereas Peroxiredoxin I, S100A9, S100A8, ALDH3A1 (Aldehyde dehydrogenase 3A1) decreased both in young susceptible and non-susceptible individuals, changes being significantly different between groups for Uteroglobin with iTRAQ and for Serpin B3 with iTRAQ and ELISA measures. Peroxiredoxin I, SerpinB3 and ALDH3A1 increased in COPD patients after smoking. We conclude that smoking induces a differential protein response in ELF of susceptible and non-susceptible young individuals, which differs from patients with established COPD. This is the first study applying unbiased proteomic profiling to unravel the underlying mechanisms that induce COPD. Our data suggest that SerpinB3 and Uteroglobin could be interesting proteins in understanding the processes leading to COPD.	[Franciosi, Lorenza; Govorukhina, Natalia; Horvatovich, Peter L.; Bischoff, Rainer] Univ Groningen, Dept Pharm Analyt Biochem, Groningen, Netherlands; [Postma, Dirkje S.; Van den Berge, Maarten; Ten Hacken, Nick H. T.] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Dept Pulm Dis, Groningen, Netherlands; [Fusetti, Fabrizia; Poolman, Bert] Univ Groningen, Dept Biochem, Netherlands Prote Ctr, Dept Biochem, Groningen, Netherlands; [Lodewijk, Monique E.; Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, GRIAC, Dept Pathol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC, Dept Pulm Dis, Groningen, Netherlands.	n.h.t.ten.hacken@umcg.nl	Bischoff, Rainer/H-5404-2011; Timens, Wim/K-5570-2013; Horvatovich, P.L./J-2154-2012	Bischoff, Rainer/0000-0001-9849-0121; Timens, Wim/0000-0002-4146-6363; Horvatovich, P.L./0000-0003-2218-1140; van den Berge, Maarten/0000-0002-9336-7340	Top Institute Pharma project [T1-108]	Top Institute Pharma project	This research was done in the framework of the Top Institute Pharma project T1-108 "Acute and chronic inflammatory responses-COPD and smoking", with partners University Medical Centre Groningen, Nycomed BV, GlaxoSmithKline, University of Groningen, University Medical Centre Utrecht and Foundation TI Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD A, 1992, EUR RESPIR J, V5, P1231; Braido F, 2007, RESP MED, V101, P2119, DOI 10.1016/j.rmed.2007.05.023; Casado B, 2007, J PROTEOME RES, V6, P4615, DOI 10.1021/pr070440q; Celedon JC, 1999, EUR RESPIR J, V14, P1009, DOI 10.1183/09031936.99.14510099; Chen H, 2010, J PROTEOME RES, V9, P2798, DOI 10.1021/pr100063r; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; de Torre C, 2006, PROTEOMICS, V6, P3949, DOI 10.1002/pmic.200500693; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Pastor MD, 2013, INT J MOL SCI, V14, P3440, DOI 10.3390/ijms14023440; Du Rand IA, 2011, THORAX, V66, P1, DOI 10.1136/thoraxjnl-2011-200713; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Franciosi L, 2011, METHODS MOL BIOL, V790, P17, DOI 10.1007/978-1-61779-319-6_2; Fumagalli M, 2012, INT J MOL SCI, V13, P13894, DOI 10.3390/ijms131113894; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Kipnis E, 2008, CHEST, V134, P338, DOI 10.1378/chest.07-1643; Kwon HS, 2012, LIFE SCI, V90, P502, DOI 10.1016/j.lfs.2012.01.003; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; Landi Claudia, 2011, J Clin Bioinforma, V1, P31, DOI 10.1186/2043-9113-1-31; Loi ATL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002178; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lorenz E, 2008, RESP MED, V102, P567, DOI 10.1016/j.rmed.2007.11.011; LUMSDEN AB, 1984, THORAX, V39, P844, DOI 10.1136/thx.39.11.844; Lunardi F, 2011, LAB INVEST, V91, P945, DOI 10.1038/labinvest.2011.1; McCloskey SC, 2001, AM J RESP CRIT CARE, V164, P1419, DOI 10.1164/ajrccm.164.8.2105002; Merkel D, 2005, PROTEOMICS, V5, P2972, DOI 10.1002/pmic.200401180; Nicholas B, 2006, PROTEOMICS, V6, P4390, DOI 10.1002/pmic.200600011; Nicholas BL, 2009, COPD, V6, P298, DOI 10.1080/15412550903049140; O'Neil SE, 2011, J PROTEOMICS, V75, P192, DOI 10.1016/j.jprot.2011.10.008; Ohlmeier S, 2012, J PROTEOME RES, V11, P599, DOI 10.1021/pr2006395; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Plymoth A, 2006, CLIN CHEM, V52, P671, DOI 10.1373/clinchem.2005.060715; Plymoth A, 2007, CLIN CHEM, V53, P636, DOI 10.1373/clinchem.2006.076075; Sabroe I, 2007, THORAX, V62, P733, DOI 10.1136/thx.2007.077768; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shijubo N, 1998, LUNG, V176, P257, DOI 10.1007/PL00007608; SIAFAKAS NM, 1995, EUR RESPIR J, V8, P1398, DOI 10.1183/09031936.95.08081398; Siafakas NM, 2002, RESP MED, V96, P615, DOI 10.1053/rmed.2002.1318; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Steen A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000052-MCP200; Tu CJ, 2014, J PROTEOME RES, V13, P627, DOI 10.1021/pr4007602; Tzortzaki EG, 2009, EUR RESPIR J, V34, P310, DOI 10.1183/09031936.00067008; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V293, pL1156, DOI 10.1152/ajplung.00081.2007; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Van Miert E, 2005, TOXICOL LETT, V159, P115, DOI 10.1016/j.toxlet.2005.05.007	46	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102037	10.1371/journal.pone.0102037	http://dx.doi.org/10.1371/journal.pone.0102037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036363	Green Submitted, gold, Green Published			2022-12-27	WOS:000339615200034
J	Liu, JJ; Witkin, AJ; Adhi, M; Grulkowski, I; Kraus, MF; Dhalla, AH; Lu, CD; Hornegger, J; Duker, JS; Fujimoto, JG				Liu, Jonathan J.; Witkin, Andre J.; Adhi, Mehreen; Grulkowski, Ireneusz; Kraus, Martin F.; Dhalla, Al-Hafeez; Lu, Chen D.; Hornegger, Joachim; Duker, Jay S.; Fujimoto, James G.			Enhanced Vitreous Imaging in Healthy Eyes Using Swept Source Optical Coherence Tomography	PLOS ONE			English	Article							VITREOMACULAR TRACTION; ANTERIOR SEGMENT; OCT	Purpose: To describe enhanced vitreous imaging for visualization of anatomic features and microstructures within the posterior vitreous and vitreoretinal interface in healthy eyes using swept-source optical coherence tomography (SS-OCT). The study hypothesis was that long-wavelength, high-speed, volumetric SS-OCT with software registration motion correction and vitreous window display or high-dynamic-range (HDR) display improves detection sensitivity of posterior vitreous and vitreoretinal features compared to standard OCT logarithmic scale display. Design: Observational prospective cross-sectional study. Methods: Multiple wide-field three-dimensional SS-OCT scans (500x500A-scans over 12x12 mm(2)) were obtained using a prototype instrument in 22 eyes of 22 healthy volunteers. A registration motion-correction algorithm was applied to compensate motion and generate a single volumetric dataset. Each volumetric dataset was displayed in three forms: (1) standard logarithmic scale display, enhanced vitreous imaging using (2) vitreous window display and (3) HDR display. Each dataset was reviewed independently by three readers to identify features of the posterior vitreous and vitreoretinal interface. Detection sensitivities for these features were measured for each display method. Results: Features observed included the bursa premacularis (BPM), area of Martegiani, Cloquet's/BPM septum, Bergmeister papilla, posterior cortical vitreous (hyaloid) detachment, papillomacular hyaloid detachment, hyaloid attachment to retinal vessel(s), and granular opacities within vitreous cortex, Cloquet's canal, and BPM. The detection sensitivity for these features was 75.0% (95% CI: 67.8%-81.1%) using standard logarithmic scale display, 80.6% (95% CI: 73.8%-86.0%) using HDR display, and 91.9% (95% CI: 86.6%-95.2%) using vitreous window display. Conclusions: SS-OCT provides non-invasive, volumetric and measurable in vivo visualization of the anatomic microstructural features of the posterior vitreous and vitreoretinal interface. The vitreous window display provides the highest sensitivity for posterior vitreous and vitreoretinal interface analysis when compared to HDR and standard OCT logarithmic scale display. Enhanced vitreous imaging with SS-OCT may help assess the natural history and treatment response in vitreoretinal interface diseases.	[Liu, Jonathan J.; Grulkowski, Ireneusz; Kraus, Martin F.; Dhalla, Al-Hafeez; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Liu, Jonathan J.; Grulkowski, Ireneusz; Kraus, Martin F.; Dhalla, Al-Hafeez; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Witkin, Andre J.; Adhi, Mehreen; Dhalla, Al-Hafeez; Duker, Jay S.] Tufts Med Ctr, New England Eye Ctr, Boston, MA USA; [Kraus, Martin F.; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Kraus, Martin F.; Hornegger, Joachim] Grad Sch Adv Opt Technol SAOT, Erlangen, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts Medical Center; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fujimoto, JG (corresponding author), MIT, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jgfuji@mit.edu	Grulkowski, Ireneusz/N-9655-2013; Hornegger, Joachim/H-2465-2017; Adhi, Mehreen/AAS-9733-2021	Grulkowski, Ireneusz/0000-0001-7688-1826; Hornegger, Joachim/0000-0002-1834-8844; 	National Institutes of Health [R01- EY11289-28, R01-CA075289-16, R44-EY022864-01]; Air Force Office of Scientific Research [FA9550-10-1-0551, FA9550-12-1-0499]; German Research Foundation [DFG-HO-1791/11-1]; DFG Research Training Group 1773; Massachusetts Lions Club; Champalimaud Vision Award Fund; Research to Prevent Blindness;  [DFG-GSC80-SAOT]; NATIONAL CANCER INSTITUTE [R01CA075289] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R44EY022864, R01EY011289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); German Research Foundation(German Research Foundation (DFG)); DFG Research Training Group 1773; Massachusetts Lions Club; Champalimaud Vision Award Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health (www.nih.gov/): R01- EY11289-28 (JGF), R01-CA075289-16 (JGF), R44-EY022864-01 (JGF); Air Force Office of Scientific Research (http://www.wpafb.af.mil/afrl/afosr/): FA9550-10-1-0551(JGF), FA9550-12-1-0499 (JGF); German Research Foundation (http://www.dfg.de/en/): DFG-HO-1791/11-1 (JH), DFG Research Training Group 1773 (JH), and DFG-GSC80-SAOT (JH); the Massachusetts Lions Club (http://lions33a.org/) (JSD); Champalimaud Vision Award Fund (http://www.fchampalimaud.org/) (JGF); and a Research to Prevent Blindness (http://www.rpbusa.org/rpb/) unrestricted grant to the New England Eye Center/Department of Ophthalmology, Tufts University School of Medicine (JSD). The sponsors or funding organizations had no role in the design or conduct of this research.	Barak Y, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/876472; Barteselli G, 2013, AM J OPHTHALMOL, V155, P727, DOI 10.1016/j.ajo.2012.10.019; Brezinski ME, 2006, OPTICAL COHERENCE TO, Vxxvii; Chang LK, 2008, AM J OPHTHALMOL, V146, P121, DOI 10.1016/j.ajo.2008.03.001; Grulkowski I, 2012, BIOMED OPT EXPRESS, V3, P2733, DOI 10.1364/BOE.3.002733; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Itakura H, 2013, ALTERATIONS POSTERIO; Itakura H, 2013, INVEST OPHTH VIS SCI, V54, P3102, DOI 10.1167/iovs.13-11769; Itakura H, 2011, RETINA-J RET VIT DIS, V31, P1400, DOI 10.1097/IAE.0b013e318206cb43; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Koizumi H, 2008, AM J OPHTHALMOL, V145, P509, DOI 10.1016/j.ajo.2007.10.014; Kraus MF, 2012, BIOMED OPT EXPRESS, V3, P1182, DOI 10.1364/BOE.3.001182; Mirza RG, 2007, SURV OPHTHALMOL, V52, P397, DOI 10.1016/j.survophthal.2007.04.007; Mojana F, 2010, AM J OPHTHALMOL, V149, P641, DOI 10.1016/j.ajo.2009.11.016; Mori K, 2012, OPHTHALMOLOGY, V119, P2600, DOI 10.1016/j.ophtha.2012.06.027; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Potsaid B, 2010, OPT EXPRESS, V18, P20029, DOI 10.1364/OE.18.020029; Saalfeld S, 2009, ENHANCE LOCAL CONTRA; Sebag J, 2002, EYE, V16, P429, DOI 10.1038/sj.eye.6700201; Sebag J, 1989, VITREOUS STRUCTURE F; Shimada Hiroyuki, 2011, International Ophthalmology, V31, P51, DOI 10.1007/s10792-010-9398-4; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Stanga PE, 2013, AM J OPHTHALMOL; Unterhuber A, 2005, OPT EXPRESS, V13, P3252, DOI 10.1364/OPEX.13.003252; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	25	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102950	10.1371/journal.pone.0102950	http://dx.doi.org/10.1371/journal.pone.0102950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036044	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200101
J	Sikorski, C; Luppa, M; Weyerer, S; Konig, HH; Maier, W; Schon, G; Petersen, JJ; Gensichen, J; Fuchs, A; Bickel, H; Wiese, B; Hansen, H; van den Bussche, H; Scherer, M; Riedel-Heller, SG				Sikorski, Claudia; Luppa, Melanie; Weyerer, Siegfried; Koenig, Hans-Helmut; Maier, Wolfgang; Schoen, Gerhard; Petersen, Juliana J.; Gensichen, Jochen; Fuchs, Angela; Bickel, Horst; Wiese, Birgitt; Hansen, Heike; van den Bussche, Hendrik; Scherer, Martin; Riedel-Heller, Steffi G.			Obesity and Associated Lifestyle in a Large Sample of Multi-Morbid German Primary Care Attendees	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY QUESTIONNAIRE; WAIST CIRCUMFERENCE; MORTALITY RISK; ALCOHOL INTAKE; OLDER-ADULTS; WEIGHT; MULTIMORBIDITY; PREVALENCE; RELIABILITY	Background: Obesity and the accompanying increased morbidity and mortality risk is highly prevalent among older adults. As obese elderly might benefit from intentional weight reduction, it is necessary to determine associated and potentially modifiable factors on senior obesity. This cross-sectional study focuses on multi-morbid patients which make up the majority in primary care. It reports on the prevalence of senior obesity and its associations with lifestyle behaviors. Methods: A total of 3,189 non-demented, multi-morbid participants aged 65-85 years were recruited in primary care within the German MultiCare-study. Physical activity, smoking, alcohol consumption and quantity and quality of nutritional intake were classified as relevant lifestyle factors. Body Mass Index (BMI, general obesity) and waist circumference (WC, abdominal obesity) were used as outcome measures and regression analyses were conducted. Results: About one third of all patients were classified as obese according to BMI. The prevalence of abdominal obesity was 73.5%. Adjusted for socio-demographic variables and objective and subjective disease burden, participants with low physical activity had a 1.6 kg/m(2) higher BMI as well as a higher WC (4.9 cm, p<0.001). Current smoking and high alcohol consumption were associated with a lower BMI and WC. In multivariate logistic regression, using elevated WC and BMI as categorical outcomes, the same pattern in lifestyle factors was observed. Only for WC, not current but former smoking was associated with a higher probability for elevated WC. Dietary intake in quantity and quality was not associated with BMI or WC in either model. Conclusions: Further research is needed to clarify if the huge prevalence discrepancy between BMI and WC also reflects a difference in obesity-related morbidity and mortality. Yet, age-specific thresholds for the BMI are needed likewise. Encouraging and promoting physical activity in older adults might a starting point for weight reduction efforts.	[Sikorski, Claudia; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Sikorski, Claudia] Leipzig Univ Med Ctr, IFB AdiposityDis, Leipzig, Germany; [Weyerer, Siegfried] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Koenig, Hans-Helmut] Hamburg Eppendorf Univ Med Ctr, Dept Med Sociol Social Med & Hlth Econ, Hamburg, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Schoen, Gerhard] Hamburg Eppendorf Univ Med Ctr, Dept Med Biometry & Epidemiol, Hamburg, Germany; Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany; [Gensichen, Jochen] Jena Univ Hosp, Dept Gen Practice, Jena, Germany; [Fuchs, Angela] Univ Dusseldorf, Fac Med, Dept Gen Practice, Dusseldorf, Germany; [Bickel, Horst] Tech Univ Munich, Dept Psychiat, D-80290 Munich, Germany; [Wiese, Birgitt] Hannover Med Sch, Inst Biometry, Hannover, Germany; [Hansen, Heike; van den Bussche, Hendrik; Scherer, Martin] Univ Hamburg, Med Ctr, Dept Primary Med Care, Hamburg, Germany	Leipzig University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Friedrich Schiller University of Jena; Heinrich Heine University Dusseldorf; Technical University of Munich; University of Munich; Hannover Medical School; University of Hamburg	Sikorski, C (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Claudia.Sikorski@medizin.uni-leipzig.de	Luppa, Melanie/AAQ-7338-2021; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021	König, Hans-Helmut/0000-0001-5711-6862; 	German Federal Ministry of Education and Research [01ET0725-31, 01ET1006A-K]; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The study is funded by the German Federal Ministry of Education and Research (grant numbers 01ET0725-31 and 01ET1006A-K). The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funding body had no further role in study design; in the collection, analysis and interpretation of data; in writing of the report; and the decision to submit the paper for publication.	Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206; [Anonymous], 2000, WHO TECHN REP SER; Atlantis E, 2008, AM J CLIN NUTR, V88, P95; Benecke A, 2003, OVERWEIGHT OBESITY; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Bullo M, 2011, PREV MED, V53, P155, DOI 10.1016/j.ypmed.2011.06.008; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Collin C, 1988, Int Disabil Stud, V10, P61; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Deutsche Gesellschaft fur Ernahrung, 2011, NUTR GUID; Dombrowski SU, 2010, OBESITY FACTS, V3, P377, DOI 10.1159/000323076; Faeh D, 2011, EUR J EPIDEMIOL; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Freedman David S., 2011, Morbidity and Mortality Weekly Report, V60, P73; Gomez-Cabello A, 2011, OBES REV, V12, P583, DOI 10.1111/j.1467-789X.2011.00878.x; Gomez-Cabello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041752; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Basterra-Gortari FJ, 2010, REV ESP CARDIOL, V63, P20, DOI 10.1016/S0300-8932(10)70005-1; Jensen GL, 2010, CURR OPIN CLIN NUTR, V13, P46, DOI 10.1097/MCO.0b013e32833309cf; Kristal Alan R, 1992, FOOD FREQUENCY QUEST; Lahti-Koski M, 2002, AM J CLIN NUTR, V75, P809, DOI 10.1093/ajcn/75.5.809; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lovejoy JC, 2003, PRIMARY CARE, V30, P317, DOI 10.1016/S0095-4543(03)00012-5; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Maske UE, 2014, PSYCHIAT PRAX; Merrill DA, 2011, PSYCHIAT CLIN N AM, V34, P249, DOI 10.1016/j.psc.2010.11.009; National Nutrition Survey II, 2008, REP RES 1; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Post RE, 2011, ARCH INTERN MED, V171, P316, DOI 10.1001/archinternmed.2010.549; Price GM, 2006, AM J CLIN NUTR, V84, P449; Reichert FF, 2009, SPORTS MED, V39, P279, DOI 10.2165/00007256-200939040-00002; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Schafer I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-145; Schafer I, 2011, 1 RESULTS M IN PRESS; Schunkert H, 2008, CLIN RES CARDIOL, V97, P827, DOI 10.1007/s00392-008-0694-1; Sharma AM, 2011, EVID BASED MED; StataCorp, 2009, STAT STAT SOFTW REL; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Verweij LM, 2013, PUBLIC HEALTH NUTR, V16, P281, DOI 10.1017/S1368980012002741; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012	51	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102587	10.1371/journal.pone.0102587	http://dx.doi.org/10.1371/journal.pone.0102587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036102	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200074
J	Araujo, AC; Marques, S; Belo, JA				Araujo, Ana Carolina; Marques, Sara; Belo, Jose Antonio			Targeted Inactivation of Cerberus Like-2 Leads to Left Ventricular Cardiac Hyperplasia and Systolic Dysfunction in the Mouse	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; CELL-CYCLE REGULATION; EMBRYONIC STEM-CELLS; ECHOCARDIOGRAPHIC-ASSESSMENT; TRANSCRIPTION FACTORS; GENE-EXPRESSION; ARTERIAL POLE; CHICK-EMBRYO; FIELD; CARDIOMYOGENESIS	Previous analysis of the Cerberus like 2 knockout (Cerl2(-/-)) mouse revealed a significant mortality during the first day after birth, mostly due to cardiac defects apparently associated with randomization of the left-right axis. We have however, identified Cerl2-associated cardiac defects, particularly a large increase in the left ventricular myocardial wall in neonates that cannot be explained by laterality abnormalities. Therefore, in order to access the endogenous role of Cerl2 in cardiogenesis, we analyzed the embryonic and neonatal hearts of Cerl2 null mutants that did not display a laterality phenotype. Neonatal mutants obtained from the compound mouse line Cer2(-/-) :: Mlc1v-nLacZ24(+), in which the pulmonary ventricle is genetically marked, revealed a massive enlargement of the ventricular myocardium in animals without laterality defects. Echocardiography analysis in Cerl2(-/-) neonates showed a left ventricular systolic dysfunction that is incompatible with a long lifespan. We uncovered that the increased ventricular muscle observed in Cerl2(-/-) mice is caused by a high cardiomyocyte mitotic index in the compact myocardium which is mainly associated with increased Ccnd1 expression levels in the left ventricle at embryonic day (E) 13. Interestingly, at this stage we found augmented left ventricular expression of Cerl2 levels when compared with the right ventricle, which may elucidate the regionalized contribution of Cerl2 to the left ventricular muscle formation. Importantly, we observed an increase of phosphorylated Smad2 (pSmad2) levels in embryonic (E13) and neonatal hearts indicating a prolonged TGF beta s/Nodal-signaling activation. Concomitantly, we detected an increase of Baf60c levels, but only in Cerl2(-/-) embryonic hearts. These results indicate that independently of its well-known role in left-right axis establishment Cerl2 plays an important role during heart development in the mouse, mediating Baf60c levels by exerting an important control of the TGFbs/Nodal-signaling pathway.	[Araujo, Ana Carolina; Marques, Sara; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Lab Embryol & Genet Manipulat, Faro, Portugal; [Araujo, Ana Carolina; Marques, Sara; Belo, Jose Antonio] Univ Algarve, Ctr Biomed Mol & Estrutural, Inst Biotechnol & Bioengn, Faro, Portugal; [Araujo, Ana Carolina] Univ Algarve, PhD Program Biomed Sci, Faro, Portugal; [Belo, Jose Antonio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC Chron Dis Res Ctr, P-1200 Lisbon, Portugal	Universidade do Algarve; Universidade do Algarve; Universidade do Algarve; Universidade Nova de Lisboa	Belo, JA (corresponding author), Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Lab Embryol & Genet Manipulat, Campus Gambelas, Faro, Portugal.	jose.belo@fcm.unl.pt	Belo, José A. A/F-4444-2012	Belo, José A. A/0000-0001-7384-0949; Marques, Sara/0000-0001-6784-5612	Fundacao para a Ciencia e Tecnologia (FCT); IBB/CBME [PEst-OE/EQB/LA0023/2011]; FCT [SFRH/BD/62081/2009]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); IBB/CBME(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by research grants from Fundacao para a Ciencia e Tecnologia (FCT), and the IBB/CBME, LA in the frame of project ref. PEst-OE/EQB/LA0023/2011. A.C. Araujo is a doctoral fellow (SFRH/BD/62081/2009) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; BENSHACHAR G, 1985, CIRC RES, V57, P759, DOI 10.1161/01.RES.57.5.759; Bento M, 2011, GENE EXPR PATTERNS, V11, P437, DOI 10.1016/j.gep.2011.07.002; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai WQ, 2013, GENE DEV, V27, P2332, DOI 10.1101/gad.225144.113; Cai WQ, 2012, CIRC RES, V111, P876, DOI 10.1161/CIRCRESAHA.112.270272; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2004, TRENDS CARDIOVAS MED, V14, P301, DOI 10.1016/j.tcm.2004.09.002; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; D'Aniello C, 2013, CARDIOVASC RES, V100, P95, DOI 10.1093/cvr/cvt166; DERUITER MC, 1992, ANAT EMBRYOL, V185, P461; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Franco D, 2001, EUR J MORPHOL, V39, P3, DOI 10.1076/ejom.39.1.3.7982; Franco D, 2006, DEV BIOL, V294, P366, DOI 10.1016/j.ydbio.2006.02.045; Francou A, 2013, BBA-MOL CELL RES, V1833, P795, DOI 10.1016/j.bbamcr.2012.10.003; Garne E, 2012, CONGENIT HEART DIS, V7, P46, DOI 10.1111/j.1747-0803.2011.00581.x; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Ghanem A, 2006, ECHOCARDIOGR-J CARD, V23, P900, DOI 10.1111/j.1540-8175.2006.00323.x; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ikenishi A, 2012, DEV GROWTH DIFFER, V54, P731, DOI 10.1111/j.1440-169X.2012.01373.x; Inacio JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060406; Kathiriya IS, 2000, AM J MED GENET, V97, P271, DOI 10.1002/1096-8628(200024)97:4<271::AID-AJMG1277>3.0.CO;2-O; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kitamura R, 2007, CIRC RES, V101, P78, DOI 10.1161/CIRCRESAHA.106.147264; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Risebro CA, 2006, THESCIENTIFICWORLDJO, V6, P1862, DOI 10.1100/tsw.2006.316; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sedmera D, 2011, DEV DYNAM, V240, P1322, DOI 10.1002/dvdy.22650; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stypmann J, 2009, LAB ANIM-UK, V43, P127, DOI 10.1258/la.2007.06001e; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Zheng B, 2003, BIOCHEMISTRY-MOSCOW+, V68, P650, DOI 10.1023/A:1024617826469; Zheng-Fischhofer Q, 2006, J CELL SCI, V119, P693, DOI 10.1242/jcs.02800	63	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102716	10.1371/journal.pone.0102716	http://dx.doi.org/10.1371/journal.pone.0102716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033293	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300084
J	Noh, KK; Chung, KW; Choi, YJ; Park, MH; Jang, EJ; Park, CH; Yoon, C; Kim, ND; Kim, MK; Chung, HY				Noh, Kyung Kyun; Chung, Ki Wung; Choi, Yeon Ja; Park, Min Hi; Jang, Eun Ji; Park, Chan Hum; Yoon, Changshin; Kim, Nam Deuk; Kim, Mi Kyung; Chung, Hae Young			beta-Hydroxy beta-Methylbutyrate Improves Dexamethasone-Induced Muscle Atrophy by Modulating the Muscle Degradation Pathway in SD Rat	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; SIGNALING PATHWAYS; UBIQUITIN LIGASES; PROTEIN-SYNTHESIS; MECHANISMS; ATTENUATION; MYOD; PROTEOLYSIS; PROTEASOME	Skeletal muscle atrophy results from various conditions including high levels of glucocorticoids, and beta-hydroxy beta-methylbutyrate (HMB; a metabolite of leucine) is a potent therapeutical supplement used to treat various muscle disorders. Recent studies have demonstrated that HMB inhibits dexamethasone-induced atrophy in cultured myotubes, but its effect on dexamethasone-induced muscle atrophy has not been determined in vivo. In the present study, we investigated the effect of HMB on dexamethasone-induced muscle atrophy in rats. Treatment with dexamethasone weakened grip strengths and increased muscle damage as determined by increased serum creatine kinase levels and by histological analysis. Dexamethasone treatment also reduced both soleus and gastrocnemius muscle masses. However, HMB supplementation significantly prevented reductions in grip strengths, reduced muscle damage, and prevented muscle mass and protein concentration decrease in soleus muscle. Biochemical analysis demonstrated that dexamethasone markedly increased levels of MuRF1 protein, which causes the ubiquitination and degradation of MyHC. Indeed, dexamethasone treatment decreased MyHC protein expression and increased the ubiquitinated-MyHC to MyHC ratio. However, HMB supplementation caused the down-regulations of MuRF1 protein and of ubiquitinated-MyHC. Furthermore, additional experiments provided evidence that HMB supplementation inhibited the nuclear translocation of FOXO1 induced by dexamethasone, and showed increased MyoD expression in the nuclear fractions of soleus muscles. These findings suggest that HMB supplementation attenuates dexamethasone-induced muscle wasting by regulating FOXO1 transcription factor and subsequent MuRF1 expression. Accordingly, our results suggest that HMB supplementation could be used to prevent steroid myopathy.	[Noh, Kyung Kyun; Chung, Ki Wung; Choi, Yeon Ja; Park, Min Hi; Jang, Eun Ji; Park, Chan Hum; Yoon, Changshin; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Dept Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea; [Kim, Mi Kyung] Pusan Natl Univ, Longev Life Sci & Technol Inst, Pusan, South Korea	Pusan National University; Pusan National University	Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan, South Korea.	hyjung@pusan.ac.kr	Park, Min Hi/AAL-9880-2020		Korean National Research Foundation - Korean Ministry of Education, Science and Technology [2009-0083538]; R&D program of MKE/KEIT (Development of Functional Food Materials and Device for Prevention of Aging-associated Muscle Function Decrease) [0040391]	Korean National Research Foundation - Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); R&D program of MKE/KEIT (Development of Functional Food Materials and Device for Prevention of Aging-associated Muscle Function Decrease)	This work was supported by the Korean National Research Foundation funded by the Korean Ministry of Education, Science and Technology (Grant no. 2009-0083538), and by the R&D program of MKE/KEIT (Grant no. 10040391, Development of Functional Food Materials and Device for Prevention of Aging-associated Muscle Function Decrease). In addition, we thank the Aging Tissue Bank for providing research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Aversa Z, 2011, INT J ONCOL, V38, P713, DOI 10.3892/ijo.2010.885; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; BOWYER SL, 1985, J ALLERGY CLIN IMMUN, V76, P234, DOI 10.1016/0091-6749(85)90708-0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carroll TB, 2010, REV ENDOCR METAB DIS, V11, P147, DOI 10.1007/s11154-010-9143-3; Clark RH, 2000, JPEN-PARENTER ENTER, V24, P133, DOI 10.1177/0148607100024003133; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Eley HL, 2008, AM J PHYSIOL-ENDOC M, V295, pE1409, DOI 10.1152/ajpendo.90530.2008; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Giannaki CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025180; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Kim JS, 2010, J NUTR BIOCHEM, V21, P1, DOI 10.1016/j.jnutbio.2009.06.014; Kornasio R, 2009, BBA-MOL CELL RES, V1793, P755, DOI 10.1016/j.bbamcr.2008.12.017; Kovarik M, 2010, J PHYSIOL BIOCHEM, V66, P311, DOI 10.1007/s13105-010-0037-3; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Magal M, 2010, J SPORT SCI, V28, P257, DOI 10.1080/02640410903440892; Marcora S, 2005, CLIN NUTR, V24, P442, DOI 10.1016/j.clnu.2005.01.006; Markowitz JA, 2012, PEDIATR NEUROL, V46, P1, DOI 10.1016/j.pediatrneurol.2011.09.001; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nissen S, 1996, J APPL PHYSIOL, V81, P2095, DOI 10.1152/jappl.1996.81.5.2095; Nissen SL, 1997, J NUTR BIOCHEM, V8, P300, DOI 10.1016/S0955-2863(97)00048-X; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Russell ST, 2009, MOL CELL BIOCHEM, V330, P171, DOI 10.1007/s11010-009-0130-5; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Smith HJ, 2005, CANCER RES, V65, P277; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vazeille E, 2012, J NUTR BIOCHEM, V23, P245, DOI 10.1016/j.jnutbio.2010.11.021; Vukovich MD, 2001, J NUTR, V131, P2049, DOI 10.1093/jn/131.7.2049; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Yamamoto D, 2010, MUSCLE NERVE, V41, P819, DOI 10.1002/mus.21621; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0	40	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102947	10.1371/journal.pone.0102947	http://dx.doi.org/10.1371/journal.pone.0102947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032690	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300111
J	O'Neill, TJ; Rivera, L; Struchkov, V; Zaheen, A; Thein, HH				O'Neill, Tyler J.; Rivera, Laura; Struchkov, Vladi; Zaheen, Ahmad; Thein, Hla-Hla			The Effect of HIV-Hepatitis C Co-Infection on Bone Mineral Density and Fracture: A Meta-Analysis	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; VIRUS-INFECTION; OSTEOPOROSIS; RISK; OSTEOPENIA; DISEASE; HETEROGENEITY; ASSOCIATION; PERSPECTIVE	Objective: There is a variable body of evidence on adverse bone outcomes in HIV patients co-infected with hepatitis C virus (HCV). We examined the association of HIV/HCV co-infection on osteoporosis or osteopenia (reduced bone mineral density; BMD) and fracture. Design: Systematic review and random effects meta-analyses. Methods: A systematic literature search was conducted for articles published in English up to 1 April 2013. All studies reporting either BMD (g/cm(2), or as a T-score) or incident fractures in HIV/HCV co-infected patients compared to either HIV mono-infected or HIV/HCV uninfected/seronegative controls were included. Random effects meta-analyses estimated the pooled odds ratio (OR) and the relative risk (RR) and associated 95% confidence intervals (CI). Results: Thirteen eligible publications (BMD N = 6; Fracture = 7) of 2,064 identified were included with a total of 427,352 subjects. No publications reported data on HCV mono-infected controls. Meta-analysis of cross-sectional studies confirmed that low bone mineral density was increasingly prevalent among co-infected patients compared to HIV mono-infected controls (pooled OR 1.98, 95% CI 1.18, 3.31) but not those uninfected (pooled OR 1.47, 95% CI 0.78, 2.78). Significant association between co-infection and fracture was found compared to HIV mono-infected from cohort and case-control studies (pooled RR 1.57, 95% CI 1.33, 1.86) and compared to HIV/HCV uninfected from cohort (pooled RR 2.46, 95% CI 1.03, 3.88) and cross-sectional studies (pooled OR 2.30, 95% CI 2.09, 2.23). Conclusions: The associations of co-infection with prevalent low BMD and risk of fracture are confirmed in this meta-analysis. Although the mechanisms of HIV/HCV co-infection's effect on BMD and fracture are not well understood, there is evidence to suggest that adverse outcomes among HIV/HCV co-infected patients are substantial.	[O'Neill, Tyler J.; Rivera, Laura; Struchkov, Vladi; Thein, Hla-Hla] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thein, Hla-Hla] Ontario Inst Canc Res, Canc Care Ontario, Toronto, ON, Canada; [Struchkov, Vladi; Zaheen, Ahmad] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Toronto; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	O'Neill, TJ (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	t.oneill@mail.utoronto.ca		Thein, Hla-Hla/0000-0003-4950-187X				Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Anostos K, 2007, ANTIVIR THER, V12, P1049; Aukrust P, 1999, J CLIN ENDOCR METAB, V84, P145, DOI 10.1210/jc.84.1.145; Badie Banafsheh Moradmand, 2011, Acta Med Iran, V49, P460; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Binkley N, 2009, J CLIN DENSITOM, V12, P413, DOI 10.1016/j.jocd.2009.06.004; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Carr A, 2001, AIDS, V15, P703, DOI 10.1097/00002030-200104130-00005; Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195; CUMMINGS SR, 1985, WESTERN J MED, V143, P684; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; El-Maouche D, 2013, ANTIVIR THER, V18, P237, DOI 10.3851/IMP2264; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Gallego-Rojo FJ, 1998, HEPATOLOGY, V28, P695, DOI 10.1002/hep.510280315; Gonzalez-Calvin JL, 2004, J CLIN ENDOCR METAB, V89, P4325, DOI 10.1210/jc.2004-0077; GRINSPOON SK, 1992, NEW ENGL J MED, V327, P1360, DOI 10.1056/NEJM199211053271906; Hansen ABE, 2012, AIDS, V26, P285, DOI 10.1097/QAD.0b013e32834ed8a7; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; King G, 2002, STAT MED, V21, P1409, DOI 10.1002/sim.1032; Knobel H, 2001, AIDS, V15, P807, DOI 10.1097/00002030-200104130-00022; Leslie WD, 2003, GASTROENTEROLOGY, V125, P941, DOI 10.1016/S0016-5085(03)01062-X; Lewiecki E Michael, 2004, South Med J, V97, P544, DOI 10.1097/00007611-200406000-00006; Lewiecki EM, 2005, J CLIN DENSITOM, V8, P143, DOI 10.1385/JCD:8:2:143; Lo Re V, 2012, HEPATOLOGY, V56, P1688, DOI 10.1002/hep.25866; Lo Re V, 2009, AIDS, V23, P2191, DOI 10.1097/QAD.0b013e32832ec258; Lofman O, 2007, ACTA ORTHOP, V78, P813, DOI 10.1080/17453670710014608; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Meyer D, 1999, AIDS, V13, P1147, DOI 10.1097/00002030-199906180-00025; Moore AL, 2001, AIDS, V15, P1731, DOI 10.1097/00002030-200109070-00019; Negredo E, 2007, AIDS, V21, P657, DOI 10.1097/QAD.0b013e3280142191; Palacios S, 2010, CLIMACTERIC, V13, P419, DOI 10.3109/13697137.2010.507886; Paton NIJ, 1997, CALCIFIED TISSUE INT, V61, P30, DOI 10.1007/s002239900288; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Rouillard S, 2001, HEPATOLOGY, V33, P301, DOI 10.1053/jhep.2001.20533; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shiau S, 2013, AIDS, V27, P1949, DOI 10.1097/QAD.0b013e328361d241; Siggeirsdottir K, 2007, EUR J EPIDEMIOL, V22, P631, DOI 10.1007/s10654-007-9163-9; Stephens EA, 1999, AIDS, V13, P2605, DOI 10.1097/00002030-199912240-00022; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tebas P, 2000, AIDS, V14, P2417, DOI 10.1097/00002030-200010200-00031; Tebas P, 2001, AIDS Read, V11, P610; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomas J, 2003, JAIDS-J ACQ IMM DEF, V33, P281, DOI 10.1097/00126334-200307010-00001; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Vecchi VL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-192; WHO Scientific Group on the Prevention and Management of Osteoporosis, 2003, PREV MAN OST REP WHO; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Yin MT, 2010, AIDS, V24, P2679, DOI 10.1097/QAD.0b013e32833f6294; Yong MK, 2011, JAIDS-J ACQ IMM DEF, V57, P205, DOI 10.1097/QAI.0b013e31821ecf4c; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101493	10.1371/journal.pone.0101493	http://dx.doi.org/10.1371/journal.pone.0101493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033046	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300018
J	Woldehaimanot, TE; Eshetie, TC; Kerie, MW				Woldehaimanot, Tewodros Eyob; Eshetie, Tesfahun Chanie; Kerie, Mirkuzie Woldie			Postoperative Pain Management among Surgically Treated Patients in an Ethiopian Hospital	PLOS ONE			English	Article							OUTCOME QUESTIONNAIRE; NARCOTIC ANALGESICS; MEDICAL INPATIENTS; PALLIATIVE CARE; QUALITY; PERCEPTION; EXPERIENCE; CANCER; SATISFACTION; EVALUATE	Background: Incidence of postoperative pain has been reported to be between 47-100%. Ineffective postoperative pain management results in tangible and intangible costs. The purpose of this study was to assess the processes and outcomes of pain management in the surgical wards of Jimma University Specialized Hospital, Ethiopia. Methods and Findings: A prospective cross sectional study was conducted among 252 postoperative patients during February 13 to April 30, 2012. A contextually modified and validated (Cronbach's alpha coefficient of 0.78) American Pain Society Patient Outcome Questionnaire was used to assess pain experience of patients. Patients' charts were reviewed to assess the pattern of analgesic use. Incidence of postoperative pain was 91.4%, and remained high over 3 measurements (McNemar's; p<0.05), and 80.1% of the patients were undertreated. The mean pain intensity, and pain interference on functional status were 6.72 +/- 1.44 and 5.61 +/- 1.13 on a 10 point Numerical rating scale respectively; both being strongly correlated(r = 0.86: p<0.001). Pain intensity was varied by ethnicity, education and preoperative information (ANOVA; P<0.05). Only 50% of the patients were adequately satisfied with their pain management. As needed (prn), solo analgesic, null analgesic, and intramuscular orders were noted for 31.3%, 89.29%, 9.7% and 20.1% of the prescription orders respectively. Though under dose, diclofenac and tramadol were the top prescribed medications, and only 57% of their dose was administered. Linear regression model showed that the predictors of satisfaction were sex of an individual and pain interference with functional status. Conclusion: Despite patients' paradoxical high satisfaction with pain management, the majority of patients were inadequately and inappropriately treated. Thus, further research is needed to determine how best to break down current barriers to effective pain management.	[Woldehaimanot, Tewodros Eyob; Eshetie, Tesfahun Chanie] Jimma Univ, Dept Pharm, Jimma, Ethiopia; [Kerie, Mirkuzie Woldie] Jimma Univ, Dept Hlth Serv Management, Jimma, Ethiopia	Jimma University; Jimma University	Woldehaimanot, TE (corresponding author), Jimma Univ, Dept Pharm, Jimma, Ethiopia.	teda.eyob@gmail.com	Eshetie, Tesfahun/AAO-2224-2020; Woldie, Mirkuzie/S-4086-2017	Eshetie, Tesfahun/0000-0001-7253-988X; Woldie, Mirkuzie/0000-0002-1777-0816	hosting Jimma University	hosting Jimma University	This research was conducted as a partial fulfillment for a Master of Science in Clinical Pharmacy awarded to the primary author Tewodros Eyob Woldehaimanot and it was solely sponsored by the hosting Jimma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KO, 2005, PAIN, V113, P5, DOI 10.1016/j.pain.2004.10.024; Barak M, 2006, ACUTE PAIN, V8, P155; Bedard D, 2006, PAIN MANAG NURS, V7, P80, DOI 10.1016/j.pmn.2006.06.001; BENDELOW G, 1993, SOCIOL HEALTH ILL, V15, P273, DOI 10.1111/1467-9566.ep10490526; Botti Mari, 2004, Int J Nurs Pract, V10, P257, DOI 10.1111/j.1440-172x.2004.00487.x; Breivik H, 1998, EUR J ANAESTH, V15, P748, DOI 10.1097/00003643-199811000-00022; Chung Joanne W Y, 2003, Nurs Health Sci, V5, P13, DOI 10.1046/j.1442-2018.2003.00130.x; Cleary J, 2013, ANN ONCOL, V24, P14, DOI 10.1093/annonc/mdt499; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Cohen E, 2008, CANCER NURS, V31, pE1, DOI 10.1097/01.NCC.0000305693.67131.7d; Colman I, 2004, NEUROLOGY, V62, P1695, DOI 10.1212/01.WNL.0000127304.91605.BA; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Dawson R, 2002, J PAIN SYMPTOM MANAG, V23, P211, DOI 10.1016/S0885-3924(01)00399-2; Dekker Annette M, 2012, J Pain Palliat Care Pharmacother, V26, P334, DOI 10.3109/15360288.2012.734897; Dihle A, 2006, J PAIN, V7, P272, DOI 10.1016/j.jpain.2005.11.005; Donnelly AJ, 2009, APPL THERAPEUTICS CL; Edwards H E, 2001, Nurs Health Sci, V3, P35, DOI 10.1046/j.1442-2018.2001.00069.x; Faponle A F, 2001, Cent Afr J Med, V47, P70; Gordon DB, 2005, ARCH INTERN MED, V165, P1574, DOI 10.1001/archinte.165.14.1574; Gordon Debra B, 2002, Pain Manag Nurs, V3, P116, DOI 10.1053/jpmn.2002.127570; Gordon DB, 2010, J PAIN, V11, P1172, DOI 10.1016/j.jpain.2010.02.012; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Human Rights Watch, 2011, GLOB STAT PAINTR ACC; JAMES FR, 1991, PAIN, V44, P279, DOI 10.1016/0304-3959(91)90097-H; Klopper Hester, 2006, Intensive Crit Care Nurs, V22, P12, DOI 10.1016/j.iccn.2005.05.001; Lin CC, 2000, PAIN, V87, P43, DOI 10.1016/S0304-3959(00)00267-0; Lorentzen V, 2012, EUR J PAIN, V16, P278, DOI 10.1016/j.ejpain.2011.06.004; Manias Elizabeth, 2005, Pain Manag Nurs, V6, P18, DOI 10.1016/j.pmn.2004.12.004; MARKS RM, 1973, ANN INTERN MED, V78, P173, DOI 10.7326/0003-4819-78-2-173; McNeill J A, 2001, Pain Manag Nurs, V2, P25, DOI 10.1053/jpmn.2001.22039; McNeill JA, 2004, J PAIN SYMPTOM MANAG, V28, P47, DOI 10.1016/j.jpainsymman.2003.11.005; MoH, 2007, NAT PAIN MAN GUID; Ocitti EF, 2000, E AFR MED J, V77, P299; Ogboli-Nwasor Elizabeth, 2012, J Pain Res, V5, P117, DOI 10.2147/JPR.S28198; Olayemi O, 2009, J OBSTET GYNAECOL RE, V35, P277, DOI 10.1111/j.1447-0756.2008.00937.x; Powell RA, 2013, FAILING NUMB PAIN UN; Selman L, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-35; Shen Q, 2008, WESTERN J NURS RES, V30, P975, DOI 10.1177/0193945908319576; Sherwood G. D., 2003, AORN J, V77, P377; Sherwood G. D., 2003, AORN J, V77, P384; Sherwood G, 2005, J RES NURS, V10, P403, DOI 10.1177/174498710501000404; Sherwood Gwen D, 2003, AORN J, V77, P377, DOI 10.1016/S0001-2092(06)61206-4; Size M, 2007, ANAESTHESIA, V62, P38, DOI 10.1111/j.1365-2044.2007.05296.x; Soyannwo O A, 1999, West Afr J Med, V18, P207; Stephens J, 2003, RHEUMATOLOGY, V42, P40, DOI 10.1093/rheumatology/keg497; Tan EC, 2008, J PAIN, V9, P849, DOI 10.1016/j.jpain.2008.04.004; Tsui S L, 1995, Acta Anaesthesiol Sin, V33, P137; Vijayan R., 2011, MANAGING ACUTE PAIN; Ward SE, 1996, J PAIN SYMPTOM MANAG, V11, P242, DOI 10.1016/0885-3924(95)00190-5; Yates P, 1998, J CLIN NURS, V7, P521, DOI 10.1046/j.1365-2702.1998.00192.x	50	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102835	10.1371/journal.pone.0102835	http://dx.doi.org/10.1371/journal.pone.0102835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033399	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300101
J	Zhao, DF; Shi, ZQ; Warriner, AH; Qiao, P; Hong, HX; Wang, YJ; Feng, X				Zhao, Dongfeng; Shi, Zhenqi; Warriner, Amy H.; Qiao, Ping; Hong, Huixian; Wang, Yongjun; Feng, Xu			Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; PPAR-GAMMA; PEROXISOME-PROLIFERATOR; BONE-RESORPTION; OSTEOBLAST DIFFERENTIATION; TERMINAL DIFFERENTIATION; POSTMENOPAUSAL WOMEN; TRANSCRIPTION FACTOR; DIABETES-MELLITUS	Thiazolidinediones are synthetic peroxisome proliferator-activated receptor gamma agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the mechanism by which thiazolidinediones augment fracture risks is not fully understood. Several groups recently demonstrated that thiazolidinediones stimulate osteoclast formation, thus proposing that thiazolidinediones induce bone loss in part by prompting osteoclastogenesis. However, numerous other studies showed that thiazolidinediones inhibit osteoclast formation. Moreover, the molecular mechanism by which thiazolidinediones modulate osteoclastogenesis is not fully understood. Here we independently address the role of thiazolidinediones in osteoclastogenesis in vitro and furthermore investigate the molecular mechanism underlying the in vitro effects of thiazolidinediones on osteoclastogenesis. Our in vitro data indicate that thiazolidinediones dose-dependently inhibit osteoclastogenesis from bone marrow macrophages, but the inhibitory effect is considerably reduced when bone marrow macrophages are pretreated with RANKL. In vitro mechanistic studies reveal that thiazolidinediones inhibit osteoclastogenesis not by impairing RANKL-induced activation of the NF-kappa B, JNK, p38 and ERK pathways in bone marrow macrophages. Nonetheless, thiazolidinediones inhibit osteoclastogenesis by suppressing RANKL-induced expression of NFATc1 and c-Fos, two key transcriptional regulators of osteoclastogenesis, in bone marrow macrophages. In addition, thiazolidinediones inhibit the RANKL-induced expression of osteoclast genes encoding matrix metalloproteinase 9, cathepsin K, tartrate-resistant acid phosphatase and carbonic anhydrase II in bone marrow macrophages. However, the ability of thiazolidinediones to inhibit the expression of NFATc1, c-Fos and the four osteoclast genes is notably weakened in RANKL-pretreated bone marrow macrophages. These in vitro studies have not only independently demonstrated that thiazolidinediones exert inhibitory effects on osteoclastogenesis but have also revealed crucial new insights into the molecular mechanism by which thiazolidinediones inhibit osteoclastogenesis.	[Zhao, Dongfeng; Wang, Yongjun] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Zhao, Dongfeng; Shi, Zhenqi; Qiao, Ping; Hong, Huixian; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Warriner, Amy H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Shanghai University of Traditional Chinese Medicine; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, YJ (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.	yjwang88@hotmail.com; xufeng@uab.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health [AR47830]; National Basic Research Program of China [2010CB530400]; Key Program of Natural Science Foundation of China [30930111]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1270]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health; National Basic Research Program of China(National Basic Research Program of China); Key Program of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, under Award Number AR47830. This work was also supported by grants from the National Basic Research Program of China (2010CB530400), the Key Program of Natural Science Foundation of China (30930111), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bazelier Marloes T, 2013, Front Endocrinol (Lausanne), V4, P11, DOI 10.3389/fendo.2013.00011; Betteridge DJ, 2011, DIABETIC MED, V28, P759, DOI 10.1111/j.1464-5491.2010.03187.x; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Chan BY, 2007, BONE, V40, P149, DOI 10.1016/j.bone.2006.07.029; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen W, 1998, J BONE MINER RES, V13, P1112, DOI 10.1359/jbmr.1998.13.7.1112; Cheng J, 2012, J INTERF CYTOK RES, V32, P34, DOI 10.1089/jir.2011.0019; Cho ES, 2012, MOL CELLS, V33, P173, DOI 10.1007/s10059-012-2240-z; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hassumi MY, 2009, INT IMMUNOPHARMACOL, V9, P1150, DOI 10.1016/j.intimp.2009.06.002; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Huang W, 2003, ARTHRITIS RES THER, V5, pR49, DOI 10.1186/ar612; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang Min, 2010, Zhonghua Yi Xue Za Zhi, V90, P2282; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005; Krishnaswami Ashok, 2010, Perm J, V14, P64; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Mabilleau G, 2010, DIABETIC MED, V27, P925, DOI 10.1111/j.1464-5491.2010.03048.x; Mabilleau Guillaume, 2011, Int J Biochem Mol Biol, V2, P240; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Moseley KF, 2012, CURR OPIN ENDOCRINOL, V19, P128, DOI 10.1097/MED.0b013e328350a6e1; Okazaki R, 1999, ENDOCRINOLOGY, V140, P5060, DOI 10.1210/en.140.11.5060; Reginato MJ, 1999, TRENDS ENDOCRIN MET, V10, P9, DOI 10.1016/S1043-2760(98)00110-6; Rho J, 2002, DNA CELL BIOL, V21, P541, DOI 10.1089/104454902320308915; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Soroceanu MA, 2004, J ENDOCRINOL, V183, P203, DOI 10.1677/joe.1.05723; Sottile V, 2004, CALCIFIED TISSUE INT, V75, P329, DOI 10.1007/s00223-004-0224-8; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wan YH, 2010, TRENDS ENDOCRIN MET, V21, P722, DOI 10.1016/j.tem.2010.08.006; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wu HC, 2013, J CELL BIOCHEM, V114, P1969, DOI 10.1002/jcb.24534; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	57	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102706	10.1371/journal.pone.0102706	http://dx.doi.org/10.1371/journal.pone.0102706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032991	gold, Green Submitted, Green Published			2022-12-27	WOS:000339418300081
J	Chang, Z; Ju, HQ; Ling, JH; Zhuang, ZN; Li, ZK; Wang, HM; Fleming, JB; Freeman, JW; Yu, DH; Huang, P; Chiao, PJ				Chang, Zhe; Ju, Huaiqiang; Ling, Jianhua; Zhuang, Zhuonan; Li, Zhongkui; Wang, Huamin; Fleming, Jason B.; Freeman, James W.; Yu, Dihua; Huang, Peng; Chiao, Paul J.			Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							HBP1 TRANSCRIPTIONAL REPRESSOR; EPITHELIAL-CELL LINES; CANCER-CELLS; EGF RECEPTOR; KINASE; TRANSFORMATION; ACTIVATION; EXPRESSION; INVASION; PATHWAY	Activation of K-ras and inactivation of p16 are the most frequently identified genetic alterations in human pancreatic epithelial adenocarcinoma (PDAC). Mouse models engineered with mutant K-ras and deleted p16 recapitulate key pathological features of PDAC. However, a human cell culture transformation model that recapitulates the human pancreatic molecular carcinogenesis is lacking. In this study, we investigated the role of p16 in hTERT-immortalized human pancreatic epithelial nestin-expressing (HPNE) cells expressing mutant K-ras (K-ras(G12V)). We found that expression of p16 was induced by oncogenic K-ras in these HPNE cells and that silencing of this induced p16 expression resulted in tumorigenic transformation and development of metastatic PDAC in an orthotopic xenograft mouse model. Our results revealed that PI3K/Akt, ERK1/2 pathways and TGF alpha signaling were activated by K-ras and involved in the malignant transformation of human pancreatic cells. Also, p38/MAPK pathway was involved in p16 up-regulation. Thus, our findings establish an experimental cell-based model for dissecting signaling pathways in the development of human PDAC. This model provides an important tool for studying the molecular basis of PDAC development and gaining insight into signaling mechanisms and potential new therapeutic targets for altered oncogenic signaling pathways in PDAC.	[Chang, Zhe; Ju, Huaiqiang; Ling, Jianhua; Zhuang, Zhuonan; Li, Zhongkui; Yu, Dihua; Chiao, Paul J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ju, Huaiqiang; Huang, Peng] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Freeman, James W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA	University of Texas System; UTMD Anderson Cancer Center; State Key Lab Oncology South China; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio	Chiao, PJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	pjchiao@mdanderson.org		Yu, Dihua/0000-0001-6231-9381	National Institutes of Health through The University of Texas MD Anderson's Cancer Center [CA016672, CA097159, CA142674, CA109405]; Viragh Family Foundation; NATIONAL CANCER INSTITUTE [R01CA109405, R01CA097159, R01CA142674, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through The University of Texas MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Viragh Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported in part by the National Institutes of Health through The University of Texas MD Anderson's Cancer Center Support Grant CA016672 and through grants CA097159, CA142674, and CA109405 (to P.J.C.); grants from Viragh Family Foundation to P.J.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bera A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082282; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang Z, 2013, CLIN CANCER RES, V19, P549, DOI 10.1158/1078-0432.CCR-12-0032; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Goessel G, 2005, P NATL ACAD SCI USA, V102, P15599, DOI 10.1073/pnas.0409730102; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hara E, 1996, MOL CELL BIOL, V16, P859; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban Ralph H, 2008, Gastrointest Cancer Res, V2, pS10; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Leung L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084366; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Schutte M, 1997, CANCER RES, V57, P3126; Serra RW, 2014, ELIFE, V3, DOI 10.7554/eLife.02313; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TSAO MS, 1987, EXP CELL RES, V168, P365, DOI 10.1016/0014-4827(87)90009-7; Ueki T, 2000, CANCER RES, V60, P1835; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhao S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.36; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412	40	39	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101452	10.1371/journal.pone.0101452	http://dx.doi.org/10.1371/journal.pone.0101452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029561	gold, Green Published			2022-12-27	WOS:000341306600015
J	Jing, D; Cai, J; Wu, Y; Shen, GH; Zhai, MM; Tong, SC; Xu, QL; Xie, KN; Wu, XM; Tang, C; Xu, XM; Liu, J; Guo, W; Jiang, MG; Luo, EP				Jing, Da; Cai, Jing; Wu, Yan; Shen, Guanghao; Zhai, Mingming; Tong, Shichao; Xu, Qiaoling; Xie, Kangning; Wu, Xiaoming; Tang, Chi; Xu, Xinmin; Liu, Juan; Guo, Wei; Jiang, Maogang; Luo, Erping			Moderate-Intensity Rotating Magnetic Fields Do Not Affect Bone Quality and Bone Remodeling in Hindlimb Suspended Rats	PLOS ONE			English	Article							PULSED ELECTROMAGNETIC-FIELDS; EXTREMELY-LOW-FREQUENCY; IN-VITRO; OSTEOPOROSIS; MODEL; MICROGRAVITY; DENSITY; DETERIORATION; PREVENTION; STRENGTH	Abundant evidence has substantiated the positive effects of pulsed electromagnetic fields (PEMF) and static magnetic fields (SMF) on inhibiting osteopenia and promoting fracture healing. However, the osteogenic potential of rotating magnetic fields (RMF), another common electromagnetic application modality, remains poorly characterized thus far, although numerous commercial RMF treatment devices have been available on the market. Herein the impacts of RMF on osteoporotic bone microarchitecture, bone strength and bone metabolism were systematically investigated in hindlimb-unloaded (HU) rats. Thirty two 3-month-old male Sprague-Dawley rats were randomly assigned to the Control (n = 10), HU (n = 10) and HU with RMF exposure (HU+RMF, n = 12) groups. Rats in the HU+RMF group were subjected to daily 2-hour exposure to moderate-intensity RMF (ranging from 0.60 T to 0.38 T) at 7 Hz for 4 weeks. HU caused significant decreases in body mass and soleus muscle mass of rats, which were not obviously altered by RMF. Three-point bending test showed that the mechanical properties of femurs in HU rats, including maximum load, stiffness, energy absorption and elastic modulus were not markedly affected by RMF. mu CT analysis demonstrated that 4-week RMF did not significantly prevent HU-induced deterioration of femoral trabecular and cortical bone microarchitecture. Serum biochemical analysis showed that RMF did not significantly change HU-induced decrease in serum bone formation markers and increase in bone resorption markers. Bone histomorphometric analysis further confirmed that RMF showed no impacts on bone remodeling in HU rats, as evidenced by unchanged mineral apposition rate, bone formation rate, osteoblast numbers and osteoclast numbers in cancellous bone. Together, our findings reveal that RMF do not significantly affect bone microstructure, bone mechanical strength and bone remodeling in HU-induced disuse osteoporotic rats. Our study indicates potentially obvious waveform-dependent effects of electromagnetic fields-stimulated osteogenesis, suggesting that RMF, at least in the present form, might not be an optimal modality for inhibiting disuse osteopenia/osteoporosis.	[Jing, Da; Shen, Guanghao; Zhai, Mingming; Tong, Shichao; Xie, Kangning; Wu, Xiaoming; Tang, Chi; Liu, Juan; Guo, Wei; Jiang, Maogang; Luo, Erping] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Cai, Jing] Fourth Mil Med Univ, Dept Endocrinol, Xijing Hosp, Xian 710032, Peoples R China; [Wu, Yan] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China; [Xu, Qiaoling] Fourth Mil Med Univ, Dept Nursing, Xian 710032, Peoples R China; [Xu, Xinmin] PLA 323 Hosp, Dept Med Engn, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Luo, EP (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.	luoerping@fmmu.edu.cn	Xie, Kangning/AAQ-1496-2020	Xie, Kangning/0000-0002-6031-8489	National Natural Science Foundation of China [51077128, 31270889]; Shaanxi Provincial Natural Science Foundation [2014JQ4139]; Doctoral Thesis Foundation of the Fourth Military Medical University [2012D01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Natural Science Foundation; Doctoral Thesis Foundation of the Fourth Military Medical University	The authors acknowledge support from the National Natural Science Foundation of China (No. 51077128 and 31270889), Shaanxi Provincial Natural Science Foundation (No. 2014JQ4139), and the Doctoral Thesis Foundation of the Fourth Military Medical University (No. 2012D01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; BASSETT CAL, 1982, JAMA-J AM MED ASSOC, V247, P623, DOI 10.1001/jama.247.5.623; BASSETT CAL, 1974, SCIENCE, V184, P575; Buijs Jeroen T, 2012, Bonekey Rep, V1, P96, DOI 10.1038/bonekey.2012.96; Chang K, 2003, BIOELECTROMAGNETICS, V24, P189, DOI 10.1002/bem.10078; Coletti D, 2007, CYTOM PART A, V71A, P846, DOI 10.1002/cyto.a.20447; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Gurgul S, 2008, BONE, V42, P74, DOI 10.1016/j.bone.2007.08.040; HALLORAN BP, 1986, ENDOCRINOLOGY, V118, P948, DOI 10.1210/endo-118-3-948; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Hu MY, 2012, BONE, V51, P819, DOI 10.1016/j.bone.2012.06.030; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jing D, 2011, OSTEOPOROSIS INT, V22, P1885, DOI 10.1007/s00198-010-1447-3; Jing D, 2014, J BONE MINER RES, V29, P2250, DOI 10.1002/jbmr.2260; Kazakia GJ, 2014, BONE; Keila S, 2001, J ENDOCRINOL, V168, P131, DOI 10.1677/joe.0.1680131; Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; Lazo MG, 2001, SPINAL CORD, V39, P208, DOI 10.1038/sj.sc.3101139; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; Li M, 2007, INT ORTHOP, V31, P767, DOI 10.1007/s00264-007-0406-x; Lloyd SA, 2012, BONE, V51, P756, DOI 10.1016/j.bone.2012.07.001; MACHWATE M, 1995, J CLIN INVEST, V96, P1245, DOI 10.1172/JCI118158; Mahavni V, 2001, CURR OPIN ONCOL, V13, P384, DOI 10.1097/00001622-200109000-00012; McCombs JS, 2004, MATURITAS, V48, P271, DOI 10.1016/j.maturitas.2004.02.005; MCELHANEY J H, 1968, Journal of Biomechanics, V1, P47, DOI 10.1016/0021-9290(68)90037-7; Morey-Holton ER, 1998, BONE, V22, p83S, DOI 10.1016/S8756-3282(98)00019-2; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Musette P, 2010, OSTEOPOROSIS INT, V21, P723, DOI 10.1007/s00198-009-1097-5; OCONNOR BT, 1969, NATURE, V222, P162, DOI 10.1038/222162a0; Pan XH, 2009, INT ORTHOP, V33, P617, DOI 10.1007/s00264-007-0506-7; Parkinson IH, 2012, OSTEOPOROSIS INT, V23, P1957, DOI 10.1007/s00198-011-1832-6; Pennes HH, 1998, J APPL PHYSIOL, V85, P5, DOI 10.1152/jappl.1998.85.1.5; Puricelli Edela, 2006, Head Face Med, V2, P43, DOI 10.1186/1746-160X-2-43; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Rizzoli R, 2011, CALCIFIED TISSUE INT, V89, P91, DOI 10.1007/s00223-011-9499-8; RUBIN CT, 1989, J BONE JOINT SURG AM, V71A, P411, DOI 10.2106/00004623-198971030-00016; Shiba K, 2008, IEEE T BIO-MED ENG, V55, P205, DOI 10.1109/TBME.2007.900550; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Sun Y, 2013, OSTEOPOROSIS INT, V24, P969, DOI 10.1007/s00198-012-2028-4; Swift JM, 2010, J BONE MINER RES, V25, P564, DOI 10.1359/jbmr.090811; TABRAH F, 1990, J BONE MINER RES, V5, P437, DOI 10.1002/jbmr.5650050504; Takata Shinjiro, 2001, Journal of Medical Investigation, V48, P147; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Thomsen JS, 2005, AVIAT SPACE ENVIR MD, V76, P915; Xu S, 2011, EVID BASED COMPLEMEN, V2011; Yamamoto Y, 2003, J DENT RES, V82, P962, DOI 10.1177/154405910308201205; Yan QC, 1998, MED ENG PHYS, V20, P397, DOI 10.1016/S1350-4533(98)00051-4; Zhang LN, 2001, J APPL PHYSIOL, V90, P2296, DOI 10.1152/jappl.2001.90.6.2296; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756; Zhang XY, 2006, BIOELECTROMAGNETICS, V27, P1, DOI 10.1002/bem.20165	53	7	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102956	10.1371/journal.pone.0102956	http://dx.doi.org/10.1371/journal.pone.0102956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047554	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100092
J	Khmaladze, E; Birdsell, DN; Naumann, AA; Hochhalter, CB; Seymour, ML; Nottingham, R; Beckstrom-Sternberg, SM; Beckstrom-Sternberg, J; Nikolich, MP; Chanturia, G; Zhgenti, E; Zakalashvili, M; Malania, L; Babuadze, G; Tsertsvadze, N; Abazashvili, N; Kekelidze, M; Tsanava, S; Imnadze, P; Ganz, HH; Getz, WM; Pearson, O; Gajer, P; Eppinger, M; Ravel, J; Wagner, DM; Okinaka, RT; Schupp, JM; Keim, P; Pearson, T				Khmaladze, Ekaterine; Birdsell, Dawn N.; Naumann, Amber A.; Hochhalter, Christian B.; Seymour, Meagan L.; Nottingham, Roxanne; Beckstrom-Sternberg, Stephen M.; Beckstrom-Sternberg, James; Nikolich, Mikeljon P.; Chanturia, Gvantsa; Zhgenti, Ekaterine; Zakalashvili, Mariam; Malania, Lile; Babuadze, Giorgi; Tsertsvadze, Nikoloz; Abazashvili, Natalia; Kekelidze, Merab; Tsanava, Shota; Imnadze, Paata; Ganz, Holly H.; Getz, Wayne M.; Pearson, Ofori; Gajer, Pawel; Eppinger, Mark; Ravel, Jacques; Wagner, David M.; Okinaka, Richard T.; Schupp, James M.; Keim, Paul; Pearson, Talima			Phylogeography of Bacillus anthracis in the Country of Georgia Shows Evidence of Population Structuring and Is Dissimilar to Other Regional Genotypes	PLOS ONE			English	Article							STRAINS; DIVERSITY	Sequence analyses and subtyping of Bacillus anthracis strains from Georgia reveal a single distinct lineage (Aust94) that is ecologically established. Phylogeographic analysis and comparisons to a global collection reveals a clade that is mostly restricted to Georgia. Within this clade, many groups are found around the country, however at least one subclade is only found in the eastern part. This pattern suggests that dispersal into and out of Georgia has been rare and despite historical dispersion within the country, for at least for one lineage, current spread is limited.	[Khmaladze, Ekaterine; Chanturia, Gvantsa; Zhgenti, Ekaterine; Zakalashvili, Mariam; Malania, Lile; Babuadze, Giorgi; Tsertsvadze, Nikoloz; Abazashvili, Natalia; Kekelidze, Merab; Tsanava, Shota; Imnadze, Paata] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Birdsell, Dawn N.; Naumann, Amber A.; Hochhalter, Christian B.; Seymour, Meagan L.; Nottingham, Roxanne; Beckstrom-Sternberg, Stephen M.; Beckstrom-Sternberg, James; Wagner, David M.; Okinaka, Richard T.; Schupp, James M.; Keim, Paul; Pearson, Talima] Univ Arizona, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Nikolich, Mikeljon P.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Ganz, Holly H.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Pearson, Ofori] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; [Gajer, Pawel; Eppinger, Mark; Ravel, Jacques] Inst Genome Sci, Baltimore, MD USA; [Eppinger, Mark] Univ Texas San Antonio, San Antonio, TX USA; [Khmaladze, Ekaterine; Tsanava, Shota; Imnadze, Paata] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia	National Center for Disease Control & Public Health - Georgia; University of Arizona; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas at San Antonio (UTSA); Ivane Javakhishvili Tbilisi State University	Pearson, T (corresponding author), Univ Arizona, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Talima.Pearson@nau.edu	Nikolich, Mikeljon/ABD-5270-2020; Ravel, Jacques/D-2530-2009; Pearson, Talima/O-7840-2019; Nikolich, Mikeljon P/ABC-9871-2021; Getz, Wayne/I-4521-2013	Pearson, Talima/0000-0003-3696-041X; Nikolich, Mikeljon P/0000-0001-5770-8980; Ravel, Jacques/0000-0002-0851-2233; Wagner, David/0000-0003-2684-6007; Getz, Wayne/0000-0001-8784-9354	U.S. Department of Homeland Security S&T CB Division Bioforensics RD Program [HSHQDC-10-C-00139]; Department of Defense's Defense Threat Reduction Agency [CBCALL12-DIAGB1-2-0194]; National Institutes of Health [GM083863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	U.S. Department of Homeland Security S&T CB Division Bioforensics RD Program(United States Department of Homeland Security (DHS)); Department of Defense's Defense Threat Reduction Agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program (HSHQDC-10-C-00139) and by the Department of Defense's Defense Threat Reduction Agency (CBCALL12-DIAGB1-2-0194). Support for collecting the samples in Namibia was provided by National Institutes of Health GM083863 grant to Wayne M. Getz. The use of products/names does not constitute endorsement by the United States DHS. The findings and opinions expressed herein belong to the authors and do not necessarily reflect the official views of the Walter Reed Army Institute of Research, the U.S. Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Durmaz R, 2012, EUR J CLIN MICROBIOL, V31, P2783, DOI 10.1007/s10096-012-1628-4; Eremenko EI, 2012, MOL GENET MICROBIOL+, V27, P74, DOI 10.3103/S0891416812020024; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Marston CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028274; Merabishvili M, 2006, APPL ENVIRON MICROB, V72, P5631, DOI 10.1128/AEM.00440-06; Ortatatli M, 2012, COMP IMMUNOL MICROB, V35, P355, DOI 10.1016/j.cimid.2012.02.005; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2013, SYST BIOL, V62, P752, DOI 10.1093/sysbio/syt038; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461	15	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102651	10.1371/journal.pone.0102651	http://dx.doi.org/10.1371/journal.pone.0102651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047912	Green Published, gold			2022-12-27	WOS:000339558100057
J	Komatsu, S; Nagai, Y; Naruse, K; Kimata, Y				Komatsu, Seiji; Nagai, Yusuke; Naruse, Keiji; Kimata, Yoshihiro			The Neutral Self-Assembling Peptide Hydrogel SPG-178 as a Topical Hemostatic Agent	PLOS ONE			English	Article							NANOFIBER SCAFFOLDS; COMPLEMENTARY OLIGOPEPTIDE; SPINAL-CORD; CULTURE; CELLS; PURAMATRIX; MORTALITY; EFFICACY; RELEASE	Conventional self-assembling peptide hydrogels are effective as topical hemostatic agents. However, there is a possibility to harm living tissues due to their low pH. The aim of the present study was to demonstrate the efficacy of SPG-178, a neutral self-assembling peptide hydrogel, as a topical hemostatic agent. First, we measured the bleeding duration of incisions made on rat livers after application of SPG-178 (1.0% w/v), SPG-178 (1.5% w/v), RADA16 (1.0% w/v), and saline (n = 12/group). Second, we observed the bleeding surfaces by transmission electron microscopy immediately after hemostasis. Third, we measured the elastic and viscous responses (G' and G '', respectively) of the hydrogels using a rheometer. Our results showed that bleeding duration was significantly shorter in the SPG-178 group than in the RADA16 group and that there were no significant differences in transmission electron microscopy findings between the groups. The greater the G' value of a hydrogel, the shorter was the bleeding duration. We concluded that SPG-178 is more effective and has several advantages: it is non-biological, transparent, nonadherent, and neutral and can be sterilized by autoclaving.	[Komatsu, Seiji] Okayama Saiseikai Gen Hosp, Dept Plast & Reconstruct Surg, Okayama, Japan; [Nagai, Yusuke; Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama 7008530, Japan; [Nagai, Yusuke] Menicon Co Ltd, Nagoya, Aichi, Japan; [Kimata, Yoshihiro] Okayama Univ, Dept Plast & Reconstruct Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University; Okayama University	Komatsu, S (corresponding author), Okayama Saiseikai Gen Hosp, Dept Plast & Reconstruct Surg, Okayama, Japan.	komats-s@cc.okayama-u.ac.jp	Sokabe, Masahiro/I-1565-2012; Komatsu, Seiji/H-7235-2013	Komatsu, Seiji/0000-0001-7625-7927; naruse, keiji/0000-0003-4100-6444	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [23792045, 40252233]; Grants-in-Aid for Scientific Research [26220203] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by Grant-in-Aid for Young Scientists (B) 23792045 provided by the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to Seiji Komatsu), and Grant-in-Aid for Challenging Exploratory Research 40252233 provided by the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan (to Keiji Naruse). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca; Akiyama N, 2013, INT J NANOMED, V8, P2629, DOI 10.2147/IJN.S47279; CARSON JL, 1988, LANCET, V1, P727; Cylwik D, 2004, J PHYSIOL PHARMACOL, V55, P563; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Degano IR, 2009, BIOMATERIALS, V30, P1156, DOI 10.1016/j.biomaterials.2008.11.021; Ellis-Behnke RG, 2006, NANOMED-NANOTECHNOL, V2, P207, DOI 10.1016/j.nano.2006.08.001; Emilia M, 2011, TRANSFUS APHER SCI, V45, P305, DOI 10.1016/j.transci.2011.10.013; Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Kim MS, 2007, BIOMED MICRODEVICES, V9, P25, DOI 10.1007/s10544-006-9016-4; Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106; Lang CJG, 1998, J NEUROL SCI, V160, P128, DOI 10.1016/S0022-510X(98)00226-3; Leugn GKK, 2012, METHOD ENZYMOL, V508, P177; Liedmann A, 2012, JOVE-J VIS EXP, DOI 10.3791/3830; Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049; Masuhara H, 2012, ANN THORAC CARDIOVAS, V18, P444, DOI 10.5761/atcs.oa.12.01977; Meng H, 2009, J BIOMED MATER RES B, V89B, P379, DOI 10.1002/jbm.b.31226; Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120; Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031; Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049; Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410; Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x; Shivachar AC, 2008, TOPICS TISSUE ENG, V4; Song H, 2010, MACROMOL BIOSCI, V10, P33, DOI 10.1002/mabi.200900129; Um E, 2008, MICROFLUID NANOFLUID, V5, P541, DOI 10.1007/s10404-008-0268-6; Wu WC, 2012, ANN SURG, V255, P708, DOI 10.1097/SLA.0b013e31824a55b9; Yasunaga H, 2007, LANCET, V370, P2063, DOI 10.1016/S0140-6736(07)61867-4; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhao Y, 2008, BIOMACROMOLECULES, V9, P1511, DOI 10.1021/bm701143g	33	27	37	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102778	10.1371/journal.pone.0102778	http://dx.doi.org/10.1371/journal.pone.0102778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047639	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100074
J	Querbes, A; Vaesen, K; Houkes, W				Querbes, Adrien; Vaesen, Krist; Houkes, Wybo			Complexity and Demographic Explanations of Cumulative Culture	PLOS ONE			English	Article							POPULATION-SIZE; TRANSMISSION; EVOLUTION; MODEL	Formal models have linked prehistoric and historical instances of technological change (e.g., the Upper Paleolithic transition, cultural loss in Holocene Tasmania, scientific progress since the late nineteenth century) to demographic change. According to these models, cumulation of technological complexity is inhibited by decreasing- while favoured by increasing-population levels. Here we show that these findings are contingent on how complexity is defined: demography plays a much more limited role in sustaining cumulative culture in case formal models deploy Herbert Simon's definition of complexity rather than the particular definitions of complexity hitherto assumed. Given that currently available empirical evidence doesn't afford discriminating proper from improper definitions of complexity, our robustness analyses put into question the force of recent demographic explanations of particular episodes of cultural change.	[Querbes, Adrien] Carnegie Mellon Univ, Dept Social & Decis Sci SDS, Pittsburgh, PA 15213 USA; [Vaesen, Krist; Houkes, Wybo] Eindhoven Univ Technol, Sch Innovat Sci, NL-5600 MB Eindhoven, Netherlands	Carnegie Mellon University; Eindhoven University of Technology	Vaesen, K (corresponding author), Eindhoven Univ Technol, Sch Innovat Sci, POB 513, NL-5600 MB Eindhoven, Netherlands.	k.vaesen@tue.nl		Vaesen, Krist/0000-0002-7496-7463; Querbes-Revier, Adrien/0000-0001-9521-4033	Netherlands Organization for Scientic Research (NWO)	Netherlands Organization for Scientic Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Adrien Querbes was supported by the Netherlands Organization for Scientic Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Bentley R, 2011, J EVOL PSYCH, V9, P1; Boyd R, CULTURAL EVOLUTION S; Collard M, 2013, PHILOS T R SOC B, V368, P1; Collard M, 2013, CURR ANTHROPOL, V54, pS388, DOI 10.1086/673881; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Hayden B, 1996, INTERD CONT, P9; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2011, CULTURAL SPECIES CUL; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Kauffman S.A., 1993, ORIGINS ORDER; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Kobayashi Y, 2012, THEOR POPUL BIOL, V82, P38, DOI 10.1016/j.tpb.2012.04.001; Lehmann L, 2013, EVOL HUM BEHAV, V34, P109, DOI 10.1016/j.evolhumbehav.2012.11.001; Mesoudi A, 2008, AM ANTIQUITY, V73, P3, DOI 10.2307/25470456; Mesoudi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018239; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Stout D, 2011, PHILOS T R SOC B, V366, P1050, DOI 10.1098/rstb.2010.0369; Vaesen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040989	21	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102543	10.1371/journal.pone.0102543	http://dx.doi.org/10.1371/journal.pone.0102543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25048625	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100043
J	Khanna, R; Powe, AC; Lun, Y; Soska, R; Feng, J; Dhulipala, R; Frascella, M; Garcia, A; Pellegrino, LJ; Xu, S; Brignol, N; Toth, MJ; Do, HV; Lockhart, DJ; Wustman, BA; Valenzano, KJ				Khanna, Richie; Powe, Allan C., Jr.; Lun, Yi; Soska, Rebecca; Feng, Jessie; Dhulipala, Rohini; Frascella, Michelle; Garcia, Anadina; Pellegrino, Lee J.; Xu, Su; Brignol, Nastry; Toth, Matthew J.; Do, Hung V.; Lockhart, David J.; Wustman, Brandon A.; Valenzano, Kenneth J.			The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; LONG-TERM; ALGLUCOSIDASE ALPHA; BETA-GLUCOSIDASE; FIBROBLASTS; INFANTILE; MUTATION; MICE; GALACTOSIDASE; ENHANCEMENT	Pompe disease is an inherited lysosomal storage disorder that results from a deficiency in acid a-glucosidase (GAA) activity due to mutations in the GAA gene. Pompe disease is characterized by accumulation of lysosomal glycogen primarily in heart and skeletal muscles, which leads to progressive muscle weakness. We have shown previously that the small molecule pharmacological chaperone AT2220 (1-deoxynojirimycin hydrochloride, duvoglustat hydrochloride) binds and stabilizes wild-type as well as multiple mutant forms of GAA, and can lead to higher cellular levels of GAA. In this study, we examined the effect of AT2220 on mutant GAA, in vitro and in vivo, with a primary focus on the endoplasmic reticulum (ER)-retained P545L mutant form of human GAA (P545L GAA). AT2220 increased the specific activity of P545L GAA toward both natural (glycogen) and artificial substrates in vitro. Incubation with AT2220 also increased the ER export, lysosomal delivery, proteolytic processing, and stability of P545L GAA. In a new transgenic mouse model of Pompe disease that expresses human P545L on a Gaa knockout background (Tg/KO) and is characterized by reduced GAA activity and elevated glycogen levels in disease-relevant tissues, daily oral administration of AT2220 for 4 weeks resulted in significant and dose-dependent increases in mature lysosomal GAA isoforms and GAA activity in heart and skeletal muscles. Importantly, oral administration of AT2220 also resulted in significant glycogen reduction in disease-relevant tissues. Compared to daily administration, less-frequent AT2220 administration, including repeated cycles of 4 or 5 days with AT2220 followed by 3 or 2 days without drug, respectively, resulted in even greater glycogen reductions. Collectively, these data indicate that AT2220 increases the specific activity, trafficking, and lysosomal stability of P545L GAA, leads to increased levels of mature GAA in lysosomes, and promotes glycogen reduction in situ. As such, AT2220 may warrant further evaluation as a treatment for Pompe disease.	[Khanna, Richie; Powe, Allan C., Jr.; Lun, Yi; Soska, Rebecca; Feng, Jessie; Dhulipala, Rohini; Frascella, Michelle; Garcia, Anadina; Pellegrino, Lee J.; Xu, Su; Brignol, Nastry; Toth, Matthew J.; Do, Hung V.; Lockhart, David J.; Wustman, Brandon A.; Valenzano, Kenneth J.] Amicus Therapeut Inc, Cranbury, NJ 08512 USA		Valenzano, KJ (corresponding author), Amicus Therapeut Inc, Cranbury, NJ 08512 USA.	kvalenzano@amicusrx.com			Amicus Therapeutics	Amicus Therapeutics	Amicus Therapeutics funded the research. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijvoet AGA, 1998, HUM MOL GENET, V7, P1815, DOI 10.1093/hmg/7.11.1815; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Chen LR, 2009, J PEDIATR-US, V155, P271, DOI 10.1016/j.jpeds.2009.03.015; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Flanagan JJ, 2009, HUM MUTAT, V30, P1683, DOI 10.1002/humu.21121; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hagemans MLC, 2005, NEUROLOGY, V64, P2139, DOI 10.1212/01.WNL.0000165979.46537.56; HASILIK A, 1980, J BIOL CHEM, V255, P4946; Hawes ML, 2007, MOL GENET METAB, V91, P343, DOI 10.1016/j.ymgme.2007.04.018; HERMANS MMP, 1994, HUM MOL GENET, V3, P2213, DOI 10.1093/hmg/3.12.2213; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; HUIE ML, 1994, HUM MOL GENET, V3, P2231; Ishii S, 2004, BBA-MOL BASIS DIS, V1690, P250, DOI 10.1016/j.bbadis.2004.07.001; Khanna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040776; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Kishnani PS, 2004, J PEDIATR-US, V144, pS35, DOI 10.1016/j.jpeds.2004.01.053; Lee CJ, 2011, J CARDIOL, V57, P115, DOI 10.1016/j.jjcc.2010.08.003; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Montalvo ALE, 2006, HUM MUTAT, V27, P999, DOI 10.1002/humu.20374; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Parenti G, 2007, MOL THER, V15, P508, DOI 10.1038/sj.mt.6300074; Pittis M G, 2008, Hum Mutat, V29, pE27, DOI 10.1002/humu.20753; Porto C, 2009, MOL THER, V17, P964, DOI 10.1038/mt.2009.53; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2002, MOL THER, V6, P601, DOI 10.1006/mthe.2002.0716; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben Nina, 2002, Current Molecular Medicine (Hilversum), V2, P145, DOI 10.2174/1566524024605789; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Shimmoto M, 1997, FEBS LETT, V417, P89, DOI 10.1016/S0014-5793(97)01263-5; Sidman RL, 2008, J NEUROPATH EXP NEUR, V67, P803, DOI 10.1097/NEN.0b013e3181815994; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; Takikita S, 2009, MOL GENET METAB, V96, P208, DOI 10.1016/j.ymgme.2008.12.012; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	51	24	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102092	10.1371/journal.pone.0102092	http://dx.doi.org/10.1371/journal.pone.0102092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036864	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200037
J	Pandit, H; Gopal, S; Sonawani, A; Yadav, AK; Qaseem, AS; Warke, H; Patil, A; Gajbhiye, R; Kulkarni, V; Al-Mozaini, MA; Idicula-Thomas, S; Kishore, U; Madan, T				Pandit, Hrishikesh; Gopal, Sandhya; Sonawani, Archana; Yadav, Ajit Kumar; Qaseem, Asif S.; Warke, Himangi; Patil, Anushree; Gajbhiye, Rahul; Kulkarni, Vijay; Al-Mozaini, Maha Ahmed; Idicula-Thomas, Susan; Kishore, Uday; Madan, Taruna			Surfactant Protein D Inhibits HIV-1 Infection of Target Cells via Interference with gp120-CD4 Interaction and Modulates Pro-Inflammatory Cytokine Production	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CARBOHYDRATE-BINDING AGENTS; SP-A; U1 CELLS; T-CELLS; TYPE-1; EXPRESSION; REPLICATION; NEUTRALIZATION; INDUCTION	Surfactant Protein SP-D, a member of the collectin family, is a pattern recognition protein, secreted by mucosal epithelial cells and has an important role in innate immunity against various pathogens. In this study, we confirm that native human SP-D and a recombinant fragment of human SP-D (rhSP-D) bind to gp120 of HIV-1 and significantly inhibit viral replication in vitro in a calcium and dose-dependent manner. We show, for the first time, that SP-D and rhSP-D act as potent inhibitors of HIV-1 entry in to target cells and block the interaction between CD4 and gp120 in a dose-dependent manner. The rhSP-D-mediated inhibition of viral replication was examined using three clinical isolates of HIV-1 and three target cells: Jurkat T cells, U937 monocytic cells and PBMCs. HIV-1 induced cytokine storm in the three target cells was significantly suppressed by rhSP-D. Phosphorylation of key kinases p38, Erk1/2 and AKT, which contribute to HIV-1 induced immune activation, was significantly reduced in vitro in the presence of rhSP-D. Notably, anti-HIV-1 activity of rhSP-D was retained in the presence of biological fluids such as cervico-vaginal lavage and seminal plasma. Our study illustrates the multi-faceted role of human SP-D against HIV-1 and potential of rhSP-D for immunotherapy to inhibit viral entry and immune activation in acute HIV infection.	[Pandit, Hrishikesh; Gopal, Sandhya; Yadav, Ajit Kumar; Madan, Taruna] Natl Inst Res Reprod Hlth ICMR, Dept Innate Immun, Bombay, Maharashtra, India; [Sonawani, Archana; Idicula-Thomas, Susan] Natl Inst Res Reprod Hlth ICMR, Ctr Informat Biol, Bombay, Maharashtra, India; [Qaseem, Asif S.; Kishore, Uday] Brunel Univ, Ctr Infect Immun & Dis Mech, London, England; [Warke, Himangi] Seth GS Med Coll, Dept Obstet & Gynecol, Bombay, Maharashtra, India; [Warke, Himangi] King Edward Mem Hosp, Bombay, Maharashtra, India; [Patil, Anushree; Gajbhiye, Rahul; Kulkarni, Vijay] Natl Inst Res Reprod Hlth ICMR, Dept Clin Res, Bombay, Maharashtra, India; [Al-Mozaini, Maha Ahmed] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Immunocompromised Host Res Sect, Riyadh 11211, Saudi Arabia	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Brunel University; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); King Faisal Specialist Hospital & Research Center	Madan, T (corresponding author), Natl Inst Res Reprod Hlth ICMR, Dept Innate Immun, Bombay, Maharashtra, India.	taruna_m@hotmail.com	Pandit, Hrishikesh/AGZ-4050-2022; Gajbhiye, Rahul/AAE-6889-2022; Kishore, Uday/Y-7976-2018; Pandit, Hrishikesh/GON-8428-2022	Pandit, Hrishikesh/0000-0003-0994-6778; Gajbhiye, Rahul/0000-0003-3864-1818; Kishore, Uday/0000-0002-6033-6759; 	Medical Innovation Fund of Indian Council of Medical Research, New Delhi, India [2011-16850]	Medical Innovation Fund of Indian Council of Medical Research, New Delhi, India	The work (Project no. 2011-16850) was supported by Medical Innovation Fund of Indian Council of Medical Research, New Delhi, India (www.icmr.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ascherl G, 1999, BLOOD, V93, P4232; Bahbouhi B, 2004, BLOOD, V103, P4581, DOI 10.1182/blood-2003-12-4172; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; BISWAS P, 1994, J VIROL, V68, P2598, DOI 10.1128/JVI.68.4.2598-2604.1994; Borron PJ, 1998, J IMMUNOL, V161, P4599; Borron PJ, 2002, J IMMUNOL, V169, P5844, DOI 10.4049/jimmunol.169.10.5844; Chirmule N, 1996, MICROBIOL REV, V60, P386, DOI 10.1128/MMBR.60.2.386-406.1996; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; Clark H, 2003, ARCH DIS CHILD, V88, P981, DOI 10.1136/adc.88.11.981; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Dodagatta-Marri E, 2014, METHODS MOL BIOL, V1100, P273, DOI 10.1007/978-1-62703-724-2_22; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Jakel A, 2013, FRONT BIOSCI-LANDMRK, V18, P1129, DOI 10.2741/4168; Jambo KC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-42; Kankavi O, 2008, FERTIL STERIL, V90, P1904, DOI 10.1016/j.fertnstert.2007.09.064; Kankavi O, 2006, THERIOGENOLOGY, V66, P1057, DOI 10.1016/j.theriogenology.2006.02.047; Keller MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008781; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kunisaki KM, 2011, HIV MED, V12, P580, DOI 10.1111/j.1468-1293.2011.00920.x; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Lin KW, 2010, J IMMUNOL, V184, P6343, DOI 10.4049/jimmunol.0901947; LONGO N, 1993, J ACQ IMMUN DEF SYND, V6, P1017; Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059047; Mahajan L, 2008, INT IMMUNOL, V20, P993, DOI 10.1093/intimm/dxn058; Mahajan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085046; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Meschi J, 2005, J GEN VIROL, V86, P3097, DOI 10.1099/vir.0.80764-0; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; POLI G, 1994, P NATL ACAD SCI USA, V91, P108, DOI 10.1073/pnas.91.1.108; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Swanson MD, 2010, J BIOL CHEM, V285, P8646, DOI 10.1074/jbc.M109.034926; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zaitseva M, 2000, BLOOD, V96, P3109, DOI 10.1182/blood.V96.9.3109.h8003109_3109_3117	57	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102395	10.1371/journal.pone.0102395	http://dx.doi.org/10.1371/journal.pone.0102395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036364	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200055
J	Xu, J; Sun, MM; Shi, Z; Harrison, PJ; Liu, HB				Xu, Jie; Sun, Mingming; Shi, Zhen; Harrison, Paul J.; Liu, Hongbin			Response of Bacterial Metabolic Activity to Riverine Dissolved Organic Carbon and Exogenous Viruses in Estuarine and Coastal Waters: Implications for CO2 Emission	PLOS ONE			English	Article							FRESH-WATER; PHYTOPLANKTON BIOMASS; GROWTH EFFICIENCY; FLOW-CYTOMETRY; BACTERIOPLANKTON; MATTER; DIVERSITY; DYNAMICS; RESPIRATION; COMMUNITIES	A cross-transplant experiment between estuarine water and seawater was conducted to examine the response of bacterial metabolic activity to riverine dissolved organic carbon (DOC) input under virus-rich and virus-free conditions, as well as to exogenous viruses. Riverine DOC input increased bacterial production significantly, but not bacterial respiration (BR) because of its high lability. The bioavailable riverine DOC influenced bulk bacterial respiration in two contrasting ways; it enhanced the bulk BR by stimulating bacterial growth, but simultaneously reduced the cell-specific BR due to its high lability. As a result, there was little stimulation of the bulk BR by riverine DOC. This might be partly responsible for lower CO2 degassing fluxes in estuaries receiving high sewage-DOC that is highly labile. Viruses restricted microbial decomposition of riverine DOC dramatically by repressing the growth of metabolically active bacteria. Bacterial carbon demand in the presence of viruses only accounted for 7-12% of that in the absence of viruses. Consequently, a large fraction of riverine DOC was likely transported offshore to the shelf. In addition, marine bacteria and estuarine bacteria responded distinctly to exogenous viruses. Marine viruses were able to infect estuarine bacteria, but not as efficiently as estuarine viruses, while estuarine viruses infected marine bacteria as efficiently as marine viruses. We speculate that the rapid changes in the viral community due to freshwater input destroyed the existing bacteria-virus relationship, which would change the bacterial community composition and affect the bacterial metabolic activity and carbon cycling in this estuary.	[Xu, Jie; Shi, Zhen] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Sun, Mingming; Harrison, Paul J.; Liu, Hongbin] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Hong Kong University of Science & Technology	Xu, J (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China.	xujie@scsio.ac.cn	Xu, Jie/AAT-9642-2021; Liu, Hongbin/AAV-8862-2020		Hundred Talented Program Startup Fund [Y35L041001]; South China Sea Institute of Oceanology; Key Project of National Natural Science Fundation of China [91128212]; University Grants Council of Hong Kong AoE project [AoE/P-04/04-4-II]	Hundred Talented Program Startup Fund; South China Sea Institute of Oceanology; Key Project of National Natural Science Fundation of China; University Grants Council of Hong Kong AoE project	Financial support for this research was provided by the Hundred Talented Program Startup Fund (Y35L041001) by South China Sea Institute of Oceanology, the Key Project of National Natural Science Fundation of China (No. 91128212) and the University Grants Council of Hong Kong AoE project (AoE/P-04/04-4-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MA, 2001, MICROBIAL ECOL, V42, P562, DOI 10.1007/s00248-001-0020-1; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Bonilla-Findji O, 2009, AQUAT MICROB ECOL, V54, P1, DOI 10.3354/ame01256; Bonilla-Findji O, 2008, DEEP-SEA RES PT II, V55, P790, DOI 10.1016/j.dsr2.2007.12.004; Borges AV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023053; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carlson CA, 2007, OCEANOGRAPHY, V20, P89, DOI 10.5670/oceanog.2007.52; Combe M, 2013, ESTUAR COAST SHELF S, V133, P58, DOI 10.1016/j.ecss.2013.08.013; Del Giorgio P.A., 2000, MICROBIAL ECOLOGY OC, P289, DOI DOI 10.1146/ANNUREV.ECOLSYS.29.1.503; Eissler Y, 2003, MAR ECOL PROG SER, V262, P71, DOI 10.3354/meps262071; FUHRMAN J, 1992, ENVIR SCI R, V43, P361; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Guo XH, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000905; He BY, 2010, MAR CHEM, V119, P52, DOI 10.1016/j.marchem.2009.12.006; Hewson I, 2003, MICROB ECOL, V46, P322, DOI 10.1007/s00248-002-1067-3; HOPKINSON CS, 1985, MAR BIOL, V87, P19, DOI 10.1007/BF00397002; Jellett JF, 1996, MAR ECOL PROG SER, V136, P213, DOI 10.3354/meps136213; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Knap A., 1996, PROTOCOLS JOINT GLOB; Kukkaro P, 2009, ENV MICROBIOL REP, V1, P71, DOI 10.1111/j.1758-2229.2008.00007.x; Langenheder S, 2004, AQUAT MICROB ECOL, V37, P137, DOI 10.3354/ame037137; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Middelboe M, 2002, AQUAT MICROB ECOL, V27, P187, DOI 10.3354/ame027187; Middelboe M, 1995, MAR ECOL PROG SER, V128, P109, DOI 10.3354/meps128109; Motegi C, 2009, AQUAT MICROB ECOL, V57, P343, DOI 10.3354/ame01365; Motegi C, 2009, LIMNOL OCEANOGR, V54, P1901, DOI 10.4319/lo.2009.54.6.1901; Mukhopadhyay SK, 2002, J ENVIRON MONITOR, V4, P549, DOI 10.1039/b201614a; OUDOT C, 1988, LIMNOL OCEANOGR, V33, P146, DOI 10.4319/lo.1988.33.1.0146; Pedros-Alio C, 1999, DEEP-SEA RES PT I, V46, P985, DOI 10.1016/S0967-0637(98)00106-X; POMEROY LR, 1991, MAR ECOL PROG SER, V75, P143, DOI 10.3354/meps075143; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Rochelle-Newall EJ, 2004, AQUAT MICROB ECOL, V37, P9, DOI 10.3354/ame037009; Shetye SR, 1999, SADHANA-ACAD P ENG S, V24, P5, DOI 10.1007/BF02747548; Stepanauskas R, 1999, LIMNOL OCEANOGR, V44, P1477, DOI 10.4319/lo.1999.44.6.1477; Strickland JDH, 1968, B FISH RES BOARD CAN, V167, P71; Sundar D, 2005, J EARTH SYST SCI, V114, P493, DOI 10.1007/BF02702025; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; WILLIAMS PJL, 1981, OCEANOL ACTA, V4, P359; Winter C, 2005, LIMNOL OCEANOGR, V50, P968, DOI 10.4319/lo.2005.50.3.0968; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231; Xu J, 2013, J GEOPHYS RES-BIOGEO, V118, P1573, DOI 10.1002/2013JG002296; Xu J, 2013, MICROB ECOL, V66, P60, DOI 10.1007/s00248-013-0207-2; Yin KD, 2000, MAR ECOL PROG SER, V194, P295, DOI 10.3354/meps194295; Zhai WD, 2007, MAR CHEM, V107, P342, DOI 10.1016/j.marchem.2007.02.011; Zhang R, 2007, ENVIRON MICROBIOL, V9, P3008, DOI 10.1111/j.1462-2920.2007.01410.x; Zhang R, 2013, FEMS MICROBIOL ECOL, V85, P443, DOI 10.1111/1574-6941.12133; Zhao H.T., 1990, EVOLUTION PEARL RIVE	55	9	10	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102490	10.1371/journal.pone.0102490	http://dx.doi.org/10.1371/journal.pone.0102490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036641	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200064
J	Lattanzio, MS; Metro, KJ; Miles, DB				Lattanzio, Matthew S.; Metro, Kevin J.; Miles, Donald B.			Preference for Male Traits Differ in Two Female Morphs of the Tree Lizard, Urosaurus ornatus	PLOS ONE			English	Article							SIDE-BLOTCHED LIZARD; MATE CHOICE; COLOR POLYMORPHISM; CORRELATIONAL SELECTION; CHEMICAL POLYMORPHISM; MALE-AGGRESSION; MALE QUALITY; EVOLUTION; SIGNALS; MAINTENANCE	Non-random female mating preferences may contribute to the maintenance of phenotypic variation in color polymorphic species. However, the effect of female preference depends on the types of male traits used as signals by receptive females. If preference signals derive from discrete male traits (i.e., morph-specific), female preferences may rapidly fix to a morph. However, female preference signals may also include condition-dependent male traits. In this scenario, female preference may differ depending on the social context (i.e., male morph availability). Male tree lizards (Urosaurus ornatus) exhibit a dewlap color polymorphism that covaries with mating behavior. Blue morph males are aggressive and defend territories, yellow males are less aggressive and defend smaller territories, and orange males are typically nomadic. Female U. ornatus are also polymorphic in dewlap color, but the covariation between dewlap color and female behavior is unknown. We performed an experiment to determine how female mate choice depends on the visual and chemical signals produced by males. We also tested whether female morphs differ in their preferences for these signals. Female preferences involved both male dewlap color and size of the ventral color patch. However, the female morphs responded to these signals differently and depended on the choice between the types of male morphs. Our experiment revealed that females may be capable of distinguishing among the male morphs using chemical signals alone. Yellow females exhibit preferences based on both chemical and visual signals, which may be a strategy to avoid ultra-dominant males. In contrast, orange females may prefer dominant males. We conclude that female U. ornatus morphs differ in mating behavior. Our findings also provide evidence for a chemical polymorphism among male lizards in femoral pore secretions.	[Lattanzio, Matthew S.; Metro, Kevin J.; Miles, Donald B.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Lattanzio, MS (corresponding author), Christopher Newport Univ, Dept Organismal & Environm Biol, Newport News, VA 23606 USA.	ML195406@ohio.edu	Miles, Donald B./AFW-0480-2022	Miles, Donald/0000-0001-5768-179X	Ariel-Appleton Research Fund; Ohio University Graduate Student Senate Original Work Grant; Ohio University Program	Ariel-Appleton Research Fund; Ohio University Graduate Student Senate Original Work Grant; Ohio University Program	Support for this research was provided by an Ariel-Appleton Research Fund and an Ohio University Graduate Student Senate Original Work Grant, both awarded to MSL, and a stipend from the Ohio University Program to Aid in Career Exploration awarded to KJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALBERTS AC, 1991, COPEIA, P69, DOI 10.2307/1446249; Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Aragon P, 2001, BEHAV ECOL SOCIOBIOL, V50, P128, DOI 10.1007/s002650100344; Bleay C, 2007, BEHAV ECOL, V18, P304, DOI 10.1093/beheco/arl101; Calsbeek B, 2010, J EVOLUTION BIOL, V23, P1138, DOI 10.1111/j.1420-9101.2010.01978.x; Calsbeek R, 2002, OECOLOGIA, V132, P468, DOI 10.1007/s00442-002-0975-8; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CARPENTER CC, 1961, ECOLOGY, V42, P199, DOI 10.2307/1933292; CARPENTER GC, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P88; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fisher RA, 1930, GENETICAL THEORY NAT; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; FRETWELL S D, 1972, P217; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Hamilton PS, 2005, ANIM BEHAV, V69, P219, DOI 10.1016/j.anbehav.2004.03.011; Healey M, 2008, ETHOLOGY, V114, P231, DOI 10.1111/j.1439-0310.2007.01469.x; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Huyghe K, 2007, INTEGR COMP BIOL, V47, P211, DOI 10.1093/icb/icm043; Huyghe K, 2012, ZOOLOGY, V115, P217, DOI 10.1016/j.zool.2011.11.001; Kingston JJ, 2003, ANIM BEHAV, V65, P735, DOI 10.1006/anbe.2003.2110; Knapp R, 2003, HORM BEHAV, V43, P83, DOI 10.1016/S0018-506X(02)00018-1; Kopena R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019410; Lancaster LT, 2009, BEHAV ECOL, V20, P993, DOI 10.1093/beheco/arp088; Lewontin RC, 1966, SYST ZOOL, V15, P141, DOI DOI 10.2307/2411632; Loew ER, 2002, J EXP BIOL, V205, P927; Lopez P, 2005, BIOL LETT-UK, V1, P404, DOI 10.1098/rsbl.2005.0360; Lopez P, 2006, J CHEM ECOL, V32, P473, DOI 10.1007/s10886-005-9012-9; Lopez P, 2009, CHEM SENSES, V34, P723, DOI 10.1093/chemse/bjp059; MANSON JH, 1994, ANIM BEHAV, V48, P473, DOI 10.1006/anbe.1994.1262; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030108; Martin M, 2013, BIOL J LINN SOC, V110, P128, DOI 10.1111/bij.12104; McElroy EJ, 2007, ETHOLOGY, V113, P1113, DOI 10.1111/j.1439-0310.2007.01420.x; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Meyers JJ, 2006, FUNCT ECOL, V20, P709, DOI 10.1111/j.1365-2435.2006.01152.x; Moore AJ, 2001, P ROY SOC B-BIOL SCI, V268, P517, DOI 10.1098/rspb.2000.1399; Morrison RL, 1996, COPEIA, P804, DOI 10.2307/1447641; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Pellitteri-Rosa D, 2014, CHEMOECOLOGY, V24, P67, DOI 10.1007/s00049-014-0148-3; de Lanuza GPI, 2013, BEHAV ECOL, V24, P273, DOI 10.1093/beheco/ars164; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Quinn VS, 2005, J HERPETOL, V39, P496, DOI 10.1670/207-04N.1; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Robertson JM, 2009, BIOL J LINN SOC, V98, P243, DOI 10.1111/j.1095-8312.2009.01291.x; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; San-Jose LM, 2013, AM NAT, V181, P396, DOI 10.1086/669159; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; THOMPSON CW, 1991, ANIM BEHAV, V42, P745, DOI 10.1016/S0003-3472(05)80120-4; Thompson JT, 2008, ANIM BEHAV, V76, P113, DOI 10.1016/j.anbehav.2007.12.015; Vercken E, 2007, J EVOLUTION BIOL, V20, P221, DOI 10.1111/j.1420-9101.2006.01208.x; Villaverde GA, 1998, SOUTHWEST NAT, V43, P92; WARD G, 1987, J FISH BIOL, V30, P679, DOI 10.1111/j.1095-8649.1987.tb05797.x	61	18	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101515	10.1371/journal.pone.0101515	http://dx.doi.org/10.1371/journal.pone.0101515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033282	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300020
J	Lou, B; Dong, JB; Li, YL; Ding, TB; Bi, TT; Li, Y; Deng, XD; Ye, DY; Jiang, XC				Lou, Bin; Dong, Jibin; Li, Yali; Ding, Tingbo; Bi, Tingting; Li, Yue; Deng, Xiaodong; Ye, Deyong; Jiang, Xian-Cheng			Pharmacologic Inhibition of Sphingomyelin Synthase (SMS) Activity Reduces Apolipoprotein-B Secretion from Hepatocytes and Attenuates Endotoxin-Mediated Macrophage Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; CORONARY-ARTERY-DISEASE; TO-RETENTION HYPOTHESIS; LOW-DENSITY-LIPOPROTEIN; COMBINED HYPERLIPIDEMIA; MEMBRANE SPHINGOMYELIN; CERAMIDE HOMEOSTASIS; DEFICIENT MICE; HEART-DISEASE; RISK-FACTOR	Sphingomyelin synthase (SMS) plays an important role in plasma atherogenic lipoprotein metabolism, inflammation, and the development of atherosclerosis. To understand whether the impaired apoB secretion and inflammation response is a direct result from lack of SMS activity, in this study, we prepared a series of compounds that inhibit SMS activity. Further, we characterized Dy105, the most potent inhibitor. We found that Dy105 treatment significantly reduces SM levels in SM-rich microdomain on cell membranes. Moreover, we found that SMS inhibition reduces apoB secretion in a human hepatoma cell line and reduces the activation of NF kappa B and p38, a MAP kinase, in bone marrow derived macrophages. These studies provided further evidence that SMS activity regulates atherogenic lipoprotein metabolism and inflammatory responses. Pharmacologic inhibition of SMS may be a new therapy for atherosclerosis by reducing apoB secretion, and reducing inflammation.	[Lou, Bin; Dong, Jibin; Li, Yali; Ding, Tingbo; Bi, Tingting; Li, Yue; Deng, Xiaodong; Ye, Deyong; Jiang, Xian-Cheng] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	Fudan University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Lou, B (corresponding author), Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China.	blou@shmu.edu.cn; dyye@shmu.edu.cn	Ye, Deyong/AAE-2173-2022	Ye, Deyong/0000-0003-0498-3019	Department of Radiologic Medicine, School of Pharmacy, Fudan University	Department of Radiologic Medicine, School of Pharmacy, Fudan University	We thank Prof. Jianhua Zhu (Department of Radiologic Medicine, School of Pharmacy, Fudan University) for his support.	Arca M, 2011, DIABETES METAB SYNDR, V4, P155, DOI 10.2147/DMSO.S11244; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; BRUNZELL JD, 1983, J LIPID RES, V24, P147; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Deng XD, 2014, EUR J MED CHEM, V73, P1, DOI 10.1016/j.ejmech.2013.12.002; Duvillard L, 2000, EUR J CLIN INVEST, V30, P685, DOI 10.1046/j.1365-2362.2000.00702.x; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRILLI M, 1993, INT REV CYTOL, V143, P1; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-71; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keating AJ, 2013, ANN PHARMACOTHER, V47, P398, DOI 10.1345/aph.1R509; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KJEKSHUS J, 1995, AM J CARDIOL, V76, pC64, DOI 10.1016/S0002-9149(99)80473-1; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Li Z, 2012, ARTERIOSCLER THROMB; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Maher V, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199754010-00001; Matteucci E, 2013, CURR MED CHEM, V20, P1397, DOI 10.2174/0929867311320110004; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Riches FM, 1998, INT J OBESITY, V22, P414, DOI 10.1038/sj.ijo.0800602; RODRIGUEZ JL, 1976, ATHEROSCLEROSIS, V23, P73, DOI 10.1016/0021-9150(76)90119-2; Schlitt A, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-5; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x; ZILVERSMIT D, 1961, CIRCULATION, V23, P370, DOI 10.1161/01.CIR.23.3.370	52	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102641	10.1371/journal.pone.0102641	http://dx.doi.org/10.1371/journal.pone.0102641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032960	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300073
J	Micallef, L; Rodgers, P				Micallef, Luana; Rodgers, Peter			eulerAPE: Drawing Area-Proportional 3-Venn Diagrams Using Ellipses	PLOS ONE			English	Article							OBSTRUCTIVE LUNG-DISEASE; VENN-DIAGRAM; MICROBIAL DIVERSITY; MONTE-CARLO; TRANSCRIPTOME; GENES; SET; INTEGRATION; SEDIMENT; PROTEOME	Venn diagrams with three curves are used extensively in various medical and scientific disciplines to visualize relationships between data sets and facilitate data analysis. The area of the regions formed by the overlapping curves is often directly proportional to the cardinality of the depicted set relation or any other related quantitative data. Drawing these diagrams manually is difficult and current automatic drawing methods do not always produce appropriate diagrams. Most methods depict the data sets as circles, as they perceptually pop out as complete distinct objects due to their smoothness and regularity. However, circles cannot draw accurate diagrams for most 3-set data and so the generated diagrams often have misleading region areas. Other methods use polygons to draw accurate diagrams. However, polygons are non-smooth and non-symmetric, so the curves are not easily distinguishable and the diagrams are difficult to comprehend. Ellipses are more flexible than circles and are similarly smooth, but none of the current automatic drawing methods use ellipses. We present eulerAPE as the first method and software that uses ellipses for automatically drawing accurate area-proportional Venn diagrams for 3-set data. We describe the drawing method adopted by eulerAPE and we discuss our evaluation of the effectiveness of eulerAPE and ellipses for drawing random 3-set data. We compare eulerAPE and various other methods that are currently available and we discuss differences between their generated diagrams in terms of accuracy and ease of understanding for real world data.	[Micallef, Luana; Rodgers, Peter] Univ Kent, Sch Comp, Canterbury, Kent, England	University of Kent	Micallef, L (corresponding author), Aalto Univ, Helsinki Inst Informat Technol, Helsinki, Finland.	L.Micallef@kent.ac.uk		Rodgers, Peter/0000-0002-4100-3596	School of Computing, University of Kent, UK	School of Computing, University of Kent, UK	The authors are employed by the School of Computing, University of Kent, UK (http://www.cs.kent.ac.uk) and thus, this research was fully funded by the School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; Benoy F, 2007, IEEE INT CONF INF VI, P771; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Blake A, 2014, P 8 INT C DIAGR REPR; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Burdon FJ, 2013, ECOL APPL, V23, P1036, DOI 10.1890/12-1190.1; Card S. K., 1991, Human Factors in Computing Systems. Reaching Through Technology. CHI '91. Conference Proceedings, P181, DOI 10.1145/108844.108874; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Chow S, 2004, LECT NOTES COMPUT SC, V2912, P466; Chow S, 2005, P 2 INT WORKSH EUL D; Chow S, 2007, MATH MAG, V80, P91; Chow SC, 2007, THESIS U VICTORIA VI; Chow S, 2005, ELECTRON NOTES THEOR, V134, P3, DOI 10.1016/j.entcs.2005.02.017; Chun HB, 2011, J CEREBR BLOOD F MET, V31, P2267, DOI 10.1038/jcbfm.2011.104; Cibella F, 2011, PEDIAT ALLERG IMM-UK, V22, P60, DOI 10.1111/j.1399-3038.2010.01097.x; CLARK AK, 1976, PSYCHOMETRIKA, V41, P401, DOI 10.1007/BF02293563; Dang TN, 2012, LECT NOTES COMPUT SC, V7431, P348, DOI 10.1007/978-3-642-33179-4_34; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Farrell G, 2001, CRIME PREVENTION STU, V12, P221; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Gresnigt MS, 2013, J IMMUNOL, V190, P5629, DOI 10.4049/jimmunol.1202601; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jepsen JU, 2012, ECOSYSTEMS, P1; Kang Y, 2011, GENOME RES, V21, P925, DOI 10.1101/gr.116103.110; Kestler HA, 2005, BIOINFORMATICS, V21, P1592, DOI 10.1093/bioinformatics/bti169; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Kim B, 2007, INTERACT COMPUT, V19, P630, DOI 10.1016/j.intcom.2007.05.004; Klees RF, 2007, MATRIX BIOL, V26, P106, DOI 10.1016/j.matbio.2006.10.001; Koffka K, 1935, PRINCIPLES GESTALT P; Lam HT, 2011, CLIN TRANSLATIONAL A, P1; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Liao L, 2011, FEMS MICROBIOL ECOL, V78, P565, DOI 10.1111/j.1574-6941.2011.01186.x; Ma X, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-23; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; Marshall RJ, 2005, J CLIN EPIDEMIOL, V58, P974, DOI 10.1016/j.jclinepi.2005.01.018; Martin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036911; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; McNamara C, 2011, SMITHSONIAN CONTRIBU, V2, P29; Micallef L, 2013, THESIS U KENT CANTER; Miller RB, 1968, P DEC 9 11 1968 AFIP, P267; Montello Daniel R., 2002, CARTOGR GEOGR INF SC, V29, P283, DOI DOI 10.1559/152304002782008503; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; PALMER SE, 1992, COGNITIVE PSYCHOL, V24, P436, DOI 10.1016/0010-0285(92)90014-S; Regenbrecht CRA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-49; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Rodgers P, 2014, IEEE T VISUALIZATION, P20; Rodgers P, 2012, IEEE T VIS COMPUT GR, V18, P1089, DOI 10.1109/TVCG.2011.143; Rodgers P, 2010, LECT NOTES ARTIF INT, V6170, P54, DOI 10.1007/978-3-642-14600-8_9; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Shiqun LS, 2009, P 22 NE SAS US GROUP; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; SPENCE I, 1978, PSYCHOMETRIKA, V43, P115, DOI 10.1007/BF02294095; Stapleton G, 2011, J VISUAL LANG COMPUT, V22, P426, DOI 10.1016/j.jvlc.2011.07.001; Szeles L, 2010, MOL ENDOCRINOL, V24, P2218, DOI 10.1210/me.2010-0215; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN A, 1985, COMPUT VISION GRAPH, V31, P156, DOI 10.1016/S0734-189X(85)80004-9; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Viegi G, 2004, CHEST, V126, P1093, DOI 10.1378/chest.126.4.1093; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Ware C., 2012, INFORM VISUALIZATION; Wieland B, 2006, J APPL MICROBIOL, V100, P316, DOI 10.1111/j.1365-2672.2005.02788.x; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; Won JY, 2014, EXP EYE RES, V118, P30, DOI 10.1016/j.exer.2013.10.020; Zielinski J, 2006, EUR RESPIR J, V27, P833, DOI 10.1183/09031936.06.00025905	67	355	358	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101717	10.1371/journal.pone.0101717	http://dx.doi.org/10.1371/journal.pone.0101717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032825	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339418300024
J	Reinhold, WC; Varma, S; Sousa, F; Sunshine, M; Abaan, OD; Davis, SR; Reinhold, SW; Kohn, KW; Morris, J; Meltzer, PS; Doroshow, JH; Pommier, Y				Reinhold, William C.; Varma, Sudhir; Sousa, Fabricio; Sunshine, Margot; Abaan, Ogan D.; Davis, Sean R.; Reinhold, Spencer W.; Kohn, Kurt W.; Morris, Joel; Meltzer, Paul S.; Doroshow, James H.; Pommier, Yves			NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses	PLOS ONE			English	Article							CELL-LINES; DRUG-SENSITIVITY; GENE-EXPRESSION; CANCER; DNA; PANEL; IDENTIFICATION; INHIBITOR; MUTATIONS; PATTERNS	Exome sequencing provides unprecedented insights into cancer biology and pharmacological response. Here we assess these two parameters for the NCI-60, which is among the richest genomic and pharmacological publicly available cancer cell line databases. Homozygous genetic variants that putatively affect protein function were identified in 1,199 genes (approximately 6% of all genes). Variants that are either enriched or depleted compared to non-cancerous genomes, and thus may be influential in cancer progression and differential drug response were identified for 2,546 genes. Potential gene knockouts are made available. Assessment of cell line response to 19,940 compounds, including 110 FDA-approved drugs, reveals approximate to 80-fold range in resistance versus sensitivity response across cell lines. 103,422 gene variants were significantly correlated with at least one compound (at p<0.0002). These include genes of known pharmacological importance such as IGF1R, BRAF, RAD52, MTOR, STAT2 and TSC2 as well as a large number of candidate genes such as NOM1, TLL2, and XDH. We introduce two new web-based CellMiner applications that enable exploration of variant-to-compound relationships for a broad range of researchers, especially those without bioinformatics support. The first tool, "Genetic variant versus drug visualization'', provides a visualization of significant correlations between drug activity-gene variant combinations. Examples are given for the known vemurafenib-BRAF, and novel ifosfamide-RAD52 pairings. The second, "Genetic variant summation'' allows an assessment of cumulative genetic variations for up to 150 combined genes together; and is designed to identify the variant burden for molecular pathways or functional grouping of genes. An example of its use is provided for the EGFR-ERBB2 pathway gene variant data and the identification of correlated EGFR, ERBB2, MTOR, BRAF, MEK and ERK inhibitors. The new tools are implemented as an updated web-based CellMiner version, for which the present publication serves as a compendium.	[Reinhold, William C.; Varma, Sudhir; Sousa, Fabricio; Sunshine, Margot; Reinhold, Spencer W.; Kohn, Kurt W.; Morris, Joel; Doroshow, James H.; Pommier, Yves] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Varma, Sudhir] HiThru Analyt LLC, Laurel, MD USA; [Sousa, Fabricio] Univ Fed Mato Grosso do Sul, Ctr Estudos Celulas Tronco Terapia Celular & Gene, Programa Posgrad Farm, Campo Grande, MS, Brazil; [Sunshine, Margot] SRA Int, Fairfax, VA USA; [Abaan, Ogan D.; Davis, Sean R.; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal de Mato Grosso do Sul; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Reinhold, WC (corresponding author), NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	wcr@mail.nih.gov; pommier@nih.gov	Varma, Sudhir/N-8763-2014; Sousa, Fabricio G/O-8878-2015; Davis, Sean/AAD-1801-2021; Reinhold, William/J-6704-2017	Varma, Sudhir/0000-0002-4096-4782; Sousa, Fabricio G/0000-0003-0444-754X; Davis, Sean/0000-0002-8991-6458; Reinhold, William/0000-0001-5513-9323	Center for Cancer Research, Intramural Program of the National Cancer Institute [Z01 BC 006150]; NATIONAL CANCER INSTITUTE [Z01BC006150, ZICBC011509, ZICBC011475] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Our studies are supported by the Center for Cancer Research, Intramural Program of the National Cancer Institute (Z01 BC 006150). The funders had no role had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Adams S, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-11; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Choi BO, 2012, HUM MUTAT; Cromer MK, 2012, J CLIN ENDOCRINOL ME; Cronin M, 2011, BIOMARK MED, V5, P293, DOI [10.2217/BMM.11.37, 10.2217/bmm.11.37]; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Doherty D, 2012, NEUROLOGY; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dyment DA, 2012, NEUROLOGY; Gao R, 2013, DNA REPAIR IN PRESS; Garner KM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-206; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gillis N, 2013, CLIN PHARM THER; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Hertz DL, 2013, PHARMACOGENOMICS, V14, P1065, DOI [10.2217/PGS.13.90, 10.2217/pgs.13.90]; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Johnston JJ, 2012, AM J HUM GENET; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Koo GC, 2012, CANC DISCOV; LEE JS, 1994, MOL PHARMACOL, V46, P627; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Moldovan F, 2012, STUD HEALTH TECHNOL, V176, P453; NCBI GEO website, AG 012750 HUM GEN CG; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Patrawala S, 2012, FUTURE ONCOL, V8, P509, DOI [10.2217/FON.12.31, 10.2217/fon.12.31]; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Reinhold WC, 2012, CANC RES; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Roschke AV, 2003, CANCER RES, V63, P8634; Ruan XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031628; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; SELL C, 1995, CANCER RES, V55, P303; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Stults DM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-23; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tanaka H, 1999, JPN J CANCER RES, V90, P1139, DOI 10.1111/j.1349-7006.1999.tb00688.x; Uluer ET, 2011, ACTA HISTOCHEM; Varma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092047; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	54	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101670	10.1371/journal.pone.0101670	http://dx.doi.org/10.1371/journal.pone.0101670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032700	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300023
J	Wu, JC; Rostami, MR; Olaya, DPC; Tzanakakis, ES				Wu, Jincheng; Rostami, Mahboubeh Rahmati; Olaya, Diana P. Cadavid; Tzanakakis, Emmanuel S.			Oxygen Transport and Stem Cell Aggregation in Stirred-Suspension Bioreactor Cultures	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; TUMOR-GROWTH; DIFFERENTIATION; HYPOXIA; COAGULATION; EXPANSION; EQUATION; DENSITY; BODIES; SYSTEM	Stirred-suspension bioreactors are a promising modality for large-scale culture of 3D aggregates of pluripotent stem cells and their progeny. Yet, cells within these clusters experience limitations in the transfer of factors and particularly O-2 which is characterized by low solubility in aqueous media. Cultured stem cells under different O-2 levels may exhibit significantly different proliferation, viability and differentiation potential. Here, a transient diffusion-reaction model was built encompassing the size distribution and ultrastructural characteristics of embryonic stem cell (ESC) aggregates. The model was coupled to experimental data from bioreactor and static cultures for extracting the effective diffusivity and kinetics of consumption of O-2 within mouse (mESC) and human ESC (hESC) clusters. Under agitation, mESC aggregates exhibited a higher maximum consumption rate than hESC aggregates. Moreover, the reaction-diffusion model was integrated with a population balance equation (PBE) for the temporal distribution of ESC clusters changing due to aggregation and cell proliferation. Hypoxia was found to be negligible for ESCs with a smaller radius than 100 mu m but became appreciable for aggregates larger than 300 mu m. The integrated model not only captured the O-2 profile both in the bioreactor bulk and inside ESC aggregates but also led to the calculation of the duration that fractions of cells experience a certain range of O-2 concentrations. The approach described in this study can be employed for gaining a deeper understanding of the effects of O-2 on the physiology of stem cells organized in 3D structures. Such frameworks can be extended to encompass the spatial and temporal availability of nutrients and differentiation factors and facilitate the design and control of relevant bioprocesses for the production of stem cell therapeutics.	[Wu, Jincheng; Rostami, Mahboubeh Rahmati; Tzanakakis, Emmanuel S.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Olaya, Diana P. Cadavid] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA	Tufts University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Tzanakakis, ES (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	Emmanuel.Tzanakakis@tufts.edu	Tzanakakis, Emmanuel/S-7617-2019; Tzanakakis, Emmanuel S/F-6868-2015	Tzanakakis, Emmanuel/0000-0002-6677-352X; Tzanakakis, Emmanuel S/0000-0002-6677-352X	National Institutes of Health (NHLBI) [R01HL103709]; New York Stem Cell Science Trust (NYSTEM) [C024355, C026714]; Mark Diamond Research Foundation award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103709] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York Stem Cell Science Trust (NYSTEM); Mark Diamond Research Foundation award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support has been provided by the National Institutes of Health (NHLBI, R01HL103709) and the New York Stem Cell Science Trust (NYSTEM, contracts C024355 and C026714) to EST. JW is the recipient of a Mark Diamond Research Foundation award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2010, AM J PHYSIOL-CELL PH, V298, pC1527, DOI 10.1152/ajpcell.00484.2009; Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Aldous DJ, 1999, BERNOULLI, V5, P3, DOI 10.2307/3318611; ANDERSON EC, 1970, BIOPHYS J, V10, P630, DOI 10.1016/S0006-3495(70)86325-1; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; BELVAL TK, 1986, BIOPHYS J, V50, P479, DOI 10.1016/S0006-3495(86)83485-3; BRUNTON GF, 1980, CELL TISSUE KINET, V13, P455, DOI 10.1111/j.1365-2184.1980.tb00486.x; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cadavid Olaya DP, 2012, BIOREACTOR CULTURE E; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Cochran DM, 2006, ANN BIOMED ENG, V34, P1247, DOI 10.1007/s10439-006-9134-4; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Frossling N., 1938, GERL BEITR GEOPHYS, V52, P170; Gassmann M, 1996, P NATL ACAD SCI USA, V93, P2867, DOI 10.1073/pnas.93.7.2867; Groebe K, 1989, Adv Exp Med Biol, V248, P175; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Jing DH, 2010, CELL TRANSPLANT, V19, P1397, DOI 10.3727/096368910X513955; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kehoe DE, 2008, BIOTECHNOL PROGR, V24, P1342, DOI 10.1002/btpr.57; Khoury M, 2010, BIOMED MICRODEVICES, V12, P1001, DOI 10.1007/s10544-010-9454-x; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Lee SH, 2008, CELL PROLIFERAT, V41, P230, DOI 10.1111/j.1365-2184.2008.00516.x; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; LOKEN MR, 1984, J CELL PHYSIOL, V118, P22, DOI 10.1002/jcp.1041180106; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PANTEN U, 1982, ENDOCRINOLOGY, V111, P1595, DOI 10.1210/endo-111-5-1595; Powers DE, 2008, BIOTECHNOL BIOENG, V101, P241, DOI 10.1002/bit.21986; Powers DE, 2010, BIOTECHNOL PROGR, V26, P805, DOI 10.1002/btpr.359; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; SMIT DJ, 1994, CHEM ENG SCI, V49, P1025, DOI 10.1016/0009-2509(94)80009-X; TOBIN T, 1990, CHEM ENG SCI, V45, P3491, DOI 10.1016/0009-2509(90)87154-K; TOSAKA N, 1982, B MATH BIOL, V44, P841; Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2; Van Winkle AP, 2012, CELLS TISSUES ORGANS, V196, P34, DOI 10.1159/000330691; von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; WRIGHT H, 1990, J STAT PHYS, V61, P843, DOI 10.1007/BF01027303; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	43	53	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102486	10.1371/journal.pone.0102486	http://dx.doi.org/10.1371/journal.pone.0102486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032842	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300056
J	Guo, F; Chen, Y; Yang, SL; Xia, H; Li, XW; Tong, ZH				Guo, Fei; Chen, Yong; Yang, Shuang-Li; Xia, Huan; Li, Xing-Wang; Tong, Zhao-Hui			Pneumocystis Pneumonia in HIV-Infected and Immunocompromised Non-HIV Infected Patients: A Retrospective Study of Two Centers in China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; CARINII-PNEUMONIA; JIROVECII PNEUMONIA; TRANSPLANT RECIPIENTS; RHEUMATOID-ARTHRITIS; DIAGNOSIS; PROGNOSIS; DISEASES; MANAGEMENT; MORTALITY	Background: Pneumocystis pneumonia (PCP) is an emerging infectious disease in immunocompromised hosts. However, the clinical characteristics of these patients are poorly understood in mainland China. Methods: We performed a retrospective study of PCP from 2008 to 2012. Information was collected regarding clinical manifestations, hospitalization, and outcome. A prognostic analysis was performed using a Cox regression model. Results: 151 cases of PCP were included; 46 non-HIV and 105 HIV cases. All-cause mortality (15.2% vs. 12.4%, p = 0.64) and the results of time-to-event analysis (log-rank test, p = 0.62) were similar between non-HIV and HIV infected cases, respectively. From 2008 to 2012, time from admission to initial treatment in non-HIV infected PCP patients showed declining trend [median (range) 20 (9-44) vs. 12 (4-24) vs. 9 (2-23) vs. 7 (2-22) vs. 7 (1-14) days]. A similar trend was observed for all-cause mortality (33.3% vs. 20.0% vs. 14.3% vs. 14.3% vs. 6.7%). Patients with four or more of the following clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) [adjusted HR (AHR) 29.06, 95% CI 2.13-396.36, P = 0.01] and admission to intensive care unit (ICU) [AHR 22.55, 95% CI 1.36-375.06, P = 0.03] were independently associated with all-cause mortality in non-HIV infected PCP patients. Variables associated with mortality in HIV infected PCP patients were admission to ICU (AHR 72.26, 95% CI 11.76-443.87, P<0.001) and albumin <= 30 g/L (AHR 9.93 95% CI 1.69-58.30, P = 0.01). Conclusions: Upon admission comprehensive clinical assessment including assessment of four or more clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) in non-HIV infected PCP patients and albumin <= 30 g/L in HIV infected patients might improve prognosis.	[Guo, Fei; Yang, Shuang-Li; Xia, Huan; Tong, Zhao-Hui] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Inst Resp Med, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Chen, Yong; Li, Xing-Wang] Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, XW (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	ditanlxw@163.com; tongzhaohuicy@sina.com			National Natural Science Foundation of China [81370102]; Beijing High-Grade Talents Health Technology Fund [2011-2-06]; Beijing Natural Science Foundation Program; Scientific Research Key Program of Beijing Municipal Commission of Education [KZ20140025026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing High-Grade Talents Health Technology Fund; Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); Scientific Research Key Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by a grant from National Natural Science Foundation of China (NO. 81370102), in part by a grant from the Beijing High-Grade Talents Health Technology Fund (NO. 2011-2-06), and in part by a grant from Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education (NO. KZ20140025026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arozullah AM, 2000, AM J RESP CRIT CARE, V161, P1081, DOI 10.1164/ajrccm.161.4.9906072; Asai N, 2012, J INFECT CHEMOTHER, V18, P898, DOI 10.1007/s10156-012-0441-4; Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Barbounis V, 2005, ANTICANCER RES, V25, P651; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Carmona Eva M, 2011, Ther Adv Respir Dis, V5, P41, DOI 10.1177/1753465810380102; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Cruciani M, 2002, EUR RESPIR J, V20, P982, DOI 10.1183/09031936.02.01372002; de Boer MGJ, 2011, J INFECTION, V62, P93, DOI 10.1016/j.jinf.2010.10.007; Held J, 2011, CLIN MICROBIOL INFEC, V17, P595, DOI 10.1111/j.1469-0691.2010.03318.x; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; McKinnell JA, 2012, TRANSPL INFECT DIS, V14, P510, DOI 10.1111/j.1399-3062.2012.00739.x; Mori S, 2012, RHEUMATOLOGY, V51, P2120, DOI 10.1093/rheumatology/kes244; Nuesch R, 1999, CLIN INFECT DIS, V29, P1519, DOI 10.1086/313534; Overgaard UM, 2007, SCAND J INFECT DIS, V39, P589, DOI 10.1080/00365540601150497; Overgaard UM, 2000, MMWR RECOMM REP, V49, pE1; Overgaard UM, 2000, MMWR RECOMM REP, V49, P1; Roblot F, 2002, EUR J CLIN MICROBIOL, V21, P523, DOI 10.1007/s10096-002-0758-5; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Segal Brahm H, 2008, J Natl Compr Canc Netw, V6, P122; Su YS, 2008, J MICROBIOL IMMUNOL, V41, P478; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Tasaka S, 2012, J INFECT CHEMOTHER, V18, P793, DOI 10.1007/s10156-012-0453-0; Thomas C F Jr, 1998, Semin Respir Infect, V13, P289; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Wang EHZ, 2012, TRANSPL INFECT DIS, V14, P519, DOI 10.1111/j.1399-3062.2012.00740.x; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5; Yoshida Y, 2012, MOD RHEUMATOL, V22, P509, DOI 10.1007/s10165-011-0523-7; ZAMAN MK, 1988, ANN INTERN MED, V109, P7, DOI 10.7326/0003-4819-109-1-7	34	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101943	10.1371/journal.pone.0101943	http://dx.doi.org/10.1371/journal.pone.0101943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029342	Green Submitted, gold, Green Published			2022-12-27	WOS:000341306600028
J	Ortin-Martinez, A; Nadal-Nicolas, FM; Jimenez-Lopez, M; Alburquerque-Bejar, JJ; Nieto-Lopez, L; Garcia-Ayuso, D; Villegas-Perez, MP; Vidal-Sanz, M; Agudo-Barriuso, M				Ortin-Martinez, Arturo; Nadal-Nicolas, Francisco M.; Jimenez-Lopez, Manuel; Alburquerque-Bejar, Juan J.; Nieto-Lopez, Leticia; Garcia-Ayuso, Diego; Villegas-Perez, Maria P.; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta			Number and Distribution of Mouse Retinal Cone Photoreceptors: Differences between an Albino (Swiss) and a Pigmented (C57/BL6) Strain	PLOS ONE			English	Article							GANGLION-CELL POPULATION; SPATIAL-DISTRIBUTION; ADULT ALBINO; COMPUTERIZED ANALYSIS; MAMMALIAN RETINA; SENSITIVE CONES; MICE; RAT; VISION; LIGHT	We purpose here to analyze and compare the population and topography of cone photoreceptors in two mouse strains using automated routines, and to design a method of retinal sampling for their accurate manual quantification. In whole-mounted retinas from pigmented C57/BL6 and albino Swiss mice, the longwave-sensitive (L) and the shortwave-sensitive (S) opsins were immunodetected to analyze the population of each cone type. In another group of retinas both opsins were detected with the same fluorophore to quantify all cones. In a third set of retinas, L-opsin and Brn3a were immunodetected to determine whether L-opsin(+) cones and retinal ganglion cells (RGCs) have a parallel distribution. Cones and RGCs were automatically quantified and their topography illustrated with isodensity maps. Our results show that pigmented mice have a significantly higher number of total cones (all-cones) and of L-opsin(+) cones than albinos which, in turn, have a higher population of S-opsin(+) cones. In pigmented animals 40% of cones are dual (cones that express both opsins), 34% genuine-L (cones that only express the L-opsin), and 26% genuine-S (cones that only express the S-opsin). In albinos, 23% of cones are genuine-S and the proportion of dual cones increases to 76% at the expense of genuine-L cones. In both strains, Lopsin(+) cones are denser in the central than peripheral retina, and all-cones density increases dorso-ventrally. In pigmented animals S-opsin(+) cones are scarce in the dorsal retina and very numerous in the ventral retina, being densest in its nasal aspect. In albinos, S-opsin(+) cones are abundant in the dorsal retina, although their highest densities are also ventral. Based on the densities of each cone population, we propose a sampling method to manually quantify and infer their total population. In conclusion, these data provide the basis to study cone degeneration and its prevention in pathologic conditions.	[Ortin-Martinez, Arturo; Nadal-Nicolas, Francisco M.; Jimenez-Lopez, Manuel; Alburquerque-Bejar, Juan J.; Nieto-Lopez, Leticia; Garcia-Ayuso, Diego; Villegas-Perez, Maria P.; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Inst Murciano Invest Biosanitaria Virgen de la Ar, Murcia, Spain; [Ortin-Martinez, Arturo; Jimenez-Lopez, Manuel; Nieto-Lopez, Leticia; Garcia-Ayuso, Diego; Villegas-Perez, Maria P.; Vidal-Sanz, Manuel] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain	University of Murcia	Agudo-Barriuso, M (corresponding author), Inst Murciano Invest Biosanitaria Virgen de la Ar, Murcia, Spain.	martabar@um.es	Vidal-Sanz, Manuel/J-6989-2016; Alburquerque-Bejar, Juan/AAA-7666-2020; Agudo-Barriuso, Marta/B-7100-2016; García-Ayuso, Diego/AAC-4954-2020	Vidal-Sanz, Manuel/0000-0002-9216-1615; Agudo-Barriuso, Marta/0000-0002-8566-9277; García-Ayuso, Diego/0000-0002-7639-5366; Ortin Martinez, Arturo/0000-0003-0492-6604; Jimenez Lopez, Manuel/0000-0002-8768-9968; Nadal-Nicolas, Francisco M./0000-0003-4121-514X; Alburquerque Bejar, Juan Jose/0000-0002-9022-124X	Fundacion Seneca [04446/GERM/07]; Spanish Ministry of Education and Science [SAF-2012-38328]; ISCIII-FEDER "Una manera de hacer Europa" [PI13/00643, PI13/01266]; Red Tematica de Investigacion Cooperativa en Oftalmologia RETICS [RD12/0034]	Fundacion Seneca(Fundacion Seneca); Spanish Ministry of Education and Science(Spanish Government); ISCIII-FEDER "Una manera de hacer Europa"; Red Tematica de Investigacion Cooperativa en Oftalmologia RETICS	Fundacion Seneca 04446/GERM/07; Spanish Ministry of Education and Science SAF-2012-38328; ISCIII-FEDER "Una manera de hacer Europa" PI13/00643, PI13/01266, Red Tematica de Investigacion Cooperativa en Oftalmologia RETICS RD12/0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Arbogast P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080910; Baden T, 2013, NEURON, V80, P1206, DOI 10.1016/j.neuron.2013.09.030; BALKEMA GW, 1991, VISUAL NEUROSCI, V6, P577, DOI 10.1017/S095252380000256X; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang L, 2013, NEURON, V77, P559, DOI 10.1016/j.neuron.2012.12.012; Donatien P, 2002, INVEST OPHTH VIS SCI, V43, P1198; DRAGER UC, 1987, NEUROSCI RES, pS75, DOI 10.1016/0921-8696(87)90009-0; Fei YJ, 2003, MOL VIS, V9, P31; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Garcia-Ayuso D, 2014, BRIT J OPHTHALMOL, V98, P396, DOI 10.1136/bjophthalmol-2013-303958; Garcia-Ayuso D, 2013, INVEST OPHTH VIS SCI, V54, P5888, DOI 10.1167/iovs.13-12643; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kuny S, 2013, INVEST OPHTHALMOL VI; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Montalban-Soler L, 2012, MOL VIS, V18, P675; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Neitz M, 2001, TRENDS NEUROSCI, V24, P248, DOI 10.1016/S0166-2236(00)01773-2; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Ortin-Martinez A, 2013, OPHTHALMIC RES, V50, P40; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Semo M, 2014, EXP EYE RES, V119, P8, DOI 10.1016/j.exer.2013.11.013; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; SZEL A, 1988, J COMP NEUROL, V273, P593, DOI 10.1002/cne.902730413; SZEL A, 1994, CELL TISSUE RES, V276, P143, DOI 10.1007/BF00354793; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Vidal-Sanz M, 2014, INVEST OPHTHALMOL VI, V55; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; VillegasPerez MP, 1996, NEUROREPORT, V7, P1995, DOI 10.1097/00001756-199608120-00028; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Whitney IE, 2011, INVEST OPHTH VIS SCI, V52, P3228, DOI 10.1167/iovs.10-6693; Williams GA, 2007, VISION RES, V47, P2037, DOI 10.1016/j.visres.2007.03.023; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6	52	78	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102392	10.1371/journal.pone.0102392	http://dx.doi.org/10.1371/journal.pone.0102392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029531	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600071
J	Ascenzi, P; di Masi, A; Tundo, GR; Pesce, A; Visca, P; Coletta, M				Ascenzi, Paolo; di Masi, Alessandra; Tundo, Grazia R.; Pesce, Alessandra; Visca, Paolo; Coletta, Massimo			Nitrosylation Mechanisms of Mycobacterium tuberculosis and Campylobacter jejuni Truncated Hemoglobins N, O, and P	PLOS ONE			English	Article							NITRITE REDUCTASE-ACTIVITY; HYDROGEN-BOND NETWORK; HUMAN SERUM-ALBUMIN; HEME DISTAL SITE; LIGAND-BINDING; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC ANALYSIS; SCAPHARCA-INAEQUIVALVIS; DIMERIC HEMOGLOBIN; NITROSATIVE STRESS	Truncated hemoglobins (trHbs) are widely distributed in bacteria and plants and have been found in some unicellular eukaryotes. Phylogenetic analysis based on protein sequences shows that trHbs branch into three groups, designated N (or I), O (or II), and P (or III). Most trHbs are involved in the O-2/NO chemistry and/or oxidation/reduction function, permitting the survival of the microorganism in the host. Here, a detailed comparative analysis of kinetics and/or thermodynamics of (i) ferrous Mycobacterium tubertulosis trHbs N and O (Mt-trHbN and Mt-trHbO, respectively), and Campylobacter jejuni trHb (CjtrHbP) nitrosylation, (ii) nitrite-mediated nitrosylation of ferrous Mt-trHbN, Mt-trHbO, and Cj-trHbP, and (iii) NO-based reductive nitrosylation of ferric Mt-trHbN, Mt-trHbO, and Cj-trHbP is reported. Ferrous and ferric Mt-trHbN and Cj-trHbP display a very high reactivity towards NO; however, the conversion of nitrite to NO is facilitated primarily by ferrous Mt-trHbN. Values of kinetic and/or thermodynamic parameters reflect specific trHb structural features, such as the ligand diffusion pathways to/from the heme, the heme distal pocket structure and polarity, and the ligand stabilization mechanisms. In particular, the high reactivity of Mt-trHbN and Cj-trHbP reflects the great ligand accessibility to the heme center by two protein matrix tunnels and the E7-path, respectively, and the penta-coordination of the heme-Fe atom. In contrast, the heme-Fe atom of Mt-trHbO the ligand accessibility to the heme center of Mt-trHbO needs large conformational readjustments, thus limiting the heme-based reactivity. These results agree with different roles of Mt-trHbN, Mt-trHbO, and Cj-trHbP in vivo.	[Ascenzi, Paolo; di Masi, Alessandra; Visca, Paolo] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [di Masi, Alessandra] Univ Roma Tre, Dept Sci, Rome, Italy; [Tundo, Grazia R.; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Tundo, Grazia R.; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Pesce, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy	Roma Tre University; Italfarmaco; Roma Tre University; University of Rome Tor Vergata; University of Genoa	Ascenzi, P (corresponding author), Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy.	ascenzi@uniroma3.it	Pesce, Alessandra/A-3660-2015; di Masi, Alessandra/K-2300-2018; Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015	COLETTA, Massimiliano/0000-0002-5489-9467; TUNDO, Grazia Raffaella/0000-0002-3866-3171; Visca, Paolo/0000-0002-6128-7039	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [PRIN 20109MXHMR_001]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, CLAR)	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, CLAR)	This work was supported by grants from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN 20109MXHMR_001 and Universita Roma Tre, CLAR 2013) to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2011, IUBMB LIFE, V63, P1094, DOI 10.1002/iub.546; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Arya S, 2013, J BIOL CHEM, V288, P29987, DOI 10.1074/jbc.M113.507301; Ascenzi P, 2008, METHOD ENZYMOL, V436, P317, DOI 10.1016/S0076-6879(08)36018-2; Ascenzi P, 2007, GENE, V398, P42, DOI 10.1016/j.gene.2007.02.043; Ascenzi P, 2007, FEBS J, V274, P551, DOI 10.1111/j.1742-4658.2006.05609.x; Ascenzi P, 2013, J BIOL INORG CHEM, V18, P939, DOI 10.1007/s00775-013-1040-2; Ascenzi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069762; Ascenzi P, 2013, BIOCHEM BIOPH RES CO, V430, P1301, DOI 10.1016/j.bbrc.2012.11.122; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V411, P185, DOI 10.1016/j.bbrc.2011.06.130; Ascenzi P, 2010, FEBS J, V277, P2474, DOI 10.1111/j.1742-4658.2010.07662.x; Ascenzi P, 2010, BIOCHEM BIOPH RES CO, V393, P196, DOI 10.1016/j.bbrc.2010.01.092; Avila-Ramirez C, 2013, ANTIOXID REDOX SIGN, V18, P424, DOI 10.1089/ars.2012.4750; Banci L, 1999, J BIOL INORG CHEM, V4, P21, DOI 10.1007/s007750050285; Bateman H, 1910, P CAMB PHILOS SOC, V15, P423; BEETLESTONE JG, 1976, J CHEM SOC DALTON, P1251, DOI 10.1039/dt9760001251; Bocedi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058842; Boffi A, 2002, BIOPHYS CHEM, V98, P209, DOI 10.1016/S0301-4622(02)00094-7; Bolli A, 2008, FEBS J, V275, P633, DOI 10.1111/j.1742-4658.2007.06223.x; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Brucker EA, 1998, PROTEINS, V30, P352, DOI 10.1002/(SICI)1097-0134(19980301)30:4<352::AID-PROT2>3.0.CO;2-L; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Chan NL, 2004, BIOCHEMISTRY-US, V43, P118, DOI 10.1021/bi030172j; CHIANCONE E, 1989, J BIOL CHEM, V264, P21062; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Davidge KS, 2013, ADV MICROB PHYSIOL, V63, P147, DOI 10.1016/B978-0-12-407693-8.00005-4; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fasano M, 2006, BIOCHEM BIOPH RES CO, V345, P704, DOI 10.1016/j.bbrc.2006.04.154; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta S, 2012, J BIOL CHEM, V287, P16435, DOI 10.1074/jbc.M111.329920; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; Harutyunyan EH, 1996, J MOL BIOL, V264, P152, DOI 10.1006/jmbi.1996.0630; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; Herold S, 2005, J BIOL INORG CHEM, V10, P946, DOI 10.1007/s00775-005-0047-8; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; Hoy JA, 2008, PLANT PHYSIOL BIOCH, V46, P371, DOI 10.1016/j.plaphy.2007.12.016; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Iovine NM, 2008, INFECT IMMUN, V76, P986, DOI 10.1128/IAI.01063-07; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Miele AE, 1999, J MOL BIOL, V290, P515, DOI 10.1006/jmbi.1999.2869; Milani M, 2004, BIOCHEMISTRY-US, V43, P5213, DOI 10.1021/bi049870+; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Mukai M, 2002, BIOCHEMISTRY-US, V41, P3897, DOI 10.1021/bi0156409; Nardini M, 2006, J BIOL CHEM, V281, P37803, DOI 10.1074/jbc.M607254200; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Ouellet H, 2007, J BIOL CHEM, V282, P7491, DOI 10.1074/jbc.M609155200; Ouellet YH, 2008, J BIOL CHEM, V283, P27270, DOI 10.1074/jbc.M804215200; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Pathania R, 2002, J BIOL CHEM, V277, P15293, DOI 10.1074/jbc.M111478200; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; PERUTZ MF, 1989, TRENDS BIOCHEM SCI, V14, P42, DOI 10.1016/0968-0004(89)90039-X; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P79, DOI 10.1016/B978-0-12-407693-8.00003-0; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; ROHLFS RJ, 1988, J BIOL CHEM, V263, P1803; ROYER WE, 1989, J BIOL CHEM, V264, P21052; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Shepherd M, 2010, J BIOL CHEM, V285, P12747, DOI 10.1074/jbc.M109.084509; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Silkstone G, 2012, BIOCHEMISTRY-US, V51, P6760, DOI 10.1021/bi300582u; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Tinajero-Trejo M, 2013, ADV MICROB PHYSIOL, V63, P97, DOI 10.1016/B978-0-12-407693-8.00004-2; Tiso M, 2012, BIOCHEMISTRY-US, V51, P5285, DOI 10.1021/bi300570v; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Trent JT, 2004, J MOL BIOL, V341, P1097, DOI 10.1016/j.jmb.2004.05.070; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wainwright LM, 2006, BIOCHEMISTRY-US, V45, P6003, DOI 10.1021/bi052247k; Wainwright LM, 2005, MICROBIOL-SGM, V151, P4079, DOI 10.1099/mic.0.28266-0; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679	90	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102811	10.1371/journal.pone.0102811	http://dx.doi.org/10.1371/journal.pone.0102811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051055	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100059
J	Cui, K; Ge, XY; Ma, HL				Cui, Kai; Ge, Xiaoyan; Ma, Honglin			Four SNPs in the CHRNA3/5 Alpha-Neuronal Nicotinic Acetylcholine Receptor Subunit Locus Are Associated with COPD Risk Based on Meta-Analyses	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-CANCER RISK; SUSCEPTIBILITY; DEPENDENCE; VARIANT; GENE; POLYMORPHISM	Background: Several single nucleotide polymorphisms (SNPs) in an alpha-neuronal nicotinic acetylcholine receptor subunit (CHRNA3/5) were identified to be associated with chronic obstructive pulmonary disease (COPD) in a study based on a Norwegian population. However, results from subsequent studies have been controversial, particularly in studies recruiting Asians. In the present study, we conducted a comprehensive search and meta-analyses to identify susceptibility SNPs for COPD in the CHRNA3/5 locus. Methods: A comprehensive literature search was conducted to find studies that have reported an association between SNPs in the CHRNA3/5 locus and COPD risk. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) for each SNP were calculated with the major allele or genotype as the reference group. The influence of individual studies on pooled measures was assessed, in addition to publication bias. Results: A total of 12 articles with 14 eligible studies were included in this analysis. Association between 4 SNPs in the CHRNA3/5 locus and COPD was evaluated and included rs1051730, rs8034191, rs6495309, and rs16969968. Significant associations between the 4 SNPs and COPD were identified under allele (rs1051730: OR = 1.14, 95% CI = 1.10-1.18; rs8034191: OR = 1.29, 95% CI = 1.18-1.41; rs6495309: OR = 1.26, 95% CI = 1.09-1.45; rs16969968: OR = 1.27, 95% CI = 1.17-1.39) and genotype models. Subgroup analysis conducted for rs1051730 showed a significant association between this SNP and COPD risk in non-Asians (OR = 1.14, 95% CI = 1.10-1.18), but not Asians (OR = 1.23, 95% CI = 0.91-1.67). Rs1051730 and rs6495309 were also significantly associated with COPD after adjusting for multiple variables, including age and smoking status. Conclusion: Our results indicate that 4 SNPs in the CHRNA3/5 locus are associated with COPD risk. Rs1051730 was particularly associated with COPD in non-Asians, but its role in Asians still needs to be verified. Additional studies will be necessary to assess the effect of rs6495309 on COPD. Although rs1051730 and rs6495309 were shown to be independent risk factors for COPD, validation studies should be performed.	[Cui, Kai; Ge, Xiaoyan; Ma, Honglin] Liaoning Med Univ, Sch Publ Hlth, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Ma, HL (corresponding author), Liaoning Med Univ, Sch Publ Hlth, Jinzhou, Liaoning, Peoples R China.	mahonglinly@163.com						Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Du M, 2012, INT J RESP, V32, P641; Gabrielsen ME, 2013, EUR J HUM GENET, V21, P1293, DOI 10.1038/ejhg.2013.26; Guo Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-64; Hoesein FAAM, 2013, PLOS ONE, V8; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Kaur-Knudsen D, 2012, EUR RESPIR J, V40, P1538, DOI 10.1183/09031936.00176811; Kaur-Knudsen D, 2011, J CLIN ONCOL, V29, P2875, DOI 10.1200/JCO.2010.32.9870; Kim DK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-9; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Lee JY, 2012, J KOREAN MED SCI, V27, P1536, DOI 10.3346/jkms.2012.27.12.1536; Niu XM, 2010, J THORAC ONCOL, V5, P658, DOI 10.1097/JTO.0b013e3181d5e447; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046071; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908; Zhang J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-158; Zhou HX, 2012, J HUM GENET, V57, P738, DOI 10.1038/jhg.2012.104	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102324	10.1371/journal.pone.0102324	http://dx.doi.org/10.1371/journal.pone.0102324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051068	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100027
J	King, TH; Kemmler, CB; Guo, ZM; Mann, D; Lu, YN; Coeshott, C; Gehring, AJ; Bertoletti, A; Ho, ZZ; Delaney, W; Gaggar, A; Subramanian, GM; McHutchison, JG; Shrivastava, S; Lee, YJL; Kottilil, S; Bellgrau, D; Rodell, T; Apelian, D				King, Thomas H.; Kemmler, Charles B.; Guo, Zhimin; Mann, Derrick; Lu, Yingnian; Coeshott, Claire; Gehring, Adam J.; Bertoletti, Antonio; Ho, Zi Z.; Delaney, William; Gaggar, Anuj; Subramanian, G. Mani; McHutchison, John G.; Shrivastava, Shikha; Lee, Yu-Jin L.; Kottilil, Shyamasundaran; Bellgrau, Donald; Rodell, Timothy; Apelian, David			A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; IMMUNE-RESPONSE; DENDRITIC CELLS; SURFACE-ANTIGEN; INFECTION; TOLERANCE; PATHOGENESIS; INDIVIDUALS; MATURATION; CIRRHOSIS	Chronic hepatitis B infection (CHB) is characterized by sub-optimal T cell responses to viral antigens. A therapeutic vaccine capable of restoring these immune responses could potentially improve HBsAg seroconversion rates in the setting of direct acting antiviral therapies. A yeast-based immunotherapy (Tarmogen) platform was used to make a vaccine candidate expressing hepatitis B virus (HBV) X, surface (S), and Core antigens (X-S-Core). Murine and human immunogenicity models were used to evaluate the type and magnitude of HBV-Ag specific T cell responses elicited by the vaccine. C57BL/6J, BALB/c, and HLA-A*0201 transgenic mice immunized with yeast expressing X-S-Core showed T cell responses to X, S and Core when evaluated by lymphocyte proliferation assay, ELISpot, intracellular cytokine staining (ICS), or tumor challenge assays. Both CD4(+) and CD8(+) T cell responses were observed. Human T cells transduced with HBc18-27 and HBs183-91 specific T cell receptors (TCRs) produced interferon gamma (IFN gamma following incubation with X-S-Core-pulsed dendritic cells (DCs). Furthermore, stimulation of peripheral blood mononuclear cells (PBMCs) isolated from CHB patients or from HBV vaccine recipients with autologous DCs pulsed with X-S-Core or a related product (S-Core) resulted in pronounced expansions of HBV Ag-specific T cells possessing a cytolytic phenotype. These data indicate that X-S-Core-expressing yeast elicit functional adaptive immune responses and supports the ongoing evaluation of this therapeutic vaccine in patients with CHB to enhance the induction of HBV-specific T cell responses.	[King, Thomas H.; Kemmler, Charles B.; Guo, Zhimin; Mann, Derrick; Lu, Yingnian; Coeshott, Claire; Bellgrau, Donald; Rodell, Timothy; Apelian, David] GlobeImmune Inc, Louisville, CO 80027 USA; [Bellgrau, Donald] Univ Colorado, Sch Med, Integrated Dept Immunol, Aurora, CO USA; [Delaney, William; Gaggar, Anuj; Subramanian, G. Mani; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Gehring, Adam J.] St Louis Univ, Sch Med, St Louis, MO USA; [Gehring, Adam J.] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA; [Gehring, Adam J.; Bertoletti, Antonio; Ho, Zi Z.] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Shrivastava, Shikha; Lee, Yu-Jin L.; Kottilil, Shyamasundaran] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Gilead Sciences; Saint Louis University; Saint Louis University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	King, TH (corresponding author), GlobeImmune Inc, Louisville, CO 80027 USA.	tom.king@globeimmune.com	Kottilil, Shyam/ABF-7605-2021; Bertoletti, Antonio/AAD-4830-2022	Bertoletti, Antonio/0000-0002-2942-0485; Lee, Yu-Jin/0000-0001-7050-9185; Gehring, Adam/0000-0003-1150-5840	Gilead Sciences, Inc.; GlobeImmune, Inc.; NIH [NIAID: AI000390-30]; Gilead	Gilead Sciences, Inc.(Gilead Sciences); GlobeImmune, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead(Gilead Sciences)	This work was supported by Gilead Sciences, Inc. and GlobeImmune, Inc. Partial funding for work done by S.K. was provided by a intramural NIH grant (NIAID: AI000390-30). All members of each funding party participated in the study design, data collection and analysis, decision to publish or preparation of the manuscript. W.D., A.G., G.S., and J.M. are affiliated with (are employees and share holders of) the commercial company Gilead Sciences. Inc. T.K., C.K., Z.G., D.M., Y.L., C.C., D.B., T.R. and D.A. are or were paid employees of the commercial company GlobeImmune, Inc. at the time this work was performed. Work performed. GlobeImmuneco authors D.A. T.K., Z.G., and C.C. are inventors on patents # 8, 722, 054, PCT publication# WO 1012/109404, and related applications. One or more products described in the manuscript has the potential to be commercialised and GlobeImmune and/or Gilead and the employees and share holders therefore (including the co author listed above) could profit directly or indirectly from such commercialization. Work performed by A.J.G. and A.B. has funding agreements with Gilead and participates on Gilead advisory boards. These facts do not alter the authors' adherence to all PLOS ONE policies on sharing data and materials as detailed online in the PLOS ONE guide for authors, except for the one restriction regarding material as listed in Competing Interest section.	Appay V, 2002, J IMMUNOL, V168, P5954, DOI 10.4049/jimmunol.168.11.5954; Aslan N, 2006, J VIRAL HEPATITIS, V13, P505, DOI 10.1111/j.1365-2893.2006.00723.x; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Bernstein MB, 2008, VACCINE, V26, P509, DOI 10.1016/j.vaccine.2007.11.033; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boehm AL, 2010, CANCER IMMUNOL IMMUN, V59, P397, DOI 10.1007/s00262-009-0759-7; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Buchmann P, 2013, VACCINE, V31, P1197, DOI 10.1016/j.vaccine.2012.12.074; Cereda V, 2011, VACCINE, V29, P4992, DOI 10.1016/j.vaccine.2011.04.101; Chen Li-Ping, 2012, World J Virol, V1, P174, DOI 10.5501/wjv.v1.i6.174; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Cortez KJ, 2013, HIV CLIN TRIALS, V14, P149, DOI 10.1310/hct1404-149; Evans A, 2008, HEPATOLOGY, V48, P759, DOI 10.1002/hep.22419; Fletcher SP, 2013, SEMIN LIVER DIS, V33, P130, DOI 10.1055/s-0033-1345713; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Hohn H, 2002, CLIN EXP IMMUNOL, V129, P309, DOI 10.1046/j.1365-2249.2002.01841.x; Jonas Maureen M, 2010, Hepatology, V52, P2192, DOI 10.1002/hep.23934; Kosinska AD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003391; Liu F, 2013, PLOS PATHOG; Lok ASF, 2013, NAT REV GASTRO HEPAT, V10, P199, DOI 10.1038/nrgastro.2013.13; Maini MK, 2010, J HEPATOL, V52, P616, DOI 10.1016/j.jhep.2009.12.017; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Menne S, 2007, J VIROL, V81, P10614, DOI 10.1128/JVI.00691-07; MILICH DR, 1987, J IMMUNOL, V139, P1223; Paludan C, 2002, J IMMUNOL, V169, P1593, DOI 10.4049/jimmunol.169.3.1593; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Remondo C, 2009, VACCINE, V27, P987, DOI 10.1016/j.vaccine.2008.12.002; Schirmbeck R, 2003, EUR J IMMUNOL, V33, P2429, DOI 10.1002/eji.200324125; Sherman AC, 2013, AIDS RES HUM RETROV, V29, P665, DOI [10.1089/aid.2012.0320, 10.1089/AID.2012.0320]; Shrivastava S, 2013, J VIRAL HEPATITIS, V20, P582, DOI 10.1111/jvh.12078; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Tamburini BA, 2012, J IMMUNOTHER, V35, P14, DOI 10.1097/CJI.0b013e3182356888; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Wansley EK, 2008, CLIN CANCER RES, V14, P4316, DOI 10.1158/1078-0432.CCR-08-0393; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739	43	48	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101904	10.1371/journal.pone.0101904	http://dx.doi.org/10.1371/journal.pone.0101904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051027	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100016
J	Liu, YG; Dan, G; Wu, LJ; Chen, GY; Wu, AL; Zeng, P; Xu, WQ				Liu, Yugang; Dan, Gang; Wu, Lijuan; Chen, Guangyu; Wu, Ailin; Zeng, Ping; Xu, Wanqing			Functional Effect of Polymorphisms in the Promoter of TNFAIP3 (A20) in Acute Pancreatitis in the Han Chinese Population	PLOS ONE			English	Article							NF-KAPPA-B; GENE POLYMORPHISMS; ENZYME A20; EXPRESSION; DISEASE; RISK; SUSCEPTIBILITY; ASSOCIATION; ACTIVATION; SEVERITY	Background: The zinc finger protein A20 is an important negative regulator of inflammation; polymorphisms in the corresponding gene, TNFAIP3, have been reported to be associated with several inflammation diseases. However, only a few studies have focused on the relationship between TNFAIP3 polymorphisms and acute pancreatitis (AP). Methods: We enrolled 201 healthy controls and 190 acute pancreatitis patients (including 47 systemic inflammatory response syndrome patients) for this study and used DNA sequencing to investigate polymorphisms in the TNFAIP3 promoter. The functional effects of these variants on transcriptional activity, A20 expression, NF-kappa B activity, and TNF-alpha and IL-1 beta levels, after in vitro lipopolysaccharide stimulation, were assessed. Results: Two SNPs (rs59693083 and rs5029924) in the TNFAIP3 promoter were selected based on bioinformatic analysis. Neither of these SNPs was associated with susceptibility to AP; however, acute pancreatitis patients who possessed the T allele of rs5029924 were more likely to experience systemic inflammatory response syndrome. Moreover, rs5029924 was found to affect TNFAIP3 promoter activity. After lipopolysaccharide stimulation, the expression of A20 protein significantly decreased, while the activity of NF-kappa B and the production of TNF-alpha and IL-1 beta significantly increased in whole blood leukocytes from subjects with the T allele. Conclusion: The rs5029924 polymorphism in the TNFAIP3 promoter may alter the risk of systemic inflammatory response syndrome in acute pancreatitis patients by influencing the expression of A20 protein.	[Liu, Yugang; Dan, Gang; Wu, Lijuan; Wu, Ailin; Zeng, Ping; Xu, Wanqing] Chengdu Mil Gen Hosp, Ctr Lab Med, Chengdu, Peoples R China; [Chen, Guangyu] Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China		Wu, LJ (corresponding author), Chengdu Mil Gen Hosp, Ctr Lab Med, Chengdu, Peoples R China.	wulijuan052@126.com			Chengdu Military General Hospital innovative Foundation	Chengdu Military General Hospital innovative Foundation	This work was supported by Grant from the Chengdu Military General Hospital innovative Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Bhatia M, 2009, FRONT BIOSCI-LANDMRK, V14, P2042, DOI 10.2741/3362; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; de-Madaria E, 2008, PANCREAS, V37, P295, DOI 10.1097/MPA.0b013e31816726d5; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gu W, 2007, ANN SURG, V246, P151, DOI 10.1097/01.sla.0000262788.67171.3f; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hofner P, 2006, PANCREATOLOGY, V6, P542, DOI 10.1159/000097363; Knight JC, 2003, CLIN SCI, V104, P493, DOI 10.1042/CS20020304; Kume K, 2009, GUT, V58, P820, DOI 10.1136/gut.2008.151688; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; LARVIN M, 1989, LANCET, V2, P201; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Li H, 2013, HUM GENET, V132, P293, DOI 10.1007/s00439-012-1250-7; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Masamune A, 2010, J GASTROENTEROL, V45, P225, DOI 10.1007/s00535-009-0163-2; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Papachristou GI, 2007, GASTROENTEROL CLIN N, V36, P277, DOI 10.1016/j.gtc.2007.03.003; Roberts SE, 2013, ALIMENT PHARM THER, V38, P539, DOI 10.1111/apt.12408; Sanchez-Ramirez CA, 2012, PANCREAS, V41, P707, DOI 10.1097/MPA.0b013e31823cd873; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Takagi Y, 2009, HUM IMMUNOL, V70, P200, DOI 10.1016/j.humimm.2009.01.006; Tejasvi T, 2011, J INVEST DERMATOL, V132, P593; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Wang HJ, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/141898; Wang Q, 2012, J MOL HISTOL, V43, P319, DOI 10.1007/s10735-012-9402-6; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Yu JH, 2002, LAB INVEST, V82, P1359, DOI 10.1097/01.LAB.0000032377.09626.C7; Zhong H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3514	40	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103104	10.1371/journal.pone.0103104	http://dx.doi.org/10.1371/journal.pone.0103104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050625	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100088
J	Kashiwagi, M; Liu, LB; Chu, KK; Sun, CH; Tanaka, A; Gardecki, JA; Tearney, GJ				Kashiwagi, Manabu; Liu, Linbo; Chu, Kengyeh K.; Sun, Chen-Hsin; Tanaka, Atsushi; Gardecki, Joseph A.; Tearney, Guillermo J.			Feasibility of the Assessment of Cholesterol Crystals in Human Macrophages Using Micro Optical Coherence Tomography	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUES; VULNERABLE PLAQUE; CELL	The presence of cholesterol crystals is a hallmark of atherosclerosis, but until recently, such crystals have been considered to be passive components of necrotic plaque cores. Recent studies have demonstrated that phagocytosis of cholesterol crystals by macrophages may actively precipitate plaque progression via an inflammatory pathway, emphasizing the need for methods to study the interaction between macrophages and crystalline cholesterol. In this study, we demonstrate the feasibility of detecting cholesterol in macrophages in situ using Micro-Optical Coherence Tomography (mu OCT), an imaging modality we have recently developed with 1-mu m resolution. Macrophages containing cholesterol crystals frequently demonstrated highly scattering constituents in their cytoplasm on mu OCT imaging, and mu OCT was able to evaluate cholesterol crystals in cultured macrophage cells. Our results suggest that mu OCT may be useful for the detection and characterization of inflammatory activity associated with cholesterol crystals in the coronary artery.	[Kashiwagi, Manabu; Chu, Kengyeh K.; Sun, Chen-Hsin; Tanaka, Atsushi; Gardecki, Joseph A.; Tearney, Guillermo J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kashiwagi, Manabu; Chu, Kengyeh K.; Sun, Chen-Hsin; Tanaka, Atsushi; Gardecki, Joseph A.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Liu, Linbo] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Liu, Linbo] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Tearney, Guillermo J.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Tearney, Guillermo J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tearney, Guillermo J.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Tearney, GJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	gtearney@mgh.harvard.edu	Liu, Linbo/O-2572-2018	Liu, Linbo/0000-0001-6691-9253	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL076398, R01HL093717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093717, R01HL076398] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by National Heart, Lung, and Blood Institute of the National Institutes of Health under award numbers R01HL076398 and R01HL093717. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ENOMOTO M, 1987, J BIOCHEM-TOKYO, V101, P933, DOI 10.1093/oxfordjournals.jbchem.a121962; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; KLINKNER AM, 1995, J HISTOCHEM CYTOCHEM, V43, P1071, DOI 10.1177/43.10.7560885; Liu LB, 2007, OPT LETT, V32, P2375, DOI 10.1364/OL.32.002375; Liu LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054473; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; LOOMIS CR, 1979, J LIPID RES, V20, P525; LOREE HM, 1994, ARTERIOSCLER THROMB, V14, P230, DOI 10.1161/01.ATV.14.2.230; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Raffel OC, 2008, EUR HEART J, V29, P1721, DOI 10.1093/eurheartj/ehn286; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; Tanaka A, 2008, CIRCULATION, V118, P2368, DOI 10.1161/CIRCULATIONAHA.108.782540; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Tearney GJ, 2003, EUR HEART J, V23, P1462; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Yun SH, 2003, OPT EXPRESS, V11, P2953, DOI 10.1364/OE.11.002953	24	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102669	10.1371/journal.pone.0102669	http://dx.doi.org/10.1371/journal.pone.0102669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048105	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100059
J	Wang, C; Song, J; Ma, ZQ; Yang, WF; Li, CQ; Zhang, XP; Hou, XG; Sun, Y; Lin, P; Liang, K; Gong, L; Wang, MJ; Liu, FQ; Li, WJ; Yan, F; Yang, JP; Wang, LS; Tian, M; Liu, JD; Zhao, RX; Chen, L				Wang, Chuan; Song, Jun; Ma, Zeqiang; Yang, Weifang; Li, Chengqiao; Zhang, Xiuping; Hou, Xinguo; Sun, Yu; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li			Fluctuation between Fasting and 2-H Postload Glucose State Is Associated with Chronic Kidney Disease in Previously Diagnosed Type 2 Diabetes Patients with HbA1c >= 7%	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; HBA(1C) VARIABILITY; RISK; COMPLICATIONS; POPULATION; PREVALENCE	Objective: To investigate how the glucose variability between fasting and a 2-h postload glucose state (2-h postload plasma glucose [2hPG]-fasting plasma glucose [FPG]) is associated with chronic kidney disease (CKD) in middle-aged and elderly Chinese patients previously diagnosed with type 2 diabetes. Design and Methods: This cross-sectional study included 1054 previously diagnosed type 2 diabetes patients who were 40 years of age and older. First, the subjects were divided into two groups based on a glycated hemoglobin (HbA1c) value of 7%. Each group was divided into two subgroups, with or without CKD. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to estimate the glomerular filtration rate (GFR). CKD was defined as eGFR < 60 mL/min/1.73 m(2). Multiple linear regression analysis was used to estimate the association between the 2hPG-FPG and eGFR. The 2hPG-FPG value was divided into four groups increasing in increments of 36 mg/dl (2.0 mmol/L): 0-72, 72-108, 108-144 and >= 144 mg/dl, based on the quartiles of patients with HbA1c levels >= 7%; then, binary logistic regression analysis was used to investigate the association between 2hPG-FPG and the risk of CKD. Results: In the patients with HbA1c levels >= 7%, the 2hPG-FPG was significantly associated with decreased eGFR and an increased risk of CKD independent of age, gender, body mass index (BMI), systolic blood pressure (BP), diastolic BP, smoking, and drinking, as well as fasting insulin, cholesterol, triglyceride, and HbA1c levels. The patients with 2hPG-FPG values >= 144 mg/dl showed an increased odds ratio (OR) of 2.640 (P = 0.033). Additionally, HbA1c was associated with an increased risk of CKD in patients with HbA1c values >= 7%. Conclusions: The short-term glucose variability expressed by 2hPG-FPG is closely associated with decreased eGFR and an increased risk of CKD in patients with poor glycemic control (HbA1c >= 7%).	[Wang, Chuan; Song, Jun; Hou, Xinguo; Sun, Yu; Lin, Peng; Liang, Kai; Gong, Lei; Wang, Meijian; Liu, Fuqiang; Li, Wenjuan; Yan, Fei; Yang, Junpeng; Wang, Lingshu; Tian, Meng; Liu, Jidong; Zhao, Ruxing; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Ma, Zeqiang] China Natl Heavy Duty Truck Grp Corp Hosp, Jinan, Shandong, Peoples R China; [Yang, Weifang] Lukang Hosp Jining, Jining, Shandong, Peoples R China; [Li, Chengqiao] Second Peoples Hosp Jining, Dept Endocrinol, Jining, Shandong, Peoples R China; [Zhang, Xiuping] Shantui Community Hlth Ctr, Jining, Shandong, Peoples R China	Shandong University	Chen, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China.	wangchuansdu.edu@163.com		hou, xinguo/0000-0003-2045-1290	Chinese Society of Endocrinology; National Natural Science Foundation of China [81100617]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; National Science and Technology Support Plan [2009BAI80B04]; Natural Science Foundation of Shandong Province [ZR2012HM014]; International Science and Technology Projects of Shandong Province [2012GGE27126]; Business Plan of Jinan Students Studying Abroad [20110407]; special scientific research fund of clinical medicine of Chinese Medical Association [12030420342]	Chinese Society of Endocrinology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Science and Technology Development Projects of Shandong Province; National Science and Technology Support Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); International Science and Technology Projects of Shandong Province; Business Plan of Jinan Students Studying Abroad; special scientific research fund of clinical medicine of Chinese Medical Association	This study was supported by grants from the Chinese Society of Endocrinology, the National Natural Science Foundation of China (No. 81100617), the Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), the National Science and Technology Support Plan (2009BAI80B04), the Natural Science Foundation of Shandong Province (ZR2012HM014), the International Science and Technology Projects of Shandong Province (2012GGE27126), the Business Plan of Jinan Students Studying Abroad (20110407), and the special scientific research fund of clinical medicine of Chinese Medical Association (12030420342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Cameron Fergus J, 2010, Pediatr Endocrinol Rev, V7 Suppl 3, P432; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036332; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Frontoni S, 2013, DIABETES RES CLIN PR, V102, P86, DOI 10.1016/j.diabres.2013.09.007; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ning G, 2012, J DIABETES, V4, P172, DOI 10.1111/j.1753-0407.2012.00182.x; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Pyram R, 2012, MATURITAS, V71, P94, DOI 10.1016/j.maturitas.2011.11.009; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Tomonaga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067848; Wang Huanjun, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P818, DOI 10.3969/j.issn.1672-7347.2013.08.010; Weber C, 2009, DIABETES TECHNOL THE, V11, P623, DOI 10.1089/dia.2009.0043; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	25	9	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102941	10.1371/journal.pone.0102941	http://dx.doi.org/10.1371/journal.pone.0102941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047354	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100090
J	Ebsen, H; Lettau, M; Kabelitz, D; Janssen, O				Ebsen, Henriette; Lettau, Marcus; Kabelitz, Dieter; Janssen, Ottmar			Identification of SH3 Domain Proteins Interacting with the Cytoplasmic Tail of the A Disintegrin and Metalloprotease 10 (ADAM10)	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CYTOSOLIC POLYPROLINE REGION; ALPHA CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; FAS LIGAND; INTERACTION PARTNERS; MEMBRANE CURVATURE; TYROSINE KINASE; BINDING-PROTEIN; SORTING NEXINS	The a disintegrin and metalloproteases (ADAMs) play a pivotal role in the control of development, adhesion, migration, inflammation and cancer. Although numerous substrates of ADAM10 have been identified, the regulation of its surface expression and proteolytic activity is still poorly defined. One current hypothesis is that both processes are in part modulated by protein-protein interactions mediated by the intracellular portion of the protease. For related proteases, especially proline-rich regions serving as docking sites for Src homology domain 3 (SH3) domain-containing proteins proved to be important for mediating regulatory interactions. In order to identify ADAM10-binding SH3 domain proteins, we screened the All SH3 Domain Phager library comprising 305 human SH3 domains using a GST fusion protein with the intracellular region of human ADAM10 as a bait for selection. Of a total of 291 analyzed phage clones, we found 38 SH3 domains that were precipitated with the ADAM10-derived fusion protein but not with GST. We verified the binding to the cytosolic portion of ADAM10 for several candidates by co-immunoprecipitation and/or pull down analyses. Intriguingly, several of the identified proteins have been implicated in regulating surface appearance and/or proteolytic activity of related ADAMs. Thus, it seems likely that they also play a role in ADAM10 biology.	[Ebsen, Henriette; Lettau, Marcus; Kabelitz, Dieter; Janssen, Ottmar] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Immunol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Janssen, O (corresponding author), Univ Kiel, Univ Hosp Schleswig Holstein, Inst Immunol, Campus Kiel, Kiel, Germany.	ottmar.janssen@uksh.de	Lettau, Marcus/H-7595-2019; Janssen, Ottmar/E-9735-2010; Kabelitz, Dieter/AAB-4199-2021; Janssen, Ottmar/N-8769-2019; Kabelitz, Dieter/A-2757-2010; Ebsen, Henriette/B-1886-2015	Lettau, Marcus/0000-0002-3824-9923; Janssen, Ottmar/0000-0002-9612-8900; Janssen, Ottmar/0000-0002-9612-8900; 	German Research Foundation (DFG) [DFG CRC 877, DFG LE2571/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Funding for this study was provided by the German Research Foundation (DFG), www.dfg.de, DFG CRC 877 project B4 - OJ; DFG CRC 877 project A7 - DK; Individual funding DFG LE2571/3-1 - ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Aguera-Gonzales S, 2011, EUR J IMMUNOL, V41, P3667, DOI [10.1002/eji.201141645, 10.1002/eji.20114165]; Albrechtsen R, 2011, EXP CELL RES, V317, P195, DOI 10.1016/j.yexcr.2010.10.003; Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Baum W, 2005, J BIOL CHEM, V280, P40012, DOI 10.1074/jbc.M502222200; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boutet P, 2009, J IMMUNOL, V182, P49, DOI 10.4049/jimmunol.182.1.49; Cao Y, 2001, BIOCHEM J, V357, P353, DOI 10.1042/0264-6021:3570353; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Ebsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076853; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Ghadimi MP, 2002, FEBS LETT, V519, P50, DOI 10.1016/S0014-5793(02)02709-6; Guardiola-Serrano F, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.62; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Leo A, 2002, J CLIN INVEST, V109, P301; Lettau M, 2006, P NATL ACAD SCI USA, V103, P5911, DOI 10.1073/pnas.0508562103; Lettau M, 2014, EXP CELL RES, V320, P290, DOI 10.1016/j.yexcr.2013.11.016; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Linkermann A, 2005, EXPERT OPIN THER TAR, V9, P119, DOI 10.1517/14728222.9.1.119; Lowell CA, 2011, COLD SPRING HARB PER, V3; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Modregger J, 2000, J CELL SCI, V113, P4511; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; Peiretti F, 2003, J CELL SCI, V116, P1949, DOI 10.1242/jcs.00415; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Poggi M, 2013, BBA-MOL CELL RES, V1833, P602, DOI 10.1016/j.bbamcr.2012.11.009; Poghosyan Z, 2002, J BIOL CHEM, V277, P4999, DOI 10.1074/jbc.M107430200; QIAN J, 2005, SIGNAL TRANSDUCT, V5, P195; Qian J, 2006, CELL SIGNAL, V18, P1327, DOI 10.1016/j.cellsig.2005.10.015; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ritter B, 1999, FEBS LETT, V454, P356, DOI 10.1016/S0014-5793(99)00830-3; Rose-John S, 2013, PHARMACOL RES, V71, P19, DOI 10.1016/j.phrs.2013.01.012; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sanzenbacher R, 1999, J IMMUNOL, V163, P3143; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Thornhill PB, 2007, FEBS LETT, V581, P4455, DOI 10.1016/j.febslet.2007.08.025; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Voss M, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-53; Wenzel J, 2001, FEBS LETT, V509, P255, DOI 10.1016/S0014-5793(01)03174-X; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Zuccato E, 2007, J CELL SCI, V120, P191, DOI 10.1242/jcs.03315	72	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102899	10.1371/journal.pone.0102899	http://dx.doi.org/10.1371/journal.pone.0102899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036101	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200095
J	Huth, L; Rose, M; Kloubert, V; Winkens, W; Schlensog, M; Hartmann, A; Knuchel, R; Dahl, E				Huth, Laura; Rose, Michael; Kloubert, Veronika; Winkens, Wiebke; Schlensog, Martin; Hartmann, Arndt; Knuechel, Ruth; Dahl, Edgar			BDNF Is Associated with SFRP1 Expression in Luminal and Basal-Like Breast Cancer Cell Lines and Primary Breast Cancer Tissues: A Novel Role in Tumor Suppression?	PLOS ONE			English	Article							WNT ANTAGONIST SFRP1; NEUROTROPHIC FACTOR; EPIGENETIC INACTIVATION; PATHWAY; GENES; BETA; PROLIFERATION; CONTRIBUTES; RECEPTOR; MAMMARY	Secreted frizzled related protein 1 (SFRP1) functions as an important inhibitor of the Wnt pathway and is a known tumor suppressor gene, which is epigenetically silenced in a variety of tumors e. g. in breast cancer. However, it is still unclear how SFRP1 exactly affects the Wnt pathway. Our aim was to decipher SFRP1 involvement in biochemical signaling in dependency of different breast cancer subtypes and to identify novel SFRP1-regulated genes. We generated SFRP1 over-expressing in vitro breast cancer models, reflecting the two major subtypes by using basal-like BT20 and luminal-like HER2-positive SKBR3 cells. DNA microarray expression profiling of these models revealed that SFRP1 expression potentially modulates Bone morphogenetic protein-and Smoothened signaling (p<0.01), in addition to the known impact on Wnt signaling. Importantly, further statistical analysis revealed that in dependency of the cancer subtype model SFRP1 may affect the canonical and non-canonical Wnt pathway (p<0.01), respectively. While SFRP1 re-expression generally mediated distinct patterns of transcriptionally induced or repressed genes in BT20 and SKBR3 cells, brain derived neurotrophic factor (BDNF) was identified as a SFRP1 induced gene in both cell lines. Although BDNF has been postulated as a putative oncogene, the co-regulation with SFRP1 indicates a potential suppressive function in breast cancer. Indeed, a positive correlation between SFRP1 and BDNF protein expression could be shown (p<0.001) in primary breast cancer samples. Moreover, TCGA dataset based analysis clearly underscores that BDNF mRNA is down-regulated in primary breast cancer samples predicting a poor prognosis of these patients. In line, we functionally provide evidence that stable BDNF re-expression in basal-like BT20 breast cancer cells blocks tumor cell proliferation. Hence, our results suggest that BDNF might rather mediate suppressive than promoting function in human breast cancer whose mode of action should be addressed in future studies.	[Huth, Laura; Rose, Michael; Kloubert, Veronika; Winkens, Wiebke; Schlensog, Martin; Knuechel, Ruth; Dahl, Edgar] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany; [Hartmann, Arndt] Univ Hosp, Inst Pathol, Erlangen, Germany	RWTH Aachen University; University of Erlangen Nuremberg	Dahl, E (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany.	edahl@ukaachen.de			DFG grant [DA329/3-1]	DFG grant(German Research Foundation (DFG))	This work was supported by DFG grant DA329/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid-Pavlidis T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-420; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blasco-Gutierrez MJ, 2007, CANCER INVEST, V25, P405, DOI 10.1080/07357900701206349; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bronzetti E, 2008, ONCOL REP, V19, P969; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Chen BY, 2013, J NEUROSCI RES, V91, P30, DOI 10.1002/jnr.23138; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Fredlund E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3236; Gauger KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-59; Hu YH, 2008, J NEUROCHEM, V105, P1, DOI 10.1111/j.1471-4159.2008.05237.x; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klopocki E, 2004, INT J ONCOL, V25, P641; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Li Z, 2007, MOL CANCER THER, V6, P3113, DOI 10.1158/1535-7163.MCT-07-0133; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Patani N, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-23; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Simon R, 2007, CANCER INFORM, V3, P11; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Wolfs TGAM, 2008, MOL IMMUNOL, V45, P3268, DOI 10.1016/j.molimm.2008.02.014; Yang XM, 2012, INT J ONCOL, V41, P1541, DOI 10.3892/ijo.2012.1581; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102558	10.1371/journal.pone.0102558	http://dx.doi.org/10.1371/journal.pone.0102558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036590	Green Published, gold			2022-12-27	WOS:000339615200070
J	Poongavanam, V; Madala, PK; Hojland, T; Veedu, RN				Poongavanam, Vasanthanathan; Madala, Praveen K.; Hojland, Torben; Veedu, Rakesh N.			Computational Investigation of Locked Nucleic Acid (LNA) Nucleotides in the Active Sites of DNA Polymerases by Molecular Docking Simulations	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; DRUG-RESISTANCE; EMERGING CLASS; APTAMERS; ANALOGS; COMPLEX; THERAPEUTICS; RECOGNITION; DIAGNOSTICS; PREDICTION	Aptamers constitute a potential class of therapeutic molecules typically selected from a large pool of oligonucleotides against a specific target. With a scope of developing unique shorter aptamers with very high biostability and affinity, locked nucleic acid (LNA) nucleotides have been investigated as a substrate for various polymerases. Various reports showed that some thermophilic B-family DNA polymerases, particularly KOD and Phusion DNA polymerases, accepted LNA-nucleoside 5'-triphosphates as substrates. In this study, we investigated the docking of LNA nucleotides in the active sites of RB69 and KOD DNA polymerases by molecular docking simulations. The study revealed that the incoming LNA-TTP is bound in the active site of the RB69 and KOD DNA polymerases in a manner similar to that seen in the case of dTTP, and with LNA structure, there is no other option than the locked C3'-endo conformation which in fact helps better orienting within the active site.	[Poongavanam, Vasanthanathan; Hojland, Torben; Veedu, Rakesh N.] Univ Southern Denmark, Nucle Acid Ctr, Odense M, Denmark; [Poongavanam, Vasanthanathan; Hojland, Torben; Veedu, Rakesh N.] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark; [Madala, Praveen K.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Veedu, Rakesh N.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Southern Denmark; University of Southern Denmark; University of Queensland; University of Queensland	Veedu, RN (corresponding author), Univ Southern Denmark, Nucle Acid Ctr, Odense M, Denmark.	rakesh@uq.edu.au	Poongavanam, Vasanthanathan/O-3945-2017	Poongavanam, Vasanthanathan/0000-0002-8880-9247; Hojland, Torben Rene/0000-0003-3087-4262	Nucleic Acid Center, University of Southern Denmark; University of Queensland	Nucleic Acid Center, University of Southern Denmark; University of Queensland(University of Queensland)	This work is supported by the Nucleic Acid Center, University of Southern Denmark. RNV also acknowledges the Fellowship from the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; ChemBioDraw, PERK INF; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gardner AF, 2004, J BIOL CHEM, V279, P11834, DOI 10.1074/jbc.M308286200; Hojland Torben, 2012, Artif DNA PNA XNA, V3, P14, DOI 10.4161/adna.19272; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jayasena SD, 1999, CLIN CHEM, V45, P1628; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kore AR, 2008, NUCLEOS NUCLEOT NUCL, V27, P1, DOI 10.1080/15257770701571693; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Kuwahara M, 2008, NUCLEIC ACIDS RES, V36, P4257, DOI 10.1093/nar/gkn404; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n; Veedu RN, 2007, NUCLEOS NUCLEOT NUCL, V26, P1207, DOI 10.1080/15257770701527844; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Veedu RN, 2010, BIOORG MED CHEM LETT, V20, P6565, DOI 10.1016/j.bmcl.2010.09.044; Veedu RN, 2010, NEW J CHEM, V34, P877, DOI 10.1039/b9nj00628a; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Veedu RN, 2009, ORG BIOMOL CHEM, V7, P1404, DOI 10.1039/b819946a; Veedu RN, 2009, MOL BIOSYST, V5, P787, DOI 10.1039/b905513b; Wang J, 2001, CELL, V105, P657; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102126	10.1371/journal.pone.0102126	http://dx.doi.org/10.1371/journal.pone.0102126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036012	Green Published, gold			2022-12-27	WOS:000339615200038
J	Saldana, Z; De la Cruz, MA; Carrillo-Casas, EM; Duran, L; Zhang, YS; Hernandez-Castro, R; Puente, JL; Daaka, Y; Giron, JA				Saldana, Zeus; De la Cruz, Miguel A.; Margarita Carrillo-Casas, Erika; Duran, Laura; Zhang, Yushan; Hernandez-Castro, Rigoberto; Puente, Jose L.; Daaka, Yehia; Giron, Jorge A.			Production of the Escherichia coli Common Pilus by Uropathogenic E. coli Is Associated with Adherence to HeLa and HTB-4 Cells and Invasion of Mouse Bladder Urothelium	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; BUNDLE-FORMING PILUS; EPITHELIAL-CELLS; BIOFILM FORMATION; COLONIZATION; FIMBRIAE; ADHESION; STRAINS; K-12	Uropathogenic Escherichia coli (UPEC) strains cause urinary tract infections and employ type 1 and P pili in colonization of the bladder and kidney, respectively. Most intestinal and extra-intestinal E. coli strains produce a pilus called E. coli common pilus (ECP) involved in cell adherence and biofilm formation. However, the contribution of ECP to the interaction of UPEC with uroepithelial cells remains to be elucidated. Here, we report that prototypic UPEC strains CFT073 and F11 mutated in the major pilin structural gene ecpA are significantly deficient in adherence to cultured HeLa (cervix) and HTB-4 (bladder) epithelial cells in vitro as compared to their parental strains. Complementation of the ecpA mutant restored adherence to wild-type levels. UPEC strains produce ECP upon growth in Luria-Bertani broth or DMEM tissue culture medium preferentially at 26 degrees C, during incubation with cultured epithelial cells in vitro at 37 degrees C, and upon colonization of mouse bladder urothelium ex vivo. ECP was demonstrated on and inside exfoliated bladder epithelial cells present in the urine of urinary tract infection patients. The ability of the CFT073 ecpA mutant to invade the mouse tissue was significantly reduced. The presence of ECP correlated with the architecture of the biofilms produced by UPEC strains on inert surfaces. These data suggest that ECP can potentially be produced in the bladder environment and contribute to the adhesive and invasive capabilities of UPEC during its interaction with the host bladder. We propose that along with other known adhesins, ECP plays a synergistic role in the multi-step infection of the urinary tract.	[Saldana, Zeus; De la Cruz, Miguel A.; Duran, Laura; Giron, Jorge A.] Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Zhang, Yushan; Daaka, Yehia] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA; [Margarita Carrillo-Casas, Erika; Hernandez-Castro, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Mexico City, DF, Mexico; [Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad Nacional Autonoma de Mexico	Saldana, Z (corresponding author), Univ Florida, Emerging Pathogens Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.	jagiron@ufl.edu	Saldana, Zeus/GLR-4422-2022	Saldana, Zeus/0000-0002-2710-2846; Puente, Jose/0000-0002-8411-4974; De la Cruz, Miguel A./0000-0001-6909-2941	National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI66012, AI079014]; Consejo Nacional de Ciencia y Tecnologia [154287, 87586]; Direccion General de Asuntos del Personal Academico [IN209713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079014, R01AI066012] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases/National Institutes of Health (www.niaid.nih.gov) (AI66012 to JAG and AI079014 to YD), from the Consejo Nacional de Ciencia y Tecnologia(www.conacyt.gob.mx) (154287 to JLP and 87586 to RHC), and from Direccion General de Asuntos del Personal Academico (www.http://dgapa.unam.mx/) (IN209713 to JLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Avelino F, 2010, INT J MED MICROBIOL, V300, P440, DOI 10.1016/j.ijmm.2010.02.002; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Blackburn D, 2009, J CLIN MICROBIOL, V47, P1781, DOI 10.1128/JCM.00260-09; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRINTON CC, 1959, NATURE, V183, P782, DOI 10.1038/183782a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lehti TA, 2010, MICROBIOL-SGM, V156, P2408, DOI 10.1099/mic.0.039610-0; Martinez-Santos VI, 2012, J BACTERIOL, V194, P5020, DOI 10.1128/JB.00915-12; MCMICHAEL JC, 1979, J BACTERIOL, V138, P969, DOI 10.1128/JB.138.3.969-975.1979; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2002, CELL MICROBIOL, V4, P257, DOI 10.1046/j.1462-5822.2002.00193.x; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Saldana Z, 2009, J BACTERIOL, V191, P3451, DOI 10.1128/JB.01539-08; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Schilling Joel D, 2002, Int Rev Immunol, V21, P291, DOI 10.1080/08830180213275; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; STAPLETON A, 1991, J INFECT DIS, V163, P773, DOI 10.1093/infdis/163.4.773; Wang ZM, 2011, J CELL BIOL, V192, P101, DOI 10.1083/jcb.201003027; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08	37	25	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101200	10.1371/journal.pone.0101200	http://dx.doi.org/10.1371/journal.pone.0101200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036370	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200013
J	Wijnen, JP; Jiang, L; Greenwood, TR; van der Kemp, WJM; Klomp, DWJ; Glunde, K				Wijnen, Jannie P.; Jiang, Lu; Greenwood, Tiffany R.; van der Kemp, Wybe J. M.; Klomp, Dennis W. J.; Glunde, Kristine			H-1/P-31 Polarization Transfer at 9.4 Tesla for Improved Specificity of Detecting Phosphomonoesters and Phosphodiesters in Breast Tumor Models	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; P-31 MR SPECTROSCOPY; IN-VIVO; RELAXATION-TIMES; HUMAN BRAIN; MALIGNANT-TRANSFORMATION; PHOSPHOLIPID-METABOLISM; NMR-SPECTROSCOPY; CANCER CELLS; 7 T	Purpose: To assess the ability of a polarization transfer (PT) magnetic resonance spectroscopy (MRS) technique to improve the detection of the individual phospholipid metabolites phosphocholine (PC), phosphoethanolamine (PE), glycerophosphocholine (GPC), and glycerophosphoethanolamine (GPE) in vivo in breast tumor xenografts. Materials and Methods: The adiabatic version of refocused insensitive nuclei enhanced by polarization transfer (BINEPT) MRS was tested at 9.4 Tesla in phantoms and animal models. BINEPT and pulse-acquire (PA) P-31 MRS was acquired consecutively from the same orthotopic MCF-7 (n = 10) and MDA-MB-231 (n = 10) breast tumor xenografts. After in vivo MRS measurements, animals were euthanized, tumors were extracted and high resolution (HR)-MRS was performed. Signal to noise ratios (SNRs) and metabolite ratios were compared for BINEPT and PA MRS, and were also measured and compared with that from HR-MRS. Results: BINEPT exclusively detected metabolites with H-1-P-31 coupling such as PC, PE, GPC, and GPE, thereby creating a significantly improved, flat baseline because overlapping resonances from immobile and partly mobile phospholipids were removed without loss of sensitivity. GPE and GPC were more accurately detected by BINEPT in vivo, which enabled a reliable quantification of metabolite ratios such as PE/GPE and PC/GPC, which are important markers of tumor aggressiveness and treatment response. Conclusion: BINEPT is advantageous over PA for detecting and quantifying the individual phospholipid metabolites PC, PE, GPC, and GPE in vivo at high magnetic field strength. As BINEPT can be used clinically, alterations in these phospholipid metabolites can be assessed in vivo for cancer diagnosis and treatment monitoring.	[Wijnen, Jannie P.; Jiang, Lu; Greenwood, Tiffany R.; Glunde, Kristine] Johns Hopkins Univ, Sch Med, Vivo Cellular & Mol Imaging Ctr, Russell H Morgan Dept Radiol & Radiol Sci,Div Can, Baltimore, MD 21218 USA; [Wijnen, Jannie P.; Jiang, Lu; van der Kemp, Wybe J. M.; Klomp, Dennis W. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Glunde, Kristine] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Utrecht University; Utrecht University Medical Center; Johns Hopkins University	Glunde, K (corresponding author), Johns Hopkins Univ, Sch Med, Vivo Cellular & Mol Imaging Ctr, Russell H Morgan Dept Radiol & Radiol Sci,Div Can, Baltimore, MD 21218 USA.	kglunde@mri.jhu.edu		Wijnen, Jannie/0000-0003-2352-3667; Jiang, Lu/0000-0002-8767-5742	Niels Stensen Foundation (Dutch private institute); National Institutes of Health (NIH) [R01 CA134695]; NATIONAL CANCER INSTITUTE [R01CA134695] Funding Source: NIH RePORTER	Niels Stensen Foundation (Dutch private institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge financial support from the Niels Stensen Foundation (Dutch private institute) and the National Institutes of Health (NIH) grant R01 CA134695. Both funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Arias-Mendoza F, 2006, NMR BIOMED, V19, P504, DOI 10.1002/nbm.1057; Bathen TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061578; Bolan PJ, 2002, MAGNET RESON MED, V48, P215, DOI 10.1002/mrm.10224; BRYANT DJ, 1988, J COMPUT ASSIST TOMO, V12, P770, DOI 10.1097/00004728-198809010-00010; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; CERDAN S, 1986, MAGNET RESON MED, V3, P432, DOI 10.1002/mrm.1910030308; Choi IY, 2000, MAGNET RESON MED, V44, P387, DOI 10.1002/1522-2594(200009)44:3<387::AID-MRM8>3.0.CO;2-3; Cudalbu C, 2009, MAGN RESON MED, V62, P862, DOI 10.1002/mrm.22022; De Graaf R.A, 2008, VIVO NMR SPECTROSCOP, VSecond; de Haan JH, 2003, MAGNET RESON MED, V50, P1302, DOI 10.1002/mrm.10630; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; DODD NJF, 1989, BRIT J CANCER, V60, P164, DOI 10.1038/bjc.1989.244; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gonen O, 1997, MAGNET RESON MED, V37, P301, DOI 10.1002/mrm.1910370228; Haddadin IS, 2009, NMR BIOMED, V22, P65, DOI 10.1002/nbm.1217; Jiang L, 2012, NEOPLASIA, V14, P732, DOI 10.1593/neo.12858; KALRA R, 1993, BRIT J CANCER, V67, P1145, DOI 10.1038/bjc.1993.211; Klomp DWJ, 2008, MAGN RESON MED, V60, P1298, DOI 10.1002/mrm.21733; Klomp DWJ, 2011, NMR BIOMED, V24, P1337, DOI 10.1002/nbm.1696; Lagemaat MW, 2013, INT SOC MAGN RES MED; Leach MO, 1998, NMR BIOMED, V11, P314, DOI 10.1002/(SICI)1099-1492(1998110)11:7<314::AID-NBM522>3.0.CO;2-Z; Mancini L, 2005, MAGN RESON MED, V54, P1065, DOI 10.1002/mrm.20659; Mancini L, 2003, MAGNET RESON MED, V50, P578, DOI 10.1002/mrm.10551; Marjanska M, 2012, NMR BIOMED, V25, P332, DOI 10.1002/nbm.1754; Meisamy S, 2005, RADIOLOGY, V236, P465, DOI 10.1148/radiol.2362040836; Morse DL, 2009, NMR BIOMED, V22, P114, DOI 10.1002/nbm.1318; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; OSBAKKEN MD, 1986, MAGNET RESON MED, V3, P1, DOI 10.1002/mrm.1910030102; REDMOND OM, 1992, MAGNET RESON MED, V25, P30, DOI 10.1002/mrm.1910250104; Schiller J, 2002, MED SCI MONITOR INT, V8, pMT205; SMITH TAD, 1993, NMR BIOMED, V6, P318, DOI 10.1002/nbm.1940060506; SMITH TAD, 1991, BRIT J CANCER, V63, P514, DOI 10.1038/bjc.1991.122; Solivera J, 2009, NMR BIOMED, V22, P663, DOI 10.1002/nbm.1387; Stehouwer BL, 2014, BREAST CANCER RES TR, V144, P583, DOI 10.1007/s10549-014-2889-7; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; van der Kemp WJM, 2013, NMR BIOMED, V26, P1299, DOI 10.1002/nbm.2952; van der Kemp WJM, 2012, MAGN RESON MED, V68, P353, DOI 10.1002/mrm.23260; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wijnen JP, 2010, NMR BIOMED, V23, P968, DOI 10.1002/nbm.1523; Wijnen JP, 2012, MAGN RESON MED, V68, P339, DOI 10.1002/mrm.23249; Xin L, 2012, MAGNETIC RESONANCE M	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102256	10.1371/journal.pone.0102256	http://dx.doi.org/10.1371/journal.pone.0102256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036036	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200045
J	Adhikari, N; Guan, WH; Capaldo, B; Mackey, AJ; Carlson, M; Ramakrishnan, S; Walek, D; Gupta, M; Mitchell, A; Eckman, P; John, R; Ashley, E; Barton, PJ; Hall, JL				Adhikari, Neeta; Guan, Weihua; Capaldo, Brian; Mackey, Aaron J.; Carlson, Marjorie; Ramakrishnan, Sundaram; Walek, Dinesha; Gupta, Manu; Mitchell, Adam; Eckman, Peter; John, Ranjit; Ashley, Euan; Barton, Paul J.; Hall, Jennifer L.			Identification of a New Target of miR-16, Vacuolar Protein Sorting 4a	PLOS ONE			English	Article							CELL-PROLIFERATION; EXPRESSION; MICRORNA-16; OSTEOSARCOMA; DISEASES; FAMILY	Rationale: The rationale was to utilize a bioinformatics approach to identify miRNA binding sites in genes with single nucleotide mutations (SNPs) to discover pathways in heart failure (HF). Objective: The objective was to focus on the genes containing miRNA binding sites with miRNAs that were significantly altered in end-stage HF and in response to a left ventricular assist device (LVAD). Methods and Results: BEDTools v2.14.3 was used to discriminate SNPs within predicted 3'UTR miRNA binding sites. A member of the miR-15/107 family, miR-16, was decreased in the circulation of end-stage HF patients and increased in response to a LVAD (p<0.001). MiR-16 decreased Vacuolar Protein Sorting 4a (VPS4a) expression in HEK 293T cells (p<0.01). The SNP rs16958754 was identified in the miR-15/107 family binding site of VPS4a which abolished direct binding of miR-16 to the 3'UTR of VPS4a (p<0.05). VPS4a was increased in the circulation of end-stage HF patients (p<0.001), and led to a decrease in the number of HEK 293T cells in vitro (p<0.001). Conclusions: We provide evidence that miR-16 decreases in the circulation of end-stage HF patients and increases with a LVAD. Modeling studies suggest that miR-16 binds to and decreases expression of VPS4a. Overexpression of VPS4a decreases cell number. Together, these experiments suggest that miR-16 and VPS4a expression are altered in end-stage HF and in response to unloading with a LVAD. This signaling pathway may lead to reduced circulating cell number in HF.	[Adhikari, Neeta; Carlson, Marjorie; Mitchell, Adam; Eckman, Peter; Hall, Jennifer L.] Univ Minnesota, Dept Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Guan, Weihua] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA; [John, Ranjit] Univ Minnesota, Dept Surg, Div Cardiothorac Surg, Minneapolis, MN 55455 USA; [Walek, Dinesha] Univ Minnesota, Genom Ctr, Minneapolis, MN 55455 USA; [Ramakrishnan, Sundaram] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Capaldo, Brian; Mackey, Aaron J.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Gupta, Manu] Royal Brompton & Harefield Trust, Cardiovasc Biomed Res Unit, Natl Inst Heart Res, London, England; [Ashley, Euan] Stanford Univ, Dept Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA; [Barton, Paul J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, London, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia; Royal Brompton & Harefield NHS Foundation Trust; Stanford University; Imperial College London	Hall, JL (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	jlhall@umn.edu		Capaldo, Brian/0000-0003-1244-8884; Barton, Paul/0000-0002-1165-7767	NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust; Imperial College London (PJB); National Institutes of Health [NIH-1 R21 HL104596-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104596] Funding Source: NIH RePORTER	NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust; Imperial College London (PJB); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust, Imperial College London (PJB) and the National Institutes of Health (NIH-1 R21 HL104596-01) (JLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari N, 2010, J MOL CELL CARDIOL, V49, P287, DOI 10.1016/j.yjmcc.2010.02.022; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Basi DL, 2007, AM J PHYSIOL-HEART C, V292, pH516, DOI 10.1152/ajpheart.00246.2006; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chen L, 2013, FEBS LETT, V587, P1366, DOI 10.1016/j.febslet.2013.03.007; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cotsapas C, 2010, DIABETOLOGIA, V53, P2334, DOI 10.1007/s00125-010-1861-2; Day L, 2013, BIOINFORMATICS; Devaux Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070644; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Goretti E, 2013, J LEUKOCYTE BIOL, V93, P645, DOI 10.1189/jlb.1012511; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Larsson E, 2010, MRNA TURNOVER RATE L; Lezina L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.483; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077951; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; PRESKILL C, 2013, SNPS MICRORNA BINDIN, V18, P327; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Subkhankulova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-268; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Wang XH, 2004, ARTERIOSCL THROM VAS, V24, P85, DOI 10.1161/01.ATV.0000104012.40720.c4	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101509	10.1371/journal.pone.0101509	http://dx.doi.org/10.1371/journal.pone.0101509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033200	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300019
J	Gonzalez-Bernal, E; Brown, GP; Shine, R				Gonzalez-Bernal, Edna; Brown, Gregory P.; Shine, Richard			Invasive Cane Toads: Social Facilitation Depends upon an Individual's Personality	PLOS ONE			English	Article							RISK-TAKING BEHAVIOR; BUFO-MARINUS; FORAGING SUCCESS; TRADE-OFFS; DISPERSAL; BOLDNESS; POPULATIONS; AGGRESSION; TRAITS; EVOLUTION	Individual variation in behavioural traits (including responses to social cues) may influence the success of invasive populations. We studied the relationship between sociality and personality in invasive cane toads (Rhinella marina) from a recently established population in tropical Australia. In our field experiments, we manipulated social cues (the presence of a feeding conspecific) near a food source. We captured and compared toads that only approached feeding sites where another toad was already present, with conspecifics that approached unoccupied feeding sites. Subsequent laboratory trials showed correlated personality differences (behavioural syndromes) between these two groups of toads. For example, toads that approached already-occupied rather than unoccupied feeding sites in the field, took longer to emerge from a shelter-site in standardized trials, suggesting these individuals are 'shy' (whereas toads that approached unoccupied feeding stations tended to be 'bold'). Manipulating hunger levels did not abolish this difference. In feeding trials, a bold toad typically outcompeted a shy toad under conditions of low prey availability, but the outcome was reversed when multiple prey items were present. Thus, both personality types may be favored under different circumstances. This invasive population of toads contains individuals that exhibit a range of personalities, hinting at the existence of a wide range of social dynamics in taxa traditionally considered to be asocial.	[Gonzalez-Bernal, Edna; Brown, Gregory P.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Gonzalez-Bernal, E (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	ednagbernal@gmail.com	Brown, Gregory P./F-9897-2011; González-Bernal, Edna/AAH-9372-2021	Brown, Gregory P./0000-0002-2924-9040; Gonzalez-Bernal, Edna/0000-0001-7817-4156	Australian Research Council [FF561365]; Mexican National Science and Technology Council (CONACyT); University of Sydney	Australian Research Council(Australian Research Council); Mexican National Science and Technology Council (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Sydney(University of Sydney)	The work was funded by the Australian Research Council (grant number FF561365), the Mexican National Science and Technology Council (CONACyT) and the University of Sydney. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018277; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blackburn Tim, 2009, pi; Bowcock H, 2008, ANIM BEHAV, V75, P1571, DOI 10.1016/j.anbehav.2007.10.011; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Cervantes MC, 2007, NEUROSCIENCE, V150, P511, DOI 10.1016/j.neuroscience.2007.09.034; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Cote J, 2011, P ROY SOC B-BIOL SCI, V278, P1670, DOI 10.1098/rspb.2010.1892; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Damsgard B, 1998, BEHAV ECOL, V9, P26, DOI 10.1093/beheco/9.1.26; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; Fogarty S, 2011, AM NAT, V177, P273, DOI 10.1086/658174; FREELAND WJ, 1986, AUST WILDLIFE RES, V13, P321, DOI 10.1071/WR9860321; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gonzalez-Bernal E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1367, DOI 10.1007/s00265-011-1147-9; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; LEVER C., 2001, CANE TOAD HIST ECOLO; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Pintor LM, 2008, OIKOS, V117, P1629, DOI 10.1111/j.1600-0706.2008.16578.x; Pintor LM, 2009, ECOLOGY, V90, P581, DOI 10.1890/08-0552.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rehage JS, 2004, BIOL INVASIONS, V6, P379, DOI 10.1023/B:BINV.0000034618.93140.a5; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Trompf L, 2014, ANIM BEHAV, V88, P99, DOI 10.1016/j.anbehav.2013.11.022; Urban MC, 2008, AM NAT, V171, pE134, DOI 10.1086/527494; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Veenema AH, 2005, PSYCHOPHARMACOLOGY, V178, P151, DOI 10.1007/s00213-004-2005-5; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	50	24	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102880	10.1371/journal.pone.0102880	http://dx.doi.org/10.1371/journal.pone.0102880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033047	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300106
J	Roschanski, N; Fischer, J; Guerra, B; Roesler, U				Roschanski, Nicole; Fischer, Jennie; Guerra, Beatriz; Roesler, Uwe			Development of a Multiplex Real-Time PCR for the Rapid Detection of the Predominant Beta-Lactamase Genes CTX-M, SHV, TEM and CIT-Type AmpCs in Enterobacteriaceae	PLOS ONE			English	Article							ESCHERICHIA-COLI; PUBLIC-HEALTH; ANTIMICROBIAL RESISTANCE; ANIMALS; EPIDEMIOLOGY; PERSPECTIVE; STRAINS; FRANCE; FOOD	Beta-lactamase resistant bacteria and especially ESBL producing Enterobacteriaceae are an increasing problem worldwide. For this reason a major interest in efficient and reliable methods for rapid screening of high sample numbers is recognizable. Therefore, a multiplex real-time PCR was developed to detect the predominant class A beta-lactamase genes bla(CTX-M), bla(SHV), bla(TEM) and CIT-type AmpCs in a one-step reaction. A set of 114 Enterobacteriaceae containing previously identified resistance gene subtypes and in addition 20 undefined animal and environmental isolates were used for the validation of this assay. To confirm the accessibility in variable settings, the real-time runs were performed analogous in two different laboratories using different real-time cyclers. The obtained results showed complete accordance between the real-time data and the predetermined genotypes. Even if sequence analyses are further necessary for a comprehensive characterization, this method was proofed to be reliable for rapid screening of high sample numbers and therefore could be an important tool for e.g. epidemiological purposes or support infection control measures.	[Roschanski, Nicole; Roesler, Uwe] Free Univ Berlin, Inst Anim Hyg & Environm Hlth, Berlin, Germany; [Fischer, Jennie; Guerra, Beatriz] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany	Free University of Berlin; Federal Institute for Risk Assessment	Roschanski, N (corresponding author), Free Univ Berlin, Inst Anim Hyg & Environm Hlth, Berlin, Germany.	nicole.roschanski@fu-berlin.de			German Federal Ministry of Education and Research [FKZ01Kl1013C, FKZ01Kl1013B]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was performed within the scope of the Research consortium RESET (http://www.reset-verbund.de/); funded by the German Federal Ministry of Education and Research; funding number FKZ01Kl1013C to UR and FKZ01Kl1013B to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Carattoli A, 2008, J CLIN MICROBIOL, V46, P103, DOI 10.1128/JCM.01542-07; Chia JH, 2005, J CLIN MICROBIOL, V43, P4486, DOI 10.1128/JCM.43.9.4486-4491.2005; CLSI, 2012, PERF STAND ANT SUSC; EFSA, 2012, EFSA J, V10; European Food Safety Authority (EFSA), 1975, EFSA J, V9; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Fluit AC, 2001, CLIN MICROBIOL REV, V14, P836, DOI 10.1128/CMR.14.4.836-871.2001; Hartmann A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00083; Helfand Marion S., 2003, Current Drug Targets - Infectious Disorders, V3, P9, DOI 10.2174/1568005033342181; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Lupo A, 2013, DIAGN MICR INFEC DIS, V77, P179, DOI 10.1016/j.diagmicrobio.2013.06.001; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Polsfuss S, 2011, J CLIN MICROBIOL, V49, P2798, DOI 10.1128/JCM.00404-11; Randegger CC, 2001, ANTIMICROB AGENTS CH, V45, P1730, DOI 10.1128/AAC.45.6.1730-1736.2001; Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004; WHO, 2011, CRIT IMP ANT HUM MED; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456	27	118	121	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100956	10.1371/journal.pone.0100956	http://dx.doi.org/10.1371/journal.pone.0100956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033234	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300011
J	Bundela, S; Sharma, A; Bisen, PS				Bundela, Saurabh; Sharma, Anjana; Bisen, Prakash S.			Potential Therapeutic Targets for Oral Cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; THERAPIES; GENES	In India, oral cancer has consistently ranked among top three causes of cancer-related deaths, and it has emerged as a top cause for the cancer-related deaths among men. Lack of effective therapeutic options is one of the main challenges in clinical management of oral cancer patients. We interrogated large pool of samples from oral cancer gene expression studies to identify potential therapeutic targets that are involved in multiple cancer hallmark events. Therapeutic strategies directed towards such targets can be expected to effectively control cancer cells. Datasets from different gene expression studies were integrated by removing batch-effects and was used for downstream analyses, including differential expression analysis. Dependency network analysis was done to identify genes that undergo marked topological changes in oral cancer samples when compared with control samples. Causal reasoning analysis was carried out to identify significant hypotheses, which can explain gene expression profiles observed in oral cancer samples. Text-mining based approach was used to detect cancer hallmarks associated with genes significantly expressed in oral cancer. In all, 2365 genes were detected to be differentially expressed genes, which includes some of the highly differentially expressed genes like matrix metalloproteinases (MMP-1/3/10/13), chemokine (C-X-C motif) ligands (IL8, CXCL-10/-11), PTHLH, SERPINE1, NELL2, S100A7A, MAL, CRNN, TGM3, CLCA4, keratins (KRT-3/4/13/76/78), SERPINB11 and serine peptidase inhibitors (SPINK-5/7). XIST, TCEAL2, NRAS and FGFR2 are some of the important genes detected by dependency and causal network analysis. Literature mining analysis annotated 1014 genes, out of which 841 genes were statistically significantly annotated. The integration of output of various analyses, resulted in the list of potential therapeutic targets for oral cancer, which included targets such as ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF and CD70.	[Bundela, Saurabh; Bisen, Prakash S.] Govt India, Def Res Dev Estab, Def Res Dev Org, Minist Def, Gwalior, Madhya Pradesh, India; [Bundela, Saurabh; Sharma, Anjana] Rani Durgavati Univ, Dept Postgrad Studies & Res Biol Sci, Jabalpur 482001, Madhya Pradesh, India; [Bisen, Prakash S.] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, Madhya Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Jiwaji University Gwalior	Bisen, PS (corresponding author), Govt India, Def Res Dev Estab, Def Res Dev Org, Minist Def, Gwalior, Madhya Pradesh, India.	psbisen@gmail.com	Bisen, Prakash S/H-3392-2019	Bisen, Prakash S/0000-0002-2818-7829	Council of Scientific and Industrial Research (CSIR), New Delhi under Emeritus Scientist scheme	Council of Scientific and Industrial Research (CSIR), New Delhi under Emeritus Scientist scheme	Financial assistance was awarded by the Council of Scientific and Industrial Research (CSIR), New Delhi under Emeritus Scientist scheme to Professor P.S. Bisen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambatipudi S, 2012, GENE CHROMOSOME CANC, V51, P161, DOI 10.1002/gcc.20940; Awada A, 2013, CURR OPIN ONCOL, V25, P296, DOI 10.1097/CCO.0b013e32835ff318; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisen P.S., 2013, BIOL ORAL CANC KEY A; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Bonferroni CE, 1936, PUBBLICAZIONI R I SU, V8, P3; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Ding J, 2002, Pac Symp Biocomput, P326; Ellis LM, 2009, CLIN CANCER RES, V15, P7471, DOI 10.1158/1078-0432.CCR-09-1070; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher R., 1970, STAT METHODS RES WOR; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Mittal AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070352; Pearson H, 2001, NATURE, V411, P631, DOI 10.1038/35079694; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Raffoul F, 2010, AUTOPHAGY, V6, P955, DOI 10.4161/auto.6.7.13041; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rudy J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-467; Sayers E, 2014, NCBI SHORT COURSES; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Turnbull AK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-35; Warnes GR, 2006, SAMPLE SIZE ESTIMATI; Wheeler SE, 2012, CLIN CANCER RES, V18, P2850, DOI 10.1158/1078-0432.CCR-11-2486; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	39	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102610	10.1371/journal.pone.0102610	http://dx.doi.org/10.1371/journal.pone.0102610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029526	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600087
J	van Ballegooijen, W; Cuijpers, P; van Straten, A; Karyotaki, E; Andersson, G; Smit, JH; Riper, H				van Ballegooijen, Wouter; Cuijpers, Pim; van Straten, Annemieke; Karyotaki, Eirini; Andersson, Gerhard; Smit, Jan H.; Riper, Heleen			Adherence to Internet-Based and Face-to-Face Cognitive Behavioural Therapy for Depression: A Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SELF-HELP; PSYCHOLOGICAL TREATMENTS; PSYCHOTHERAPY; ANXIETY; MODERATE; ACCEPTABILITY; INTERVENTIONS; MEDICATION; SYMPTOMS	Background: Internet-based cognitive behavioural therapy (iCBT) is an effective and acceptable treatment for depression, especially when it includes guidance, but its treatment adherence has not yet been systematically studied. We conducted a meta-analysis, comparing the adherence to guided iCBT with the adherence to individual face-to-face CBT. Methods: Studies were selected from a database of trials that investigate treatment for adult depression (see www.evidencebasedpsychotherapies.org), updated to January 2013. We identified 24 studies describing 26 treatment conditions (14 face-to-face CBT, 12 guided iCBT), by means of these inclusion criteria: targeting depressed adults, no comorbid somatic disorder or substance abuse, community recruitment, published in the year 2000 or later. The main outcome measure was the percentage of completed sessions. We also coded the percentage of treatment completers (separately coding for 100% or at least 80% of treatment completed). Results: We did not find studies that compared guided iCBT and face-to-face CBT in a single trial that met our inclusion criteria. Face-to-face CBT treatments ranged from 12 to 28 sessions, guided iCBT interventions consisted of 5 to 9 sessions. Participants in face-to-face CBT completed on average 83.9% of their treatment, which did not differ significantly from participants in guided iCBT (80.8%, P = .59). The percentage of completers (total intervention) was significantly higher in face-to-face CBT (84.7%) than in guided iCBT (65.1%, P<.001), as was the percentage of completers of 80% or more of the intervention (face-to-face CBT: 85.2%, guided iCBT: 67.5%, P = .003). Non-completers of face-to-face CBT completed on average 24.5% of their treatment, while non-completers of guided iCBT completed on average 42.1% of their treatment. Conclusion: We did not find studies that compared guided iCBT and face-to-face CBT in a single trial. Adherence to guided iCBT appears to be adequate and could be equal to adherence to face-to-face CBT.	[van Ballegooijen, Wouter; Cuijpers, Pim; van Straten, Annemieke; Karyotaki, Eirini; Riper, Heleen] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [van Ballegooijen, Wouter; Smit, Jan H.; Riper, Heleen] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, GGZ InGeest, Amsterdam, Netherlands; [van Ballegooijen, Wouter; Cuijpers, Pim; van Straten, Annemieke; Karyotaki, Eirini; Smit, Jan H.; Riper, Heleen] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Riper, Heleen] Leuphana Univ, Luneburg, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Linkoping University; Karolinska Institutet; Leuphana University Luneburg	van Ballegooijen, W (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	w.van.ballegooijen@vu.nl	Cuijpers, Pim/G-1703-2013; van Straten, Annemieke/P-8495-2019; Andersson, Gerhard/J-8529-2012	van Straten, Annemieke/0000-0001-6875-2215; Andersson, Gerhard/0000-0003-4753-6745; van Ballegooijen, Wouter/0000-0002-9189-6695; Cuijpers, Pim/0000-0001-5497-2743; Karyotaki, Eirini/0000-0002-0071-2599				Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Beck A, 1979, COGNITIVE THERAPY DE; Bendelin N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-107; Berger Thomas, 2011, Cognitive Behaviour Therapy, V40, P251, DOI 10.1080/16506073.2011.616531; Bodenmann G, 2008, J CONSULT CLIN PSYCH, V76, P944, DOI 10.1037/a0013467; Castonguay LG, 2004, J PSYCHOTHERAPY INTE, V14, P4, DOI DOI 10.1037/1053-0479.14.1.4; Choi I, 2012, J AFFECT DISORDERS, V136, P459, DOI 10.1016/j.jad.2011.11.003; Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695; Christensen H, 2006, AUST NZ J PSYCHIAT, V40, P59, DOI 10.1080/j.1440-1614.2006.01743.x; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Clarke Greg, 2009, Cognitive Behaviour Therapy, V38, P222, DOI 10.1080/16506070802675353; Constantino MJ, 2008, PSYCHOTHERAPY, V45, P122, DOI 10.1037/0033-3204.45.2.122; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; David D, 2008, J CLIN PSYCHOL, V64, P728, DOI 10.1002/jclp.20487; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Donkin L, 2012, J MED INTERNET RES, V14, P262, DOI 10.2196/jmir.2100; Donkin L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1772; Dunlop BW, 2012, J PSYCHIATR RES, V46, P375, DOI 10.1016/j.jpsychires.2011.11.003; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Gerhards SAH, 2010, BRIT J PSYCHIAT, V196, P310, DOI 10.1192/bjp.bp.109.065748; Gun SY, 2011, AUSTRALAS PSYCHIATRY, V19, P259, DOI 10.3109/10398562.2011.562295; Hatchett GT, 2003, PSYCHOTHERAPY, V40, P226, DOI 10.1037/0033-3204.40.3.226; Hautzinger M, 2008, Z KL PSYCH PSYCHOTH, V37, P52, DOI 10.1026/1616-3443.37.1.52; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Johansson R, 2012, EXPERT REV NEUROTHER, V12, P861, DOI [10.1586/ERN.12.63, 10.1586/ern.12.63]; Johansson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036905; Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607; Kelders SM, 2012, J MED INTERNET RES, V14, P17, DOI 10.2196/jmir.2104; Lewinsohn PM, 1984, COPING DEPRESSION CO; McBride C, 2006, J CONSULT CLIN PSYCH, V74, P1041, DOI 10.1037/0022-006X.74.6.1041; Melville KM, 2010, BRIT J CLIN PSYCHOL, V49, P455, DOI 10.1348/014466509X472138; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Mitchell AJ, 2007, PSYCHIAT SERV, V58, P868, DOI 10.1176/appi.ps.58.6.868; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004; Ruwaard Jeroen, 2009, Cognitive Behaviour Therapy, V38, P206, DOI 10.1080/16506070802408086; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Serfaty MA, 2009, ARCH GEN PSYCHIAT, V66, P1332, DOI 10.1001/archgenpsychiatry.2009.165; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Strauman TJ, 2006, J CONSULT CLIN PSYCH, V74, P367, DOI 10.1037/0022-006X.74.2.367; Swift JK, 2012, J CONSULT CLIN PSYCH, V80, P547, DOI 10.1037/a0028226; Teismann T, 2011, PSYCHOTHER PSYCH MED, V61, P295, DOI 10.1055/s-0030-1270453; Thompson LW, 2001, AM J GERIAT PSYCHIAT, V9, P225, DOI 10.1176/appi.ajgp.9.3.225; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224; Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.954; Watson JC, 2003, J CONSULT CLIN PSYCH, V71, P773, DOI 10.1037/0022-006X.71.4.773; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190	56	201	202	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100674	10.1371/journal.pone.0100674	http://dx.doi.org/10.1371/journal.pone.0100674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029507	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600007
J	Yang, H; Li, YM; Wu, W; Sun, QW; Zhang, YZ; Zhao, W; Lv, HB; Xia, Q; Hu, PJ; Li, HH; Qian, JM				Yang, Hong; Li, Yumei; Wu, Wei; Sun, Qingwen; Zhang, Yunzhong; Zhao, Wei; Lv, Hongbo; Xia, Qing; Hu, Pinjin; Li, Haihua; Qian, Jiaming			The Incidence of Inflammatory Bowel Disease in Northern China: A Prospective Population-Based Study	PLOS ONE			English	Article							CROHNS-DISEASE; EPIDEMIOLOGY; PREVALENCE	Aims & Backgrounds: Although inflammatory bowel diseases (IBD) are emerging and increasing in China, epidemiologic data are rarely available. This study was to investigate the epidemiological and clinical characteristics of IBD in Northern China. Methods: This is a prospective, population-based study of incidence of IBD in Daqing, Heilongjiang province of Northern China from March 1, 2012 to February 28, 2013. All incident patients with IBD were clinically identified by IBD specialist group from five main General Hospitals covering the healthcare service for 1,343,364 residents in the urban areas of Daqing. IBD cases included in this study were followed-up for three months for diagnosis confirmation. Results: A total of 27 new IBD cases including 25 cases of ulcerative colitis (UC) and 2 cases of Crohn's disease (CD) were identified. The population at risk was 1,343,364 person years. Age-adjusted incidence for total IBD, CD and UC were 1.77, 0.13, and 1.64 per 100,000population, respectively. A male predominance was found in CD patients (male to female ratio was 2: 0). In contrast, no obvious gender predominance was found in UC patients (male to female ratio was 1:1.1). CD patients were diagnosed at an average age of 39.5 years. The main disease phenotypes of UC were distal colitis with a 24% of proctitis and 56% of left-sided colitis. The mean diagnostic age of UC patients was 48.9 years. Conclusions: This is the first report on the incidence of IBD in the Northern Chinese population. A lower incidence of IBD, similar male predominance for CD, similar disease phenotype of UC, and lower disease activity was observed in Daqing compared to that in Southern China.	[Yang, Hong; Qian, Jiaming] Beijing Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Li, Yumei; Sun, Qingwen; Lv, Hongbo; Xia, Qing; Li, Haihua] Daqing Longnan Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Wu, Wei] Daqing Oilfield Gen Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Zhang, Yunzhong] Daqing People Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Zhao, Wei] Daqing Fourth Hosp, Dept Gastroenterol, Daqing, Peoples R China; [Hu, Pinjin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Sun Yat Sen University	Qian, JM (corresponding author), Beijing Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China.	qianjiaming1957@126.com			Health Research & Special Projects Grant [201002020]	Health Research & Special Projects Grant	This study was supported by Health Research & Special Projects Grant(No. 201002020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Green C, 2006, AM J EPIDEMIOL, V164, P615, DOI 10.1093/aje/kwj260; HARVEY RF, 1980, LANCET, V1, P514; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Prideaux L, 2012, J GASTROEN HEPATOL, V27, P1266, DOI 10.1111/j.1440-1746.2012.07150.x; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Zeng ZR, 2013, J GASTROEN HEPATOL, V28, P1148, DOI 10.1111/jgh.12164; Zhao J, 2013, INFLAMM BOWEL DIS, V19, P1839, DOI 10.1097/MIB.0b013e31828a6551	13	53	80	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101296	10.1371/journal.pone.0101296	http://dx.doi.org/10.1371/journal.pone.0101296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029440	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600013
J	Lo Re, S; Yakoub, Y; Devosse, R; Uwambayinema, F; Couillin, I; Ryffel, B; Marbaix, E; Lison, D; Huaux, F				Lo Re, Sandra; Yakoub, Yousof; Devosse, Raynal; Uwambayinema, Francine; Couillin, Isabelle; Ryffel, Bernard; Marbaix, Etienne; Lison, Dominique; Huaux, Francois			Uncoupling between Inflammatory and Fibrotic Responses to Silica: Evidence from MyD88 Knockout Mice	PLOS ONE			English	Article							INDUCED LUNG INFLAMMATION; TUMOR-NECROSIS-FACTOR; INDUCED PULMONARY INFLAMMATION; RECEPTOR ANTAGONIST; NALP3 INFLAMMASOME; MURINE SILICOSIS; T-LYMPHOCYTES; C57BL/6 MICE; NMRI MICE; FIBROSIS	The exact implication of innate immunity in granuloma formation and irreversible lung fibrosis remains to be determined. In this study, we examined the lung inflammatory and fibrotic responses to silica in MyD88-knockout (KO) mice. In comparison to wild-type (WT) mice, we found that MyD88-KO animals developed attenuated lung inflammation, neutrophil accumulation and IL-1 beta release in response to silica. Granuloma formation was also less pronounced in MyD88-KO mice after silica. This limited inflammatory response was not accompanied by a concomitant attenuation of lung collagen accumulation after silica. Histological analyses revealed that while pulmonary fibrosis was localized in granulomas in WT animals, it was diffusely distributed throughout the parenchyma in MyD88-KO mice. Robust collagen accumulation was also observed in mice KO for several other components of innate immunity (IL-1R, IL-1, ASC, NALP3, IL-18R, IL-33R, TRIF, and TLR2-3-4,). We additionally show that pulmonary fibrosis in MyD88-KO mice was associated with the accumulation of pro-fibrotic regulatory T lymphocytes (T regs) and pro-fibrotic cytokine expression (TGF-beta, IL-10 and PDGF-B), not with T helper (Th) 17 cell influx. Our findings indicate that the activation of MyD88-related innate immunity is central in the establishment of particle-induced lung inflammatory and granuloma responses. The development of lung fibrosis appears uncoupled from inflammation and may be orchestrated by a T reg-associated pathway.	[Lo Re, Sandra; Yakoub, Yousof; Devosse, Raynal; Uwambayinema, Francine; Lison, Dominique; Huaux, Francois] Catholic Univ Louvain, IREC, Louvain Ctr Toxicol & Appl Pharmacol LTAP, B-1200 Brussels, Belgium; [Couillin, Isabelle; Ryffel, Bernard] Univ Orleans, CNRS, UMR7355, Transgenose Inst,INEM, Orleans, France; [Marbaix, Etienne] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Universite Catholique Louvain	Huaux, F (corresponding author), Catholic Univ Louvain, IREC, Louvain Ctr Toxicol & Appl Pharmacol LTAP, B-1200 Brussels, Belgium.	francois.huaux@uclouvain.be	Lison, Dominique/A-8985-2010	Lison, Dominique/0000-0001-6557-2518	"Marshall" Programme d'excellence Diane convention; Fonds de la Recherche Scientifique Medicale (FRSM); Actions de Recherche Concertees, Communaute francaise de Belgique, Direction de la Recherche Scientifique [ARC 09/14-021]; Fondation Contre le Cancer; Fonds de la Recherche Scientifique (FNRS) [PDR T.0119.13 14633768]; European Commission [FP7-HEALTH-F4-2008, 202047]; Agence Nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES, France)	"Marshall" Programme d'excellence Diane convention; Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees, Communaute francaise de Belgique, Direction de la Recherche Scientifique; Fondation Contre le Cancer; Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES, France)	This work was funded by the "Marshall" Programme d'excellence Diane convention, by the Fonds de la Recherche Scientifique Medicale (FRSM), by Actions de Recherche Concertees, Communaute francaise de Belgique, Direction de la Recherche Scientifique (ARC 09/14-021), by the Fondation Contre le Cancer, by the Fonds de la Recherche Scientifique (FNRS; Project PDR T.0119.13 14633768), by the European Commission under FP7-HEALTH-F4-2008 (Contract no. 202047), and by Agence Nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES, France). F.H. is a Research Associate with the FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarin V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-112; Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Barbarin V, 2004, AM J RESP CELL MOL, V31, P78, DOI 10.1165/rcmb.2003-0299OC; Bauer C, 2013, AM J RESP CELL MOL, V48, P781, DOI 10.1165/rcmb.2012-0479OC; Beamer CA, 2007, AM J RESP CELL MOL, V37, P729, DOI 10.1165/rcmb.2007-0099OC; Beamer CA, 2012, TOXICOL SCI, V126, P554, DOI 10.1093/toxsci/kfs024; Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Brass DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040789; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chen Y, 2014, TOXICOL APPL PHARM, V275, P62, DOI 10.1016/j.taap.2013.11.012; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Davis Gerald S., 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P53; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Fujihashi K, 1996, J EXP MED, V183, P1929, DOI 10.1084/jem.183.4.1929; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Giordano G, 2010, TOXICOL SCI, V116, P682, DOI 10.1093/toxsci/kfq158; Gordon H, 1936, AM J PATHOL, V12, P545; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Guo JL, 2013, ARCH TOXICOL, V87, P1963, DOI 10.1007/s00204-013-1063-z; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huaux F, 1999, AM J RESP CELL MOL, V20, P561, DOI 10.1165/ajrcmb.20.4.3342; Huaux F, 2002, J IMMUNOL, V169, P2653, DOI 10.4049/jimmunol.169.5.2653; Huaux F, 1998, AM J RESP CELL MOL, V18, P51, DOI 10.1165/ajrcmb.18.1.2911; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Langley RJ, 2011, J TOXICOL ENV HEAL A, V74, P1261, DOI 10.1080/15287394.2011.595669; Lee CG, 2002, J BIOL CHEM, V277, P35466, DOI 10.1074/jbc.M206395200; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Lo Re S, 2013, J LEUKOCYTE BIOL, V93, P499, DOI 10.1189/jlb.0512261; Lo Re S, 2011, AM J RESP CRIT CARE, V184, P1270, DOI 10.1164/rccm.201103-0516OC; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; Madala SK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-51; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Misson P, 2004, J LEUKOCYTE BIOL, V76, P926, DOI 10.1189/jlb.0104019; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Ortiz LA, 2001, AM J RESP CRIT CARE, V163, P244, DOI 10.1164/ajrccm.163.1.2002123; Papiris Spyros A, 2007, J Inflamm (Lond), V4, P14, DOI 10.1186/1476-9255-4-14; Pernis Benvenuto, 2005, Acta Biomed, V76 Suppl 2, P38; Petsonk EL, 2013, AM J RESP CRIT CARE, V187, P1178, DOI 10.1164/rccm.201301-0042CI; PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0; Rabolli V, 2011, TOXICOL LETT, V203, P127, DOI 10.1016/j.toxlet.2011.03.009; ROLFE MW, 1993, AM REV RESPIR DIS, V148, P1378, DOI 10.1164/ajrccm/148.5.1378; Ruth JH, 1996, J IMMUNOL, V156, P2503; Scherbart AM, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-31; Shimbori C, 2012, INT ARCH ALLERGY IMM, V158, P241, DOI 10.1159/000331439; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tarantal AF, 2010, EUR RESPIR J, V36, P907, DOI 10.1183/09031936.00011810; ten Berge B, 2012, RHEUMATOLOGY, V51, P37, DOI 10.1093/rheumatology/ker316; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weston Ainsley, 2011, IARC Sci Publ, P387; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Zhang YX, 2012, EUR J IMMUNOL, V42, P1523, DOI 10.1002/eji.201141933; Zhou T, 2012, J OCCUP ENVIRON MED, V54, P459, DOI 10.1097/JOM.0b013e31824525ab	70	32	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e99383	10.1371/journal.pone.0099383	http://dx.doi.org/10.1371/journal.pone.0099383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050810	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100002
J	Robert, G; Munoz, N; Melchiorre, M; Sanchez, F; Lascano, R				Robert, German; Munoz, Nacira; Melchiorre, Mariana; Sanchez, Federico; Lascano, Ramiro			Expression of Animal Anti-Apoptotic Gene Ced-9 Enhances Tolerance during Glycine max L.-Bradyrhizobium japonicum Interaction under Saline Stress but Reduces Nodule Formation	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; YELLOW 2 CELLS; SALT STRESS; OSMOTIC-STRESS; ROOT HAIRS; BCL-XL; EN-ROUTE; TOBACCO; NECROSIS; INDUCTION	The mechanisms by which the expression of animal cell death suppressors in economically important plants conferred enhanced stress tolerance are not fully understood. In the present work, the effect of expression of animal antiapoptotic gene Ced-9 in soybean hairy roots was evaluated under root hairs and hairy roots death-inducing stress conditions given by i) Bradyrhizobium japonicum inoculation in presence of 50 mM NaCl, and ii) severe salt stress (150 mM NaCl), for 30 min and 3 h, respectively. We have determined that root hairs death induced by inoculation in presence of 50 mM NaCl showed characteristics of ordered process, with increased ROS generation, MDA and ATP levels, whereas the cell death induced by 150 mM NaCl treatment showed non-ordered or necrotic-like characteristics. The expression of Ced-9 inhibited or at least delayed root hairs death under these treatments. Hairy roots expressing Ced-9 had better homeostasis maintenance, preventing potassium release; increasing the ATP levels and controlling the oxidative damage avoiding the increase of reactive oxygen species production. Even when our results demonstrate a positive effect of animal cell death suppressors in plant cell ionic and redox homeostasis under cell death-inducing conditions, its expression, contrary to expectations, drastically inhibited nodule formation even under control conditions.	[Robert, German; Munoz, Nacira; Melchiorre, Mariana; Lascano, Ramiro] Ctr Invest Agr INTA, Inst Fisiol & Recursos Genet Vegetales, Cordoba, Argentina; [Robert, German; Munoz, Nacira; Lascano, Ramiro] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Fisiol Vegetal, RA-5000 Cordoba, Argentina; [Sanchez, Federico] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62191, Morelos, Mexico	Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Cordoba; Universidad Nacional Autonoma de Mexico	Lascano, R (corresponding author), Ctr Invest Agr INTA, Inst Fisiol & Recursos Genet Vegetales, Cordoba, Argentina.	lascano.ramiro@inta.gob.ar	Robert, Germán/HHN-6321-2022	Robert, German/0000-0002-6220-1225; Lascano, Hernan Ramiro/0000-0002-9576-9941; Munoz, Nacira/0000-0002-4792-9357	Agencia de Promocion Cientifica y Tecnologica, Argentina; Instituto Nacional de Tecnologia Agropecuaria (INTA); Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT); CONACYT de Mexico	Agencia de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Instituto Nacional de Tecnologia Agropecuaria (INTA); Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT); CONACYT de Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Agencia de Promocion Cientifica y Tecnologica, Argentina; Instituto Nacional de Tecnologia Agropecuaria (INTA); and Scientific and Technological Cooperation Program between Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT), and CONACYT de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; [Anonymous], 1970, MANUAL PRACTICAL STU; Blanco FA, 2009, PLANT CELL, V21, P2797, DOI 10.1105/tpc.108.063420; ASHRAF M, 1994, CRIT REV PLANT SCI, V13, P17, DOI 10.1080/713608051; Atlante A, 2005, BBA-BIOENERGETICS, V1708, P50, DOI 10.1016/j.bbabio.2005.01.009; Azad AK, 2008, J EXP BOT, V59, P2085, DOI 10.1093/jxb/ern066; Baron C, 1995, ANNU REV GENET, V29, P107, DOI 10.1146/annurev.ge.29.120195.000543; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Bozhkov PV, 2011, CELL DEATH DIFFER, V18, P1239, DOI 10.1038/cdd.2011.86; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Casolo V, 2005, J EXP BOT, V56, P997, DOI 10.1093/jxb/eri093; Chen SR, 2004, J EXP BOT, V55, P2617, DOI 10.1093/jxb/erh275; Chen X, 2009, PLANT PHYSIOL BIOCH, V47, P407, DOI 10.1016/j.plaphy.2008.12.021; DELGADO MJ, 1994, SOIL BIOL BIOCHEM, V26, P371, DOI 10.1016/0038-0717(94)90286-0; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; Demidchik V, 2007, PLANT J, V49, P377, DOI 10.1111/j.1365-313X.2006.02971.x; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; Estrada-Navarrete G, 2006, MOL PLANT MICROBE IN, V19, P1385, DOI 10.1094/MPMI-19-1385; Felle HH, 2000, PLANT PHYSIOL, V124, P1373, DOI 10.1104/pp.124.3.1373; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fujiki Y, 2007, PLANT PHYSIOL, V143, P1132, DOI 10.1104/pp.106.093864; Fukuda K, 1999, J GASTROEN HEPATOL, V14, P682, DOI 10.1046/j.1440-1746.1999.01935.x; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gillespie KM, 2007, NAT PROTOC, V2, P871, DOI 10.1038/nprot.2007.101; GUILBAULT GG, 1968, ANAL CHEM, V40, P1256, DOI 10.1021/ac60264a027; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Katsuhara M, 1996, PLANT CELL PHYSIOL, V37, P169, DOI 10.1093/oxfordjournals.pcp.a028928; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lee Y, 2008, PLANT PHYSIOL, V147, P1886, DOI 10.1104/pp.108.121590; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; Mitsuhara I, 1999, CURR BIOL, V9, P775, DOI 10.1016/S0960-9822(99)80341-8; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Mlejnek P, 2003, PLANT CELL ENVIRON, V26, P1723, DOI 10.1046/j.1365-3040.2003.01090.x; Munoz N, 2014, FUNCT PLANT BIOL, V41, P96, DOI 10.1071/FP13085; Munoz N, 2012, ENVIRON EXP BOT, V78, P76, DOI 10.1016/j.envexpbot.2011.12.008; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Newell JM, 1998, J EXP BOT, V49, P817, DOI 10.1093/jexbot/49.322.817; Oldroyd GED, 2005, PLANT PHYSIOL, V137, P1205, DOI 10.1104/pp.104.057661; Papucci L, 2004, CELL TISSUE RES, V316, P197, DOI 10.1007/s00441-004-0872-z; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Qiao J, 2002, PLANT CELL PHYSIOL, V43, P992, DOI 10.1093/pcp/pcf122; Rodriguez M, 2013, REDOX REP, V18, P27, DOI 10.1179/1351000212Y.0000000035; Rodriguez M, 2010, J PLANT PHYSIOL, V167, P1137, DOI 10.1016/j.jplph.2010.03.004; Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/en.141.6.2003; Shabala S, 2007, PLANTA, V227, P189, DOI 10.1007/s00425-007-0606-z; SINGLETON PW, 1984, PLANT PHYSIOL, V74, P72, DOI 10.1104/pp.74.1.72; SIONIT N, 1977, AGRON J, V69, P274, DOI 10.2134/agronj1977.00021962006900020018x; Slesak I, 2002, PLANT PHYSIOL BIOCH, V40, P669, DOI 10.1016/S0981-9428(02)01409-2; Tablada C, 2012, INFOSTAT SOFTWARE ES; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Teng X, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.72; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; Tsujimoto Yoshihide, 1997, Leukemia (Basingstoke), V11, P380; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; Valenti D, 2007, BBA-BIOENERGETICS, V1767, P66, DOI 10.1016/j.bbabio.2006.11.004; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; Wan JR, 2005, MOL PLANT MICROBE IN, V18, P458, DOI 10.1094/MPMI-18-0458; Xu P, 2004, P NATL ACAD SCI USA, V101, P15805, DOI 10.1073/pnas.0407094101; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	74	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101747	10.1371/journal.pone.0101747	http://dx.doi.org/10.1371/journal.pone.0101747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050789	Green Published, gold			2022-12-27	WOS:000339551100013
J	Almeida-Suhett, CP; Prager, EM; Pidoplichko, V; Figueiredo, TH; Marini, AM; Li, Z; Eiden, LE; Braga, MFM				Almeida-Suhett, Camila P.; Prager, Eric M.; Pidoplichko, Volodymyr; Figueiredo, Taiza H.; Marini, Ann M.; Li, Zheng; Eiden, Lee E.; Braga, Maria F. M.			Reduced GABAergic Inhibition in the Basolateral Amygdala and the Development of Anxiety-Like Behaviors after Mild Traumatic Brain Injury	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NICOTINIC ACETYLCHOLINE-RECEPTORS; CONTROLLED CORTICAL IMPACT; BENZODIAZEPINE-RECEPTOR; SYNAPTIC-TRANSMISSION; PREFRONTAL CORTEX; PANIC DISORDER; BINDING; SENSITIVITY; MICE	Traumatic brain injury (TBI) is a major public health concern affecting a large number of athletes and military personnel. Individuals suffering from a TBI risk developing anxiety disorders, yet the pathophysiological alterations that result in the development of anxiety disorders have not yet been identified. One region often damaged by a TBI is the basolateral amygdala (BLA); hyperactivity within the BLA is associated with increased expression of anxiety and fear, yet the functional alterations that lead to BLA hyperexcitability after TBI have not been identified. We assessed the functional alterations in inhibitory synaptic transmission in the BLA and one mechanism that modulates excitatory synaptic transmission, the alpha(7) containing nicotinic acetylcholine receptor (alpha(7)-nAChR), after mTBI, to shed light on the mechanisms that contribute to increased anxiety-like behaviors. Seven and 30 days after a mild controlled cortical impact (CCI) injury, animals displayed significantly greater anxiety-like behavior. This was associated with a significant loss of GABAergic interneurons and significant reductions in the frequency and amplitude of spontaneous and miniature GABA(A)-receptor mediated inhibitory postsynaptic currents (IPSCs). Decreases in the mIPSC amplitude were associated with reduced surface expression of alpha 1, beta 2, and gamma 2 GABA(A) receptor subunits. However, significant increases in the surface expression and current mediated by alpha(7)-nAChR, were observed, signifying increases in the excitability of principal neurons within the BLA. These results suggest that mTBI causes not only a significant reduction in inhibition in the BLA, but also an increase in neuronal excitability, which may contribute to hyperexcitability and the development of anxiety disorders.	[Almeida-Suhett, Camila P.; Prager, Eric M.; Marini, Ann M.; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Program Neurosci, Bethesda, MD 20814 USA; [Pidoplichko, Volodymyr; Figueiredo, Taiza H.; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Marini, Ann M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Almeida-Suhett, Camila P.; Marini, Ann M.; Li, Zheng; Eiden, Lee E.; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Li, Zheng] NIMH, Sect Clin Studies, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Eiden, Lee E.] NIMH, Mol Neurosci Sect, Intramural Res Program, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Braga, MFM (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Program Neurosci, Bethesda, MD 20814 USA.	maria.braga@usuhs.edu	Prager, Eric/O-1567-2015; Li, Zheng/I-8016-2014; Almeida-Suhett, Camila/I-8045-2016	Prager, Eric/0000-0002-3810-0985; Li, Zheng/0000-0002-2978-2531; Eiden, Lee/0000-0001-7524-944X; Almeida-Suhett, Camila/0000-0002-7588-9487	Department of Defense in the Center for Neuroscience and Regenerative Medicine [G1702Z]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386] Funding Source: NIH RePORTER	Department of Defense in the Center for Neuroscience and Regenerative Medicine(United States Department of Defense); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge the Department of Defense in the Center for Neuroscience and Regenerative Medicine for financially supporting the present work. Grant# G1702Z. URL of funder's website: http://www.usuhs.mil/cnrm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Aroniadou-Anderjaska V, 2012, NEUROSCIENCE, V221, P157, DOI 10.1016/j.neuroscience.2012.07.006; Bailey SJ, 2004, J NEUROSCI, V24, P6343, DOI 10.1523/JNEUROSCI.0563-04.2004; Barazangi N, 2001, J NEUROPHYSIOL, V86, P463, DOI 10.1152/jn.2001.86.1.463; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bremner JD, 2000, AM J PSYCHIAT, V157, P1120, DOI 10.1176/appi.ajp.157.7.1120; Bremner JD, 2000, BIOL PSYCHIAT, V47, P96, DOI 10.1016/S0006-3223(99)00188-2; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chen J, 2013, NEUROSCI LETT, V541, P275, DOI 10.1016/j.neulet.2013.02.005; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cowley DS, 1997, J CLIN PSYCHIAT, V58, P555, DOI 10.4088/JCP.v58n1208; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Faraday MM, 2001, PHARMACOL BIOCHEM BE, V70, P475, DOI 10.1016/S0091-3057(01)00642-6; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Feuerbach D, 2009, NEUROPHARMACOLOGY, V56, P254, DOI 10.1016/j.neuropharm.2008.08.025; Figueiredo TH, 2011, BRIT J PHARMACOL, V164, P1495, DOI 10.1111/j.1476-5381.2011.01427.x; Figueiredo TH, 2011, J PHARMACOL EXP THER, V336, P303, DOI 10.1124/jpet.110.171835; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GLUE P, 1991, LANCET, V337, P563, DOI 10.1016/0140-6736(91)91359-3; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holzschneider Kathrin, 2011, Dialogues Clin Neurosci, V13, P453; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jiang L, 2008, J NEUROPHYSIOL, V99, P1988, DOI 10.1152/jn.00933.2007; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Klein RC, 2006, J PHYSIOL-LONDON, V576, P865, DOI 10.1113/jphysiol.2006.118232; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Paxinos G, 2005, RAT BRAIN STEROTAXIC, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Pidoplichko VI, 2005, J NEUROSCI METH, V142, P55, DOI 10.1016/j.jneumeth.2004.07.012; Pidoplichko VI, 2013, J NEUROPHYSIOL, V110, P2358, DOI 10.1152/jn.01030.2012; Prager EM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00038; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; RoyByrne P, 1996, AM J PSYCHIAT, V153, P1444; Sah P, 2003, ANN NY ACAD SCI, V985, P67; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Sibille E, 2000, J NEUROSCI, V20, P2758; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tiihonen J, 1997, MOL PSYCHIATR, V2, P463, DOI 10.1038/sj.mp.4000329; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Villarreal G, 2001, Semin Clin Neuropsychiatry, V6, P131, DOI 10.1053/scnp.2001.21840; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; WOMBLE MD, 1993, J NEUROPHYSIOL, V70, P2056, DOI 10.1152/jn.1993.70.5.2056; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020	72	75	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102627	10.1371/journal.pone.0102627	http://dx.doi.org/10.1371/journal.pone.0102627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047645	gold, Green Submitted, Green Published			2022-12-27	WOS:000339558100054
J	Delvaux, B; Howard, D				Delvaux, Bertrand; Howard, David			A New Method to Explore the Spectral Impact of the Piriform Fossae on the Singing Voice: Benchmarking Using MRI-Based 3D-Printed Vocal Tracts	PLOS ONE			English	Article							RADIATION	The piriform fossae are the 2 pear-shaped cavities lateral to the laryngeal vestibule at the lower end of the vocal tract. They act acoustically as side-branches to the main tract, resulting in a spectral zero in the output of the human voice. This study investigates their spectral role by comparing numerical and experimental results of MRI-based 3D printed Vocal Tracts, for which a new experimental method (based on room acoustics) is introduced. The findings support results in the literature: the piriform fossae create a spectral trough in the region 4-5 kHz and act as formants repellents. Moreover, this study extends those results by demonstrating numerically and perceptually the impact of having large piriform fossae on the sung output.	[Delvaux, Bertrand; Howard, David] Univ York, Dept Elect, Audiolab, York YO10 5DD, N Yorkshire, England; [Delvaux, Bertrand; Howard, David] Univ York, York Ctr Singing Sci, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Delvaux, B (corresponding author), Univ York, Dept Elect, Audiolab, York YO10 5DD, N Yorkshire, England.	bertrand.delvaux@gmail.com		Howard, david/0000-0001-9516-9551				Aalto D, 2011, 17 INT C PHON SCI; Ashalatha PR, 2011, TXB ANATOMY PHYSL NU; Bunch M, 2000, J VOICE, V14, P363, DOI 10.1016/S0892-1997(00)80081-8; Dalmont JP, 2001, J SOUND VIB, V244, P505, DOI 10.1006/jsvi.2000.3487; Dang JW, 1998, J ACOUST SOC AM, V104, P1075, DOI 10.1121/1.423324; Dang JW, 1997, J ACOUST SOC AM, V101, P456, DOI 10.1121/1.417990; Davies L, 1993, VOCAL FOLD PHYSL FRO, P93; Engwall O, 1999, TECHNICAL REPORT; Engwall O., 2006, SPEECH PRODUCTION MO, P301; Farina A., ADV IMPULSE RESPONSE, P4; Farina A., 2000, PREPRINTS AUDIO ENG, P1; Honda K, 2010, COMPUT METHOD BIOMEC, V13, P443, DOI 10.1080/10255842.2010.490528; INGARD U, 1953, J ACOUST SOC AM, V25, P830; Kitamura T, 2005, ACOUST SCI TECHNOL, V26; LEVINE H, 1948, PHYS REV, V73, P383, DOI 10.1103/PhysRev.73.383; Meng Q., 2008, P 2 INT C SIGN PROC, P1; MOTOKI K, 1992, J ACOUST SOC AM, V92, P2577, DOI 10.1121/1.404430; NOMURA Y, 1960, J PHYS SOC JPN, V15, P510, DOI 10.1143/JPSJ.15.510; PAINTER C, 1986, ARCH OTO-RHINO-LARYN, V243, P329, DOI 10.1007/BF00460212; Rubin P, 2007, TNM STAGING ATLAS; Schwenk K., 2000, FEEDING FORM FUNCTIO, V1st; Speed M, THESIS U YORK; Speed M, 2014, IEEE-ACM T AUDIO SPE, V22, P453, DOI 10.1109/TASLP.2013.2294579; Stan GB, 2002, J AUDIO ENG SOC, V50, P249; Stone M, 2007, J ACOUST SOC AM, V122, P532, DOI 10.1121/1.2715659; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; Takemoto H, 2006, J ACOUST SOC AM, V119, P1037, DOI 10.1121/1.2151823; Titze IR, 1997, J ACOUST SOC AM, V101, P2234, DOI 10.1121/1.418246; Titze IR, 2001, J VOICE, V15, P519, DOI 10.1016/S0892-1997(01)00052-2	30	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102680	10.1371/journal.pone.0102680	http://dx.doi.org/10.1371/journal.pone.0102680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048199	Green Accepted, Green Published, gold			2022-12-27	WOS:000339558100060
J	Bernues, A; Rodriguez-Ortega, T; Ripoll-Bosch, R; Alfnes, F				Bernues, Alberto; Rodriguez-Ortega, Tamara; Ripoll-Bosch, Raimon; Alfnes, Frode			Socio-Cultural and Economic Valuation of Ecosystem Services Provided by Mediterranean Mountain Agroecosystems	PLOS ONE			English	Article							CONSERVATION; LANDSCAPE; EUROPE; PREFERENCES; GRASSLAND; FRAMEWORK; PRODUCTS; SYSTEMS; CHOICE	The aim of this work was to elucidate the socio-cultural and economic value of a number of ecosystem services delivered by mountain agroecosystems (mostly grazing systems) in Euro-Mediterranean regions. We combined deliberative (focus groups) and survey-based stated-preference methods (choice modelling) to, first, identify the perceptions of farmers and other citizens on the most important ecosystem services and, second, to value these in economic terms according to the willingness to pay of the local (residents of the study area) and general (region where the study area is located) populations. Cultural services (particularly the aesthetic and recreational values of the landscape), supporting services (biodiversity maintenance) and some regulating services (particularly fire risk prevention) were clearly recognized by both farmers and citizens, with different degrees of importance according to their particular interests and objectives. The prevention of forest fires (approximate to 50% of total willingness to pay) was valued by the general population as a key ecosystem service delivered by these agroecosystems, followed by the production of specific quality products linked to the territory (approximate to 20%), biodiversity (approximate to 20%) and cultural landscapes (approximate to 10%). The value given by local residents to the last two ecosystem services differed considerably (approximate to 10 and 25% for biodiversity and cultural landscape, respectively). The Total Economic Value of mountain agroecosystems was approximate to 120 (sic) person(-1) year(-1), three times the current level of support of agro-environmental policies. By targeting and quantifying the environmental objectives of the European agri-environmental policy and compensating farmers for the public goods they deliver, the so-called "green'' subsidies may become true Payments for Ecosystems Services.	[Bernues, Alberto] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Bernues, Alberto; Rodriguez-Ortega, Tamara; Ripoll-Bosch, Raimon] Ctr Invest & Tecnol Agroalimentaria Aragon, Dept Tecnol Prod Anim, Zaragoza, Spain; [Ripoll-Bosch, Raimon] Wageningen Univ, Anim Prod Syst Grp, NL-6700 AP Wageningen, Netherlands; [Alfnes, Frode] Norwegian Univ Life Sci, Sch Business & Econ, As, Norway	Norwegian University of Life Sciences; Wageningen University & Research; Norwegian University of Life Sciences	Bernues, A (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	alberto.bernues@nmbu.no	Bosch, Raimon Ripoll/AAB-5177-2022; Bernués, Alberto/C-1393-2010; Alfnes, Frode/AAD-8398-2020; Alfnes, Frode/I-8970-2016	Bosch, Raimon Ripoll/0000-0002-1234-7015; Bernués, Alberto/0000-0002-3237-9751; Alfnes, Frode/0000-0002-3072-9308; Alfnes, Frode/0000-0002-3072-9308; Rodriguez-Ortega, Tamara/0000-0002-8592-2754	European Commission [299794]; Spanish Ministry of Economy and Competitiveness, Government of Aragon [INIA-RTA2011-00133-C02-02]; Spanish Ministry of Economy and Competitiveness, Government of Aragon FEDER [INIA-RTA2011-00133-C02-02]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness, Government of Aragon; Spanish Ministry of Economy and Competitiveness, Government of Aragon FEDER	The research was funded by: Marie Curie FP7-PEOPLE-2011 IEF, Contract no. 299794 (European Commission) and INIA-RTA2011-00133-C02-02 (Spanish Ministry of Economy and Competitiveness, Government of Aragon and FEDER). TR-O and RR-B acknowledge the doctoral financial support of INIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfnes F., 2011, The Oxford Handbook of the economics of food consumption and policy, P215; [Anonymous], 2005, EC HUM WELL BEING SY; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bernues A, 2005, LIVEST PROD SCI, V96, P75, DOI 10.1016/j.livprodsci.2005.05.023; Bernues A, 2011, LIVEST SCI, V139, P44, DOI 10.1016/j.livsci.2011.03.018; Bernues A, 2003, FOOD QUAL PREFER, V14, P265, DOI 10.1016/S0950-3293(02)00085-X; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Cooper T., 2009, PROVISION PUBLIC GOO; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; De Groot R.S., 2010, INTEGRATING ECOLOGIC; Garcia-Llorente M, 2012, ENVIRON SCI POLICY, V19-20, P136, DOI 10.1016/j.envsci.2012.01.006; Gibon A, 2005, LIVEST PROD SCI, V96, P11, DOI 10.1016/j.livprodsci.2005.05.009; Gomez-Baggethun E, 2011, PROG PHYS GEOG, V35, P613, DOI 10.1177/0309133311421708; Guerrero L, 2010, FOOD QUAL PREFER, V21, P225, DOI 10.1016/j.foodqual.2009.06.003; Guerrero L, 2009, APPETITE, V52, P345, DOI 10.1016/j.appet.2008.11.008; Hartter J, 2010, SOC NATUR RESOUR, V23, P207, DOI 10.1080/08941920903360372; Hazeu GW, 2010, 62010 EUR ENV AG; Hensher D. A., 2005, APPL CHOICE EC PRIME; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lenglet F, 2014, FOOD QUAL PREFER, V32, P264, DOI 10.1016/j.foodqual.2013.09.003; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; McCracken D. I., 2005, Global change and mountain regions: an overview of current knowledge, P573; Oteros-Rozas E, 2013, REG ENVIRON CHANGE, P1; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Parks S, 2013, ECOSYST SERV, V3, pE1, DOI 10.1016/j.ecoser.2012.12.002; Pascual U., 2010, EC ECOSYSTEMS BIODIV, P184; Pearce D, 1993, EC VALUES NATURAL WO; Pereira E, 2005, ECOL SOC, V10; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Riedel JL, 2007, LIVEST SCI, V111, P153, DOI 10.1016/j.livsci.2006.12.013; Riedel JL, 2013, RANGELAND ECOL MANAG, V66, P224, DOI 10.2111/REM-D-11-00196.1; Rodriguez-Ortega T, 2014, ANIMAL, V8, P1361, DOI 10.1017/S1751731114000421; Rodriguez-Ortega T, 2013, FARMERS CITIZENS PER, P121; Ruiz-Mirazo J, 2011, AGR ECOSYST ENVIRON, V141, P13, DOI 10.1016/j.agee.2011.02.002; SAS Institute Inc, 2014, SAS ETS 9 3 US GUID; Sayadi S, 2009, LAND USE POLICY, V26, P334, DOI 10.1016/j.landusepol.2008.04.003; Scarpa R, 2009, EUR REV AGRIC ECON, V36, P151, DOI 10.1093/erae/jbp012; Soini K, 2007, LAND USE POLICY, V24, P311, DOI 10.1016/j.landusepol.2006.03.001; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Swinton SM, 2007, ECOL ECON, V64, P245, DOI 10.1016/j.ecolecon.2007.09.020; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; van Oudenhoven APE, 2012, ECOL INDIC, V21, P110, DOI 10.1016/j.ecolind.2012.01.012; Zander KK, 2013, ECOL ECON, V93, P219, DOI 10.1016/j.ecolecon.2013.06.002	48	108	108	5	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102479	10.1371/journal.pone.0102479	http://dx.doi.org/10.1371/journal.pone.0102479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036276	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200062
J	Borges, P; Valente, LMP; Veron, V; Dias, K; Panserat, S; Medale, F				Borges, Pedro; Valente, Luisa M. P.; Veron, Vincent; Dias, Karine; Panserat, Stephane; Medale, Francoise			High Dietary Lipid Level Is Associated with Persistent Hyperglycaemia and Downregulation of Muscle Akt-mTOR Pathway in Senegalese Sole (Solea senegalensis)	PLOS ONE			English	Article							GLUCONEOGENIC ENZYME EXPRESSION; FAT/LOW-CARBOHYDRATE DIET; LOW-PROTEIN INTAKE; RAINBOW-TROUT; INSULIN-RESISTANCE; NUTRIENT UTILIZATION; GLUCOSE-INTOLERANCE; GROWTH-PERFORMANCE; FATTY-ACIDS; SIGNALING SYSTEM	High levels of dietary lipids are incorporated in feeds for most teleost fish to promote growth and reduce nitrogen waste. However, in Senegalese sole (Solea senegalensis) previous studies revealed that increasing the level of dietary lipids above 8% negatively affect growth and nutrient utilization regardless of dietary protein content. It has been shown that glucose regulation and metabolism can be impaired by high dietary fat intake in mammals, but information in teleost fish is scarce. The aim of this study was to assess the possible effect of dietary lipids on glucose metabolism in Senegalese sole with special emphasis on the regulation of proteins involved in the muscle insulin-signalling pathway. Senegalese sole juveniles (29 g) were fed two isonitrogenous diets (53% dry matter) for 88 days. These two diets were one with a high lipid level (similar to 17%, HL) and a moderate starch content (similar to 14%, LC), and the other being devoid of fish oil (4% lipid, LL) and with high starch content (similar to 23%, HC). Surprisingly, feeding Senegalese sole the HL/LC diet resulted in prolonged hyperglycaemia, while fish fed on LL/HC diet restored basal glycaemia 2 h after feeding. The hyperglycaemic phenotype was associated with greater glucose-6-phosphatase activity (a key enzyme of hepatic glucose production) and lower citrate synthase activity in the liver, with significantly higher liver glycogen content. Sole fed on HL/LC diet also had significantly lower hexokinase activity in muscle, although hexokinase activity was low with both dietary treatments. The HL/LC diet was associated with significant reductions in muscle AKT, p70 ribosomal S6-K1 Kinase (S6K-1) and ribosomal protein S6 (S6) 2 h after feeding, suggesting down regulation of the AKT-mTOR nutrient signalling pathway in these fish. The results of this study show for the first time that high level of dietary lipids strongly affects glucose metabolism in Senegalese sole.	[Borges, Pedro; Valente, Luisa M. P.] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Borges, Pedro; Valente, Luisa M. P.] Univ Porto, ICBAS, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Borges, Pedro; Veron, Vincent; Dias, Karine; Panserat, Stephane; Medale, Francoise] Pole Hydrobiol, INRA UR 1067, St Pee Sur Nivelle, France	Universidade do Porto; Universidade do Porto; INRAE; Universite de Pau et des Pays de l'Adour	Medale, F (corresponding author), Pole Hydrobiol, INRA UR 1067, St Pee Sur Nivelle, France.	medale@st-pee.inra.fr	Quality, Aquaculture Seafood/AAD-7718-2019; Borges, Pedro/G-4172-2015; Valente, Luisa/A-3769-2010	Panserat, Stephane/0000-0002-4479-9868; Borges, Pedro/0000-0002-2328-1576; Medale, Francoise/0000-0002-8083-1298; Valente, Luisa/0000-0002-2496-4854	Fundacao para a Ciencia e Tecnologia of Portugal [SFRH/BD/47780/2008]	Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology)	The present study was supported by Fundacao para a Ciencia e Tecnologia of Portugal (PhD grant SFRH/BD/47780/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEGRE M, 1988, ANAL BIOCHEM, V173, P185, DOI 10.1016/0003-2697(88)90176-5; BARZILAI N, 1993, J BIOL CHEM, V268, P25019; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Blasco J, 1996, J COMP PHYSIOL B, V165, P534, DOI 10.1007/BF00387514; Borges P, 2013, COMP BIOCHEM PHYS A, V166, P26, DOI 10.1016/j.cbpa.2013.05.007; Borges P, 2013, BRIT J NUTR, V109, P1373, DOI 10.1017/S0007114512003418; Borges P, 2009, BRIT J NUTR, V102, P1007, DOI 10.1017/S0007114509345262; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Cheng AC, 2006, ZOOL STUD, V45, P492; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; CHO CY, 1994, AQUACULTURE, V124, P293, DOI 10.1016/0044-8486(94)90403-0; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Dias J, 1998, AQUACULTURE, V161, P169, DOI 10.1016/S0044-8486(97)00268-8; Dias J, 2004, AQUAC RES, V35, P1122, DOI 10.1111/j.1365-2109.2004.01135.x; Diaz M, 2007, J EXP BIOL, V210, P2346, DOI 10.1242/jeb.002857; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Enes P, 2011, REV FISH SCI, V19, P201, DOI 10.1080/10641262.2011.579363; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Figueiredo-Silva AC, 2012, J EXP BIOL, V215, P169, DOI 10.1242/jeb.063933; Flamment M, 2008, BIOCHIMIE, V90, P1407, DOI 10.1016/j.biochi.2008.05.003; Funes V, 2006, GEN COMP ENDOCR, V149, P166, DOI 10.1016/j.ygcen.2006.05.017; Guerreiro I, 2012, AQUACULT NUTR, V18, P98, DOI 10.1111/j.1365-2095.2011.00884.x; Guerreiro I, 2014, AQUAC RES, V45, P289, DOI 10.1111/j.1365-2109.2012.03226.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hemre G.-I., 1995, Aquaculture Research, V26, P149, DOI 10.1111/j.1365-2109.1995.tb00896.x; Hemre GI, 1999, AQUACULT NUTR, V5, P9; Hildreth KL, 2012, OBESITY, V20, P1549, DOI 10.1038/oby.2012.19; HILLESTAD M, 1994, AQUACULTURE, V124, P109, DOI 10.1016/0044-8486(94)90366-2; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Hutchins CG, 1998, AQUACULTURE, V161, P187, DOI 10.1016/S0044-8486(97)00269-X; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Kirchner S, 2005, COMP BIOCHEM PHYS B, V140, P333, DOI 10.1016/j.cbpc.2004.10.019; Kirchner S, 2003, J NUTR, V133, P2561; Kusunoki M, 2002, METABOLISM, V51, P792, DOI 10.1053/meta.2002.32732; LEE DJ, 1973, J NUTR, V103, P916, DOI 10.1093/jn/103.6.916; Massillon D, 1997, DIABETES, V46, P153, DOI 10.2337/diabetes.46.1.153; Mediavilla D, 2007, BBA-GEN SUBJECTS, V1770, P706, DOI 10.1016/j.bbagen.2006.11.014; Meton I, 1999, BRIT J NUTR, V82, P223, DOI 10.1017/S0007114599001403; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; MOMMSEN TP, 1991, REV AQUAT SCI, V4, P225; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; PALMER TN, 1972, J FISH BIOL, V4, P311, DOI 10.1111/j.1095-8649.1972.tb05680.x; Panserat S, 2002, J NUTR, V132, P137, DOI 10.1093/jn/132.2.137; Planas JV, 2000, AM ZOOL, V40, P223, DOI 10.1668/0003-1569(2000)040[0223:FIIIAI]2.0.CO;2; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Polakof S, 2010, J EXP BIOL, V213, P1443, DOI 10.1242/jeb.037689; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; SINGER TD, 1990, CAN J FISH AQUAT SCI, V47, P873, DOI 10.1139/f90-100; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Stone DAJ, 2003, REV FISH SCI, V11, P337, DOI 10.1080/10641260390260884; SU JY, 1995, INT J BIOCHEM CELL B, V27, P1277, DOI 10.1016/1357-2725(95)00104-W; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Valente LMP, 2011, AQUACULTURE, V318, P128, DOI 10.1016/j.aquaculture.2011.05.026; Vergara JM, 1996, FISHERIES SCI, V62, P624, DOI 10.2331/fishsci.62.624; Wang Y, 2003, ENDOCRINE, V22, P85, DOI 10.1385/ENDO:22:2:85; Wang Y, 2002, ENDOCRINE, V17, P185, DOI 10.1385/ENDO:17:3:185; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; WILSON RP, 1994, AQUACULTURE, V124, P67, DOI 10.1016/0044-8486(94)90363-8; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wise S, 1997, J CLIN ENDOCR METAB, V82, P1828, DOI 10.1210/jc.82.6.1828; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002	73	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102196	10.1371/journal.pone.0102196	http://dx.doi.org/10.1371/journal.pone.0102196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036091	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200039
J	Kurppa, KJ; Rokavec, M; Sundvall, M; Kellokumpu-Lehtinen, PL; Joensuu, H; Brauch, H; Elenius, K				Kurppa, Kari J.; Rokavec, Matjaz; Sundvall, Maria; Kellokumpu-Lehtinen, Pirkko-Liisa; Joensuu, Heikki; Brauch, Hiltrud; Elenius, Klaus			ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENOME-WIDE ASSOCIATION; MUTATIONS; AMPLIFICATION; TRASTUZUMAB; GROWTH	A number of genetic variants have been linked to increased risk of breast cancer. Little is, however, known about the prognostic significance of hereditary factors. Here, we investigated the frequency and prognostic significance of two ERBB4 promoter region variants, -782G>T (rs62626348) and -815A>T (rs62626347), in a cohort of 1010 breast cancer patients. The frequency of nine previously described somatic ERBB4 kinase domain mutations was also analyzed. Clinical material used in the study consisted of samples from the phase III, adjuvant, FinHer breast cancer trial involving 1010 women. Tumor DNA samples were genotyped for ERBB4 variants and somatic mutations using matrix-assisted laser desorption ionization/time of flight mass spectrometry. Paraffin-embedded tumor sections from all patients were immunohistochemically stained for ErbB4 expression. Association of ERBB4 genotype to distant disease-free survival (DDFS) was assessed using Kaplan-Meier and Cox regression analyses. Genotyping was successful for 91-93% of the 1010 samples. Frequencies observed for the ERBB4 variants were 2.5% and 1.3% for -782G>T and -815A>T, respectively. Variant -815A>T was significantly associated with poor survival (HR = 2.86 [95% CI 1.15-6.67], P = 0.017). In contrast, variant -782G>T was associated with well-differentiated cancer (P = 0.019). Two (0.2%) ERBB4 kinase domain mutations were found, both of which have previously been shown to be functional and promote cancer cell growth in vitro. These data present the germ-line ERBB4 variant -815A>T as a novel prognostic marker in high-risk early breast cancer and indicate the presence of rare but potentially oncogenic somatic ERBB4 mutations in breast cancer.	[Kurppa, Kari J.; Sundvall, Maria; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Kurppa, Kari J.; Sundvall, Maria; Elenius, Klaus] Univ Turku, Medicity Res Labs, Turku, Finland; [Kurppa, Kari J.] Turku Doctoral Programme Mol Med, Turku, Finland; [Rokavec, Matjaz; Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Rokavec, Matjaz; Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Sundvall, Maria; Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland; [Kellokumpu-Lehtinen, Pirkko-Liisa] Tampere Univ Hosp, Dept Oncol, Tampere, Finland; [Brauch, Hiltrud] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland	University of Turku; University of Turku; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Turku; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Turku, Finland.	klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021; Rokavec, Matjaz/J-4518-2019	Elenius, Klaus/0000-0001-5700-0827; Sundvall, Maria H/0000-0002-0494-2965; Brauch, Hiltrud/0000-0001-7531-2736; Joensuu, Heikki/0000-0003-0281-2507; Kurppa, Kari/0000-0001-8286-2429; Rokavec, Matjaz/0000-0002-2540-877X	Academy of Finland [137845]; Finnish Cancer Organizations; Sigrid Juselius Foundation; Turku University Hospital [13785]; Finnish Cultural Foundation; Ida Montin Foundation; Jenny and Antti Wihuri Foundation; Cancer Foundation Finland sr [130077, 120084, 130093, 110071] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ida Montin Foundation; Jenny and Antti Wihuri Foundation; Cancer Foundation Finland sr	This work was supported by the following sources of funding: The Academy of Finland (ref. 137845; http://www.aka.fi; KE); Finnish Cancer Organizations (http://www.cancer.fi; KE); Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation; KE); Turku University Hospital (ref. 13785; http://www.vsshp.fi/fi/evo-rahoitus; KE); Finnish Cultural Foundation (http://www.skr.fi; KK); Ida Montin Foundation (http://www.idamontininsaatio.fi; KK); and the Jenny and Antti Wihuri Foundation (http://www.wihurinrahasto.fi; KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacus SS, 1996, AM J PATHOL, V148, P549; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Hollmen M, 2009, ONCOGENE, V28, P1309, DOI 10.1038/onc.2008.481; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joensuu H, 2003, CLIN CANCER RES, V9, P923; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Lodge AJ, 2003, J CLIN PATHOL, V56, P300, DOI 10.1136/jcp.56.4.300; Loi S, 2013, JNCI-J NATL CANCER I, V105, P960, DOI 10.1093/jnci/djt121; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rokavec M, 2007, CLIN CANCER RES, V13, P7506, DOI 10.1158/1078-0432.CCR-07-0457; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200	23	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102388	10.1371/journal.pone.0102388	http://dx.doi.org/10.1371/journal.pone.0102388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036186	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200054
J	Mondani, H; Holme, P; Liljeros, F				Mondani, Hernan; Holme, Petter; Liljeros, Fredrik			Fat-Tailed Fluctuations in the Size of Organizations: The Role of Social Influence	PLOS ONE			English	Article							FIRM GROWTH-RATES; BUSINESS FIRMS; SCALING BEHAVIOR; COMPANY GROWTH; OUTPUT GROWTH; DYNAMICS; ECONOMICS; LAW; MODEL; SPECIFICITIES	Organizational growth processes have consistently been shown to exhibit a fatter-than-Gaussian growth-rate distribution in a variety of settings. Long periods of relatively small changes are interrupted by sudden changes in all size scales. This kind of extreme events can have important consequences for the development of biological and socio-economic systems. Existing models do not derive this aggregated pattern from agent actions at the micro level. We develop an agent-based simulation model on a social network. We take our departure in a model by a Schwarzkopf et al. on a scale-free network. We reproduce the fat-tailed pattern out of internal dynamics alone, and also find that it is robust with respect to network topology. Thus, the social network and the local interactions are a prerequisite for generating the pattern, but not the network topology itself. We further extend the model with a parameter delta that weights the relative fraction of an individual's neighbours belonging to a given organization, representing a contextual aspect of social influence. In the lower limit of this parameter, the fraction is irrelevant and choice of organization is random. In the upper limit of the parameter, the largest fraction quickly dominates, leading to a winner-takes-all situation. We recover the real pattern as an intermediate case between these two extremes.	[Mondani, Hernan; Holme, Petter; Liljeros, Fredrik] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Holme, Petter; Liljeros, Fredrik] Inst Futures Studies, Stockholm, Sweden	Stockholm University; Sungkyunkwan University (SKKU); Umea University	Mondani, H (corresponding author), Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden.	hernan.mondani@sociology.su.se	Mondani, Hernan/AAD-8412-2022; Holme, Petter/A-7646-2008; Liljeros, Fredrik G I/I-2667-2018	Mondani, Hernan/0000-0003-2685-9238; Holme, Petter/0000-0003-2156-1096; Liljeros, Fredrik G I/0000-0001-8642-6624	National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2011947]; Swedish Research Council; Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation) [P12-0705:1]	National Research Foundation of Korea (NRF) - Ministry of Education; Swedish Research Council(Swedish Research CouncilEuropean Commission); Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	PH was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2011947) and the Swedish Research Council. FL and HM are grateful to Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation) grant nr. P12-0705:1 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 1997, PHYSICA A, V244, P1, DOI 10.1016/S0378-4371(97)00301-4; Amaral LAN, 1997, J PHYS I, V7, P621; Amaral LAN, 1998, PHYS REV LETT, V80, P1385, DOI 10.1103/PhysRevLett.80.1385; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Bottazzi G, 2003, REV IND ORGAN, V23, P217, DOI 10.1023/B:REIO.0000031366.28559.c1; Bottazzi G, 2003, PHYSICA A, V324, P213, DOI 10.1016/S0378-4371(02)01889-7; Bottazzi G, 2007, LEM PAPER SERIES; Bottazzi G, 2002, LEM PAPER SERIES; Bottazzi G, 2001, LEM PAPER SERIES; Bottazzi G, 2006, RAND J ECON, V37, P235, DOI 10.1111/j.1756-2171.2006.tb00014.x; Buldyrev SV, 1997, J PHYS I, V7, P635, DOI 10.1051/jp1:1997181; CARLEY K, 1991, AM SOCIOL REV, V56, P331, DOI 10.2307/2096108; Castaldi C, 2009, EMPIR ECON, V37, P475, DOI 10.1007/s00181-008-0242-x; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; COLEMAN JS, 1986, AM J SOCIOL, V91, P1309, DOI 10.1086/228423; De Fabritiis G, 2003, PHYSICA A, V324, P38, DOI 10.1016/S0378-4371(03)00043-8; Dosi G, 2005, LEM PAPER SERIES; Fagiolo G, 2007, EUR PHYS J B, V57, P205, DOI 10.1140/epjb/e2007-00153-0; Fu DF, 2005, P NATL ACAD SCI USA, V102, P18801, DOI 10.1073/pnas.0509543102; Fu DF, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036118; Gaffeo E, 2003, PHYSICA A, V324, P117, DOI 10.1016/S0378-4371(02)01890-3; Gibrat R., 1931, INEGALITES EC; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Gupta HM, 2007, PHYSICA A, V375, P643, DOI 10.1016/j.physa.2006.09.025; Gupta HM, 2003, PHYSICA A, V323, P626, DOI 10.1016/S0378-4371(03)00017-7; Hart PE, 1996, ECON J, V106, P1242, DOI 10.2307/2235518; Hedstrom P, 2005, DISSECTING SOCIAL PR; HYMER S, 1962, J POLIT ECON, V70, P556, DOI 10.1086/258716; Ijiri Y, 1977, SKEW DISTRIBUTIONS S; Ishikawa A, 2006, PHYSICA A, V367, P425, DOI 10.1016/j.physa.2005.12.005; Ishikawa A, 2006, PHYSICA A, V363, P367, DOI 10.1016/j.physa.2005.08.038; Ishikawa A, 2007, PHYSICA A, V383, P79, DOI 10.1016/j.physa.2007.04.089; JOVANOVIC B, 1982, ECONOMETRICA, V50, P649, DOI 10.2307/1912606; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kalecki M, 1945, ECONOMETRICA, V13, P161, DOI 10.2307/1907013; Keitt TH, 2002, PHILOS T R SOC B, V357, P627, DOI 10.1098/rstb.2001.1013; Kuran T., 1995, PRIVATE TRUTHS PUBLI; Lee YK, 1998, PHYS REV LETT, V81, P3275, DOI 10.1103/PhysRevLett.81.3275; Liljeros F, 2001, THESIS STOCKHOLM U S; LUCAS RE, 1978, BELL J ECON, V9, P508, DOI 10.2307/3003596; MANSFIELD E, 1962, AM ECON REV, V52, P1023; Matia K, 2004, EUROPHYS LETT, V67, P498, DOI 10.1209/epl/i2004-10070-4; Plerou V, 1999, NATURE, V400, P433, DOI 10.1038/22719; Plerou V, 1999, PHYS REV E, V60, P6519, DOI 10.1103/PhysRevE.60.6519; Podobnik B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056102; Riccaboni M, 2008, P NATL ACAD SCI USA, V105, P19595, DOI 10.1073/pnas.0810478105; Schwarzkopf Y, 2010, PREPRINT; Schweiger A, 2007, PHYSICS0703023VL ARX; SIMON HA, 1958, AM ECON REV, V48, P607; SIMON HA, 1964, J POLIT ECON, V72, P81, DOI 10.1086/258856; SINGH A, 1975, REV ECON STUD, V42, P15, DOI 10.2307/2296816; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Sutton J, 1997, J ECON LIT, V35, P40; Sutton J, 2002, PHYSICA A, V312, P577, DOI 10.1016/S0378-4371(02)00852-X; Sznajd-Weron K, 2005, ACTA PHYS POL B, V36, P2537; Wilson J, 2000, ANNU REV SOCIOL, V26, P215, DOI 10.1146/annurev.soc.26.1.215; Wyart M, 2003, PHYSICA A, V326, P241, DOI 10.1016/S0378-4371(03)00267-X	58	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100527	10.1371/journal.pone.0100527	http://dx.doi.org/10.1371/journal.pone.0100527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036729	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200008
J	Shi, SB; Liang, JJ; Liu, T; Yuan, XR; Ruan, B; Sun, LF; Tang, YH; Yang, B; Hu, D; Huang, CX				Shi, Shaobo; Liang, Jinjun; Liu, Tao; Yuan, Xiaoran; Ruan, Bing; Sun, Lifang; Tang, Yanhong; Yang, Bo; Hu, Dan; Huang, Congxin			Depression Increases Sympathetic Activity and Exacerbates Myocardial Remodeling after Myocardial Infarction: Evidence from an Animal Experiment	PLOS ONE			English	Article							CHRONIC MILD STRESS; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; HEART-FAILURE; PROGNOSTIC ASSOCIATION; CARDIOVASCULAR-DISEASE; NERVOUS-SYSTEM; RODENT MODEL; RAT STRAINS; SYMPTOMS	Depression is an independent risk factor for cardiovascular events and mortality in patients with myocardial infarction (MI). Excessive sympathetic activation and serious myocardial remodeling may contribute to this association. The aim of this study was to discuss the effect of depression on sympathetic activity and myocardial remodeling after MI. Wild-type (WT) rats were divided into a sham group (Sham), a myocardial infarction group (MI), a depression group (D), and a myocardial infarction plus depression group (MI+D). Compared with controls, the MI+D animals displayed depression-like behaviors and attenuated body weight gain. The evaluation of sympathetic activity showed an increased level in plasma concentrations of epinephrine and norepinephrine and higher expression of myocardial tyrosine hydroxylase in the MI+D group than the control groups (p<0.05 for all). Cardiac function and morphologic analyses revealed a decreased fractional shortening accompanied by increased left ventricular dimensions, thinning myocardium wall, and reduced collagen repair in the MI+D group compared with the MI group (p<0.05 for all). Frequent premature ventricular contractions, prolonged QT duration and ventricular repolarization duration, shorted effective refractory period, and increased susceptibility to ventricular arrhythmia were displayed in MI+D rats. These results indicate that sympathetic hyperactivation and exacerbated myocardial remodeling may be a plausible mechanism linking depression to an adverse prognosis after MI.	[Shi, Shaobo; Liang, Jinjun; Liu, Tao; Yuan, Xiaoran; Ruan, Bing; Sun, Lifang; Tang, Yanhong; Yang, Bo; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Shi, Shaobo; Liang, Jinjun; Liu, Tao; Yuan, Xiaoran; Ruan, Bing; Sun, Lifang; Tang, Yanhong; Huang, Congxin] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Hu, Dan] Masonic Med Res Lab, Utica, NY USA	Wuhan University; Wuhan University; Masonic Medical Research Laboratory	Shi, SB (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China.	sanshisanshi@126.com; huangcongxin1951@163.com		Hu, Dan/0000-0002-0994-8434	National Key Basic Research Development Program of China (The 973 Program) [2012CB518604]; Natural Science Foundation of China [81200139]; Fundamental Research Funds for the Central Universities, China [2014302020201]	National Key Basic Research Development Program of China (The 973 Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Basic Research Development Program of China (The 973 Program, grant number: 2012CB518604), the Natural Science Foundation of China Grants (Grant number: 81200139) and the Fundamental Research Funds for the Central Universities, China (grant number: 2014302020201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Bouzinova EV, 2012, PSYCHOSOM MED, V74, P278, DOI 10.1097/PSY.0b013e31824c40a9; Brugada J, 2012, EUR HEART J, V33, P687, DOI 10.1093/eurheartj/ehr405; Carnevali L, 2013, PSYCHOSOM MED, V75, P42, DOI 10.1097/PSY.0b013e318276cb0d; Cherry EM, 2012, AM J PHYSIOL-HEART C, V302, pH2451, DOI 10.1152/ajpheart.00770.2011; Ciarka A, 2008, EXPERT OPIN INV DRUG, V17, P1315, DOI [10.1517/13543780802303805, 10.1517/13543784.17.9.1315 ]; Du XJ, 1999, CARDIOVASC RES, V43, P919, DOI 10.1016/S0008-6363(99)00139-X; Grippo AJ, 2004, AM J PHYSIOL-HEART C, V286, pH619, DOI 10.1152/ajpheart.00450.2003; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Henze M, 2013, AM J PHYSIOL-HEART C, V304, pH444, DOI 10.1152/ajpheart.00763.2012; Huang CJ, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00314; Huffman JC, 2013, EVID-BASED MENT HEAL, V16, P110, DOI 10.1136/eb-2013-101537; Jokinen J, 2009, J AFFECT DISORDERS, V116, P88, DOI 10.1016/j.jad.2008.10.025; Kim YH, 2012, HEART, V98, P1378, DOI 10.1136/heartjnl-2012-302180; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; Lee TM, 2009, AM J PHYSIOL-HEART C, V297, pH512, DOI 10.1152/ajpheart.00077.2009; Li LF, 2012, PHYTOTHER RES, V26, P1189, DOI 10.1002/ptr.3706; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Meijer A, 2013, BRIT J PSYCHIAT, V203, P90, DOI 10.1192/bjp.bp.112.111195; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Neelakantan S, 2013, NATURE, V493, pS16, DOI 10.1038/493S16a; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Qin M, 2013, J CARDIOL, V61, P162, DOI 10.1016/j.jjcc.2012.08.016; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Sanchez-Gonzalez MA, 2013, AM J HYPERTENS, V26, P1389, DOI 10.1093/ajh/hpt131; Smolderen KG, 2009, CIRC-CARDIOVASC QUAL, V2, P328, DOI 10.1161/CIRCOUTCOMES.109.868588; Spijkerman TA, 2005, J PSYCHOSOM RES, V58, P425, DOI 10.1016/j.jpsychores.2005.02.005; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480; Wang YM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-32; Whang W, 2005, J AM COLL CARDIOL, V45, P1090, DOI 10.1016/j.jacc.2004.12.053; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Zhang WG, 1999, AM J PHYSIOL-HEART C, V276, pH1608, DOI 10.1152/ajpheart.1999.276.5.H1608	35	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101734	10.1371/journal.pone.0101734	http://dx.doi.org/10.1371/journal.pone.0101734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036781	Green Submitted, gold, Green Published			2022-12-27	WOS:000339615200022
J	Zhu, Y; Yang, JY; Yeh, F; Cole, SA; Haack, K; Lee, ET; Howard, BV; Zhao, JY				Zhu, Yun; Yang, Jingyun; Yeh, Fawn; Cole, Shelley A.; Haack, Karin; Lee, Elisa T.; Howard, Barbara V.; Zhao, Jinying			Joint Association of Nicotinic Acetylcholine Receptor Variants with Abdominal Obesity in American Indians: The Strong Heart Family Study	PLOS ONE			English	Article							61 GENETIC-VARIANTS; BODY-FAT; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; RISK-FACTORS; MASS; HYPERTENSION; OVERWEIGHT; DEPENDENCE; CHILDREN	Cigarette smoke is a strong risk factor for obesity and cardiovascular disease. The effect of genetic variants involved in nicotine metabolism on obesity or body composition has not been well studied. Though many genetic variants have previously been associated with adiposity or body fat distribution, a single variant usually confers a minimal individual risk. The goal of this study is to evaluate the joint association of multiple variants involved in cigarette smoke or nicotine dependence with obesity-related phenotypes in American Indians. To achieve this goal, we genotyped 61 tagSNPs in seven genes encoding nicotine acetylcholine receptors (nAChRs) in 3,665 American Indians participating in the Strong Heart Family Study. Single SNP association with obesity-related traits was tested using family-based association, adjusting for traditional risk factors including smoking. Joint association of all SNPs in the seven nAChRs genes were examined by gene-family analysis based on weighted truncated product method (TPM). Multiple testing was controlled by false discovery rate (FDR). Results demonstrate that multiple SNPs showed weak individual association with one or more measures of obesity, but none survived correction for multiple testing. However, gene-family analysis revealed significant associations with waist circumference (p = 0.0001) and waist-to-hip ratio (p = 0.0001), but not body mass index (p = 0.20) and percent body fat (p = 0.29), indicating that genetic variants are jointly associated with abdominal, but not general, obesity among American Indians. The observed combined genetic effect is independent of cigarette smoking per se. In conclusion, multiple variants in the nAChR gene family are jointly associated with abdominal obesity in American Indians, independent of general obesity and cigarette smoking per se.	[Zhu, Yun; Zhao, Jinying] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Yang, Jingyun] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL USA; [Yeh, Fawn; Lee, Elisa T.] Univ Oklahoma, Hlth Sci Ctr, Ctr Amer Indian Hlth Res, Oklahoma City, OK USA; [Cole, Shelley A.; Haack, Karin] Texas Biomed Res Inst, San Antonio, TX USA; [Howard, Barbara V.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Howard, Barbara V.] Georgetown Univ, Washington, DC USA; [Howard, Barbara V.] Howard Univ, Ctr Translat Sci, Washington, DE USA	Tulane University; Rush University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Texas Biomedical Research Institute; MedStar Health Research Institute; Georgetown University	Zhao, JY (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.		Zhu, Yun/N-3403-2014; Zhu, Yun/AAD-5474-2020; Yang, Jingyun/D-5361-2009	Zhu, Yun/0000-0002-9500-5415; Zhu, Yun/0000-0002-9500-5415; Yang, Jingyun/0000-0002-3495-3710	seed grant from the Oklahoma Tobacco Research Center; National Institutes of Health [K01AG034259, R21HL092363, R01DK091369];  [U01HL65520];  [U01HL41642];  [U01HL41652];  [U01HL41654];  [U01HL6552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092363, U01HL041642, R01HL109301, U01HL041652, U01HL041654, U01HL065520, U01HL065521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG034259] Funding Source: NIH RePORTER	seed grant from the Oklahoma Tobacco Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a seed grant from the Oklahoma Tobacco Research Center and National Institutes of Health Grants K01AG034259, R21HL092363, R01DK091369 and Cooperative Agreement Grants U01HL65520, U01HL41642, U01HL41652, U01HL41654, and U01HL65521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Clair C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-23; Daley CM, 2010, ETHNIC DIS, V20, P334; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; HOWARD BV, 1992, DIABETES, V41, P4, DOI 10.2337/diab.41.2.S4; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; John U, 2005, INT J OBESITY, V29, P1289, DOI 10.1038/sj.ijo.0803028; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045815; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Li MD, 2010, AM J MED GENET B, V153B, P745, DOI 10.1002/ajmg.b.31043; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Pasquali R, 2000, INT J OBESITY, V24, pS47, DOI 10.1038/sj.ijo.0801277; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Sheng XG, 2013, OXFORD B ECON STAT, V75, P624, DOI 10.1111/j.1468-0084.2012.00705.x; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Yang JY, 2013, CIRC-CARDIOVASC GENE, V6, P89, DOI 10.1161/CIRCGENETICS.112.963967; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870; Yun Ji Eun, 2012, J Prev Med Public Health, V45, P316, DOI 10.3961/jpmph.2012.45.5.316	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102220	10.1371/journal.pone.0102220	http://dx.doi.org/10.1371/journal.pone.0102220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036316	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200041
J	Zizic, M; Zivic, M; Maksimovic, V; Stanic, M; Krizak, S; Antic, TC; Zakrzewska, J				Zizic, Milan; Zivic, Miroslav; Maksimovic, Vuk; Stanic, Marina; Krizak, Strahinja; Antic, Tijana Cvetic; Zakrzewska, Joanna			Vanadate Influence on Metabolism of Sugar Phosphates in Fungus Phycomyces blakesleeanus	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; FRUCTOSE 2,6-BISPHOSPHATE; SOLUBLE EXOPOLYPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; NEUROSPORA-CRASSA; VANADIUM; INHIBITION; YEAST; TRANSPORT	The biological and chemical basis of vanadium action in fungi is relatively poorly understood. In the present study, we investigate the influence of vanadate (V5+) on phosphate metabolism of Phycomyces blakesleeanus. Addition of V5+ caused increase of sugar phosphates signal intensities in P-31 NMR spectra in vivo. HPLC analysis of mycelial phosphate extracts demonstrated increased concentrations of glucose 6 phosphate, fructose 6 phosphate, fructose 1, 6 phosphate and glucose 1 phosphate after V5+ treatment. Influence of V5+ on the levels of fructose 2, 6 phosphate, glucosamine 6 phosphate and glucose 1, 6 phosphate (HPLC), and polyphosphates, UDPG and ATP (P-31 NMR) was also established. Increase of sugar phosphates content was not observed after addition of vanadyl (V4+), indicating that only vanadate influences its metabolism. Obtained results from in vivo experiments indicate catalytic/inhibitory vanadate action on enzymes involved in reactions of glycolysis and glycogenesis i.e., phosphoglucomutase, phosphofructokinase and glycogen phosphorylase in filamentous fungi.	[Zizic, Milan; Maksimovic, Vuk; Stanic, Marina; Krizak, Strahinja] Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia; [Zivic, Miroslav; Antic, Tijana Cvetic] Univ Belgrade, Fac Biol, Dept Physiol & Biophys, Belgrade, Serbia; [Zakrzewska, Joanna] NMR Lab, Inst Gen & Phys Chem, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Zizic, M (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Dept Life Sci, Belgrade, Serbia.	mzizic@imsi.rs	Zizic, Milan/T-9537-2019; Živić, Miroslav/GMW-7405-2022	Živić, Miroslav/0000-0002-0314-5032; Cvetic Antic, Tijana/0000-0003-1676-7508; Maksimovic, Vuk/0000-0002-9883-186X; Stanic, Marina/0000-0002-2779-7932; Zizic, Milan/0000-0003-1268-6698	Ministry of Education, Science and Technologic Development of Republic of Serbia [173040]	Ministry of Education, Science and Technologic Development of Republic of Serbia	This work was supported by Grant of Ministry of Education, Science and Technologic Development of Republic of Serbia, 173040, www.mpn.gov.rs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksieva P, 2003, Z NATURFORSCH C, V58, P239; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barany M., 1984, PHOSPHORUS 31 NMR PR, P511; BARTRONS R, 1982, FEBS LETT, V143, P137, DOI 10.1016/0014-5793(82)80290-1; BENABE JE, 1987, J BIOL CHEM, V262, P9555; Berry RE, 1999, ANGEW CHEM INT EDIT, V38, P795, DOI 10.1002/(SICI)1521-3773(19990315)38:6<795::AID-ANIE795>3.0.CO;2-7; BOWMAN BJ, 1983, J BACTERIOL, V153, P286, DOI 10.1128/JB.153.1.286-291.1983; BOWMAN BJ, 1983, J BACTERIOL, V153, P292, DOI 10.1128/JB.153.1.292-296.1983; CARRERAS J, 1982, BIOCHIM BIOPHYS ACTA, V705, P238, DOI 10.1016/0167-4838(82)90183-2; CARRERAS M, 1988, ARCH BIOCHEM BIOPHYS, V264, P155, DOI 10.1016/0003-9861(88)90580-2; CATALAN RE, 1980, BIOCHEM BIOPH RES CO, V96, P672, DOI 10.1016/0006-291X(80)91407-2; CHASTEEN ND, 1990, VANADIUM BIOL SYSTEM; CLIMENT F, 1981, BIOCHEM BIOPH RES CO, V101, P570, DOI 10.1016/0006-291X(81)91297-3; COHEN MD, 1987, INORG CHIM A-BIOINOR, V138, P179, DOI 10.1016/S0020-1693(00)81220-7; CRANS DC, 1992, J AM CHEM SOC, V114, P4926, DOI 10.1021/ja00038a081; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; CRANS DC, 1990, J AM CHEM SOC, V112, P427, DOI 10.1021/ja00157a063; CRANS DC, 1990, BIOCHEMISTRY-US, V29, P6698, DOI 10.1021/bi00480a020; DIEZ M, 1988, INT J BIOCHEM, V20, P801, DOI 10.1016/0020-711X(88)90067-5; Dreuckhammer GD, 1999, J ORG CHEM, V54, P70; EVANS FE, 1977, P NATL ACAD SCI USA, V74, P4909, DOI 10.1073/pnas.74.11.4909; Francois J, 1984, EUR J BIOCHEM, V164, P369; GOMEZFOIX AM, 1988, BIOCHEM J, V255, P507; Gordon J, 2001, METHOD ENZYMOL, V201, P477; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guranowski A, 1998, BBA-GEN SUBJECTS, V1380, P232, DOI 10.1016/S0304-4165(97)00147-5; Han CC, 2009, BIOL TRACE ELEM RES, V127, P278, DOI 10.1007/s12011-008-8246-0; Jolly L, 2000, J BACTERIOL, V182, P1280, DOI 10.1128/JB.182.5.1280-1285.2000; Kalac P, 2000, FOOD CHEM, V69, P273, DOI 10.1016/S0308-8146(99)00264-2; KLEIN G, 1989, J CELL SCI, V94, P127; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Mannazzu I, 2001, ANN MICROBIOL, V51, P1; Mannazzu I, 1997, FEMS MICROBIOL LETT, V147, P23, DOI 10.1016/S0378-1097(96)00497-1; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; NOURELDEEN AF, 1985, J BIOL CHEM, V260, P6836; OKAR DA, 1995, BIOCHEM J, V308, P189, DOI 10.1042/bj3080189; REHDER D, 1992, BIOMETALS, V5, P3, DOI 10.1007/BF01079691; Rehder D, 2003, INORG CHEM COMMUN, V6, P604, DOI 10.1016/S1387-7003(03)00050-9; Rehder D., 2008, BIOINORGANIC VANADIU; RIDER MH, 1990, EUR J BIOCHEM, V190, P53, DOI 10.1111/j.1432-1033.1990.tb15544.x; RUA J, 1993, J GEN MICROBIOL, V139, P217, DOI 10.1099/00221287-139-2-217; Rua J, 2008, RES MICROBIOL, V159, P200, DOI 10.1016/j.resmic.2008.01.002; RUDOLPH H, 1970, ARCH MIKROBIOL, V72, P175, DOI 10.1007/BF00409522; SCHWABE U, 1979, NATURE, V277, P143, DOI 10.1038/277143a0; SHANKS JV, 1988, BIOTECHNOL BIOENG, V32, P1138, DOI 10.1002/bit.260320907; Stanic M, 2013, RES MICROBIOL, V164, P770, DOI 10.1016/j.resmic.2013.03.002; STANKIEWICZ PJ, 1995, MET IONS BIOL SYST, V31, P287; SUTTER RP, 1975, P NATL ACAD SCI USA, V72, P127, DOI 10.1073/pnas.72.1.127; Tsiani E, 1997, TEM, V8, P52; TU JC, 1977, CYTOBIOS, V20, P121; VANDERCAMMEN A, 1990, J GEN MICROBIOL, V136, P137, DOI 10.1099/00221287-136-1-137; VANLAERE A, 1983, P NATL ACAD SCI-BIOL, V80, P6601; VANLAERE AJ, 1983, J GEN MICROBIOL, V129, P3281; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; Voet D, 1995, BIOCHEMISTRY-US, P497; WURST H, 1994, J BIOL CHEM, V269, P10996; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Zivic M, 2007, ANTON LEEUW INT J G, V91, P169, DOI 10.1007/s10482-006-9108-4; Zizic M, 2013, THESIS U BELGRADE; Zizic M, 2013, RES MICROBIOL, V164, P61, DOI 10.1016/j.resmic.2012.08.007	62	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102849	10.1371/journal.pone.0102849	http://dx.doi.org/10.1371/journal.pone.0102849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036378	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200090
J	Broker, MEE; Ijzermans, JNM; Witjes, CDM; van Vuuren, HJ; de Man, RA				Broker, Mirelle E. E.; Ijzermans, Jan N. M.; Witjes, Caroline D. M.; van Vuuren, Hanneke J.; de Man, Robert A.			The Predictive Value of Golgi Protein 73 in Differentiating Benign from Malignant Liver Tumors	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SERUM MARKER; ALPHA-FETOPROTEIN; GP73; EXPRESSION; BIOMARKERS; HEPATITIS; CORRELATE; GOLPH2	Introduction: In the work up of primary solid liver lesions it is essential to differentiate correctly between benign and malignant tumors, such as hepatocellular adenoma (HCA) and hepatocellular carcinoma (HCC) respectively. A promising new marker to detect HCC is Golgi Protein 73 (GP73). Studies comparing patients with HCC and cirrhosis with normal controls suggested that GP73 is specific for patients with HCC; however, patients with other liver tumors were not included. We therefore studied the predictive value of GP73 in differentiating between solid benign and malignant liver tumors. Materials and Methods: This study included 264 patients: 88 patients with HCC, 88 with hepatocellular adenoma (HCA), and 88 with focal nodal hyperplasia (FNH). A blood sample was collected from each patient to measure GP73 levels using a quantitative ELISA assay and differences in outcome between subgroups were compared. The receiver operating characteristic (ROC) curve, sensitivity and specificity of GP73 were calculated and compared to alpha-fetoprotein (AFP) levels. Results: When comparing malignant and benign liver tumors the area under ROC was 0.701 and 0.912 for GP73 and AFP respectively. Test characteristics revealed a sensitivity of 60% for GP73 and 65% for AFP; in addition the specificity was 77% for GP73 and 96% for AFP. Conclusion: Although the literature suggests that GP73 is a valuable serum marker in patients with HCC, the serum concentration may also be increased in patients with solid benign liver tumors. Therefore, a GP73 assay is less suitable for discriminating between primary malignant and benign tumors of the liver.	[Broker, Mirelle E. E.; Ijzermans, Jan N. M.; Witjes, Caroline D. M.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [van Vuuren, Hanneke J.; de Man, Robert A.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Broker, MEE (corresponding author), Erasmus MC, Dept Surg, Rotterdam, Netherlands.	m.broker@erasmusmc.nl						Assy N, 2009, WORLD J GASTROENTERO, V15, P3217, DOI 10.3748/wjg.15.3217; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Cardinale V, 2012, HEPATOLOGY, V55, DOI 10.1002/hep.25587; Comunale MA, 2004, PROTEOMICS, V4, P826, DOI 10.1002/pmic.200300625; Ehrl Denis, 2012, HPB Surg, V2012, P891787, DOI 10.1155/2012/891787; Evers ACC, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5639; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; Hou SC, 2013, ONCOL LETT, V6, P1152, DOI 10.3892/ol.2013.1522; Hu JS, 2010, MED ONCOL, V27, P339, DOI 10.1007/s12032-009-9215-y; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; LITTLE JM, 1990, WORLD J SURG, V14, P448, DOI 10.1007/BF01658665; Mao YL, 2010, GUT, V59, P1687, DOI 10.1136/gut.2010.214916; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Morota K, 2011, CLIN CHEM LAB MED, V49, P711, DOI 10.1515/CCLM.2011.097; Riener MO, 2009, HEPATOLOGY, V49, P1602, DOI 10.1002/hep.22843; Sarbah SA, 2004, DIGEST DIS SCI, V49, P850, DOI 10.1023/B:DDAS.0000030098.75759.32; Shan SG, 2013, HEPATOL RES; Shi Y, 2011, TECHNOL CANCER RES T, V10, P287, DOI 10.7785/tcrt.2012.500205; Tian LY, 2011, INT J CANCER, V129, P1923, DOI 10.1002/ijc.25838; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Wise J, 2008, BRIT MED J, V336, P1041, DOI 10.1136/bmj.39560.444468.AD; Witjes CDM, 2013, HEPATOL INT, V7, P59, DOI 10.1007/s12072-012-9374-3; Zhou Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-17	23	14	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100187	10.1371/journal.pone.0100187	http://dx.doi.org/10.1371/journal.pone.0100187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033446	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300006
J	Quaiser, A; Bodi, X; Dufresne, A; Naquin, D; Francez, AJ; Dheilly, A; Coudouel, S; Pedrot, M; Vandenkoornhuyse, P				Quaiser, Achim; Bodi, Xavier; Dufresne, Alexis; Naquin, Delphine; Francez, Andre-Jean; Dheilly, Alexandra; Coudouel, Sophie; Pedrot, Mathieu; Vandenkoornhuyse, Philippe			Unraveling the Stratification of an Iron-Oxidizing Microbial Mat by Metatranscriptomics	PLOS ONE			English	Article							SEQUENCE; METHANOTROPHS; METAGENOMICS; SEDIMENT; SOFTWARE; DENMARK; AARHUS; SEA	A metatranscriptomic approach was used to study community gene expression in a naturally occurring iron-rich microbial mat. Total microbial community RNA was reversely transcribed and sequenced by pyrosequencing. Characterization of expressed gene sequences provided accurate and detailed information of the composition of the transcriptionally active community and revealed phylogenetic and functional stratifications within the mat. Comparison of 16S rRNA reads and delineation of OTUs showed significantly lower values of metatranscriptomic-based richness and diversity in the upper parts of the mat than in the deeper regions. Taxonomic affiliation of rRNA sequences and mRNA genome recruitments indicated that iron-oxidizing bacteria affiliated to the genus Leptothrix, dominated the community in the upper layers of the mat. Surprisingly, type I methanotrophs contributed to the majority of the sequences in the deep layers of the mat. Analysis of mRNA expression patterns showed that genes encoding the three subunits of the particulate methane monooxygenase (pmoCAB) were the most highly expressed in our dataset. These results provide strong hints that iron-oxidation and methane-oxidation occur simultaneously in microbial mats and that both groups of microorganisms are major players in the functioning of this ecosystem.	[Quaiser, Achim; Bodi, Xavier; Dufresne, Alexis; Francez, Andre-Jean; Vandenkoornhuyse, Philippe] Univ Rennes 1, CNRS EcoBio UMR6553, Rennes, France; [Naquin, Delphine] CNRS FRC3115 Ctr Recherches Gif Sur Yvette, Gif Sur Yvette, France; [Dheilly, Alexandra; Coudouel, Sophie] Univ Rennes 1, CNRS OSUR UMS3343, Plateforme Genom Environm & Fonct, Rennes, France; [Pedrot, Mathieu] Univ Rennes 1, CNRS Geosci UMR6118, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes	Quaiser, A (corresponding author), Univ Rennes 1, CNRS EcoBio UMR6553, Rennes, France.	Achim.Quaiser@univ-rennes1.fr	Pédrot, Mathieu/AAG-5794-2020	Naquin, Delphine/0000-0001-9174-4686; Pedrot, Mathieu/0000-0001-5215-3808; Dufresne, Alexis/0000-0001-8231-9098	INSU-CNRS EC2CO program; University of Rennes/CNRS; council of "Region Bretagne''; Observatoire des Sciences de l'Univers de Rennes'	INSU-CNRS EC2CO program; University of Rennes/CNRS; council of "Region Bretagne''; Observatoire des Sciences de l'Univers de Rennes'	This work was supported by funding from the INSU-CNRS EC2CO program, a grant from the University of Rennes/CNRS, from the council of "Region Bretagne'' and from the "Observatoire des Sciences de l'Univers de Rennes'' to A. Q. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bodelier PLE, 2012, ECOL EVOL, V2, P106, DOI 10.1002/ece3.34; Bruun AM, 2010, GEOMICROBIOL J, V27, P15, DOI 10.1080/01490450903232165; Chan CS, 2009, GEOCHIM COSMOCHIM AC, V73, P3807, DOI 10.1016/j.gca.2009.02.036; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; Davis RE, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005413; Dopheide A, 2011, APPL ENVIRON MICROB, V77, P4564, DOI 10.1128/AEM.02421-10; EMERSON D, 1994, APPL ENVIRON MICROB, V60, P4022, DOI 10.1128/AEM.60.11.4022-4031.1994; EMERSON D, 1994, APPL ENVIRON MICROB, V60, P4032, DOI 10.1128/AEM.60.11.4032-4038.1994; Fleming EJ, 2014, ISME J, V8, P804, DOI 10.1038/ismej.2013.197; Fleming EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017769; Han JI, 2004, ENVIRON MICROBIOL, V6, P388, DOI 10.1111/j.1462-2920.2004.00572.x; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kato S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00089; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; KOMADEL P, 1988, CLAY CLAY MINER, V36, P379, DOI 10.1346/CCMN.1988.0360415; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Reim A, 2012, ISME J, V6, P2128, DOI 10.1038/ismej.2012.57; Roden EE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00172; Schloss PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-34; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Svenning MM, 2011, J BACTERIOL, V193, P6418, DOI 10.1128/JB.05380-11; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Urich T, 2011, HDB MOL MICROBIAL EC, P587; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vollrath S, 2012, GEOMICROBIOL J, V29, P550, DOI 10.1080/01490451.2011.594147; Wang JJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00064; Weber KA, 2006, ENVIRON MICROBIOL, V8, P100, DOI 10.1111/j.1462-2920.2005.00873.x; WR-PO, 2010, R LANG ENV STAT COMP	41	25	25	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102561	10.1371/journal.pone.0102561	http://dx.doi.org/10.1371/journal.pone.0102561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033299	Green Published, gold			2022-12-27	WOS:000339418300060
J	Xie, XS; Zubarev, RA				Xie, Xueshu; Zubarev, Roman A.			Effects of Low-Level Deuterium Enrichment on Bacterial Growth	PLOS ONE			English	Article							HEAVY-WATER; BIOLOGICAL PROCESSES; STABLE-ISOTOPES; CULTIVATION; SPECIFICITY; CELLS; D2O	Using very precise (+/- 0.05%) measurements of the growth parameters for bacteria E. coli grown on minimal media, we aimed to determine the lowest deuterium concentration at which the adverse effects that are prominent at higher enrichments start to become noticeable. Such a threshold was found at 0.5% D, a surprisingly high value, while the ultralow deuterium concentrations (<= 0.25% D) showed signs of the opposite trend. Bacterial adaptation for 400 generations in isotopically different environment confirmed preference for ultralow (<= 0.25% D) enrichment. This effect appears to be similar to those described in sporadic but multiple earlier reports. Possible explanations include hormesis and isotopic resonance phenomena, with the latter explanation being favored.	[Xie, Xueshu; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden	Karolinska Institutet	Zubarev, RA (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden.	Roman.Zubarev@ki.se	Zubarev, Roman A/W-7891-2018	Zubarev, Roman A/0000-0001-9839-2089; Xie, Xueshu/0000-0002-5605-1961	Swedish Research Council [2011-3726]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (Grant # 2011-3726). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TC, 1934, SCIENCE, V79, P370, DOI 10.1126/science.79.2051.370; Barnes T. C, 1935, PROTOPLASMA, V22, P431; Barnes T. C, 1933, J AM CHEM SOC, V55, P4332; Barnes T. C, 1933, J AM CHEM SOC, V55, P5059; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P667, DOI 10.1177/0960327109358917; Curry J, 1935, SCIENCE, V81, P275, DOI 10.1126/science.81.2098.275; Ernest B, 1960, PROC NATL ACAD SCI, V46, P777; FOWLER EB, 1972, BIOTECHNOL BIOENG, V14, P819, DOI 10.1002/bit.260140511; Hammel SC, 2013, REJUV RES, V16, P98, DOI 10.1089/rej.2012.1368; Katz J. J., 1971, ISOTOPE EFFECTS CHEM, P286; KATZ JJ, 1966, SCIENCE, V151, P1187, DOI 10.1126/science.151.3715.1187; KATZ JJ, 1957, JNCI-J NATL CANCER I, V18, P641; Koletzko B, 1997, EUR J PEDIATR, V156, pS12, DOI 10.1007/PL00014267; Kreuzer-Martin HW, 2007, APPL ENVIRON MICROB, V73, P3896, DOI 10.1128/AEM.02906-06; Kreuzer-Martin HW, 2006, BIOCHEMISTRY-US, V45, P13622, DOI 10.1021/bi0609164; LOBYSHEV VI, 1983, BIOFIZIKA+, V28, P666; LOBYSHEV VI, 1982, BIOFIZIKA+, V27, P595; LOBYSHEV VI, 1978, BIOFIZIKA+, V23, P390; Lockemann G, 1934, BER DTSCH CHEM GES, V67, P1299, DOI 10.1002/cber.19340670733; Madigan M.T., 2012, BROCK BIOLOGY OF MIC; Nikitin DI, 2003, BIOFIZIKA+, V48, P678; Paliy O, 2003, J APPL MICROBIOL, V94, P580, DOI 10.1046/j.1365-2672.2003.01866.x; ROKOP S, 1969, BIOCHIM BIOPHYS ACTA, V191, P707, DOI 10.1016/0005-2744(69)90365-9; Sambrook J., 2001, MOL CLONING LAB MANU; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; UPHAUS RA, 1967, BIOCHIM BIOPHYS ACTA, V141, P625, DOI 10.1016/0304-4165(67)90191-2; Urey HC, 1932, PHYS REV, V39, P164, DOI 10.1103/PhysRev.39.164; Zubarev Roman A., 2011, Genomics Proteomics & Bioinformatics, V9, P15, DOI 10.1016/S1672-0229(11)60003-X; Zubarev RA, 2010, CENT EUR J BIOL, V5, P190, DOI 10.2478/s11535-009-0069-2	29	15	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102071	10.1371/journal.pone.0102071	http://dx.doi.org/10.1371/journal.pone.0102071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033078	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300034
J	Zhang, J; Zhang, M; Tian, SK; Lu, LL; Shohag, MJI; Yang, XE				Zhang, Jie; Zhang, Min; Tian, Shengke; Lu, Lingli; Shohag, M. J. I.; Yang, Xiaoe			Metallothionein 2 (SaMT2) from Sedum alfredii Hance Confers Increased Cd Tolerance and Accumulation in Yeast and Tobacco	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; COLOCASIA-ESCULENTA; CADMIUM TOLERANCE; GENE FAMILY; HYPERACCUMULATOR; EXPRESSION; COPPER; MECHANISMS; ECOTYPES; ENZYMES	Metallothioneins are cysteine-rich metal-binding proteins. In the present study, SaMT2, a type 2 metallothionein gene, was isolated from Cd/Zn co-hyperaccumulator Sedum alfredii Hance. SaMT2 encodes a putative peptide of 79 amino acid residues including two cysteine-rich domains. The transcript level of SaMT2 was higher in shoots than in roots of S. alfredii, and was significantly induced by Cd and Zn treatments. Yeast expression assay showed SaMT2 significantly enhanced Cd tolerance and accumulation in yeast. Ectopic expression of SaMT2 in tobacco enhanced Cd and Zn tolerance and accumulation in both shoots and roots of the transgenic plants. The transgenic plants had higher antioxidant enzyme activities and accumulated less H2O2 than wild-type plants under Cd and Zn treatment. Thus, SaMT2 could significantly enhance Cd and Zn tolerance and accumulation in transgenic tobacco plants by chelating metals and improving antioxidant system.	[Zhang, Jie; Zhang, Min; Tian, Shengke; Lu, Lingli; Shohag, M. J. I.; Yang, Xiaoe] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yang, XE (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	xyang@zju.edu.cn	Zhang, Jie/E-4768-2013; Shohag, Md. J. I./I-3060-2014; Tian, Shengke/G-8307-2016	Zhang, Jie/0000-0002-8344-5907; Shohag, Md. J. I./0000-0002-8799-4401; Tian, Shengke/0000-0001-8242-3581	Fundamental Research Funds for the Central Universities [2013FZA6005]; National Natural Science Foundation of China [31372128, 21177107]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the Fundamental Research Funds for the Central Universities (No. 2013FZA6005), National Natural Science Foundation of China (No. 31372128; 21177107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks RR, 1998, PLANTS THAT HYPERACCUMULATE HEAVY METALS: THEIR ROLE IN PHYTOREMEDIATION, MICROBIOLOGY, ARCHAEOLOGY, MINERAL EXPLORATION AND PHYTOMINING, P55; CAKMAK I, 1993, J EXP BOT, V44, P127, DOI 10.1093/jxb/44.1.127; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Hassinen VH, 2009, J EXP BOT, V60, P187, DOI 10.1093/jxb/ern287; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hsieh HM, 1996, PLANT MOL BIOL, V32, P525, DOI 10.1007/BF00019104; HSIEH HM, 1995, PLANT MOL BIOL, V28, P381, DOI 10.1007/BF00020388; Jin XF, 2008, J HAZARD MATER, V156, P387, DOI 10.1016/j.jhazmat.2007.12.064; Jin XF, 2008, ENVIRON TOXICOL, V23, P517, DOI 10.1002/tox.20362; Kim YO, 2013, PLANT PHYSIOL BIOCH, V64, P25, DOI 10.1016/j.plaphy.2012.12.009; Kim YO, 2011, BIOSCI BIOTECH BIOCH, V75, P1912, DOI 10.1271/bbb.110289; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Lv YY, 2013, PLANT SOIL, V367, P507, DOI 10.1007/s11104-012-1486-y; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; Mir G, 2004, J EXP BOT, V55, P2483, DOI 10.1093/jxb/erh254; Roosens NH, 2004, FEBS LETT, V577, P9, DOI 10.1016/j.febslet.2004.08.084; Sekhar K, 2011, ENVIRON EXP BOT, V72, P131, DOI 10.1016/j.envexpbot.2011.02.017; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Xia Y, 2012, ACTA PHYSIOL PLANT, V34, P1819, DOI 10.1007/s11738-012-0980-4; Xia Y, 2012, J HAZARD MATER, V233, P65, DOI 10.1016/j.jhazmat.2012.06.047; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Zhao FJ, 2009, CURR OPIN PLANT BIOL, V12, P373, DOI 10.1016/j.pbi.2009.04.005; ZHENG X, 1992, PLANT SCI, V81, P47, DOI 10.1016/0168-9452(92)90023-F; ZHOU JM, 1995, MOL GEN GENET, V248, P318, DOI 10.1007/BF02191599	32	55	61	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102750	10.1371/journal.pone.0102750	http://dx.doi.org/10.1371/journal.pone.0102750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032704	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300087
J	Simova, O; Weineck, G; Schuetze, T; Wegscheider, K; Panzer, U; Stahl, RAK; Gerloff, C; Magnus, T				Simova, Olga; Weineck, Gabriele; Schuetze, Thorsten; Wegscheider, Karl; Panzer, Ulf; Stahl, Rolf A. K.; Gerloff, Christian; Magnus, Tim			Neuropsychological Outcome after Complicated Shiga Toxin-Producing Escherichia coli Infection	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SEQUELAE; OUTBREAK	Background: The diarrhea associated hemolytic uremic syndrome (HUS) is a major cause of acute uremic failure in children, but not very common in adults. The enterohaemorrhagic Escherichia coli -epidemic in Germany in 2011 affected mostly young and healthy adults. While their immediate deficits have been published, not much is known about the time course and degree of recovery concerning cognitive and behavioral impairment. Methods and Findings: Twenty patients with Shiga toxin -producing Escherichia coli infection and neurological symptoms underwent comprehensive neuropsychological assessment 3 months and 1 year after the acute disease. Overall, there was an excellent recovery of cognitive functions. In a detailed neuropsychological analysis no significant deficits could be noticed 1 year after the infection in terms of cognitive function, alertness, executive functions and speech. Interestingly there were no correlations between different indicators for severity of disease (hemoglobin and creatinin levels, days of hospitalization, neurological symptoms and MRI changes) and neuropsychological outcome. However, there were a small number of patients with limitations in every day and professional life even one year after the acute disease. Conclusions: Our study does not provide definitive answers regarding risk factors for these limitations. Still since Shiga toxin -producing Escherichia coli infection is a rare condition in adults, the information this study provides is important for the clinical practice. On one hand for consulting patients and on the other to raise the awareness of the physicians to possible long term complains and the consideration of neuropsychological assessment and supportive psychological treatment.	[Simova, Olga; Weineck, Gabriele; Schuetze, Thorsten; Gerloff, Christian; Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Inst Biometr, Hamburg, Germany; [Panzer, Ulf; Stahl, Rolf A. K.] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med & Clin 3, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Magnus, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	t.magnus@uke.de		Gerloff, Christian/0000-0002-6484-8882				Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Baumler G., 1985, FARB WORT INTERFEREN; Beckers K., 1992, RIVERMEAD BEHAV MEMO; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Flachenecker R, 2006, NERVENARZT, V77, P165, DOI 10.1007/s00115-005-1990-x; Franke G.H., 2002, SCL 90 R SYMPTOM CHE; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Herrmann-Lingen C, 1985, HADS D HOSP ANXIETY; Hurting C., 2000, WMS R WECHSLER GEDAC; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; SCHLIEPER A, 1992, ARCH DIS CHILD, V67, P930, DOI 10.1136/adc.67.7.930; Schlieper A, 1999, ARCH DIS CHILD, V80, P214, DOI 10.1136/adc.80.3.214; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Torgersen J, 2011, ACTA ANAESTH SCAND, V55, P1044, DOI 10.1111/j.1399-6576.2011.02500.x; Zimmermann P, 2007, TEST ATTENUANCE PERF	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103029	10.1371/journal.pone.0103029	http://dx.doi.org/10.1371/journal.pone.0103029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050708	Green Submitted, gold, Green Published			2022-12-27	WOS:000339551100078
J	Uhrig, L; Ciobanu, L; Djemai, B; Le Bihan, D; Jarraya, B				Uhrig, Lynn; Ciobanu, Luisa; Djemai, Boucif; Le Bihan, Denis; Jarraya, Bechir			Sedation Agents Differentially Modulate Cortical and Subcortical Blood Oxygenation: Evidence from Ultra-High Field MRI at 17.2 T	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; CEREBRAL GLUCOSE-UTILIZATION; FLOW; METABOLISM; SEVOFLURANE; ISOFLURANE; PROPOFOL; BRAIN; ANESTHESIA; MIDAZOLAM	Background: Sedation agents affect brain hemodynamic and metabolism leading to specific modifications of the cerebral blood oxygenation level. We previously demonstrated that ultra-high field (UHF) MRI detects changes in cortical blood oxygenation following the administration of sedation drugs commonly used in animal research. Here we applied the UHF-MRI method to study clinically relevant sedation drugs for their effects on cortical and subcortical (thalamus, striatum) oxygenation levels. Methods: We acquired T2*-weighted images of Sprague-Dawley rat brains at 17.2T in vivo. During each MRI session, rats were first anesthetized with isoflurane, then with a second sedative agent (sevoflurane, propofol, midazolam, medetomidine or ketamine-xylazine) after stopping isoflurane. We computed a T2*-oxygenation-ratio that aimed at estimating cerebral blood oxygenation level for each sedative agent in each region of interest: cortex, hippocampus, thalamus and striatum. Results: The T2*-oxygenation-ratio was consistent across scan sessions. This ratio was higher with inhalational agents than with intravenous agents. Under sevoflurane and medetomidine, T2*-oxygenation-ratio was homogenous across the brain regions. Intravenous agents (except medetomidine) induced a T2*-oxygenation-ratio imbalance between cortex and subcortical regions: T2*-oxygenation-ratio was higher in the cortex than the subcortical areas under ketamine-xylazine; T2*-oxygenation-ratio was higher in subcortical regions than in the cortex under propofol or midazolam. Conclusion: Preclinical UHF MRI is a powerful method to monitor the changes in cerebral blood oxygenation level induced by sedative agents across brain structures. This approach also allows for a classification of sedative agents based on their differential effects on cerebral blood oxygenation level.	[Uhrig, Lynn; Ciobanu, Luisa; Djemai, Boucif; Le Bihan, Denis; Jarraya, Bechir] CEA Saclay, Commissariat Energie Atom & Energies Alternat, NeuroSpin, F-91191 Gif Sur Yvette, France; [Uhrig, Lynn; Jarraya, Bechir] Equipe Avenir INSERM Bettencourt Schueller, NeuroSpin, Unite Rech NeuroImagerie Applicat Clin & Translat, Gif Sur Yvette, France; [Jarraya, Bechir] Univ Versailles St Quentin, Foch Hosp, Neuromodulat Unit, Dept Neurosurg, Suresnes, France	CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay	Jarraya, B (corresponding author), CEA Saclay, Commissariat Energie Atom & Energies Alternat, NeuroSpin, F-91191 Gif Sur Yvette, France.	bechir.jarraya@cea.fr	Jarraya, Bechir/R-6023-2019; Ciobanu, Luisa/E-7331-2014	Jarraya, Bechir/0000-0003-0878-763X; Ciobanu, Luisa/0000-0001-6932-6859; Uhrig, Lynn/0000-0002-2737-0197	Inserm Avenir program; French National Research Agency (ANR) [ANR-08-PCVI-0009-01]; European Research Council; Fondation Bettencourt Schueller	Inserm Avenir program(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency (ANR)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Fondation Bettencourt Schueller	This work was supported by the Inserm Avenir program and the French National Research Agency (ANR) through grant ANR-08-PCVI-0009-01. LU is funded by a senior grant of the European Research Council (NeuroConsc Program). LU and BJ are supported by the Inserm Avenir program and the Fondation Bettencourt Schueller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKIRE MT, 1995, ANESTHESIOLOGY, V82, pA27; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; BAUGHMAN VL, 1987, ANESTHESIOLOGY, V67, P314, DOI 10.1097/00000542-198709000-00006; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Bernal Byron, 2012, J Clin Med Res, V4, P363, DOI 10.4021/jocmr1047w; BLAMIRE AM, 1992, P NATL ACAD SCI USA, V89, P11069, DOI 10.1073/pnas.89.22.11069; Bundgaard H, 1998, ACTA ANAESTH SCAND, V42, P621, DOI 10.1111/j.1399-6576.1998.tb05292.x; Ciobanu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032645; CROSBY G, 1982, ANESTHESIOLOGY, V56, P437, DOI 10.1097/00000542-198206000-00005; DEARDEN NM, 1993, ACTA NEUROCHIR, P91; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; FORSTER A, 1982, ANESTHESIOLOGY, V56, P453, DOI 10.1097/00000542-198206000-00009; Griffin KM, 2010, NEUROIMAGE, V51, P1395, DOI 10.1016/j.neuroimage.2010.03.024; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Hayama HR, 2012, ANESTHESIOLOGY, V117, P981, DOI 10.1097/ALN.0b013e31826be467; Heath KJ, 1997, ANESTH ANALG, V85, P1284, DOI 10.1097/00000539-199712000-00019; Iannetti GD, 2007, MAGN RESON IMAGING, V25, P978, DOI 10.1016/j.mri.2007.03.018; Jansen GFA, 1999, ANESTH ANALG, V89, P358, DOI 10.1097/00000539-199908000-00021; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kim SGP, 2011, SUSCEPTIBILITY WEIGH, P637; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Li DB, 1998, JMRI-J MAGN RESON IM, V8, P1236, DOI 10.1002/jmri.1880080609; Liao R, 2010, EUR J ANAESTH, V27, P369, DOI 10.1097/EJA.0b013e32832edc70; Lovell AT, 1999, ANESTH ANALG, V88, P554, DOI 10.1097/00000539-199903000-00017; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Mielck F, 1999, ANESTH ANALG, V89, P364, DOI 10.1097/00000539-199908000-00022; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Ogawa Y, 2010, ANESTH ANALG, V111, P1279, DOI 10.1213/ANE.0b013e3181f42fc0; OLSEN KS, 1992, BRIT J ANAESTH, V69, P263, DOI 10.1093/bja/69.3.263; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prielipp RC, 2002, ANESTH ANALG, V95, P1052, DOI 10.1097/00000539-200210000-00048; Reinsfelt B, 2011, ACTA ANAESTH SCAND, V55, P118, DOI 10.1111/j.1399-6576.2010.02324.x; ROSE A, 1948, J OPT SOC AM, V38, P196, DOI 10.1364/JOSA.38.000196; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Scheidegger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044799; SMITH AL, 1972, ANESTHESIOLOGY, V36, P378, DOI 10.1097/00000542-197204000-00015; Takuwa H, 2012, BRAIN RES, V1472, P107, DOI 10.1016/j.brainres.2012.06.049; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; VANHEMELRIJCK J, 1990, ANESTH ANALG, V71, P49; Yablonskiy DA, 2013, NMR BIOMED, V26, P963, DOI 10.1002/nbm.2839; Yoshitani K, 2004, ANESTH ANALG, V98, P471, DOI [10.1213/01.ANE.0000099755.97885.3C, 10.1213/01.ANE.000099755.97885.3C]	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e100323	10.1371/journal.pone.0100323	http://dx.doi.org/10.1371/journal.pone.0100323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050866	Green Submitted, gold, Green Published			2022-12-27	WOS:000339551100003
J	McNair, A; Nakagawa, S; Grimm, V				McNair, Alistair Senior; Nakagawa, Shinichi; Grimm, Volker			The Evolutionary Consequences of Disrupted Male Mating Signals: An Agent-Based Modelling Exploration of Endocrine Disrupting Chemicals in the Guppy	PLOS ONE			English	Article							RUNAWAY SEXUAL SELECTION; COSTLY MATE PREFERENCES; REDUCING MUTATION LOAD; POECILIA-RETICULATA; BEHAVIORAL-RESPONSES; GENETIC-VARIATION; TRAITS; CHOICE; RESOLUTION; INFECTION	Females may select a mate based on signalling traits that are believed to accurately correlate with heritable aspects of male quality. Anthropogenic actions, in particular chemicals released into the environment, are now disrupting the accuracy of mating signals to convey information about male quality. The long-term prediction for disrupted mating signals is most commonly loss of female preference. Yet, this prediction has rarely been tested using quantitative models. We use agent-based models to explore the effects of rapid disruption of mating signals. In our model, a gene determines survival. Males signal their level of genetic quality via a signal trait, which females use to select a mate. We allowed this system of sexual selection to become established, before introducing a disruption between the male signal trait and quality, which was similar in nature to that induced by exogenous chemicals. Finally, we assessed the capacity of the system to recover from this disruption. We found that within a relatively short time frame, disruption of mating signals led to a lasting loss of female preference. Decreases in mean viability at the population-level were also observed, because sexual-selection acting against newly arising deleterious mutations was relaxed. The ability of the population to recover from disrupted mating signals was strongly influenced by the mechanisms that promoted or maintained genetic diversity in traits under sexual selection. Our simple model demonstrates that environmental perturbations to the accuracy of male mating signals can result in a long-term loss of female preference for those signals within a few generations. What is more, the loss of this preference can have knock-on consequences for mean population fitness.	[McNair, Alistair Senior; Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, Otago, New Zealand; [McNair, Alistair Senior] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [McNair, Alistair Senior] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Grimm, Volker] Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Saxony, Germany; [Grimm, Volker] Univ Potsdam, Inst Biochem & Biol, Potsdam, Brandenburg, Germany	University of Otago; University of Sydney; University of Sydney; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Potsdam	McNair, A (corresponding author), Univ Otago, Dept Zool, Dunedin, Otago, New Zealand.	alistair.senior1985@gmail.com	Nakagawa, Shinichi/B-5571-2011	Nakagawa, Shinichi/0000-0002-7765-5182	DAAD (German Academic Exchange Program); Helmholtz Centre for Environmental Research - UFZ, Leipzig; Marsden Fund, New Zealand [UOO0812]	DAAD (German Academic Exchange Program)(Deutscher Akademischer Austausch Dienst (DAAD)); Helmholtz Centre for Environmental Research - UFZ, Leipzig; Marsden Fund, New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	The authors would like to thank the DAAD (German Academic Exchange Program; https://www.daad.de/en/), the Helmholtz Centre for Environmental Research - UFZ, Leipzig, and the Marsden Fund (http://royalsociety.org.nz/programmes/funds/marsden/; UOO0812), New Zealand, for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; [Anonymous], 2003, ANIMAL SIGNALS; [Anonymous], 1994, SEXUAL SELECTION; Arbuthnott D, 2012, EVOLUTION, V66, P2127, DOI 10.1111/j.1558-5646.2012.01584.x; Baatrup E, 2001, ENVIRON HEALTH PERSP, V109, P1063, DOI 10.2307/3454962; Barrett RDH, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P216; Bonduriansky R, 2013, J EVOLUTION BIOL, V26, P76, DOI 10.1111/jeb.12028; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2009, J FISH BIOL, V75, P2108, DOI 10.1111/j.1095-8649.2009.02405.x; Candolin U, 2007, J EVOLUTION BIOL, V20, P233, DOI 10.1111/j.1420-9101.2006.01207.x; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Candolin U, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P201; Chandler CH, 2013, EVOLUTION, V67, P110, DOI 10.1111/j.1558-5646.2012.01750.x; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; DEJONG MCM, 1991, J EVOLUTION BIOL, V4, P637, DOI 10.1046/j.1420-9101.1991.4040637.x; Eeva T, 1998, FUNCT ECOL, V12, P607, DOI 10.1046/j.1365-2435.1998.00221.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Eshel I, 2000, EVOL ECOL RES, V2, P509; Gordon SP, 2012, EVOLUTION, V66, P912, DOI 10.1111/j.1558-5646.2011.01495.x; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hall DW, 2000, EVOLUTION, V54, P1862, DOI 10.1111/j.0014-3820.2000.tb01233.x; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Jarzebowska M, 2010, EVOLUTION, V64, P1283, DOI 10.1111/j.1558-5646.2009.00905.x; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Karino K, 2010, J FISH BIOL, V77, P299, DOI 10.1111/j.1095-8649.2010.02688.x; KAVUMPURATH S, 1993, AQUACULTURE, V116, P83, DOI 10.1016/0044-8486(93)90224-M; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Kokko H, 2005, EVOLUTION, V59, P1876; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2003, ANN ZOOL FENN, V40, P207; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Kuijper B, 2012, ANNU REV ECOL EVOL S, V43, P287, DOI 10.1146/annurev-ecolsys-110411-160245; Lane JE, 2011, ANIM BEHAV, V81, P909, DOI 10.1016/j.anbehav.2011.02.003; Lehtonen TK, 2010, BIOL LETTERS, V6, P21, DOI 10.1098/rsbl.2009.0558; Lenth R., 2019, Journal of Statistical Software, V60, P1; LODI E, 1978, CARYOLOGIA, V31, P475, DOI 10.1080/00087114.1978.10796767; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; McGuigan K, 2011, EVOLUTION, V65, P2816, DOI 10.1111/j.1558-5646.2011.01346.x; Mcnair A, 2012, BIOL REV, V87, P900, DOI 10.1111/j.1469-185X.2012.00230.x; Miller CW, 2007, P ROY SOC B-BIOL SCI, V274, P1279, DOI 10.1098/rspb.2006.0413; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; POMIANKOWSKI A, 1991, EVOLUTION, V45, P1422, DOI 10.1111/j.1558-5646.1991.tb02645.x; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Rempel MA, 2008, INT REV CEL MOL BIO, V267, P207, DOI 10.1016/S1937-6448(08)00605-9; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; Robertson B, 2013, TRENDS ECOLOGY EVOLU; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Senior AM, 2013, FISH FISH, V14, P60, DOI 10.1111/j.1467-2979.2011.00446.x; Shenoy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030611; Shenoy K, 2011, FUNCT ECOL, V25, P433, DOI 10.1111/j.1365-2435.2010.01787.x; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Tinghitella RM, 2009, EVOLUTION, V63, P2087, DOI 10.1111/j.1558-5646.2009.00698.x; Tuomainen U, 2011, EVOL ECOL RES, V13, P697; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Vergara P, 2012, J EVOLUTION BIOL, V25, P20, DOI 10.1111/j.1420-9101.2011.02399.x; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wilensky U., 1999, NETLOGO; Zhan SH, 2014, J EVOLUTION BIOL, V27, P391, DOI 10.1111/jeb.12308	75	2	2	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103100	10.1371/journal.pone.0103100	http://dx.doi.org/10.1371/journal.pone.0103100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047080	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100107
J	Sun, SQ; Peng, QK; Shakoor, A				Sun, Shiquan; Peng, Qinke; Shakoor, Adnan			A Kernel-Based Multivariate Feature Selection Method for Microarray Data Classification	PLOS ONE			English	Article							GENE SELECTION; CANCER; PREDICTION; INFORMATION; DISCOVERY; ALGORITHM	High dimensionality and small sample sizes, and their inherent risk of overfitting, pose great challenges for constructing efficient classifiers in microarray data classification. Therefore a feature selection technique should be conducted prior to data classification to enhance prediction performance. In general, filter methods can be considered as principal or auxiliary selection mechanism because of their simplicity, scalability, and low computational complexity. However, a series of trivial examples show that filter methods result in less accurate performance because they ignore the dependencies of features. Although few publications have devoted their attention to reveal the relationship of features by multivariate-based methods, these methods describe relationships among features only by linear methods. While simple linear combination relationship restrict the improvement in performance. In this paper, we used kernel method to discover inherent nonlinear correlations among features as well as between feature and target. Moreover, the number of orthogonal components was determined by kernel Fishers linear discriminant analysis (FLDA) in a self-adaptive manner rather than by manual parameter settings. In order to reveal the effectiveness of our method we performed several experiments and compared the results between our method and other competitive multivariate-based features selectors. In our comparison, we used two classifiers (support vector machine, k-nearest neighbor) on two group datasets, namely two-class and multi-class datasets. Experimental results demonstrate that the performance of our method is better than others, especially on three hard-classify datasets, namely Wang's Breast Cancer, Gordon's Lung Adenocarcinoma and Pomeroy's Medulloblastoma.	[Sun, Shiquan; Peng, Qinke; Shakoor, Adnan] Xi An Jiao Tong Univ, Syst Engn Inst, Sch Elect & Informat Engn, Xian 710049, Peoples R China	Xi'an Jiaotong University	Peng, QK (corresponding author), Xi An Jiao Tong Univ, Syst Engn Inst, Sch Elect & Informat Engn, Xian 710049, Peoples R China.	qkpeng@xjtu.edu.cn	Sun, Shiquan/AAA-2541-2019; shakoor, Adnan/AAF-8270-2020	shakoor, Adnan/0000-0003-0646-5231	National Natural Science Foundation of China [61173111, 60774086]; Ph. D. Programs Foundation of Ministry of Education of China [20090201110027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was jointly supported by the National Natural Science Foundation of China (grant numbers 61173111, 60774086) and the Ph. D. Programs Foundation of Ministry of Education of China (grant number 20090201110027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Balagani KS, 2010, IEEE T PATTERN ANAL, V32, P1342, DOI 10.1109/TPAMI.2010.62; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brown G, 2012, J MACH LEARN RES, V13, P27; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; De Jay N, 2013, BIOINFORMATICS, V29, P2365, DOI 10.1093/bioinformatics/btt383; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Draminski M, 2008, BIOINFORMATICS, V24, P110, DOI 10.1093/bioinformatics/btm486; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Gutkin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006416; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Ji GL, 2011, IEEE T SYST MAN CY C, V41, P830, DOI 10.1109/TSMCC.2010.2078503; Kannan SS, 2010, KNOWL-BASED SYST, V23, P580, DOI 10.1016/j.knosys.2010.03.016; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lee KE, 2003, BIOINFORMATICS, V19, P90, DOI 10.1093/bioinformatics/19.1.90; Li GZ, 2012, PATTERN RECOGN LETT, V33, P524, DOI 10.1016/j.patrec.2011.11.009; Nanni L, 2012, BIOINFORMATICS, V28, P1151, DOI 10.1093/bioinformatics/bts108; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Piao Y, 2012, BIOINFORMATICS, V28, P3306, DOI 10.1093/bioinformatics/bts602; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; RANNAR S, 1994, J CHEMOMETR, V8, P111, DOI 10.1002/cem.1180080204; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Shi P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-375; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sun X, 2012, PATTERN RECOGN, V45, P2992, DOI 10.1016/j.patcog.2012.02.001; Wang HQ, 2007, PATTERN RECOGN, V40, P3379, DOI 10.1016/j.patcog.2007.04.007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wold H., 1966, MULTIVARIATE ANAL; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Wold S., 1993, 3D QSAR DRUG DESIGN; Xiong MM, 2001, GENOME RES, V11, P1878, DOI 10.1101/gr.190001; Yang K, 2006, BMC BIOINFORMATICS, V7; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; You WJ, 2014, EXPERT SYST APPL, V41, P1463, DOI 10.1016/j.eswa.2013.08.043; You WJ, 2014, IEEE T HUM-MACH SYST, V44, P125, DOI 10.1109/THMS.2013.2288777; You WJ, 2014, KNOWL-BASED SYST, V55, P15, DOI 10.1016/j.knosys.2013.10.004; Yu L, 2004, J MACH LEARN RES, V5, P1205	43	80	82	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102541	10.1371/journal.pone.0102541	http://dx.doi.org/10.1371/journal.pone.0102541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048512	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100042
J	Violan, C; Foguet-Boreu, Q; Flores-Mateo, G; Salisbury, C; Blom, J; Freitag, M; Glynn, L; Muth, C; Valderas, JM				Violan, Concepcio; Foguet-Boreu, Quinti; Flores-Mateo, Gemma; Salisbury, Chris; Blom, Jeanet; Freitag, Michael; Glynn, Liam; Muth, Christiane; Valderas, Jose M.			Prevalence, Determinants and Patterns of Multimorbidity in Primary Care: A Systematic Review of Observational Studies	PLOS ONE			English	Review							MULTIPLE CHRONIC CONDITIONS; CHRONIC DISEASES; GENERAL-PRACTICE; HEALTH-CARE; COMORBIDITY; POPULATION; INTERVENTIONS; INFORMATION; MORBIDITY; NETWORK	Introduction: Multimorbidity is a major concern in primary care. Nevertheless, evidence of prevalence and patterns of multimorbidity, and their determinants, are scarce. The aim of this study is to systematically review studies of the prevalence, patterns and determinants of multimorbidity in primary care. Methods: Systematic review of literature published between 1961 and 2013 and indexed in Ovid (CINAHL, PsychINFO, Medline and Embase) and Web of Knowledge. Studies were selected according to eligibility criteria of addressing prevalence, determinants, and patterns of multimorbidity and using a pretested proforma in primary care. The quality and risk of bias were assessed using STROBE criteria. Two researchers assessed the eligibility of studies for inclusion (Kappa = 0.86). Results: We identified 39 eligible publications describing studies that included a total of 70,057,611 patients in 12 countries. The number of health conditions analysed per study ranged from 5 to 335, with multimorbidity prevalence ranging from 12.9% to 95.1%. All studies observed a significant positive association between multimorbidity and age (odds ratio [OR], 1.26 to 227.46), and lower socioeconomic status (OR, 1.20 to 1.91). Positive associations with female gender and mental disorders were also observed. The most frequent patterns of multimorbidity included osteoarthritis together with cardiovascular and/or metabolic conditions. Conclusions: Well-established determinants of multimorbidity include age, lower socioeconomic status and gender. The most prevalent conditions shape the patterns of multimorbidity. However, the limitations of the current evidence base means that further and better designed studies are needed to inform policy, research and clinical practice, with the goal of improving health-related quality of life for patients with multimorbidity. Standardization of the definition and assessment of multimorbidity is essential in order to better understand this phenomenon, and is a necessary immediate step.	[Violan, Concepcio; Foguet-Boreu, Quinti; Flores-Mateo, Gemma] Inst Univ Invest Atencio Primaria Jordi Gol, Cent Res Unit, Barcelona, Catalunya, Spain; [Violan, Concepcio; Foguet-Boreu, Quinti; Flores-Mateo, Gemma] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Salisbury, Chris] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Blom, Jeanet] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Freitag, Michael] Univ Jena, Sch Med, Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Glynn, Liam] Natl Univ Ireland, Discipline Gen Practice, Galway, Ireland; [Muth, Christiane] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany; [Valderas, Jose M.] Univ Exeter, Sch Med, Hlth Serv & Policy Res Grp, Exeter, Devon, England	Autonomous University of Barcelona; University of Bristol; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Friedrich Schiller University of Jena; Ollscoil na Gaillimhe-University of Galway; Goethe University Frankfurt; University of Exeter	Valderas, JM (corresponding author), Univ Exeter, Sch Med, Hlth Serv & Policy Res Grp, Exeter, Devon, England.	J.M.Valderas-Martinez@exeter.ac.uk	Freitag, Michael H./G-4887-2011; Valderas, Jose M/Y-9814-2019; Violan, Concepcion/I-4493-2019; Violán, Concepcion/HHC-2893-2022; Freitag, Michael/AAJ-1188-2021; Valderas, Jose M/G-7967-2014; Salisbury, Chris/C-6724-2008	Freitag, Michael H./0000-0002-7572-2011; Violan, Concepcion/0000-0003-3309-5360; Violán, Concepcion/0000-0003-3309-5360; Freitag, Michael/0000-0002-7572-2011; Valderas, Jose M/0000-0002-9299-1555; Salisbury, Chris/0000-0002-4378-3960; Flores-Mateo, Gemma/0000-0001-6901-7327; Glynn, Liam/0000-0002-6153-9363; Foguet-Boreu, Quinti/0000-0002-6069-5305	Clinician Scientist Award from the National Institute for Health Research, Department of Health, United Kingdom; Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) as part the Primary Care Prevention and Health Promotion Research Network (rediAPP); ISCiii-RETICS [RD12/0005]; ISCiii [PI12/00427]; Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	Clinician Scientist Award from the National Institute for Health Research, Department of Health, United Kingdom; Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) as part the Primary Care Prevention and Health Promotion Research Network (rediAPP); ISCiii-RETICS; ISCiii(Instituto de Salud Carlos III); Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); National Institute for Health Research(National Institute for Health Research (NIHR))	Jose M. Valderas was supported by a Clinician Scientist Award from the National Institute for Health Research, Department of Health, United Kingdom. Improving the management of long term conditions with the clinical use of patient reported outcome measures in Primary Care. Period: 01/3/2011-01/3/2016. This work has been also co-funded by by the Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) as part the Primary Care Prevention and Health Promotion Research Network (rediAPP), by ISCiii-RETICS (RD12/0005) and by a grant for research projects ISCiii (PI12/00427). QFB is supported by a scholarship awarded by Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2004, G GERONTOL, V52, P267; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Brilleman SL, 2013, BRIT J GEN PRACT, V63, pE274, DOI 10.3399/bjgp13X665242; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Lochner KA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120137; Macleod U, 2004, EUR J GEN PRACT, V10, P24, DOI 10.3109/13814780409094223; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; METSEMAKERS JFM, 1992, BRIT J GEN PRACT, V42, P102; Minas M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-252; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muggah E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-452; Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1; Naessens JM, 2011, AM J MANAG CARE, V17, P118; Newcomer SR, 2011, AM J MANAG CARE, V17, pE324; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Rizza A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-113; ROSE AT, 1984, FAM PRACT, V1, P162, DOI 10.1093/fampra/1.3.162; Salisbury C, 2011, BR J GEN PRACT, V61; Salisbury C, 2012, LANCET, V380, P7, DOI 10.1016/S0140-6736(12)60482-6; Saltman DC, 2005, POSTGRAD MED J, V81, P474, DOI 10.1136/pgmj.2004.028530; Perez MIS, 2010, REV PANAM SALUD PUBL, V27, P80, DOI 10.1590/S1020-49892010000100012; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; SCHELLEVIS FG, 1993, J CLIN EPIDEMIOL, V46, P469, DOI 10.1016/0895-4356(93)90024-U; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Stange KC, 2012, ANN FAM MED, V10, P2, DOI 10.1370/afm.1354; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Tacken Margot A J B, 2011, Ned Tijdschr Geneeskd, V155, pA3109; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2006, J CLIN EPIDEMIOL, V59, P934, DOI 10.1016/j.jclinepi.2006.02.009; van den Bussche H, 2013, J CLIN EPIDEMIOL, V66, P209, DOI 10.1016/j.jclinepi.2012.07.019; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Ware JE, 2007, USERS MANUAL SF 36V2; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	57	507	532	6	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102149	10.1371/journal.pone.0102149	http://dx.doi.org/10.1371/journal.pone.0102149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25048354	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100020
J	de Vries, NJ; Carlson, J; Moscato, P				de Vries, Natalie Jane; Carlson, Jamie; Moscato, Pablo			A Data-Driven Approach to Reverse Engineering Customer Engagement Models: Towards Functional Constructs	PLOS ONE			English	Article							CONSUMERS; NETWORK; CREATE; BRAND; FLOW	Online consumer behavior in general and online customer engagement with brands in particular, has become a major focus of research activity fuelled by the exponential increase of interactive functions of the internet and social media platforms and applications. Current research in this area is mostly hypothesis-driven and much debate about the concept of Customer Engagement and its related constructs remains existent in the literature. In this paper, we aim to propose a novel methodology for reverse engineering a consumer behavior model for online customer engagement, based on a computational and data-driven perspective. This methodology could be generalized and prove useful for future research in the fields of consumer behaviors using questionnaire data or studies investigating other types of human behaviors. The method we propose contains five main stages; symbolic regression analysis, graph building, community detection, evaluation of results and finally, investigation of directed cycles and common feedback loops. The 'communities' of questionnaire items that emerge from our community detection method form possible 'functional constructs' inferred from data rather than assumed from literature and theory. Our results show consistent partitioning of questionnaire items into such 'functional constructs' suggesting the method proposed here could be adopted as a new data-driven way of human behavior modeling.	[de Vries, Natalie Jane; Moscato, Pablo] Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Newcastle, NSW 2300, Australia; [de Vries, Natalie Jane; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Fac Engn & Built Environm, Newcastle, NSW 2300, Australia; [Carlson, Jamie] Univ Newcastle, Newcastle Business Sch, Fac Business & Law, Newcastle, NSW 2300, Australia	University of Newcastle; University of Newcastle; University of Newcastle	Moscato, P (corresponding author), Univ Newcastle, Prior Res Ctr Bioinformat Biomarker Discovery & I, Newcastle, NSW 2300, Australia.	pablo.moscato@newcastle.edu.au	Carlson, Jamie/AAP-5387-2020; Carlson, Jamie/G-7535-2013; MOSCATO, PABLO ALBERTO/G-7668-2013	Carlson, Jamie/0000-0002-1622-5939; Moscato, Pablo/0000-0003-2570-5966				Abu-Mostafa Y.S., 2012, LEARNING DATA AML BO; Ahmed A, 2009, P NATL ACAD SCI USA, V106, P11878, DOI 10.1073/pnas.0901910106; Allgaier N., 2011, REVERSE ENG BRAIN EU; [Anonymous], [No title captured]; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Brodie RJ, 2011, J SERV RES-US, V14, P252, DOI 10.1177/1094670511411703; Carlson J, 2012, J SPORT MANAGE, V26, P463, DOI 10.1123/jsm.26.6.463; Chu SC, 2011, INT J ADVERT, V30, P47, DOI 10.2501/IJA-30-1-047-075; Cvijikj IP, 2013, ONLINE ENGA IN PRESS; Dash, 2012, MARKETING RES APPL O; Dwivedi A, 2013, J CONSUM MARK, V30, P450, DOI 10.1108/JCM-01-2013-0414; Facebook, 2014, FAC PAG INS; Fleiss JL, 2003, MEASUREMENT INTERRAT; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Giustolisi O, 2006, J HYDROINFORM, V8, P207, DOI 10.2166/hydro.2006.020b; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; Gross J.L., 2003, HDB GRAPH THEORY; Hair J., 2008, MARK RES, Vfourth; Hair J. F., 2017, ADV ISSUES PARTIAL L; Hennig-Thurau T, 2010, J SERV RES-US, V13, P311, DOI 10.1177/1094670510375460; Hoffman DL, 2009, J INTERACT MARK, V23, P23, DOI 10.1016/j.intmar.2008.10.003; Hohenstein N., 2007, SELF CONGRUITY ANTEC, P118; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jahn B, 2012, J SERV MANAGE, V23, P344, DOI 10.1108/09564231211248444; Koza JR, 1992, GENETIC PROGRAMMING; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Kumar V, 2013, J SERV MANAGE, V24, P330, DOI 10.1108/09564231311327021; Lambdin C, 2012, THEOR PSYCHOL, V22, P67, DOI 10.1177/0959354311429854; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Liebetrau AM, 1983, MEASURES ASS MEASURE; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Neri F., 2012, HDB MEMETIC ALGORITH; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nutonian, 2013, EUR; O'Cass A, 2012, J SERV MARK, V26, P419, DOI 10.1108/08876041211257909; O'Cass A, 2011, BRIT J MANAGE, V22, P646, DOI 10.1111/j.1467-8551.2010.00694.x; O'Cass A, 2010, INTERNET RES, V20, P115, DOI 10.1108/10662241011032209; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Rosen KH, 1988, DISCRETE MATH ITS AP; Santos JM, 2009, LECT NOTES COMPUT SC, V5769, P175, DOI 10.1007/978-3-642-04277-5_18; Sashi CM, 2012, MANAGE DECIS, V50, P253, DOI 10.1108/00251741211203551; Sawhney M, 2005, J INTERACT MARK, V19, P4, DOI 10.1002/dir.20046; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Smits GF, 2005, GENET PROGR SER, V8, P283, DOI 10.1007/0-387-23254-0_17; van Doorn J, 2010, J SERV RES-US, V13, P253, DOI 10.1177/1094670510375599; Verleye K, 2014, J SERV RES-US, V17, P68, DOI 10.1177/1094670513494015; Vivek SD, 2012, J MARKET THEORY PRAC, V20, P127, DOI 10.2753/MTP1069-6679200201; Vladislavleva EJ, 2009, IEEE T EVOLUT COMPUT, V13, P333, DOI 10.1109/TEVC.2008.926486; Wagner D, 2007, COMP CLUSTERINGS OVE	54	13	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102768	10.1371/journal.pone.0102768	http://dx.doi.org/10.1371/journal.pone.0102768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036766	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200085
J	Deng, H; Sun, J; Ma, J; Li, L; Fang, LX; Zhang, QJ; Liu, YH; Liao, XP				Deng, Hui; Sun, Jian; Ma, Jun; Li, Liang; Fang, Liang-Xing; Zhang, Qijing; Liu, Ya-Hong; Liao, Xiao-Ping			Identification of the Multi-Resistance Gene cfr in Escherichia coli Isolates of Animal Origin	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; BACILLUS STRAIN; 1ST REPORT; CONFERS RESISTANCE; PLASMID; SWINE; OXAZOLIDINONES; ENVIRONMENT; PHENICOLS; CHINA	Previous study indicated that the multi-resistance gene cfr was mainly found in gram-positive bacteria, such as Staphylococcus and Enterococcus, and was sporadically detected in Escherichia coli. Little is known about the prevalence and transmission mechanism of cfr in E. coli. In this study, the presence of cfr in E. coli isolates collected during 2010-2012 from food-producing animals in Guangdong Province of China was investigated, and the cfr-positive E. coli isolates were characterized by PFGE, plasmid profiling, and genetic environment analysis. Of the 839 E. coli isolates, 10 isolates from pig were cfr positive. All the cfr-positive isolates presented a multi-resistance phenotype and were genetically divergent as determined by PFGE. In 8 out of the 10 strains, the cfr gene was located on plasmids of similar to 30 kb. Restriction digestion of the plasmids with EcoRI and sequence hybridization with a cfr-specific probe revealed that the cfr-harboring fragments ranged from 6 to 23 kb and a similar to 18 kb cfr-carrying fragment was common for the plasmids that were similar to 30 kb. Four different genetic environments of cfr were detected, in which cfr is flanked by two identical copies of IS26, which may loop out the intervening sequence through homologous recombination. Among the 8 plasmids of similar to 30 kb, 7 plasmids shared the same genetic environment. These results demonstrate plasmid-carried cfr in E. coli and suggest that transposition and homologous recombination mediated by IS26 might have played a rule in the transfer of the cfr gene in E. coli.	[Deng, Hui; Sun, Jian; Ma, Jun; Li, Liang; Fang, Liang-Xing; Zhang, Qijing; Liu, Ya-Hong; Liao, Xiao-Ping] South China Agr Univ, Natl Reference Lab Vet Drug Residues SCAU, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Liao, XP (corresponding author), South China Agr Univ, Natl Reference Lab Vet Drug Residues SCAU, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	xpliao@scau.edu.cn		Li, Liang/0000-0003-3571-8058	National Science Fund for Distinguished Young Scholars [31125026]; National Natural Science Foundation [31272609]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT13063]; Science and Technology Program of Guangzhou, China [2011J2200054]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China; Science and Technology Program of Guangzhou, China	This work was supported by the National Science Fund for Distinguished Young Scholars (Grant No. 31125026), the National Natural Science Foundation (Grant No. 31272609), Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (Grant No. IRT13063) and Science and Technology Program of Guangzhou, China (Grant No. 2011J2200054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2007, J ANTIMICROB CHEMOTH, V59, P880, DOI 10.1093/jac/dkm065; CLSI, 2012, M100S22 CLSI; Dai L, 2010, ANTIMICROB AGENTS CH, V54, P3953, DOI 10.1128/AAC.00169-10; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P1005, DOI 10.1093/jac/dkr041; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Liu Y, 2014, J ANTIMICROB CHEMOTH, V69, P892, DOI 10.1093/jac/dkt459; Liu Y, 2013, ANTIMICROB AGENTS CH, V57, P42, DOI 10.1128/AAC.01605-12; Liu Y, 2012, ANTIMICROB AGENTS CH, V56, P1650, DOI 10.1128/AAC.06091-11; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Shen JZ, 2013, J ANTIMICROB CHEMOTH, V68, P1697, DOI 10.1093/jac/dkt092; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Wang Y, 2013, ANTIMICROB AGENTS CH, V57, P4061, DOI 10.1128/AAC.00713-13; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1824, DOI 10.1093/jac/dks163; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1547, DOI 10.1093/jac/dks075; Wang Y, 2012, J ANTIMICROB CHEMOTH, V67, P1094, DOI 10.1093/jac/dks020; Wang Y, 2012, ANTIMICROB AGENTS CH, V56, P1485, DOI 10.1128/AAC.05827-11; Wang Y, 2011, J ANTIMICROB CHEMOTH, V66, P2521, DOI 10.1093/jac/dkr322; Zhang WJ, 2014, J ANTIMICROB CHEMOTH, V69, P385, DOI 10.1093/jac/dkt355; Zhang WJ, 2011, J ANTIMICROB CHEMOTH, V66, P1174, DOI 10.1093/jac/dkr037	23	24	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102378	10.1371/journal.pone.0102378	http://dx.doi.org/10.1371/journal.pone.0102378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036029	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200052
J	Zhang, Y; Liu, J; Peng, X; Zhu, CC; Han, J; Luo, J; Rui, R				Zhang, Yu; Liu, Jun; Peng, Xu; Zhu, Cheng-Cheng; Han, Jun; Luo, Jia; Rui, Rong			KIF20A Regulates Porcine Oocyte Maturation and Early Embryo Development	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN; CENTRAL SPINDLE; PASSENGER COMPLEX; AURORA-B; CYTOKINESIS; MEIOSIS; MITOSIS; ORGANIZATION; KINETOCHORE; CHROMOSOMES	KIF20A (Kinesin-like family member 20A), also called mitotic kinesin-like proteins 2 (MKLP2), is a mammalian mitotic kinesin-like motor protein of the Kinesin superfamily proteins (KIFs), which was originally involved in Golgi apparatus dynamics and thought to essential for cell cycle regulation during successful cytokinesis. In the present study, we investigated whether KIF20A has roles on porcine oocyte meiotic maturation and subsequent early embryo development. By immunofluorescence staining, KIF20A was found to exhibit a dynamic localization pattern during meiosis. KIF20A was restricted to centromeres after germinal vesicle breakdown (GVBD), transferred to the midbody at telophase I (TI), and again associated with centromeres at metaphase II (MII). Inhibition of endogenous KIF20A via a specific inhibitor, Paprotrain, resulted in failure of polar body extrusion. Further cell cycle analysis showed that the percentage of oocytes that arrested at early metaphase I (MI) stage increased after KIF20A activity inhibition; however, the proportion of oocytes at anaphase/telophase I (ATI) and MII stages decreased significantly. Our results also showed that KIF20A inhibition did not affect spindle morphology. In addition, KIF20A was localized at the nucleus of early embryos, and KIF20A inhibition resulted in failure of early parthenogenetic embryo development. These results demonstrated that KIF20A is critical for porcine oocyte meiotic maturation and subsequent early embryo development.	[Zhang, Yu; Peng, Xu; Rui, Rong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Yu; Liu, Jun; Zhu, Cheng-Cheng; Han, Jun] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Luo, Jia] Technol Ctr Guangxi Entry Exit Inspect & Quaranti, Nanning, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Rui, R (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	rrui@njau.edu.cn			National Basic Research Program of China [2014CB138503]; Ministry of Education of China [20120097120007, 20130097110020]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Basic Research Program of China (2014CB138503), and Research Fund for the Doctoral Program of the Ministry of Education of China (20120097120007 and 20130097110020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Allan VJ, 1999, CURR OPIN CELL BIOL, V11, P476, DOI 10.1016/S0955-0674(99)80068-4; Cesario JM, 2006, J CELL SCI, V119, P4770, DOI 10.1242/jcs.03235; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Jang JK, 2005, MOL BIOL CELL, V16, P4684, DOI 10.1091/mbc.E04-11-0964; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; NISLOW C, 1990, J CELL BIOL, V111, P511, DOI 10.1083/jcb.111.2.511; Nislow C, 1992, PLUS END DIRECTED MO; Radford SJ, 2012, GENETICS, V192, P417, DOI 10.1534/genetics.112.143495; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Sharif B, 2010, J CELL SCI, V123, P4292, DOI 10.1242/jcs.067447; Shuda K, 2009, MOL REPROD DEV, V76, P1094, DOI 10.1002/mrd.21075; Vernos I, 1996, CURR OPIN CELL BIOL, V8, P4, DOI 10.1016/S0955-0674(96)80041-X; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yu T, 2007, J VIROL, V81, P1736, DOI 10.1128/JVI.01638-06	33	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102898	10.1371/journal.pone.0102898	http://dx.doi.org/10.1371/journal.pone.0102898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036038	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200094
J	Danielewska, ME; Krzyzanowska-Berkowska, P; Iskander, DR				Danielewska, Monika E.; Krzyzanowska-Berkowska, Patrycja; Iskander, D. Robert			Glaucomatous and Age-Related Changes in Corneal Pulsation Shape. The Ocular Dicrotism	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; BLOOD-FLOW; INTRAOCULAR-PRESSURE; PULSE-WAVE; ARTERIAL STIFFNESS; EYE-MOVEMENTS; FUNDUS PULSE; RIGIDITY; HEMODYNAMICS	Purpose: To ascertain whether the incidence of ocular dicrotic pulse (ODP) increases with age, it is more pronounced in glaucomatous than in normal eyes and whether it is related to cardiovascular activity. Methods: 261 subjects aged 47 to 78 years were included in the study and classified into four groups: primary open angle glaucoma (POAG), primary angle-closure glaucoma (PACG), glaucoma suspects with glaucomatous optic disc appearance (GODA) and the controls (CG). Additionally, in each group, subjects with ODP were divided into two age subgroups around the median age. A non-contact ultrasonic method was used to measure corneal indentation pulse (CIP) synchronically with the acquisition of electrocardiography (ECG) and blood pulse signals. ODP was assessed from the acquired signals that were numerically processed in a custom written program. Results: ODP incidence was about 78%, 66%, 66% and 84% for CG, GODA, POAG, and PACG group, respectively. With advancing age, the ODP incidence increased for all subjects (Delta = 12%), the highest being for the PACG and POAG groups (Delta = 30%). GODA group did not show an age-related increase in the incidence of ODP. Conclusions: The ocular dicrotism, measured with non-contact ultrasonic method, was found to be a common phenomenon in elderly subjects. The increased ODP incidence in PACG and POAG group may correspond to either higher stiffness of glaucoma eyes, biochemical abnormalities in eye tissues, changes in ocular hemodynamics, may reflect the effect of medications or be a combination of all those factors. The results of GODA group suggest different mechanisms governing their ocular pulse that makes them less susceptible to generating ODP and having decreased predisposition to glaucoma.	[Danielewska, Monika E.; Iskander, D. Robert] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Krzyzanowska-Berkowska, Patrycja] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University	Danielewska, ME (corresponding author), Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland.	monika.danielewska@pwr.edu.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534	National Science Centre grant [UMO-2011/01/N/ST7/05391]; Foundation for Polish Science [VENTURES/2011-7/4]	National Science Centre grant(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Supported, in part, by the National Science Centre grant, number UMO-2011/01/N/ST7/05391 to MED (www.ncn.gov.pl/?language=en) and funds from the Foundation for Polish Science project numer VENTURES/2011-7/4 to MED (www.fnp.org.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2003, PHYSIOL MEAS, V24, P297, DOI 10.1088/0967-3334/24/2/306; Altan-Yaycioglu R, 2001, EUR J OPHTHALMOL, V11, P37, DOI 10.1177/112067210101100108; ANGELONE A, 1964, J APPL PHYSIOL, V19, P479, DOI 10.1152/jappl.1964.19.3.479; Berisha F, 2010, ACTA OPHTHALMOL, V88, P766, DOI 10.1111/j.1755-3768.2009.01577.x; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; BOSLEY TM, 1993, STROKE, V24, P6, DOI 10.1161/01.STR.24.1.6; Boudaoud S, 2005, IEEE T SIGNAL PROCES, V53, P3644, DOI 10.1109/TSP.2005.855106; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; CARTER JE, 1983, J GERONTOL, V38, P318, DOI 10.1093/geronj/38.3.318; Chung HS, 1990, SURV OPHTHALMOL, V43, pS43; Conover MB, 2003, MOSBYS POCKET GUIDE; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Danielewska ME, 2012, IOVS, P53; Danielewska ME, 2014, OPTOMETRY VISION SCI, V91, P54, DOI 10.1097/OPX.0000000000000113; Danielewska ME, 2012, CLIN EXP OPTOM, V95, P631, DOI 10.1111/j.1444-0938.2012.00775.x; Dastiridou AI, 2009, INVEST OPHTH VIS SCI, V50, P5718, DOI 10.1167/iovs.09-3760; Daxer A, 1998, INVEST OPHTH VIS SCI, V39, P644; Dion C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054207; DRANCE SM, 1960, ARCH OPHTHALMOL-CHIC, V63, P668; Duijm HFA, 1997, AM J OPHTHALMOL, V123, P644; Ebneter A, 2009, EYE, V23, P606, DOI 10.1038/eye.2008.47; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Evans DW, 2002, GRAEF ARCH CLIN EXP, V240, P475, DOI 10.1007/s00417-002-0460-4; EWY GA, 1969, CIRCULATION, V39, P655, DOI 10.1161/01.CIR.39.5.655; Findl O, 2000, AM J OPHTHALMOL, V130, P589, DOI 10.1016/S0002-9394(00)00636-X; Fleming W J, 1881, J Anat Physiol, V15, P278; Fontana ST, 1984, ARCH OPHTHALMOL-CHIC, V102, P46; Friedenwald J.S., 1937, AM J OPHTHALMOL, V20, P985, DOI [DOI 10.1016/S0002-9394(37)90425-2, 10.1016/S0002-9394(37)90425-2, 10.1016/s0002-9394(37)90425-2]; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Galabin A L, 1873, J Anat Physiol, V8, P1; Galassi F, 2003, ARCH OPHTHALMOL-CHIC, V121, P1711, DOI 10.1001/archopht.121.12.1711; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Grunwald JE, 1998, ARCH OPHTHALMOL-CHIC, V116, P150; Harris A, 1998, SURV OPHTHALMOL, V42, P509, DOI 10.1016/S0039-6257(98)00011-3; Harris A, 2008, CAN J OPHTHALMOL, V43, P328, DOI 10.3129/i08-051; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; HORVEN I, 1971, ARCH OPHTHALMOL-CHIC, V86, P5, DOI 10.1001/archopht.1971.01000010007002; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; Iskander DR, 2006, OPHTHAL PHYSL OPT, V26, P572, DOI 10.1111/j.1475-1313.2006.00415.x; KANAI A, 1973, Annals of Ophthalmology, V5, P285; Kanngiesser HE, 2005, J GLAUCOMA, V14, P344, DOI 10.1097/01.ijg.0000176936.16015.4e; Kasprzak HT, 2007, EYE, V21, P1212, DOI 10.1038/sj.eye.6702578; Kasprzak HT, 2010, IEEE T INSTRUM MEAS, V59, P164, DOI 10.1109/TIM.2009.2022431; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Kiel J.W., 2010, OCULAR CIRCULATION; Kiss B, 2001, MICROVASC RES, V61, P1, DOI 10.1006/mvre.2000.2269; Kowalska MA, 2011, IEEE T BIO-MED ENG, V58, P674, DOI 10.1109/TBME.2010.2100819; LAKATTA EG, 1987, J AM COLL CARDIOL, V10, pA42, DOI 10.1016/S0735-1097(87)80447-3; Lam AKC, 2003, OPTOMETRY VISION SCI, V80, P305, DOI 10.1097/00006324-200304000-00008; LANGHAM ME, 1989, ACTA OPHTHALMOL, V67, P9; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; Lewis T, 1906, J PHYSIOL-LONDON, V34, P414; Licznerski TJ, 2011, ULTRASONICS, V51, P960, DOI 10.1016/j.ultras.2011.05.011; Mackenzie J, 1902, STUDY PULSE ARTERIAL; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; MCDONALD PT, 1979, ANN SURG, V189, P44, DOI 10.1097/00000658-197901000-00009; McDowell CM, 2012, EXP EYE RES, V100, P65, DOI 10.1016/j.exer.2012.04.016; MEADOWS WR, 1971, AM HEART J, V82, P596, DOI 10.1016/0002-8703(71)90328-0; Millasseau SC, 2002, CLIN SCI, V103, P371, DOI 10.1042/cs1030371; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Nichols W, 1998, MCDONALDS BLOOD FLOW; NORTHROP RB, 1977, IEEE T BIO-MED ENG, V24, P139, DOI 10.1109/TBME.1977.326118; ORCHARD RC, 1980, CIRCULATION, V62, P1107, DOI 10.1161/01.CIR.62.5.1107; ORourke MF, 1996, J HYPERTENS, V14, pS147; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Piltz-Seymour IR, 2001, AM J OPHTHALMOL, V132, P63, DOI 10.1016/S0002-9394(01)00871-6; Quigley HA, 2003, J GLAUCOMA, V12, P167, DOI 10.1097/00061198-200304000-00013; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Satilmis M, 2003, AM J OPHTHALMOL, V135, P664, DOI 10.1016/S0002-9394(02)02156-6; Schultz DS, 2008, INVEST OPHTH VIS SCI, V49, P4232, DOI 10.1167/iovs.08-1970; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; SHEREBRIN MH, 1990, IEEE T BIO-MED ENG, V37, P313, DOI 10.1109/10.52332; Sherwood L, 2006, FUNDAMENTALS PHYSIOL; Silver D M, 1994, Surv Ophthalmol, V38 Suppl, pS72, DOI 10.1016/0039-6257(94)90049-3; SILVER DM, 1989, ACTA OPHTHALMOL, V67, P25; SMITH D, 1986, BRIT HEART J, V56, P531; Steinhart MR, 2012, MOL VIS, V18, P1093; Szkulmowska A, 2009, OPT EXPRESS, V17, P10584, DOI 10.1364/OE.17.010584; TENGROTH B, 1984, ACTA OPHTHALMOL, V62, P999; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; TREW DR, 1991, GRAEF ARCH CLIN EXP, V229, P553, DOI 10.1007/BF00203321; Uebaba K, 1999, CIRCULATION, V33, p211A; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Zink JM, 2003, BRIT J OPHTHALMOL, V87, P1487, DOI 10.1136/bjo.87.12.1487; ZUCKERMAN JL, 1977, INVEST OPHTH VIS SCI, V16, P1018	94	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102814	10.1371/journal.pone.0102814	http://dx.doi.org/10.1371/journal.pone.0102814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032962	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300097
J	Muthu, M; Cheriyan, VT; Munie, S; Levi, E; Frank, J; Ashour, AE; Singh, M; Rishi, AK				Muthu, Magesh; Cheriyan, Vino T.; Munie, Sara; Levi, Edi; Frank, John; Ashour, Abdelkader E.; Singh, Mandip; Rishi, Arun K.			Mechanisms of Neuroblastoma Cell Growth Inhibition by CARP-1 Functional Mimetics	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-REGULATORY PROTEIN-1; ANAPHASE-PROMOTING COMPLEX; HIGH-RISK NEUROBLASTOMA; DOWN-REGULATION; BREAST-CANCER; IN-VITRO; CYCLE; ACTIVATION; EXPRESSION	Neuroblastomas (NBs) are a clinically heterogeneous group of extra cranial pediatric tumors. Patients with high-risk, metastatic NBs have a long-term survival rate of below 40%, and are often resistant to current therapeutic modalities. Due to toxic side effects associated with radiation and chemotherapies, development of new agents is warranted to overcome resistance and effectively treat this disease in clinic. CARP-1 functional mimetics (CFMs) are an emerging class of small molecule compounds that inhibit growth of diverse cancer cell types. Here we investigated NB inhibitory potential of CFMs and the molecular mechanisms involved. CFM-1, -4, and -5 inhibited NB cell growth, in vitro, independent of their p53 and MYCN status. CFM-4 and -5 induced apoptosis in NB cells in part by activating pro-apoptotic stress-activated kinases (SAPKs) p38 and JNK, stimulating CARP-1 expression and cleavage of PARP1, while promoting loss of the oncogenes C and N-myc as well as mitotic cyclin B1. Treatments of NB cells with CFM-4 or -5 also resulted in loss of Inhibitory kappa B (I kappa B) alpha and beta proteins. Micro-RNA profiling revealed upregulation of XIAP-targeting miR513a-3p in CFM-4-treated NB, mesothelioma, and breast cancer cells. Moreover, exposure of NB and breast cancer cells to CFM-4 or -5 resulted in diminished expression of antiapoptotic XIAP1, cIAP1, and Survivin proteins. Expression of anti-miR513a-5p or miR513a-5p mimic, however, interfered with or enhanced, respectively, the breast cancer cell growth inhibition by CFM-4. CFMs also impacted biological properties of the NB cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Our studies indicate anti-NB properties of CFM-4 and 5, and suggest that these CFMs and/or their future analogs have potential as anti-NB agents.	[Muthu, Magesh; Cheriyan, Vino T.; Munie, Sara; Levi, Edi; Frank, John; Rishi, Arun K.] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA; [Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Muthu, Magesh; Cheriyan, Vino T.; Munie, Sara; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Levi, Edi] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Ashour, Abdelkader E.] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh, Saudi Arabia; [Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; King Saud University; State University System of Florida; Florida A&M University	Rishi, AK (corresponding author), Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA.	Rishia@Karmanos.org	Ashour, Abdelkader/ABH-8235-2020; muthu, magesh/N-6987-2017	Ashour, Abdelkader/0000-0003-3978-8045; muthu, magesh/0000-0003-3311-8120; Levi, Edi/0000-0003-1809-2866	Department of Veterans Affairs Merit Review grant; NCI/NIH Cancer Center; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia [MED-1768-02]	Department of Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NCI/NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia	This work was supported by the Department of Veterans Affairs Merit Review grant (AKR), and the NCI/NIH Cancer Center Support Grant to Karmanos Cancer Institute, Detroit, Michigan, and a grant from the National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia (Grant No. MED-1768-02; AEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Ashour AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066733; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger R, 2011, MOL CANCER THER, V10, P1867, DOI 10.1158/1535-7163.MCT-11-0218; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Bourboulia D, 2013, ONCOTARGET, V4, P166; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Endo Y, 2013, ENDOCR-RELAT CANCER, V20, P91, DOI 10.1530/ERC-12-0207; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jamal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089146; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Keshelava N, 1998, CANCER RES, V58, P5396; Kim HC, 2014, ONCOTARGET; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; Luo PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027298; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Olshan AF, 2000, NEUROBLASTOMA, P33; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shaw Leslie M., 2004, V294, P97; Shin S, 2012, BIOCHIMIE, V94, P1431, DOI 10.1016/j.biochi.2012.03.023; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076662; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yelamanchili SV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.498; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	57	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102567	10.1371/journal.pone.0102567	http://dx.doi.org/10.1371/journal.pone.0102567			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033461	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000339418300062
J	Nonnemaker, JM; Allen, JA; Davis, KC; Kamyab, K; Duke, JC; Farrelly, MC				Nonnemaker, James M.; Allen, Jane A.; Davis, Kevin C.; Kamyab, Kian; Duke, Jennifer C.; Farrelly, Matthew C.			The Influence of Antismoking Television Advertisements on Cessation by Race/Ethnicity, Socioeconomic Status, and Mental Health Status	PLOS ONE			English	Article							PROMOTE SMOKING-CESSATION; MEDIA CAMPAIGNS; DISADVANTAGED POPULATIONS; UNITED-STATES; QUIT SMOKING; ADULTS; DISPARITIES; PREVALENCE; SMOKERS; INTERVENTIONS	Disparities in tobacco use and smoking cessation by race/ethnicity, education, income, and mental health status remain despite recent successes in reducing tobacco use. It is unclear to what extent media campaigns promote cessation within these population groups. This study aims to (1) assess whether exposure to antitobacco advertising is associated with making a quit attempt within a number of population subgroups, and (2) determine whether advertisement type differentialy affects cessation behavior across subgroups. We used data from the New York Adult Tobacco Survey (NY-ATS), a cross-sectional, random-digit-dial telephone survey of adults aged 18 or older in New York State conducted quarterly from 2003 through 2011 (N = 53,706). The sample for this study consists of 9,408 current smokers from the total NY-ATS sample. Regression methods were used to examine the effect of New York State's antismoking advertising, overall and by advertisement type (graphic and/or emotional), on making a quit attempt in the past 12 months. Exposure to antismoking advertising was measured in two ways: gross rating points (a measure of potential exposure) and self-reported confirmed recall of advertisements. This study yields three important findings. First, antismoking advertising promotes quit attempts among racial/ethnic minority smokers and smokers of lower education and income. Second, advertising effectiveness is attributable in part to advertisements with strong graphic imagery or negative emotion. Third, smokers with poor mental health do not appear to benefit from exposure to antismoking advertising of any type. This study contributes to the evidence about how cessation media campaigns can be used most effectively to increase quit attempts within vulnerable subgroups. In particular, it suggests that a general campaign can promote cessation among a range of sociodemographic groups. More research is needed to understand what message strategies might work for those with poor mental health.	[Nonnemaker, James M.; Allen, Jane A.; Davis, Kevin C.; Kamyab, Kian; Duke, Jennifer C.; Farrelly, Matthew C.] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Nonnemaker, JM (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	jnonnemaker@rti.org			New York State Department of Health [C022586]	New York State Department of Health	The New York State Department of Health provided funding for the conduct of the research and writing of the article under contract no. C022586. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Allen JA, 2011, HANDBOOK OF AFRICAN AMERICAN HEALTH: SOCIAL AND BEHAVIORAL INTERVENTIONS, P79, DOI 10.1007/978-1-4419-9616-9_5; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Biener L, 2000, TOB CONTROL, V9, P401, DOI 10.1136/tc.9.4.401; Bryant J, 2011, ADDICTION, V106, P1568, DOI 10.1111/j.1360-0443.2011.03467.x; Christiansen B, 2012, J STUD ALCOHOL DRUGS, V73, P874, DOI 10.15288/jsad.2012.73.874; Cokkinides VE, 2008, AM J PREV MED, V34, P404, DOI 10.1016/j.amepre.2008.02.003; Davis KC, 2007, J ADOLESCENT HEALTH, V41, P430, DOI 10.1016/j.jadohealth.2007.05.008; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638; Fagan P, 2007, J HEALTH CARE POOR U, V18, P52, DOI 10.1353/hpu.2007.0119; Farrelly MC, 2012, AM J PREV MED, V43, P475, DOI 10.1016/j.amepre.2012.07.023; Farrelly MC, 2011, TOB CONTROL, V20, P279, DOI 10.1136/tc.2010.042234; Farrelly MC, 2009, AM J PREV MED, V36, P379, DOI 10.1016/j.amepre.2009.01.019; Farrelly MC, 2005, AM J PUBLIC HEALTH, V95, P425, DOI 10.2105/AJPH.2004.049692; Hymowitz N, 1996, J NATL MED ASSOC, V88, P249; Kahende JW, 2011, INT J ENV RES PUB HE, V8, P3871, DOI 10.3390/ijerph8103871; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Levinson AH, 2004, AM J PREV MED, V26, P105, DOI 10.1016/j.amepre.2003.10.012; McClave AK, 2010, AM J PUBLIC HEALTH, V100, P2464, DOI 10.2105/AJPH.2009.188136; National Cancer Institute, 2008, TOB CONTR MON, V19; Niederdeppe J, 2008, SOC SCI MED, V67, P1343, DOI 10.1016/j.socscimed.2008.06.037; Niederdeppe J, 2008, AM J PUBLIC HEALTH, V98, P916, DOI 10.2105/AJPH.2007.117499; Niederdeppe J, 2011, SOC SCI MED, V72, P773, DOI 10.1016/j.socscimed.2010.12.025; Richards CS, 2013, J CONSULT CLIN PSYCH, V81, P263, DOI 10.1037/a0027793; Southwell BG, 2002, J HEALTH COMMUN, V7, P445, DOI 10.1080/10810730290001800; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H, V11-4658; Thorndike AN, 2002, AM J PUBLIC HEALTH, V92, P437, DOI 10.2105/AJPH.92.3.437; Vallone DM, 2011, AM J HEALTH PROMOT, V25, pS38, DOI 10.4278/ajhp.100617-QUAN-201; Wakefield MA, 2011, HEALTH EDUC RES, V26, P988, DOI 10.1093/her/cyr054; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0	34	22	22	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102943	10.1371/journal.pone.0102943	http://dx.doi.org/10.1371/journal.pone.0102943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033449	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300110
J	Persson, BD; Jaffe, AB; Fearns, R; Danahay, H				Persson, B. David; Jaffe, Aron B.; Fearns, Rachel; Danahay, Henry			Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation	PLOS ONE			English	Article							MUCOCILIARY DIFFERENTIATION; BRONCHIAL EPITHELIUM; BARRIER FUNCTION; RSV; ASTHMA; IL-13; BRONCHIOLITIS; INTERFERON; MECHANISMS; TARGET	Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality worldwide, causing severe respiratory illness in infants and immune compromised patients. The ciliated cells of the human airway epithelium have been considered to be the exclusive target of RSV, although recent data have suggested that basal cells, the progenitors for the conducting airway epithelium, may also become infected in vivo. Using either mechanical or chemical injury models, we have demonstrated a robust RSV infection of p63(+) basal cells in air-liquid interface (ALI) cultures of human bronchial epithelial cells. In addition, proliferating basal cells in 2D culture were also susceptible to RSV infection. We therefore tested the hypothesis that RSV infection of this progenitor cell would influence the differentiation status of the airway epithelium. RSV infection of basal cells on the day of seeding (MOI <= 0.0001), resulted in the formation of an epithelium that showed a profound loss of ciliated cells and gain of secretory cells as assessed by acetylated alpha-tubulin and MUC5AC/MUC5B immunostaining, respectively. The mechanism driving the switch in epithelial phenotype is in part driven by the induced type I and type III interferon response that we demonstrate is triggered early following RSV infection. Neutralization of this response attenuates the RSV-induced loss of ciliated cells. Together, these data show that through infection of proliferating airway basal cells, RSV has the potential to influence the cellular composition of the airway epithelium. The resulting phenotype might be expected to contribute towards both the severity of acute infection, as well as to the longer-term consequences of viral exacerbations in patients with pre-existing respiratory diseases.	[Persson, B. David; Jaffe, Aron B.] Novartis Inst BioMed Res, Cambridge, MA USA; [Fearns, Rachel] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Danahay, Henry] Novartis Inst BioMed Res, Resp Dis Area, Horsham, W Sussex, England	Novartis; Boston University; Novartis	Danahay, H (corresponding author), Novartis Inst BioMed Res, Resp Dis Area, Horsham, W Sussex, England.	henry.danahay@novartis.com		Fearns, Rachel/0000-0003-0783-7498; Jaffe, Aron/0000-0002-6220-0476	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This study was funded by Novartis Institutes for Biomedical Research. Authors B. D. Persson, A. B. Jaffe and H. Danahay are employees of Novartis Institutes for BioMedical Research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black Craig Patrick, 2003, Respir Care, V48, P209; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Collins PL, 2007, FIELDS VIROLOGY, P1601; Ebbert JO, 2005, RESPIRATION, V72, P263, DOI 10.1159/000085367; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Garofalo RP, 2004, J MED VIROL, V73, P289, DOI 10.1002/jmv.20089; Gonzalez PA, 2012, REV MED VIROL, V22, P230, DOI 10.1002/rmv.1704; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Harris J, 2003, CELL MICROBIOL, V5, P671, DOI 10.1046/j.1462-5822.2003.00313.x; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Lasfar A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349575; LEVENSON RM, 1987, ARCH INTERN MED, V147, P791, DOI 10.1001/archinte.147.4.791; Lotz MT, 2012, CURR ALLERGY ASTHM R, V12, P380, DOI 10.1007/s11882-012-0278-z; Maggon K, 2004, REV MED VIROL, V14, P149, DOI 10.1002/rmv.423; Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037; Meyerholz DK, 2004, MICROBES INFECT, V6, P1312, DOI 10.1016/j.micinf.2004.08.006; MLB.com, 2013, 1 4 GAM 2013 WORLD S; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Okabayashi T, 2011, VIRUS RES, V160, P360, DOI 10.1016/j.virusres.2011.07.011; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Oshansky CM, 2009, FUTURE MICROBIOL, V4, P279, DOI 10.2217/FMB.09.1; OTaUF Power, 2011, CELLULAR MOL CHARACT; Papin JF, 2013, AM J PHYSL LUNG CELL; Ramaswamy M, 2009, COPD, V6, P64, DOI 10.1080/15412550902724024; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sethi S, 2012, AM J MED, V125, P1162, DOI 10.1016/j.amjmed.2012.06.024; Smith CM, 2013, EUR RESP J; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; van Benten IJ, 2003, J MED VIROL, V71, P290, DOI 10.1002/jmv.10482; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Villenave R, 2013, TRENDS MICROBIOL; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Westerly BD, 2010, IMMUNOL ALLERGY CLIN, V30, P523, DOI 10.1016/j.iac.2010.08.006; Wong JYW, 2005, THORAX, V60, P582, DOI 10.1136/thx.2004.024638; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zdrenghea MT, 2012, EUR RESPIR J, V39, P712, DOI 10.1183/09031936.00099811; Zhang LQ, 2011, VIROLOGY, V421, P67, DOI 10.1016/j.virol.2011.08.020; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	54	40	40	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102368	10.1371/journal.pone.0102368	http://dx.doi.org/10.1371/journal.pone.0102368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033192	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300051
J	Lattin, CR; Ngai, HM; Romero, LM				Lattin, Christine R.; Ngai, Heather M.; Romero, L. Michael			Evaluating the Stress Response as a Bioindicator of Sub-Lethal Effects of Crude Oil Exposure in Wild House Sparrows (Passer domesticus)	PLOS ONE			English	Article							DUCKS ANAS-PLATYRHYNCHOS; ENDOCRINE-DISRUPTING CHEMICALS; MALLARD DUCKS; SEASONAL-CHANGES; ADRENOCORTICAL ACTIVITY; BLOOD PARAMETERS; TREE SWALLOWS; CORTICOSTERONE; SPILL; PETROLEUM	Petroleum can disrupt endocrine function in humans and wildlife, and interacts in particularly complex ways with the hypothalamus-pituitary-adrenal (HPA) axis, responsible for the release of the stress hormones corticosterone and cortisol (hereafter CORT). Ingested petroleum can act in an additive fashion with other stressors to cause increased mortality, but it is not clear exactly why-does petroleum disrupt feedback mechanisms, stress hormone production, or both? This laboratory study aimed to quantify the effects of ingested Gulf of Mexico crude oil on the physiological stress response of house sparrows (Passer domesticus). We examined baseline and stress-induced CORT, negative feedback, and adrenal sensitivity in house sparrows given a 1% oil or control diet (n = 12 in each group). We found that four weeks on a 1% oil diet did not alter baseline CORT titers or efficacy of negative feedback, but significantly reduced sparrows' ability to secrete CORT in response to a standardized stressor and adrenocorticotropin hormone injection, suggesting that oil damages the steroid-synthesizing cells of the adrenal. In another group of animals on the same 1% oil (n = 9) or control diets (n = 8), we examined concentrations of eight different blood chemistry parameters, and CORT in feathers grown before and during the feeding experiments as other potential biomarkers of oil exposure. None of the blood chemistry parameters differed between birds on the oil and control diets after two or four weeks of feeding, nor did feather CORT differ between the two groups. Overall, this study suggests that the response of CORT to stressors, but not baseline HPA function, may be a particularly sensitive bioindicator of sub-lethal chronic effects of crude oil exposure.	[Lattin, Christine R.; Ngai, Heather M.; Romero, L. Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University	Lattin, CR (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	Christine.Lattin@tufts.edu	Lattin, Christine/E-5662-2013	Lattin, Christine/0000-0003-4030-4212	National Science Foundation [IOS-1048529]; Tufts Institute for the Environment undergraduate summer grant; Environmental Protection Agency's Science to Achieve Results fellowship; Direct For Biological Sciences [1048529] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Tufts Institute for the Environment undergraduate summer grant; Environmental Protection Agency's Science to Achieve Results fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the following: National Science Foundation grant IOS-1048529 to LMR (www.nsf.gov); Tufts Institute for the Environment undergraduate summer grant to HMN and fellowship to CRL (environment.tufts.edu); and The Environmental Protection Agency's Science to Achieve Results fellowship to CRL (www.epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PH, 2006, AVIAN POULT BIOL REV, V17, P125, DOI 10.3184/147020606783438740; Alonso-Alvarez C, 2007, AQUAT TOXICOL, V84, P103, DOI 10.1016/j.aquatox.2007.06.004; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Andres BA, 1997, J WILDLIFE MANAGE, V61, P1322, DOI 10.2307/3802132; Awerman JL, 2010, COMP BIOCHEM PHYS A, V156, P136, DOI 10.1016/j.cbpa.2010.01.010; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Breuner CW, 2001, J NEUROENDOCRINOL, V13, P412, DOI 10.1046/j.1365-2826.2001.00646.x; BURNS KA, 1994, ESTUAR COAST SHELF S, V38, P349, DOI 10.1006/ecss.1994.1025; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; CHEN J, 2011, JYI, V21, P84; Cray C, 2011, J AVIAN MED SURG, V25, P14, DOI 10.1647/2010-004.1; Crossin GT, 2013, GEN COMP ENDOCR, V193, P112, DOI 10.1016/j.ygcen.2013.07.011; DARLINGTON DN, 1990, ENDOCRINOLOGY, V127, P759, DOI 10.1210/endo-127-2-759; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Dickens MJ, 2009, GEN COMP ENDOCR, V160, P76, DOI 10.1016/j.ygcen.2008.10.023; Drake KR, 2001, CONDOR, V103, P259, DOI 10.1650/0010-5422(2001)103[0259:MHUASO]2.0.CO;2; Fairhurst GD, 2013, J EXP BIOL, V216, P4071, DOI 10.1242/jeb.091280; Fowler GS, 1995, AUK, V112, P382, DOI 10.2307/4088725; Franceschini MD, 2008, ENVIRON TOXICOL CHEM, V27, P2326, DOI 10.1897/07-602.1; Franceschini MD, 2009, ECOTOXICOLOGY, V18, P514, DOI 10.1007/s10646-009-0309-2; Gagnon A, 2006, AQUAT TOXICOL, V78, P59, DOI 10.1016/j.aquatox.2006.02.004; Geraci J, 2012, SEA MAMMALS OIL CONF, P298; GORSLINE J, 1981, ARCH ENVIRON CON TOX, V10, P765, DOI 10.1007/BF01054860; GORSLINE J, 1982, ARCH ENVIRON CON TOX, V11, P497, DOI 10.1007/BF01056078; Greenacre CB, 2008, J AVIAN MED SURG, V22, P291, DOI 10.1647/2007-034.1; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; HARVEY S, 1981, GEN COMP ENDOCR, V45, P372, DOI 10.1016/0016-6480(81)90077-0; Hinson JP, 2006, BEST PRACT RES CL EN, V20, P111, DOI 10.1016/j.beem.2005.09.006; Hinson JP, 1999, ENDOCRINE AND HORMONAL TOXICOLOGY, P67; HOLMES WN, 1979, ENVIRON RES, V20, P425, DOI 10.1016/0013-9351(79)90017-3; Karr KE, 2006, CLIN AVIAN MED, P611; Lattin CR, 2012, GEN COMP ENDOCR, V178, P494, DOI 10.1016/j.ygcen.2012.07.013; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Leighton Frederick A., 1993, Environmental Reviews, V1, P92; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Love OP, 2003, ECOTOXICOLOGY, V12, P199, DOI 10.1023/A:1022502826800; Lumeij J. T., 1997, Clinical biochemistry of domestic animals., P857, DOI 10.1016/B978-012396305-5/50031-2; Massey JG, 2007, 9 INT EFF OIL WILDL, P169; Newman SH, 2000, ENVIRON POLLUT, V107, P295, DOI 10.1016/S0269-7491(99)00171-2; Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376; Norris DO, 2000, AM ZOOL, V40, P393, DOI 10.1668/0003-1569(2000)040[0393:EDOTSA]2.0.CO;2; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P173, DOI [10.1017/CBO9780511806384.009, DOI 10.1017/CBO9780511806384]; RATTNER BA, 1981, COMP BIOCHEM PHYS C, V68, P103, DOI 10.1016/0306-4492(81)90002-2; Reavill D.R., 2000, LAB MED AVIAN EXOTIC, V1st ed., P353; Reddy CM, 2002, ENVIRON SCI TECHNOL, V36, P4754, DOI 10.1021/es020656n; Romero LM, 2006, GEN COMP ENDOCR, V149, P66, DOI 10.1016/j.ygcen.2006.05.011; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Rosskopf Jr WJ, 1996, DIS CAGE AVIARY BIRD; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; SAPOLSKY RM, 1991, BIOL PSYCHIAT, V30, P1008, DOI 10.1016/0006-3223(91)90121-2; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seiser PE, 2000, MAR POLLUT BULL, V40, P152, DOI 10.1016/S0025-326X(99)00194-0; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Wada H, 2009, ENVIRON SCI TECHNOL, V43, P6031, DOI 10.1021/es803707f; WINGFIELD JC, 1992, J EXP ZOOL, V264, P419, DOI 10.1002/jez.1402640407	61	22	22	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102106	10.1371/journal.pone.0102106	http://dx.doi.org/10.1371/journal.pone.0102106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029334	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600036
J	Luostari, K; Hartikainen, JM; Tengstrom, M; Palvimo, JJ; Kataja, V; Mannermaa, A; Kosma, VM				Luostari, Kaisa; Hartikainen, Jaana M.; Tengstrom, Maria; Palvimo, Jorma J.; Kataja, Vesa; Mannermaa, Arto; Kosma, Veli-Matti			Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-CELLS EXPRESS; PROSTATE-CANCER; OVARIAN-CANCER; THERAPEUTIC INTERVENTION; POTENTIAL CANDIDATE; COLORECTAL CANCERS; HEPSIN GENE; MATRIPTASE; SURVIVAL	Type II transmembrane serine proteases (TTSPs) are related to tumor growth, invasion, and metastasis in cancer. Genetic variants in these genes may alter their function, leading to cancer onset and progression, and affect patient outcome. Here, 464 breast cancer cases and 370 controls were genotyped for 82 single-nucleotide polymorphisms covering eight genes. Association of the genotypes was estimated against breast cancer risk, breast cancer-specific survival, and survival in different treatment groups, and clinicopathological variables. SNPs in TMPRSS3 (rs3814903 and rs11203200), TMPRSS7 (rs1844925), and HGF (rs5745752) associated significantly with breast cancer risk (P-trend = 0.008-0.042). SNPs in TMPRSS1 (rs12151195 and rs12461158), TMPRSS2 (rs2276205), TMPRSS3 (rs3814903), and TMPRSS7 (rs2399403) associated with prognosis (P = 0.004-0.046). When estimating the combined effect of the variants, the risk of breast cancer was higher with 4-5 alleles present compared to 0-2 alleles (P = 0.0001; OR, 2.34; 95% CI, 1.39-3.94). Women with 6-8 survival-associating alleles had a 3.3 times higher risk of dying of breast cancer compared to women with 1-3 alleles (P = 0.001; HR, 3.30; 95% CI, 1.58-6.88). The results demonstrate the combined effect of variants in TTSPs and their related genes in breast cancer risk and patient outcome. Functional analysis of these variants will lead to further understanding of this gene family, which may improve individualized risk estimation and development of new strategies for treatment of breast cancer.	[Luostari, Kaisa; Hartikainen, Jaana M.; Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Luostari, Kaisa; Hartikainen, Jaana M.; Palvimo, Jorma J.; Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Luostari, Kaisa; Hartikainen, Jaana M.; Palvimo, Jorma J.; Mannermaa, Arto; Kosma, Veli-Matti] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Luostari, Kaisa; Hartikainen, Jaana M.; Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Imaging Ctr, SF-70210 Kuopio, Finland; [Tengstrom, Maria; Kataja, Vesa] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Tengstrom, Maria; Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Palvimo, Jorma J.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Mannermaa, A (corresponding author), Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Kuopio, Finland.	arto.mannermaa@uef.fi	Hartikainen, Jaana M/E-6256-2015	Hartikainen, Jaana M/0000-0001-8267-1905; Kataja, Vesa/0000-0003-4846-4843; Palvimo, Jorma/0000-0003-2373-0578	special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organizations; Academy of Finland; strategic funding of the University of Eastern Finland	special Government Funding (EVO) of Kuopio University Hospital; Cancer Fund of Northern Savo; Finnish Cancer Organizations; Academy of Finland(Academy of Finland); strategic funding of the University of Eastern Finland	The KBCP was financially supported by grants from the special Government Funding (EVO) of Kuopio University Hospital (www.psshp.fi), the Cancer Fund of Northern Savo (www.pohjois-savonsyopayhdistys.fi), the Finnish Cancer Organizations (www.cancer.fi), the Academy of Finland (www.aka.fi), and by the strategic funding of the University of Eastern Finland (www.uef.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergum C, 2012, J CELL PHYSIOL, V227, P1604, DOI 10.1002/jcp.22877; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Castells A, 2000, CANCER RES, V60, P2836; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Guerrero K, 2012, GYNECOL ONCOL, V125, P720, DOI 10.1016/j.ygyno.2012.03.026; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Hartikainen JM, 2006, CLIN CANCER RES, V12, P1454, DOI 10.1158/1078-0432.CCR-05-1417; Hartikainen JM, 2005, CANCER EPIDEM BIOMAR, V14, P75; Hirano A, 2001, CLIN CANCER RES, V7, P876; Holt SK, 2010, PROSTATE, V70, P1012, DOI 10.1002/pros.21135; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huang LL, 2011, INT J CLIN EXP PATHO, V4, P644; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kauppinen JM, 2010, CANCER EPIDEM BIOMAR, V19, P2133, DOI 10.1158/1055-9965.EPI-10-0418; Kotsopoulos J, 2012, STEROIDS, V77, P1, DOI 10.1016/j.steroids.2011.10.002; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Owen KA, 2010, BIOCHEM J, V426, P219, DOI 10.1042/BJ20091448; Pal P, 2006, HUM GENET, V120, P187, DOI 10.1007/s00439-006-0204-3; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Pellikainen MJ, 2003, J CLIN PATHOL, V56, P214, DOI 10.1136/jcp.56.3.214; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sawasaki T, 2004, TUMOR BIOL, V25, P141, DOI 10.1159/000079146; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Tanimoto H, 2001, TUMOR BIOL, V22, P104, DOI 10.1159/000050604; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tuhkanen H, 2013, INT J CANCER, V133, P2334, DOI 10.1002/ijc.28254; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Underwood LJ, 2000, BBA-MOL BASIS DIS, V1502, P337, DOI 10.1016/S0925-4439(00)00058-2; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Viloria CG, 2007, BRIT J CANCER, V97, P201, DOI 10.1038/sj.bjc.6603856; Xing P, 2011, J INVEST MED, V59, P803, DOI 10.2310/JIM.0b013e31821451a1; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102519	10.1371/journal.pone.0102519	http://dx.doi.org/10.1371/journal.pone.0102519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029565	Green Submitted, gold, Green Published			2022-12-27	WOS:000341306600079
J	Pollock, FJ; Lamb, JB; Field, SN; Heron, SF; Schaffelke, B; Shedrawi, G; Bourne, DG; Willis, BL				Pollock, F. Joseph; Lamb, Joleah B.; Field, Stuart N.; Heron, Scott F.; Schaffelke, Britta; Shedrawi, George; Bourne, David G.; Willis, Bette L.			Sediment and Turbidity Associated with Offshore Dredging Increase Coral Disease Prevalence on Nearby Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; INDO-PACIFIC; BAND DISEASE; NUTRIENT ENRICHMENT; WATER-QUALITY; CLIMATE; ECOLOGY; RUNOFF; TERRESTRIAL	In recent decades, coral reef ecosystems have declined to the extent that reefs are now threatened globally. While many water quality parameters have been proposed to contribute to reef declines, little evidence exists conclusively linking specific water quality parameters with increased disease prevalence in situ. Here we report evidence from in situ coral health surveys confirming that chronic exposure to dredging-associated sediment plumes significantly increase the prevalence of white syndromes, a devastating group of globally important coral diseases. Coral health surveys were conducted along a dredging-associated sediment plume gradient to assess the relationship between sedimentation, turbidity and coral health. Reefs exposed to the highest number of days under the sediment plume (296 to 347 days) had two-fold higher levels of disease, largely driven by a 2.5-fold increase in white syndromes, and a six-fold increase in other signs of compromised coral health relative to reefs with little or no plume exposure (0 to 9 days). Multivariate modeling and ordination incorporating sediment exposure level, coral community composition and cover, predation and multiple thermal stress indices provided further confirmation that sediment plume exposure level was the main driver of elevated disease and other compromised coral health indicators. This study provides the first evidence linking dredging-associated sedimentation and turbidity with elevated coral disease prevalence in situ. Our results may help to explain observed increases in global coral disease prevalence in recent decades and suggest that minimizing sedimentation and turbidity associated with coastal development will provide an important management tool for controlling coral disease epizootics.	[Pollock, F. Joseph; Lamb, Joleah B.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Pollock, F. Joseph; Lamb, Joleah B.; Willis, Bette L.] Australian Inst Marine Sci, AIMS JCU, Townsville, Qld 4810, Australia; [Pollock, F. Joseph; Lamb, Joleah B.; Willis, Bette L.] James Cook Univ, Townsville, Qld 4811, Australia; [Pollock, F. Joseph; Schaffelke, Britta; Bourne, David G.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Field, Stuart N.; Shedrawi, George] Marine Sci Program, Dept Pk & Wildlife, Kensington, WA, Australia; [Field, Stuart N.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Heron, Scott F.] NOAA Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Marine Geophys Lab, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science; University of Western Australia; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University	Pollock, FJ (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Frederic.Pollock1@jcu.edu.au	Lamb, Joleah/D-1994-2018; Heron, Scott F/E-7928-2011; Bourne, David G/B-5073-2008	Lamb, Joleah/0000-0002-7005-9994; Bourne, David G/0000-0002-1492-8710; Shedrawi, George/0000-0002-4507-7293; Pollock, Joseph/0000-0001-5467-8499; Heron, Scott/0000-0001-5262-6978	Australian National Network in Marine Science (ANNiMS) PhD mobility scholarship awarded; ANNiMS Industry Research grant awarded; project through DPaW's Dredging Audit and Surveillance Program as part of environmental offsets	Australian National Network in Marine Science (ANNiMS) PhD mobility scholarship awarded; ANNiMS Industry Research grant awarded; project through DPaW's Dredging Audit and Surveillance Program as part of environmental offsets	This work was partially funded by an Australian National Network in Marine Science (ANNiMS) PhD mobility scholarship awarded to FJP and an ANNiMS Industry Research grant awarded to JBL. The Gorgon Joint Venture (http://www.chevronaustralia.com/our-businesses/gorgon) also largely funded the project through DPaW's Dredging Audit and Surveillance Program as part of environmental offsets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Beeden R, 2008, UNDERWATER CARDS ASE; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Douvere F., 2012, MISSION REPORT REACT; Evans RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051668; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Falkowski P.G., 1990, P89; Flores F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037795; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gorley C.K., 2006, GETTING STARTED PRIM; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hayes ML, 2001, HYDROBIOLOGIA, V460, P213, DOI 10.1023/A:1013121503937; Heron S., 2012, P 12 INT COR REEF S; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; HODGSON G, 1990, MAR BIOL, V104, P493, DOI 10.1007/BF01314355; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Masini R, 2011, NODE 1 DREDGING SCI, P23; Maynard JA, 2011, CORAL REEFS, V30, P485, DOI 10.1007/s00338-010-0708-0; Nearing MA, 2005, CATENA, V61, P131, DOI 10.1016/j.catena.2005.03.007; Onton K, 2011, MAR ECOL PROG SER, V433, P75, DOI 10.3354/meps09156; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Pocock YP, 1972, GEOL RUNDSCH, V61, P598, DOI DOI 10.1007/BF01896337; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Ravindran J, 2006, MAR BIOL, V149, P347, DOI 10.1007/s00227-005-0192-1; RICHMOND RH, 1993, AM ZOOL, V33, P524; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; Rosenberg E, 2007, OCEANOGRAPHY, V20, P146, DOI 10.5670/oceanog.2007.60; STAFFORDSMITH MG, 1993, MAR BIOL, V115, P229, DOI 10.1007/BF00346340; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; The World Association for Waterborne Transport Infrastructure, 2010, DREDG PORT CONSTR CO, P75; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; unep/gpa (United Nations Environmental Programme and Global Programme of Action for the Protection of Marine Environment from Land-based Pollution), 2006, PROT COAST MAR ENV L; Vollmer SV, 2008, BIOL FAC PUBL; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Western Australia Department of Environment and Conservation, 2007, MAN PLAN MONT BARR I; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1	57	135	140	3	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102498	10.1371/journal.pone.0102498	http://dx.doi.org/10.1371/journal.pone.0102498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029525	Green Published, gold, Green Accepted			2022-12-27	WOS:000341306600078
J	Wang, CW; Liu, YJ; Lee, YH; Hueng, DY; Fan, HC; Yang, FC; Hsueh, CJ; Kao, HW; Juan, CJ; Hsu, HH				Wang, Chih-Wei; Liu, Yi-Jui; Lee, Yi-Hsiung; Hueng, Dueng-Yuan; Fan, Hueng-Chuen; Yang, Fu-Chi; Hsueh, Chun-Jen; Kao, Hung-Wen; Juan, Chun-Jung; Hsu, Hsian-He			Hematoma Shape, Hematoma Size, Glasgow Coma Scale Score and ICH Score: Which Predicts the 30-Day Mortality Better for Intracerebral Hematoma?	PLOS ONE			English	Article							RISK STRATIFICATION; HEMORRHAGE; GROWTH; VALIDATION; WARFARIN; THERAPY; VOLUME	Purpose: To investigate the performance of hematoma shape, hematoma size, Glasgow coma scale (GCS) score, and intracerebral hematoma (ICH) score in predicting the 30-day mortality for ICH patients. To examine the influence of the estimation error of hematoma size on the prediction of 30-day mortality. Materials and Methods: This retrospective study, approved by a local institutional review board with written informed consent waived, recruited 106 patients diagnosed as ICH by non-enhanced computed tomography study. The hemorrhagic shape, hematoma size measured by computer-assisted volumetric analysis (CAVA) and estimated by ABC/2 formula, ICH score and GCS score was examined. The predicting performance of 30-day mortality of the aforementioned variables was evaluated. Statistical analysis was performed using Kolmogorov-Smirnov tests, paired t test, nonparametric test, linear regression analysis, and binary logistic regression. The receiver operating characteristics curves were plotted and areas under curve (AUC) were calculated for 30-day mortality. A P value less than 0.05 was considered as statistically significant. Results: The overall 30-day mortality rate was 15.1% of ICH patients. The hematoma shape, hematoma size, ICH score, and GCS score all significantly predict the 30-day mortality for ICH patients, with an AUC of 0.692 (P = 0.0018), 0.715 (P = 0.0008) (by ABC/2) to 0.738 (P = 0.0002) (by CAVA), 0.877 (P<0.0001) (by ABC/2) to 0.882 (P<0.0001) (by CAVA), and 0.912 (P<0.0001), respectively. Conclusion: Our study shows that hematoma shape, hematoma size, ICH scores and GCS score all significantly predict the 30-day mortality in an increasing order of AUC. The effect of overestimation of hematoma size by ABC/2 formula in predicting the 30-day mortality could be remedied by using ICH score.	[Wang, Chih-Wei; Hsueh, Chun-Jen; Kao, Hung-Wen; Juan, Chun-Jung; Hsu, Hsian-He] Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Wang, Chih-Wei; Hueng, Dueng-Yuan; Fan, Hueng-Chuen; Yang, Fu-Chi; Hsueh, Chun-Jen; Kao, Hung-Wen; Juan, Chun-Jung; Hsu, Hsian-He] Natl Def Med Ctr, Taipei, Taiwan; [Liu, Yi-Jui; Lee, Yi-Hsiung] Feng Chia Univ, Dept Automat Control Engn, Taichung, Taiwan; [Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Fan, Hueng-Chuen] Triserv Gen Hosp, Dept Pediat, Taipei, Taiwan; [Yang, Fu-Chi] Triserv Gen Hosp, Dept Neurol, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Feng Chia University; Tri-Service General Hospital; Tri-Service General Hospital; Tri-Service General Hospital	Juan, CJ (corresponding author), Triserv Gen Hosp, Dept Radiol, Taipei, Taiwan.	peterjuancj@yahoo.com.tw	Hueng, Dueng-Yuan/AAM-7807-2021; Liu, Yi-Jui/AAH-8540-2020; Juan, Chun-Jung/AAE-8438-2020	Hueng, Dueng-Yuan/0000-0001-7868-3161; Liu, Yi-Jui/0000-0001-5865-6836; Yang, Fu-Chi/0000-0001-6831-3634; Juan, Chun-Jung/0000-0001-5219-0406	National Science Council, Taiwan, R.O.C. [NSC 101-2314-B-016-031-MY2]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The corresponding author (Chun-Jung Juan) is receiving financial support from National Science Council (NSC 101-2314-B-016-031-MY2), Taiwan, R.O.C. for participating WFNRS 2014, XXth Symposium Neuroradiologicum and presenting this work in part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barras CD, 2009, STROKE, V40, P1325, DOI 10.1161/STROKEAHA.108.536888; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Chuang YC, 2009, INT J QUAL HEALTH C, V21, P441, DOI 10.1093/intqhc/mzp041; Clarke JL, 2004, NEUROCRIT CARE, V1, P53, DOI 10.1385/NCC:1:1:53; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Flemming KD, 1999, J NEUROL NEUROSUR PS, V66, P600, DOI 10.1136/jnnp.66.5.600; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; FUJII Y, 1994, J NEUROSURG, V80, P51, DOI 10.3171/jns.1994.80.1.0051; Godoy DA, 2006, STROKE, V37, P1038, DOI 10.1161/01.STR.0000206441.79646.49; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Peng SY, 2010, EUR J NEUROL, V17, P945, DOI 10.1111/j.1468-1331.2010.02955.x; Stein M, 2011, ACTA NEUROCHIR SUPPL, V112, P9, DOI 10.1007/978-3-7091-0661-7_2; Strik HM, 2005, NEURORADIOLOGY, V47, P417, DOI 10.1007/s00234-005-1373-9; Takahashi O, 2006, QJM-INT J MED, V99, P743, DOI 10.1093/qjmed/hcl107; Thiex R, 2004, J NEUROL, V251, P1443, DOI 10.1007/s00415-004-0554-5; Wang CW, 2009, ACTA RADIOL, V50, P306, DOI 10.1080/02841850802647039; Weimar C, 2006, J NEUROL NEUROSUR PS, V77, P601, DOI 10.1136/jnnp.2005.081117; Wessels T, 2004, AM J NEURORADIOL, V25, P257; Zurasky JA, 2005, NEUROLOGY, V64, P725, DOI 10.1212/01.WNL.0000152045.56837.58	24	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102326	10.1371/journal.pone.0102326	http://dx.doi.org/10.1371/journal.pone.0102326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029592	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600063
J	Covarrubias, R; Wilhelm, AJ; Major, AS				Covarrubias, Roman; Wilhelm, Ashley J.; Major, Amy S.			Specific Deletion of LDL Receptor-Related Protein on Macrophages Has Skewed In Vivo Effects on Cytokine Production by Invariant Natural Killer T Cells	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; NKT CELLS; ALPHA-2-MACROGLOBULIN RECEPTOR; APOPTOTIC CELLS; LIPID ANTIGEN; IFN-GAMMA; LRP; ACTIVATION; EXPRESSION; CALRETICULIN	Expression of molecules involved in lipid homeostasis such as the low density lipoprotein receptor (LDLr) on antigen presenting cells (APCs) has been shown to enhance invariant natural killer T (iNKT) cell function. However, the contribution to iNKT cell activation by other lipoprotein receptors with shared structural and ligand binding properties to the LDLr has not been described. In this study, we investigated whether a structurally related receptor to the LDLr, known as LDL receptor-related protein (LRP), plays a role in iNKT cell activation. We found that, unlike the LDLr which is highly expressed on all immune cells, the LRP was preferentially expressed at high levels on F4/80(+) macrophages (M Phi). We also show that CD169(+) M Phi s, known to present antigen to iNKT cells, exhibited increased expression of LRP compared to CD169(-) M Phi s. To test the contribution of M Phi LRP to iNKT cell activation we used a mouse model of M Phi LRP conditional knockout (LRP-cKO). LRP-cKO M Phi s pulsed with glycolipid alpha-galactosylceramide (alpha GC) elicited normal IL-2 secretion by iNKT hybridoma and in vivo challenge of LRP-cKO mice led to normal IFN-gamma, but blunted IL-4 response in both serum and intracellular expression by iNKT cells. Flow cytometric analyses show similar levels of MHC class-I like molecule CD1d on LRP-cKO M Phi s and normal glycolipid uptake. Survey of the iNKT cell compartment in LRP-cKO mice revealed intact numbers and percentages and no homeostatic disruption as evidenced by the absence of programmed death-1 and Ly-49 surface receptors. Mixed bone marrow chimeras showed that the inability iNKT cells to make IL-4 is cell extrinsic and can be rescued in the presence of wild type APCs. Collectively, these data demonstrate that, although M Phi LRP may not be necessary for IFN-gamma responses, it can contribute to iNKT cell activation by enhancing early IL-4 secretion.	[Covarrubias, Roman; Major, Amy S.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Wilhelm, Ashley J.; Major, Amy S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Major, AS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	amy.major@vanderbilt.edu			National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI) [R01HL989310]; NRSA from NIH/NHLBI [1F32HL114244-01A1]; NIH/NHLBI [5T32HL007751]; NRSA from National Institute of Allergy and Infectious Disease [1F31AI102544-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751, R01HL089310, F32HL114244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI102544] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NRSA from NIH/NHLBI; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NRSA from National Institute of Allergy and Infectious Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (R01HL989310 to A.S.M.) from the National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI), NRSA from NIH/NHLBI (1F32HL114244-01A1 to A.J.W), and Training Grant in Mechanisms of Vascular Disease (5T32HL007751 to R.C.) from NIH/NHLBI and a NRSA (1F31AI102544-01A1 to R. C.) from National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LL, 2009, BLOOD, V114, P2411, DOI 10.1182/blood-2009-04-211417; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bowers EV, 2009, J LEUKOCYTE BIOL, V86, P1259, DOI 10.1189/jlb.1008653; Chen WHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039039; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Geijtenbeek TBH, 2002, BLOOD, V100, P2908, DOI 10.1182/blood-2002-04-1044; GENG YJ, 1992, J CLIN INVEST, V89, P1322, DOI 10.1172/JCI115718; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Grimsley PG, 1997, THROMB RES, V88, P485, DOI 10.1016/S0049-3848(97)00287-9; Gudleski-O'Regan N, 2012, CELL HOST MICROBE, V12, P86, DOI 10.1016/j.chom.2012.05.012; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Hussaini IM, 1996, J LEUKOCYTE BIOL, V59, P733, DOI 10.1002/jlb.59.5.733; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Kawasaki N, 2013, P NATL ACAD SCI USA, V110, P7826, DOI 10.1073/pnas.1219888110; Kim S, 2008, J CLIN INVEST, V118, P2301, DOI [10.1172/JC133071, 10.1172/JCI33071]; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; Kosaka S, 2001, CIRCULATION, V103, P1142, DOI 10.1161/01.CIR.103.8.1142; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Matsutake Toyoshi, 2010, Cancer Immun, V10, P7; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Sag D, 2012, J IMMUNOL, V189, P5129, DOI 10.4049/jimmunol.1201570; Sim RB, 1998, IMMUNOBIOLOGY, V199, P208, DOI 10.1016/S0171-2985(98)80028-4; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Singh N, 1999, J IMMUNOL, V163, P2373; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Xu GL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt110; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zeng DF, 2003, J CLIN INVEST, V112, P1211, DOI 10.1172/JCI200317165	60	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102236	10.1371/journal.pone.0102236	http://dx.doi.org/10.1371/journal.pone.0102236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050824	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100024
J	Hsu, HJ; Yen, CH; Wu, IW; Hsu, KH; Chen, CK; Sun, CY; Chou, CC; Chen, CY; Tsai, CJ; Wu, MS; Lee, CC				Hsu, Heng-Jung; Yen, Chiung-Hui; Wu, I-Wen; Hsu, Kuang-Hung; Chen, Chih-Ken; Sun, Chiao-Yin; Chou, Chia-Chi; Chen, Chun-Yu; Tsai, Chi-Jen; Wu, Mai-Szu; Lee, Chin-Chan			The Association of Uremic Toxins and Inflammation in Hemodialysis Patients	PLOS ONE			English	Article							P-CRESOL; CARDIOVASCULAR RISK; INDOXYL SULFATE; ALL-CAUSE; MORTALITY; REMOVAL; SURVIVAL	Background: Cardiovascular disease is the leading cause of mortality in hemodialysis patients and is associated with chronic inflammation. Elevation of uremic toxins, particular protein-bound uremic toxins, is a possible cause of hyper-inflammation in hemodialysis patients. But the association between uremic toxins and inflammatory markers in hemodialysis is still unclear. Methods: We conducted a cross-sectional study to evaluate the association of the serum uremic toxins and inflammatory markers in hemodialysis patients. Results: The uremic toxins were not associated with inflammatory markers-including high sensitivity C-reactive protein, IL(Interleukin) -1 beta, IL-6, tumor necrosis factor-alpha. In multiple linear regression, serum levels of total p-cresol sulfate (PCS) were independently significantly associated with serum total indoxyl sulfate (IS) (standardized coefficient: 0.274, p<0.001), and co-morbidity of diabetes mellitus (DM) (standardized coefficient: 0.342, p<0.001) and coronary artery disease (CAD) (standardized coefficient: 0.128, p = 0.043). The serum total PCS levels in hemodialysis with co-morbidity of DM and CAD were significantly higher than those without co-morbidity of DM and CAD (34.10 +/- 23.44 vs. 16.36 +/- 13.06 mg/L, p<0.001). Serum levels of total IS was independently significantly associated with serum creatinine (standardized coefficient: 0.285, p<0.001), total PCS (standardized coefficient: 0.239, p = 0.001), and synthetic membrane dialysis (standardized coefficient: 0.139, p = 0.046). Conclusion: The study showed that serum levels of total PCS and IS were not associated with pro-inflammatory markers in hemodialysis patients. Besides, serum levels of total PCS were independently positively significantly associated with co-morbidity of CAD and DM.	[Hsu, Heng-Jung; Wu, I-Wen; Sun, Chiao-Yin; Chou, Chia-Chi; Chen, Chun-Yu; Tsai, Chi-Jen; Lee, Chin-Chan] Chang Gung Mem Hosp, Div Nephrol, Keelung, Taiwan; [Hsu, Heng-Jung] Chang Gung Univ, Coll Med, Taoyuan Sch Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Yen, Chiung-Hui] Taipei Med Univ Hosp, Dept Pediat, Taipei, Taiwan; [Hsu, Kuang-Hung] Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taoyuan, Taiwan; [Chen, Chih-Ken] Chang Gung Mem Hosp, Div Psychiat, Keelung, Taiwan; [Wu, Mai-Szu] Taipei Med Univ Hosp, Div Nephrol, Taipei, Taiwan; [Wu, Mai-Szu] Taipei Med Univ, Dept Internal Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Wu, MS (corresponding author), Taipei Med Univ Hosp, Div Nephrol, Taipei, Taiwan.	maiszuwu@gmail.com; leefang@adm.cgmh.org.tw		Hsu, Kuang-Hung/0000-0003-2642-7689; WU, I-WEN/0000-0001-8535-3582	Chang Gung Memorial Hospital Research Fund [CMRPG260363]	Chang Gung Memorial Hospital Research Fund(Chang Gung Memorial Hospital)	This study was supported by grants from the Chang Gung Memorial Hospital Research Fund (CMRPG260363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Bologa RM, 1998, AM J KIDNEY DIS, V32, P107, DOI 10.1053/ajkd.1998.v32.pm9669431; Brunet P, 2003, ADV RENAL REPLACE TH, V10, P310, DOI 10.1053/j.arrt.2003.08.002; Cianciolo G, 2008, AM J NEPHROL, V28, P941, DOI 10.1159/000142363; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; De Smet R, 2007, NEPHROL DIAL TRANSPL, V22, P2006, DOI 10.1093/ndt/gfm065; Glorieux G, 2009, SEMIN DIALYSIS, V22, P423, DOI 10.1111/j.1525-139X.2009.00593.x; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Lee CT, 2010, PERITON DIALYSIS INT, V30, P456, DOI 10.3747/pdi.2009.00092; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; Martinez AW, 2005, J AM SOC NEPHROL, V16, P3430, DOI 10.1681/ASN.2005030310; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Raff AC, 2008, CURR OPIN NEPHROL HY, V17, P560, DOI 10.1097/MNH.0b013e32830f45b6; Stefoni S, 2003, CONTRIB NEPHROL, V138, P68; TODESCO T, 1993, AM J GASTROENTEROL, V88, P751; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Wang CP, 2013, J NEPHROL, V26, P111, DOI 10.5301/jn.5000111; Welch Adam C, 2003, Diabetes Forecast, V56, P65; Wu IW, 2012, NEPHROL DIAL TRANSPL, V27, P1169, DOI 10.1093/ndt/gfr453; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	25	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102691	10.1371/journal.pone.0102691	http://dx.doi.org/10.1371/journal.pone.0102691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051062	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100049
J	Johannessen, A; Skaret, G; Langard, L; Slotte, A; Husebo, A; Ferno, A				Johannessen, Arne; Skaret, Georg; Langard, Lise; Slotte, Aril; Husebo, Ase; Ferno, Anders			The Dynamics of a Metapopulation: Changes in Life-History Traits in Resident Herring that Co-Occur with Oceanic Herring during Spawning	PLOS ONE			English	Article							CLUPEA-HARENGUS; CARRYING CAPACITIES; PARTIAL MIGRATION; TRADE-OFFS; POPULATIONS; MATURATION; GROWTH; SEA; REPRODUCTION; MORTALITY	Different populations of Atlantic herring are regarded as forming a metapopulation, but we know little about the dynamics of the connectivity and degree of interbreeding between the populations. Based on data from three periods between 1962 and 2011, we identified the presence of two components of herring in a small semi-enclosed coastal marine ecosystem based on different somatic growth patterns and mean vertebrae sum (VS). The two components were interpreted as belonging to a resident herring population and the migratory, oceanic Norwegian spring spawning (NSS) herring population, and they co-occurred during spawning. In the 1960s, resident herring characterized by slow growth and low VS co-occurred with rapid growth, high VS oceanic NSS herring. Similar slow-growing resident and rapid-growing NSS herring were found in the 1970-80s, but both populations now had low VS suggesting similar origins. Finally, in the 2000s both populations showed rapid growth. The changes coincided with the NSS herring going from a state of high abundance and oceanic distribution to a collapse in the late 1960s that resulted in a coastal distribution closer to resident herring populations, before full recovery and resumption of the migratory, oceanic pattern in the 1990s. During all three periods, NSS herring were only present in the local system up to an age of about five years, but the synchronous spawning of the populations supports mixed spawning and interbreeding. During the investigation period both longevity, length at age (growth) and length-at-first maturity increased markedly for the resident herring, which then became more similar to the NSS herring. Genetic and/or cultural factors are believed to be the main causes of the observed changes in life history traits, although some effect of changes in environmental factors cannot be excluded. Our study suggests that relationships among populations in a metapopulation can be highly dynamic.	[Johannessen, Arne; Langard, Lise; Ferno, Anders] Univ Bergen, Dept Biol, Bergen, Norway; [Skaret, Georg; Langard, Lise; Slotte, Aril; Husebo, Ase; Ferno, Anders] Inst Marine Res, N-5024 Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Johannessen, A (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Arne.Johannessen@bio.uib.no			University of Bergen; Institute of Marine Research	University of Bergen; Institute of Marine Research	The work was funded by the University of Bergen and the Institute of Marine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aasen O, 1952, REPORTS NORWEGIAN FI, V10; AKSLAND M, 1983, Fiskeridirektoratets Skrifter Serie Havundersokelser, V17, P297; AKSNES DL, 1983, SARSIA, V68, P195, DOI 10.1080/00364827.1983.10420572; AKSNES DL, 1989, MAR ECOL PROG SER, V50, P263, DOI 10.3354/meps050263; Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Bagoien E, 2001, LIMNOL OCEANOGR, V46, P1494; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BURD AC, 1985, CAN J FISH AQUAT SCI, V42, P192; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Corten A, 2002, REV FISH BIOL FISHER, V11, P339; Crnokrak P, 2000, J EVOLUTION BIOL, V13, P396, DOI 10.1046/j.1420-9101.2000.00188.x; Dahl O, 1981, LINDASPOLLENE NATURL; DAHL O, 1973, FISKDIR SKR        H, V16, P148; Dragesund O., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P43; Dragesund O, 1997, SARSIA, V82, P97, DOI 10.1080/00364827.1997.10413643; Dragesund O., 2008, NORWEGIAN SPRING SPA, P41; Eggers F, 2013, THESIS U BERGEN BERG; Ellingsen E, 1973, THESIS U BERGEN NORW; Engelhard GH, 2004, MAR ECOL PROG SER, V272, P245, DOI 10.3354/meps272245; Engelhard GH, 2003, ICES J MAR SCI, V60, P304, DOI 10.1016/S1054-3139(03)00017-1; FOSSA JH, 1992, SARSIA, V77, P237; Geffen AJ, 2009, ICES J MAR SCI, V66, P1688, DOI 10.1093/icesjms/fsp028; HAMRE J, 1994, BIODIVERS CONSERV, V3, P473, DOI 10.1007/BF00115154; HAMRE J, 1990, BIOLOGY AND FISHERIES OF THE NORWEGIAN SPRING SPAWNING HERRING AND BLUE WHITING IN THE NORTHEAST ATLANTIC, P5; Harma C, 2012, FISH RES, V121, P31, DOI 10.1016/j.fishres.2012.01.005; Hay DE, 2000, LOW WAKE FI, V18, P381; Hemmer-Hansen J, 2013, MOL ECOL, V22, P2653, DOI 10.1111/mec.12284; HOGNESTAD PT, 1994, ICES J MAR SCI, V51, P281, DOI 10.1006/jmsc.1994.1029; Holst JC, 1998, ICES J MAR SCI, V55, P987, DOI 10.1006/jmsc.1998.0371; Huse G, 2010, MAR ECOL PROG SER, V409, P189, DOI 10.3354/meps08620; Husebo A, 2005, MAR FRESHWATER RES, V56, P763, DOI 10.1071/MF04170; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johannessen A, 2009, ICES J MAR SCI, V66, P1740, DOI 10.1093/icesjms/fsp183; Johannessen P, 1980, RESIPIENTUNDERSOKELS; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Jorstad KE, 1981, CM1981H64 ICES; Jorstad KE, 1986, 1986H63 ICES CM; Kitano J, 2012, ICHTHYOL RES, V59, P293, DOI 10.1007/s10228-012-0289-8; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Langard L, 2014, J FISH BIOL, V84, P1202, DOI 10.1111/jfb.12329; LANGARD L, 2006, 2006O09 ICES CM; Langard L, 2013, THESIS U BERGEN NORW; Langard L, 2014, MAR ECOL PROG SER, V501, P251, DOI 10.3354/meps10718; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R, 1970, SOME MATH QUESTIONS, P70; LIE U, 1978, Fiskeridirektoratets Skrifter Serie Havundersokelser, V16, P369; Lindsey C.C., 1988, P197; McQuinn IH, 1997, FISH B-NOAA, V95, P126; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; Metcalfe JD, 2006, J FISH BIOL, V69, P48, DOI 10.1111/j.1095-8649.2006.01275.x; Mjanger H., 2011, HDB PROVETAKING FISK; Ohman MD, 2004, ICES J MAR SCI, V61, P687, DOI 10.1016/j.icesjms.2004.03.016; Overholtz WJ, 2002, FISH B-NOAA, V100, P593; Parrish B. B., 1965, Oceanography and Marine Biology Annual Review, V3, P323; PAVLOV DA, 1998, J ICHTHYOL+, V38, P251; Petitgas P, 2010, ICES J MAR SCI, V67, P1841, DOI 10.1093/icesjms/fsq082; RICKER W E, 1975, P382; ROFF DA, 1983, CAN J FISH AQUAT SCI, V40, P1395, DOI 10.1139/f83-161; ROSENBERG R, 1982, FISH RES, V1, P83; Rottingen I, 1992, 1991H18 ICES CM; Runnstrom S, 1936, FISKDIR SKR HAVUNDER, V5, P1; Runnstrom Sven, 1941, FISKERIDIREKTORATETS SKRIFTER SER HAVUNDER SOKELSER REPT NORWEGIAN FISH AND MARINE INVEST, V6, P5; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Sahashi G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2539; SALVANES AGV, 1995, FISH OCEANOGR, V4, P17; Silva FFG, 2013, FISH RES, V138, P71, DOI 10.1016/j.fishres.2012.07.013; Slotte A, 1999, J FISH BIOL, V54, P338, DOI 10.1111/j.1095-8649.1999.tb00834.x; Sorensen OB, 2012, THESIS U BERGEN NORW; Stearns S.C., 1992, pi; Stephenson R.L., 2002, ICES MAR SCI S, V215, P305; Stephenson RL, 2009, ICES J MAR SCI, V66, P1733, DOI 10.1093/icesjms/fsp189; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; Theriault V, 2007, J EVOLUTION BIOL, V20, P2266, DOI 10.1111/j.1420-9101.2007.01417.x; von Bertalanffy L, 1934, ROUX ARCH DEV BIOL, V131, P613, DOI 10.1007/BF00650112; Wysujack K, 2009, ECOL FRESHW FISH, V18, P52, DOI 10.1111/j.1600-0633.2008.00322.x	76	10	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102462	10.1371/journal.pone.0102462	http://dx.doi.org/10.1371/journal.pone.0102462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051066	gold, Green Published			2022-12-27	WOS:000339551100038
J	Sjovall, F; Morota, S; Frostner, EA; Hansson, MJ; Elmer, E				Sjoevall, F.; Morota, S.; Frostner, Asander E.; Hansson, M. J.; Elmer, E.			Cytokine and Nitric Oxide Levels in Patients with Sepsis - Temporal Evolvement and Relation to Platelet Mitochondrial Respiratory Function (vol 9, e97673, 2014)	PLOS ONE			English	Correction													Elmér, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014	Elmér, Eskil/0000-0001-7901-1826; Hansson, Magnus/0000-0002-0201-0638; Asander Frostner, Eleonor/0000-0001-8426-4836				Sjovall F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097673	1	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103756	10.1371/journal.pone.0103756	http://dx.doi.org/10.1371/journal.pone.0103756			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051116	Green Published, gold			2022-12-27	WOS:000339551100105
J	Jayanthan, A; Ruan, YB; Truong, TH; Narendran, A				Jayanthan, Aarthi; Ruan, Yibing; Truong, Tony H.; Narendran, Aru			Aurora Kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic Agents	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GROWTH IN-VIVO; B-KINASE; CHROMOSOME SEGREGATION; INHIBITOR CCT129202; ANTICANCER DRUGS; CENP-E; POTENT; CANCER	Leukemia is the most common pediatric malignancy, constituting more than 30% of all childhood cancers. Although cure rates have improved greatly, approximately one in five children relapse and poor survival rates post relapse remain a challenge. Given this, more effective and innovative therapeutic strategies are needed in order to improve prognosis. Aurora kinases, a family of serine/threonine kinases essential for the regulation of several mitotic processes, have been identified as potential targets for cancer therapeutics. Elevated expression of Aurora kinases has been demonstrated in several malignancies and is associated with aberrant mitotic activity, aneuploidy and alterations in chromosomal structure and genome instability. Based on this rationale, a number of small molecule inhibitors have been formulated and advanced to human studies in the recent past. A comparative analysis of these agents in cytotoxicity and target modulation analyses against a panel of leukemia cells provides novel insights into the unique mechanisms and codependent activity pathways involved in targeting Aurora kinases, constituting a distinctive preclinical experimental framework to identify appropriate agents and combinations in future clinical studies.	[Jayanthan, Aarthi; Ruan, Yibing; Narendran, Aru] Univ Calgary, Lab Preclin & Drug Discovery Studies, POETIC, Calgary, AB, Canada; [Truong, Tony H.; Narendran, Aru] Alberta Childrens Prov Gen Hosp, Div Pediat Oncol, Calgary, AB T2T 5C7, Canada	University of Calgary; Alberta Childrens Hospital; University of Calgary	Narendran, A (corresponding author), Univ Calgary, Lab Preclin & Drug Discovery Studies, POETIC, Calgary, AB, Canada.	a.narendran@ucalgary.ca			Kids Cancer Care Foundation of Alberta (KCCFA); Alberta Children's Hospital Foundation (ACHF); Alberta Children's Hospital for Child and Maternal Health (ACHRI); ACHF; Canadian Institutes for Health Research (CIHR)	Kids Cancer Care Foundation of Alberta (KCCFA); Alberta Children's Hospital Foundation (ACHF); Alberta Children's Hospital for Child and Maternal Health (ACHRI); ACHF; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Kids Cancer Care Foundation of Alberta (KCCFA) and Alberta Children's Hospital Foundation (ACHF). AJ is the recipient of a Canadian Institutes for Health Research (CIHR) Training Program in Genetics, Child Development and Health Graduate Studentship awarded by Alberta Children's Hospital for Child and Maternal Health (ACHRI) and a McCarthy Tetrault Graduate Studentship awarded by ACHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane D, 2008, CANCER SCI, V99, P1251, DOI 10.1111/j.1349-7006.2008.00810.x; Aliagas-Martin I, 2009, J MED CHEM, V52, P3300, DOI 10.1021/jm9000314; Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Broekman F, 2011, WORLD J CLIN ONCOL, V2, P80, DOI 10.5306/wjco.v2.i2.80; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Chan F, 2007, MOL CANCER THER, V6, P3147, DOI 10.1158/1535-7163.MCT-07-2156; Cheng C, 2012, MOL PHARMACEUT, V9, P1971, DOI 10.1021/mp2006714; Curry J, 2009, CELL CYCLE, V8, P1921, DOI 10.4161/cc.8.12.8741; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P1199, DOI 10.1517/13543784.13.9.1199; Emanuel S, 2005, CANCER RES, V65, P9038, DOI 10.1158/0008-5472.CAN-05-0882; Emanuele MJ, 2009, METHODS MOL BIOL, V545, P221, DOI 10.1007/978-1-60327-993-2_13; Fancelli D, 2005, J MED CHEM, V48, P3080, DOI 10.1021/jm049076m; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Harrison CJ, 2011, CLIN LAB MED, V31, P631, DOI 10.1016/j.cll.2011.08.016; Hegarat N, 2011, J CELL BIOL, V195, P1103, DOI 10.1083/jcb.201105058; Hochegger H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120185; How J, 2012, EXPERT OPIN INV DRUG, V21, P717, DOI 10.1517/13543784.2012.668882; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Hrabakova R, 2013, J PROTEOME RES, V12, P455, DOI 10.1021/pr300819m; Jayanthan A, 2013, LEUKEMIA LYMPHOMA, V54, P1505, DOI 10.3109/10428194.2012.752079; Kaestner P, 2009, MOL CANCER THER, V8, P2046, DOI 10.1158/1535-7163.MCT-09-0323; Kaspers GJL, 2012, EXPERT REV ANTICANC, V12, P405, DOI [10.1586/era.12.1, 10.1586/ERA.12.1]; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Keen N, 2009, CANCER METAST REV, V28, P185, DOI 10.1007/s10555-009-9184-9; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Khan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026512; Kimura M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.108; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li ML, 2010, BIOCHEM PHARMACOL, V79, P122, DOI 10.1016/j.bcp.2009.08.011; Locatelli F, 2013, CURR OPIN ONCOL, V25, P707, DOI 10.1097/CCO.0000000000000011; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Molhoek KR, 2011, MELANOMA RES, V21, P274, DOI 10.1097/CMR.0b013e328343a1d6; Moore AS, 2010, LEUKEMIA, V24, P671, DOI 10.1038/leu.2010.15; Nabzdyk CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-48; Okabe S, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-32; Okabe S, 2010, ANN HEMATOL, V89, P1081, DOI 10.1007/s00277-010-0998-x; Oslob JD, 2008, BIOORG MED CHEM LETT, V18, P4880, DOI 10.1016/j.bmcl.2008.07.073; Ota T, 2002, CANCER RES, V62, P5168; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Puumala SE, 2013, PEDIATR BLOOD CANCER, V60, P728, DOI 10.1002/pbc.24464; Qi WQ, 2011, BIOCHEM PHARMACOL, V81, P881, DOI 10.1016/j.bcp.2011.01.017; Seamon JA, 2006, MOL CANCER THER, V5, P2459, DOI 10.1158/1535-7163.MCT-06-0339; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Smith Catherine C, 2013, Am Soc Clin Oncol Educ Book, P313, DOI 10.1200/EdBook_AM.2013.33.313; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Steeghs N, 2009, J CLIN ONCOL, V27, P5094, DOI 10.1200/JCO.2008.21.6655; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482; Tentler JJ, 2010, CLIN CANCER RES, V16, P2989, DOI 10.1158/1078-0432.CCR-10-0325; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Wang SD, 2010, J MED CHEM, V53, P4367, DOI 10.1021/jm901913s; Yakushijin Y, 2004, LEUKEMIA LYMPHOMA, V45, P1741, DOI 10.1080/10428190410001683615; Yamauchi T, 2013, CANCER SCI, V104, P926, DOI 10.1111/cas.12164; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700; Yoshida K, 2011, BIOCHEM PHARMACOL, V82, P1884, DOI 10.1016/j.bcp.2011.09.015	64	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102741	10.1371/journal.pone.0102741	http://dx.doi.org/10.1371/journal.pone.0102741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048812	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100065
J	Fu, YX; Zhou, HL; Wang, SY; Wei, Q				Fu, Yanxia; Zhou, Hailing; Wang, Shuangyan; Wei, Qun			Glycyrol Suppresses Collagen-Induced Arthritis by Regulating Autoimmune and Inflammatory Responses	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CALCINEURIN; CYCLOSPORINE; PROGRESSION; TACROLIMUS; CYTOKINES; PATHWAYS; FUTURE; ONSET; IL-17	Glycyrol is a natural compound extracted from Glycyrrhiza uralensis, first reported by us to be a new immunosuppressant. Here, we demonstrate its beneficial effect in collagen-induced arthritis (CIA) in mice, a model for rheumatoid arthritis (RA) in man, and we document the underlying mechanisms. Peroral administration of glycyrol significantly reduced clinical scores, alleviated cartilage and bone erosion and reduced levels of serum inflammatory cytokines. Glycyrol also decreased delayed-type hypersensitivity, improved carbon clearance and reduced acetic acid-induced capillary permeability. Furthermore, glycyrol decreased NF-kappa B and NFAT transcriptional activities and inhibited IL-2 expression. The therapeutic effect of glycyrol was associated with down-regulation of both autoimmune and inflammatory reactions. In addition, we demonstrated that glycyrol has minimal acute toxicity in mice. Therefore, we propose that glycyrol may hold promise for future treatment of RA.	[Fu, Yanxia; Zhou, Hailing; Wang, Shuangyan; Wei, Qun] Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing, Peoples R China	Beijing Normal University	Wei, Q (corresponding author), Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing, Peoples R China.				National Natural Science Foundation of China; National Important Novel Medicine Research Project; Fundamental Research Funds for the Central Universities; Beijing Education Committee	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Important Novel Medicine Research Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Education Committee	The work was supported by the National Natural Science Foundation of China, the National Important Novel Medicine Research Project, the Fundamental Research Funds for the Central Universities and the special fund of the co-construction project from the Beijing Education Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; BENNETT WM, 1986, ANNU REV MED, V37, P215; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Cen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066503; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gorman CL, 2008, BEST PRACT RES CL RH, V22, P221, DOI 10.1016/j.berh.2008.01.003; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Hua YL, 2012, FOOD CHEM, V132, P739, DOI 10.1016/j.foodchem.2011.11.010; Huang LJ, 2010, J AGR FOOD CHEM, V58, P8983, DOI 10.1021/jf101390q; Jin YL, 2008, TETRAHEDRON LETT, V49, P6835, DOI 10.1016/j.tetlet.2008.09.070; Kim HS, 2011, J ETHNOPHARMACOL, V136, P392, DOI 10.1016/j.jep.2011.01.016; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Kockx M, 2010, PHARMACOL THERAPEUT, V128, P106, DOI 10.1016/j.pharmthera.2010.06.001; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Lubberts E, 2003, J IMMUNOL, V170, P2655, DOI 10.4049/jimmunol.170.5.2655; Mauri C, 1996, EUR J IMMUNOL, V26, P1511, DOI 10.1002/eji.1830260716; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Pierer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023539; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; STALLARD N, 1995, HUM EXP TOXICOL, V14, P315, DOI 10.1177/096032719501400401; Strid J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000387; THOMSON AW, 1984, AGENTS ACTIONS, V15, P307, DOI 10.1007/BF01972366; Umar S., 2012, INT J DRUG DEV RES, V4, P210; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Venkatesha SH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/986797; Vinay DS, 2012, CYTOKINE, V57, P305, DOI 10.1016/j.cyto.2011.12.005; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031368; Yocum DE, 2003, ARTHRITIS RHEUM-US, V48, P3328, DOI 10.1002/art.11363; Yoo SA, 2006, J IMMUNOL, V177, P2681, DOI 10.4049/jimmunol.177.4.2681	34	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e98137	10.1371/journal.pone.0098137	http://dx.doi.org/10.1371/journal.pone.0098137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036817	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200001
J	Liu, GF; Lin, CD; Xin, ZQ				Liu, Guofang; Lin, Chongde; Xin, Ziqiang			The Effects of Within- and Between-Group Competition on Trust and Trustworthiness among Acquaintances	PLOS ONE			English	Article							INTERGROUP COMPETITION; COOPERATION; PUNISHMENT; EVOLUTION; REPUTATION; CONFLICT; REWARD; TASK	Several studies have indicated that between-group competition is a key stimulator of trust and trustworthiness. Another important but neglected type of competition may also affect trust and trustworthiness: within-group competition, especially competition among acquaintances. The present study investigated the effects of both within- and between-group competition on trust and trustworthiness, which were measured using an investment game played by acquaintances. We found that, compared to the participants' performance in the non-competition condition, when individuals were motivated to compete with their in-group members or the other groups for financial rewards, they demonstrated more trust. When individuals were motivated to compete with their in-group members, they exhibited lower trustworthiness than in non-competition and between-group competition. In addition, within-group competition decreased the trustor's payoff while both within-and between-group competition increased the trustee's payoff. Finally, we found that males trusted their group members more than females.	[Liu, Guofang; Lin, Chongde] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Liu, Guofang] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Xin, Ziqiang] Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Central University of Finance & Economics	Xin, ZQ (corresponding author), Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Beijing, Peoples R China.	xinziqiang@sohu.com		Xin, Ziqiang/0000-0001-9983-2322	MOE of China [NCET-10-0869]; National Social Science Foundation of China [11CSH046]	MOE of China(Ministry of Education, China); National Social Science Foundation of China	The present study was supported by a program (NCET-10-0869) for New Century Excellent Talents in University from MOE of China (URL: http://www.moe.gov.cn/) and a project (11CSH046) from National Social Science Foundation of China (URL: http://www.npopss-cn.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Barker JL, 2012, BEHAV ECOL, V23, P735, DOI 10.1093/beheco/ars020; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bolton G, 2008, J MANAGE INFORM SYST, V25, P145, DOI 10.2753/M1S0742-1222250207; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Burks SV, 2003, J ECON BEHAV ORGAN, V51, P195, DOI 10.1016/S0167-2681(02)00093-8; Burton-Chellew MN, 2010, EVOL HUM BEHAV, V31, P104, DOI 10.1016/j.evolhumbehav.2009.07.005; Charness G, 2011, GAME ECON BEHAV, V72, P361, DOI 10.1016/j.geb.2010.09.002; Chaudhuri A, 2007, SOUTH ECON J, V73, P959, DOI 10.2307/20111937; Cikara M, 2011, PSYCHOL SCI, V22, P306, DOI 10.1177/0956797610397667; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; Dasgupta P, 2009, LESSONS E ASIA GLOBA, P119; De Cremer D, 2002, J SOC PSYCHOL, V142, P541, DOI 10.1080/00224540209603917; De Dreu CKW, 2012, HORM BEHAV, V61, P419, DOI 10.1016/j.yhbeh.2011.12.009; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; Deutsch M., 1962, COOPERATION TRUST SO; Deutsch M, 1949, HUM RELAT, V2, P199, DOI 10.1177/001872674900200301; EREV I, 1993, J EXP SOC PSYCHOL, V29, P463, DOI 10.1006/jesp.1993.1021; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fernald RD, 2011, CURR BIOL, V21, pR508, DOI 10.1016/j.cub.2011.05.038; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gunnthorsdottir A, 2006, ORGAN BEHAV HUM DEC, V101, P184, DOI 10.1016/j.obhdp.2005.08.005; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hogg M.A., 1988, SOCIAL IDENTIFICATIO; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; Huck S, 2012, GAME ECON BEHAV, V76, P195, DOI 10.1016/j.geb.2012.06.010; Johnson, 1989, COOPERATION COMPETIT; Johnson DW, 2005, GENET SOC GEN PSYCH, V131, P285, DOI 10.3200/MONO.131.4.285-358; JOHNSON DW, 1981, PSYCHOL BULL, V89, P47, DOI 10.1037/0033-2909.89.1.47; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Mulder LB, 2006, J EXP SOC PSYCHOL, V42, P147, DOI 10.1016/j.jesp.2005.03.002; NIU JH, 2010, INT J PSYCHOL STUD, V2, P12, DOI DOI 10.5539/ijps.v2n1p12; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Puurtinen M, 2009, P ROY SOC B-BIOL SCI, V276, P355, DOI 10.1098/rspb.2008.1060; RABBIE JM, 1969, J PERS SOC PSYCHOL, V13, P269, DOI 10.1037/h0028284; Rebers S, 2012, HUM NATURE-INT BIOS, V23, P173, DOI 10.1007/s12110-012-9136-x; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; ROSENBAUM ME, 1980, J PERS SOC PSYCHOL, V39, P626, DOI 10.1037/0022-3514.39.4.626; RUSCHER JB, 1991, PERS SOC PSYCHOL B, V17, P595, DOI 10.1177/0146167291176001; Sharan S., 1990, COOPERATIVE LEARNING; Sigmund K, 2012, J THEOR BIOL, V299, P25, DOI 10.1016/j.jtbi.2011.03.024; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tajfel H., 1981, SOCIAL IDENTITY INTE; Tan JHW, 2007, ECON LETT, V96, P133, DOI 10.1016/j.econlet.2006.12.031; Turner J.C., 1987, REDISCOVERING SOCIAL; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; West SA, 2006, CURR BIOL, V16, P1103, DOI 10.1016/j.cub.2006.03.069; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	53	2	3	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103074	10.1371/journal.pone.0103074	http://dx.doi.org/10.1371/journal.pone.0103074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036147	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200109
J	Yu, CL; Deng, M; Zheng, L; He, RL; Yang, J; Yau, SST				Yu, Chenglong; Deng, Mo; Zheng, Lu; He, Rong Lucy; Yang, Jie; Yau, Stephen S. -T.			DFA7, a New Method to Distinguish between Intron-Containing and Intronless Genes	PLOS ONE			English	Article							PROTEIN MAP; GENOME; REPRESENTATION; SPACE	Intron-containing and intronless genes have different biological properties and statistical characteristics. Here we propose a new computational method to distinguish between intron-containing and intronless gene sequences. Seven feature parameters alpha, beta, gamma, lambda, theta, phi, and sigma based on detrended fluctuation analysis (DFA) are fully used, and thus we can compute a 7-dimensional feature vector for any given gene sequence to be discriminated. Furthermore, support vector machine (SVM) classifier with Gaussian radial basis kernel function is performed on this feature space to classify the genes into intron-containing and intronless. We investigate the performance of the proposed method in comparison with other state-of-the-art algorithms on biological datasets. The experimental results show that our new method significantly improves the accuracy over those existing techniques.	[Yu, Chenglong] South Australian Hlth & Med Res Inst, Mind Brain Theme, Adelaide, SA, Australia; [Deng, Mo] Huashang Fund Management Co Ltd, Quant Investment Dept, Beijing, Peoples R China; [Zheng, Lu] Carnegie Mellon Univ, Elect & Comp Engn & CyLab Mobil Res Ctr, Moffett Field, CA USA; [He, Rong Lucy] Chicago State Univ, Dept Biol Sci, Chicago, IL 60628 USA; [Yang, Jie] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL USA; [Yau, Stephen S. -T.] Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China	South Australian Health & Medical Research Institute (SAHMRI); Carnegie Mellon University; Chicago State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tsinghua University	He, RL (corresponding author), Chicago State Univ, Dept Biol Sci, Chicago, IL 60628 USA.	rhe@csu.edu; jyang06@uic.edu; yau@uic.edu		Yu, Chenglong/0000-0002-0546-2779; Yang, Jie/0000-0002-9034-4223	U.S. National Science Foundation [DMS-1120824]; China National Science Foundation [31271408]; Direct For Mathematical & Physical Scien [1120824] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research is supported by the U.S. National Science Foundation grant DMS-1120824, China National Science Foundation grant 31271408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SM, 2005, BIOCHEM BIOPH RES CO, V337, P1192, DOI 10.1016/j.bbrc.2005.09.172; Agarwal SM, 2005, BIOCHEM BIOPH RES CO, V331, P512, DOI 10.1016/j.bbrc.2005.03.209; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brent MR, 2005, GENOME RES, V15, P1777, DOI 10.1101/gr.3866105; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carr K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009550; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Deng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017293; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; Gunther F, 2010, R J, V2, P30; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Kak S, 2002, INFORM SCIENCES, V148, P97, DOI 10.1016/S0020-0255(02)00281-5; Lanier W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002171; Louhichi A, 2011, GENE, V488, P35, DOI 10.1016/j.gene.2011.08.013; Ma BG, 2007, BIOSYSTEMS, V90, P20, DOI 10.1016/j.biosystems.2006.06.004; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; PRABHU VV, 1992, NATURE, V359, P782, DOI 10.1038/359782a0; Shabalina SA, 2010, MOL BIOL EVOL, V27, P1745, DOI 10.1093/molbev/msq086; Shu JH, 2005, P 2005 ACM S APPL CO, P202; Yau SST, 2003, NUCLEIC ACIDS RES, V31, P3078, DOI 10.1093/nar/gkg432; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Yu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064328; Yu CL, 2013, J THEOR BIOL, V318, P197, DOI 10.1016/j.jtbi.2012.11.005; Yu CL, 2011, GENE, V486, P110, DOI 10.1016/j.gene.2011.07.002; Yu CL, 2011, INFORM SCIENCES, V181, P1484, DOI 10.1016/j.ins.2010.12.010; Yu CL, 2010, DNA RES, V17, P155, DOI 10.1093/dnares/dsq008; Zhang CQ, 2008, INT C COMP ELEC ENG, P169, DOI 10.1109/ICCEE.2008.35; Zhang CT, 1998, J THEOR BIOL, V192, P467, DOI 10.1006/jtbi.1998.0671; Zhang CT, 2003, BIOINFORMATICS, V19, P593, DOI 10.1093/bioinformatics/btg041	30	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101363	10.1371/journal.pone.0101363	http://dx.doi.org/10.1371/journal.pone.0101363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036549	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200014
J	Bilcke, J; Coenen, S; Beutels, P				Bilcke, Joke; Coenen, Samuel; Beutels, Philippe			Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All	PLOS ONE			English	Article							HEALTHY-CHILDREN; VACCINATION; IMPACT	This is one of the first studies to (1) describe the out-of-hospital burden of influenza-like-illness (ILI) and clinically diagnosed flu, also for patients not seeking professional medical care, (2) assess influential background characteristics, and (3) formally compare the burden of ILI in patients with and without a clinical diagnosis of flu. A general population sample with recent ILI experience was recruited during the 2011-2012 influenza season in Belgium. Half of the 2250 respondents sought professional medical care, reported more symptoms (especially more often fever), a longer duration of illness, more use of medication (especially antibiotics) and a higher direct medical cost than patients not seeking medical care. The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5-6 symptoms over a 6-day period; required 1.6 physician visits and 86-91% took medication. An average episode amounted to is an element of 51-is an element of 53 in direct medical costs, 4 days of absence from work or school and the loss of 0.005 quality-adjusted life-years. Underlying illness led to greater costs and lower quality-of-life. The costs of ILI patients with clinically diagnosed flu tended to increase, while those of ILI patients without clinically diagnosed flu tended to decrease with age. Recently vaccinated persons experienced lower costs and a higher quality-of-life, but this was only the case for patients not seeking professional medical care. This information can be used directly to evaluate the implementation of cost-effective prevention and control measures for influenza. In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries.	[Bilcke, Joke; Beutels, Philippe] Univ Antwerp, Fac Med & Hlth Sci, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO,WHO Collabo, B-2020 Antwerp, Belgium; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Coenen, Samuel] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol,WHO Collaborating Ctr, B-2020 Antwerp, Belgium; [Beutels, Philippe] Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Antwerp; University of Antwerp; University of Antwerp; World Health Organization	Bilcke, J (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO,WHO Collabo, B-2020 Antwerp, Belgium.	joke.bilcke@uantwerp.be	Coenen, Samuel JA/A-6410-2011; Bilcke, Joke/AAC-8932-2019; Beutels, Philippe/A-1919-2010; Geurts, José W/O-3673-2014	Coenen, Samuel JA/0000-0002-1238-8052; Bilcke, Joke/0000-0001-5720-5291; Beutels, Philippe/0000-0001-5034-3595; 	Belgian Health Care Knowledge Centre; Research Foundation - Flanders (FWO) [G.0274.08N]; European Commission Framework Programme 6	Belgian Health Care Knowledge Centre; Research Foundation - Flanders (FWO)(FWO); European Commission Framework Programme 6(European Commission)	This study was funded by the Belgian Health Care Knowledge Centre. JB is supported by a postdoctoral grant from the Research Foundation - Flanders (FWO). GRACE is funded via European Commission Framework Programme 6 and Research Foundation - Flanders (FWO G.0274.08N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova EN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-968; Beutels P, 2013, SEASONAL INFLUENZA 2; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cleemput I, 2012, HLTH TECHNOLOGY ASSE, V2nd; Esposito S, 2011, J INFECTION, V62, P379, DOI 10.1016/j.jinf.2011.02.015; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Hollmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060477; Jit M, 2013, HUM VACC IMMUNOTHER, V9, P834, DOI 10.4161/hv.23637; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Michiels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060348; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Newall AT, 2013, PHARMACOECONOMICS, V31, P693, DOI 10.1007/s40273-013-0060-7; Nicholson K G, 1992, Semin Respir Infect, V7, P26; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Ortega-Sanchez IR, 2012, VACCINE, V30, P4175, DOI 10.1016/j.vaccine.2012.04.057; Payne L, 2005, Euro Surveill, V10, P241; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; Ploin D, 2003, PEDIATR INFECT DIS J, V22, pS218, DOI 10.1097/01.inf.0000092191.78339.1a; Ploin D, 2007, PEDIATR INFECT DIS J, V26, P142, DOI 10.1097/01.inf.0000253062.41648.60; Principi N, 2004, ARCH DIS CHILD, V89, P1002, DOI 10.1136/adc.2003.045401; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Yin JK, 2013, INFLUENZA OTHER RESP, V7, P1103, DOI 10.1111/irv.12138; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063788	25	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102634	10.1371/journal.pone.0102634	http://dx.doi.org/10.1371/journal.pone.0102634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032688	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300071
J	Jung, J; Shin, H; Bang, S; Mok, HJ; Suh, CS; Kim, KP; Lim, HJ				Jung, Jaehun; Shin, Hyejin; Bang, Soyoung; Mok, Hyuck Jun; Suh, Chang Suk; Kim, Kwang Pyo; Lim, Hyunjung Jade			Analysis of the Phospholipid Profile of Metaphase II Mouse Oocytes Undergoing Vitrification	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; LIPID PHASE-TRANSITION; SINGLE-EMBRYO; CHILLING SENSITIVITY; CELL REGULATION; BOVINE OOCYTES; CERAMIDE; PHOSPHOINOSITIDES; APOPTOSIS; DYNAMICS	Oocyte freezing confers thermal and chemical stress upon the oolemma and various other intracellular structures due to the formation of ice crystals. The lipid profiles of oocytes and embryos are closely associated with both, the degrees of their membrane fluidity, as well as the degree of chilling and freezing injuries that may occur during cryopreservation. In spite of the importance of lipids in the process of cryopreservation, the phospholipid status in oocytes and embryos before and after freezing has not been investigated. In this study, we employed mass spectrometric analysis to examine if vitrification has an effect on the phospholipid profiles of mouse oocytes. Freshly prepared metaphase II mouse oocytes were vitrified using copper grids and stored in liquid nitrogen for 2 weeks. Fresh and vitrified-warmed oocytes were subjected to phospholipid extraction procedure. Mass spectrometric analyses revealed that multiple species of phospholipids are reduced in vitrified-warmed oocytes. LIFT analyses identified 31 underexpressed and 5 overexpressed phospholipids in vitrified mouse oocytes. The intensities of phosphatidylinositol (PI) {18:2/16:0} [M-H]- and phosphatidylglycerol (PG) {14:0/18:2} [M-H]- were decreased the most with fold changes of 30.5 and 19.1 in negative ion mode, respectively. Several sphingomyelins (SM) including SM {d38:3} [M+H]+ and SM {d34:0} [M+K]+ were decreased significantly in positive ion mode. Overall, the declining trend of multiple phospholipids demonstrates that vitrification has a marked effect on phospholipid profiles of oocytes. These results show that the identified phospholipids can be used as potential biomarkers of oocyte undergoing vitrification and will allow for the development of strategies to preserve phospholipids during oocyte cryopreservation.	[Jung, Jaehun] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul, South Korea; [Shin, Hyejin; Bang, Soyoung; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Jung, Jaehun; Mok, Hyuck Jun; Kim, Kwang Pyo] Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, Gyeonggi Do, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Kyung Hee University; Seoul National University (SNU)	Kim, KP (corresponding author), Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea.	kimkp@khu.ac.kr; hlim@konkuk.ac.kr	Kim, Kwang Pyo/AAG-1815-2020; Lim, Hyunjung/D-5343-2011	Lim, Hyunjung/0000-0003-2191-666X; Kim, Kwang Pyo/0000-0003-0095-3787	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055, https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; Apparicio M, 2012, REPROD DOMEST ANIM, V47, P113, DOI 10.1111/rda.12003; Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062; Arav A, 2000, CRYO-LETT, V21, P179; Bang S, 2014, REPRODUCTION, V148, P11, DOI 10.1530/REP-14-0036; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boldt J, 2011, REPROD BIOMED ONLINE, V23, P314, DOI 10.1016/j.rbmo.2010.11.019; Castaneda CA, 2013, THERIOGENOLOGY, V79, P417, DOI 10.1016/j.theriogenology.2012.10.006; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; Combelles CMH, 2012, INT J DEV BIOL, V56, P919, DOI 10.1387/ijdb.120132cc; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Edwards JL, 2005, ANAL CHEM, V77, P2201, DOI 10.1021/ac048323r; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferreira CR, 2012, J MASS SPECTROM, V47, P29, DOI 10.1002/jms.2022; Ferreira CR, 2012, ANAL BIOANAL CHEM, V404, P2915, DOI 10.1007/s00216-012-6426-4; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Fuchs B, 2011, PROG LIPID RES, V50, P132, DOI 10.1016/j.plipres.2010.10.001; Ghetler Y, 2005, HUM REPROD, V20, P3385, DOI 10.1093/humrep/dei236; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Gomes CM, 2008, FERTIL STERIL, V90, P1396, DOI 10.1016/j.fertnstert.2007.08.025; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Kang HS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-465; Kang S, 2011, INT J GYNECOL CANCER, V21, P1566, DOI 10.1097/IGC.0b013e318226c5f5; Katz-Jaffe MG, 2008, FERTIL STERIL, V89, P1441, DOI 10.1016/j.fertnstert.2007.03.098; Kim Y, 2010, EXP MOL MED, V42, P1, DOI 10.3858/emm.2010.42.1.001; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; LOEWENSTEIN JE, 1964, J EMBRYOL EXP MORPH, V12, P113; Monzo C, 2012, HUM REPROD, V27, P2160, DOI 10.1093/humrep/des153; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Park YS, 2011, CLIN CHIM ACTA, V412, P1978, DOI 10.1016/j.cca.2011.07.008; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Riggs R, 2010, FERTIL STERIL, V93, P109, DOI 10.1016/j.fertnstert.2008.09.084; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Shanta SR, 2011, ANAL CHEM, V83, P1252, DOI 10.1021/ac1029659; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Tata A, 2013, J MASS SPECTROM, V48, P844, DOI 10.1002/jms.3231; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yan J, 2011, J ASSIST REPROD GEN, V28, P643, DOI 10.1007/s10815-011-9563-3	45	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102620	10.1371/journal.pone.0102620	http://dx.doi.org/10.1371/journal.pone.0102620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033391	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300069
J	Fechter, D; Storch, I				Fechter, Dominik; Storch, Ilse			How Many Wolves (Canis lupus) Fit into Germany? The Role of Assumptions in Predictive Rule-Based Habitat Models for Habitat Generalists	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; SPECIES DISTRIBUTION; WOLF DISTRIBUTION; HOME RANGES; CONSERVATION; ROADS; SUITABILITY; PREDATION; PACK; RECOLONIZATION	Due to legislative protection, many species, including large carnivores, are currently recolonizing Europe. To address the impending human-wildlife conflicts in advance, predictive habitat models can be used to determine potentially suitable habitat and areas likely to be recolonized. As field data are often limited, quantitative rule based models or the extrapolation of results from other studies are often the techniques of choice. Using the wolf (Canis lupus) in Germany as a model for habitat generalists, we developed a habitat model based on the location and extent of twelve existing wolf home ranges in Eastern Germany, current knowledge on wolf biology, different habitat modeling techniques and various input data to analyze ten different input parameter sets and address the following questions: (1) How do a priori assumptions and different input data or habitat modeling techniques affect the abundance and distribution of potentially suitable wolf habitat and the number of wolf packs in Germany? (2) In a synthesis across input parameter sets, what areas are predicted to be most suitable? (3) Are existing wolf pack home ranges in Eastern Germany consistent with current knowledge on wolf biology and habitat relationships? Our results indicate that depending on which assumptions on habitat relationships are applied in the model and which modeling techniques are chosen, the amount of potentially suitable habitat estimated varies greatly. Depending on a priori assumptions, Germany could accommodate between 154 and 1769 wolf packs. The locations of the existing wolf pack home ranges in Eastern Germany indicate that wolves are able to adapt to areas densely populated by humans, but are limited to areas with low road densities. Our analysis suggests that predictive habitat maps in general, should be interpreted with caution and illustrates the risk for habitat modelers to concentrate on only one selection of habitat factors or modeling technique.	[Fechter, Dominik; Storch, Ilse] Univ Freiburg, Chair Wildlife Ecol & Management, Baden Wurttemberg, Germany	University of Freiburg	Fechter, D (corresponding author), Univ Freiburg, Chair Wildlife Ecol & Management, Baden Wurttemberg, Germany.	dominik.fechter@wildlife.uni-freiburg.de	Storch, Ilse/N-7478-2019; Storch, Ilse/P-6806-2019	Storch, Ilse/0000-0002-3252-2036	Evanglisches Studienwerk Villigst e.V.; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Evanglisches Studienwerk Villigst e.V.; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This project was funded by the Evanglisches Studienwerk Villigst e.V. (www.evstudienwerk.de). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens V, 2006, ECOL MODEL, V195, P3, DOI 10.1016/j.ecolmodel.2005.11.043; [Anonymous], 1986, CONSERVATION BIOL SC; Ansorge Hermann, 2007, Berichte der Naturforschenden Gesellschaft Oberlausitz, V15, P105; BALLARD WB, 1987, WILDLIFE MONOGR, P1; Beck JL, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P251, DOI 10.1016/B978-0-12-373631-4.00010-1; Berg W.E., 1982, P4; Blanco JC, 2005, CAN J ZOOL, V83, P312, DOI 10.1139/Z05-016; BLANCO JC, 1992, BIOL CONSERV, V60, P73, DOI 10.1016/0006-3207(92)91157-N; Boitani L., 1982, P158; Boitani L, 2000, CONV CONS EUR WILDL, V113; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Burgman MA, 2001, ECOL APPL, V11, P70, DOI 10.1890/1051-0761(2001)011[0070:SRBOHS]2.0.CO;2; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; Corsi F, 1999, CONSERV BIOL, V13, P150, DOI 10.1046/j.1523-1739.1999.97269.x; Cushman SA, 2013, TECHNICAL GUIDE MONI, P135; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Eggermann J, 2009, IMPACT HEBITAT FRAGM; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Falcucci A, 2013, BIOL CONSERV, V158, P63, DOI 10.1016/j.biocon.2012.08.029; Findo S, 2004, FOLIA ZOOL, V53, P17; Fritts SH, 1981, WILDLIFE MONOGR, V80, P1; FULLER TK, 1989, WILDLIFE MONOGR, P1; FULLER TK, 1992, WILDLIFE SOC B, V20, P42; Fuller TK, 1995, INT WOLF CTR TECHNIC, V27; Glenz C, 2001, LANDSCAPE URBAN PLAN, V55, P55, DOI 10.1016/S0169-2046(01)00119-0; Gros PM, 1999, BIODIVERS CONSERV, V8, P1561, DOI 10.1023/A:1008950114827; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagen R, 2014, SCI TOTAL ENVIRON, V468, P140, DOI 10.1016/j.scitotenv.2013.08.022; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Hovens JPM, 2005, MAMM BIOL, V70, P210, DOI 10.1016/j.mambio.2004.12.003; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Jedrzejewska B, 1996, MAMMAL REV, V26, P103; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Kaartinen S, 2005, ANN ZOOL FENN, V42, P523; Kaczensky P, 2013, STATUS MANAGEMENT DI; Kaczensky P, 2006, MEDIENPRASENS AKZEPT, P9; Kilgo JC, 2002, WILDLIFE SOC B, V30, P783; Kissling WD, 2009, ECOGRAPHY, V32, P807, DOI 10.1111/j.1600-0587.2009.05781.x; Kusak J, 2005, EUR J WILDLIFE RES, V51, P254, DOI 10.1007/s10344-005-0111-2; Kusak J., 2002, THESIS U ZAGREB; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Ludwig I, 2011, LECT NOTES GEOINF CA, V1, P65, DOI 10.1007/978-3-642-19789-5_4; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Mech LD, 2006, WILDLIFE SOC B, V34, P874, DOI 10.2193/0091-7648(2006)34[874:PFOAWL]2.0.CO;2; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; MECH LD, 1988, WILDLIFE SOC B, V16, P85; MECH LD, 1977, J MAMMAL, V58, P559, DOI 10.2307/1380004; MECH LD, 1989, AM MIDL NAT, V121, P387, DOI 10.2307/2426043; Mech LD., 1998, WOLVES DENALI; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; MESSIER F, 1985, CAN J ZOOL, V63, P1068, DOI 10.1139/z85-160; Mladenoff DJ, 1999, ECOL APPL, V9, P37, DOI 10.1890/1051-0761(1999)009[0037:PGWLRL]2.0.CO;2; MLADENOFF DJ, 1995, CONSERV BIOL, V9, P279, DOI 10.1046/j.1523-1739.1995.9020279.x; Molinari-Jobin A, 2012, ANIM CONSERV, V15, P266, DOI 10.1111/j.1469-1795.2011.00511.x; Morrison ML., 2006, WILDLIFE HABITAT REL; Mouton AM, 2009, ENVIRON MODELL SOFTW, V24, P982, DOI 10.1016/j.envsoft.2009.02.005; Nelson ME, 2000, CAN FIELD NAT, V114, P503; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Nowak S, 2005, ACTA THERIOL, V50, P263, DOI 10.1007/BF03194489; Okarma H, 1998, J MAMMAL, V79, P842, DOI 10.2307/1383092; Okarma H, 1997, WOLF OKOLOGIE VERHAL; PAQUET P, 1996, TRANSPORTATION WILDL, P46; Peterson R.O., 1988, PIT PENDULUM ISSUES, P105; PETERSON RO, 1984, J WILDLIFE MANAGE, P1; Peterson Rolf O., 2003, P104; Promberger C, 1996, ANN REPORT, V1, P1; Reinhardt I., 2007, FACHKONZEPT LEBEN WO, V201, P5; ROGERS LL, 1980, J WILDLIFE MANAGE, V44, P253; Ryabov LS, 1987, OTDELENE BIOL, V92, P3; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Sathyakumar S, 2001, URSUS-SERIES, V12, P21; Schadt S, 2002, ECOL APPL, V12, P1469; Starfield AM, 1997, J WILDLIFE MANAGE, V61, P261, DOI 10.2307/3802581; STARFIELD AM, 1990, BIOSCIENCE, V40, P601, DOI 10.2307/1311300; Switalski TA, 2006, WINTER SOLSTICE, V11, P6; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; Theuerkauf J, 2003, CAN J ZOOL, V81, P163, DOI 10.1139/Z02-190; Theuerkauf J, 2007, ANN ZOOL FENN, V44, P225; Thiel RP, 1998, CAN FIELD NAT, V112, P340; THIEL RP, 1985, AM MIDL NAT, V113, P404, DOI 10.2307/2425590; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Vila Carles, 1995, Canadian Circumpolar Institute Occasional Publication, V35, P335; Wagner C, 2012, MAMM BIOL, V77, P196, DOI 10.1016/j.mambio.2011.12.004; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wotschikowsky Ulrich, 2010, P201	87	25	26	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101798	10.1371/journal.pone.0101798	http://dx.doi.org/10.1371/journal.pone.0101798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029506	Green Published, gold			2022-12-27	WOS:000341306600023
J	Patenaude-Monette, M; Belisle, M; Giroux, JF				Patenaude-Monette, Martin; Belisle, Marc; Giroux, Jean-Francois			Balancing Energy Budget in a Central-Place Forager: Which Habitat to Select in a Heterogeneous Environment?	PLOS ONE			English	Article							BEHAVIORAL ECOLOGY; MULTIPLE SCALES; GULLS; MOVEMENT; LANDSCAPES; SEARCH; URBAN; INFORMATION; DIET	Foraging animals are influenced by the distribution of food resources and predation risk that both vary in space and time. These constraints likely shape trade-offs involving time, energy, nutrition, and predator avoidance leading to a sequence of locations visited by individuals. According to the marginal-value theorem (MVT), a central-place forager must either increase load size or energy content when foraging farther from their central place. Although such a decision rule has the potential to shape movement and habitat selection patterns, few studies have addressed the mechanisms underlying habitat use at the landscape scale. Our objective was therefore to determine how Ring-billed gulls (Larus delawarensis) select their foraging habitats while nesting in a colony located in a heterogeneous landscape. Based on locations obtained by fine-scale GPS tracking, we used resource selection functions (RSFs) and residence time analyses to identify habitats selected by gulls for foraging during the incubation and brood rearing periods. We then combined this information to gull survey data, feeding rates, stomach contents, and calorimetric analyses to assess potential trade-offs. Throughout the breeding season, gulls selected landfills and transhipment sites that provided higher mean energy intake than agricultural lands or riparian habitats. They used landfills located farther from the colony where no deterrence program had been implemented but avoided those located closer where deterrence measures took place. On the other hand, gulls selected intensively cultured lands located relatively close to the colony during incubation. The number of gulls was then greater in fields covered by bare soil and peaked during soil preparation and seed sowing, which greatly increase food availability. Breeding Ring-billed gulls thus select habitats according to both their foraging profitability and distance from their nest while accounting for predation risk. This supports the predictions of the MVT for central-place foraging over large spatial scales.	[Patenaude-Monette, Martin; Giroux, Jean-Francois] Univ Quebec, Dept Sci Biol, Grp Rech Ecol Comportementale & Anim, Montreal, PQ H3C 3P8, Canada; [Belisle, Marc] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Quebec; University of Quebec Montreal; University of Sherbrooke	Giroux, JF (corresponding author), Univ Quebec, Dept Sci Biol, Grp Rech Ecol Comportementale & Anim, CP 8888, Montreal, PQ H3C 3P8, Canada.	giroux.jean-francois@uqam.ca	Giroux, Jean-François/L-7945-2019	Giroux, Jean-François/0000-0002-6732-489X; Belisle, Marc/0000-0003-0657-6724; Patenaude-Monette, Martin/0000-0001-7272-2115	Natural Sciences and Engineering Research Council of Canada; Canadian Wildlife Service; ICI Environnement; Falcon Environmental Services; Chamard et Associes; Waste Management; BFI Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Wildlife Service; ICI Environnement; Falcon Environmental Services; Chamard et Associes; Waste Management; BFI Canada	The research was supported by grants to JFG and MB from the Natural Sciences and Engineering Research Council of Canada, the Canadian Wildlife Service, ICI Environnement, Falcon Environmental Services, Chamard et Associes, Waste Management, and BFI Canada. MPM was supported by a scholarship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amano T, 2006, ECOL MONOGR, V76, P601, DOI 10.1890/0012-9615(2006)076[0601:DIGFWI]2.0.CO;2; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bastille-Rousseau G, 2010, J ANIM ECOL, V79, P1157, DOI 10.1111/j.1365-2656.2010.01737.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Batschelet E, 1981, CIRCULAR STAT BIOL; Beauchamp G, 1997, J ANIM ECOL, V66, P671, DOI 10.2307/5920; Belant JL, 1997, LANDSCAPE URBAN PLAN, V38, P245, DOI 10.1016/S0169-2046(97)00037-6; Belant JL, 1998, LANDSCAPE URBAN PLAN, V43, P11, DOI 10.1016/S0169-2046(98)00100-5; Bellier E, 2010, OIKOS, V119, P988, DOI 10.1111/j.1600-0706.2009.17808.x; BERNSTEIN C, 1991, J ANIM ECOL, V60, P205, DOI 10.2307/5455; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Brousseau P, 1996, COLON WATERBIRD, V19, P22, DOI 10.2307/1521803; Bukacinska M, 1996, AUK, V113, P300; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Environment Canada, 2010, NAT CLIM DAT INF ARC; ESRI, 2009, ARCGIS VERS 9 3 1; FADQ, 2010, BAS DONN CULT ASS 20; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Freitas C, 2008, J APPL ECOL, V45, P1213, DOI 10.1111/j.1365-2664.2008.01505.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gaston Anthony J., 2007, Marine Ornithology, V35, P119; Giraldeau L.A., 2000, MG BEH ECOL; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Maciusik B, 2010, ECOL RES, V25, P263, DOI 10.1007/s11284-009-0649-7; Manly B.F.J., 2002, RESOURCE SELECTION A; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Natural Resources Canada, 2009, LAND COV CIRC 2000 V, V1.0; Natural Resources Canada, 2010, CANVEC VERS 1 1; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; Olsson O, 2008, THEOR POPUL BIOL, V74, P22, DOI 10.1016/j.tpb.2008.04.005; Orians G.H., 1979, P155; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Pallet I.L., 2012, BIRDS N AM ONLINE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racine F, 2012, ANIM BEHAV, V84, P175, DOI 10.1016/j.anbehav.2012.04.028; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; SCHOENER TW, 1979, AM NAT, V114, P902, DOI 10.1086/283537; Schwemmer P, 2008, LANDSCAPE ECOL, V23, P355, DOI 10.1007/s10980-008-9194-y; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Shamoun-Baranes J, 2006, J EXP BIOL, V209, P3489, DOI 10.1242/jeb.02385; SIBLY RM, 1983, J ANIM ECOL, V52, P51, DOI 10.2307/4587; Stephen D., 1986, FORAGING BEHAV; Thieriot E, 2012, APPL ANIM BEHAV SCI, V142, P109, DOI 10.1016/j.applanim.2012.09.008; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	55	34	35	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102162	10.1371/journal.pone.0102162	http://dx.doi.org/10.1371/journal.pone.0102162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029498	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600038
J	Li, XF; Zhou, FY; Jiang, CY; Wang, YN; Lu, YQ; Yang, F; Wang, NC; Yang, HJ; Zheng, YF; Zhang, JR				Li, Xufeng; Zhou, Fuyou; Jiang, Chunyu; Wang, Yinuo; Lu, Yanqiang; Yang, Fei; Wang, Nengchao; Yang, Haijun; Zheng, Yanfang; Zhang, Jiren			Identification of a DNA Methylome Profile of Esophageal Squamous Cell Carcinoma and Potential Plasma Epigenetic Biomarkers for Early Diagnosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; PROMOTER HYPERMETHYLATION; METHYLATION; EXPRESSION; GROWTH; CANCER; DAL-1; PROGNOSIS; EPB41L3; BINDING	DNA methylation is a critical epigenetic mechanism involved in key cellular processes. Its deregulation has been linked to many human cancers including esophageal squamous cell carcinoma (ESCC). This study was designed to explore the whole methylation status of ESCC and to identify potential plasma biomarkers for early diagnosis. We used Infinium Methylation 450k array to analyze ESCC tissues (n = 4), paired normal surrounding tissues (n = 4) and normal mucosa from healthy individuals (n = 4), and combined these with gene expression data from the GEO database. One hundred and sixty eight genes had differentially methylated CpG sites in their promoter region and a gene expression pattern inverse to the direction of change in DNA methylation. These genes were involved in several cancer-related pathways. Three genes were validated in additional 42 ESCC tissues and paired normal surrounding tissues. The methylation frequency of EPB41L3, GPX3, and COL14A1 were higher in tumor tissues than in normal surrounding tissues (P<0.017). The higher methylation frequency of EPB41l3 was correlated with large tumor size (P = 0.044) and advanced pT tumor stage (P = 0.001). The higher methylation frequency of GPX3 and COL14A1 were correlated with advanced pN tumor stage (P = 0.001 and P<0.001). The methylation of EPB41L3, GPX3, and COL14A1 genes were only found in ESCC patients' plasma, but not in normal individuals upon testing 42 ESCC patients and 50 healthy individuals. Diagnostic sensitivity was increased when methylation of any of the 3 genes were counted (64.3% sensitivity and 100% specificity). These differentially methylated genes in plasma may be used as biomarkers for early diagnosis of ESCC.	[Li, Xufeng; Jiang, Chunyu; Zheng, Yanfang; Zhang, Jiren] Southern Med Univ, ZhuJiang Hosp, Ctr Oncol, Guangzhou, Guangdong, Peoples R China; [Zhou, Fuyou; Wang, Nengchao; Yang, Haijun] Anyang Canc Hosp, Anyang, Peoples R China; [Wang, Yinuo; Lu, Yanqiang; Yang, Fei; Zhang, Jiren] Inst Targeted Mol Med, Shanghai, Peoples R China	Southern Medical University - China	Zheng, YF (corresponding author), Southern Med Univ, ZhuJiang Hosp, Ctr Oncol, Guangzhou, Guangdong, Peoples R China.	18665000236@163.com; zhangjiren@126.com	jiang, chunyu/HHC-6040-2022	Zhou, Fu-You/0000-0002-6548-4099; Zheng, Yanfang/0000-0002-5591-6425; Napolitano, Francesco/0000-0003-0884-1851	National Natural Science Foundation of China [81202073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science Foundation of China (Grant No. 81202073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2013, SURG TODAY; Bernkopf DB, 2008, EXPERT OPIN THER TAR, V12, P845, DOI 10.1517/14728222.12.7.845 ; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Charboneau AL, 2002, INT J CANCER, V100, P181, DOI 10.1002/ijc.10470; Dafou D, 2010, NEOPLASIA, V12, P579, DOI 10.1593/neo.10340; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ehnis T, 1997, J BIOL CHEM, V272, P20414, DOI 10.1074/jbc.272.33.20414; Eijsink JJH, 2012, INT J CANCER, V130, P1861, DOI 10.1002/ijc.26326; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Feugaing DDS, 2013, EUR J CELL BIOL, V92, P1, DOI 10.1016/j.ejcb.2012.08.004; Gutmann DH, 2000, HUM MOL GENET, V9, P1495, DOI 10.1093/hmg/9.10.1495; Hamilton JP, 2006, CLIN CANCER RES, V12, P6637, DOI 10.1158/1078-0432.CCR-06-1781; He YL, 2011, DIGEST DIS SCI, V56, P681, DOI 10.1007/s10620-010-1369-0; Heller G, 2006, ONCOGENE, V25, P959, DOI 10.1038/sj.onc.1209115; Heller G, 2007, BREAST CANCER RES TR, V103, P283, DOI 10.1007/s10549-006-9377-7; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Kaz AM, 2014, CANCER LETT, V342, P193, DOI 10.1016/j.canlet.2012.02.036; Kikuchi S, 2005, CLIN CANCER RES, V11, P2954, DOI 10.1158/1078-0432.CCR-04-2206; Kuroki T, 2003, CANCER RES, V63, P3724; Lee OJ, 2005, NEOPLASIA, V7, P854, DOI 10.1593/neo.05328; Li B, 2011, EPIGENETICS-US, V6, P307, DOI 10.4161/epi.6.3.14182; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lima SCS, 2011, EPIGENETICS-US, V6, P1217, DOI 10.4161/epi.6.10.17199; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mizuiri H, 2005, CANCER SCI, V96, P571, DOI 10.1111/j.1349-7006.2005.00082.x; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Nie Y, 2002, CARCINOGENESIS, V23, P1713, DOI 10.1093/carcin/23.10.1713; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Peng DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046214; Robb VA, 2004, ONCOGENE, V23, P3589, DOI 10.1038/sj.onc.1207445; Roth MJ, 2006, ONCOL REP, V15, P1591; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Simon R, 2007, CANCER INFORM, V3, P11; Smith E, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-42; Takeno S, 2004, AM J CLIN PATHOL, V122, P78, DOI 10.1309/WJL90JPEM17RBUHT; Teh MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034329; Tran YK, 1999, CANCER RES, V59, P35; Tzao C, 2005, J THORAC CARDIOV SUR, V130, P1371, DOI 10.1016/j.jtcvs.2005.06.004; Wang JM, 2008, CANCER EPIDEM BIOMAR, V17, P118, DOI 10.1158/1055-9965.EPI-07-0733; Yamada D, 2006, INT J CANCER, V118, P916, DOI 10.1002/ijc.21450; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Yue CM, 2003, WORLD J GASTROENTERO, V9, P1174, DOI 10.3748/wjg.v9.i6.1174; Zhang L, 2003, CARCINOGENESIS, V24, P1039, DOI 10.1093/carcin/bgg062	49	42	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103162	10.1371/journal.pone.0103162	http://dx.doi.org/10.1371/journal.pone.0103162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050929	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100092
J	Tang, MJ; Tian, YH; Li, DL; Lv, JW; Li, Q; Kuang, CC; Hu, PC; Wang, Y; Wang, J; Su, K; Wei, L				Tang, Mengjie; Tian, Yihao; Li, Doulin; Lv, Jiawei; Li, Qun; Kuang, Changchun; Hu, Pengchao; Wang, Ying; Wang, Jing; Su, Ke; Wei, Lei			TNF-alpha Mediated Increase of HIF-1 alpha Inhibits VASP Expression, Which Reduces Alveolar-Capillary Barrier Function during Acute Lung Injury (ALI)	PLOS ONE			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; RESPIRATORY-DISTRESS-SYNDROME; UP-REGULATION; LIPOPOLYSACCHARIDE; CELLS; ACTIVATION; HYPOXIA; INFLAMMATION; HIF-1; MICE	Acute lung injury (ALI) is an inflammatory disorder associated with reduced alveolar-capillary barrier function and increased pulmonary vascular permeability. Vasodilator-stimulated phosphoprotein (VASP) is widely associated with all types of modulations of cytoskeleton rearrangement-dependent cellular morphology and function, such as adhesion, shrinkage, and permeability. The present studies were conducted to investigate the effects and mechanisms by which tumor necrosis factor-alpha (TNF-alpha) increases the tight junction permeability in lung tissue associated with acute lung inflammation. After incubating A549 cells for 24 hours with different concentrations (0-100 ng/mL) of TNF-alpha, 0.1 to 8 ng/mL TNF-alpha exhibited no significant effect on cell viability compared with the 0 ng/mL TNF-alpha group (control group). However, 10 ng/mL and 100 ng/mL TNF-alpha dramatically inhibited the viability of A549 cells compared with the control group (*p<0.05). Monolayer cell permeability assay results indicated that A549 cells incubated with 10 ng/mL TNF-alpha for 24 hours displayed significantly increased cell permeability (*p<0.05). Moreover, the inhibition of VASP expression increased the cell permeability (*p<0.05). Pretreating A549 cells with cobalt chloride (to mimic a hypoxia environment) increased protein expression level of hypoxia inducible factor-1 alpha (HIF-1 alpha) (*p<0.05), whereas protein expression level of VASP decreased significantly (*p<0.05). In LPS-induced ALI mice, the concentrations of TNF-alpha in lung tissues and serum significantly increased at one hour, and the value reached a peak at four hours. Moreover, the Evans Blue absorption value of the mouse lung tissues reached a peak at four hours. The HIF-1 alpha protein expression level in mouse lung tissues increased significantly at four hours and eight hours (**p<0.001), whereas the VASP protein expression level decreased significantly (**p<0.01). Taken together, our data demonstrate that HIF-1 alpha acts downstream of TNF-alpha to inhibit VASP expression and to modulate the acute pulmonary inflammation process, and these molecules play an important role in the impairment of the alveolar-capillary barrier.	[Tang, Mengjie; Tian, Yihao; Li, Doulin; Kuang, Changchun; Hu, Pengchao; Wang, Ying; Wang, Jing; Wei, Lei] Wuhan Univ, Dept Pathol & Pathophysiol, Res Ctr Food & Drug Evaluat, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China; [Tang, Mengjie] Cent S Univ, Hunan Prov Tumor Hosp, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Lv, Jiawei] Wuhan Univ, Zhongnan Hosp, Coll Clin Med 2, Wuhan 430072, Hubei, Peoples R China; [Li, Qun] Wuhan Univ, Renmin Hosp, Coll Clin Med 2, Wuhan 430072, Hubei, Peoples R China; [Su, Ke] Wuhan Univ, Renmin Hosp, Div Nephrol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Central South University; Wuhan University; Wuhan University; Wuhan University	Wei, L (corresponding author), Wuhan Univ, Dept Pathol & Pathophysiol, Res Ctr Food & Drug Evaluat, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China.	leiweifr@hotmail.com		Tang, Meng-jie/0000-0001-6701-2581	National Natural Science Foundation of China [81172043]; Hubei Science Foundation [2009CDA074]; Fundamental Research Funds for the Central Universities [2012301020208]; laboratory and equipment administration of Wuhan University under project "Open Experimentation Program of Experimental Teaching Center of Wuhan University"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); laboratory and equipment administration of Wuhan University under project "Open Experimentation Program of Experimental Teaching Center of Wuhan University"	This work was supported by the National Natural Science Foundation of China under Grant No. 81172043, the Hubei Science Foundation under Grant 2009CDA074, the Fundamental Research Funds for the Central Universities No. 2012301020208 and the laboratory and equipment administration of Wuhan University under project "Open Experimentation Program of Experimental Teaching Center of Wuhan University". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Ato M, 2002, IMMUNOLOGY, V106, P554, DOI 10.1046/j.1365-2567.2002.01450.x; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Chen BY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000881; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Favarin DC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/164202; Figueroa XF, 2004, MICROVASC RES, V68, P247, DOI 10.1016/j.mvr.2004.06.009; Freedman SD, 2002, J APPL PHYSIOL, V92, P2169, DOI 10.1152/japplphysiol.00927.2001; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Goetze S, 1999, HYPERTENSION, V33, P183, DOI 10.1161/01.HYP.33.1.183; Guzman E, 2013, MAR DRUGS, V11, P1140, DOI 10.3390/md11041140; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Heneghan AF, 2014, ANN SURG, V259, P394, DOI 10.1097/SLA.0b013e318284f510; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Hohenstein B, 2005, J AM SOC NEPHROL, V16, P986, DOI 10.1681/ASN.2004070591; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jin YY, 2013, PULM PHARMACOL THER, V26, P661, DOI 10.1016/j.pupt.2013.03.013; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lee S, 2009, MOL CELL NEUROSCI, V42, P382, DOI 10.1016/j.mcn.2009.08.010; Li H, 2013, CHEST, V144, P876, DOI 10.1378/chest.12-2429; Li Y, 2008, EUR J PHARMACOL, V590, P417, DOI 10.1016/j.ejphar.2008.06.047; Lidington D, 2002, J CELL PHYSIOL, V193, P373, DOI 10.1002/jcp.10179; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Miyoshi K, 2013, AM J RESP CRIT CARE, V187, P262, DOI 10.1164/rccm.201205-0851OC; Osorio F, 2013, SEMIN IMMUNOPATHOL, V35, P293, DOI 10.1007/s00281-013-0368-6; Ozaki H, 1999, J IMMUNOL, V163, P553; Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437; Rentsendorj O, 2008, AM J PHYSIOL-LUNG C, V294, pL686, DOI 10.1152/ajplung.00417.2007; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Simon AM, 2004, J VASC RES, V41, P323, DOI 10.1159/000079614; Su K, 2012, DNA CELL BIOL, V31, P1078, DOI 10.1089/dna.2011.1563; Tonon R, 2002, BIORHEOLOGY, V39, P153; Tsapournioti S, 2013, J CELL PHYSIOL, V228, P1745, DOI 10.1002/jcp.24331; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055311; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	44	27	34	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102967	10.1371/journal.pone.0102967	http://dx.doi.org/10.1371/journal.pone.0102967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051011	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100071
J	Treberg, MA; Turkington, R				Treberg, Michael A.; Turkington, Roy			Species-Specific Responses to Community Density in an Unproductive Perennial Plant Community	PLOS ONE			English	Article							BOREAL FOREST; LEVEL CONSEQUENCES; FIELD EXPERIMENTS; COMPETITION; DIVERSITY; FACILITATION; DEPENDENCE; UNDERSTORY; VEGETATION; INTENSITY	Most studies of density dependent regulation in plants consider a single target species, but regulation may also occur at the level of the entire community. Knowing whether a community is at carrying capacity is essential for understanding its behaviour because low density plant communities may behave quite differently than their high density counterparts. Also, because the intensity of density dependence may differ considerably between species and physical environments, generalizations about its effects on community structure requires comparisons under a range of conditions. We tested if: (1) density dependent regulation occurs at the level of an entire plant community as well as within individual species; (2) the intensity (effect of increasing community density on mean plant mass) and importance (the effect of increasing density, relative to other factors, on mean plant mass) of competition increases, decreases or remains unchanged with increasing fertilization; (3) there are species-specific responses to changes in community density and productivity. In 63 1 m 2 plots, we manipulated the abundance of the nine most common species by transplanting or removing them to create a series of Initial Community Densities above and below the average natural field density, such that the relative proportion of species was consistent for all densities. Plots were randomly assigned to one of three fertilizer levels. At the community level, negative density dependence of mean plant size was observed for each of the 4 years of the study and both the intensity and importance of competition increased each year. At the species level, most species' mean plant mass were negatively density dependent. Fertilizer had a significant effect only in the final year when it had a negative effect on mean plant mass. Our data demonstrate a yield-density response at the entire community-level using perennial plant species in a multi-year experiment.	[Turkington, Roy] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Turkington, R (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	royt@mail.ubc.ca			Natural Sciences and Engineering Research Council (NSERC) Discovery grant; NSERC; UBC Graduate Scholarship; Northern Sciences Training Program grant	Natural Sciences and Engineering Research Council (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC Graduate Scholarship; Northern Sciences Training Program grant	Funding for this research was provided by a Natural Sciences and Engineering Research Council (NSERC) Discovery grant to RT, an NSERC Graduate Scholarship, a UBC Graduate Scholarship, and a Northern Sciences Training Program grant to MAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii K, 2002, ARCT ANTARCT ALP RES, V34, P251, DOI 10.2307/1552482; Bennett JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043703; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cody W. J., 2000, FLORA YUKON TERRITOR; DITOMMASO A, 1989, VEGETATIO, V84, P9, DOI 10.1007/BF00054662; Dlott F, 2000, PLANT ECOL, V151, P239, DOI 10.1023/A:1026510727987; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Goldberg DE, 1998, J ECOL, V86, P983, DOI 10.1046/j.1365-2745.1998.00319.x; GOLDBERG DE, 1995, FOLIA GEOBOT PHYTOTX, V30, P231, DOI 10.1007/BF02812101; GOLDBERG DE, 1994, ECOLOGY, V75, P1503, DOI 10.2307/1937473; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Gough L, 2000, J ECOL, V88, P54, DOI 10.1046/j.1365-2745.2000.00426.x; Graham S, 2000, CAN J BOT, V78, P753, DOI 10.1139/cjb-78-6-753; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Harper J. L, 1977, POPULATION BIOL PLAN; He JS, 2005, BASIC APPL ECOL, V6, P505, DOI 10.1016/j.baae.2005.04.002; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; KADMON R, 1995, J ECOL, V83, P253, DOI 10.2307/2261564; KAREIVA P, 1994, ECOLOGY, V75, P1527; Kerkhoff AJ, 2007, BIOSCIENCE, V57, P489, DOI 10.1641/B570606; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; Krebs CJ, 2014, ARCTIC; Lamb EG, 2008, AM NAT, V171, P777, DOI 10.1086/587528; Lortie CJ, 2002, J ECOL, V90, P435, DOI 10.1046/j.1365-2745.2002.00686.x; McLellan AJ, 1997, J ECOL, V85, P479, DOI 10.2307/2960571; Rajaniemi TK, 2009, J VEG SCI, V20, P836, DOI 10.1111/j.1654-1103.2009.01086.x; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Rajaniemi TK, 2000, J VEG SCI, V11, P433, DOI 10.2307/3236636; Rees M, 2013, ECOL LETT, V16, P291, DOI 10.1111/ele.12037; Sammul M, 2000, OECOLOGIA, V125, P18, DOI 10.1007/PL00008887; Sandel B, 2009, OIKOS, V118, P1284, DOI 10.1111/j.1600-0706.2009.17421.x; *SAS I INC, 1995, JMP; Shilo-Volin H, 2005, OIKOS, V108, P241, DOI 10.1111/j.0030-1299.2005.12904.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Storm C, 2008, J VEG SCI, V19, P343, DOI 10.3170/2008-8-18374; TILMAN D, 1988; Treberg MA, 2010, BOTANY, V88, P753, DOI 10.1139/B10-048; Treberg MA, 2010, ARCT ANTARCT ALP RES, V42, P113, DOI 10.1657/1938-4246-42.1.113; Turkington R, 2005, J ARID ENVIRON, V61, P377, DOI 10.1016/j.jaridenv.2004.09.016; Turkington R, 2002, J ECOL, V90, P325, DOI 10.1046/j.1365-2745.2001.00666.x; Turkington R, 2014, ARCTIC; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Weiner J, 2010, ANNU REV ECOL EVOL S, V41, P173, DOI 10.1146/annurev-ecolsys-102209-144642; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; Zamfir M, 2000, J ECOL, V88, P243, DOI 10.1046/j.1365-2745.2000.00442.x	48	1	1	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102430	10.1371/journal.pone.0102430	http://dx.doi.org/10.1371/journal.pone.0102430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050710	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100034
J	Milfont, TL; Evans, L; Sibley, CG; Ries, J; Cunningham, A				Milfont, Taciano L.; Evans, Laurel; Sibley, Chris G.; Ries, Jan; Cunningham, Andrew			Proximity to Coast Is Linked to Climate Change Belief	PLOS ONE			English	Article							ENVIRONMENTAL ENGAGEMENT; PUBLIC PERCEPTION; EXPERIENCE; BARRIERS; WILLINGNESS; PERSPECTIVE; MITIGATION; DECISIONS; ATTITUDES; BEHAVIOR	Psychologists have examined the many psychological barriers to both climate change belief and concern. One barrier is the belief that climate change is too uncertain, and likely to happen in distant places and times, to people unlike oneself. Related to this perceived psychological distance of climate change, studies have shown that direct experience of the effects of climate change increases climate change concern. The present study examined the relationship between physical proximity to the coastline and climate change belief, as proximity may be related to experiencing or anticipating the effects of climate change such as sea-level rise. We show, in a national probability sample of 5,815 New Zealanders, that people living in closer proximity to the shoreline expressed greater belief that climate change is real and greater support for government regulation of carbon emissions. This proximity effect held when adjusting for height above sea level and regional poverty. The model also included individual differences in respondents' sex, age, education, political orientation, and wealth. The results indicate that physical place plays a role in the psychological acceptance of climate change, perhaps because the effects of climate change become more concrete and local.	[Milfont, Taciano L.; Evans, Laurel; Ries, Jan] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Sibley, Chris G.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Cunningham, Andrew] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand	Victoria University Wellington; University of Auckland; Victoria University Wellington	Milfont, TL (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	taciano.milfont@vuw.ac.nz	Sibley, Chris G/D-2974-2009; Milfont, Taciano L/GCA-0840-2022; Milfont, Taciano L./N-3425-2015	Sibley, Chris G/0000-0002-4064-8800; Milfont, Taciano L/0000-0001-6838-6307; Milfont, Taciano L./0000-0001-6838-6307	Marsden Fast Start grant from The Royal Society of New Zealand (Te Putea Rangahau a Marsden) awarded [NZAVS-09]; University of Auckland FRDF [3624435/9853]; ECREA [3626075]	Marsden Fast Start grant from The Royal Society of New Zealand (Te Putea Rangahau a Marsden) awarded; University of Auckland FRDF; ECREA	Preparation of this manuscript was partially supported by a Marsden Fast Start grant from The Royal Society of New Zealand (Te Putea Rangahau a Marsden) awarded to Taciano L. Milfont. Collection of the New Zealand Attitudes and Values Study 2009 (NZAVS-09) data analyzed in this paper was funded by University of Auckland FRDF (#3624435/9853) and ECREA (#3626075) grants awarded to Chris Sibley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeola FO, 2009, ENVIRON BEHAV, V41, P459, DOI 10.1177/0013916508316651; Borick C, 2003, FALL 2012 NSEE FINDI; Boykoff MT, 2013, AM BEHAV SCI, V57, P796, DOI 10.1177/0002764213476846; Brody S, 2012, CLIM POLICY, V12, P1, DOI 10.1080/14693062.2011.579261; Brody SD, 2008, ENVIRON BEHAV, V40, P72, DOI 10.1177/0013916506298800; Christ O., 2012, OXFORD HDB PERSONALI, P239; Dutt V, 2012, J ENVIRON PSYCHOL, V32, P19, DOI 10.1016/j.jenvp.2011.10.003; Evans L, 2014, GLOBAL ENVIRON CHANG, V25, P69, DOI 10.1016/j.gloenvcha.2013.12.013; Fairbrother M, 2013, EUR SOCIOL REV, V29, P910, DOI 10.1093/esr/jcs068; Fransson N, 1999, J ENVIRON PSYCHOL, V19, P369, DOI 10.1006/jevp.1999.0141; Franzen A, 2010, EUR SOCIOL REV, V26, P219, DOI 10.1093/esr/jcp018; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Horizon Poll, 2012, PEOPL WANT MOR ACT C; Hunter LM, 2004, SOC SCI QUART, V85, P677, DOI 10.1111/j.0038-4941.2004.00239.x; IPCC, 2012, MANAGING RISKS EXTRE; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Leiserowitz A., 2012, PUBLIC SUPPORT CLIMA; Leiserowitz A, 2014, CLIMATE CHANGE AM MI; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McClure J., 2011, AUSTRALAS J DISASTER, V2, P3; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Milfont TL, 2013, PERS SOC PSYCHOL B, V39, P1127, DOI 10.1177/0146167213490805; Milfont TL, 2012, INT J PSYCHOL, V47, P325, DOI 10.1080/00207594.2011.647029; Milfont TL, 2012, J ENVIRON PSYCHOL, V32, P187, DOI 10.1016/j.jenvp.2011.12.006; Milfont TL, 2010, ENVIRON SCI ENG TECH, P19; Milfont TL, 2012, ECOPSYCHOL, V42, P269, DOI DOI 10.1089/EC0.2012.0058; Nerlich B, 2010, WIRES CLIM CHANGE, V1, P97, DOI 10.1002/wcc.002; Oreskes N., 2010, MERCHANTS DOUBT; Pampel FC, 2014, SOC SCI QUART, V95, P57, DOI 10.1111/ssqu.12045; PAWLIK K, 1991, INT J PSYCHOL, V26, P547, DOI 10.1080/00207599108247143; Pew Research Center, 2013, CONT PART DIV VIEWS; Ratter BMW, 2012, ENVIRON SCI POLICY, V18, P3, DOI 10.1016/j.envsci.2011.12.007; Reser JosephP., 2012, PUBLIC RISK PERCEPTI; Salmond C., 2007, NZDEP2006 INDEX DEPR; Schultz PW, 2014, ENVIRON BEHAV, V46, P267, DOI 10.1177/0013916512458579; Scoop Media, 2009, HUG SUPP EXTR CLIM C; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Sibley CG, 2014, APPENDIX CONSECUTIVE; Sibley CG, 2013, ANAL SOC ISS PUB POL, V13, P245, DOI 10.1111/asap.12008; Sibley CG, 2011, ANAL SOC ISS PUB POL, V11, P201, DOI 10.1111/j.1530-2415.2011.01244.x; Slovic P., 1982, JUDGMENT UNCERTAINTY, DOI DOI 10.1017/CBO9780511809477; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Stanford Woods Institute for the Environment, 2013, SURV RES US VIEWS CL; Statistics New Zealand, 2006, AR NZ LIV CLOS COAST; STONE ER, 1994, ORGAN BEHAV HUM DEC, V60, P387, DOI 10.1006/obhd.1994.1091; Swim J., 2009, PSYCHOL GLOBAL CLIMA; Viscusi WK, 2006, J RISK UNCERTAINTY, V33, P13, DOI 10.1007/s11166-006-0169-6; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093; Zelezny LC, 2000, J SOC ISSUES, V56, P443, DOI 10.1111/0022-4537.00177	57	68	68	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103180	10.1371/journal.pone.0103180	http://dx.doi.org/10.1371/journal.pone.0103180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25047568	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100112
J	Zhu, B; Wu, XM; Zhi, XY; Liu, L; Zheng, QM; Sun, GF				Zhu, Bo; Wu, Xiaomei; Zhi, Xueyuan; Liu, Lei; Zheng, Quanmei; Sun, Guifan			Methylenetetrahydrofolate Reductase C677T Polymorphism and Type 2 Diabetes Mellitus in Chinese Population: A Meta-Analysis of 29 Case-Control Studies	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; GENETIC PREDISPOSITION; PLASMA HOMOCYSTEINE; COMMON MUTATION; RISK-FACTORS; ASSOCIATION; DISEASE; MTHFR; HYPERHOMOCYSTEINEMIA	Background: Methylenetetrahydrofolate reductase (MTHFR), a key enzyme in folate metabolism, had significant effects on the homocysteine levels. The common functional MTHFR C677T polymorphism had been extensively researched. Several studies had evaluated the relationship between MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM), but the results were still controversial in the Chinese Han population. This meta-analysis was conducted to evaluate the relationship between MTHFR C677T polymorphism and T2DM in the Chinese Han population. Methods: We searched the relevant studies in multiple electronic databases, which published up to December 2013. We reviewed and extracted data from all the included studies on the relationship between MTHFR C677T polymorphism and T2DM in the Chinese Han population. The odds ratios (ORs) and their 95% confidence intervals (95%CIs) were used to evaluate the relationship. Fixed-effects and random-effects meta-analysis were used to pool ORs by the heterogeneity. Publication bias and sensitivity analysis were also examined. Results: 29 studies were finally included in our meta-analysis, which contained 4656 individuals with T2DM and 2127 healthy controls. There was a significant relationship between MTHFR C677T polymorphism and T2DM under dominant (OR: 1.70, 95% CI: 1.42-2.02), recessive (OR: 1.48, 95% CI: 1.21-1.80), homozygous (OR: 1.89, 95% CI: 1.47-2.42), heterozygous (OR: 1.58, 95% CI: 1.33-1.87), and additive (OR: 1.46, 95% CI: 1.28-1.68) genetic model in a random-effects model. Subgroup analysis also reached similar results. Sensitivity analysis indicated that the overall result were dependable. Conclusions: There was a significant relationship between MTHFR C677T polymorphism and T2DM in the Chinese Han population. The results of our meta-analysis suggested that MTHFR 677T allele might be a risk genetic factor of T2DM in the Chinese Han population.	[Zhu, Bo; Zhi, Xueyuan; Zheng, Quanmei; Sun, Guifan] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China; [Wu, Xiaomei] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Med, Shenyang, Peoples R China; [Zhu, Bo] Liaoning Acad Safety Sci, Shenyang, Peoples R China; [Liu, Lei] China Med Univ, Hosp 1, Key Lab Endocrine Dis Liaoning Prov, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Sun, GF (corresponding author), China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China.	sungf@mail.cmu.edu.cn						Abbas S, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-80; Al-Rubeaan K, 2013, GENE, V520, P166, DOI 10.1016/j.gene.2013.02.017; Bazzaz JT, 2010, MOL BIOL REP, V37, P105, DOI 10.1007/s11033-009-9545-z; Bleich S, 2006, ALCOHOL CLIN EXP RES, V30, P587, DOI 10.1111/j.1530-0277.2006.00068.x; Chen AR, 2010, CLIN INVEST MED, V33, pE290, DOI 10.25011/cim.v33i5.14354; Chen AR., 2004, CHIN J PREV CONTR CH, V12, P195; Chen P, 2008, J QIQIHAR MED COLL, V29, P672; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Dai H., 2012, CHIN J TRAUMA DISABI, V20, P4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flores-Martinez SE, 2004, ANN GENET-PARIS, V47, P339, DOI 10.1016/j.anngen.2004.05.004; Friedman G, 1999, J NUTR, V129, P1656, DOI 10.1093/jn/129.9.1656; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Guo L, 2005, J CLIN INTERNAL MED, V22, P468; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hemati T, 2011, IRAN J REPROD MED, V9, P223; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsu HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077931; Hu L, 2009, CHINESE J GEN PRATIT, V08, P385; Hu S, 2001, CHINESE J MED GENET, V18, P118; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Li H, 2012, DIABETES RES CLIN PR, V98, P226, DOI 10.1016/j.diabres.2012.05.010; Liang W, 2005, STUDY MTHFR GENE POL; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Luo D, 2008, J CHINA JAPAN FRIEND, V22, P24; [罗丹 LUO Dan], 2007, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V25, P114; Mao L, 2004, ACAD MED NANTONG, V24, P146; Mao L, 2004, ACAD MED NANTONG, V24, P150; Medina MA, 2001, EUR J BIOCHEM, V268, P3871, DOI 10.1046/j.1432-1327.2001.02278.x; Mehri S, 2010, CLIN BIOCHEM, V43, P259, DOI 10.1016/j.clinbiochem.2009.10.008; Mei Q, 2012, CHINA MED HERALD, V09, P162; Nafiye Y, 2010, FERTIL STERIL, V93, P1864, DOI 10.1016/j.fertnstert.2008.12.024; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Patterson S, 2006, J ENDOCRINOL, V189, P301, DOI 10.1677/joe.1.06537; Qin XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042538; Qiu Y, 2009, ZHE JIANG MED J, V31, P426; Radha V, 2007, INDIAN J MED RES, V125, P259; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Schachter M, 2003, HUM REPROD, V18, P721, DOI 10.1093/humrep/deg190; Scullion SMJ, 2012, J ENDOCRINOL, V214, P233, DOI 10.1530/JOE-11-0461; Shi C, 2006, PCR CHINESE J DIABET, V14, P258; [史杰萍 Shi Jieping], 2002, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V28, P371; Sibani S, 2000, HUM MUTAT, V15, P280, DOI 10.1002/(SICI)1098-1004(200003)15:3<280::AID-HUMU9>3.3.CO;2-9; Sun JZ, 2005, MOL CELL ENDOCRINOL, V229, P95, DOI 10.1016/j.mce.2004.09.003; Sun L., 2013, J MED MOL BIOL, V10, P95; [孙磊 Sun Lei], 2004, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V20, P536; Sun Y, 2006, 3 LAB MED C 3 PROV 2, P126; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang L, 2001, CHINESE J OCULAR FUN, V17, P198; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; [闻杰 WEN Jie], 2008, [上海医学, Shanghai Medical Journal], V31, P47; Xiao Y, 2006, J GUIYANG MED COLL, V31, P317; Xu JS., 2003, CLIN FOCUS, V18, P787; Yang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057917; Yang GQ., 2001, CHIN J ENDOCRINOL ME, V17, P224; Yue H., 2006, CHIN J GEN PRACT, Vl5, P725; Zhang C, 2007, J CLIN INTERNAL MED, V24, P458; [张国栋 Zhang Guodong], 2002, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V18, P362; [张巧慧 ZHANG Qiao-hui], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P356; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074521; Zhou J, 2004, J APOPLEXY NERVOUS D, V21, P136	63	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102443	10.1371/journal.pone.0102443	http://dx.doi.org/10.1371/journal.pone.0102443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047451	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100031
J	Atkinson, PJ; Wise, AK; Flynn, BO; Nayagam, BA; Richardson, RT				Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Richardson, Rachael T.			Hair Cell Regeneration after ATOH1 Gene Therapy in the Cochlea of Profoundly Deaf Adult Guinea Pigs	PLOS ONE			English	Article							MAMMALIAN COCHLEA; IN-VIVO; MATH1; HEARING; EXPRESSION; NEURONS; NEUROTROPHIN-3; EPITHELIUM; TRAUMA	The degeneration of hair cells in the mammalian cochlea results in permanent sensorineural hearing loss. This study aimed to promote the regeneration of sensory hair cells in the mature cochlea and their reconnection with auditory neurons through the introduction of ATOH1, a transcription factor known to be necessary for hair cell development, and the introduction of neurotrophic factors. Adenoviral vectors containing ATOH1 alone, or with neurotrophin-3 and brain derived neurotrophic factor were injected into the lower basal scala media of guinea pig cochleae four days post ototoxic deafening. Guinea pigs treated with ATOH1 gene therapy, alone, had a significantly greater number of cells expressing hair cell markers compared to the contralateral non-treated cochlea when examined 3 weeks post-treatment. This increase, however, did not result in a commensurate improvement in hearing thresholds, nor was there an increase in synaptic ribbons, as measured by CtBP2 puncta after ATOH1 treatment alone, or when combined with neurotrophins. However, hair cell formation and synaptogenesis after co-treatment with ATOH1 and neurotrophic factors remain inconclusive as viral transduction was reduced due to the halving of viral titres when the samples were combined. Collectively, these data suggest that, whilst ATOH1 alone can drive non-sensory cells towards an immature sensory hair cell phenotype in the mature cochlea, this does not result in functional improvements after aminoglycoside-induced deafness.	[Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Richardson, Rachael T.] Bion Inst, East Melbourne, Vic, Australia; [Atkinson, Patrick J.; Wise, Andrew K.; Nayagam, Bryony A.; Richardson, Rachael T.] Univ Melbourne, Dept Otolaryngol, East Melbourne, Vic, Australia; [Wise, Andrew K.; Richardson, Rachael T.] Univ Melbourne, Dept Med Bion, East Melbourne, Vic, Australia; [Nayagam, Bryony A.] Univ Melbourne, Dept Audiol & Speech Pathol, Parkville, Vic 3052, Australia	Bionics Institute; University of Melbourne; University of Melbourne; University of Melbourne	Richardson, RT (corresponding author), Bion Inst, East Melbourne, Vic, Australia.	rrichardson@bionicsinstitute.org	Wise, Andrew/B-5943-2014	Wise, Andrew/0000-0001-9715-8784; Nayagam, Bryony/0000-0003-1069-6059; Richardson, Rachael/0000-0002-2412-8354	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council [GNT1024350]; Action on Hearing Loss; Royal Victorian Eye and Ear Hospital; University of Melbourne; Victorian Government through its Operational Infrastructure Support Program; RNID [G39] Funding Source: researchfish	Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Action on Hearing Loss; Royal Victorian Eye and Ear Hospital; University of Melbourne(University of Melbourne); Victorian Government through its Operational Infrastructure Support Program; RNID	The authors wish to acknowledge the generous support of the Garnett Passe and Rodney Williams Memorial Foundation (PJA), the National Health and Medical Research Council (GNT1024350) (RTR), Action on Hearing Loss (RTR), the Royal Victorian Eye and Ear Hospital (PJA) and the University of Melbourne (PJA). The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052338; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Chen P, 2002, DEVELOPMENT, V129, P2495; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P280; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P19, DOI 10.1007/s10162-004-5024-3; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; Kraft S, 2013, LARYNGOSCOPE, V123, P992, DOI 10.1002/lary.22171; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Wang Q, 2011, J NEUROSCI, V31, P7938, DOI 10.1523/JNEUROSCI.1434-10.2011; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yang JM, 2013, NEUROSCI LETT, V549, P7, DOI 10.1016/j.neulet.2013.04.053; Yang JM, 2012, J NEUROSCI, V32, P3712, DOI 10.1523/JNEUROSCI.6093-11.2012; Yang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046355	27	55	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102077	10.1371/journal.pone.0102077	http://dx.doi.org/10.1371/journal.pone.0102077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036727	Green Published, gold			2022-12-27	WOS:000339615200036
J	Delisle, VC; Kwakkenbos, L; Hudson, M; Baron, M; Thombs, BD				Delisle, Vanessa C.; Kwakkenbos, Linda; Hudson, Marie; Baron, Murray; Thombs, Brett D.		Canadian Scleroderma Res Grp	An Assessment of the Measurement Equivalence of English and French Versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in Systemic Sclerosis	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; POSITIVE AFFECT; SYMPTOMS; RELIABILITY; PREVALENCE; CLASSIFICATION; VALIDITY; CRITERIA	Objectives: Center for Epidemiologic Studies Depression (CES-D) Scale scores in English-and French-speaking Canadian systemic sclerosis (SSc) patients are commonly pooled in analyses, but no studies have evaluated the metric equivalence of the English and French CES-D. The study objective was to examine the metric equivalence of the CES-D in English-and French-speaking SSc patients. Methods: The CES-D was completed by 1007 English-speaking and 248 French-speaking patients from the Canadian Scleroderma Research Group Registry. Confirmatory factor analysis (CFA) was used to assess the factor structure in both samples. The Multiple-Indicator Multiple-Cause (MIMIC) model was utilized to assess differential item functioning (DIF). Results: A two-factor model (Positive and Negative affect) showed excellent fit in both samples. Statistically significant, but small-magnitude, DIF was found for 3 of 20 CES-D items, including items 3 (Blues), 10 (Fearful), and 11 (Sleep). Prior to accounting for DIF, French-speaking patients had 0.08 of a standard deviation (SD) lower latent scores for the Positive factor (95% confidence interval [CI]-0.25 to 0.08) and 0.09 SD higher scores (95% CI-0.07 to 0.24) for the Negative factor than English-speaking patients. After DIF correction, there was no change on the Positive factor and a non-significant increase of 0.04 SD on the Negative factor for French-speaking patients (difference = 0.13 SD, 95% CI-0.03 to 0.28). Conclusions: The English and French versions of the CES-D, despite minor DIF on several items, are substantively equivalent and can be used in studies that combine data from English-and French-speaking Canadian SSc patients.	[Delisle, Vanessa C.; Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada; [Delisle, Vanessa C.; Kwakkenbos, Linda; Hudson, Marie; Baron, Murray; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University	Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Kwakkenbos, Linda/GXH-2756-2022; Baron, Murray/AAF-9486-2019; Pope, Janet/G-3342-2011	Kwakkenbos, Linda/0000-0002-1573-4504; Pope, Janet/0000-0003-1479-5302	Canadian Institutes of Health Research; Fonds de la Recherche en Sante Quebec; Arthritis Society; Actelion; Pfizer pharmaceuticals	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Arthritis Society; Actelion; Pfizer pharmaceuticals(Pfizer)	Ms. Delisle is supported by a Canadian Institutes of Health Research doctoral award. Dr. Kwakkenbos is supported by a Fonds de la Recherche en Sante Quebec postdoctoral fellowship. Dr. Thombs is supported by an Investigator Salary Award from the Arthritis Society. Dr. Baron is the director of the Canadian Scleroderma Research Group (CSRG) and the CSRG has received educational grants from Actelion and Pfizer pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhajeri H, 2013, ARTHRITIS RHEUM S, VS10, P772; [Anonymous], 2005, KELLEYS TXB RHEUMATO; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Buck U, 2010, MUSCULOSKELET CARE, V8, P197, DOI 10.1002/msc.181; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contrada RJ, 2006, PSYCHOSOM MED, V68, P922, DOI 10.1097/01.psy.0000244391.56598.10; Fuhrer R, 1989, EUROPEAN PSYCHIAT, V4, P163, DOI DOI 10.1037/T10444-000; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hoogeboom TJ, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001161, 10.1136/bmjopen-2013-003563]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunt SM, 2004, J EPIDEMIOL COMMUN H, V58, P618, DOI 10.1136/jech.2003.010074; Jewett LR, 2013, RHEUMATOLOGY, V52, P669, DOI 10.1093/rheumatology/kes347; KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447; Kwakkenbos L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053923; Kwakkenbos L, 2012, J PSYCHOSOM RES, V72, P199, DOI 10.1016/j.jpsychores.2011.12.005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Moskowitz JT, 2003, PSYCHOSOM MED, V65, P620, DOI 10.1097/01.PSY.0000073873.74829.23; Muller H, 2012, BRIT J DERMATOL, V166, P343, DOI 10.1111/j.1365-2133.2011.10624.x; Muthen B., 2010, MPLUS USERS GUIDE; Newton EG, 2012, QUAL HEALTH RES, V22, P1195, DOI 10.1177/1049732312449207; Nietert PJ, 2005, J RHEUMATOL, V32, P51; O'Rourke N, 2003, CAN J AGING, V22, P323, DOI 10.1017/S0714980800003937; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Rhee SH, 1999, ARTHRIT CARE RES, V12, P392, DOI 10.1002/1529-0131(199912)12:6<392::AID-ART7>3.0.CO;2-9; Rogler LH, 1999, AM PSYCHOL, V54, P424, DOI 10.1037/0003-066X.54.6.424; Schroevers MJ, 2000, QUAL LIFE RES, V9, P1015, DOI 10.1023/A:1016673003237; Stansbury JP, 2006, J PERS ASSESS, V86, P10, DOI 10.1207/s15327752jpa8601_03; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Teresi JA, 2006, MED CARE, V44, pS39, DOI 10.1097/01.mlr.0000245452.48613.45; Thombs BD, 2012, CLIN EXP RHEUMATOL, V30, pS23; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P431, DOI 10.1002/art.23328; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P438, DOI 10.1002/art.23329; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tyndall A, 2005, Ann Rheum Dis, V64, P1107, DOI 10.1136/ard.2005.036038; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Wigley FM, 2003, RHEUMATOLOGY, P1463; Zumbo BD, 1999, HDB THEORY METHODS D	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102897	10.1371/journal.pone.0102897	http://dx.doi.org/10.1371/journal.pone.0102897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036894	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200093
J	Liew, G; Wang, JJ; Rochtchina, E; Wong, TY; Mitchell, P				Liew, Gerald; Wang, Jie Jin; Rochtchina, Elena; Wong, Tien Yin; Mitchell, Paul			Complete Blood Count and Retinal Vessel Calibers	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; AGE-RELATED MACULOPATHY; CHRONIC KIDNEY-DISEASE; VASCULAR CALIBER; MICROVASCULAR ABNORMALITIES; LEUKOCYTE COUNT; CELL COUNT; ARTERIOLAR; RISK; DIAMETERS	Objective: The influence of hematological indices such as complete blood count on microcirculation is poorly understood. Retinal microvasculature can be directly visualized and vessel calibers are associated with a range of ocular and systemic diseases. We examined the association of complete blood count with retinal vessel calibers. Methods: Cross-sectional population-based Blue Mountains Eye Study, n = 3009, aged 49+ years. Complete blood count was measured from fasting blood samples taken at baseline examination, 1992-4. Retinal arteriolar and venular calibers were measured from digitized retinal photographs using a validated semi-automated computer program. Results: All analyses adjusted for age, sex, systolic blood pressure, diabetes, smoking and fellow vessel caliber. Higher hematocrit, white cell count and platelet count were associated with narrower arteriolar caliber (p = 0.02, 0.03 and 0.001 respectively), while higher hemoglobin, hematocrit, red cell count, white cell count and platelet count were associated with wider venular caliber (p < 0.0001 for all). Each quintile increase in hematocrit, white cell count and platelet count was associated with approximately 0.5 mu m narrower arteriolar caliber; whereas each quintile increase in all of the complete blood count components was associated with approximately 1-2 mm wider venular caliber. Conclusions: These associations show that elevated levels of hematological indices can have adverse effects on the microcirculation.	[Liew, Gerald; Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Ctr Vis Res, Sydney, NSW, Australia; [Liew, Gerald; Wang, Jie Jin; Wong, Tien Yin] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore, Singapore	University of Sydney; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center	Wang, JJ (corresponding author), Univ Sydney, Ctr Vis Res, Sydney, NSW, Australia.	jiejin_wang@wmi.usyd.edu.au	Wang, Jie Jin/P-1499-2014; Liew, Gerald/AAB-6870-2022; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014	Wang, Jie Jin/0000-0001-9491-4898; Wong, Tien Yin/0000-0002-8448-1264; 	Australian National Health & Medical Research Council (NHMRC) [153948, 211069, 302068]	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the Australian National Health & Medical Research Council (NHMRC, Project grant IDs: 153948, 211069 & 302068). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Cheung ATW, 2002, BLOOD, V99, P3999, DOI 10.1182/blood.V99.11.3999; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; De Jong FJ, 2008, OPHTHALMOLOGY, V115, P887, DOI 10.1016/j.ophtha.2007.06.036; Elkind MSV, 2005, ATHEROSCLEROSIS, V181, P329, DOI 10.1016/j.atherosclerosis.2005.01.013; Elkind MSV, 2002, STROKE, V33, P2587, DOI 10.1161/01.STR.0000034400.71491.10; Gangaputra S, 2012, AM J OPHTHALMOL, V153, P434, DOI 10.1016/j.ajo.2011.08.028; Grunwald JE, 2012, AM J CARDIOL, V110, P246, DOI 10.1016/j.amjcard.2012.03.014; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, DIABETES, V55, P506, DOI 10.2337/diabetes.55.02.06.db05-0546; Ikram MK, 2006, BRAIN, V129, P182, DOI 10.1093/brain/awh688; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Jones JG, 2000, BRIT J ANAESTH, V84, P226, DOI 10.1093/oxfordjournals.bja.a013407; Kifley A, 2008, MICROCIRCULATION, V15, P373, DOI 10.1080/10739680701812220; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Klein BEK, 2011, ARCH OPHTHALMOL-CHIC, V129, P490, DOI 10.1001/archophthalmol.2011.57; Kofoed PK, 2009, INVEST OPHTH VIS SCI, V50, P3960, DOI 10.1167/iovs.08-3217; Li LJ, 2011, INT J PEDIATR OBES, V6, P267, DOI 10.3109/17477166.2011.583657; Liew G, 2012, KIDNEY BLOOD PRESS R, V35, P589, DOI 10.1159/000339173; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Martin-Ventura JL, 2012, THROMB HAEMOSTASIS, V108, P435, DOI 10.1160/TH12-04-0248; MAILATH L, 1976, KLIN MONATSBL AUGENH, V169, P343; Metivier F, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/oxfordjournals.ndt.a027970; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nguyen TT, 2006, TRENDS ENDOCRIN MET, V17, P262, DOI 10.1016/j.tem.2006.07.006; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Nicholson GT, 2011, J PEDIATR-US, V159, P789, DOI 10.1016/j.jpeds.2011.05.013; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Salvi SM, 2005, EYE, V19, P928, DOI 10.1038/sj.eye.6701683; Schiffrin EL, 2012, BASIC CLIN PHARMACOL, V110, P70, DOI 10.1111/j.1742-7843.2011.00760.x; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Stokes KY, 2006, MICROCIRCULATION, V13, P377, DOI 10.1080/10739680600745877; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; TAYLOR GA, 1994, INVEST RADIOL, V29, P188, DOI 10.1097/00004424-199402000-00013; Tedeschi-Reiner E, 2005, AM J CARDIOL, V96, P1107, DOI 10.1016/j.amjcard.2005.05.070; Told R, 2012, EXP EYE RES, V97, P49, DOI 10.1016/j.exer.2012.01.010; Wang JJ, 2004, BRIT J OPHTHALMOL, V88, P104, DOI 10.1136/bjo.88.1.104; Wang L, 2008, HYPERTENSION, V51, P119, DOI 10.1161/HYPERTENSIONAHA.107.098343; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102230	10.1371/journal.pone.0102230	http://dx.doi.org/10.1371/journal.pone.0102230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036459	Green Published, gold			2022-12-27	WOS:000339615200042
J	Liu, K; Lin, XL; Zhou, Q; Ma, T; Han, LY; Mao, GC; Chen, J; Yue, X; Wang, HQ; Zhang, L; Jin, GX; Jiang, JM; Zhao, JS; Zou, BB				Liu, Kui; Lin, Xialu; Zhou, Qi; Ma, Ting; Han, Liyuan; Mao, Guochuan; Chen, Jian; Yue, Xia; Wang, Huiqin; Zhang, Lu; Jin, Guixiu; Jiang, Jianmin; Zhao, Jinshun; Zou, Baobo			The Associations between Two Vital GSTs Genetic Polymorphisms and Lung Cancer Risk in the Chinese Population: Evidence from 71 Studies	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; OXIDATIVE DNA-DAMAGE; POOLED-ANALYSIS; ADJUVANT IMMUNOTHERAPY; SUSCEPTIBILITY; CYP1A1; METAANALYSIS; SMOKING; EPIDEMIOLOGY; GENOTYPES	Background: The genetic polymorphisms of glutathione S-transferase (GSTs) have been suspected to be related to the development of lung cancer while the current results are conflicting, especially in the Chinese population. Methods: Data on genetic polymorphisms of glutathione S-transferase Mu 1 (GSTM1) from 68 studies, glutathione S-transferase theta 1 (GSTT1) from 17 studies and GSTM1-GSTT1 from 8 studies in the Chinese population were reanalyzed on their association with lung cancer risk. Odds ratios (OR) were pooled using forest plots. 9 subgroups were all or partly performed in the subgroup analyses. The Galbraith plot was used to identify the heterogeneous records. Potential publication biases were detected by Begg's and Egger's tests. Results: 71 eligible studies were identified after screening of 1608 articles. The increased association between two vital GSTs genetic polymorphisms and lung cancer risk was detected by random-effects model based on a comparable heterogeneity. Subgroup analysis showed a significant relationship between squamous carcinoma (SC), adenocarcinoma (AC) or small cell lung carcinoma (SCLC) and GSTM1 null genotype, as well as SC or AC and GSTT1 null genotype. Additionally, smokers with GSTM1 null genotype had a higher lung cancer risk than non-smokers. Our cumulative meta-analysis demonstrated a stable and reliable result of the relationship between GSTM1 null genotype and lung cancer risk. After the possible heterogeneous articles were omitted, the adjusted risk of GSTs and lung cancer susceptibility increased (fixed-effects model: ORGSTM1 = 1.23, 95% CI: 1.19 to 1.27, P<0.001; ORGSTT1 = 1.18, 95% CI: 1.10 to 1.26, P<0.001; ORGSTM1-GSTT1 = 1.33, 95% CI: 1.10 to 1.61, P = 0.004). Conclusions: An increased risk of lung cancer with GSTM1 and GSTT1 null genotype, especially with dual null genotype, was found in the Chinese population. In addition, special histopathological classification of lung cancers and a wide range of gene-environment and gene-gene interaction analysis should be taken into consideration in future studies.	[Liu, Kui; Lin, Xialu; Zhou, Qi; Ma, Ting; Han, Liyuan; Mao, Guochuan; Yue, Xia; Wang, Huiqin; Jin, Guixiu; Zhao, Jinshun; Zou, Baobo] Ningbo Univ, Sch Med, Dept Preventat Med, Zhejiang Prov Key Lab Pathol & Physiol Technol, Ningbo 315211, Zhejiang, Peoples R China; [Liu, Kui; Ma, Ting; Jiang, Jianmin] Zhejiang Prov Ctr Dis Control & Prevent, Dept Sci Res & Informat Management, Hangzhou, Zhejiang, Peoples R China; [Mao, Guochuan] Municipal Ctr Dis Prevent & Control Ningbo City, Ningbo, Zhejiang, Peoples R China; [Chen, Jian] Anhui Med Univ, Dept Epidemiol & Hlth Stat, Hefei, Anhui, Peoples R China; [Zhang, Lu] Anhui Med Univ, Sch Hlth Management, Hefei, Anhui, Peoples R China	Ningbo University; Zhejiang Provincial Center for Disease Control & Prevention; Anhui Medical University; Anhui Medical University	Jiang, JM (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Sci Res & Informat Management, Hangzhou, Zhejiang, Peoples R China.	jmjiang@cdc.zj.cn; zhaojinshun@nbu.edu.cn; zoubaobo@nbu.edu.cn	wang, hui/GRS-4730-2022		National Nature Science Foundation of China [81273111]; Foundations of Innovative Research Team of Educational Commission of Zhejiang Province [T200907]; Nature Science Foundation of Ningbo city [2012A610185]; Ningbo Scientific Projects [2012C5019, SZX11073]; Scientific Innovation Team Project of Ningbo [2011B82014]; Innovative Research Team of Ningbo [2009B21002]; K.C. Wong Magna Fund in Ningbo University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of Innovative Research Team of Educational Commission of Zhejiang Province; Nature Science Foundation of Ningbo city; Ningbo Scientific Projects; Scientific Innovation Team Project of Ningbo; Innovative Research Team of Ningbo; K.C. Wong Magna Fund in Ningbo University	This work was supported by the National Nature Science Foundation of China (Grant No. 81273111), the Foundations of Innovative Research Team of Educational Commission of Zhejiang Province (T200907), the Nature Science Foundation of Ningbo city (Grant No. 2012A610185), the Ningbo Scientific Projects (2012C5019 and SZX11073), the Scientific Innovation Team Project of Ningbo (No. 2011B82014), Innovative Research Team of Ningbo (2009B21002), and K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C., 2011, CONT MED, V17, P50; [Anonymous], 2012, AM CANC SOC CANC FAC; [白图雅 BAI Tuya], 2011, [中国公共卫生, China Public Health], V27, P723; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; [曹燕飞 Cao Yanfei], 2004, [生命科学研究, Life science research], V8, P126; Carlsten C, 2008, AM J EPIDEMIOL, V167, P759, DOI 10.1093/aje/kwm383; Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008; Chan-Yeung M, 2004, LUNG CANCER, V45, P155, DOI 10.1016/j.lungcan.2004.01.016; Chang FH, 2009, ACAD J XIAN JIAOTONG, V21, P225; Chang Fuhou, 2006, Zhongguo Fei Ai Za Zhi, V9, P413, DOI 10.3779/j.issn.1009-3419.2006.05.04; Chen Chun-mei, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P23, DOI 10.3760/cma.j.issn.1003-9406.2012.01.007; Chen H., 2008, SHANDONG MED J, V48, P20; Chen HC, 2006, DIS MARKERS, V22, P141, DOI 10.1155/2006/436497; Chen LH, 2003, INT J ADV MANUF TECH, V22, P1, DOI 10.1007/s00170-003-1621-2; Chen Senqing, 2001, Mutation Research, V458, P41, DOI 10.1016/S1383-5726(01)00011-5; [陈思东 Chen Sidong], 2004, [肿瘤, Tumor], V24, P99; Chen SQ, 1999, CARCINOGENESIS TERAT, V11, P119; Cheng YW, 2001, ENVIRON MOL MUTAGEN, V37, P304, DOI 10.1002/em.1037; Cheng YW, 2000, EUR J CANCER, V36, P1381, DOI 10.1016/S0959-8049(00)00131-3; Chou YC, 2005, J MED SCI, V25, P021; de Mello RA, 2013, BIOMED CENTRAL LT S2, pP57; DEJONG JL, 1991, BIOCHEM BIOPH RES CO, V180, P15, DOI 10.1016/S0006-291X(05)81248-3; Dong C. T., 2004, J ENV OCCUP MED, V21, P440; Du GuoBo, 2011, Chinese Clinical Oncology, V16, P602; Ebina T, 2008, LUNG CANCER, V60, P246, DOI 10.1016/j.lungcan.2007.09.016; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan J, 2010, J ONCOLOGY, V16, P922; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; FRYER AA, 1993, BIOCHEM J, V295, P313, DOI 10.1042/bj2950313; Gackowski D, 2003, CANCER RES, V63, P4899; Gao J. R., 1998, CARCINOGENESIS TERAT, V10, P149; Gao Y, 1999, MUTAT RES-GEN TOX EN, V444, P441, DOI 10.1016/S1383-5718(99)00092-3; Ge H, 1996, LUNG CANCER-J IASLC, V15, P355, DOI 10.1016/0169-5002(95)00598-6; Gu Yan-Fei, 2007, Zhonghua Yi Xue Za Zhi, V87, P3064; Gu Yanfei, 2004, Zhongguo Fei Ai Za Zhi, V7, P112, DOI 10.3779/j.issn.1009-3419.2004.02.08; Han R. L., 2012, CENTRAL S PHARM, V10, P1; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; He DX, 2006, CANC RES PREVENTION, V33, P383; He DX, 2006, CANC RES PREVENTION, V33, P308; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hosgood HD, 2007, MUTAT RES-REV MUTAT, V636, P134, DOI 10.1016/j.mrrev.2007.02.002; Hu L, 2012, PHARMACOGENET GENOM, V22, P812, DOI 10.1097/FPC.0b013e328358d92b; Huang X. H., 2004, J PUBLIC HLTH PREV M, V15, P24; Iwai K, 2012, CANCER IMMUNOL IMMUN, V61, P1781, DOI 10.1007/s00262-012-1226-4; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin YT, 2011, CANCER EPIDEMIOL, V35, P182, DOI 10.1016/j.canep.2010.06.004; Jin YT, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-422; KIMURA H, 1995, LUNG CANCER-J IASLC, V13, P31, DOI 10.1016/0169-5002(95)00478-J; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Lam WK, 2004, INT J TUBERC LUNG D, V8, P1045; Lan Q, 1999, Wei Sheng Yan Jiu, V28, P9; Lan Q, 2004, TOXICOLOGY, V198, P301, DOI 10.1016/j.tox.2004.02.006; Lee KM, 2008, CANCER EPIDEM BIOMAR, V17, P1120, DOI 10.1158/1055-9965.EPI-07-2786; Lei M. F., 2007, MODERN PREVENTIVE ME, V34, P724; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Li Dairong, 2005, Zhongguo Fei Ai Za Zhi, V8, P14, DOI 10.3779/j.issn.1009-3419.2005.01.03; Li RM, 2012, CANCER IMMUNOL IMMUN, V61, P2125, DOI 10.1007/s00262-012-1260-2; Li W. Y., 2003, TUBERCULOSIS THORACI, V4, P280; Li WY, 2012, LUNG, V190, P91, DOI 10.1007/s00408-011-9338-8; Li Y., 2011, J CHINESE PRACTICAL, V25, P140; [李英 LI Ying], 2006, [郑州大学学报. 医学版, Journal of Zhengzhou University.Medical Sciences], V41, P1061; [梁戈玉 Liang Geyu], 2004, [遗传, Hereditas(Beijing)], V26, P584; Liu DZ, 2012, CLIN CHIM ACTA, V414, P188, DOI 10.1016/j.cca.2012.09.016; [刘京男 Liu Jingnan], 2012, [基础医学与临床, Basic & Clinical Medicine], V32, P1194; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057043; Liu Q, 2008, SHANDONG MED J, V48, P32; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; London SJ, 2000, LANCET, V356, P724, DOI 10.1016/S0140-6736(00)02631-3; Lu WF, 2002, INT J CANCER, V102, P275, DOI 10.1002/ijc.10712; [罗晨玲 Luo Chenling], 2004, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V31, P1218; Luo CL, 2004, CHINESE J CLIN ONCOL, V31, P1224; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Qi X. S, 2008, CHIN OCCUP MED, V35, P361; Qi XS, 2008, CHINA OCCUPATIONAL M, V35, P367; [钱碧云 Qian BiYun], 2006, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V33, P500; Qiao GB, 2002, ACAD J SUMS, V23, P25; Qu YH, 1998, ZHONGLIU, V18, P80; Raimondi S, 2006, AM J EPIDEMIOL, V164, P1027, DOI 10.1093/aje/kwj321; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sasco AJ, 2004, LUNG CANCER, V45, pS3, DOI 10.1016/j.lungcan.2004.07.998; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Shi XQ, 2008, LUNG CANCER, V59, P155, DOI 10.1016/j.lungcan.2007.08.004; [石云 Shi Yun], 2002, [华中科技大学学报. 医学版, Journal of Huazhong University of Science and Technology], V31, P14; Shukla RK, 2013, ASIAN PAC J CANCER P, V14, P3345, DOI 10.7314/APJCP.2013.14.5.3345; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith G, 1995, CANCER SURV, V25, P27; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Sun G. F., 1995, CHIN J TUBERC RESP D, V18, P167; Sun GF, 1997, CANCER LETT, V113, P169, DOI 10.1016/S0304-3835(97)04612-0; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Tucker ZCG, 2012, CANCER TREAT REV, V38, P650, DOI 10.1016/j.ctrv.2011.11.008; Tyczynski JE, 2003, LANCET ONCOL, V4, P45, DOI 10.1016/S1470-2045(03)00960-4; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Vlastos F, 2013, J CANC THERAPY, V04, P24; Wang J, 2003, THEOR COMPUT SCI, V296, P1, DOI 10.1016/S0304-3975(02)00427-9; Wang JW, 2003, CANCER LETT, V201, P185, DOI 10.1016/S0304-3835(03)00480-4; Wang Na, 2012, Wei Sheng Yan Jiu, V41, P251; [王启明 WANG Qiming], 2006, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V33, P8; Wang YD, 2010, CANCER EPIDEMIOL, V34, P593, DOI 10.1016/j.canep.2010.05.008; Wang Yan-ge, 2007, Journal of Plant Resources and Environment, V16, P1; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675; [夏英 XIA Ying], 2008, [中华放射医学与防护杂志, Chinese Journal of Radiological Medicine and Protection], V28, P327; Xin Y, 2002, J YUNNAN NORMAL U, V22, P52; Yang XHR, 2004, CANCER LETT, V214, P197, DOI 10.1016/j.canlet.2004.06.040; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yao WA, 2006, STRUCT ENG MECH, V22, P1; Yao Z. G., 2012, CHINESE J MED GUIDE, V14, P185; Yao ZG, 2012, CHINESE J MED GUIDE, V14, P188; Ye W. Y., 2004, CHIN J PUBLIC HLTH, V20, P1120; Ye WeiYun, 2005, Acta Nutrimenta Sinica, V27, P17; Ye Z, 2006, PLOS MED, V3, P524, DOI 10.1371/journal.pmed.0030091; Yuan Tianzhu, 2005, Zhongguo Fei Ai Za Zhi, V8, P107, DOI 10.3779/j.issn.1009-3419.2005.02.07; Zhang J. K., 2002, CHINA PUBLIC HLTH, V18, P273; [张吉凯 Zhang Jiakai], 2002, [中国病理生理杂志, Chinese Journal of Pathophysiology], V18, P352; Zhang JF, 2011, ACS CATAL, V1, P32, DOI 10.1021/cs100047p; [章龙珍 Zhang Longzhen], 2002, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V29, P536; Zhao JS, 2005, INT J ONCOL, V27, P247; Zheng Dejie, 2010, Zhongguo Fei Ai Za Zhi, V13, P506, DOI 10.3779/j.issn.1009-3419.2010.05.23; Zhou HF, 2013, MOL BIOL REP, V40, P5713, DOI 10.1007/s11033-013-2674-4; Zhu Xiao-Xia, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P817	128	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102372	10.1371/journal.pone.0102372	http://dx.doi.org/10.1371/journal.pone.0102372			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036724	Green Submitted, gold, Green Published			2022-12-27	WOS:000339615200050
J	Sahin, U; Lapaquette, P; Andrieux, A; Faure, G; Dejean, A				Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Faure, Guilhem; Dejean, Anne			Sumoylation of Human Argonaute 2 at Lysine-402 Regulates Its Stability	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; POSTTRANSLATIONAL MODIFICATIONS; PML DEGRADATION; SMALL RNAS; SUMO; PATHWAY; PROTEINS; PHOSPHORYLATION; BIOGENESIS; CANCER	Gene silencing by small RNAs has emerged as a powerful post-transcriptional regulator of gene expression, however processes underlying regulation of the small RNA pathway in vivo are still largely elusive. Here, we identified sumoylation as a novel post-translational modification acting on Ago2, the main effector of small RNA-mediated gene silencing. We demonstrate that Ago2 can be modified by SUMO1 and SUMO2/3 and identified Lys402 as the major Ago2 sumoylation site in vivo. Ago2 physically interacts with the SUMO E2 conjugating enzyme Ubc9 and the E3 ligase RanBP2 facilitates Ago2 sumoylation in vitro. Mutation of Lys402 enhances the stability of Ago2 protein and impairment of cellular sumoylation by siRNA-or shRNA-mediated extinction of Ubc9 or in Ubc9 knockout mouse tissues results in increased steady-state levels and enhanced stability of Ago2. Similarly, knockdown of RanBP2 or of the SAE2 E1 enzyme enhances Ago2 protein levels. Lys402 is located in the L2g1 loop linking the PAZ and PIWI domains of Ago2, in the immediate vicinity of Tyr393 which can be phosphorylated, implying that the L2g1 linker represents an easily accessible hot spot for post-translational modifications. Altogether, our results show that sumoylation of Ago2 at Lys402 negatively regulates its stability, thereby establishing a first link between SUMO and the small RNA machinery.	[Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Dejean, Anne] Inst Pasteur, Lab Nucl Org & Oncogenesis, Paris, France; [Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Dejean, Anne] Inst Natl Sante & Rech Med, U993, Paris, France; [Sahin, Umut; Lapaquette, Pierre; Andrieux, Alexandra; Dejean, Anne] Equipe Labellise Ligue Natl Contre Canc, Paris, France; [Faure, Guilhem] Univ Paris 06, CNRS, UMR7590, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Sahin, U (corresponding author), Inst Pasteur, Lab Nucl Org & Oncogenesis, Paris, France.	umut.sahin@inserm.fr; anne.dejean@pasteur.fr	Sahin, Umut Kivanc/P-5872-2018; Dejean, Anne/L-5145-2018; Lapaquette, Pierre/AAF-5537-2020; Sahin, Umut/AAO-3948-2020	Sahin, Umut Kivanc/0000-0003-3074-3633; Sahin, Umut/0000-0002-4100-5751; Lapaquette, Pierre/0000-0002-2680-351X; Faure, Guilhem/0000-0001-9537-2277	Ligue Nationale Contre le Cancer (LNCC, Equipe Labellisee); Odyssey-RE; Institut National du Cancer; L'Agence Nationale de la Recherche; European Research Council; LNCC	Ligue Nationale Contre le Cancer (LNCC, Equipe Labellisee); Odyssey-RE; Institut National du Cancer(Institut National du Cancer (INCA) France); L'Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); LNCC	This work was supported by grants from Ligue Nationale Contre le Cancer (LNCC, Equipe Labellisee), Odyssey-RE, Institut National du Cancer, L'Agence Nationale de la Recherche and European Research Council. P.L. was supported by the LNCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gu Shuo, 2010, Silence, V1, P11, DOI 10.1186/1758-907X-1-11; Heo I, 2009, CELL, V139, P28, DOI 10.1016/j.cell.2009.09.013; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Voller D, 2013, BR J CANC; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	39	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102957	10.1371/journal.pone.0102957	http://dx.doi.org/10.1371/journal.pone.0102957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036361	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200103
J	Tabatadze, N; Sato, SM; Woolley, CS				Tabatadze, Nino; Sato, Satoru M.; Woolley, Catherine S.			Quantitative Analysis of Long-Form Aromatase mRNA in the Male and Female Rat Brain	PLOS ONE			English	Article							GENE-EXPRESSION; SYNAPTIC-TRANSMISSION; ADULT MALE; ESTROGEN; ESTRADIOL; CYP19; CYTOCHROME-P450; HIPPOCAMPUS; ANDROGENS; ALPHA	In vitro studies show that estrogens acutely modulate synaptic function in both sexes. These acute effects may be mediated in vivo by estrogens synthesized within the brain, which could fluctuate more rapidly than circulating estrogens. For this to be the case, brain regions that respond acutely to estrogens should be capable of synthesizing them. To investigate this question, we used quantitative real-time PCR to measure expression of mRNA for the estrogen-synthesizing enzyme, aromatase, in different brain regions of male and female rats. Importantly, because brain aromatase exists in two forms, a long form with aromatase activity and a short form with unknown function, we targeted a sequence found exclusively in long-form aromatase. With this approach, we found highest expression of aromatase mRNA in the amygdala followed closely by the bed nucleus of the stria terminalis (BNST) and preoptic area (POA); we found moderate levels of aromatase mRNA in the dorsal hippocampus and cingulate cortex; and aromatase mRNA was detectable in brainstem and cerebellum, but levels were very low. In the amygdala, gonadal/hormonal status regulated aromatase expression in both sexes; in the BNST and POA, castration of males down-regulated aromatase, whereas there was no effect of estradiol in ovariectomized females. In the dorsal hippocampus and cingulate cortex, there were no differences in aromatase levels between males and females or effects of gonadal/hormonal status. These findings demonstrate that long-form aromatase is expressed in brain regions that respond acutely to estrogens, such as the dorsal hippocampus, and that gonadal/hormonal regulation of aromatase differs among different brain regions.	[Tabatadze, Nino; Sato, Satoru M.; Woolley, Catherine S.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Tabatadze, N (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	n-tabatadze@northwestern.edu		Woolley, Catherine/0000-0002-8069-2646	National Institutes of Health (National Institute of Neurological Disorders and Stroke) [NS037324]; National Institute of Mental Health [MH095248]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037324, R29NS037324] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (National Institute of Neurological Disorders and Stroke; http://www.ninds.nih.gov/; NS037324; CSW and National Institute of Mental Health; http://www.nimh.nih.gov/; MH095248; CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELGADIR SE, 1994, ENDOCRINOLOGY, V135, P395, DOI 10.1210/en.135.1.395; Caradec J, 2010, BRIT J CANCER, V103, P1475, DOI 10.1038/sj.bjc.6605851; Enjuanes A, 2003, EUR J ENDOCRINOL, V148, P519, DOI 10.1530/eje.0.1480519; FLORES F, 1973, SCIENCE, V180, P1074, DOI 10.1126/science.180.4090.1074; GERSTENFELD LC, 1985, MOL CELL BIOL, V5, P1425, DOI 10.1128/MCB.5.6.1425; Golovine K, 2003, BIOL REPROD, V68, P978, DOI 10.1095/biolreprod.102.008037; HARADA N, 1990, BIOCHEM BIOPH RES CO, V166, P365, DOI 10.1016/0006-291X(90)91954-Q; HARADA N, 1993, BRAIN RES, V622, P243, DOI 10.1016/0006-8993(93)90825-8; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; HONDA S, 1994, BIOCHEM BIOPH RES CO, V198, P1153, DOI 10.1006/bbrc.1994.1163; Huang GZ, 2012, NEURON, V74, P801, DOI 10.1016/j.neuron.2012.03.035; Iivonen S, 2006, NEUROSCIENCE, V137, P1143, DOI 10.1016/j.neuroscience.2005.10.023; JAKAB RL, 1993, J STEROID BIOCHEM, V44, P481, DOI 10.1016/0960-0760(93)90253-S; Kramar EA, 2009, J NEUROSCI, V29, P12982, DOI 10.1523/JNEUROSCI.3059-09.2009; Lephart ED, 1996, BRAIN RES REV, V22, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEANS GD, 1989, J BIOL CHEM, V264, P19385; NAFTOLIN F, 1972, ENDOCRINOLOGY, V90, P295, DOI 10.1210/endo-90-1-295; Paxinos G, 2004, RAT BRAIN STEROTAXIC; Pietranera L, 2011, NEUROSCIENCE, V174, P151, DOI 10.1016/j.neuroscience.2010.11.044; ROSELLI C E, 1987, Steroids, V50, P495, DOI 10.1016/0039-128X(87)90034-1; ROSELLI CE, 1984, ENDOCRINOLOGY, V114, P192, DOI 10.1210/endo-114-1-192; Roselli CE, 1998, BIOL REPROD, V58, P79, DOI 10.1095/biolreprod58.1.79; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; Sakurada Y, 2006, HISTOCHEM CELL BIOL, V126, P735, DOI 10.1007/s00418-006-0205-2; SANGHERA MK, 1991, ENDOCRINOLOGY, V129, P2834, DOI 10.1210/endo-129-6-2834; SCHUMACHER M, 1987, BRAIN RES, V422, P137, DOI 10.1016/0006-8993(87)90548-8; SELMANOFF MK, 1977, ENDOCRINOLOGY, V101, P841, DOI 10.1210/endo-101-3-841; SHINODA K, 1989, J COMP NEUROL, V290, P502, DOI 10.1002/cne.902900405; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Simpson ER, 1997, FASEB J, V11, P29, DOI 10.1096/fasebj.11.1.9034163; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Sorwell KG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.004; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stoffel-Wagner B, 1998, BIOCHEM BIOPH RES CO, V244, P768, DOI 10.1006/bbrc.1998.8337; Stoffel-Wagner B, 1999, J STEROID BIOCHEM, V70, P237, DOI 10.1016/S0960-0760(99)00114-4; TEYLER TJ, 1980, SCIENCE, V209, P1017, DOI 10.1126/science.7190730; TODA K, 1990, EUR J BIOCHEM, V193, P559, DOI 10.1111/j.1432-1033.1990.tb19372.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; YamadaMouri N, 1997, J STEROID BIOCHEM, V60, P325, DOI 10.1016/S0960-0760(96)00222-1; Zhao CJ, 2007, J COMP NEUROL, V500, P557, DOI 10.1002/cne.21193; Zhu SJ, 2002, J ENDOCRINOL, V172, P31, DOI 10.1677/joe.0.1720031	47	48	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100628	10.1371/journal.pone.0100628	http://dx.doi.org/10.1371/journal.pone.0100628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036039	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200010
J	Upadhyay, RK; Gupta, A; Ranjan, S; Singh, R; Pathre, UV; Nath, P; Sane, AP				Upadhyay, Rakesh Kumar; Gupta, Asmita; Ranjan, Sanjay; Singh, Ruchi; Pathre, Uday V.; Nath, Pravendra; Sane, Aniruddha P.			The EAR Motif Controls the Early Flowering and Senescence Phenotype Mediated by Over-Expression of SlERF36 and Is Partly Responsible for Changes in Stomatal Density and Photosynthesis	PLOS ONE			English	Article							ACTIVE TRANSCRIPTIONAL REPRESSOR; WATER-USE EFFICIENCY; GENOME-WIDE ANALYSIS; DROUGHT TOLERANCE; ETHYLENE BIOSYNTHESIS; CO2 CONCENTRATION; STRESS RESPONSES; GENE-EXPRESSION; ABSCISIC-ACID; SALT STRESS	The EAR motif is a small seven amino acid motif associated with active repression of several target genes. We had previously identified SlERF36 as an EAR motif containing gene from tomato and shown that its over-expression results in early flowering and senescence and a 25-35% reduction of stomatal density, photosynthesis and stomatal conductance in transgenic tobacco. In order to understand the role of the EAR motif in governing the phenotypes, we have expressed the full-length SlERF36 and a truncated form, lacking the EAR motif under the CaMV35S promoter, in transgenic Arabidopsis. Plants over-expressing the full-length SlERF36 show prominent early flowering under long day as well as short day conditions. The early flowering leads to an earlier onset of senescence in these transgenic plants which in turn reduces vegetative growth, affecting rosette, flower and silique sizes. Stomatal number is reduced by 38-39% while photosynthesis and stomatal conductance decrease by about 30-40%. Transgenic plants over-expressing the truncated version of SlERF36 (lacking the C-terminal EAR motif), show phenotypes largely matching the control with normal flowering and senescence indicating that the early flowering and senescence is governed by the EAR motif. On the other hand, photosynthetic rates and stomatal number were also reduced in plants expressing SlERF36DEAR although to a lesser degree compared to the full-length version indicating that these are partly controlled by the EAR motif. These studies show that the major phenotypic changes in plant growth caused by over-expression of SlERF36 are actually mediated by the EAR motif.	[Upadhyay, Rakesh Kumar; Gupta, Asmita; Nath, Pravendra; Sane, Aniruddha P.] Natl Bot Res Inst, CSIR, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India; [Ranjan, Sanjay; Pathre, Uday V.] Natl Bot Res Inst, CSIR, Dept Plant Physiol, Lucknow 226001, Uttar Pradesh, India; [Upadhyay, Rakesh Kumar] USDA ARS, Beltsville Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD 20705 USA; [Upadhyay, Rakesh Kumar] Penn State Univ, Dept Biol, Harrisburg, PA USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Sane, AP (corresponding author), Natl Bot Res Inst, CSIR, Plant Gene Express Lab, Lucknow 226001, Uttar Pradesh, India.	saneanil@rediffmail.com	Upadhyay, Rakesh K./J-3926-2019	Upadhyay, Rakesh K./0000-0001-6742-5853; SINGH, RUCHI/0000-0003-4696-5150	Department of Biotechnology, Government of India [GAP244525]; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by a grant (GAP244525) from the Department of Biotechnology, Government of India, to A. P. S. Senior Research Fellowship was provided by the Council of Scientific and Industrial Research, Government of India, to R. K. U., A. S., R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doheny-Adams T, 2012, PHILOS T R SOC B, V367, P547, DOI 10.1098/rstb.2011.0272; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kagale S, 2011, EPIGENETICS-US, V6, P141, DOI 10.4161/epi.6.2.13627; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Koyama T, 2013, PLANT PHYSIOL, V162, P991, DOI 10.1104/pp.113.218115; Li ZF, 2011, PLANT J, V68, P88, DOI 10.1111/j.1365-313X.2011.04670.x; Lu J, 2011, PLANT J, V68, P583, DOI 10.1111/j.1365-313X.2011.04709.x; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; Ogata T, 2012, J GEN PLANT PATHOL, V78, P8, DOI 10.1007/s10327-011-0355-5; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pan IC, 2010, PLANTA, V232, P1075, DOI 10.1007/s00425-010-1235-5; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Shimada T, 2011, CELL MOL LIFE SCI, V68, P2081, DOI 10.1007/s00018-011-0685-7; Song CP, 2006, PLANT MOL BIOL, V60, P241, DOI 10.1007/s11103-005-3880-9; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Upadhyay RK, 2013, J EXP BOT, V64, P3237, DOI 10.1093/jxb/ert162; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; Woodward FI, 2002, NEW PHYTOL, V153, P477, DOI 10.1046/j.0028-646X.2001.00338.x; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Yoo CY, 2010, PLANT CELL, V22, P4128, DOI 10.1105/tpc.110.078691; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhang HW, 2013, PLANTA, V237, P1443, DOI 10.1007/s00425-013-1852-x	42	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101995	10.1371/journal.pone.0101995	http://dx.doi.org/10.1371/journal.pone.0101995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036097	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200032
J	Wu, MJ; Zhao, YF; Wang, R; Zheng, WX; Guo, XJ; Wu, SQ; Ma, XQ; He, J				Wu, Meijing; Zhao, Yanfang; Wang, Rui; Zheng, Wenxin; Guo, Xiaojing; Wu, Shunquan; Ma, Xiuqiang; He, Jia			Epidemiology of Functional Abdominal Bloating and Its Impact on Health Related Quality of Life: Male-Female Stratified Propensity Score Analysis in a Population Based Survey in Mainland China	PLOS ONE			English	Article							PROSTATE-CANCER OUTCOMES; BOWEL DISORDERS; GASTROINTESTINAL-DISEASES; ASSOCIATIONS; DEPRESSION; PREVALENCE; VALIDATION; SILC	Background: The epidemiology of Functional abdominal bloating (FAB) and its impact on health-related quality of life (HRQoL) in Chinese people remains unclear. Methods: Randomised, stratified, multi-stage sampling methodology was used to select a representative sample of the general population from five cities in China (n = 16,078). All respondents completed the modified Rome II questionnaire; 20% were asked to complete the 36-item Short Form (SF-36). The associated factors of FAB were analyzed. The effects of FAB on HRQoL were estimated with gender stratification using propensity score techniques in 20% subsample. Results: Overall, 643 individuals (4.00%) had FAB and it was more prevalent in males than in females (4.87% vs. 3.04%, P, 0.001). For males, self-reported history of dyspepsia was most strongly associated with FAB (OR = 2.78; 95% CI: 1.59, 4.72). However, the most strongly associated factor was self-reported health status for females (moderate health vs. good health: OR = 2.06, 95% CI: 1.07, 3.96. P = 0.030; poor health vs. good health: OR = 5.71, 95% CI: 2.06, 15.09). Concerning HRQoL, FAB was found to be related to two domains: role limitation due to physical problems (P = 0.030) and bodily pain (P, 0.001) in females. While, in males, there were significant differences in multiple domains between those with and without FAB. Conclusion: The prevalence of FAB in China was lower than previous reports. Males who had ever been diagnosed with dyspepsia and females who were in a poor self-reported health status were correlated with a higher prevalence of FAB. FAB affected only physical health in females, but impaired both physical and mental health in males.	[Wu, Meijing; Zhao, Yanfang; Wang, Rui; Guo, Xiaojing; Wu, Shunquan; Ma, Xiuqiang; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Zheng, Wenxin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA	Naval Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	He, J (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yeah.net	zhao, yan/GWC-9174-2022	He, Jia/0000-0002-2338-9501	key discipline construction of evidence-based public health in Shanghai [12GWZX0602]; National Natural Science Foundation of China [81373105]	key discipline construction of evidence-based public health in Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the key discipline construction of evidence-based public health in Shanghai (no. 12GWZX0602), and the National Natural Science Foundation of China (no. 81373105). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fang H, 2010, NICOTINE TOB RES, V12, P1211, DOI 10.1093/ntr/ntq170; Hansen B, 2009, OPTMATCH FUNCTIONS O; Harder VS, 2008, AM J EPIDEMIOL, V168, P592, DOI 10.1093/aje/kwn184; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; HO D SE, 2011, MATCHIT 2 4 20 NONPA; Hoffman RM, 2006, AM J MED, V119, P418, DOI 10.1016/j.amjmed.2005.06.072; JOHNSEN R, 1986, BRIT MED J, V292, P1633, DOI 10.1136/bmj.292.6536.1633; Kutner NG, 2005, NEPHROL DIAL TRANSPL, V20, P2159, DOI 10.1093/ndt/gfh973; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Nie Y, 2001, FOREIGN MED SCI, V28, P4; Penson DF, 2003, J CLIN ONCOL, V21, P1147, DOI 10.1200/JCO.2003.07.139; Ping L, 2003, PRACTICAL MED, V19, P3; Reeve BB, 2009, JNCI-J NATL CANCER I, V101, P860, DOI 10.1093/jnci/djp123; Ridgeway G MD, 2012, TWANG 1 2 4 TOOLKIT; Schmulson M, 2011, ALIMENT PHARM THER, V33, P1071, DOI 10.1111/j.1365-2036.2011.04637.x; Sullivan Stephen Norman, 2012, ISRN Gastroenterol, V2012, P721820, DOI 10.5402/2012/721820; Thompson WG, 1999, GUT, V45, P43; Tuteja AK, 2008, AM J GASTROENTEROL, V103, P1241, DOI 10.1111/j.1572-0241.2007.01755.x; WALKER EA, 1992, AM J MED, V92, pS26, DOI 10.1016/0002-9343(92)90133-V; Xia J, 2012, J NAVAL GEN HOSP, V23, P3; Yan XY, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-86; Zhang M, 2011, NAUTICAL MED HYPERBA, V18, P4; Zhao YF, 2011, ALIMENT PHARM THER, V34, P1020, DOI 10.1111/j.1365-2036.2011.04809.x	27	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102320	10.1371/journal.pone.0102320	http://dx.doi.org/10.1371/journal.pone.0102320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036100	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200046
J	Bortolamiol, S; Cohen, M; Potts, K; Pennec, F; Rwaburindore, P; Kasenene, J; Seguya, A; Vignaud, Q; Krief, S				Bortolamiol, Sarah; Cohen, Marianne; Potts, Kevin; Pennec, Flora; Rwaburindore, Protase; Kasenene, John; Seguya, Andrew; Vignaud, Quentin; Krief, Sabrina			Suitable Habitats for Endangered Frugivorous Mammals: Small-Scale Comparison, Regeneration Forest and Chimpanzee Density in Kibale National Park, Uganda	PLOS ONE			English	Article							PAN-TROGLODYTES SCHWEINFURTHII; PRIMATE COMMUNITY DYNAMICS; SYMPATRIC LOWLAND GORILLAS; OLD-GROWTH FOREST; BUDONGO-FOREST; ECOLOGICAL CONSTRAINTS; FEMALE CHIMPANZEES; LOPE RESERVE; GROUP-SIZE; DIET	Landscape patterns and chimpanzee (Pan troglodytes schweinfurthii) densities in Kibale National Park show important variation among communities that are geographically close to one another (from 1.5 to 5.1 chimpanzees/km(2)). Anthropogenic activities inside the park (past logging activities, current encroachment) and outside its limits (food and cash crops) may impact the amount and distribution of food resources for chimpanzees (frugivorous species) and their spatial distribution within the park. Spatial and temporal patterns of fruit availability were recorded over 18 months at Sebitoli (a site of intermediate chimpanzee density and higher anthropic pressure) with the aim of understanding the factors explaining chimpanzee density there, in comparison to results from two other sites, also in Kibale: Kanyawara (low chimpanzee density) and Ngogo (high density, and furthest from Sebitoli). Because of the post-logging regenerating status of the forest in Sebitoli and Kanyawara, smaller basal area (BA) of fruiting trees most widely consumed by the chimpanzees in Kanyawara and Sebitoli was expected compared to Ngogo (not logged commercially). Due to the distance between sites, spatial and temporal fruit abundance in Sebitoli was expected to be more similar to Kanyawara than to Ngogo. While species functional classes consumed by Sebitoli chimpanzees (foods eaten during periods of high or low fruit abundance) differ from the two other sites, Sebitoli is very similar to Kanyawara in terms of land-cover and consumed species. Among feeding trees, Ficus species are particularly important resources for chimpanzees at Sebitoli, where their basal area is higher than at Kanywara or Ngogo. Ficus species provided a relatively consistent supply of food for chimpanzees throughout the year, and we suggest that this could help to explain the unusually high density of chimpanzees in such a disturbed site.	[Bortolamiol, Sarah; Cohen, Marianne] Paris Diderot Univ, Sorbonne Paris Cite, Labe Dynam Sociales & Recomposit Espaces, UMR 7533, Paris, France; [Bortolamiol, Sarah; Pennec, Flora; Vignaud, Quentin; Krief, Sabrina] UMR 7206 Ecoanthropol & Ethnobiol MNHN CNRS Paris, Paris, France; [Cohen, Marianne; Vignaud, Quentin] Paris Diderot Univ, Sorbonne Paris Cite, Paris, France; [Potts, Kevin] Augsburg Coll, Dept Biol, Minneapolis, MN USA; [Rwaburindore, Protase; Kasenene, John] Makerere Univ, Dept Bot, Kampala, Uganda; [Bortolamiol, Sarah; Krief, Sabrina] Kibale Natl Pk, Sebitoli UWA Stn, Great Ape Conservat Project PCGS, Ft Portal, Uganda; [Seguya, Andrew] Uganda Wildlife Author, Kampala, Uganda	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Augsburg University; Makerere University	Bortolamiol, S (corresponding author), Paris Diderot Univ, Sorbonne Paris Cite, Labe Dynam Sociales & Recomposit Espaces, UMR 7533, Paris, France.	bortolamiol.sarah@gmail.com	Marianne, Cohen/GPX-5979-2022	Marianne, Cohen/0000-0002-3411-2647	National Museum of Natural History/ATM 16; ANR JC-JC SAFAPE; Projet pour la Conservation des Grands Singes and Societe Francophone de Primatologie	National Museum of Natural History/ATM 16; ANR JC-JC SAFAPE(French National Research Agency (ANR)); Projet pour la Conservation des Grands Singes and Societe Francophone de Primatologie	Field trips have been granted by the National Museum of Natural History/ATM 16, ANR JC-JC SAFAPE, Projet pour la Conservation des Grands Singes and Societe Francophone de Primatologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsler SJ, 2009, THESIS U MICHIGAN AN; Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; [Anonymous], 2001, FORET TROPICALE HUMI; BROWN JH, 1981, AM ZOOL, V21, P877; BUTYNSKI TM, 1990, ECOL MONOGR, V60, P1, DOI 10.2307/1943024; Caldecott JO, 2005, ATLAS MONDIAL GRANDS; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; CANT J G H, 1980, Primates, V21, P538, DOI 10.1007/BF02373842; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Chapman CA, 2000, CONSERV BIOL, V14, P207, DOI 10.1046/j.1523-1739.2000.98592.x; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2005, Tropical Fruits and Frugivores: The Search for Strong Interactors, P75, DOI 10.1007/1-4020-3833-X_5; Chapman CA, 1997, AFR J ECOL, V35, P287, DOI 10.1111/j.1365-2028.1997.083-89083.x; Chapman CA, 1997, BIOTROPICA, V29, P396, DOI 10.1111/j.1744-7429.1997.tb00035.x; Chapman CA, 2000, AM J PRIMATOL, V50, P169, DOI 10.1002/(SICI)1098-2345(200003)50:3&lt;169::AID-AJP1&gt;3.0.CO;2-P; Chapman CA, 2000, INT J PRIMATOL, V21, P565, DOI 10.1023/A:1005557002854; Chapman Colin A., 1994, P41; Chapman CA, 2010, ECOL APPL, V20, P179, DOI 10.1890/09-0128.1; CONKLIN NL, 1994, BIOCHEM SYST ECOL, V22, P137, DOI 10.1016/0305-1978(94)90004-3; *FOOD AGR ORG, 2000, GLOB FOR RES ASS 200; GANZHORN JU, 1995, ECOLOGY, V76, P2084, DOI 10.2307/1941683; Goodall J., 1986, CHIMPANZEES GOMBE PA; Green R.H., 1966, RES POPUL ECOL, V8, P1, DOI [10.1007/BF02524740, DOI 10.1007/BF02524740]; Greig Smith P, 1983, QUANTITATIVE PLANT E; Hartter J.N., 2007, LANDSCAPE CHANGE KIB; Hartter J, 2011, LANDSCAPE ECOL, V26, P877, DOI 10.1007/s10980-011-9616-0; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Hockings KJ, 2011, PRIMATOL MONOGR, P221, DOI 10.1007/978-4-431-53921-6_24; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Janmaat KRL, 2013, ANIM COGN, V16, P851, DOI 10.1007/s10071-013-0617-z; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Kasenene J. M., 1980, THESIS MAKERERE U KA; LEIGHTON M, 1983, P181; Lwanga JS, 2006, PRIMATES, V47, P230, DOI 10.1007/s10329-005-0173-5; Marsh KL, 2003, PRIMATES FRAGMENTS E; Masi S, 2012, PHYSIOL BEHAV, V105, P337, DOI 10.1016/j.physbeh.2011.08.012; Matsumoto-Oda A, 1999, FOLIA PRIMATOL, V70, P154, DOI 10.1159/000021688; Matsumoto-Oda A, 1998, INT J PRIMATOL, V19, P999, DOI 10.1023/A:1020322203166; Mitani JC, 2005, ANIM BEHAV, V70, P1079, DOI 10.1016/j.anbehav.2005.02.012; Mitani JC, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P102, DOI 10.1017/CBO9780511606397.011; Mitani JC, 2000, INT J PRIMATOL, V21, P269, DOI 10.1023/A:1005477504728; Mulley BG, 2004, J ENVIRON MANAGE, V71, P193, DOI 10.1016/j.jenvman.2004.02.002; Narat V, 2012, PRIMATOLOGIE, P4; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; Ohashi G, 2011, PRIMATES, V52, P1, DOI 10.1007/s10329-010-0212-8; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; Osmaston H.A., 1959, WORKING PLAN KIBALE; Pontzer H, 2006, INT J PRIMATOL, V27, P295, DOI 10.1007/s10764-005-9011-2; Potts KB, 2011, INT J PRIMATOL, V32, P669, DOI 10.1007/s10764-011-9494-y; Potts KB, 2011, BIOTROPICA, V43, P256, DOI 10.1111/j.1744-7429.2010.00671.x; Potts KB, 2009, J ANIM ECOL, V78, P1269, DOI 10.1111/j.1365-2656.2009.01578.x; Quiatt D, 2002, AFR J ECOL, V40, P303, DOI 10.1046/j.1365-2028.2002.00356.x; Remis MJ, 2002, INT J PRIMATOL, V23, P231, DOI 10.1023/A:1013837426426; Reynolds V, 1998, OECOLOGIA, V115, P331, DOI 10.1007/s004420050524; Skorupa J.P., 1988, THESIS U CALIFORNIA; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; Struhsaker T.T., 1975, RED COLOBUS MONKEY; STRUHSAKER T. T., 1997, ECOLOGY AFRICAN RAIN; Thompson ME, 2008, AM J PHYS ANTHROPOL, V135, P171, DOI 10.1002/ajpa.20718; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; TUTIN CEG, 1991, PHILOS T ROY SOC B, V334, P179, DOI 10.1098/rstb.1991.0107; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; Tweheyo M, 2003, AFR J ECOL, V41, P306, DOI 10.1111/j.1365-2028.2003.00475.x; Tweheyo M, 2004, FOREST ECOL MANAG, V188, P267, DOI 10.1016/j.foreco.2003.07.028; Uganda Wildlife Authority, 2005, GROUND CENS MAMM KIB; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wanyama F, 2010, AFR J ECOL, V48, P953, DOI 10.1111/j.1365-2028.2009.01197.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wrangham Richard W., 1996, P45, DOI 10.1017/CBO9780511752414.006; Wrangham RW, 2000, PRIMATE MALES, P248; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1993, INT J PRIMATOL, V14, P243, DOI 10.1007/BF02192634; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	74	26	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102177	10.1371/journal.pone.0102177	http://dx.doi.org/10.1371/journal.pone.0102177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033459	gold, Green Published			2022-12-27	WOS:000339418300038
J	Kamath, U; De Jong, K; Shehu, A				Kamath, Uday; De Jong, Kenneth; Shehu, Amarda			Effective Automated Feature Construction and Selection for Classification of Biological Sequences	PLOS ONE			English	Article							FACTOR-BINDING SITES; I-HYPERSENSITIVE SITE; HIDDEN MARKOV-MODELS; GENETIC ALGORITHMS; ACCURATE RECOGNITION; FEATURE GENERATION; NEURAL NETWORK; PREDICTION; IDENTIFICATION; DNA	Background: Many open problems in bioinformatics involve elucidating underlying functional signals in biological sequences. DNA sequences, in particular, are characterized by rich architectures in which functional signals are increasingly found to combine local and distal interactions at the nucleotide level. Problems of interest include detection of regulatory regions, splice sites, exons, hypersensitive sites, and more. These problems naturally lend themselves to formulation as classification problems in machine learning. When classification is based on features extracted from the sequences under investigation, success is critically dependent on the chosen set of features. Methodology: We present an algorithmic framework (EFFECT) for automated detection of functional signals in biological sequences. We focus here on classification problems involving DNA sequences which state-of-the-art work in machine learning shows to be challenging and involve complex combinations of local and distal features. EFFECT uses a two-stage process to first construct a set of candidate sequence-based features and then select a most effective subset for the classification task at hand. Both stages make heavy use of evolutionary algorithms to efficiently guide the search towards informative features capable of discriminating between sequences that contain a particular functional signal and those that do not. Results: To demonstrate its generality, EFFECT is applied to three separate problems of importance in DNA research: the recognition of hypersensitive sites, splice sites, and ALU sites. Comparisons with state-of-the-art algorithms show that the framework is both general and powerful. In addition, a detailed analysis of the constructed features shows that they contain valuable biological information about DNA architecture, allowing biologists and other researchers to directly inspect the features and potentially use the insights obtained to assist wet-laboratory studies on retainment or modification of a specific signal.	[Kamath, Uday; De Jong, Kenneth; Shehu, Amarda] George Mason Univ, Fairfax, VA 22030 USA; [De Jong, Kenneth] George Mason Univ, Krasnow Inst, Fairfax, VA 22030 USA; [Shehu, Amarda] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University	De Jong, K (corresponding author), George Mason Univ, Fairfax, VA 22030 USA.	kdejong@gmu.edu; amarda@gmu.edu		Shehu, Amarda/0000-0001-5230-4610				Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Bajic V, 2006, GENOME BIOL, V489, P457; Barash Y, 2003, RECOMB INT C RES COM, P1; Ben-Gal I, 2005, BIOINFORMATICS, V21, P2657, DOI 10.1093/bioinformatics/bti410; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bernal A, 2003, PLOS COMPUT BIOL, V3, pe54; Bins J, 2000, THESIS COLORADO STAT; Bishop C. M., 2007, BAYESIAN STAT, P3; Bishop Christopher M., 2006, PATTERN RECOGNITION; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; BLUM AL, 1992, NEURAL NETWORKS, V5, P117, DOI 10.1016/S0893-6080(05)80010-3; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BRILL FZ, 1992, IEEE T NEURAL NETWOR, V3, P324, DOI 10.1109/72.125874; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Bystroff Christopher, 2008, V413, P173; Cai DY, 2000, BIOINFORMATICS, V16, P152, DOI 10.1093/bioinformatics/16.2.152; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chuzhanova NA, 1998, BIOINFORMATICS, V14, P139, DOI 10.1093/bioinformatics/14.2.139; Claverie J, NATURE, V752, P752; CLAVERIE JM, 1994, NATURE, V371, P752, DOI 10.1038/371752a0; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cramer NL, 1985, 1 INT C GENETIC ALGO, P183; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Davis RA, 2006, CHEMOMETR INTELL LAB, V81, P50, DOI 10.1016/j.chemolab.2005.09.006; De Jong K. A., 2001, EVOLUTIONARY COMPUTA; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dharmasaroja P., 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P1664, DOI 10.1109/BMEI.2011.6098522; Dogan RI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-410; Dosin CD, 1997, EVOL COMPUT, V5, P1; ENCODE Consortium, 2012, NATURE, V489, P457; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Grau J, 2012, J MACH LEARN RES, V13, P1967; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Habib T, 2008, BMC GENOMICS, V9, pS1; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Huang JJ, 2007, PATTERN RECOGN LETT, V28, P1825, DOI 10.1016/j.patrec.2007.05.011; Hyafil L., 1976, Information Processing Letters, V5, P15, DOI 10.1016/0020-0190(76)90095-8; Islamaj R, 2006, LECT NOTES ARTIF INT, V4213, P553; IUPAC Committee, 1985, BIOCHEMISTRY-US, V229, P75; Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101; Iwamoto S, 2000, J BIOL CHEM, V275, P27324; Jiang B, 2007, BIOINFORMATICS, V23, P2823, DOI 10.1093/bioinformatics/btm473; JURKA J, 1993, NUCLEIC ACIDS RES, V21, P2252, DOI 10.1093/nar/21.9.2252; Kamath U, 2010, P 12 ANN C GEN EV CO, P179; Kamath U, 2010, P INT C BIOINSP MOD, P213; Kamath U, 2010, P IEEE C EV COMP JUL, P1; Kamath U, 2012, IEEE ACM T COMPUT BI, V9, P1387, DOI 10.1109/TCBB.2012.53; Kamath U, 2011, J BIOINF COMPUT BIOL, V9, P399, DOI 10.1142/S0219720011005586; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Keilwagen J, 2010, BMC BIOINFORMATICS, V11, P1; Keilwagen J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001070; Kernytsky A, 2009, PROTEINS, V75, P75, DOI 10.1002/prot.22211; Kim W, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P390; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; Kittler J., 1978, Pattern Recognition and Signal Processing, P41; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Koza J.R., 1992, PROGRAMMING COMPUTER; Kuncheva LI, 1999, PATTERN RECOGN LETT, V20, P1149, DOI 10.1016/S0167-8655(99)00082-3; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEARDI R, 1992, J CHEMOMETR, V6, P267, DOI 10.1002/cem.1180060506; LESLIE C, 2002, P PSB, V7, P566; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; LOWREY CH, 1992, P NATL ACAD SCI USA, V89, P1143, DOI 10.1073/pnas.89.3.1143; Luke S, 2010, ECJ JAV BAS EV COMP; Luque-Escamilla PL, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061925; Majoros WH, 2003, NUCLEIC ACIDS RES, V31, P3601, DOI 10.1093/nar/gkg527; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Muni DP, 2006, IEEE T SYST MAN CY B, V36, P106, DOI 10.1109/TSMCB.2005.854499; Ng AY, 2002, NEURAL INFORM PROCES, P1; Noble W.S., 2004, KERNEL METHODS COMPU, P71; Noble WS, 2005, BIOINFORMATICS, V21, pI338, DOI 10.1093/bioinformatics/bti1047; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Qicheng Ma, 1998, Joint Conference on Intelligent Systems 1999 (JCIS'98), P392; Ramirez R, 2007, LECT NOTES COMPUT SC, V4448, P311; Randou E. G., 2013, 2013 IEEE 3 INT C CO, P1; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rish I, 2001, IJCAI 2001 WORKSH EM, P41; Rish I, 2001, TECHNICAL REPORT; Riviere R, 2008, J DISCRET ALGORITHMS, V6, P192, DOI 10.1016/j.jda.2007.06.001; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Schmidhuber J, 1987, THESIS; Schultheiss SJ, 2010, METHODS MOL BIOL, V674, P213, DOI 10.1007/978-1-60761-854-6_13; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Siedlecki W., 1988, International Journal of Pattern Recognition and Artificial Intelligence, V2, P197, DOI 10.1142/S0218001488000145; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Sinha S, 2002, NUCLEIC ACIDS RES, V30, P5549, DOI 10.1093/nar/gkf669; Smialowski P, 2006, PROTEINS, V62, P343, DOI 10.1002/prot.20789; Smith Stephen Frederick, 1980, LEARNING SYSTEM BASE; Sonnenburg S, 2002, LECT NOTES COMPUT SC, V2415, P329; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Spears WM, 1992, FDN GENETIC ALGORITH, V2, P221; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Taher Leila, 2007, Journal of Physics: Conference Series, V90, DOI 10.1088/1742-6596/90/1/012004; Tech M, 2005, BIOINFORMATICS, V21, P3568, DOI 10.1093/bioinformatics/bti563; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; Veltri D, 2013, INT C BIOINF COMP BI, P1; Venkatraman V, 2004, J CHEM INF COMP SCI, V44, P1686, DOI 10.1021/ci049933v; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xing E. P., 2002, ADV NEURAL INFORM PR, P200; Yakhnenko O., 2005, ICDM IEEE INT C DAT, P1; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu JJ, 2007, NEOPLASIA, V9, P292, DOI 10.1593/neo.07121; Zhang WS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-157; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	120	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e99982	10.1371/journal.pone.0099982	http://dx.doi.org/10.1371/journal.pone.0099982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033270	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300004
J	Ortiz, RH; Maitre, A; Barbeau, D; Lafontaine, M; Bouchard, M				Ortiz, Roberto Heredia; Maitre, Anne; Barbeau, Damien; Lafontaine, Michel; Bouchard, Michele			Use of Physiologically-Based Pharmacokinetic Modeling to Simulate the Profiles of 3-Hydroxybenzo(a) pyrene in Workers Exposed to Polycyclic Aromatic Hydrocarbons	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; URINARY-EXCRETION; PARTITION-COEFFICIENTS; METABOLITES; BENZO(A)PYRENE; 1-HYDROXYPYRENE; RISK; DISPOSITION; BIOMARKER; KINETICS	Biomathematical modeling has become an important tool to assess xenobiotic exposure in humans. In the present study, we have used a human physiologically-based pharmacokinetic (PBPK) model and an simple compartmental toxicokinetic model of benzo(a) pyrene (BaP) kinetics and its 3-hydroxybenzo(a) pyrene (3-OHBaP) metabolite to reproduce the time-course of this biomarker of exposure in the urine of industrially exposed workers and in turn predict the most plausible exposure scenarios. The models were constructed from in vivo experimental data in rats and then extrapolated from animals to humans after assessing and adjusting the most sensitive model parameters as well as species specific physiological parameters. Repeated urinary voids from workers exposed to polycyclic aromatic hydrocarbons (PAHs) have been collected over the course of a typical workweek and during subsequent days off work; urinary concentrations of 3-OHBaP were then determined. Based on the information obtained for each worker (BaP air concentration, daily shift hours, tasks, protective equipment), the time courses of 3-OHBaP in the urine of the different workers have been simulated using the PBPK and toxicokinetic models, considering the various possible exposure routes, oral, dermal and inhalation. Both models were equally able to closely reproduce the observed time course of 3-OHBaP in the urine of workers and predicted similar exposure scenarios. Simulations of various scenarios suggest that the workers under study were exposed mainly by the dermal route. Comparison of measured air concentration levels of BaP with simulated values needed to obtain a good approximation of observed time course further pointed out that inhalation was not the main route of exposure for most of the studied workers. Both kinetic models appear as a useful tool to interpret biomonitoring data of PAH exposure on the basis of 3-OHBaP levels.	[Ortiz, Roberto Heredia; Bouchard, Michele] Univ Montreal, Chaire Anal & Gest Risques Toxicol, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada; [Ortiz, Roberto Heredia; Bouchard, Michele] Univ Montreal, Inst Rech Sante Publ, Montreal, PQ, Canada; [Maitre, Anne; Barbeau, Damien] Univ Grenoble 1, CHU Grenoble, Equipe Environm & Predict Sante Populat, Lab TIMC,UMR 5525, La Tronche, France; [Lafontaine, Michel] Inst Natl Rech & Secur, Vandoeuvre Les Nancy, France	Universite de Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Bouchard, M (corresponding author), Univ Montreal, Chaire Anal & Gest Risques Toxicol, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada.	michele.bouchard@umontreal.ca		Barbeau, Damien/0000-0002-7071-096X	Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES) [2011-CRD-13]; Chair in Toxicological Risk Assessment and Management of the University of Montreal	Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES)(French National Research Agency (ANR)); Chair in Toxicological Risk Assessment and Management of the University of Montreal	This work was supported by the Agence nationale de securite sanitaire de l'alimentation, de l'environnement et du travail (ANSES) [grant number 2011-CRD-13] and the Chair in Toxicological Risk Assessment and Management of the University of Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Barbeau D, 2011, ANALYST, V136, P1183, DOI 10.1039/c0an00428f; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Bouchard M, 2003, TOXICOL SCI, V73, P182, DOI 10.1093/toxsci/kfg061; Bouchard M, 2001, TOXICOL SCI, V64, P169, DOI 10.1093/toxsci/64.2.169; Bouchard M, 1996, TOXICOL APPL PHARM, V139, P301, DOI 10.1006/taap.1996.0169; Bouchard M, 2008, INT ARCH OCC ENV HEA, V81, P355, DOI 10.1007/s00420-007-0220-1; Bouchard M, 2006, ANN OCCUP HYG, V50, P505, DOI [10.1093/annhyg/mel005, 10.1093/annhyg/me1005]; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Campo L, 2010, TOXICOL LETT, V192, P72, DOI 10.1016/j.toxlet.2008.12.018; Cao DX, 2005, J TOXICOL ENV HEAL A, V68, P2227, DOI 10.1080/15287390500182164; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Forster K, 2008, OCCUP ENVIRON MED, V65, P224, DOI 10.1136/oem.2006.030809; Gendre C, 2004, POLYCYCL AROMAT COMP, V24, P433, DOI 10.1080/10406630490468766; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Gundel J, 2000, INT ARCH OCC ENV HEA, V73, P270, DOI 10.1007/s004200050427; Heredia-Ortiz R, 2013, J PHARMACOKINET PHAR, V40, P669, DOI 10.1007/s10928-013-9338-9; Heredia-Ortiz R, 2011, TOXICOL SCI, V122, P275, DOI 10.1093/toxsci/kfr135; Humans I.W.G.o.t.E.o.C.R.t., 2010, IARC MONOGR EVAL CAR, V94, P1; JONGENEELEN FJ, 1986, SCAND J WORK ENV HEA, V12, P137, DOI 10.5271/sjweh.2166; JONGENEELEN FJ, 1987, J CHROMATOGR-BIOMED, V413, P227, DOI 10.1016/0378-4347(87)80230-X; Jongeneelen F, 2012, INT ARCH OCC ENV HEA, V85, P689, DOI 10.1007/s00420-011-0713-9; Lafontaine M, 2004, POLYCYCL AROMAT COMP, V24, P441, DOI 10.1080/10406630490471447; Lafontaine M, 2000, ANN OCCUP HYG, V44, P89, DOI 10.1093/annhyg/44.2.89; Lafontaine M, 2002, POLYCYCL AROMAT COMP, V22, P579, DOI 10.1080/10406630290103753; LIKHACHEV AJ, 1992, ENVIRON HEALTH PERSP, V98, P211, DOI 10.2307/3431273; Lipscomb JC, 2012, ADV EXP MED BIOL, V745, P76, DOI 10.1007/978-1-4614-3055-1_6; Marie C, 2010, J APPL TOXICOL, V30, P402, DOI 10.1002/jat.1511; MORIMOTO Y, 1992, J PHARM PHARMACOL, V44, P634, DOI 10.1111/j.2042-7158.1992.tb05484.x; Payan JP, 2009, ARCH TOXICOL, V83, P873, DOI 10.1007/s00204-009-0440-0; Peters SA, 2011, PHYSIOLOGICALLY BASE, Vxvii; Peyret T, 2010, TOXICOL APPL PHARM, V249, P197, DOI 10.1016/j.taap.2010.09.010; Rey-Salgueiro L, 2008, SCI TOTAL ENVIRON, V406, P279, DOI 10.1016/j.scitotenv.2008.07.059; Saltelli A, 2004, SENSITIVITY ANAL PRA, pxi; Saltelli A, 2008, GLOBAL SENSITIVITY A, px; SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111, DOI 10.1063/1.555833; Scheepers PTJ, 2009, SCAND J WORK ENV HEA, V35, P212, DOI 10.5271/sjweh.1326; Schmitt W, 2008, TOXICOL IN VITRO, V22, P457, DOI 10.1016/j.tiv.2007.09.010; Scientific Committee on Food, 2002, POL AR HYDR OCC FOOD; Simon P, 2000, J CHROMATOGR B, V748, P337, DOI 10.1016/S0378-4347(00)00350-9; WEYAND EH, 1986, CANCER RES, V46, P5655	41	11	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102570	10.1371/journal.pone.0102570	http://dx.doi.org/10.1371/journal.pone.0102570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032692	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300063
J	Mantella, NM; Youngentob, SL				Mantella, Nicole M.; Youngentob, Steven L.			Prenatal Alcohol Exposure Increases Postnatal Acceptability of Nicotine Odor and Taste in Adolescent Rats	PLOS ONE			English	Article							GESTATIONAL ETHANOL EXPOSURE; NEUROPHYSIOLOGIC OLFACTORY RESPONSE; SOLITARY CHEMOSENSORY CELLS; FETAL-ETHANOL; RECEPTOR; SMOKING; SENSITIVITY; TOBACCO; EXPRESSION; DESENSITIZATION	Human studies indicate that alcohol exposure during gestation not only increases the chance for later alcohol abuse, but also nicotine dependence. The flavor attributes of both alcohol and nicotine can be important determinants of their initial acceptance and they both share the component chemosensory qualities of an aversive odor, bitter taste and oral irritation. There is a growing body of evidence demonstrating epigenetic chemosensory mechanisms through which fetal alcohol exposure increases adolescent alcohol acceptance, in part, by decreasing the aversion to alcohol's bitter and oral irritation qualities, as well as its odor. Given that alcohol and nicotine have noteworthy chemosensory qualities in common, we investigated whether fetal exposure to alcohol increased the acceptability of nicotine's odor and taste in adolescent rats. Study rats were alcohol-exposed during fetal development via the dams' liquid diet. Control animals received ad lib access to an iso-caloric, iso-nutritive diet throughout gestation. Odorant-induced innate behavioral responses to nicotine odor (Experiment 1) or orosensory-mediated responses to nicotine solutions (Experiment 2) were obtained, using whole-body plethysmography and brief access lick tests, respectively. Compared to controls, rats exposed to fetal alcohol showed an enhanced nicotine odor response that was paralleled by increased oral acceptability of nicotine. Given the common aversive component qualities imbued in the flavor profiles of both drugs, our findings demonstrate that like postnatal alcohol avidity, fetal alcohol exposure also influences nicotine acceptance, at a minimum, by decreasing the aversion of both its smell and taste. Moreover, they highlight potential chemosensory-based mechanism(s) by which fetal alcohol exposure increases the later initial risk for nicotine use, thereby contributing to the co-morbid expression with enhanced alcohol avidity. Where common chemosensory mechanisms are at play, our results suggest broader implications related to the consequence of fetal exposure with one substance of abuse and initial acceptability of others.	[Mantella, Nicole M.; Youngentob, Steven L.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Youngentob, Steven L.] SUNY Syracuse, Dev Exposure Alcohol Res Ctr, Syracuse, NY USA; [Youngentob, Steven L.] SUNY Binghamton, Dev Exposure Alcohol Res Ctr, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Youngentob, SL (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.	youngens@upstate.edu			NIH-NIDA [1R21DA027740-01]; NIH-NIAAA [AA014871, AA017823]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017823, R01AA014871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027740] Funding Source: NIH RePORTER	NIH-NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH-NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH-NIDA Grant # 1R21DA027740-01 and NIH-NIAAA Grants AA014871 and AA017823 to S.L. Youngentob. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlaouiIsmaili O, 1997, CHEM SENSES, V22, P237, DOI 10.1093/chemse/22.3.237; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; Bachmanov AA, 2003, ALCOHOL CLIN EXP RES, V27, P220, DOI 10.1097/01.ALC.0000051021.99641.19; Baer JS, 1998, J STUD ALCOHOL, V59, P533, DOI 10.15288/jsa.1998.59.533; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; BATEL P, 1995, ADDICTION, V90, P977, DOI 10.1111/j.1360-0443.1995.tb03507.x; BECKER HC, 1995, NEUROTOXICOL TERATOL, V17, P57, DOI 10.1016/0892-0362(94)00055-I; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Bobo JK, 2000, ALCOHOL RES HEALTH, V24, P225; BRESLAU N, 1995, BEHAV GENET, V25, P95, DOI 10.1007/BF02196920; Bryant B, 2010, ACS CHEM NEUROSCI, V1, P246, DOI 10.1021/cn900042c; CAIN WS, 1980, NATURE, V284, P255, DOI 10.1038/284255a0; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Carstens E, 2007, CHEM SENSES, V32, P811, DOI 10.1093/chemse/bjm048; Chotro MG, 2003, ALCOHOL, V30, P19, DOI 10.1016/S0741-8329(03)00037-5; Collins AC, 1996, ALCOHOL CLIN EXP RES, V20, P990, DOI 10.1111/j.1530-0277.1996.tb01936.x; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dessirier JM, 1999, CHEM SENSES, V24, P405, DOI 10.1093/chemse/24.4.405; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; Doyon WM, 2013, BIOCHEM PHARMACOL, V86, P1181, DOI 10.1016/j.bcp.2013.07.007; DRISCOLL CD, 1990, NEUROTOXICOL TERATOL, V12, P231, DOI 10.1016/0892-0362(90)90094-S; Eade AM, 2010, ALCOHOL CLIN EXP RES, V34, P206, DOI 10.1111/j.1530-0277.2009.01083.x; Eade AM, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-3; EDWARDS DA, 1987, EXPERIENTIA, V43, P868, DOI 10.1007/BF01951644; Ellingson J, 2009, BEHAV GENET, V39, P62, DOI 10.1007/s10519-008-9232-1; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Fertig JB, 2002, ALCOHOL CLIN EXP RES, V26, P1909, DOI 10.1097/01.ALC.0000040845.55554.69; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Glendinning JI, 2012, EXP BIOL MED, V237, P236, DOI 10.1258/ebm.2011.011345; GULLIVER SB, 1995, J STUD ALCOHOL, V56, P202, DOI 10.15288/jsa.1995.56.202; Hannigan JH, 1999, ALCOHOL ALCOHOLISM E; HILL DL, 1987, J NEUROPHYSIOL, V57, P481, DOI 10.1152/jn.1987.57.2.481; HILL DL, 1988, SCIENCE, V241, P1826, DOI 10.1126/science.3175625; HILL DL, 1986, BEHAV NEUROSCI, V100, P390, DOI 10.1037/0735-7044.100.3.390; Hill DL, 2004, NUTR REV, V62, pS208, DOI 10.1111/j.1753-4887.2004.tb00101.x; Hudson R, 1998, ANN NY ACAD SCI, V855, P109, DOI 10.1111/j.1749-6632.1998.tb10552.x; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; HUMMEL T, 1992, CHEM SENSES, V17, P13, DOI 10.1093/chemse/17.1.13; Istavan J, 1984, PSYCH B, V95; Jackson KM, 2002, ADDICTION, V97, P517, DOI 10.1046/j.1360-0443.2002.00082.x; KAPLAN AR, 1964, NATURE, V202, P1366, DOI 10.1038/2021366a0; Kichko TI, 2013, J PHARMACOL EXP THER, V347, P529, DOI 10.1124/jpet.113.205971; Kim U, 2003, SCIENCE, V229; Larsson A, 2005, ALCOHOL ALCOHOLISM, V40, P349, DOI 10.1093/alcalc/agh180; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2002, ALCOHOL, V28, P157, DOI 10.1016/S0741-8329(02)00244-6; LICHTENSTEIGER W, 1988, PROG BRAIN RES, V73, P137, DOI 10.1016/S0079-6123(08)60502-6; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Mantella NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084989; Middleton FA, 2009, BRAIN RES, V1252, P105, DOI 10.1016/j.brainres.2008.11.023; MILLER MW, 1992, BRAIN RES, V595, P17, DOI 10.1016/0006-8993(92)91447-M; MILLER MW, 1987, J COMP NEUROL, V257, P372, DOI 10.1002/cne.902570306; Muneoka K, 1999, NEUROTOXICOL TERATOL, V21, P603, DOI 10.1016/S0892-0362(99)00028-8; OLEY N, 1975, J COMP PHYSIOL PSYCH, V88, P477, DOI 10.1037/h0076401; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Pfinder M, 2014, ALCOHOL ALCOHOLISM, V49, P143, DOI 10.1093/alcalc/agt166; Prestia LT, 2013, ALCOHOL CLIN EXP RES, V37, p64A; Prestia LT, 2011, ALCOHOL CLIN EXP RES, V35, p259A; Pritchard WS, 1996, PSYCHOPHARMACOLOGY, V127, P55, DOI 10.1007/BF02805975; ROSE JE, 1985, PHARMACOL BIOCHEM BE, V23, P289, DOI 10.1016/0091-3057(85)90572-6; San-Emeterio EP, 2006, NEUROSCI LETT, V403, P276, DOI 10.1016/j.neulet.2006.04.053; Saunders C J, 2013, F1000Res, V2, P74, DOI 10.12688/f1000research.2-74.v1; SEMKE E, 1995, NATURWISSENSCHAFTEN, V82, P148; Silver WL, 2006, CHEM SENSES, V31, P807, DOI 10.1093/chemse/bjl022; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; Snedecor SM, 2006, ADDICT BEHAV, V31, P2309, DOI 10.1016/j.addbeh.2006.02.016; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002; Streissguth AP, 1998, ALCOHOL CLIN EXP RES, V22, P325, DOI 10.1111/j.1530-0277.1998.tb03656.x; Substance Abuse and Mental Health Services Administration (SAMHSA), 2013, HHS PUBL; Thuerauf N, 2006, NEUROPSYCHOPHARMACOL, V31, P450, DOI 10.1038/sj.npp.1300842; Thuerauf N, 2000, J CLIN PSYCHOPHARM, V20, P472, DOI 10.1097/00004714-200008000-00012; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; US Department of Health and Human Services, 2007, ALCOHOL ALERT 71, V71, P1; VAVROUSEKJAKUBA EM, 1991, ALCOHOL CLIN EXP RES, V15, P129, DOI 10.1111/j.1530-0277.1991.tb00530.x; Walker JC, 1996, DRUG DEVELOP RES, V38, P160, DOI 10.1002/(SICI)1098-2299(199607/08)38:3/4<160::AID-DDR4>3.0.CO;2-K; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P668, DOI 10.2105/AJPH.74.7.668; Yamaguchi K, 1984, AM J PUB HLTH, V74; Yates WR, 1998, ALCOHOL ALCOHOLISM, V33, P488, DOI 10.1093/alcalc/33.5.488; Yates WR, 1998, ALCOHOL CLIN EXP RES, V22, P914, DOI 10.1111/j.1530-0277.1998.tb03889.x; Youngentob SL, 2005, CHEM SENSES, V30, P219, DOI 10.1093/chemse/bji017; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1293, DOI 10.1037/0735-7044.121.6.1293; Youngentob SL, 2007, BEHAV NEUROSCI, V121, P1306, DOI 10.1037/0735-7044.121.6.1306; Youngentob SL, 2012, EXP BIOL MED, V237, P1197, DOI 10.1258/ebm.2012.012132; Youngentob SL, 2009, P NATL ACAD SCI USA, V106, P5359, DOI 10.1073/pnas.0809804106; Zacny JP, 1990, BEHAV ASPECTS ALCOHO	90	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102255	10.1371/journal.pone.0102255	http://dx.doi.org/10.1371/journal.pone.0102255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029285	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600052
J	Paul, MC; Gilbert, M; Desvaux, S; Andriamanivo, HR; Peyre, M; Khong, NV; Thanapongtharm, W; Chevalier, V				Paul, Mathilde C.; Gilbert, Marius; Desvaux, Stephanie; Andriamanivo, Harena Rasamoelina; Peyre, Marisa; Nguyen Viet Khong; Thanapongtharm, Weerapong; Chevalier, Veronique			Agro-Environmental Determinants of Avian Influenza Circulation: A Multisite Study in Thailand, Vietnam and Madagascar	PLOS ONE			English	Article							RISK-FACTORS; SOUTHEAST-ASIA; HPAI H5N1; VIRUS; INFECTION; OUTBREAKS; DUCKS; PATTERNS; BACKYARD; CLUSTERS	Outbreaks of highly pathogenic avian influenza have occurred and have been studied in a variety of ecological systems. However, differences in the spatial resolution, geographical extent, units of analysis and risk factors examined in these studies prevent their quantitative comparison. This study aimed to develop a high-resolution, comparative study of a common set of agro-environmental determinants of avian influenza viruses (AIV) in domestic poultry in four different environments: (1) lower-Northern Thailand, where H5N1 circulated in 2004-2005, (2) the Red River Delta in Vietnam, where H5N1 is circulating widely, (3) the Vietnam highlands, where sporadic H5N1 outbreaks have occurred, and (4) the Lake Alaotra region in Madagascar, which features remarkable similarities with Asian agro-ecosystems and where low pathogenic avian influenza viruses have been found. We analyzed H5N1 outbreak data in Thailand in parallel with serological data collected on the H5 subtype in Vietnam and on low pathogenic AIV in Madagascar. Several agro-environmental covariates were examined: poultry densities, landscape dominated by rice cultivation, proximity to a water body or major road, and human population density. Relationships between covariates and AIV circulation were explored using spatial generalized linear models. We found that AIV prevalence was negatively associated with distance to the closest water body in the Red River Delta, Vietnam highlands and Madagascar. We also found a positive association between AIV and duck density in the Vietnam highlands and Thailand, and with rice landscapes in Thailand and Madagascar. Our findings confirm the important role of wetlands-rice-ducks ecosystems in the epidemiology of AI in diverse settings. Variables influencing circulation of the H5 subtype in Southeast Asia played a similar role for low pathogenic AIV in Madagascar, indicating that this area may be at risk if a highly virulent strain is introduced.	[Paul, Mathilde C.; Desvaux, Stephanie; Peyre, Marisa; Chevalier, Veronique] UR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France; [Paul, Mathilde C.] Univ Toulouse, INP ENVT, UMR ENVT INRA IHAP 1225, Toulouse, France; [Gilbert, Marius] Univ Libre Bruxelles, Brussels, Belgium; [Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Desvaux, Stephanie] Direct Reg Alimentat Agr & Foret Languedoc Roussi, Montpellier, France; [Andriamanivo, Harena Rasamoelina] FOFIFA DRZV, Antananarivo, Madagascar; [Andriamanivo, Harena Rasamoelina] Fac Med Antananarivo, Dept Vet, Antananarivo, Madagascar; [Nguyen Viet Khong] Natl Inst Vet Res, Hanoi, Vietnam; [Thanapongtharm, Weerapong] Dept Livestock Dev, Bangkok, Thailand	CIRAD; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS	Paul, MC (corresponding author), UR AGIRs, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France.	m.paul@envt.fr		Gilbert, Marius/0000-0003-3708-3359; Peyre, Marisa/0000-0002-0887-3418; PAUL, Mathilde C./0000-0003-2940-8547; Thanapongtharm, Weerapong/0000-0002-9957-2011	French Ministry of Foreign and European Affairs; French Research Agency project EcoFlu [ANR-06-SEST-12]; French-Thai PHC program	French Ministry of Foreign and European Affairs; French Research Agency project EcoFlu; French-Thai PHC program	This work was part of the FSP GRIPAVI project and was funded by the French Ministry of Foreign and European Affairs. The authors thank the French Research Agency project EcoFlu (ANR-06-SEST-12) and the French-Thai PHC program which provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Andriamanivo HR, 2012, PREV VET MED, V104, P114, DOI 10.1016/j.prevetmed.2011.10.008; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Cecchi G, 2008, GEOSPATIAL HEALTH, V3, P7, DOI 10.4081/gh.2008.227; Chaichoune K, 2009, J GEN VIROL, V90, P216, DOI 10.1099/vir.0.005660-0; Claes G, 2013, EPIDEMIOLOGY INFECT, P1; De Visscher M-N, 2013, EMPRES ANIMAL HLTH, V360, P26; Desvaux S, 2013, EPIDEMIOL INFECT, V141, P776, DOI 10.1017/S0950268812001628; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; Desvaux S, 2012, EPIDEMIOLOGY HIGHLY; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2011, ECOHEALTH, P1; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Goutard FL, 2012, PREV VET MED, V105, P223, DOI 10.1016/j.prevetmed.2011.12.020; Guerrini L, 2014, GEOSPATIAL HEALTH, V8, P445, DOI 10.4081/gh.2014.33; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Hogerwerf L, 2010, ECOHEALTH; International B, 2012, IMP BIRD AR FACTSH L; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Leo L, 2011, PREV VET MED, V102, P50, DOI 10.1016/j.prevetmed.2011.06.006; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Morens D. M., 2013, MBIO, V4; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Paul M, 2011, ACTA TROP, V118, P209, DOI 10.1016/j.actatropica.2011.03.009; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Souris M, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-3; Thanapongtharm W, 2013, GEOSPATIAL HEALTH, V8, P193, DOI 10.4081/gh.2013.66; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; Tombari W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053524; Tran A, 2010, INT J APPL EARTH OBS, V12, P1, DOI 10.1016/j.jag.2009.09.014; Tran CC, 2013, ISPRS INT J GEO-INF, V2, P1106, DOI 10.3390/ijgi2041106; Trevennec K, 2011, ACTA TROP, V120, P160, DOI 10.1016/j.actatropica.2011.07.010; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Wang LY, 2013, EMERG INFECT DIS, V19, P1898, DOI 10.3201/eid1911.130815; Ward M, 2008, ENV ANTHROPOGENIC RI; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; World Health Organization (WHO), 2014, 10 WHO; Xiao XM, 2006, REMOTE SENS ENVIRON, V100, P95, DOI 10.1016/j.rse.2005.10.004	46	13	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101958	10.1371/journal.pone.0101958	http://dx.doi.org/10.1371/journal.pone.0101958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029441	Green Submitted, gold, Green Published			2022-12-27	WOS:000341306600029
J	Bennett, GR; Peters, R; Wang, XH; Hanne, J; Sobol, RW; Bundschuh, R; Fishel, R; Yoder, KE				Bennett, Geoffrey R.; Peters, Ryan; Wang, Xiao-hong; Hanne, Jeungphill; Sobol, Robert W.; Bundschuh, Ralf; Fishel, Richard; Yoder, Kristine E.			Repair of Oxidative DNA Base Damage in the Host Genome Influences the HIV Integration Site Sequence Preference	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSCRIPTIONAL COACTIVATOR LEDGF/P75; HUMAN-CELLS; POLYMERASE-BETA; PWWP DOMAIN; IN-VITRO; CHROMATIN-BINDING; STRUCTURAL BASIS; MAMMALIAN-CELLS; GAPPED DNA	Host base excision repair (BER) proteins that repair oxidative damage enhance HIV infection. These proteins include the oxidative DNA damage glycosylases 8-oxo-guanine DNA glycosylase (OGG1) and mutY homolog (MYH) as well as DNA polymerase beta (Pol beta). While deletion of oxidative BER genes leads to decreased HIV infection and integration efficiency, the mechanism remains unknown. One hypothesis is that BER proteins repair the DNA gapped integration intermediate. An alternative hypothesis considers that the most common oxidative DNA base damages occur on guanines. The subtle consensus sequence preference at HIV integration sites includes multiple G: C base pairs surrounding the points of joining. These observations suggest a role for oxidative BER during integration targeting at the nucleotide level. We examined the hypothesis that BER repairs a gapped integration intermediate by measuring HIV infection efficiency in Pol beta null cell lines complemented with active site point mutants of Pol beta. A DNA synthesis defective mutant, but not a 59dRP lyase mutant, rescued HIV infection efficiency to wild type levels; this suggeted Pol beta DNA synthesis activity is not necessary while 59dRP lyase activity is required for efficient HIV infection. An alternate hypothesis that BER events in the host genome influence HIV integration site selection was examined by sequencing integration sites in OGG1 and MYH null cells. In the absence of these 8-oxo-guanine specific glycosylases the chromatin elements of HIV integration site selection remain the same as in wild type cells. However, the HIV integration site sequence preference at G: C base pairs is altered at several positions in OGG1 and MYH null cells. Inefficient HIV infection in the absence of oxidative BER proteins does not appear related to repair of the gapped integration intermediate; instead oxidative damage repair may participate in HIV integration site preference at the sequence level.	[Bennett, Geoffrey R.; Peters, Ryan; Hanne, Jeungphill; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Bennett, Geoffrey R.; Peters, Ryan; Hanne, Jeungphill; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Sobol, Robert W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Xiao-hong; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA USA; [Sobol, Robert W.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Bundschuh, Ralf; Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Internal Med, Dept Chem & Biochem, Div Hematol,Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yoder, KE (corresponding author), Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA.	kristine.yoder@osumc.edu	wang, xiao/HGB-7081-2022; Yoder, Kristine/E-4353-2011; Bundschuh, Ralf A/B-9623-2008; Sobol, Robert W./E-4125-2013	wang, xiao/0000-0002-4088-3341; Yoder, Kristine/0000-0002-5598-9018; Bundschuh, Ralf A/0000-0002-6699-8614; Sobol, Robert W./0000-0001-7385-3563	National Cancer Institute [CA148629]; National Institute of Allergy and Infectious Diseases Extramural Activities [AI82422, AI99854]; National Science Foundation Division of Materials Research [DMR-01105458]; NATIONAL CANCER INSTITUTE [R01CA148629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099854, R21AI082422] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1105458] Funding Source: National Science Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases Extramural Activities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation Division of Materials Research(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The following National Institutes of Health grants supported this work: National Cancer Institute (www.cancer.gov) grant CA148629 to RWS, and National Institute of Allergy and Infectious Diseases Extramural Activities (www.niaid.nih.gov) grants AI82422 and AI99854 were both awarded to co-investigators KEY and RF. A National Science Foundation Division of Materials Research (http://www.nsf.gov/div/index.jsp?div=DMR) grant DMR-01105458 supported RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SD, 2005, J VIROL, V79, P12035, DOI 10.1128/JVI.79.18.12035-12044.2005; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; BOR YC, 1995, P NATL ACAD SCI USA, V92, P10334, DOI 10.1073/pnas.92.22.10334; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2011, METHODS, V53, P39, DOI 10.1016/j.ymeth.2010.04.004; Coffin J, 1997, RETROVIRUSES; Crise B, 2005, J VIROL, V79, P12199, DOI 10.1128/JVI.79.19.12199-12204.2005; DIZDAROGLU M, 1991, ARCH BIOCHEM BIOPHYS, V285, P388, DOI 10.1016/0003-9861(91)90378-V; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Espeseth AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017612; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Gijsbers R, 2011, J BIOL CHEM, V286, P41812, DOI 10.1074/jbc.M111.255711; Guo H, 2003, P NATL ACAD SCI USA, V100, P3743, DOI 10.1073/pnas.0737062100; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maillot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060734; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; McNeely M, 2011, J MOL BIOL, V410, P811, DOI 10.1016/j.jmb.2011.03.073; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; MILLS JB, 1994, BIOCHEMISTRY-US, V33, P1797, DOI 10.1021/bi00173a024; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Prasad R, 2005, DNA REPAIR, V4, P1347, DOI 10.1016/j.dnarep.2005.08.009; Roll C, 1998, BIOCHEMISTRY-US, V37, P4059, DOI 10.1021/bi972377w; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Schrijvers R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-84; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Sobol RW, 2012, CHEM BIOL, V19, P313, DOI 10.1016/j.chembiol.2012.03.002; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Yoder KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017862; ZMUDZKA BZ, 1988, NUCLEIC ACIDS RES, V16, P9587, DOI 10.1093/nar/16.20.9587	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103164	10.1371/journal.pone.0103164	http://dx.doi.org/10.1371/journal.pone.0103164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051054	gold, Green Published			2022-12-27	WOS:000339551100093
J	Franco, AO; Gomes, MGM; Rowland, M; Coleman, PG; Davies, CR				Franco, Ana O.; Gomes, M. Gabriela M.; Rowland, Mark; Coleman, Paul G.; Davies, Clive R.			Controlling Malaria Using Livestock-Based Interventions: A One Health Approach	PLOS ONE			English	Article							PYRETHROID-IMPREGNATED BEDNETS; ANOPHELES-GAMBIAE COMPLEX; TSETSE-FLIES GLOSSINA; RISK-FACTORS; PLASMODIUM-FALCIPARUM; FEEDING-BEHAVIOR; CATTLE OWNERSHIP; PUNJAB PROVINCE; BITING BEHAVIOR; TREATED CATTLE	Where malaria is transmitted by zoophilic vectors, two types of malaria control strategies have been proposed based on animals: using livestock to divert vector biting from people (zooprophylaxis) or as baits to attract vectors to insecticide sources (insecticide-treated livestock). Opposing findings have been obtained on malaria zooprophylaxis, and despite the success of an insecticide-treated livestock trial in Pakistan, where malaria vectors are highly zoophilic, its effectiveness is yet to be formally tested in Africa where vectors are more anthropophilic. This study aims to clarify the different effects of livestock on malaria and to understand under what circumstances livestock-based interventions could play a role in malaria control programmes. This was explored by developing a mathematical model and combining it with data from Pakistan and Ethiopia. Consistent with previous work, a zooprophylactic effect of untreated livestock is predicted in two situations: if vector population density does not increase with livestock introduction, or if livestock numbers and availability to vectors are sufficiently high such that the increase in vector density is counteracted by the diversion of bites from humans to animals. Although, as expected, insecticide-treatment of livestock is predicted to be more beneficial in settings with highly zoophilic vectors, like South Asia, we find that the intervention could also considerably decrease malaria transmission in regions with more anthropophilic vectors, like Anopheles arabiensis in Africa, under specific circumstances: high treatment coverage of the livestock population, using a product with stronger or longer lasting insecticidal effect than in the Pakistan trial, and with small (ideally null) repellency effect, or if increasing the attractiveness of treated livestock to malaria vectors. The results suggest these are the most appropriate conditions for field testing insecticide-treated livestock in an Africa region with moderately zoophilic vectors, where this intervention could contribute to the integrated control of malaria and livestock diseases.	[Franco, Ana O.; Gomes, M. Gabriela M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Franco, Ana O.; Rowland, Mark; Coleman, Paul G.; Davies, Clive R.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Instituto Gulbenkian de Ciencia; University of London; London School of Hygiene & Tropical Medicine	Franco, AO (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	afranco@igc.gulbenkian.pt	Gomes, Gabriela/H-7218-2014	Gomes, Gabriela/0000-0002-1454-4979; de Oliveira Franco, Ana Isabel/0000-0002-9195-965X	Portuguese Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/9605/2002]; Fundo Social Europeu (FSE); EPIWORK - European Commission [231807]; London School of Hygiene and Tropical Medicine; Programa Operacional Ciencia e Inovacao (POCI)	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fundo Social Europeu (FSE)(European Social Fund (ESF)); EPIWORK - European Commission; London School of Hygiene and Tropical Medicine; Programa Operacional Ciencia e Inovacao (POCI)(Portuguese Foundation for Science and Technology)	Ana O. Franco was funded by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT - SFRH/BD/9605/2002), co-financed by the Programa Operacional Ciencia e Inovacao 2010 (POCI 2010) and Fundo Social Europeu (FSE), and by EPIWORK - European Commission (Grant Agreement 231807). The publication fees were paid by the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 1990, ENV HLTH CRIT 101 ME; [Anonymous], 1993, MOSQUITO ECOLOGY FIE; [Anonymous], 1968, PUBLICATIONS S AFRIC; Bardosh K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-204; Bekele J, 2010, VET PARASITOL, V168, P177, DOI 10.1016/j.vetpar.2009.11.028; Bettini S., 1998, Parassitologia (Rome), V40, P423; BEUGNET F, 1995, VET PARASITOL, V56, P325, DOI 10.1016/0304-4017(94)00686-7; Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; Brumpt E, 1944, ANN PARASITOLOGIE HU, V20; BURKOT TR, 1989, AM J TROP MED HYG, V40, P229, DOI 10.4269/ajtmh.1989.40.229; CHANIOTIS BN, 1983, J MED ENTOMOL, V20, P222, DOI 10.1093/jmedent/20.2.222; Chareonviriyaphap T, 2012, BEHAV RESPONSES MOSQ; Charlwood JD, 1996, J MED ENTOMOL, V33, P202, DOI 10.1093/jmedent/33.2.202; CHARLWOOD JD, 1987, MED VET ENTOMOL, V1, P319, DOI 10.1111/j.1365-2915.1987.tb00361.x; CHARLWOOD JD, 1995, B ENTOMOL RES, V85, P29, DOI 10.1017/S0007485300051981; CHARLWOOD JD, 1985, B ENTOMOL RES, V75, P463, DOI 10.1017/S0007485300014577; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Curtis CF, 1998, PHILOS T ROY SOC B, V353, P1769, DOI 10.1098/rstb.1998.0329; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Donnelly MJ, 2000, INSECT MOL BIOL, V9, P357, DOI 10.1046/j.1365-2583.2000.00197.x; ELLIOTT M, 1989, PESTIC SCI, V27, P337, DOI 10.1002/ps.2780270403; ESCALAR G., 1933, RIV MALARIOL, V12, P373; FOIL LD, 1994, REV SCI TECH OIE, V13, P1125, DOI 10.20506/rst.13.4.821; Franco A, 2010, EFFECTS LIVESTOCK MA; Fritz ML, 2009, ANN TROP MED PARASIT, V103, P539, DOI 10.1179/000349809X12459740922138; Fritz ML, 2012, J MED ENTOMOL, V49, P326, DOI 10.1603/ME11098; George JE, 2000, ANN NY ACAD SCI, V916, P583, DOI 10.1111/j.1749-6632.2000.tb05340.x; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Habtewold T, 2004, MED VET ENTOMOL, V18, P408, DOI 10.1111/j.0269-283X.2004.00525.x; Habtewold T, 2001, T ROY SOC TROP MED H, V95, P584, DOI 10.1016/S0035-9203(01)90086-0; Habtewold T, 2004, THESIS U GREENWICH G; Hacket LW, 1937, MALARIA EUROPE; Hewitt S, 1999, TROP MED INT HEALTH, V4, P481, DOI 10.1046/j.1365-3156.1999.00433.x; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; IVCC, 2007, P INN VECT CONTR CON; Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676; Kawaguchi I, 2004, P ROY SOC B-BIOL SCI, V271, P301, DOI 10.1098/rspb.2003.2575; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Kobylinski KC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-381; Kolaczinski JH, 2008, INT J EPIDEMIOL, V37, P344, DOI 10.1093/ije/dym275; KRAFSUR E S, 1982, Parassitologia (Rome), V24, P105; KRAFSUR ES, 1977, J MED ENTOMOL, V14, P180, DOI 10.1093/jmedent/14.2.180; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; MACDONALD G, 1952, Trop Dis Bull, V49, P813; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mahande AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-109; MAHMOOD F, 1981, MOSQ NEWS, V41, P41; MCLAUGHLIN RE, 1990, J AM MOSQUITO CONTR, V6, P283; MCLAUGHLIN RE, 1989, J AM MOSQUITO CONTR, V5, P60; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Molineaux L., 1988, P913; NASCI RS, 1990, J MED ENTOMOL, V27, P1031, DOI 10.1093/jmedent/27.6.1031; Nasell I, 1985, LECT NOTES BIOMATH, P46; NEDELMAN J, 1985, MATH BIOSCI, V73, P159, DOI 10.1016/0025-5564(85)90010-0; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rayaisse JB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000632; REISEN WK, 1986, ANN TROP MED PARASIT, V80, P53, DOI 10.1080/00034983.1986.11811984; REISEN WK, 1982, J MED ENTOMOL, V19, P98, DOI 10.1093/jmedent/19.1.98; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Rodriguez-Vivas RI, 2006, VET PARASITOL, V136, P335, DOI 10.1016/j.vetpar.2005.05.069; Ross R., 1911, PREVENTION MALARIA; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; RUSSELL PAUL F., 1934, RIV MALARIOL, V13, P610; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Schmidtmann ET, 2001, J MED ENTOMOL, V38, P728, DOI 10.1603/0022-2585-38.5.728; SCHULTZ G W, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P49; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; Seyoum A, 2002, East Afr Med J, V79, P485; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; STANDFAST HA, 1984, J ECON ENTOMOL, V77, P419, DOI 10.1093/jee/77.2.419; SUBRAMANIAN S, 1991, Indian Journal of Malariology, V28, P29; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; Taye A, 2006, ACTA TROP, V97, P50, DOI 10.1016/j.actatropica.2005.08.002; THOMSON MC, 1987, TROP PEST MANAGE, V33, P329, DOI 10.1080/09670878709371177; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; USDA, 1976, CONTR INS AFF LIV; VALE GA, 1985, B ENTOMOL RES, V75, P209, DOI 10.1017/S0007485300014292; VALE GA, 1988, B ENTOMOL RES, V78, P31, DOI 10.1017/S0007485300016059; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van der Hoek W, 1998, T ROY SOC TROP MED H, V92, P265, DOI 10.1016/S0035-9203(98)91003-3; Verhage DF, 2005, NETH J MED, V63, P52; Vythilingam I., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P544; W.H.O, 1991, 9 1989 10 1990 M; WARREL DA, 2002, ESSENTIAL MALARIOLOG; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; WHO, 1982, WHO OFFS PUBL, V66; WILSON ML, 1993, PARASITOL TODAY, V9, P83, DOI 10.1016/0169-4758(93)90210-7; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	99	32	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101699	10.1371/journal.pone.0101699	http://dx.doi.org/10.1371/journal.pone.0101699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050703	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000339551100012
J	Guglielmi, V; Maresca, L; D'Adamo, M; Di Roma, M; Lanzillo, C; Federici, M; Lauro, D; Preziosi, P; Bellia, A; Sbraccia, P				Guglielmi, Valeria; Maresca, Luciano; D'Adamo, Monica; Di Roma, Mauro; Lanzillo, Chiara; Federici, Massimo; Lauro, Davide; Preziosi, Paolo; Bellia, Alfonso; Sbraccia, Paolo			Age-Related Different Relationships between Ectopic Adipose Tissues and Measures of Central Obesity in Sedentary Subjects	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; METABOLIC RISK-FACTORS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; REGIONAL DIFFERENCES; PHYSICAL-ACTIVITY; AFRICAN-AMERICAN; ASSOCIATION; INFILTRATION; INFLAMMATION	Accumulation of fat at ectopic sites has been gaining attention as pivotal contributor of insulin resistance, metabolic syndrome and related cardiovascular complications. Intermuscular adipose tissue (IMAT), located between skeletal muscle bundles and beneath muscle fascia, has been linked to physical inactivity, ageing and body mass index, but little is known about its relationship with the other AT compartments, in particular with increasing age. To address this issue, erector spinae IMAT, epicardial (EAT), intraabdominal (IAAT) and abdominal subcutaneous adipose tissue (SAT) were simultaneously measured by Magnetic Resonance Imaging (MRI) and related to waist circumference measurements and age in 32 sedentary subjects without cardiovascular disease (18 men; 14 women; mean age 48.5 +/- 14 years). Fasting glucose, triglycerides and HDL-cholesterol were also assessed. We observed that, after dividing individuals according to age (<= or >50 years), IMAT and EAT depots were significantly more expanded in older subjects (63.2 +/- 8.3 years) than in the younger ones (38.4 +/- 5.2 years) (p<0.001). Overall, both IMAT and EAT showed stronger positive associations with increasing age (beta = 0.63 and 0.67, respectively, p<0.001 for both) than with waist circumference (beta = 0.55 and 0.49, respectively, p<0.01 for both) after adjusting for gender. In addition, the gender-adjusted associations of IMAT and EAT with waist circumference and IAAT were significant in individuals <= 50 years only (p<0.05 for all) and not in the older ones. In contrast, no age-related differences were seen in the relationships of IAAT and SAT with waist circumference. Finally, serum triglycerides levels turned out not to be independently related with ectopic IMAT and EAT. In conclusion, the expansion of IMAT and EAT in sedentary subjects is more strongly related to age than waist circumference, and a positive association of these ectopic depots with waist circumference and IAAT amount can be postulated in younger individuals only.	[Guglielmi, Valeria; D'Adamo, Monica; Federici, Massimo; Lauro, Davide; Bellia, Alfonso; Sbraccia, Paolo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Maresca, Luciano; Di Roma, Mauro; Preziosi, Paolo] Policlin Casilino, Dept Diagnost Imaging, Rome, Italy; [Lanzillo, Chiara] Policlin Casilino, Dept Cardiol, Rome, Italy	University of Rome Tor Vergata	Sbraccia, P (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	sbraccia@med.uniroma2.it	D'Adamo, Monica/AAL-4676-2020; bellia, alfonso/AIA-9860-2022; Federici, Massimo/G-9940-2012; Lauro, Davide/K-4683-2018	D'Adamo, Monica/0000-0002-1673-1591; Federici, Massimo/0000-0003-4989-5194; Lauro, Davide/0000-0002-8597-4415; Guglielmi, Valeria/0000-0002-6912-7814	Ministero dell'Universita e della Ricerca [prot. 2010329EKE_003]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e della Ricerca(prot. 2010329EKE_003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Albu JB, 2005, AM J CLIN NUTR, V82, P1210, DOI 10.1093/ajcn/82.6.1210; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; Bazzocchi A, 2014, PRIM CARE DIABETES; Bazzocchi A, 2013, CLIN NUTR, V32, P569, DOI 10.1016/j.clnu.2012.10.004; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Boettcher M, 2009, J MAGN RESON IMAGING, V29, P1340, DOI 10.1002/jmri.21754; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Gallagher D, 2009, AM J CLIN NUTR, V89, P807, DOI 10.3945/ajcn.2008.26955; Gastaldelli A, 2010, NUTR METAB CARDIOVAS, V20, P481, DOI 10.1016/j.numecd.2010.05.005; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Greulich S, 2012, CIRCULATION, V126, P2324, DOI 10.1161/CIRCULATIONAHA.111.039586; Hafer-Macko CE, 2005, STROKE, V36, P2021, DOI 10.1161/01.STR.0000177878.33559.fe; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Janssen I, 2002, DIABETES CARE, V25, P431, DOI 10.2337/diacare.25.3.431; Jensen GL, 2008, JPEN-PARENTER ENTER, V32, P656, DOI 10.1177/0148607108324585; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; Karampinos DC, 2012, J MAGN RESON IMAGING, V35, P899, DOI 10.1002/jmri.23512; Kim MK, 2009, J APPL PHYSIOL, V106, P5, DOI 10.1152/japplphysiol.90756.2008; Manini TM, 2007, AM J CLIN NUTR, V85, P377, DOI 10.1093/ajcn/85.2.377; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Marras WS, 2001, CLIN BIOMECH, V16, P38, DOI 10.1016/S0268-0033(00)00046-2; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Rossi A, 2010, OBESITY, V18, P2379, DOI 10.1038/oby.2010.48; Ruan XY, 2007, J APPL PHYSIOL, V102, P748, DOI 10.1152/japplphysiol.00304.2006; Sacks HS, 2011, DIABETES CARE, V34, P730, DOI 10.2337/dc10-2083; Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755; Silaghi A, 2008, OBESITY, V16, P2424, DOI 10.1038/oby.2008.379; SOBOL W, 1991, INT J OBESITY, V15, P589; Song MY, 2004, AM J CLIN NUTR, V79, P874; Stanhope KL, 2008, AM J CLIN NUTR, V88, p1733S, DOI 10.3945/ajcn.2008.25825D; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Thamer C, 2004, DIABETES CARE, V27, P2726, DOI 10.2337/diacare.27.11.2726; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Venteclef N, 2015, EUR HEART J, V36, P795, DOI 10.1093/eurheartj/eht099; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang TD, 2009, J CLIN ENDOCR METAB, V94, P662, DOI 10.1210/jc.2008-0834; Yim JE, 2007, INT J OBESITY, V31, P1400, DOI 10.1038/sj.ijo.0803621; Zoico E, 2013, ARCH GERONTOL GERIAT, V57, P411, DOI 10.1016/j.archger.2013.06.001	49	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103381	10.1371/journal.pone.0103381	http://dx.doi.org/10.1371/journal.pone.0103381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051047	gold, Green Submitted, Green Published			2022-12-27	WOS:000339551100104
J	Kobayashi, J; Yoshida, M; Tarui, S; Hirata, M; Nagai, Y; Kasahara, S; Naruse, K; Ito, H; Sano, S; Oh, H				Kobayashi, Junko; Yoshida, Masashi; Tarui, Suguru; Hirata, Masataka; Nagai, Yusuke; Kasahara, Shingo; Naruse, Keiji; Ito, Hiroshi; Sano, Shunji; Oh, Hidemasa			Directed Differentiation of Patient-Specific Induced Pluripotent Stem Cells Identifies the Transcriptional Repression and Epigenetic Modification of NKX2-5, HAND1, and NOTCH1 in Hypoplastic Left Heart Syndrome	PLOS ONE			English	Article							VENTRICULAR OUTFLOW TRACT; CARDIAC PROGENITOR CELLS; AORTIC-VALVE; STEM/PROGENITOR CELLS; DISEASE; MUTATIONS; EXPRESSION; MORPHOGENESIS; INFARCTION; PROMOTER	The genetic basis of hypoplastic left heart syndrome (HLHS) remains unknown, and the lack of animal models to reconstitute the cardiac maldevelopment has hampered the study of this disease. This study investigated the altered control of transcriptional and epigenetic programs that may affect the development of HLHS by using disease-specific induced pluripotent stem (iPS) cells. Cardiac progenitor cells (CPCs) were isolated from patients with congenital heart diseases to generate patient-specific iPS cells. Comparative gene expression analysis of HLHS-and biventricle (BV) heart-derived iPS cells was performed to dissect the complex genetic circuits that may promote the disease phenotype. Both HLHS-and BV heart-derived CPCs were reprogrammed to generate disease-specific iPS cells, which showed characteristic human embryonic stem cell signatures, expressed pluripotency markers, and could give rise to cardiomyocytes. However, HLHS-iPS cells exhibited lower cardiomyogenic differentiation potential than BV-iPS cells. Quantitative gene expression analysis demonstrated that HLHS-derived iPS cells showed transcriptional repression of NKX2-5, reduced levels of TBX2 and NOTCH/HEY signaling, and inhibited HAND1/2 transcripts compared with control cells. Although both HLHS-derived CPCs and iPS cells showed reduced SRE and TNNT2 transcriptional activation compared with BV-derived cells, co-transfection of NKX2-5, HAND1, and NOTCH1 into HLHS-derived cells resulted in synergistic restoration of these promoters activation. Notably, gain- and loss-of-function studies revealed that NKX2-5 had a predominant impact on NPPA transcriptional activation. Moreover, differentiated HLHS-derived iPS cells showed reduced H3K4 dimethylation as well as histone H3 acetylation but increased H3K27 trimethylation to inhibit transcriptional activation on the NKX2-5 promoter. These findings suggest that patient-specific iPS cells may provide molecular insights into complex transcriptional and epigenetic mechanisms, at least in part, through combinatorial expression of NKX2-5, HAND1, and NOTCH1 that coordinately contribute to cardiac malformations in HLHS.	[Kobayashi, Junko; Tarui, Suguru; Hirata, Masataka; Kasahara, Shingo; Sano, Shunji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Surg, Okayama 7008530, Japan; [Yoshida, Masashi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008530, Japan; [Nagai, Yusuke; Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama 7008530, Japan; [Oh, Hidemasa] Okayama Univ Hosp, Dept Regenerat Med, Ctr Innovat Clin Med, Okayama, Japan	Okayama University; Okayama University; Okayama University; Okayama University	Oh, H (corresponding author), Okayama Univ Hosp, Dept Regenerat Med, Ctr Innovat Clin Med, Okayama, Japan.	hidemasa@md.okayama-u.ac.jp	Sokabe, Masahiro/I-1565-2012; Kobayashi, Junjiro/J-8547-2015	naruse, keiji/0000-0003-4100-6444	Ministry of Education, Culture, Sports, Science and Technology; Japanese Science and Technology Agency; Ministry of Health, Labour, and Welfare; Grants-in-Aid for Scientific Research [26220203] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology, and the Japanese Science and Technology Agency (to H.O.), and by a grant from the Ministry of Health, Labour, and Welfare (to H.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron DJ, 2009, LANCET, V374, P551, DOI 10.1016/S0140-6736(09)60563-8; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Epstein JA, 2010, NEW ENGL J MED, V363, P1638, DOI 10.1056/NEJMra1003941; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hickey EJ, 2012, J AM COLL CARDIOL, V59, pS43, DOI 10.1016/j.jacc.2011.04.046; Hinton RB, 2009, J AM COLL CARDIOL, V53, P1065, DOI 10.1016/j.jacc.2008.12.023; Iascone M, 2011, CLIN GENET; Jiang Y, 2014, STEM CELL TRANSL MED, V3, P416, DOI 10.5966/sctm.2013-0105; Lamour JM, 2009, J AM COLL CARDIOL, V54, P160, DOI 10.1016/j.jacc.2009.04.020; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Narsinh K, 2011, CIRC RES, V108, P1146, DOI 10.1161/CIRCRESAHA.111.240374; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Pasini A, 2013, CELL BIOCHEM BIOPHYS, V67, P255, DOI 10.1007/s12013-013-9610-z; Reamon-Buettner SM, 2008, HUM MOL GENET, V17, P1397, DOI 10.1093/hmg/ddn027; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sano S, 2003, J THORAC CARDIOV SUR, V126, P504, DOI 10.1016/S0022-5223(02)73575-7; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sorensen AL, 2010, MOL BIOL CELL, V21, P2066, DOI 10.1091/mbc.E10-01-0018; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052; Tateishi K, 2007, BIOCHEM BIOPH RES CO, V352, P635, DOI 10.1016/j.bbrc.2006.11.096; Tsuchihashi T, 2011, DEV BIOL, V351, P62, DOI 10.1016/j.ydbio.2010.12.023; Wang L, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt96; Watanabe Y, 2006, DEVELOPMENT, V133, P1625, DOI 10.1242/dev.02344; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yamamoto A, 2009, J NEUROSCI RES, V87, P2615, DOI 10.1002/jnr.22094; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	43	42	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102796	10.1371/journal.pone.0102796	http://dx.doi.org/10.1371/journal.pone.0102796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050861	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100057
J	Ambrosini, R; Borgoni, R; Rubolini, D; Sicurella, B; Fiedler, W; Bairlein, F; Baillie, SR; Robinson, RA; Clark, JA; Spina, F; Saino, N				Ambrosini, Roberto; Borgoni, Riccardo; Rubolini, Diego; Sicurella, Beatrice; Fiedler, Wolfgang; Bairlein, Franz; Baillie, Stephen R.; Robinson, Robert A.; Clark, Jacquie A.; Spina, Fernando; Saino, Nicola			Modelling the Progression of Bird Migration with Conditional Autoregressive Models Applied to Ringing Data	PLOS ONE			English	Article							SWALLOW HIRUNDO-RUSTICA; RECENT CLIMATE-CHANGE; LONG-TERM TRENDS; SPRING MIGRANTS; ARRIVAL; RESPONSES; GEOLOCATORS; REGRESSION; PHENOLOGY	Migration is a fundamental stage in the life history of several taxa, including birds, and is under strong selective pressure. At present, the only data that may allow for both an assessment of patterns of bird migration and for retrospective analyses of changes in migration timing are the databases of ring recoveries. We used ring recoveries of the Barn Swallow Hirundo rustica collected from 1908-2008 in Europe to model the calendar date at which a given proportion of birds is expected to have reached a given geographical area ('progression of migration') and to investigate the change in timing of migration over the same areas between three time periods (1908-1969, 1970-1990, 1991-2008). The analyses were conducted using binomial conditional autoregressive (CAR) mixed models. We first concentrated on data from the British Isles and then expanded the models to western Europe and north Africa. We produced maps of the progression of migration that disclosed local patterns of migration consistent with those obtained from the analyses of the movements of ringed individuals. Timing of migration estimated from our model is consistent with data on migration phenology of the Barn Swallow available in the literature, but in some cases it is later than that estimated by data collected at ringing stations, which, however, may not be representative of migration phenology over large geographical areas. The comparison of median migration date estimated over the same geographical area among time periods showed no significant advancement of spring migration over the whole of Europe, but a significant advancement of autumn migration in southern Europe. Our modelling approach can be generalized to any records of ringing date and locality of individuals including those which have not been recovered subsequently, as well as to geo-referenced databases of sightings of migratory individuals.	[Ambrosini, Roberto; Sicurella, Beatrice] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Borgoni, Riccardo] Univ Milano Bicocca, Dipartimento Econ Metodi Quantitativi & Strategie, Milan, Italy; [Rubolini, Diego; Saino, Nicola] Univ Milano Bicocca, Dipartimento Biosci, Milan, Italy; [Fiedler, Wolfgang] Max Plank Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [Bairlein, Franz] Inst Avian Res Vogelwarte Helgoland, Wilhelmshaven, Germany; [Baillie, Stephen R.; Robinson, Robert A.; Clark, Jacquie A.] British Trust Ornithol, Thetford, Norfolk, England; [Spina, Fernando] Ist Super Protez & Ric Ambientale, Ozzano Dellemilia, BO, Italy	University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca; Max Planck Society; British Trust for Ornithology	Ambrosini, R (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	roberto.ambrosini@unimib.it	Fiedler, Wolfgang/AAG-4510-2021; Ambrosini, Roberto/F-3188-2012; Rubolini, Diego/F-2851-2011; borgoni, riccardo/AAZ-4171-2020; Baillie, Stephen/H-3023-2013; Robinson, Robert/B-8237-2009	Fiedler, Wolfgang/0000-0003-1082-4161; Ambrosini, Roberto/0000-0002-7148-1468; Rubolini, Diego/0000-0003-2703-5783; borgoni, riccardo/0000-0002-2520-3512; Baillie, Stephen/0000-0001-5126-9470; Robinson, Robert/0000-0003-0504-9906; Saino, Nicola/0000-0002-0230-3967				Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Ambrosini R, 2011, CLIM RES, V49, P131, DOI 10.3354/cr01025; Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; Baddeley A, 2010, ELECTRON J STAT, V4, P1151, DOI 10.1214/10-EJS581; Bates D, 2012, LME4 LINEAR MIXED EF; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Bauer S, 2009, BIOL LETTERS, V5, P433, DOI 10.1098/rsbl.2009.0324; Bivand RS, 2008, USE R, P1; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Cramp J, 1988, BIRDS W PALEARCTIC, VV; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; EFRON B, 1978, J AM STAT ASSOC, V73, P113, DOI 10.2307/2286531; Fiedler W, 2003, AVIAN MIGRATION, P21; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Korner-Nievergelt F, 2010, J AVIAN BIOL, V41, P8, DOI 10.1111/j.1600-048X.2009.04907.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mackay AJ, 2002, LEICESTERSHIRE RUTLA; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller Anders Pape, 2010, P33; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; R Core Team, 2012, R LANG ENV STAT COMP; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Rubolini D, 2002, J AVIAN BIOL, V33, P15, DOI 10.1034/j.1600-048X.2002.330104.x; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Rubolini D, 2007, INT J BIOMETEOROL, V51, P553, DOI 10.1007/s00484-007-0094-7; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Scandolara C, 2014, J AVIAN BIO IN PRESS; Schmidt Ernst, 2007, Vogelwarte, V45, P27; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; SPARKS TH, 1995, J ECOL, V83, P321, DOI 10.2307/2261570; SPINA F, 1994, OSTRICH, V65, P137, DOI 10.1080/00306525.1994.9639676; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Turner A., 2006, BARN SWALLOW; Van Noordwijk, 2001, EURING EXCHANGE CODE; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	45	11	13	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102440	10.1371/journal.pone.0102440	http://dx.doi.org/10.1371/journal.pone.0102440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047331	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100030
J	Choi, Y; Kim, HS; Woo, J; Hwang, EH; Cho, KW; Kim, S; Moon, WK				Choi, YoonSeok; Kim, Hoe Suk; Woo, Jisu; Hwang, Eun Hye; Cho, Kyoung-Won; Kim, Soonhag; Moon, Woo Kyung			Real-Time Imaging of the Epithelial-Mesenchymal Transition Using microRNA-200a Sequence-Based Molecular Beacon-Conjugated Magnetic Nanoparticles	PLOS ONE			English	Article							ALTERNATIVE SPLICING REPORTERS; LIVING CELLS; MESSENGER-RNA; MIR-200 FAMILY; CANCER-CELLS; E-CADHERIN; REPRESSORS ZEB1; NUCLEIC-ACID; IN-VIVO; METASTASIS	The epithelial-mesenchymal transition (EMT) plays important roles in tumor progression to metastasis. Thus, the development of an imaging probe that can monitor transient periods of the EMT process in live cells is required for a better understanding of metastatic process. Inspired by the fact that the mRNA expression levels of zinc finger E-box-binding homeobox 1 (ZEB1) increase when cells adopt mesenchyme characteristics and that microRNA-200a (miR-200a) can bind to ZEB1 mRNA, we conjugated molecular beacon (MB) mimicking mature miR-200a to magnetic nanoparticles (miR-200a-MB-MNPs) and devised an imaging method to observe transitional changes in the cells during EMT. Transforming growth factor-beta 1 treated epithelial cells and breast cancer cell lines representing both epithelial and mesenchymal phenotypes were used for the validation of miR-200a-MB-MNPs as an EMT imaging probe. The real-time imaging of live cells acquired with the induction of EMT revealed an increase in fluorescence signals by miR-200a-MB-MNPs, cell morphology alterations, and the loss of cell-cell adhesion. Our results suggest that miR-200a-MB-MNPs can be used as an imaging probe for the real-time monitoring of the EMT process in live cells.	[Choi, YoonSeok; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Choi, YoonSeok; Kim, Hoe Suk; Woo, Jisu; Hwang, Eun Hye; Cho, Kyoung-Won; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Kim, Hoe Suk; Cho, Kyoung-Won; Moon, Woo Kyung] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Kim, Soonhag] CHA Univ, Coll Biomed Sci, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Pochon Cha University	Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	moonwk@snu.ac.kr			National Research Foundation (NRF) of Korea grant from the Korean government (MEST) [2012-01010846]; Seoul National University Hospital [03-2012-0040]	National Research Foundation (NRF) of Korea grant from the Korean government (MEST); Seoul National University Hospital	This work was supported by a National Research Foundation (NRF) of Korea grant from the Korean government (MEST; No. 2012-01010846) and by a grant from Seoul National University Hospital (03-2012-0040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bao G, 2009, ANNU REV BIOMED ENG, V11, P25, DOI 10.1146/annurev-bioeng-061008-124920; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Catrina IE, 2012, ACS CHEM BIOL, V7, P1586, DOI 10.1021/cb300178a; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen AK, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn331; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Eger A, 2000, J CELL BIOL, V148, P173, DOI 10.1083/jcb.148.1.173; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He XX, 2003, J AM CHEM SOC, V125, P7168, DOI 10.1021/ja034450d; Hwang DW, 2010, SMALL, V6, P81, DOI 10.1002/smll.200901262; Iversen F, 2013, THERANOSTICS, V3, P201, DOI 10.7150/thno.5743; Jones R, 2009, AM J PHYSIOL-CELL PH, V296, pC498, DOI 10.1152/ajpcell.00462.2008; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Law WC, 2012, THERANOSTICS, V2, P695, DOI 10.7150/thno.3459; Li YS, 2008, BIOCHEM BIOPH RES CO, V373, P457, DOI 10.1016/j.bbrc.2008.05.038; Medley CD, 2005, ANAL CHEM, V77, P4713, DOI 10.1021/ac050881y; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nuovo GJ, 2009, BIOTECHNIQUES, V46, P115, DOI 10.2144/000113068; Oltean S, 2008, CLIN EXP METASTAS, V25, P611, DOI 10.1007/s10585-008-9186-y; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peng XH, 2005, CANCER RES, V65, P1909, DOI 10.1158/0008-5472.CAN-04-3196; Perlette J, 2001, ANAL CHEM, V73, P5544, DOI 10.1021/ac010633b; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rodriguez AJ, 2007, SEMIN CELL DEV BIOL, V18, P202, DOI 10.1016/j.semcdb.2007.02.002; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Sheridan C, 2012, NAT BIOTECHNOL, V30, P471, DOI 10.1038/nbt0612-471; Shin SJ, 2013, INTEGR BIOL-UK, V5, P29, DOI 10.1039/c2ib20047c; Sokol DL, 1998, P NATL ACAD SCI USA, V95, P11538, DOI 10.1073/pnas.95.20.11538; Somarelli JA, 2013, RNA, V19, P116, DOI 10.1261/rna.035097.112; Tan WH, 2004, CURR OPIN CHEM BIOL, V8, P547, DOI 10.1016/j.cbpa.2004.08.010; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsourkas A, 2002, NUCLEIC ACIDS RES, V30, P5168, DOI 10.1093/nar/gkf635; Tsourkas Andrew, 2003, Briefings in Functional Genomics & Proteomics, V1, P372, DOI 10.1093/bfgp/1.4.372; Tyagi Sanjay, 2012, F1000 Med Rep, V4, P10, DOI 10.3410/M4-10; Wang H, 2009, ACS NANO, V3, P2451, DOI 10.1021/nn9006303; Wang Q, 2013, THERANOSTICS, V3, P395, DOI 10.7150/thno.5935; Wang W, 2008, NUCLEIC ACIDS RES, V36, P4913, DOI 10.1093/nar/gkn475; Yang CJ, 2007, NUCLEIC ACIDS RES, V35, P4030, DOI 10.1093/nar/gkm358; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeh HY, 2008, P NATL ACAD SCI USA, V105, P17522, DOI 10.1073/pnas.0807066105; Yigit MV, 2012, PHARM RES-DORDR, V29, P1180, DOI 10.1007/s11095-012-0679-7	46	10	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102164	10.1371/journal.pone.0102164	http://dx.doi.org/10.1371/journal.pone.0102164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048580	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100022
J	Estrada-Pena, A; Carreon, D; Almazan, C; de la Fuente, J				Estrada-Pena, Agustin; Carreon, Diana; Almazan, Consuelo; de la Fuente, Jose			Modeling the Impact of Climate and Landscape on the Efficacy of White Tailed Deer Vaccination for Cattle Tick Control in Northeastern Mexico	PLOS ONE			English	Article							BOOPHILUS-ANNULATUS ACARI; IXODES-RICINUS; ANIMAL MOVEMENT; IXODIDAE; HABITAT; INFESTATIONS; MICROPLUS; SIMULATION	Cattle ticks are distributed worldwide and affect animal health and livestock production. White tailed deer (WTD) sustain and spread cattle tick populations. The aim of this study was to model the efficacy of anti-tick vaccination of WTD to control tick infestations in the absence of cattle vaccination in a territory where both host species coexist and sustain cattle tick populations. Agent-based models that included land cover/landscape properties (patch size, distances to patches) and climatic conditions were built in a GIS environment to simulate WTD vaccine effectiveness under conditions where unvaccinated cattle shared the landscape. Published and validated information on tick life cycle was used to build models describing tick mortality and developmental rates. Data from simulations were applied to a large territory in northeastern Mexico where cattle ticks are endemic and WTD and cattle share substantial portions of the habitat. WTD movements were simulated together with tick population dynamics considering the actual landscape and climatic features. The size of the vegetation patches and the distance between patches were critical for the successful control of tick infestations after WTD vaccination. The presence of well-connected, large vegetation patches proved essential for tick control, since the tick could persist in areas of highly fragmented habitat. The continued application of one yearly vaccination on days 1-70 for three years reduced tick abundance/animal/patch by a factor of 40 and 60 for R. annulatus and R. microplus, respectively when compared to non-vaccinated controls. The study showed that vaccination of WTD alone during three consecutive years could result in the reduction of cattle tick populations in northeastern Mexico. Furthermore, the results of the simulations suggested the possibility of using vaccines to prevent the spread and thus the re-introduction of cattle ticks into tick-free areas.	[Estrada-Pena, Agustin] Fac Vet Med, Dept Parasitol, Zaragoza, Spain; [Carreon, Diana] Univ Autonoma Tamaulipas, Inst Ecol Aplicada, Ciudad Victoria, Tamaulipas, Mexico; [Almazan, Consuelo] Univ Autonoma Tamaulipas, Fac Med Vet & Zootecnia, Ciudad Victoria, Tamaulipas, Mexico; [de la Fuente, Jose] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ciudad Real, Spain; [de la Fuente, Jose] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Universidad Autonoma de Tamaulipas; Universidad Autonoma de Tamaulipas; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater	de la Fuente, J (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ciudad Real, Spain.	jose_delafuente@yahoo.com	de la Fuente, José/AAU-1197-2020	de la Fuente, José/0000-0001-7383-9649; Estrada Pena, Agustin/0000-0001-7483-046X	EU [278976]	EU(European Commission)	This research was supported by the EU FP7 ANTIGONE project number 278976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delfin-Alfonso CA, 2009, TROP CONSERV SCI, V2, P215, DOI 10.1177/194008290900200208; BARNARD DR, 1991, J MED ENTOMOL, V28, P557, DOI 10.1093/jmedent/28.5.557; Carreon D, 2012, VACCINE, V30, P273, DOI 10.1016/j.vaccine.2011.10.099; Castle C., 2006, SERIES-J SPAN ECON; Corson MS, 2004, ECOL MODEL, V180, P487, DOI 10.1016/j.ecolmodel.2004.04.034; De la Fuente J, 2006, PARASITE IMMUNOL, V28, P275, DOI 10.1111/j.1365-3024.2006.00828.x; de la Fuente J, 1998, VACCINE, V16, P366, DOI 10.1016/S0264-410X(97)00208-9; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23, DOI 10.1017/S1466252307001193; de la Fuente Jose, 2003, Expert Rev Vaccines, V2, P583; de la Fuente J, 2011, VET PARASITOL, V181, P17, DOI 10.1016/j.vetpar.2011.04.018; de la Vega R., 1984, Revista de Salud Animal, V6, P59; de Leon AAP, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-36; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Estrada-Pena A, 2006, VET PARASITOL, V142, P350, DOI 10.1016/j.vetpar.2006.07.003; Estrada-Pena A, 2014, MED VET ENTOMOL, V28, P35, DOI 10.1111/mve.12009; Felix AB, 2007, J WILDLIFE MANAGE, V71, P804, DOI 10.2193/2006-366; GEORGE J E, 1990, Journal of Agricultural Entomology, V7, P119; GRAHAM OH, 1966, ANN ENTOMOL SOC AM, V59, P450, DOI 10.1093/aesa/59.3.450; Hagerman A., 2010, 102 AGR FOOD POL CTR, P1; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Hanks EM, 2012, ARXIV12111992; Hanley T.A., 2012, FORAGE RESOURCE EVAL; Hellickson MW, 2008, SOUTHWEST NAT, V53, P1, DOI 10.1894/0038-4909(2008)53[1:SRASFO]2.0.CO;2; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Lohmeyer KH, 2011, J MED ENTOMOL, V48, P770, DOI 10.1603/ME10209; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Marshall C.M., 1993, P 28 N AM WILDL NAT, P226; Merino O, 2011, VACCINE, V29, P8575, DOI 10.1016/j.vaccine.2011.09.023; Morgan ER, 2004, TRENDS ECOL EVOL, V19, P181, DOI 10.1016/j.tree.2004.01.011; MOUNT GA, 1991, J MED ENTOMOL, V28, P223, DOI 10.1093/jmedent/28.2.223; Pound JM, 2010, J ECON ENTOMOL, V103, P211, DOI 10.1603/EC09359; Racelis AE, 2012, J MED ENTOMOL, V49, P410, DOI 10.1603/ME11104; Rodriguez-Vivas RI, 2013, EXP APPL ACAROL, V60, P543, DOI 10.1007/s10493-013-9672-z; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; STREY OF, 1991, J MED ENTOMOL, V28, P165, DOI 10.1093/jmedent/28.1.165; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Tang WW, 2010, GEOGR COMPASS, V4, pCP7, DOI 10.1111/j.1749-8198.2010.00337.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Walter WD, 2009, LANDSCAPE ECOL, V24, P1405, DOI 10.1007/s10980-009-9374-4; Wang HH, 2012, ECOL MODEL, V243, P42, DOI 10.1016/j.ecolmodel.2012.06.007; Willadsen P, 2006, VET PARASITOL, V138, P161, DOI 10.1016/j.vetpar.2006.01.050	42	16	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102905	10.1371/journal.pone.0102905	http://dx.doi.org/10.1371/journal.pone.0102905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047078	Green Published, gold			2022-12-27	WOS:000339558100087
J	Li, L; Yan, HF; Niu, M; Tu, TY; Li, SJ; Xing, FW				Li, Lin; Yan, Hai-Fei; Niu, Miao; Tu, Tie-Yao; Li, Shi-Jin; Xing, Fu-Wu			Re-Establishment of the Genus Ania Lindl. (Orchidaceae)	PLOS ONE			English	Article							CHLOROPLAST DNA; MOLECULAR PHYLOGENETICS; SEQUENCES; NUCLEAR; EVOLUTION; REGIONS	Ania Lindl. is a small genus of the tribe Collabieae subtribe Collabiinae (Orchidaceae). For the last 150 years, it has generally been treated as a synonym of Tainia Blume. In this study, we critically re-examined morphological characters that have been used to distinguish Ania from Tainia, and assessed the phylogeny of Tainia using morphological and palynological characters. Sequences of the nuclear ribosomal ITS, chloroplast trnL intron and combined DNA data sets were analysed to clarify the delimitation and the phylogeny of these groups. The morphological and palynological survey revealed a number of useful diagnostic characters which permit a clear definition of Ania, after the exclusion of a single taxonomically questionable species. Results confirmed that Ania is distinct from Tainia. Phylogenetic reconstructions based on molecular data provided the greatest resolution and produced a morphologically well differentiated clade of Ania. In addition to morphological and suggested palynological characters, the phylogenies were also supported by karyological evidence. Our results support the independent generic status of Ania. The genus name Ania is revived and re-established.	[Li, Lin; Yan, Hai-Fei; Niu, Miao; Tu, Tie-Yao; Li, Shi-Jin; Xing, Fu-Wu] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Niu, Miao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lisj@scib.ac.cn; xinfw@scib.ac.cn		Tu, Tieyao/0000-0001-7385-008X	National Natural Science Foundation of China [31100149, 31270248]; Special Foundation for National Basic Research of the Ministry of Science and Technology, China [2013FY112100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for National Basic Research of the Ministry of Science and Technology, China	This research has been financially supported by grants from the National Natural Science Foundation of China (Grant Nos. 31100149 and 31270248) and Special Foundation for National Basic Research of the Ministry of Science and Technology, China (Grant No. 2013FY112100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Mikio, 1992, Journal of Japanese Botany, V67, P330; Bentham G., 1883, GENERA PLANTARUM, V3, DOI 10.5962/bhl.title.747; Bentham G, 1881, BOT J LINNEAN SOC, V18, P281, DOI DOI 10.1111/J.1095-8339.1881.TB01258.X; BISWAS BK, 1980, TAXON, V29, P163; Blume CL, 1828, FLORA JAVAE NEC NONI, P1; Blume CL, 1856, MUSEUM BOT LUGDANO B, V2, P185; Blume CL, 1825, BUJDRAGEN FLORA NEDE, V7, P354; Brandham PE, 1999, GENERA ORCHIDACEARUM, V1, P67; Chen SC, 2009, FLORA CHINA, V25, P281; Douzery EJP, 1999, AM J BOT, V86, P887, DOI 10.2307/2656709; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Dressler RL, 1993, PHYLOGENY CLASSIFICA; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gene Codes Corporation, 2005, SEQ VERS 4 5; Hooker J.D., 1887, FLORA BRIT INDIA, V5, DOI 10.5962/bhl.title.678; Hu SY, 1977, THESIS; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kocyan A, 2004, PLANT SYST EVOL, V247, P203, DOI 10.1007/s00606-004-0133-3; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Li L, 2009, SYSTEMATICS TAINIA; Lindley J, 1830, GENERA SPECIES ORC 2; Mehra P.N, 1976, TAXON, V25, P631; NELSON G, 1979, SYST ZOOL, V28, P1, DOI 10.2307/2412995; Pearce NR, 2002, FLORA BHUTAN 3, V3; Pfitzer EHH, 1889, NATURL PFLANZ, P147; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pridgeon Alec M., 1997, Lindleyana, V12, P89; Radhamoni G, 1985, NEW BOT, V12, P77; Rambaut A, 2007, SE AL SEQUENCE ALIGN; Reichenbach HG, 1857, BONPLANDIA, V5, P31; Ridley HN, 1907, MAT FLORA MALAYAN PE, V1, P114; ROHLF FJ, 1982, MATH BIOSCI, V59, P131; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHILL R, 1977, Pollen et Spores, V19, P5; Schlechter R, 1915, HDB ORCHIDEENLIEBHAB, p[127, 316]; Schlechter R, 1919, REPERT SP NOV REGNI, V4, P179; Schlechter R, 1919, REPERT SP NOV REGNI, V4, P246; Seidenfaden G, 1992, OPERA BOT, V114, P78; Seidenfaden G, 1986, OPERA BOT, V89, P24; Senghas K, 1984, SCHLECHTER R ORCHIDE, V1, P852; SHARMA AK, 1966, NUCLEUS CALCUTTA, V9, P177; Smith JJ, 1910, B DEP AGR IND NEERL, V43, P18; Smith JJ, 1912, B JARD BOT BUITENZ 2, V8, P5; Soliva M, 2001, MOL PHYLOGENET EVOL, V20, P78, DOI 10.1006/mpev.2001.0953; Summerhayes VS, 1939, BOT MAG, V161, P9553; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TANAKA R, 1972, BOT MAG TOKYO, V85, P43, DOI 10.1007/BF02489199; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner H, 1992, ORCHID MONOGRAPHS, V6, P43; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Vogel de EF, 2005, GENERA ORCHIDACEARUM, Vvol. 4, P158; Xiang XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087625; Zwickl DJ, 2006, THESIS UT AUSTIN	56	3	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103129	10.1371/journal.pone.0103129	http://dx.doi.org/10.1371/journal.pone.0103129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047255	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100109
J	Mantello, CC; Cardoso-Silva, CB; da Silva, CC; de Souza, LM; Scaloppi, EJ; Goncalves, PD; Vicentini, R; de Souza, AP				Mantello, Camila Campos; Cardoso-Silva, Claudio Benicio; da Silva, Carla Cristina; de Souza, Livia Moura; Scaloppi Junior, Erivaldo Jose; Goncalves, Paulo de Souza; Vicentini, Renato; de Souza, Anete Pereira			De Novo Assembly and Transcriptome Analysis of the Rubber Tree (Hevea brasiliensis) and SNP Markers Development for Rubber Biosynthesis Pathways	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MICROSATELLITE MARKERS; RNA-SEQ; PLANT; PROTEINS; GENE; TOOL; ARABIDOPSIS; ANNOTATION; RESOLUTION	Hevea brasiliensis (Willd. Ex Adr. Juss.) Muell.-Arg. is the primary source of natural rubber that is native to the Amazon rainforest. The singular properties of natural rubber make it superior to and competitive with synthetic rubber for use in several applications. Here, we performed RNA sequencing (RNA-seq) of H. brasiliensis bark on the Illumina GAIIx platform, which generated 179,326,804 raw reads on the Illumina GAIIx platform. A total of 50,384 contigs that were over 400 bp in size were obtained and subjected to further analyses. A similarity search against the non-redundant (nr) protein database returned 32,018 (63%) positive BLASTx hits. The transcriptome analysis was annotated using the clusters of orthologous groups (COG), gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Pfam databases. A search for putative molecular marker was performed to identify simple sequence repeats (SSRs) and single nucleotide polymorphisms (SNPs). In total, 17,927 SSRs and 404,114 SNPs were detected. Finally, we selected sequences that were identified as belonging to the mevalonate (MVA) and 2-C-methyl-D-erythritol 4-phosphate (MEP) pathways, which are involved in rubber biosynthesis, to validate the SNP markers. A total of 78 SNPs were validated in 36 genotypes of H. brasiliensis. This new dataset represents a powerful information source for rubber tree bark genes and will be an important tool for the development of microsatellites and SNP markers for use in future genetic analyses such as genetic linkage mapping, quantitative trait loci identification, investigations of linkage disequilibrium and marker-assisted selection.	[Mantello, Camila Campos; Cardoso-Silva, Claudio Benicio; da Silva, Carla Cristina; de Souza, Livia Moura; Vicentini, Renato; de Souza, Anete Pereira] Univ Estadual Campinas UNICAMP, CBMEG, Sao Paulo, Brazil; [Scaloppi Junior, Erivaldo Jose] Agencia Paulista Tecnol Agronegocios, Sao Paulo, Brazil; [Goncalves, Paulo de Souza] IAC, Sao Paulo, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Sao Paulo, Brazil	Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas	Mantello, CC (corresponding author), Univ Estadual Campinas UNICAMP, CBMEG, Cidade Univ Zeferino Vaz, Sao Paulo, Brazil.	camila.mantello@gmail.com; anete@unicamp.br	DE SOUZA, ANETE PEREIRA/B-8663-2012; Cardoso da Silva, Cláudio Benício/J-2326-2015; Vicentini, Renato/C-5967-2012	DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Cardoso da Silva, Cláudio Benício/0000-0002-4592-0113; Vicentini, Renato/0000-0002-0527-1083; Campos Mantello, Camila/0000-0002-9716-0400; Scaloppi Junior, Erivaldo Jose/0000-0002-8050-2187; Da Silva, Carla/0000-0003-4779-0014	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [562979/2010-7, 478701/2012-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50562-4, 2012/50491-8]; FAPESP [2008/55974-1, 2011/50188-0, 12/11109-0, 2009/52975-0, 12/05473-1]; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (562979/2010-7 and 478701/2012-8) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2007/50562-4 and 2012/50491-8). The scholarships were provided by FAPESP to CCM (2008/55974-1, 2011/50188-0), CBCS (12/11109-0), CCS (2009/52975-0) and LMS (12/05473-1). APS, PSG and RV are recipients of a research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Allegre M, 2012, DNA RES, V19, P23, DOI 10.1093/dnares/dsr039; [Anonymous], 1997, TFPGA TOOLS POPULATI; Badger M, 2003, PHOTOSYNTH RES, V77, P83, DOI 10.1023/A:1025821717773; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Chow KS, 2007, J EXP BOT, V58, P2429, DOI 10.1093/jxb/erm093; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Doyle J. J., 1987, PHYTOCHEM B, P11; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Fraser LG, 2004, THEOR APPL GENET, V108, P1010, DOI 10.1007/s00122-003-1517-4; Gronover CS, 2009, NATURAL RUBBER BIOSY; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Hirakawa H, 2013, DNA RES, V20, P221, DOI 10.1093/dnares/dst005; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lam KC, 2007, GENOME, V50, P1001, DOI 10.1139/G07-077; Le Guen V, 2011, PLANT BREEDING, V130, P294, DOI 10.1111/j.1439-0523.2010.01774.x; Le Guen V, 2011, TREE GENET GENOMES, V7, P877, DOI 10.1007/s11295-011-0381-7; Leitch AR, 1998, MOL CYTOGENETIC STUD, P464; Lespinasse D, 2000, THEOR APPL GENET, V100, P127, DOI 10.1007/s001220050018; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Marconi Thiago G, 2011, BMC Res Notes, V4, P264, DOI 10.1186/1756-0500-4-264; Meglecz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040861; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pires JM, 2002, TAXONOMIA FITOGEOGRA, P103; Pootakham W, 2011, AM J BOT, V98, pE337, DOI 10.3732/ajb.1100228; Priyadarshan PM, 2003, GENET RESOUR CROP EV, V50, P101, DOI 10.1023/A:1022972320696; Pushparajah E, 2001, TREE CROP ECOSYSTEMS; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Raj S, 2005, INT J BIOMETEOROL, V49, P189, DOI 10.1007/s00484-004-0222-6; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Saha T., 2012, GENOMICS TREE CROPS, P261, DOI [10.1007/978-1-4614-0920-5, DOI 10.1007/978-1-4614-0920-5]; Sakdapipanich JT, 2007, J BIOSCI BIOENG, V103, P287, DOI 10.1263/jbb.103.287; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Sando T, 2008, BIOSCI BIOTECH BIOCH, V72, P2903, DOI 10.1271/bbb.80387; Silva CC, 2014, MOL BREEDING, V34, P1035, DOI 10.1007/s11032-014-0095-2; Souza LM, 2009, CONSERV GENET RESOUR, V1, P75, DOI 10.1007/s12686-009-9018-7; Souza LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061238; Splicing PRNA, 1998, RNA SECONDARY STRUCT, P15941; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; TANAKA Y, 1989, PLANT PHYSIOL, V90, P1403, DOI 10.1104/pp.90.4.1403; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	68	55	58	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102665	10.1371/journal.pone.0102665	http://dx.doi.org/10.1371/journal.pone.0102665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048025	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100058
J	Savazzi, F; Massaro, D; Di Dio, C; Gallese, V; Gilli, G; Marchetti, A				Savazzi, Federica; Massaro, Davide; Di Dio, Cinzia; Gallese, Vittorio; Gilli, Gabriella; Marchetti, Antonella			Exploring Responses to Art in Adolescence: A Behavioral and Eye-Tracking Study	PLOS ONE			English	Article							BRAIN-DEVELOPMENT; CHILDREN; ATTENTION; THERAPY; MOTION; FMRI	Adolescence is a peculiar age mainly characterized by physical and psychological changes that may affect the perception of one's own and others' body. This perceptual peculiarity may influence the way in which bottom-up and top-down processes interact and, consequently, the perception and evaluation of art. This study is aimed at investigating, by means of the eye-tracking technique, the visual explorative behavior of adolescents while looking at paintings. Sixteen color paintings, categorized as dynamic and static, were presented to twenty adolescents; half of the images represented natural environments and half human individuals; all stimuli were displayed under aesthetic and movement judgment tasks. Participants' ratings revealed that, generally, nature images are explicitly evaluated as more appealing than human images. Eye movement data, on the other hand, showed that the human body exerts a strong power in orienting and attracting visual attention and that, in adolescence, it plays a fundamental role during aesthetic experience. In particular, adolescents seem to approach human-content images by giving priority to elements calling forth movement and action, supporting the embodiment theory of aesthetic perception.	[Savazzi, Federica; Gilli, Gabriella] Univ Cattolica Sacro Cuore, Dept Psychol, Res Unit Psychol Art, I-20123 Milan, Italy; [Massaro, Davide; Marchetti, Antonella] Univ Cattolica Sacro Cuore, Dept Psychol, Res Unit Theory Mind, I-20123 Milan, Italy; [Di Dio, Cinzia; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] Columbia Univ, Dept Art Hist & Archaeol, New York, NY USA; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; University of Parma; Columbia University; Istituto Italiano di Tecnologia - IIT	Savazzi, F (corresponding author), Fdn Don Carlo Gnocchi, IRCCS Santa Maria Nascente, Milan, Italy.	fsavazzi@dongnocchi.it	MARCHETTI, Antonella/AAL-6051-2020; Di Dio, Cinzia/HGB-3168-2022; Marchetti, Antonella/W-2226-2018; Gallese, Vittorio/ABD-5097-2021; Massaro, Davide/K-1233-2019	MARCHETTI, Antonella/0000-0001-9985-0539; Marchetti, Antonella/0000-0001-9985-0539; Gallese, Vittorio/0000-0003-4815-3607; Massaro, Davide/0000-0002-4511-6897	Universita Cattolica del Sacro Cuore	Universita Cattolica del Sacro Cuore	This work was supported by D1 research grant from the Universita Cattolica del Sacro Cuore to AM and GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; [Anonymous], 2009, HDB DEPRESSION; Bell BA, 2010, SAS GLOB FOR 2010; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; BOSELIE F, 1985, AM J PSYCHOL, V98, P1, DOI 10.2307/1422765; Boyer TW, 2006, DEV REV, V26, P291, DOI 10.1016/j.dr.2006.05.002; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Cinzia D, 2009, CURR OPIN NEUROBIOL, V19, P682, DOI 10.1016/j.conb.2009.09.001; Cupchik G.C., 1996, HDB PERCEPTION CONIT, P62; CUPCHIK GC, 1979, SCAND J PSYCHOL, V20, P93, DOI 10.1111/j.1467-9450.1979.tb00688.x; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Falk John Howard, 2000, LEARNING MUSEUMS VIS; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Freeman N. H., 2004, HDB RES POLICY ART E, P359, DOI [10.4324/9781410609939-23., DOI 10.4324/9781410609939-23]; Freeman NH, 2012, ARTE PSICHE SOC PROC, P107; Freeman NH, 2010, ART HUMAN DEV, P185; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2012, ENCY HUMAN BEHAV; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Gori S, 2008, SPATIAL VISION, V21, P201, DOI 10.1163/156856808784532635; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2010, SPIE C SERIES, V7527, P36, DOI [10.1016/j.cag.2009.04.003, DOI 10.1016/J.CAG.2009.04.003]; Harnden B, 2004, ART PSYCHOTHER, V31, P165, DOI 10.1016/j.aip.2004.03.005; Hekker P., 2008, PRODUCT EXPERIENCE, P259, DOI [DOI 10.1016/B978-008045089-6.50013-7, 10.1016/B978-008045089-6.50013-7]; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hooper-Greenhill E., 2010, INT J HERIT STUD, V6, P9, DOI [10.1080/135272500363715, DOI 10.1080/135272500363715]; Hubard OM, 2007, STUD ART EDUC, V48, P247, DOI 10.2307/25475828; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P755, DOI 10.2466/PMS.95.7.755-766; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kramer AF, 2005, DEV PSYCHOL, V41, P760, DOI 10.1037/0012-1649.41.5.760; Ladouceur CD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00065; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Linesch D., 1988, ADOLESCENT ART THERA; Locher P. J., 2006, PSYCHOL SCI, V48, P106, DOI DOI 10.1198/016214504000000683; Locher P, 2008, SPATIAL VISION, V21, P55, DOI 10.1163/156856808782713762; Locher PJ, 1996, EMPIRICAL STUDIES AR, DOI [10.1198/016214504000000683, DOI 10.1198/016214504000000683]; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; Massaro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037285; Millis K, 2008, DISCOURSE PROCESS, V45, P263, DOI 10.1080/01638530802070015; Monk CS, 2003, NEUROIMAGE, V20, P420, DOI 10.1016/S1053-8119(03)00355-0; Moon B, 1999, ART THERAPY J AM ART, V16, P78, DOI [10.1080/07421656.1999.10129671, DOI 10.1080/07421656.1999.10129671]; Parsons M. J., 1987, WE UNDERSTAND ART CO; Pihko E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00094; Ramachandran V.S., 1999, J CONSCIOUSNESS STUD, V6, P15, DOI [10.1179/174327908X392906, DOI 10.1179/174327908X392906]; Riley S, 2001, WESTERN J MED, V175, P54, DOI 10.1136/ewjm.175.1.54; Ritchhart R, 2007, J MUS EDUC, V32, P137; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Ronconi L, 2013, BRAIN COGNITION, V82, P213, DOI 10.1016/j.bandc.2013.04.006; Ronconi L, 2013, CORTEX, V49, P1025, DOI 10.1016/j.cortex.2012.03.005; Ronconi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049019; Santella A., 2004, P EYE TRACKING RES A, P27, DOI DOI 10.1145/968363.968368; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Tishman S., 2006, ARTFUL THINKING FINA; Wallraven C, 2009, COMPUT GRAPH-UK, V33, P484, DOI 10.1016/j.cag.2009.04.003; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yates TM, 2004, CLIN PSYCHOL REV, V24, P35, DOI 10.1016/j.cpr.2003.10.001; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T	68	21	21	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102888	10.1371/journal.pone.0102888	http://dx.doi.org/10.1371/journal.pone.0102888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25048813	Green Published, gold			2022-12-27	WOS:000339558100085
J	Wang, YF; Du, FX; Zhao, HY; Yu, XH; Liu, J; Xiao, Y; Lu, CZ; Li, X; Wang, YL; Wang, B; Niu, WQ				Wang, Yuefei; Du, Fengxia; Zhao, Hongye; Yu, Xiaohong; Liu, Jun; Xiao, Yu; Lu, Changzhu; Li, Xue; Wang, Yanli; Wang, Bin; Niu, Wenquan			Synergistic Association between Two Alcohol Metabolism Relevant Genes and Coronary Artery Disease among Chinese Hypertensive Patients	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; ALDH2 GLU504LYS POLYMORPHISM; HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; HAN CHINESE; METAANALYSIS; EPISTASIS; GENETICS; JAPANESE	Objective: Coronary artery disease (CAD) is a multifactorial and polygenic disease. The aim of this study was to examine the association between six polymorphisms of four alcohol metabolism relevant genes (ADH1B, ADH1C, ALDH1b1, ALDH2) and the risk of CAD in Han Chinese. Methods and Results: This was a hospital-based case-control study involving 1365 hypertensive patients. All study subjects were angiographically confirmed. Genotypes were determined with ligase detection reaction method. There was no observable deviation from the Hardy-Weinberg equilibrium for six examined polymorphisms in controls. The genotype and allele distributions of ALDH1b1 rs2073478 and ALDH2 rs671 polymorphisms differed significantly between the two groups (P# 0.005), even after the Bonferroni correction. The most common allele combination was A-C-C-G-C-G (alleles in order of rs1229984, rs1693482, rs2228093, rs2073478, rs886205, rs671) and its frequency was slightly higher in controls than in CAD patients (P = 0.067). After assigning the most common allele combination as a reference, allele combination A-C-C-T-C-A, which simultaneously possessed the risk alleles of rs2073478 and rs671 polymorphisms, was associated with a 1.80-fold greater risk of CAD. Further, a two-locus model including rs2073478 and rs671 that had a maximal testing accuracy of 0.598 and a cross-validation consistency of 10 (P = 0.008) was deemed as the overall best MDR model, which was further validated by classical Logistic regression model. Conclusion: Our findings provide clear evidence for both individual and interactive associations of ALDH1b1 and ALDH2 genes with the development of CAD in Han Chinese.	[Wang, Yuefei; Zhao, Hongye; Xiao, Yu; Lu, Changzhu; Li, Xue; Wang, Bin] Qiqihar Med Univ, Dept Physiol, Qiqihar, Heilongjiang, Peoples R China; [Du, Fengxia] Qiqihar Med Univ, Dept Etiol, Qiqihar, Heilongjiang, Peoples R China; [Yu, Xiaohong; Liu, Jun] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian, Liaoning, Peoples R China; [Wang, Yanli] Qiqihar Med Univ, Div Cardiol 3, Dept Internal Med, Affiliated Hosp 2, Qiqihar, Heilongjiang, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China	Qiqihar Medical University; Qiqihar Medical University; Dalian Medical University; Qiqihar Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, B (corresponding author), Qiqihar Med Univ, Dept Physiol, Qiqihar, Heilongjiang, Peoples R China.	wangbinqqhr@163.com; niuwenquan_shcn@163.com			Department of Education Science and Technology Research Project in Heilongjiang Province [12521621]; Shanghai Rising Star Program [11QA1405500]	Department of Education Science and Technology Research Project in Heilongjiang Province; Shanghai Rising Star Program	This study received grants from the Department of Education Science and Technology Research Project in Heilongjiang Province (12521621), and the Shanghai Rising Star Program (11QA1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Lorgeril M, 2004, HEART, V90, P355, DOI 10.1136/hrt.2003.022350; de Lorgeril M, 2002, CIRCULATION, V106, P1465, DOI 10.1161/01.CIR.0000029745.63708.E9; Gemayel Carol, 2002, Cardiol Rev, V10, P182, DOI 10.1097/00045415-200205000-00007; Gu JY, 2014, ARCH MED RES, V45, P76, DOI 10.1016/j.arcmed.2013.10.002; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Guo YJ, 2010, ATHEROSCLEROSIS, V211, P545, DOI 10.1016/j.atherosclerosis.2010.03.030; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han HG, 2013, GENE, V526, P134, DOI 10.1016/j.gene.2013.05.002; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Khanna M, 1999, ONCOGENE, V18, P27, DOI 10.1038/sj.onc.1202291; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lieb W, 2013, CIRCULATION, V128, P1131, DOI 10.1161/CIRCULATIONAHA.113.005350; Lieb W, 2013, HYPERTENSION, V61, P995, DOI 10.1161/HYPERTENSIONAHA.111.00275; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Qi Y, 2008, EUR J EPIDEMIOL, V23, P143, DOI 10.1007/s10654-007-9208-0; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Roberts R, 2012, CURR OPIN CARDIOL, V27, P221, DOI 10.1097/HCO.0b013e3283515b4b; Stewart SH, 2002, NUTR METAB CARDIOVAS, V12, P148; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Takagi S, 2002, HYPERTENS RES, V25, P677; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Wang Hongju, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P542; Wang Q, 2013, DNA CELL BIOL, V32, P393, DOI 10.1089/dna.2013.1995; Wild SH, 2006, BMJ-BRIT MED J, V333, P1009, DOI 10.1136/bmj.39024.568738.43; Yu XH, 2014, THROMB RES, V133, P229, DOI 10.1016/j.thromres.2013.11.017; Yu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076966; Zintzaras E, 2008, ARCH INTERN MED, V168, P1077, DOI 10.1001/archinte.168.10.1077	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103161	10.1371/journal.pone.0103161	http://dx.doi.org/10.1371/journal.pone.0103161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047496	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100111
J	Korucuoglu, M; Isci, S; Ozgur, A; Otu, HH				Korucuoglu, Melike; Isci, Senol; Ozgur, Arzucan; Otu, Hasan H.			Bayesian Pathway Analysis of Cancer Microarray Data	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR P53; GENE-SET APPROACH; METASTASIS; PROGRESSION; DISCOVERY; GROWTH; MODEL	High Throughput Biological Data (HTBD) requires detailed analysis methods and from a life science perspective, these analysis results make most sense when interpreted within the context of biological pathways. Bayesian Networks (BNs) capture both linear and nonlinear interactions and handle stochastic events in a probabilistic framework accounting for noise making them viable candidates for HTBD analysis. We have recently proposed an approach, called Bayesian Pathway Analysis (BPA), for analyzing HTBD using BNs in which known biological pathways are modeled as BNs and pathways that best explain the given HTBD are found. BPA uses the fold change information to obtain an input matrix to score each pathway modeled as a BN. Scoring is achieved using the Bayesian-Dirichlet Equivalent method and significance is assessed by randomization via bootstrapping of the columns of the input matrix. In this study, we improve on the BPA system by optimizing the steps involved in "Data Preprocessing and Discretization'', "Scoring'', "Significance Assessment'', and "Software and Web Application''. We tested the improved system on synthetic data sets and achieved over 98% accuracy in identifying the active pathways. The overall approach was applied on real cancer microarray data sets in order to investigate the pathways that are commonly active in different cancer types. We compared our findings on the real data sets with a relevant approach called the Signaling Pathway Impact Analysis (SPIA).	[Korucuoglu, Melike; Ozgur, Arzucan] Bogazici Univ Bebek, Dept Comp Engn, Istanbul, Turkey; [Isci, Senol] Sci & Technol Res Council Turkey TUBITAK, Informat & Informat Secur Res Ctr, Gebze, Kocaeli, Turkey; [Otu, Hasan H.] Istanbul Bilgi Univ, Dept Genet & Bioengn, Istanbul, Turkey; [Otu, Hasan H.] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA	Bogazici University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Istanbul Bilgi University; University of Nebraska System; University of Nebraska Lincoln	Otu, HH (corresponding author), Istanbul Bilgi Univ, Dept Genet & Bioengn, Santral Campus, Istanbul, Turkey.	hotu2@unl.edu	Ozgur, Arzucan/I-3147-2012	Ozgur, Arzucan/0000-0001-8376-1056; Otu, Hasan/0000-0002-9253-8152	Scientific and Technological Research Council of Turkey (TUBITAK) [111E042]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) grant number 111E042 (HHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chaker S, 2013, THYROID, V23, P201, DOI 10.1089/thy.2012.0405; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Drier Y, 2013, P NATL ACAD SCI USA, V110, P6388, DOI 10.1073/pnas.1219651110; Edwards D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-167; England B, 2013, TUMOR BIOL, V34, P2063, DOI 10.1007/s13277-013-0871-3; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffiths TRL, 1996, BRIT J CANCER, V74, P579, DOI 10.1038/bjc.1996.404; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Hayakawa K, 2009, ANTICANCER RES, V29, P1211; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Imoto Seiya, 2003, J Bioinform Comput Biol, V1, P231, DOI 10.1142/S0219720003000071; Isci S, 2011, BIOINFORMATICS, V27, P1667, DOI 10.1093/bioinformatics/btr269; Jagannathan L, 2012, GENE, V494, P130, DOI 10.1016/j.gene.2011.11.031; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Kontkanen P, 2007, INFORM PROCESS LETT, V103, P227, DOI 10.1016/j.ipl.2007.04.003; Krupp M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-53; Lane N., 2009, LIFE ASCENDING 10 GR; Lang K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-27; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Li J, 2012, J HUM GENET, V57, P642, DOI 10.1038/jhg.2012.86; Li SZ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r115; Li Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-520; Lu M, 2014, FEBS LETT; Lu Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn434; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Mieczkowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041541; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Murase D, 2009, J BIOL CHEM, V284, P4343, DOI 10.1074/jbc.M805570200; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rissanen JJ, 1996, IEEE T INFORM THEORY, V42, P40, DOI 10.1109/18.481776; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sehgal A, 1998, INT J CANCER, V76, P451, DOI 10.1002/(SICI)1097-0215(19980518)76:4<451::AID-IJC1>3.0.CO;2-Q; Silander T, 2010, INT J APPROX REASON, V51, P544, DOI 10.1016/j.ijar.2010.01.012; Spirtes P., 1995, P 11 C UNC ART INT, P491; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang PI, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r125; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Zastre JA, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-16; [No title captured]; [No title captured]	60	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102803	10.1371/journal.pone.0102803	http://dx.doi.org/10.1371/journal.pone.0102803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036210	Green Published, gold			2022-12-27	WOS:000339615200089
J	Zanardelli, M; Micheli, L; Cinci, L; Failli, P; Ghelardini, C; Mannelli, LD				Zanardelli, Matteo; Micheli, Laura; Cinci, Lorenzo; Failli, Paola; Ghelardini, Carla; Mannelli, Lorenzo Di Cesare			Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPAR gamma Agonism as Preventive Pharmacological Approach	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INDUCED OXIDATIVE STRESS; DOPAMINERGIC NEURODEGENERATION; 1ST-LINE TREATMENT; COLORECTAL-CANCER; NERVOUS-SYSTEM; ROSIGLITAZONE; BRAIN; RAT; INFLAMMATION	The development of neuropathic syndromes is an important, dose limiting side effect of anticancer agents like platinum derivates, taxanes and vinca alkaloids. The causes of neurotoxicity are still unclear but the impairment of the oxidative equilibrium is strictly related to pain. Two intracellular organelles, mitochondria and peroxisomes cooperate to the maintaining of the redox cellular state. Whereas a relationship between chemotherapy-dependent mitochondrial alteration and neuropathy has been established, the role of peroxisome is poor explored. In order to study the mechanisms of oxaliplatin-induced neurotoxicity, peroxisomal involvement was evaluated in vitro and in vivo. In primary rat astrocyte cell culture, oxaliplatin (10 mu M for 48 h or 1 mu M for 5 days) increased the number of peroxisomes, nevertheless expression and functionality of catalase, the most important antioxidant defense enzyme in mammalian peroxisomes, were significantly reduced. Five day incubation with the selective Peroxisome Proliferator Activated Receptor-gamma (PPAR-gamma) antagonist G3335 (30 mu M) induced a similar peroxisomal impairment suggesting a relationship between PPAR gamma signaling and oxaliplatin neurotoxicity. The PPAR gamma agonist rosiglitazone (10 mu M) reduced the harmful effects induced both by G3335 and oxaliplatin. In vivo, in a rat model of oxaliplatin induced neuropathy, a repeated treatment with rosiglitazone (3 and 10 mg kg(-1) per os) significantly reduced neuropathic pain evoked by noxious (Paw pressure test) and non-noxious (Cold plate test) stimuli. The behavioral effect paralleled with the prevention of catalase impairment induced by oxaliplatin in dorsal root ganglia. In the spinal cord, catalase protection was showed by the lower rosiglitazone dosage without effect on the astrocyte density increase induced by oxaliplatin. Rosiglitazone did not alter the oxaliplatin-induced mortality of the human colon cancer cell line HT-29. These results highlight the role of peroxisomes in oxaliplatin-dependent nervous damage and suggest PPAR gamma stimulation as a candidate to counteract oxaliplatin neurotoxicity.	[Zanardelli, Matteo; Micheli, Laura; Cinci, Lorenzo; Failli, Paola; Ghelardini, Carla; Mannelli, Lorenzo Di Cesare] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba Pharmacol & Toxicol Sect, Florence, Italy	University of Florence	Mannelli, LD (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Neurofarba Pharmacol & Toxicol Sect, Florence, Italy.	lorenzo.mannelli@unifi.it	; Di Cesare Mannelli, Lorenzo/A-1641-2015	GHELARDINI, CARLA/0000-0001-9856-8144; Di Cesare Mannelli, Lorenzo/0000-0001-8374-4432; Micheli, Laura/0000-0001-8834-5801; Cinci, Lorenzo/0000-0002-1799-4828; Failli, Paola/0000-0003-3879-9068	Italian Ministry of Instruction, University and Research (MIUR); University of Florence	Italian Ministry of Instruction, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Florence	This research was funded by the Italian Ministry of Instruction, University and Research (MIUR) and by the University of Florence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benedusi V, 2012, J BIOL CHEM, V287, P35899, DOI 10.1074/jbc.M112.366419; Bernardo A, 2008, PPAR RES, V2008, DOI 10.1155/2008/864140; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; Bottelbergs A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-61; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Carniglia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057313; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Chen YM, 2001, GLIA, V33, P343, DOI 10.1002/1098-1136(20010315)33:4<343::AID-GLIA1033>3.0.CO;2-H; Choi JH, 2007, EUR J PHARMACOL, V571, P106, DOI 10.1016/j.ejphar.2007.06.042; Cimini A, 2009, J ALZHEIMERS DIS, V18, P935, DOI 10.3233/JAD-2009-1199; Crosby MB, 2006, CLIN IMMUNOL, V118, P276, DOI 10.1016/j.clim.2005.09.018; D'Amico A, 2013, HAND CLINIC, V113, P1437, DOI 10.1016/B978-0-444-59565-2.00013-7; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; ELLIOTT BM, 1986, CARCINOGENESIS, V7, P795, DOI 10.1093/carcin/7.5.795; Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.10206; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Gray E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-63; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Han CH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-495; Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Joshi H, 2014, EXPERT OPIN INV DRUG, V23, P501, DOI 10.1517/13543784.2014.884708; Kamboj SS, 2010, J NEUROCHEM, V112, P77, DOI 10.1111/j.1471-4159.2009.06435.x; Kannarkat G, 2007, CURR OPIN NEUROL, V20, P719; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Kou JQ, 2011, ACTA NEUROPATHOL, V122, P271, DOI 10.1007/s00401-011-0836-9; Landreth G, 2008, NEUROTHERAPEUTICS, V5, P481, DOI 10.1016/j.nurt.2008.05.003; Lee EY, 2012, TOXICOL LETT, V213, P332, DOI 10.1016/j.toxlet.2012.07.016; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; LEIGHTON GE, 1988, BRIT J PHARMACOL, V93, P553, DOI 10.1111/j.1476-5381.1988.tb10310.x; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Mannelli LD, 2013, FREE RADICAL BIO MED, V61, P143, DOI 10.1016/j.freeradbiomed.2013.03.019; Mannelli LD, 2014, NEUROPHARMACOLOGY, V79, P37, DOI 10.1016/j.neuropharm.2013.10.034; Mannelli LD, 2012, J PAIN, V13, P276, DOI 10.1016/j.jpain.2011.11.009; Masoud A, 2012, HUM EXP TOXICOL, V31, P1214, DOI 10.1177/0960327112446842; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Morrison JG, 2000, J PHARMACEUT BIOMED, V24, P1, DOI 10.1016/S0731-7085(00)00377-0; Napolitano M, 2011, BRAIN RES BULL, V85, P231, DOI 10.1016/j.brainresbull.2011.03.011; Perdomo MC, 2011, DOMEST ANIM ENDOCRIN, V41, P118, DOI 10.1016/j.domaniend.2011.05.005; Powers JM, 1998, BRAIN PATHOL, V8, P101; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 1999, P NUTR SOC, V58, P1025, DOI 10.1017/S0029665199001342; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Raikwar HP, 2006, J NEUROIMMUNOL, V178, P76, DOI 10.1016/j.jneuroim.2006.05.013; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ribeiro D, 2012, HISTOL HISTOPATHOL, V27, P661, DOI 10.14670/HH-27.661; Salvemini D, 2010, LIFE SCI, V86, P604, DOI 10.1016/j.lfs.2009.06.011; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Sheu WHH, 2011, J PHARMACEUT BIOMED, V54, P759, DOI 10.1016/j.jpba.2010.10.008; Souglakos J, 2002, J CLIN ONCOL, V20, P2651, DOI 10.1200/JCO.2002.08.015; Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Sun H, 2012, NEUROL SCI, V33, P559, DOI 10.1007/s10072-011-0774-2; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Trompier D, 2014, BIOCHIMIE, V98, P102, DOI 10.1016/j.biochi.2013.09.009; Venkateshappa C, 2012, NEUROCHEM RES, V37, P1601, DOI 10.1007/s11064-012-0755-8; Wang B, 2013, FREE RADICAL BIO MED, V65, P882, DOI 10.1016/j.freeradbiomed.2013.08.173; Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018; Ye F, 2006, CHEMBIOCHEM, V7, P74, DOI 10.1002/cbic.200500186; Zanardelli M, 2013, P 36 C IT SOC PHARM; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	78	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102758	10.1371/journal.pone.0102758	http://dx.doi.org/10.1371/journal.pone.0102758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036594	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200084
J	Depiereux, S; Liagre, M; Danis, L; De Meulder, B; Depiereux, E; Segner, H; Kestemont, P				Depiereux, Sophie; Liagre, Melanie; Danis, Lorraine; De Meulder, Bertrand; Depiereux, Eric; Segner, Helmut; Kestemont, Patrick			Intersex Occurrence in Rainbow Trout (Oncorhynchus mykiss) Male Fry Chronically Exposed to Ethynylestradiol	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; ENDOCRINE DISRUPTING CHEMICALS; MOLECULAR SEX-DIFFERENTIATION; GENE-EXPRESSION; MESSENGER-RNA; SALMO-TRUTTA; ENVIRONMENTAL CONCENTRATIONS; GONADAL DIFFERENTIATION; PLASMA VITELLOGENIN; ESTROGENIC EXPOSURE	This study aimed to investigate the male-to-female morphological and physiological transdifferentiation process in rainbow trout (Oncorhynchus mykiss) exposed to exogenous estrogens. The first objective was to elucidate whether trout develop intersex gonads under exposure to low levels of estrogen. To this end, the gonads of an all-male population of fry exposed chronically (from 60 to 136 days post fertilization - dpf) to several doses (from environmentally relevant 0.01 mu g/L to supra-environmental levels: 0.1, 1 and 10 mu g/L) of the potent synthetic estrogen ethynylestradiol (EE2) were examined histologically. The morphological evaluations were underpinned by the analysis of gonad steroid (testosterone, estradiol and 11-ketotestosterone) levels and of brain and gonad gene expression, including estrogen-responsive genes and genes involved in sex differentiation in (gonads: cyp19a1a, ER isoforms, vtg, dmrt1, sox9a2; sdY; cyp11b; brain: cyp19a1b, ER isoforms). Intersex gonads were observed from the first concentration used (0.01 mu g EE2/L) and sexual inversion could be detected from 0.1 mg EE2/L. This was accompanied by a linear decrease in 11-KT levels, whereas no effect on E2 and T levels was observed. Q-PCR results from the gonads showed downregulation of testicular markers (dmrt1, sox9a2; sdY; cyp11b) with increasing EE2 exposure concentrations, and upregulation of the female vtg gene. No evidence was found for a direct involvement of aromatase in the sex conversion process. The results from this study provide evidence that gonads of male trout respond to estrogen exposure by intersex formation and, with increasing concentration, by morphological and physiological conversion to phenotypic ovaries. However, supra-environmental estrogen concentrations are needed to induce these changes.	[Depiereux, Sophie; Liagre, Melanie; Danis, Lorraine; Kestemont, Patrick] Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium; [De Meulder, Bertrand; Depiereux, Eric] Univ Namur, Unit Res Mol Biol URBM NARILIS, Namur, Belgium; [Segner, Helmut] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Bern, Switzerland	University of Namur; University of Namur; University of Bern	Depiereux, S (corresponding author), Univ Namur, Lab Ecophysiol & Ecotoxicol, Unit Res Environm & Evolutionary Biol URBE NARILI, Namur, Belgium.	sophiedepiereux@gmail.com; patrick.kestemont@unamur.be	PANIS, CAROLINA/AAM-7214-2021	PANIS, CAROLINA/0000-0002-0104-4369	Fonds de la Recherche Scientifique - FNRS, Belgium [FC 83738]	Fonds de la Recherche Scientifique - FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS)	Fonds de la Recherche Scientifique - FNRS, Belgium, grant number: FC 83738 (http://www.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann GE, 2002, AQUAT TOXICOL, V60, P203, DOI 10.1016/S0166-445X(02)00003-6; Aguayo S, 2004, SCI TOTAL ENVIRON, V328, P69, DOI 10.1016/j.scitotenv.2004.02.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auriol M, 2006, PROCESS BIOCHEM, V41, P525, DOI 10.1016/j.procbio.2005.09.017; Babin Patrick J., 2007, P39, DOI 10.1007/978-1-4020-6235-3_2; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; Baron D, 2005, MOL REPROD DEV, V71, P471, DOI 10.1002/mrd.20229; Bernet D, 2004, DIS AQUAT ORGAN, V61, P137, DOI 10.3354/dao061137; BILLARD R, 1992, AQUACULTURE, V100, P263, DOI 10.1016/0044-8486(92)90385-X; Billard R, 1973, C AQ BREST FRANC, P161; Bjerregaard LB, 2006, ECOTOXICOLOGY, V15, P315, DOI 10.1007/s10646-006-0061-9; Bjerregaard LB, 2008, ECOTOXICOLOGY, V17, P252, DOI 10.1007/s10646-008-0192-2; Bogdal C, 2009, CHEMOSPHERE, V74, P434, DOI 10.1016/j.chemosphere.2008.09.058; Bon E, 1997, COMP BIOCHEM PHYS B, V117, P75, DOI 10.1016/S0305-0491(96)00252-0; Boyce-Derricott J, 2009, GEN COMP ENDOCR, V161, P73, DOI 10.1016/j.ygcen.2008.11.022; Boyce-Derricott J, 2010, MOL CELL ENDOCRINOL, V315, P277, DOI 10.1016/j.mce.2009.09.032; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Brown KH, 2007, REPRODUCTION, V134, P659, DOI 10.1530/REP-07-0169; Burki R, 2006, ENVIRON TOXICOL CHEM, V25, P2077, DOI 10.1897/05-545R.1; Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q; Cavileer T, 2009, SEX DEV, V3, P214, DOI 10.1159/000228722; Chakraborty T, 2011, MOL CELL ENDOCRINOL, V333, P47, DOI 10.1016/j.mce.2010.12.002; Cheshenko K, 2008, GEN COMP ENDOCR, V155, P31, DOI 10.1016/j.ygcen.2007.03.005; Christiansen LB, 1998, MAR ENVIRON RES, V46, P137, DOI 10.1016/S0141-1136(97)00047-0; Cousin M, 1988, EFFETS METHYLTESTOST; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; Dagnelie P., 1998, STAT THEORIQUE APPL; Dalla Valle L, 2005, J STEROID BIOCHEM, V94, P49, DOI 10.1016/j.jsbmb.2005.01.010; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dietrich DR, 2009, HISTOLOGICAL ANAL EN; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Filby AL, 2005, BIOL REPROD, V73, P648, DOI 10.1095/biolreprod.105.039701; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; FOSTIER A, 1986, FISH PHYSIOL BIOCHEM, V2, P87, DOI 10.1007/BF02264076; Grier H. J., 1993, SERTOLI CELL, P704; Grier HJ, 2007, J MORPHOL, V268, P293, DOI 10.1002/jmor.10518; Grier HJ, 2002, 53 GCFI, V53; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Hecker M, 2006, REV ENVIRON CONTAM T, V187, P103, DOI 10.1007/0-387-32885-8_3; Hirakawa I, 2012, CHEMOSPHERE, V87, P668, DOI 10.1016/j.chemosphere.2011.12.047; Jalabert B, 2010, TRUITE ARC EN CIEL B; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; JOHNSTONE R, 1978, AQUACULTURE, V13, P115, DOI 10.1016/0044-8486(78)90106-0; Katsu Y, 2007, ENVIRON SCI TECHNOL, V41, P3368, DOI 10.1021/es062797l; Kazeto Y, 2004, AQUAT TOXICOL, V69, P25, DOI 10.1016/j.aquatox.2004.04.008; KESTEMONT P, 1989, J APPL ICHTHYOL, V5, P111, DOI 10.1111/j.1439-0426.1989.tb00482.x; Kishida M, 2001, COMP BIOCHEM PHYS B, V129, P261, DOI 10.1016/S1096-4959(01)00319-0; Korner O, 2007, AQUAT SCI, V69, P26, DOI 10.1007/s00027-006-0842-5; Kortner TM, 2009, GEN COMP ENDOCR, V164, P91, DOI 10.1016/j.ygcen.2009.05.009; Krisfalusi M, 2000, MOL REPROD DEV, V56, P495, DOI 10.1002/1098-2795(200008)56:4&lt;495::AID-MRD7&gt;3.0.CO;2-E; Lange A, 2009, ENVIRON SCI TECHNOL, V43, P1219, DOI 10.1021/es802661p; Lange A, 2008, TOXICOL SCI, V106, P113, DOI 10.1093/toxsci/kfn151; LEBRUN C, 1982, REPROD NUTR DEV, V22, P405, DOI 10.1051/rnd:19820312; Legler J, 2002, SCI TOTAL ENVIRON, V293, P69, DOI 10.1016/S0048-9697(01)01146-9; LEROUX MG, 1993, BIOCHIM BIOPHYS ACTA, V1172, P226, DOI 10.1016/0167-4781(93)90302-T; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lyssimachou A, 2006, TOXICOL SCI, V91, P82, DOI 10.1093/toxsci/kfj136; MacKay ME, 1996, COMP BIOCHEM PHYS C, V115, P201, DOI 10.1016/S0742-8413(96)00093-X; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; McMillan Donald B., 2007, pIX; Melamed P, 2005, MOL ASP FISH MAR BIO; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nadzialek S, 2011, ARCH ENVIRON CON TOX, V60, P471, DOI 10.1007/s00244-010-9548-8; Nagler JJ, 2007, GENE, V392, P164, DOI 10.1016/j.gene.2006.12.030; Nagler JJ, 2000, J MOL ENDOCRINOL, V25, P243, DOI 10.1677/jme.0.0250243; Orn S, 2003, AQUAT TOXICOL, V65, P397, DOI 10.1016/S0166-445X(03)00177-2; Palace VP, 2009, CAN J FISH AQUAT SCI, V66, P1920, DOI 10.1139/F09-125; Pandian TJ, 1995, AQUACULTURE, V138, P1, DOI 10.1016/0044-8486(95)01075-0; Pellegrini E, 2005, GEN COMP ENDOCR, V142, P60, DOI 10.1016/j.ygcen.2004.12.003; Piferrer F, 2001, AQUACULTURE, V197, P229, DOI 10.1016/S0044-8486(01)00589-0; Porter CM, 2003, ECOTOX ENVIRON SAFE, V54, P199, DOI 10.1016/S0147-6513(02)00056-8; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Quillett E, 2004, J FISH BIOL, V64, P1147, DOI 10.1111/j.1095-8649.2004.00373.x; Routledge EJ, 1998, ENVIRON SCI TECHNOL, V32, P1559, DOI 10.1021/es970796a; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabo-Attwood T, 2004, MOL CELL ENDOCRINOL, V218, P107, DOI 10.1016/j.mce.2003.12.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz S, 2000, AQUAT TOXICOL, V50, P363, DOI 10.1016/S0166-445X(00)00090-4; Schubert S, 2008, AQUAT TOXICOL, V90, P65, DOI 10.1016/j.aquatox.2008.08.002; Schwaiger J, 2002, AQUAT TOXICOL, V59, P177, DOI 10.1016/S0166-445X(01)00248-X; Segner H, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P1145, DOI 10.1016/B978-0-12-382032-7.10086-4; Sheahan DA, 1994, CHRONIC EFFECTS POLL, P99; Simpson T, 1976, COUNC EXPLOR SEA, V6; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; TAKASHIMA F, 1980, B JPN SOC SCI FISH, V46, P1317; Tarrant H, 2008, ENVIRON TOXICOL CHEM, V27, P1773, DOI 10.1897/07-436; Upadhyay SN, 1977, MORPHOLOGIE GONADES; van Aerle R, 2001, ENVIRON TOXICOL CHEM, V20, P2841, DOI 10.1002/etc.5620201225; VANDENHURK R, 1979, CELL TISSUE RES, V199, P289, DOI 10.1007/BF00236140; Verslycke T, 2002, COMP BIOCHEM PHYS C, V132, P483, DOI 10.1016/S1532-0456(02)00111-4; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Vizziano-Cantonnet D, 2008, J MOL ENDOCRINOL, V41, P277, DOI 10.1677/JME-08-0039; Watson CS, 2007, STEROIDS, V72, P124, DOI 10.1016/j.steroids.2006.11.002; Weber LP, 2003, AQUAT TOXICOL, V63, P431, DOI 10.1016/S0166-445X(02)00208-4; Yano A, 2012, CURR BIOL NULL	100	35	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e98531	10.1371/journal.pone.0098531	http://dx.doi.org/10.1371/journal.pone.0098531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033040	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300002
J	Suzukawa, K; Tomlin, J; Pak, K; Chavez, E; Kurabi, A; Baird, A; Wasserman, SI; Ryan, AF				Suzukawa, Keigo; Tomlin, Julia; Pak, Kwang; Chavez, Eduardo; Kurabi, Arwa; Baird, Andrew; Wasserman, Stephen I.; Ryan, Allen F.			A Mouse Model of Otitis Media Identifies HB-EGF as a Mediator of Inflammation-Induced Mucosal Proliferation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; MIDDLE-EAR MUCOSA; PROHB-EGF; EXPRESSION; RECEPTOR; INDUCTION; DIFFERENTIATION; REGENERATION; PNEUMONIAE	Objective: Otitis media is one of the most common pediatric infections. While it is usually treated without difficulty, up to 20% of children may progress to long-term complications that include hearing loss, impaired speech and language development, academic underachievement, and irreversible disease. Hyperplasia of middle ear mucosa contributes to the sequelae of acute otitis media and is of important clinical significance. Understanding the role of growth factors in the mediation of mucosal hyperplasia could lead to the development of new therapeutic interventions for this disease and its sequelae. Methods: From a whole genome gene array analysis of mRNA expression during acute otitis media, we identified growth factors with expression kinetics temporally related to hyperplasia. We then tested these factors for their ability to stimulate mucosal epithelial growth in vitro, and determined protein levels and histological distribution in vivo for active factors. Results: From the gene array, we identified seven candidate growth factors with upregulation of mRNA expression kinetics related to mucosal hyperplasia. Of the seven, only HB-EGF (heparin-binding-epidermal growth factor) induced significant mucosal epithelial hyperplasia in vitro. Subsequent quantification of HB-EGF protein expression in vivo via Western blot analysis confirmed that the protein is highly expressed from 6 hours to 24 hours after bacterial inoculation, while immunohistochemistry revealed production by middle ear epithelial cells and infiltrating lymphocytes. Conclusion: Our data suggest an active role for HB-EGF in the hyperplasia of the middle ear mucosal epithelium during otitis media. These results imply that therapies targeting HB-EGF could ameliorate mucosal growth during otitis media, and thereby reduce detrimental sequelae of this childhood disease.	[Suzukawa, Keigo; Tomlin, Julia; Pak, Kwang; Chavez, Eduardo; Kurabi, Arwa; Ryan, Allen F.] Univ Calif San Diego, Sch Med, Div Otolaryngol, La Jolla, CA 92093 USA; [Suzukawa, Keigo; Tomlin, Julia; Pak, Kwang; Chavez, Eduardo; Kurabi, Arwa; Baird, Andrew; Wasserman, Stephen I.; Ryan, Allen F.] Vet Adm Med Ctr, La Jolla, CA USA; [Baird, Andrew] Univ Calif San Diego, Sch Med, Dept Surg, Div Trauma, La Jolla, CA 92093 USA; [Wasserman, Stephen I.] Univ Calif San Diego, Sch Med, Dept Med, Div Allergy Immunol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego	Ryan, AF (corresponding author), Univ Calif San Diego, Sch Med, Div Otolaryngol, La Jolla, CA 92093 USA.	afryan@ucsd.edu		Baird, Andrew/0000-0003-0027-9905; Noel, Julia/0000-0001-9955-3315	National Institute of Health/National Institute on Deafness and Other Communication Disorders [DC000129, DC012595, DC006279]; Research Service of the VA [BX001205, RS000977]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012595, R01DC000129, R01DC006279] Funding Source: NIH RePORTER	National Institute of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Research Service of the VA; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Grants DC000129 and DC012595 [AFR] and DC006279 [SIW] from the National Institute of Health/National Institute on Deafness and Other Communication Disorders, and BX001205 and RS000977 [AFR] from the Research Service of the VA provided funding and resources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD A, 1989, BRIT MED BULL, V45, P438, DOI 10.1093/oxfordjournals.bmb.a072333; BAIRD A, 1991, CANCER CELL-MON REV, V3, P239; Basbaum C, 2002, NOVART FDN SYMP, V248, P171; Basbaum C., 2002, NOVART FDN SYMP, V248, P277; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Daimon E, 2005, BIOL REPROD, V73, P163, DOI 10.1095/biolreprod.104.038539; DLUZ SM, 1993, J BIOL CHEM, V268, P18330; Ebmeyer J, 2005, J ALLERGY CLIN IMMUN, V116, P1129, DOI 10.1016/j.jaci.2005.07.026; El-Sayed Y, 1998, AM J OTOLARYNG, V19, P149; FUKUDA K, 1995, ARTERIOSCL THROM VAS, V15, P1680, DOI 10.1161/01.ATV.15.10.1680; Furukawa M, 2007, INFECT IMMUN, V75, P2562, DOI 10.1128/IAI.01656-06; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hernandez M, 2008, J INFECT DIS, V198, P1862, DOI 10.1086/593213; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Junttila TT, 2000, TRENDS CARDIOVAS MED, V10, P304, DOI 10.1016/S1050-1738(01)00065-2; Kiml V, 2013, AM J RESP CRIT CARE, V187, P228, DOI 10.1164/rccm.201210-1843CI; KISO S, 1995, HEPATOLOGY, V22, P1584, DOI 10.1016/0270-9139(95)90168-X; KOUTNOUYAN HA, 1994, LARYNGOSCOPE, V104, P350; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kumagai K, 2010, ORAL SURG ORAL MED O, V110, P748, DOI 10.1016/j.tripleo.2010.06.022; Kurabi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061394; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Leibovitz E, 2007, PEDIATR INFECT DIS J, V26, pS8, DOI 10.1097/INF.0b013e318154b24a; Leichtle A, 2010, J IMMUNOL, V184, P3087, DOI 10.4049/jimmunol.0901167; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Lin JQ, 2001, J BIOL CHEM, V276, P30127, DOI 10.1074/jbc.M010237200; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Maw R, 1999, LANCET, V353, P960, DOI 10.1016/S0140-6736(98)05295-7; McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214; Melhus A, 2000, INFECT IMMUN, V68, P4024, DOI 10.1128/IAI.68.7.4024-4031.2000; Melhus A, 2003, APMIS, V111, P989, DOI 10.1034/j.1600-0463.2003.1111012.x; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Morita S, 2007, MOL VIS, V13, P2119; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Ogihara S, 2000, ALIMENT PHARM THERAP, V14, P183, DOI 10.1046/j.1365-2036.2000.014s1183.x; Palacios SD, 2001, LARYNGOSCOPE, V111, P874, DOI 10.1097/00005537-200105000-00022; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Pawankar R, 2007, CURR ALLERGY ASTHM R, V7, P202, DOI 10.1007/s11882-007-0073-4; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; POWELL PP, 1993, AM J PATHOL, V143, P784; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; RYAN AF, 1993, ACTA OTO-LARYNGOL, V113, P68, DOI 10.3109/00016489309135769; Ryan AF, 2006, BRAIN RES, V1091, P3, DOI 10.1016/j.brainres.2006.02.004; Sagmeister S, 2008, J HEPATOL, V49, P955, DOI 10.1016/j.jhep.2008.06.031; Schuknecht HF, 1993, PATHOLOGY EAR, Vxv, P672; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; Swanson KV, 2011, CELL MICROBIOL, V13, P1078, DOI 10.1111/j.1462-5822.2011.01603.x; Takenobu H, 2003, J BIOL CHEM, V278, P17255, DOI 10.1074/jbc.M211835200; Tian C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034944; TOS M, 1977, ANN OTO RHINOL LARYN, V86, P209, DOI 10.1177/000348947708600212; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; VANBLITTERSWIJK CA, 1986, ACTA OTO-LARYNGOL, V101, P453, DOI 10.3109/00016488609108632; Vinante F, 1999, BLOOD, V94, P3169, DOI 10.1182/blood.V94.9.3169.421k30_3169_3177; Virok D, 2003, J INFECT DIS, V188, P1310, DOI 10.1086/379047; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; World Health Organization, 2004, CHRON SUPP OT MED BU; WRIGHT CG, 1994, ANN OTO RHINOL LARYN, V103, P24, DOI 10.1177/00034894941030S507; Yamashita T, 2009, J INVEST DERMATOL, V129, P262, DOI 10.1038/jid.2008.366	69	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102739	10.1371/journal.pone.0102739	http://dx.doi.org/10.1371/journal.pone.0102739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033458	Green Published, gold			2022-12-27	WOS:000339418300086
J	Zhang, WX; Ming, QZ; Shi, ZT; Chen, GJ; Niu, J; Lei, GL; Chang, FQ; Zhang, HC				Zhang, Wenxiang; Ming, Qingzhong; Shi, Zhengtao; Chen, Guangjie; Niu, Jie; Lei, Guoliang; Chang, Fengqin; Zhang, Hucai			Lake Sediment Records on Climate Change and Human Activities in the Xingyun Lake Catchment, SW China	PLOS ONE			English	Article							LATE QUATERNARY; ENVIRONMENTAL-CHANGES; ORGANIC-MATTER; LACUSTRINE SEDIMENTS; LATE PLEISTOCENE; GRAIN-SIZE; NW CHINA; PLATEAU; MONSOON; CARBON	Sediments from Xinyun Lake in central Yunnan, southwest China, provide a record of environmental history since the Holocene. With the application of multi-proxy indicators (total organic carbon (TOC), total nitrogen (TN), delta C-13 and delta N-15 isotopes, C/N ratio, grain size, magnetic susceptibility (MS) and CaCO3 content), as well as accelerator mass spectrometry (AMS) C-14 datings, four major climatic stages during the Holocene have been identified in Xingyun's catchment. A marked increase in lacustrine palaeoproductivity occurred from 11.06 to 9.98 cal. ka BP, which likely resulted from an enhanced Asian southwest monsoon and warm-humid climate. Between 9.98 and 5.93 cal. ka BP, a gradually increased lake level might have reached the optimum water depth, causing a marked decline in coverage by aquatic plants and lake productivity of the lake. This was caused by strong Asian southwest monsoon, and coincided with the global Holocene Optimum. During the period of 5.60-1.35 cal. ka BP, it resulted in a warm and dry climate at this stage, which is comparable to the aridification of India during the mid- and late Holocene. The intensifying human activity and land-use in the lake catchment since the early Tang Dynasty(similar to 1.35 cal. ka BP) were associated with the ancient Dian culture within Xingyun's catchment. The extensive deforestation and development of agriculture in the lake catchment caused heavy soil loss. Our study clearly shows that long-term human activities and land-use change have strongly impacted the evolution of the lake environment and therefore modulated the sediment records of the regional climate in central Yunnan for more than one thousand years.	[Zhang, Wenxiang; Ming, Qingzhong; Shi, Zhengtao; Chen, Guangjie; Niu, Jie; Chang, Fengqin; Zhang, Hucai] Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Key Lab Plateau Surface Proc & Environm Changes Y, Kunming, Peoples R China; [Lei, Guoliang] Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou, Peoples R China	Yunnan Normal University	Zhang, HC (corresponding author), Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Key Lab Plateau Surface Proc & Environm Changes Y, Kunming, Peoples R China.	hucaizhang@yahoo.com	Chen, Guangjie/AEO-1991-2022; Chen, Guangjie/J-3826-2017	Chen, Guangjie/0000-0001-8035-6565	National Natural Science Foundation of China [41201204, U1133601, U0933604, 41101189]; Key Science Research Foundation of the Education Department of Yunnan Province [2012Z014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science Research Foundation of the Education Department of Yunnan Province	This research was supported by the National Natural Science Foundation of China (Grant No. 41201204, U1133601, U0933604 and 41101189) and the Key Science Research Foundation of the Education Department of Yunnan Province (Grant No. 2012Z014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascomb CL, 1961, CHEM IND, V45, P1826; Bellwood, 2005, 1 FARM OR AGR SOC; Brown R, 1991, ISOTOPES CLIMATES; Chang FQ, 2008, J CHINA UNIV GEOSCI, V19, P1, DOI 10.1016/S1002-0705(08)60019-9; Chen JA, 2004, SCI CHINA SER D, V47, P954, DOI 10.1360/03yd0160; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Dodson JR, 2013, QUATERNARY SCI REV, V72, P108, DOI 10.1016/j.quascirev.2013.04.021; Flad R, 2010, HOLOCENE, V20, P955, DOI 10.1177/0959683609358914; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Higham C, 2011, J WORLD PREHIST, V24, P227, DOI 10.1007/s10963-011-9054-6; Hodell DA, 1998, LIMNOL OCEANOGR, V43, P200, DOI 10.4319/lo.1998.43.2.0200; Hodell DA, 1999, QUATERNARY RES, V52, P369, DOI 10.1006/qres.1999.2072; Hu SY, 2002, CHINESE SCI BULL, V47, P613, DOI 10.1360/02tb9141; IPCC, 2007, CLIM CHANG 2007 PHYS; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; KRISHNAMURTHY RV, 1986, NATURE, V323, P150, DOI 10.1038/323150a0; Lamb AL, 2004, QUATERNARY SCI REV, V23, P881, DOI 10.1016/j.quascirev.2003.06.010; Li XC, 2008, ARCHAEOLOGY, V8, P76; Li XZ, 2012, CHEM GEOL, V300, P88, DOI 10.1016/j.chemgeo.2012.01.010; Li XQ, 2007, HOLOCENE, V17, P555, DOI 10.1177/0959683607078978; Li XQ, 2012, J ARCHAEOL SCI, V39, P3141, DOI 10.1016/j.jas.2012.04.052; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lucke A, 2003, QUATERNARY SCI REV, V22, P569, DOI 10.1016/S0277-3791(02)00187-7; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; Nakamura T, 2000, NUCL INSTRUM METH B, V172, P52, DOI 10.1016/S0168-583X(00)00398-0; Ponton C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050722; Prins M, 2000, MAR GEOL, V169, P351, DOI 10.1016/S0025-3227(00)00087-6; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Routh J, 2007, J PALEOLIMNOL, V37, P529, DOI 10.1007/s10933-006-9032-7; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; SHEN J, 2005, SCI CHINA SER D, V48, P353; Shi ZT, 2005, YUNNAN GEOGRAPHIC EN, V17, P24; Sirocko F, 1996, SCIENCE, V272, P526, DOI 10.1126/science.272.5261.526; Sirocko F, 1993, NATURE, V323, P48; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Song L, 2012, CHINESE SCI BULL, V57, P2595, DOI 10.1007/s11434-012-5191-2; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; Thornton C P, 2004, OXFORD J ARCHAEOL, V23, P83, DOI DOI 10.1111/J.1468-0092.2004.00203.X; Vanniere B, 2003, J ARCHAEOL SCI, V30, P1283, DOI 10.1016/S0305-4403(03)00017-7; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Watanabe T, 2004, EARTH PLANET SC LETT, V222, P285, DOI 10.1016/j.epsl.2004.02.009; [吴健 WU Jian], 2010, [沉积学报, Acta Sedimentologica Sinica], V28, P365; Wu WX, 2004, QUATERN INT, V117, P153, DOI 10.1016/S1040-6182(03)00125-3; Xu H, 2014, QUATERNARY SCI REV, V89, P85, DOI 10.1016/j.quascirev.2014.02.011; Yan W M, 1997, ARCHAEOLOGY, V9, P71; Yang DP, 1997, J PALEOLIMNOL, V17, P369; Yu G., 2001, LAKE RECORDS CHINA P; Yu XX, 1987, COLLECTION CHINESE H, V2, P121; 陈敬安, 2002, [中国科学. D辑, 地球科学, Science in China], V32, P73; Zhang HC, 2004, PALAEOGEOGR PALAEOCL, V211, P45, DOI 10.1016/j.palaeo.2004.04.006; Zhang HL, 2010, QUATERN INT, V212, P14, DOI 10.1016/j.quaint.2009.07.007; Zhang ZK, 2001, CHINESE SCI BULL, V46, P80, DOI 10.1007/BF03187241; Zhao KL, 2013, QUATERN INT, V311, P81, DOI 10.1016/j.quaint.2013.06.035	55	33	44	11	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102167	10.1371/journal.pone.0102167	http://dx.doi.org/10.1371/journal.pone.0102167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033404	gold, Green Submitted, Green Published			2022-12-27	WOS:000339418300037
J	Avery, L				Avery, Leon			A Model of the Effect of Uncertainty on the C elegans L2/L2d Decision	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; POPULATION-GROWTH; PHEROMONE; LONGEVITY; SELECTION; STRENGTH; GENETICS; HISTORY; FOOD	At the end of the first larval stage, the C elegans larva chooses between two developmental pathways, an L2 committed to reproductive development and an L2d, which has the option of undergoing reproductive development or entering the dauer diapause. I develop a quantitative model of this choice using mathematical tools developed for pricing financial options. The model predicts that the optimal decision must take into account not only the expected potential for reproductive growth, but also the uncertainty in that expected potential. Because the L2d has more flexibility than the L2, it is favored in unpredictable environments. I estimate that the ability to take uncertainty into account may increase reproductive value by as much as 5%, and discuss possible experimental tests for this ability.	Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA	Virginia Commonwealth University	Avery, L (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	lavery3@vcu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL046154] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL046154] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Artyukhin AB, 2013, J BIOL CHEM; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1993, J EXP BIOL, V175, P283; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chen JJ, 2007, J GERONTOL A-BIOL, V62, P126, DOI 10.1093/gerona/62.2.126; Chen JJ, 2004, J NEMATOL, V36, P107; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Cutter AD, 2004, EVOLUTION, V58, P651, DOI 10.1111/j.0014-3820.2004.tb01687.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fisher RA, 1930, GENETICAL THEORY NAT; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Houston AI, 1999, MODELS ADAPTIVE BEHA; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Muschiol Daniel, 2009, BMC Ecol, V9, P14, DOI 10.1186/1472-6785-9-14; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; Shreve S., 2005, STOCHASTIC CALCULUS; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wood W.B., 1988, Cold Spring Harbor Monograph Series, V17, P1	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100580	10.1371/journal.pone.0100580	http://dx.doi.org/10.1371/journal.pone.0100580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029446	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600006
J	Feng, W; Zhang, YQ; Jia, X; Wu, B; Zha, TS; Qin, SG; Wang, B; Shao, CX; Liu, JB; Fa, KY				Feng, Wei; Zhang, Yuqing; Jia, Xin; Wu, Bin; Zha, Tianshan; Qin, Shugao; Wang, Ben; Shao, Chenxi; Liu, Jiabin; Fa, Keyu			Impact of Environmental Factors and Biological Soil Crust Types on Soil Respiration in a Desert Ecosystem	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CO2 EFFLUX; FOREST; PINE; PRECIPITATION; DEPENDENCE; FLUXES; ROOTS	The responses of soil respiration to environmental conditions have been studied extensively in various ecosystems. However, little is known about the impacts of temperature and moisture on soils respiration under biological soil crusts. In this study, CO2 efflux from biologically-crusted soils was measured continuously with an automated chamber system in Ningxia, northwest China, from June to October 2012. The highest soil respiration was observed in lichen-crusted soil (0.9360.43 mu mol m(-2) s(-1)) and the lowest values in algae-crusted soil (0.73+/-0.31 mu mol m(-2) s(-1)). Over the diurnal scale, soil respiration was highest in the morning whereas soil temperature was highest in the midday, which resulted in diurnal hysteresis between the two variables. In addition, the lag time between soil respiration and soil temperature was negatively correlated with the soil volumetric water content and was reduced as soil water content increased. Over the seasonal scale, daily mean nighttime soil respiration was positively correlated with soil temperature when moisture exceeded 0.075 and 0.085 m(3) m(-3) in lichen-and moss-crusted soil, respectively. However, moisture did not affect on soil respiration in algae-crusted soil during the study period. Daily mean nighttime soil respiration normalized by soil temperature increased with water content in lichen-and moss-crusted soil. Our results indicated that different types of biological soil crusts could affect response of soil respiration to environmental factors. There is a need to consider the spatial distribution of different types of biological soil crusts and their relative contributions to the total C budgets at the ecosystem or landscape level.	[Feng, Wei; Zhang, Yuqing; Jia, Xin; Wu, Bin; Zha, Tianshan; Qin, Shugao; Wang, Ben; Shao, Chenxi; Liu, Jiabin; Fa, Keyu] Beijing Forestry Univ, Yanchi Res Stn, Coll Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University	Zhang, YQ (corresponding author), Beijing Forestry Univ, Yanchi Res Stn, Coll Soil & Water Conservat, Beijing, Peoples R China.	zhangyqbjfu@gmail.com; wubin@bjfu.edu.cn			National Key Technology Research and Development Program of China for 12th Five-year Plan [2012BAD16B02]; National Natural Science Foundation of China [31170666]	National Key Technology Research and Development Program of China for 12th Five-year Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was fund by the National Key Technology Research and Development Program of China for 12th Five-year Plan (2012BAD16B02) and the National Natural Science Foundation of China (31170666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YF, 2013, J FOOD AGRIC ENVIRON, V11, P1449; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; BIRCH H. F., 1958, Plant and Soil, V10, P9, DOI 10.1007/BF01343734; Bouma TJ, 1997, PLANT SOIL, V195, P221, DOI 10.1023/A:1004278421334; Cable JM, 2011, BIOGEOCHEMISTRY, V103, P71, DOI 10.1007/s10533-010-9448-z; Castillo-Monroy AP, 2011, ECOSYSTEMS, V14, P835, DOI 10.1007/s10021-011-9449-3; Castillo-Monroy AP, 2011, J VEG SCI, V22, P165, DOI 10.1111/j.1654-1103.2010.01236.x; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Feng W, 2014, ARID LAND RES MANAG, V28, P186, DOI 10.1080/15324982.2013.835006; Feng W, 2013, SCI WORLD J, DOI 10.1155/2013/408560; Flechard CR, 2007, AGR FOREST METEOROL, V142, P66, DOI 10.1016/j.agrformet.2006.11.006; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Housman DC, 2007, SOIL BIOL BIOCHEM, V39, P2138, DOI 10.1016/j.soilbio.2007.03.015; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Lange O. L., 2003, BIOL SOIL CRUSTS STR, P177, DOI [10.1007/978-3-642-56475-8_15, DOI 10.1007/978-3-642-56475-8_15, DOI 10.1007/978-3-642-56475-8]; Lange OL, 2001, ECOL STU AN, V150, P217; LeHouerou HN, 1996, J ARID ENVIRON, V34, P133, DOI 10.1006/jare.1996.0099; Liu LC, 2006, J HYDROL, V328, P331, DOI 10.1016/j.jhydrol.2005.12.004; Maestre FT, 2003, APPL SOIL ECOL, V23, P199, DOI 10.1016/S0929-1393(03)00050-7; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Stoy PC, 2007, PLANT CELL ENVIRON, V30, P700, DOI 10.1111/j.1365-3040.2007.01655.x; Su YG, 2013, SOIL BIOL BIOCHEM, V58, P332, DOI 10.1016/j.soilbio.2012.12.006; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Thomas AD, 2010, J ARID ENVIRON, V74, P131, DOI 10.1016/j.jaridenv.2009.07.005; Thomas AD, 2011, GEODERMA, V167-68, P284, DOI 10.1016/j.geoderma.2011.07.034; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Warren S.D., 2003, BIOL SOIL CRUST STRU, P327, DOI [10.1007/978-3-642-56475-8_24, DOI 10.1007/978-3-642-56475-8_24]; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	41	28	32	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102954	10.1371/journal.pone.0102954	http://dx.doi.org/10.1371/journal.pone.0102954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050837	gold, Green Submitted, Green Published			2022-12-27	WOS:000339551100069
J	Sodhi, SS; Ghosh, M; Song, KD; Sharma, N; Kim, JH; Kim, NE; Lee, SJ; Kang, CW; Oh, SJ; Jeong, DK				Sodhi, Simrinder Singh; Ghosh, Mrinmoy; Song, Ki Duk; Sharma, Neelesh; Kim, Jeong Hyun; Kim, Nam Eun; Lee, Sung Jin; Kang, Chul Woong; Oh, Sung Jong; Jeong, Dong Kee			An Approach to Identify SNPs in the Gene Encoding Acetyl-CoA Acetyltransferase-2 (ACAT-2) and Their Proposed Role in Metabolic Processes in Pig	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CHOLESTEROL ACYLTRANSFERASE; SKELETAL-MUSCLE; LIPID RAFTS; EXPRESSION; COENZYME; DIETARY; LIVER; ABSORPTION; INTESTINE	The novel liver protein acetyl-CoA acetyltransferase-2 (ACAT2) is involved in the beta-oxidation and lipid metabolism. Its comprehensive relative expression, in silico non-synonymous single nucleotide polymorphism (nsSNP) analysis, as well as its annotation in terms of metabolic process with another protein from the same family, namely, acetyl-CoA acyltransferase-2 (ACAA2) was performed in Sus scrofa. This investigation was conducted to understand the most important nsSNPs of ACAT2 in terms of their effects on metabolic activities and protein conformation. The two most deleterious mutations at residues 122 (I to V) and 281 (R to H) were found in ACAT2. Validation of expression of genes in the laboratory also supported the idea of differential expression of ACAT2 and ACAA2 conceived through the in silico analysis. Analysis of the relative expression of ACAT2 and ACAA2 in the liver tissue of Jeju native pig showed that the former expressed significantly higher (P<0.05). Overall, the computational prediction supported by wet laboratory analysis suggests that ACAT2 might contribute more to metabolic processes than ACAA2 in swine. Further associations of SNPs in ACAT2 with production traits might guide efforts to improve growth performance in Jeju native pigs.	[Sodhi, Simrinder Singh; Ghosh, Mrinmoy; Sharma, Neelesh; Kim, Jeong Hyun; Kim, Nam Eun; Oh, Sung Jong; Jeong, Dong Kee] Jeju Natl Univ, Fac Biotechnol, Dept Anim Biotechnol, Jeju Si, Jeju Do, South Korea; [Song, Ki Duk] Hankyong Natl Univ, Anim Genom & Breeding Ctr, Anseong, Gyeonggi Do, South Korea; [Lee, Sung Jin] Kangwon Natl Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Chunchon, South Korea; [Kang, Chul Woong] Jeju Natl Univ, Coll Engn, Dept Mech & Syst Engn, Jeju Si, Jeju Do, South Korea; [Jeong, Dong Kee] Jeju Natl Univ, SARI, Jeju Si, Jeju Do, South Korea	Jeju National University; Hankyong National University; Kangwon National University; Jeju National University; Jeju National University	Jeong, DK (corresponding author), Jeju Natl Univ, Fac Biotechnol, Dept Anim Biotechnol, Jeju Si, Jeju Do, South Korea.	dkjeong@jejunu.ac.kr	Sharma, Neelesh/G-9806-2013; Ghosh, Mrinmoy/ABB-4479-2021	Sharma, Neelesh/0000-0003-3932-4064; Ghosh, Mrinmoy/0000-0001-6817-622X; Lee, Sung-Jin/0000-0001-9348-8356	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ009032022012, PJ008196]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This study was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ009032022012 and PJ008196), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SM, 2011, NUCLEIC ACIDS RES, V39, pD975, DOI 10.1093/nar/gkq1024; Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Baik M, 2009, ASIAN AUSTRAL J ANIM, V22, P871, DOI 10.5713/ajas.2009.90061; Bellott AC, 2005, J APPL PHYSIOL, V98, P1554, DOI 10.1152/japplphysiol.01070.2004; Cao W, 2008, BBA-GEN SUBJECTS, V1780, P873, DOI 10.1016/j.bbagen.2008.02.007; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cochran SD, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-49; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Frank JW, 2007, J NUTR, V137, P315, DOI 10.1093/jn/137.2.315; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Guryev V, 2004, GENOME RES, V14, P1438, DOI 10.1101/gr.2154304; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Hussain MRM, 2012, GENE, V508, P188, DOI 10.1016/j.gene.2012.07.014; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kushwaha RS, 2005, J NUTR BIOCHEM, V16, P714, DOI 10.1016/j.jnutbio.2005.03.010; Li H. Y., 2008, THESIS; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; Ma XY, 2010, AMINO ACIDS, V38, P95, DOI 10.1007/s00726-008-0213-8; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nguyen TM, 2012, J LIPID RES, V53, P1598, DOI 10.1194/jlr.M026823; Okrouhla M, 2008, CZECH J FOOD SCI, V26, P464, DOI 10.17221/18/2008-CJFS; Orford M, 2012, J DAIRY SCI, V95, P3419, DOI 10.3168/jds.2011-4732; OSADA K, 1994, LIPIDS, V29, P555, DOI 10.1007/BF02536627; Panitz F, 2007, BIOINFORMATICS, V23, pI387, DOI 10.1093/bioinformatics/btm192; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Riechman SE, 2007, J GERONTOL A-BIOL, V62, P1164, DOI 10.1093/gerona/62.10.1164; Rozen S, 2000, Methods Mol Biol, V132, P365; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; Van Poucke M, 2001, CYTOGENET CELL GENET, V93, P297, DOI 10.1159/000057001; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wood J. D., 2001, Concepts in pig science 2001. The 3rd Annual Turtle Lake Pig Science Conference, P17; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	41	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102432	10.1371/journal.pone.0102432	http://dx.doi.org/10.1371/journal.pone.0102432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050817	Green Submitted, gold, Green Published			2022-12-27	WOS:000339551100035
J	Tao, J; Li, MY; Qian, HZ; Wang, LJ; Zhang, Z; Ding, HF; Ji, YC; Li, DL; Xiao, D; Hazlitt, M; Vermund, SH; Xiu, XF; Bao, YG				Tao, Jun; Li, Ming-ying; Qian, Han-Zhu; Wang, Li-Juan; Zhang, Zheng; Ding, Hai-Feng; Ji, Ya-Cheng; Li, Dong-liang; Xiao, Dong; Hazlitt, Melissa; Vermund, Sten H.; Xiu, Xiangfei; Bao, Yugang			Home-Based HIV Testing for Men Who Have Sex with Men in China: A Novel Community-Based Partnership to Complement Government Programs	PLOS ONE			English	Article							PREVENTION; INFECTION; BARRIERS; HOPE; MSM	Background: The coverage of HIV testing among Chinese men who have sex with men (MSM) remains low after the scale-up of free HIV testing at government-sponsored testing sites. We evaluated the feasibility of home-based HIV self-testing and the willingness to be HIV tested at community-based organizations (CBO). Methods: We recruited MSM via on-line advertisement, where they completed an on-line informed consent and subsequent questionnaire survey. Eligible MSM received HIV rapid testing kits by mail, performed the test themselves and reported the result remotely. Results: Of the 220 men taking a home-based HIV self-testing, 33 MSM (15%) were seropositive. Nearly 65% of the men reported that they were willing to take HIV testing at CBO, while 28% preferred receiving free HIV testing in the government programs at local Centers for Disease Control and Prevention (CDC). Older and lower-income MSM, those who self-reported homosexual orientation, men with no history of sexually transmitted diseases and a lower number of sexual partners in the past six months were associated with preference for taking HIV testing at CBOs. The top three self-reported existing barriers for HIV testing were: no perception of HIV risk (56%), fear of an HIV positive result being reported to the government (41%), and fear of a positive HIV test result (36%). Conclusion: Home-based HIV self-testing is an alternative approach for increasing the coverage of HIV testing among Chinese MSM. CBO-based HIV testing is a potential alternative, but further studies are needed to evaluate its feasibility.	[Tao, Jun; Qian, Han-Zhu; Vermund, Sten H.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Li, Ming-ying; Li, Dong-liang] Xicheng Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Qian, Han-Zhu] Vanderbilt Univ, Dept Med, Div Epidemiol, Nashville, TN USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Wang, Li-Juan; Zhang, Zheng; Ding, Hai-Feng] Chaoyang Dist Ctr Dis Control & Prevent, Beijing, Peoples R China; [Ji, Ya-Cheng] Heibei Med Univ, Shijiazhuang, Hebei, Peoples R China; [Xiao, Dong] Chaoyang Chinese AIDS Volunteer Grp, Beijing, Peoples R China; [Hazlitt, Melissa] Meharry Med Coll, Nashville, TN 37208 USA; [Xiu, Xiangfei; Bao, Yugang] AHF, AHF China Program, Beijing, Peoples R China; [Bao, Yugang] Cent South Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Vanderbilt University; Vanderbilt University; Vanderbilt University; Hebei Medical University; Meharry Medical College; Central South University	Qian, HZ (corresponding author), Vanderbilt Univ, Vanderbilt Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	han-zhu.qian@vanderbilt.edu; yugang.bao@aidshealth.org	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Tao, Jun/0000-0002-1940-8634	AIDS Healthcare Foundation (AHF), California, USA; Amos Christie Chair Endowment of Vanderbilt University; Fogarty AIDS International Training and Research Program (National Institutes of Health) [D43TW001035]; FOGARTY INTERNATIONAL CENTER [D43TW001035, R25TW009337] Funding Source: NIH RePORTER	AIDS Healthcare Foundation (AHF), California, USA; Amos Christie Chair Endowment of Vanderbilt University; Fogarty AIDS International Training and Research Program (National Institutes of Health); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the AIDS Healthcare Foundation (AHF), California, USA, (http://www.aidshealth.org/) the Amos Christie Chair Endowment of Vanderbilt University, and the Fogarty AIDS International Training and Research Program (National Institutes of Health grant D43TW001035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HT, 2007, AIDS BEHAV, V11, P778, DOI 10.1007/s10461-007-9215-x; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; Harris GE, 2007, AIDS PATIENT CARE ST, V21, P843, DOI 10.1089/apc.2006.0207; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Jain Vivek, 2010, Curr HIV/AIDS Rep, V7, P60, DOI 10.1007/s11904-010-0044-6; Keenan PA, 2001, AIDS EDUC PREV, V13, P541, DOI 10.1521/aeap.13.6.541.21439; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; PHILLIPS KA, 1995, NEW ENGL J MED, V332, P1308, DOI 10.1056/NEJM199505113321918; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Walensky RP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001101; Xu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064652; Xun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080594; Zakher B, 2014, AIDS CARE, V26, P514, DOI 10.1080/09540121.2013.832723; Zhang DP, 2008, AIDS CARE, V20, P1128, DOI 10.1080/09540120701842829; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zhang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060106; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	26	37	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102812	10.1371/journal.pone.0102812	http://dx.doi.org/10.1371/journal.pone.0102812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0QO	25051160	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100060
J	Asefa, A; Teshome, W				Asefa, Anteneh; Teshome, Wondu			Total Delay in Treatment among Smear Positive Pulmonary Tuberculosis Patients in Five Primary Health Centers, Southern Ethiopia: A Cross Sectional Study	PLOS ONE			English	Article							SEEKING BEHAVIOR; SERVICE DELAY; CARE	Introduction: The global burden of Tuberculosis (TB) remains enormous. Delay in TB diagnosis may lead to a higher infectious pool in the community and a more advanced disease state at presentation increasing the risk of mortality. This study is conducted to determine the total delay before treatment among smear positive Pulmonary Tuberculosis (PTB) patients. Methods: A health institution based cross sectional study was conducted in five primary health centers in southern Ethiopia from June to December 2012. A total of 328 smear positive PTB patients were enrolled in the study. A structured and pretested questionnaire was used. Median patient, diagnostic, and treatment delays were calculated to determine the total delay. Multiple logistic regression analysis was used to identify factors associated with total delay. Results: The median patient, diagnostic, treatment and total delays measured in days were 30 (IQR 20.2, 60), 7 (IQR: 3, 14), 3 (IQR: 1, 4) and 45 (IQR: 34.5, 69.5) days respectively. Patients for whom treatment was not initiated within 45 days of onset of symptom(s) (total delay) constituted 49% of the study participants (59.5% among males and 39.2% among females; P<0.001). Total delay was found to be associated with: being female [AOR = 0.34, 95% CI: 0.18-0.62], having attended tertiary level education [AOR = 0.11, 95% CI: 0.02-0.55], perceived severity of stigma during the current TB disease course [AOR = 2.18, 95% CI: 1.07, 4.42] and living in houses with higher family size [AOR = 0.26, 95% CI: 0.11, 0.61]. Conclusion: Total delay in treatment of TB is still high in the study area. Patient's sex, perceived stigma, educational status and family size are significantly contributing for total delay. Therefore, a concerted effort should be taken in order to improve health seeking behavior of the community on TB and to reduce delays from seeking care after experiencing TB symptoms.	[Asefa, Anteneh; Teshome, Wondu] Hawassa Univ, Sch Publ & Environm Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia	Hawassa University	Asefa, A (corresponding author), Hawassa Univ, Sch Publ & Environm Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia.	antex98@yahoo.com	Asefa, Anteneh/AAG-6341-2020	Asefa, Anteneh/0000-0003-4470-1848; Teshome, Wondu/0000-0001-8292-7026	Hawassa University	Hawassa University	This study is funded by Hawassa University. Website: www.hu.edu.et. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal S, 2012, Kathmandu Univ Med J (KUMJ), V10, P48; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Belay M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-369; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Brouwer JA, 1998, INT J TUBERC LUNG D, V2, P231; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Colvin M, 2003, INT J TUBERC LUNG D, V7, pS86; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Diez M, 2004, EUR J PUBLIC HEALTH, V14, P151, DOI 10.1093/eurpub/14.2.151; dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25; Hinderaker SG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-306; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Mebratie AD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004020; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Mulenga C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-756; Norcross WA, 1996, J FAM PRACTICE, V43, P475; Olumuyiwa O, 2004, BMC PUBLIC HLTH, V4; Regional Health Bureau, ANN PERF REP 2012 13; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Thorson A, 2000, LANCET, V356, P1823, DOI 10.1016/S0140-6736(00)03241-4; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2006, DIAGN TREATM DEL TUB; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, STOP TB STRAT BUILD; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	33	27	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102884	10.1371/journal.pone.0102884	http://dx.doi.org/10.1371/journal.pone.0102884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048601	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100083
J	Gubensek, J; Buturovic-Ponikvar, J; Romozi, K; Ponikvar, R				Gubensek, Jakob; Buturovic-Ponikvar, Jadranka; Romozi, Karmen; Ponikvar, Rafael			Factors Affecting Outcome in Acute Hypertriglyceridemic Pancreatitis Treated with Plasma Exchange: An Observational Cohort Study	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMOFILTRATION; POLYMORPHONUCLEAR CELL DEGRANULATION; REGIONAL CITRATE ANTICOAGULATION; CRITICALLY-ILL PATIENTS; HYPERLIPIDEMIC PANCREATITIS; FOLLOW-UP; HEPARIN; MANAGEMENT; APHERESIS; PLASMAPHERESIS	Objectives: The optimal therapy for hypertriglyceridemic acute pancreatitis, especially the role of plasma exchange (PE), is not entirely clear. The aim of our large, single-center, observational, cohort study was to analyze the factors affecting outcome in hypertriglyceridemic pancreatitis treated with PE. Methods: We included 111 episodes of hypertriglyceridemic pancreatitis treated with PE, which occurred in 103 different patients. The Acute Physiology and Chronic Health Evaluation (APACHE) II score, triglycerides, delay to first PE, and PE treatment details were retrospectively obtained from the patients' records. The main outcome measures were length of hospitalization and in-hospital mortality. Results: The patients were 47 +/- 9 years old and the median APACHE II score at first PE was 4 (inter-quartile range (IQR) 2-7). There was a seasonal variation in the incidence of hypertriglyceridemic pancreatitis, and the recurrence rate was 1.6% per year. Triglycerides at presentation did not correlate with APACHE II or influence the outcome. The mean reduction in triglycerides during PE was 59% (from 44 +/- 31 to 18 +/- 15 mmol/l), which was twice the reduction observed during conservative treatment (27% daily). The median hospital stay was 16 days (IQR 10-24) and in-hospital mortality was 5%. The median delay to first PE was 35 hours (IQR 24-52), and there was no difference in mortality in the early and late PE groups (7% vs. 6%, p = 0.79). The group with citrate anticoagulation during PE had a significantly lower mortality than the group with heparin anticoagulation (1% vs. 11%, p = 0.04), and citrate was an independent predictor also in the multivariate model (p = 0.049). Conclusions: PE effectively reduced serum triglycerides faster than could be expected with conservative treatment. The delay in PE therapy did not influence survival. We found that citrate anticoagulation during PE was associated with reduced mortality, which should be confirmed in a randomized study.	[Gubensek, Jakob; Buturovic-Ponikvar, Jadranka; Romozi, Karmen; Ponikvar, Rafael] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia	University Medical Centre Ljubljana	Gubensek, J (corresponding author), Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia.	jakob.gubensek@kclj.si	Gubensek, Jakob/A-5077-2010	Gubensek, Jakob/0000-0002-5394-3729; Buturovic-Ponikvar, Jadranka/0000-0001-7473-3731	Slovenian Research Agency [P3-0323]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The study was funded by grant P3-0323 from the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonic M, 2009, THER APHER DIAL, V13, P322, DOI 10.1111/j.1744-9987.2009.00733.x; Athyros VG, 2002, J CLIN GASTROENTEROL, V34, P472, DOI 10.1097/00004836-200204000-00020; Balachandra S, 2006, INT J CLIN PRACT, V60, P156, DOI 10.1111/j.1368-5031.2005.00645.x; Baranyai T, 2012, CLIN LIPIDOL, V7, P731, DOI 10.2217/CLP.12.69; Berger Z, 2001, REV MED CHILE, V129, P1373; BETTERIDGE DJ, 1978, LANCET, V1, P1368; Bos JC, 1997, NEPHROL DIAL TRANSPL, V12, P1387, DOI 10.1093/ndt/12.7.1387; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Chen CH, 2006, J FORMOS MED ASSOC, V105, P550, DOI 10.1016/S0929-6646(09)60149-2; Chen JH, 2004, WORLD J GASTROENTERO, V10, P2272; Christian JB, 2012, J CLIN LIPIDOL, V6, P450, DOI 10.1016/j.jacl.2012.08.007; Deng LH, 2008, WORLD J GASTROENTERO, V14, P4558, DOI 10.3748/wjg.14.4558; Ewald N, 2009, CURR OPIN LIPIDOL, V20, P497, DOI 10.1097/MOL.0b013e3283319a1d; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Gabutti L, 2004, J NEPHROL, V17, P819; Gritters M, 2006, NEPHROL DIAL TRANSPL, V21, P153, DOI 10.1093/ndt/gfi069; Gubensek J, 2009, THER APHER DIAL, V13, P314, DOI 10.1111/j.1744-9987.2009.00731.x; Henzen C, 1999, SCHWEIZ MED WSCHR, V129, P1242; Hetzel GR, 2011, NEPHROL DIAL TRANSPL, V26, P232, DOI 10.1093/ndt/gfq575; Hofbauer B, 1996, GUT, V38, P753, DOI 10.1136/gut.38.5.753; Hu GY, 2012, PANCREAS, V41, P845, DOI 10.1097/MPA.0b013e318247d784; Kyriakidis AV, 2006, DIGESTION, V73, P259, DOI 10.1159/000095425; LEESE T, 1991, ANN ROY COLL SURG, V73, P207; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; MCLEOD BC, 1983, ARTIF ORGANS, V7, P443, DOI 10.1111/j.1525-1594.1983.tb04224.x; OMOKAWA S, 1990, INT J ARTIF ORGANS, V13, P768, DOI 10.1177/039139889001301110; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Schwartz J, 2013, J CLIN APHERESIS, V28, P145, DOI 10.1002/jca.21276; SEARLES GE, 1992, CAN MED ASSOC J, V147, P1806; Skok P, 2008, ZDR VESTN, V77, P573; Stegmayr B, 2008, TRANSFUS APHER SCI, V39, P247, DOI 10.1016/j.transci.2008.09.003; Stegmayr B, 2007, TRANSFUS APHER SCI, V36, P13, DOI 10.1016/j.transci.2006.06.009; STEINBERG W, 1994, NEW ENGL J MED, V330, P1198, DOI 10.1056/NEJM199404283301706; Tiranathanagul K, 2011, THER APHER DIAL, V15, P556, DOI 10.1111/j.1744-9987.2011.00996.x; TOSKES PP, 1990, GASTROENTEROL CLIN N, V19, P783; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016; Yeh JH, 2003, J CLIN APHERESIS, V18, P181, DOI 10.1002/jca.10063	39	56	66	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102748	10.1371/journal.pone.0102748	http://dx.doi.org/10.1371/journal.pone.0102748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047332	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100070
J	van Schalkwijk, DB; Pasman, WJ; Hendriks, HFJ; Verheij, ER; Rubingh, CM; van Bochove, K; Vaes, WHJ; Adiels, M; Freidig, AP; de Graaf, AA				van Schalkwijk, Daniel B.; Pasman, Wilrike J.; Hendriks, Henk F. J.; Verheij, Elwin R.; Rubingh, Carina M.; van Bochove, Kees; Vaes, Wouter H. J.; Adiels, Martin; Freidig, Andreas P.; de Graaf, Albert A.			Dietary Medium Chain Fatty Acid Supplementation Leads to Reduced VLDL Lipolysis and Uptake Rates in Comparison to Linoleic Acid Supplementation	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; LONG-CHAIN; PLASMA; CHOLESTEROL; TRIGLYCERIDES; EICOSANOIDS; LIPOPROTEINS; ATORVASTATIN; CONSUMPTION; METABOLISM	Dietary medium chain fatty acids (MCFA) and linoleic acid follow different metabolic routes, and linoleic acid activates PPAR receptors. Both these mechanisms may modify lipoprotein and fatty acid metabolism after dietary intervention. Our objective was to investigate how dietary MCFA and linoleic acid supplementation and body fat distribution affect the fasting lipoprotein subclass profile, lipoprotein kinetics, and postprandial fatty acid kinetics. In a randomized double blind cross-over trial, 12 male subjects (age 51 +/- 7 years; BMI 28.5 +/- 0.8 kg/m(2)), were divided into 2 groups according to waist-hip ratio. They were supplemented with 60 grams/day MCFA (mainly C8:0, C10:0) or linoleic acid for three weeks, with a washout period of six weeks in between. Lipoprotein subclasses were measured using HPLC. Lipoprotein and fatty acid metabolism were studied using a combination of several stable isotope tracers. Lipoprotein and tracer data were analyzed using computational modeling. Lipoprotein subclass concentrations in the VLDL and LDL range were significantly higher after MCFA than after linoleic acid intervention. In addition, LDL subclass concentrations were higher in lower body obese individuals. Differences in VLDL metabolism were found to occur in lipoprotein lipolysis and uptake, not production; MCFAs were elongated intensively, in contrast to linoleic acid. Dietary MCFA supplementation led to a less favorable lipoprotein profile than linoleic acid supplementation. These differences were not due to elevated VLDL production, but rather to lower lipolysis and uptake rates.	[van Schalkwijk, Daniel B.; Pasman, Wilrike J.; Hendriks, Henk F. J.; Verheij, Elwin R.; Rubingh, Carina M.; van Bochove, Kees; Vaes, Wouter H. J.; Freidig, Andreas P.; de Graaf, Albert A.] TNO, NL-3700 AJ Zeist, Netherlands; [van Schalkwijk, Daniel B.] Leiden Amsterdam Ctr Drug Res, Analyt Sci Div, Leiden, Netherlands; [van Schalkwijk, Daniel B.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Adiels, Martin] Univ Gothenburg, Dept Math Sci, Gothenburg, Sweden	Netherlands Organization Applied Science Research; Leiden University; Leiden University - Excl LUMC; University of Gothenburg	de Graaf, AA (corresponding author), TNO, NL-3700 AJ Zeist, Netherlands.	albert.degraaf@tno.nl	Vaes, Wouter/AAA-2751-2021; Hendriks, Henk/AAU-5987-2021	van Bochove, Kees/0000-0002-8589-0609; de Graaf, Albert/0000-0002-1067-3570	Dutch government [04003]; Netherlands Bioinformatics Centre	Dutch government; Netherlands Bioinformatics Centre	This study was financially supported by Dutch government through grant 'Healthy Nutrition'(grant number 04003). D.B.v.S. was supported by the Netherlands Bioinformatics Centre, Biorange project SP3.3.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2005, J LIPID RES, V46, P58, DOI 10.1194/jlr.M400108-JLR200; Asakura L, 2000, AM J CLIN NUTR, V71, P701, DOI 10.1093/ajcn/71.3.701; BACH AC, 1982, AM J CLIN NUTR, V36, P950, DOI 10.1093/ajcn/36.5.950; Bilz S, 2004, J LIPID RES, V45, P174, DOI 10.1194/jlr.M300309-JLR200; Biolo G, 2001, METABOLISM, V50, P19, DOI 10.1053/meta.2001.17726; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ginsberg HN, 2007, AM J CARDIOL, V99, p56I, DOI 10.1016/j.amjcard.2007.03.024; HILL JO, 1990, J LIPID RES, V31, P407; HORROBIN DF, 1987, INT J CARDIOL, V17, P241, DOI 10.1016/0167-5273(87)90073-8; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; *ISO, 1990, 55081990 ISO; ISO, 2000, 55092000 ISO; Kistemaker C, 1998, 98 TNO, P812; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Marten B, 2006, INT DAIRY J, V16, P1374, DOI 10.1016/j.idairyj.2006.06.015; McCloy U, 2004, J LIPID RES, V45, P474, DOI 10.1194/jlr.M300304-JLR200; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Sato K, 2005, J NUTR, V135, P1636, DOI 10.1093/jn/135.7.1636; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; SHEN BW, 1977, P NATL ACAD SCI USA, V74, P837, DOI 10.1073/pnas.74.3.837; St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621; St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467; St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; SWIFT LL, 1992, AM J CLIN NUTR, V56, P881, DOI 10.1093/ajcn/56.5.881; Tachibana S, 2005, BBA-MOL CELL BIOL L, V1737, P36, DOI 10.1016/j.bbalip.2005.09.001; Thomas TR, 2001, J APPL PHYSIOL, V90, P1239, DOI 10.1152/jappl.2001.90.4.1239; TURKENKOPF IJ, 1982, J NUTR, V112, P1254, DOI 10.1093/jn/112.7.1254; van Bochove K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038072; van Eijk HMH, 2003, J NUTR, V133, p2084S, DOI 10.1093/jn/133.6.2084S; van Schalkwijk Daniel B, 2011, J Clin Bioinforma, V1, P29, DOI 10.1186/2043-9113-1-29; van Schalkwijk DB, 2010, BRIEF BIOINFORM, V11, P403, DOI 10.1093/bib/bbp071; van Schalkwijk DB, 2009, J LIPID RES, V50, P2398, DOI 10.1194/jlr.M800354-JLR200; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Walker C, 2009, AM FAM PHYSICIAN, V79, P571	39	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e100376	10.1371/journal.pone.0100376	http://dx.doi.org/10.1371/journal.pone.0100376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25049048	Green Published, gold			2022-12-27	WOS:000339558100005
J	Golledge, J; Hankey, GJ; Yeap, BB; Almeida, OP; Flicker, L; Norman, PE				Golledge, Jonathan; Hankey, Graeme J.; Yeap, Bu B.; Almeida, Osvaldo P.; Flicker, Leon; Norman, Paul E.			Reported High Salt Intake Is Associated with Increased Prevalence of Abdominal Aortic Aneurysm and Larger Aortic Diameter in Older Men	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MINERALOCORTICOID RECEPTOR; URINARY SODIUM; METAANALYSIS; RUPTURE; RECOMMENDATIONS; HYPERTENSION; MANAGEMENT; REDUCTION	Background: Salt intake has been implicated in the pathogenesis of abdominal aortic aneurysm (AAA) through studies in rodent models but not previously studied in humans. The aim of this study was to examine the association between reported addition of salt to food and the prevalence of AAA. Methods: A risk factor questionnaire which contained a question about salt intake was included as part of a population screening study for AAA in 11742 older men. AAA presence was assessed by abdominal ultrasound imaging using a reproducible protocol. Results: The prevalence of AAA was 6.9, 8.5 and 8.6% in men who reported adding salt to food never, sometimes and always, respectively, p = 0.005. Addition of salt to food sometimes (odds ratio [OR]: 1.22, 95% confidence interval [CI]: 1.03-1.44) or always (OR: 1.23, 95% CI 1.04-1.47) was independently associated with AAA after adjustment for other risk factors including age, waist-hip ratio, blood pressure, history of hypertension, high cholesterol, angina, diabetes, myocardial infarction and stroke. Salt intake was also independently associated with aortic diameter (beta 0.023, p = 0.012). In men with no prior history of hypertension, high cholesterol, angina, myocardial infarction or stroke (n = 4185), the association between addition of salt to food sometimes (OR: 1.41, 95% CI 0.96-2.08) or always (OR: 1.52, 95% CI 1.04-2.22) and AAA remained evident. Conclusion: Reported salt intake is associated with AAA in older men. Additional studies are needed to determine whether reducing salt intake would protect against AAA.	[Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol, Fremantle, WA, Australia; [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] WA Ctr Hlth Ageing, Med Res Ctr, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia	James Cook University; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Golledge, J (corresponding author), James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	Flicker, Leon/AAE-1530-2022; Almeida, Osvaldo P./A-4925-2008; Hankey, Graeme J/H-4968-2014; golledge, jonathan/I-2371-2013	Flicker, Leon/0000-0002-3650-0475; Almeida, Osvaldo P./0000-0002-8689-6199; Hankey, Graeme J/0000-0002-6044-7328; golledge, jonathan/0000-0002-5779-8848	National Health and Medical Research Council [279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710, 1060557]; Office of Health and Medical Research, Queensland Government; National Health and Medical Research Council, Australia [1019921]; Office of Health and Medical Research	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Office of Health and Medical Research, Queensland Government; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Office of Health and Medical Research	The Health In Men Study has been supported by grants from National Health and Medical Research Council (279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710 and 1060557). Additional funding from the Office of Health and Medical Research, Queensland Government supported this work. JG holds a Practitioner Fellowship from the National Health and Medical Research Council, Australia (1019921). JG holds a Senior Clinical Research Fellowship from the Office of Health and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P695, DOI 10.1053/j.ajkd.2006.07.017; Dijk JM, 2004, STROKE, V35, P1642, DOI 10.1161/01.STR.0000130513.77186.26; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2013, ARTERIOSCL THROM VAS, V33, P1456, DOI 10.1161/ATVBAHA.113.301819; Golledge J, 2009, CURR OPIN CARDIOL, V24, P532, DOI 10.1097/HCO.0b013e328330c2d3; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Liu S, 2013, ARTERIOSCL THROM VAS, V33, P1568, DOI 10.1161/ATVBAHA.112.300820; Nishijo N, 1998, LAB INVEST, V78, P1059; Norman P, 2004, CIRCULATION, V110, P862, DOI 10.1161/01.CIR.0000138746.14425.00; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; O'Donnell MJ, 2013, EUR HEART J, V34, P1034, DOI 10.1093/eurheartj/ehs409; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; PETRIE JC, 1986, BRIT MED J, V293, P611, DOI 10.1136/bmj.293.6547.611; Rhodes DG, 2013, AM J CLIN NUTR, V97, P958, DOI 10.3945/ajcn.112.044982; Safar ME, 2009, HYPERTENSION, V54, P203, DOI 10.1161/HYPERTENSIONAHA.109.129585; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Sweeting MJ, 2012, BRIT J SURG, V99, P655, DOI 10.1002/bjs.8707; Tada Y, 2009, HYPERTENSION, V54, P552, DOI 10.1161/HYPERTENSIONAHA.109.134130; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf	24	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102578	10.1371/journal.pone.0102578	http://dx.doi.org/10.1371/journal.pone.0102578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036037	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000339615200073
J	Lim, LZ; Shi, JH; Mu, YG; Song, JX				Lim, Liangzhong; Shi, Jiahai; Mu, Yuguang; Song, Jianxing			Dynamically-Driven Enhancement of the Catalytic Machinery of the SARS 3C-Like Protease by the S284-T285-I286/A Mutations on the Extra Domain	PLOS ONE			English	Article							RESPIRATORY-SYNDROME CORONAVIRUS; COV MAIN PROTEINASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; DIMER INTERFACE; ACTIVE-SITE; M-PRO; ENZYME; DIMERIZATION; SIMULATIONS	Previously we revealed that the extra domain of SARS 3CLpro mediated the catalysis via different mechanisms. While the R298A mutation completely abolished the dimerization, thus resulting in the inactive catalytic machinery, N214A inactivated the enzyme by altering its dynamics without significantly perturbing its structure. Here we studied another mutant with S284-T285-I286 replaced by Ala (STI/A) with a 3.6-fold activity increase and slightly enhanced dimerization. We determined its crystal structure, which still adopts the dimeric structure almost identical to that of the wild-type (WT), except for slightly tighter packing between two extra-domains. We then conducted 100-ns molecular dynamics (MD) simulations for both STI/A and WT, the longest reported so far for 3CLpro. In the simulations, two STI/A extra domains become further tightly packed, leading to a significant volume reduction of the nano-channel formed by residues from both catalytic and extra domains. The enhanced packing appears to slightly increase the dynamic stability of the N-finger and the first helix residues, which subsequently triggers the redistribution of dynamics over residues directly contacting them. This ultimately enhances the dynamical stability of the residues constituting the catalytic dyad and substrate-binding pockets. Further correlation analysis reveals that a global network of the correlated motions exists in the protease, whose components include all residues identified so far to be critical for the dimerization and catalysis. Most strikingly, the N214A mutation globally decouples this network while the STI/A mutation alters the correlation pattern. Together with previous results, the present study establishes that besides the classic structural allostery, the dynamic allostery also operates in the SARS 3CLpro, which is surprisingly able to relay the perturbations on the extra domain onto the catalytic machinery to manifest opposite catalytic effects. Our results thus imply a promising avenue to design specific inhibitors for 3CL proteases by disrupting their dynamic correlation network.	[Lim, Liangzhong; Shi, Jiahai; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	dbssjx@nus.edu.sg	Shi, Jiahai/AAH-1103-2019; shi, jiahai/D-7650-2013; Song, Jianxing/H-8026-2012	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Song, Jianxing/0000-0003-0224-6322	Ministry of Education of Singapore (MOE) [R-154-002-580-112]; Tier 2 Grant [MOE 2011-T2-1-096 (R154-000-525-112)]	Ministry of Education of Singapore (MOE); Tier 2 Grant	This study was supported by Ministry of Education of Singapore (MOE) Tier 3 Grant R-154-002-580-112, and also partly by Tier 2 Grant MOE 2011-T2-1-096 (R154-000-525-112) to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Bacha U, 2004, BIOCHEMISTRY-US, V43, P4906, DOI 10.1021/bi0361766; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Barrila J, 2010, BIOCHEMISTRY-US, V49, P4308, DOI 10.1021/bi1002585; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang HP, 2007, BIOPHYS J, V92, P1374, DOI 10.1529/biophysj.106.091736; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen S, 2005, J BIOL CHEM, V280, P164, DOI 10.1074/jbc.M408211200; Chen S, 2008, J BIOL CHEM, V283, P554, DOI 10.1074/jbc.M705240200; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Graziano V, 2006, BIOCHEMISTRY-US, V45, P14632, DOI 10.1021/bi061746y; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Hu TC, 2009, VIROLOGY, V388, P324, DOI 10.1016/j.virol.2009.03.034; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Khosla C, 2001, NATURE, V409, P247, DOI 10.1038/35051723; Kuang WF, 2005, BIOCHEM BIOPH RES CO, V331, P1554, DOI 10.1016/j.bbrc.2005.04.072; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TW, 2007, J MOL BIOL, V366, P916, DOI 10.1016/j.jmb.2006.11.078; Lee TW, 2005, J MOL BIOL, V353, P1137, DOI 10.1016/j.jmb.2005.09.004; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Ma BY, 2013, TOP CURR CHEM, V337, P123, DOI 10.1007/128_2012_316; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mu YG, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3120483; Nemova N. N., 2008, Biomeditsinskaya Khimiya, V54, P42; Pang YP, 2004, PROTEINS, V57, P747, DOI 10.1002/prot.20249; Ren ZL, 2013, PROTEIN CELL, V4, P248, DOI 10.1007/s13238-013-2841-3; Saen-Oon S, 2008, BIOPHYS J, V94, P4078, DOI 10.1529/biophysj.107.121913; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Verschueren KHG, 2008, CHEM BIOL, V15, P597, DOI 10.1016/j.chembiol.2008.04.011; WARREN LD, 2007, PYMOL MOL GRAPHICS S; Watney JB, 2003, J AM CHEM SOC, V125, P3745, DOI 10.1021/ja028487u; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Yin JA, 2007, J MOL BIOL, V371, P1060, DOI 10.1016/j.jmb.2007.06.001; Zheng KW, 2007, PROTEINS, V66, P467, DOI 10.1002/prot.21160; Zhong N, 2008, J VIROL, V82, P4227, DOI 10.1128/JVI.02612-07; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	63	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101941	10.1371/journal.pone.0101941	http://dx.doi.org/10.1371/journal.pone.0101941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036652	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200029
J	Benitez, SG; Castro, AE; Patterson, SI; Munoz, EM; Seltzer, AM				Benitez, Sergio G.; Castro, Analia E.; Patterson, Sean I.; Munoz, Estela M.; Seltzer, Alicia M.			Hypoxic Preconditioning Differentially Affects GABAergic and Glutamatergic Neuronal Cells in the Injured Cerebellum of the Neonatal Rat	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ACTIVE CASPASE-3 EXPRESSION; ISCHEMIC-INJURY; PURKINJE-CELLS; SELECTIVE VULNERABILITY; POSTNATAL-DEVELOPMENT; TRANSCRIPTION FACTOR; PROGENITOR CELLS; BRAIN-INJURY; PROTEIN	In this study we examined cerebellar alterations in a neonatal rat model of hypoxic-ischemic brain injury with or without hypoxic preconditioning (Pc). Between postnatal days 7 and 15, the cerebellum is still undergoing intense cellular proliferation, differentiation and migration, dendritogenesis and synaptogenesis. The expression of glutamate decarboxylase 1 (GAD67) and the differentiation factor NeuroD1 were examined as markers of Purkinje and granule cells, respectively. We applied quantitative immunohistochemistry to sagittal cerebellar slices, and Western blot analysis of whole cerebella obtained from control (C) rats and rats submitted to Pc, hypoxia-ischemia (L) and a combination of both treatments (PcL). We found that either hypoxia-ischemia or Pc perturbed the granule cells in the posterior lobes, affecting their migration and final placement in the internal granular layer. These effects were partially attenuated when the Pc was delivered prior to the hypoxia-ischemia. Interestingly, whole nuclear NeuroD1 levels in Pc animals were comparable to those in the C rats. However, a subset of Purkinje cells that were severely affected by the hypoxic-ischemic insult-showing signs of neuronal distress at the levels of the nucleus, cytoplasm and dendritic arborization-were not protected by Pc. A monoclonal antibody specific for GAD67 revealed a three-band pattern in cytoplasmic extracts from whole P15 cerebella. A similar to 110 kDa band, interpreted as a potential homodimer of a truncated form of GAD67, was reduced in Pc and L groups while its levels were close to the control animals in PcL rats. Additionally we demonstrated differential glial responses depending on the treatment, including astrogliosis in hypoxiated cerebella and a selective effect of hypoxia-ischemia on the vimentin-immunolabeled intermediate filaments of the Bergmann glia. Thus, while both glutamatergic and GABAergic cerebellar neurons are compromised by the hypoxic-ischemic insult, the former are protected by a preconditioning hypoxia while the latter are not.	[Benitez, Sergio G.; Castro, Analia E.; Munoz, Estela M.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Lab Neurobiol,Chronobiol Sect,Inst Histol & Embry, Mendoza, Argentina; [Patterson, Sean I.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Traumat & Tox Les Nervous Syst Sect,Inst Histol &, Mendoza, Argentina; [Seltzer, Alicia M.] Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Neonatal Brain Dev Sect,Inst Histol & Embryol Men, Mendoza, Argentina	Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza; Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza; Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza	Seltzer, AM (corresponding author), Natl Univ Cuyo, Natl Sci & Tech Res Council CONICET, Natl Agcy Sci & Technol Promot ANPCyT,Sch Med, Neonatal Brain Dev Sect,Inst Histol & Embryol Men, Mendoza, Argentina.	aseltzer@fcm.uncu.edu.ar		Munoz, Estela/0000-0002-6701-1535	CONICET; ANPCyT; SECTyP-UNCuyo [06/J394]; FCM-UNCuyo [138/11CD]; PICT-CONICET [2006-451, 2007-682, 2012-174]; PIP-CONICET [112-201101-00247, 114-200901-00354]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); SECTyP-UNCuyo; FCM-UNCuyo; PICT-CONICET; PIP-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors were supported by CONICET (http://www.conicet.gov.ar), ANPCyT (http://www.agencia.mincyt.gob.ar), SECTyP-UNCuyo (http://www.uncuyo.edu.ar) and FCM-UNCuyo (http://fcm.uncuyo.edu.ar); PICT-CONICET 2006-451 to AMS and EMM; PICT-CONICET 2007-682 and 2012-174, and PIP-CONICET 112-201101-00247 to EMM; PIP-CONICET 114-200901-00354, SECTyP-UNCuyo 06/J394 and FCM-UNCuyo 138/11CD to SIP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2010, EXP PHYSIOL, V95, P251, DOI 10.1113/expphysiol.2008.045575; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; Battaglioli G, 2005, NEUROCHEM RES, V30, P989, DOI 10.1007/s11064-005-6772-0; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; Biran V, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/858929; Biran V, 2011, NEUROBIOL DIS, V41, P138, DOI 10.1016/j.nbd.2010.09.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Cai J, 2012, J PATHOL, V226, P495, DOI 10.1002/path.2980; Castillo M, 2007, AM J NEURORADIOL, V28, P20; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; Consalez GG, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00123; Dore-Duffy P, 2007, ANTIOXID REDOX SIGN, V9, P1363, DOI 10.1089/ars.2007.1713; Savastano LE, 2010, J NEUROSCI METH, V192, P22, DOI 10.1016/j.jneumeth.2010.07.007; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2010, J ANAT, V217, P429, DOI 10.1111/j.1469-7580.2010.01226.x; Finckbone V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.003.2009; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; HUANG J, 1994, J APPL PHYSIOL, V77, P1006, DOI 10.1152/jappl.1994.77.2.1006; Ichikawa R, 2011, J NEUROSCI, V31, P16916, DOI 10.1523/JNEUROSCI.2396-11.2011; Johnsen SD, 2002, J CHILD NEUROL, V17, P320, DOI 10.1177/088307380201700502; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kadam SD, 2008, BRAIN RES, V1208, P35, DOI 10.1016/j.brainres.2008.02.037; Kanaani J, 1999, J BIOL CHEM, V274, P37200, DOI 10.1074/jbc.274.52.37200; Kelley MH, 2008, J NEUROCHEM, V107, P668, DOI 10.1111/j.1471-4159.2008.05617.x; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; LARRAMENDL L. M. H., 1967, BRAIN RES, V5, P15, DOI 10.1016/0006-8993(67)90216-8; Lee HT, 2009, J NEUROSCI, V29, P4356, DOI 10.1523/JNEUROSCI.5497-08.2009; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lopez-Aguilera F, 2012, NEUROSCIENCE, V216, P1, DOI 10.1016/j.neuroscience.2012.04.070; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Luo YQ, 2008, J BIOL CHEM, V283, P24789, DOI 10.1074/jbc.M800649200; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Millen KJ, 2008, CURR OPIN NEUROBIOL, V18, P12, DOI 10.1016/j.conb.2008.05.010; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Oomman S, 2004, J COMP NEUROL, V476, P154, DOI 10.1002/cne.20223; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pan N, 2009, CELL TISSUE RES, V337, P407, DOI 10.1007/s00441-009-0826-6; Peng JHF, 2005, DEV BRAIN RES, V156, P87, DOI 10.1016/j.devbrainres.2005.02.002; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004371; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Riva D, 2013, APPL NEUROPSYCH-CHIL, V2, P97, DOI 10.1080/21622965.2013.791092; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Saugstad OD, 2011, NEONATOLOGY, V99, P250, DOI 10.1159/000320332; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Sha D, 2005, MOL BRAIN RES, V136, P255, DOI 10.1016/j.molbrainres.2005.02.005; Sha D, 2008, BRAIN RES, V1207, P9, DOI 10.1016/j.brainres.2008.02.033; Sheikh SN, 1996, J NEUROCHEM, V66, P2082; Shrivastava K, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/781512; Sike A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084915; Sizonenko SV, 2008, INT J DEV NEUROSCI, V26, P37, DOI 10.1016/j.ijdevneu.2007.08.014; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; SZABO G, 1994, MOL CELL BIOL, V14, P7535, DOI 10.1128/MCB.14.11.7535; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Tirapu-Ustarroz J, 2011, REV NEUROLOGIA, V53, P301, DOI 10.33588/rn.5305.2010747; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; White ML, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120464; WILLIAMSON S, 1995, J AUTONOM NERV SYST, V55, P18, DOI 10.1016/0165-1838(95)00028-V; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Yip J, 2007, ACTA NEUROPATHOL, V113, P559, DOI 10.1007/s00401-006-0176-3; Zhuang JG, 2008, J APPL PHYSIOL, V104, P1351, DOI 10.1152/japplphysiol.00824.2007	82	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102056	10.1371/journal.pone.0102056	http://dx.doi.org/10.1371/journal.pone.0102056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032984	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300033
J	Mutch, WAC; Ellis, MJ; Graham, MR; Wourms, V; Raban, R; Fisher, JA; Mikulis, D; Leiter, J; Ryner, L				Mutch, W. Alan C.; Ellis, Michael J.; Graham, M. Ruth; Wourms, Vincent; Raban, Roshan; Fisher, Joseph A.; Mikulis, David; Leiter, Jeffrey; Ryner, Lawrence			Brain MRI CO2 Stress Testing: A Pilot Study in Patients with Concussion	PLOS ONE			English	Article							CEREBROVASCULAR RESPONSE; WHITE-MATTER; SPORTS; RECOVERY; KNOWLEDGE; INJURY	Background: There is a real need for quantifiable neuro-imaging biomarkers in concussion. Here we outline a brain BOLD-MRI CO2 stress test to assess the condition. Methods: This study was approved by the REB at the University of Manitoba. A group of volunteers without prior concussion were compared to post-concussion syndrome (PCS) patients - both symptomatic and recovered asymptomatic. Five 3-minute periods of BOLD imaging at 3.0 T were studied - baseline 1 (BL1- at basal CO2 tension), hypocapnia (CO2 decreased similar to 5 mmHg), BL2, hypercapnia (CO2 increased similar to 10 mmHg) and BL3. Data were processed using statistical parametric mapping (SPM) for 1st level analysis to compare each subject's response to the CO2 stress at the p = 0.001 level. A 2nd level analysis compared each PCS patient's response to the mean response of the control subjects at the p = 0.05 level. Results: We report on 5 control subjects, 8 symptomatic and 4 asymptomatic PCS patients. Both increased and decreased response to CO2 was seen in all PCS patients in the 2nd level analysis. The responses were quantified as reactive voxel counts: whole brain voxel counts (2.0 +/- 1.6%, p = 0.012 for symptomatic patients for CO2 response < controls and 3.0 +/- 5.1%, p = 0.139 for CO2 response > controls: 0.49 +/- 0.31%, p = 0.053 for asymptomatic patients for CO2 response < controls and 4.4 +/- 6.8%, p = 0.281 for CO2 response > controls). Conclusions: Quantifiable alterations in regional cerebrovascular responsiveness are present in concussion patients during provocative CO2 challenge and BOLD MRI and not in healthy controls. Future longitudinal studies must aim to clarify the relationship between CO2 responsiveness and individual patient symptoms and outcomes.	[Mutch, W. Alan C.; Graham, M. Ruth; Wourms, Vincent; Raban, Roshan] Univ Manitoba, Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Hlth Sci Ctr, Neurosurg Sect, Winnipeg, MB R3T 2N2, Canada; [Fisher, Joseph A.] Univ Toronto, Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON M5G 1L7, Canada; [Mikulis, David] Univ Toronto, Toronto Western Hosp, Dept Radiol, Sect Neuroimaging, Toronto, ON M5T 2S8, Canada; [Leiter, Jeffrey] Univ Manitoba, Dept Surg, Pan Am Clin, Winnipeg, MB R3T 2N2, Canada; [Ryner, Lawrence] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manitoba; University of Manitoba	Mutch, WAC (corresponding author), Univ Manitoba, Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada.	wacmutch@shaw.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; Mutch, W. Alan/0000-0001-7174-7839	Anesthesia Oversight Committee	Anesthesia Oversight Committee	Anesthesia Oversight Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Ashburner J, 2012, NEUROIMAGE, V62, P791, DOI 10.1016/j.neuroimage.2011.10.025; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kiebel SJ, 2004, NEUROIMAGE, V22, P503, DOI 10.1016/j.neuroimage.2004.02.013; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Langlois JA, 2008, J HEAD TRAUMA REHAB, V21, P375; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mardimae A, 2012, PFLUG ARCH EUR J PHY, V464, P345, DOI 10.1007/s00424-012-1148-1; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Mutch WAC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057881; Mutch WAC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047443; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Regan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070751; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Sobczyk O, 2014, NEUROIMAGE, V92, P56, DOI 10.1016/j.neuroimage.2014.01.051; Tormenti M, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12282; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005	38	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102181	10.1371/journal.pone.0102181	http://dx.doi.org/10.1371/journal.pone.0102181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032707	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300039
J	Rodrigue-Gervais, IG; Rigsby, H; Jouan, L; Willems, B; Lamarre, D				Rodrigue-Gervais, Ian Gael; Rigsby, Hawley; Jouan, Loubna; Willems, Bernard; Lamarre, Daniel			Intact Dendritic Cell Pathogen-Recognition Receptor Functions Associate with Chronic Hepatitis C Treatment-Induced Viral Clearance	PLOS ONE			English	Article							PERSISTENT LCMV INFECTION; VIRUS-INFECTION; IN-VIVO; IMMUNE-RESPONSES; VACCINE; BLOCKADE; THERAPY; PEGINTERFERON; EXPRESSION; RIBAVIRIN	Although studies have addressed the exhaustion of the host's immune response to HCV and its role in treatment, there is little information about the possible contribution of innate immunity to treatment-induced clearance. We hypothesized that because intact myeloid dendritic cell (MDC) pathogen sensing functions are associated with improved HCV-specific CD8(+) T cell functionality in some chronically infected patients, it might enhance HCV clearance rate under standard interferon therapy. To investigate this hypothesis, TLR-induced MDC activation and HCV-specific CD8(+) T cell response quality were monitored longitudinally at the single-cell level using polychromatic flow cytometry in chronically infected patients undergoing interferon therapy. We correlated the immunological, biochemical and virological data with response to treatment. We demonstrate that the clinical efficacy of interferon-induced viral clearance is influenced by the extent to which HCV inhibits MDC functions before treatment, rather than solely on a breakdown of the extrinsic T cell immunosuppressive environment. Thus, viral inhibition of MDC functions before treatment emerges as a co-determining factor in the clinical efficacy of interferon therapy during chronic HCV infection.	[Rodrigue-Gervais, Ian Gael; Rigsby, Hawley; Jouan, Loubna; Willems, Bernard; Lamarre, Daniel] Univ Montreal CR CHUM, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Willems, Bernard; Lamarre, Daniel] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Lamarre, D (corresponding author), Univ Montreal CR CHUM, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.	daniel.lamarre@umontreal.ca			Canadian Institute of Health Research [MOP-79546]; Novartis/Canadian Liver Foundation Hepatology Research Chair	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Novartis/Canadian Liver Foundation Hepatology Research Chair	This work was supported by Canadian Institute of Health Research grant MOP-79546 and by the Novartis/Canadian Liver Foundation Hepatology Research Chair (D.L.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Casazza JP, 2013, J INFECT DI IN PRESS; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hel Z, 2000, NAT MED, V6, P1140, DOI 10.1038/80481; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lauer GM, 2013, J INFECT DIS, V207, pS7, DOI 10.1093/infdis/jis762; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039368; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Miyazaki M, 2008, J MED VIROL, V80, P980, DOI 10.1002/jmv.21174; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Ng CT, 2011, CURR OPIN VIROL, V1, P160, DOI 10.1016/j.coviro.2011.05.006; Rodrigue-Gervais IG, 2007, J VIROL, V81, P5537, DOI 10.1128/JVI.01741-06; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Schurich A, 2012, PLOS PATHOG, V9; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thompson AJ, 2012, GASTROENTEROLOGY, V142, P1335, DOI 10.1053/j.gastro.2012.01.046; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; Walsh KB, 2012, CELL HOST MICROBE, V11, P643, DOI 10.1016/j.chom.2012.04.016; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	37	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102605	10.1371/journal.pone.0102605	http://dx.doi.org/10.1371/journal.pone.0102605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033043	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300066
J	Treinys, R; Kaselis, A; Jover, E; Bagnard, D; Satkauskas, S				Treinys, Rimantas; Kaselis, Andrius; Jover, Emmanuel; Bagnard, Dominique; Satkauskas, Saulius			R-Type Calcium Channels Are Crucial for Semaphorin 3A-Induced DRG Axon Growth Cone Collapse	PLOS ONE			English	Article							TRIVALENT METAL-CATIONS; CA2+ CHANNELS; MEMBRANE-TRANSPORT; GUIDANCE MOLECULES; SENSORY NEURONS; SMOOTH-MUSCLE; TRPC CHANNELS; CELLS; SIGNALS; EXPRESSION	Semaphorin 3A (Sema3A) is a secreted protein involved in axon path-finding during nervous system development. Calcium signaling plays an important role during axonal growth in response to different guidance cues; however it remains unclear whether this is also the case for Sema3A. In this study we used intracellular calcium imaging to figure out whether Sema3Ainduced growth cone collapse is a Ca2+ dependent process. Intracellular Ca2+ imaging results using Fura-2 AM showed Ca2+ increase in E15 mice dorsal root ganglia neurons upon Sema3A treatment. Consequently we analyzed Sema3A effect on growth cones after blocking or modifying intracellular and extracellular Ca2+ channels that are expressed in E15 mouse embryos. Our results demonstrate that Sema3A increased growth cone collapse rate is blocked by the non-selective R-and T-type Ca2+ channel blocker NiCl2 and by the selective R-type Ca2+ channel blocker SNX482. These Ca2+ channel blockers consistently decreased the Sema3A-induced intracellular Ca2+ concentration elevation. Overall, our results demonstrate that Sema3A-induced growth cone collapses are intimately related with increase in intracellular calcium concentration mediated by R-type calcium channels.	[Treinys, Rimantas; Kaselis, Andrius; Satkauskas, Saulius] Vytautas Magnus Univ, Dept Biol, Biophys Res Grp, Kaunas, Lithuania; [Treinys, Rimantas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Jover, Emmanuel] INCI UPR CNRS 3212, Strasbourg, France; [Bagnard, Dominique] Univ Strasbourg, INSERM U1109, Lab MN3t, Labex Medalis, Strasbourg, France	Vytautas Magnus University; Lithuanian University of Health Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Satkauskas, S (corresponding author), Vytautas Magnus Univ, Dept Biol, Biophys Res Grp, Kaunas, Lithuania.	s.satkauskas@gmf.vdu.lt	Bagnard, Dominique/I-6535-2013; Satkauskas, Saulius/Z-4144-2019; Satkauskas, Saulius/AAD-7045-2020	Satkauskas, Saulius/0000-0002-9001-7767; Bagnard, Dominique/0000-0002-5261-902X; Treinys, Rimantas/0000-0002-7590-7606	Research Council of Lithuania [MOS-7, T40]; Student Research Fellowship Award [SDS-2012-014]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Student Research Fellowship Award	This work has been supported by Research Council of Lithuania (Grants MOS-7 and T40) and Student Research Fellowship Award for A. Kaselis (SDS-2012-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Arroyo G, 2003, EUR J PHARMACOL, V475, P11, DOI 10.1016/S0014-2999(03)02084-3; Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Balemba OB, 2006, AM J PHYSIOL-GASTR L, V290, pG655, DOI 10.1152/ajpgi.00310.2005; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Behar O, 1999, P NATL ACAD SCI USA, V96, P13501, DOI 10.1073/pnas.96.23.13501; Ben-Zvi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070085; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BIAGI BA, 1990, AM J PHYSIOL, V259, pC515, DOI 10.1152/ajpcell.1990.259.3.C515; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chew LJ, 1998, MOL NEUROBIOL, V18, P175, DOI 10.1007/BF02741300; Chi XX, 2009, J CELL SCI, V122, P4351, DOI 10.1242/jcs.053280; Diaz D, 2005, J MEMBRANE BIOL, V207, P91, DOI 10.1007/s00232-005-0804-1; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hong K, 2010, NEUROSCIENTIST, V16, P65, DOI 10.1177/1073858409340702; Huang ZH, 2011, J CELL SCI, V124, P186, DOI 10.1242/jcs.071357; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Joddar B, 2013, BIOMATERIALS, V34, P9593, DOI 10.1016/j.biomaterials.2013.08.019; Kaczmarek JS, 2012, P NATL ACAD SCI USA, V109, P7888, DOI 10.1073/pnas.1205869109; KATER SB, 1991, J NEUROSCI, V11, P891; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Mitchell CB, 2012, J NEUROCHEM, V122, P1155, DOI 10.1111/j.1471-4159.2012.07840.x; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639, DOI 10.1113/jphysiol.1993.sp019835; Moreno C, 2011, IUBMB LIFE, V63, P856, DOI 10.1002/iub.547; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nishikitani M, 2007, TOHOKU J EXP MED, V211, P151, DOI 10.1620/tjem.211.151; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Plazas PV, 2012, PROCEEDINGS OF THE N, V110, P1524; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Shcheglovitov A, 2005, BIOCHEM PHARMACOL, V69, P841, DOI 10.1016/j.bcp.2004.11.024; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Talley EM, 1999, J NEUROSCI, V19, P1895; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Yamane M, 2012, BIOCHEM BIOPH RES CO, V422, P333, DOI 10.1016/j.bbrc.2012.05.003; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102357	10.1371/journal.pone.0102357	http://dx.doi.org/10.1371/journal.pone.0102357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032951	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300049
J	Umeki, H; Tokuyama, R; Ide, S; Okubo, M; Tadokoro, S; Tezuka, M; Tatehara, S; Satomura, K				Umeki, Hirochika; Tokuyama, Reiko; Ide, Shinji; Okubo, Mitsuru; Tadokoro, Susumu; Tezuka, Mitsuki; Tatehara, Seiko; Satomura, Kazuhito			Leptin Promotes Wound Healing in the Oral Mucosa	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR EXPRESSION; GENE-EXPRESSION; PROLIFERATION; LOCALIZATION; ACTIVATION; BRAIN; KERATINOCYTES; METABOLISM; INDUCTION	Introduction: Leptin, a 16 kDa circulating anti-obesity hormone, exhibits many physiological properties. Recently, leptin was isolated from saliva; however, its function in the oral cavity is still unclear. In this study, we investigated the physiological role of leptin in the oral cavity by focusing on its effect on wound healing in the oral mucosa. Methods: Immunohistochemical analysis was used to examine the expression of the leptin receptor (Ob-R) in human/rabbit oral mucosa. To investigate the effect of leptin on wound healing in the oral mucosa, chemical wounds were created in rabbit oral mucosa, and leptin was topically administered to the wound. The process of wound repair was histologically observed and quantitatively analyzed by measuring the area of ulceration and the duration required for complete healing. The effect of leptin on the proliferation, differentiation and migration of human oral mucosal epithelial cells (RT7 cells) was investigated using crystal violet staining, reverse transcription polymerase chain reaction (RT-PCR) and a wound healing assay, respectively. Results: Ob-R was expressed in spinous/granular cells in the epithelial tissue and vascular endothelial cells in the subepithelial connective tissue of the oral mucosa. Topical administration of leptin significantly promoted wound healing and shortened the duration required for complete healing. Histological analysis of gingival tissue beneath the ulceration showed a denser distribution of blood vessels in the leptin-treated group. Although the proliferation and differentiation of RT7 cells were not affected by leptin, the migration of these cells was accelerated in the presence of leptin. Conclusion: Topically administered leptin was shown to promote wound healing in the oral mucosa by accelerating epithelial cell migration and enhancing angiogenesis around the wounded area. These results strongly suggest that topical administration of leptin may be useful as a treatment to promote wound healing in the oral mucosa.	[Umeki, Hirochika; Tokuyama, Reiko; Ide, Shinji; Okubo, Mitsuru; Tadokoro, Susumu; Tezuka, Mitsuki; Tatehara, Seiko; Satomura, Kazuhito] Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Yokohama, Kanagawa, Japan	Tsurumi University	Satomura, K (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Yokohama, Kanagawa, Japan.	satomura-k@tsurumi-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24593016, 25293415, 24659905, 23792392, 24593015]; Grants-in-Aid for Scientific Research [25861984] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (No. 24593016, 25293415, 24659905, 23792392, and 24593015) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin S, 2005, PEPTIDES, V26, P647, DOI 10.1016/j.peptides.2004.11.008; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Bryson JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE417, DOI 10.1152/ajpendo.1999.277.3.E417; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; De Matteis R, 1998, P NUTR SOC, V57, P441, DOI 10.1079/PNS19980063; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; GIBRAN NS, 1994, J SURG RES, V56, P226, DOI 10.1006/jsre.1994.1036; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Groschl M, 2005, J MOL ENDOCRINOL, V34, P353, DOI 10.1677/jme.1.01658; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Guerra B, 2007, J APPL PHYSIOL, V102, P1786, DOI 10.1152/japplphysiol.01313.2006; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; HATTON MN, 1987, J ORAL MAXIL SURG, V45, P496, DOI 10.1016/S0278-2391(87)80009-5; Hwa JJ, 1996, HORM METAB RES, V28, P659, DOI 10.1055/s-2007-979873; Islam MS, 1997, BIOCHEM BIOPH RES CO, V238, P851, DOI 10.1006/bbrc.1997.7399; Jin L, 1999, J CLIN ENDOCR METAB, V84, P2903, DOI 10.1210/jc.84.8.2903; Keswani SG, 2013, WOUND REPAIR REGEN, V21, P554, DOI 10.1111/wrr.12065; Kume K, 2002, J HISTOCHEM CYTOCHEM, V50, P159, DOI 10.1177/002215540205000204; Le M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048040; MARTIN P, 1993, DEV GENET, V14, P225, DOI 10.1002/dvg.1020140309; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Nauta A, 2011, ORAL DIS, V17, P541, DOI 10.1111/j.1601-0825.2011.01787.x; Ohta K, 2008, J DENT RES, V87, P1160, DOI 10.1177/154405910808701211; ROBERTS AB, 1983, FED PROC, V42, P2621; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Spicer LJ, 1997, ENDOCRINOLOGY, V138, P3374, DOI 10.1210/en.138.8.3374; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Stallmeyer B, 2001, J INVEST DERMATOL, V117, P98, DOI 10.1046/j.0022-202x.2001.01387.x; Tanabe K, 1997, BIOCHEM BIOPH RES CO, V241, P765, DOI 10.1006/bbrc.1997.7894; Ten Cate AR, 1994, ORAL HISTOLOGY; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	44	30	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101984	10.1371/journal.pone.0101984	http://dx.doi.org/10.1371/journal.pone.0101984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033454	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300030
J	Derakhshan, A; Sardarinia, M; Khalili, D; Momenan, AA; Azizi, F; Hadaegh, F				Derakhshan, Arash; Sardarinia, Mahsa; Khalili, Davood; Momenan, Amir Abbas; Azizi, Fereidoun; Hadaegh, Farzad			Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							POPULATION-BASED INCIDENCE; 3RD NATIONAL SURVEILLANCE; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; WAIST CIRCUMFERENCE; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; CENTRAL OBESITY; LIFE-STYLE; PREVALENCE	Objective: To investigate the population-based incidence of type 2 diabetes and its potential risk factors in a sex-split cohort of Iranian population. Materials and Methods: A total of 8400 non-diabetic participants, aged >= 20 years (3620 men and 4780 women) entered the study. Crude and age standardized incidence rates per 1000 person-years were calculated for whole population and each sex separately. Cox proportional hazard models were used to evaluate hazard ratios (HR) and 95% confidence intervals for all potential risk factors in both uni-variable and multivariable models. Results: During a median follow-up of 9.5 years, 736 new cases of diabetes were identified, including 433 women and 303 men. The annual crude and age-standardized incidence rates (95% CI) of diabetes in the total population were 10.6 (9.92-11.4) and 9.94 (7.39-13.6) per 1000 person-years of follow-up and the corresponding sex specific rates were 10.2 (9.13-11.4) and 9.36 (5.84-14.92) in men and 11.0 (9.99-12.0) and 10.1 (7.24-13.9) in women, respectively. In the multivariable model, the risk for incident diabetes was significantly associated with fasting and 2 hour post challenge plasma glucose as well as family history of diabetes in both men and women. However, among women, only the contribution of wrist circumference to incident diabetes achieved statistical significance [HR: 1.16 (1.03-1.31)] with waist/height ratio being marginally significant [HR: 1.02 (0.99-1.04)]; while among men, only body mass index was a significant predictor [HR: 1.12 (1.02-1.22)]. Additionally, low education level conferred a higher risk for incident diabetes only among men [HR: 1.80 (1.23-2.36); P for interaction with sex = 0.003]. Conclusion: Overall, sex did not significantly modify the impact of risk factors associated with diabetes among Iranian adults; however, among modifiable risk factors, the independent role of lower education and general adiposity in men and central adiposity in women might require different preventive strategies.	[Derakhshan, Arash; Sardarinia, Mahsa; Khalili, Davood; Momenan, Amir Abbas; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Khalili, Davood/T-2913-2017; Azizi, Fereidoun/ABD-4136-2021; hadaegh, farzad/K-2460-2017; Derakhshan, Arash/AAD-7505-2019	Khalili, Davood/0000-0003-4956-1039; Azizi, Fereidoun/0000-0002-6470-2517; Derakhshan, Arash/0000-0001-7335-1918; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Auryan S, 2008, DIABETES OBES METAB, V10, P1135, DOI 10.1111/j.1463-1326.2008.00896.x; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bennet L, 2014, PRIM CARE DIABETES; BERNS MAM, 1988, INT J EPIDEMIOL, V17, P789, DOI 10.1093/ije/17.4.789; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Bozorgmanesh M, 2012, J ENDOCRINOL INVEST, V35, P14, DOI 10.3275/7728; Bozorgmanesh M, 2011, DIABETIC MED, V28, P1330, DOI 10.1111/j.1464-5491.2011.03343.x; Bozorgmanesh M, 2012, ACTA DIABETOL, V49, P341, DOI 10.1007/s00592-011-0298-5; Committee IR, 2005, GUID DAT PROC AN INT; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Esteghamati A, 2011, J PHYS ACT HEALTH, V8, P27, DOI 10.1123/jpah.8.1.27; Esteghamati A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-167; Franklin SS, 1997, CIRCULATION, V96, P308; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; Green A, 2003, DIABETES-METAB RES, V19, P3, DOI 10.1002/dmrr.340; GREENFIELD MS, 1980, METABOLISM, V29, P1095, DOI 10.1016/0026-0495(80)90221-8; Hadaegh F, 2009, J ENDOCRINOL INVEST, V32, P724, DOI [10.3275/6399, 10.1007/BF03346527]; Hadaegh F, 2007, DIABETES RES CLIN PR, V76, P449, DOI 10.1016/j.diabres.2006.09.030; Hadaegh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076304; Harati H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-186; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Holden SE, 2013, DIABETES OBES METAB, V15, P844, DOI 10.1111/dom.12123; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-426; Jensen MD, 2006, OBESITY, V14, p20S, DOI 10.1038/oby.2006.278; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Li CY, 2010, DIABETES RES CLIN PR, V89, P79, DOI 10.1016/j.diabres.2010.02.014; Magee MJ, 2013, PREV MED; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mohan V, 2008, J Assoc Physicians India, V56, P152; Noto D, 2012, ACTA DIABETOL, V49, P145, DOI 10.1007/s00592-011-0305-x; Noudeh YJ, 2013, J CLIN ENDOCR METAB, V98, P777, DOI 10.1210/jc.2012-2416; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Strandberg AY, 2013, ANN MED, V45, P336, DOI 10.3109/07853890.2013.785233; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Valdes S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yoon U, 2013, METABOLISM, V62, P303, DOI 10.1016/j.metabol.2012.07.009	56	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102563	10.1371/journal.pone.0102563	http://dx.doi.org/10.1371/journal.pone.0102563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029368	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600085
J	Simeone, P; Trerotola, M; Urbanella, A; Lattanzio, R; Ciavardelli, D; Di Giuseppe, F; Eleuterio, E; Sulpizio, M; Eusebi, V; Pession, A; Piantelli, M; Alberti, S				Simeone, Pasquale; Trerotola, Marco; Urbanella, Andrea; Lattanzio, Rossano; Ciavardelli, Domenico; Di Giuseppe, Fabrizio; Eleuterio, Enrica; Sulpizio, Marilisa; Eusebi, Vincenzo; Pession, Annalisa; Piantelli, Mauro; Alberti, Saverio			A Unique Four-Hub Protein Cluster Associates to Glioblastoma Progression	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; WEB SERVER; C-MYC; IDENTIFICATION; EXPRESSION; CANCER; GENES; CLASSIFICATION; MECHANISMS; APOPTOSIS	Gliomas are the most frequent brain tumors. Among them, glioblastomas are malignant and largely resistant to available treatments. Histopathology is the gold standard for classification and grading of brain tumors. However, brain tumor heterogeneity is remarkable and histopathology procedures for glioma classification remain unsatisfactory for predicting disease course as well as response to treatment. Proteins that tightly associate with cancer differentiation and progression, can bear important prognostic information. Here, we describe the identification of protein clusters differentially expressed in high-grade versus low-grade gliomas. Tissue samples from 25 high-grade tumors, 10 low-grade tumors and 5 normal brain cortices were analyzed by 2D-PAGE and proteomic profiling by mass spectrometry. This led to identify 48 differentially expressed protein markers between tumors and normal samples. Protein clustering by multivariate analyses (PCA and PLS-DA) provided discrimination between pathological samples to an unprecedented extent, and revealed a unique network of deranged proteins. We discovered a novel glioblastoma control module centered on four major network hubs: Huntingtin, HNF4 alpha, c-Myc and 14-3-3 zeta. Immunohistochemistry, western blotting and unbiased proteome-wide meta-analysis revealed altered expression of this glioblastoma control module in human glioma samples as compared with normal controls. Moreover, the four-hub network was found to cross-talk with both p53 and EGFR pathways. In summary, the findings of this study indicate the existence of a unifying signaling module controlling glioblastoma pathogenesis and malignant progression, and suggest novel targets for development of diagnostic and therapeutic procedures.	[Simeone, Pasquale; Trerotola, Marco; Urbanella, Andrea; Lattanzio, Rossano; Piantelli, Mauro; Alberti, Saverio] Fdn Univ G dAnnunzio, Ce SI, Unit Canc Pathol, Chieti, Italy; [Ciavardelli, Domenico] Univ Kore Enna, Sch Human & Social Sci, Enna, Italy; [Ciavardelli, Domenico] Univ G DAnnunzio, Ce SI, Mol Neurol Unit, Chieti, Italy; [Di Giuseppe, Fabrizio; Eleuterio, Enrica; Sulpizio, Marilisa] Univ G dAnnunzio Fdn, Ce SI, Aging Res Ctr, Chieti, Italy; [Lattanzio, Rossano; Di Giuseppe, Fabrizio; Eleuterio, Enrica; Sulpizio, Marilisa; Piantelli, Mauro] Univ G DAnnunzio, Sch Med & Hlth Sci, Dept Expt & Clin Sci, Chieti, Italy; [Di Giuseppe, Fabrizio; Eleuterio, Enrica; Sulpizio, Marilisa] StemTeCh Grp, Chieti, Italy; [Eusebi, Vincenzo] Univ Cattolica Sacro Cuore, Dept Tutela Salute Donna Vita Nascente Bambino &, Policlin Univ Agostino Gemelli, I-00168 Rome, Italy; [Pession, Annalisa] M Malpighi Bellaria Hosp, Surg Pathol Sect, Bologna, Italy; [Alberti, Saverio] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Universita Kore di ENNA; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; G d'Annunzio University of Chieti-Pescara	Alberti, S (corresponding author), Fdn Univ G dAnnunzio, Ce SI, Unit Canc Pathol, Chieti, Italy.	s.alberti@unich.it	Lattanzio, Rossano/K-1927-2018; Alberti, Saverio/M-4511-2014; Trerotola, Marco/J-9015-2016; Simeone, Pasquale/K-7549-2016	Lattanzio, Rossano/0000-0001-9803-4476; Alberti, Saverio/0000-0002-4647-6042; Trerotola, Marco/0000-0003-1855-7002; Simeone, Pasquale/0000-0003-4430-480X; Pession, Annalisa/0000-0001-9035-9698	Fondazione of the Cassa di Risparmio della Provincia di Chieti; Italian Association for Cancer Research (AIRC); Italian Ministry of Health [RicOncol RF-EMR-2006-361866]; Italian Ministry of Research (MIUR-FISR "Novel technologies for glioblastoma assessment" Neurobiotechnologies Grant) [481]; Italian Ministry of Development ("Made in Italy") [MI01_00424]	Fondazione of the Cassa di Risparmio della Provincia di Chieti; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research (MIUR-FISR "Novel technologies for glioblastoma assessment" Neurobiotechnologies Grant); Italian Ministry of Development ("Made in Italy")	This work was supported by the Fondazione of the Cassa di Risparmio della Provincia di Chieti, the Italian Association for Cancer Research (AIRC), the Italian Ministries of Health (RicOncol RF-EMR-2006-361866), Research (MIUR-FISR "Novel technologies for glioblastoma assessment" Neurobiotechnologies Grant No 481) and Development ("Made in Italy," Contract No MI01_00424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Aldape K, 2000, CANCER-AM CANCER SOC, V88, P2342, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO;2-X; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Bleeker FE, 2012, J NEURO-ONCOL, V108, P11, DOI 10.1007/s11060-011-0793-0; Bradley SV, 2007, CANCER RES, V67, P3609, DOI 10.1158/0008-5472.CAN-06-4803; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Chumbalkar Vaibhav, 2008, Curr Probl Cancer, V32, P143, DOI 10.1016/j.currproblcancer.2008.02.005; DeVita V.T.L., 2008, HELLMAN ROSENBERGS C; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Eriksson L., 2006, MULTI MEGAVARIATE 1; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Frattini V, 2013, NAT GENET; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; GALARRAGA J, 1986, METAB BRAIN DIS, V1, P279, DOI 10.1007/BF00999357; Gimenez M, 2010, PROTEOMICS, V10, P2812, DOI 10.1002/pmic.200900722; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hanash SM, 2002, PROTEOMICS, V2, P69, DOI 10.1002/1615-9861(200201)2:1<69::AID-PROT69>3.3.CO;2-#; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; Huber E, 2004, J VIROL, V78, P7478, DOI 10.1128/JVI.78.14.7478-7489.2004; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kleno TG, 2004, PROTEOMICS, V4, P868, DOI 10.1002/pmic.200300663; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Levanen Bettina, 2009, V519, P113, DOI 10.1007/978-1-59745-281-6_8; Liang SF, 2009, PROTEOM CLIN APPL, V3, P743, DOI 10.1002/prca.200800198; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Maeda Y, 2002, MOL ENDOCRINOL, V16, P402, DOI 10.1210/me.16.2.402; Marengo E, 2008, ANAL BIOANAL CHEM, V390, P1327, DOI 10.1007/s00216-008-1837-y; Marie SK, 2011, METABOLISM BRAIN CAN; Martinho O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030769; Marucci G, 2008, VIRCHOWS ARCH, V453, P599, DOI 10.1007/s00428-008-0685-7; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; McLeod J, 2009, FASEB J, V23, P2942, DOI 10.1096/fj.08-121657; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Minagawa H, 2008, BIOCHEM BIOPH RES CO, V366, P186, DOI 10.1016/j.bbrc.2007.11.101; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Niclou SP, 2010, J PROTEOMICS, V73, P1823, DOI 10.1016/j.jprot.2010.03.007; Norden B, 2005, CHEM BIODIVERS, V2, P1487, DOI 10.1002/cbdv.200590120; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Okamoto H, 2007, CANCER BIOL THER, V6, P391, DOI 10.4161/cbt.6.3.3731; Oksvold MP, 2004, FEBS LETT, V569, P207, DOI 10.1016/j.febslet.2004.05.068; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pitts A, 2012, J BIOL CHEM, V287, P22717, DOI 10.1074/jbc.M111.334565; Radner H, 2002, PATHOLOGE, V23, P260, DOI 10.1007/s00292-002-0530-8; Rahman-Roblick R, 2008, ONCOGENE, V27, P4854, DOI 10.1038/onc.2008.124; Rasheed B K, 1999, Curr Opin Oncol, V11, P162; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Somiari RI, 2005, J CHROMATOGR B, V815, P215, DOI 10.1016/j.jchromb.2004.11.012; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Sun HM, 2004, J CHEM INF COMP SCI, V44, P748, DOI 10.1021/ci030304f; The WHO, 2020, CLASSIFICATION TUMOU; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vergara D, 2013, MOL BIOSYST, V9, P1127, DOI 10.1039/c2mb25401h; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wiklund S, 2007, J CHEMOMETR, V21, P427, DOI 10.1002/cem.1086; Xia J, 2012, NUCL ACIDS RES; Xia J, 2002, METABOLOMIC DATA PRO; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Yang XL, 2011, NEUROSURGERY, V68, P932, DOI 10.1227/NEU.0b013e3182098c30; Ziegler DS, 2008, J CLIN ONCOL, V26, P493, DOI 10.1200/JCO.2007.13.9717	87	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103030	10.1371/journal.pone.0103030	http://dx.doi.org/10.1371/journal.pone.0103030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050814	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100079
J	Frolund, M; Bjornelius, E; Lidbrink, P; Ahrens, P; Jensen, JS				Frolund, Maria; Bjornelius, Eva; Lidbrink, Peter; Ahrens, Peter; Jensen, Jorgen Skov			Comparison between Culture and a Multiplex Quantitative Real-Time Polymerase Chain Reaction Assay Detecting Ureaplasma urealyticum and U-parvum	PLOS ONE			English	Article							NONGONOCOCCAL URETHRITIS; MYCOPLASMA-GENITALIUM; CHLAMYDIA-TRACHOMATIS; SP-NOV; DISEASE; ASSOCIATION; MEN; DYSPLASIA; SPECIMENS; BIOVAR-2	A novel multiplex quantitative real-time polymerase chain reaction (qPCR) for simultaneous detection of U. urealyticum and U. parvum was developed and compared with quantitative culture in Shepard's 10 C medium for ureaplasmas in urethral swabs from 129 men and 66 women, and cervical swabs from 61 women. Using culture as the gold standard, the sensitivity of the qPCR was 96% and 95% for female urethral and cervical swabs, respectively. In male urethral swabs the sensitivity was 89%. The corresponding specificities were 100%, 87% and 99%. The qPCR showed a linear increasing DNA copy number with increasing colour-changing units. Although slightly less sensitive than culture, this multiplex qPCR assay detecting U. urealyticum and U. parvum constitutes a simple and fast alternative to the traditional methods for identification of ureaplasmas and allows simultaneous species differentiation and quantitation in clinical samples. Furthermore, specimens overgrown by other bacteria using the culture method can be evaluated in the qPCR.	[Frolund, Maria; Ahrens, Peter; Jensen, Jorgen Skov] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Bjornelius, Eva; Lidbrink, Peter] Huddinge Univ Hosp, Karolinska Inst, Dept Dermatovenereol, S-14186 Huddinge, Sweden	Statens Serum Institut; Karolinska Institutet	Jensen, JS (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark.	JSJ@ssi.dk	Jensen, Jørgen Skov/H-5159-2019	Jensen, Jørgen Skov/0000-0002-7464-7435; Ahrens, Peter/0000-0003-3776-7929	Danish Public Health Care System	Danish Public Health Care System	Testing for U. urealyticum and U. parvum at Statens Serum Institut is provided for a testing fee, which is paid by the Danish Public Health Care System, financed through income taxes. The authors' employment at Statens Serum Institut does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	BLANCHARD A, 1993, CLIN INFECT DIS, V17, pS148, DOI 10.1093/clinids/17.Supplement_1.S148; BOWIE WR, 1977, J CLIN INVEST, V59, P735, DOI 10.1172/JCI108694; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Carne CA, 2013, INT J STD AIDS, V24, P273, DOI 10.1177/0956462412472306; Deguchi T, 2004, SEX TRANSM DIS, V31, P192, DOI 10.1097/01.OLQ.0000114653.26951.71; Ekiel AM, 2009, J KOREAN MED SCI, V24, P1177, DOI 10.3346/jkms.2009.24.6.1177; Horner P, 2001, CLIN INFECT DIS, V32, P995, DOI 10.1086/319594; Jensen JS, 2004, SEX TRANSM DIS, V31, P499, DOI 10.1097/01.olq.0000135992.98883.e4; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Kafetzis DA, 2004, CLIN INFECT DIS, V39, P1113, DOI 10.1086/424505; Kasper DC, 2011, J PERINAT MED, V39, P331, DOI [10.1515/JPM.2011.022, 10.1515/jpm.2011.022]; Kong F, 1999, INT J SYST BACTERIOL, V49, P89; Kong FR, 1999, INT J SYST BACTERIOL, V49, P1879; Ondondo RO, 2010, SEX TRANSM INFECT, V86, P271, DOI 10.1136/sti.2009.040394; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Povlsen K, 1998, J CLIN MICROBIOL, V36, P3211, DOI 10.1128/JCM.36.11.3211-3216.1998; Povlsen K, 2002, EUR J CLIN MICROBIOL, V21, P97, DOI 10.1007/s10096-001-0665-1; ROBERTSON JA, 1990, NUCLEIC ACIDS RES, V18, P1451, DOI 10.1093/nar/18.6.1451; ROBERTSON JA, 1984, J CLIN MICROBIOL, V19, P857, DOI 10.1128/JCM.19.6.857-864.1984; ROBERTSON JA, 1993, J CLIN MICROBIOL, V31, P824, DOI 10.1128/JCM.31.4.824-830.1993; Robertson JA, 2002, INT J SYST EVOL MICR, V52, P587, DOI 10.1099/00207713-52-2-587; SHEPARD MC, 1974, INT J SYST BACTERIOL, V24, P160, DOI 10.1099/00207713-24-2-160; SHEPARD MC, 1983, METHODS MYCOPLASMOLO, V1, P137; Shimada Y, 2014, INT J STD AIDS, V25, P294, DOI 10.1177/0956462413504556; TaylorRobinson D, 1996, SEX TRANSM DIS, V23, P86, DOI 10.1097/00007435-199601000-00020; Totten PA, 2008, SEXUALLY TRANSMITTED, P709; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; Wetmore CM, 2011, J INFECT DIS, V204, P1274, DOI 10.1093/infdis/jir517; WONG JL, 1977, SEX TRANSM DIS, V4, P4, DOI 10.1097/00007435-197701000-00002; Xiao L, 2010, J CLIN MICROBIOL, V48, P2715, DOI 10.1128/JCM.01877-09; Yamazaki T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-82; Yoshida T, 2007, SEX TRANSM DIS, V34, P416, DOI 10.1097/01.olq.0000243621.89212.40	32	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102743	10.1371/journal.pone.0102743	http://dx.doi.org/10.1371/journal.pone.0102743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047036	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100066
J	Alegana, VA; Wright, JA; Nahzat, SM; Butt, W; Sediqi, AW; Habib, N; Snow, RW; Atkinson, PM; Noor, AM				Alegana, Victor A.; Wright, Jim A.; Nahzat, Sami M.; Butt, Waqar; Sediqi, Amad W.; Habib, Naeem; Snow, Robert W.; Atkinson, Peter M.; Noor, Abdisalan M.			Modelling the Incidence of Plasmodium vivax and Plasmodium falciparum Malaria in Afghanistan 2006-2009	PLOS ONE			English	Article							SPACE; TIME; DETERMINANTS; TRANSMISSION; REGRESSION; PROGRESS	Identifying areas that support high malaria risks and where populations lack access to health care is central to reducing the burden in Afghanistan. This study investigated the incidence of Plasmodium vivax and Plasmodium falciparum using routine data to help focus malaria interventions. Methods: To estimate incidence, the study modelled utilisation of the public health sector using fever treatment data from the 2012 national Malaria Indicator Survey. A probabilistic measure of attendance was applied to population density metrics to define the proportion of the population within catchment of a public health facility. Malaria data were used in a Bayesian spatio-temporal conditional-autoregressive model with ecological or environmental covariates, to examine the spatial and temporal variation of incidence. Findings: From the analysis of healthcare utilisation, over 80% of the population was within 2 hours' travel of the nearest public health facility, while 64.4% were within 30 minutes' travel. The mean incidence of P. vivax in 2009 was 5.4 (95% Crl 3.2-9.2) cases per 1000 population compared to 1.2 (95% Crl 0.4-2.9) cases per 1000 population for P. falciparum. P. vivax peaked in August while P. falciparum peaked in November. 32% of the estimated 30.5 million people lived in regions where annual incidence was at least 1 case per 1,000 population of P. vivax; 23.7% of the population lived in areas where annual P. falciparum case incidence was at least 1 per 1000. Conclusion: This study showed how routine data can be combined with household survey data to model malaria incidence. The incidence of both P. vivax and P. falciparum in Afghanistan remain low but the co-distribution of both parasites and the lag in their peak season provides challenges to malaria control in Afghanistan. Future improved case definition to determine levels of imported risks may be useful for the elimination ambitions in Afghanistan.	[Alegana, Victor A.; Snow, Robert W.; Noor, Abdisalan M.] KEMRI Wellcome Trust, Dept Publ Hlth, Spatial Hlth Metr Grp, Nairobi, Kenya; [Alegana, Victor A.; Wright, Jim A.; Atkinson, Peter M.] Univ Southampton, Ctr Geog Hlth Res Geog & Environm, Highfield Southampton, England; [Nahzat, Sami M.; Sediqi, Amad W.] Minist Publ Hlth, Natl Malaria & Leishmaniasis Control Programme, Kabul, Afghanistan; [Butt, Waqar; Habib, Naeem] WHO Off, Kabul, Afghanistan; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	University of Southampton; University of Oxford	Alegana, VA (corresponding author), KEMRI Wellcome Trust, Dept Publ Hlth, Spatial Hlth Metr Grp, Nairobi, Kenya.	valegana@kemri-wellcome.org; anoor@kemri-wellcome.org	Alegana, Victor/P-6579-2019; Wright, Jim/C-7881-2013; Snow, Robert William/AFR-1436-2022	Alegana, Victor/0000-0001-5177-9227; Wright, Jim/0000-0002-8842-2181; Snow, Robert William/0000-0003-3725-6088; Atkinson, Peter/0000-0002-5489-6880	Commonwealth fellowship [KECS-2012-601]; Wellcome Trust as an Intermediate Research Fellow [095127]; Wellcome Trust as Principal Research Fellow [079080]; Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme [092654]	Commonwealth fellowship; Wellcome Trust as an Intermediate Research Fellow(Wellcome Trust); Wellcome Trust as Principal Research Fellow(Wellcome Trust); Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme(Wellcome Trust)	VAA is supported by a Commonwealth fellowship (KECS-2012-601). AMN is supported by the Wellcome Trust as an Intermediate Research Fellow (#095127). RWS is supported by the Wellcome Trust as Principal Research Fellow (#079080). This work was partly funded by a Wellcome Trust Major Overseas Programme grant to the KEMRI/Wellcome Trust Research Programme (#092654). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegana VA, 2013, SPAT SPATIO-TEMPORAL, V7, P25, DOI 10.1016/j.sste.2013.09.001; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; [Anonymous], J STAT PLANNING INFE; [Anonymous], NAT HLTH MAN INF SYS; [Anonymous], NAT MAL TREATM GUID; [Anonymous], GLOB PUBLIC HLTH; [Anonymous], 2003, BAS PACK HLTH SERV A; [Anonymous], 2008, BESTGLM BEST SUBSET; [Anonymous], 2013, J INFECT DIS; [Anonymous], GUID MAL IND SURV MI; [Anonymous], CHALLENGES OPTIONS; [Anonymous], MAL IND SURV; [Anonymous], AFGHANISTAN ANN MALA; [Anonymous], AFGH RES EV UN BRIEF; [Anonymous], COUNTR PROF; [Anonymous], 2010, BAS PACK HLTH SERV A; [Anonymous], 2009, MAL RAP DIAGN TEST P; [Anonymous], 1998, HUMAN DEV REPORT; [Anonymous], 2011, AFGH MORT SURV 2010; [Anonymous], NAT MAL STRAT PLAN 2; [Anonymous], 2 MAL IND SURV ISL R; [Anonymous], 2010, GUID TREATM MAL; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Dao NVH, 2007, T ROY SOC TROP MED H, V101, P534, DOI 10.1016/j.trstmh.2007.01.003; DELFINI LF, 1989, T ROY SOC TROP MED H, V83, P316, DOI 10.1016/0035-9203(89)90486-0; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; DY F J, 1954, Bull World Health Organ, V11, P725; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Ghosh SK, 2006, J STAT PLAN INFER, V136, P1360, DOI 10.1016/j.jspi.2004.10.008; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Kolaczinski J, 2005, LANCET, V365, P1506, DOI 10.1016/S0140-6736(05)66423-9; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Manh BH, 2011, INT J PARASITOL, V41, P109, DOI 10.1016/j.ijpara.2010.08.005; Nateghpour M, 2011, Bull Soc Pathol Exot, V104, P321, DOI 10.1007/s13149-011-0134-8; Neelon BH, 2010, STAT MODEL, V10, P421, DOI 10.1177/1471082X0901000404; RAMACHANDRA T, 1951, Bull World Health Organ, V3, P639; Rowland M, 1997, T ROY SOC TROP MED H, V91, P252, DOI 10.1016/S0035-9203(97)90065-1; Rowland M, 2002, T ROY SOC TROP MED H, V96, P620, DOI 10.1016/S0035-9203(02)90331-7; Sahu SK, 2012, APPL STOCH MODEL BUS, V28, P395, DOI 10.1002/asmb.1951; Shah I, 1997, ANN TROP MED PARASIT, V91, P591, DOI 10.1080/00034989760680; Sinclair D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008492.pub2; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steinhardt LC, 2011, HEALTH POLICY PLANN, V26, pII92, DOI 10.1093/heapol/czr069; Tatem AJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-52; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization, 2007, MAL EL FIELD MAN LOW	53	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102304	10.1371/journal.pone.0102304	http://dx.doi.org/10.1371/journal.pone.0102304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033452	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300046
J	Ding, XC; Zhou, N; Lin, H; Chen, JJ; Zhao, CY; Zhou, GK; Hejtmancik, JF; Qi, YH				Ding, Xuchen; Zhou, Nan; Lin, Hui; Chen, Jianjun; Zhao, Chunyuan; Zhou, Guangkai; Hejtmancik, J. Fielding; Qi, Yanhua			A Novel MIP Gene Mutation Analysis in a Chinese Family Affected with Congenital Progressive Punctate Cataract	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CATARACT; MAJOR INTRINSIC PROTEIN; SPLICE-SITE MUTATION; NUCLEAR CATARACT; NONSENSE MUTATION; MISSENSE MUTATION; LAMELLAR; LENS; IDENTIFICATION; UNDERLIES	Congenital cataracts are one of the leading causes of visual impairment and blindness in children, and genetic factors play an important role in their development. This study aimed to identify the genetic defects associated with autosomal dominant congenital progressive punctate cataracts in a Chinese family and to explore the potential pathogenesis. Detailed family history and clinical data were recorded, and all the family members' blood samples were collected for DNA extraction. Linkage analysis was performed by microsatellite markers that are associated with punctate cataracts, and logarithm (base 10) of odds (LOD) scores were calculated using the LINKAGE program. Positive two-point LOD scores were obtained at markers D12S1622 (Z(max) = 2.71 at theta = 0.0), D12S1724 (Z(max) = 2.71 at theta = 0.0), and D12S90 (Z(max) = 2.71 at theta = 0.0), which flank the major intrinsic protein of lens fiber (MIP) gene on chromosomal region 12q13. Direct sequencing of the encoding region of the MIP gene revealed a novel mutation (G>D) in exon 4 at nucleotide 644, which caused a substitution of glycine to aspartic acid at codon 215 (p.G215D) for the MIP protein. The mutation cosegregated with all patients with congenital progressive punctate cataracts, but it was absent in the healthy members. Bioinformatics analysis predicted that the mutation affects the function of the MIP protein. The wild type (WT) and G215D mutant of MIP were transfected with green fluorescent protein (GFP) into Hela cells separately, and it was found that the G215D mutant was aberrantly located in the cytoplasm instead of in the plasma membrane. In summary, our study presented genetic and functional evidence linking the new MIP mutation of G215D to autosomal dominant congenital cataracts, which adds to the list of MIP mutations linked to congenital progressive punctate cataracts.	[Ding, Xuchen; Zhou, Nan; Lin, Hui; Zhao, Chunyuan; Zhou, Guangkai; Qi, Yanhua] Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China; [Chen, Jianjun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Chen, Jianjun] Tongji Univ, Sch Med, Tongji Eye Inst, Shanghai 200092, Peoples R China; [Chen, Jianjun; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Harbin Medical University; Tongji University; Tongji University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Qi, YH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Harbin, Peoples R China.	qi_yanhua@yahoo.com	chen, jianjun/AAG-7572-2019		National Natural Science Foundation of China [81341026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [grant number 81341026]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCALA J, 1975, EXP EYE RES, V21, P581, DOI 10.1016/0014-4835(75)90040-8; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Berry V, 2011, MOL VIS, V17, P1249; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Chen Q, 2009, MOL VIS, V15, P1359; Conley YP, 2000, AM J HUM GENET, V66, P1426, DOI 10.1086/302871; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gu F, 2007, MOL VIS, V13, P1651; Hansen L, 2007, MOL VIS, V13, P2019; Jamieson RV, 2007, HUM MUTAT, V28, P968, DOI 10.1002/humu.20545; Jiang J, 2009, MOL VIS, V15, P38; Kumar GS, 2013, EXP EYE RES, V110, P136, DOI 10.1016/j.exer.2012.10.010; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Li FF, 2008, MOL VIS, V14, P750; Li XQ, 2012, HUM MUTAT, V33, P391, DOI 10.1002/humu.21648; Lin H, 2007, MOL VIS, V13, P1822; Mackay DS, 2002, AM J HUM GENET, V71, P1216, DOI 10.1086/344212; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Qi YH, 2004, HUM GENET, V114, P192, DOI 10.1007/s00439-003-1049-7; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Shiels A, 2007, AM J HUM GENET, V81, P596, DOI 10.1086/519980; Sindhu Kumari S, 2014, BIOCH BIOPHYS ACTA; Su DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059926; Su DM, 2012, MOL VIS, V18, P3057; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Vanita V, 2002, MOL CELL BIOCHEM, V368, P167; Varadaraj K, 2008, EXP EYE RES, V87, P9, DOI 10.1016/j.exer.2008.04.001; Wang KJ, 2011, MOL VIS, V17, P70; Watanabe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050737; Weisschuh N, 2012, MOL VIS, V18, P174; Xiao Xueshan, 2011, Mol Vis, V17, P2049; Yang GX, 2011, MOL VIS, V17, P1320; Yu LC, 2001, BLOOD, V98, P3840, DOI 10.1182/blood.V98.13.3840; Yu YB, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-6; Zeng L, 2013, MOL VIS, V19, P2244; Zhou DA, 2013, MOL VIS, V19, P789	38	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102733	10.1371/journal.pone.0102733	http://dx.doi.org/10.1371/journal.pone.0102733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033405	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300085
J	Kaneko, A; Sankai, Y				Kaneko, Ai; Sankai, Yoshiyuki			Long-Term Culture of Rat Hippocampal Neurons at Low Density in Serum-Free Medium: Combination of the Sandwich Culture Technique with the Three-Dimensional Nanofibrous Hydrogel PuraMatrix	PLOS ONE			English	Article							DISPERSED CELL-CULTURE; IN-VITRO; CEREBRAL METABOLISM; SURVIVAL; 2-MERCAPTOETHANOL; DIFFERENTIATION; NEUROTOXICITY; ADVANTAGES; GROWTH	The primary culture of neuronal cells plays an important role in neuroscience. There has long been a need for methods enabling the long-term culture of primary neurons at low density, in defined serum-free medium. However, the lower the cell density, the more difficult it is to maintain the cells in culture. Therefore, we aimed to develop a method for long-term culture of neurons at low density, in serum-free medium, without the need for a glial feeder layer. Here, we describe the work leading to our determination of a protocol for long-term (>2 months) primary culture of rat hippocampal neurons in serum-free medium at the low density of 3x10(4) cells/mL (8.9x10(3) cells/cm(2)) without a glial feeder layer. Neurons were cultured on a three-dimensional nanofibrous hydrogel, PuraMatrix, and sandwiched under a coverslip to reproduce the in vivo environment, including the three-dimensional extracellular matrix, low-oxygen conditions, and exposure to concentrated paracrine factors. We examined the effects of varying PuraMatrix concentrations, the timing and presence or absence of a coverslip, the timing of neuronal isolation from embryos, cell density at plating, medium components, and changing the medium or not on parameters such as developmental pattern, cell viability, neuronal ratio, and neurite length. Using our method of combining the sandwich culture technique with PuraMatrix in Neurobasal medium/B27/L-glutamine for primary neuron culture, we achieved longer neurites (>= 3,000 mm), greater cell viability (>= 30%) for 2 months, and uniform culture across the wells. We also achieved an average neuronal ratio of 97%, showing a nearly pure culture of neurons without astrocytes. Our method is considerably better than techniques for the primary culture of neurons, and eliminates the need for a glial feeder layer. It also exhibits continued support for axonal elongation and synaptic activity for long periods (>6 weeks).	[Kaneko, Ai; Sankai, Yoshiyuki] Univ Tsukuba, Ctr Cybern Res, Tsukuba, Ibaraki, Japan	University of Tsukuba	Kaneko, A (corresponding author), Univ Tsukuba, Ctr Cybern Res, Tsukuba, Ibaraki, Japan.	kaneko@ccr.tsukuba.ac.jp			Center for Cybernics Research (CCR) - World Leading Human-Assistive Technology Supporting a Long-Lived and Healthy Society; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Center for Cybernics Research (CCR) - World Leading Human-Assistive Technology Supporting a Long-Lived and Healthy Society; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Center for Cybernics Research (CCR) - World Leading Human-Assistive Technology Supporting a Long-Lived and Healthy Society granted by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program, http://www.jsps.go.jp/english/e-first/first_reinforcement.html) initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKER G, 1998, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Brewer G.J., 1994, FOCUS, V16, P6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Goslin K., 1998, CULTURING NERVE CELL, P339; GRILL RJ, 1993, BRAIN RES, V613, P168, DOI 10.1016/0006-8993(93)90470-8; GULATI SC, 1980, ACTA NEUROCHIR, V53, P39, DOI 10.1007/BF02074519; Hansen MB, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00031; HARRIS WA, 1985, J NEUROSCI RES, V13, P101, DOI 10.1002/jnr.490130108; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; ISHII K, 1993, NEUROSCI LETT, V163, P159, DOI 10.1016/0304-3940(93)90371-Q; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Khan MZ, 2005, MOL CELL NEUROSCI, V30, P58, DOI 10.1016/j.mcn.2005.05.007; LaPlaca MC, 2010, ARTECH HSE METH BIOE, P187; LUCIUS R, 1995, ANN ANAT, V177, P447, DOI 10.1016/S0940-9602(11)80152-4; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Sango K, 2003, EXP NEUROL, V182, P1, DOI 10.1016/S0014-4886(03)00090-6; SCHERER J, 1995, DEV BRAIN RES, V89, P214, DOI 10.1016/0165-3806(95)00128-Z; Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; ZUPPING R, 1972, J NEUROSURG, V36, P451, DOI 10.3171/jns.1972.36.4.0451	29	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102703	10.1371/journal.pone.0102703	http://dx.doi.org/10.1371/journal.pone.0102703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032834	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300080
J	Gao, XH; Zhang, GY; Wang, Y; Zhang, HY				Gao, Xian-Hui; Zhang, Guo-Yi; Wang, Ying; Zhang, Hui-Ying			Correlations of MTHFR 677C > T Polymorphism with Cardiovascular Disease in Patients with End-Stage Renal Disease: A Meta-Analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; CHRONIC KIDNEY-DISEASE; CHRONIC-HEMODIALYSIS PATIENTS; ONE-CARBON METABOLISM; VASCULAR CALCIFICATION; C677T POLYMORPHISM; RISK-FACTOR; HYPERHOMOCYSTEINEMIA; HOMOCYSTEINE; DIALYSIS	Objective: This meta-analysis was conducted to evaluate the correlations of a common polymorphism (677C>T) in the methylenetetrahydrofolate reductase (MTHFR) gene with risk of cardiovascular disease (CVD) in patients with end-stage renal disease (ESRD). Method: The following electronic databases were searched without language restrictions: Web of Science (1945 similar to 2013), the Cochrane Library Database (Issue 12, 2013), MEDLINE (1966 similar to 2013), EMBASE (1980 similar to 2013), CINAHL (1982 similar to 2013) and the Chinese Biomedical Database (CBM) (1982 similar to 2013). Meta-analysis was performed using STATA statistical software. Odds ratios (ORs) with their 95% confidence intervals (95% CIs) were calculated. Results: Eight cohort studies met all inclusion criteria and were included in this meta-analysis. A total of 2,292 ESRD patients with CVD were involved in this meta-analysis. Our meta-analysis results revealed that the MTHFR 677C>T polymorphism might increase the risk of CVD in ESRD patients (TT vs. CC: OR = 2.75, 95% CI = 1.35 similar to 5.59, P = 0.005; CT+TT vs. CC: OR = 1.39, 95% CI = 1.09 similar to 1.78, P = 0.008; TT vs. CC+CT: OR = 2.52, 95% CI = 1.25 similar to 5.09, P = 0.010; respectively). Further subgroup analysis by ethnicity suggested that the MTHFR 677C > T polymorphism was associated with an elevated risk for CVD in ESRD patients among Asians (TT vs. CC: OR = 3.38, 95% CI = 1.11 similar to 10.28, P = 0.032; CT+TT vs. CC: OR = 1.44, 95% CI = 1.05 similar to 1.97, P = 0.022; TT vs. CC+CT: OR = 3.15, 95% CI = 1.02 similar to 9.72, P = 0.046; respectively), but not among Africans or Caucasians (all P > 0.05). Conclusion: Our findings indicate that the MTHFR 677C>T polymorphism may be associated with an elevated risk for CVD in ESRD patients, especially among Asians.	[Gao, Xian-Hui; Zhang, Guo-Yi] Liaoning Med Univ, Sch Publ Hlth, Lab Prevent Med, Jinzhou, Peoples R China; [Wang, Ying] Liaoning Med Univ, Sch Publ Hlth, Dept Toxicol, Jinzhou, Peoples R China; [Zhang, Hui-Ying] Liaoning Med Univ, Affiliated Hosp 1, Sleep Monitoring Ctr, Jinzhou, Peoples R China	Jinzhou Medical University; Jinzhou Medical University; Jinzhou Medical University	Gao, XH (corresponding author), Liaoning Med Univ, Sch Publ Hlth, Lab Prevent Med, Jinzhou, Peoples R China.	gaoxianhui16@126.com						Abbas S, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-80; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Aucella F, 2005, NEPHROL DIAL TRANSPL, V20, P382, DOI 10.1093/ndt/gfh620; Benight NM, 2011, AM J PHYSIOL-GASTR L, V301, pG249, DOI 10.1152/ajpgi.00076.2011; Chonchol M, 2011, ANN MED, V43, P273, DOI 10.3109/07853890.2010.543923; Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177; Cozzolino M, 2010, BLOOD PURIFICAT, V29, P347, DOI 10.1159/000302722; Di Minno MND, 2010, THROMB HAEMOSTASIS, V103, P942, DOI 10.1160/TH09-06-0393; Field MS, 2013, J NUTR, V143, P41, DOI 10.3945/jn.112.169821; Fukasawa M, 2003, AM J KIDNEY DIS, V41, P637, DOI 10.1053/ajkd.2003.50125; Fung MM, 2012, NEPHROL DIAL TRANSPL, V27, P197, DOI 10.1093/ndt/gfr257; Garner JL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109066; Haviv YS, 2002, NEPHRON, V92, P120, DOI 10.1159/000064485; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Heinz J, 2009, AM J KIDNEY DIS, V54, P478, DOI 10.1053/j.ajkd.2009.01.266; Ibrahim S, 2009, CLIN EXP NEPHROL, V13, P501, DOI 10.1007/s10157-009-0194-2; Kendrick J, 2008, NAT CLIN PRACT NEPHR, V4, P672, DOI 10.1038/ncpneph0954; Kimura H, 2000, J AM SOC NEPHROL, V11, P885, DOI 10.1681/ASN.V115885; Lee SY, 2011, J KOREAN MED SCI, V26, P461, DOI 10.3346/jkms.2011.26.3.461; Matias PJ, 2010, CLIN J AM SOC NEPHRO, V5, P905, DOI 10.2215/CJN.06510909; McIntyre CW, 2010, BLOOD PURIFICAT, V29, P105, DOI 10.1159/000245634; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Morimoto K, 2002, NEPHRON, V90, P43, DOI 10.1159/000046313; Palacio S, 2011, CLIN J AM SOC NEPHRO, V6, P1089, DOI 10.2215/CJN.10481110; Pereira TV, 2006, CANCER EPIDEM BIOMAR, V15, P1956, DOI 10.1158/1055-9965.EPI-06-0334; Perna AF, 2013, NEPHROL DIAL TRANSPL, V28, P1214, DOI 10.1093/ndt/gfs510; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Rubino E, 2009, CEPHALALGIA, V29, P818, DOI 10.1111/j.1468-2982.2007.01400.x; Safarinejad MR, 2011, MED ONCOL, V28, pS398, DOI 10.1007/s12032-010-9723-9; Shemin D, 2001, AM J KIDNEY DIS, V38, pS91, DOI 10.1053/ajkd.2001.27412; Shiotsu Y, 2011, CLIN J AM SOC NEPHRO, V6, P718, DOI 10.2215/CJN.08310910; Spellicy CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051330; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stanger O, 2009, EXPERT REV NEUROTHER, V9, P1393, DOI 10.1586/ERN.09.75; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Weiner DE, 2011, AM J KIDNEY DIS, V58, P773, DOI 10.1053/j.ajkd.2011.03.034; Winkelmayer WC, 2011, J AM SOC NEPHROL, V22, P349, DOI 10.1681/ASN.2010050459; Wrone EM, 2001, KIDNEY INT, V60, P1106, DOI 10.1046/j.1523-1755.2001.0600031106.x; Yang QH, 2012, AM J CLIN NUTR, V95, P1245, DOI 10.3945/ajcn.111.022384; Yun KU, 2013, EUR J NUTR, V52, P127, DOI 10.1007/s00394-011-0294-0; Zhang J, 2010, BREAST CANCER RES TR, V123, P549, DOI 10.1007/s10549-010-0783-5; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	43	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102323	10.1371/journal.pone.0102323	http://dx.doi.org/10.1371/journal.pone.0102323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050994	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100026
J	Guo, YN; Sun, MZ; Garfinkel, A; Zhao, X				Guo, Yina; Sun, Mingzhu; Garfinkel, Alan; Zhao, Xin			Mechanisms of Side Branching and Tip Splitting in a Model of Branching Morphogenesis	PLOS ONE			English	Article							PATTERN-FORMATION; LUNG DEVELOPMENT	Recent experimental work in lung morphogenesis has described an elegant pattern of branching phenomena. Two primary forms of branching have been identified: side branching and tip splitting. In our previous study of lung branching morphogenesis, we used a 4 variable partial differential equation (PDE), due to Meinhardt, as our mathematical model to describe the reaction and diffusion of morphogens creating those branched patterns. By altering key parameters in the model, we were able to reproduce all the branching styles and the switch between branching modes. Here, we attempt to explain the branching phenomena described above, as growing out of two fundamental instabilities, one in the longitudinal (growth) direction and the other in the transverse direction. We begin by decoupling the original branching process into two semi-independent sub-processes, 1) a classic activator/inhibitor system along the growing stalk, and 2) the spatial growth of the stalk. We then reduced the full branching model into an activator/inhibitor model that embeds growth of the stalk as a controllable parameter, to explore the mechanisms that determine different branching patterns. We found that, in this model, 1) side branching results from a pattern-formation instability of the activator/inhibitor subsystem in the longitudinal direction. This instability is far from equilibrium, requiring a large inhomogeneity in the initial conditions. It successively creates periodic activator peaks along the growing stalk, each of which later on migrates out and forms a side branch; 2) tip splitting is due to a Turing-style instability along the transversal direction, that creates the spatial splitting of the activator peak into 2 simultaneously-formed peaks at the growing tip, the occurrence of which requires the widening of the growing stalk. Tip splitting is abolished when transversal stalk widening is prevented; 3) when both instabilities are satisfied, tip bifurcation occurs together with side branching.	[Guo, Yina; Sun, Mingzhu; Zhao, Xin] Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China; [Garfinkel, Alan] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Garfinkel, Alan] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Zhao, Xin] Tianjin Key Lab Intelligent Robot, Tianjin, Peoples R China; [Sun, Mingzhu] State Key Lab Robot, Shenyang, Peoples R China	Nankai University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences	Garfinkel, A (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	agarfinkel@mednet.ucla.edu; zhaoxin@nankai.edu.cn			National Natural Science Foundation of China (NSFC) [61327802, 61273341]; National High Technology Research and Development Program ('863' Program) of China [2013AA041102]; Research Fund for Doctoral Program of Higher Education of China [2011003111032]; State Key Laboratory of Robotics [2013-O03]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ('863' Program) of China(National High Technology Research and Development Program of China); Research Fund for Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); State Key Laboratory of Robotics	This work was supported by The National Natural Science Foundation of China (NSFC; Grant Nos. 61327802, 61273341), the National High Technology Research and Development Program ('863' Program) of China (Grant No. 2013AA041102), the Research Fund for Doctoral Program of Higher Education of China (Grant No. 2011003111032) and the Opening Project of State Key Laboratory of Robotics (No. 2013-O03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clement R, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/1/016003; Clement R, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/066006; Clement R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036925; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dias AS, 2014, SCIENCE NEW YORK NY; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; Guo YN, 2014, J PHYSIOL-LONDON, V592, P313, DOI 10.1113/jphysiol.2013.261099; MEINHARDT H, 1976, DIFFERENTIATION, V6, P117, DOI 10.1111/j.1432-0436.1976.tb01478.x; Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; Murray, 2002, MATH BIOL I INTRO IN; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Weaver M, 2000, DEVELOPMENT, V127, P2695	15	48	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102718	10.1371/journal.pone.0102718	http://dx.doi.org/10.1371/journal.pone.0102718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050616	Green Published, gold			2022-12-27	WOS:000339551100055
J	Knelman, JE; Schmidt, SK; Lynch, RC; Darcy, JL; Castle, SC; Cleveland, CC; Nemergut, DR				Knelman, Joseph E.; Schmidt, Steven K.; Lynch, Ryan C.; Darcy, John L.; Castle, Sarah C.; Cleveland, Cory C.; Nemergut, Diana R.			Nutrient Addition Dramatically Accelerates Microbial Community Succession	PLOS ONE			English	Article							SOIL BACTERIAL COMMUNITIES; PHOSPHORUS LIMITATION; NITROGEN-FERTILIZATION; GLACIER FORELAND; DIVERSITY; ECOSYSTEM; GROWTH; CARBON; CHRONOSEQUENCE; PRODUCTIVITY	The ecological mechanisms driving community succession are widely debated, particularly for microorganisms. While successional soil microbial communities are known to undergo predictable changes in structure concomitant with shifts in a variety of edaphic properties, the causal mechanisms underlying these patterns are poorly understood. Thus, to specifically isolate how nutrients - important drivers of plant succession - affect soil microbial succession, we established a full factorial nitrogen (N) and phosphorus (P) fertilization plot experiment in recently deglaciated (similar to 3 years since exposure), unvegetated soils of the Puca Glacier forefield in Southeastern Peru. We evaluated soil properties and examined bacterial community composition in plots before and one year after fertilization. Fertilized soils were then compared to samples from three reference successional transects representing advancing stages of soil development ranging from 5 years to 85 years since exposure. We found that a single application of +NP fertilizer caused the soil bacterial community structure of the three-year old soils to most resemble the 85-year old soils after one year. Despite differences in a variety of soil edaphic properties between fertilizer plots and late successional soils, bacterial community composition of +NP plots converged with late successional communities. Thus, our work suggests a mechanism for microbial succession whereby changes in resource availability drive shifts in community composition, supporting a role for nutrient colimitation in primary succession. These results suggest that nutrients alone, independent of other edaphic factors that change with succession, act as an important control over soil microbial community development, greatly accelerating the rate of succession.	[Knelman, Joseph E.; Nemergut, Diana R.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Knelman, Joseph E.; Schmidt, Steven K.; Lynch, Ryan C.; Darcy, John L.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Castle, Sarah C.; Cleveland, Cory C.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Nemergut, Diana R.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Montana System; University of Montana; University of Colorado System; University of Colorado Boulder	Nemergut, DR (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	nemergut@colorado.edu	Schmidt, Steven K/G-2771-2010	Schmidt, Steven K/0000-0002-9175-2085; Cleveland, Cory/0000-0002-8804-4248	National Science Foundation of the USA [DEB-0922267, MCB-0455606]; Division Of Environmental Biology [1027341, 1258160] Funding Source: National Science Foundation	National Science Foundation of the USA(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation of the USA (http://nsf.gov/) through grants for studying microbial succession following glacial retreat (DEB-0922267) to DRN, SKS, and CCC; the Alpine Microbial Observatory (MCB-0455606) to SKS; and a graduate research fellowship to JEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borin S, 2010, ENVIRON MICROBIOL, V12, P293, DOI 10.1111/j.1462-2920.2009.02059.x; Brown SP, 2014, MOL ECOL, V23, P481, DOI 10.1111/mec.12487; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; Clarke Gorley, 2006, PRIMER V6 USER MANUA; Cline LC, 2014, ENVIRON MICROBIOL, V16, P1538, DOI 10.1111/1462-2920.12281; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; Deiglmayr K, 2006, ENVIRON MICROBIOL, V8, P1600, DOI 10.1111/j.1462-2920.2006.01051.x; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Drakare S, 2002, MICROB ECOL, V44, P327, DOI 10.1007/s00248-002-1013-4; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards IP, 2006, MICROB ECOL, V52, P679, DOI 10.1007/s00248-006-9097-x; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2010, RES MICROBIOL, V161, P635, DOI [10.1016/J.resmic.2010.06.002, 10.1016/j.resmic.2010.06.002]; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Goransson H, 2011, SOIL BIOL BIOCHEM, V43, P1333, DOI 10.1016/j.soilbio.2011.03.006; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Jangid K, 2013, MOL ECOL, V22, P3415, DOI 10.1111/mec.12325; Jeannotte R, 2004, BIOL FERT SOILS, V40, P201, DOI 10.1007/s00374-004-0760-4; Knelman JE, 2012, SOIL BIOL BIOCHEM, V46, P172, DOI 10.1016/j.soilbio.2011.12.001; Lajtha K, 1999, LT EC RES NETWK SER, V2, P115; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Matejovic I, 1997, COMMUN SOIL SCI PLAN, V28, P1499, DOI 10.1080/00103629709369892; Matthews JA., 1992, ECOLOGY RECENTLY DEG; Meola M, 2014, ENVIRON MICROBIOL, V16, P1918, DOI 10.1111/1462-2920.12435; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nemergut DR, 2007, MICROB ECOL, V53, P110, DOI 10.1007/s00248-006-9144-7; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Noll M, 2008, SOIL BIOL BIOCHEM, V40, P2611, DOI 10.1016/j.soilbio.2008.07.012; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; Schmidt SK, 2011, GEODERMA, V163, P135, DOI 10.1016/j.geoderma.2011.04.014; Schmidt SK, 2009, EXTREMOPHILES, V13, P807, DOI 10.1007/s00792-009-0268-9; Schmidt SK, 2012, PLANT ECOL DIVERS, V5, P513, DOI 10.1080/17550874.2012.738714; Schutte UME, 2009, ISME J, V3, P1258, DOI 10.1038/ismej.2009.71; UGOLINI F. C., 1968, Proc. Symp. "Biology of Alder" 40th a. Meet. N.W. Sci. Ass., P115; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van Wijnen HJ, 1999, J ECOL, V87, P265, DOI 10.1046/j.1365-2745.1999.00349.x; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Vitousek PM, 1999, ECOSYSTEMS, V2, P505, DOI 10.1007/s100219900098; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002797; Weaver R.W., 1994, METHODS SOIL ANAL 2; Yoshitake S, 2007, POLAR RES, V26, P22, DOI 10.1111/j.1751-8369.2007.00001.x; Zumsteg A, 2012, MICROB ECOL, V63, P552, DOI 10.1007/s00248-011-9991-8	61	65	67	4	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102609	10.1371/journal.pone.0102609	http://dx.doi.org/10.1371/journal.pone.0102609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050551	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100043
J	Shanahan, HP; Owen, AM; Harrison, AP				Shanahan, Hugh P.; Owen, Anne M.; Harrison, Andrew P.			Bioinformatics on the Cloud Computing Platform Azure	PLOS ONE			English	Article							EXPRESSION; GENOMICS; UPDATE	We discuss the applicability of the Microsoft cloud computing platform, Azure, for bioinformatics. We focus on the usability of the resource rather than its performance. We provide an example of how R can be used on Azure to analyse a large amount of microarray expression data deposited at the public database ArrayExpress. We provide a walk through to demonstrate explicitly how Azure can be used to perform these analyses in Appendix S1 and we offer a comparison with a local computation. We note that the use of the Platform as a Service (PaaS) offering of Azure can represent a steep learning curve for bioinformatics developers who will usually have a Linux and scripting language background. On the other hand, the presence of an additional set of libraries makes it easier to deploy software in a parallel (scalable) fashion and explicitly manage such a production run with only a few hundred lines of code, most of which can be incorporated from a template. We propose that this environment is best suited for running stable bioinformatics software by users not involved with its development.	[Shanahan, Hugh P.] Univ London, Dept Comp Sci, Egham, Surrey, England; [Owen, Anne M.; Harrison, Andrew P.] Univ Essex, Dept Math Sci, Colchester CO4 3SQ, Essex, England; [Harrison, Andrew P.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of London; Royal Holloway University London; University of Essex; University of Essex	Shanahan, HP (corresponding author), Univ London, Dept Comp Sci, Egham, Surrey, England.	Hugh.Shanahan@rhul.ac.uk		Shanahan, Hugh/0000-0003-1374-6015	VENUS-C EU network	VENUS-C EU network	The research for this paper was made possible by funding from the VENUS-C EU network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-77; Afgan Enis, 2012, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1109s38; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Bachle M, 2007, IEEE SOFTWARE, V24, P105, DOI 10.1109/MS.2007.176; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Contrino S, 2012, NUCLEIC ACIDS RES, V40, pD1082, DOI 10.1093/nar/gkr921; Di Tommaso P, 2010, BIOINFORMATICS, V26, P1903, DOI 10.1093/bioinformatics/btq304; Eriksson Henrik, 2011, AMIA Annu Symp Proc, V2011, P364; Feng W, 2004, ADV PAR COM, V13, P653; Firdhous M., 2011, KALEIDOSCOPE 2011 FU, P1; Foster I., 2008, P 2008 GRID COMP ENV, P1, DOI [10.1109/GCE.2008.4738445, DOI 10.1109/GCE.2008.4738445]; Fusaro VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002147; Grandison T., 2010, Proceedings of the 2010 IEEE Congress on Services (SERVICES-1), P191, DOI 10.1109/SERVICES.2010.111; Habegger L, 2012, BIOINFORMATICS; Halligan BD, 2009, J PROTEOME RES, V8, P3148, DOI 10.1021/pr800970z; Hongbing Zhu, 2010, Proceedings 2010 3rd International Conference on Intelligent Networks and Intelligent Systems (ICINIS 2010), P463, DOI 10.1109/ICINIS.2010.41; Kim Hyunjoo, 2009, Proc IEEE/ACM Int Conf Grid Computing, V2009, P34; Langdon WB, 2009, BRIEF BIOINFORM, V10, P259, DOI 10.1093/bib/bbp018; Leite A. F., 2012, 2012 19 INT C HIGH P, P1, DOI [DOI 10.1109/HIPC.2012.6507500, 10.1109/HiPC.2012.6507500]; Mell P., 2011, NATL I STANDARDS TEC, V800-145; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Qiu J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S3; Rodriguez-Martinez Manuel, 2010, 2010 IEEE 3rd International Conference on Cloud Computing (CLOUD 2010), P443, DOI 10.1109/CLOUD.2010.81; Ropella GEP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-168; Shanahan HP, 2011, NUCL ACIDS RES; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Stockinger H, 2006, 2006 2 IEEE INT C E, P58, DOI [10.1109/E-SCIENCE.2006.261142, DOI 10.1109/E-SCIENCE.2006.261142]; Taylor RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S1; Wall DP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-259; Wang ZK, 2011, BIOINFORMATICS, V27, P1045, DOI 10.1093/bioinformatics/btr091; Widera P, 2011, CORROSION, P10; Zhang L, 2012, BIOINFORMATICS, V28, P294, DOI 10.1093/bioinformatics/btr630	33	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102642	10.1371/journal.pone.0102642	http://dx.doi.org/10.1371/journal.pone.0102642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050811	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000339551100046
J	Kamoshita, M; Ozawa, Y; Kubota, S; Miyake, S; Tsuda, C; Nagai, N; Yuki, K; Shimmura, S; Umezawa, K; Tsubota, K				Kamoshita, Mamoru; Ozawa, Yoko; Kubota, Shunsuke; Miyake, Seiji; Tsuda, Chiduru; Nagai, Norihiro; Yuki, Kenya; Shimmura, Shigeto; Umezawa, Kazuo; Tsubota, Kazuo			AMPK-NF-kappa B Axis in the Photoreceptor Disorder during Retinal Inflammation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTOXIN-INDUCED UVEITIS; II TYPE-1 RECEPTOR; ANGIOTENSIN-II; MACULAR DEGENERATION; OCULAR INFLAMMATION; LUNG INJURY; IN-VIVO; CELLS; INHIBITION	Recent progress in molecular analysis has revealed the possible involvement of multiple inflammatory signaling pathways in pathogenesis of retinal degeneration. However, how aberrant signaling pathways cause tissue damage and dysfunction is still being elucidated. Here, we focus on 59-adenosine monophosphate (AMP)-activated protein kinase (AMPK), originally recognized as a key regulator of energy homeostasis. AMPK is also modulated in response to inflammatory signals, although its functions in inflamed tissue are obscure. We investigated the role of activated AMPK in the retinal neural damage and visual function impairment caused by inflammation. For this purpose, we used a mouse model of lipopolysaccharide-induced inflammation in the retina, and examined the effects of an AMPK activator, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). During inflammation, activated AMPK in the neural retina was decreased, but AICAR treatment prevented this change. Moreover, the electroretinogram (ERG) a-wave response, representing photoreceptor function, showed visual dysfunction in this model that was prevented by AICAR. Consistently, the model showed shortened photoreceptor outer segments (OSs) with reduced levels of rhodopsin, a visual pigment concentrated in the OSs, in a post-transcriptional manner, and these effects were also prevented by AICAR. In parallel, the level of activated NF-kappa B increased in the retina during inflammation, and this increase was suppressed by AICAR. Treatment with an NF-kappa B inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ) preserved the rhodopsin level during inflammation, suppressing NF-kappa B. These findings indicated that AMPK activation by AICAR and subsequent NF-kappa B inhibition had a protective effect on visual function, and that AMPK activation played a neuroprotective role during retinal inflammation.	[Kamoshita, Mamoru; Ozawa, Yoko; Kubota, Shunsuke; Miyake, Seiji; Tsuda, Chiduru; Nagai, Norihiro; Yuki, Kenya] Keio Univ, Sch Med, Lab Retinal Cell Biol, Shinjuku Ku, Tokyo, Japan; [Kamoshita, Mamoru; Ozawa, Yoko; Kubota, Shunsuke; Nagai, Norihiro; Yuki, Kenya; Shimmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med Screening, Nagakute, Aichi 48011, Japan	Keio University; Keio University; Aichi Medical University	Ozawa, Y (corresponding author), Keio Univ, Sch Med, Lab Retinal Cell Biol, Shinjuku Ku, Tokyo, Japan.	ozawa@a5.keio.jp	Ozawa, Yoko/AAH-9888-2020		JSPS KAKENHI [24592647]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research, JSPS KAKENHI to Y.O. (24592647). http://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga A, 2002, J BIOL CHEM, V277, P24625, DOI 10.1074/jbc.M112063200; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Droge W, 2006, CURR OPIN CLIN NUTR, V9, P190; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Haegens A, 2012, AM J PHYSIOL-LUNG C, V302, pL103, DOI 10.1152/ajplung.00084.2011; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kubota S, 2009, INVEST OPHTH VIS SCI, V50, P3512, DOI 10.1167/iovs.08-2666; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Mares JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P470, DOI 10.1001/archophthalmol.2010.314; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ozawa Y, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/506137; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Takeiri M, 2012, ORG BIOMOL CHEM, V10, P3053, DOI 10.1039/c2ob07104e; Tikellis G, 2010, MICROCIRCULATION, V17, P381, DOI 10.1111/j.1549-8719.2010.00033.x; Witkin AJ, 2011, CURR OPIN OPHTHALMOL, V22, P185, DOI 10.1097/ICU.0b013e3283459724; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022; Yamamoto M, 2008, J MED CHEM, V51, P5780, DOI 10.1021/jm8006245; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	45	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103013	10.1371/journal.pone.0103013	http://dx.doi.org/10.1371/journal.pone.0103013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048039	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100098
J	Kim, Y; Lee, HG; Dmitrieva, N; Kim, J; Kaur, B; Friedman, A				Kim, Yangjin; Lee, Hyun Geun; Dmitrieva, Nina; Kim, Junseok; Kaur, Balveen; Friedman, Avner			Choindroitinase ABC I-Mediated Enhancement of Oncolytic Virus Spread and Anti Tumor Efficacy: A Mathematical Model	PLOS ONE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; VESICULAR STOMATITIS-VIRUS; EXTRACELLULAR-MATRIX; INTRATUMORAL SPREAD; CELL-PROLIFERATION; MALIGNANT GLIOMAS; HYALURONIC-ACID; VIRAL THERAPY; HYBRID MODEL; BRAIN	Oncolytic viruses are genetically engineered viruses that are designed to kill cancer cells while doing minimal damage to normal healthy tissue. After being injected into a tumor, they infect cancer cells, multiply inside them, and when a cancer cell is killed they move on to spread and infect other cancer cells. Chondroitinase ABC (Chase-ABC) is a bacterial enzyme that can remove a major glioma ECM component, chondroitin sulfate glycosoamino glycans from proteoglycans without any deleterious effects in vivo. It has been shown that Chase-ABC treatment is able to promote the spread of the viruses, increasing the efficacy of the viral treatment. In this paper we develop a mathematical model to investigate the effect of the Chase-ABC on the treatment of glioma by oncolytic viruses (OV). We show that the model's predictions agree with experimental results for a spherical glioma. We then use the model to test various treatment options in the heterogeneous microenvironment of the brain. The model predicts that separate injections of OV, one into the center of the tumor and another outside the tumor will result in better outcome than if the total injection is outside the tumor. In particular, the injection of the ECM-degrading enzyme (Chase-ABC) on the periphery of the main tumor core need to be administered in an optimal strategy in order to infect and eradicate the infiltrating glioma cells outside the tumor core in addition to proliferative cells in the bulk of tumor core. The model also predicts that the size of tumor satellites and distance between the primary tumor and multifocal/satellite lesions may be an important factor for the efficacy of the viral therapy with Chase treatment.	[Kim, Yangjin; Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Dmitrieva, Nina; Kaur, Balveen] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Kim, Junseok] Korea Univ, Dept Math, Seoul, South Korea; [Kim, Yangjin] Konkuk Univ, Dept Math, Seoul, South Korea	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Korea University; Konkuk University	Kim, Y (corresponding author), Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA.	ahyouhappy@gmail.com	Kim, Junseok/AAH-5349-2019; Kim, Yangjin/C-9681-2014; kaur, Balveen/E-3355-2011	Kim, Yangjin/0000-0002-8905-8481; Kim, Junseok/0000-0002-0484-9189	Konkuk University; NATIONAL CANCER INSTITUTE [R01CA150153, P01CA163205] Funding Source: NIH RePORTER	Konkuk University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the faculty research fund of Konkuk University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005; Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Aubert M, 2006, PHYS BIOL, V3, P93, DOI 10.1088/1478-3975/3/2/001; Badoual M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046013; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Barcellos-Hoff MH, 2009, SEMIN RADIAT ONCOL, V19, P163, DOI 10.1016/j.semradonc.2009.02.004; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Chauviere A, 2010, MATH MED BIOL, V27, P255, DOI 10.1093/imammb/dqp021; Cheema TA, 2013, P NATL ACAD SCI USA, V110, P12006, DOI 10.1073/pnas.1307935110; Choi IK, 2010, GENE THER, V17, P190, DOI 10.1038/gt.2009.142; CHOUCAIR AK, 1986, J NEUROSURG, V65, P654, DOI 10.3171/jns.1986.65.5.0654; Connor JH, 2004, J VIROL, V78, P8960, DOI 10.1128/JVI.78.17.8960-8970.2004; Corwin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079115; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; DAHL D, 1982, J HISTOCHEM CYTOCHEM, V30, P912, DOI 10.1177/30.9.6182187; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; DELPECH B, 1993, EUR J CANCER, V29A, P1012, DOI 10.1016/S0959-8049(05)80214-X; Dmitrieva N, 2011, CLIN CANCER RES, V17, P1362, DOI 10.1158/1078-0432.CCR-10-2213; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; Dutt S, 2006, THESCIENTIFICWORLDJO, V6, P1114, DOI 10.1100/tsw.2006.219; Dwyer CA, 2011, MOL TARGETS CNS TUMO, P239; Eikenes L, 2004, CANCER RES, V64, P4768, DOI 10.1158/0008-5472.CAN-03-1472; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; FRYER HJL, 1992, J BIOL CHEM, V267, P9874; Gerin C, 2012, CELL PROLIFERAT, V45, P76, DOI 10.1111/j.1365-2184.2011.00790.x; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121; Grumet M, 1996, PERSPECT DEV NEUROBI, V3, P319; Gu WL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-128; Guedan S, 2010, MOL THER, V18, P1275, DOI 10.1038/mt.2010.79; Harpold HLP, 2007, J NEUROPATH EXP NEUR, V66, P1, DOI 10.1097/nen.0b013e31802d9000; Harsh GR, 2000, J NEUROSURG, V92, P804, DOI 10.3171/jns.2000.92.5.0804; Haseley A, 2012, CANCER RES, V72, P1353, DOI 10.1158/0008-5472.CAN-11-2526; Haseley Amy, 2009, Recent Pat CNS Drug Discov, V4, P1; Hatzikirou H, 2010, MATH MED BIOL, V27, P255; HEINEGARD D, 1981, BIOCHEM J, V197, P355, DOI 10.1042/bj1970355; Hong CS, 2010, GENE THER, V17, P1200, DOI 10.1038/gt.2010.66; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; Kaur B, 2012, CURR PHARM BIOTECHNO, V13, P1842, DOI 10.2174/138920112800958814; Kaur B, 2009, CURR GENE THER, V9, P341, DOI 10.2174/156652309789753329; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kim J, 2012, BIOMATERIALS, V33, P1838, DOI 10.1016/j.biomaterials.2011.11.020; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Klekner A, 2013, EVOLUTION MOL BIOL B, P3; Kuriyama N, 2000, HUM GENE THER, V11, P2219, DOI 10.1089/104303400750035744; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lowengrub JS, 2010, NONLINEARITY, V23, pR1, DOI 10.1088/0951-7715/23/1/R01; Lun X, 2006, JNCI-J NATL CANCER I, V98, P1546, DOI 10.1093/jnci/djj413; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Mok W, 2009, CLIN CANCER RES, V15, P2352, DOI 10.1158/1078-0432.CCR-08-2082; Mok W, 2007, CANCER RES, V67, P10664, DOI 10.1158/0008-5472.CAN-07-3107; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363; Msaouel P, 2009, CURR OPIN MOL THER, V11, P43; Muir EM, 2010, J BIOTECHNOL, V145, P103, DOI 10.1016/j.jbiotec.2009.11.002; Netti PA, 2000, CANCER RES, V60, P2497; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; ODONOGHUE JA, 1995, J NUCL MED, V36, P1902; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2006, CURR OPIN PHARMACOL, V6, P494, DOI 10.1016/j.coph.2006.06.001; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Parker JN, 2009, NEUROTHERAPEUTICS, V6, P558, DOI 10.1016/j.nurt.2009.04.011; PASQUIER B, 1980, CANCER, V45, P112, DOI 10.1002/1097-0142(19800101)45:1<112::AID-CNCR2820450121>3.0.CO;2-9; Patan S, 2004, CANC TREAT, V117, P3; Pham K, 2012, J BIOL DYNAM, V6, P54, DOI 10.1080/17513758.2011.590610; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Pulkkanen KJ, 2005, MOL THER, V12, P585, DOI 10.1016/j.ymthe.2005.07.357; Puumalainen AM, 1998, HUM GENE THER, V9, P1769, DOI 10.1089/hum.1998.9.12-1769; Ram Z, 1997, NAT MED, V3, P1354, DOI 10.1038/nm1297-1354; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Stolarska MA, 2009, PHILOS T R SOC A, V367, P3525, DOI 10.1098/rsta.2009.0095; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Verheije MH, 2009, J VIROL, V83, P7507, DOI 10.1128/JVI.00495-09; Viapiano M., 2009, GLIOMA INVASION MECH; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Wang C., 2014, MOL PHARM; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; Whitley RJ, 2013, P NATL ACAD SCI USA, V110, P11672, DOI 10.1073/pnas.1310253110; Wollmann G, 2005, J VIROL, V79, P6005, DOI 10.1128/JVI.79.10.6005-6022.2005; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	101	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102499	10.1371/journal.pone.0102499	http://dx.doi.org/10.1371/journal.pone.0102499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047810	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100036
J	Riou, C; Gray, CM; Lugongolo, M; Gwala, T; Kiravu, A; Deniso, P; Stewart-Isherwood, L; Omar, SV; Grobusch, MP; Coetzee, G; Conradie, F; Ismail, N; Kaplan, G; Fallows, D				Riou, Catherine; Gray, Clive M.; Lugongolo, Masixole; Gwala, Thabisile; Kiravu, Agano; Deniso, Pamela; Stewart-Isherwood, Lynsey; Omar, Shaheed Vally; Grobusch, Martin P.; Coetzee, Gerrit; Conradie, Francesca; Ismail, Nazir; Kaplan, Gilla; Fallows, Dorothy			A Subset of Circulating Blood Mycobacteria-Specific CD4 T Cells Can Predict the Time to Mycobacterium tuberculosis Sputum Culture Conversion	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; WHOLE-BLOOD; IFN-GAMMA; BIOMARKERS; INFECTION; CHALLENGES; RESPONSES; LOAD; CHEMOTHERAPY; ASSOCIATION	We investigated 18 HIV-negative patients with MDR-TB for M. tuberculosis (Mtb)- and PPD-specific CD4 T cell responses and followed them over 6 months of drug therapy. Twelve of these patients were sputum culture (SC) positive and six patients were SC negative upon enrollment. Our aim was to identify a subset of mycobacteria- specific CD4 T cells that would predict time to culture conversion. The total frequency of mycobacteria-specific CD4 T cells at baseline could not distinguish patients showing positive or negative SC. However, a greater proportion of late-differentiated (LD) Mtb- and PPD-specific memory CD4 T cells was found in SC positive patients than in those who were SC negative (p = 0.004 and p = 0.0012, respectively). Similarly, a higher co-expression of HLA-DR(+)Ki67(+) on Mtb- and PPD-specific CD4 T cells could also discriminate between sputum SC positive versus SC negative ( p = 0.004 and p = 0.001, respectively). Receiver operating characteristic (ROC) analysis revealed that baseline levels of Ki67(+)HLA-DR+ Mtb- and PPD-specific CD4 T cells were predictive of the time to sputum culture conversion, with area-under-the-curve of 0.8 ( p = 0.027). Upon treatment, there was a significant decline of these Ki67(+)HLA-DR+ T cell populations in the first 2 months, with a progressive increase in mycobacteria-specific polyfunctional IFN gamma(+)IL2(+)TNF alpha(+) CD4 T cells over 6 months. Thus, a subset of activated and proliferating mycobacterial-specific CD4 T cells (Ki67(+)HLA-DR+) may provide a valuable marker in peripheral blood that predicts time to sputum culture conversion in TB patients at the start of treatment.	[Riou, Catherine; Gray, Clive M.; Kiravu, Agano] Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa; [Riou, Catherine; Gray, Clive M.; Kiravu, Agano] Univ Cape Town, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Lugongolo, Masixole; Gwala, Thabisile; Omar, Shaheed Vally; Coetzee, Gerrit; Ismail, Nazir] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Deniso, Pamela; Stewart-Isherwood, Lynsey; Conradie, Francesca] Univ Witwatersrand, Right Care & Clin HIV Res Unit, Johannesburg, South Africa; [Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Div Internal Med,Dept Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Kaplan, Gilla; Fallows, Dorothy] Int Ctr Publ Hlth, Publ Hlth Res Inst, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ USA	University of Cape Town; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Amsterdam; Academic Medical Center Amsterdam	Gray, CM (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa.	clive.gray@uct.ac.za	Omar, Shaheed Vally/AAB-5071-2020	Omar, Shaheed Vally/0000-0001-6983-1636; Gray, Clive/0000-0002-9293-901X	National Institute of Allergy and Infectious Diseases grant [RO1 AI80737]; Fogarty Global Infectious Diseases fellowship [D43TW008264]; FOGARTY INTERNATIONAL CENTER [D43TW008264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080737] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases grant; Fogarty Global Infectious Diseases fellowship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an National Institute of Allergy and Infectious Diseases grant (RO1 AI80737) and a Fogarty Global Infectious Diseases fellowship (D43TW008264). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann R, 2013, TUBERCULOSIS, V93, P239, DOI 10.1016/j.tube.2012.09.003; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Eum SY, 2010, RESPIRATION, V80, P275, DOI 10.1159/000283687; Foo DG, 2011, ANTIMICROB AGENTS CH, V55, P3677, DOI 10.1128/AAC.00136-11; GERDES J, 1984, J IMMUNOL, V133, P1710; Gray CM, 1999, J IMMUNOL, V162, P1780; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Health SADo, 2011, MAN DRUG RES TUB POL; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Jacobsen M, 2008, BIOL CHEM, V389, P487, DOI 10.1515/BC.2008.053; Jiang J, 2010, J CLIN IMMUNOL, V30, P566, DOI 10.1007/s10875-010-9418-1; Lienhardt C, 2010, INT J TUBERC LUNG D, V14, P528; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nunn A, 2013, CURR OPIN PULM MED, V19, P273, DOI 10.1097/MCP.0b013e32835f27f8; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Riou C, 2012, J IMMUNOL, V188, P2198, DOI 10.4049/jimmunol.1102813; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Schluger NW, 2013, SEMIN RESP CRIT CARE, V34, P60, DOI 10.1055/s-0032-1333545; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Tudor C, 2013, Int J Tuberc Lung Dis, V17, P22, DOI 10.5588/ijtld.13.0109; Veenstra H, 2007, CLIN IMMUNOL, V124, P336, DOI 10.1016/j.clim.2007.05.014; Wallis R, 2005, CURR MED CHEM ANTIIN, V4, P1; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2010, LANCET INFECT DIS, V10, P70, DOI 10.1016/S1473-3099(10)70002-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Wang XJ, 2010, J INFECTION, V60, P133, DOI 10.1016/j.jinf.2009.10.048; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; Wong EB, 2013, TRENDS MICROBIOL, V21, P493, DOI 10.1016/j.tim.2013.05.002; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	40	23	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102178	10.1371/journal.pone.0102178	http://dx.doi.org/10.1371/journal.pone.0102178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048802	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100024
J	Wang, Y; Cui, HX; Li, K; Sun, CJ; Du, W; Cui, JH; Zhao, X; Chen, WJ				Wang, Yan; Cui, Haixin; Li, Kui; Sun, Changjiao; Du, Wei; Cui, Jinhui; Zhao, Xiang; Chen, Wenjie			A Magnetic Nanoparticle-Based Multiple-Gene Delivery System for Transfection of Porcine Kidney Cells	PLOS ONE			English	Article							CHITOSAN-DNA NANOPARTICLES; IRON-OXIDE NANOPARTICLES; IN-VIVO; MAGNETOFECTION; THERAPY; FORCE; TRANSFORMATION; ENDOCYTOSIS; EFFICIENCY; EXPRESSION	Superparamagnetic nanoparticles are promising candidates for gene delivery into mammalian somatic cells and may be useful for reproductive cloning using the somatic cell nuclear transfer technique. However, limited investigations of their potential applications in animal genetics and breeding, particularly multiple-gene delivery by magnetofection, have been performed. Here, we developed a stable, targetable and convenient system for delivering multiple genes into the nuclei of porcine somatic cells using magnetic Fe3O4 nanoparticles as gene carriers. After surface modification by polyethylenimine, the spherical magnetic Fe3O4 nanoparticles showed strong binding affinity for DNA plasmids expressing the genes encoding a green (DNA(GFP)) or red (DNA(DsRed)) fluorescent protein. At weight ratios of DNAGFP or DNADsRed to magnetic nanoparticles lower than or equal to 10: 1 or 5: 1, respectively, the DNA molecules were completely bound by the magnetic nanoparticles. Atomic force microscopy analyses confirmed binding of the spherical magnetic nanoparticles to stretched DNA strands up to several hundred nanometers in length. As a result, stable and efficient co-expression of GFP and DsRed in porcine kidney PK-15 cells was achieved by magnetofection. The results presented here demonstrate the potential application of magnetic nanoparticles as an attractive delivery system for animal genetics and breeding studies.	[Wang, Yan; Cui, Haixin; Sun, Changjiao; Du, Wei; Cui, Jinhui; Zhao, Xiang; Chen, Wenjie] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	haixincui@ieda.org.cn		CHEN, WenJie/0000-0001-9512-9664	Basic Scientific Research Fund of National Nonprofit Institutes (BSRF) [201108]; National Transgenic Major Program [2009ZX08010-006B]	Basic Scientific Research Fund of National Nonprofit Institutes (BSRF); National Transgenic Major Program	The authors thank the Basic Scientific Research Fund of National Nonprofit Institutes (BSRF 201108) and National Transgenic Major Program (No. 2009ZX08010-006B) for the financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, CURR TOP MED CHEM, V8, P311; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Amalfitano A, 2004, METHODS, V33, P173, DOI 10.1016/j.ymeth.2003.11.006; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Bae KH, 2011, BIOMATERIALS, V32, P176, DOI 10.1016/j.biomaterials.2010.09.039; Bardi G, 2010, BIOMATERIALS, V31, P6555, DOI 10.1016/j.biomaterials.2010.04.063; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Dai Shun-Hong, 1998, Acta Genetica Sinica, V25, P345; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Duceppe N, 2009, BIOMATERIALS, V30, P2625, DOI 10.1016/j.biomaterials.2009.01.017; Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671; Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959; Gu W, 2010, EUROPEAN CELLS MAT, V20, P294; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Johannsen M, 2006, PROSTATE, V66, P97, DOI 10.1002/pros.20324; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Kawakami S, 2000, PHARMACEUT RES, V17, P306, DOI 10.1023/A:1007501122611; Kim TI, 2009, J CONTROL RELEASE, V136, P132, DOI 10.1016/j.jconrel.2009.01.028; Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003; Lee PW, 2008, BIOMATERIALS, V29, P742, DOI 10.1016/j.biomaterials.2007.10.034; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Li P, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245104; Lin CC, 2006, MOL THER, V13, pS291, DOI 10.1016/j.ymthe.2006.08.835; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; Lu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084703; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Mansouri S, 2006, BIOMATERIALS, V27, P2060, DOI 10.1016/j.biomaterials.2005.09.020; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Park JS, 2010, BIOMATERIALS, V31, P124, DOI 10.1016/j.biomaterials.2009.09.023; Park JS, 2011, BIOMATERIALS, V32, P3679, DOI 10.1016/j.biomaterials.2011.01.063; Plank C, 2003, EXPERT OPIN BIOL TH, V3, P745, DOI 10.1517/14712598.3.5.745; Plank C, 2003, BIOL CHEM, V384, P737, DOI 10.1515/BC.2003.082; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Salem AK, 2003, NAT MATER, V2, P668, DOI 10.1038/nmat974; Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; Shaheen SM, 2011, BIOMATERIALS, V32, P6342, DOI 10.1016/j.biomaterials.2011.05.014; Shao SQ, 2010, J GENET GENOMICS, V37, P805, DOI 10.1016/S1673-8527(09)60098-9; Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108; Wegman F, 2011, EUR CELLS MATER, V21, P230, DOI 10.22203/eCM.v021a18; Xu FQ, 2008, PLANT SCI, V175, P674, DOI 10.1016/j.plantsci.2008.07.002; Yang AF, 2009, J BIOTECHNOL, V139, P1, DOI 10.1016/j.jbiotec.2008.08.012; Zhang XQ, 2005, J CONTROL RELEASE, V102, P749, DOI 10.1016/j.jconrel.2004.10.024; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039490; 1999, Patent No. 5899880	52	28	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102886	10.1371/journal.pone.0102886	http://dx.doi.org/10.1371/journal.pone.0102886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048709	gold, Green Published			2022-12-27	WOS:000339558100084
J	Whitehead, SR; Reid, E; Sapp, J; Poveda, K; Royer, AM; Posto, AL; Kessler, A				Whitehead, Susan R.; Reid, Ellen; Sapp, Joseph; Poveda, Katja; Royer, Anne M.; Posto, Amanda L.; Kessler, Andre			A Specialist Herbivore Uses Chemical Camouflage to Overcome the Defenses of an Ant-Plant Mutualism	PLOS ONE			English	Article							EXTRAFLORAL NECTARIES; SOCIAL PARASITISM; HOST-SPECIFICITY; ECOLOGY; PROTECTION; EVOLUTION; SPIDER; EXPLOITATION; DIVERSITY; CHEMISTRY	Many plants and ants engage in mutualisms where plants provide food and shelter to the ants in exchange for protection against herbivores and competitors. Although several species of herbivores thwart ant defenses and extract resources from the plants, the mechanisms that allow these herbivores to avoid attack are poorly understood. The specialist insect herbivore, Piezogaster reclusus (Hemiptera: Coreidae), feeds on Neotropical bull-horn acacias (Vachellia collinsii) despite the presence of Pseudomyrmex spinicola ants that nest in and aggressively defend the trees. We tested three hypotheses for how P. reclusus feeds on V. collinsii while avoiding ant attack: (1) chemical camouflage via cuticular surface compounds, (2) chemical deterrence via metathoracic defense glands, and (3) behavioral traits that reduce ant detection or attack. Our results showed that compounds from both P. reclusus cuticles and metathoracic glands reduce the number of ant attacks, but only cuticular compounds appear to be essential in allowing P. reclusus to feed on bull-horn acacia trees undisturbed. In addition, we found that ant attack rates to P. reclusus increased significantly when individuals were transferred between P. spinicola ant colonies. These results are consistent with the hypothesis that chemical mimicry of colony-specific ant or host plant odors plays a key role in allowing P. reclusus to circumvent ant defenses and gain access to important resources, including food and possibly enemy-free space. This interaction between ants, acacias, and their herbivores provides an excellent example of the ability of herbivores to adapt to ant defenses of plants and suggests that herbivores may play an important role in the evolution and maintenance of mutualisms.	[Whitehead, Susan R.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Reid, Ellen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Sapp, Joseph] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Whitehead, Susan R.; Poveda, Katja] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Royer, Anne M.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Royer, Anne M.] Michigan State Univ, Dept Plant Biol, Hickory Corners, MI USA; [Posto, Amanda L.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Kessler, Andre] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA	University of Colorado System; University of Colorado Boulder; Louisiana State University System; Louisiana State University; University of California System; University of California Santa Cruz; Cornell University; Michigan State University; Michigan State University; Indiana University System; Indiana University Bloomington; Cornell University	Kessler, A (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	ak357@cornell.edu	Sapp, Joseph/AAT-5221-2020; Sapp, Joseph R/U-9417-2018	Sapp, Joseph R/0000-0002-2231-9878; Whitehead, Susan/0000-0002-7089-4594; Kessler, Andre/0000-0002-1797-7518; Royer, Anne/0000-0002-8486-3078				Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Alves-Silva E, 2013, ENTOMOL SCI, V16, P162, DOI 10.1111/ens.12004; [Anonymous], [No title captured]; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Bates D., 2013, LME4 LINEAR MIXED EF; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brandt M, 2006, INSECT SOC, V53, P291, DOI 10.1007/s00040-006-0871-z; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BUSCHINGER A, 1986, TRENDS ECOL EVOL, V1, P155, DOI 10.1016/0169-5347(86)90044-3; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Cini A, 2009, BIOL LETTERS, V5, P459, DOI 10.1098/rsbl.2009.0140; Crawley M.J., 2007, R BOOK; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Dyer LA, 2001, J CHEM ECOL, V27, P581, DOI 10.1023/A:1010345123670; Elgar MA, 2004, NATURWISSENSCHAFTEN, V91, P143, DOI 10.1007/s00114-004-0507-y; Elmes GW, 1999, P ROY SOC B-BIOL SCI, V266, P447, DOI 10.1098/rspb.1999.0658; ESPELIE KE, 1991, ARCH INSECT BIOCHEM, V17, P223, DOI 10.1002/arch.940170406; Eubanks MD, 1997, OECOLOGIA, V109, P454, DOI 10.1007/s004420050105; FRITZ RS, 1992, PLANT RESISTANCE HER; Garcia LC, 2013, ECOL ENTOMOL, V38, P230, DOI 10.1111/een.12012; Gillespie TW, 2000, PLANT ECOL, V147, P37, DOI 10.1023/A:1009848525399; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Heil M, 2000, NATURWISSENSCHAFTEN, V87, P555, DOI 10.1007/s001140050778; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2013, J ECOL, V101, P684, DOI 10.1111/1365-2745.12060; HEPBURN H R, 1971, Journal of the Kansas Entomological Society, V44, P187; Hothorn T., 2013, MULTCOMP SIMULTANEOU; Huxley C.R., 1991, ANT PLANT INTERACTIO; Jackson DE, 2006, CURR BIOL, V16, pR570, DOI 10.1016/j.cub.2006.07.015; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Janzen DH, 1983, COSTA RICAN NATURAL; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Kautz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037691; Kendrick A, 2006, OTS COURSEBOOK 2006, P53; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; KOPTUR S, 1988, ECOLOGY, V69, P278, DOI 10.2307/1943183; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Marazzi B, 2013, ANN BOT-LONDON, V111, P1243, DOI 10.1093/aob/mct109; Meehan CJ, 2009, CURR BIOL, V19, pR892, DOI 10.1016/j.cub.2009.08.049; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Portugal AHA, 2005, J CHEM ECOL, V31, P2551, DOI 10.1007/s10886-005-7613-y; Pringle EG, 2013, SOCIOBIOLOGY, V60, P242; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; REHR SS, 1973, J ANIM ECOL, V42, P405, DOI 10.2307/3294; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Seigler DS, 2005, PHYTOLOGIA, V87, P139; Silveira HCP, 2010, AM NAT, V175, P261, DOI 10.1086/649580; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Vander Meer Robert K., 1998, P79; YOUNG BE, 1990, BIOTROPICA, V22, P310, DOI 10.2307/2388543; Zuur Alain F., 2009, P1; [No title captured]	57	7	7	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102604	10.1371/journal.pone.0102604	http://dx.doi.org/10.1371/journal.pone.0102604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047551	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100052
J	Xu, QF; Hou, W; Zheng, Y; Liu, C; Gong, ZJ; Lu, C; Lai, W; Maibach, HI				Xu, Qingfang; Hou, Wei; Zheng, Yue; Liu, Chen; Gong, Zijian; Lu, Chun; Lai, Wei; Maibach, Howard I.			Ultraviolet A-Induced Cathepsin K Expression Is Mediated via MAPK/AP-1 Pathway in Human Dermal Fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; HUMAN SKIN; GENE-EXPRESSION; OSTEOCLAST DIFFERENTIATION; LUNG FIBROSIS; P38 MAPK; COLLAGEN; JNK; UVA	Background: Cathepsin K (CatK), a cysteine protease with the potent elastolytic activity, plays a predominant role in intracellular elastin degradation in human dermal fibroblasts (HDFs), and contributes to solar elastosis. In previous studies, CatK expression was downregulated in photoaged skin and fibroblasts, but upregulated in acute UVA-irradiated skin and fibroblasts. The underlying mechanisms regulating UVA-induced CatK expression remain elusive. Objective: This study investigates mechanisms involved in the regulation of UVA-induced CatK expression in HDFs. Methods: Primary HDFs were exposed to UVA. Cell proliferation was analyzed using a colorimetric assay of relative cell number. Quantitative real-time RT-PCR and Western blot were performed to detect CatK expression in HDFs on three consecutive days after 10 J/cm(2) UVA irradiation, or cells treated with increasing UVA doses. UVA-activated MAPK/AP-1 pathway was examined by Western blot. Effects of inhibition of MAPK pathway and knockdown of Jun and Fos on UVA-induced CatK expression were also measured by real-time RT-PCR and Western blot. Results: UVA significantly increased CatK mRNA and protein expression in a dose-dependent manner. UVA-induced CatK expression occurred along with UVA-activated phosphorylation of JNK, p38 and Jun, UVA-increased expression of Fos. Inactivation of JNK and p38MAPK pathways both remarkably decreased UVA-induced CatK expression, which was suppressed more by inhibition of JNK pathway. Furthermore, knockdown of Jun and Fos significantly attenuated basal and UVA-induced CatK expression. Conclusion: UVA is capable of increasing CatK expression in HDFs, most likely by activation of MAPK pathway and of AP-1, which has been shown to be the case for matrix metalloproteinases. As current strategies for selecting anti-photoaging agents focus on their ability to decrease MMPs' expression through inhibiting UV-activated MAPK pathway, future strategies should also consider their effect on CatK expression.	[Xu, Qingfang; Hou, Wei; Zheng, Yue; Liu, Chen; Gong, Zijian; Lu, Chun; Lai, Wei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatovenereol, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Wei] Xinjiang Med Univ, Teaching Hosp 1, Dept Dermatovenereol, Urumqi, Peoples R China; [Maibach, Howard I.] Univ Calif San Francisco, Sch Med, Dept Dermatol, San Francisco, CA USA	Sun Yat Sen University; Xinjiang Medical University; University of California System; University of California San Francisco	Lai, W (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatovenereol, Guangzhou 510275, Guangdong, Peoples R China.	drlaiwei@163.com			National Natural Science Foundation of China [81171523]; Scientific Program of Guangdong Province [2012B031800057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Program of Guangdong Province	This work was supported by grants from National Natural Science Foundation of China Research grant (No. 81171523), the Scientific Program of Guangdong Province (No. 2012B031800057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERNSTEIN EF, 1994, J INVEST DERMATOL, V103, P182, DOI 10.1111/1523-1747.ep12392693; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Codriansky KA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1356, DOI 10.1111/j.1751-1097.2009.00592.x; Dong KK, 2008, EXP DERMATOL, V17, P1037, DOI 10.1111/j.1600-0625.2008.00747.x; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Gilchrest BA, 2009, J INVEST DERM SYMP P, V14, P25, DOI 10.1038/jidsymp.2009.9; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Keegan PM, 2012, MOL CELL BIOCHEM, V367, P65, DOI 10.1007/s11010-012-1320-0; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073877; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; Krutmann J, 2009, J INVEST DERM SYMP P, V14, P44, DOI 10.1038/jidsymp.2009.1; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lee YK, 2012, ARCH DERMATOL RES, V304, P73, DOI 10.1007/s00403-011-1176-2; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Muto J., 2007, J INVEST DERMATOL, V127, P1286; Pang M, 2007, GENE, V403, P151, DOI 10.1016/j.gene.2007.08.007; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Quintanilla-Dieck MJ, 2009, EXP DERMATOL, V18, P596, DOI 10.1111/j.1600-0625.2009.00855.x; Rhie GE, 2001, J INVEST DERMATOL, V117, P1212, DOI 10.1046/j.0022-202x.2001.01469.x; Rijken F, 2009, J INVEST DERM SYMP P, V14, P67, DOI 10.1038/jidsymp.2009.15; Ruettger A, 2008, J BIOL CHEM, V283, P1043, DOI 10.1074/jbc.M704915200; Runger TM, 2007, J INVEST DERMATOL, V127, P293, DOI 10.1038/sj.jid.5700535; Saarialho-Kere U, 1999, J INVEST DERMATOL, V113, P664, DOI 10.1046/j.1523-1747.1999.00731.x; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shin S, 2013, INT J MED SCI, V10, P8, DOI 10.7150/ijms.5385; Silvers AL, 2006, PHOTOCHEM PHOTOBIOL, V82, P423, DOI 10.1562/2005-08-26-RA-659; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Thompson M, 2006, ANN NY ACAD SCI, V1085, P170, DOI 10.1196/annals.1383.034; Troen BR, 2006, ANN NY ACAD SCI, V1068, P165, DOI 10.1196/annals.1346.018; Tsukahara K, 2001, J INVEST DERMATOL, V117, P671, DOI 10.1046/j.0022-202x.2001.01450.x; van den Brule S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-84; Zheng Y, 2011, SKIN PHARMACOL PHYS, V24, P10, DOI 10.1159/000314725	38	25	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102732	10.1371/journal.pone.0102732	http://dx.doi.org/10.1371/journal.pone.0102732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048708	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100064
J	Brahmbhatt, A; NievesTorres, E; Yang, BX; Edwards, WD; Chaudhury, PR; Lee, MK; Kong, H; Mukhopadhyay, D; Kumar, R; Misra, S				Brahmbhatt, Akshaar; NievesTorres, Evelyn; Yang, Binxia; Edwards, William D.; Chaudhury, Prabir Roy; Lee, Min Kyun; Kong, Hyunjoon; Mukhopadhyay, Debabrata; Kumar, Rajiv; Misra, Sanjay			The Role of Iex-1 in the Pathogenesis of Venous Neointimal Hyperplasia Associated with Hemodialysis Arteriovenous Fistula	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; EARLY RESPONSE GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIGH-DOSE CALCITRIOL; B TARGET GENE; INCREASED EXPRESSION; OXIDATIVE STRESS; VASCULAR ACCESS; POLYTETRAFLUOROETHYLENE GRAFTS; MATRIX METALLOPROTEINASE-2	Arteriovenous fistulas (AVFs) used for hemodialysis fail because of venous neointimal hyperplasia (VNH). There are 1,500,000 patients that have end stage renal disease worldwide and the majority requires hemodialysis. In the present study, the role of the intermediate early response gene X-1 (IEX-1), also known as IER-3 in the pathogenesis of VNH was evaluated. In human samples removed from failed AVF, there was a significant increase in IEX-1 expression localized to the adventitia. In Iex-1(-/-) mice and wild type (WT) controls, chronic kidney disease was induced and an AVF placed 28 days later by connecting the carotid artery to jugular vein. The outflow vein was removed three days following the creation of the AVF and gene expression analysis demonstrated a significant decrease in vascular endothelial growth factor-A (Vegf-A) and monocyte chemoattractant protein-1 (Mcp-1) gene expression in Iex-1(-/-) mice when compared to WT mice (P<0.05). At 28 days after AVF placement, histomorphometric and immune-histochemical analyses of the outflow vein demonstrated a significant decrease in neointimal hyperplasia with an increase in average lumen vessel area associated with a decrease in fibroblast, myofibroblast, and Ly6C staining. There was a decrease in proliferation (Ki-67) and an increase in the TUNEL staining in Iex-1 KO mice compared to WT. In addition, there was a decrease in Vegf-A, Mcp-1, and matrix metalloproteiniase9 (Mmp-9) staining. Iex-1 expression was reduced in vivo and in vitro using nanoparticles coated with calcitriol, an inhibitor of Iex-1 that demonstrated that Iex-1 reduction results in decrease in Vegf-A. In aggregate, these results indicate that the absence of IEX-1 gene results in reduced VNH accompanied with a decrease in proliferation, reduced fibroblast, myofibroblast, and Ly6C staining accompanied with increased apoptosis mediated through a reduction in Vegf-A/Mcp-1 axis and Mmp-9. Adventitial delivery of nanoparticles coated with calcitriol reduced Iex-1 and VNH.	[Brahmbhatt, Akshaar; NievesTorres, Evelyn; Yang, Binxia; Misra, Sanjay] Univ Cincinnati, Dept Radiol, Vasc & Intervent Radiol Translat Lab, Cincinnati, OH 45220 USA; [Edwards, William D.] Univ Cincinnati, Dept Lab Med & Pathol, Cincinnati, OH USA; [Chaudhury, Prabir Roy] Univ Cincinnati, Dept Med, Div Nephrol & Hypertens, Cincinnati, OH USA; [Lee, Min Kyun; Kong, Hyunjoon] Univ Illinois, Dept Biomol & Chem Engn, Champaign, IL USA; [Mukhopadhyay, Debabrata; Kumar, Rajiv; Misra, Sanjay] Mayo Clin, Dept Med, Dept Biochem & Mol Biol, Rochester, MN USA; [Kumar, Rajiv] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic	Misra, S (corresponding author), Univ Cincinnati, Dept Radiol, Vasc & Intervent Radiol Translat Lab, Cincinnati, OH 45220 USA.	misra.sanjay@mayo.edu		Kumar, Rajiv/0000-0003-3497-3057	National Heart, Lung, And Blood Institute [R01HL098967]; Society of Interventional Radiology Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098967, R01HL109192] Funding Source: NIH RePORTER	National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Society of Interventional Radiology Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a R01HL098967 (SM) from the National Heart, Lung, And Blood Institute, Society of Interventional Radiology Foundation (AB), and Howard Hughes Medical Institute (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jaishi AA, 2014, AM J KIDNEY DIS, V63, P464, DOI 10.1053/j.ajkd.2013.08.023; [Anonymous], 1996, COMMITTEE CARE USE L; Arlt A, 2001, ONCOGENE, V20, P69, DOI 10.1038/sj.onc.1204061; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Beer TM, 2001, SEMIN ONCOL, V28, P49, DOI 10.1053/sonc.2001.26901; Beer TM, 2007, J CLIN ONCOL, V25, P669, DOI 10.1200/JCO.2006.06.8197; Bojakowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036482; CHARLES CH, 1993, ONCOGENE, V8, P797; Chen M, 2007, NEPHROL DIAL TRANSPL, V22, P139, DOI 10.1093/ndt/gfl509; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; De Keulenaer GW, 2002, CIRC RES, V90, P690, DOI 10.1161/01.RES.0000012922.40318.05; de Laval B, 2014, BLOOD, V123, P509, DOI 10.1182/blood-2013-07-515874; Hofstra L, 1995, J AM SOC NEPHROL, V6, P1625; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Im HJ, 2002, ONCOGENE, V21, P3706, DOI 10.1038/sj.onc.1205450; Janardhanan R, 2013, KIDNEY INT, V84, P338, DOI 10.1038/ki.2013.112; Juncos JP, 2011, J AM SOC NEPHROL, V22, P43, DOI 10.1681/ASN.2010040373; Kobayashi T, 1998, BIOCHEM BIOPH RES CO, V251, P868, DOI 10.1006/bbrc.1998.9556; Krishnamoorthy MK, 2012, KIDNEY INT, V81, P745, DOI 10.1038/ki.2011.468; Kumar R, 1998, BIOCHEM BIOPH RES CO, V253, P336, DOI 10.1006/bbrc.1998.9692; Kumar R, 2003, RECENT RESULTS CANC, V164, P123; Misra S, 2005, KIDNEY INT, V68, P2890, DOI 10.1111/j.1523-1755.2005.00763.x; Misra S, 2008, AM J PHYSIOL-HEART C, V294, pH2219, DOI 10.1152/ajpheart.00650.2007; Misra S, 2008, J VASC INTERV RADIOL, V19, P587, DOI 10.1016/j.jvir.2008.01.005; Misra S, 2008, J VASC INTERV RADIOL, V19, P260, DOI 10.1016/j.jvir.2007.10.029; Misra S, 2008, J VASC INTERV RADIOL, V19, P252, DOI 10.1016/j.jvir.2007.10.031; Misra S, 2006, CARDIOVASC INTER RAD, V29, P624, DOI 10.1007/s00270-005-0168-z; Misra S, 2010, J VASC INTERV RADIOL, V21, P1255, DOI 10.1016/j.jvir.2010.02.043; Misra S, 2010, J VASC INTERV RADIOL, V21, P896, DOI 10.1016/j.jvir.2010.02.030; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Pawlak K, 2006, MED SCI MONITOR, V12, pCR181; Pietzsch A, 1998, BIOCHEM BIOPH RES CO, V245, P651, DOI 10.1006/bbrc.1998.8500; REKHTER M, 1993, ARTERIOSCLER THROMB, V13, P609, DOI 10.1161/01.ATV.13.4.609; Riella MC, 2013, NAT REV NEPHROL, V9, P348, DOI 10.1038/nrneph.2013.76; Rooijens PPGM, 2004, EUR J VASC ENDOVASC, V28, P583, DOI 10.1016/j.ejvs.2004.08.014; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Schafer H, 1999, BIOCHEM BIOPH RES CO, V262, P139, DOI 10.1006/bbrc.1999.1131; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Schmidt WE, 1999, ANN NY ACAD SCI, V880, P147, DOI 10.1111/j.1749-6632.1999.tb09517.x; Schulze PC, 2003, CIRC RES, V93, P1210, DOI 10.1161/01.RES.0000103635.38096.2F; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Sommer SL, 2006, J APPL PHYSIOL, V100, P707, DOI 10.1152/japplphysiol.00306.2005; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Torres ECN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094510; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Weiss MF, 2001, AM J KIDNEY DIS, V37, P970, DOI 10.1016/S0272-6386(05)80013-7; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yang B, 2014, KIDNEY INT, V85, P289, DOI 10.1038/ki.2013.290; Yang BX, 2009, J VASC INTERV RADIOL, V20, P946, DOI 10.1016/j.jvir.2009.03.044	49	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102542	10.1371/journal.pone.0102542	http://dx.doi.org/10.1371/journal.pone.0102542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036043	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200066
J	Deng, B; Wang, CW; Arnardottir, HH; Li, YS; Cheng, CYC; Dalli, J; Serhan, CN				Deng, Bin; Wang, Chin-Wei; Arnardottir, Hildur H.; Li, Yongsheng; Cheng, Chien-Yee Cindy; Dalli, Jesmond; Serhan, Charles N.			Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages	PLOS ONE			English	Article							CYTOSOLIC EPOXIDE HYDROLASE; HUMAN PLATELET 12-LIPOXYGENASE; 5,6-DIHYDROXY-7,9,11,14-EICOSATETRAENOIC ACID; ARACHIDONIC-ACID; DENDRITIC CELLS; HUMAN-BLOOD; RESOLUTION; LEUKOTRIENE-A4; GENERATION; PROTECTINS	Maresins are a new family of anti-inflammatory and pro-resolving lipid mediators biosynthesized from docosahexaenoic acid (DHA) by macrophages. Here we identified a novel pro-resolving product, 13R, 14S-dihydroxy-docosahexaenoic acid (13R, 14S-diHDHA), produced by human macrophages. PCR mapping of 12-lipoxygenase (12-LOX) mRNA sequence in human macrophages and platelet showed that they are identical. This human 12-LOX mRNA and enzyme are expressed in monocyte-derived cell lineage, and enzyme expression levels increase with maturation to macrophages or dendritic cells. Recombinant human 12-LOX gave essentially equivalent catalytic efficiency (k(cat)/K-M) with arachidonic acid (AA) and DHA as substrates. Lipid mediator metabololipidomics demonstrated that human macrophages produce a novel bioactive product 13,14-dihydroxy-docosahexaenoic acid in addition to maresin-1, 7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid (MaR1). Co-incubations with human recombinant 12-LOX and soluble epoxide hydrolase (sEH) demonstrated that biosynthesis of 13,14-dihydroxy-docosahexaenoic acid (13,14-diHDHA) involves the 13S,14S-epoxy-maresin intermediate produced from DHA by 12-LOX, followed by conversion via soluble epoxide hydrolase (sEH). This new 13,14-diHDHA displayed potent anti-inflammatory and pro-resolving actions, and at 1 ng reduced neutrophil infiltration in mouse peritonitis by similar to 40% and at 10 pM enhanced human macrophage phagocytosis of zymosan by similar to 90%. However, MaR1 proved more potent than the 13R,14S-diHDHA at enhancing efferocytosis with human macrophages. Taken together, the present findings demonstrate that macrophages produced a novel bioactive product identified in the maresin metabolome as 13R,14S-dihydroxy-docosahexaenoic acid, from DHA via conversion by human 12-LOX followed by sEH. Given its potent bioactions, we coined 13R,14S-diHDHA maresin 2 (MaR2).	[Deng, Bin; Wang, Chin-Wei; Arnardottir, Hildur H.; Li, Yongsheng; Cheng, Chien-Yee Cindy; Dalli, Jesmond; Serhan, Charles N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury,Dept Anesthe, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Serhan, CN (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury,Dept Anesthe, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu		Li, Yongsheng/0000-0003-2175-9449; Arnardottir, Hildur/0000-0002-5163-3946; Dalli, Jesmond/0000-0001-6328-3640	U.S. National Institutes of Health [P01GM095467, R01GM38765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health grant nos. P01GM095467 and R01GM38765. The content is solely the responsibility of the authors and does not necessarily reflect the official view of NIH/NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; CHEN XS, 1993, FASEB J, V7, P694, DOI 10.1096/fasebj.7.8.8500694; Cronin A, 2011, J LIPID RES, V52, P712, DOI 10.1194/jlr.M009639; Dalli J, 2013, FASEB J; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Draper AJ, 1999, TOXICOL SCI, V50, P30, DOI 10.1093/toxsci/50.1.30; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; HAEGGSTROM J, 1988, BIOCHIM BIOPHYS ACTA, V958, P469, DOI 10.1016/0005-2760(88)90233-0; HAEGGSTROM J, 1986, J BIOL CHEM, V261, P6332; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; IZUMI T, 1990, P NATL ACAD SCI USA, V87, P7477, DOI 10.1073/pnas.87.19.7477; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Nordgren TM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-51; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2003, J IMMUNOL METHODS, V281, P79, DOI 10.1016/S0022-1759(03)00278-3; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Sampaio A, 2010, FUNDAMENTALS INFLAMM, P488; SEIDEGARD J, 1984, CANCER RES, V44, P3654; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x; SHEPPARD KA, 1992, BIOCHIM BIOPHYS ACTA, V1133, P223, DOI 10.1016/0167-4889(92)90073-K; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; TAKAHASHI Y, 1993, J BIOL CHEM, V268, P16443; Tian HB, 2012, STEM CELLS DEV, V21, P1187, DOI 10.1089/scd.2011.0220; Tian HB, 2011, J BIOL CHEM, V286, P4443, DOI 10.1074/jbc.M110.100388; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	40	103	107	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102362	10.1371/journal.pone.0102362	http://dx.doi.org/10.1371/journal.pone.0102362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036362	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200048
J	Jiang, Y; Li, LL; Liu, B; Zhang, YH; Chen, Q; Li, CQ				Jiang, Ying; Li, Longling; Liu, Bin; Zhang, Yanhong; Chen, Qian; Li, Changqing			Vagus Nerve Stimulation Attenuates Cerebral Ischemia and Reperfusion Injury via Endogenous Cholinergic Pathway in Rat	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ISCHEMIA/REPERFUSION INJURY; ANTIINFLAMMATORY PATHWAY; VAGAL-STIMULATION; ARTERY OCCLUSION; HEME OXYGENASE-1; INFARCT SIZE; BLOOD-FLOW; STROKE; ACETYLCHOLINE	Inflammation and apoptosis play critical roles in the acute progression of ischemic injury pathology. Emerging evidence indicates that vagus nerve stimulation (VNS) following focal cerebral ischemia and reperfusion (I/R) may be neuroprotective by limiting infarct size. However, the underlying molecular mechanisms remain unclear. In this study, we investigated whether the protective effects of VNS in acute cerebral I/R injury were associated with anti-inflammatory and anti-apoptotic processes. Male Sprague-Dawley (SD) rats underwent VNS at 30 min after focal cerebral I/R surgery. Twenty-four h after reperfusion, neurological deficit scores, infarct volume, and neuronal apoptosis were evaluated. In addition, the levels of pro-inflammatory cytokines were detected using enzyme-linked immune sorbent assay (ELISA), and immunofluorescence staining for the endogenous "cholinergic anti-inflammatory pathway" was also performed. The protein expression of a7 nicotinic acetylcholine receptor (a7nAchR), phosphorylated Akt (p-Akt), and cleaved caspase 3 in ischemic penumbra were determined with Western blot analysis. I/R rats treated with VNS (I/R+VNS) had significantly better neurological deficit scores, reduced cerebral infarct volume, and decreased number of TdT mediated dUTP nick end labeling (TUNEL) positive cells. Furthermore, in the ischemic penumbra of the I/R+ VNS group, the levels of pro-inflammatory cytokines and cleaved caspase 3 protein were significantly decreased, and the levels of a7nAchR and phosphorylated Akt were significantly increased relative to the I/R alone group. These results indicate that VNS is neuroprotective in acute cerebral I/R injury by suppressing inflammation and apoptosis via activation of cholinergic and a7nAchR/Akt pathways.	[Jiang, Ying; Li, Longling; Liu, Bin; Zhang, Yanhong; Chen, Qian; Li, Changqing] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University	Li, CQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing, Peoples R China.	licq9217@cqmu.edu.cn			National Nature and Science Foundation of China [81271306]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature and Science Foundation of China (Grant NO. 81271306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay I, 2011, BRAIN RES, V1392, P110, DOI 10.1016/j.brainres.2011.03.060; Ay I, 2009, NEUROSCI LETT, V459, P147, DOI 10.1016/j.neulet.2009.05.018; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Boon P, 2006, SEIZURE-EUR J EPILEP, V15, P259, DOI 10.1016/j.seizure.2006.02.014; Borckardt Jeffrey J, 2005, Pain Res Manag, V10, P9; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Calvillo L, 2011, J CARDIOVASC PHARM, V58, P500, DOI 10.1097/FJC.0b013e31822b7204; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Conway CR, 2012, BRAIN STIMUL, V5, P163, DOI 10.1016/j.brs.2011.03.001; Duris K, 2011, STROKE, V42, P3530, DOI 10.1161/STROKEAHA.111.619965; Fanselow MS, 2013, BIOL PSYCHIAT, V73, P1043, DOI 10.1016/j.biopsych.2013.03.025; Fu SH, 2014, N-S ARCH PHARMACOL, V387, P87, DOI 10.1007/s00210-013-0922-8; Furmaga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034844; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hiraki T, 2012, J NEUROSCI RES, V90, P887, DOI 10.1002/jnr.22812; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Kakinuma Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004887; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Kong YH, 2013, NEUROCHEM RES, V38, P815, DOI 10.1007/s11064-013-0984-5; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Morris GL, 2013, EPILEPSY CURR, V13, P297, DOI 10.5698/1535-7597-13.6.297; Mravec B, 2010, AUTON NEUROSCI-BASIC, V158, P8, DOI 10.1016/j.autneu.2010.08.009; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Schabitz WR, 1996, J NEUROL SCI, V138, P21, DOI 10.1016/0022-510X(95)00341-X; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Sun ZH, 2012, BRAIN STIMUL, V5, P1, DOI 10.1016/j.brs.2011.01.009; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; You SJ, 2007, J KOREAN MED SCI, V22, P442, DOI 10.3346/jkms.2007.22.3.442; Zhang L, 2010, BRAIN RES, V1357, P157, DOI 10.1016/j.brainres.2010.08.007	40	68	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102342	10.1371/journal.pone.0102342	http://dx.doi.org/10.1371/journal.pone.0102342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036185	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200047
J	Nie, CJ; Li, HR; Yang, LS; Zhong, GM; Zhang, L				Nie, Chengjing; Li, Hairong; Yang, Linsheng; Zhong, Gemei; Zhang, Lan			Socio-Economic Factors of Bacillary Dysentery Based on Spatial Correlation Analysis in Guangxi Province, China	PLOS ONE			English	Article							METEOROLOGICAL FACTORS; CLIMATE VARIATIONS; EPIDEMICS; DISEASE; QUEENSLAND; REGRESSION; AUSTRALIA; NORTHERN; CITIES; BRAZIL	Background: In the past decade, bacillary dysentery was still a big public health problem in China, especially in Guangxi Province, where thousands of severe diarrhea cases occur every year. Methods: Reported bacillary dysentery cases in Guangxi Province were obtained from local Centers for Diseases Prevention and Control. The 14 socio-economic indexes were selected as potential explanatory variables for the study. The spatial correlation analysis was used to explore the associations between the selected factors and bacillary dysentery incidence at county level, which was based on the software of ArcGIS10.2 and GeoDA 0.9.5i. Results: The proportion of primary industry, the proportion of younger than 5-year-old children in total population, the number of hospitals per thousand persons and the rates of bacillary dysentery incidence show statistically significant positive correlation. But the proportion of secondary industry, per capital GDP, per capital government revenue, rural population proportion, popularization rate of tap water in rural area, access rate to the sanitation toilets in rural, number of beds in hospitals per thousand persons, medical and technical personnel per thousand persons and the rate of bacillary dysentery incidence show statistically significant negative correlation. The socio-economic factors can be divided into four aspects, including economic development, health development, medical development and human own condition. The four aspects were not isolated from each other, but interacted with each other.	[Nie, Chengjing] Hebei Univ Econ & Business, Sch Publ Adm & Policy, Shijiazhuang, Peoples R China; [Nie, Chengjing; Li, Hairong; Yang, Linsheng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Zhong, Gemei] Guangxi Ctr Dis Prevent & Control, Inst Environm Hlth & Endem Dis Prevent, Nanning, Peoples R China; [Zhang, Lan] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Beijing, Peoples R China	Hebei University of Economics & Business; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Yang, LS (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	yangls@igsnrr.ac.cn	Yang, Linsheng/H-4326-2011	Yang, Linsheng/0000-0001-9603-6507	program of national science infrastructure platform [2013FY114600-3-1]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-Q03-01]; National Key Technology RD Program [2008BAK50B05]	program of national science infrastructure platform; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology RD Program(National Key Technology R&D Program)	This study was supported by the program of national science infrastructure platform (2013FY114600-3-1), Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-Q03-01), and the National Key Technology R&D Program (2008BAK50B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381; China MoHPR, 2005, PLAN NAT SURV BAC DY; Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022; El Bushra HE, 1999, E AFR MED J, V76, P255; Filipe JAN, 2004, J THEOR BIOL, V226, P125, DOI 10.1016/S0022-5193(03)00278-9; Gao L, 2014, AM J TROP MED HYG, V90, P697, DOI 10.4269/ajtmh.13-0198; Gatton ML, 2004, AM J TROP MED HYG, V71, P629, DOI 10.4269/ajtmh.2004.71.629; GOTTWALD TR, 1992, PHYTOPATHOLOGY, V82, P843, DOI 10.1094/Phyto-82-843; Guan P, 2008, JPN J INFECT DIS, V61, P356; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Li ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03239; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Liu G, 2013, ENVIRON MONIT ASSESS, V185, P9549, DOI 10.1007/s10661-013-3272-6; Lue Ye, 2008, Zhonghua Yufang Yixue Zazhi, V42, P342; Ma SL, 2013, CHIN J INTEGR MED, V19, P182, DOI 10.1007/s11655-012-1239-z; Ma WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062122; Mahmoud A A, 1976, Gaz Egypt Paediatr Assoc, V24, P82; Martinez J M, 1973, Bol Oficina Sanit Panam, V75, P213; Mateu J, 2014, BIOM J; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Moya MP, 2012, REV FAC CIEN MED U N, V69, P160; Nicolas X, 2007, PRESSE MED, V36, P1606, DOI 10.1016/j.lpm.2007.03.001; Penatti MPA, 2007, BRAZ J MED BIOL RES, V40, P249, DOI 10.1590/S0100-879X2006005000069; Quinn HE, 2005, J MED ENTOMOL, V42, P882, DOI 10.1603/0022-2585(2005)042[0882:AOBFVD]2.0.CO;2; Savary S, 2001, PLANT PATHOL, V50, P53, DOI 10.1046/j.1365-3059.2001.00531.x; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Xu LY, 2013, ENVIRON POLLUT, V178, P102, DOI 10.1016/j.envpol.2013.03.006; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zhang Y, 2008, PUBLIC HEALTH REP, V123, P61, DOI 10.1177/003335490812300109; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhang Y, 2012, J ENVIRON MONITOR, V14, P510, DOI 10.1039/c1em10391a; Zhong Hao-jie, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P304	33	13	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102020	10.1371/journal.pone.0102020	http://dx.doi.org/10.1371/journal.pone.0102020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036182	gold, Green Submitted, Green Published			2022-12-27	WOS:000339615200033
J	Ren, CL; Zhang, GF; Xia, N; Jin, CH; Zhang, XH; Hao, JF; Guan, HB; Tang, H; Li, JA; Cai, DL				Ren, Cai-Li; Zhang, Guo-Fu; Xia, Nan; Jin, Chun-Hui; Zhang, Xiu-Hua; Hao, Jian-Feng; Guan, Hong-Bo; Tang, Hong; Li, Jian-An; Cai, De-Liang			Effect of Low-Frequency rTMS on Aphasia in Stroke Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE BRAIN-STIMULATION; NONFLUENT APHASIA; LANGUAGE FUNCTION; RECOVERY; THERAPY; SPEECH; TMS	Background: Small clinical trials have reported that low-frequency repetitive transcranial magnetic stimulation (rTMS) might improve language recovery in patients with aphasia after stroke. However, no systematic reviews or meta-analyses studies have investigated the effect of rTMS on aphasia. The objective of this study was to perform a meta-analysis of studies that explored the effects of low-frequency rTMS on aphasia in stroke patients. Methods: We searched PubMed, CENTRAL, Embase, CINAHL, ScienceDirect, and Journals@Ovid for randomized controlled trials published between January 1965 and October 2013 using the keywords "aphasia OR language disorders OR anomia OR linguistic disorders AND repetitive transcranial magnetic stimulation OR rTMS''. We used fixed-and random-effects models to estimate the standardized mean difference (SMD) and a 95% CI for the language outcomes. Results: Seven eligible studies involving 160 stroke patients were identified in this meta-analysis. A significant effect size of 1.26 was found for the language outcome severity of impairment (95% CI = 0.80 to 1.71) without heterogeneity (I-2 = 0%, P = 0.44). Further analyses demonstrated prominent effects for the naming subtest (SMD = 0.52, 95% CI = 0.18 to 0.87), repetition (SMD = 0.54, 95% CI = 0.16 to 0.92), writing (SMD = 0.70, 95% CI = 0.19 to 1.22), and comprehension (the Token test: SMD = 0.58, 95% CI = 0.07 to 1.09) without heterogeneity (I-2 = 0%). The SMD of AAT and BDAE comprehension subtests was 0.32 (95% CI = 20.08 to 0.72) with moderate heterogeneity (I-2 = 32%, P = 0.22). The effect size did not change significantly even when any one trial was eliminated. None of the patients from the 7 included articles reported adverse effects from rTMS. Conclusions: Low-frequency rTMS with a 90% resting motor threshold that targets the triangular part of the right inferior frontal gyrus (IFG) has a positive effect on language recovery in patients with aphasia following stroke. Further well-designed studies with larger populations are required to ascertain the long-term effects of rTMS in aphasia treatment.	[Ren, Cai-Li; Zhang, Xiu-Hua; Hao, Jian-Feng; Guan, Hong-Bo; Tang, Hong; Cai, De-Liang] Nanjing Med Univ, Wuxi Tongren Int Rehabil Hosp, Dept Rehabil Med, Wuxi, Jiangsu, Peoples R China; [Zhang, Guo-Fu; Jin, Chun-Hui] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Ren, Cai-Li; Xia, Nan; Li, Jian-An] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Li, JA (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China.	lijianan@carm.org.cn; caidl001@163.com	Xia, Nan/ABG-4600-2021					Abo M, 2012, EUR NEUROL, V68, P199, DOI 10.1159/000338773; Barwood CHS, 2013, NEUROREHABILITATION, V32, P915, DOI 10.3233/NRE-130915; Barwood CHS, 2012, BRAIN STIMUL, V5, P274, DOI 10.1016/j.brs.2011.03.005; Barwood CHS, 2011, NEUROREHABILITATION, V28, P113, DOI 10.3233/NRE-2011-0640; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Brady MC, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000425.pub4, 10.1002/14651858.CD000425.pub3]; Cappa SF, 2002, NEUROLOGY, V59, P720, DOI 10.1212/WNL.59.5.720; Cotelli M, 2008, EUR J NEUROL, V15, P1286, DOI 10.1111/j.1468-1331.2008.02202.x; Cotelli M, 2012, EUR J NEUROL, V19, P1404, DOI 10.1111/j.1468-1331.2012.03699.x; Cotelli M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00151; Cotelli M, 2006, ARCH NEUROL-CHICAGO, V63, P1602, DOI 10.1001/archneur.63.11.1602; Cruice M, 2010, J FLUENCY DISORD, V35, P173, DOI 10.1016/j.jfludis.2010.05.008; Dickey L, 2010, ARCH PHYS MED REHAB, V91, P196, DOI 10.1016/j.apmr.2009.09.020; Elsner B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009760.pub2; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; Hartmann A., 2013, NEUROPHYSIOL CLIN, V43, P70, DOI [10.1016/j.neucli.2012.11.012, DOI 10.1016/J.NEUCLI.2012.11.012]; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Heiss WD, 2013, CEREBROVASC DIS, V36, P363, DOI 10.1159/000355499; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hilari K, 2010, CLIN REHABIL, V24, P181, DOI 10.1177/0269215509346090; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kindler J, 2012, STROKE, V43, P2175, DOI 10.1161/STROKEAHA.111.647503; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Martin PI, 2009, CURR NEUROL NEUROSCI, V9, P451, DOI 10.1007/s11910-009-0067-9; Martin Paula I., 2004, Seminars in Speech and Language, V25, P181; Medina J, 2012, APHASIOLOGY, V26, P1153, DOI 10.1080/02687038.2012.710316; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Naeser MA, 2011, BRAIN LANG, V119, P206, DOI 10.1016/j.bandl.2011.07.005; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Seniow J, 2013, TOP STROKE REHABIL, V20, P250, DOI 10.1310/tsr2003-250; Sloan JA, 2005, J CLIN EPIDEMIOL, V58, P1217, DOI 10.1016/j.jclinepi.2005.07.009; Sparing R, 2001, J CLIN NEUROPHYSIOL, V18, P326, DOI 10.1097/00004691-200107000-00004; Thiel A, 2006, J CEREBR BLOOD F MET, V26, P1122, DOI 10.1038/sj.jcbfm.9600350; Thiel A, 2013, STROKE, V44, P2240, DOI 10.1161/STROKEAHA.111.000574; Vuksanovic J, 2013, NEUROCASE, V3; Waldowski K, 2012, SCI WORLD J, DOI 10.1100/2012/518568; Weiduschat N, 2011, STROKE, V42, P409, DOI 10.1161/STROKEAHA.110.597864; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef	39	68	71	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102557	10.1371/journal.pone.0102557	http://dx.doi.org/10.1371/journal.pone.0102557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036386	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200069
J	Roberts, SK; McAinsh, M; Cantopher, H; Sandison, S				Roberts, Stephen K.; McAinsh, Martin; Cantopher, Hanna; Sandison, Sean			Calcium Dependence of Eugenol Tolerance and Toxicity in Saccharomyces cerevisiae	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; CANDIDA-ALBICANS; OXIDATIVE STRESS; MECHANISM; INFLUX; YEAST; CALCINEURIN; AMIODARONE	Eugenol is a plant-derived phenolic compound which has recognised therapeutical potential as an antifungal agent. However little is known of either its fungicidal activity or the mechanisms employed by fungi to tolerate eugenol toxicity. A better exploitation of eugenol as a therapeutic agent will therefore depend on addressing this knowledge gap. Eugenol initiates increases in cytosolic Ca2+ in Saccharomyces cerevisiae which is partly dependent on the plasma membrane calcium channel, Cch1p. However, it is unclear whether a toxic cytosolic Ca2+ elevation mediates the fungicidal activity of eugenol. In the present study, no significant difference in yeast survival was observed following transient eugenol treatment in the presence or absence of extracellular Ca2+. Furthermore, using yeast expressing apoaequorin to report cytosolic Ca2+ and a range of eugenol derivatives, antifungal activity did not appear to be coupled to Ca2+ influx or cytosolic Ca2+ elevation. Taken together, these results suggest that eugenol toxicity is not dependent on a toxic influx of Ca2+. In contrast, careful control of extracellular Ca2+ (using EGTA or BAPTA) revealed that tolerance of yeast to eugenol depended on Ca2+ influx via Cch1p. These findings expose significant differences between the antifungal activity of eugenol and that of azoles, amiodarone and carvacrol. This study highlights the potential to use eugenol in combination with other antifungal agents that exhibit differing modes of action as antifungal agents to combat drug resistant infections.	[Roberts, Stephen K.; Cantopher, Hanna; Sandison, Sean] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [McAinsh, Martin] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Lancaster University; Lancaster University	Roberts, SK (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	s.k.roberts@lancaster.ac.uk		McAinsh, Martin Robert/0000-0003-4294-6470; roberts, stephen/0000-0003-1740-5330	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Carrasco H, 2012, MOLECULES, V17, P1002, DOI 10.3390/molecules17011002; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Darvishi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076028; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Groppi S, 2011, CELL CALCIUM, V49, P376, DOI 10.1016/j.ceca.2011.03.006; Khan A, 2011, FEMS YEAST RES, V11, P114, DOI 10.1111/j.1567-1364.2010.00697.x; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Loukin S, 2008, FASEB J, V22, P2405, DOI 10.1096/fj.07-101410; Maresova L, 2009, J BIOL CHEM, V284, P2795, DOI 10.1074/jbc.M806693200; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; Muller EM, 2001, GENETICS, V159, P1527; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; Rao A, 2010, ANTIMICROB AGENTS CH, V54, P5062, DOI 10.1128/AAC.01050-10; Roberts SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043989; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Zhang YQ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00133; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008	24	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102712	10.1371/journal.pone.0102712	http://dx.doi.org/10.1371/journal.pone.0102712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036027	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000339615200080
J	Santos, EMM; Marquering, HA; Berkhemer, OA; van Zwam, WH; van der Lugt, A; Majoie, CB; Niessen, WJ				Santos, Emilie M. M.; Marquering, Henk A.; Berkhemer, Olvert A.; van Zwam, Wim H.; van der Lugt, Aad; Majoie, Charles B.; Niessen, Wiro J.		MR CLEAN Investigators	Development and Validation of Intracranial Thrombus Segmentation on CT Angiography in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; RECANALIZATION; THROMBOLYSIS	Background and Purpose: Thrombus characterization is increasingly considered important in predicting treatment success for patients with acute ischemic stroke. The lack of intensity contrast between thrombus and surrounding tissue in CT images makes manual delineation a difficult and time consuming task. Our aim was to develop an automated method for thrombus measurement on CT angiography and validate it against manual delineation. Materials and Methods: Automated thrombus segmentation was achieved using image intensity and a vascular shape prior derived from the segmentation of the contralateral artery. In 53 patients with acute ischemic stroke due to proximal intracranial arterial occlusion, automated length and volume measurements were performed. Accuracy was assessed by comparison with inter-observer variation of manual delineations using intraclass correlation coefficients and Bland-Altman analyses. Results: The automated method successfully segmented the thrombus for all 53 patients. The intraclass correlation of automated and manual length and volume measurements were 0.89 and 0.84. Bland-Altman analyses yielded a bias (limits of agreement) of -0.4 (-8.8, 7.7) mm and 8 (-126, 141) mm(3) for length and volume, respectively. This was comparable to the best interobserver agreement, with an intraclass correlation coefficients of 0.90 and 0.85 and a bias (limits of agreement) of -0.1 (-11.2, 10.9) mm and -17 (-216, 185) mm(3). Conclusions: The method facilitates automated thrombus segmentation for accurate length and volume measurements, is relatively fast and requires minimal user input, while being insensitive to high hematocrit levels and vascular calcifications. Furthermore, it has the potential to assess thrombus characteristics of low-density thrombi.	[Santos, Emilie M. M.; van der Lugt, Aad; Niessen, Wiro J.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Santos, Emilie M. M.; Niessen, Wiro J.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Santos, Emilie M. M.; Marquering, Henk A.; Berkhemer, Olvert A.; Majoie, Charles B.] AMC, Dept Radiol, Amsterdam, Netherlands; [Santos, Emilie M. M.; Marquering, Henk A.] AMC, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [van Zwam, Wim H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Delft University of Technology	Santos, EMM (corresponding author), Erasmus MC, Dept Radiol, Rotterdam, Netherlands.	e.santos@erasmusmc.nl	Vroomen, Patrick C.A.J./O-3664-2014; Demchuk, Andrew M/E-1103-2012	Vroomen, Patrick C.A.J./0000-0003-4806-417X; Demchuk, Andrew M/0000-0002-4930-7789; Dippel, Diederik/0000-0002-9234-3515; Niessen, Wiro/0000-0002-5822-1995; Brouwer, Patrick A./0000-0003-0041-2833; Marquering, Henk/0000-0002-1414-6313; Santos, Emilie/0000-0003-2153-1938	Technology Foundation STW [11632]; MRCLEAN (Dutch Heart Foundation); ITEA3 project MEDUSA [10004]	Technology Foundation STW(Technologiestichting STW); MRCLEAN (Dutch Heart Foundation); ITEA3 project MEDUSA	Technology Foundation STW under Grant 11632, MRCLEAN (Dutch Heart Foundation). http://www.carisma-airspace.nl. ITEA3 project MEDUSA under grant number 10004. https://itea3.org/project/medusa.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789; Fitzsimmons PR, 2011, STROKE RES IN PRESS; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Heckel F, LECT NOTES INFORM, V154, P1338; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Krings T, 2006, STROKE, V37, P399, DOI 10.1161/01.STR.0000199062.09010.77; LEYS D, 1992, STROKE, V23, P317, DOI 10.1161/01.STR.23.3.317; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; Metz CT, 2008, MICCAI 2008 WORKSH P; Molina CA, 2005, STROKE, V36, P2333, DOI 10.1161/01.STR.0000185933.44619.1b; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Riedel CH, 2012, STROKE, V43, P2319, DOI 10.1161/STROKEAHA.112.649921; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Riedel CH, 2010, STROKE, V41, P1659, DOI 10.1161/STROKEAHA.110.580662; Schaap M, 2011, IEEE T MED IMAGING, V30, P1974, DOI 10.1109/TMI.2011.2160556; Shahzad R, 2012, MICCAI 2012 WORKSH P; Spiotta AM, 2013, J NEUROINTE IN PRESS; Wintermark M, 2013, J AM COLL RADIOL, V10, P828, DOI [10.1016/j.jacr.2013.06.019, 10.3174/ajnr.A3690]; Yoo AJ, 2011, EXPERT REV CARDIOVAS, V9, P857, DOI [10.1586/erc.11.56, 10.1586/ERC.11.56]; Zhu LF, 2012, STROKE, V43, P787, DOI 10.1161/STROKEAHA.110.612986	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101985	10.1371/journal.pone.0101985	http://dx.doi.org/10.1371/journal.pone.0101985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032691	Green Published, gold			2022-12-27	WOS:000339418300031
J	Sicurella, M; Nicoli, F; Gallerani, E; Volpi, I; Berto, E; Finessi, V; Destro, F; Manservigi, R; Cafaro, A; Ensoli, B; Caputo, A; Gavioli, R; Marconi, PC				Sicurella, Mariaconcetta; Nicoli, Francesco; Gallerani, Eleonora; Volpi, Ilaria; Berto, Elena; Finessi, Valentina; Destro, Federica; Manservigi, Roberto; Cafaro, Aurelio; Ensoli, Barbara; Caputo, Antonella; Gavioli, Riccardo; Marconi, Peggy C.			An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge	PLOS ONE			English	Article							T-CELL RESPONSE; NF-KAPPA-B; HUMORAL IMMUNE-RESPONSE; GLYCOPROTEIN-K GK; GENITAL HERPES; TRANSCRIPTION FACTOR; DENDRITIC CELLS; OCULAR HERPES; VACCINE DEVELOPMENT; BET EXPRESSION	Herpes simplex virus types 1 and 2 (HSV1 and HSV2) are common infectious agents in both industrialized and developing countries. They cause recurrent asymptomatic and/or symptomatic infections, and life-threatening diseases and death in newborns and immunocompromised patients. Current treatment for HSV relies on antiviral medications, which can halt the symptomatic diseases but cannot prevent the shedding that occurs in asymptomatic patients or, consequently, the spread of the viruses. Therefore, prevention rather than treatment of HSV infections has long been an area of intense research, but thus far effective anti-HSV vaccines still remain elusive. One of the key hurdles to overcome in anti-HSV vaccine development is the identification and effective use of strategies that promote the emergence of Th1-type immune responses against a wide range of epitopes involved in the control of viral replication. Since the HIV1 Tat protein has several immunomodulatory activities and increases CTL recognition of dominant and subdominant epitopes of heterologous antigens, we generated and assayed a recombinant attenuated replication-competent HSV1 vector containing the tat gene (HSV1-Tat). In this proof-of-concept study we show that immunization with this vector conferred protection in 100% of mice challenged intravaginally with a lethal dose of wild-type HSV1. We demonstrate that the presence of Tat within the recombinant virus increased and broadened Th1-like and CTL responses against HSV-derived T-cell epitopes and elicited in most immunized mice detectable IgG responses. In sharp contrast, a similarly attenuated HSV1 recombinant vector without Tat (HSV1-LacZ), induced low and different T cell responses, no measurable antibody responses and did not protect mice against the wild-type HSV1 challenge. These findings strongly suggest that recombinant HSV1 vectors expressing Tat merit further investigation for their potential to prevent and/or contain HSV1 infection and dissemination.	[Sicurella, Mariaconcetta; Volpi, Ilaria; Berto, Elena; Manservigi, Roberto; Marconi, Peggy C.] Univ Ferrara, Dept Life Sci & Biotechnol, Sect Appl Microbiol & Pathol, I-44100 Ferrara, Italy; [Nicoli, Francesco; Gallerani, Eleonora; Finessi, Valentina; Destro, Federica; Gavioli, Riccardo] Univ Ferrara, Dept Life Sci & Biotechnol, Sect Biochem & Mol Biol, I-44100 Ferrara, Italy; [Sicurella, Mariaconcetta; Destro, Federica; Caputo, Antonella] Univ Padua, Dept Mol Med, Padua, Italy; [Cafaro, Aurelio; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy	University of Ferrara; University of Ferrara; University of Padua; Istituto Superiore di Sanita (ISS)	Gavioli, R (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Sect Biochem & Mol Biol, I-44100 Ferrara, Italy.	gvr@unife.it; mcy@unife.it	, Francesco/I-8040-2019; Marconi, Peggy/K-7733-2016; Destro, Federica/K-5904-2016; Caputo, Antonella/ABE-7851-2020; Gavioli, Riccardo/K-7594-2016; Cafaro, Aurelio/K-5314-2016; Ensoli, Barbara/J-9169-2016; Sicurella, Mariaconcetta/AAA-7030-2019	, Francesco/0000-0001-6327-5958; Destro, Federica/0000-0002-3014-0165; Caputo, Antonella/0000-0002-1241-0299; Gavioli, Riccardo/0000-0002-7805-4290; Ensoli, Barbara/0000-0002-0545-8737; Sicurella, Mariaconcetta/0000-0003-3996-3667; Marconi, Peggy C. R./0000-0003-3488-0491; MANSERVIGI, Roberto/0000-0002-2827-229X; Cafaro, Aurelio/0000-0001-9675-6344	University of Ferrara; University of Padova; CARIPARO Foundation (Padova)	University of Ferrara; University of Padova; CARIPARO Foundation (Padova)(Fondazione Cariparo)	This work was supported by grants from the University of Ferrara and the University of Padova. AIDS Vaccine Integrated Project (AVIP, VI FP), Italian National Institute of Health (AIDS Program ISS-2009), the Italian Ministry for the University and Scientific Research (PRIN-2009) and FAR (2010 and 2011) from the University of Ferrara. Mariaconcetta Sicurella was recipient of a PhD fellowship from CARIPARO Foundation (Padova) and Federica Destro of a post-doctorate fellowship from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2007, J IMMUNOL, V178, P5465, DOI 10.4049/jimmunol.178.9.5465; Akhrameyeva NV, 2011, J VIROL, V85, P5036, DOI 10.1128/JVI.02548-10; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; Awasthi S, 2008, VACCINE, V26, P1195, DOI 10.1016/j.vaccine.2007.12.032; BANKS TA, 1993, J VIROL, V67, P613, DOI 10.1128/JVI.67.1.613-616.1993; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Battaglia PA, 1997, INT J ONCOL, V11, P1007; Bellino S, 2009, REV RECENT CLIN TRIA, V4, P195, DOI 10.2174/157488709789957529; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Brockman MA, 2002, J VIROL, V76, P3678, DOI 10.1128/JVI.76.8.3678-3687.2002; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Caputo A, 2009, INT REV IMMUNOL, V28, P285, DOI 10.1080/08830180903013026; Chentoufi Aziz Alami, 2012, Curr Trends Immunol, V13, P51; Chentoufi AA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/187585; Chentoufi AA, 2010, FUTURE VIROL, V5, P525, DOI 10.2217/FVL.10.44; Chew T, 2009, VIRUSES-BASEL, V1, P979, DOI 10.3390/v1030979; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; Coleman JL, 2013, HUM VACC IMMUNOTHER, V9; Cunningham AL, 2006, J INFECT DIS, V194, pS11, DOI 10.1086/505359; Dasgupta G, 2012, J VIROL, V86, P4358, DOI 10.1128/JVI.07107-11; Dasgupta G, 2009, EXPERT REV VACCINES, V8, P1023, DOI 10.1586/ERV.09.60; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Demarchi F, 1999, J VIROL, V73, P7080, DOI 10.1128/JVI.73.8.7080-7086.1999; Dervillez X, 2013, J IMMUNOL, V191, P5124, DOI 10.4049/jimmunol.1301415; Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22; Dreyfus DH, 2013, J ALLERGY CLIN IMMUN; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Fraefel C, 2011, METHODS MOL BIOL, V737, P303, DOI 10.1007/978-1-61779-095-9_13; Gadzinski A, 2012, VACCINE, V30, P2859, DOI 10.1016/j.vaccine.2012.02.042; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2002, INT J CANCER, V101, P532, DOI 10.1002/ijc.10653; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Ghasemi M, 2013, CYTOTHERAPY, V15, P352, DOI 10.1016/j.jcyt.2012.11.012; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Nguyen HV, 2012, BLOOD, V119, P4174, DOI 10.1182/blood-2011-09-378182; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hansen SG, SCIENCE, V340; Haynes JR, 2006, VACCINE, V24, P5016, DOI 10.1016/j.vaccine.2006.03.046; HEBERKATZ E, 1985, J IMMUNOL, V135, P1385; Hofstetter AM, 2014, CURR OPIN INFECT DIS, V27, P75, DOI 10.1097/QCO.0000000000000029; Jamali A, 2007, COMP IMMUNOL MICROB, V30, P71, DOI 10.1016/j.cimid.2006.10.002; Jones Cheryl A, 2004, Herpes, V11, P12; Jungmann E, 2007, CLIN EVID; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Khan AA, 2014, HUM VACC IMMUNOTHER, V10; Khanna KM, 2004, CURR OPIN IMMUNOL, V16, P463, DOI 10.1016/j.coi.2004.05.003; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Kittiworakarn J, 2006, J BIOL CHEM, V281, P3105, DOI 10.1074/jbc.M509899200; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Koelle DM, 2006, CURR OPIN INVEST DR, V7, P136; KOKEN SEC, 1994, GENE, V144, P243, DOI 10.1016/0378-1119(94)90384-0; Krisky DM, 1998, GENE THER, V5, P1517, DOI 10.1038/sj.gt.3300755; Krisky DM, 1997, GENE THER, V4, P1120, DOI 10.1038/sj.gt.3300497; Kronenberg K, 2010, J INVEST DERMATOL, V130, P2602, DOI 10.1038/jid.2010.171; Kulkarni A, 2005, BIOCHEM BIOPH RES CO, V329, P706, DOI 10.1016/j.bbrc.2005.02.042; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lafrenie RM, 1997, J IMMUNOL, V159, P4077; Lang A, 2005, J IMMUNOL, V174, P2919, DOI 10.4049/jimmunol.174.5.2919; Lauterbach H, 2005, J GEN VIROL, V86, P2401, DOI 10.1099/vir.0.81104-0; Leghmari K, 2008, CELL IMMUNOL, V254, P46, DOI 10.1016/j.cellimm.2008.06.011; Lu ZM, 2009, J INVEST DERMATOL, V129, P1174, DOI 10.1038/jid.2008.349; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Mott KR, 2009, INVEST OPHTH VIS SCI, V50, P2903, DOI 10.1167/iovs.08-2957; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Nicoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077746; Nopora K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00348; Osorio Y, 2007, VIRUS RES, V128, P71, DOI 10.1016/j.virusres.2007.04.007; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Ouwendijk WJD, 2013, CURR OPIN VIROL, V3, P452, DOI 10.1016/j.coviro.2013.04.004; PAGLIA P, 1993, J EXP MED, V178, P1893, DOI 10.1084/jem.178.6.1893; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Pepose JS, 2006, AM J OPHTHALMOL, V141, P547, DOI 10.1016/j.ajo.2005.10.008; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Rajcani J, 2006, FOLIA MICROBIOL, V51, P67, DOI 10.1007/BF02932160; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Roizman B, 1996, P NATL ACAD SCI USA, V93, P11307, DOI 10.1073/pnas.93.21.11307; Rudd BD, 2010, J IMMUNOL, V184, P2958, DOI 10.4049/jimmunol.0903493; SALVUCCI LA, 1995, J VIROL, V69, P1122, DOI 10.1128/JVI.69.2.1122-1131.1995; Sheridan BS, 2009, J VIROL, V83, P2237, DOI 10.1128/JVI.01699-08; Shin HN, 2013, TRENDS IMMUNOL, V34, P487, DOI 10.1016/j.it.2013.08.001; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12; Smith C, 2010, HUM VACCINES, V6, P1062, DOI 10.4161/hv.6.12.13347; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stefanidou M, 2013, J VIROL, V87, P1443, DOI 10.1128/JVI.01302-12; Svensson A, 2005, J IMMUNOL, V174, P6266, DOI 10.4049/jimmunol.174.10.6266; Svensson A, 2008, J GEN VIROL, V89, P2262, DOI 10.1099/vir.0.2008/001305-0; Tavares F, 2013, VACCINE, V31, P1759, DOI 10.1016/j.vaccine.2013.01.002; Taylor PD, 2010, J SYST PALAEONTOL, V8, P1, DOI 10.1080/14772011003603119; TOGNON M, 1985, INT OPHTHALMOL, V8, P13, DOI 10.1007/BF00136456; Vitagliano L, 2011, BIOCHIMIE, V93, P1592, DOI 10.1016/j.biochi.2011.05.025; Whitley RJ, 2002, J CLIN INVEST, V110, P145, DOI [10.1172/JCI200216126, 10.1172/JCI0216126]; Wilson SS, 2009, EXPERT REV ANTI-INFE, V7, P559, DOI [10.1586/eri.09.34, 10.1586/ERI.09.34]; YAMASHITA K, 1989, J EXP MED, V170, P997, DOI 10.1084/jem.170.3.997; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110; Zhu XP, 2014, VIRUSES-BASEL, V6, P371, DOI 10.3390/v6020371	105	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100844	10.1371/journal.pone.0100844	http://dx.doi.org/10.1371/journal.pone.0100844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033084	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300010
J	Appel, S; Ankerne, J; Appel, J; Oberthuer, A; Mallmann, P; Dotsch, J				Appel, Sarah; Ankerne, Janina; Appel, Jan; Oberthuer, Andre; Mallmann, Peter; Doetsch, Joerg			CNN3 Regulates Trophoblast Invasion and Is Upregulated by Hypoxia in BeWo Cells	PLOS ONE			English	Article							P38 MAP-KINASE; SMOOTH-MUSCLE; GROWTH-FACTOR; ACTIN CYTOSKELETON; GENE-EXPRESSION; HLA-G; CALPONIN; OXYGEN; PROTEIN; PREGNANCY	CNN3 is an ubiquitously expressed F-actin binding protein, shown to regulate trophoblast fusion and hence seems to play a role in the placentation process. In this study we demonstrate that CNN3 levels are upregulated under low oxygen conditions in the trophoblast cell line BeWo. Since hypoxia is discussed to be a pro-migratory stimulus for placental cells, we examined if CNN3 is involved in trophoblast invasion. Indeed, when performing a matrigel invasion assay we were able to show that CNN3 promotes BeWo cell invasion. Moreover, CNN3 activates the MAPKs ERK1/2 and p38 in trophoblast cells and interestingly, both kinases are involved in BeWo invasion. However, when we repeated the experiments under hypoxic conditions, CNN3 did neither promote cell invasion nor MAPK activation. These results indicate that CNN3 promotes invasive processes by the stimulation of ERK1/2 and/or p38 under normoxic conditions in BeWo cells, but seems to have different functions at low oxygen levels. We further speculated that CNN3 expression might be altered in human placentas derived from pregnancies complicated by IUGR and preeclampsia, since these placental disorders have been described to go along with impaired trophoblast invasion. Our studies show that, at least in our set of placenta samples, CNN3 expression is neither deregulated in IUGR nor in preeclampsia. In summary, we identified CNN3 as a new pro-invasive protein in trophoblast cells that is induced under low oxygen conditions.	[Appel, Sarah; Ankerne, Janina; Appel, Jan; Doetsch, Joerg] Univ Cologne, Dept Pediat & Adolescent Med, D-50931 Cologne, Germany; [Oberthuer, Andre] Univ Cologne, Childrens Hosp, Neonatal & Pediat Intens Care Unit, D-50931 Cologne, Germany; [Mallmann, Peter] Univ Cologne, Dept Obstet & Gynecol, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Appel, S (corresponding author), Univ Cologne, Dept Pediat & Adolescent Med, D-50931 Cologne, Germany.	sarah.appel@uk-koeln.de		Appel, Sarah/0000-0003-0315-6513	Koeln Fortune grants [40/2011, 99/2012]	Koeln Fortune grants	This study was supported by Koeln Fortune grants 40/2011 and 99/2012 to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Appel S, 2010, MOL BIOL CELL, V21, P1409, DOI 10.1091/mbc.E09-06-0451; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Burgstaller G, 2002, J CELL SCI, V115, P2021; Daimon E, 2013, ARCH DERMATOL RES, V305, P571, DOI 10.1007/s00403-013-1343-8; Danninger C, 2000, J CELL SCI, V113, P3725; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Frank HG, 2006, PATHOLOGY HUMAN PLAC, P191, DOI [10.1007/0-387-26742-5_9, DOI 10.1007/0-387-26742-5_9]; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Goncharova EA, 2002, BIOL CHEM, V383, P115, DOI 10.1515/BC.2002.012; Graham CH, 1998, BLOOD, V91, P3300, DOI 10.1182/blood.V91.9.3300.3300_3300_3307; Graham CH, 2000, PLACENTA, V21, P443, DOI 10.1053/plac.2000.0543; Hayashi M, 2005, ENDOCRINOLOGY, V146, P4682, DOI 10.1210/en.2005-0416; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; James JL, 2006, HUM REPROD UPDATE, V12, P137, DOI 10.1093/humupd/dmi043; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kilburn BA, 2000, BIOL REPROD, V62, P739, DOI 10.1095/biolreprod62.3.739; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Lash GE, 2002, CAN J PHYSIOL PHARM, V80, P103, DOI 10.1139/Y02-008; Lash GE, 2001, BIOCHEM BIOPH RES CO, V287, P622, DOI 10.1006/bbrc.2001.5618; Le Bouteiller P, 1999, HUM REPROD UPDATE, V5, P223, DOI 10.1093/humupd/5.3.223; MEZGUELDI M, 1995, J BIOL CHEM, V270, P8867, DOI 10.1074/jbc.270.15.8867; Mino T, 1998, EUR J BIOCHEM, V251, P262, DOI 10.1046/j.1432-1327.1998.2510262.x; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rosario GX, 2008, DEV BIOL, V314, P362, DOI 10.1016/j.ydbio.2007.12.007; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; Struwe E, 2010, CLIN ENDOCRINOL, V72, P241, DOI 10.1111/j.1365-2265.2009.03659.x; TAKAHASHI K, 1988, J HYPERTENS, V6, pS40, DOI 10.1097/00004872-198812040-00008; Tzschoppe A, 2011, CLIN ENDOCRINOL, V74, P459, DOI 10.1111/j.1365-2265.2010.03943.x; Tzschoppe A, 2009, PEDIATR RES, V65, P647, DOI 10.1203/PDR.0b013e31819e7337; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zhang Y, 2009, TRANSPL P, V41, P1767, DOI 10.1016/j.transproceed.2009.03.064	49	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103216	10.1371/journal.pone.0103216	http://dx.doi.org/10.1371/journal.pone.0103216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050546	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100098
J	Peng, SC; Liao, CT; Peng, CH; Cheng, AJ; Chen, SJ; Huang, CG; Hsieh, WP; Yen, TC				Peng, Shih-Chi; Liao, Chun-Ta; Peng, Chien-Hua; Cheng, Ann-Joy; Chen, Shu-Jen; Huang, Chung-Guei; Hsieh, Wen-Ping; Yen, Tzu-Chen			MicroRNAs MiR-218, MiR-125b, and Let-7g Predict Prognosis in Patients with Oral Cavity Squamous Cell Carcinoma	PLOS ONE			English	Article							EXPRESSION PROFILES; CANCER CELLS; RISK-FACTORS; IDENTIFICATION; DEREGULATION; PROGRESSION; INVASION; MIRNAS	MicroRNAs (miRNAs) have a major impact on regulatory networks in human carcinogenesis. In this study, we sought to investigate the prognostic significance of miRNAs in patients with oral cavity squamous cell carcinoma (OSCC). In a discovery phase, RNA was extracted from 58 OSCC tumor samples and paired normal tissues. MiRNAs expression was evaluated with TaqMan Array Card and TaqMan MicroRNA assays. The prognostic significance of the miRNA signature identified in the discovery phase was validated by qRT-PCR in a replication set consisting of 141 formalin-fixed, paraffine-mbedded (FFPE) samples. We identified a miRNA regulatory network centered on the three hub genes (SP1, MYC, and TP53) that predicted distinct clinical endpoints. Three miRNAs (miR-218, miR-125b, and let-7g) and their downstream response genes had a concordant prognostic significance on disease-free survival and disease-specific survival rates. In addition, patients with a reduced expression of miR-218, miR-125b, and let-7g have a higher risk of poor outcomes in presence of specific risk factors (p-stage III-IV, pT3-4, or pN+). Our findings indicate that specific miRNAs have prognostic significance in OSCC patients and may improve prognostic stratification over traditional risk factors.	[Peng, Shih-Chi; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Peng, Shih-Chi; Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan; [Peng, Shih-Chi; Liao, Chun-Ta; Peng, Chien-Hua; Cheng, Ann-Joy; Chen, Shu-Jen; Huang, Chung-Guei; Yen, Tzu-Chen] Chang Gung Univ, Taoyuan, Taiwan; [Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan; [Peng, Chien-Hua] Chang Gung Mem Hosp, Resource Ctr Clin Res, Taoyuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Mem Hosp, Dept Med Biotechnol, Taoyuan, Taiwan; [Chen, Shu-Jen] Chang Gung Mem Hosp, Dept Biomed Sci, Taoyuan, Taiwan; [Huang, Chung-Guei] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Tsing Hua University	Hsieh, WP (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	wphsieh@stat.nthu.edu.tw; yen1110@adm.cgmh.org.tw	Cheng, Ann-Joy/AAI-4374-2020	Cheng, Ann-Joy/0000-0002-1317-0725	Chang Gung Medical Foundation [CMRPG3C0831]; National Council of Science [99-2628-B-182A-002-MY3]	Chang Gung Medical Foundation; National Council of Science	This work was supported by a grant from Chang Gung Medical Foundation (CMRPG3C0831), and was also partly supported by National Council of Science (99-2628-B-182A-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Boldrup Linda, 2012, J Carcinog, V11, P18, DOI 10.4103/1477-3163.104007; Bovee JV, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-3; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Chun H, 2009, GENETICS, V182, P79, DOI 10.1534/genetics.109.100362; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fang NB, 1998, P NATL ACAD SCI USA, V95, P3380, DOI 10.1073/pnas.95.7.3380; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Heller JD, 2001, CANCER RES, V61, P5499; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Huang RCC, 2006, SEMIN ONCOL, V33, P479, DOI 10.1053/j.seminoncol.2006.04.010; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2010, ANN SURG ONCOL, V17, P1118, DOI 10.1245/s10434-009-0894-6; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nishikawa Y, 2011, ONCOL REP, V26, P587, DOI 10.3892/or.2011.1324; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Perez-Sayans M, 2012, J ORAL PATHOL MED, V41, P433, DOI 10.1111/j.1600-0714.2011.01121.x; Phipps LE, 2011, MOL CANCER RES, V9, P249, DOI 10.1158/1541-7786.MCR-11-0021; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Shi LJ, 2014, HEAD NECK; Shiiba M, 2013, BRIT J CANCER, V108, P1817, DOI 10.1038/bjc.2013.175; Soga D, 2013, ONCOL REP, V30, P579, DOI 10.3892/or.2013.2488; Stucken E, 2010, J OTOLARYNGOL-HEAD N, V39, P76, DOI 10.2310/7070.2009.080313; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Uchikado Y, 2006, INT J ONCOL, V29, P1337; Vigneswaran N, 2005, INT J ONCOL, V26, P103; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64	51	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102403	10.1371/journal.pone.0102403	http://dx.doi.org/10.1371/journal.pone.0102403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050621	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100033
J	Canale, D; de Braganca, AC; Goncalves, JG; Shimizu, MHM; Sanches, TR; Andrade, L; Volpini, RA; Seguro, AC				Canale, Daniele; de Braganca, Ana Carolina; Goncalves, Janaina Garcia; Massola Shimizu, Maria Heloisa; Sanches, Talita Rojas; Andrade, Lucia; Volpini, Rildo Aparecido; Seguro, Antonio Carlos			Vitamin D Deficiency Aggravates Nephrotoxicity, Hypertension and Dyslipidemia Caused by Tenofovir: Role of Oxidative Stress and Renin-Angiotensin System	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC HEPATITIS-B; HIV-INFECTION; 1,25-DIHYDROXYVITAMIN D-3; ANTIRETROVIRAL THERAPY; PARATHYROID-HORMONE; RAT; SUPPLEMENTATION; ASSOCIATION; GLUTATHIONE	Vitamin D deficiency (VDD) is prevalent among HIV-infected individuals. Vitamin D has been associated with renal and cardiovascular diseases because of its effects on oxidative stress, lipid metabolism and renin-angiotensin-aldosterone system (RAAS). Tenofovir disoproxil fumarate (TDF), a widely used component of antiretroviral regimens for HIV treatment, can induce renal injury. The aim of this study was to investigate the effects of VDD on TDF-induced nephrotoxicity. Wistar rats were divided into four groups: control, receiving a standard diet for 60 days; VDD, receiving a vitamin D-free diet for 60 days; TDF, receiving a standard diet for 60 days with the addition of TDF (50 mg/kg food) for the last 30 days; and VDD+ TDF receiving a vitamin D-free diet for 60 days with the addition of TDF for the last 30 days. TDF led to impaired renal function, hyperphosphaturia, hypophosphatemia, hypertension and increased renal vascular resistance due to downregulation of the sodium-phosphorus cotransporter and upregulation of angiotensin II and AT1 receptor. TDF also increased oxidative stress, as evidenced by higher TBARS and lower GSH levels, and induced dyslipidemia. Association of TDF and VDD aggravated renovascular effects and TDF-induced nephrotoxicity due to changes in the redox state and involvement of RAAS.	[Canale, Daniele; de Braganca, Ana Carolina; Goncalves, Janaina Garcia; Massola Shimizu, Maria Heloisa; Sanches, Talita Rojas; Andrade, Lucia; Volpini, Rildo Aparecido; Seguro, Antonio Carlos] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo	Seguro, AC (corresponding author), Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.	trulu@usp.br	Volpini, Rildo Aparecido/L-5690-2019; Garcia Gonçalves, Janaina/C-6218-2015; Volpini, Rildo A/B-7521-2013; Shimizu, Maria/B-7887-2013; de Braganca, Ana Carolina/E-7892-2014; Sanches, Talita R/A-2953-2015; Andrade, Lucia C/C-5223-2014; Canale, Daniele/E-8922-2014	Volpini, Rildo Aparecido/0000-0001-6611-2249; Volpini, Rildo A/0000-0001-6611-2249; Andrade, Lucia C/0000-0002-3078-8957; de Braganca, Ana Carolina/0000-0002-1398-2512; Canale, Daniele/0000-0001-8609-683X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [309947/2009-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50227-9, 2011/50409-7, 2010/52294-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 309947/2009-0) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2012/50227-9; 2011/50409-7; 2010/52294-0). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Banakar MC, 2004, WORLD J GASTROENTERO, V10, P1268; Borges-Santos MD, 2012, NUTRITION, V28, P753, DOI 10.1016/j.nut.2011.10.014; Boyd SD, 2011, AM J HEALTH-SYST PH, V68, P991, DOI 10.2146/ajhp100156; Childs K, 2012, AIDS, V26, P253, DOI 10.1097/QAD.0b013e32834f324b; Cuppari L, 2011, J RENAL NUTR, V21, P113, DOI 10.1053/j.jrn.2010.10.007; Deeks ED, 2010, DRUGS, V70, P2315, DOI 10.2165/11203800-000000000-00000; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Gonzalez EA, 2004, AM J NEPHROL, V24, P503, DOI 10.1159/000081023; HENE RJ, 1984, NEPHRON, V37, P94, DOI 10.1159/000183221; Ismail A, 2000, J NUTR BIOCHEM, V11, P170, DOI 10.1016/S0955-2863(99)00090-X; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Kanjanavanit S, 2011, ANTIVIR THER, V16, P1351, DOI 10.3851/IMP1897; Kelly J, 2009, J PROSTHODONT, V18, P473, DOI 10.1111/j.1532-849X.2009.00446.x; Kong J, 2008, KIDNEY INT, V74, P1577, DOI 10.1038/ki.2008.452; Kopkan L, 2010, AM J PHYSIOL-RENAL, V299, pF656, DOI 10.1152/ajprenal.00047.2010; Kuhlmann A, 2004, AM J PHYSIOL-RENAL, V286, pF526, DOI 10.1152/ajprenal.00316.2003; KURNIK BRC, 1984, AM J PHYSIOL, V247, pF177, DOI 10.1152/ajprenal.1984.247.1.F177; Li YC, 2011, CURR DIABETES REV, V7, P35, DOI 10.2174/157339911794273964; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; Liborio AB, 2008, KIDNEY INT, V74, P910, DOI 10.1038/ki.2008.252; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masia M, 2012, AIDS RES HUM RETROV, V28, P242, DOI [10.1089/aid.2011.0052, 10.1089/AID.2011.0052]; McGee KC, 2012, ANTIVIR THER, V17, P495, DOI 10.3851/IMP2017; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; NATH KA, 1990, J CLIN INVEST, V86, P1179, DOI 10.1172/JCI114824; Patzak A, 2007, CURR OPIN NEPHROL HY, V16, P46, DOI 10.1097/MNH.0b013e328011a89b; Petchey WG, 2011, NEPHROLOGY, V16, P351, DOI 10.1111/j.1440-1797.2011.01450.x; Salum E, 2013, DIABETES RES CLIN PR, V100, P243, DOI 10.1016/j.diabres.2013.03.008; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Schroten NF, 2013, AM HEART J, V166, P357, DOI 10.1016/j.ahj.2013.05.009; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sudfeld CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040036; Tamez H, 2013, CURR OPIN NEPHROL HY, V22, P204, DOI 10.1097/MNH.0b013e32835d919b; Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212; Ulerich Linda, 2010, Nephrol Nurs J, V37, P429; Vogt BL, 2007, BIOCHEM PHARMACOL, V73, P1613, DOI 10.1016/j.bcp.2007.01.033; Zhao SS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-111	41	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103055	10.1371/journal.pone.0103055	http://dx.doi.org/10.1371/journal.pone.0103055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048368	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100101
J	Gurska, D; Garm, A				Gurska, Daniela; Garm, Anders			Cell Proliferation in Cubozoan Jellyfish Tripedalia cystophora and Alatina moseri	PLOS ONE			English	Article							BOX JELLYFISH; NERVOUS-SYSTEM; LIFE-CYCLE; HYDRA-ATTENUATA; FINE-STRUCTURE; METAMORPHOSIS; REGENERATION; CUBOPOLYP; EVOLUTION; PATTERNS	Cubozoans (box jellyfish) undergo remarkable body reorganization throughout their life cycle when, first, they metamorphose from swimming larvae to sessile polyps, and second, through the metamorphosis from sessile polyps to free swimming medusae. In the latter they develop complex structures like the central nervous system (CNS) and visual organs. In the present study several aspects of cell proliferation at different stages of the life cycle of the box jellyfish Tripedalia cystophora and Alatina moseri have been examined through in vivo labeling of cells in the synthetic phase (S phase) of the cell cycle. Proliferation zones were found in metamorphosing polyps, as well as in juvenile medusae, where both the rhopalia and pedalia have enhanced rates of proliferation. The results also indicate a rather fast cell turnover in the rhopalia including the rhopalial nervous system (RNS). Moreover, T. cystophora showed diurnal pattern of cell proliferation in certain body parts of the medusa, with higher proliferation rates at nighttime. This is true for two areas in close connection with the CNS: the stalk base and the rhopalia.	[Gurska, Daniela; Garm, Anders] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark	University of Copenhagen	Garm, A (corresponding author), Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark.	algarm@bio.ku.dk	Garm, Anders/K-4362-2014	Garm, Anders/0000-0002-2080-735X; Pontieri, Daniela/0000-0001-7756-5331	Villum Fundation [VKR022166]	Villum Fundation(Villum Fonden)	AG acknowledges the financial support from the Villum Fundation (grant# VKR022166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson A. C., 1976, COELENTERATE ECOLOGY, P227, DOI [10.1007/978-1-4757-9724-4_24, DOI 10.1007/978-1-4757-9724-4_24]; BERGER EW, 1900, MEM BIOL LAB J HOPKI, V4, P1; Biederbick A, 1998, CELL TISSUE RES, V291, P277, DOI 10.1007/s004410050997; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; CAMPBELL RD, 1974, J CELL SCI, V16, P349; CHAPMAN DM, 1978, HELGOLAND WISS MEER, V31, P128, DOI 10.1007/BF02296994; Claus C., 1878, ARBEITEN ZOOLOGISCHE, V1, P1; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; CONANT FS, 1898, MEM BIOL LAB J HOPKI, V4, P1; DAVID CN, 1972, J CELL SCI, V11, P557; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Ekstrom P, 2008, CELL TISSUE RES, V333, P115, DOI 10.1007/s00441-008-0614-8; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; Gold DA, 2013, DEV GENES EVOL, V223, P53, DOI 10.1007/s00427-012-0429-1; Green DR, 2011, MEANS END APOPTOSIS; Johnson CH, 2010, CELL CYCLE, V9, P3864, DOI 10.4161/cc.9.19.13205; KOIZUMI O, 1992, J COMP NEUROL, V326, P7, DOI 10.1002/cne.903260103; LASKA G, 1984, ZOOMORPHOLOGY, V104, P163, DOI 10.1007/BF00312135; Laska G., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P107; LASKAMEHNERT G, 1985, HELGOLANDER MEERESUN, V39, P129, DOI 10.1007/BF01997447; Mackie GO, 2008, TISSUE CELL, V40, P21, DOI 10.1016/j.tice.2007.08.005; Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155; Nilsson DE, 2005, CURR BIOL, V15, pR94, DOI 10.1016/j.cub.2005.01.027; Parkefelt L, 2005, J COMP NEUROL, V492, P251, DOI 10.1002/cne.20658; Passamaneck YJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-34; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Satterlie RA, 2002, CAN J ZOOL, V80, P1654, DOI 10.1139/Z02-132; SINGER II, 1971, J EMBRYOL EXP MORPH, V26, P253; Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472; Spring J, 2000, DEV BIOL, V228, P363, DOI 10.1006/dbio.2000.9956; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; WERNER B, 1971, NATURE, V232, P582, DOI 10.1038/232582a0; YAMASU T, 1976, CELL TISSUE RES, V170, P325, DOI 10.1007/BF00219415	36	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102628	10.1371/journal.pone.0102628	http://dx.doi.org/10.1371/journal.pone.0102628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047715	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100055
J	Lee, SM; Choi, HJ; Oh, CH; Oh, JW; Han, JS				Lee, Se-Min; Choi, Hye-Jin; Oh, Cheong-Hae; Oh, Jae-Won; Han, Joong-Soo			Leptin Increases TNF-alpha Expression and Production through Phospholipase D1 in Raw 264.7 Cells	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; INDUCED NEURITE OUTGROWTH; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; P70 S6 KINASE; PROTEIN-KINASE; MAMMALIAN TARGET; DENDRITIC CELLS; BODY-WEIGHT; H19-7 CELLS	Epidemiological evidence suggests that obesity is associated with inflammation of the respiratory tract and the pathogenesis of asthma. The purpose of this study was to examine the role of phospholipase D1 (PLD1) in leptin-induced expression of the proinflammatory cytokine, tumor necrosis factor (TNF)-alpha, and to suggest a molecular link between obesity and respiratory tract inflammation. We investigated whether leptin, a typical adipocytokine, plays a role in the expression of TNF-alpha through increased PLD1 activity in Raw 264.7. Leptin enhanced the activity of PLD1 through activation of PLC gamma and Src, while PLD1 siRNA decreased the leptin-induced expression and production of TNF-alpha. Leptin-induced PLD activation was also inhibited by a PLCc inhibitor (PAO) and Src kinase inhibitor (PP2), indicating that PLCc and Src kinase are upstream activators of PLD1. Down-regulation of PLD1 also completely blocked activation of p70S6K, an activator of JNK. Leptin-induced expression of TNF-alpha was also prevented by inhibition of p70S6K and JNK. Taken together, these results indicate that PLD1 acts as an important regulator of leptin-induced expression of TNF-alpha by participating in the PLCc/Src/PLD1/PA/ p70S6K/JNK pathway.	[Choi, Hye-Jin; Oh, Cheong-Hae; Han, Joong-Soo] Hanyang Univ, Biomed Res Inst, Coll Med, Seoul 133791, South Korea; [Choi, Hye-Jin; Oh, Cheong-Hae; Han, Joong-Soo] Hanyang Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 133791, South Korea; [Lee, Se-Min; Oh, Jae-Won] Hanyang Univ, Dept Pediat, Coll Med, Seoul 133791, South Korea	Hanyang University; Hanyang University; Hanyang University	Han, JS (corresponding author), Hanyang Univ, Biomed Res Inst, Coll Med, Seoul 133791, South Korea.	jshan@hanyang.ac.kr	Han, Joong-Soo/P-2072-2015	Han, Joong-Soo/0000-0002-0875-6158	Korea Science and Engineering Foundation through the Medical Research Center at Hanyang University College of Medicine, Republic of Korea [NRF-2012R1A5A2A34671243]; National Research Foundation of Korea (NRF) - Mid-career Researcher Program [NRF-2010-0026844]	Korea Science and Engineering Foundation through the Medical Research Center at Hanyang University College of Medicine, Republic of Korea; National Research Foundation of Korea (NRF) - Mid-career Researcher Program	This study was supported by the Korea Science and Engineering Foundation (NRF-2012R1A5A2A34671243) through the Medical Research Center at Hanyang University College of Medicine, Republic of Korea, and the National Research Foundation of Korea (NRF), funded by the Mid-career Researcher Program (NRF-2010-0026844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Anand AR, 2008, J IMMUNOL, V180, P5636, DOI 10.4049/jimmunol.180.8.5636; Bandyopadhaya A, 2009, MOL IMMUNOL, V46, P1129, DOI 10.1016/j.molimm.2008.11.003; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kang HK, 2004, INT IMMUNOPHARMACOL, V4, P911, DOI 10.1016/j.intimp.2004.04.001; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200; Kim Sung-Jo, 2010, J Periodontal Implant Sci, V40, P119, DOI 10.5051/jpis.2010.40.3.119; Kraiss LW, 2000, AM J PHYSIOL-HEART C, V278, pH1537, DOI 10.1152/ajpheart.2000.278.5.H1537; Lee CH, 2008, MOL IMMUNOL, V45, P3693, DOI 10.1016/j.molimm.2008.06.007; Lee JS, 2005, J CELL SCI, V118, P4405, DOI 10.1242/jcs.02564; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Lin CI, 2008, CELL SIGNAL, V20, P1804, DOI 10.1016/j.cellsig.2008.06.008; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mancuso P, 2004, AM J PHYSIOL-LUNG C, V287, pL497, DOI 10.1152/ajplung.00010.2004; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; Mattioli B, 2005, J IMMUNOL, V174, P6820, DOI 10.4049/jimmunol.174.11.6820; Maya-Monteiro CM, 2008, J BIOL CHEM, V283, P2203, DOI 10.1074/jbc.M706706200; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nakashima S, 1999, CHEM PHYS LIPIDS, V98, P153, DOI 10.1016/S0009-3084(99)00027-4; Oh DY, 2008, J NEUROSCI RES, V86, P1557, DOI 10.1002/jnr.21602; Oh DY, 2007, J CELL BIOCHEM, V101, P221, DOI 10.1002/jcb.21166; Okenwa C, 2013, J IMMUNOL, V191, P2589, DOI 10.4049/jimmunol.1300466; Park SY, 2008, CYTOKINE, V44, P126, DOI 10.1016/j.cyto.2008.07.006; Park SY, 2009, J BIOL CHEM, V284, P20099, DOI 10.1074/jbc.M109.010017; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shen JH, 2005, LIFE SCI, V77, P1502, DOI 10.1016/j.lfs.2005.04.004; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Takekoshi K, 2001, ENDOCRINOLOGY, V142, P4861, DOI 10.1210/en.142.11.4861; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vaughan T, 2010, MOL IMMUNOL, V47, P2515, DOI 10.1016/j.molimm.2010.06.006; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; YAMAKAWA T, 1995, CLIN IMMUNOL IMMUNOP, V75, P51, DOI 10.1006/clin.1995.1052; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158	50	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102373	10.1371/journal.pone.0102373	http://dx.doi.org/10.1371/journal.pone.0102373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047119	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100028
J	Lin, YX; Cheng, Y; Jin, J; Jin, XL; Jiang, HY; Yan, HW; Cheng, BJ				Lin, Yongxiang; Cheng, Ying; Jin, Jing; Jin, Xiaolei; Jiang, Haiyang; Yan, Hanwei; Cheng, Beijiu			Genome Duplication and Gene Loss Affect the Evolution of Heat Shock Transcription Factor Genes in Legumes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DISEASE RESISTANCE GENES; STRESS-RESPONSE; GLYCINE-MAX; ACTIVATOR FUNCTION; ARABIDOPSIS; EXPRESSION; FAMILY; PROTEINS; LOTUS	Whole-genome duplication events (polyploidy events) and gene loss events have played important roles in the evolution of legumes. Here we show that the vast majority of Hsf gene duplications resulted from whole genome duplication events rather than tandem duplication, and significant differences in gene retention exist between species. By searching for intraspecies gene colinearity (microsynteny) and dating the age distributions of duplicated genes, we found that genome duplications accounted for 42 of 46 Hsf-containing segments in Glycine max, while paired segments were rarely identified in Lotus japonicas, Medicago truncatula and Cajanus cajan. However, by comparing interspecies microsynteny, we determined that the great majority of Hsf-containing segments in Lotus japonicas, Medicago truncatula and Cajanus cajan show extensive conservation with the duplicated regions of Glycine max. These segments formed 17 groups of orthologous segments. These results suggest that these regions shared ancient genome duplication with Hsf genes in Glycine max, but more than half of the copies of these genes were lost. On the other hand, the Glycine max Hsf gene family retained approximately 75% and 84% of duplicated genes produced from the ancient genome duplication and recent Glycine-specific genome duplication, respectively. Continuous purifying selection has played a key role in the maintenance of Hsf genes in Glycine max. Expression analysis of the Hsf genes in Lotus japonicus revealed their putative involvement in multiple tissue-/developmental stages and responses to various abiotic stimuli. This study traces the evolution of Hsf genes in legume species and demonstrates that the rates of gene gain and loss are far from equilibrium in different species.	[Lin, Yongxiang; Cheng, Ying; Jin, Jing; Jin, Xiaolei; Jiang, Haiyang; Yan, Hanwei; Cheng, Beijiu] Anhui Agr Univ, Sch Life Sci, Key Lab Crop Biol Anhui Prov, Hefei, Anhui, Peoples R China; [Lin, Yongxiang] Anhui Acad Agr Sci, Crop Res Inst, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences	Cheng, BJ (corresponding author), Anhui Agr Univ, Sch Life Sci, Key Lab Crop Biol Anhui Prov, Hefei, Anhui, Peoples R China.	bjchengahau@163.com			Special Fund for Agro-scientific Research in the Public Interest [201303001]; Genetically Modified Organisms Breeding Major Projects [2011ZX08003-002]	Special Fund for Agro-scientific Research in the Public Interest; Genetically Modified Organisms Breeding Major Projects	This work was supported by grants from the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303001) and the Genetically Modified Organisms Breeding Major Projects (Grant No. 2011ZX08003-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cannon SB, 2003, MOL GENET GENOMICS, V270, P347, DOI 10.1007/s00438-003-0928-x; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Cheng Y, 2012, FEBS J, V279, P2431, DOI 10.1111/j.1742-4658.2012.08621.x; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Czarnecka-Verner E, 2004, PLANT MOL BIOL, V56, P57, DOI 10.1007/s11103-004-2307-3; CZARNECKAVERNER E, 1995, PLANT MOL BIOL, V29, P37, DOI 10.1007/BF00019117; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; De Grassi A, 2008, GENE, V421, P1, DOI 10.1016/j.gene.2008.05.011; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Doring P, 2000, PLANT CELL, V12, P265, DOI 10.1105/tpc.12.2.265; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Giorno F, 2010, J EXP BOT, V61, P453, DOI 10.1093/jxb/erp316; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kim KD, 2009, PLANT PHYSIOL, V151, P1066, DOI 10.1104/pp.109.141739; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; Lin YX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-76; Lohmann C, 2004, MOL GENET GENOMICS, V271, P11, DOI 10.1007/s00438-003-0954-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Mittal D, 2009, PLANT PHYSIOL BIOCH, V47, P785, DOI 10.1016/j.plaphy.2009.05.003; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; NOVER L, 1987, ENZYME MICROB TECH, V9, P130, DOI 10.1016/0141-0229(87)90066-4; Nover L, 1997, CELL MOL LIFE SCI, V53, P80, DOI 10.1007/PL00000583; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Peteranderl R, 1999, BIOCHEMISTRY-US, V38, P3559, DOI 10.1021/bi981774j; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schlueter JA, 2006, GENETICS, V174, P1017, DOI 10.1534/genetics.105.055020; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Shin JH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-133; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van K, 2008, DNA RES, V15, P93, DOI 10.1093/dnares/dsn001; Widholm JM, 2001, PHYSIOL PLANTARUM, V112, P540, DOI 10.1034/j.1399-3054.2001.1120411.x; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young ND, 2012, ANNU REV PLANT BIOL, V63, P283, DOI 10.1146/annurev-arplant-042110-103754; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891	87	55	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102825	10.1371/journal.pone.0102825	http://dx.doi.org/10.1371/journal.pone.0102825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047803	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100076
J	Tuna, EE; Karimov, JH; Liu, TM; Bebek, O; Fukamachi, K; Cavusoglu, MC				Tuna, E. Erdem; Karimov, Jamshid H.; Liu, Taoming; Bebek, Ozkan; Fukamachi, Kiyotaka; Cavusoglu, M. Cenk			Towards Active Tracking of Beating Heart Motion in the Presence of Arrhythmia for Robotic Assisted Beating Heart Surgery	PLOS ONE			English	Article							PREDICTION; FEASIBILITY; ALGORITHMS	In robotic assisted beating heart surgery, the control architecture for heart motion tracking has stringent requirements in terms of bandwidth of the motion that needs to be tracked. In order to achieve sufficient tracking accuracy, feed-forward control algorithms, which rely on estimations of upcoming heart motion, have been proposed in the literature. However, performance of these feed-forward motion control algorithms under heart rhythm variations is an important concern. In their past work, the authors have demonstrated the effectiveness of a receding horizon model predictive control-based algorithm, which used generalized adaptive predictors, under constant and slowly varying heart rate conditions. This paper extends these studies to the case when the heart motion statistics change abruptly and significantly, such as during arrhythmias. A feasibility study is carried out to assess the motion tracking capabilities of the adaptive algorithms in the occurrence of arrhythmia during beating heart surgery. Specifically, the tracking performance of the algorithms is evaluated on prerecorded motion data, which is collected in vivo and includes heart rhythm irregularities. The algorithms are tested using both simulations and bench experiments on a three degree-of-freedom robotic test bed. They are also compared with a position-plus-derivative controller as well as a receding horizon model predictive controller that employs an extended Kalman filter algorithm for predicting future heart motion.	[Tuna, E. Erdem; Liu, Taoming; Cavusoglu, M. Cenk] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Karimov, Jamshid H.; Fukamachi, Kiyotaka] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Bebek, Ozkan] Ozyegin Univ, Dept Mech Engn, Istanbul, Turkey	Case Western Reserve University; Cleveland Clinic Foundation; Ozyegin University	Tuna, EE (corresponding author), Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA.	eet12@case.edu	Tuna, Eser/HGD-0550-2022; Bebek, Ozkan/A-4706-2013	Tuna, Eser/0000-0001-5874-502X; Bebek, Ozkan/0000-0003-2721-9777; Cavusoglu, M. Cenk/0000-0003-2800-5922	NSF [IIS-0905344, CNS-1035602]; National Institutes of Health [R21 HL096941, R01 EB018108]; Direct For Computer & Info Scie & Enginr [1035602] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018108] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by NSF under grants IIS-0905344 and CNS-1035602, and National Institutes of Health under grants R21 HL096941 and R01 EB018108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B.D.O., 2007, OPTIMAL CONTROL LINE; Bachta W, 2009, IEEE T BIO-MED ENG, V56, P2551, DOI 10.1109/TBME.2009.2026054; Bader T, 2007, IEEE INT CONF ROBOT, P2261, DOI 10.1109/ROBOT.2007.363656; Bebek O, 2008, THESIS; Bebek O, 2007, IEEE T ROBOT, V23, P468, DOI 10.1109/TRO.2007.895077; Bogatyrenko E, 2011, INT J COMPUT ASS RAD, V6, P387, DOI 10.1007/s11548-010-0517-5; Bogatyrenko E, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P67, DOI 10.1109/IROS.2009.5354398; Bowthorpe M, 2014, IEEE J BIOMED HEALTH, V18, P157, DOI 10.1109/JBHI.2013.2267494; Camacho EF, 1999, MODEL PREDICTIVE CON; Cavusoglu MC, 2002, PRESENCE-TELEOP VIRT, V11, P555, DOI 10.1162/105474602321050695; Clarke D. W., 1988, IEEE Control Systems Magazine, V8, P49, DOI 10.1109/37.1874; Cuvillon L, 2005, LECT NOTES COMPUT SC, V3750, P551, DOI 10.1007/11566489_68; Dione D, 1997, P ANN INT IEEE EMBS, V19, P848, DOI 10.1109/IEMBS.1997.757790; Franke TJ, 2008, IEEE INT CONF ROBOT, P2916, DOI 10.1109/ROBOT.2008.4543652; Franke TJ, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P515; GARCIA CE, 1989, AUTOMATICA, V25, P335, DOI 10.1016/0005-1098(89)90002-2; Ginhoux R, 2005, IEEE T ROBOT, V21, P67, DOI 10.1109/TRO.2004.833812; Lemma Massimo, 2005, Interact Cardiovasc Thorac Surg, V4, P222, DOI 10.1510/icvts.2004.098517; Liu HC, 2004, COMPUT CHEM ENG, V28, P1635, DOI 10.1016/j.compchemeng.2004.01.009; Liu T.S., 2011, NE AGR U, V31, P115; Menold P., 1999, P 7 MED C CONTR AUT, P1110; Nakamura Y, 2001, IEEE INT CONF ROBOT, P2014, DOI 10.1109/ROBOT.2001.932903; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Ortmaier T, 2005, IEEE T BIO-MED ENG, V52, P1729, DOI 10.1109/TBME.2005.855716; Pearson RK, 2002, IEEE T CONTR SYST T, V10, P55, DOI 10.1109/87.974338; RATCLIFFE MB, 1995, IEEE T BIO-MED ENG, V42, P587, DOI 10.1109/10.387198; Richa R, 2011, MED IMAGE ANAL, V15, P302, DOI 10.1016/j.media.2010.12.002; Richa R, 2008, IEEE ENG MED BIO, P3261, DOI 10.1109/IEMBS.2008.4649900; Roka A, 2008, J ELECTROCARDIOL, V41, P131, DOI 10.1016/j.jelectrocard.2007.05.015; Takagaki M, 2005, MED SCI MONITOR, V11, pBR147; Takagaki M, 2002, HEART, V88, P170, DOI 10.1136/heart.88.2.170; Trejos AL, 1999, LECT NOTES COMPUT SC, V1679, P1088; Tuna EE, 2013, IEEE T ROBOT, V29, P261, DOI 10.1109/TRO.2012.2217676; Yuen S. G., 2010, MED IMAGE ANAL; Yuen SG, 2009, INT J ROBOT RES, V28, P1355, DOI 10.1177/0278364909104065	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102877	10.1371/journal.pone.0102877	http://dx.doi.org/10.1371/journal.pone.0102877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048462	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100082
J	Wang, JZ; Gu, BH; Huang, JH; Han, XG; Lin, GH; Zheng, FW; Li, YC				Wang, Jianzhu; Gu, Binhe; Huang, Jianhui; Han, Xingguo; Lin, Guanghui; Zheng, Fawen; Li, Yuncong			Terrestrial Contributions to the Aquatic Food Web in the Middle Yangtze River	PLOS ONE			English	Article							UPPER MISSISSIPPI RIVER; THREE-GORGES DAM; STABLE-ISOTOPES; ORGANIC-MATTER; FRESH-WATER; ENERGY-SOURCES; CARBON FLOW; FISH; FLOODPLAIN; CONSERVATION	Understanding the carbon sources supporting aquatic consumers in large rivers is essential for the protection of ecological integrity and for wildlife management. The relative importance of terrestrial and algal carbon to the aquatic food webs is still under intensive debate. The Yangtze River is the largest river in China and the third longest river in the world. The completion of the Three Gorges Dam (TGD) in 2003 has significantly altered the hydrological regime of the middle Yangtze River, but its immediate impact on carbon sources supporting the river food web is unknown. In this study, potential production sources from riparian and the main river channel, and selected aquatic consumers (invertebrates and fish) at an upstream constricted-channel site (Luoqi), a midstream estuarine site (Huanghua) and a near dam limnetic site (Maoping) of the TGD were collected for stable isotope (delta C-13 and delta N-15) and IsoSource analyses. Model estimates indicated that terrestrial plants were the dominant carbon sources supporting the consumer taxa at the three study sites. Algal production appeared to play a supplemental role in supporting consumer production. The contribution from C-4 plants was more important than that of C-3 plants at the upstream site while C-3 plants were the more important carbon source to the consumers at the two impacted sites (Huanghua and Maoping), particularly at the midstream site. There was no trend of increase in the contribution of autochthonous production from the upstream to the downstream sites as the flow rate decreased dramatically along the main river channel due to the construction of TGD. Our findings, along with recent studies in rivers and lakes, are contradictory to studies that demonstrate the importance of algal carbon in the aquatic food web. Differences in system geomorphology, hydrology, habitat heterogeneity, and land use may account for these contradictory findings reported in various studies.	[Wang, Jianzhu] Collaborat Innovat Ctr Geohazards & Ecoenvironm T, Yichang, Hubei Province, Peoples R China; [Gu, Binhe] Univ Florida, Soil & Water Sci Dept, Gainesville, FL 32611 USA; [Huang, Jianhui] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Lin, Guanghui] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Zheng, Fawen] Nanjing Res Inst Hydrol & Water Resources, Nanjing, Jiangsu, Peoples R China; [Li, Yuncong] Univ Florida, IFAS, Ctr Trop Res & Educ, Soil & Water Sci Dept, Homestead, FL 33031 USA	State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Tsinghua University; State University System of Florida; University of Florida	Gu, BH (corresponding author), Univ Florida, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	gubinhe@gmail.com	Han, Xingguo/K-7552-2016; Li, Yuncong/B-9517-2009	Han, Xingguo/0000-0002-1836-975X; Li, Yuncong/0000-0001-6331-083X	National Natural Science Foundation of China (NSFC) [51179094, 30700091]; Chinese Academy of Sciences; NSFC [41376158]; Key Project of Knowledge Innovation Direction Program [KSCX2-SW-109]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); Key Project of Knowledge Innovation Direction Program	This research was supported by National Natural Science Foundation of China (NSFC grant No. 51179094 and 30700091) to JW and Chinese Academy of Sciences through a "Baren Project'' fund to GL and a Key Project of Knowledge Innovation Direction Program (Grant No. KSCX2-SW-109) to JH. Manuscript preparation is supported by NSFC (grant No. 41376158) to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2003, CAN J FISH AQUAT SCI, V60, P309, DOI 10.1139/F03-019; Bowen SH, 1987, C P INT CTR LIV AQ R, V14, P192; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Bunn SE, 2003, FRESHWATER BIOL, V48, P619, DOI 10.1046/j.1365-2427.2003.01031.x; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Clapcott JE, 2003, FRESHWATER BIOL, V48, P1105, DOI 10.1046/j.1365-2427.2003.01077.x; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Cole JJ, 2010, P NAT ACA SCI, V108, P1975; Delong MD, 2006, OECOLOGIA, V147, P76, DOI 10.1007/s00442-005-0241-y; Delong MD, 2001, REGUL RIVER, V17, P217, DOI 10.1002/rrr.614; Doi H, 2009, POPUL ECOL, V51, P57, DOI 10.1007/s10144-008-0127-z; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Dudgeon D, 2010, AQUAT CONSERV, V20, P127, DOI 10.1002/aqc.1098; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Finlay JC, 2002, ECOLOGY, V83, P1845, DOI 10.1890/0012-9658(2002)083[1845:SSOCFI]2.0.CO;2; Fu BJ, 2010, PROG PHYS GEOG, V34, P741, DOI 10.1177/0309133310370286; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Goulding M., 1980, FISHES LHE FOREST; Gu BH, 2011, OECOLOGIA, V165, P1083, DOI 10.1007/s00442-010-1888-6; Gushing CE, 2006, RIVER STREAM ECOSYST; HAMILTON SK, 1992, OECOLOGIA, V89, P324, DOI 10.1007/BF00317409; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; Hoffman JC, 2008, ESTUAR COAST, V31, P898, DOI 10.1007/s12237-008-9073-4; Huryn AD, 2001, FRESHWATER BIOL, V46, P213, DOI 10.1046/j.1365-2427.2001.00648.x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kawaguchi Y, 2003, ECOLOGY, V84, P701, DOI 10.1890/0012-9658(2003)084[0701:TIIDTL]2.0.CO;2; Kendall C, 2001, HYDROL PROCESS, V15, P1301, DOI 10.1002/hyp.216; Leite RG, 2002, ECOL FRESHW FISH, V11, P56, DOI 10.1034/j.1600-0633.2002.110106.x; Lin Y, 2006, THESIS CHINESE ACAD; Liu J., 1992, RESOUR ENV YANGTZE V, V1, P17, DOI DOI 10.1093/BIOSCI/BIX110; MANN KH, 1988, LIMNOL OCEANOGR, V33, P910, DOI 10.4319/lo.1988.33.4_part_2.0910; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Park YS, 2003, CONSERV BIOL, V17, P1748, DOI 10.1111/j.1523-1739.2003.00430.x; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; POMEROY LR, 1991, COMPARATIVE ANALYSES OF ECOSYSTEMS, P97; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Reid DJ, 2008, FRESHWATER BIOL, V53, P2036, DOI 10.1111/j.1365-2427.2008.02025.x; Robertson CR, 2008, ECOL FRESHW FISH, V17, P119, DOI 10.1111/j.1600-0633.2007.00265.x; Salazar JG, 2000, J ENVIRON DEV, V9, P160; SEDELL J R, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P49; Shen GZ, 2004, SCIENCE, V304, P681; Sobczak WV, 2002, P NATL ACAD SCI USA, V99, P8101, DOI 10.1073/pnas.122614399; Thorp JH, 1998, OECOLOGIA, V117, P551, DOI 10.1007/s004420050692; THORP JH, 1994, OIKOS, V70, P305, DOI 10.2307/3545642; Thorp JH, 2002, OIKOS, V96, P543, DOI 10.1034/j.1600-0706.2002.960315.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Wantzen KM, 2002, AQUAT SCI, V64, P239, DOI 10.1007/PL00013196; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Wu Y, 2007, ESTUAR COAST SHELF S, V71, P13, DOI 10.1016/j.ecss.2006.08.016; Xie P, 2003, SCIENCE, V302, P1149; Xu X, 2011, THESIS CHONGQING U C; Yi YJ, 2010, J HYDROL, V387, P283, DOI 10.1016/j.jhydrol.2010.04.018; Zeng H, 2006, THESIS CHINESE ACAD; Zeug SC, 2008, ECOLOGY, V89, P1733, DOI 10.1890/07-1064.1; Zhang S, 2005, DISTRIBUTION NUTR PL	57	13	18	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102473	10.1371/journal.pone.0102473	http://dx.doi.org/10.1371/journal.pone.0102473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047656	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100034
J	Xie, Q; Hu, B; Dong, N; Wong, DS				Xie, Qi; Hu, Bin; Dong, Na; Wong, Duncan S.			Anonymous Three-Party Password-Authenticated Key Exchange Scheme for Telecare Medical Information Systems	PLOS ONE			English	Article							PROTOCOL; CRYPTANALYSIS; EFFICIENT; SECURE	Telecare Medical Information Systems (TMIS) provide an effective way to enhance the medical process between doctors, nurses and patients. For enhancing the security and privacy of TMIS, it is important while challenging to enhance the TMIS so that a patient and a doctor can perform mutual authentication and session key establishment using a third-party medical server while the privacy of the patient can be ensured. In this paper, we propose an anonymous three-party password-authenticated key exchange (3PAKE) protocol for TMIS. The protocol is based on the efficient elliptic curve cryptosystem. For security, we apply the pi calculus based formal verification tool ProVerif to show that our 3PAKE protocol for TMIS can provide anonymity for patient and doctor while at the same time achieves mutual authentication and session key security. The proposed scheme is secure and efficient, and can be used in TMIS.	[Xie, Qi; Hu, Bin; Dong, Na] Hangzhou Normal Univ, Hangzhou Key Lab Cryptog & Network Secur, Hangzhou, Zhejiang, Peoples R China; [Wong, Duncan S.] City Univ Hong Kong, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China	Hangzhou Normal University; City University of Hong Kong	Xie, Q (corresponding author), Hangzhou Normal Univ, Hangzhou Key Lab Cryptog & Network Secur, Hangzhou, Zhejiang, Peoples R China.	qixie68@126.com; tinrant@163.com	XIE, Qi/AAO-2190-2020; Xie, Qi/E-3286-2015		National Natural Science Foundation of China [61070153]; Major State Basic Research Development (973) Program of China [2013CB834205]; Natural Science Foundation of Zhejiang Province [LZ12F02005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development (973) Program of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This research was supported by the National Natural Science Foundation of China (No. 61070153, URL http://www.nsfc.gov.cn/), the Major State Basic Research Development (973) Program of China (No. 2013CB834205, URL http://www.973.gov.cn/AreaAppl.aspx), and Natural Science Foundation of Zhejiang Province (No. LZ12F02005, URL http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2001, ACM SIGPLAN NOTICES, V36, P104, DOI 10.1145/373243.360213; Abadi M, 2009, LECT NOTES COMPUT SC, V5643, P35, DOI 10.1007/978-3-642-02658-4_5; Arapinis M., 2012, P ACM C COMP COMM SE, P205; Arapinis M, 2010, 2010 23RD IEEE COMPUTER SECURITY FOUNDATIONS SYMPOSIUM (CSF), P107, DOI 10.1109/CSF.2010.15; Blanchet B, 2013, PROVERIF CRYPTOGRAPH; Chung HR, 2008, INFORM SCIENCES, V178, P220, DOI 10.1016/j.ins.2007.08.004; Guo H, 2008, COMPUT SECUR, V27, P16, DOI 10.1016/j.cose.2008.03.001; Hong Lai, 2012, Mathematical Problems in Engineering, DOI 10.1155/2012/454823; Huang HF, 2009, INT J COMMUN SYST, V22, P857, DOI 10.1002/dac.1002; Kocarev L, 2011, CHAOS BASED CRYPTOGR, P53; Lee CC, 2013, NONLINEAR DYNAM, V73, P125, DOI 10.1007/s11071-013-0772-4; Li CT, 2008, COMPUT COMMUN, V31, P2803, DOI 10.1016/j.comcom.2007.12.005; Li WM, 2012, COMPUT COMMUN, V35, P188, DOI 10.1016/j.comcom.2011.09.003; Lou DC, 2011, INT J COMMUN SYST, V24, P504, DOI 10.1002/dac.1172; Lu RX, 2007, COMPUT SECUR, V26, P94, DOI 10.1016/j.cose.2006.08.005; Nam J, 2009, IEEE COMMUN LETT, V13, P205, DOI 10.1109/LCOMM.2009.081609; Phan RCW, 2008, INFORM SCIENCES, V178, P2849, DOI 10.1016/j.ins.2008.02.008; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P4052, DOI 10.1016/j.cnsns.2010.02.014; Wu SH, 2013, INT J COMMUN SYST, V26, P674, DOI 10.1002/dac.1362; Xie Q, 2013, NONLINEAR DYNAM, V74, P1021, DOI 10.1007/s11071-013-1020-7; Xie Q, 2013, INF TECHNOL CONTROL, V42, P231, DOI 10.5755/j01.itc.42.3.1905; Xie Q, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9911-6; Yang JH, 2012, J SYST SOFTWARE, V85, P340, DOI 10.1016/j.jss.2011.08.024; Yoon EJ, 2011, INT J COMMUN SYST, V24, P532, DOI 10.1002/dac.1168; Yoon EJ, 2011, COMMUN NONLINEAR SCI, V16, P2383, DOI 10.1016/j.cnsns.2010.09.021; Zhao FJ, 2013, NONLINEAR DYNAM, V74, P419, DOI 10.1007/s11071-013-0979-4	26	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102747	10.1371/journal.pone.0102747	http://dx.doi.org/10.1371/journal.pone.0102747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047235	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100069
J	Ali, MA; Wieczorek, K; Kreil, DP; Bohlmann, H				Ali, Muhammad Amjad; Wieczorek, Krzysztof; Kreil, David P.; Bohlmann, Holger			The Beet Cyst Nematode Heterodera schachtii Modulates the Expression of WRKY Transcription Factors in Syncytia to Favour Its Development in Arabidopsis Roots	PLOS ONE			English	Article							GENE-EXPRESSION; PSEUDOMONAS-SYRINGAE; NEGATIVE REGULATORS; RESISTANCE; SENESCENCE; CAMALEXIN; THALIANA; KINASE; PLANTS; STRESS	Cyst nematodes invade the roots of their host plants as second stage juveniles and induce a syncytium which is the only source of nutrients throughout their life. A recent transcriptome analysis of syncytia induced by the beet cyst nematode Heterodera schachtii in Arabidopsis roots has shown that thousands of genes are up-regulated or down-regulated in syncytia as compared to root segments from uninfected plants. Among the down-regulated genes are many which code for WRKY transcription factors. Arabidopsis contains 66 WRKY genes with 59 represented by the ATH1 GeneChip. Of these, 28 were significantly down-regulated and 6 up-regulated in syncytia as compared to control root segments. We have studied here the down-regulated genes WRKY6, WRKY11, WRKY17 and WRKY33 in detail. We confirmed the down-regulation in syncytia with promoter:: GUS lines. Using various overexpression lines and mutants it was shown that the down-regulation of these WRKY genes is important for nematode development, probably through interfering with plant defense reactions. In case of WRKY33, this might involve the production of the phytoalexin camalexin.	[Ali, Muhammad Amjad; Wieczorek, Krzysztof; Bohlmann, Holger] Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, Vienna, Austria; [Ali, Muhammad Amjad] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol, Dept Plant Pathol, Faisalabad, Pakistan; [Kreil, David P.] Univ Nat Resources & Life Sci, Dept Biotechnol, Chair Bioinformat, Vienna, Austria; [Kreil, David P.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Natural Resources & Life Sciences, Vienna; University of Agriculture Faisalabad; University of Natural Resources & Life Sciences, Vienna; University of Warwick	Bohlmann, H (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, Vienna, Austria.	holger.bohlmann@boku.ac.at	Wieczorek, Krzysztof/ABD-4894-2020; Ali, Muhammad/GXH-4405-2022; Kreil, D/O-1783-2013; ali, muhammad/GYR-3505-2022; Ali, Muhammad Amjad/D-3335-2013	Ali, Muhammad/0000-0002-1444-7888; Kreil, D/0000-0001-7538-2056; Ali, Muhammad Amjad/0000-0001-5381-7039	Austrian Science Fund [P20471-B11]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (P20471-B11): www.fwf.ac.at. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Ali MA, 2013, PLANT J, V74, P852, DOI 10.1111/tpj.12170; Ali MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-47; Ali MA, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-37; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; Bar-Or C, 2005, EUR J PLANT PATHOL, V111, P181, DOI 10.1007/s10658-004-2134-z; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Chen YF, 2009, PLANT CELL, V21, P3554, DOI 10.1105/tpc.108.064980; EPPLE P, 1995, PLANT PHYSIOL, V109, P813, DOI 10.1104/pp.109.3.813; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Geng XQ, 2012, PLANT CELL, V24, P4763, DOI 10.1105/tpc.112.105312; Goellner M, 2001, PLANT CELL, V13, P2241, DOI 10.1105/tpc.13.10.2241; Grunewald W, 2008, PLANT PHYSIOL, V148, P358, DOI 10.1104/pp.108.119131; Hammes UZ, 2005, MOL PLANT MICROBE IN, V18, P1247, DOI 10.1094/MPMI-18-1247; Holtorf S, 1995, PLANT MOL BIOL, V29, P637, DOI 10.1007/BF00041155; HUANG JS, 1991, PLANT PHYSIOL, V96, P1302, DOI 10.1104/pp.96.4.1302; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Ju rgensen K, 2001, UNTERSUCHUNGEN ZUM A; Kasajima I, 2010, PHYSIOL PLANTARUM, V139, P80, DOI 10.1111/j.1399-3054.2010.01349.x; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Matthews BF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-96; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Petersen K, 2008, PLANT SIGNAL BEHAV, V3, P1033, DOI 10.4161/psb.6878; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Puthoff DP, 2003, PLANT J, V33, P911, DOI 10.1046/j.1365-313X.2003.01677.x; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schon M, 2013, MOL PLANT MICROBE IN, V26, P758, DOI 10.1094/MPMI-11-12-0265-R; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Siddique S, 2011, PLANT PHYSIOL BIOCH, V49, P1100, DOI 10.1016/j.plaphy.2011.07.005; Siddique S, 2009, NEW PHYTOL, V184, P457, DOI 10.1111/j.1469-8137.2009.02981.x; SIJMONS PC, 1991, PLANT J, V1, P245, DOI 10.1111/j.1365-313X.1991.00245.x; Sobczak M, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P61, DOI 10.1007/978-94-007-0434-3_4; Szakasits D, 2007, PLANT MOL BIOL REP, V25, P115, DOI 10.1007/s11105-007-0013-4; Szakasits D, 2009, PLANT J, V57, P771, DOI 10.1111/j.1365-313X.2008.03727.x; Takemoto D, 2005, PLANT PHYSIOL, V138, P1491, DOI 10.1104/pp.104.058388; VEECH JA, 1982, J NEMATOL, V14, P2; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wieczorek K, 2008, PLANT J, V53, P336, DOI 10.1111/j.1365-313X.2007.03340.x; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Xing DH, 2008, MOL PLANT, V1, P459, DOI 10.1093/mp/ssn020; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	61	39	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102360	10.1371/journal.pone.0102360	http://dx.doi.org/10.1371/journal.pone.0102360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033038	gold, Green Submitted, Green Published			2022-12-27	WOS:000339418300050
J	Crisan, AF; Oancea, C; Timar, B; Fira-Mladinescu, O; Crisan, A; Tudorache, V				Crisan, Alexandru F.; Oancea, Cristian; Timar, Bogdan; Fira-Mladinescu, Ovidiu; Crisan, Alexandru; Tudorache, Voicu			Cognitive Impairment in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							OLD-AGE; DECLINE; INFLAMMATION; DEMENTIA; MARKERS; PROGRESSION; RISK; COPD	Background/Purpose: Chronic obstructive pulmonary disease (COPD), especially in severe forms, is commonly associated with multiple cognitive problems. Montreal Cognitive Assessment test (MoCA) is used to detect cognitive impairment evaluating several areas: visuospatial, memory, attention and fluency. Our study aim was to evaluate the impact of stable COPD and exacerbation (AECOPD) phases on cognitive status using MoCA questionnaire. Methods: We enrolled 39 patients (pts), smokers with COPD group D (30 stable and 9 in AECOPD) and 13 healthy subjects (control group), having similar level of education and no significant differences regarding the anthropometric measurements. We analyzed the differences in MoCA score between these three groups and also the correlation between this score and inflammatory markers. Results: Patients with AECOPD had a significant (p, 0.001) decreased MoCA score (14.6 +/- 3.4) compared to stable COPD (20.2 +/- 2.4) and controls (24.2 +/- 5.8). The differences between groups were more accentuated for the language abstraction and attention (p<0.001) and delayed recall and orientation (p<0.001) sub-topics. No significant variance of score was observed between groups regarding visuospatial and naming score (p = 0.095). The MoCA score was significantly correlated with forced expiratory volume (r = 0.28) and reverse correlated with C-reactive protein (CRP) (r = -0.57), fibrinogen (r = -0.58), erythrocyte sedimentation rate (ESR) (r = -0.55) and with the partial pressure of CO2 (r = -0.47). Conclusions: According to this study, COPD significantly decreases the cognitive status in advanced and acute stages of the disease.	[Crisan, Alexandru F.; Oancea, Cristian; Fira-Mladinescu, Ovidiu; Tudorache, Voicu] Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania; [Timar, Bogdan] Univ Med & Farm Timisoara, Dept Biostat & Med Informat, Timisoara, Romania; [Crisan, Alexandru] Univ Med & Farm Timisoara, Dept Infect Dis, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Oancea, C (corresponding author), Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania.	oancea@umft.ro	Crișan, Alexandru/AHE-4031-2022; Fira-Mladinescu, Ovidiu/C-5736-2011	Fira-Mladinescu, Ovidiu/0000-0002-9034-5218				Antonelli-Incalzi R, 2006, CHEST, V130, P1687, DOI 10.1378/chest.130.6.1687; Areza-Fegyveres Renata, 2010, Dement. neuropsychol., V4, P14, DOI 10.1590/S1980-57642010DN40100003; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Di Carlo A, 2007, NEUROLOGY, V68, P1909, DOI 10.1212/01.wnl.0000263132.99055.0d; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; GRANT I, 1982, ARCH INTERN MED, V142, P1470, DOI 10.1001/archinte.142.8.1470; HEATON RK, 1983, ARCH INTERN MED, V143, P1941, DOI 10.1001/archinte.143.10.1941; Incalzi RA, 1998, RESP MED, V92, P527, DOI 10.1016/S0954-6111(98)90303-1; Isoaho R, 1996, Int Psychogeriatr, V8, P113, DOI 10.1017/S1041610296002517; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rafnsson SB, 2007, J AM GERIATR SOC, V55, P700, DOI 10.1111/j.1532-5415.2007.01158.x; Sabia S, 2012, ARCH GEN PSYCHIAT, V69, P627, DOI 10.1001/archgenpsychiatry.2011.2016; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Solfrizzi V, 2006, CLIN CHIM ACTA, V364, P91, DOI 10.1016/j.cca.2005.06.015; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Villeneuve S, 2012, CHEST, V142, P1516, DOI 10.1378/chest.11-3035; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x	22	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102468	10.1371/journal.pone.0102468	http://dx.doi.org/10.1371/journal.pone.0102468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033379	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300053
J	Chen, CM; Chen, IC; Huang, YC; Juan, HF; Chen, YL; Chen, YC; Lin, CH; Lee, LC; Lee, CM; Lee-Chen, GJ; Lai, YJ; Wu, YR				Chen, Chiung-Mei; Chen, I-Cheng; Huang, Yi-Cheng; Juan, Hsueh-Fen; Chen, Ying-Lin; Chen, Yi-Chun; Lin, Chih-Hsin; Lee, Li-Ching; Lee, Chi-Mei; Lee-Chen, Guey-Jen; Lai, Yun-Ju; Wu, Yih-Ru			FBXO7 Y52C Polymorphism as a Potential Protective Factor in Parkinson's Disease	PLOS ONE			English	Article							EARLY-ONSET PARKINSONISM; BOX PROTEIN FBXO7; F-BOX; MUTATIONS; ATP13A2; GENE	Mutations in the F-box only protein 7 gene (FBXO7), the substrate-specifying subunit of SCF E3 ubiquitin ligase complex, cause Parkinson's disease (PD)-15 (PARK15). To identify new variants, we sequenced FBXO7 cDNA in 80 Taiwanese early onset PD patients (age at onset <= 50) and only two known variants, Y52C (c.155A>G) and M115I (c.345G> A), were found. To assess the association of Y52C and M115I with the risk of PD, we conducted a case-control study in a cohort of PD and ethnically matched controls. There was a nominal difference in the Y52C G allele frequency between PD and controls (p = 0.045). After combining data from China [1], significant difference in the Y52C G allele frequency between PD and controls (p = 0.012) and significant association of G allele with decreased PD risk (p = 0.017) can be demonstrated. Upon expressing EGFP-tagged Cys52 FBXO7 in cells, a significantly reduced rate of FBXO7 protein decay was observed when compared with cells expressing Tyr52 FBXO7. In silico modeling of Cys52 exhibited a more stable feature than Tyr52. In cells expressing Cys52 FBXO7, the level of TNF receptor-associated factor 2 (TRAF2) was significantly reduced. Moreover, Cys52 FBXO7 showed stronger interaction with TRAF2 and promoted TRAF2 ubiquitination, which may be responsible for the reduced TRAF2 expression in Cys52 cells. After induced differentiation, SH-SY5Y cells expressing Cys52 FBXO7 displayed increased neuronal outgrowth. We therefore hypothesize that Cys52 variant of FBXO7 may contribute to reduced PD susceptibility in Chinese.	[Chen, Chiung-Mei; Chen, I-Cheng; Chen, Yi-Chun; Lin, Chih-Hsin; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Yi-Cheng; Chen, Ying-Lin; Lee, Li-Ching; Lee, Chi-Mei; Lee-Chen, Guey-Jen; Lai, Yun-Ju] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University; National Taiwan University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; yunjulai@ntnu.edu.tw; yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	Chen, I-Cheng/0000-0001-6235-6289; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council [NSC99-2628-B-182A-063-MY3, NSC100-2325-B-003-001]; Executive Yuan; Chang Gung Memorial Hospital [CMRPG3D005]; National Taiwan Normal University, Taipei, Taiwan [NTNU100-D-02]	National Science Council(Ministry of Science and Technology, Taiwan); Executive Yuan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Taiwan Normal University, Taipei, Taiwan	This work was supported by grants NSC99-2628-B-182A-063-MY3 and NSC100-2325-B-003-001 from National Science Council, Executive Yuan, CMRPG3D005 from Chang Gung Memorial Hospital, and NTNU100-D-02 from National Taiwan Normal University, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Chen CM, 2011, AM J MED GENET B, V156B, P720, DOI 10.1002/ajmg.b.31214; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Flood PM, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/216298; Fung HC, 2006, NEUROSCI LETT, V394, P33, DOI 10.1016/j.neulet.2005.10.005; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Lee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035302; Lin CH, 2013, NEUROBIOL AGING, V34; Luo LZ, 2010, NEUROSCI LETT, V482, P86, DOI 10.1016/j.neulet.2010.06.083; Matsuda N, 2010, J ALZHEIMERS DIS, V19, P1, DOI 10.3233/JAD-2010-1231; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Paisan-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; SIDELL N, 1982, J NATL CANCER I, V68, P589; Spatola M., 2014, PARKINSONISM RELA S1, V20, pS35, DOI DOI 10.1016/S1353-8020(13)70011-7; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Wu YR, 2010, AM J MED GENET B, V153B, P229, DOI 10.1002/ajmg.b.30977; Zhao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048911; Zhao TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016983; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	30	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101392	10.1371/journal.pone.0101392	http://dx.doi.org/10.1371/journal.pone.0101392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029497	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600014
J	Furriel, A; Campos-Silva, P; Silva, PCGP; Costa, WS; Sampaio, FJB; Gregorio, BM				Furriel, Angelica; Campos-Silva, Pamella; Guedes Picarote Silva, Paola Cariello; Costa, Waldemar Silva; Barcellos Sampaio, Francisco Jose; Gregorio, Bianca Martins			Diets Rich in Saturated and Polyunsaturated Fatty Acids Induce Morphological Alterations in the Rat Ventral Prostate	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; HYPERPLASIA; CHOLESTEROL; THERAPY; OBESITY; CANCER; MACRONUTRIENTS; NUTRITION; ANDROGENS	Aim: To evaluate the influence of dietary lipid quality on the body mass, carbohydrate metabolism and morphology of the rat ventral prostate. Materials and Methods: Wistar rats were divided into four groups: SC (standard chow), HF-S (high-fat diet rich in saturated fatty acids), HF-P (high-fat diet rich in polyunsaturated fatty acids) and HF-SP (high-fat diet rich in saturated and polyunsaturated fatty acids). We analyzed body mass, fat mass deposits, plasma blood, insulin resistance and the ventral prostate structure. Results: Groups that received high-fat diets were heavier and presented larger fat deposits than SC group. The HF-S and HF-SP groups had higher glucose, insulin and total cholesterol serum levels and insulin resistance compared with the SC. The acinar area, epithelium height and area density of the lumen were higher in the HF-SP than in the other groups. The epithelium area density and epithelial cell proliferation were greater in the HF-P and HF-SP than in the SC group. All of the groups that received high-fat diets had greater area density of the stroma, area density of smooth muscle cells and stromal cell proliferation compared with the SC group. Conclusion: Diets rich in saturated and/or polyunsaturated fatty acids induced overweight. Independently of insulin resistance, polyunsaturated fatty acids increased prostate stromal and epithelial cell proliferation. Saturated fatty acids influenced only stromal cellular proliferation. These structural and morphometric alterations may be considered risk factors for the development of adverse remodeling process in the rat ventral	[Furriel, Angelica; Campos-Silva, Pamella; Guedes Picarote Silva, Paola Cariello; Costa, Waldemar Silva; Barcellos Sampaio, Francisco Jose; Gregorio, Bianca Martins] Univ Estado Rio De Janeiro, Dept Anat, Urogenital Res Unit, Biomed Ctr, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Gregorio, BM (corresponding author), Univ Estado Rio De Janeiro, Dept Anat, Urogenital Res Unit, Biomed Ctr, Rio De Janeiro, Brazil.	bmgregorio.uerj@gmail.com	Sampaio, Francisco/AAS-2479-2020; Gregório, Bianca Martins/O-4359-2014	Gregório, Bianca Martins/0000-0001-8138-7734; BARCELLOS SAMPAIO, FRANCISCO JOSE/0000-0001-9087-9319	FAPERJ; CNPq; CAPES	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPERJ, CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravi F, 2006, UROLOGY, V67, P1205, DOI 10.1016/j.urology.2006.01.007; Coelho DF, 2011, BRAZ J MED BIOL RES, V44, P966, DOI 10.1590/S0100-879X2011007500107; Gerdes MJ, 2004, PROSTATE, V58, P299, DOI 10.1002/pros.10327; Giovannucci E, 2003, HORM METAB RES, V35, P694, DOI 10.1055/s-2004-814147; Gorden P, 2012, ENDOCR PRACT, V18, P763, DOI 10.4158/EP12139.RA; GROSS SA, 1987, J SUBMICR CYTOL PATH, V19, P77; Grossmann M, 2013, BEST PRACT RES CL EN, V27, P603, DOI 10.1016/j.beem.2013.05.001; Hautanen A, 2000, INT J OBESITY, V24, pS64, DOI 10.1038/sj.ijo.0801281; Hodson L, 2001, EUR J CLIN NUTR, V55, P908, DOI 10.1038/sj.ejcn.1601234; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Issa MM, 2007, AM J MANAG CARE, V13, pS4; Kapoor D, 2005, CLIN ENDOCRINOL, V63, P239, DOI 10.1111/j.1365-2265.2005.02299.x; LIANG TM, 1992, BIOCHEM J, V285, P557, DOI 10.1042/bj2850557; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Montoya MT, 2002, AM J CLIN NUTR, V75, P484, DOI 10.1093/ajcn/75.3.484; Morgan DA, 2001, BRAZILIAN J UROLOGY, V27, P26; Morgan DA, 1993, AM J PHYSIOL, V264, P423, DOI 0165-1838(95)00108-5; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; Rahman NU, 2007, BJU INT, V100, P658, DOI 10.1111/j.1464-410X.2007.07069.x; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ribeiro DL, 2012, J ANDROL, V33, P854, DOI 10.2164/jandrol.111.016089; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; SANDA MG, 1994, J UROLOGY, V152, P115, DOI 10.1016/S0022-5347(17)32831-8; Souza-Mello V, 2007, BRIT J NUTR, V98, P1159, DOI 10.1017/S0007114507771878; Suzuki S, 2002, AM J CLIN NUTR, V75, P689, DOI 10.1093/ajcn/75.4.689; van Kuilenburg J, 2011, J CLIN LIPIDOL, V5, P273, DOI 10.1016/j.jacl.2011.05.003; Vikram A, 2010, PROSTATE, V70, P79, DOI 10.1002/pros.21041; Vikram A, 2010, EUR J PHARMACOL, V641, P75, DOI 10.1016/j.ejphar.2010.05.042; Zhou J, 2012, SCI WORLD J IN PRESS	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102876	10.1371/journal.pone.0102876	http://dx.doi.org/10.1371/journal.pone.0102876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029463	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600102
J	Hamasaki, T; Nakamichi, N; Teruya, K; Shirahata, S				Hamasaki, Takeki; Nakamichi, Noboru; Teruya, Kiichiro; Shirahata, Sanetaka			Removal Efficiency of Radioactive Cesium and Iodine Ions by a Flow-Type Apparatus Designed for Electrochemically Reduced Water Production	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; AQUEOUS-SOLUTIONS; PLATINUM NANOPARTICLES; CAENORHABDITIS-ELEGANS; SAFETY REGULATIONS; DNA-DAMAGE; LIFE-SPAN; FUKUSHIMA; RADIATION; HYDROGEN	The Fukushima Daiichi Nuclear Power Plant accident on March 11, 2011 attracted people's attention, with anxiety over possible radiation hazards. Immediate and long-term concerns are around protection from external and internal exposure by the liberated radionuclides. In particular, residents living in the affected regions are most concerned about ingesting contaminated foodstuffs, including drinking water. Efficient removal of radionuclides from rainwater and drinking water has been reported using several pot-type filtration devices. A currently used flow-type test apparatus is expected to simultaneously provide radionuclide elimination prior to ingestion and protection from internal exposure by accidental ingestion of radionuclides through the use of a micro-carbon carboxymethyl cartridge unit and an electrochemically reduced water production unit, respectively. However, the removability of radionuclides from contaminated tap water has not been tested to date. Thus, the current research was undertaken to assess the capability of the apparatus to remove radionuclides from artificially contaminated tap water. The results presented here demonstrate that the apparatus can reduce radioactivity levels to below the detection limit in applied tap water containing either 300 Bq/kg of Cs-137 or 150 Bq/kg of I-125. The apparatus had a removal efficiency of over 90% for all concentration ranges of radio-cesium and -iodine tested. The results showing efficient radionuclide removability, together with previous studies on molecular hydrogen and platinum nanoparticles as reactive oxygen species scavengers, strongly suggest that the test apparatus has the potential to offer maximum safety against radionuclide-contaminated foodstuffs, including drinking water.	[Hamasaki, Takeki; Nakamichi, Noboru; Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 812, Japan	Kyushu University	Shirahata, S (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 812, Japan.	sirahata@grt.kyushu-u.ac.jp	Takeki, Tomikawa/AAC-8060-2019		Grants-in-Aid for Scientific Research [26450161] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akpolat M, 2009, ARCH TOXICOL, V83, P609, DOI 10.1007/s00204-008-0352-4; Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; Awual MR, 2014, CHEM ENG J, V242, P127, DOI 10.1016/j.cej.2013.12.072; Borai EH, 2009, J HAZARD MATER, V172, P416, DOI 10.1016/j.jhazmat.2009.07.033; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Christodouleas JP, 2011, NEW ENGL J MED, V364, P2334, DOI 10.1056/NEJMra1103676; Chuai YH, 2012, BIOCHEM J, V442, P49, DOI 10.1042/BJ20111786; Dahiya S, 2008, J HAZARD MATER, V150, P376, DOI 10.1016/j.jhazmat.2007.04.134; Ding DH, 2014, J HAZARD MATER, V270, P187, DOI 10.1016/j.jhazmat.2014.01.056; El-Kamash AM, 2008, J HAZARD MATER, V151, P432, DOI 10.1016/j.jhazmat.2007.06.009; EWING D, 1987, ARCH BIOCHEM BIOPHYS, V254, P53, DOI 10.1016/0003-9861(87)90080-4; Fukuda S, 2014, J PLANT RES, V127, P79, DOI 10.1007/s10265-013-0596-9; Gobbel GT, 1998, J NEUROSCI, V18, P147; GOOSSENS R, 1989, WATER RES, V23, P693, DOI 10.1016/0043-1354(89)90201-7; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Higaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037184; Hu BY, 2012, J HAZARD MATER, V217, P85, DOI 10.1016/j.jhazmat.2012.02.071; Jagetia GC, 2005, LIFE SCI, V77, P780, DOI 10.1016/j.lfs.2005.01.015; Kamei D, 2012, THER APHER DIAL, V16, P87, DOI 10.1111/j.1744-9987.2011.01029.x; KAMETANI K, 1992, BUNSEKI KAGAKU, V41, P337; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kim MJ, 2006, LIFE SCI, V79, P2288, DOI 10.1016/j.lfs.2006.07.027; Kinjo T, 2012, CYTOTECHNOLOGY, V64, P357, DOI 10.1007/s10616-012-9469-7; Koizumi A, 2013, ENVIRON SCI TECHNOL, V47, P9612, DOI 10.1021/es401422g; Kosaka K, 2012, WATER RES, V46, P4397, DOI 10.1016/j.watres.2012.05.055; Li YP, 2002, CYTOTECHNOLOGY, V40, P139, DOI 10.1023/A:1023936421448; Li YP, 2011, CYTOTECHNOLOGY, V63, P119, DOI 10.1007/s10616-010-9317-6; Liu X, 2014, BIORESOUR TECHNOL; Ministry of Health Labour and Welfare Japan, MEAS RES RAD FOODST; Ministry of Health Labour and Welfare Japan, INF GREAT E JAP EART; Mizuno T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01742; Momoshima N, 2012, J ENVIRON RADIOACTIV, V111, P28, DOI 10.1016/j.jenvrad.2011.09.001; Murakami M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03599; Nakanishi H, 2013, NANO BIOMED ENG, V5, P76, DOI [10.5101/nbe.v5i2.p76-85, DOI 10.5101/NBE.V5I2.P76-85]; Nakanishi T, 2014, J ENVIRON RADIOACTIV, V128, P9, DOI 10.1016/j.jenvrad.2013.10.019; Nuclear Regulation Authority (NRA), 2013, MON INF ENV RAD LEV; Nunomura A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/200682323; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta T, 2012, J ENVIRON RADIOACTIV, V111, P38, DOI 10.1016/j.jenvrad.2011.11.017; Osmanlioglu AE, 2007, APPL RADIAT ISOTOPES, V65, P17, DOI 10.1016/j.apradiso.2006.08.012; Pangeni B, 2014, CHEM ENG J, V242, P109, DOI 10.1016/j.cej.2013.12.042; Parajuli D, 2013, ENVIRON SCI TECHNOL, V47, P3800, DOI 10.1021/es303467n; Qian LR, 2010, J RADIAT RES, V51, P741, DOI 10.1269/jrr.10093; Qian LR, 2010, FREE RADICAL RES, V44, P275, DOI 10.3109/10715760903468758; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Rana D, 2013, DESALINATION, V321, P77, DOI 10.1016/j.desal.2012.11.007; Sato I, 2011, J TOXICOL SCI, V36, P829, DOI 10.2131/jts.36.829; Sengupta P, 2014, J HAZARD MATER, V266, P94, DOI 10.1016/j.jhazmat.2013.12.010; Shakir K, 2007, SEP PURIF TECHNOL, V54, P373, DOI 10.1016/j.seppur.2006.10.006; Shimura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044200; Shirahata S, 2012, TRENDS FOOD SCI TECH, V23, P124, DOI 10.1016/j.tifs.2011.10.009; Song KC, 1997, SEP PURIF TECHNOL, V12, P215, DOI 10.1016/S1383-5866(97)00045-2; Spulber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042078; Spyropoulos BG, 2011, DIGEST DIS SCI, V56, P285, DOI 10.1007/s10620-010-1307-1; Szabo J, 2014, ENV INT; Tagami K, 2011, CHEMOSPHERE, V84, P1282, DOI 10.1016/j.chemosphere.2011.05.050; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Terasaki Y, 2011, AM J PHYSIOL-LUNG C, V301, pL415, DOI 10.1152/ajplung.00008.2011; Teruya K, 2013, BIOL PHARM BULL, V36, P352, DOI 10.1248/bpb.b12-00709; Thakur P, 2013, SCI TOTAL ENVIRON, V458, P577, DOI 10.1016/j.scitotenv.2013.03.105; Thammawong C, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1689-z; Valsala TP, 2009, J HAZARD MATER, V166, P1148, DOI 10.1016/j.jhazmat.2008.12.019; Vijayalaxmi, 2004, INT J RADIAT ONCOL, V59, P639, DOI 10.1016/j.ijrobp.2004.02.006; Vipin AK, 2013, J HAZARD MATER, V258, P93, DOI 10.1016/j.jhazmat.2013.04.024; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; WATARI K, 1988, J NUCL SCI TECHNOL, V25, P495, DOI 10.3327/jnst.25.495; Yan Hanxu, 2011, BMC Proc, V5 Suppl 8, pP69, DOI 10.1186/1753-6561-5-S8-P69; Yan HX, 2011, BIOSCI BIOTECH BIOCH, V75, P1295, DOI 10.1271/bbb.110072; Yan HX, 2010, BIOSCI BIOTECH BIOCH, V74, P2011, DOI 10.1271/bbb.100250; Ye J, 2008, BIOL PHARM BULL, V31, P19, DOI 10.1248/bpb.31.19; Yoshihisa Y, 2011, FREE RADICAL RES, V45, P326, DOI 10.3109/10715762.2010.532494; Yoshihisa Y, 2010, EXP DERMATOL, V19, P1000, DOI 10.1111/j.1600-0625.2010.01128.x; Yoshinobu H, 2012, Patent application number, Patent No. [US 20120132578, 20120132578]; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635	77	18	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102218	10.1371/journal.pone.0102218	http://dx.doi.org/10.1371/journal.pone.0102218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029447	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600046
J	Tajuddin, N; Moon, KH; Marshall, SA; Nixon, K; Neafsey, EJ; Kim, HY; Collins, MA				Tajuddin, Nuzhath; Moon, Kwan-Hoon; Marshall, S. Alex; Nixon, Kimberly; Neafsey, Edward J.; Kim, Hee-Yong; Collins, Michael A.			Neuroinflammation and Neurodegeneration in Adult Rat Brain from Binge Ethanol Exposure: Abrogation by Docosahexaenoic Acid	PLOS ONE			English	Article							ALCOHOL-INDUCED NEURODEGENERATION; CYTOSOLIC PHOSPHOLIPASE A(2); SLICE CULTURES; AQUAPORIN-4 EXPRESSION; NEURONAL DEGENERATION; COGNITIVE IMPAIRMENT; ACTIVATION; DAMAGE; EDEMA; INTOXICATION	Evidence that brain edema and aquaporin-4 (AQP4) water channels have roles in experimental binge ethanol-induced neurodegeneration has stimulated interest in swelling/edema-linked neuroinflammatory pathways leading to oxidative stress. We report here that neurotoxic binge ethanol exposure produces comparable significant effects in vivo and in vitro on adult rat brain levels of AQP4 as well as neuroinflammation-linked enzymes: key phospholipase A2 (PLA2) family members and poly (ADP-ribose) polymerase-1 (PARP-1). In adult male rats, repetitive ethanol intoxication (3 gavages/d for 4 d, similar to 9 g/kg/d, achieving blood ethanol levels similar to 375 mg/dl; "Majchrowicz" model) significantly increased AQP4, Ca+2-dependent PLA2 GIVA (cPLA2), phospho-cPLA2 GIVA (p-cPLA2), secretory PLA2 GIIA (sPLA2) and PARP-1 in regions incurring extensive neurodegeneration in this model-hippocampus, entorhinal cortex, and olfactory bulb-but not in two regions typically lacking neurodamage, frontal cortex and cerebellum. Also, ethanol reduced hippocampal Ca+2-independent PLA2 GVIA (iPLA2) levels and increased brain "oxidative stress footprints" (4-hydroxynonenal-adducted proteins). For in vitro studies, organotypic cultures of rat hippocampal-entorhinocortical slices of adult age (similar to 60 d) were ethanol-binged (100 mM or,450 mg/dl) for 4 d, which augments AQP4 and causes neurodegeneration (Collins et al. 2013). Reproducing the in vivo results, cPLA2, p-cPLA2, sPLA2 and PARP-1 were significantly elevated while iPLA2 was decreased. Furthermore, supplementation with docosahexaenoic acid (DHA; 22:6n-3), known to quell AQP4 and neurodegeneration in ethanol-treated slices, blocked PARP-1 and PLA2 changes while counteracting endogenous DHA reduction and increases in oxidative stress footprints (3-nitrotyrosinated proteins). Notably, the PARP-1 inhibitor PJ-34 suppressed binge ethanol-dependent neurodegeneration, indicating PARP upstream involvement. The results with corresponding models support involvement of AQP4- and PLA2-associated neuroinflammatory pro-oxidative pathways in the neurodamage, with potential regulation by PARP-1 as well. Furthermore, DHA emerges as an effective inhibitor of these binge ethanol-dependent neuroinflammatory pathways as well as associated neurodegeneration in adult-age brain.	[Tajuddin, Nuzhath; Moon, Kwan-Hoon; Neafsey, Edward J.; Collins, Michael A.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60660 USA; [Marshall, S. Alex; Nixon, Kimberly] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA; [Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA	Loyola University Chicago; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Collins, MA (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60660 USA.	mcollin@luc.edu	Nixon, Kimberly/A-1217-2015; Neafsey, Edward J./ABG-3419-2021; Nixon, Kimberly/Y-9270-2019	Nixon, Kimberly/0000-0002-3466-9912	NIH [U01 AA018279, R01 AA0016959, T32 DA016176]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016959, ZIAAA000284, U01AA018279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA016176] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH U01 AA018279 (MAC), R01 AA0016959 (KN), and T32 DA016176 (SAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Adermark L, 2011, ADDICT BIOL, V16, P43, DOI 10.1111/j.1369-1600.2010.00206.x; Akbar M, 2006, J NEUROSCI RES, V83, P432, DOI 10.1002/jnr.20744; Alexander LD, 2004, KIDNEY INT, V65, P551, DOI 10.1111/j.1523-1755.2004.00405.x; Aschner M, 2001, BRAIN RES, V900, P219, DOI 10.1016/S0006-8993(01)02314-9; Barron S, 2008, ALCOHOL CLIN EXP RES, V32, P929, DOI 10.1111/j.1530-0277.2008.00649.x; Basavappa S, 1998, J NEUROPHYSIOL, V79, P1441, DOI 10.1152/jn.1998.79.3.1441; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Berry JN, 2012, NEUROSCIENCE, V222, P147, DOI 10.1016/j.neuroscience.2012.07.033; Blanco AM, 2007, FRONT BIOSCI-LANDMRK, V12, P2616, DOI 10.2741/2259; Brown J, 2009, NEUROCHEM RES, V34, P260, DOI 10.1007/s11064-008-9765-y; Cao DH, 2005, LIFE SCI, V78, P74, DOI 10.1016/j.lfs.2005.04.083; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Cieslik M, 2013, NEUROCHEM INT, V62, P626, DOI 10.1016/j.neuint.2013.02.016; Cippitelli A, 2014, ADDICT BIOL, V19, P27, DOI 10.1111/j.1369-1600.2012.00451.x; Cippitelli A, 2010, BIOL PSYCHIAT, V67, P823, DOI 10.1016/j.biopsych.2009.12.018; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Collins MA, 2013, NEUROTOX RES, V23, P105, DOI 10.1007/s12640-012-9360-5; Collins Michael A, 2012, Front Biosci (Elite Ed), V4, P1358; Corso TD, 1998, ALCOHOL CLIN EXP RES, V22, P217, DOI 10.1111/j.1530-0277.1998.tb03641.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; Czapski GA, 2013, NEUROCHEM INT, V62, P664, DOI 10.1016/j.neuint.2013.01.020; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Eckert GP, 2013, PROSTAG LEUKOTR ESS, V88, P105, DOI 10.1016/j.plefa.2012.05.006; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Furuya H, 2000, Environ Health Prev Med, V5, P103, DOI 10.1265/ehpm.2000.103; Galluzzi L, 2014, MOL MECH REGULATED N; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gotz ME, 2001, ALCOHOL CLIN EXP RES, V25, P717, DOI 10.1111/j.1530-0277.2001.tb02272.x; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hamelink C, 2005, J PHARMACOL EXP THER, V314, P780, DOI 10.1124/jpet.105.085779; Haussinger D, 2005, METAB BRAIN DIS, V20, P285, DOI 10.1007/s11011-005-7908-2; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Hoda MN, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-21; HUDSPITH M, 1985, ALCOHOL, V2, P133, DOI 10.1016/0741-8329(85)90030-8; HUNT WA, 1993, ALCOHOL, V10, P559, DOI 10.1016/0741-8329(93)90083-Z; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Jones AW, 1999, J STUD ALCOHOL, V60, P400, DOI 10.15288/jsa.1999.60.400; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kim HY, 2008, CHEM PHYS LIPIDS, V153, P34, DOI 10.1016/j.chemphyslip.2008.02.014; Kim HY, 2011, PROSTAG OTH LIPID M, V96, P114, DOI 10.1016/j.prostaglandins.2011.07.002; Kim HY, 2010, PROSTAG LEUKOTR ESS, V82, P165, DOI 10.1016/j.plefa.2010.02.025; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Langelier B, 2005, LIPIDS, V40, P719, DOI 10.1007/s11745-005-1435-8; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Lin TN, 2004, J NEUROCHEM, V90, P637, DOI 10.1111/j.1471-4159.2004.02540.x; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Marshall SA, 2013, NEUROBIOL DIS; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Orr SK, 2013, PROSTAG LEUKOTR ESS, V88, P97, DOI 10.1016/j.plefa.2012.05.008; Oyama LM, 2000, ALCOHOL, V21, P201, DOI 10.1016/S0741-8329(00)00074-4; Patten AR, 2013, NEUROSCI LETT, V551, P7, DOI 10.1016/j.neulet.2013.05.051; Patten AR, 2013, J NUTR BIOCHEM, V24, P760, DOI 10.1016/j.jnutbio.2012.04.003; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Shield KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051923; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Strokin M, 2006, NEUROSCIENCE, V140, P547, DOI 10.1016/j.neuroscience.2006.02.026; Sun GY, 2012, MOL NEUROBIOL, V46, P85, DOI 10.1007/s12035-012-8261-1; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; SWITZER RC, 1982, ANAT REC, V202, pA186; Tajuddin NF, 2013, ALCOHOL, V47, P39, DOI 10.1016/j.alcohol.2012.09.003; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Umhau JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075333; Virta JJ, 2010, J ALZHEIMERS DIS, V22, P939, DOI 10.3233/JAD-2010-100870; Wang ML, 2006, BIOCHEM BIOPH RES CO, V350, P399, DOI 10.1016/j.bbrc.2006.09.057; Wen ZM, 2007, J NEUROSCI RES, V85, P1568, DOI 10.1002/jnr.21263; Wen ZM, 2004, J NEUROCHEM, V89, P1368, DOI 10.1111/j.1471-4159.2004.02433.x; Xu DZ, 2001, EXP BIOL MED, V226, P927, DOI 10.1177/153537020122601008; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang H, 2013, NEUROCHEM RES, V38, P753, DOI 10.1007/s11064-013-0974-7; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014; Zou JY, 1996, ALCOHOL CLIN EXP RES, V20, P1406, DOI 10.1111/j.1530-0277.1996.tb01141.x	99	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e101223	10.1371/journal.pone.0101223	http://dx.doi.org/10.1371/journal.pone.0101223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029343	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600012
J	Kim, ET; Kim, YE; Kim, YJ; Lee, MK; Hayward, GS; Ahn, JH				Kim, Eui Tae; Kim, Young-Eui; Kim, Ye Ji; Lee, Myoung Kyu; Hayward, Gary S.; Ahn, Jin-Hyun			Analysis of Human Cytomegalovirus-Encoded SUMO Targets and Temporal Regulation of SUMOylation of the Immediate-Early Proteins IE1 and IE2 during Infection	PLOS ONE			English	Article							COVALENT MODIFICATION; VIRAL REPLICATION; NUCLEAR-BODIES; CONJUGATING ENZYME; GENE-PRODUCT; KINASE BGLF4; PML; BINDING; UBC9; EXPRESSION	Post-translational modification of proteins by members of the small ubiquitin-like modifier (SUMO) is involved in diverse cellular functions. Many viral proteins are SUMO targets and also interact with the cellular SUMOylation system. During human cytomegalovirus (HCMV) infection, the immediate-early (IE) proteins IE1 and IE2 are covalently modified by SUMO. IE2 SUMOylation promotes its transactivation activity, whereas the role of IE1 SUMOylation is not clear. We performed in silico, genome-wide analysis to identify possible SUMOylation sites in HCMV-encoded proteins and evaluated their modification using the E. coli SUMOylation system and in vitro assays. We found that only IE1 and IE2 are substantially modified by SUMO in E. coli, although US34A was also identified as a possible SUMO target in vitro. We also found that SUMOylation of IE1 and IE2 is temporally regulated during viral infection. Levels of SUMO-modified form of IE1 were increased during the early phase of infection, but decreased in the late phase when IE2 and its SUMO-modified forms were expressed at high levels. IE2 expression inhibited IE1 SUMOylation in cotransfection assays. As in IE2 SUMOylation, PIAS1, a SUMO E3 ligase, interacted with IE1 and enhanced IE1 SUMOylation. In in vitro assays, an IE2 fragment that lacked covalent and non-covalent SUMO attachment sites, but was sufficient for PIAS1 binding, effectively inhibited PIAS1-mediated SUMOylation of IE1, indicating that IE2 expression negatively regulates IE1 SUMOylation. We also found that the IE2-mediated downregulation of IE1 SUMOylation correlates with the IE1 activity to repress the promoter containing the interferon stimulated response elements. Taken together, our data demonstrate that IE1 and IE2 are the main viral SUMO targets in HCMV infection and that temporal regulation of their SUMOylation may be important in the progression of this infection.	[Kim, Eui Tae; Kim, Young-Eui; Kim, Ye Ji; Lee, Myoung Kyu; Ahn, Jin-Hyun] Sungkyunkwan Univ Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon, South Korea; [Hayward, Gary S.] Johns Hopkins Univ Sch Med, Viral Oncol Program, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Sungkyunkwan University (SKKU); Johns Hopkins University; Johns Hopkins Medicine	Ahn, JH (corresponding author), Sungkyunkwan Univ Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon, South Korea.	jahn@skku.edu	Lee, Myoung Kyu/AAC-6836-2022	Lee, Myoung Kyu/0000-0002-6217-4415; Kim, Eui Tae/0000-0002-1631-3197	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2005-2001163, 2012R1A2A2A01002551]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2005-2001163 and 2012R1A2A2A01002551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 1997, J VIROL, V71, P4599, DOI 10.1128/JVI.71.6.4599-4613.1997; Ahn JH, 1999, J VIROL, V73, P10458, DOI 10.1128/JVI.73.12.10458-10471.1999; Ahn JH, 1998, MOL CELL BIOL, V18, P4899, DOI 10.1128/MCB.18.8.4899; Ahn JH, 2001, J VIROL, V75, P3859, DOI 10.1128/JVI.75.8.3859-3872.2001; Barrasa MI, 2003, J VIROL, V77, P4760, DOI 10.1128/JVI.77.8.4760-4772.2003; Berndt A, 2009, J VIROL, V83, P12881, DOI 10.1128/JVI.01525-09; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Hagemeier SR, 2010, J VIROL, V84, P4383, DOI 10.1128/JVI.02369-09; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heaton PR, 2011, VIRUS RES, V158, P199, DOI 10.1016/j.virusres.2011.04.001; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Huh YH, 2008, J VIROL, V82, P10444, DOI 10.1128/JVI.00833-08; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kang H, 2006, J GEN VIROL, V87, P2181, DOI 10.1099/vir.0.81787-0; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim ET, 2010, J VIROL, V84, P8111, DOI 10.1128/JVI.00459-10; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Krauss S, 2009, J VIROL, V83, P12854, DOI 10.1128/JVI.01164-09; Lee HR, 2004, J GEN VIROL, V85, P2149, DOI 10.1099/vir.0.79954-0; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lee JM, 2003, FEBS LETT, V555, P322, DOI 10.1016/S0014-5793(03)01268-7; Li RW, 2012, J VIROL, V86, P5412, DOI 10.1128/JVI.00314-12; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Margulies BJ, 2007, VIRUS RES, V123, P57, DOI 10.1016/j.virusres.2006.08.003; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Nevels M, 2004, J VIROL, V78, P7803, DOI 10.1128/JVI.78.14.7803-7812.2004; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Paulus C, 2006, P NATL ACAD SCI USA, V103, P3840, DOI 10.1073/pnas.0600007103; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; PIZZORNO MC, 1991, J VIROL, V65, P3839, DOI 10.1128/JVI.65.7.3839-3852.1991; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sadanari H, 2005, ARCH VIROL, V150, P1763, DOI 10.1007/s00705-005-0559-0; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scherer M, 2013, J GEN VIROL, V94, P1373, DOI 10.1099/vir.0.051078-0; Shin HJ, 2012, J GEN VIROL, V93, P716, DOI 10.1099/vir.0.037986-0; Sinigalia E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049630; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spengler ML, 2002, J VIROL, V76, P2990, DOI 10.1128/JVI.76.6.2990-2996.2002; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Tavalai N, 2011, J VIROL, V85, P9447, DOI 10.1128/JVI.00870-11; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Wilkinson GWG, 1998, J GEN VIROL, V79, P1233, DOI 10.1099/0022-1317-79-5-1233; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Xu YX, 2001, J VIROL, V75, P10683, DOI 10.1128/JVI.75.22.10683-10695.2001; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	63	73	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103308	10.1371/journal.pone.0103308	http://dx.doi.org/10.1371/journal.pone.0103308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050850	Green Submitted, gold, Green Published			2022-12-27	WOS:000339551100102
J	Mennella, JA; Reed, DR; Roberts, KM; Mathew, PS; Mansfield, CJ				Mennella, Julie A.; Reed, Danielle R.; Roberts, Kristi M.; Mathew, Phoebe S.; Mansfield, Corrine J.			Age-Related Differences in Bitter Taste and Efficacy of Bitter Blockers	PLOS ONE			English	Article							SWEET; PHENYLTHIOCARBAMIDE; INDIVIDUALS; PREFERENCES; SENSITIVITY; SUPPRESSION; PERCEPTION; PREVENTION; MASKING; HEALTH	Background: Bitter taste is the primary culprit for rejection of pediatric liquid medications. We probed the underlying biology of bitter sensing and the efficacy of two known bitter blockers in children and adults. Methods: A racially diverse group of 154 children (3-10 years old) and their mothers (N = 118) evaluated the effectiveness of two bitter blockers, sodium gluconate (NaG) and monosodium glutamate (MSG), for five food-grade bitter compounds (quinine, denatonium benzoate, caffeine, propylthiouracil (PROP), urea) using a forced-choice method of paired comparisons. The trial was registered at clinicaltrials.gov (NCT01407939). Results: The blockers reduced bitterness in 7 of 10 bitter-blocker combinations for adults but only 3 of 10 for children, suggesting that efficacy depends on age and is also specific to each bitter-blocker combination. Only the bitterness of urea was reduced by both blockers in both age groups, whereas the bitterness of PROP was not reduced by either blocker in either age group regardless of TAS2R38 genotype. Children liked the salty taste of the blocker NaG more than did adults, but both groups liked the savory taste of MSG equally. Conclusions and Relevance: Bitter blocking was less effective in children, and the efficacy of blocking was both age and compound specific. This knowledge will pave the way for evidence-based strategies to help develop better-tasting medicines and highlights the conclusion that adult panelists and genotyping alone may not always be appropriate in evaluating the taste of a drug geared for children.	[Mennella, Julie A.; Reed, Danielle R.; Roberts, Kristi M.; Mathew, Phoebe S.; Mansfield, Corrine J.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Mennella, JA (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	mennella@monell.org		Mennella, Julie/0000-0002-8855-0204; Reed, Danielle/0000-0002-4374-6107	National Institute of Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH) [R01 DC011287]; NIH-NIDCD [P30DC011735]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC011735, R01DC011287] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors acknowledge the National Institute of Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), for funding and support for this project (R01 DC011287). Genotyping was performed at the Monell at the Genotyping and DNA/RNA Analysis Core, which is supported, in part, by funding from NIH-NIDCD core grant P30DC011735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; ANLIKER JA, 1991, AM J CLIN NUTR, V54, P316, DOI 10.1093/ajcn/54.2.316; [Anonymous], CIT TRANSF RAC ETHN; Bartoshuk L., 1980, BIOL BEHAVIORAL ASPE, P83; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; BEAUCHAMP GK, 1990, DEV PSYCHOL, V26, P539, DOI 10.1037/0012-1649.26.4.539; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Breslin PAS, 1997, NATURE, V387, P563, DOI 10.1038/42388; Breslin PAS, 1995, CHEM SENSES, V20, P609, DOI 10.1093/chemse/20.6.609; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; COWART BJ, 1994, PHYSIOL BEHAV, V56, P1237, DOI 10.1016/0031-9384(94)90371-9; Delwiche JF, 2001, PERCEPT PSYCHOPHYS, V63, P761, DOI 10.3758/BF03194436; Giacoia GP, 2012, CLIN THER, V34, pS1, DOI 10.1016/j.clinthera.2012.09.013; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Guo SW, 2001, ANN HUM BIOL, V28, P111; Keast RSJ, 2004, CHEM SENSES, V29, P431, DOI 10.1093/chemse/bjh045; Keast RSJ, 2002, PHARM RES-DORDR, V19, P1019, DOI 10.1023/A:1016474607993; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; KROEZE JHA, 1985, PHYSIOL BEHAV, V35, P779, DOI 10.1016/0031-9384(85)90412-3; LAWLESS HT, 1983, J TOXICOL-CLIN TOXIC, V19, P951; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; MATTES RD, 1985, AM J CLIN NUTR, V41, P672, DOI 10.1093/ajcn/41.4.672; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; Mennella JA, 2003, DEV PSYCHOBIOL, V43, P120, DOI 10.1002/dev.10127; Mennella JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092201; Mennella JA, 2013, CLIN THER, V35, P1225, DOI 10.1016/j.clinthera.2013.06.007; Mennella JA, 2011, CHEM SENSES, V36, P345, DOI 10.1093/chemse/bjq134; Mennella JA, 2011, CHEM SENSES, V36, P161, DOI 10.1093/chemse/bjq106; Mennella JA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-60; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Milne CP, 2008, CLIN THER, V30, P2133, DOI 10.1016/j.clinthera.2008.11.019; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Narukawa M, 2012, BIOSCI BIOTECH BIOCH, V76, P2282, DOI 10.1271/bbb.120560; Palmer RK, 2007, MOL INTERV, V7, P87, DOI 10.1124/mi.7.2.9; RODGERS GC, 1994, PEDIATRICS, V93, P68; Roy G.M., 1997, MODIFYING BITTERNESS, Vfirst; Salunke S, 2013, INT J PHARMACEUT, V457, P310, DOI 10.1016/j.ijpharm.2013.09.013; SCHIFFMAN SS, 1994, NEUROBIOL AGING, V15, P743, DOI 10.1016/0197-4580(94)90057-4; SIBERT JR, 1991, ARCH EMERG MED, V8, P1; Siegel S., 1988, NONPARAMETRIC STAT B, V2nd, P168; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Spielman AI, 2010, J VIS EXP; Stein LJ, 2003, APPETITE, V40, P119, DOI 10.1016/S0195-6663(02)00173-3; Stevens JC, 1996, CHEM SENSES, V21, P211, DOI 10.1093/chemse/21.2.211	47	39	40	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103107	10.1371/journal.pone.0103107	http://dx.doi.org/10.1371/journal.pone.0103107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050705	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100089
J	Wang, KH; Zhang, XZ; Goatley, M; Ervin, E				Wang, Kehua; Zhang, Xunzhong; Goatley, Mike; Ervin, Erik			Heat Shock Proteins in Relation to Heat Stress Tolerance of Creeping Bentgrass at Different N Levels	PLOS ONE			English	Article							MOLECULAR CHAPERONES; FOLIAR APPLICATION; GENE FAMILY; EXPRESSION; HSP90; ARABIDOPSIS; NITROGEN; CYTOKININ; HSP101; THERMOTOLERANCE	Heat stress is a primary factor causing summer bentgrass decline. Changes in gene expression at the transcriptional and/or translational level are thought to be a fundamental mechanism in plant response to environmental stresses. Heat stress redirects protein synthesis in higher plants and results in stress protein synthesis, particularly heat shock proteins (HSPs). The goal of this work was to analyze the expression pattern of major HSPs in creeping bentgrass (Agrostis stolonifera L.) during different heat stress periods and to study the influence of nitrogen (N) on the HSP expression patterns. A growth chamber study on 'Penn-A4' creeping bentgrass subjected to 38/28 degrees C day/night for 50 days, was conducted with four nitrate rates (no N-0, low N-2.5, medium N-7.5, and high N-12.5 kg N ha(-1)) applied biweekly. Visual turfgrass quality (TQ), normalized difference vegetation index (NDVI), photochemical efficiency of photosystem II (Fv/Fm), shoot electrolyte leakage (ShEL), and root viability (RV) were monitored, along with the expression pattern of HSPs. There was no difference in measured parameters between treatments until week seven, except TQ at week five. At week seven, grass at medium N had better TQ, NDVI, and Fv/Fm accompanied by lower ShEL and higher RV, suggesting a major role in improved heat tolerance. All the investigated HSPs (HSP101, HSP90, HSP70, and sHSPs) were up-regulated by heat stress. Their expression patterns indicated cooperation between different HSPs and their roles in bentgrass thermotolerance. In addition, their production seems to be resource dependent. This study could further improve our understanding about how different N levels affect bentgrass thermotolerance.	[Wang, Kehua] China Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Wang, Kehua; Zhang, Xunzhong; Goatley, Mike; Ervin, Erik] Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA	China Agricultural University; Virginia Polytechnic Institute & State University	Wang, KH (corresponding author), China Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	kehwang@cau.edu.cn			Virginia Agricultural Experiment Station	Virginia Agricultural Experiment Station	This study was supported by the Virginia Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Agarwal M, 2003, PLANT MOL BIOL, V51, P543, DOI 10.1023/A:1022324920316; Al-Niemi TS, 2002, J THERM BIOL, V27, P547, DOI 10.1016/S0306-4565(02)00029-3; Batra G, 2007, J BIOSCIENCES, V32, P611, DOI 10.1007/s12038-007-0060-x; Beard JB., 2002, TURF MANAGEMENT GOLF, V2nd ed; Bharti K., 2002, PLANT SIGNAL TRANSDU, P74; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Campbell JL, 2001, BBA-GENE STRUCT EXPR, V1517, P270, DOI 10.1016/S0167-4781(00)00292-X; Carrow R.N., 2001, TURFGRASS SOIL FERTI; Cho EK, 2009, BIOTECHNOL LETT, V31, P597, DOI 10.1007/s10529-008-9880-5; Crevel G, 2001, J CELL SCI, V114, P2015; Deloche O, 1997, J BACTERIOL, V179, P6066, DOI 10.1128/jb.179.19.6066-6075.1997; DEROCHER AE, 1991, PLANT PHYSIOL, V96, P1038, DOI 10.1104/pp.96.4.1038; DUBLE RL, 2001, TURFGRASSES THEIR MA; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Fry J., 2004, APPL TURFGRASS SCI P; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Fu JM, 2003, J PLANT NUTR, V26, P81, DOI 10.1081/PLN-120016498; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Harndahl U, 1999, CELL STRESS CHAPERON, V4, P129; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; He Y, 2007, CROP SCI, V47, P2513, DOI 10.2135/cropsci2006.12.0821; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Heckathorn SA, 1996, OECOLOGIA, V105, P413, DOI 10.1007/BF00328745; Hong SW, 2001, PLANT J, V27, P25, DOI 10.1046/j.1365-313x.2001.01066.x; HSIEH MH, 1992, PLANT PHYSIOL, V99, P1279, DOI 10.1104/pp.99.4.1279; Huang BR, 2008, J INTEGR PLANT BIOL, V50, P1230, DOI 10.1111/j.1744-7909.2008.00735.x; Karlin S, 1998, J MOL EVOL, V47, P565, DOI 10.1007/PL00006413; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JH, 1996, MOL GEN GENET, V252, P11, DOI 10.1007/BF02173200; Leone A, 2003, ABIOTIC STRESSES IN PLANTS, P1; LIU H, 2007, HDB TURFGRASS MANAGE, P555; Liu XH, 2002, CROP SCI, V42, P466, DOI 10.2135/cropsci2002.0466; Ludwig-Muller J, 2000, PLANT PHYSIOL, V123, P949, DOI 10.1104/pp.123.3.949; Luthe DS, 2000, BOOK SOIL P, P283; Malik MK, 1999, PLANT J, V20, P89, DOI 10.1046/j.1365-313X.1999.00581.x; McLellan CA, 2007, PLANT PHYSIOL, V145, P174, DOI 10.1104/pp.107.101808; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; Nieto-Sotelo J, 2002, PLANT CELL, V14, P1621, DOI 10.1105/tpc.010487; Park SY, 1996, PLANT PHYSIOL, V111, P515, DOI 10.1104/pp.111.2.515; PELLETT HM, 1963, AGRON J, V55, P473, DOI 10.2134/agronj1963.00021962005500050019x; Pote J, 2006, J AM SOC HORTIC SCI, V131, P608, DOI 10.21273/JASHS.131.5.608; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rachmilevitch S, 2007, PHYSIOL PLANTARUM, V129, P163, DOI 10.1111/j.1399-3054.2006.00784.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schulze E-D., 2005, PLANT ECOL; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tawfik AA, 1996, AM POTATO J, V73, P261, DOI 10.1007/BF02849276; Totten FW, 2007, GOLF COURSE MANAGEME, V75, P110; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang D, 2008, J INTEGR PLANT BIOL, V50, P1416, DOI 10.1111/j.1744-7909.2008.00748.x; Wang DF, 2003, PLANT PHYSIOL, V133, P319, DOI 10.1104/pp.102.018309; Wang KH, 2007, HORTSCIENCE, V42, P386, DOI 10.21273/HORTSCI.42.2.386; Wang KH, 2013, J PLANT NUTR, V36, P1549, DOI 10.1080/01904167.2013.799184; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; Xu Y., 2011, INT J PROTEOMICS, V2011; Xu Y, 2010, J EXP BOT, V61, P3273, DOI 10.1093/jxb/erq149; Xu Y, 2009, CROP SCI, V49, P1876, DOI 10.2135/cropsci2008.07.0441; Young TE, 2001, PLANT PHYSIOL, V127, P777, DOI 10.1104/pp.010160; Zhang XZ, 2008, CROP SCI, V48, P364, DOI 10.2135/cropsci2007.05.0262; Zhang Y, 2005, J EXP BOT, V56, P897, DOI 10.1093/jxb/eri082; Zhao WY, 2008, BIOL PLANTARUM, V52, P113, DOI 10.1007/s10535-008-0021-8	72	35	36	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102914	10.1371/journal.pone.0102914	http://dx.doi.org/10.1371/journal.pone.0102914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050702	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100067
J	Gibson, RA; Robertson, J; Mistry, H; McCallum, S; Fernando, D; Wyres, M; Yosipovitch, G				Gibson, Rachel A.; Robertson, Jon; Mistry, Harshna; McCallum, Stewart; Fernando, Disala; Wyres, Melody; Yosipovitch, Gil			A Randomised Trial Evaluating the Effects of the TRPV1 Antagonist SB705498 on Pruritus Induced by Histamine, and Cowhage Challenge in Healthy Volunteers	PLOS ONE			English	Article							NEUROGENIC INFLAMMATION; VANILLOID RECEPTOR-1; ATOPIC-DERMATITIS; ACTIVATION; SB-705498; POTENTIATION; CHANNELS; THERAPY; REVEALS; MODEL	Background: Transient receptor potential vanilloid type 1 (TRPV1) is a non-selective cation channel widely expressed in skin tissues, and peripheral sensory nerve fibres. Activation of TRPV1 releases neuropeptides; the resulting neurogenic inflammation is believed to contribute to the development of pruritus. A TRPV1 antagonist has the potential to perform as an anti-pruritic agent. SB705498 is a TRPV1 antagonist that has demonstrated in vitro activity against cloned TRPV1 human receptors and when orally administered has demonstrated pharmacodynamic activity in animal models and clinical studies. Objectives: To select a topical dose of SB705498 using the TRPV1 agonist capsaicin; to confirm engagement of the TRPV1 antagonistic action of SB705498 and assess whether the dose selected has an effect on itch induced by two challenge agents. Methods: A clinical study was conducted in 16 healthy volunteers to assess the effects of 3 doses of SB705498 on skin flare induced by capsaicin. Subjects with a robust capsaicin response were chosen to determine if the selected topical formulation of SB705498 had an effect on challenge agent induced itch. Results: Following capsaicin challenge the greatest average reduction in area of flare was seen for the 3% formulation. This dose was selected for further investigation. Itch intensity induced by two challenge agents (cowhage and histamine) was assessed on the Computerised Visual Analogue Scale. The difference in average itch intensity (Weighted Mean Over 15 Mins) between the 3% dose of SB705498 and placebo for the cowhage challenge was -0.64, whilst the histamine challenge showed on average a -4.65 point change. Conclusions: The 3% topical formulation of SB705498 cream was clinically well tolerated and had target specific pharmacodynamic activity. However there were no clinically significant differences on pruritus induced by either challenge agent in comparison to placebo. SB705498 is unlikely to be of symptomatic benefit for histaminergic or non-histaminergic induced itch.	[Gibson, Rachel A.] GlaxoSmithKline, Acad Discovery Performance Unit, Stevenage, Herts, England; [Robertson, Jon] GlaxoSmithKline, Quantitat Sci, Stevenage, Herts, England; [Mistry, Harshna] Clin Pharmacol Sci & Study Operat GlaxoSmithKline, Cambridge, England; [McCallum, Stewart] GlaxoSmithKline, Acad Discovery Performance Unit, Collegeville, PA USA; [Fernando, Disala] GlaxoSmithKline, Clin Unit, Cambridge, England; [Wyres, Melody] Stiefel, Clin Dev, Res Triangle Pk, NC USA; [Yosipovitch, Gil] Temple Univ, Sch Med, Dept Dermatol, Philadelphia, PA 19122 USA; [Yosipovitch, Gil] Temple Univ, Sch Med, Temple Itch Ctr, Philadelphia, PA 19122 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gibson, RA (corresponding author), GlaxoSmithKline, Acad Discovery Performance Unit, Stevenage, Herts, England.	rachel.a.gibson@gsk.com	Yosipovitch, Gil/K-3517-2019; McCallum, Stewart W/E-1289-2018	McCallum, Stewart W/0000-0001-7550-5845; Gibson, Rachel/0000-0002-1338-1290	GlaxoSmithKline Research and Development	GlaxoSmithKline Research and Development(GlaxoSmithKline)	The study NCT01673529 was funded by GlaxoSmithKline Research and Development. The following authors are all employees of GlaxoSmithKline - Rachel A. Gibson, Jon Robertson, Harshna Mistry, Stewart McCallum, Disala Fernando and Melody Wyres. The funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alenmyr L, 2012, BASIC CLIN PHARMACOL, V110, P264, DOI 10.1111/j.1742-7843.2011.00803.x; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Belghiti M, 2013, J BIOL CHEM, V288, P9675, DOI 10.1074/jbc.M113.455162; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Changani K, 2013, BRIT J PHARMACOL, V169, P580, DOI 10.1111/bph.12145; Chizh BA, 2007, PAIN, V132, P132, DOI 10.1016/j.pain.2007.06.006; Costa R, 2008, BRIT J PHARMACOL, V154, P1094, DOI 10.1038/bjp.2008.172; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Davis JB, 2005, NEUR M PLANN; Francke K, 2009, CLIN PHARMACOL THER, V85, pS62; Gunthorpe MJ, 2007, J PHARMACOL EXP THER, V321, P1183, DOI 10.1124/jpet.106.116657; Hutter MM, 2005, PANCREAS, V30, P260, DOI 10.1097/01.mpa.0000153616.63384.24; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2007, J NEUROSCI, V27, P7490, DOI 10.1523/JNEUROSCI.1249-07.2007; Kofler L, 2011, SCHOLARLY NETWORK IS, DOI [10.5402/2011/353045, DOI 10.5402/2011/353045]; Lim KM, 2012, ARCH PHARM RES, V35, P393, DOI 10.1007/s12272-012-0321-6; Ortonne JP, 2012, EUR J INTERN MED, V23, P26, DOI 10.1016/j.ejim.2011.09.008; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Patel T, 2010, EXPERT OPIN PHARMACO, V11, P1673, DOI 10.1517/14656566.2010.484420; Reddy VB, 2008, J NEUROSCI, V28, P4331, DOI 10.1523/JNEUROSCI.0716-08.2008; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Valdes-Rodriguez R, 2013, CURR TOP MED CHEM, V13, P335; Xiao BL, 2011, NAT NEUROSCI, V14, P540, DOI 10.1038/nn.2813; Yosipovitch G, 2000, BRIT J DERMATOL, V143, P969, DOI 10.1046/j.1365-2133.2000.03829.x; Yosipovitch G, 2008, CURR ALLERGY ASTHM R, V8, P306, DOI 10.1007/s11882-008-0049-z; Yun JW, 2011, J INVEST DERMATOL, V131, P1576, DOI 10.1038/jid.2011.87; Yun JW, 2011, J DERMATOL SCI, V62, P8, DOI 10.1016/j.jdermsci.2010.10.014	29	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e100610	10.1371/journal.pone.0100610	http://dx.doi.org/10.1371/journal.pone.0100610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047038	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100006
J	Rajapaksha, H; Petrovsky, N				Rajapaksha, Harinda; Petrovsky, Nikolai			In Silico Structural Homology Modelling and Docking for Assessment of Pandemic Potential of a Novel H7N9 Influenza Virus and Its Ability to Be Neutralized by Existing Anti-Hemagglutinin Antibodies	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; A VIRUSES; MOLECULAR-DYNAMICS; SEQUENCE-ANALYSIS; SCORING FUNCTION; HUMAN INFECTION; H2 STRAINS; RECOGNITION; EPITOPE; H1	The unpredictable nature of pandemic influenza and difficulties in early prediction of pandemic potential of new isolates present a major challenge for health planners. Vaccine manufacturers, in particular, are reluctant to commit resources to development of a new vaccine until after a pandemic is declared. We hypothesized that a structural bioinformatics approach utilising homology-based molecular modelling and docking approaches would assist prediction of pandemic potential of new influenza strains alongside more traditional laboratory and sequence-based methods. The newly emerged Chinese A/Hangzhou/1/2013 (H7N9) influenza virus provided a real-life opportunity to test this hypothesis. We used sequence data and a homology-based approach to construct a 3D-structural model of H7-Hangzhou hemagglutinin (HA) protein. This model was then used to perform docking to human and avian sialic acid receptors to assess respective binding affinities. The model was also used to perform docking simulations with known neutralizing antibodies to assess their ability to neutralize the newly emerged virus. The model predicted H7N9 could bind to human sialic acid receptors thereby indicating pandemic potential. The model also confirmed that existing antibodies against the HA head region are unable to neutralise H7N9 whereas antibodies, e.g. Cr9114, targeting the HA stalk region should bind with high affinity to H7N9. This indicates that existing stalk antibodies initially raised against H5N1 or other influenza A viruses could be therapeutically beneficial in prevention and/or treatment of H7N9 infections. The subsequent publication of the H7N9 HA crystal structure confirmed the accuracy of our in-silico structural model. Antibody docking studies performed using the H7N9 HA crystal structure supported the model's prediction that existing stalk antibodies could cross-neutralise the H7N9 virus. This study demonstrates the value of using in-silico structural modelling approaches to complement physical studies in characterization of new influenza viruses.	[Rajapaksha, Harinda; Petrovsky, Nikolai] Vaxine Pty Ltd, Adelaide, SA, Australia; [Petrovsky, Nikolai] Flinders Univ S Australia, Flinders Med Ctr, Dept Endocrinol & Diabet, Adelaide, SA 5001, Australia; [Petrovsky, Nikolai] Flinders Univ S Australia, Flinders Med Ctr, Vaxine Pty Ltd, Adelaide, SA 5001, Australia	Flinders Medical Centre; Flinders University South Australia; Flinders Medical Centre; Flinders University South Australia	Petrovsky, N (corresponding author), Vaxine Pty Ltd, Bedford Pk, Adelaide, SA, Australia.	nikolai.petrovsky@flinders.edu.au	Petrovsky, Nikolai/P-1912-2017	Petrovsky, Nikolai/0000-0002-1580-5245; Rajapaksha, Kolin Harinda/0000-0001-7521-0991	National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN272200800039C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NP and HR are supported by contract HHSN272200800039C from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; De Groot A.S., 2013, HUM VACCIN IMMUNOTHE, V9; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Dortmans JCFM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03058; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Huang Q, 2003, BBA-BIOMEMBRANES, V1614, P3, DOI 10.1016/S0005-2736(03)00158-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imai M, 1998, VIRUS RES, V53, P129, DOI 10.1016/S0168-1702(97)00143-3; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Jonges M, 2013, EUROSURVEILLANCE, V18, P2; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu Q, 2013, MICROBES INFECT, V15, P432, DOI 10.1016/j.micinf.2013.04.004; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Morens D. M., 2013, MBIO, V4; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; OKUNO Y, 1994, J VIROL, V68, P517, DOI 10.1128/JVI.68.1.517-520.1994; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Pedotti M, 2011, INT J MOL SCI, V12, P226, DOI 10.3390/ijms12010226; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sangster MY, 2013, CLIN VACCINE IMMUNOL, V20, P867, DOI 10.1128/CVI.00735-12; Schenk C, 2013, EURO SURVEILL, V18; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tambunan USF, 2010, BIOINFORMATION, V5, P244, DOI 10.6026/97320630005244; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu H, 2013, N ENGL J MED; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xu D, 2009, J MOL BIOL, V387, P465, DOI 10.1016/j.jmb.2009.01.040; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	64	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102618	10.1371/journal.pone.0102618	http://dx.doi.org/10.1371/journal.pone.0102618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047593	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100053
J	Zhang, P; Yi, S; Li, X; Liu, R; Jiang, H; Huang, Z; Liu, Y; Wu, J; Huang, Y				Zhang, Peng; Yi, Shuhong; Li, Xi; Liu, Ruilei; Jiang, Hua; Huang, Zenan; Liu, Yu; Wu, Juekun; Huang, Yong			Preparation of Triple-Negative Breast Cancer Vaccine through Electrofusion with Day-3 Dendritic Cells	PLOS ONE			English	Article							HUMAN MONOCYTES; T-CELLS; CLASS-I; DIFFERENTIATION; GENERATION; STRATEGY; FUTURE	Dendritic cells (DCs) are professional antigen-presenting cells (APCs) in human immune system. DC-based tumor vaccine has met with some success in specific malignancies, inclusive of breast cancer. In this study, we electrofused MDA-MB-231 breast cancer cell line with day-3 DCs derived from peripheral blood monocytes, and explored the biological characteristics of fusion vaccine and its anti-tumor effects in vitro. Day-3 mature DCs were generated from day-2 immature DCs by adding cocktails composed of TNF-alpha, IL-1 beta, IL-6 and PEG(2). Day-3 mature DCs were identified and electofused with breast cancer cells to generate fusion vaccine. Phenotype of fusion cells were identified by fluorescence microscope and flow cytometer. The fusion vaccine was evaluated for T cell proliferation, secretion of IL-12 and IFN-gamma, and induction of tumor-specific CTL response. Despite differences in morphology, day-3 and day-7 DC expressed similar surface markers. The secretion of IL-12 and IFN-gamma in fusion vaccine group was much higher than that in the control group. Compared with control group, DC-tumor fusion vaccine could better stimulate the proliferation of allogeneic T lymphocytes and kill more breast cancer cells (MDA-MB-231) in vitro. Day-3 DCs had the same function as the day-7 DCs, but with a shorter culture period. Our findings suggested that day-3 DCs fused with whole apoptotic breast cancer cells could elicit effective specific antitumor T cell responses in vitro and may be developed into a prospective candidate for adoptivet immunotherapy.	[Zhang, Peng; Li, Xi; Liu, Ruilei; Jiang, Hua; Huang, Zenan; Liu, Yu; Wu, Juekun; Huang, Yong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Thyroid & Breast Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yi, Shuhong] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Thyroid & Breast Surg, Guangzhou 510275, Guangdong, Peoples R China.	dryonghuang@189.cn			Fundamental Research Funds for the Central Universities - Ministry of Education of China [09ykpy15]	Fundamental Research Funds for the Central Universities - Ministry of Education of China	This study was supported by the Fundamental Research Funds for the Central Universities (grant number 09ykpy15), funded by the Ministry of Education of China. http://www.moe.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2005, J CLIN IMMUNOL, V25, P87, DOI 10.1007/s10875-005-2814-2; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Avigan DE, 2007, J IMMUNOTHER, V30, P749, DOI 10.1097/CJI.0b013e3180de4ce8; Benencia F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/425476; Bohnenkamp HR, 2004, CELL IMMUNOL, V231, P112, DOI 10.1016/j.cellimm.2004.12.007; Bonehill A, 2004, J IMMUNOL, V172, P6649, DOI 10.4049/jimmunol.172.11.6649; Burdek M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-90; Campbell-Anson Ryan E, 2008, J Immune Based Ther Vaccines, V6, P1, DOI 10.1186/1476-8518-6-1; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Curigliano G, 2007, EXPERT REV ANTICANC, V7, P1225, DOI 10.1586/14737140.7.9.1225; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Dauer M, 2005, J IMMUNOL METHODS, V302, P145, DOI 10.1016/j.jim.2005.05.010; Delirezh N, 2009, CELL IMMUNOL, V257, P23, DOI 10.1016/j.cellimm.2009.02.002; Fong L, 2000, ANNU REV IMMUNOL, V18, P245, DOI 10.1146/annurev.immunol.18.1.245; Jarnjak-Jankovic S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-119; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Ma WX, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-34; Mittenclorf EA, 2007, CANCER-AM CANCER SOC, V110, P1677, DOI 10.1002/cncr.22978; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Trefzer U, 2005, VACCINE, V23, P2367, DOI 10.1016/j.vaccine.2005.01.081; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Tuyaerts S, 2007, CANCER IMMUNOL IMMUN, V56, P1513, DOI 10.1007/s00262-007-0334-z; Zhang YF, 2007, BREAST CANCER RES TR, V105, P277, DOI 10.1007/s10549-006-9457-8	25	23	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102197	10.1371/journal.pone.0102197	http://dx.doi.org/10.1371/journal.pone.0102197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036145	gold, Green Submitted, Green Published			2022-12-27	WOS:000339615200040
J	Baron, JL; Vikram, A; Duda, S; Stout, JE; Bibby, K				Baron, Julianne L.; Vikram, Amit; Duda, Scott; Stout, Janet E.; Bibby, Kyle			Shift in the Microbial Ecology of a Hospital Hot Water System following the Introduction of an On-Site Monochloramine Disinfection System	PLOS ONE			English	Article							DRINKING-WATER; OPPORTUNISTIC PATHOGENS; PSEUDOMONAS-AERUGINOSA; BACTERIAL-POPULATIONS; COMMUNITY STRUCTURE; CHLORAMINE DECAY; SURFACE-WATER; BIOFILMS; CONTAMINATION; RESISTANCE	Drinking water distribution systems, including premise plumbing, contain a diverse microbiological community that may include opportunistic pathogens. On-site supplemental disinfection systems have been proposed as a control method for opportunistic pathogens in premise plumbing. The majority of on-site disinfection systems to date have been installed in hospitals due to the high concentration of opportunistic pathogen susceptible occupants. The installation of on-site supplemental disinfection systems in hospitals allows for evaluation of the impact of on-site disinfection systems on drinking water system microbial ecology prior to widespread application. This study evaluated the impact of supplemental monochloramine on the microbial ecology of a hospital's hot water system. Samples were taken three months and immediately prior to monochloramine treatment and monthly for the first six months of treatment, and all samples were subjected to high throughput Illumina 16S rRNA region sequencing. The microbial community composition of monochloramine treated samples was dramatically different than the baseline months. There was an immediate shift towards decreased relative abundance of Betaproteobacteria, and increased relative abundance of Firmicutes, Alphaproteobacteria, Gammaproteobacteria, Cyanobacteria and Actinobacteria. Following treatment, microbial populations grouped by sampling location rather than sampling time. Over the course of treatment the relative abundance of certain genera containing opportunistic pathogens and genera containing denitrifying bacteria increased. The results demonstrate the driving influence of supplemental disinfection on premise plumbing microbial ecology and suggest the value of further investigation into the overall effects of premise plumbing disinfection strategies on microbial ecology and not solely specific target microorganisms.	[Baron, Julianne L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Baron, Julianne L.; Duda, Scott; Stout, Janet E.] Special Pathogens Lab, Pittsburgh, PA USA; [Vikram, Amit; Stout, Janet E.; Bibby, Kyle] Univ Pittsburgh, Swanson Sch Engn, Dept Civil & Environm Engn, Pittsburgh, PA 15260 USA; [Bibby, Kyle] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bibby, K (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Civil & Environm Engn, Pittsburgh, PA 15260 USA.	BibbyKJ@pitt.edu	Vikram, Amit/G-5816-2010; Bibby, Kyle J/C-6189-2018	Vikram, Amit/0000-0002-1207-9292; Bibby, Kyle J/0000-0003-3142-6090	Alfred P. Sloan Foundation [B2013-12]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This project was funded by a grant from the Alfred P. Sloan Foundation (grant B2013-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Berry D, 2010, APPL ENVIRON MICROB, V76, P6685, DOI 10.1128/AEM.00644-10; BSR/ASHRAE, 2011, PREV LEG ASS BUILD W; Buse HY, 2011, LETT APPL MICROBIOL, V53, P217, DOI 10.1111/j.1472-765X.2011.03094.x; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiao TH, 2014, ENVIRON SCI TECHNOL, V48, P4038, DOI 10.1021/es4055725; Douterelo I, 2013, WATER RES, V47, P503, DOI 10.1016/j.watres.2012.09.053; Duda S, 2014, EVALUATION NEW UNPUB; Duda S, 2013, 8 INT C LEG; Edgar RC, 2010, BIOINFORMATICS; Emtiazi F, 2004, WATER RES, V38, P1197, DOI 10.1016/j.watres.2003.10.056; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flannery B, 2006, EMERG INFECT DIS, V12, P588; Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12; Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Hoefel D, 2005, APPL ENVIRON MICROB, V71, P6479, DOI 10.1128/AEM.71.11.6479-6488.2005; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Jensen N, 2003, LETT APPL MICROBIOL, V36, P9, DOI 10.1046/j.1472-765X.2003.01251.x; Kandiah S, 2012, ASS PROF INF CONTR E; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P2492, DOI 10.1128/AEM.54.10.2492-2499.1988; Lin YE, 2011, INFECT CONT HOSP EP, V32, P166, DOI 10.1086/657934; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marchesi I, 2012, AM J INFECT CONTROL, V40, P279, DOI 10.1016/j.ajic.2011.03.008; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; Mathieu L, 2009, WATER RES, V43, P3375, DOI 10.1016/j.watres.2009.05.005; Mondello Placido, 2006, Infez Med, V14, P235; Morisita M, 1959, MEMOIRS FS E, V2; National Research Council (NRC), 2006, DRINK WAT DISTR SYST; Nguyen C, 2012, WATER RES, V46, P611, DOI 10.1016/j.watres.2011.11.006; Perola O, 2002, J HOSP INFECT, V50, P196, DOI 10.1053/jhin.2001.1163; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008; Revetta RP, 2013, FEMS MICROBIOL ECOL; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Squier, 2000, Curr Infect Dis Rep, V2, P490, DOI 10.1007/s11908-000-0049-1; Stout J. E., 2011, HOSP EPIDEMIOLOGY IN; Stout J.E., 2012, ASS WAT TECHN ANN CO; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Sydnor ERM, 2012, INFECT CONT HOSP EP, V33, P235, DOI 10.1086/664047; van der Wielen PWJJ, 2013, APPL ENVIRON MICROB, V79, P825, DOI 10.1128/AEM.02748-12; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang H, 2014, ENVIRON SCI TECHNOL, V48, P1426, DOI 10.1021/es402636u; Wang H, 2013, ENVIRON SCI TECHNOL, V47, P10117, DOI 10.1021/es402455r; Wang H, 2012, APPL ENVIRON MICROB, V78, P6285, DOI 10.1128/AEM.01492-12; White C, 2011, APPL ENVIRON MICROB, V77, P5557, DOI 10.1128/AEM.02446-10; Williams MM, 2013, BIOFOULING, V29, P147, DOI 10.1080/08927014.2012.757308; Williams MM, 2003, APPL ENVIRON MICROB, V69, P5463, DOI 10.1128/AEM.69.9.5463-5471.2003; Yapicioglu H, 2012, J PAEDIATR CHILD H, V48, P430, DOI 10.1111/j.1440-1754.2011.02248.x; Zhang Y, 2008, J ENVIRON ENG, V134, P521, DOI 10.1061/(ASCE)0733-9372(2008)134:7(521); Zhang Y, 2009, J AM WATER WORKS ASS, V101, P51; Zhang Y, 2009, ENVIRON SCI TECHNOL, V43, P1890, DOI 10.1021/es802482s	56	53	53	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102679	10.1371/journal.pone.0102679	http://dx.doi.org/10.1371/journal.pone.0102679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033448	Green Accepted, Green Published, gold			2022-12-27	WOS:000339418300078
J	Haque, S; Nawrot, DA; Alakurtti, S; Ghemtio, L; Yli-Kauhaluoma, J; Tammela, P				Haque, Shafiul; Nawrot, Dorota A.; Alakurtti, Sami; Ghemtio, Leo; Yli-Kauhaluoma, Jari; Tammela, Paivi			Screening and Characterisation of Antimicrobial Properties of Semisynthetic Betulin Derivatives	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; CRYSTAL-STRUCTURE; ANTIBACTERIAL ACTIVITY; ANTIMALARIAL ACTIVITY; BIOLOGICAL-ACTIVITY; ACID-BINDING; OUTER BARK; PREDICTION; TRITERPENOIDS; STABILITY	Betulin (lup-20(29)-ene-3 beta, 28-diol) is a naturally occurring triterpene, which is found in substantial amounts from the outer bark of birch trees. A library of 51 structurally diverse semisynthetic betulin derivatives was screened against five bacterial strains, Enterobacter aerogenes, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus and a fungal strain Candida albicans, using broth microdilution assays. Primary antimicrobial screening at 50 mu M concentration led to the identification of five compounds showing antimicrobial properties (inhibition of growth by >70% against one or more microbial strains). According to the dose-response results, 28-O-(N-acetylanthraniloyl) betulin (compound 5) was the most active, showing MIC90 of 6.25 mu M against two Gram-positive bacteria, E. faecalis and S. aureus. However, the activity of this compound was affected by albumin binding, which was demonstrated by the loss of activity in a host-pathogen co-culture assay as well as in the antibacterial assay in the presence of increased concentration of albumin. Furthermore, the effects on mammalian cells were evaluated by cytotoxicity assessment on hepatocyte cell culture after 24 h exposure to the compounds. Betulinic aldehyde (18), betulin-28-oxime (31) and hetero cycloadduct with acetoxy groups at carbon atoms 3 and 28 and ethyl substituent at the triazolo ring (43) displayed cytotoxicity towards hepatocytes, with IC50 values of 47, 25 and 16 mu M, respectively. The IC50 value for 28-O-(N-acetylanthraniloyl) betulin (5) was 56 mu M. The current study presents an insight into using betulin scaffold for developing derivatives with antibacterial potential, and furthermore the necessity of in-depth analysis of found actives through selectivity profiling and follow-up studies including in silico ADMET predictions.	[Haque, Shafiul; Nawrot, Dorota A.; Ghemtio, Leo; Tammela, Paivi] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Alakurtti, Sami; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland; [Alakurtti, Sami] VTT Tech Res Ctr Finland, Espoo, Finland	University of Helsinki; University of Helsinki; VTT Technical Research Center Finland	Tammela, P (corresponding author), Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland.	paivi.tammela@helsinki.fi	HAQUE, SHAFIUL/AAN-2946-2020; Tammela, Päivi/A-4670-2010	HAQUE, SHAFIUL/0000-0002-2989-121X; Tammela, Päivi/0000-0003-4697-8066; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; ghemtio, leo/0000-0003-3591-5676	European Union [227239]; Academy of Finland [252308]; Biocenter Finland (Drug Discovery and Chemical Biology Network)	European Union(European Commission); Academy of Finland(Academy of Finland); Biocenter Finland (Drug Discovery and Chemical Biology Network)	The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no. 227239 [ForestSpeCs], Academy of Finland (Grant 252308) and Biocenter Finland (Drug Discovery and Chemical Biology Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Alakurtti S, 2010, BIOORGAN MED CHEM, V18, P1573, DOI 10.1016/j.bmc.2010.01.003; Magina MDA, 2012, QUIM NOVA, V35, P1184, DOI 10.1590/S0100-40422012000600022; [Anonymous], TOP 10 CAUSES OF DEA; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Boryczka S, 2012, J PHARM SCI-US, V101, P4458, DOI 10.1002/jps.23321; Bringmann G, 1997, PLANTA MED, V63, P255, DOI 10.1055/s-2006-957666; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Cheng A, 2003, J COMPUT AID MOL DES, V17, P811, DOI 10.1023/B:JCAM.0000021834.50768.c6; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Chung PY, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-25; Cichewicz RH, 2004, MED RES REV, V24, P90, DOI 10.1002/med.10053; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dehelean CA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-137; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; EKMAN R, 1983, HOLZFORSCHUNG, V37, P205, DOI 10.1515/hfsg.1983.37.4.205; Fears R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002556; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; Fulda S, 1999, INT J CANCER, V82, P435, DOI 10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 1998, J BIOL CHEM, V273, P33942, DOI 10.1074/jbc.273.51.33942; Gehrke ITS, 2013, J ETHNOPHARMACOL, V148, P486, DOI 10.1016/j.jep.2013.04.043; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HESS SC, 1995, J ETHNOPHARMACOL, V47, P97, DOI 10.1016/0378-8741(95)01260-K; Jager S, 2008, MOLECULES, V13, P3224, DOI 10.3390/molecules13123224; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kazakova OB, 2011, CHEM NAT COMPD+, V47, P752, DOI 10.1007/s10600-011-0050-y; Kazakova OB, 2010, RUSS J BIOORG CHEM+, V36, P383, DOI 10.1134/S1068162010030155; Kim DSHL, 1998, BIOORG MED CHEM LETT, V8, P1707, DOI 10.1016/S0960-894X(98)00295-9; Kleymann G, 2004, J BIOMOL SCREEN, V9, P578, DOI 10.1177/1087057104265291; Krasutsky PA, 2002, WO patent, Patent No. [2002/26761, 200226761]; Kvasnica M, 2005, BIOORGAN MED CHEM, V13, P3447, DOI 10.1016/j.bmc.2005.03.006; Loonen H, 1999, ENVIRON TOXICOL CHEM, V18, P1763, DOI 10.1002/etc.5620180822; Moghaddam M. G., 2012, Pharmacology and Pharmacy, V3, P119, DOI 10.4236/pp.2012.32018; Monaghan RL, 2006, BIOCHEM PHARMACOL, V71, P901, DOI 10.1016/j.bcp.2005.11.023; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; NCCLS- NATIONAL COMITE CLINICAL LABORATORY STANDARDS, 2003, NCCLS DOCUMENT M7 A6; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; NICK A, 1995, PHYTOCHEMISTRY, V40, P1691, DOI 10.1016/0031-9422(95)00491-O; Patocka J, 2003, J APPL BIOMED, V1, P7, DOI [DOI 10.32725/JAB.2003.002, https://doi.org/10.32725/jab.2003.002, DOI 10.32725/jab.2003.002]; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Pohjala L, 2009, J NAT PROD, V72, P1917, DOI 10.1021/np9003245; Prachayasittikul S, 2010, EXCLI J, V9, P1; Roychoudhury S, 2003, J BIOMOL SCREEN, V8, P555, DOI 10.1177/1087057103256917; Salin O, 2010, BIOCHEM PHARMACOL, V80, P1141, DOI 10.1016/j.bcp.2010.06.051; Sathya Bama S, 2012, INT J PHARM PHARM SC, V4, P557; Selzer E, 2000, J INVEST DERMATOL, V114, P935, DOI 10.1046/j.1523-1747.2000.00972.x; Sinha B. N., 2009, Journal of Natural Remedies, V9, P99; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Susnow RG, 2003, J CHEM INF COMP SCI, V43, P1308, DOI 10.1021/ci030283p; Tene M, 2009, INT J BIOL CHEM SCI, V3, P538; Tolstikov GA, 2005, CHEM SUSTAIN DEV, V13, P1; Xia XY, 2004, J MED CHEM, V47, P4463, DOI 10.1021/jm0303195; YLI-KAUHALUOMA J, 2007, WO Patent application, Patent No. [2007/141389, 2007141389, 141389]; Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214; Zenger K, 2013, J PHARM PHARMACOL, V65, P1765, DOI 10.1111/jphp.12070	63	42	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102696	10.1371/journal.pone.0102696	http://dx.doi.org/10.1371/journal.pone.0102696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032708	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300079
J	Jiao, ZH; Li, M; Feng, YX; Shi, JC; Zhang, J; Shao, B				Jiao, Zhi-Hao; Li, Ming; Feng, Yi-Xing; Shi, Jia-Chen; Zhang, Jing; Shao, Bing			Hormesis Effects of Silver Nanoparticles at Non-Cytotoxic Doses to Human Hepatoma Cells	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; P38 MAPK ACTIVATION; IN-VITRO TOXICITY; OXIDATIVE STRESS; DEPENDENT TOXICITY; MAMMALIAN-CELLS; PARTICLE-SIZE; DNA-DAMAGE; PROLIFERATION; CYTOTOXICITY	Silver nanoparticles (AgNPs) have attracted considerable attentions due to their unique properties and diverse applications. Although it has been reported that AgNPs have acute toxic effects on a variety of cultured mammalian cells and animal models, few studies have been conducted to evaluate the associated risk of AgNPs to human health at non-cytotoxic doses. In this paper, HepG2 cells were exposed to 10 nm and 100 nm AgNPs under non-cytotoxic conditions, and cell viability was assessed. At low doses, AgNPs displayed "hormesis'' effects by accelerating cell proliferation. Further studies indicated that the activation states of MAPKs were differentially regulated in this process. Specifically, by increasing the expression of downstream genes, p38 MAPK played a central role in non-cytotoxic AgNP-induced hormesis. Moreover, the treatment of HepG2 cells with silver ions (Ag+) at the same dose levels induced distinct biological effects, suggesting that different intrinsic properties exist for AgNPs and Ag+.	[Jiao, Zhi-Hao; Li, Ming; Feng, Yi-Xing; Shi, Jia-Chen; Zhang, Jing; Shao, Bing] Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China		Shao, B (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China.	shaobingch@sina.com	shao, bing/L-8793-2019		Capital Health Research and Development of Special [2011-1014-01]; Beijing Municipal Senior Technical Training Plan in Health System [2011-2-29]	Capital Health Research and Development of Special; Beijing Municipal Senior Technical Training Plan in Health System	This work was supported by the Capital Health Research and Development of Special (2011-1014-01, http://www.bjhb.gov.cn/) and the Beijing Municipal Senior Technical Training Plan in Health System (2011-2-29, http://www.bjhb.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Benn T, 2010, J ENVIRON QUAL, V39, P1875, DOI 10.2134/jeq2009.0363; Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cha K, 2008, BIOTECHNOL LETT, V30, P1893, DOI 10.1007/s10529-008-9786-2; Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dubas ST, 2008, MATER LETT, V62, P2661, DOI 10.1016/j.matlet.2008.01.033; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Gerber C, 2006, NAT NANOTECHNOL, V1, P3, DOI 10.1038/nnano.2006.70; Gopinath P, 2010, COLLOID SURFACE B, V77, P240, DOI 10.1016/j.colsurfb.2010.01.033; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Iavicoli I, 2010, DOSE-RESPONSE, V8, P501, DOI 10.2203/dose-response.10-016.Iavicoli; Kaur J, 2013, FOOD CHEM TOXICOL, V51, P1, DOI 10.1016/j.fct.2012.08.044; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kim YS, 2008, INHAL TOXICOL, V20, P575, DOI 10.1080/08958370701874663 ; Lankoff A, 2012, TOXICOL LETT, V208, P197, DOI 10.1016/j.toxlet.2011.11.006; Lee HY, 2010, J NANOPART RES, V12, P1567, DOI 10.1007/s11051-009-9666-2; Lim D, 2012, ENVIRON TOXICOL CHEM, V31, P585, DOI 10.1002/etc.1706; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rashidi L, 2011, CRIT REV FOOD SCI, V51, P723, DOI 10.1080/10408391003785417; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Scown TM, 2010, TOXICOL SCI, V115, P521, DOI 10.1093/toxsci/kfq076; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shin SH, 2007, INT IMMUNOPHARMACOL, V7, P1813, DOI 10.1016/j.intimp.2007.08.025; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Takenaka S, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3454667; Tang JL, 2009, J NANOSCI NANOTECHNO, V9, P4924, DOI 10.1166/jnn.2009.1269; Veronesi B, 2014, ACS SUSTAINABLE CHEM; Vigneshwaran N, 2007, J NANOSCI NANOTECHNO, V7, P1893, DOI 10.1166/jnn.2007.737; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yu SJ, 2013, ENVIRON SCI TECHNOL, V47, P3268, DOI 10.1021/es304346p; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	61	74	74	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102564	10.1371/journal.pone.0102564	http://dx.doi.org/10.1371/journal.pone.0102564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033410	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300061
J	Shimizu, M; Goto, M; Kawai, T; Yamashita, A; Kusakabe, Y				Shimizu, Madoka; Goto, Masao; Kawai, Takayuki; Yamashita, Atsuko; Kusakabe, Yuko			Distinct Human and Mouse Membrane Trafficking Systems for Sweet Taste Receptors T1r2 and T1r3	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GABA(B) RECEPTORS; SUBTYPE 1; DOMAIN; IDENTIFICATION; EXPRESSION; RESPONSES; REGION; GENE; GUSTDUCIN	The sweet taste receptors T1r2 and T1r3 are included in the T1r taste receptor family that belongs to class C of the G protein-coupled receptors. Heterodimerization of T1r2 and T1r3 is required for the perception of sweet substances, but little is known about the mechanisms underlying this heterodimerization, including membrane trafficking. We developed tagged mouse T1r2 and T1r3, and human T1R2 and T1R3 and evaluated membrane trafficking in human embryonic kidney 293 (HEK293) cells. We found that human T1R3 surface expression was only observed when human T1R3 was coexpressed with human T1R2, whereas mouse T1r3 was expressed without mouse T1r2 expression. A domain-swapped chimera and truncated human T1R3 mutant showed that the Venus flytrap module and cysteine-rich domain (CRD) of human T1R3 contain a region related to the inhibition of human T1R3 membrane trafficking and coordinated regulation of human T1R3 membrane trafficking. We also found that the Venus flytrap module of both human T1R2 and T1R3 are needed for membrane trafficking, suggesting that the coexpression of human T1R2 and T1R3 is required for this event. These results suggest that the Venus flytrap module and CRD receive taste substances and play roles in membrane trafficking of human T1R2 and T1R3. These features are different from those of mouse receptors, indicating that human T1R2 and T1R3 are likely to have a novel membrane trafficking system.	[Shimizu, Madoka; Goto, Masao; Kawai, Takayuki; Kusakabe, Yuko] NARO, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Yamashita, Atsuko] RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan; [Yamashita, Atsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; RIKEN; Okayama University	Kusakabe, Y (corresponding author), NARO, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	ykusa@affrc.go.jp	Yamashita, Atsuko/H-5566-2017; Kusakabe, Yuko/AAA-1944-2019	Yamashita, Atsuko/0000-0002-8001-4642; 	Research for the Utilization and Industrialization of Agricultural Biotechnology from the Ministry of Agriculture, Forestry and Fisheries; Targeted Proteins Research Program from MEXT; JSPS KAKENHI [25450194]	Research for the Utilization and Industrialization of Agricultural Biotechnology from the Ministry of Agriculture, Forestry and Fisheries; Targeted Proteins Research Program from MEXT; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant of the Research for the Utilization and Industrialization of Agricultural Biotechnology from the Ministry of Agriculture, Forestry and Fisheries, the Targeted Proteins Research Program from MEXT, and JSPS KAKENHI Grant Number 25450194. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; BARTOSHUK LM, 1975, J COMP PHYSIOL PSYCH, V89, P971, DOI 10.1037/h0077172; BEAUCHAMP GK, 1977, J COMP PHYSIOL PSYCH, V91, P1118, DOI 10.1037/h0077380; Bhattacharya A, 2010, J NEUROCHEM, V112, P723, DOI 10.1111/j.1471-4159.2009.06493.x; Danilova V, 2004, J NEUROPHYSIOL, V92, P1067, DOI 10.1152/jn.01183.2003; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Goudet C, 2004, P NATL ACAD SCI USA, V101, P378, DOI 10.1073/pnas.0304699101; Guo YZ, 2006, AMINO ACIDS, V30, P397, DOI 10.1007/s00726-006-0332-z; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Hu JX, 2000, J BIOL CHEM, V275, P16382, DOI 10.1074/jbc.M000277200; Ishimaru Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045426; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Knollman PE, 2005, J BIOL CHEM, V280, P24506, DOI 10.1074/jbc.M501978200; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kusakabe Y, 2002, CHEM SENSES, V27, P445, DOI 10.1093/chemse/27.5.445; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martin SC, 1999, MOL CELL NEUROSCI, V13, P180, DOI 10.1006/mcne.1999.0741; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pagano A, 2001, J NEUROSCI, V21, P1189; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Ueda T, 2003, J NEUROSCI, V23, P7376; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	31	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e100425	10.1371/journal.pone.0100425	http://dx.doi.org/10.1371/journal.pone.0100425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029362	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600005
J	Tu, LH; Chen, G; Peng, Y; Hu, HL; Hu, TX; Zhang, J; Li, XW; Liu, L; Tang, Y				Tu, Li-hua; Chen, Gang; Peng, Yong; Hu, Hong-ling; Hu, Ting-xing; Zhang, Jian; Li, Xian-wei; Liu, Li; Tang, Yi			Soil Biochemical Responses to Nitrogen Addition in a Bamboo Forest	PLOS ONE			English	Article							MICROBIAL BIOMASS; FUNGAL COMMUNITIES; DEPOSITION ALTERS; EXTRACTION METHOD; ENZYME-ACTIVITIES; ORGANIC-MATTER; LITTER DECAY; CARBON; HARDWOOD; DENITRIFICATION	Many vital ecosystem processes take place in the soils and are greatly affected by the increasing active nitrogen (N) deposition observed globally. Nitrogen deposition generally affects ecosystem processes through the changes in soil biochemical properties such as soil nutrient availability, microbial properties and enzyme activities. In order to evaluate the soil biochemical responses to elevated atmospheric N deposition in bamboo forest ecosystems, a two-year field N addition experiment in a hybrid bamboo (Bambusa pervariabilis x Dendrocalamopsis daii) plantation was conducted. Four levels of N treatment were applied: (1) control (CK, without N added), (2) low-nitrogen (LN, 50 kg N ha(-1) year(-1)), (3) medium-nitrogen (MN, 150 kg N ha(-1) year(-1)), and (4) high-nitrogen (HN, 300 kg N ha(-1) year(-1)). Results indicated that N addition significantly increased the concentrations of NH4+, NO3+, microbial biomass carbon, microbial biomass N, the rates of nitrification and denitrification; significantly decreased soil pH and the concentration of available phosphorus, and had no effect on the total organic carbon and total N concentration in the 0-20 cm soil depth. Nitrogen addition significantly stimulated activities of hydrolytic enzyme that acquiring N (urease) and phosphorus (acid phosphatase) and depressed the oxidative enzymes (phenol oxidase, peroxidase and catalase) activities. Results suggest that (1) this bamboo forest ecosystem is moving towards being limited by P or co-limited by P under elevated N deposition, (2) the expected progressive increases in N deposition may have a potential important effect on forest litter decomposition due to the interaction of inorganic N and oxidative enzyme activities, in such bamboo forests under high levels of ambient N deposition.	[Tu, Li-hua; Chen, Gang; Peng, Yong; Hu, Hong-ling; Hu, Ting-xing; Zhang, Jian; Li, Xian-wei] Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China; [Liu, Li] Sichuan Agr Univ, Personnel Dept, Yaan, Sichuan, Peoples R China; [Tang, Yi] Sichuan Agr Univ, Coll Hort, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Hu, TX (corresponding author), Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China.	hutx001@163.com			National Natural Science Foundation of China [31300522]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20125103120018]; Sichuan Provincial Education Department of China [12ZA118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sichuan Provincial Education Department of China	This project was supported by the National Natural Science Foundation of China (No. 31300522), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20125103120018) and the Scientific Research Fund of Sichuan Provincial Education Department of China (No. 12ZA118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwa HA, 1999, SOIL BIOL BIOCHEM, V31, P769, DOI 10.1016/S0038-0717(98)00177-1; Allison SD, 2011, SOIL BIOL, V22, P229, DOI 10.1007/978-3-642-14225-3_12; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; [Anonymous], 2010, GLOBAL FOREST RESOUR; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; Bell C, 2014, BIOGEOCHEMISTRY, V117, P1, DOI 10.1007/s10533-013-9935-0; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Burton AJ, 2012, GLOBAL CHANGE BIOL, V18, P258, DOI 10.1111/j.1365-2486.2011.02527.x; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; de Vries W, 2009, FOREST ECOL MANAG, V258, P1814, DOI 10.1016/j.foreco.2009.02.034; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; FRANKENBERGER WT, 1983, PLANT SOIL, V74, P301, DOI 10.1007/BF02181348; Freeman C, 2004, SOIL BIOL BIOCHEM, V36, P1663, DOI 10.1016/j.soilbio.2004.07.012; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gan HJ, 2013, ECOL APPL, V23, P1311, DOI 10.1890/12-1895.1; Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Gumiero B, 2011, J APPL ECOL, V48, P1135, DOI 10.1111/j.1365-2664.2011.02025.x; Hassett JE, 2009, MICROB ECOL, V57, P728, DOI 10.1007/s00248-008-9440-5; Haynes RJ, 2000, SOIL BIOL BIOCHEM, V32, P211, DOI 10.1016/S0038-0717(99)00148-0; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Ingwersen J, 1999, SOIL SCI SOC AM J, V63, P117, DOI 10.2136/sssaj1999.03615995006300010018x; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lyyemperumal K, 2008, APPL SOIL ECOL, V38, P128, DOI 10.1016/j.apsoil.2007.10.001; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Micks P, 2004, FOREST ECOL MANAG, V196, P57, DOI 10.1016/j.foreco.2004.03.012; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Perring MP, 2008, P NATL ACAD SCI USA, V105, P1971, DOI 10.1073/pnas.0711618105; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Samuelson L, 2009, FOREST ECOL MANAG, V258, P2431, DOI 10.1016/j.foreco.2009.08.020; Sinsabaugh RL, 2004, SOIL BIOL BIOCHEM, V36, P1509, DOI 10.1016/j.soilbio.2004.04.026; Sinsabaugh RL, 2000, SOIL BIOL BIOCHEM, V32, P2095, DOI 10.1016/S0038-0717(00)00102-4; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sirulnik AG, 2007, SOIL BIOL BIOCHEM, V39, P24, DOI 10.1016/j.soilbio.2006.04.048; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Tu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088752; Tu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075862; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Tu LH, 2011, PEDOSPHERE, V21, P685, DOI 10.1016/S1002-0160(11)60171-9; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wallenstein MD, 2006, FOREST ECOL MANAG, V222, P459, DOI 10.1016/j.foreco.2005.11.002; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Xu YB, 2013, J SOIL SEDIMENT, V13, P699, DOI 10.1007/s11368-013-0650-1	66	14	17	12	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102315	10.1371/journal.pone.0102315	http://dx.doi.org/10.1371/journal.pone.0102315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029346	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600060
J	Lee, F; Luevano, M; Veys, P; Yong, K; Madrigal, A; Shaw, BE; Saudemont, A				Lee, Fuiyee; Luevano, Martha; Veys, Paul; Yong, Kwee; Madrigal, Alejandro; Shaw, Bronwen E.; Saudemont, Aurore			The Effects of CAMPATH-1H on Cell Viability Do Not Correlate to the CD52 Density on the Cell Surface	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; UMBILICAL-CORD BLOOD; BONE-MARROW-TRANSPLANTATION; NATURAL-KILLER-CELLS; LOW-DOSE ALEMTUZUMAB; IMMUNE RECONSTITUTION; T-CELLS; IN-VITRO; MONOCLONAL-ANTIBODIES; CONDITIONING REGIMEN	Graft versus host disease (GvHD) is one of the main complications after hematological stem cell transplantation (HSCT). CAMPATH-1H is used in the pre-transplant conditioning regimen to effectively reduce GvHD by targeting CD52 antigens on T cells resulting in their depletion. Information regarding CD52 expression and the effects of CAMPATH-1H on immune cells is scant and limited to peripheral blood (PB) T and B cells. To date, the effects of CAMPATH-1H on cord blood (CB) cells has not been studied. Here we aimed to analyze CD52 expression and the effects of CAMPATH-1H on fresh or frozen, resting or activated, PB mononuclear cells (PBMC) and CB mononuclear cells (CBMC). In resting state, CD52 expression was higher in CB than PB T cell subsets (653.66 +/- 26.68 vs 453.32 +/- 19.2) and B cells (622.2 +/- 20.65 vs 612.0 +/- 9.101) except for natural killer (NK) cells where CD52 levels were higher in PB (421.0 +/- 9.857) than CB (334.3 +/- 9.559). In contrast, CD52 levels were comparable across all cell types after activation. CAMPATH-1H depleted resting cells more effectively than activated cells with approximately 80-95% of apoptosis observed with low levels of necrosis. There was no direct correlation between cell surface CD52 density and depleting effects of CAMPATH-1H. In addition, no difference in cell viability was noted when different concentrations of CAMPATH-1H were used. CD52 was not expressed on HSC but began to be expressed as the cells differentiate, implying that CAMPATH-1H could potentially affect HSC differentiation and proliferation. Our study provides insightful information, which contributes to the better understanding in the use of CAMPATH-1H as part of the conditioning regime in HSCT.	[Lee, Fuiyee; Luevano, Martha; Veys, Paul; Yong, Kwee; Madrigal, Alejandro; Shaw, Bronwen E.; Saudemont, Aurore] UCL, Inst Canc, London, England; [Lee, Fuiyee; Luevano, Martha; Veys, Paul; Madrigal, Alejandro; Shaw, Bronwen E.; Saudemont, Aurore] Anthony Nolan Res Inst, London, England; [Veys, Paul] Great Ormond St Hosp Children NHS, London, England; [Shaw, Bronwen E.] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Saudemont, A (corresponding author), UCL, Inst Canc, London, England.	aurore.saudemont@anthonynolan.org		Madrigal, Alejandro/0000-0001-8359-9917; Saudemont, Aurore/0000-0002-9376-8339	Anthony Nolan	Anthony Nolan	The work was funded by Anthony Nolan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPERLEY JF, 1986, BONE MARROW TRANSPL, V1, P53; Bertz H, 2009, BIOL BLOOD MARROW TR, V15, P1563, DOI 10.1016/j.bbmt.2009.08.002; Brutkiewicz RR, 2002, CRIT REV ONCOL HEMAT, V41, P287, DOI 10.1016/S1040-8428(01)00198-6; Chakrabarti S, 2002, BLOOD, V99, P4357, DOI 10.1182/blood.V99.12.4357; Cull GM, 2000, BRIT J HAEMATOL, V108, P754, DOI 10.1046/j.1365-2141.2000.01879.x; D'Sa S, 2003, BRIT J HAEMATOL, V123, P309, DOI 10.1046/j.1365-2141.2003.04612.x; Dodero A, 2005, EXP HEMATOL, V33, P920, DOI 10.1016/j.exphem.2005.05.009; Dyer MJS, 1999, SEMIN ONCOL, V26, P52; Elter T, 2008, LEUKEMIA LYMPHOMA, V49, P2256, DOI 10.1080/10428190802475303; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Gartner F, 2013, CYTOTHERAPY, V15, P1237, DOI 10.1016/j.jcyt.2013.05.016; GILLEECE MH, 1993, BLOOD, V82, P807; Ginaldi L, 1998, LEUKEMIA RES, V22, P185, DOI 10.1016/S0145-2126(97)00158-6; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; HALE G, 1985, J IMMUNOL, V134, P3056; HALE G, 1990, TISSUE ANTIGENS, V35, P118, DOI 10.1111/j.1399-0039.1990.tb01767.x; HALE G, 1993, J REPROD IMMUNOL, V23, P189, DOI 10.1016/0165-0378(93)90007-5; Hale G, 1998, BLOOD, V92, P4581, DOI 10.1182/blood.V92.12.4581.424k22_4581_4590; HALE G, 1983, BLOOD, V62, P873; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Klabusay M, 2007, CYTOM PART B-CLIN CY, V72B, P363, DOI 10.1002/cyto.b.20181; Kottaridis PD, 2000, BLOOD, V96, P2419; Lane JR, 2014, BIOL BLOOD MARROW TR, V20, P243, DOI 10.1016/j.bbmt.2013.11.005; Li BH, 2009, BLOOD, V114, P5007, DOI 10.1182/blood-2009-06-225474; Lim CK, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-19; Lindemans CA, 2014, BLOOD, V123, P126, DOI 10.1182/blood-2013-05-502385; Lowenstein H, 2006, TRANSPLANT INT, V19, P927, DOI 10.1111/j.1432-2277.2006.00382.x; Luevano M, 2012, HUM IMMUNOL, V73, P248, DOI 10.1016/j.humimm.2011.12.015; Mone AP, 2006, LEUKEMIA, V20, P272, DOI 10.1038/sj.leu.2404014; Morris EC, 2003, BLOOD, V102, P404, DOI 10.1182/blood-2002-09-2687; Olweus J, 1994, Immunomethods, V5, P179, DOI 10.1006/immu.1994.1054; Parikh SH, 2014, BIOL BLOOD MARROW TR, V20, P326, DOI 10.1016/j.bbmt.2013.11.021; Penack O, 2008, BONE MARROW TRANSPL, V41, P377, DOI 10.1038/sj.bmt.1705911; Perez SA, 2003, BLOOD, V101, P3444, DOI 10.1182/blood-2002-05-1501; Rao SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039416; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rossmann E D, 2001, Hematol J, V2, P300, DOI 10.1038/sj.thj.6200119; Saito Y, 2011, LEUKEMIA, V25, P921, DOI 10.1038/leu.2011.36; Spyridonidis A, 2011, BONE MARROW TRANSPL, V46, P1363, DOI 10.1038/bmt.2010.308; Vela-Ojeda J, 2010, STEM CELLS DEV, V19, P333, DOI 10.1089/scd.2009.0216; WALDMANN H, 1984, LANCET, V2, P483; XIA MQ, 1991, EUR J IMMUNOL, V21, P1677, DOI 10.1002/eji.1830210714; XIA MQ, 1993, MOL IMMUNOL, V30, P1089	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103254	10.1371/journal.pone.0103254	http://dx.doi.org/10.1371/journal.pone.0103254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050704	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100100
J	Li, XF; Yao, L; Ye, Q; Zhao, XJ				Li, Xiaofei; Yao, Li; Ye, Qing; Zhao, Xiaojie			Online Spatial Normalization for Real-Time fMRI	PLOS ONE			English	Article							3D IMAGE REGISTRATION; PRINCIPAL AXES; AFFINE REGISTRATION; LOCALIZATION; ACTIVATION; TOOL; MNI	Real-time functional magnetic resonance imaging (rtfMRI) is a recently emerged technique that demands fast data processing within a single repetition time (TR), such as a TR of 2 seconds. Data preprocessing in rtfMRI has rarely involved spatial normalization, which can not be accomplished in a short time period. However, spatial normalization may be critical for accurate functional localization in a stereotactic space and is an essential procedure for some emerging applications of rtfMRI. In this study, we introduced an online spatial normalization method that adopts a novel affine registration (AFR) procedure based on principal axes registration (PA) and Gauss-Newton optimization (GN) using the self-adaptive beta parameter, termed PA-GN(beta) AFR and nonlinear registration (NLR) based on discrete cosine transform (DCT). In AFR, PA provides an appropriate initial estimate of GN to induce the rapid convergence of GN. In addition, the beta parameter, which relies on the change rate of cost function, is employed to self-adaptively adjust the iteration step of GN. The accuracy and performance of PA-GN(beta) AFR were confirmed using both simulation and real data and compared with the traditional AFR. The appropriate cutoff frequency of the DCT basis function in NLR was determined to balance the accuracy and calculation load of the online spatial normalization. Finally, the validity of the online spatial normalization method was further demonstrated by brain activation in the rtfMRI data.	[Li, Xiaofei; Yao, Li; Ye, Qing; Zhao, Xiaojie] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China; [Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhao, XJ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China.	zhaoxj86@hotmail.com	Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [60931003, 61071178]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [61210001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of National Natural Science Foundation of China (grant number 60931003), the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (grant number 61210001), and National Natural Science Foundation of China (grant number 61071178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT NM, 1990, J NUCL MED, V31, P1717; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bulow H, 2000, PATTERN RECOGN LETT, V21, P329, DOI 10.1016/S0167-8655(99)00163-4; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Desmond JE, 1997, HUM BRAIN MAPP, V5, P58, DOI 10.1002/(SICI)1097-0193(1997)5:1<58::AID-HBM6>3.0.CO;2-M; DHAWAN AP, 1995, IEEE T BIO-MED ENG, V42, P1079, DOI 10.1109/10.469374; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Feigl GC, 2008, EJSO-EUR J SURG ONC, V34, P708, DOI 10.1016/j.ejso.2007.06.011; Fox PT, 1995, HUMAN BRAIN MAPPING, V3, P161; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gao K, 2003, 9 ANN M OHBM NEW YOR; Gembris D, 2000, MAGN RESON MED, V43, P259, DOI 10.1002/(SICI)1522-2594(200002)43:2<259::AID-MRM13>3.0.CO;2-P; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jaklic A, 2003, IEEE T SYST MAN CY B, V33, P648, DOI 10.1109/TSMCB.2003.814299; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Kekhia H, 2011, NEUROSURG CLIN N AM, V22, P111, DOI 10.1016/j.nec.2011.01.004; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lee JH, 2008, HUM BRAIN MAPP, V29, P157, DOI 10.1002/hbm.20377; Lin QH, 2010, HUM BRAIN MAPP, V31, P1076, DOI 10.1002/hbm.20919; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mathiak K, 2001, MAGNET RESON MED, V45, P167, DOI 10.1002/1522-2594(200101)45:1<167::AID-MRM1023>3.0.CO;2-M; Moller M, 2005, EUR RADIOL, V15, P292, DOI 10.1007/s00330-004-2513-z; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Ruiz S., 2013, BIOL PSYCHO IN PRESS; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Salas-Gonzalez D, 2008, ELECTRON LETT, V44, P1291, DOI 10.1049/el:20081838; Talairach J., 1988, COPLANAR STEREOTAXIC; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; Wurm G, 2008, INT J COMPUT ASS RAD, V3, P191, DOI 10.1007/s11548-008-0237-2; Zhao XJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00866; Zhilkin P, 2000, MAGN RESON IMAGING, V18, P1143, DOI 10.1016/S0730-725X(00)00209-5; Zhilkin P, 2004, MAGN RESON IMAGING, V22, P55, DOI 10.1016/j.mri.2003.05.004; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	44	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103302	10.1371/journal.pone.0103302	http://dx.doi.org/10.1371/journal.pone.0103302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050799	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100101
J	Lima, LR; De Almeida, AJ; Tourinho, RD; Hasselmann, B; Ximenez, LLL; De Paula, VS				Lima, Lyana Rodrigues; De Almeida, Adilson Jose; Tourinho, Renata dos Santos; Hasselmann, Barbara; Lewis Ximenez, Lia Laura; De Paula, Vanessa Salete			Evidence of Hepatitis A Virus Person-to-Person Transmission in Household Outbreaks	PLOS ONE			English	Article							RIO-DE-JANEIRO; INTRAFAMILIAL TRANSMISSION; INFECTION; SEROPREVALENCE; VACCINATION; PREVALENCE; EPIDEMIOLOGY; SUBGENOTYPES; CIRCULATION; ANTIBODIES	The person-to-person transmission of the hepatitis A virus primarily occurs in enclosed spaces, particularly in the presence of inadequate hygiene conditions and a high proportion of susceptible individuals. Thus, intimate family contact stands out as a risk factor for HAV infection dissemination. The present study aimed to evaluate the occurrence of household HAV transmission. Blood samples were collected from patients with hepatitis A (index cases) and their family members (contacts) that were referred to an ambulatory care clinic specializing in viral hepatitis. A total of 97 samples were collected from 30 families with a confirmed hepatitis A case (index case). Serological and molecular techniques for the diagnosis of hepatitis A were conducted on all samples. HAV infection (anti-HAV IgM + and/ or HAV RNA +) was detected in 34.3% (23/67) of the contacts; 34.3% (23/67) of the contacts were immune to HAV, and 31.4% (21/67) were susceptible. In the household contacts, HAV immunity was significantly associated with older age; susceptibility to infection and HAV infection were associated with younger age. Household outbreaks were detected in 16/30 families studied. Co-circulation of subgenotypes IA and IB was found in the household outbreaks, and person-to-person transmission was evidenced in six of the household outbreaks, with 100% homology between the index case and contact strains. The results demonstrated the relevance of HAV household transmission, reaffirming the need for hepatitis A vaccine administration in susceptible contacts and effective infection control procedures to prevent the extension of household outbreaks.	[Lima, Lyana Rodrigues; Tourinho, Renata dos Santos; De Paula, Vanessa Salete] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Desenvolvimento Tecnol Virol, Rio De Janeiro, Brazil; [De Almeida, Adilson Jose; Hasselmann, Barbara; Lewis Ximenez, Lia Laura] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [De Almeida, Adilson Jose] Univ Fed Estado Rio de Janeiro, Setor Hematol, Hosp Univ Gaffree & Guinle, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	De Paula, VS (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Desenvolvimento Tecnol Virol, Rio De Janeiro, Brazil.	vdepaula@ioc.fiocruz.br	de Paula, Vanessa S/I-8037-2016	de Paula, Vanessa S/0000-0002-6314-754X; Lewis-Ximenez, Lia Laura/0000-0002-3447-4621				Amado LA, 2011, J MED VIROL, V83, P768, DOI 10.1002/jmv.22045; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P38; Banerjee I, 2008, J MED VIROL, V80, P1858, DOI 10.1002/jmv.21263; Fernandez MDB, 2012, CLIN MICROBIOL INFEC, V18, pE548, DOI 10.1111/1469-0691.12034; Brasil. Ministerio da Saude, 2012, APR DIA MUND LUT HEP; Costa-Mattioli M, 2002, J VIROL, V76, P9516, DOI 10.1128/JVI.76.18.9516-9525.2002; Costa-Mattioli M, 2002, J VIRAL HEPATITIS, V9, P101, DOI 10.1046/j.1365-2893.2002.00336.x; Ximenes RAD, 2010, CAD SAUDE PUBLICA, V26, P1693, DOI 10.1590/S0102-311X2010000900003; De Paula VS, 2007, WATER RES, V41, P1169, DOI 10.1016/j.watres.2006.11.029; de Paula VS, 2012, FUTURE VIROL, V7, P461, DOI 10.2217/FVL.12.35; de Paula VS, 2002, J MED VIROL, V66, P22, DOI 10.1002/jmv.2106; FEINSTONE SM, 1973, SCIENCE, V182, P1026, DOI 10.1126/science.182.4116.1026; Hamaguchi T, 2008, EMERG INFECT DIS, V14, P828, DOI 10.3201/eid1405.071121; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Kumbang J, 2012, EPIDEMIOL INFECT, V140, P1813, DOI 10.1017/S0950268811002561; Kurkela S, 2012, EPIDEMIOL INFECT, V140, P2172, DOI 10.1017/S0950268812000015; Lu L, 2004, J GEN VIROL, V85, P2943, DOI 10.1099/vir.0.80304-0; McFarland N, 2011, EPIDEMIOL INFECT, V139, P336, DOI 10.1017/S0950268810001433; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; Robertson BH, 2000, J MED VIROL, V62, P144, DOI 10.1002/1096-9071(200010)62:2&lt;144::AID-JMV4&gt;3.0.CO;2-I; Roma E, 2009, J CLIN GASTROENTEROL, V43, P711, DOI 10.1097/MCG.0b013e318192fd8a; SATO T, 1988, TOHOKU J EXP MED, V155, P387, DOI 10.1620/tjem.155.387; Somani SK, 2003, J VIRAL HEPATITIS, V10, P446, DOI 10.1046/j.1365-2893.2003.00458.x; Victor JC, 2006, AM J EPIDEMIOL, V163, P204, DOI 10.1093/aje/kwj029; Villar LM, 2006, BRAZ J MED BIOL RES, V39, P873, DOI 10.1590/S0100-879X2006000700004; Vitral CL, 2008, J VIRAL HEPATITIS, V15, P22, DOI 10.1111/j.1365-2893.2008.01024.x; Vitral CL, 1998, MEM I OSWALDO CRUZ, V93, P1, DOI 10.1590/S0074-02761998000100001; Vitral CL, 2012, MEM I OSWALDO CRUZ, V107, P652, DOI 10.1590/S0074-02762012000500012; Wu S, 2014, INT J MED SCI, V11, P60, DOI 10.7150/ijms.7728	31	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102925	10.1371/journal.pone.0102925	http://dx.doi.org/10.1371/journal.pone.0102925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050760	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100068
J	Mody, A; Bartz, S; Hornik, CP; Kiyimba, T; Bain, J; Muehlbauer, M; Kiboneka, E; Stevens, R; St Peter, JV; Newgard, CB; Bartlett, J; Freemark, M				Mody, Aaloke; Bartz, Sarah; Hornik, Christoph P.; Kiyimba, Tonny; Bain, James; Muehlbauer, Michael; Kiboneka, Elizabeth; Stevens, Robert; St Peter, John V.; Newgard, Christopher B.; Bartlett, John; Freemark, Michael			Effects of HIV Infection on the Metabolic and Hormonal Status of Children with Severe Acute Malnutrition	PLOS ONE			English	Article							ADIPOSE-TISSUE; MALNOURISHED CHILDREN; LEPTIN CONCENTRATIONS; UNDERNUTRITION; LIPODYSTROPHY; CONSEQUENCES; ADIPONECTIN; PREVALENCE; EXPRESSION; MANAGEMENT	Background: HIV infection occurs in 30% of children with severe acute malnutrition in sub-Saharan Africa. Effects of HIV on the pathophysiology and recovery from malnutrition are poorly understood. Methods: We conducted a prospective cohort study of 75 severely malnourished Ugandan children. HIV status/CD4 counts were assessed at baseline; auxologic data and blood samples were obtained at admission and after 14 days of inpatient treatment. We utilized metabolomic profiling to characterize effects of HIV infection on metabolic status and subsequent responses to nutritional therapy. Findings: At admission, patients (mean age 16.3 mo) had growth failure (mean W/H z-score 24.27 in non-edematous patients) that improved with formula feeding (mean increase 1.00). 24% (18/75) were HIV-infected. Nine children died within the first 14 days of hospitalization; mortality was higher for HIV-infected patients (33% v. 5%, OR = 8.83). HIV-infected and HIV-negative children presented with elevated NEFA, ketones, and even-numbered acylcarnitines and reductions in albumin and amino acids. Leptin, adiponectin, insulin, and IGF-1 levels were low while growth hormone, cortisol, and ghrelin levels were high. At baseline, HIV-infected patients had higher triglycerides, ketones, and even-chain acylcarnitines and lower leptin and adiponectin levels than HIV-negative patients. Leptin levels rose in all patients following nutritional intervention, but adiponectin levels remained depressed in HIV-infected children. Baseline hypoleptinemia and hypoadiponectinemia were associated with increased mortality. Conclusions: Our findings suggest a critical interplay between HIV infection and adipose tissue storage and function in the adaptation to malnutrition. Hypoleptinemia and hypoadiponectinemia may contribute to high mortality rates among malnourished, HIV-infected children.	[Mody, Aaloke; Bartz, Sarah; Freemark, Michael] Duke Univ, Med Ctr, Pediat Div Quantitat Sci, Div Pediat Endocrinol & Diabet, Durham, NC 27708 USA; [Hornik, Christoph P.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Bain, James; Muehlbauer, Michael; Stevens, Robert; Newgard, Christopher B.; Freemark, Michael] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Bartlett, John; Freemark, Michael] Duke Univ, Med Ctr, Duke Global Hlth Inst, Durham, NC USA; [St Peter, John V.] PepsiCo Inc, Long Term Res, Global Res & Dev, Purchase, NY USA; [Kiboneka, Elizabeth] Mulago Hosp Complex, Mwanamugimu Nutr Unit, Kampala, Uganda	Duke University; Duke University; Duke University; Duke University; PepsiCo; Mulago National Referral Hospital	Mody, A (corresponding author), Duke Univ, Med Ctr, Pediat Div Quantitat Sci, Div Pediat Endocrinol & Diabet, Durham, NC 27708 USA.	aalokemody@gmail.com	StPeter, John/N-1140-2019; Kiyimba, Tonny/GXH-0357-2022; Mody, Aaloke/ABE-5131-2020	Mody, Aaloke/0000-0003-3787-365X; St. Peter, John/0000-0003-4359-7524; Kiyimba, Tonny/0000-0003-2464-1614; Bain, James R./0000-0002-8917-9187	Genentech Foundation; PepsiCo, Inc.; Duke Global Health Institute; US National Institutes of Health [P30AI64518, U01AI067854, D43CA153722, D43TW06732]; HRSA [T84HA21123]; NIH [DK58398]; FOGARTY INTERNATIONAL CENTER [D43TW006732] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	Genentech Foundation(Roche HoldingGenentech); PepsiCo, Inc.; Duke Global Health Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Genentech Foundation, PepsiCo, Inc., and the Duke Global Health Institute (to SB, MF, and AM). John A. Bartlett is supported by US National Institutes of Health awards P30AI64518, U01AI067854, D43CA153722, and D43TW06732, and HRSA award T84HA21123. Christopher Newgard and the Stedman Metabolomics Center are supported by NIH grant DK58398. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript. Dr. St. Peter, who is employed by PepsiCo, Inc., assisted with data analysis and approved the final manuscript as submitted.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ashworth A., 2003, GUIDELINES INPATIENT; Azzoni L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-33; Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Bartz S, 2014, J CLIN ENDOCRINOL ME; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Chinkhumba J, 2008, T ROY SOC TROP MED H, V102, P639, DOI 10.1016/j.trstmh.2008.04.028; Feigerlova E, 2008, J CLIN ENDOCR METAB, V93, P2800, DOI 10.1210/jc.2007-2138; Fergusson P, 2009, ARCH DIS CHILD, V94, P512, DOI 10.1136/adc.2008.142646; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Giralt M, 2006, ANTIVIR THER, V11, P729; Hammond E, 2010, CLIN INFECT DIS, V51, P591, DOI 10.1086/655765; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; Higgins PB, 2008, AM J CLIN NUTR, V88, P1277, DOI 10.3945/ajcn.2008.26357; Kim MH, 2012, JAIDS-J ACQ IMM DEF, V59, P173, DOI 10.1097/QAI.0b013e3182405f8f; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Lomenick JP, 2008, OBESITY, V16, P547, DOI 10.1038/oby.2007.129; Lomenick JP, 2009, J CLIN ENDOCR METAB, V94, P4463, DOI 10.1210/jc.2009-0949; Manary MJ, 2006, METABOLISM, V55, P550, DOI 10.1016/j.metabol.2005.11.009; Musoke PM, 2011, AM J CLIN NUTR, V94, p1716S, DOI 10.3945/ajcn.111.018374; Nonogaki K, 2008, VITAM HORM, V77, P149, DOI 10.1016/S0083-6729(06)77007-8; Norrelund H, 2005, GROWTH HORM IGF RES, V15, P95, DOI 10.1016/j.ghir.2005.02.005; Prendergast A, 2011, AIDS, V25, P951, DOI 10.1097/QAD.0b013e328345e56b; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Soliman AT, 2000, METABOLISM, V49, P819, DOI 10.1053/meta.2000.6745; Sweeney LL, 2007, AIDS, V21, P895, DOI 10.1097/QAD.0b013e3280adc91e; Tsiodras S, 2006, AM J INFECT DIS, V2, P141, DOI 10.3844/ajidsp.2006.141.152; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Verkauskiene R, 2006, PEDIATR RES, V60, P225, DOI 10.1203/01.pdr.0000228335.64894.26; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Villarroya J, 2010, ANTIVIR THER, V15, P1021, DOI 10.3851/IMP1669; Warren MP, 2011, J CLIN ENDOCR METAB, V96, P333, DOI 10.1210/jc.2009-2304	35	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102233	10.1371/journal.pone.0102233	http://dx.doi.org/10.1371/journal.pone.0102233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050734	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100023
J	Du, XH; Zhang, H; Liu, YW; Yu, WP; Huang, CB; Li, XD				Du, Xiaohong; Zhang, Hua; Liu, Yuanwu; Yu, Wanpeng; Huang, Chaobin; Li, Xiangdong			Perinatal Exposure to Low-Dose Methoxychlor Impairs Testicular Development in C57BL/6 Mice	PLOS ONE			English	Article							ESTROGENIC ENDOCRINE DISRUPTORS; INTRAUTERINE GROWTH RESTRICTION; IN-UTERO EXPOSURE; RETINOIC ACID; PREIMPLANTATION EXPOSURES; REPRODUCTIVE DEVELOPMENT; METABOLIC SYNDROME; CRITICAL-APPRAISAL; GENE-EXPRESSION; RECEPTOR-ALPHA	Methoxychlor (MXC), an organochlorine pesticide, has adverse effects on male reproduction at toxicological doses. Humans and wild animals are exposed to MXC mostly through contaminated dietary intake. Higher concentrations of MXC have been found in human milk, raising the demand for the risk assessment of offspring after maternal exposure to low doses of MXC. In this study, pregnant mice (F0) were given intraperitoneal daily evening injections of 1 mg/kg/d MXC during their gestational (embryonic day 0.5, E0.5) and lactational periods (postnatal day 21.5, P21.5), and the F1 males were assessed. F1 testes were collected at P0.5, P21.5 and P45.5. Maternal exposure to MXC disturbed the testicular development. Serum testosterone levels decreased, whereas estradiol levels increased. To understand the molecular mechanisms of exposure to MXC in male reproduction, the F1 testes were examined for changes in the expression of steroidogenesis- and spermatogenesis-related genes. RT-PCR analysis demonstrated that MXC significantly decreased Cyp11 alpha 1 and increased Cyp19 alpha 1; furthermore, it downregulated certain spermatogenic genes (Dazl, Boll, Rarg, Stra8 and Cyclin-alpha 1). In summary, perinatal exposure to low-dose MXC disturbs the testicular development in mice. This animal study of exposure to low-dose MXC in F1 males suggests similar dysfunctional effects on male reproduction in humans.	[Du, Xiaohong; Zhang, Hua; Liu, Yuanwu; Yu, Wanpeng; Huang, Chaobin; Li, Xiangdong] China Agr Univ, State Key Lab AgroBiotechnol, Fac Biol Sci, Beijing 100094, Peoples R China	China Agricultural University	Li, XD (corresponding author), China Agr Univ, State Key Lab AgroBiotechnol, Fac Biol Sci, Beijing 100094, Peoples R China.	xiangdongli@cau.edu.cn	æ, æä/GLR-4816-2022	Liu, Yuanwu/0000-0001-5132-6252; Li, Xiangdong/0000-0003-2261-2393	National Natural Science Foundation of China [31071316]; China 973 Project [2009CB941701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 973 Project(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 31071316, http://www.nsfc.gov.cn/) to XL and the China 973 Project (Grant No. 2009CB941701, http://www.ost.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AMANN RP, 1962, AM J ANAT, V110, P69, DOI 10.1002/aja.1001100107; Amstislavsky SY, 2006, REPROD TOXICOL, V21, P154, DOI 10.1016/j.reprotox.2005.07.009; Amstislavsky SY, 2004, REPROD TOXICOL, V18, P103, DOI 10.1016/j.reprotox.2003.10.008; Andersen HR, 2008, ENVIRON HEALTH PERSP, V116, P566, DOI 10.1289/ehp.10790; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Botella B, 2004, ENVIRON RES, V96, P34, DOI 10.1016/j.envres.2003.10.001; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Chapin RE, 1997, FUND APPL TOXICOL, V40, P138, DOI 10.1006/faat.1997.2381; Chen YC, 2007, J ENDOCRINOL, V192, P527, DOI 10.1677/JOE-06-0087; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649; Cummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899; Cupp AS, 2003, J ANDROL, V24, P736; De Jager C, 2006, J ANDROL, V27, P16, DOI 10.2164/jandrol.05121; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Gaido KW, 1999, ENDOCRINOLOGY, V140, P5746, DOI 10.1210/en.140.12.5746; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Gould ML, 2007, REPRODUCTION, V134, P271, DOI 10.1530/REP-07-0025; GRAY LE, 1989, FUND APPL TOXICOL, V12, P92, DOI 10.1016/0272-0590(89)90065-1; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Huang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096781; HUHTANIEMI I, 1985, J CLIN ENDOCR METAB, V61, P698, DOI 10.1210/jcem-61-4-698; JACKSON H, 1959, BRIT J PHARM CHEMOTH, V14, P149, DOI 10.1111/j.1476-5381.1959.tb01375.x; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; Komarek M, 2010, ENVIRON INT, V36, P138, DOI 10.1016/j.envint.2009.10.005; Kristensen F, 1997, EPIDEMIOLOGY, V8, P537, DOI 10.1097/00001648-199709000-00011; Laviola G, 2005, BRAIN RES BULL, V65, P235, DOI 10.1016/j.brainresbull.2004.11.015; Li XD, 2001, ENDOCRINOLOGY, V142, P2435, DOI 10.1210/en.142.6.2435; Li XD, 2008, GEN COMP ENDOCR, V159, P1, DOI 10.1016/j.ygcen.2008.07.025; Lin W, 2011, AM J PATHOL, V178, P1233, DOI 10.1016/j.ajpath.2010.11.056; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; McClive PJ, 2003, GENESIS, V37, P84, DOI 10.1002/gene.10231; Murono EP, 2005, REPROD TOXICOL, V20, P503, DOI 10.1016/j.reprotox.2005.03.002; Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5; Neitzke U, 2008, PLACENTA, V29, P246, DOI 10.1016/j.placenta.2007.11.014; Neitzke U, 2011, MICROCIRCULATION, V18, P304, DOI 10.1111/j.1549-8719.2011.00089.x; Oduwole OO, 2014, FASEB J; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Palanza P, 2002, NEUROTOXICOL TERATOL, V24, P55, DOI 10.1016/S0892-0362(01)00191-X; Palanza P, 2001, HORM BEHAV, V40, P252, DOI 10.1006/hbeh.2001.1697; Park Sun Kyun, 2010, J Prev Med Public Health, V43, P1, DOI 10.3961/jpmph.2010.43.1.1; Ricceri L, 2006, TOXICOL SCI, V93, P105, DOI 10.1093/toxsci/kfl032; Roy AK, 1999, VITAM HORM, V55, P309; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Sambrook J., 2001, MOL CLONING LAB MANU, P518; Schurmann A, 2002, MOL CELL BIOL, V22, P2761, DOI 10.1128/MCB.22.8.2761-2768.2002; Smink A, 2008, ACTA PAEDIATR, V97, P1465, DOI 10.1111/j.1651-2227.2008.00937.x; Staub C, 2002, TOXICOL APPL PHARM, V180, P129, DOI 10.1006/taap.2002.9369; Suzuki M, 2004, J REPROD DEVELOP, V50, P455, DOI 10.1262/jrd.50.455; Sweeney T, 2007, THERIOGENOLOGY, V67, P1068, DOI 10.1016/j.theriogenology.2006.12.010; Toft G, 2007, ENVIRON HEALTH PERSP, V115, P15, DOI 10.1289/ehp.9352; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Valvi D, 2012, ENVIRON HEALTH PERSP, V120, P451, DOI 10.1289/ehp.1103862; Volle DH, 2009, J CLIN INVEST, V119, P3752, DOI 10.1172/JCI38521; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; White KL, 2005, TOXICOLOGY, V207, P271, DOI 10.1016/j.tox.2004.09.011; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wohlfahrt-Veje C, 2011, ENV HLTH, V10, P10; Yokoi K, 2003, BIOL TRACE ELEM RES, V93, P141, DOI 10.1385/BTER:93:1-3:141; Zachow R, 2006, REPROD TOXICOL, V22, P659, DOI 10.1016/j.reprotox.2006.04.018; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795	63	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103016	10.1371/journal.pone.0103016	http://dx.doi.org/10.1371/journal.pone.0103016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048109	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100099
J	Hirayama, K; Moroz, LL; Hatcher, NG; Gillette, R				Hirayama, Keiko; Moroz, Leonid L.; Hatcher, Nathan G.; Gillette, Rhanor			Neuromodulatory Control of a Goal-Directed Decision	PLOS ONE			English	Article							PLEUROBRANCHAEA-CALIFORNICA; FEEDING-BEHAVIOR; SEROTONERGIC MODULATION; CLIONE-LIMACINA; APLYSIA; INTERNEURONS; NETWORK; NEURONS; MOLLUSK; SWIM	Many cost-benefit decisions reduce to simple choices between approach or avoidance (or active disregard) to salient stimuli. Physiologically, critical factors in such decisions are modulators of the homeostatic neural networks that bias decision processes from moment to moment. For the predatory sea-slug Pleurobranchaea, serotonin (5-HT) is an intrinsic modulatory promoter of general arousal and feeding. We correlated 5-HT actions on appetitive state with its effects on the approach-avoidance decision in Pleurobranchaea. 5-HT and its precursor 5-hydroxytryptophan (5-HTP) augmented general arousal state and reduced feeding thresholds in intact animals. Moreover, 5-HT switched the turn response to chemosensory stimulation from avoidance to orienting in many animals. In isolated CNSs, bath application of 5-HT both stimulated activity in the feeding motor network and switched the fictive turn response to unilateral sensory nerve stimulation from avoidance to orienting. Previously, it was shown that increasing excitation state of the feeding network reversibly switched the turn motor network response from avoidance to orienting, and that 5-HT levels vary inversely with nutritional state. A simple model posits a critical role for 5-HT in control of the turn network response by corollary output of the feeding network. In it, 5-HT acts as an intrinsic neuromodulatory factor coupled to nutritional status and regulates approach-avoidance via the excitation state of the feeding network. Thus, the neuromodulator is a key organizing element in behavioral choice of approach or avoidance through its actions in promoting appetitive state, in large part via the homeostatic feeding network.	[Moroz, Leonid L.; Hatcher, Nathan G.; Gillette, Rhanor] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Hirayama, Keiko; Gillette, Rhanor] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, R (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	rhanor@illinois.edu		Moroz, Leonid/0000-0002-1333-3176	NSF [IOB 04-47358]; NIH [R21 DA023445]; Division Of Integrative Organismal Systems [1146575] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023445] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NSF IOB 04-47358 and NIH R21 DA023445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY MS, 1976, J EXP BIOL, V65, P361; CORRENT G, 1978, SCIENCE, V202, P977, DOI 10.1126/science.309655; DAVIS WJ, 1983, J NEUROPHYSIOL, V49, P1557, DOI 10.1152/jn.1983.49.6.1557; DAVIS WJ, 1971, Z VERGL PHYSIOL, V75, P207; DAVIS WJ, 1978, SCIENCE, V199, P801, DOI 10.1126/science.622572; Fickbohm DJ, 2000, J NEUROSCI, V20, P1622; GILLETTE R, 1977, J COMP PHYSIOL, V116, P129, DOI 10.1007/BF00605400; GILLETTE R, 1991, J EXP BIOL, V156, P335; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Gittette R, 2006, INTEGR COMP BIOL, V46, P838, DOI 10.1093/icb/icl024; Hatcher NG, 2008, J NEUROCHEM, V104, P1358, DOI 10.1111/j.1471-4159.2007.05084.x; Hirayama K, 2012, CURR BIOL, V22, P118, DOI 10.1016/j.cub.2011.10.055; Jing J, 2003, J NEUROSCI, V23, P3039; Jing J, 2000, J NEUROPHYSIOL, V83, P1346, DOI 10.1152/jn.2000.83.3.1346; Kabotyanskii E A, 1991, Neurosci Behav Physiol, V21, P422, DOI 10.1007/BF01200277; Katz PS, 1995, J NEUROPHYSIOL, V74, P2281, DOI 10.1152/jn.1995.74.6.2281; KUPFERMANN I, 1979, FED PROC, V38, P2095; LENT CM, 1991, J COMP PHYSIOL A, V168, P191, DOI 10.1007/BF00218411; LENT CM, 1989, AM ZOOL, V29, P1241; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; Marinesco S, 2004, J NEUROPHYSIOL, V92, P2468, DOI 10.1152/jn.00209.2004; Marinesco S, 2004, J NEUROPHYSIOL, V92, P2487, DOI 10.1152/jn.00210.2004; MEULEMANS A, 1987, BRAIN RES, V414, P158, DOI 10.1016/0006-8993(87)91339-4; Murphy AD, 2001, PROG NEUROBIOL, V63, P383, DOI 10.1016/S0301-0082(00)00049-6; Noboa V, 2013, J EXP BIOL, V216, P3231, DOI 10.1242/jeb.079384; Norekian TP, 1996, J NEUROPHYSIOL, V75, P538, DOI 10.1152/jn.1996.75.2.538; PALOVCIK RA, 1982, BEHAV NEURAL BIOL, V35, P383, DOI 10.1016/S0163-1047(82)91034-2; Satterlie RA, 1996, INVERTEBR NEUROSCI, V2, P157, DOI 10.1007/BF02214171; Straub VA, 2001, J NEUROSCI, V21, P1767, DOI 10.1523/JNEUROSCI.21-05-01767.2001; Stuart JN, 2004, J NEUROCHEM, V90, P734, DOI 10.1111/j.1471-4159.2004.02538.x; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yafremava LS, 2011, J NEUROPHYSIOL, V105, P2885, DOI 10.1152/jn.00124.2011; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	34	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102240	10.1371/journal.pone.0102240	http://dx.doi.org/10.1371/journal.pone.0102240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048964	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100025
J	Li, J; Kang, YJ; Wei, LG; Liu, WJ; Tian, YP; Chen, BZ; Lin, XD; Li, Y; Feng, GS; Lu, ZX				Li, Jun; Kang, Yujia; Wei, Longgang; Liu, Wenjie; Tian, Yingpu; Chen, Baozhen; Lin, Xiandong; Li, Yang; Feng, Gen-Sheng; Lu, Zhongxian			Tyrosine Phosphatase Shp2 Mediates the Estrogen Biological Action in Breast Cancer via Interaction with the Estrogen Extranuclear Receptor	PLOS ONE			English	Article							SOLID TUMORS; ACTIVATING MUTATIONS; PTPN11 MUTATIONS; CELLS; PROTEIN; GROWTH; MEMBRANE; KINASE; PHOSPHORYLATION; PROMOTES	The extranuclear estrogen receptor pathway opens up novel perspectives in many physiological and pathological processes, especially in breast carcinogenesis. However, its function and mechanisms are not fully understood. Herein we present data identifying Shp2, a SH2-containing tyrosine phosphatase, as a critical component of extranuclear ER pathway in breast cancer. The research checked that the effect of Shp2 on the tumor formation and growth in animal model and investigated the regulation of Shp2 on the bio-effect and signaling transduction of estrogen in breast cancer cell lines. The results showed that Shp2 was highly expressed in more than 60% of total 151 breast cancer cases. The inhibition of Shp2 activity by PHPS1 (a Shp2 inhibitor) delayed the development of dimethylbenz(a)anthracene (DMBA)-induced tumors in the rat mammary gland and also blocked tumor formation in MMTV-pyvt transgenic mice. Estradiol (E2) stimulated protein expression and phosphorylation of Shp2, and induced Shp2 binding to ER alpha and IGF-1R around the membrane to facilitate the phosphorylation of Erk and Akt in breast cancer cells MCF7. Shp2 was also involved in several biological effects of the extranuclear ER-initiated pathway in breast cancer cells. Specific inhibitors (phps1, phps4 and NSC87877) or small interference RNAs (siRNA) of Shp2 remarkably suppressed E2-induced gene transcription (Cyclin D1 and trefoil factor 1 (TFF1)), rapid DNA synthesis and late effects on cell growth. These results introduced a new mechanism for Shp2 oncogenic action and shed new light on extranuclear ER-initiated action in breast tumorigenesis by identifying a novel associated protein, Shp2, for extranuclear ER pathway, which might benefit the therapy of breast cancer.	[Li, Jun; Kang, Yujia; Wei, Longgang; Liu, Wenjie; Tian, Yingpu; Li, Yang; Lu, Zhongxian] Xiamen Univ, Xiamen City Key Lab Metab Dis, Xiamen, Fujian, Peoples R China; [Li, Jun; Kang, Yujia; Wei, Longgang; Liu, Wenjie; Tian, Yingpu; Li, Yang; Lu, Zhongxian] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China; [Chen, Baozhen; Lin, Xiandong] Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Xiamen University; Xiamen University; University of California System; University of California San Diego; University of California System; University of California San Diego	Lu, ZX (corresponding author), Xiamen Univ, Xiamen City Key Lab Metab Dis, Xiamen, Fujian, Peoples R China.	zhongxian@xmu.edu.cn	Lu, ZX/G-4586-2010		National Basic Research Program of China [2010CB945004]; National Natural Science Foundation of China [30772546]; Fundamental Research Funds for the Central Universities [2010121099]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (grant no. 2010CB945004), the National Natural Science Foundation of China (grant no. 30772546), and the Fundamental Research Funds for the Central Universities (grant no. 2010121099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00030; Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bolli A, 2011, RECENT PATENTS ENDOC, V5, P210, DOI 10.2174/187221411797265881; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chakravarty D, 2010, CANCER RES, V70, P4092, DOI 10.1158/0008-5472.CAN-09-3834; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Cortez V, 2010, Minerva Ginecol, V62, P573; Costa I, 2002, ARCH PATHOL LAB MED, V126, P915; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Dos Santos EG, 2002, ENDOCRINOLOGY, V143, P930; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Feng GS, 2006, EXPERT OPIN THER TAR, V10, P135, DOI 10.1517/14728222.10.1.135; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Fu XD, 2007, GYNECOL ENDOCRINOL, V23, P131, DOI 10.1080/09513590601181457; Furcht CM, 2012, ONCOGENE; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; He Z, 2012, MOL CELL BIOL, V32, P1867, DOI 10.1128/MCB.06712-11; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hou HA, 2007, LEUKEMIA; Irsik DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070926; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; LABRIE F, 1995, BREAST CANCER RES TR, V33, P237, DOI 10.1007/BF00665948; Lappano R, 2013, J STEROID BIOCHEM, V137, P50, DOI 10.1016/j.jsbmb.2013.03.005; Lazzara MJ, 2010, CANCER RES, V70, P3843, DOI 10.1158/0008-5472.CAN-09-3421; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; Martinelli S, 2006, CANCER GENET CYTOGEN, V166, P124, DOI 10.1016/j.cancergencyto.2005.10.003; Miyamoto D, 2008, ONCOGENE, V27, P3508, DOI 10.1038/sj.onc.1211019; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Navis AC, 2010, ACTA NEUROPATHOL, V119, P157, DOI 10.1007/s00401-009-0614-0; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Williams C, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.370; Wu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004914; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622; Zhou X, 2008, HISTOPATHOLOGY, V53, P389, DOI 10.1111/j.1365-2559.2008.03103.x; Zhou XD, 2009, J BIOL CHEM, V284, P12226, DOI 10.1074/jbc.M900020200; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR130, DOI 10.1186/bcr959	55	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102847	10.1371/journal.pone.0102847	http://dx.doi.org/10.1371/journal.pone.0102847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048202	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100080
J	McGeoch, JEM; McGeoch, MW				McGeoch, Julie E. M.; McGeoch, Malcolm W.			Polymer Amide as an Early Topology	PLOS ONE			English	Article							AMINO-ACIDS; SUBUNIT-C; PARAMETERS; CHEMISTRY; PEPTIDES; OCEAN; STATE; FORM	Hydrophobic polymer amide (HPA) could have been one of the first normal density materials to accrete in space. We present ab initio calculations of the energetics of amino acid polymerization via gas phase collisions. The initial hydrogen-bonded di-peptide is sufficiently stable to proceed in many cases via a transition state into a di-peptide with an associated bound water molecule of condensation. The energetics of polymerization are only favorable when the water remains bound. Further polymerization leads to a hydrophobic surface that is phase-separated from, but hydrogen bonded to, a small bulk water complex. The kinetics of the collision and subsequent polymerization are discussed for the low-density conditions of a molecular cloud. This polymer in the gas phase has the properties to make a topology, viz. hydrophobicity allowing phase separation from bulk water, capability to withstand large temperature ranges, versatility of form and charge separation. Its flexible tetrahedral carbon atoms that alternate with more rigid amide groups allow it to deform and reform in hazardous conditions and its density of hydrogen bonds provides adhesion that would support accretion to it of silicon and metal elements to form a stellar dust material.	[McGeoch, Julie E. M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [McGeoch, Malcolm W.] PLEX LLC, Fall River, MA USA	Harvard University	McGeoch, JEM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	mcgeoch@fas.harvard.edu			PLEX LLC	PLEX LLC	The authors received no specific funding for this work. Author Malcolm W. McGeoch is affiliated with PLEX LLC. PLEX LLC provided support in the form of salary for author MWM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andersen JU, 2004, PHYS CHEM CHEM PHYS, V6, P2676, DOI 10.1039/b316845j; [Anonymous], VERT FUNCT SEQ HPA A; [Anonymous], SPART 04 10 MAC; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Bernatowicz TJ, 1996, ASTROPHYS J, V472, P760, DOI 10.1086/178105; Blagojevic V, 2003, MON NOT R ASTRON SOC, V339, pL7, DOI 10.1046/j.1365-8711.2003.06351.x; Brack A, 2007, CHEM BIODIVERS, V4, P665, DOI 10.1002/cbdv.200790057; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Cau P, 2002, ASTRON ASTROPHYS, V392, P203, DOI 10.1051/0004-6361:20020924; CHERCHNEFF I, 1992, ASTROPHYS J, V401, P269, DOI 10.1086/172059; Cyburt RH, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.023505; Dunkley J, 2009, ASTROPHYS J SUPPL S, V180, P306, DOI 10.1088/0067-0049/180/2/306; Ehrenfreund P, 2001, ASTROPHYS J, V550, pL95, DOI 10.1086/319491; Fedoseev G, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4738893; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; HERBST E, 1985, ASTROPHYS J, V292, P484, DOI 10.1086/163179; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hollis JM, 2002, ASTROPHYS J, V571, pL59, DOI 10.1086/341148; Holtom PD, 2005, ASTROPHYS J, V626, P940, DOI 10.1086/430106; JENSEN JH, 1992, J PHYS CHEM-US, V96, P8340, DOI 10.1021/j100200a025; KOBAYASHI K, 1990, ORIGINS LIFE EVOL B, V20, P99, DOI 10.1007/BF01808270; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Kuan YJ, 2003, ASTROPHYS J, V593, P848, DOI 10.1086/375637; Lewis A, 2006, MON NOT R ASTRON SOC, V373, P561, DOI 10.1111/j.1365-2966.2006.10983.x; Li PS, 1997, J AM CHEM SOC, V119, P1116, DOI 10.1021/ja962058c; Lolkema JS, 2003, FEBS LETT, V543, P47, DOI 10.1016/S0014-5793(03)00398-3; Maeda S, 2006, ASTROPHYS J, V640, P823, DOI 10.1086/500169; Martin RB, 1998, BIOPOLYMERS, V45, P351, DOI 10.1002/(SICI)1097-0282(19980415)45:5<351::AID-BIP3>3.0.CO;2-K; McGeoch JEM, 2000, MED BIOL ENG COMPUT, V38, P113, DOI 10.1007/BF02344699; McGeoch JEM, 2008, J R SOC INTERFACE, V5, P311, DOI 10.1098/rsif.2007.1146; McGeoch MW, 2014, SPECTRUM EARLY UNPUB; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; National Center for Biotechnology Information, 2009, ATP5G1 SYNTH SUB C P; PAULING L, 1952, J AM CHEM SOC, V74, P3964, DOI 10.1021/ja01135a531; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Pizzarello S, 2013, P NATL ACAD SCI USA, V110, P15614, DOI 10.1073/pnas.1309113110; Popova OP, 2013, SCIENCE, V342, P1069, DOI 10.1126/science.1242642; Price WD, 1997, J PHYS CHEM A, V101, P8844, DOI 10.1021/jp9722418; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; Simakov MB, 1996, ADV SPACE RES, V18, P61, DOI 10.1016/0273-1177(96)00028-2; Snyder LE, 2005, ASTROPHYS J, V619, P914, DOI 10.1086/426677; Stancil PC, 1996, ASTROPHYS J, V458, P401, DOI 10.1086/176824; Thomas D, 2005, ASTROPHYS J, V621, P673, DOI 10.1086/426932; Valley JW, 2014, NAT GEOSCI, V7, P219, DOI [10.1038/ngeo2075, 10.1038/NGEO2075]; WILSON AT, 1959, NATURE, V184, P99, DOI 10.1038/184099a0	46	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103036	10.1371/journal.pone.0103036	http://dx.doi.org/10.1371/journal.pone.0103036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048204	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100100
J	Polajnar, M; Zavasnik-Bergant, T; Skerget, K; Vizovisek, M; Vidmar, R; Fonovic, M; Kopitar-Jerala, N; Petrovic, U; Navarro, S; Ventura, S; Zerovnik, E				Polajnar, Mira; Zavasnik-Bergant, Tina; Skerget, Katja; Vizovisek, Matej; Vidmar, Robert; Fonovic, Marko; Kopitar-Jerala, Natasa; Petrovic, Uros; Navarro, Susanna; Ventura, Salvador; Zerovnik, Eva			Human Stefin B Role in Cell's Response to Misfolded Proteins and Autophagy	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; AMYLOID-FIBRIL FORMATION; UNVERRICHT-LUNDBORG-DISEASE; CATHEPSIN-D; CYSTATIN-B; ALZHEIMERS-DISEASE; IN-VITRO; NEURODEGENERATIVE DISEASE; CYSTEINE PROTEINASES; GENETIC ASSOCIATION	Alternative functions, apart from cathepsins inhibition, are being discovered for stefin B. Here, we investigate its role in vesicular trafficking and autophagy. Astrocytes isolated from stefin B knock-out (KO) mice exhibited an increased level of protein aggregates scattered throughout the cytoplasm. Addition of stefin B monomers or small oligomers to the cell medium reverted this phenotype, as imaged by confocal microscopy. To monitor the identity of proteins embedded within aggregates in wild type (wt) and KO cells, the insoluble cell lysate fractions were isolated and analyzed by mass spectrometry. Chaperones, tubulins, dyneins, and proteosomal components were detected in the insoluble fraction of wt cells but not in KO aggregates. In contrast, the insoluble fraction of KO cells exhibited increased levels of apolipoprotein E, fibronectin, clusterin, major prion protein, and serpins H1 and I2 and some proteins of lysosomal origin, such as cathepsin D and CD63, relative to wt astrocytes. Analysis of autophagy activity demonstrated that this pathway was less functional in KO astrocytes. In addition, synthetic dosage lethality (SDL) gene interactions analysis in Saccharomyces cerevisiae expressing human stefin B suggests a role in transport of vesicles and vacuoles These activities would contribute, directly or indirectly to completion of autophagy in wt astrocytes and would account for the accumulation of protein aggregates in KO cells, since autophagy is a key pathway for the clearance of intracellular protein aggregates.	[Polajnar, Mira; Zavasnik-Bergant, Tina; Skerget, Katja; Vizovisek, Matej; Vidmar, Robert; Fonovic, Marko; Kopitar-Jerala, Natasa; Zerovnik, Eva] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia; [Polajnar, Mira; Vizovisek, Matej; Vidmar, Robert; Fonovic, Marko; Zerovnik, Eva] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Skerget, Katja; Petrovic, Uros] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Navarro, Susanna; Ventura, Salvador] Autonomous Univ Barcelona, Inst Biotechnol & Biomed, Bellaterra, Spain; [Zerovnik, Eva] CipKeBip Ctr Excellence Integrated Approaches Che, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Autonomous University of Barcelona	Zerovnik, E (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia.	eva.zerovnik@ijs.si	Ventura, Salvador/C-7021-2008; Vizovišek, Matej/AAM-7147-2021; Fonović, Marko/X-9957-2019; Ventura, Salvador/AAY-3170-2021; Zerovnik, Eva/AAB-6498-2022; Vidmar, Robert/O-9075-2017	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Fonovic, Marko/0000-0002-8375-6713; Vizovisek, Matej/0000-0002-3860-1659; Navarro, Susanna/0000-0001-8160-9536; Petrovic, Uros/0000-0002-9743-9145; Vidmar, Robert/0000-0001-5068-3119	Ministry for Science and Technology of the Republic of Slovenia via the Slovenian Research Agency (ARRS);  [J7-4050];  [J2-9699];  [P1-0140]	Ministry for Science and Technology of the Republic of Slovenia via the Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); ; ; 	The work was supported by the projects J7-4050 (led by E. Z..), J2-9699 (co-led by U.P) and the program P1-0140 (Proteolysis and its regulation, led by B. Turk; all financed by the Ministry for Science and Technology of the Republic of Slovenia via the Slovenian Research Agency (ARRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Anderluh G, 2005, FEBS J, V272, P3042, DOI 10.1111/j.1742-4658.2005.04717.x; Anderluh G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00085; ARSTILA AU, 1968, AM J PATHOL, V53, P687; Bagnoli S, 2002, NEUROSCI LETT, V328, P273, DOI 10.1016/S0304-3940(02)00547-5; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Bertram L, 2001, ANN NEUROL, V49, P114, DOI 10.1002/1531-8249(200101)49:1<114::AID-ANA18>3.0.CO;2-M; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BRZIN J, 1984, BIOCHEM BIOPH RES CO, V118, P103, DOI 10.1016/0006-291X(84)91073-8; Butinar M, 2013, ONCOGENE; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Ceru S, 2005, MED HYPOTHESES, V64, P955, DOI 10.1016/j.mehy.2004.11.038; Ceru S, 2008, AMYLOID, V15, P147, DOI 10.1080/13506120802193555; Ceru S, 2008, FEBS LETT, V582, P203, DOI 10.1016/j.febslet.2007.12.002; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Cipollini E, 2008, BBA-MOL CELL RES, V1783, P312, DOI 10.1016/j.bbamcr.2007.08.007; Cohen NR, 2011, ACTA NEUROPATHOL, V121, P421, DOI 10.1007/s00401-010-0738-2; Corboy Michael J., 2005, V301, P305; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crawford FC, 2000, NEUROSCI LETT, V289, P61, DOI 10.1016/S0304-3940(00)01260-X; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; ELDRIDGE R, 1983, LANCET, V2, P838, DOI 10.1016/s0140-6736(83)90749-3; Genton P, 2010, EPILEPSIA, V51, P37, DOI 10.1111/j.1528-1167.2009.02441.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kopitar-Jerala NA, 2005, FEBS LETT, V579, P2149, DOI 10.1016/j.febslet.2005.03.002; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Laurent-Matha V, 2012, FASEB J, V26, P5172, DOI 10.1096/fj.12-205229; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; LENARCIC B, 1991, FEBS LETT, V280, P211, DOI 10.1016/0014-5793(91)80295-E; LENARCIC B, 1988, BIOCHEM BIOPH RES CO, V154, P765, DOI 10.1016/0006-291X(88)90206-9; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; Malik M, 2011, NEUROCHEM RES, V36, P754, DOI 10.1007/s11064-010-0395-9; Mateo I, 2002, AM J MED GENET, V114, P31, DOI 10.1002/ajmg.1623; Mattiazzi M, 2010, MOL GENET GENOMICS, V283, P519, DOI 10.1007/s00438-010-0533-8; Mcllroy SP, 1999, NEUROSCI LETT, V273, P140, DOI 10.1016/S0304-3940(99)00635-7; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Papassotiropoulos A, 2000, ANN NEUROL, V47, P399, DOI 10.1002/1531-8249(200003)47:3<399::AID-ANA22>3.3.CO;2-X; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Polajnar M, 2011, TRENDS MOL MED, V17, P293, DOI 10.1016/j.molmed.2011.02.005; Rabzelj S, 2005, PROTEIN SCI, V14, P2713, DOI 10.1110/ps.051609705; Rabzelj S, 2008, FEBS J, V275, P2455, DOI 10.1111/j.1742-4658.2008.06390.x; Sadik G, 1999, INT J BIOCHEM CELL B, V31, P1327, DOI 10.1016/S1357-2725(99)00053-9; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Schechter I, 2008, BIOL CHEM, V389, P313, DOI 10.1515/BC.2008.025; Skerget K, 2010, J BIOL CHEM, V285, P3201, DOI 10.1074/jbc.M109.024620; Skerget K, 2009, PROTEINS, V74, P425, DOI 10.1002/prot.22156; Sun T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00093; Taler-Vercic A, 2010, BIOESSAYS, V32, P1020, DOI 10.1002/bies.201000079; Tizon B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009819; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Ulbrich L, 2013, CELL MOL NEUROBIOL; van der Hilst JCH, 2009, EUR J CLIN INVEST, V39, P412, DOI 10.1111/j.1365-2362.2009.02104.x; Ventura S, 2011, CURR MOL MED, V11, P582, DOI 10.2174/156652411800615117; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang F, 2010, CELL DEATH DIFFER, V17, P1354, DOI 10.1038/cdd.2010.29; Zerovnik E, 2011, FEBS J, V278, P2263, DOI 10.1111/j.1742-4658.2011.08149.x; Zerovnik E, 2009, BIOESSAYS, V31, P597, DOI 10.1002/bies.200900012; Zhou JW, 2012, J ALZHEIMERS DIS, V28, P471, DOI 10.3233/JAD-2011-111469	72	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102500	10.1371/journal.pone.0102500	http://dx.doi.org/10.1371/journal.pone.0102500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047918	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100037
J	Thorfve, A; Bergstrand, A; Ekstrom, K; Lindahl, A; Thomsen, P; Larsson, A; Tengvall, P				Thorfve, Anna; Bergstrand, Anna; Ekstrom, Karin; Lindahl, Anders; Thomsen, Peter; Larsson, Anette; Tengvall, Pentti			Gene Expression Profiling of Peri-Implant Healing of PLGA-Li+ Implants Suggests an Activated Wnt Signaling Pathway In Vivo	PLOS ONE			English	Article							BONE-FORMATION; BETA-CATENIN; OSTEOGENIC DIFFERENTIATION; CALCIUM-PHOSPHATE; OSSEOINTEGRATION; CELL; LITHIUM; MACROPHAGE; SCLEROSTIN; MEDIATION	Bone development and regeneration is associated with the Wnt signaling pathway that, according to literature, can be modulated by lithium ions (Li+). The aim of this study was to evaluate the gene expression profile during peri-implant healing of poly(lactic-co-glycolic acid) (PLGA) implants with incorporated Li+, while PLGA without Li+ was used as control, and a special attention was then paid to the Wnt signaling pathway. The implants were inserted in rat tibia for 7 or 28 days and the gene expression profile was investigated using a genome-wide microarray analysis. The results were verified by qPCR and immunohistochemistry. Histomorphometry was used to evaluate the possible effect of Li+ on bone regeneration. The microarray analysis revealed a large number of significantly differentially regulated genes over time within the two implant groups. The Wnt signaling pathway was significantly affected by Li+, with approximately 34% of all Wnt-related markers regulated over time, compared to 22% for non-Li+ containing (control; Ctrl) implants. Functional cluster analysis indicated skeletal system morphogenesis, cartilage development and condensation as related to Li+. The downstream Wnt target gene, FOSL1, and the extracellular protein-encoding gene, ASPN, were significantly upregulated by Li+ compared with Ctrl. The presence of beta-catenin, FOSL1 and ASPN positive cells was confirmed around implants of both groups. Interestingly, a significantly reduced bone area was observed over time around both implant groups. The presence of periostin and calcitonin receptor-positive cells was observed at both time points. This study is to the best of the authors' knowledge the first report evaluating the effect of a local release of Li+ from PLGA at the fracture site. The present study shows that during the current time frame and with the present dose of Li+ in PLGA implants, Li+ is not an enhancer of early bone growth, although it affects the Wnt signaling pathway.	[Thorfve, Anna; Ekstrom, Karin; Thomsen, Peter; Tengvall, Pentti] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Inst Clin Sci, Gothenburg, Sweden; [Thorfve, Anna; Ekstrom, Karin; Lindahl, Anders; Thomsen, Peter; Tengvall, Pentti] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden; [Bergstrand, Anna; Larsson, Anette] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Bergstrand, Anna; Larsson, Anette] SuMo BIOMAT VINN Excellence Ctr, Gothenburg, Sweden; [Bergstrand, Anna] Stiftelsen Chalmers Ind Tekn, Gothenburg, Sweden; [Lindahl, Anders] Univ Gothenburg, Dept Clin Chem & Transfus Med, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Thorfve, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Inst Clin Sci, Gothenburg, Sweden.	anna.thorfve@biomaterials.gu.se	Lindahl, Anders/H-9550-2014; Larsson, Anette/D-1954-2013; Ekström, Karin/M-7501-2013	Lindahl, Anders/0000-0003-2871-5166; Ekström, Karin/0000-0001-7808-4572; Thomsen, Peter/0000-0003-3910-6665; Larsson, Anette/0000-0002-6119-8423	Swedish Research Council (VR) [K2009-52X-09495-22-3, 621-2011-6037]; BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; SuMo Biomaterials VINN Excellence Center; Handlanden Hjalmar Svensson Research Foundation	Swedish Research Council (VR)(Swedish Research Council); BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy; SuMo Biomaterials VINN Excellence Center; Handlanden Hjalmar Svensson Research Foundation	The support of the Swedish Research Council (VR grants K2009-52X-09495-22-3 and 621-2011-6037), the BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, the SuMo Biomaterials VINN Excellence Center and the Handlanden Hjalmar Svensson Research Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Alblowi J, 2013, BONE, V53, P294, DOI 10.1016/j.bone.2012.12.006; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592; Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014; Bonucci EE, 2011, FRONT BIOSCI ELITE E, V17, P100; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Devarajan-Ketha H, 2012, BIOCHEM BIOPH RES CO, V417, P830, DOI 10.1016/j.bbrc.2011.12.048; Donos N, 2011, CLIN ORAL IMPLAN RES, V22, P365, DOI 10.1111/j.1600-0501.2010.02113.x; Dreifke MB, 2013, J BIOMED MATER RES A, V101, P2436, DOI 10.1002/jbm.a.34521; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Ertugrul AS, 2013, AUST DENT J, V58, P170, DOI 10.1111/adj.12022; Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x; Gimble JM, 2012, CLIN BIOCHEM, V45, P874, DOI 10.1016/j.clinbiochem.2012.03.006; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Han PP, 2012, BIOMATERIALS, V33, P6370, DOI 10.1016/j.biomaterials.2012.05.061; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Heo JS, 2010, MOL CELLS, V30, P449, DOI 10.1007/s10059-010-0139-3; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikegawa S, 2008, CURR MED CHEM, V15, P724, DOI 10.2174/092986708783885237; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanovski S, 2011, CLIN ORAL IMPLAN RES, V22, P373, DOI 10.1111/j.1600-0501.2010.02112.x; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kerachian MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3062; Khangs G, 2006, ENCY MED DEVICES INS, P366; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kojima N, 2008, CLIN ORAL IMPLAN RES, V19, P173, DOI 10.1111/j.1600-0501.2007.01432.x; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lanao RPF, 2013, J BIOMED MATER RES A, V101, P3123, DOI 10.1002/jbm.a.34623; Lanao RPF, 2013, TISSUE ENG PART B-RE, V19, P380, DOI [10.1089/ten.teb.2012.0443, 10.1089/ten.TEB.2012.0443]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lories RJ, 2013, NAT REV RHEUMATOL, V9, P328, DOI 10.1038/nrrheum.2013.25; Malhi GS, 2012, AUST NZ J PSYCHIAT, V46, P192, DOI 10.1177/0004867412437346; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Meyer F, 2012, J ORTHOP RES, V30, P864, DOI 10.1002/jor.22019; Miclea RL, 2011, OSTEOARTHR CARTILAGE, V19, P1363, DOI 10.1016/j.joca.2011.07.014; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058622; Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036; Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shinohara K, 2011, J ORTHOP RES, V29, P1064, DOI 10.1002/jor.21374; Son JS, 2013, J BIOMED MATER RES B, V101B, P247, DOI 10.1002/jbm.b.32834; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208; Thalji G, 2013, BONE, V52, P444, DOI 10.1016/j.bone.2012.07.026; Thorfve A, 2012, CARTILAGE, V3, P43, DOI 10.1177/1947603511414178; Tiainen J, 2004, J BIOMED MATER RES B, V70B, P49, DOI 10.1002/jbm.b.30013; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9; Wang F, 2010, EUR J PHARMACOL, V640, P226, DOI 10.1016/j.ejphar.2010.04.024; Wang JW, 2009, DENT MATER, V25, P353, DOI 10.1016/j.dental.2008.07.013; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wise JK, 2010, PLOS ONE, V5, DOI [10.1371/journal.-pone.0012987, DOI 10.1371/JOURNAL.-PONE.0012987]; Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129; Zupan J, 2013, BIOCHEM MEDICA, V23, P43, DOI 10.11613/BM.2013.007	71	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102597	10.1371/journal.pone.0102597	http://dx.doi.org/10.1371/journal.pone.0102597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047349	gold, Green Published			2022-12-27	WOS:000339558100050
J	Uliano-Silva, M; Americo, JA; Brindeiro, R; Dondero, F; Prosdocimi, F; Rebelo, MD				Uliano-Silva, Marcela; Americo, Juliana Alves; Brindeiro, Rodrigo; Dondero, Francesco; Prosdocimi, Francisco; Rebelo, Mauro de Freitas			Gene Discovery through Transcriptome Sequencing for the Invasive Mussel Limnoperna fortunei	PLOS ONE			English	Article							HEAT-STRESS; EXPRESSION; CONSEQUENCES; REPERTOIRE; COMPLEXITY; DATABASE; LIMITS; MODEL	The success of the Asian bivalve Limnoperna fortunei as an invader in South America is related to its high acclimation capability. It can inhabit waters with a wide range of temperatures and salinity and handle long-term periods of air exposure. We describe the transcriptome of L. fortunei aiming to give a first insight into the phenotypic plasticity that allows non-native taxa to become established and widespread. We sequenced 95,219 reads from five main tissues of the mussel L. fortunei using Roche's 454 and assembled them to form a set of 84,063 unigenes (contigs and singletons) representing partial or complete gene sequences. We annotated 24,816 unigenes using a BLAST sequence similarity search against a NCBI nr database. Unigenes were divided into 20 eggNOG functional categories and 292 KEGG metabolic pathways. From the total unigenes, 1,351 represented putative full-length genes of which 73.2% were functionally annotated. We described the first partial and complete gene sequences in order to start understanding bivalve invasiveness. An expansion of the hsp70 gene family, seen also in other bivalves, is present in L. fortunei and could be involved in its adaptation to extreme environments, e.g. during intertidal periods. The presence of toll-like receptors gives a first insight into an immune system that could be more complex than previously assumed and may be involved in the prevention of disease and extinction when population densities are high. Finally, the apparent lack of special adaptations to extremely low O-2 levels is a target worth pursuing for the development of a molecular control approach.	[Uliano-Silva, Marcela; Americo, Juliana Alves; Rebelo, Mauro de Freitas] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil; [Brindeiro, Rodrigo] Univ Fed Rio de Janeiro, Inst Biol, Rio de Janeiro, Brazil; [Dondero, Francesco] Univ Piemonte Orientale, Dept Sci & Technol Innovat, Alessandria, Italy; [Prosdocimi, Francisco] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University of Eastern Piedmont Amedeo Avogadro; Universidade Federal do Rio de Janeiro	Dondero, F (corresponding author), Univ Piemonte Orientale, Dept Sci & Technol Innovat, Alessandria, Italy.	francesco.dondero@mfn.unipmn.it	da Silva, Marcela Uliano/ABA-3296-2020; Prosdocimi, Francisco/V-5252-2019; Prosdocimi, Francisco/F-6847-2012; Dondero, Francesco/J-1528-2012	da Silva, Marcela Uliano/0000-0001-6723-4715; Prosdocimi, Francisco/0000-0002-6761-3069; Prosdocimi, Francisco/0000-0002-6761-3069; Dondero, Francesco/0000-0001-7945-3712; Alves Americo, Juliana/0000-0001-9443-6144	Brazilian National Research Council CNPq [473419/2010-6]	Brazilian National Research Council CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Work was funded by the Brazilian National Research Council CNPq (proc: 473419/2010-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtiarizadeh MR, 2012, GENET MOL RES, V11, P1558, DOI 10.4238/2012.May.21.12; Bastos VLFC, 2007, BIOCHIMIE, V89, P1332, DOI 10.1016/j.biochi.2007.04.003; Bell EC, 1996, J EXP BIOL, V199, P1005; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Calazans SHC, 2013, MAR ENVIRON RES, V91, P104, DOI 10.1016/j.marenvres.2013.02.012; Darrigran G, 2011, ZOOL SCI, V28, P1, DOI 10.2108/zsj.28.1; De Beuf K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-303; de Oliveira MD, 2000, HYDROBIOLOGIA, V427, P101; Egas C, 2012, MAR DRUGS, V10, P1765, DOI 10.3390/md10081765; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Karatayev AY, 2007, J SHELLFISH RES, V26; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mateo DR, 2010, DEV COMP IMMUNOL, V34, P710, DOI 10.1016/j.dci.2010.02.006; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; MORTON B, 1973, Malacologia, V12, P265; Oliveira MD, 2010, AQUAT INVASIONS, V5, P59, DOI 10.3391/ai.2010.5.1.8; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; Pastorino Guido, 1993, Neotropica (La Plata), V39, P34; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Souza DS, ECOTOXICOL ENV SAF, V76, P153; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Sun J, 2012, MOL ECOL RESOUR, V12, P1133, DOI 10.1111/1755-0998.12014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telles GP, 2001, GENET MOL BIOL, V24, P17, DOI 10.1590/S1415-47572001000100004; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Uliano-Silva M, 2013, EXPLORING THEMES AQU, P135; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063927; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Zeng F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt372; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	53	34	34	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102973	10.1371/journal.pone.0102973	http://dx.doi.org/10.1371/journal.pone.0102973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047650	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100094
J	van den Berg, E; Bem, RA; Bos, AP; Lutter, R; van Woensel, JBM				van den Berg, Elske; Bem, Reinout A.; Bos, Albert P.; Lutter, Rene; van Woensel, Job B. M.			The Effect of TIP on Pneumovirus-Induced Pulmonary Edema in Mice	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TUMOR-NECROSIS-FACTOR; LECTIN-LIKE DOMAIN; ALVEOLAR FLUID CLEARANCE; ACUTE LUNG INJURY; PNEUMONIA VIRUS; TRACT INFECTION; FACTOR-ALPHA; RSV INFECTION; IN-VITRO	Background: Pulmonary edema plays a pivotal role in the pathophysiology of respiratory syncytial virus (RSV)-induced respiratory failure. In this study we determined whether treatment with TIP (AP301), a synthetic cyclic peptide that mimics the lectin-like domain of human TNF, decreases pulmonary edema in a mouse model of severe human RSV infection. TIP is currently undergoing clinical trials as a therapy for pulmonary permeability edema and has been shown to decrease pulmonary edema in different lung injury models. Methods: C57BL/6 mice were infected with pneumonia virus of mice (PVM) and received TIP or saline (control group) by intratracheal instillation on day five (early administration) or day seven (late administration) after infection. In a separate set of experiments the effect of multiple dose administration of TIP versus saline was tested. Pulmonary edema was determined by the lung wet-to-dry (W/D) weight ratio and was assessed at different time-points after the administration of TIP. Secondary outcomes included clinical scores and lung cellular response. Results: TIP did not have an effect on pulmonary edema in different dose regimens at different time points during PVM infection. In addition, TIP administration did not affect clinical severity scores or lung cellular response. Conclusion: In this murine model of severe RSV infection TIP did not affect pulmonary edema nor course of disease.	[van den Berg, Elske; Bem, Reinout A.; Bos, Albert P.; van Woensel, Job B. M.] Emma Childrens Hosp, Acad Med Ctr, Pediat Intens Care Unit, Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med & Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Berg, E (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Pediat Intens Care Unit, Amsterdam, Netherlands.	elske.vandenberg@amc.uva.nl	A., Reinout/AAN-1411-2021	Bem, Reinout Alexander/0000-0002-9454-5321	APEPTICO GmbH, Vienna, Austria; Janivo Foundation [2011.063]	APEPTICO GmbH, Vienna, Austria; Janivo Foundation	The study was funded in part by APEPTICO GmbH, Vienna, Austria, which is the title holder of the TIP peptide AP301. Additional funding was received by the Janivo Foundation (reference 2011.063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 1999, AM J PHYSIOL-LUNG C, V277, pL1057, DOI 10.1152/ajplung.1999.277.5.L1057; Bem RA, 2013, PEDIATR CRIT CARE ME, V14, pE243, DOI 10.1097/PCC.0b013e31828a7f9b; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Braun C, 2005, J IMMUNOL, V175, P3402, DOI 10.4049/jimmunol.175.5.3402; CHAMPIGNY G, 1994, EMBO J, V13, P2177, DOI 10.1002/j.1460-2075.1994.tb06494.x; Chen L, 2009, AM J RESP CELL MOL, V40, P588, DOI 10.1165/rcmb.2008-0034OC; Cook PM, 1998, J GEN VIROL, V79, P2411, DOI 10.1099/0022-1317-79-10-2411; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; Domachowske JB, 2000, J IMMUNOL, V165, P2677, DOI 10.4049/jimmunol.165.5.2677; Dunn MCC, 2011, ANTIVIR THER, V16, P309, DOI 10.3851/IMP1763; Dyer KD, 2012, VIRUSES-BASEL, V4, P3494, DOI 10.3390/v4123494; Elia N, 2003, AM J RESP CRIT CARE, V168, P1043, DOI 10.1164/rccm.200206-618OC; Hamacher J, 2010, CRIT CARE MED, V38, P871, DOI 10.1097/CCM.0b013e3181cdf725; Hartmann EK, 2013, ACTA ANAESTH SCAND, V57, P334, DOI 10.1111/aas.12034; Hazemi P, 2010, J MED CHEM, V53, P8021, DOI 10.1021/jm100767p; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Lee CG, 2000, AM J RESP CELL MOL, V23, P662, DOI 10.1165/ajrcmb.23.5.4188; LUCAS R, 1994, SCIENCE, V263, P814, DOI 10.1126/science.8303299; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; NITTA K, 1994, RESP PHYSIOL, V95, P43, DOI 10.1016/0034-5687(94)90046-9; Papin JF, 2013, AM J PHYSIOL-LUNG C, V304, pL530, DOI 10.1152/ajplung.00173.2012; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; PITTET JF, 1994, J CLIN INVEST, V94, P663, DOI 10.1172/JCI117383; Rosenberg HF, 2012, CURR MED CHEM, V19, P1424; Rosenberg HF, 2008, IMMUNOL LETT, V118, P6, DOI 10.1016/j.imlet.2008.03.013; Song WF, 2010, ANN NY ACAD SCI, V1203, P79, DOI 10.1111/j.1749-6632.2010.05560.x; TCHEPICHEV S, 1995, AM J PHYSIOL-CELL PH, V269, pC805, DOI 10.1152/ajpcell.1995.269.3.C805; Vadasz I, 2008, CRIT CARE MED, V36, P1543, DOI 10.1097/CCM.0b013e31816f485e; van den Berg E, 2011, AM J PHYSIOL-LUNG C, V301, pL451, DOI 10.1152/ajplung.00368.2010; van Woensel JBM, 2003, THORAX, V58, P383, DOI 10.1136/thorax.58.5.383; van Woensel JBM, 2003, BMJ-BRIT MED J, V327, P36, DOI 10.1136/bmj.327.7405.36; van Woensel JBM, 2011, CRIT CARE MED, V39, P1779, DOI 10.1097/CCM.0b013e318218a030; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102749	10.1371/journal.pone.0102749	http://dx.doi.org/10.1371/journal.pone.0102749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047452	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100071
J	Xie, HX; Li, B; Li, L; Zou, XL; Zhu, CR; Li, Y; Gao, N; Chen, QM; Li, LJ				Xie, Huixu; Li, Bo; Li, Li; Zou, Xiao-li; Zhu, Cai-rong; Li, Yi; Gao, Ning; Chen, Qianming; Li, Longjiang			Association of Increased Circulating Catecholamine and Glucocorticoid Levels with Risk of Psychological Problems in Oral Neoplasm Patients	PLOS ONE			English	Article							OVARIAN-CARCINOMA; CHRONIC STRESS; CANCER; TUMOR; DEPRESSION; GROWTH; ANGIOGENESIS; APOPTOSIS	Background: Noradrenergic pathways and glucocorticoid-mediated signal pathways have been implicated in the growth and progression of oral cancer. Patients with oral neoplasms can have high psychological distress levels, but the effects of stress-related hormones on oral neoplasm growth are unknown. Methods: We have investigated the relationships between pre-surgical measurements of psychological problems with Symptom Checklist-90-revised Inventory (SCL90-R), tumor histology, circulating blood catecholamine and glucocorticoid levels among 75 oral neoplasm patients, including 40 oral cancer patients and 35 benign oral tumor patients. Results: The results showed that most dimension scores of SCL90-R did not show a significant difference between the two groups except depression (p = 0.0201) and obsessive-compulsion (p = 0.0093), with the scores for these symptoms being higher among oral cancer group versus the benign oral tumor group. The differences of total score, average score and other monomial factor scores were not statistically significant. The mean concentrations of catecholamine and glucocorticoid in peripheral blood of the oral cancer group were higher than those in benign oral tumor group (p<0.01). We also examined whether associations observed between biobehavioral measures and circulating blood catecholamine and glucocorticoid levels extended to other compartments in the oral cancer group. Conclusions: These findings suggest that stress hormones may affect oral cancer behavior by influencing the tumor micro-environment though the circulating blood.	[Xie, Huixu; Li, Bo; Li, Yi; Gao, Ning; Chen, Qianming; Li, Longjiang] Sichuan Univ, West China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China; [Xie, Huixu; Li, Bo; Li, Yi; Gao, Ning; Chen, Qianming; Li, Longjiang] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Li, Li] West China Second Univ Hosp, Dept Med Record Management, Chengdu, Peoples R China; [Zou, Xiao-li; Zhu, Cai-rong] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, LJ (corresponding author), Sichuan Univ, West China Sch Stomatol, Chengdu 610064, Sichuan, Peoples R China.	muzili63@163.com		Li, Long-jiang/0000-0003-1446-0692	National Natural Science Foundation of China [81172578, 81001209]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81321002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by the National Natural Science Foundation of China (Grant No. 81172578 and 81001209) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 81321002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037/0278-6133.20.1.20; Bernabe DG, 2011, BRAIN BEHAV IMMUN, V25, P574, DOI 10.1016/j.bbi.2010.12.012; Biswas R, 2006, J NEUROIMMUNOL, V171, P120, DOI 10.1016/j.jneuroim.2005.09.014; DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; Gu Q, 2008, ANAL CHIM ACTA, V609, P192, DOI 10.1016/j.aca.2008.01.017; KIECOLTGLASER JK, 1985, J BEHAV MED, V8, P311, DOI 10.1007/BF00848366; Lutgendorf SK, 2011, BRAIN BEHAV IMMUN, V25, P250, DOI 10.1016/j.bbi.2010.10.012; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Olsen CA, 2009, J MED CHEM, V52, P7836, DOI 10.1021/jm900850t; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579; Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802; Tarcic N, 1998, J NEUROIMMUNOL, V82, P40, DOI 10.1016/S0165-5728(97)00186-0; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Yano A, 2006, CLIN CANCER RES, V12, P3003, DOI 10.1158/1078-0432.CCR-05-2085	19	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e99179	10.1371/journal.pone.0099179	http://dx.doi.org/10.1371/journal.pone.0099179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048798	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100003
J	Huang, JD; Amaral, J; Lee, JW; Rodriguez, IR				Huang, Jiahn-Dar; Amaral, Juan; Lee, Jung Wha; Rodriguez, Ignacio R.			7-Ketocholesterol-Induced Inflammation Signals Mostly through the TLR4 Receptor Both In Vitro and In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; BIOLOGICAL-ACTIVITY; CYTOKINE PRODUCTION; WNT PATHWAY; INHIBITOR; OXYSTEROLS; CELLS; MECHANISMS; OXIDATION	The cholesterol oxide 7-ketocholesterol (7KCh) has been implicated in numerous age-related diseases such as atherosclerosis, Alzheimer's disease, Parkinson's disease, cancer and age-related macular degeneration. It is formed by the autooxidation of cholesterol and especially cholesterol-fatty acid esters found in lipoprotein deposits. This molecule causes complex and potent inflammatory responses in vitro and in vivo. It is suspected of causing chronic inflammation in tissues exposed to oxidized lipoprotein deposits. In this study we have examined the inflammatory pathways activated by 7KCh both in cultured ARPE19 cells and in vivo using 7KCh-containing implants inserted into the anterior chamber of the rat eye. Our results indicate that 7KCh-induced inflammation is mediated mostly though the TLR4 receptor with some cross-activation of EGFR-related pathways. The majority of the cytokine inductions seem to signal via the TRIF/TRAM side of the TLR4 receptor. The MyD88/TIRAP side only significantly effects IL-1 beta inductions. The 7KCh-induced inflammation also seems to involve a robust ER stress response. However, this response does not seem to involve a calcium efflux-mediated UPR. Instead the ER stress response seems to be mediated by yet identified kinases activated through the TLR4 receptor. Some of the kinases identified are the RSKs which seem to mediate the cytokine inductions and the cell death pathway but do not seem to be involved in the ER stress response.	[Huang, Jiahn-Dar; Amaral, Juan; Lee, Jung Wha; Rodriguez, Ignacio R.] NEI, Retinal Cell & Mol Biol Lab, Mech Retinal Dis Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Rodriguez, IR (corresponding author), NEI, Retinal Cell & Mol Biol Lab, Mech Retinal Dis Sect, NIH, Bethesda, MD 20892 USA.	rodriguezi@nei.nih.gov		Amaral, Juan/0000-0001-8755-9170	National Eye Institute Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000307] Funding Source: NIH RePORTER	National Eye Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Eye Institute Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056099; Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chiang EY, 2011, J IMMUNOL, V186, P1279, DOI 10.4049/jimmunol.1002821; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Dzeletovic S, 1995, CHEM PHYS LIPIDS, V78, P119, DOI 10.1016/0009-3084(95)02489-6; Erridge C, 2007, FREE RADICAL RES, V41, P260, DOI 10.1080/10715760601070091; Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Han YC, 1996, CANCER RES, V56, P3859; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang JD, 2012, BBA-MOL CELL BIOL L, V1821, P637, DOI 10.1016/j.bbalip.2012.01.013; Inagaki-Ohara Kyoko, 2013, JAKSTAT, V2, pe24053, DOI 10.4161/jkst.24053; Lara R, 2013, CANCER RES, V73, P5301, DOI 10.1158/0008-5472.CAN-12-4448; Larrayoz IM, 2010, INVEST OPHTH VIS SCI, V51, P4942, DOI 10.1167/iovs.09-4854; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee WH, 2009, Z NATURFORSCH C, V64, P307; Liao PL, 2010, TOXICOL LETT, V197, P88, DOI 10.1016/j.toxlet.2010.05.002; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Liu J, 2009, ARCH BIOCHEM BIOPHYS, V487, P54, DOI 10.1016/j.abb.2009.05.004; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lordan S, 2009, J NUTR BIOCHEM, V20, P321, DOI 10.1016/j.jnutbio.2009.01.001; Lyons MA, 2001, BBA-MOL CELL BIOL L, V1530, P209, DOI 10.1016/S1388-1981(01)00083-X; Lyons MA, 1999, J LIPID RES, V40, P1846; Markman B, 2013, CURR PHARM DESIGN, V19, P895, DOI 10.2174/138161213804547213; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ohtsuka M, 2006, J ATHEROSCLER THROMB, V13, P256, DOI 10.5551/jat.13.256; Poli G, 2013, REDOX BIOL, V1, P125, DOI 10.1016/j.redox.2012.12.001; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Ratti M, 2014, ANTI-CANCER DRUG, V25, P127, DOI 10.1097/CAD.0000000000000035; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Rodriguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820; Rodriguez IR, 2004, INVEST OPHTH VIS SCI, V45, P2830, DOI 10.1167/iovs.04-0075; Ruiz-Nunez B, 2013, J NUTR BIOCHEM, V24, P1183, DOI 10.1016/j.jnutbio.2013.02.009; SANCHEZMARGALET V, 1994, BIOCHEM BIOPH RES CO, V204, P446, DOI 10.1006/bbrc.1994.2480; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Shi G, 2013, IOVS 2013, V2013, P150; Smith JA, 2005, CANCER RES, V65, P1027; STANDAERT ML, 1995, BIOCHEM BIOPH RES CO, V209, P1082, DOI 10.1006/bbrc.1995.1608; Su XQ, 2006, EUR J IMMUNOL, V36, P199, DOI 10.1002/eji.200535415; Tolloczko B, 2004, J PHARMACOL EXP THER, V311, P787, DOI 10.1124/jpet.104.069013; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; van Reyk DM, 2006, REDOX REP, V11, P255, DOI 10.1179/135100006X155003; Vejux A, 2008, BRAZ J MED BIOL RES, V41, P545, DOI 10.1590/S0100-879X2008000700001; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; Wang SF, 2013, BIOCHEM PHARMACOL, V86, P548, DOI 10.1016/j.bcp.2013.06.006; Yamada M, 2005, J MED CHEM, V48, P7457, DOI 10.1021/jm050623t; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57; Zhao W, 2012, FEBS LETT, V586, P705, DOI 10.1016/j.febslet.2012.01.016; Zhou MX, 2003, ONCOGENE, V22, P8137, DOI 10.1038/sj.onc.1206911	69	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100985	10.1371/journal.pone.0100985	http://dx.doi.org/10.1371/journal.pone.0100985			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036103	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200011
J	Jung, H; Lee, JA; Choi, S; Lee, H; Ahn, B				Jung, Hana; Lee, Jin A.; Choi, Seoyoon; Lee, Hyunwoo; Ahn, Byungchan			Characterization of the Caenorhabditis elegans HIM-6/BLM Helicase: Unwinding Recombination Intermediates	PLOS ONE			English	Article							BLOOMS-SYNDROME HELICASE; STRAND BREAK REPAIR; TOPOISOMERASE-III-ALPHA; SYNDROME GENE-PRODUCT; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; REPLICATION FORKS; GENOME STABILITY; BIOCHEMICAL-CHARACTERIZATION; HOMOLOGOUS RECOMBINATION	Mutations in three human RecQ genes are implicated in heritable human syndromes. Mutations in BLM, a RecQ gene, cause Bloom syndrome (BS), which is characterized by short stature, cancer predisposition, and sensitivity to sunlight. BLM is a RecQ DNA helicase that, with interacting proteins, is able to dissolve various DNA structures including double Holliday junctions. A BLM ortholog, him-6, has been identified in Caenorhabditis elegans, but little is known about its enzymatic activities or its in vivo roles. By purifying recombinant HIM-6 and performing biochemical assays, we determined that the HIM-6 has DNA-dependent ATPase activity HIM-6 and helicase activity that proceeds in the 3'-5' direction and needs at least five 3' overhanging nucleotides. HIM-6 is also able to unwind DNA structures including D-loops and Holliday junctions. Worms with him-6 mutations were defective in recovering the cell cycle arrest after HU treatment. These activities strongly support in vivo roles for HIM-6 in processing recombination intermediates.	[Jung, Hana; Lee, Jin A.; Choi, Seoyoon; Lee, Hyunwoo; Ahn, Byungchan] Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea	University of Ulsan	Ahn, B (corresponding author), Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea.	bbccahn@mail.ulsan.ac.kr		Lee, Jin-A/0000-0002-8390-2311	Basic Research Promotion Fund through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2011-0364, NRF-2013-0343]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Basic Research Promotion Fund through the National Research Foundation of Korea - Ministry of Education, Science and Technology; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported the Basic Research Promotion Fund through the National Research Foundation of Korea (NRF-2011-0364, NRF-2013-0343) funded by the Ministry of Education, Science and Technology. http://ernd.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Agostinho A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003591; Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2001, EMBO J, V20, P5791; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Choi DH, 2013, J MICROBIOL, V51, P105, DOI 10.1007/s12275-013-3048-2; Cobb JA, 2006, NUCLEIC ACIDS RES, V34, P4106, DOI 10.1093/nar/gkl557; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Grabowski MM, 2005, MECH AGEING DEV, V126, P1314, DOI 10.1016/j.mad.2005.08.005; Groocock LM, 2012, MOL CELL BIOL, V32, P276, DOI 10.1128/MCB.06184-11; Hyun M, 2008, BIOCHEMISTRY-US, V47, P7583, DOI 10.1021/bi800197m; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kim YC, 2002, GENES CELLS, V7, P19, DOI 10.1046/j.1356-9597.2001.00496.x; Kim YM, 2005, MOL CELLS, V20, P228; Kusano K, 1999, GENETICS, V151, P1027; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Manthei KA, 2013, CELL MOL LIFE SCI, V70, P4067, DOI 10.1007/s00018-013-1325-1; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; O'Neil NJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003582; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Saito TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003586; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sidorova JM, 2013, DNA REPAIR, V12, P128, DOI 10.1016/j.dnarep.2012.11.005; Srivastava V, 2009, J CELL SCI, V122, P3093, DOI 10.1242/jcs.051813; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Traverso G, 2003, CANCER RES, V63, P8578; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Watt PM, 1996, GENETICS, V144, P935; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102402	10.1371/journal.pone.0102402	http://dx.doi.org/10.1371/journal.pone.0102402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036527	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200056
J	Lee, WK; Su, YA; Song, TJ; Chiu, YC; Lin, CH				Lee, We-Kang; Su, Yi-An; Song, Tzu-Jiun; Chiu, Yao-Chu; Lin, Ching-Hung			Are Normal Decision-Makers Sensitive to Changes in Value Contrast under Uncertainty? Evidence from the Iowa Gambling Task	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; SEX-DIFFERENCES; PERFORMANCE; DAMAGE; DECKS; GAIN	The Iowa Gambling Task (IGT) developed by Bechara et al. in 1994 is used to diagnose patients with Ventromedial Medial Prefrontal Cortex (VMPFC) lesions, and it has become a landmark in research on decision making. According to Bechara et al., the manipulation of progressive increments of monetary value can normalize the performance of patients with VMPFC lesions; thus, they developed a computerized version of the IGT. However, the empirical results showed that patients' performances did not improve as a result of this manipulation, which suggested that patients with VMPFC lesions performed myopically for future consequences. Using the original version of the IGT, some IGT studies have demonstrated that increments of monetary value significantly influence the performance of normal subjects in the IGT. However, other research has resulted in inconsistent findings. In this study, we used the computerized IGT (1X-IGT) and manipulated the value contrast of progressive increments (i.e., by designing the 10X-IGT, which contained 10 times of progressive increment) to investigate the influence of value contrast on the performance of normal subjects. The resulting empirical observations indicated that the value contrast (1X-vs. 10X-IGT) of the progressive increment had no effect on the performance of normal subjects. This study also provides a discussion of the issue of value in IGT-related studies. Moreover, we found the "prominent deck B phenomenon" in both versions of the IGT, which indicated that the normal subjects were guided mostly by the gain-loss frequency, rather than by the monetary value contrast. In sum, the behavioral performance of normal subjects demonstrated a low correlation with changes in monetary value, even in the 10X-IGT.	[Lee, We-Kang; Su, Yi-An; Song, Tzu-Jiun; Chiu, Yao-Chu] Soochow Univ, Dept Psychol, Taipei, Taiwan; [Lee, We-Kang] Natl Chengchi Univ, Dept Psychol, Taipei 11623, Taiwan; [Lin, Ching-Hung] China Med Univ Hosp, Biomed Engn R&D Ctr, Taipei, Taiwan; [Lin, Ching-Hung] Natl Chiao Tung Univ, Biomed Elect Translat Res Ctr, Hsinchu, Taiwan; [Lin, Ching-Hung] Kaohsiung Med Univ, Dept Psychol, Kaohsiung, Taiwan	Soochow University; National Chengchi University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Chiu, YC (corresponding author), Soochow Univ, Dept Psychol, Taipei, Taiwan.	yaochu@mail2000.com.tw; eandy924@gmail.com		Lin, Ching-Hung/0000-0003-3618-0579	National Science Council of Taiwan [NSC 99-2410-H-031-025]; National Chiao Tung University; Ministry of Education, Taiwan [MOE-100W960]; Kaohsiung Medical University [KMU-Q103022]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Chiao Tung University; Ministry of Education, Taiwan(Ministry of Education, Taiwan); Kaohsiung Medical University	The authors would like to thank the National Science Council of Taiwan for financially supporting this study under Contract No. NSC 99-2410-H-031-025. The fifth author was also supported in part by the "Aim for the Top University Plan" of National Chiao Tung University and the Ministry of Education, Taiwan (MOE-100W960) and by Kaohsiung Medical University (KMU-Q103022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bechara A., 2007, IOWA GAMBLING TASK P; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Chiu Y.C., 2012, PSYCHOL RES PROGR PS, P93; Chiu YC, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-37; Chiu YC, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-13; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio A, 1994, DESCARTES ERROR EMOT; Fernie G, 2006, BRAIN COGNITION, V60, P94, DOI 10.1016/j.bandc.2005.09.011; Fum D, 2008, SOMATIC MARKERS FREQ; Horstmann A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00061; Li XL, 2009, MODERN BUSINESS TRAD, V12; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; Lin CH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00220; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047202; Lin CH, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-45; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Penolazzi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058946; Steingroever H, 2013, PSYCHOL ASSESSMENT, V25, P180, DOI 10.1037/a0029929; Takano Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009368; Tomb I, 2002, NAT NEUROSCI, V5, P1103, DOI 10.1038/nn1102-1103; Upton DJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00034; van den Bos R, 2006, BIOL PSYCHOL, V71, P155, DOI 10.1016/j.biopsycho.2005.05.003; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Wilder KE, 1998, SCHIZOPHR RES, V30, P169, DOI 10.1016/S0920-9964(97)00135-7	31	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101878	10.1371/journal.pone.0101878	http://dx.doi.org/10.1371/journal.pone.0101878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036094	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200025
J	Reis, MF; Namorado, S; Aguiar, P; Precioso, J; Nunes, B; Veloso, L; Santos, S; Miguel, JP				Reis, Maria Fatima; Namorado, Sonia; Aguiar, Pedro; Precioso, Jose; Nunes, Baltazar; Veloso, Luis; Santos, Sandra; Miguel, Jose Pereira			Patterns of Adherence to and Compliance with the Portuguese Smoke-Free Law in the Leisure-Hospitality Sector	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; SPANISH SMOKING; PUBLIC PLACES; FREE POLICIES; EXPOSURE; IMPACT; BAN; ATTITUDES; BARS	Background: In 2008, the Portuguese smoke-free law came into effect including partial bans in the leisure-hospitality (LH) sector. The objective of the study is to assess the prevalence of smoking control policies (total ban, smoking permission and designated smoking areas) adopted by the LH sector in Portugal. The levels of noncompliance with each policy are investigated as well as the main factors associated with smoking permission and noncompliance with the law. Methods: Cross-sectional study conducted between January 2010 and May 2011. A random sample of venues was selected from the Portuguese LH sector database, proportionally stratified according to type, size and geographical area. All venues were assessed in loco by an observer. The independent effects of venues' characteristics on smoking permission and the level of noncompliance with the law were explored using logistic regression. Results: Overall, 1.412 venues were included. Total ban policy was adopted by 75.9% of venues, while 8.4% had designated smoking areas. Smoking ban was more prevalent in restaurants (85.9%). Only 29.7% of discos/bars/pubs opted for complete ban. Full or partial smoking permission was higher in discos/bar/pubs (OR = 7.37; 95% CI 4.87 to 11.17). Noncompliance with the law was higher in venues allowing smoking and lower in places with complete ban (33.6% and 7.6% respectively, p < 0.001). Discos/bars/pubs with full smoking permission had the highest level of noncompliance (OR = 3.31; 95% CI 1.40 to 7.83). Conclusions: Our findings show a high adherence to smoking ban policy by the Portuguese LH sector. Nonetheless, one quarter of the venues is fully or partially permissive towards smoking, with the discos/bars/pubs considerably contributing to this situation. Venues with smoking permission policies were less compliant with the legislation. The implementation of a comprehensive smoke-free law, without any exceptions, is essential to effectively protect people from the second hand smoke.	[Reis, Maria Fatima] Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1699 Lisbon, Portugal; [Reis, Maria Fatima; Namorado, Sonia; Santos, Sandra; Miguel, Jose Pereira] Univ Lisbon, Fac Med, Inst Prevent Med, P-1699 Lisbon, Portugal; [Aguiar, Pedro] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal; [Precioso, Jose] Univ Minho, Inst Educ, Braga, Portugal; [Nunes, Baltazar] Inst Nacl Saude Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal; [Veloso, Luis] Eurotrials, Clin Data Unit, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade Nova de Lisboa; Universidade do Minho; Instituto Nacional de Saude Dr. Ricardo Jorge	Reis, MF (corresponding author), Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1699 Lisbon, Portugal.	mfreis@fm.ul.pt	Namorado, Sónia/D-7168-2015; Nunes, Baltazar/V-8903-2019; AGUIAR, PEDRO/B-2662-2013	Namorado, Sónia/0000-0002-7500-8811; Nunes, Baltazar/0000-0001-6230-7209; AGUIAR, PEDRO/0000-0002-0074-7732; Precioso, Jose/0000-0002-7889-8290; Reis, Maria de Fatima/0000-0001-7894-5096	Direccao Geral da Saude (DGS); national funding institution Fundacao para a Ciencia e Tecnologia (FCT)	Direccao Geral da Saude (DGS); national funding institution Fundacao para a Ciencia e Tecnologia (FCT)	The work is part of a large Epidemiological Study on the Portuguese Tobacco Control Policy, developed by the Instituto de Medicina Preventiva da Faculdade de Medicina de Lisboa and supported, in its preliminary part, by the Direccao Geral da Saude (DGS) and, in the second part, by the national funding institution Fundacao para a Ciencia e Tecnologia (FCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cains T, 2004, TOB CONTROL, V13, P17, DOI 10.1136/tc.2003.005488; Erazo M, 2010, TOB CONTROL, V19, P469, DOI 10.1136/tc.2009.035402; European Network for Smoking Prevention, 2001, SMOK FREE WORKPL IMP; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Galan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-224; Glantz SA, 2001, JAMA-J AM MED ASSOC, V286, P462, DOI 10.1001/jama.286.4.462; Global Smokefree Partnership, 2010, ART 8 STAT REP 2010; Global Smokefree Partnership, 2008, GLOB VOIC WORK SMOK; Goel S, 2013, TOB CONTROL; Hyland A, 2012, TOB CONTROL, V21, P154, DOI 10.1136/tobaccocontrol-2011-050389; Hyland A, 2009, NICOTINE TOB RES, V11, P642, DOI 10.1093/ntr/ntp063; IARC Working Group, 2009, IARC HDB CANC PREV T; Jones MR, 2013, TOB CONTROL, V22, P308, DOI 10.1136/tobaccocontrol-2011-050203; Kotzias D, 2004, FRESEN ENVIRON BULL, V13, P1536; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lopez MJ, 2013, NICOTINE TOB RES, V15, P992, DOI 10.1093/ntr/nts218; Lopez MJ, 2012, TOB CONTROL, V21, P407, DOI 10.1136/tc.2010.042275; Martinez-Sanchez JM, 2010, GAC SANIT, V24, P241, DOI 10.1016/j.gaceta.2010.02.007; Mons U, 2012, EUR J PUBLIC HEALTH, V22, P10, DOI 10.1093/eurpub/ckr202; Mulcahy M, 2005, TOB CONTROL, V14, P384, DOI 10.1136/tc.2005.011635; Nebot M, 2005, TOB CONTROL, V14, P60, DOI 10.1136/tc.2004.008581; Nebot M, 2009, EV IMP MED SAN FRENT; Nebot M, 2009, ENVIRON HEALTH PERSP, V117, P344, DOI 10.1289/ehp.11845; Nogueira PJ, 2011, REL PRIM AV IMP RES; Office for Tobacco Control, 2005, SMOK FREE WORKPL IR; Precioso J, 2009, REV SAUDE PUB, V2, P22; Precioso José, 2011, Rev. Port. Sau. Pub., V29, P22; Ravara SB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-720; Reis MD, 2010, TOB CONTROL, V19, P171, DOI 10.1136/tc.2008.028720; Schneider NK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-907; Sureda X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089430; Tang H, 2004, TOB CONTROL, V13, P87, DOI 10.1136/tc.2003.004390; Thomson G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-64; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; *WHO, 2007, PROT EXP 2 HAND TOB; World Health Organization, 2009, WHO REP GLOB TOB EP	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102421	10.1371/journal.pone.0102421	http://dx.doi.org/10.1371/journal.pone.0102421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036725	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200057
J	Robbins, RM; Gbur, SC; Beitel, GJ				Robbins, Renee M.; Gbur, Samantha C.; Beitel, Greg J.			Non-Canonical Roles for Yorkie and Drosophila Inhibitor of Apoptosis 1 in Epithelial Tube Size Control	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; SEPTATE JUNCTIONS; TUMOR-SUPPRESSOR; ORGAN SIZE; CASPASE INHIBITION; TRACHEAL SYSTEM; GENETIC-CONTROL; CELL POLARITY; PROTEIN; MORPHOGENESIS	Precise control of epithelial tube size is critical for organ function, yet the molecular mechanisms remain poorly understood. Here, we examine the roles of cell growth and a highly conserved organ growth regulatory pathway in controlling the dimensions of the Drosophila tracheal (airway) system, a well-characterized system for investigating epithelial tube morphogenesis. We find that tracheal tube-size is regulated in unexpected ways by the transcription factor Yorkie (Yki, homolog of mammalian YAP and TAZ) and the Salvador/Warts/Hippo (SWH) kinase pathway. Yki activity typically promotes cell division, inhibits apoptosis, and can promote cell growth. However, reducing Yki activity in developing embryos increases rather than decreases the length of the major tracheal tubes, the dorsal trunks (DTs). Similarly, reduction of Hippo pathway activity, which antagonizes Yki, shortens tracheal DTs. yki mutations do not alter DT cell volume or cell number, indicating that Yki and the Hippo pathway regulate cell shape and apical surface area, but not volume. Yki does not appear to act through known tracheal pathways of apical extracellular matrix, septate junctions (SJs), basolateral or tubular polarity. Instead, the Hippo pathway and Yki appear to act downstream or in parallel to SJs because a double mutant combination of an upstream Hippo pathway activator, kibra, and the SJ component sinu have the short tracheal phenotype of a kibra mutant. We demonstrate that the critical target of Yki in tube size control is Drosophila Inhibitor of Apoptosis 1 (DIAP1), which in turn antagonizes the Drosophila effector caspase, Ice. Strikingly, there is no change in tracheal cell number in DIAP1 or Ice mutants, thus epithelial tube size regulation defines new non-apoptotic roles for Yki, DIAP1 and Ice.	[Robbins, Renee M.; Gbur, Samantha C.; Beitel, Greg J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Robbins, Renee M.; Gbur, Samantha C.; Beitel, Greg J.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Beitel, GJ (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	beitel@northwestern.edu			US National Institutes of Health [R01GM108964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108964] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by the US National Institutes of Health (www.nih.gov) grant R01GM108964 to GJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Arias A.M., 1993, DEV DROSOPHILA, P609; Baer MM, 2010, MECH DEVELOP, V127, P28, DOI 10.1016/j.mod.2009.11.003; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Chou TB, 1996, GENETICS, V144, P1673; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; FEHON RG, 1994, DEVELOPMENT, V120, P545; Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Harvey KF, 2012, COLD SPRING HARBOR P, V4; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Iruela-Arispe ML, 2013, DEVELOPMENT, V140, P2851, DOI 10.1242/dev.070680; Kumar Sharad, 2004, Sci STKE, V2004, ppe49, DOI 10.1126/stke.2542004pe49; Kuranaga E, 2012, GENES CELLS, V17, P83, DOI 10.1111/j.1365-2443.2011.01579.x; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Le T, 2007, BIOTECHNIQUES, V42, P162, DOI 10.2144/000112386; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lisi S, 2000, GENETICS, V154, P669; Liu YR, 2013, MELANOMA RES, V23, P243, DOI 10.1097/CMR.0b013e3283625498; Lucas EP, 2013, J CELL BIOL, V201, P875, DOI 10.1083/jcb.201210073; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shrestha A, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00078; Spradling AC, 1999, GENETICS, V153, P135; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Yarbrough WM, 2010, J CARDIOVASC PHARM, V55, P408, DOI 10.1097/FJC.0b013e3181d4ca66; Yokokura T, 2004, J BIOL CHEM, V279, P52603, DOI 10.1074/jbc.M409691200; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	74	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101609	10.1371/journal.pone.0101609	http://dx.doi.org/10.1371/journal.pone.0101609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036253	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200019
J	Wu, J; Wang, J; Pan, CT; Guan, XY; Wang, Y; Liu, SY; He, YJ; Chen, JL; Chen, LF; Lu, G				Wu, Jian; Wang, Jie; Pan, Changtian; Guan, Xiaoyan; Wang, Yan; Liu, Songyu; He, Yanjun; Chen, Jingli; Chen, Lifei; Lu, Gang			Genome-Wide Identification of MAPKK and MAPKKK Gene Families in Tomato and Transcriptional Profiling Analysis during Development and Stress Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAF-LIKE MAPKKK; ARABIDOPSIS-THALIANA; CELL-DEATH; SOLANUM-LYCOPERSICON; SIGNAL-TRANSDUCTION; POSITIVE REGULATOR; PLANT IMMUNITY; RICE; EXPRESSION	Mitogen-activated protein kinase (MAPK) cascades have important functions in plant growth, development, and response to various stresses. The MAPKK and MAPKKK gene families in tomato have never been systematically analyzed. In this study, we performed a genome-wide analysis of the MAPKK and MAPKKK gene families in tomato and identified 5 MAPKK genes and 89 MAPKKK genes. Phylogenetic analyses of the MAPKK and MAPKKK gene families showed that all the MAPKK genes formed four groups (groups A, B, C, and D), whereas all the MAPKKK genes were classified into three subfamilies, namely, MEKK, RAF, and ZIK. Evolutionary analysis showed that whole genome or chromosomal segment duplications were the main factors responsible for the expansion of the MAPKK and MAPKKK gene families in tomato. Quantitative real-time RT-PCR analysis showed that the majority of MAPKK and MAPKKK genes were expressed in all tested organs with considerable differences in transcript levels indicating that they might be constitutively expressed. However, the expression level of most of these genes changed significantly under heat, cold, drought, salt, and Pseudomonas syringae treatment. Furthermore, their expression levels exhibited significant changes in response to salicylic acid and indole-3-acetic acid treatment, implying that these genes might have important roles in the plant hormone network. Our comparative analysis of the MAPKK and MAPKKK families would improve our understanding of the evolution and functional characterization of MAPK cascades in tomato.	[Wu, Jian; Wang, Jie; Pan, Changtian; Guan, Xiaoyan; Wang, Yan; Liu, Songyu; He, Yanjun; Chen, Jingli; Chen, Lifei; Lu, Gang] Zhejiang Univ, Dept Hort, Key Lab Hort Plant Growth Dev & Biotechnol, Agr Minist China, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Lu, G (corresponding author), Zhejiang Univ, Dept Hort, Key Lab Hort Plant Growth Dev & Biotechnol, Agr Minist China, Hangzhou, Zhejiang, Peoples R China.	glu@zju.edu.cn	Pan, Changtian/AAG-8526-2019	Pan, Changtian/0000-0002-5852-059X	Nation Natural Science Foundation of China [31071337, 31271633]; Natural Science Foundation of Zhejiang province, China [R3110209]	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Grants from the Nation Natural Science Foundation of China [Grant numbers 31071337, 31271633] and the Natural Science Foundation of Zhejiang province, China (R3110209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beck M, 2011, NEW PHYTOL, V189, P1069, DOI 10.1111/j.1469-8137.2010.03565.x; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Champion A, 2004, TRENDS PLANT SCI, V9, P123, DOI 10.1016/j.tplants.2004.01.005; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Cristina M, 2010, Annual Review of Plant Biology, V61, P621; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; Daisuke S, 2011, PLANT BIOTECHNOL, V28, P463; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Frye CA, 1998, PLANT CELL, V10, P947, DOI 10.1105/tpc.10.6.947; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Hong WF, 2007, J INTEGR PLANT BIOL, V49, P843, DOI 10.1111/j.1744-7909.2007.00505.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Liu ZN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-594; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Melech-Bonfil S, 2011, PLANT SIGNAL BEHAV, V6, P154, DOI 10.4161/psb.6.1.14311; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Melikant B, 2004, FEBS LETT, V576, P5, DOI 10.1016/j.febslet.2004.08.051; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Mitsumune MG, 2006, J EXP BOT, V57, P4171; MIZOGUCHI T, 1994, PLANT J, V5, P111, DOI 10.1046/j.1365-313X.1994.5010111.x; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Neupane A, 2013, EVOL BIOINFORM, V9, P363, DOI 10.4137/EBO.S12526; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Oh CS, 2011, J BIOL CHEM, V286, P14129, DOI 10.1074/jbc.M111.225086; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samuel MA, 2002, PLANT CELL, V14, P2059, DOI 10.1105/tpc.002337; Samuel MA, 2005, J EXP BOT, V56, P2195, DOI 10.1093/jxb/eri219; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Wu T, 2011, MOL BIOL REP, V38, P3967, DOI 10.1007/s11033-010-0514-3; Xing Y, 2007, J EXP BOT, V58, P2969, DOI 10.1093/jxb/erm144; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	58	70	77	17	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103032	10.1371/journal.pone.0103032	http://dx.doi.org/10.1371/journal.pone.0103032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036993	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200107
J	Butler, T; Dick, C; Carlson, ML; Whittall, JB				Butler, Timothy; Dick, Cynthia; Carlson, Matthew L.; Whittall, Justen B.			Transcriptome Analysis of a Petal Anthocyanin Polymorphism in the Arctic Mustard, Parrya nudicaulis	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; GENE-EXPRESSION; FLOWER COLOR; GENOME SIZE; NEIGHBORING GENES; ARABIDOPSIS; EVOLUTION; SEQUENCE; COEXPRESSION; RNA	Angiosperms are renown for their diversity of flower colors. Often considered adaptations to pollinators, the most common underlying pigments, anthocyanins, are also involved in plants' stress response. Although the anthocyanin biosynthetic pathway is well characterized across many angiosperms and is composed of a few candidate genes, the consequences of blocking this pathway and producing white flowers has not been investigated at the transcriptome scale. We take a transcriptome-wide approach to compare expression differences between purple and white petal buds in the arctic mustard, Parrya nudicaulis, to determine which genes' expression are consistently correlated with flower color. Using mRNA-Seq and de novo transcriptome assembly, we assembled an average of 722 bp per gene (49.81% coding sequence based on the A. thaliana homolog) for 12,795 genes from the petal buds of a pair of purple and white samples. Our results correlate strongly with qRT-PCR analysis of nine candidate genes in the anthocyanin biosynthetic pathway where chalcone synthase has the greatest difference in expression between color morphs (P/W = similar to 7x). Among the most consistently differentially expressed genes between purple and white samples, we found 3 x more genes with higher expression in white petals than in purple petals. These include four unknown genes, two drought-response genes (CDSP32, ERD5), a cold-response gene (GR-RBP2), and a pathogen defense gene (DND1). Gene ontology analysis of the top 2% of genes with greater expression in white relative to purple petals revealed enrichment in genes associated with stress responses including cold, drought and pathogen defense. Unlike the uniform downregulation of chalcone synthase that may be directly involved in the loss of petal anthocyanins, the variable expression of several genes with greater expression in white petals suggest that the physiological and ecological consequences of having white petals may be microenvironment-dependent.	[Butler, Timothy; Dick, Cynthia; Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Carlson, Matthew L.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA	Santa Clara University; University of Alaska System; University of Alaska Anchorage	Whittall, JB (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	jwhittall@scu.edu		Butler, Timothy/0000-0001-5803-1035	NSF IPY; SCU Undergraduate Research Initiative Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	NSF IPY(National Science Foundation (NSF)); SCU Undergraduate Research Initiative Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funds were provided by NSF IPY to JBW & MLC and an SCU Undergraduate Research Initiative Award to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Bennett M., 2005, PLANT DNA C VALUES D; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chen WH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-178; Cooley AM, 2011, CURR BIOL, V21, P700, DOI 10.1016/j.cub.2011.03.028; Dick CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018230; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fulkerson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032790; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gilad Y, 2009, TRENDS GENET, V25, P463, DOI 10.1016/j.tig.2009.09.003; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Jeukens J, 2010, MOL ECOL, V19, P5389, DOI 10.1111/j.1365-294X.2010.04934.x; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kohn MH, 2008, GENES GENET SYST, V83, P265, DOI 10.1266/ggs.83.265; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Melendez-Ackerman E, 1998, EVOLUTION, V52, P1293, DOI 10.1111/j.1558-5646.1998.tb02011.x; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOSQUIN T, 1966, EVOLUTION CANADAS FL, P41; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pielou E.C., 1994, NATURALISTS GUIDE AR; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Streisfeld MA, 2005, EVOLUTION, V59, P2548, DOI 10.1111/j.0014-3820.2005.tb00968.x; Streisfeld MA, 2011, EVOLUTION, V65, P629, DOI 10.1111/j.1558-5646.2010.01165.x; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; von Wettberg EJ, 2010, EVOL ECOL RES, V12, P457; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Whittall J, 2009, NEW PHYTOL, V182, P5, DOI 10.1111/j.1469-8137.2009.02796.x; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURRENT PROTOCOLS BI, V31	60	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101338	10.1371/journal.pone.0101338	http://dx.doi.org/10.1371/journal.pone.0101338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033465	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300014
J	Chennupati, R; Meens, MJPMT; Marion, V; Janssen, BJ; Lamers, WH; De Mey, JGR; Kohler, SE				Chennupati, Ramesh; Meens, Merlijn J. P. M. T.; Marion, Vincent; Janssen, Ben J.; Lamers, Wouter H.; De Mey, Jo G. R.; Kohler, S. Eleonore			Endothelial Arginine Resynthesis Contributes to the Maintenance of Vasomotor Function in Male Diabetic Mice	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; DEPENDENT HYPERPOLARIZATION; ARGININOSUCCINATE SYNTHASE; GAP-JUNCTIONS; ARGINASE; INHIBITION; EXPRESSION; ARTERIES; INSULIN; DYSFUNCTION	Aim: Argininosuccinate synthetase (ASS) is essential for recycling L-citrulline, the by-product of NO synthase (NOS), to the NOS substrate L-arginine. Here, we assessed whether disturbed arginine resynthesis modulates endothelium-dependent vasodilatation in normal and diabetic male mice. Methods and Results: Endothelium-selective Ass-deficient mice (Ass(fl/fl) /Tie2Cre(tg/-) = Ass-KOTie2) were generated by crossing Ass(fl/fl) mice (= control) with Tie2Cre mice. Gene ablation in endothelial cells was confirmed by immunohistochemistry. Blood pressure (MAP) was recorded in 34-week-old male mice. Vasomotor responses were studied in isolated saphenous arteries of 12-and 34-week-old Ass-KOTie2 and control animals. At the age of 10 weeks, diabetes was induced in control and AssKO(Tie2) mice by streptozotocin injections. Vasomotor responses of diabetic animals were studied 10 weeks later. MAP was similar in control and Ass-KOTie2 mice. Depletion of circulating L-arginine by arginase 1 infusion or inhibition of NOS activity with L-NAME resulted in an increased MAP (10 and 30 mmHg, respectively) in control and Ass-KOTie2 mice. Optimal arterial diameter, contractile responses to phenylephrine, and relaxing responses to acetylcholine and sodium nitroprusside were similar in healthy control and Ass-KOTie2 mice. However, in diabetic Ass-KOTie2 mice, relaxation responses to acetylcholine and endothelium-derived NO (EDNO) were significantly reduced when compared to diabetic control mice. Conclusions: Absence of endothelial citrulline recycling to arginine did not affect blood pressure and systemic arterial vasomotor responses in healthy mice. EDNO-mediated vasodilatation was significantly more impaired in diabetic Ass-KOTie2 than in control mice demonstrating that endothelial arginine recycling becomes a limiting endothelial function in diabetes.	[Chennupati, Ramesh; Marion, Vincent; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Chennupati, Ramesh; Meens, Merlijn J. P. M. T.; Janssen, Ben J.; De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands; [Chennupati, Ramesh; Janssen, Ben J.; De Mey, Jo G. R.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Chennupati, Ramesh; Marion, Vincent; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, Nutr Metab & Toxicol NUTRIM, Maastricht, Netherlands; [Meens, Merlijn J. P. M. T.; Marion, Vincent] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [De Mey, Jo G. R.] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [De Mey, Jo G. R.] Odense Univ Hosp, Dept Cardiovasc & Thorac Surg, DK-5000 Odense, Denmark	Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Geneva; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Kohler, SE (corresponding author), Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands.	leo.koehler@maastrichtuniversity.nl	Lamers, Wouter H./D-2965-2012; Marion, Vincent/H-9730-2016; Köhler, Eleonore/D-2915-2012	Köhler, Eleonore/0000-0003-1977-9977; De Mey, Jo G. R./0000-0001-6274-8071; Chennupati, Ramesh/0000-0002-3994-5285; Marion, Vincent/0000-0002-8271-7376	Grant Netherlands Heart Foundation NHF [2008B107]	Grant Netherlands Heart Foundation NHF	Grant Netherlands Heart Foundation NHF (Nederlands hartstichting; project 2008B107). The website is: https://www.hartstichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; BAYDOUN AR, 1990, BIOCHEM BIOPH RES CO, V173, P940, DOI 10.1016/S0006-291X(05)80876-9; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Chen F, 2014, CELL PHYSIOL BIOCHEM, V33, P1058, DOI 10.1159/000358676; Chennupati R, 2013, BRIT J PHARMACOL, V169, P1486, DOI 10.1111/bph.12175; Chicoine LG, 2004, AM J PHYSIOL-LUNG C, V287, pL60, DOI 10.1152/ajplung.00194.2003; Dahl G, 2007, CELL COMMUN ADHES, V14, P259, DOI 10.1080/15419060801891018; Elkayam U, 2002, J CARD FAIL, V8, P15, DOI 10.1054/jcaf.2002.31910; Feron O, 1999, J CLIN INVEST, V103, P897, DOI 10.1172/JCI4829; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; GOLD ME, 1989, BIOCHEM BIOPH RES CO, V164, P714, DOI 10.1016/0006-291X(89)91518-0; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Haines RJ, 2012, BIOCHEM BIOPH RES CO, V421, P9, DOI 10.1016/j.bbrc.2012.03.074; Hilgers RHP, 2010, J PHARMACOL EXP THER, V333, P210, DOI 10.1124/jpet.109.161448; HOGG N, 1993, FEBS LETT, V334, P170, DOI 10.1016/0014-5793(93)81706-6; Hou CJY, 2008, J HISTOCHEM CYTOCHEM, V56, P745, DOI 10.1369/jhc.2008.950816; Karbach S, 2011, J MOL CELL CARDIOL, V51, P855, DOI 10.1016/j.yjmcc.2011.07.024; Kurz S, 1997, J CLIN INVEST, V99, P369, DOI 10.1172/JCI119166; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; Levin-Iaina N, 2007, RENAL FAILURE, V29, P1031, DOI 10.1080/08860220701641744; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; Marion V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067021; Matchkov VV, 2004, BRIT J PHARMACOL, V142, P961, DOI 10.1038/sj.bjp.0705870; NUSSLER AK, 1994, J BIOL CHEM, V269, P1257; Persson P, 2014, HYPERTENSION, V64, P323, DOI 10.1161/HYPERTENSIONAHA.114.03519; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Sandow SL, 2004, J PHYSIOL-LONDON, V556, P875, DOI 10.1113/jphysiol.2003.058669; Shin W, 2012, EXP MOL MED, V44, P594, DOI 10.3858/emm.2012.44.10.068; Storkebaum E, 2010, CIRCULATION, V122, P273, DOI 10.1161/CIRCULATIONAHA.109.929364; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Toque HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072277; Tsihlis ND, 2011, CELL BIOCHEM BIOPHYS, V60, P89, DOI 10.1007/s12013-011-9179-3; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Vukosavljevic N, 2006, MICROVASC RES, V71, P48, DOI 10.1016/j.mvr.2005.10.006; Wang GR, 1998, P NATL ACAD SCI USA, V95, P4888, DOI 10.1073/pnas.95.9.4888; Wijnands KAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037439; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029649; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	48	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102264	10.1371/journal.pone.0102264	http://dx.doi.org/10.1371/journal.pone.0102264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033204	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300043
J	Dietert, K; Reppe, K; Mundhenk, L; Witzenrath, M; Gruber, AD				Dietert, Kristina; Reppe, Katrin; Mundhenk, Lars; Witzenrath, Martin; Gruber, Achim D.			mCLCA3 Modulates IL-17 and CXCL-1 Induction and Leukocyte Recruitment in Murine Staphylococcus aureus Pneumonia	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; ACUTE LUNG INJURY; AIRWAY EPITHELIUM; CYSTIC-FIBROSIS; MUCUS OVERPRODUCTION; EXPRESSION; INFLAMMATION; DISEASE; ASTHMA; MODEL	The human hCLCA1 and its murine ortholog mCLCA3 (calcium-activated chloride channel regulators) are exclusively expressed in mucus cells and linked to inflammatory airway diseases with increased mucus production, such as asthma, cystic fibrosis and chronic obstructive pulmonary disease. Both proteins have a known impact on the mucus cell metaplasia trait in these diseases. However, growing evidence points towards an additional role in innate immune responses. In the current study, we analyzed Staphylococcus aureus pneumonia, an established model to study pulmonary innate immunity, in mCLCA3-deficient and wild-type mice, focusing on the cellular and cytokine-driven innate inflammatory response. We compared clinical signs, bacterial clearance, leukocyte immigration and cytokine responses in the bronchoalveolar compartment, as well as pulmonary vascular permeability, histopathology, mucus cell number and mRNA expression levels of selected genes (mClca1 to 7, Muc5ac, Muc5b, Muc2, Cxcl-1, Cxcl-2, Il-17). Deficiency of mCLCA3 resulted in decreased neutrophilic infiltration into the bronchoalveolar space during bacterial infection. Only the cytokines IL-17 and the murine CXCL-8 homolog CXCL-1 were decreased on mRNA and protein levels during bacterial infection in mCLCA3-deficient mice compared to wild-type controls. However, no differences in clinical outcome, histopathology or mucus cell metaplasia were observed. We did not find evidence for regulation of any other CLCA homolog that would putatively compensate for the lack of mCLCA3. In conclusion, mCLCA3 appears to modulate leukocyte response via IL-17 and murine CXCL-8 homologs in acute Staphylococcus aureus pneumonia which is well in line with the proposed function of hCLCA1 as a signaling molecule acting on alveolar macrophages.	[Dietert, Kristina; Mundhenk, Lars; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Reppe, Katrin; Witzenrath, Martin] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gruber, AD (corresponding author), Free Univ Berlin, Dept Vet Pathol, Berlin, Germany.	achim.gruber@fu-berlin.de	Gruber, Achim D./ABA-4514-2021	Dietert, Kristina/0000-0002-5667-6750	German Research Foundation (DFG) [SFB-TR 84 C3, SFB-TR 84 C6]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) SFB-TR 84 C3, C6 (to M.W.) and Z1b (to A.D.G.). http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Braun J, 2010, J CYST FIBROS, V9, P351, DOI 10.1016/j.jcf.2010.06.003; Braun J, 2010, HISTOCHEM CELL BIOL, V133, P285, DOI 10.1007/s00418-009-0667-0; Brouillard F, 2005, MOL CELL PROTEOMICS, V4, P1762, DOI 10.1074/mcp.M500098-MCP200; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; CRUZORIVE LM, 1987, J MICROSC-OXFORD, V145, P121; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2001, ARCH PEDIATRIE, V8, p742S, DOI 10.1016/S0929-693X(01)80190-1; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Hauber HP, 2007, J ENDOTOXIN RES, V13, P109, DOI 10.1177/0968051907079168; Hauber HP, 2010, J CYST FIBROS, V9, P277, DOI 10.1016/j.jcf.2010.05.002; Hegab AE, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012484; HUANG S, 1992, AM J PATHOL, V141, P981; Jensen HE, 2010, IN VIVO, V24, P257; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123; Kohler J, 2011, MICROBES INFECT, V13, P914, DOI 10.1016/j.micinf.2011.05.004; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laan M, 1999, J IMMUNOL, V162, P2347; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Long AJ, 2006, AM J RESP CELL MOL, V35, P357, DOI 10.1165/rcmb.2005-0451OC; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Mundhenk L, 2012, AM J RESP CELL MOL, V47, P87, DOI 10.1165/rcmb.2010-0508OC; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Reppe K, 2009, AM J RESP CELL MOL, V40, P474, DOI 10.1165/rcmb.2008-0071OC; Robichaud A, 2005, AM J RESP CELL MOL, V33, P303, DOI 10.1165/rcmb.2004-0372OC; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082367; Thai P, 2005, AM J RESP CELL MOL, V33, P523, DOI 10.1165/rcmb.2004-0220RC; Ulrich M, 1998, AM J RESP CELL MOL, V19, P83, DOI 10.1165/ajrcmb.19.1.3137; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9; Wolter DJ, 2013, CLIN INFECT DIS, V57, P384, DOI 10.1093/cid/cit270; Wong JK, 2013, PEDIAT PULMONOL; Zhang HL, 2010, CHINESE MED J-PEKING, V123, P1603, DOI 10.3760/cma.j.issn.0366-6999.2010.12.022; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	53	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102606	10.1371/journal.pone.0102606	http://dx.doi.org/10.1371/journal.pone.0102606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033194	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300067
J	Hassan, SED; Bell, TH; Stefani, FOP; Denis, D; Hijri, M; St-Arnaud, M				Hassan, Saad El-Din; Bell, Terrence H.; Stefani, Franck O. P.; Denis, David; Hijri, Mohamed; St-Arnaud, Marc			Contrasting the Community Structure of Arbuscular Mycorrhizal Fungi from Hydrocarbon-Contaminated and Uncontaminated Soils following Willow (Salix spp. L.) Planting	PLOS ONE			English	Article							METAL-POLLUTED SOILS; MOLECULAR DIVERSITY; AGRICULTURAL SOILS; SPORE GERMINATION; HEAVY-METALS; AM FUNGI; GROWTH; ROOTS; RHIZOSPHERE; BACTERIAL	Phytoremediation is a potentially inexpensive alternative to chemical treatment of hydrocarbon-contaminated soils, but its success depends heavily on identifying factors that govern the success of root-associated microorganisms involved in hydrocarbon degradation and plant growth stimulation. Arbuscular mycorrhizal fungi (AMF) form symbioses with many terrestrial plants, and are known to stimulate plant growth, although both species identity and the environment influence this relationship. Although AMF are suspected to play a role in plant adaptation to hydrocarbon contamination, their distribution in hydrocarbon-contaminated soils is not well known. In this study, we examined how AMF communities were structured within the rhizosphere of 11 introduced willow cultivars as well as unplanted controls across uncontaminated and hydrocarbon-contaminated soils at the site of a former petrochemical plant. We obtained 69 282 AMF-specific 18S rDNA sequences using 454-pyrosequencing, representing 27 OTUs. Contaminant concentration was the major influence on AMF community structure, with different AMF families dominating at each contaminant level. The most abundant operational taxonomic unit in each sample represented a large proportion of the total community, and this proportion was positively associated with increasing contamination, and seemingly, by planting as well. The most contaminated soils were dominated by three phylotypes closely related to Rhizophagus irregularis, while these OTUs represented only a small proportion of sequences in uncontaminated and moderately contaminated soils. These results suggest that in situ inoculation of AMF strains could be an important component of phytoremediation treatments, but that strains should be selected from the narrow group that is both adapted to contaminant toxicity and able to compete with indigenous AMF species.	[Hassan, Saad El-Din] Al Azhar Univ, Fac Sci, Dept Bot & Microbiol, Cairo, Egypt; [Bell, Terrence H.; Stefani, Franck O. P.; Denis, David; Hijri, Mohamed; St-Arnaud, Marc] Univ Montreal, Inst Rech Biol Vegetale, Biodivers Ctr, Montreal, PQ H1X 2B2, Canada; [Bell, Terrence H.; Stefani, Franck O. P.; Denis, David; Hijri, Mohamed; St-Arnaud, Marc] Jardin Bot Montreal, Montreal, PQ, Canada	Egyptian Knowledge Bank (EKB); Al Azhar University; Universite de Montreal	St-Arnaud, M (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Biodivers Ctr, Montreal, PQ H1X 2B2, Canada.	marc.st-arnaud@umontreal.ca	Hijri, Mohamed/AAL-5737-2021; Hijri, Mohamed/ABC-5969-2021; Hassan, Saad El-Din/AAV-6138-2021; St-Arnaud, Marc/D-1184-2017	Hijri, Mohamed/0000-0001-6112-8372; Hassan, Saad El-Din/0000-0002-8443-1275; St-Arnaud, Marc/0000-0002-7181-9895; Bell, Terrence/0000-0003-3603-7270	Genome Canada - GenoRem Project; Fonds quebecois de la recherche sur la nature et les technologies; Genome Quebec	Genome Canada - GenoRem Project; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Genome Quebec	This work was supported by the Genome Quebec and Genome Canada funded GenoRem Project. T.H. Bell was supported by a postdoctoral grant from the Fonds quebecois de la recherche sur la nature et les technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Audet P, 2007, ENVIRON POLLUT, V147, P609, DOI 10.1016/j.envpol.2006.10.006; Beauchamp VB, 2006, NEW PHYTOL, V170, P369, DOI 10.1111/j.1469-8137.2006.01668.x; Bedini S, 2010, SOIL BIOL BIOCHEM, V42, P758, DOI 10.1016/j.soilbio.2010.01.010; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Bell TH, 2014, TRENDS BIOT IN PRESS, DOI [10.1016/j.tibtech.2014.1002.1008, DOI 10.1016/J.TIBTECH.2014.1002.1008]; Bunn R, 2009, ECOLOGY, V90, P1378, DOI 10.1890/07-2080.1; Cabello MN, 1997, FEMS MICROBIOL ECOL, V22, P233, DOI 10.1016/S0168-6496(96)00094-3; Calonne M, 2014, BOTANY, V92, P173, DOI 10.1139/cjb-2013-0094; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chen JH, 2014, FEMS MICROBIOL ECOL, V87, P164, DOI 10.1111/1574-6941.12212; Dai ML, 2012, CAN J MICROBIOL, V58, P81, DOI [10.1139/W11-111, 10.1139/w11-111]; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; de la Providencia IE, MOL ANAL PETRO UNPUB; Debiane D, 2008, ENVIRON EXP BOT, V64, P120, DOI 10.1016/j.envexpbot.2008.04.003; Debiane D, 2011, FUNGAL BIOL-UK, V115, P782, DOI 10.1016/j.funbio.2011.06.003; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellouze W, 2012, APPL SOIL ECOL, V60, P98, DOI 10.1016/j.apsoil.2012.02.004; Fester T, 2013, MICROB BIOTECHNOL, V6, P80, DOI 10.1111/j.1751-7915.2012.00357.x; Franco-Ramirez A, 2007, J BASIC MICROB, V47, P378, DOI 10.1002/jobm.200610293; Gaur A, 2004, CURR SCI INDIA, V86, P528; Glassman SI, 2012, ECOLOGY, V93, P1550, DOI 10.1890/10-2135.1; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hassan SE, 2013, BIOL FERT SOILS, V49, P1109, DOI 10.1007/s00374-013-0813-7; Hassan SED, 2011, MOL ECOL, V20, P3469, DOI 10.1111/j.1365-294X.2011.05142.x; Hassan SE, 2013, NEW BIOTECHNOL, V30, P780, DOI 10.1016/j.nbt.2013.07.002; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Huang YZ, 2014, CHEM ECOL, V30, P118, DOI 10.1080/02757540.2013.841892; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joner EJ, 2003, ENVIRON SCI TECHNOL, V37, P2371, DOI 10.1021/es020196y; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jumpponen A, 2007, MICROB ECOL, V53, P233, DOI 10.1007/s00248-004-0006-x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Lioussanne L, 2010, SOIL BIOL BIOCHEM, V42, P473, DOI 10.1016/j.soilbio.2009.11.034; Liu AiGuo, 2009, International Journal of Phytoremediation, V11, P39, DOI 10.1080/15226510802363444; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Marmiroli M, 2011, TREE PHYSIOL, V31, P1319, DOI 10.1093/treephys/tpr090; Marschner P, 1997, PLANT SOIL, V189, P11, DOI 10.1023/A:1004266907442; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; NELSEN CE, 1982, PLANTA, V154, P407, DOI 10.1007/BF01267807; Nuccio EE, 2013, ENVIRON MICROBIOL, V15, P1870, DOI 10.1111/1462-2920.12081; Oehl F, 2009, AGR ECOSYST ENVIRON, V134, P257, DOI 10.1016/j.agee.2009.07.008; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Paradi I, 2006, FOREST ECOL MANAG, V237, P366, DOI 10.1016/j.foreco.2006.09.059; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos-Gonzalez JC, 2007, APPL ENVIRON MICROB, V73, P5613, DOI 10.1128/AEM.00262-07; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Sikes BA, 2012, OIKOS, V121, P1791, DOI 10.1111/j.1600-0706.2012.20160.x; Sipila TP, 2008, ISME J, V2, P968, DOI 10.1038/ismej.2008.50; Staffa A, 2013, EXPLOITING FLX CHEM; Vallino M, 2006, ENVIRON MICROBIOL, V8, P971, DOI 10.1111/j.1462-2920.2006.00980.x; Van der Heijden EW, 2001, PLANT SOIL, V228, P275, DOI 10.1023/A:1004850423794; van der Heijden EW, 2001, MYCORRHIZA, V10, P185, DOI 10.1007/s005720000077; van der Heijden EW, 1999, CAN J BOT, V77, P1821, DOI 10.1139/cjb-77-12-1821; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Verdin A, 2006, MYCORRHIZA, V16, P397, DOI 10.1007/s00572-006-0055-8; Vierheilig H, 2000, SOIL BIOL BIOCHEM, V32, P589, DOI 10.1016/S0038-0717(99)00155-8; Volante A, 2005, MYCORRHIZA, V16, P43, DOI 10.1007/s00572-005-0012-y; WEISSENHORN I, 1993, PLANT SOIL, V157, P247, DOI 10.1007/BF00011053; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Yergeau E, 2014, ISME J, V8, P344, DOI 10.1038/ismej.2013.163; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017	77	35	35	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102838	10.1371/journal.pone.0102838	http://dx.doi.org/10.1371/journal.pone.0102838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032685	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300103
J	Kang, M; Ryu, J; Lee, D; Lee, MS; Kim, HJ; Nam, SH; Song, HE; Choi, J; Lee, GH; Kim, TY; Lee, H; Kim, SJ; Ye, SK; Kim, S; Lee, JW				Kang, Minkyung; Ryu, Jihye; Lee, Doohyung; Lee, Mi-Sook; Kim, Hye-Jin; Nam, Seo Hee; Song, Haeng Eun; Choi, Jungeun; Lee, Gyu-Ho; Kim, Tai Young; Lee, Hansoo; Kim, Sang Jick; Ye, Sang-Kyu; Kim, Semi; Lee, Jung Weon			Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-CELL MOTILITY; SIGNALING PATHWAYS; CROSS-TALK; C-SRC; CANCER; EXPRESSION; ADHESION; MICRODOMAINS; SUPERFAMILY	Transmembrane 4 L6 family member 5 (TM4SF5) is overexpressed during CCl4-mediated murine liver fibrosis and in human hepatocellular carcinomas. The tetraspanins form tetraspanin-enriched microdomains (TEMs) consisting of large membrane protein complexes on the cell surface. Thus, TM4SF5 may be involved in the signal coordination that controls liver malignancy. We investigated the relationship between TM4SF5-positive TEMs with liver fibrosis and tumorigenesis, using normal Chang hepatocytes that lack TM4SF5 expression and chronically TGF beta 1-treated Chang cells that express TM4SF5. TM4SF5 expression is positively correlated with tumorigenic CD151 expression, but is negatively correlated with tumor-suppressive CD63 expression in mouse fibrotic and human hepatic carcinoma tissues, indicating cooperative roles of the tetraspanins in liver malignancies. Although CD151 did not control the expression of TM4SF5, TM4SF5 appeared to control the expression levels of CD151 and CD63. TM4SF5 interacted with CD151, and caused the internalization of CD63 from the cell surface into late lysosomal membranes, presumably leading to terminating the tumor-suppressive functions of CD63. TM4SF5 could overcome the tumorigenic effects of CD151, especially cell migration and extracellular matrix (ECM)-degradation. Taken together, TM4SF5 appears to play a role in liver malignancy by controlling the levels of tetraspanins on the cell surface, and could provide a promising therapeutic target for the treatment of liver malignancies.	[Kang, Minkyung; Ye, Sang-Kyu] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kang, Minkyung; Ryu, Jihye; Lee, Doohyung; Lee, Mi-Sook; Kim, Hye-Jin; Song, Haeng Eun; Lee, Gyu-Ho; Kim, Tai Young; Lee, Jung Weon] Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Med Bioconvergence Res Ctr, Dept Pharm,Res Inst Pharmaceut Sci, Seoul, South Korea; [Nam, Seo Hee; Choi, Jungeun; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Lee, Hansoo; Kim, Semi] Kangwon Natl Univ, Dept Biol Sci, Chunchon, Kangwon Do, South Korea; [Kim, Sang Jick] Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, JW (corresponding author), Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Med Bioconvergence Res Ctr, Dept Pharm,Res Inst Pharmaceut Sci, Seoul, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; KIM, TAI YOUNG/0000-0001-8086-2476	National Research Foundation of Korea (NRF) for the Tumor Microenvironment Global Core Research Center (GCRC) - Korea government (Ministry of Science, ICT & Future Planning) [2011-0030001]; Medicinal Bioconvergence Research Center [NRF-2012M3A6A4054271];  [2012-0005606/2013-035235]	National Research Foundation of Korea (NRF) for the Tumor Microenvironment Global Core Research Center (GCRC) - Korea government (Ministry of Science, ICT & Future Planning); Medicinal Bioconvergence Research Center; 	This work was supported by the National Research Foundation of Korea (NRF) grant for the Tumor Microenvironment Global Core Research Center (GCRC) funded by the Korea government (Ministry of Science, ICT & Future Planning) (2011-0030001), for senior researchers program (Leap research, 2012-0005606/2013-035235), and for Medicinal Bioconvergence Research Center (NRF-2012M3A6A4054271) to JWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; DETCHOKUL S, 2013, BR J PHARM; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Hong IK, 2012, J BIOL CHEM, V287, P32027, DOI 10.1074/jbc.M111.314443; Jung O, 2013, BBA-MOL CELL RES, V1833, P629, DOI 10.1016/j.bbamcr.2012.11.026; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kang M, 2012, BIOCHEM J, V443, P691, DOI 10.1042/BJ20111584; Kim HP, 2005, BBA-MOL CELL RES, V1743, P151, DOI 10.1016/j.bbamcr.2004.09.014; Kim SM, 2012, Korean Patent, Patent No. [10- 2012- 0085437., 10201200085437]; Kim SM, 2012, Korean Patent, Patent No. [10- 2012- 0085436, 1020120085436]; Lee MS, 2012, BBA-MOL CELL RES, V1823, P514, DOI 10.1016/j.bbamcr.2011.11.017; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lee SA, 2011, FRONT BIOSCI-LANDMRK, V16, P1752, DOI 10.2741/3818; Lee SA, 2010, J CELL BIOCHEM, V111, P59, DOI 10.1002/jcb.22662; Lee SY, 2006, EXP CELL RES, V312, P2983, DOI 10.1016/j.yexcr.2006.06.001; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Radford KJ, 1997, J IMMUNOL, V158, P3353; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Sala-Valdes M, 2012, EXPERT OPIN THER TAR, V16, P985, DOI 10.1517/14728222.2012.712688; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Testa JE, 1999, CANCER RES, V59, P3812; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Zhong W, 2009, HEPATOLOGY, V50, P1524, DOI 10.1002/hep.23189	31	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102817	10.1371/journal.pone.0102817	http://dx.doi.org/10.1371/journal.pone.0102817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033048	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300098
J	Zhao, TF; Zhang, QY; Long, HL; Xu, L				Zhao, Tanfeng; Zhang, Qingyou; Long, Hailin; Xu, Lu			Graph Theoretical Representation of Atomic Asymmetry and Molecular Chirality of Benzenoids in Two-Dimensional Space	PLOS ONE			English	Article							CONTINUOUS SYMMETRY MEASURES; POLYHEX HYDROCARBONS; SHAPE; ENUMERATION; SIMILARITY	In order to explore atomic asymmetry and molecular chirality in 2D space, benzenoids composed of 3 to 11 hexagons in 2D space were enumerated in our laboratory. These benzenoids are regarded as planar connected polyhexes and have no internal holes; that is, their internal regions are filled with hexagons. The produced dataset was composed of 357,968 benzenoids, including more than 14 million atoms. Rather than simply labeling the huge number of atoms as being either symmetric or asymmetric, this investigation aims at exploring a quantitative graph theoretical descriptor of atomic asymmetry. Based on the particular characteristics in the 2D plane, we suggested the weighted atomic sum as the descriptor of atomic asymmetry. This descriptor is measured by circulating around the molecule going in opposite directions. The investigation demonstrates that the weighted atomic sums are superior to the previously reported quantitative descriptor, atomic sums. The investigation of quantitative descriptors also reveals that the most asymmetric atom is in a structure with a spiral ring with the convex shape going in clockwise direction and concave shape going in anticlockwise direction from the atom. Based on weighted atomic sums, a weighted F index is introduced to quantitatively represent molecular chirality in the plane, rather than merely regarding benzenoids as being either chiral or achiral. By validating with enumerated benzenoids, the results indicate that the weighted F indexes were in accordance with their chiral classification (achiral or chiral) over the whole benzenoids dataset. Furthermore, weighted F indexes were superior to previously available descriptors. Benzenoids possess a variety of shapes and can be extended to practically represent any shape in 2D space-our proposed descriptor has thus the potential to be a general method to represent 2D molecular chirality based on the difference between clockwise and anticlockwise sums around a molecule.	[Zhao, Tanfeng; Zhang, Qingyou; Long, Hailin; Xu, Lu] Henan Univ, Coll Chem & Chem Engn, Inst Environm & Analyt Sci, Kaifeng, Peoples R China; [Xu, Lu] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun 130022, Peoples R China	Henan University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Zhang, QY (corresponding author), Henan Univ, Coll Chem & Chem Engn, Inst Environm & Analyt Sci, Kaifeng, Peoples R China.	zhqingyou@aliyun.com		Zhao, Tanfeng/0000-0002-6654-3679; Zhang, Qingyou/0000-0002-8923-0843	National Natural Science Foundation of China [20875022]; International Science and Technology Cooperation of Henan Province [114300510009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation of Henan Province	This work was supported from 2009-2011 by the National Natural Science Foundation of China (No. 20875022, http://www.nsfc.gov.cn/). From 2011-2014, this work was funded by the International Science and Technology Cooperation of Henan Province (No. 114300510009) and our collaborators in the research group of Prof. Joao Aires-de-Sousa (Universidade Nova de Lisboa, Portugal), http://www.hnkjt.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MS, 2010, J COMPUT AID MOL DES, V24, P789, DOI 10.1007/s10822-010-9374-0; Buda A. B., 1991, ELEM MATH, V46, P65; Caporossi G, 1998, J CHEM INF COMP SCI, V38, P610, DOI 10.1021/ci970116n; Dryzun C, 2009, PHYS CHEM CHEM PHYS, V11, P9653, DOI 10.1039/b911179d; Fennell CJ, 2010, J AM CHEM SOC, V132, P234, DOI 10.1021/ja906399e; Huang PY, 2012, NANO LETT, V12, P1081, DOI 10.1021/nl204423x; Kelvin WTB, 1904, BALTIMORE LECTURES M, P439; MEYER AY, 1991, J COMPUT AID MOL DES, V5, P427, DOI 10.1007/BF00125663; MEZEY PG, 1995, J MATH CHEM, V17, P185, DOI 10.1007/BF01164847; Nicholls A, 2010, J MED CHEM, V53, P3862, DOI 10.1021/jm900818s; Randic M, 1996, J CHEM INF COMP SCI, V36, P429, DOI 10.1021/ci950091x; Randic M, 1996, J CHEM INF COMP SCI, V36, P1183, DOI 10.1021/ci960014h; Randic M, 2001, J CHEM INF COMP SCI, V41, P639, DOI 10.1021/ci000115m; RANDIC M, 1995, J CHEM INF COMP SCI, V35, P594, DOI 10.1021/ci00025a031; TOSIC R, 1995, J CHEM INF COMP SCI, V35, P181, DOI 10.1021/ci00024a002; Voge M, 2002, J CHEM INF COMP SCI, V42, P456, DOI 10.1021/ci010098g; Yan X, 2013, J CHEM INF MODEL, V53, P1967, DOI 10.1021/ci300601q; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; ZABRODSKY H, 1995, J AM CHEM SOC, V117, P462, DOI 10.1021/ja00106a053; ZABRODSKY H, 1993, J AM CHEM SOC, V115, P8278, DOI 10.1021/ja00071a042; Zauhar RJ, 2008, United States Patent Application, Patent No. 20080294404; Zhang QY, 2010, CHEM J CHINESE U, V31, P1620; Zhang QY, 2011, ACTA CHIM SINICA, V69, P311	23	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102043	10.1371/journal.pone.0102043	http://dx.doi.org/10.1371/journal.pone.0102043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032832	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300032
J	Cambou, MC; Perez-Brumer, AG; Segura, ER; Salvatierra, HJ; Lama, JR; Sanchez, J; Clark, JL				Cambou, Mary C.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Javier Salvatierra, H.; Lama, Javier R.; Sanchez, Jorge; Clark, Jesse L.			The Risk of Stable Partnerships: Associations between Partnership Characteristics and Unprotected Anal Intercourse among Men Who Have Sex with Men and Transgender Women Recently Diagnosed with HIV and/or STI in Lima, Peru	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONDOM USE; NEGOTIATED SAFETY; GAY MEN; BEHAVIOR; TRANSMISSION; EPIDEMIC; PATTERNS; SAMPLE	Background: Partnership type is an important factor associated with unprotected anal intercourse (UAI) and subsequent risk for HIV and sexually transmitted infections (STI). We examined the association of partnership type with UAI among men who have sex with men (MSM) and male-to-female transgender women (TGW) in Lima, Peru, recently diagnosed with HIV and/or STI. Methods: We report data from a cross-sectional analysis of MSM and TGW recently diagnosed with HIV and/or STI in Lima, Peru between 2011 and 2012. We surveyed participants regarding UAI with up to their three most recent sexual partners according to partner type. Multivariable Generalized Estimate Equating (GEE) models with Poisson distribution were used to estimate prevalence ratios (PR) for UAI according to partner type. Results: Among 339 MSM and TGW recently diagnosed with HIV and/or STI (mean age: 30.6 years, SD 9.0), 65.5% self-identified as homosexual/gay, 16.0% as bisexual, 15.2% as male-to-female transgender, and 3.3% as heterosexual. Participants provided information on 893 recent male or TGW partners with whom they had engaged in insertive or receptive anal intercourse: 28.9% stable partners, 56.4% non-stable/non-transactional partners (i.e. casual or anonymous), and 14.7% transactional partners (i.e. transactional sex client or sex worker). Unprotected anal intercourse was reported with 41.3% of all partners. In multivariable analysis, factors associated with UAI included partnership type (non-stable/non-transactional partner APR 0.73, [95% CI 0.59-0.91], transactional partner APR 0.53 [0.36-0.78], p<0.05) and the number of previous sexual encounters with the partner (>10 encounters APR 1.43 [1.06-1.92], p<0.05). Conclusion: UAI was more commonly reported for stable partners and in partnerships with >10 sexual encounters, suggesting UAI is more prevalent in partnerships with a greater degree of interpersonal commitment. Further research assessing partner-level factors and behavior is critical for improving HIV and/or STI prevention efforts among Peruvian MSM and TGW.	[Cambou, Mary C.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Clark, Jesse L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Cambou, Mary C.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Clark, Jesse L.] Program Global Hlth, Los Angeles, CA USA; [Perez-Brumer, Amaya G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Javier Salvatierra, H.; Lama, Javier R.; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University	Clark, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	JLClark@mednet.ucla.edu	Oliveira, Claudia DL/G-8618-2011	Clark, Jesse/0000-0001-5862-6530; Segura, Eddy R/0000-0003-3580-7712; Perez-Brumer, Amaya/0000-0003-2441-4358	National Institutes of Health [R25 MH087222, K23 MH084611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, R25MH087222, K23MH084611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) R25 MH087222 "South American Program in HIV Prevention Research (SAPHIR)'' (Recipient: MCC); and K23 MH084611 "Partner Notification Strategies for HIV/STI Control in Urban Peru'' (PI: JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Behrens T, 2004, METHOD INFORM MED, V43, P505; BOSGA MB, 1995, AIDS EDUC PREV, V7, P103; Carballo-Dieguez A, 1997, AIDS BEHAV, V1, P9, DOI DOI 10.1023/A:1026257620055; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Clark JL, 2008, SEX TRANSM INFECT, V84, P449, DOI 10.1136/sti.2008.031310; Clark J, 2013, AIDS BEHAV, V17, P1313, DOI 10.1007/s10461-012-0210-5; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Davidovich U, 2000, AIDS, V14, P701, DOI 10.1097/00002030-200004140-00009; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Gorbach PM, 2003, J URBAN HEALTH, V80, P15; Guzman R, 2005, JAIDS-J ACQ IMM DEF, V38, P82, DOI 10.1097/00126334-200501010-00015; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Hoff CC, 1997, J ACQ IMMUN DEF SYND, V14, P72, DOI 10.1097/00042560-199701010-00012; Jacobson JO, 2014, AIDS BEHAV, V18, P88, DOI 10.1007/s10461-013-0478-0; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; KIPPAX S, 1993, AIDS, V7, P257, DOI 10.1097/00002030-199302000-00015; Knox J, 2010, PSYCHOL HEALTH MED, V15, P660, DOI 10.1080/13548506.2010.507772; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Macaluso M, 2000, AIDS, V14, P537, DOI 10.1097/00002030-200003310-00009; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McLean J., 1994, AIDS Care, V6, P331, DOI 10.1080/09540129408258645; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; Moreau-Gruet F, 2001, AIDS, V15, P1025, DOI 10.1097/00002030-200105250-00011; Nagaraj S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-181; Perez-Brumer AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059072; Rocha GM, 2013, AIDS BEHAV, V17, P1288, DOI 10.1007/s10461-012-0398-4; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Siegler AJ, 2013, JAIDS-J ACQ IMM DEF, V64, P307, DOI 10.1097/QAI.0b013e3182a0e880; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; Villaran MV, 2012, AM J MENS HEALTH, V6, P266, DOI 10.1177/1557988311431628; Wagner GJ, 1998, AIDS EDUC PREV, V10, P245	39	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102894	10.1371/journal.pone.0102894	http://dx.doi.org/10.1371/journal.pone.0102894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029514	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600103
J	Gremse, F; Krone, O; Thamm, M; Kiessling, F; Tolba, RH; Rieger, S; Gremse, C				Gremse, Felix; Krone, Oliver; Thamm, Mirko; Kiessling, Fabian; Tolba, Rene Hany; Rieger, Siegfried; Gremse, Carl			Performance of Lead-Free versus Lead-Based Hunting Ammunition in Ballistic Soap	PLOS ONE			English	Article							RIFLE BULLETS; BLOOD LEAD; COMPUTED-TOMOGRAPHY; WILDLIFE MANAGEMENT; CALIFORNIA CONDORS; POTENTIAL TOXICITY; DIETARY EXPOSURE; HEALTH-RISKS; COPPER; DEER	Background: Lead-free hunting bullets are an alternative to lead-containing bullets which cause health risks for humans and endangered scavenging raptors through lead ingestion. However, doubts concerning the effectiveness of lead-free hunting bullets hinder the wide-spread acceptance in the hunting and wildlife management community. Methods: We performed terminal ballistic experiments under standardized conditions with ballistic soap as surrogate for game animal tissue to characterize dimensionally stable, partially fragmenting, and deforming lead-free bullets and one commonly used lead-containing bullet. The permanent cavities created in soap blocks are used as a measure for the potential wound damage. The soap blocks were imaged using computed tomography to assess the volume and shape of the cavity and the number of fragments. Shots were performed at different impact speeds, covering a realistic shooting range. Using 3D image segmentation, cavity volume, metal fragment count, deflection angle, and depth of maximum damage were determined. Shots were repeated to investigate the reproducibility of ballistic soap experiments. Results: All bullets showed an increasing cavity volume with increasing deposited energy. The dimensionally stable and fragmenting lead-free bullets achieved a constant conversion ratio while the deforming copper and lead-containing bullets showed a ratio, which increases linearly with the total deposited energy. The lead-containing bullet created hundreds of fragments and significantly more fragments than the lead-free bullets. The deflection angle was significantly higher for the dimensionally stable bullet due to its tumbling behavior and was similarly low for the other bullets. The deforming bullets achieved higher reproducibility than the fragmenting and dimensionally stable bullets. Conclusion: The deforming lead-free bullet closely resembled the deforming lead-containing bullet in terms of energy conversion, deflection angle, cavity shape, and reproducibility, showing that similar terminal ballistic behavior can be achieved. Furthermore, the volumetric image processing allowed superior analysis compared to methods that involve cutting of the soap blocks.	[Gremse, Felix; Thamm, Mirko; Kiessling, Fabian] Rhein Westfal TH Aachen, Univ Hosp, Aachen, Germany; [Krone, Oliver] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Tolba, Rene Hany] Rhein Westfal TH Aachen, Univ Hosp, Aachen, Germany; [Rieger, Siegfried; Gremse, Carl] HNE Eberswalde, Eberswalde, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Leibniz Institut fur Zoo und Wildtierforschung; RWTH Aachen University; RWTH Aachen University Hospital	Gremse, C (corresponding author), HNE Eberswalde, Eberswalde, Germany.	carl.gremse@hnee.de	Kiessling, Fabian/Y-2417-2019	Kiessling, Fabian/0000-0002-7341-0399; Gremse, Carl/0000-0002-9936-4255	Mecklenburg West Pomerania Ministry for Agriculture, Environment and Consumer Protection; German Federal Ministry of Food and Agriculture [09HS023]; Philips Research, Aachen, Germany	Mecklenburg West Pomerania Ministry for Agriculture, Environment and Consumer Protection; German Federal Ministry of Food and Agriculture; Philips Research, Aachen, Germany	The authors kindly acknowledge funding by the Mecklenburg West Pomerania Ministry for Agriculture, Environment and Consumer Protection, the German Federal Ministry of Food and Agriculture (grant number 09HS023), as well as funding by Philips Research, Aachen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery D, 2009, INGESTION LEAD SPENT, P161, DOI DOI 10.4080/ILSA.2009.0115; Baatz M, 2009, COMB CHEM HIGH T SCR, V12, P908, DOI 10.2174/138620709789383196; Bedrosian B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051978; Bellinger DC, 2013, ENVIRON HEALTH PERSP, V121, pA178, DOI 10.1289/ehp.1306945; Bellinger DC, 2013, MICROBIOL ENV TOXICO; Bierkens J, 2012, SCI TOTAL ENVIRON, V414, P90, DOI 10.1016/j.scitotenv.2011.10.048; Bolliger SA, 2010, INT J LEGAL MED, V124, P613, DOI 10.1007/s00414-010-0503-z; Bundesinstitut fur Risikobewertung, 2011, GES UMW BEI VERW BLE; Bundesinstitut fur Risikobewertung, 2013, BFR S FORSCH ZUM THE; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Caudell JN, 2013, WILDLIFE SOC B, V37, P824, DOI 10.1002/wsb.311; Caudell Joe N., 2012, Human-Wildlife Interactions, V6, P105; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Cornatzer WE., 2009, INGESTION LEAD SPENT, P154; EFSA Panel on Contaminants in the Food Chain (CONTAM), 2010, SCI OP LEAD FOOD; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Franson JC, 2012, ARCH ENVIRON CON TOX, V62, P145, DOI 10.1007/s00244-011-9671-1; Green RE, 2012, FOOD CHEM TOXICOL, V50, P4180, DOI 10.1016/j.fct.2012.08.032; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Gremse C, 2014, ERWEITERTER BERICHT; Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069; Gremse F, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P363, DOI 10.1007/978-3-642-12945-2_25; Grund Marrett D., 2010, Human-Wildlife Interactions, V4, P257; Hauser R, 2008, ENVIRON HEALTH PERSP, V116, P976, DOI 10.1289/ehp.10516; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Iqbal S, 2009, ENVIRON RES, V109, P952, DOI 10.1016/j.envres.2009.08.007; Irschik I, 2013, EUR J WILDLIFE RES, V59, P129, DOI 10.1007/s10344-012-0656-9; JANZON B, 1982, ACTA CHIR SCAND, P79; Jeffery AJ, 2008, CLIN RADIOL, V63, P1160, DOI 10.1016/j.crad.2008.03.003; Johansen P, 2006, ENVIRON POLLUT, V142, P93, DOI 10.1016/j.envpol.2005.09.015; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Kneubuehl B, 2013, GESCHOSSE BALLISTIK; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P1, DOI 10.1007/978-3-642-20356-5; Knott J, 2010, SCI TOTAL ENVIRON, V409, P95, DOI 10.1016/j.scitotenv.2010.08.053; Knott Jeff, 2009, Conservation Evidence, V6, P71; Krone Oliver, 2009, P289, DOI 10.4080/ilsa.2009.0207; Lambertucci SA, 2010, ENVIRON SCI TECHNOL, V44, P7759, DOI 10.1021/es102667c; Lindboe M, 2012, FOOD ADDIT CONTAM A, V29, P1052, DOI 10.1080/19440049.2012.680201; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Nawaratne S, 1997, J COMPUT ASSIST TOMO, V21, P481, DOI 10.1097/00004728-199705000-00027; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Perdekamp MG, 2008, INT J LEGAL MED, V122, P81, DOI 10.1007/s00414-007-0161-y; Perdekamp MG, 2013, INT J LEGAL MED, V127, P791, DOI 10.1007/s00414-012-0808-1; Rutty GN, 2008, INT J LEGAL MED, V122, P1, DOI 10.1007/s00414-006-0145-3; Schyma C, 2012, FORENSIC SCI INT, V214, P82, DOI 10.1016/j.forsciint.2011.07.021; Spicher V, 2008, BLEIVERGIFTUNGEN BEI, P81; Stroud Richard K., 2009, P119; Thomas VG, 2008, SCI TOTAL ENVIRON, V394, P283, DOI 10.1016/j.scitotenv.2008.01.049; Thomas VG, 2007, SCI TOTAL ENVIRON, V374, P71, DOI 10.1016/j.scitotenv.2006.10.004; Thomas VG, 2013, AMBIO, V42, P737, DOI 10.1007/s13280-012-0361-7; Trinogga A, 2013, SCI TOTAL ENVIRON, V443, P226, DOI 10.1016/j.scitotenv.2012.10.084; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101	57	32	32	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102015	10.1371/journal.pone.0102015	http://dx.doi.org/10.1371/journal.pone.0102015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029572	Green Published, gold			2022-12-27	WOS:000341306600031
J	Wang, WL; Chen, KX; Liu, Q; Johnston, N; Ma, ZH; Zhang, FC; Zheng, XF				Wang, Weilan; Chen, Kaixu; Liu, Qing; Johnston, Nathan; Ma, Zhenghai; Zhang, Fuchun; Zheng, Xiufen			Suppression of Tumor Growth by Pleurotus ferulae Ethanol Extract through Induction of Cell Apoptosis, and Inhibition of Cell Proliferation and Migration	PLOS ONE			English	Article							GANODERMA-LUCIDUM; IN-VITRO; CANCER-CELLS; CYCLE ARREST; ANTICANCER; MUSHROOMS; PROTEINS; MELANOMA; MAITAKE; VIVO	Cancer is the second leading cause of death worldwide. Edible medicinal mushrooms have been used in traditional medicine as regimes for cancer patients. Recently anti-cancer bioactive components from some mushrooms have been isolated and their anti-cancer effects have been tested. Pleurotus ferulae, a typical edible medicinal mushroom in Xinjiang China, has also been used to treat cancer patients in folk medicine. However, little studies have been reported on the anticancer components of Pleurotus ferulae. This study aims to extract bioactive components from Pleurotus ferulae and to investigate the anti-cancer effects of the extracts. We used ethanol to extract anti-cancer bioactive components enriched with terpenoids from Pleurotus ferulae. We tested the anti-tumour effects of ethanol extracts on the melanoma cell line B16F10, the human gastric cancer cell line BGC 823 and the immortalized human gastric epithelial mucosa cell line GES-1 in vitro and a murine melanoma model in vivo. Cell toxicity and cell proliferation were measured by MTT assays. Cell cycle progression, apoptosis, caspase 3 activity, mitochondrial membrane potential (MMP), migration and gene expression were studied in vitro. PFEC suppressed tumor cell growth, inhibited cell proliferation, arrested cells at G0/G1 phases and was not toxic to non-cancer cells. PFEC also induced cell apoptosis and necrosis, increased caspase 3 activity, reduced the MMP, prevented cell invasion and changed the expression of genes associated with apoptosis and the cell cycle. PFEC delayed tumor formation and reduced tumor growth in vivo. In conclusion, ethanol extracted components from Pleurotus ferulae exert anti-cancer effects through direct suppression of tumor cell growth and invasion, demonstrating its therapeutic potential in cancer treatment.	[Wang, Weilan; Chen, Kaixu; Ma, Zhenghai; Zhang, Fuchun; Zheng, Xiufen] Xinjiang Univ, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China; [Liu, Qing] Jilin Univ, Norman Bethune Coll Med, Changchun 130023, Peoples R China; [Johnston, Nathan; Zheng, Xiufen] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Zheng, Xiufen] Lawson Hlth Res Inst, London, ON, Canada	Xinjiang University; Jilin University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Zhang, FC (corresponding author), Xinjiang Univ, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China.	zfcxj@sina.com; xzheng26@uwo.ca		Ma, Zhenghai/0000-0002-0930-7696	National Natural Science Foundation of China [31260267]; Xinjiang University, Heart and Stroke Foundation of Canada; Lawson Health Research Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang University, Heart and Stroke Foundation of Canada; Lawson Health Research Institute	The study was supported by grants from National Natural Science Foundation of China (31260267), Xinjiang University, Heart and Stroke Foundation of Canada and Lawson Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, BBA-GEN SUBJECTS, V1810, P519, DOI 10.1016/j.bbagen.2011.02.010; Alam N, 2012, SAUDI J BIOL SCI, V19, P111, DOI 10.1016/j.sjbs.2011.11.004; Albeituni SH, 2013, ANTI-CANCER AGENT ME, V13, P689, DOI 10.2174/1871520611313050003; Ansor NM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-256; Arpha K, 2012, J AGR FOOD CHEM, V60, P9834, DOI 10.1021/jf302433r; Boh B, 2013, RECENT PAT ANTI-CANC, V8, P255, DOI 10.2174/1574891X113089990036; Ding ZY, 2014, ANN MICROBIOL, V64, P121, DOI 10.1007/s13213-013-0640-y; Fong ZV, 2014, BRIT J DERMATOL, V170, P20, DOI 10.1111/bjd.12687; Gan Yong, 2001, Mycosystema, V20, P228; Gong YN, 2008, J GANSU LIANHE U NAT, V02, P64; Hsiao YC, 2007, J BIOMED SCI, V14, P107, DOI 10.1007/s11373-006-9117-3; Kim KH, 2013, J NAT PROD, V76, P845, DOI 10.1021/np300801x; Kim SP, 2013, J AGR FOOD CHEM, V61, P4898, DOI 10.1021/jf400916c; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Lee YS, 2010, J ETHNOPHARMACOL, V131, P56, DOI 10.1016/j.jep.2010.05.064; Lemieszek MK, 2013, FOOD FUNCT, V4, P575, DOI 10.1039/c2fo30324h; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Liu J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00905; Montoya S, 2012, WORLD J MICROB BIOT, V28, P1533, DOI 10.1007/s11274-011-0957-2; Alonso EN, 2013, J MED FOOD, V16, P602, DOI 10.1089/jmf.2012.0222; Rains JL, 2011, MOL CELL BIOCHEM, V349, P77, DOI 10.1007/s11010-010-0662-8; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Soares AA, 2013, MOLECULES, V18, P7609, DOI 10.3390/molecules18077609; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; Sun XH, 2002, ACTA NUTRIMENTA SINI, V24, P139; Trajkovic LMH, 2009, NUTR CANCER, V61, P696, DOI 10.1080/01635580902898743; Urbanelli S, 2003, HEREDITY, V90, P253, DOI 10.1038/sj.hdy.6800239; Wang CY, 2013, CARBOHYD POLYM, V94, P479, DOI 10.1016/j.carbpol.2013.01.034; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Weidmann V, 2013, BEILSTEIN J ORG CHEM, V9, P2233, DOI 10.3762/bjoc.9.262; Wu GS, 2012, FITOTERAPIA, V83, P408, DOI 10.1016/j.fitote.2011.12.004; Yang L, 2010, PROGR MODERN BIOMEDI, V20, P3957; [杨琳 Yang Lin], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P2114; Yin X, 2013, J NAT PROD, V76, P1365, DOI 10.1021/np400359y	34	26	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102673	10.1371/journal.pone.0102673	http://dx.doi.org/10.1371/journal.pone.0102673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029345	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600092
J	dos Santos, KC; Braga, CP; Barbanera, PO; Seiva, FRF; Fernandes, A; Fernandes, AAH				dos Santos, Klinsmann Carolo; Braga, Camila Pereira; Barbanera, Pedro Octavio; Ferreira Seiva, Fabio Rodrigues; Fernandes Junior, Ary; Henrique Fernandes, Ana Angelica			Cardiac Energy Metabolism and Oxidative Stress Biomarkers in Diabetic Rat Treated with Resveratrol	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; RED WINE; PROINFLAMMATORY CYTOKINES; PYRUVATE-DEHYDROGENASE; GLUCOSE-UPTAKE; GLUTATHIONE; HYPERGLYCEMIA; CARDIOPROTECTION; CARDIOMYOPATHY; DYSFUNCTION	Resveratrol (RSV), polyphenol from grape, was studied to evaluate its effects on calorimetric parameters, energy metabolism, and antioxidants in the myocardium of diabetic rats. The animals were randomly divided into four groups (n = 8): C (control group): normal rats; C-RSV: normal rats receiving RSV; DM: diabetic rats; and DM-RSV: diabetics rats receiving RSV. Type 1 diabetes mellitus was induced with administration of streptozotocin (STZ; 60 mg(-1) body weight, single dose, i.p.). After 48 hours of STZ administration, the animals received RSV (1.0 mg/kg/day) for gavage for 30 days. Food, water, and energy intake were higher in the DM group, while administration of RSV caused decreases (p<0.05) in these parameters. The glycemia decreased and higher final body weight increased in DM-RSV when compared with the DM group. The diabetic rats showed higher serum-free fatty acid, which was normalized with RSV. Oxygen consumption (VO2) and carbon dioxide production (VCO2) decreased (p<0.05) in the DM group. This was accompanied by reductions in RQ. The C-RSV group showed higher VO2 and VCO2 values. Pyruvate dehydrogenase activity was lower in the DM group and normalizes with RSV. The DM group exhibited higher myocardial beta-hydroxyacyl coenzyme-A dehydrogenase and citrate synthase activity, and RSV decreased the activity of these enzymes. The DM group had higher cardiac lactate dehydrogenase compared to the DM-RSV group. Myocardial protein carbonyl was increased in the DM group. RSV increased reduced glutathione in the cardiac tissue of diabetic animals. The glutathione reductase activity was higher in the DM-RSV group compared to the DM group. In conclusion, diabetes is accompanied by cardiac energy metabolism dysfunction and change in the biomarkers of oxidative stress. The cardioprotective effect may be mediated through RVS's ability to normalize free fatty acid oxidation, enhance utilization glucose, and control the biomarkers' level of oxidative stress under diabetic conditions.	[dos Santos, Klinsmann Carolo; Braga, Camila Pereira; Barbanera, Pedro Octavio; Henrique Fernandes, Ana Angelica] Sao Paulo State Univ UNESP, Inst Biosci, Dept Chem & Biochem, Botucatu, SP, Brazil; [Ferreira Seiva, Fabio Rodrigues] North Parana State Univ UENP, Inst Biol, Bandeirantes, Parana, Brazil; [Fernandes Junior, Ary] Sao Paulo State Univ UNESP, Inst Biosci, Dept Microbiol & Immunol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual do Norte do Parana (UENP); Universidade Estadual Paulista	Fernandes, AAH (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci, Dept Chem & Biochem, Botucatu, SP, Brazil.	angelica@ibb.unesp.br	Fernandes, Ana Angelica Henrique/D-5291-2012; Seiva, Fábio R.F./I-5452-2013; Seiva, Fábio RF/C-6812-2012; Pereira Braga, Camila/J-3031-2015; Fernandes, Ary/D-5276-2012; dos Santos, Klinsmann Carolo/O-2088-2014	Seiva, Fábio R.F./0000-0002-7461-8773; dos Santos, Klinsmann Carolo/0000-0002-0775-7853	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/12957-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; number process 2013/12957-8) for financial support, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) by research grants to KCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awwadi N, 2004, J AGR FOOD CHEM, V52, P1008, DOI 10.1021/jf030417z; An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Bertoni AG, 2003, DIABETES CARE, V26, P2791, DOI 10.2337/diacare.26.10.2791; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang CC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-47; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Ciapaite J, 2011, BBA-MOL CELL BIOL L, V1811, P441, DOI 10.1016/j.bbalip.2011.05.005; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Das DK, 1999, DRUG EXP CLIN RES, V25, P115; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Deng JY, 2008, DIABETES, V57, P1814, DOI 10.2337/db07-1750; Diniz YS, 2004, FOOD CHEM TOXICOL, V42, P313, DOI 10.1016/j.fct.2003.09.006; Galhardi CM, 2004, FOOD CHEM TOXICOL, V42, P2053, DOI 10.1016/j.fct.2004.07.020; Hamadi N, 2012, J BIOCHEM MOL TOXIC, V26, P384, DOI 10.1002/jbt.21432; Fernandes AAH, 2010, BIOMED PHARMACOTHER, V64, P214, DOI 10.1016/j.biopha.2009.08.007; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; Huang HP, 2010, FREE RADICAL BIO MED, V49, P1710, DOI 10.1016/j.freeradbiomed.2010.08.032; Ivanov VV, 2011, B EXP BIOL MED+, V151, P314, DOI 10.1007/s10517-011-1318-8; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Labayen I, 1999, EUR J NUTR, V38, P158, DOI 10.1007/s003940050057; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Likidlilid Atip, 2007, Journal of the Medical Association of Thailand, V90, P1759; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LOPASCHUK GD, 1983, CAN J PHYSIOL PHARM, V61, P439, DOI 10.1139/y83-068; MANDARINO LJ, 1987, J CLIN INVEST, V80, P655, DOI 10.1172/JCI113118; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Murray AJ, 2007, CURR OPIN CLIN NUTR, V10, P704, DOI 10.1097/MCO.0b013e3282f0ecbe; Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518; Okoshi Katashi, 2007, Arq Bras Endocrinol Metab, V51, P160, DOI 10.1590/S0004-27302007000200004; Otani H, 2002, J NEUROCHEM, V80, P780; Palsamy P, 2008, BIOMED PHARMACOTHER, V62, P598, DOI 10.1016/j.biopha.2008.06.037; Palsamy P, 2010, J CELL PHYSIOL, V224, P423, DOI 10.1002/jcp.22138; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; Penumathsa SV, 2009, CAN J PHYSIOL PHARM, V87, P275, DOI 10.1139/Y09-013; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; REGOUW BJM, 1971, CLIN CHIM ACTA, V31, P187, DOI 10.1016/0009-8981(71)90377-9; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010; RODRIGUES B, 1995, J MOL CELL CARDIOL, V27, P169, DOI 10.1016/S0022-2828(08)80016-8; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tachi Y, 2001, LIFE SCI, V69, P1039, DOI 10.1016/S0024-3205(01)01183-3; Takata Kazumi, 1997, Journal of Medical Investigation, V44, P67; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Turan B, 2012, J BIOENERG BIOMEMBR, V44, P281, DOI 10.1007/s10863-012-9429-0; Vassort G, 2010, CARDIOVASC TOXICOL, V10, P73, DOI 10.1007/s12012-010-9064-0; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Westbrook R, 2009, J GERONTOL A-BIOL, V64, P443, DOI 10.1093/gerona/gln075; Wilkinson J.H., 1965, INTRO DIAGNOSTIC ENZ; Wohl P, 2004, METABOLISM, V53, P655, DOI 10.1016/j.metabol.2003.12.013; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhang HR, 2009, ARTERIOSCL THROM VAS, V29, P1164, DOI 10.1161/ATVBAHA.109.187146	67	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102775	10.1371/journal.pone.0102775	http://dx.doi.org/10.1371/journal.pone.0102775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050809	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100056
J	Seo, H; Jang, DM; Yi, JM; Min, HG; Hwang, JH				Seo, Hyungseok; Jang, Dong-Min; Yi, Jung-Min; Min, Hong-Gi; Hwang, Jai-Hyun			The Accuracy of the New Landmark Using Respiratory Jugular Venodilation and Direct Palpation in Right Internal Jugular Vein Access	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERIZATION; ULTRASOUND GUIDANCE; CANNULATION; PLACEMENT; EMERGENCY; COMPLICATIONS; PUNCTURE; ANATOMY	Background: Although ultrasonography is recommended in internal jugular vein (IJV) catheterization, the landmark-guided technique should still be considered. The central landmark using the two heads of the sternocleidomastoid muscle is widely used, but it is inaccurate for IJV access. As an alternative landmark, we investigated the accuracy of the new landmark determined by inspection of the respiratory jugular venodilation and direct IJV palpation in right IJV access by ultrasonography. Methods and Findings: Thirty patients were enrolled. After induction of anesthesia, the central landmark was marked at the cricoid cartilage level (M1) and the alternative landmark determined by inspection of the respiratory jugular venodilation and direct palpation of IJV was also marked at the same level (M2). Using ultrasonography, the location of IJV was identified (M3) and the distance between M1 and M3 as well as between M2 and M3 were measured. The median (interquartile range) distance between the M2 and M3 was 3.5 (2.0-6.0) mm, compared to 17.5 (12.8-21.3) mm between M1 and M3. (P<0.001) The dispersion of distances between M2 and M3 was significantly smaller than between M1 and M3. (P<0.001) The visibility of respiratory jugular venodilation was associated with CVP more than 4 mmHg. Limitations of the present study are that the inter-observer variability was not investigated and that the visibility of the alternative landmark can be limited to right IJV in adults. Conclusion: The alternative landmark may allow shorter distance for the right side IJV access than the central landmark and can offer advantages in right IJV catheterization when ultrasound device is unavailable.	[Seo, Hyungseok; Jang, Dong-Min; Yi, Jung-Min; Min, Hong-Gi; Hwang, Jai-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea	University of Ulsan; Asan Medical Center	Min, HG (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	anesthminhg@gmail.com	Seo, hyungseok/F-4071-2011	Seo, hyungseok/0000-0003-4574-9122; Yi, JungMin/0000-0003-4481-8923				Atkinson P, 2005, EMERG MED J, V22, P158, DOI 10.1136/emj.2003.011288; Bailey PL, 2007, ANESTH ANALG, V104, P491, DOI 10.1213/01.ane.0000255289.78333.c2; Bailey PL, 2006, ANESTH ANALG, V102, P1327, DOI 10.1213/01.ane.0000202467.10465.12; Balls A, 2010, AM J EMERG MED, V28, P561, DOI 10.1016/j.ajem.2009.02.003; BAZARAL M, 1981, CRIT CARE MED, V9, P307, DOI 10.1097/00003246-198104000-00004; Calvert N, 2003, Health Technol Assess, V7, P1; CHATRATH RR, 1983, ANAESTHESIA, V38, P380, DOI 10.1111/j.1365-2044.1983.tb10464.x; DENYS BG, 1993, CIRCULATION, V87, P1557, DOI 10.1161/01.CIR.87.5.1557; Devine PJ, 2007, SOUTH MED J, V100, P1022, DOI 10.1097/SMJ.0b013e318073c89c; ENGLISH ICW, 1969, ANAESTHESIA, V24, P521, DOI 10.1111/j.1365-2044.1969.tb02905.x; Feller-Kopman D, 2007, CHEST, V132, P302, DOI 10.1378/chest.06-2711; Froehlich CD, 2009, CRIT CARE MED, V37, P1090, DOI 10.1097/CCM.0b013e31819b570e; Girard TD, 2005, J CRIT CARE, V20, P224, DOI 10.1016/j.jcrc.2005.06.005; Hamilton DR, 2012, J APPL PHYSIOL, V112, P454, DOI 10.1152/japplphysiol.00557.2011; Hayashi H, 2000, J CARDIOTHOR VASC AN, V14, P425, DOI 10.1053/jcan.2000.7939; Hayashi H, 2000, J CARDIOTHOR VASC AN, V14, P40, DOI 10.1016/S1053-0770(00)90054-5; Hong JY, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.12.005; Jefferson P, 2002, ANAESTHESIA, V57, P365, DOI 10.1046/j.1365-2044.2002.02319.x; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Matera JT, 2010, EMERG MED AUSTRALAS, V22, P514, DOI 10.1111/j.1742-6723.2010.01347.x; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Miller AH, 2002, ACAD EMERG MED, V9, P800, DOI 10.1111/j.1553-2712.2002.tb02168.x; ODA M, 1981, ANAESTHESIA, V36, P896, DOI 10.1111/j.1365-2044.1981.tb08866.x; RAO TLK, 1977, ANESTHESIOLOGY, V46, P362, DOI 10.1097/00000542-197705000-00015; SHOJANIA KG, 2001, EVID REP TECHNOL ASS, V1, P1; Valdueza JM, 2000, LANCET, V355, P200; Wang R, 2006, J EMERG MED, V31, P283, DOI 10.1016/j.jemermed.2005.12.026	27	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103089	10.1371/journal.pone.0103089	http://dx.doi.org/10.1371/journal.pone.0103089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050554	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100087
J	Wang, YF; Chen, PY; Chang, W; Zhu, FQ; Xu, LL; Wang, SL; Chang, LY; Luo, J; Liu, GJ				Wang, Yun Fu; Chen, Ping You; Chang, Wei; Zhu, Fi Qi; Xu, Li Li; Wang, Song Lin; Chang, Li Ying; Luo, Jie; Liu, Guang Jian			Clinical Significance of Tumor Necrosis Factor-alpha Inhibitors in the Treatment of Sciatica: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HERNIATION-INDUCED SCIATICA; FORM HEALTH SURVEY; DISC HERNIATION; DOUBLE-BLIND; BACK-PAIN; FOLLOW-UP; MONOCLONAL-ANTIBODY; DOSE-RESPONSE; ETANERCEPT; INFLIXIMAB	Background and Objective: Currently, no satisfactory treatment is available for sciatica caused by herniated discs and/or spinal stenosis. The objective of this study is to assess the value of tumor necrosis factor (TNF)-alpha inhibitors in the treatment of sciatica. Methods: Without language restrictions, we searched PubMed, OVID, EMBASE, the Web of Science, the Clinical Trials Registers, the Cochrane Central Register of Controlled Trials and the China Academic Library and Information System. We then performed a systematic review and meta-analysis on the enrolled trials that met the inclusion criteria. Results: Nine prospective randomized controlled trials (RCTs) and two before-after controlled trials involving 531 patients met our inclusion criteria and were included in this study. Our systematic assessment and meta-analysis demonstrated that in terms of the natural course of the disease, compared with the control condition, TNF-alpha inhibitors neither significantly relieved lower back and leg pain (both p>0.05) nor enhanced the proportion of patients who felt overall satisfaction (global perceived effect (satisfaction)) or were able to return to work (return to work) (combined endpoint; p>0.05) at the short-term, medium-term and long-term follow-ups. In addition, compared with the control condition, TNF-alpha inhibitors could reduce the risk ratio (RR) of discectomy or radicular block (combined endpoint; RR = 0.51, 95% CI 0.26 to 1.00, p = 0.049) at medium-term follow-up, but did not decrease RR at the short-term (RR = 0.64, 95% CI 0.17 to 2.40, p = 0.508) and long-term follow-ups (RR = 0.64, 95% CI 0.40 to 1.03, p = 0.065). Conclusion: The currently available evidence demonstrated that other than reducing the RR of discectomy or radicular block (combined endpoint) at medium-term follow-up, TNF-alpha inhibitors showed limited clinical value in the treatment of sciatica caused by herniated discs and/or spinal stenosis.	[Wang, Yun Fu; Xu, Li Li; Wang, Song Lin; Luo, Jie; Liu, Guang Jian] Hubei Univ Med, Taihe Hosp, Dept Neurol, Shiyan City, Hubei Province, Peoples R China; [Chen, Ping You] Hubei Univ Med, Taihe Hosp, Med Imaging Ctr, Shiyan City, Hubei Province, Peoples R China; [Chang, Wei] Hubei Univ Med, Taihe Hosp, Dept Spine Surg, Shiyan City, Hubei Province, Peoples R China; [Zhu, Fi Qi] Shantou Univ, Coll Med, Yuebei Peoples Hosp, Dept Neurol, Shaoguan City, Guangdong, Peoples R China; [Chang, Li Ying] Hubei Univ Arts & Sci, Xiangyang Ctr Hosp, Dept Neurol, Xiangyang City, Hubei Province, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; Shantou University; Hubei University of Arts & Science	Luo, J (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Neurol, Shiyan City, Hubei Province, Peoples R China.	luojie_001@126.com; liuguangjian@aliyun.com	xu, li/GNH-3667-2022		Sowers Foundation for Evidence-Based Medicine of Taihe Hospital	Sowers Foundation for Evidence-Based Medicine of Taihe Hospital	This study received financial support from the Sowers Foundation for Evidence-Based Medicine of Taihe Hospital (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade P, 2013, EUR SPINE J, V22, P714, DOI 10.1007/s00586-012-2502-x; Andrade P, 2011, PAIN, V152, P2645, DOI 10.1016/j.pain.2011.08.012; Ashworth J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-208; Autio RA, 2006, SPINE, V31, P2641, DOI 10.1097/01.brs.0000244616.64962.9e; Becker C, 2007, SPINE, V32, P1803, DOI 10.1097/BRS.0b013e3181076514; Buenaventura RM, 2009, PAIN PHYSICIAN, V12, P233; Chia S, 2003, ARTERIOSCL THROM VAS, V23, P695, DOI 10.1161/01.ATV.0000065195.22904.FA; Cohen SP, 2007, ANESTHESIOLOGY, V107, P99, DOI 10.1097/01.anes.0000267518.20363.0d; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Di Martino A, 2013, EXPERT OPIN THER TAR, V17, P1461, DOI 10.1517/14728222.2013.834330; Fairbank J C, 1980, Physiotherapy, V66, P271; Genevay S, 2004, ANN RHEUM DIS, V63, P1120, DOI 10.1136/ard.2003.016451; Genevay S, 2012, ANN RHEUM DIS, V71, P560, DOI 10.1136/annrheumdis-2011-200373; Genevay S, 2010, ARTHRITIS RHEUM-US, V62, P2339, DOI 10.1002/art.27499; Habtemariam A, 1999, SPINE, V24, P1516, DOI 10.1097/00007632-199908010-00003; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Igarashi A, 2004, SPINE, V29, P2091, DOI 10.1097/01.brs.0000141265.55411.30; Issack PS, 2012, J AM ACAD ORTHOP SUR, V20, P527, DOI 10.5435/JAAOS-20-08-527; Ito K, 2013, GLOB SPINE J, V3, P145, DOI 10.1055/s-0033-1347300; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Karppinen J, 2003, SPINE, V28, P750, DOI 10.1097/00007632-200304150-00004; Karppinen J, 2009, OPEN SPINE J, V1, P9, DOI DOI 10.2174/1876532700901010009; Kawakami M, 2000, CLIN ORTHOP RELAT R, P268; Korhonen T, 2004, SPINE, V29, P2115, DOI 10.1097/01.brs.0000141179.58778.6c; Korhonen T, 2005, SPINE, V30, P2724, DOI 10.1097/01.brs.0000190815.13764.64; Korhonen T, 2006, SPINE, V31, P2759, DOI 10.1097/01.brs.0000245873.23876.1e; Kume K, 2008, ANN RHEUM DIS S, V67, P131; Lee JH, 2012, PAIN PHYSICIAN, V15, P213; Lewis R, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15390; Liang C, 2013, ACTA ANAESTH SCAND, V57, P271, DOI 10.1111/j.1399-6576.2012.02670.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Okoro T, 2010, J SPINAL DISORD TECH, V23, P74, DOI 10.1097/BSD.0b013e31819afdc4; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roncoroni C, 2011, RHEUMATOLOGY, V50, P1603, DOI 10.1093/rheumatology/ker151; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams NH, 2013, EUR SPINE J; Xie WR, 2005, PAIN, V116, P243, DOI 10.1016/j.pain.2005.04.017; Zhou QH, 2011, J PHARMACOL EXP THER, V339, P618, DOI 10.1124/jpet.111.185876	44	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103147	10.1371/journal.pone.0103147	http://dx.doi.org/10.1371/journal.pone.0103147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050851	Green Submitted, gold, Green Published			2022-12-27	WOS:000339551100091
J	Veldman, K; Bultmann, U; Stewart, RE; Ormel, J; Verhulst, FC; Reijneveld, SA				Veldman, Karin; Bultmann, Ute; Stewart, Roy E.; Ormel, Johan; Verhulst, Frank C.; Reijneveld, Sijmen A.			Mental Health Problems and Educational Attainment in Adolescence: 9-Year Follow-Up of the TRAILS Study	PLOS ONE			English	Article							INDIVIDUAL-LIVES SURVEY; PSYCHIATRIC-DISORDERS; DEPRESSION; TRAJECTORIES; CHILDREN; OUTCOMES; SAMPLE	Background: This study examines if mental health problems at age 11 and changes in mental health problems between age 11 and 16 predict educational attainment of adolescents at age 19, overall and stratified by gender. Methods: Data from 1711 adolescents (76.8% from initial cohort) of the Tracking Adolescents' Individual Lives Survey (TRAILS), a Dutch prospective cohort study with 9year follow-up, were used. Mental health problems (externalizing, internalizing and attention problems) were measured by the Youth Self Report and the Child Behavior Checklist at ages 11 and 16. Difference scores for mental health problems between age 11 and 16 were calculated. Educational attainment was assessed at age 19. Results: Externalizing, internalizing and attention problems at age 11 were significantly associated with low educational attainment at age 19 (crude model). When adjusted for demographic variables and the other mental health problems, only the association for attention problems remained significant (odds ratio (OR), 95% confidence interval: 3.19, 2.11-4.83). Increasing externalizing problems between age 11 and 16 also predicted low educational attainment at age 19 (OR 3.12, 1.83-5.32). Among girls, increasing internalizing problems between age 11 and 16 predicted low educational attainment (OR 2.21, 1.25-3.94). For boys, no significant association was found for increasing internalizing problems and low educational attainment. For increasing attention problems between age 11 and 16 no significant association with low educational attainment was found. Conclusions: Externalizing, internalizing and attention problems at age 11 and an increase of these problems during adolescence predicted low educational attainment at age 19. Early treatment of these mental health problems may improve educational attainment, and reduce socioeconomic health differences in adulthood.	[Veldman, Karin; Bultmann, Ute; Stewart, Roy E.; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [Ormel, Johan] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Verhulst, Frank C.] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Veldman, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands.	k.veldman@umcg.nl	Ormel, Johan/C-6094-2013; ormel, johan/AAC-5584-2019	ormel, johan/0000-0002-5463-037X; Reijneveld, Sijmen/0000-0002-1206-7523; Stewart, Roy/0000-0001-9227-433X; Bultmann, Ute/0000-0001-9589-9220	Netherlands Organization for Scientific Research NWO (Medical Research Council program grant) [GB-MW 940-38-011]; ZonMW Brainpower grant [100-001-004]; ZonMw Risk Behavior and Dependence grants [60-60600-97-118]; ZonMw Culture and Health grant [261-98-710]; Social Sciences Council medium-sized investment grants [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Social Sciences Council project grants [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; NWO large-sized investment grant [175.010.2003.005]; NWO Longitudinal Survey and Panel Funding [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]	Netherlands Organization for Scientific Research NWO (Medical Research Council program grant); ZonMW Brainpower grant; ZonMw Risk Behavior and Dependence grants; ZonMw Culture and Health grant; Social Sciences Council medium-sized investment grants; Social Sciences Council project grants; NWO large-sized investment grant; NWO Longitudinal Survey and Panel Funding; Dutch Ministry of Justice (WODC); European Science Foundation(European Science Foundation (ESF)European Commission); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), and the participating universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Breslau J, 2011, J PSYCHIATR RES, V45, P295, DOI 10.1016/j.jpsychires.2010.06.014; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Duchesne S, 2008, J YOUTH ADOLESCENCE, V37, P1134, DOI 10.1007/s10964-007-9224-0; Ettner SL, 1997, IND LABOR RELAT REV, V51, P64, DOI 10.2307/2525035; Fletcher JM, 2008, HEALTH ECON, V17, P1215, DOI 10.1002/hec.1319; Fletcher JM, 2010, HEALTH ECON, V19, P855, DOI 10.1002/hec.1526; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Henry Kimberly L, 2007, J Prim Prev, V28, P505, DOI 10.1007/s10935-007-0115-7; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; Jaspers M, 2012, J ADOLESCENT HEALTH, V51, P637, DOI 10.1016/j.jadohealth.2012.03.017; Jaspers M, 2010, J PEDIATR-US, V157, P316, DOI 10.1016/j.jpeds.2010.02.015; Jonsson U, 2010, EUR PSYCHIAT, V25, P396, DOI 10.1016/j.eurpsy.2010.01.016; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Lee S, 2011, BRIT J PSYCHIAT, V198, P327; Lee S, 2009, BRIT J PSYCHIAT, V194, P411, DOI 10.1192/bjp.bp.108.054841; Lee SS, 2010, J CLIN CHILD ADOLESC, P37; Massetti GM, 2008, J ABNORM CHILD PSYCH, V36, P399, DOI 10.1007/s10802-007-9186-4; McLeod JD, 2007, AM J SOCIOL, V113, P653, DOI 10.1086/521849; Miech RA, 1999, AM J SOCIOL, V104, P1096, DOI 10.1086/210137; Monuteaux MC, 2009, J AM ACAD CHILD PSY, V48, P757, DOI 10.1097/CHI.0b013e3181a5661b; Needham BL, 2009, J ADOLESCENT HEALTH, V45, P179, DOI 10.1016/j.jadohealth.2008.12.015; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; Sattler J., 1992, ASSESSMENT CHILDREN; SILVERSTEIN AB, 1967, J CONSULT PSYCHOL, V31, P635, DOI 10.1037/h0025110; Smith JP, 2010, SOC SCI MED, V71, P110, DOI 10.1016/j.socscimed.2010.02.046; van Nieuwenhuijzen M, 2009, PREV MED, V48, P572, DOI 10.1016/j.ypmed.2009.04.008; VERHULST FC, 1992, J CHILD PSYCHOL PSYC, V33, P1011, DOI 10.1111/j.1469-7610.1992.tb00922.x; Wechsler DW., 1999, INTELLIGENCE SCALE C; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018	34	55	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101751	10.1371/journal.pone.0101751	http://dx.doi.org/10.1371/journal.pone.0101751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25047692	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100014
J	Anic, GM; Weinstein, SJ; Mondul, AM; Mannisto, S; Albanes, D				Anic, Gabriella M.; Weinstein, Stephanie J.; Mondul, Alison M.; Mannisto, Satu; Albanes, Demetrius			Serum Vitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer	PLOS ONE			English	Article							CIRCULATING 25-HYDROXYVITAMIN D; PROSTATE-CANCER; GC-GLOBULIN; COLON; ASSOCIATION; MEN; SUPPLEMENTATION; REPRODUCIBILITY; RECEPTOR; COHORT	Background: We previously reported a positive association between serum 25-hydroxyvitamin D (25(OH)D) and colorectal cancer risk. To further elucidate this association, we examined the molar ratio of 25(OH)D to vitamin D binding protein (DBP), the primary 25(OH)D transport protein, and whether DBP modified the association between 25(OH)D and colorectal cancer risk. Methods: In a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, controls were 1: 1 matched to 416 colorectal cancer cases based on age and date of blood collection. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) for quartiles of 25(OH)D, DBP, and the molar ratio of 25(OH)D: DBP, a proxy for free, unbound circulating 25(OH)D. Results: Comparing highest to lowest quartiles, DBP was not associated with colorectal cancer risk (OR = 0.91; 95% CI: 0.58, 1.42, p for trend = 0.58); however, a positive risk association was observed for the molar ratio of 25(OH)D: DBP (OR = 1.44; 95% CI: 0.92, 2.26, p for trend = 0.04). In stratified analyses, the positive association between 25(OH)D and colorectal cancer was stronger among men with DBP levels above the median (OR = 1.89; 95% CI: 1.07, 3.36, p for trend = 0.01) than below the median (OR = 1.20; 95% CI: 0.68, 2.12, p for trend = 0.87), although the interaction was not statistically significant (p for interaction = 0.24). Conclusion: Circulating DBP may influence the association between 25(OH)D and colorectal cancer in male smokers, with the suggestion of a stronger positive association in men with higher DBP concentrations. This finding should be examined in other populations, especially those that include women and non-smokers.	[Anic, Gabriella M.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Anic, Gabriella M.; Weinstein, Stephanie J.; Mondul, Alison M.; Albanes, Demetrius] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Mannisto, Satu] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Finland National Institute for Health & Welfare	Anic, GM (corresponding author), NCI, Canc Prevent Fellowship Program, Canc Prevent Div, NIH, Bethesda, MD 20892 USA.	gabriella.anic@nih.gov	Albanes, Demetrius/B-9749-2015; Weinstein, Stephanie J/P-1627-2017	Weinstein, Stephanie J/0000-0002-3834-1535; Mondul, Alison/0000-0002-8843-1416; Mannisto, Satu/0000-0002-8668-3046	Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute; US Public Health Service from the Division of Cancer Prevention, National Cancer Institute [N01-CN-45165, N01-RC-45035, N01-RC-37004, HHSN261201000006C]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010195] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute; US Public Health Service from the Division of Cancer Prevention, National Cancer Institute; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute. Additionally, this research was supported by US Public Health Service contracts N01-CN-45165, N01-RC-45035, N01-RC-37004, and HHSN261201000006C from the Division of Cancer Prevention, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-oanzi ZH, 2006, CLIN CHEM, V52, P248, DOI 10.1373/clinchem.2005.059568; Andreassen TK, 2006, HORM METAB RES, V38, P279, DOI 10.1055/s-2006-925348; [Anonymous], 2009, CERT AN STAND REF MA; BOUILLON R, 1981, J CLIN INVEST, V67, P589, DOI 10.1172/JCI110072; Brown AJ, 2012, KIDNEY INT, V82, P5, DOI 10.1038/ki.2012.135; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; CORDER EH, 1995, CANCER EPIDEM BIOMAR, V4, P655; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Fears TR, 2000, CANCER EPIDEM BIOMAR, V9, P403; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P10, DOI 10.1093/aje/kwq116; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; Gregory KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013428; HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8; Hansen CM, 2001, FRONT BIOSCI-LANDMRK, V6, pD820, DOI 10.2741/Hansen; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hiraki LT, 2013, CANCER EPIDEM BIOMAR, V22, P2037, DOI 10.1158/1055-9965.EPI-13-0209; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Holt PR, 2002, CANCER EPIDEM BIOMAR, V11, P113; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Lin JH, 2013, CLIN GASTROENTEROL H, V11, P419, DOI 10.1016/j.cgh.2012.11.012; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Malik S, 2013, CRIT REV CL LAB SCI, V50, P1, DOI 10.3109/10408363.2012.750262; Matsunawa M, 2009, TOXICOL SCI, V109, P50, DOI 10.1093/toxsci/kfp044; Mondul AM, 2012, BRIT J CANCER, V107, P1589, DOI 10.1038/bjc.2012.417; Mondul AM, 2014, INT J CANCER, V134, P2699, DOI 10.1002/ijc.28596; Nagasawa H, 2005, ANTICANCER RES, V25, P3689; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; PIETINEN P, 1988, AM J EPIDEMIOL, V128, P655, DOI 10.1093/oxfordjournals.aje.a115013; Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096; Sonderman JS, 2012, AM J EPIDEMIOL, V176, P615, DOI 10.1093/aje/kws141; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Tangpricha V, 2001, LANCET, V357, P1673, DOI 10.1016/S0140-6736(00)04831-5; Ternes SB, 2013, NUTR CANCER, V65, P900, DOI 10.1080/01635581.2013.805422; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wei PL, 2009, ANN SURG, V249, P978, DOI 10.1097/SLA.0b013e3181a6ce7e; Weinstein SJ, 2013, INT J CANCER, V132, P2940, DOI 10.1002/ijc.27969; Weinstein SJ, 2012, CANCER RES, V72, P1190, DOI 10.1158/0008-5472.CAN-11-2950; Weinstein SJ, 2011, AM J EPIDEMIOL, V173, P499, DOI 10.1093/aje/kwq398; Wu WKK, 2005, CANCER RES, V65, P5272, DOI 10.1158/0008-5472.CAN-05-0205; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	49	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102966	10.1371/journal.pone.0102966	http://dx.doi.org/10.1371/journal.pone.0102966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036524	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200104
J	Brown, PA; Lemaitre, E; Briand, FX; Courtillon, C; Guionie, O; Allee, C; Toquin, D; Bayon-Auboyer, MH; Jestin, V; Eterradossi, N				Brown, Paul A.; Lemaitre, Evelyne; Briand, Francois-Xavier; Courtillon, Celine; Guionie, Olivier; Allee, Chantal; Toquin, Didier; Bayon-Auboyer, Marie-Helene; Jestin, Veronique; Eterradossi, Nicolas			Molecular Comparisons of Full Length Metapneumovirus (MPV) Genomes, Including Newly Determined French AMPV-C and -D Isolates, Further Supports Possible Subclassification within the MPV Genus	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TURKEY RHINOTRACHEITIS VIRUS; SMALL HYDROPHOBIC PROTEIN; AVIAN-METAPNEUMOVIRUS; FUSION PROTEIN; SUBGROUP-C; SUBTYPE-C; GLYCOPROTEIN GENE; IN-VITRO; ATTACHMENT GLYCOPROTEIN	Four avian metapneumovirus (AMPV) subgroups (A-D) have been reported previously based on genetic and antigenic differences. However, until now full length sequences of the only known isolates of European subgroup C and subgroup D viruses (duck and turkey origin, respectively) have been unavailable. These full length sequences were determined and compared with other full length AMPV and human metapneumoviruses (HMPV) sequences reported previously, using phylogenetics, comparisons of nucleic and amino acid sequences and study of codon usage bias. Results confirmed that subgroup C viruses were more closely related to HMPV than they were to the other AMPV subgroups in the study. This was consistent with previous findings using partial genome sequences. Closer relationships between AMPV-A, B and D were also evident throughout the majority of results. Three metapneumovirus "clusters'' HMPV, AMPV-C and AMPV-A, B and D were further supported by codon bias and phylogenetics. The data presented here together with those of previous studies describing antigenic relationships also between AMPV-A, B and D and between AMPV-C and HMPV may call for a subclassification of metapneumoviruses similar to that used for avian paramyxoviruses, grouping AMPV-A, B and D as type I metapneumoviruses and AMPV-C and HMPV as type II.	[Brown, Paul A.; Lemaitre, Evelyne; Briand, Francois-Xavier; Courtillon, Celine; Guionie, Olivier; Allee, Chantal; Toquin, Didier; Bayon-Auboyer, Marie-Helene; Jestin, Veronique; Eterradossi, Nicolas] Univ Europeenne Bretagne, French Agcy Food Environm & Occupat Hlth Safety A, Avian & Rabbit Virol Immunol & Parasitol Unit VIP, Ploufragan Plouzane Lab, Ploufragan, France	Universite de Bretagne Occidentale	Brown, PA (corresponding author), Univ Europeenne Bretagne, French Agcy Food Environm & Occupat Hlth Safety A, Avian & Rabbit Virol Immunol & Parasitol Unit VIP, Ploufragan Plouzane Lab, Ploufragan, France.	Paul.brown@anses.fr		Courtillon, Celine/0000-0002-3006-764X; BRIAND, Francois-Xavier/0000-0002-8094-9368	Regional Council of Brittany (Region Bretagne) SAD METABE 7160 programme; Departement des Cotes d'Armor	Regional Council of Brittany (Region Bretagne) SAD METABE 7160 programme(Region Bretagne); Departement des Cotes d'Armor(Region Bretagne)	Regional Council of Brittany (Region Bretagne) SAD METABE 7160 programme and of Departement des Cotes d'Armor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez R, 2004, VIRUS RES, V105, P67, DOI 10.1016/j.virusres.2004.04.019; Bao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062568; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Bayon-Auboyer MH, 2000, J GEN VIROL, V81, P2723, DOI 10.1099/0022-1317-81-11-2723; Bayon-Auboyer MH, 1999, ARCH VIROL, V144, P1091, DOI 10.1007/s007050050572; Bennett RS, 2005, J VIROL, V79, P14834, DOI 10.1128/JVI.79.23.14834-14842.2005; Bennett RS, 2004, AVIAN DIS, V48, P902, DOI 10.1637/7208-051804R; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Boere G., 2006, FLYWAY CONCEPT WHAT; Brown PA, 2013, J VIROL METHODS, V193, P121, DOI 10.1016/j.jviromet.2013.05.007; Brown PA, 2009, VIRUS RES, V146, P13, DOI 10.1016/j.virusres.2009.08.009; Buys S.B., 1980, TURKEYS, P36; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Catelli E, 2006, VACCINE, V24, P6476, DOI 10.1016/j.vaccine.2006.06.076; Chockalingam AK, 2010, AVIAN DIS, V54, P915, DOI 10.1637/9016-081909-RESNOTE.1; Clubbe J, 2011, VACCINE, V29, P9493, DOI 10.1016/j.vaccine.2011.10.024; Collins P., 2001, RESP SYNCYTIAL VIRUS; Cook JKA, 2000, VET J, V160, P118, DOI 10.1053/tvjl.2000.0486; Cook JKA, 1999, AVIAN PATHOL, V28, P607, DOI 10.1080/03079459994407; Cox RG, 2012, J VIROL, V86, P12148, DOI 10.1128/JVI.01133-12; Crowe James E Jr, 2004, Pediatr Infect Dis J, V23, pS215, DOI 10.1097/01.inf.0000144668.81573.6d; de Almeida RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076413; de Graaf M, 2009, J GEN VIROL; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; de Graaf M, 2008, J GEN VIROL, V89, P975, DOI 10.1099/vir.0.83537-0; de Graaf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058572; Deng QJ, 2011, VIRUS RES, V160, P102, DOI 10.1016/j.virusres.2011.05.020; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dolganiuc V, 2003, J VIROL, V77, P12968, DOI 10.1128/JVI.77.24.12968-12979.2003; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; Easton AJ, 1997, VIRUS RES, V48, P27, DOI 10.1016/S0168-1702(96)01430-X; Esperante SA, 2013, BIOCHEMISTRY-US, V52, P6779, DOI 10.1021/bi401029q; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; GIRAUD P, 1986, VET REC, V119, P606; Govindarajan D, 2005, VIRUS GENES, V30, P331, DOI 10.1007/s11262-005-6775-6; Govindarajan D, 2004, J GEN VIROL, V85, P3671, DOI 10.1099/vir.0.80400-0; Govindarajan D, 2004, VIRUS RES, V105, P59, DOI 10.1016/j.virusres.2004.04.014; Govindarajan D, 2006, J VIROL, V80, P5790, DOI 10.1128/JVI.00138-06; Herfst S, 2008, J VIROL, V82, P8891, DOI 10.1128/JVI.00472-08; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Kong BW, 2008, VIRUS RES, V132, P114, DOI 10.1016/j.virusres.2007.11.006; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lee EH, 2007, VIRUS RES, V128, P18, DOI 10.1016/j.virusres.2007.03.029; Leyrat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080371; Li J, 1996, VIRUS RES, V41, P185, DOI 10.1016/0168-1702(96)01288-9; LING R, 1992, J GEN VIROL, V73, P1709, DOI 10.1099/0022-1317-73-7-1709; LING R, 1995, VIRUS RES, V36, P247, DOI 10.1016/0168-1702(95)00008-E; Ling R, 2008, J GEN VIROL, V89, P525, DOI 10.1099/vir.0.83309-0; Loo LH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-294; LOUNSBACH GR, 1993, J GEN VIROL, V74, P2559, DOI 10.1099/0022-1317-74-12-2559; Lupini C, 2011, AVIAN PATHOL, V40, P525, DOI 10.1080/03079457.2011.607428; Lwamba HCM, 2005, VIRUS RES, V107, P83, DOI 10.1016/j.virusres.2004.07.002; Mas V, 2011, J VIROL, V85, P12650, DOI 10.1128/JVI.05485-11; MCDOUGALL JS, 1986, VET REC, V118, P206, DOI 10.1136/vr.118.8.206; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Naylor CJ, 2004, J GEN VIROL, V85, P3219, DOI 10.1099/vir.0.80229-0; Naylor CJ, 1998, J GEN VIROL, V79, P1393, DOI 10.1099/0022-1317-79-6-1393; Naylor CJ, 2010, VACCINE, V28, P6800, DOI 10.1016/j.vaccine.2010.07.015; Pham QN, 2005, J VIROL, V79, P15114, DOI 10.1128/JVI.79.24.15114-15122.2005; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; Pringle C R, 1998, Arch Virol, V143, P1449, DOI 10.1007/s007050050389; Randhawa JS, 1997, J VIROL, V71, P9849, DOI 10.1128/JVI.71.12.9849-9854.1997; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ren JP, 2012, J VIROL, V86, P13049, DOI 10.1128/JVI.01248-12; Schlender J, 2003, J VIROL, V77, P4609, DOI 10.1128/JVI.77.8.4609-4616.2003; Shin HJ, 2000, J CLIN MICROBIOL, V38, P4282, DOI 10.1128/JCM.38.11.4282-4284.2000; Sugiyama M, 2010, VIRUS GENES, V41, P389, DOI 10.1007/s11262-010-0518-z; Svenda M, 1997, VIRUS RES, V48, P57, DOI 10.1016/S0168-1702(96)01426-8; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner SJ, 2014, P NATL ACAD SCI USA, V111, P1580, DOI 10.1073/pnas.1317262111; Toquin D, 1999, Vet Rec, V145, P680; Toquin D, 2006, VIRUS GENES, V32, P97, DOI 10.1007/s11262-005-5850-3; Toquin D, 2003, J GEN VIROL, V84, P2169, DOI 10.1099/vir.0.19043-0; Toquin D, 2000, AVIAN DIS, V44, P977, DOI 10.2307/1593075; Toquin D, 2006, COMP SUCEPTIBILITY S, P70; Toquin D, 1999, VET REC, V23, P145; Turpin EA, 2008, AVIAN PATHOL, V37, P343, DOI 10.1080/03079450802068566; Ulbrandt ND, 2008, J GEN VIROL, V89, P3113, DOI 10.1099/vir.0.2008/005199-0; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Velayudhan BT, 2008, VIRUS GENES, V37, P266, DOI 10.1007/s11262-008-0220-6; Wei L, 2013, EMERG INFECT DIS, V19, P1092, DOI 10.3201/eid1907.121126; Wei Y, 2014, J VIROL; Werle B, 1998, VACCINE, V16, P1127, DOI 10.1016/S0264-410X(98)80109-6; WILDING GP, 1986, VET REC, V118, P735, DOI 10.1136/vr.118.26.735-b; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; WYETH PJ, 1986, VET REC, V119, P139, DOI 10.1136/vr.119.6.139-a; YU Q, 1992, VIROLOGY, V186, P426, DOI 10.1016/0042-6822(92)90007-C; YU Q, 1992, J GEN VIROL, V73, P1355, DOI 10.1099/0022-1317-73-6-1355; Yunus AS, 2003, VIRUS RES, V93, P91, DOI 10.1016/S0168-1702(03)00074-1; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhong Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/460837	96	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102740	10.1371/journal.pone.0102740	http://dx.doi.org/10.1371/journal.pone.0102740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036224	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200082
J	Cullati, S; Licker, MJ; Francis, P; Degiorgi, A; Bezzola, P; Courvoisier, DS; Chopard, P				Cullati, Stephane; Licker, Marc-Joseph; Francis, Patricia; Degiorgi, Adriana; Bezzola, Paula; Courvoisier, Delphine S.; Chopard, Pierre			Implementation of the Surgical Safety Checklist in Switzerland and Perceptions of Its Benefits: Cross-Sectional Survey	PLOS ONE			English	Article							OPERATING-ROOM BRIEFINGS; PATIENT SAFETY; HEALTH-CARE; MORBIDITY; MORTALITY; PARTICIPATION; TRENDS; HOSPITALS; SURGERY; IMPACT	Objectives: To examine the implementation of the Surgical Safety Checklist (SSC) among surgeons and anaesthetists working in Swiss hospitals and clinics and their perceptions of the SSC. Methods: Cross-sectional survey at the 97th Annual Meeting of the Swiss Society of Surgery, Switzerland, 2010. Opinions of the SSC were assessed with a 6-item questionnaire. Results: 152 respondents answered the questionnaire (participation rate 35.1%). 64.7% respondents acknowledged having a checklist in their hospital or their clinic. Median implementation year was 2009. More than 8 out of 10 respondents reported their team applied the Sign In and the Time Out very often or quasi systematically, whereas almost half of respondents acknowledged the Sign Out was applied never or rarely. The majority of respondents agreed that the checklist improves safety and team communication, and helps to develop a safety culture. However, they were less supportive about the opinion that the checklist facilitates teamwork and eliminates social hierarchy between caregivers. Conclusions: This survey indicates that the SSC has been largely implemented in many Swiss hospitals and clinics. Both surgeons and anaesthetists perceived the SSC as a valuable tool in improving intraoperative patient safety and communication among health care professionals, with lesser importance in facilitating teamwork (and eliminating hierarchical categories).	[Cullati, Stephane; Francis, Patricia; Chopard, Pierre] Univ Hosp Geneva, Qual Care Serv, Geneva, Switzerland; [Licker, Marc-Joseph] Univ Hosp Geneva, Div Anesthesiol, Geneva, Switzerland; [Degiorgi, Adriana] Ente Osped Cantonale, Qual Care Unit, Lugano, Switzerland; [Bezzola, Paula] Patient Safety Fdn, Zurich, Switzerland; [Courvoisier, Delphine S.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Cullati, S (corresponding author), Univ Hosp Geneva, Qual Care Serv, Geneva, Switzerland.	stephane.cullati@hcuge.ch	chopard, pierre/L-8697-2014; Cullati, Stephane/F-7991-2011	Cullati, Stephane/0000-0002-3881-446X; licker, marc/0000-0002-3691-4440				Abdel-Galil K, 2010, BRIT J ORAL MAX SURG, V48, P397, DOI 10.1016/j.bjoms.2010.01.007; Aveling EL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003039; Bohmer AB, 2012, ACTA ANAESTH SCAND, V56, P332, DOI 10.1111/j.1399-6576.2011.02590.x; Borchard A, 2012, ANN SURG, V256, P925, DOI 10.1097/SLA.0b013e3182682f27; Bragg Krista, 2012, Nurs Manage, V43, P38, DOI 10.1097/01.NUMA.0000412221.68897.3a; Buljac-Samardzic M, 2010, HEALTH POLICY, V94, P183, DOI 10.1016/j.healthpol.2009.09.015; Cabarrot P, 2011, ANN FR ANESTH, V30, P469, DOI 10.1016/j.annfar.2011.04.007; Calland JF, 2011, AM SURGEON, V77, P1131; Cullati S, 2013, BMJ QUAL SAF, V22, P639, DOI 10.1136/bmjqs-2012-001634; Cunat C, 2011, ANN FR ANESTH, V30, P484, DOI 10.1016/j.annfar.2011.04.004; De Thomasson E, 2013, RISQUES QUALITE, V10, P156; Hurtado JJD, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-169; Fargen KM, 2012, J NEUROINTERV SURG, DOI [10.1136/neurintsurg-2012-01043, DOI 10.1136/NEURINTSURG-2012-01043]; Fishpool S, 2010, CLIN OTOLARYNGOL, V35, P439, DOI 10.1111/j.1749-4486.2010.02200.x; Fourcade A, 2012, BMJ QUAL SAF, V21, P191, DOI 10.1136/bmjqs-2011-000094; Fuller RL, 2009, HEALTH CARE FINANC R, V30, P17; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gueguen T, 2011, ANN FR ANESTH, V30, P489, DOI 10.1016/j.annfar.2011.04.006; Haller G, 2008, INT J QUAL HEALTH C, V20, P254, DOI 10.1093/intqhc/mzn018; HALLETT JW, 1995, J VASC SURG, V21, P750, DOI 10.1016/S0741-5214(05)80006-0; Hani D, 2010, BR J ORAL MAXILLOFAC, V48, pS37; Haynes AB, 2011, BMJ QUAL SAF, V20, P102, DOI 10.1136/bmjqs.2009.040022; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Johnston G, 2009, J BONE JOINT SURG AM, V91A, P2577, DOI 10.2106/JBJS.H.01615; Kaderli R, 2012, ARCH CLIN EXPT SURG, V1, P158; Kearns RJ, 2011, BMJ QUAL SAF, V20, P818, DOI 10.1136/bmjqs.2010.050179; Kelly JJ, 2011, JT COMM J QUAL PATIE, V37, P285, DOI 10.1016/S1553-7250(11)37036-5; Khoshbin A, 2009, CAN J SURG, V52, P309; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Ko HCH, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-211; Makary MA, 2007, J AM COLL SURGEONS, V204, P236, DOI 10.1016/j.jamcollsurg.2006.10.018; Malyar N, 2013, EUR HEART J, V34, P2706, DOI 10.1093/eurheartj/eht288; Mascherek AC, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-36; McDowell DS, 2014, AORN J, V99, P125; Millar W J, 1995, Health Rep, V7, P19; Millar WJ, 1995, HLTH REP, V7, P21; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; NHS, 2009, WHO SURG SAF CHECKL; Nugent E, 2013, IRISH J MED SCI, V182, P171, DOI 10.1007/s11845-012-0851-4; Papaconstantinou HT, 2013, OCHSNER J, V13, P299; Patterson P, 2009, OR MANAGER, V25, P6; Patterson Pat, 2009, OR Manager, V25, P7; Paugam-Burtz C, 2011, ANN FR ANESTH, V30, P475, DOI 10.1016/j.annfar.2011.04.005; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Perneger TV, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-6; Pickering SP, 2013, BRIT J SURG, V100, P1664, DOI 10.1002/bjs.9305; Rateau F, 2011, ANN FR ANESTH, V30, P479, DOI 10.1016/j.annfar.2011.04.003; Rodrigo-Rincon MI, 2011, REV CALID ASSIST, V26, P380, DOI 10.1016/j.cali.2011.03.005; Rydenfalt C, 2013, INT J QUAL HEALTH C, V25, P182, DOI 10.1093/intqhc/mzt004; Rydenfalt C, 2013, BMJ QUALITY SAFETY; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sivathasan Niroshan, 2010, JRSM Short Rep, V1, P40, DOI 10.1258/shorts.2010.010007; Spence J, 2011, BMJ QUAL SAF, V20, P580, DOI 10.1136/bmjqs.2010.044826; Suva D, 2012, AM J MED QUAL, V27, P313, DOI 10.1177/1062860611423805; Thomassen O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-53; Vats A, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5433; World Health Organization, GLOB SUPP SAF SURG S; World Health Organization, 2009, SAF SURG SAV LIV EUR; World Health Organization, 2009, WHO GUID SAF SURG 20; World Health Organization (WHO), 2008, WORLD ALL PAT SAF SA; Ziegenfuss JY, 2012, EVAL HEALTH PROF, V35, P507, DOI 10.1177/0163278711435542	61	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101915	10.1371/journal.pone.0101915	http://dx.doi.org/10.1371/journal.pone.0101915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036453	gold, Green Submitted, Green Published			2022-12-27	WOS:000339615200028
J	Mo, F; Wyatt, AW; Sun, Y; Brahmbhatt, S; McConeghy, BJ; Wu, CX; Wang, YZ; Gleave, ME; Volik, SV; Collins, CC				Mo, Fan; Wyatt, Alexander W.; Sun, Yue; Brahmbhatt, Sonal; McConeghy, Brian J.; Wu, Chunxiao; Wang, Yuzhuo; Gleave, Martin E.; Volik, Stanislav V.; Collins, Colin C.			Systematic Identification and Characterization of RNA Editing in Prostate Tumors	PLOS ONE			English	Article							DNA-SEQUENCING DATA; HUMAN TRANSCRIPTOME; NONCODING RNAS; ACCURATE IDENTIFICATION; MOLECULAR-CLONING; SEQ DATA; CANCER; DISCOVERY; ALIGNMENT; GENOME	RNA editing modifies the sequence of primary transcripts, potentially resulting in profound effects to RNA structure and protein-coding sequence. Recent analyses of RNA sequence data are beginning to provide insights into the distribution of RNA editing across the entire transcriptome, but there are few published matched whole genome and transcriptome sequence datasets, and designing accurate bioinformatics methodology has proven highly challenging. To further characterize the RNA editome, we analyzed 16 paired DNA-RNA sequence libraries from prostate tumor specimens, employing a comprehensive strategy to rescue low coverage sites and minimize false positives. We identified over a hundred thousand putative RNA editing events, a third of which were recurrent in two or more samples, and systematically characterized their type and distribution across the genome. Within genes the majority of events affect non-coding regions such as introns and untranslated regions (UTRs), but 546 genes had RNA editing events predicted to result in deleterious amino acid alterations. Finally, we report a potential association between RNA editing of microRNA binding sites within 39 UTRs and increased transcript expression. These results provide a systematic characterization of the landscape of RNA editing in low coverage sequence data from prostate tumor specimens. We demonstrate further evidence for RNA editing as an important regulatory mechanism and suggest that the RNA editome should be further studied in cancer.	[Mo, Fan; Wyatt, Alexander W.; Sun, Yue; Brahmbhatt, Sonal; McConeghy, Brian J.; Wu, Chunxiao; Wang, Yuzhuo; Gleave, Martin E.; Volik, Stanislav V.; Collins, Colin C.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Mo, Fan; Wyatt, Alexander W.; Sun, Yue; Brahmbhatt, Sonal; McConeghy, Brian J.; Wu, Chunxiao; Wang, Yuzhuo; Gleave, Martin E.; Volik, Stanislav V.; Collins, Colin C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Wang, Yuzhuo] BC Canc Agcy, Dept Expt Therapeut, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency	Collins, CC (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada.	ccollins@prostatecentre.com		Gleave, Martin/0000-0003-4235-0167; Wang, Yuzhuo/0000-0002-9749-8591	Prostate Cancer Canada; Prostate Cancer Foundation; Canadian Institutes of Health Research; Canadian Prostate Cancer Genome Network; Canadian Cancer Society Research Institute; Coalition to Cure Prostate Cancer Young Investigator Award; Prostate Cancer Foundation BC; National Natural Science Foundation of China [60171009]	Prostate Cancer Canada; Prostate Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Prostate Cancer Genome Network; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Coalition to Cure Prostate Cancer Young Investigator Award; Prostate Cancer Foundation BC; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Prostate Cancer Canada (CC, YW), Prostate Cancer Foundation (CC, YW), Canadian Institutes of Health Research (YW), The Canadian Prostate Cancer Genome Network (CC), Canadian Cancer Society Research Institute (CC), Coalition to Cure Prostate Cancer Young Investigator Award (AW), Prostate Cancer Foundation BC (AW), and National Natural Science Foundation of China, No. 60171009 (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen L, 2013, NAT MED; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033720; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Lagana A, 2012, BIOINFORMATICS, V28, P3166, DOI 10.1093/bioinformatics/bts589; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lee JH, 2013, RNA; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin D, 2013, CANC RES CANRES, V2921; Liu W, 2013, CANCER; Louro R, 2008, GENOMICS, V92, P18, DOI 10.1016/j.ygeno.2008.03.013; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mo F, 2012, J CLIN MICROBIOL, V50, P536, DOI 10.1128/JCM.06170-11; Moor CH, 2005, MECH TRANSLATIONAL C, VElsevier, P49; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamashita T, 2013, BRAIN RES; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zinshteyn B, 2009, WIRES SYST BIOL MED, V1, P202, DOI 10.1002/wsbm.10	67	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101431	10.1371/journal.pone.0101431	http://dx.doi.org/10.1371/journal.pone.0101431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036877	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200016
J	Zaspel, JM; Weller, SJ; Wardwell, CT; Zahiri, R; Wahlberg, N				Zaspel, Jennifer M.; Weller, Susan J.; Wardwell, Charles T.; Zahiri, Reza; Wahlberg, Niklas			Phylogeny and Evolution of Pharmacophagy in Tiger Moths (Lepidoptera: Erebidae: Arctiinae)	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; DEFENSE-MECHANISMS; PLANTS; SYSTEMS; CHOICE; CATERPILLAR; ARTHROPODS; INFERENCE; SELECTION; TAXA	The focus of this study was to reconstruct a phylogenetic hypothesis for the moth subfamily Arctiinae (tiger moths, woolly bears) to investigate the evolution of larval and adult pharmacophagy of pyrrolizidine alkaloids (PAs) and the pathway to PA chemical specialization in Arctiinae. Pharmacophagy, collection of chemicals for non-nutritive purposes, is well documented in many species, including the model species Utetheisa ornatrix L. A total of 86 exemplar ingroup species representing tiger moth tribes and subtribes (68 genera) and nine outgroup species were selected. Ingroup species included the most species-rich generic groups to represent the diversity of host-plant associations and pharmacophagous behaviors found throughout Arctiinae. Up to nine genetic markers were sequenced: one mitochondrial (COI barcode region), one nuclear rRNA (D2 region, 28S rRNA), and seven nuclear protein-coding gene fragments: elongation factor 1-alpha protein, wingless, ribosomal protein subunit S5, carbamoylphosphate synthase domain regions, glyceraldehyde-3-phosphate dehydrogenase, isocitrate dehydrogenase and cytosolic malate dehydrogenase. A total of 6984 bp was obtained for most species. These data were analyzed using model-based phylogenetic methods: maximum likelihood (ML) and Bayesian inference (BI). Ancestral pharmacophagous behaviors and obligate PA associations were reconstructed using the resulting Bayes topology and Reconstructing Ancestral States in Phylogenies (RASP) software. Our results corroborate earlier studies on the evolution of adult pharmacophagous behaviors, suggesting that this behavior arose multiple times and is concentrated in the phaegopterine-euchromiine-ctenuchine clade (PEC). Our results suggest that PA specialization may have arisen early in the phylogeny of the subfamily and that facultative larval pharmacophagous behaviors are the derived condition.	[Zaspel, Jennifer M.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Weller, Susan J.; Wardwell, Charles T.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Zahiri, Reza] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Wahlberg, Niklas] Univ Turku, Dept Biol, Genet Lab, SF-20500 Turku, Finland; [Weller, Susan J.] Univ Minnesota, Bell Museum Nat Hist, Minneapolis, MN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Guelph; University of Turku; University of Minnesota System; University of Minnesota Twin Cities	Zaspel, JM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	jzaspel@purdue.edu	Zahiri, Reza/G-5797-2018; Wahlberg, Niklas/B-7765-2008	Zahiri, Reza/0000-0001-6274-6973; Wahlberg, Niklas/0000-0002-1259-3363	NSF-DEB [0919185]; UMN Agricultural Experiment Station; Purdue University; CIMO; Finnish Cultural Foundation; Alfred Kordelin Foundation	NSF-DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); UMN Agricultural Experiment Station; Purdue University; CIMO; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Alfred Kordelin Foundation	Funding for the study was provided by NSF-DEB 0919185 to S. Weller and J. Zaspel. Additional funds were provided by UMN Agricultural Experiment Station and Purdue University. The following Finnish foundations also provided support for this research: CIMO, Finnish Cultural Foundation and the Alfred Kordelin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendib A, 1998, CR ACAD SCI III-VIE, V321, P1007, DOI 10.1016/S0764-4469(99)80056-0; BENN M, 1979, EXPERIENTIA, V35, P731, DOI 10.1007/BF01968208; Bernays EA, 2005, NATURE, V436, P476, DOI 10.1038/436476a; Bernays EA, 2002, J COMP PHYSIOL A, V188, P715, DOI 10.1007/s00359-002-0345-3; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; Boada R, 1997, THESIS WAKE FOREST U; BOPPRE M, 1985, J COMP PHYSIOL A, V157, P569, DOI 10.1007/BF01351351; BOPPRE M, 1990, J CHEM ECOL, V16, P165, DOI 10.1007/BF01021277; BOPPRE M, 1981, ECOL ENTOMOL, V6, P449, DOI 10.1111/j.1365-2311.1981.tb00637.x; Bowers M. Deane, 2009, P83; Brehm G, 2007, ANN MO BOT GARD, V94, P463, DOI 10.3417/0026-6493(2007)94[463:PAAPLV]2.0.CO;2; CAPINERA JL, 1978, J ECON ENTOMOL, V71, P661, DOI 10.1093/jee/71.4.661; Capinera JL., 2001, HDB VEGETABLE PESTS; CHO SW, 1995, MOL BIOL EVOL, V12, P650; CONNER WE, 1980, BEHAV ECOL SOCIOBIOL, V7, P55, DOI 10.1007/BF00302519; Conner WE, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P248, DOI 10.1017/CBO9780511542664.008; Conner WE, 2000, P NATL ACAD SCI USA, V97, P14406, DOI 10.1073/pnas.260503797; Conner WE, 2009, J INSECT CONSERV; Conner William E., 2009, P155; Conner William E., 2009, P177; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; DaCosta M, 2007, THESIS U MINNESOTA S; Dacosta MA, 2005, ZOOTAXA, P1; Davidson Robert B., 1997, Journal of the Lepidopterists' Society, V51, P288; Dubatolov Vladimir V., 2009, Atalanta (Marktleuthen), V40, P285; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; FERGUSON D C, 1985, Entomography, V3, P181; FORBES WTM, 1960, LEPIDOPTERA NEW YO 4; GOSS GJ, 1979, ENVIRON ENTOMOL, V8, P487, DOI 10.1093/ee/8.3.487; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartmann T, 2005, INSECT BIOCHEM MOLEC, V35, P391, DOI 10.1016/j.ibmb.2004.12.010; Hartmann T., 1995, CHEM BIOL PERSPECT, V9, P155; Hartmann Thomas, 2009, P55; Hauser CL, 1997, SYST ENTOMOL, V22, P1, DOI 10.1046/j.1365-3113.1997.d01-21.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Holloway J.D., 1988, MOTHS BORNEO FAMILY; Hwang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045523; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P15013, DOI 10.1073/pnas.96.26.15013; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Iyengar VK, 1999, P NATL ACAD SCI USA, V96, P9169, DOI 10.1073/pnas.96.16.9169; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kiriakoff S. G., 1950, Biologisch Jaarboek Antwerpen, V17, P66; Kitching IJ, 1998, HDB ZOOLOGY ARTHROPO, VIV, P355, DOI DOI 10.1515/9783110804744.355; KRASNOFF SB, 1990, ZOOL J LINN SOC-LOND, V99, P319, DOI 10.1111/j.1096-3642.1990.tb00558.x; KRASNOFF SB, 1989, J CHEM ECOL, V15, P47, DOI 10.1007/BF02027773; Lafontaine JD, 2010, ZOOKEYS, P6, DOI 10.3897/zookeys.40.414; LAMUNYON CW, 1993, P NATL ACAD SCI USA, V90, P4689, DOI 10.1073/pnas.90.10.4689; LaMunyon CW, 1997, ECOL ENTOMOL, V22, P69, DOI 10.1046/j.1365-2311.1997.00033.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee S, 2008, SYST ENTOMOL, V33, P595, DOI 10.1111/j.1365-3113.2008.00430.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; PLISKE TE, 1975, ENVIRON ENTOMOL, V4, P474, DOI 10.1093/ee/4.3.474; PLISKE TE, 1975, ENVIRON ENTOMOL, V4, P455, DOI 10.1093/ee/4.3.455; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROTHSCHILD M, 1979, BIOL J LINN SOC, V12, P305, DOI 10.1111/j.1095-8312.1979.tb00062.x; Schmidt BC, 2008, ZOOTAXA, P1; Schulz Stefan, 2009, P145; Scott CH, 2014, SYST ENTOMOL, V39, P286, DOI 10.1111/syen.12047; Simmons RB, 2002, P ROY SOC B-BIOL SCI, V269, P983, DOI 10.1098/rspb.2002.1970; Simmons RB, 2012, ANN ENTOMOL SOC AM, V105, P804, DOI 10.1603/AN11166; Singer Michael S., 2009, P103; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wagner D.L, 2005, CATERPILLARS E N AM, DOI [DOI 10.1515/9781400834143, DOI 10.1515/9781400838295], Patent No. [2203.04766, 220304766]; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Warren LO, 1970, ARKANSAS AGR EXPT ST, V759; Watson A., 1986, Occasional Papers on Systematic Entomology, P1; Weller, 2002, CLADISTIC STUDY ARCT; Weller SJ, 1999, BIOL J LINN SOC, V68, P557, DOI 10.1111/j.1095-8312.1999.tb01188.x; Weller Susan, 2009, P11; Yu Y., 2011, RASP RECONSTRUCT ANC; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zaspel JM, 2013, ZOOL ANZ, V253, P6, DOI 10.1016/j.jcz.2013.06.001; Zaspel JM, 2012, MOL PHYLOGENET EVOL, V65, P786, DOI 10.1016/j.ympev.2012.06.029; Zaspel JM, 2006, ZOOTAXA, P1; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; [No title captured]	85	48	51	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101975	10.1371/journal.pone.0101975	http://dx.doi.org/10.1371/journal.pone.0101975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036028	Green Submitted, gold, Green Published			2022-12-27	WOS:000339615200031
J	Sommansson, A; Saudi, WSW; Nylander, O; Sjoblom, M				Sommansson, Anna; Saudi, Wan Salman Wan; Nylander, Olof; Sjoblom, Markus			The Ethanol-Induced Stimulation of Rat Duodenal Mucosal Bicarbonate Secretion In Vivo Is Critically Dependent on Luminal Cl-	PLOS ONE			English	Article							APICAL CL-/HCO3-EXCHANGER; HCO3-SECRETION; ALKALINE SECRETION; ACID; PERMEABILITY; CFTR; TRANSPORT; CAMP; IDENTIFICATION; INHIBITION	Alcohol may induce metabolic and functional changes in gastrointestinal epithelial cells, contributing to impaired mucosal barrier function. Duodenal mucosal bicarbonate secretion (DBS) is a primary epithelial defense against gastric acid and also has an important function in maintaining the homeostasis of the juxtamucosal microenvironment. The aim in this study was to investigate the effects of the luminal perfusion of moderate concentrations of ethanol in vivo on epithelial DBS, fluid secretion and paracellular permeability. Under thiobarbiturate anesthesia, a similar to 30-mm segment of the proximal duodenum with an intact blood supply was perfused in situ in rats. The effects on DBS, duodenal transepithelial net fluid flux and the blood-to-lumen clearance of Cr-51-EDTA were investigated. Perfusing the duodenum with isotonic solutions of 10% or 15% ethanol-by-volume for 30 min increased DBS in a concentration-dependent manner, while the net fluid flux did not change. Pre-treatment with the CFTR inhibitor CFTRinh172 (i.p. or i.v.) did not change the secretory response to ethanol, while removing Cl- from the luminal perfusate abolished the ethanol-induced increase in DBS. The administration of hexamethonium (i.v.) but not capsazepine significantly reduced the basal net fluid flux and the ethanol-induced increase in DBS. Perfusing the duodenum with a combination of 1.0 mM HCl and 15% ethanol induced significantly greater increases in DBS than 15% ethanol or 1.0 mM HCl alone but did not influence fluid flux. Our data demonstrate that ethanol induces increases in DBS through a mechanism that is critically dependent on luminal Cl- and partly dependent on enteric neural pathways involving nicotinic receptors. Ethanol and HCl appears to stimulate DBS via the activation of different bicarbonate transporting mechanisms.	[Sommansson, Anna; Saudi, Wan Salman Wan; Nylander, Olof; Sjoblom, Markus] Uppsala Univ, Dept Neurosci, Div Gastrointestinal Physiol, Uppsala, Sweden	Uppsala University	Sjoblom, M (corresponding author), Uppsala Univ, Dept Neurosci, Div Gastrointestinal Physiol, Uppsala, Sweden.	Markus.Sjoblom@neuro.uu.se	Saudi, Wan Salman Wan/I-5866-2016	Saudi, Wan Salman Wan/0000-0001-6424-2066	Emil and Ragna Borjesson Foundation; Lars Hiertas Foundation	Emil and Ragna Borjesson Foundation; Lars Hiertas Foundation	We thank Gunilla Jedstedt and Marie Heidenvall for their excellent technical assistance. Support was given by the Emil and Ragna Borjesson Foundation and the Lars Hiertas Foundation.	Akiba Y, 1999, AM J PHYSIOL-GASTR L, V277, pG268, DOI 10.1152/ajpgi.1999.277.2.G268; Akiba Y, 2005, AM J PHYSIOL-GASTR L, V289, pG753, DOI 10.1152/ajpgi.00130.2005; ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; [Anonymous], 2012, PHYSL GASTROINTESTIN; Clarke LL, 1998, AM J PHYSIOL-GASTR L, V274, pG718, DOI 10.1152/ajpgi.1998.274.4.G718; DRAPER LR, 1983, GUT, V24, P399, DOI 10.1136/gut.24.5.399; Flemstrom G, 2001, NEWS PHYSIOL SCI, V16, P23; FLEMSTROM G, 1987, PHYSL GASTROINTESTIN, P1011; Hogan DL, 1997, GASTROENTEROLOGY, V113, P533, DOI 10.1053/gast.1997.v113.pm9247473; Hogan DL, 1997, AM J PHYSIOL-GASTR L, V272, pG872, DOI 10.1152/ajpgi.1997.272.4.G872; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; ISENBERG JI, 1993, AM J PHYSIOL, V265, pG677, DOI 10.1152/ajpgi.1993.265.4.G677; Jacob P, 2002, GASTROENTEROLOGY, V122, P709, DOI 10.1053/gast.2002.31875; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Juric M, 2013, INFLAMM BOWEL DIS, V19, P904, DOI 10.1097/MIB.0b013e3182813322; Kagawa S, 2003, DIGEST DIS SCI, V48, P1850, DOI 10.1023/A:1025480003388; Ko SBH, 2002, AM J PHYSIOL-CELL PH, V283, pC1206, DOI 10.1152/ajpcell.00512.2001; KRISHNAMRA N, 1986, J NUTR SCI VITAMINOL, V32, P229, DOI 10.3177/jnsv.32.229; LACY ER, 1986, DIGEST DIS SCI, V31, pS101, DOI 10.1007/BF01309332; Levitt MD, 1997, AM J PHYSIOL-GASTR L, V273, pG951, DOI 10.1152/ajpgi.1997.273.4.G951; Myers CP, 1998, GASTROENTEROLOGY, V114, P527, DOI 10.1016/S0016-5085(98)70536-0; NYLANDER O, 1989, AM J PHYSIOL, V257, pG653; Nylander O, 2001, AM J PHYSIOL-GASTR L, V281, pG1169, DOI 10.1152/ajpgi.2001.281.5.G1169; Pihl L, 2008, ACTA PHYSIOL, V193, P67, DOI 10.1111/j.1748-1716.2007.01777.x; Pihl L, 2010, ACTA PHYSIOL, V200, P181, DOI 10.1111/j.1748-1716.2010.02112.x; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Singh AK, 2008, ACTA PHYSIOL, V193, P357, DOI 10.1111/j.1748-1716.2008.01854.x; Singh AK, 2013, J PHYSIOL-LONDON, V591, P5377, DOI 10.1113/jphysiol.2013.254854; Sommansson A, 2013, AM J PHYSIOL-GASTR L, V305, pG95, DOI 10.1152/ajpgi.00074.2013; Sommansson A, 2013, J PINEAL RES, V54, P282, DOI 10.1111/jpi.12013; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; TSAI JH, 1991, TOHOKU J EXP MED, V164, P81, DOI 10.1620/tjem.164.81; Tuo BG, 2006, GASTROENTEROLOGY, V130, P349, DOI 10.1053/j.gastro.2005.10.017; Vaquera J, 2002, HISTOL HISTOPATHOL, V17, P199, DOI 10.14670/HH-17.199; VATTAY P, 1989, ACTA PHYSIOL HUNG, V73, P251; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; World Health Organization, 2011, GLOB STAT REP ALC HL; Xu J, 2003, AM J PHYSIOL-GASTR L, V285, pG1225, DOI 10.1152/ajpgi.00236.2003; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102654	10.1371/journal.pone.0102654	http://dx.doi.org/10.1371/journal.pone.0102654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033198	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300075
J	Wang, LS; Jiao, Y; Cao, YH; Liu, GF; Wang, YJ; Gu, WK				Wang, Lishi; Jiao, Yan; Cao, Yanhong; Liu, Gaifen; Wang, Yongjun; Gu, Weikuan			Limitation Positive Loci in QTL Mapping Using Recombinant Inbred Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PANEL	While the identification of causal genes of quantitative trait loci (QTL) remains a difficult problem in the post-genome era, the number of QTL continues to accumulate, mainly identified using the recombinant inbred (RI) strains. Over the last decade, hundreds of publications have reported nearly a thousand QTL identified from RI strains. We hypothesized that the inaccuracy of most of these QTL makes it difficult to identify causal genes. Using data from RI strains derived from C57BL/6J (B6) X DBA/2J (D2), we tested the possibility of detection of reliable QTL with different numbers of strains in the same trait in five different traits. Our results indicated that studies using RI strains of less than 30 in general have a higher probability of failing to detect reliable QTL. Errors in many studies could include false positive loci, switches between QTL with small and major effects, and missing the real major loci. The similar data was obtained from a RI strain population derived from a different pair of parents and a RI strain population of rat. Thus, thousands of reported QTL from studies of RI strains may need to be double-checked for accuracy before proceeding to causal gene identification.	[Wang, Lishi; Jiao, Yan; Cao, Yanhong; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg, Memphis, TN 38152 USA; [Wang, Lishi; Jiao, Yan; Cao, Yanhong; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, BME, Memphis, TN USA; [Jiao, Yan] Mudanjiang Med Coll, Mudanjiang, Peoples R China; [Cao, Yanhong] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Inst Kaschin Beck Dis, Harbin, Peoples R China; [Cao, Yanhong] Educ Bur Heilongjiang Prov, Harbin, Peoples R China; [Cao, Yanhong] Minist Hlth 23618104, Harbin, Peoples R China; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med Res, Hohhot, Inner Mongolia, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Mudanjiang Medical University; Chinese Center for Disease Control & Prevention; Harbin Medical University; Capital Medical University; Inner Mongolia Medical University	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg, Memphis, TN 38152 USA.	wgu@uthsc.edu			National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health [1R01AA016342]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, TN; National Natural Science Foundation of China [81171679]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016342] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, TN; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (1R01AA016342 to WG), Genediscovery Core at UTHSC, the Veterans Administration Medical Center in Memphis, TN, and National Natural Science Foundation of China (Project 81171679 to YHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Bennett B, 2002, ALCOHOL CLIN EXP RES, V26, P1615, DOI 10.1097/01.ALC.0000037136.49550.B3; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Buresova M, 2006, PHYSIOL GENOMICS, V26, P226, DOI 10.1152/physiolgenomics.00056.2006; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2001, SCIENCE, V294; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Goodman S, 2007, PLOS MED, V4, P773, DOI 10.1371/journal.pmed.0040168; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Huang Y, 2013, GENET MOL RES, V12, P3662, DOI 10.4238/2013.September.18.1; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Manenti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000331; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; Philip VM, 2011, GENOME RES, V21, P1223, DOI 10.1101/gr.113886.110; Porcu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018405; RYAN J, 1987, J NATL CANCER I, V79, P1351; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102307	10.1371/journal.pone.0102307	http://dx.doi.org/10.1371/journal.pone.0102307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032693	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300047
J	Klein, BA; Stiegler, M; Klein, A; Tautz, J				Klein, Barrett Anthony; Stiegler, Martin; Klein, Arno; Tautz, Juergen			Mapping Sleeping Bees within Their Nest: Spatial and Temporal Analysis of Worker Honey Bee Sleep	PLOS ONE			English	Article							AGE POLYETHISM; COLONY; HIVE; THERMOREGULATION; DEPRIVATION; DYNAMICS; COMB; REST	Patterns of behavior within societies have long been visualized and interpreted using maps. Mapping the occurrence of sleep across individuals within a society could offer clues as to functional aspects of sleep. In spite of this, a detailed spatial analysis of sleep has never been conducted on an invertebrate society. We introduce the concept of mapping sleep across an insect society, and provide an empirical example, mapping sleep patterns within colonies of European honey bees (Apis mellifera L.). Honey bees face variables such as temperature and position of resources within their colony's nest that may impact their sleep. We mapped sleep behavior and temperature of worker bees and produced maps of their nest's comb contents as the colony grew and contents changed. By following marked bees, we discovered that individuals slept in many locations, but bees of different worker castes slept in different areas of the nest relative to position of the brood and surrounding temperature. Older worker bees generally slept outside cells, closer to the perimeter of the nest, in colder regions, and away from uncapped brood. Younger worker bees generally slept inside cells and closer to the center of the nest, and spent more time asleep than awake when surrounded by uncapped brood. The average surface temperature of sleeping foragers was lower than the surface temperature of their surroundings, offering a possible indicator of sleep for this caste. We propose mechanisms that could generate caste-dependent sleep patterns and discuss functional significance of these patterns.	[Klein, Barrett Anthony] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Stiegler, Martin; Tautz, Juergen] Univ Wurzburg, BEEgrp, Biozentrum, D-97070 Wurzburg, Germany; [Klein, Arno] Sage Bionetworks, Seattle, WA USA	University of Wisconsin System; University of Wurzburg	Klein, BA (corresponding author), Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA.	barrett@pupating.org	Klein, Arno/Z-4901-2019	Klein, Arno/0000-0002-0707-2889	National Science Foundation [0710142]; Deutscher Akademischer Austausch Dienst [A0670415]; Environmental Science Institute, The University of Texas at Austin; Bienenforschung Wurzburg e.V.	National Science Foundation(National Science Foundation (NSF)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Environmental Science Institute, The University of Texas at Austin; Bienenforschung Wurzburg e.V.	BAK received the following funding: Doctoral Dissertation Improvement Grant #0710142, National Science Foundation (http://www.nsf.gov). Deutscher Akademischer Austausch Dienst #A0670415 (https://www.daad.org). Environmental Science Institute, The University of Texas at Austin (no number; http://www.esi.utexas.edu). Bienenforschung Wurzburg e.V. (no number; http://www.bienenforschung.biozentrum.uni-wuerzburg.de/bienenforschung_wuerzburg_ev/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1995, OECOLOGIA, V102, P156, DOI 10.1007/BF00333246; Anderson JR, 1998, AM J PRIMATOL, V46, P63, DOI 10.1002/(SICI)1098-2345(1998)46:1<63::AID-AJP5>3.0.CO;2-T; Anderson JR, 2000, SLEEP MED REV, V4, P355, DOI 10.1053/smrv.2000.0105; Baracchi D, 2010, ETHOLOGY, V116, P579, DOI 10.1111/j.1439-0310.2010.01770.x; Bates D, 2006, LME4 PACKAGE; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; CAMAZINE S, 1991, BEHAV ECOL SOCIOBIOL, V28, P61, DOI 10.1007/BF00172140; CARTWRIGHT BA, 1987, BIOL CYBERN, V57, P85, DOI 10.1007/BF00318718; CLARK DL, 1990, ANIM BEHAV, V39, P1138, DOI 10.1016/S0003-3472(05)80786-9; Dustmann JH, 2000, BIENEN KONNEN FARBEN; Eban-Rothschild AD, 2008, J EXP BIOL, V211, P2408, DOI 10.1242/jeb.016915; FAHRENHOLZ L, 1989, J COMP PHYSIOL B, V159, P551, DOI 10.1007/BF00694379; FLANIGAN WF, 1973, ELECTROEN CLIN NEURO, V34, P521, DOI 10.1016/0013-4694(73)90069-2; FRANKS NR, 1992, BEHAV ECOL SOCIOBIOL, V30, P109; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; HESS W. R., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P465, DOI 10.1007/BF00340746; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Humphrey JAC, 2008, J THEOR BIOL, V250, P194, DOI 10.1016/j.jtbi.2007.09.026; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Kaiser W., 2002, Journal of Sleep Research, V11, P115; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; Klein BA, 2008, J EXP BIOL, V211, P3028, DOI 10.1242/jeb.017426; Klein BA, 2011, ANIM BEHAV, V82, P77, DOI 10.1016/j.anbehav.2011.03.026; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Kovac H, 2007, J INSECT PHYSIOL, V53, P1250, DOI 10.1016/j.jinsphys.2007.06.019; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Moore D, 2001, J INSECT PHYSIOL, V47, P843, DOI 10.1016/S0022-1910(01)00057-9; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; Noser R, 2010, ANIM COGN, V13, P145, DOI 10.1007/s10071-009-0254-8; Pieron H, 1913, PROBLEME PHYSL SOMME; Pinheiro J, 2002, MIXED EFFECTS MODELS, P83; R Development Core Team, 2005, R LANG ENV STAT COMP; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; SAKAGAMI SHOICHI F., 1953, JAPANESE JOUR ZOOL, V11, P117; Sauer S, 2004, J SLEEP RES, V13, P145, DOI 10.1111/j.1365-2869.2004.00393.x; Sauer S, 2003, J COMP PHYSIOL A, V189, P599, DOI 10.1007/s00359-003-0436-9; Sauer S, 1999, P 1 GOTT C GERM NEUR, VII, P241; Sauer S, 1998, APIDOLOGIE, V29, P445; Schmolz E, 2002, THERMOCHIM ACTA, V382, P221, DOI 10.1016/S0040-6031(01)00740-7; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, ETHOLOGY, V87, P284; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; SZABO TI, 1985, J APICULT RES, V24, P27, DOI 10.1080/00218839.1985.11100645; Tobler I., 1985, ENDOGENOUS SLEEP SUB, P57; Vega L, 2011, J THERM ANAL CALORIM, V104, P233, DOI 10.1007/s10973-011-1373-4; von Frisch K., 1967, DANCE LANGUAGE ORIEN; von Frisch K, 1977, PUBLICATION LINDAUER, V23; Witteveen BH, 2009, MAR ECOL PROG SER, V393, P173, DOI 10.3354/meps08231	54	15	15	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102316	10.1371/journal.pone.0102316	http://dx.doi.org/10.1371/journal.pone.0102316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029445	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600061
J	Jain, M; Zhang, L; Boufraqech, M; Liu-Chittenden, Y; Bussey, K; Demeure, MJ; Wu, XL; Su, L; Pacak, K; Stratakis, CA; Kebebew, E				Jain, Meenu; Zhang, Lisa; Boufraqech, Myriem; Liu-Chittenden, Yi; Bussey, Kimberly; Demeure, Michael J.; Wu, Xiaolin; Su, Ling; Pacak, Karel; Stratakis, Constantine A.; Kebebew, Electron			ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195	PLOS ONE			English	Article							GROWTH; GENE; IDENTIFICATION; TUMOR; ASSOCIATION; RESISTANCE; MUTATIONS; MICRORNAS; INVASION; PROTEIN	Background: Several members of the zinc finger protein family have been recently shown to have a role in cancer initiation and progression. Zinc finger protein 367 (ZNF367) is a member of the zinc finger protein family and is expressed in embryonic or fetal erythroid tissue but is absent in normal adult tissue. Methodology/Principal Findings: We show that ZNF367 is overexpressed in adrenocortical carcinoma, malignant pheochromocytoma/paraganglioma and thyroid cancer as compared to normal tissue and benign tumors. Using both functional knockdown and ectopic overexpression in multiple cell lines, we show that ZNF367 inhibits cellular proliferation, invasion, migration, and adhesion to extracellular proteins in vitro and in vivo. Integrated gene and microRNA expression analyses showed an inverse correlation between ZNF367 and miR-195 expression. Luciferase assays demonstrated that miR-195 directly regulates ZNF367 expression and that miR-195 regulates cellular invasion. Moreover, integrin alpha 3 (ITGA3) expression was regulated by ZNF367. Conclusions/Significance: Our findings taken together suggest that ZNF367 regulates cancer progression.	[Jain, Meenu; Zhang, Lisa; Boufraqech, Myriem; Liu-Chittenden, Yi; Kebebew, Electron] NCI, Endocrine Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bussey, Kimberly; Demeure, Michael J.] Translat Genom Res Inst, Phoenix, AZ USA; [Wu, Xiaolin; Su, Ling] SAIC Frederick Inc, Lab Mol Technol, Frederick Natl Lab Canc Res, Frederick, MD USA; [Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth, Sect Med Neuroendocrinol, NIH, Bethesda, MD USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth, Sect Endocrinol & Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kebebew, E (corresponding author), NCI, Endocrine Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Bussey, Kimberly J./D-2567-2011; Boufraqech, Myriem/E-4823-2016; Stratakis, Constantine/AAP-4745-2020	Bussey, Kimberly/0000-0003-1001-8207; Liu, Yi/0000-0001-6357-5360	Center for Cancer Research, National Cancer Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2012, MOL ENDOCRINOL, V26, P493, DOI 10.1210/me.2011-1004; AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Asano H, 2004, BIOCHEM J, V384, P647, DOI 10.1042/BJ20040394; Bai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038875; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duan ZF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006967; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Gerdin A., 2010, ACTA OPHTHALMOLOGICA, V88; Gilligan P, 2002, GENE, V294, P35, DOI 10.1016/S0378-1119(02)00793-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kuramoto K, 2000, CANCER RES, V60, P425; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Pasini B, 2009, J INTERN MED, V266, P19, DOI 10.1111/j.1365-2796.2009.02111.x; Rink L, 2009, MOL CANCER THER, V8, P2172, DOI 10.1158/1535-7163.MCT-09-0193; Rossi M, 2004, CANCER LETT, V215, P229, DOI 10.1016/j.canlet.2004.05.014; Sachs N, 2012, P NATL ACAD SCI USA, V109, P21468, DOI 10.1073/pnas.1204614110; Seyhan AA, 2012, MOL BIOSYST, V8, P1553, DOI 10.1039/c2mb05512k; Slaby O, 2012, GENE CHROMOSOME CANC, V51, P707, DOI 10.1002/gcc.21957; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Wang T, 2012, J CELL MOL MED, V16, P1134, DOI 10.1111/j.1582-4934.2011.01388.x; Wang XQ, 2012, MED ONCOL, V29, P919, DOI 10.1007/s12032-011-9880-5; Xekouki P, 2012, J CLIN ENDOCR METAB, V97, pE357, DOI 10.1210/jc.2011-1179; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216	27	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101423	10.1371/journal.pone.0101423	http://dx.doi.org/10.1371/journal.pone.0101423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047265	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100009
J	Kalle, M; Papareddy, P; Kasetty, G; van der Plas, MJA; Morgelin, M; Malmsten, M; Schmidtchen, A				Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; van der Plas, Mariena J. A.; Morgelin, Matthias; Malmsten, Martin; Schmidtchen, Artur			A Peptide of Heparin Cofactor II Inhibits Endotoxin-Mediated Shock and Invasive Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; HOST-DEFENSE PEPTIDES; SEVERE SEPSIS; ANTIMICROBIAL PEPTIDES; INFLAMMATORY RESPONSE; BACTERIAL-INFECTIONS; ACTIVATION; TIFACOGIN; EFFICACY; SYSTEM	Sepsis and septic shock remain important medical problems with high mortality rates. Today's treatment is based mainly on using antibiotics to target the bacteria, without addressing the systemic inflammatory response, which is a major contributor to mortality in sepsis. Therefore, novel treatment options are urgently needed to counteract these complex sepsis pathologies. Heparin cofactor II (HCII) has recently been shown to be protective against Gram-negative infections. The antimicrobial effects were mapped to helices A and D of the molecule. Here we show that KYE28, a 28 amino acid long peptide representing helix D of HCII, is antimicrobial against the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida albicans. Moreover, KYE28 binds to LPS and thereby reduces LPS-induced pro-inflammatory responses by decreasing NF-kappa B/AP-1 activation in vitro. In mouse models of LPS-induced shock, KYE28 significantly enhanced survival by dampening the pro-inflammatory cytokine response. Finally, in an invasive Pseudomonas infection model, the peptide inhibited bacterial growth and reduced the pro-inflammatory response, which lead to a significant reduction of mortality. In summary, the peptide KYE28, by simultaneously targeting bacteria and LPS-induced pro-inflammatory responses represents a novel therapeutic candidate for invasive infections.	[Kalle, Martina; Papareddy, Praveen; Kasetty, Gopinath; van der Plas, Mariena J. A.; Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Biomed Ctr, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, Biomed Ctr, Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Schmidtchen, Artur] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Lund University; Lund University; Uppsala University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kalle, M (corresponding author), Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Biomed Ctr, Lund, Sweden.	martina.kalle@gmail.com	Schmidtchen, Artur/F-9507-2015; van der Plas, Mariena/GYV-3702-2022	van der Plas, Mariena/0000-0002-3233-2881; Papareddy, Praveen/0000-0002-3872-478X; Malmsten, Martin/0000-0003-0046-5599	Swedish Research Council [2012-1883, 1842]; Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation; Crafoord Foundation; Osterlund Foundation; Kock Foundation; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Welander-Finsen Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Crafoord Foundation; Osterlund Foundation; Kock Foundation; Swedish Government Funds for Clinical Research (ALF)	This work was supported by grants from the Swedish Research Council (project 2012-1883 and 1842), the Welander-Finsen, Knut and Alice Wallenberg, Crafoord, Osterlund, Kock Foundations, and The Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2001, CRIT CARE MED, V29, P2081, DOI 10.1097/00003246-200111000-00007; Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dhainaut JF, 2005, CRIT CARE MED, V33, P341, DOI 10.1097/01.CCM.0000153520.31562.48; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Fritsche TR, 2008, J ANTIMICROB CHEMOTH, V61, P1092, DOI 10.1093/jac/dkn074; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; Kalle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051313; Kasetty G, 2011, J INNATE IMMUN, V3, P471, DOI 10.1159/000327016; Kasetty G, 2011, ANTIMICROB AGENTS CH, V55, P2880, DOI 10.1128/AAC.01515-10; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Laterre PF, 2009, CRIT CARE, V13, DOI 10.1186/cc7747; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004388.pub5; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Papareddy P, 2014, BBA-BIOMEMBRANES, V1838, P1225, DOI 10.1016/j.bbamem.2014.01.026; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; PATEL RT, 1994, BRIT J SURG, V81, P1306, DOI 10.1002/bjs.1800810914; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.02126.x; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Singh S, 2013, BBA-BIOMEMBRANES, V1828, P2709, DOI 10.1016/j.bbamem.2013.06.015; Sonesson A, 2011, EXP DERMATOL, V20, P1004, DOI 10.1111/j.1600-0625.2011.01391.x; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tossi A, 2000, BIOPOLYMERS, V55, P4; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wiedermann CJ, 2006, CRIT CARE MED, V34, P285, DOI 10.1097/01.CCM.0000194731.08896.99; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	53	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102577	10.1371/journal.pone.0102577	http://dx.doi.org/10.1371/journal.pone.0102577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047075	Green Published, gold			2022-12-27	WOS:000339558100047
J	Mostocotto, C; Carbone, M; Battistelli, C; Ciotti, A; Amati, P; Maione, R				Mostocotto, Cassandra; Carbone, Mariarosaria; Battistelli, Cecilia; Ciotti, Agnese; Amati, Paolo; Maione, Rossella			Poly(ADP-Ribosyl)ation Is Required to Modulate Chromatin Changes at c-MYC Promoter during Emergence from Quiescence	PLOS ONE			English	Article							MAP KINASE; HISTONE ACETYLATION; TRANSCRIPTIONAL REGULATION; GENE ACTIVATION; PARP-1; CELLS; PHOSPHOACETYLATION; DIFFERENTIATION; POLYMERASE-1; CASCADES	Poly(ADP-ribosyl)ation is a post-translational modification of various proteins and participates in the regulation of chromatin structure and transcription through complex mechanisms not completely understood. We have previously shown that PARP-1, the major family member of poly(ADP-ribose)polymerases, plays an important role in the cell cycle reactivation of resting cells by regulating the expression of Immediate Early Response Genes, such as c-MYC, c-FOS, JUNB and EGR-1. In the present work we have investigated the molecular mechanisms by which the enzyme induces c-MYC transcription upon serum stimulation of quiescent cells. We show that PARP-1 is constitutively associated in vivo to a c-MYC promoter region recognized as biologically relevant for the transcriptional regulation of the gene. Moreover, we report that serum stimulation causes the prompt accumulation of ADP-ribose polymers on the same region and that this modification is required for chromatin decondensation and for the exchange of negative for positive transcriptional regulators. Finally we provide evidence that the inhibition of PARP activity along with serum stimulation impairs c-MYC induction by preventing the proper accumulation of histone H3 phosphoacetylation, a specific chromatin mark for the activation of Immediate Early Response Genes. These findings not only suggest a novel strategy by which PARP-1 regulates the transcriptional activity of promoters but also provide new information about the complex regulation of c-MYC expression, a critical determinant of the transition from quiescence to proliferation.	[Mostocotto, Cassandra; Carbone, Mariarosaria; Battistelli, Cecilia; Ciotti, Agnese; Amati, Paolo; Maione, Rossella] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Mostocotto, Cassandra; Carbone, Mariarosaria; Battistelli, Cecilia; Ciotti, Agnese; Amati, Paolo; Maione, Rossella] Pasteur Inst Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome	Maione, R (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy.	maione@bce.uniroma1.it	Battistelli, Cecilia/AFD-8694-2022	Battistelli, Cecilia/0000-0002-5611-7377	Italian Ministry of University and Research - Basic research investment fund (MIUR/FIRB) - collaboration Istituto Pasteur-Fondazione Cenci Bolognetti/Institut Pasteur Paris; Tavola Valdese - fondi OPM by way of "Associazione per lo Sviluppo delle Scienze Pasteuriane"; Fondazione Adriano Buzzati-Traverso'; Consorzio Interuniversitario Biotecnologie'	Italian Ministry of University and Research - Basic research investment fund (MIUR/FIRB) - collaboration Istituto Pasteur-Fondazione Cenci Bolognetti/Institut Pasteur Paris; Tavola Valdese - fondi OPM by way of "Associazione per lo Sviluppo delle Scienze Pasteuriane"; Fondazione Adriano Buzzati-Traverso'; Consorzio Interuniversitario Biotecnologie'	This work was supported by grants from Italian Ministry of University and Research - Basic research investment fund (MIUR/FIRB) - collaboration Istituto Pasteur-Fondazione Cenci Bolognetti/Institut Pasteur Paris and from Tavola Valdese - fondi OPM by way of "Associazione per lo Sviluppo delle Scienze Pasteuriane''. CM and MC were supported by fellowships from "Fondazione Adriano Buzzati-Traverso'' and "Consorzio Interuniversitario Biotecnologie'' respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Davie JR, 2010, ADV ENZYME REGUL, V50, P135, DOI 10.1016/j.advenzreg.2009.10.008; Fekete A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042690; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fimia GM, 1998, MOL BIOL CELL, V9, P1449, DOI 10.1091/mbc.9.6.1449; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Hottiger MO, 2011, FEBS LETT, V585, P1595, DOI 10.1016/j.febslet.2011.03.031; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, MOL ASPECTS MED; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; MAJELLO B, 1995, ONCOGENE, V10, P1841; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; O'Donnell A, 2013, EMBO REP, V14, P1084, DOI 10.1038/embor.2013.164; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pullner A, 1996, J BIOL CHEM, V271, P31452, DOI 10.1074/jbc.271.49.31452; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Thomas C, 2013, MOL ASPECTS MED, V34, P1124, DOI 10.1016/j.mam.2013.04.001; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082872; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96	44	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102575	10.1371/journal.pone.0102575	http://dx.doi.org/10.1371/journal.pone.0102575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047032	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100046
J	Bustillo-Zabalbeitia, I; Montessuit, S; Raemy, E; Basanez, G; Terrones, O; Martinou, JC				Bustillo-Zabalbeitia, Itsasne; Montessuit, Sylvie; Raemy, Etienne; Basanez, Gorka; Terrones, Oihana; Martinou, Jean-Claude			Specific Interaction with Cardiolipin Triggers Functional Activation of Dynamin-Related Protein 1	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; MITOCHONDRIAL FISSION; OXIDATIVE-PHOSPHORYLATION; CONFORMATIONAL-CHANGES; MEMBRANE-BINDING; MAMMALIAN-CELLS; DRP1; GTPASE; FUSION; DOMAIN	Dynamin-Related Protein 1 (Drp1), a large GTPase of the dynamin superfamily, is required for mitochondrial fission in healthy and apoptotic cells. Drp1 activation is a complex process that involves translocation from the cytosol to the mitochondrial outer membrane (MOM) and assembly into rings/spirals at the MOM, leading to membrane constriction/division. Similar to dynamins, Drp1 contains GTPase (G), bundle signaling element (BSE) and stalk domains. However, instead of the lipid-interacting Pleckstrin Homology (PH) domain present in the dynamins, Drp1 contains the so-called B insert or variable domain that has been suggested to play an important role in Drp1 regulation. Different proteins have been implicated in Drp1 recruitment to the MOM, although how MOM-localized Drp1 acquires its fully functional status remains poorly understood. We found that Drp1 can interact with pure lipid bilayers enriched in the mitochondrion-specific phospholipid cardiolipin (CL). Building on our previous study, we now explore the specificity and functional consequences of this interaction. We show that a four lysine module located within the B insert of Drp1 interacts preferentially with CL over other anionic lipids. This interaction dramatically enhances Drp1 oligomerization and assembly-stimulated GTP hydrolysis. Our results add significantly to a growing body of evidence indicating that CL is an important regulator of many essential mitochondrial functions.	[Bustillo-Zabalbeitia, Itsasne; Basanez, Gorka; Terrones, Oihana] Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain; [Bustillo-Zabalbeitia, Itsasne; Basanez, Gorka; Terrones, Oihana] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Montessuit, Sylvie; Raemy, Etienne; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; University of Geneva	Terrones, O (corresponding author), Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain.	oihana.terrones@ehu.es; Jean-Claude.Martinou@unige.ch	Terrones, Oihana/AAA-8903-2019; Basanez, Gorka/L-9509-2014; Terrones, Oihana/I-4023-2015	Basanez, Gorka/0000-0002-7475-7861; martinou, Jean-claude/0000-0002-9847-2051; Terrones, Oihana/0000-0001-7421-6486	Swiss National Science Foundation [31993A-141068/1]; IGE3; State of Geneva; Spanish Ministerio de Ciencia e Innovacion [BFU2011-28566]; Basque Government [IT838-13]; FEBS Short-Term fellowship; Basque Government	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); IGE3; State of Geneva; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Basque Government(Basque Government); FEBS Short-Term fellowship; Basque Government(Basque Government)	This work was funded by the Swiss National Science Foundation (31993A-141068/1), IGE3 and the State of Geneva (J.-C.M.), the Spanish Ministerio de Ciencia e Innovacion grant BFU2011-28566 and the Basque Government grant IT838-13 (G.B., O.T.). O.T. was supported by a postdoctoral Juan de la Cierva fellow, Spanish Government, and by a FEBS Short-Term fellowship. I.B.-Z. was supported by a predoctoral fellowship from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bui HT, 2012, J CELL BIOL, V199, P613, DOI 10.1083/jcb.201207079; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cocklin S, 2006, J MOL RECOGNIT, V19, P354, DOI 10.1002/jmr.784; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Guo C, 2013, EMBO J; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onoue K, 2012, J CELL SCI; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinibaldi F, 2013, BIOCHEMISTRY; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	72	107	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102738	10.1371/journal.pone.0102738	http://dx.doi.org/10.1371/journal.pone.0102738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036098	gold, Green Published			2022-12-27	WOS:000339615200081
J	Mubarqui, RL; Perez, RC; Kladt, RA; Lopez, JLZ; Parker, A; Seck, MT; Sall, B; Bouyer, J				Mubarqui, Ruben Leal; Perez, Rene Cano; Kladt, Roberto Angulo; Lopez, Jose Luis Zavala; Parker, Andrew; Seck, Momar Talla; Sall, Baba; Bouyer, Jeremy			The Smart Aerial Release Machine, a Universal System for Applying the Sterile Insect Technique	PLOS ONE			English	Article							TSETSE-FLIES; PALPALIS-GAMBIENSIS; MATING PERFORMANCE; DIPTERA; GLOSSINIDAE; ZANZIBAR; SENEGAL; MODELS; UNGUJA; ISLAND	Background: Beyond insecticides, alternative methods to control insect pests for agriculture and vectors of diseases are needed. Management strategies involving the mass-release of living control agents have been developed, including genetic control with sterile insects and biological control with parasitoids, for which aerial release of insects is often required. Aerial release in genetic control programmes often involves the use of chilled sterile insects, which can improve dispersal, survival and competitiveness of sterile males. Currently available means of aerially releasing chilled fruit flies are however insufficiently precise to ensure homogeneous distribution at low release rates and no device is available for tsetse. Methodology/Principal Findings: Here we present the smart aerial release machine, a new design by the Mubarqui Company, based on the use of vibrating conveyors. The machine is controlled through Bluetooth by a tablet with Android Operating System including a completely automatic guidance and navigation system (MaxNav software). The tablet is also connected to an online relational database facilitating the preparation of flight schedules and automatic storage of flight reports. The new machine was compared with a conveyor release machine in Mexico using two fruit flies species (Anastrepha ludens and Ceratitis capitata) and we obtained better dispersal homogeneity (% of positive traps, p<0.001) for both species and better recapture rates for Anastrepha ludens (p<0.001), especially at low release densities (<1500 per ha). We also demonstrated that the machine can replace paper boxes for aerial release of tsetse in Senegal. Conclusions/Significance: This technology limits damages to insects and allows a large range of release rates from 10 flies/km(2) for tsetse flies up to 600 000 flies/km(2) for fruit flies. The potential of this machine to release other species like mosquitoes is discussed. Plans and operating of the machine are provided to allow its use worldwide.	[Mubarqui, Ruben Leal; Perez, Rene Cano; Kladt, Roberto Angulo] Serv Aereos Biol & Forest Mubarqui, Cuidad Victoria, Mexico; [Lopez, Jose Luis Zavala] Programa Moscamed, Tapachula, Mexico; [Parker, Andrew] Int Atom Energy Agcy FAO IAEA, Joint Food & Agr Org, Insect Pest Control Lab, Programme Nucl Tech Food & Agr, Vienna, Austria; [Seck, Momar Talla; Bouyer, Jeremy] Inst Senegalais Rech Agricoles, Lab Natl Elevage & Rech Vet, Dakar, Hann, Senegal; [Sall, Baba] Direct Serv Vet, Dakar, Senegal; [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Bouyer, Jeremy] INRA, Unite Mixte Rech 1309, Montpellier, France	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; CIRAD; INRAE	Bouyer, J (corresponding author), Inst Senegalais Rech Agricoles, Lab Natl Elevage & Rech Vet, Dakar, Hann, Senegal.	bouyer@cirad.fr	Bouyer, Jérémy/AAK-7370-2020	Bouyer, Jérémy/0000-0002-1913-416X; Parker, Andrew Gordon/0000-0001-8187-1278	Mubarqui Company; International Atomic Energy Agency	Mubarqui Company; International Atomic Energy Agency(International Atomic Energy Agency)	The work was funded by the Mubarqui Company and the International Atomic Energy Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Arredondo J, 2013, EFECTO TIEMPO HIPOXI; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Bates D., 2011, LME4 LINEAR MIXED EE; BAUER B, 1984, REV ELEVAGE MED VET, V37, P9; Bjelis M, 2011, J APPL ENTOMOL, V137, P154; Bouyer J, 2008, MED VET ENTOMOL, V22, P140, DOI 10.1111/j.1365-2915.2008.00727.x; Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002; Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Day MF, 2012, INSECT PATHOLOGY ADV, V1, P29; Dicko AH, 2014, P NATL ACAD IN PRESS; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Enkerlin W., 2007, GUIDANCE PACKING SHI; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gutierrez Ruelas JM, 2012, SITUACION ACTUAL MOS; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leal Mubarqui R, 2005, MANUAL OPERACION MET; Liedo P, 2007, FLA ENTOMOL, V90, P33, DOI 10.1653/0015-4040(2007)90[33:IMPOMS]2.0.CO;2; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Mutika GN, 2013, ENTOMOL EXP APPL, V146, P177, DOI 10.1111/j.1570-7458.2012.01305.x; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491; RULL J, 1996, FRUIT FLY PESTS WORL, P561; SCHWARZ AJ, 1985, FLA ENTOMOL, V68, P467, DOI 10.2307/3495135; Tan LT, 2011, J APPL ENTOMOL, P126; Tween G., 2007, P229, DOI 10.1007/978-1-4020-6059-5_21; Villasenor A, 2000, CURRENT PROGR MEDFLY, P361; Vreysen M. J. B., 2007, AREA WIDE CONTROL IN; Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857; Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026; Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Zavala JL, 2014, 9 INT S FRUIT FLIES	37	30	30	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103077	10.1371/journal.pone.0103077	http://dx.doi.org/10.1371/journal.pone.0103077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036274	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200110
J	Quan, CQ; Wang, M; Ren, FJ				Quan, Changqin; Wang, Meng; Ren, Fuji			An Unsupervised Text Mining Method for Relation Extraction from Biomedical Literature	PLOS ONE			English	Article							INFORMATION; PROTEINS	The wealth of interaction information provided in biomedical articles motivated the implementation of text mining approaches to automatically extract biomedical relations. This paper presents an unsupervised method based on pattern clustering and sentence parsing to deal with biomedical relation extraction. Pattern clustering algorithm is based on Polynomial Kernel method, which identifies interaction words from unlabeled data; these interaction words are then used in relation extraction between entity pairs. Dependency parsing and phrase structure parsing are combined for relation extraction. Based on the semi-supervised KNN algorithm, we extend the proposed unsupervised approach to a semi-supervised approach by combining pattern clustering, dependency parsing and phrase structure parsing rules. We evaluated the approaches on two different tasks: (1) Protein-protein interactions extraction, and (2) Gene-suicide association extraction. The evaluation of task (1) on the benchmark dataset (AImed corpus) showed that our proposed unsupervised approach outperformed three supervised methods. The three supervised methods are rule based, SVM based, and Kernel based separately. The proposed semi-supervised approach is superior to the existing semi-supervised methods. The evaluation on gene-suicide association extraction on a smaller dataset from Genetic Association Database and a larger dataset from publicly available PubMed showed that the proposed unsupervised and semi-supervised methods achieved much higher F-scores than co-occurrence based method.	[Quan, Changqin; Wang, Meng; Ren, Fuji] Hefei Univ Technol, Sch Comp & Informat, AnHui Prov Key Lab Affect Comp & Adv Intelligent, Hefei, Peoples R China; [Ren, Fuji] Univ Tokushima, Fac Engn, Tokushima 770, Japan	Hefei University of Technology; Tokushima University	Quan, CQ (corresponding author), Hefei Univ Technol, Sch Comp & Informat, AnHui Prov Key Lab Affect Comp & Adv Intelligent, Hefei, Peoples R China.	quanchqin@gmail.com	quan, changqin/GLR-1730-2022		National High-Tech Research & Development Program of China 863 Program [2012AA011103]; National Program on Key Basic Research Project of China 973 Program [2014CB347600]; National Natural Science Foundation of China [61203312]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [1206c0805039]; Key Science, Technology Program of Anhui Province [1206c0805039]; Ministry of Education, Science, Sports and Culture, Japan; Program for New Century Excellent Talents in University [NCET-12-0836]; Open Project Program of the National Laboratory of Pattern Recognition (NLPR);  [22240021]	National High-Tech Research & Development Program of China 863 Program(National High Technology Research and Development Program of China); National Program on Key Basic Research Project of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Key Science, Technology Program of Anhui Province; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Open Project Program of the National Laboratory of Pattern Recognition (NLPR); 	This research has been partially supported by the National High-Tech Research & Development Program of China 863 Program under Grant No. 2012AA011103, National Program on Key Basic Research Project of China 973 Program under Grant No. 2014CB347600, National Natural Science Foundation of China under Grant No. 61203312, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and Key Science, Technology Program of Anhui Province under Grant No. 1206c0805039, and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (A), 22240021, the Program for New Century Excellent Talents in University under grant NCET-12-0836, and the Open Project Program of the National Laboratory of Pattern Recognition (NLPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonseca E., 2012, P 50 ANN M ASS COMP, P54; Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Banko M, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2670; Bie T, 2004, KERNEL METHODS EXPLO, V3138, P16; Bollegala Danushka, 2010, P 19 INT C WORLD WID, p151 , DOI DOI 10.1145/1772690.1772707; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Chen ES, 2008, J AM MED INFORM ASSN, V15, P87, DOI 10.1197/jamia.M2401; Costanza A, 2014, INT J LEGAL MED, V128, P73, DOI 10.1007/s00414-013-0835-6; Erkan G., 2007, P 2007 JOINT C EMP M, P228; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Kerrien S, 2002, NUCLEIC ACIDS RES, V40, P841; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Mitsumori T, 2006, IEICE T INF SYST, VE89D, P2464, DOI 10.1093/ietisy/e89-d.8.2464; Miwa M, 2009, INT J MED INFORM, V78, pE39, DOI 10.1016/j.ijmedinf.2009.04.010; Miyao Y, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P1017; Mooney RJ, 2006, ADV NEURAL INFORM PR, P171; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Qiu GA, 2011, COMPUT LINGUIST, V37, P9, DOI 10.1162/coli_a_00034; Rinaldi F, 2007, ARTIF INTELL MED, V39, P127, DOI 10.1016/j.artmed.2006.08.005; Rink B, 2011, J AM MED INFORM ASSN, V18, P594, DOI 10.1136/amiajnl-2011-000153; Roberts A., 2008, PROC WORKSHOP CURREN, P10, DOI DOI 10.3115/1572306.1572309; Sekine S, 2006, P COLING ACL MAIN C, P731; Titov Ivan, 2011, P 49 ANN M ASS COMP, P1445; Yakushiji A., 2005, P 11 ANN M ASS NAT L, P93; Yao Limin, 2011, P EMNLP; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	31	42	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102039	10.1371/journal.pone.0102039	http://dx.doi.org/10.1371/journal.pone.0102039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036529	Green Published, gold			2022-12-27	WOS:000339615200035
J	Roe, K; Orillo, B; Verma, S				Roe, Kelsey; Orillo, Beverly; Verma, Saguna			West Nile Virus-Induced Cell Adhesion Molecules on Human Brain Microvascular Endothelial Cells Regulate Leukocyte Adhesion and Modulate Permeability of the In Vitro Blood-Brain Barrier Model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; T-CELLS; INFECTION; EXPRESSION; MIGRATION; ICAM-1; TRANSMIGRATION; MONOCYTES; VCAM-1; ENTRY	Characterizing the mechanisms by which West Nile virus (WNV) causes blood-brain barrier (BBB) disruption, leukocyte infiltration into the brain and neuroinflammation is important to understand the pathogenesis of WNV encephalitis. Here, we examined the role of endothelial cell adhesion molecules (CAMs) in mediating the adhesion and transendothelial migration of leukocytes across human brain microvascular endothelial cells (HBMVE). Infection with WNV (NY99 strain) significantly induced ICAM-1, VCAM-1, and E-selectin in human endothelial cells and infected mice brain, although the levels of their ligands on leukocytes (VLA-4, LFA-1 and MAC-1) did not alter. The permeability of the in vitro BBB model increased dramatically following the transmigration of monocytes and lymphocytes across the models infected with WNV, which was reversed in the presence of a cocktail of blocking antibodies against ICAM-1, VCAM-1, and E-selectin. Further, WNV infection of HBMVE significantly increased leukocyte adhesion to the HBMVE monolayer and transmigration across the infected BBB model. The blockade of these CAMs reduced the adhesion and transmigration of leukocytes across the infected BBB model. Further, comparison of infection with highly neuroinvasive NY99 and non-lethal (Eg101) strain of WNV demonstrated similar level of virus replication and fold-increase of CAMs in HBMVE cells suggesting that the non-neuropathogenic response of Eg101 is not because of its inability to infect HBMVE cells. Collectively, these results suggest that increased expression of specific CAMs is a pathological event associated with WNV infection and may contribute to leukocyte infiltration and BBB disruption in vivo. Our data further implicate that strategies to block CAMs to reduce BBB disruption may limit neuroinflammation and virus-CNS entry via 'Trojan horse' route, and improve WNV disease outcome.	[Roe, Kelsey; Orillo, Beverly; Verma, Saguna] Univ Hawaii, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA	University of Hawaii System	Verma, S (corresponding author), Univ Hawaii, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	saguna@hawaii.edu			Centers of Biomedical Research Excellence [P20RR018727]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018727] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by grants from the Centers of Biomedical Research Excellence (P20RR018727) and institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Avolio C, 2003, BRAIN RES BULL, V61, P357, DOI 10.1016/S0361-9230(03)00098-4; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dobbie MS, 1999, BRAIN RES, V830, P330, DOI 10.1016/S0006-8993(99)01436-5; Eugenin EA, 2006, J LEUKOCYTE BIOL, V79, P444, DOI 10.1189/jlb.0405215; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Giri R, 2002, AM J PHYSIOL-CELL PH, V283, pC895, DOI 10.1152/ajpcell.00293.2001; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12; Hussmann KL, 2014, J GEN VIROL; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Kanwar JR, 2000, IMMUNOL CELL BIOL, V78, P641, DOI 10.1046/j.1440-1711.2000.00947.x; Kim YC, 2000, J DERMATOL SCI, V24, P38, DOI 10.1016/S0923-1811(00)00080-3; King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012; Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Mestre L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-102; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Schafer A, 2011, J VIROL, V85, P10682, DOI 10.1128/JVI.05032-11; Scherbik SV, 2007, J VIROL, V81, P12005, DOI 10.1128/JVI.01359-07; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Shen J, 1997, J VIROL, V71, P9323, DOI 10.1128/JVI.71.12.9323-9332.1997; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, J VIROL, V82, P8956, DOI 10.1128/JVI.01118-08; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Verma S, 2010, VIROLOGY, V397, P130, DOI 10.1016/j.virol.2009.10.036; Verma S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-66; Wang SH, 2008, J IMMUNOL, V181, P2084, DOI 10.4049/jimmunol.181.3.2084; Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298; Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003; Wu DT, 2000, J NEUROVIROL, V6, pS82	49	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102598	10.1371/journal.pone.0102598	http://dx.doi.org/10.1371/journal.pone.0102598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036379	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200076
J	Singh, VK; Barman, C; Tandon, R				Singh, Vineet Kumar; Barman, Chandan; Tandon, Rajesh			Nectar Robbing Positively Influences the Reproductive Success of Tecomella undulata (Bignoniaceae)	PLOS ONE			English	Article							PLANT REPRODUCTION; POLLEN LIMITATION; POLLINATION; ROBBERS; BIOLOGY; FRUIT; CONSEQUENCES; BEHAVIOR; CHEATERS; FLOWERS	The net consequence of nectar robbing on reproductive success of plants is usually negative and the positive effect is rarely produced. We evaluated the influence of nectar robbing on the behaviour of pollinators and the reproductive success of Tecomella undulata (Bignoniaceae) in a natural population. Experimental pollinations showed that the trees were strictly self-incompatible. The three types of floral colour morphs of the tree viz. red, orange and yellow, lacked compatibility barriers. The pollinators (Pycnonotus cafer and Pycnonotus leucotis) and the robber (Nectarinia asiatica) showed equal preference for all the morphs, as they visited each morph with nearly equal frequency and flower-handling time. The sunbirds caused up to 60% nectar robbing, mostly (99%) by piercing through the corolla tube. Although nectar is replenished at regular intervals, insufficient amount of nectar compelled the pollinators to visit additional trees in bloom. Data of manual nectar robbing from the entire tree showed that the pollinators covered lower number of flowers per tree (5 flowers/tree) and more trees per bout (7 trees/bout) than the unrobbed ones (19 flowers/tree and 2 trees bout). The robbed trees set a significantly greater amount of fruits than the unrobbed trees. However, the number of seeds in a fruit did not differ significantly. The study shows that plant-pollinator-robber interaction may benefit the self-incompatible plant species under conditions that increases the visits of pollinators among the compatible conspecifics in a population.	[Singh, Vineet Kumar; Barman, Chandan; Tandon, Rajesh] Univ Delhi, Dept Bot, Delhi 110007, India	University of Delhi	Tandon, R (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	rjtnd@rediffmail.com	SINGH, VINEET KUMAR/AAT-9481-2021	Tandon, Rajesh/0000-0003-3318-5956	Ministry of Environment & Forests, Government of India [22/9/2010-RE]	Ministry of Environment & Forests, Government of India	The work was supported by the Ministry of Environment & Forests, Government of India [22/9/2010-RE]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizmendi MC, 1996, FUNCT ECOL, V10, P119, DOI 10.2307/2390270; Bittencourt NS, 2011, FLORA, V206, P872, DOI 10.1016/j.flora.2011.05.004; Bittencourt NS, 2004, PLANT SYST EVOL, V247, P241, DOI 10.1007/s00606-004-0142-2; Bittencourt NS, 2003, ANN BOT-LONDON, V91, P827, DOI 10.1093/aob/mcg088; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burkle LA, 2007, AM J BOT, V94, P1935, DOI 10.3732/ajb.94.12.1935; Castellanos MC, 2002, AM J BOT, V89, P111, DOI 10.3732/ajb.89.1.111; Castro S, 2008, PLANT ECOL, V199, P201, DOI 10.1007/s11258-008-9424-z; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Darwin C., 1872, EFFECTS CROSS SELF F; DEJONG TJ, 1992, OECOLOGIA, V89, P310, DOI 10.1007/BF00317407; Faegri K., 1979, PRINCIPLES POLLINATI; Fumero-Caban JJ, 2013, PLANT SPEC BIOL, V28, P224, DOI 10.1111/j.1442-1984.2012.00388.x; GALEN C, 1983, OIKOS, V41, P245, DOI 10.2307/3544271; Genini J, 2010, BIOL LETTERS, V6, P494, DOI 10.1098/rsbl.2009.1021; Gibbs PE, 1999, ANN BOT-LONDON, V84, P449, DOI 10.1006/anbo.1999.0933; HEINRICH B, 1972, SCIENCE, V176, P597, DOI 10.1126/science.176.4035.597; HERNANDEZ HM, 1979, ANN MO BOT GARD, V66, P512, DOI 10.2307/2398843; HODGES CM, 1985, ECOLOGY, V66, P179, DOI 10.2307/1941318; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2002, OECOLOGIA, V133, P525, DOI 10.1007/s00442-002-1060-z; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Irwin RE, 2001, OECOLOGIA, V129, P161, DOI 10.1007/s004420100739; Irwin RE, 2000, OIKOS, V91, P499, DOI 10.1034/j.1600-0706.2000.910311.x; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; KLINKHAMER PGL, 1993, OIKOS, V66, P180, DOI 10.2307/3545212; KNOX RB, 1989, AUST J BOT, V37, P103, DOI 10.1071/BT9890103; Leonard AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055914; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Milet-Pinheiro P, 2009, PLANT BIOLOGY, V11, P131, DOI 10.1111/j.1438-8677.2008.00118.x; Miller TE, 1996, ECOLOGY, V77, P1329, DOI 10.2307/2265530; Morris WF, 1996, ECOLOGY, V77, P1451, DOI 10.2307/2265542; Morris WF, 2010, ECOLOGY, V91, P1276, DOI 10.1890/08-2278.1; Navarro L, 2000, AM J BOT, V87, P980, DOI 10.2307/2656997; Pandey RP, 1983, ASSESSMENT THREATENE, P55; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Richardson SC, 2004, OECOLOGIA, V139, P246, DOI 10.1007/s00442-004-1504-8; ROUBIK DW, 1982, ECOLOGY, V63, P354, DOI 10.2307/1938953; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; Sharma KC, 2011, INDIAN J FUNDAM APPL, V1, P50; SUGDEN EA, 1986, AM J BOT, V73, P919, DOI 10.2307/2444305; Tandon R, 2003, ANN BOT-LONDON, V92, P715, DOI 10.1093/aob/mcg193; Traveset A, 1998, FUNCT ECOL, V12, P459, DOI 10.1046/j.1365-2435.1998.00212.x; Utelli AB, 2001, OECOLOGIA, V127, P266, DOI 10.1007/s004420000580; Vikas, 2009, J TROP ECOL, V25, P93, DOI 10.1017/S0266467408005634; Wang YS, 2013, J MATH BIOL, V66, P1155, DOI 10.1007/s00285-012-0527-8; Zhu XF, 2010, BIOL LETTERS, V6, P785, DOI 10.1098/rsbl.2010.0345	49	25	26	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102607	10.1371/journal.pone.0102607	http://dx.doi.org/10.1371/journal.pone.0102607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036554	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200077
J	Rietdijk, WJR; Franken, IHA; Thurik, AR				Rietdijk, Wim J. R.; Franken, Ingmar H. A.; Thurik, A. Roy			Internal Consistency of Event-Related Potentials Associated with Cognitive Control: N2/P3 and ERN/Pe	PLOS ONE			English	Article							BRAIN ACTIVITY; RESPONSE-INHIBITION; ERP COMPONENTS; FUNCTIONAL-SIGNIFICANCE; ERROR; RELIABILITY; TASKS; STABILITY; VALIDITY; N2	Recent studies in psychophysiology show an increased attention for examining the reliability of Event-Related Potentials (ERPs), which are measures of cognitive control (e.g., Go/No-Go tasks). An important index of reliability is the internal consistency (e.g., Cronbach's alpha) of a measure. In this study, we examine the internal consistency of the N2 and P3 in a Go/No-Go task. Furthermore, we attempt to replicate the previously found internal consistency of the Error-Related Negativity (ERN) and Positive-Error (Pe) in an Eriksen Flanker task. Healthy participants performed a Go/No-Go task and an Eriksen Flanker task, whereby the amplitudes of the correct No-Go N2/P3, and error trials for ERN/Pe were the variables of interest. This study provides evidence that the N2 and P3 in a Go/No-Go task are internally consistent after 20 and 14 trials are included in the average, respectively. Moreover, the ERN and Pe become internally consistent after approximately 8 trials are included in the average. In addition guidelines and suggestions for future research are discussed.	[Rietdijk, Wim J. R.; Thurik, A. Roy] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [Franken, Ingmar H. A.] Erasmus Univ, Inst Psychol, Rotterdam, Netherlands; [Thurik, A. Roy] Panteia, Zoetermeer, Netherlands; [Thurik, A. Roy] GSCM Montpellier Business Sch, Montpellier, France	Erasmus University Rotterdam; Erasmus University Rotterdam	Rietdijk, WJR (corresponding author), Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands.	rietdijk@ese.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008; Thurik, Roy/A-9386-2012	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Thurik, Roy/0000-0002-0242-6908	Erasmus University	Erasmus University	Funding (4x100 euro) was obtained from the host university of the corresponding author (Erasmus University) to pay the winning participant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi A., 1997, PSYCHOL TESTING; BERNSTEIN PS, 1995, J EXP PSYCHOL HUMAN, V21, P1312, DOI 10.1037/0096-1523.21.6.1312; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Cohen J, 1997, INT J PSYCHOPHYSIOL, V25, P249, DOI 10.1016/S0167-8760(96)00743-X; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Franken IHA, 2000, ADDICT BEHAV, V25, P99, DOI 10.1016/S0306-4603(98)00112-9; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G, 2012, CURR DIR PSYCHOL SCI, V21, P101, DOI 10.1177/0963721412436809; Kiang M, 2013, CLIN NEUROPHYSIOL, V124, P667, DOI 10.1016/j.clinph.2012.09.029; Littel M, 2012, ADDICT BIOL, V17, P934, DOI 10.1111/j.1369-1600.2012.00467.x; Luijten M, 2013, J PSYCH NEUROSCI, V38; Luijten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018898; Maguire MJ, 2011, BRAIN COGNITION, V76, P77, DOI 10.1016/j.bandc.2011.02.015; Maguire MJ, 2009, BRAIN COGNITION, V71, P196, DOI 10.1016/j.bandc.2009.08.018; Marhe R, 2013, BIOL PSYCHIAT, V73, P782, DOI 10.1016/j.biopsych.2012.12.016; Meyer A, 2014, PSYCHOPHYSI IN PRESS; Meyer A, 2013, PSYCHOPHYSIOLOGY, V50, P1220, DOI 10.1111/psyp.12132; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pontifex MB, 2010, PSYCHOPHYSIOLOGY, V47, P767, DOI 10.1111/j.1469-8986.2010.00974.x; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Wostmann NM, 2013, BRAIN COGNITION, V81, P82, DOI 10.1016/j.bandc.2012.09.010; Yudkowsky R., 2019, ASSESSMENT HLTH PROF	31	76	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102672	10.1371/journal.pone.0102672	http://dx.doi.org/10.1371/journal.pone.0102672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033272	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300076
J	Uthirajoo, E; Ramiah, H; Kanesan, J; Reza, AW				Uthirajoo, Eswaran; Ramiah, Harikrishnan; Kanesan, Jeevan; Reza, Ahmed Wasif			Wideband LTE Power Amplifier with Integrated Novel Analog Pre-Distorter Linearizer for Mobile Wireless Communications	PLOS ONE			English	Article							PREDISTORTION; DESIGN; GAIN	For the first time, a new circuit to extend the linear operation bandwidth of a LTE (Long Term Evolution) power amplifier, while delivering a high efficiency is implemented in less than 1 mm(2) chip area. The 950 mu m x 900 mu m monolithic microwave integrated circuit (MMIC) power amplifier (PA) is fabricated in a 2 mm InGaP/GaAs process. An on-chip analog pre-distorter (APD) is designed to improve the linearity of the PA, up to 20 MHz channel bandwidth. Intended for 1.95 GHz Band 1 LTE application, the PA satisfies adjacent channel leakage ratio (ACLR) and error vector magnitude (EVM) specifications for a wide LTE channel bandwidth of 20 MHz at a linear output power of 28 dBm with corresponding power added efficiency (PAE) of 52.3%. With a respective input and output return loss of 30 dB and 14 dB, the PA's power gain is measured to be 32.5 dB while exhibiting an unconditional stability characteristic from DC up to 5 GHz. The proposed APD technique serves to be a good solution to improve linearity of a PA without sacrificing other critical performance metrics.	[Uthirajoo, Eswaran; Ramiah, Harikrishnan; Kanesan, Jeevan; Reza, Ahmed Wasif] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Ramiah, H (corresponding author), Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia.	hrkhari@um.edu.my	RAMIAH, HARIKRISHNAN/B-8594-2010; KANESAN, JEEVAN/B-8707-2010; Reza, Ahmed Wasif/ABE-5779-2020	KANESAN, JEEVAN/0000-0001-9949-3105; Ramiah, Harikrishnan/0000-0003-3505-6525	UM High Impact Research Grant from the Ministry of Higher Education Malaysia [UM.C/HIR/MOHE/ENG/51]	UM High Impact Research Grant from the Ministry of Higher Education Malaysia	This research is supported by the UM High Impact Research Grant UM.C/HIR/MOHE/ENG/51 from the Ministry of Higher Education Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter R, 2010, IETE TECH REV, V27, P493, DOI 10.4103/0256-4602.67150; Carvalho N, 1999, MICROWAVE J; Cha J, 2004, IEEE T MICROW THEORY, V52, P655, DOI 10.1109/TMTT.2003.822030; Cho KJ, 2004, IEEE MICROW WIREL CO, V14, P153, DOI 10.1109/LMWC.2004.827117; Choi J, 2011, IEEE T MICROW THEORY, V59, P1796, DOI 10.1109/TMTT.2011.2134108; Chung S, 2008, IEEE T MICROW THEORY, V56, P2248, DOI 10.1109/TMTT.2008.2003139; Cripps S, 2012, HDB RF MICROWAVE POW; DAndrea AN, 1996, IEEE T COMMUN, V44, P1477, DOI 10.1109/26.544464; Eswaran U, 2013, TURKISH J E IN PRESS; Farhadi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048903; Francois B, 2002, IEEE T MICROW THEORY, V50, P1714; Gray P. R., 2009, ANAL DESIGN ANALOG I; Hammi O, 2007, INT MIDW S CIRC SYST, P1201; Hassan M, 2012, IEEE T MICROW THEORY, V60, P1321, DOI 10.1109/TMTT.2012.2187537; Hau G, 2001, IEEE T MICROW THEORY, V49, P1194, DOI 10.1109/22.925522; Jianbao Deng, 2011, Proceedings of the 2011 IEEE 9th International Conference on ASIC (ASICON 2011), P808, DOI 10.1109/ASICON.2011.6157328; Katz A, 2001, IEEE MICROW MAG, V2, P37, DOI 10.1109/6668.969934; Kim B, 2011, IEEE T CIRCUITS-II, V58, P857, DOI 10.1109/TCSII.2011.2172528; Kim W, 2002, IEEE T MICROW THEORY, V50, P1714, DOI 10.1109/TMTT.2002.800396; Landin PN, 2012, IEEE T MICROW THEORY, V60, P1907, DOI 10.1109/TMTT.2012.2187532; Lee C, 2012, J ELECTROMAGNET WAVE, V26, P633, DOI 10.1080/09205071.2012.710783; Lee MW, 2010, J ELECTROMAGNET WAVE, V24, P2537, DOI 10.1163/156939310793675619; Li Y, 2011, IEEE T MICROW THEORY, V59, P2525, DOI 10.1109/TMTT.2011.2164550; Park HM, 2000, IEEE T MICROW THEORY, V48, P898, DOI 10.1109/22.846715; Rana M. M., 2010, Proceedings of the Second International Conference on Communication Software and Networks (ICCSN 2010), P516, DOI 10.1109/ICCSN.2010.53; Rumney M., 2009, LTE EVOLUTION 4G WIR; Sang L, 2012, J ELECTROMAGNET WAVE, V26, P284, DOI 10.1163/156939312800030820; Tuffery A., 2011, 2011 IEEE 9th International New Circuits and Systems Conference (NEWCAS 2011), P221, DOI 10.1109/NEWCAS.2011.5981295; Wong SK, 2012, J ELECTROMAGNET WAVE, V26, P512, DOI 10.1163/156939312800030659; Yamanouchi S, 2007, IEEE T MICROW THEORY, V55, P493, DOI 10.1109/TMTT.2006.890515	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101862	10.1371/journal.pone.0101862	http://dx.doi.org/10.1371/journal.pone.0101862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033049	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300026
J	Kumar, A; Harrelson, T; Lewis, NE; Gallagher, EJ; LeRoith, D; Shiloach, J; Betenbaugh, MJ				Kumar, Amit; Harrelson, Thomas; Lewis, Nathan E.; Gallagher, Emily J.; LeRoith, Derek; Shiloach, Joseph; Betenbaugh, Michael J.			Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice	PLOS ONE			English	Article							PROTEIN REFERENCE DATABASE; SUBUNIT-RELATED PROTEIN; HUMAN SKELETAL-MUSCLE; HUMAN METABOLIC NETWORK; FATTY-ACID-METABOLISM; INSULIN-RESISTANCE; MOLECULAR-CLONING; MENDELIAN-INHERITANCE; PANCREATIC-ISLET; SYSTEMS BIOLOGY	Computational models using metabolic reconstructions for in silico simulation of metabolic disorders such as type 2 diabetes mellitus (T2DM) can provide a better understanding of disease pathophysiology and avoid high experimentation costs. There is a limited amount of computational work, using metabolic reconstructions, performed in this field for the better understanding of T2DM. In this study, a new algorithm for generating tissue-specific metabolic models is presented, along with the resulting multi-confidence level (MCL) multi-tissue model. The effect of T2DM on liver, muscle, and fat in MKR mice was first studied by microarray analysis and subsequently the changes in gene expression of frank T2DM MKR mice versus healthy mice were applied to the multi-tissue model to test the effect. Using the first multi-tissue genome-scale model of all metabolic pathways in T2DM, we found out that branched-chain amino acids' degradation and fatty acids oxidation pathway is downregulated in T2DM MKR mice. Microarray data showed low expression of genes in MKR mice versus healthy mice in the degradation of branched-chain amino acids and fatty-acid oxidation pathways. In addition, the flux balance analysis using the MCL multi-tissue model showed that the degradation pathways of branched-chain amino acid and fatty acid oxidation were significantly downregulated in MKR mice versus healthy mice. Validation of the model was performed using data derived from the literature regarding T2DM. Microarray data was used in conjunction with the model to predict fluxes of various other metabolic pathways in the T2DM mouse model and alterations in a number of pathways were detected. The Type 2 Diabetes MCL multi-tissue model may explain the high level of branched-chain amino acids and free fatty acids in plasma of Type 2 Diabetic subjects from a metabolic fluxes perspective.	[Kumar, Amit; Harrelson, Thomas; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Kumar, Amit; Shiloach, Joseph] NIDDK, Biotechnol Core Lab, Biotechnol Core Lab, Bethesda, MD 20892 USA; [Lewis, Nathan E.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Gallagher, Emily J.; LeRoith, Derek] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Gallagher, Emily J.; LeRoith, Derek] Icahn Sch Med Mt Sinai, Metab Inst, New York, NY 10029 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Brigham Young University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Betenbaugh, MJ (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	beten@jhu.edu	Lewis, Nathan/ABE-7290-2020	Lewis, Nathan/0000-0001-7700-3654; Harrelson, Thomas/0000-0002-8689-4273; Kumar, Amit/0000-0003-2140-5130	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075080, P30DK079637] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for the study was provided by the Intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Barbosa M, 2012, CLIN GENET, V81, P47, DOI 10.1111/j.1399-0004.2011.01638.x; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Bliksrud YT, 2005, J MOL MED-JMM, V83, P406, DOI 10.1007/s00109-005-0648-2; Boden G, 1999, P ASSOC AM PHYSICIAN, V111, P241, DOI 10.1046/j.1525-1381.1999.99220.x; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-110; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Cha BS, 2005, AM J PHYSIOL-ENDOC M, V289, pE151, DOI 10.1152/ajpendo.00141.2004; Champe PC., 2005, BIOCHEMISTRY-US; Chuang D. T., 2001, METABOLIC MOL BASES; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Deng YF, 2002, DNA SEQUENCE, V13, P301, DOI 10.1080/1042517021000011636; Devlin T. M., 2002, TXB BIOCH CLIN CORRE; Dianzani I, 1998, HUM MUTAT, V12, P267, DOI 10.1002/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.3.CO;2-0; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; ETO K, 1994, BIOCHEM BIOPH RES CO, V198, P990, DOI 10.1006/bbrc.1994.1141; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Ferrer J, 1996, DIABETES, V45, P262, DOI 10.2337/diabetes.45.2.262; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Halvatsiotis PG, 2002, DIABETES NUTR METAB, V15, P136; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hamosh A, 2001, METABOLIC MOL BASES; Han D, 2011, J PROTEOME RES, V10, P564, DOI 10.1021/pr100759a; Harvey JW, 2005, VET CLIN PATH, V34, P248, DOI 10.1111/j.1939-165X.2005.tb00049.x; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Hilton JE, 2003, HUM MUTAT, V22, P67, DOI 10.1002/humu.10236; Hojlund K, 2008, MOL CELL PROTEOMICS, V7, P257, DOI 10.1074/mcp.M700304-MCP200; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; ISHIKAWA M, 1987, Acta Paediatrica Japonica, V29, P224; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Jones JG, 1998, AM J PHYSIOL-ENDOC M, V275, pE843, DOI 10.1152/ajpendo.1998.275.5.E843; Keating SM, 2006, BIOINFORMATICS, V22, P1275, DOI 10.1093/bioinformatics/btl111; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; LEDLEY FD, 1990, BIOESSAYS, V12, P335, DOI 10.1002/bies.950120706; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li XR, 2004, BIOCHEM BIOPH RES CO, V320, P625, DOI 10.1016/j.bbrc.2004.05.205; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Marks DB, 1996, BASIC MED BIOCH CLIN; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; MILLAN JL, 1987, P NATL ACAD SCI USA, V84, P5311, DOI 10.1073/pnas.84.15.5311; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Modaressi S, 1996, BIOCHEM J, V315, P807, DOI 10.1042/bj3150807; Mudd SH, 2003, J INHERIT METAB DIS, V26, P443, DOI 10.1023/A:1025121326959; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nordlie RC, 1985, ENZYMES BIOL MEMBRAN; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Ohgami M, 2003, BIOCHEM PHARMACOL, V65, P989, DOI 10.1016/S0006-2952(02)01656-8; Orten JM, 1975, HUMAN BIOCH; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Phang J. M., 2001, METABOLIC MOL BASES; PISTERS PWT, 1991, METABOLISM, V40, P59, DOI 10.1016/0026-0495(91)90193-Z; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qiu LH, 2005, MOL CELL PROTEOMICS, V4, P1311, DOI 10.1074/mcp.M500016-MCP200; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; REISH O, 1995, AM J HUM GENET, V57, P127; Saltiel AR, 2000, J CLIN INVEST, V106, P163, DOI 10.1172/JCI10533; Salway J.G., 2017, METABOLISM GLANCE; Sanchez JC, 2002, MOL CELL PROTEOMICS, V1, P509, DOI 10.1074/mcp.M200033-MCP200; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; SCHOLTE HR, 1971, BIOCHIM BIOPHYS ACTA, V231, P479, DOI 10.1016/0005-2760(71)90115-9; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200; Shlomi T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.22; Skovbro M, 2008, DIABETOLOGIA, V51, P1253, DOI 10.1007/s00125-008-1014-z; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Tillmann H, 1998, GENE, V212, P295, DOI 10.1016/S0378-1119(98)00181-4; Tomoeda K, 2000, MOL GENET METAB, V71, P506, DOI 10.1006/mgme.2000.3085; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang YL, 2012, BMC SYST BIOL, V6, DOI [10.1186/1752-0509-6-153, 10.1186/1752-0509-6-S3-S21]; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	111	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102319	10.1371/journal.pone.0102319	http://dx.doi.org/10.1371/journal.pone.0102319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029527	gold, Green Published, Green Submitted			2022-12-27	WOS:000341306600062
J	Tian, Y; Wang, JR; Ye, Y; Sun, LQ; Fan, YR; Wang, L; Li, J; Wang, ZX; Wang, KM				Tian, Yun; Wang, Jirong; Ye, Ying; Sun, Liqun; Fan, Yingrui; Wang, Li; Li, Juan; Wang, Zhaoxia; Wang, Keming			Apolipoprotein E Polymorphism and Colorectal Neoplasm: Results from a Meta-Analysis	PLOS ONE			English	Article							CHOLESTEROL TRANSPORT PROTEIN; TRIGLYCERIDE-RICH PARTICLES; AMINO-ACID-SEQUENCE; E GENOTYPE; E PHENOTYPE; METABOLIC GENOTYPES; LIPID-METABOLISM; BREAST-CANCER; RECTAL-CANCER; SERUM-LIPIDS	To investigate the relationship of Apolipoprotein E (APOE) gene polymorphism to colorectal neoplasia (CRN), we performed a systematic review and meta-analysis. Eligible studies were identified through a systematic literature review from PubMed, EMBASE, and the Science Citation Index up to February 2014. A combined analysis was performed, followed by a subgroup analyses stratified by the study design. We used data collected from 8 prospective studies involving respectively a total of 9243 participants and 4310 CRN cases which including 438 patients with colorectal adenoma (CRA), and 3873 patients with colorectal carcinoma (CRC). The pooled data from this meta-analysis indicated there was no significant association between APOE polymorphism and CRN (epsilon 2: P = 0.51, OR 1.04 95% CI 0.93 to 1.16; epsilon 4: P = 0.72, OR 0.98 95% CI 0.90 to 1.07). Interestingly, subgroup analysis demonstrated there was a significant decreased risk for proximal CRN in patients with APOE epsilon 4 (P = 0.0007, OR 0.52 95% CI 0.35 to 0.76). Data showed no significant association between APOE genotype and overall CRN. However, compared with those carry APOE epsilon 3 alleles, persons with APOE epsilon 4 genotype have significant decreased risk suffering from proximal CRN but not from distal CRN.	[Tian, Yun; Wang, Jirong; Fan, Yingrui; Wang, Li; Li, Juan; Wang, Zhaoxia; Wang, Keming] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Ye, Ying] Xuzhou Med Coll, Emergency Ctr, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China; [Sun, Liqun] Nanjing Med Univ, Dept Intens Care Unit, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University	Wang, KM (corresponding author), Nanjing Med Univ, Dept Oncol, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China.	drkemingwang@sina.cn			National Natural Science Foundation of China [81200263, 81302110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by the National Natural Science Foundation of China (Grant 81200263 and 81302110). The funders had no role in study design, decision to publish, or preparation of the manuscript.	Anderson WF, 2002, JNCI-J NATL CANCER I, V94, P1126; BAYERDORFFER E, 1995, GUT, V36, P268, DOI 10.1136/gut.36.2.268; BAYERDORFFER E, 1993, GASTROENTEROLOGY, V104, P145, DOI 10.1016/0016-5085(93)90846-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Butler WJ, 2001, J GASTROEN HEPATOL, V16, P631, DOI 10.1046/j.1440-1746.2001.02501.x; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Chang SJ, 2006, BREAST CANCER RES TR, V98, P109, DOI 10.1007/s10549-005-9137-0; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Davidson NO, 1996, GASTROENTEROLOGY, V110, P2006, DOI 10.1053/gast.1996.v110.agast962006; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ganan A, 2004, HUM BIOL, V76, P253, DOI 10.1353/hub.2004.0031; Grocott HP, 2001, J THORAC CARDIOV SUR, V122, P622, DOI 10.1067/mtc.2001.115152; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILL MJ, 1989, BAILLIERE CLIN GASTR, V3, P567, DOI 10.1016/0950-3528(89)90018-3; Ho YY, 2000, BIOCHEMISTRY-US, V39, P4746, DOI 10.1021/bi992294a; Jofre-Monseny L, 2007, BRIT J NUTR, V97, P864, DOI 10.1017/S0007114507669219; Kervinen K, 1996, GASTROENTEROLOGY, V110, P1785, DOI 10.1053/gast.1996.v110.pm8964404; KESANIEMI YA, 1987, J CLIN INVEST, V80, P578, DOI 10.1172/JCI113107; Khan TA, 2013, INT J EPIDEMIOL, V42, P475, DOI 10.1093/ije/dyt034; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MIETTINEN TA, 1991, ANN MED, V23, P181, DOI 10.3109/07853899109148045; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mrkonjic M, 2009, BRIT J CANCER, V100, P1966, DOI 10.1038/sj.bjc.6605097; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Niemi Mari, 2002, Eur J Intern Med, V13, P37, DOI 10.1016/S0953-6205(01)00191-1; RALL SC, 1982, J BIOL CHEM, V257, P4171; REDDY BS, 1973, J NATL CANCER I, V50, P1437, DOI 10.1093/jnci/50.6.1437; Roberts-Thomson IC, 1999, EUR J CANCER PREV, V8, P207, DOI 10.1097/00008469-199906000-00008; Saadat M, 2012, CANCER RES TREAT, V44, P121, DOI 10.4143/crt.2012.44.2.121; SANDLER RS, 1993, JNCI-J NATL CANCER I, V85, P884, DOI 10.1093/jnci/85.11.884; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; Shin A, 2010, ASIAN PAC J CANCER P, V11, P281; Shinomiya S, 2001, CANCER LETT, V164, P33, DOI 10.1016/S0304-3835(00)00724-2; Slattery ML, 2005, CARCINOGENESIS, V26, P1422, DOI 10.1093/carcin/bgi088; Slattery ML, 2005, NUTR CANCER, V51, P155, DOI 10.1207/s15327914nc5102_5; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Souza DRS, 2009, BRAZ J MED BIOL RES, V42, P397, DOI 10.1590/S0100-879X2009000500001; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Swertfeger DK, 2001, FRONT BIOSCI-LANDMRK, V6, pD526, DOI 10.2741/Swertfeg; UTERMANN G, 1987, AM HEART J, V113, P433, DOI 10.1016/0002-8703(87)90610-7; VOGEL T, 1994, J CELL BIOCHEM, V54, P299, DOI 10.1002/jcb.240540306; Watson MA, 2003, CLIN SCI, V104, P537, DOI 10.1042/CS20020329; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100; Xue P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045849; Zhou ZY, 2006, SAUDI MED J, V27, P161	54	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102477	10.1371/journal.pone.0102477	http://dx.doi.org/10.1371/journal.pone.0102477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029444	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600077
J	Warlich, E; Schambach, A; Lock, D; Wedekind, D; Glage, S; Eckardt, D; Bosio, A; Knobel, S				Warlich, Eva; Schambach, Axel; Lock, Dominik; Wedekind, Dirk; Glage, Silke; Eckardt, Dominik; Bosio, Andreas; Knoebel, Sebastian			FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							SURFACE-MARKERS; SOMATIC-CELLS; IPS CELLS; IN-VITRO; EXPRESSION; TRANSPLANTATION; GENERATION; FIBROBLASTS; DIFFERENTIATION; MAINTENANCE	Cellular reprogramming of somatic cells into induced pluripotent stem cells (iPSC) opens up new avenues for basic research and regenerative medicine. However, the low efficiency of the procedure remains a major limitation. To identify iPSC, many studies to date relied on the activation of pluripotency-associated transcription factors. Such strategies are either retrospective or depend on genetically modified reporter cells. We aimed at identifying naturally occurring surface proteins in a systematic approach, focusing on antibody-targeted markers to enable live-cell identification and selective isolation. We tested 170 antibodies for differential expression between mouse embryonic fibroblasts (MEF) and mouse pluripotent stem cells (PSC). Differentially expressed markers were evaluated for their ability to identify and isolate iPSC in reprogramming cultures. Epithelial cell adhesion molecule (EPCAM) and stage-specific embryonic antigen 1 (SSEA1) were upregulated early during reprogramming and enabled enrichment of OCT4 expressing cells by magnetic cell sorting. Downregulation of somatic marker FAS was equally suitable to enrich OCT4 expressing cells, which has not been described so far. Furthermore, FAS downregulation correlated with viral transgene silencing. Finally, using the marker SSEA-1 we exemplified that magnetic separation enables the establishment of bona fide iPSC and propose strategies to enrich iPSC from a variety of human source tissues.	[Warlich, Eva; Lock, Dominik; Eckardt, Dominik; Bosio, Andreas; Knoebel, Sebastian] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Warlich, Eva; Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Warlich, Eva; Schambach, Axel; Glage, Silke] REBIRTH Cluster Excellence, Hannover, Germany; [Schambach, Axel] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Wedekind, Dirk; Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	Miltenyi Biotec; Hannover Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Hannover Medical School	Knobel, S (corresponding author), Miltenyi Biotec GmbH, Bergisch Gladbach, Germany.	sebastiank@miltenyibiotec.de	Schambach, Axel/C-5491-2011	Lock, Dominik/0000-0002-3056-4582; Bosio, Andreas/0000-0001-9776-2535	Deutsche Forschungsgemeinschaft [SFB738]; DAAD; German Federal Ministry of Education and Research (BMBF); European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB738, Cluster of Excellence REBIRTH), the DAAD, the German Federal Ministry of Education and Research (BMBF) and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujarour R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01179; Barral S, 2013, STEM CELL RES, V10, P133, DOI 10.1016/j.scr.2012.10.005; Beelen DW, 2000, BONE MARROW TRANSPL, V26, P823, DOI 10.1038/sj.bmt.1702635; Bitan M, 2005, EXP HEMATOL, V33, P713, DOI 10.1016/j.exphem.2005.03.004; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brunlid G, 2007, STEM CELLS, V25, P2551, DOI 10.1634/stemcells.2006-0745; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y; Despres D, 2000, J HEMATOTH STEM CELL, V9, P557; Dick E, 2011, STEM CELL RES, V6, P158, DOI 10.1016/j.scr.2010.10.002; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gundry RL, 2012, MOL CELL PROTEOMICS, V11, P303, DOI 10.1074/mcp.M112.018135; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Handgretinger R, 1998, BONE MARROW TRANSPL, V21, P987, DOI 10.1038/sj.bmt.1701228; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hau A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049636; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hirano K, 2013, BIOCHEM BIOPH RES CO, V430, P1175, DOI 10.1016/j.bbrc.2012.12.005; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Kahler DJ, PLOS ONE, V8; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Lang P, 1999, BONE MARROW TRANSPL, V24, P583, DOI 10.1038/sj.bmt.1701961; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Sheard MA, 2003, CANCER RES, V63, P7176; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zweigerdt R, 2003, CYTOTHERAPY, V5, P399, DOI 10.1080/14653240310003062	61	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102171	10.1371/journal.pone.0102171	http://dx.doi.org/10.1371/journal.pone.0102171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029550	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600039
J	Livrozet, M; Vandermeersch, S; Mesnard, L; Thioulouse, E; Jaubert, J; Boffa, JJ; Haymann, JP; Baud, L; Bazin, D; Daudon, M; Letavernier, E				Livrozet, Marine; Vandermeersch, Sophie; Mesnard, Laurent; Thioulouse, Elizabeth; Jaubert, Jean; Boffa, Jean-Jacques; Haymann, Jean-Philippe; Baud, Laurent; Bazin, Dominique; Daudon, Michel; Letavernier, Emmanuel			An Animal Model of Type A Cystinuria Due to Spontaneous Mutation in 129S2/SvPasCrl Mice	PLOS ONE			English	Article							RENAL-FAILURE; NEPHROLITHIASIS; UROLITHIASIS; INFLAMMATION	Cystinuria is an autosomal recessive disease caused by the mutation of either SLC3A1 gene encoding for rBAT (type A cystinuria) or SLC7A9 gene encoding for b(0,+) AT (type B cystinuria). Here, we evidenced in a commonly used congenic 129S2/SvPasCrl mouse substrain a dramatically high frequency of kidney stones that were similar to those of patients with cystinuria. Most of 129S2/SvPasCrl exhibited pathognomonic cystine crystals in urine and an aminoaciduria profile similar to that of patients with cystinuria. In addition, we observed a heterogeneous inflammatory infiltrate and cystine tubular casts in the kidney of cystinuric mice. As compared to another classical mouse strain, C57BL/6J mice, 129S2/SvPasCrl mice had an increased mortality associated with bilateral obstructive hydronephrosis. In 129S2/SvPasCrl mice, the heavy subunit rBAT of the tetrameric transporter of dibasic amino acids was absent in proximal tubules and we identified a single pathogenic mutation in a highly conserved region of the Slc3a1 gene. This novel mouse model mimicking human disease would allow us further pathophysiological studies and may be useful to analyse the crystal/tissue interactions in cystinuria.	[Livrozet, Marine; Vandermeersch, Sophie; Boffa, Jean-Jacques; Haymann, Jean-Philippe; Baud, Laurent; Daudon, Michel; Letavernier, Emmanuel] Univ Paris 06, Sorbonne Univ, UMR S 702, Paris, France; [Livrozet, Marine; Vandermeersch, Sophie; Boffa, Jean-Jacques; Haymann, Jean-Philippe; Baud, Laurent; Daudon, Michel; Letavernier, Emmanuel] INSERM, UMR S 702, Paris, France; [Mesnard, Laurent] Cornell Univ, Dept Physiol & Biophys, Ithaca, NY USA; [Thioulouse, Elizabeth] Hop Trousseau, AP HP, F-75571 Paris, France; [Jaubert, Jean] Inst Pasteur, Mouse Funct Genet Unit, Paris, France; [Jaubert, Jean] CNRS, URA 2578, Paris, France; [Boffa, Jean-Jacques; Haymann, Jean-Philippe; Baud, Laurent; Daudon, Michel; Letavernier, Emmanuel] Hop Tenon, AP HP, F-75970 Paris, France; [Bazin, Dominique] Univ Paris 06, Sorbonne Univ, CNRS, LCMCP,Coll France, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Cornell University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Letavernier, E (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S 702, Paris, France.	emmanuel.letavernier@tnn.aphp.fr	Wilson, Matthew H/K-3193-2013; , Bazin/C-6306-2014	, Bazin/0000-0002-5112-9061; VANDERMEERSCH, sophie/0000-0001-6021-1334	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey F, 2000, J UROLOGY, V163, P1419, DOI 10.1016/S0022-5347(05)67633-1; Bartoccioni P, 2008, HUM MOL GENET, V17, P1845, DOI 10.1093/hmg/ddn080; Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; Bazin D, 2012, CHEM REV, V112, P5092, DOI 10.1021/cr200068d; Chillaron J, 2010, NAT REV NEPHROL, V6, P424, DOI 10.1038/nrneph.2010.69; Coulombe P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3065; Daudon M, 2003, UROL RES, V31, P207, DOI 10.1007/s00240-003-0319-0; Daudon M, 2008, PROG UROL, V18, P802, DOI 10.1016/j.purol.2008.09.029; Dello Strologo L, 2002, J AM SOC NEPHROL, V13, P2547, DOI 10.1097/01.ASN.0000029586.17680.E5; Ercolani M, 2010, INT UROL NEPHROL, V42, P57, DOI 10.1007/s11255-009-9597-y; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Ishola DA, 2006, NEPHROL DIAL TRANSPL, V21, P591, DOI 10.1093/ndt/gfi303; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Knauf F, 2013, KIDNEY INT, V84, P895, DOI 10.1038/ki.2013.207; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Peters T, 2003, HUM MOL GENET, V12, P2109, DOI 10.1093/hmg/ddg189; Romero Victoriano, 2010, Rev Urol, V12, pe86; Salido EC, 2006, P NATL ACAD SCI USA, V103, P18249, DOI 10.1073/pnas.0607218103; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Worcester EM, 2006, J UROLOGY, V176, P600, DOI 10.1016/j.juro.2006.03.095; Yang TX, 2005, AM J PHYSIOL-RENAL, V288, pF1125, DOI 10.1152/ajprenal.00219.2004	23	26	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102700	10.1371/journal.pone.0102700	http://dx.doi.org/10.1371/journal.pone.0102700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048459	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100062
J	Lind, M; Kallman, T; Chen, J; Ma, XF; Bousquet, J; Morgante, M; Zaina, G; Karlsson, B; Elfstrand, M; Lascoux, M; Stenlid, J				Lind, Marten; Kallman, Thomas; Chen, Jun; Ma, Xiao-Fei; Bousquet, Jean; Morgante, Michele; Zaina, Giusi; Karlsson, Bo; Elfstrand, Malin; Lascoux, Martin; Stenlid, Jan			A Picea abies Linkage Map Based on SNP Markers Identifies QTLs for Four Aspects of Resistance to Heterobasidion parviporum Infection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COASTAL DOUGLAS-FIR; CONTROLLING ADAPTIVE TRAITS; SHIKIMATE HYDROXYCINNAMOYLTRANSFERASE; LEAF RUST; GENE MAP; EVOLUTION; CONIFER; GROWTH; ROT	A consensus linkage map of Picea abies, an economically important conifer, was constructed based on the segregation of 686 SNP markers in a F-1 progeny population consisting of 247 individuals. The total length of 1889.2 cM covered 96.5% of the estimated genome length and comprised 12 large linkage groups, corresponding to the number of haploid P. abies chromosomes. The sizes of the groups (from 5.9 to 9.9% of the total map length) correlated well with previous estimates of chromosome sizes (from 5.8 to 10.8% of total genome size). Any locus in the genome has a 97% probability to be within 10 cM from a mapped marker, which makes the map suited for QTL mapping. Infecting the progeny trees with the root rot pathogen Heterobasidion parviporum allowed for mapping of four different resistance traits: lesion length at the inoculation site, fungal spread within the sapwood, exclusion of the pathogen from the host after initial infection, and ability to prevent the infection from establishing at all. These four traits were associated with two, four, four and three QTL regions respectively of which none overlapped between the traits. Each QTL explained between 4.6 and 10.1% of the respective traits phenotypic variation. Although the QTL regions contain many more genes than the ones represented by the SNP markers, at least four markers within the confidence intervals originated from genes with known function in conifer defence; a leucoanthocyanidine reductase, which has previously been shown to upregulate during H. parviporum infection, and three intermediates of the lignification process; a hydroxycinnamoyl CoA shikimate/quinate hydroxycinnamoyltransferase, a 4-coumarate CoA ligase, and a R2R3-MYB transcription factor.	[Lind, Marten; Elfstrand, Malin; Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Kallman, Thomas; Chen, Jun; Ma, Xiao-Fei; Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Bousquet, Jean] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ, Canada; [Morgante, Michele; Zaina, Giusi] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; [Karlsson, Bo] Skogforsk, Svalov, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Laval University; University of Udine; Skogforsk	Lind, M (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	marten.lind@slu.se	Stenlid, Jan/K-5909-2019; Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065; Lind, Marten/0000-0002-3817-2823; Kallman, Thomas/0000-0003-0498-2665; Lascoux, Martin/0000-0003-1699-9042; Stenlid, Jan/0000-0002-5344-2094; MORGANTE, Michele/0000-0003-2591-2156; Elfstrand, Malin/0000-0002-0214-5284	European Community; Seventh Framework Programme (FP7/2007-2013) [211868]; Swedish Research Council FORMAS [dnr 217-2007-433]; Biodiversa projects Linktree; TipTree [ANR-12-EBID-0003]; Swedish Foundation for Strategic Research (SSF) [R8b08-0011]	European Community(European Commission); Seventh Framework Programme (FP7/2007-2013); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Biodiversa projects Linktree; TipTree; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	Financial support was received from the European Community's Sixth Framework Programme, under the Network of Excellence Evoltree (www.evoltree.eu/), by the Seventh Framework Programme (FP7/2007-2013) under the grant agreement no 211868 (Project Noveltree, www.noveltree.eu/), and by the Swedish Research Council FORMAS grant dnr 217-2007-433 (www.formas.se/en). Support also came from the Biodiversa projects Linktree (www.igv.fi.cnr.it/linktree/) and TipTree, grant ANR-12-EBID-0003 (www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2[CODE] = ANR-12-EBID-0003), and from the Swedish Foundation for Strategic Research (SSF), grant number R8b08-0011 (www.stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achere V, 2004, THEOR APPL GENET, V108, P1602, DOI [10.1007/s00122-004-1587-y, 10.1007/s00122-004-1595-y]; Alves AA, 2012, EUPHYTICA, V183, P27, DOI 10.1007/s10681-011-0455-5; Arnerup J, 2010, SCAND J FOREST RES, V25, P106, DOI 10.1080/02827581003730799; Arnerup J, 2011, INDUCED DEFENCE REPO; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Beavis WD, 1998, MOL DISSECTION COMPL; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broman KW, 2003, GENETICS, V163, P1169; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Chancerel E, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-50; Chancerel E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-368; Chen J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-589; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Danielsson M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-154; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Echt CS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-17; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Farjon A, 1990, PINACEAE DRAWINGS DE; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Freeman JS, 2008, GENETICS, V178, P563, DOI 10.1534/genetics.107.081414; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; GROSS GG, 1974, EUR J BIOCHEM, V42, P453, DOI 10.1111/j.1432-1033.1974.tb03359.x; Hammerbacher A, 2011, BIOSYNTHESIS POLYPHE; Jermstad KD, 2003, GENETICS, V165, P1489; Jermstad KD, 2001, THEOR APPL GENET, V102, P1142, DOI 10.1007/s001220000505; Karlsson B, 2006, SCAND J FOREST RES, V21, P108, DOI 10.1080/02827580500529969; Kim BG, 2011, J KOREAN SOC APPL BI, V54, P817, DOI 10.3839/jksabc.2011.125; KUBISIAK TL, 1995, THEOR APPL GENET, V90, P1119, DOI 10.1007/BF00222931; LANDER ES, 1989, GENETICS, V121, P185; Lange K, 1982, AM J HUMAN GENETICS, V34; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Liu X, 2011, J AGR SCI, V3; Loman J, 2007, STAT YB FORESTRY OFF; Lubaretz O, 1996, THEOR APPL GENET, V92, P411, DOI 10.1007/BF00223687; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P1529, DOI 10.1007/s11295-013-0646-4; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Moriguchi Y, 2012, BMC GENOMICS, V13; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Neves LG, 2014, G3-GENES GENOM GENET, V4, P29, DOI 10.1534/g3.113.008714; Nystedt B, 2013, NATURE; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pavy N, 2013, MOL ECOL RESOUR, V13, P324, DOI 10.1111/1755-0998.12062; Pavy N, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-84; Pelgas B, 2005, THEOR APPL GENET, V111, P1466, DOI 10.1007/s00122-005-0068-2; Pelgas B, 2006, THEOR APPL GENET, V113, P1371, DOI 10.1007/s00122-006-0354-7; Pelgas B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-145; Plough LV, 2011, GENETICS, V189, P1473, DOI 10.1534/genetics.111.131854; Prunier J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-368; Raherison E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-434; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Samils B, 2011, TREE GENET GENOMES, V7, P1219, DOI 10.1007/s11295-011-0408-0; SAX KARL, 1933, JOUR ARNOLD ARBORETUM, V14, P356; Schnable PS, 1998, CURR OPIN PLANT BIOL, V1, P123, DOI 10.1016/S1369-5266(98)80013-7; Siljak-Yakovlev S, 2002, THEOR APPL GENET, V104, P505, DOI 10.1007/s001220100755; Stenlid J, 1986, SCAND J FOREST RES, V1, P303, DOI 10.1080/02827588609382421; Thor M, 2005, SCAND J FOREST RES, V20, P165, DOI 10.1080/02827580510008347; Ukrainetz NK, 2008, TREE GENET GENOMES, V4, P159, DOI 10.1007/s11295-007-0097-x; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wagner A, 2007, P NATL ACAD SCI USA, V104, P11856, DOI 10.1073/pnas.0701428104; Williams CG, 2009, CONIFER REPRODUCTIVE BIOLOGY, P39; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Woodward S, 1998, BIOL ECOLOGY IMPACT; Xu SZ, 2003, GENETICS, V165, P2259; Yin TM, 2003, THEOR APPL GENET, V106, P1075, DOI 10.1007/s00122-003-1194-3	72	37	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101049	10.1371/journal.pone.0101049	http://dx.doi.org/10.1371/journal.pone.0101049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036209	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200012
J	Mori, K; Kitazawa, R; Kondo, T; Mori, M; Hamada, Y; Nishida, M; Minami, Y; Haraguchi, R; Takahashi, Y; Kitazawa, S				Mori, Kiyoshi; Kitazawa, Riko; Kondo, Takeshi; Mori, Michiko; Hamada, Yasuhiro; Nishida, Michiru; Minami, Yasuhiro; Haraguchi, Ryuma; Takahashi, Yutaka; Kitazawa, Sohei			Diabetic Osteopenia by Decreased beta-Catenin Signaling Is Partly Induced by Epigenetic Derepression of sFRP-4 Gene	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; INDUCED OXIDATIVE STRESS; GLYCATION END-PRODUCTS; HIGH-BONE-MASS; TRANSCRIPTIONAL REGULATION; METHYLATION STATUS; HYDROGEN-PEROXIDE; PROMOTER REGION; LRP5 GENE; MICE	In diabetics, methylglyoxal (MG), a glucose-derived metabolite, plays a noxious role by inducing oxidative stress, which causes and exacerbates a series of complications including low-turnover osteoporosis. In the present study, while MG treatment of mouse bone marrow stroma-derived ST2 cells rapidly suppressed the expression of osteotrophic Wnt-targeted genes, including that of osteoprotegerin (OPG, a decoy receptor of the receptor activator of NF-kappaB ligand (RANKL)), it significantly enhanced that of secreted Frizzled-related protein 4 (sFRP-4, a soluble inhibitor of Wnts). On the assumption that upregulated sFRP-4 is a trigger that downregulates Wnt-related genes, we sought out the molecular mechanism whereby oxidative stress enhanced the sFRP-4 gene. Sodium bisulfite sequencing revealed that the sFRP-4 gene was highly methylated around the sFRP-4 gene basic promoter region, but was not altered by MG treatment. Electrophoretic gel motility shift assay showed that two continuous CpG loci located five bases upstream of the TATA-box were, when methylated, a target of methyl CpG binding protein 2 (MeCP2) that was sequestered upon induction of 8-hydroxy-2-deoxyguanosine, a biomarker of oxidative damage to DNA. These in vitro data suggest that MG-derived oxidative stress (not CpG demethylation) epigenetically and rapidly derepress sFRP-4 gene expression. We speculate that under persistent oxidative stress, as in diabetes and during aging, osteopenia and ultimately low-turnover osteoporosis become evident partly due to osteoblastic inactivation by suppressed Wnt signaling of mainly canonical pathways through the derepression of sFRP-4 gene expression.	[Mori, Kiyoshi; Kitazawa, Riko; Kondo, Takeshi; Mori, Michiko; Kitazawa, Sohei] Kobe Univ, Grad Sch Med, Dept Pathol, Div Diagnost Mol Pathol, Kobe, Hyogo 657, Japan; [Mori, Kiyoshi] Osaka Natl Hosp, Natl Hosp Org, Dept Pathol, Osaka, Japan; [Kitazawa, Riko; Kitazawa, Sohei] Ehime Univ, Grad Sch Med, Dept Mol Pathol, Toon City, Ehime, Japan; [Kitazawa, Riko; Haraguchi, Ryuma; Kitazawa, Sohei] Ehime Univ Hosp, Dept Diagnost Pathol, Toon City, Ehime, Japan; [Kondo, Takeshi] Kobe Univ, Grad Sch Med, Dept Legal Med, Kobe, Hyogo 657, Japan; [Hamada, Yasuhiro] Univ Tokushima, Inst Hlth Biosci, Dept Therapeut Nutr, Tokushima 770, Japan; [Nishida, Michiru; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan; [Takahashi, Yutaka] Kobe Univ, Grad Sch Med, Dept Internal Med, Kobe, Hyogo 657, Japan	Kobe University; Osaka National Hospital; Ehime University; Ehime University; Kobe University; Tokushima University; Kobe University; Kobe University	Kitazawa, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Pathol, Div Diagnost Mol Pathol, Kobe, Hyogo 657, Japan.	kitazawa@m.ehime-u.ac.jp	Kitazawa, Sohei/E-5602-2010	Kitazawa, Sohei/0000-0002-7466-7356	Ministry of Education, Culture, Sports, Science and Technology, Japan [21790351, 16590278, 19390100, 19659086, 20790283, 25860143, 18590372, 21590419, 24590461]; Grants-in-Aid for Scientific Research [22590333, 24790640, 26670176] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21790351 to K. M., 16590278, 19390100 and 19659086 to S. K., 20790283 to T. K., 25860143 to R. H., 18590372, 21590419 and 24590461 to R. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou S, 2003, BIOCHEM SOC T, V31, P1394; Akhand AA, 2001, FREE RADICAL BIO MED, V31, P1228, DOI 10.1016/S0891-5849(01)00702-X; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bocker MT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1826; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen JR, 2010, J BONE MINER RES, V25, P1117, DOI 10.1002/jbmr.7; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; Fujii H, 2008, BONE, V42, P372, DOI 10.1016/j.bone.2007.10.007; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Hamada Y, 2007, BONE, V40, P1408, DOI 10.1016/j.bone.2006.12.057; Hamada Y, 2009, BONE, V44, P936, DOI 10.1016/j.bone.2008.12.011; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Takagi H, 2008, J GASTROENTEROL, V43, P378, DOI 10.1007/s00535-008-2170-0; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wong VKW, 2003, BIOL CHEM, V384, P1147, DOI 10.1515/BC.2003.127; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	41	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102797	10.1371/journal.pone.0102797	http://dx.doi.org/10.1371/journal.pone.0102797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036934	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200086
J	Gray, K; Schmitt, P; Strohminger, N; Kassam, KS				Gray, Kurt; Schmitt, Peter; Strohminger, Nina; Kassam, Karim S.			The Science of Style: In Fashion, Colors Should Match Only Moderately	PLOS ONE			English	Article								Fashion is an essential part of human experience and an industry worth over $1.7 trillion. Important choices such as hiring or dating someone are often based on the clothing people wear, and yet we understand almost nothing about the objective features that make an outfit fashionable. In this study, we provide an empirical approach to this key aesthetic domain, examining the link between color coordination and fashionableness. Studies reveal a robust quadratic effect, such that that maximum fashionableness is attained when outfits are neither too coordinated nor too different. In other words, fashionable outfits are those that are moderately matched, not those that are ultra-matched ("matchy-matchy'') or zero-matched ("clashing''). This balance of extremes supports a broader hypothesis regarding aesthetic preferences-the Goldilocks principle-that seeks to balance simplicity and complexity.	[Gray, Kurt; Schmitt, Peter] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27514 USA; [Strohminger, Nina] Duke Univ, Dept Psychol, Durham, NC 27706 USA; [Kassam, Karim S.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Carnegie Mellon University	Gray, K (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27514 USA.	kurtgray@unc.edu		Gray, Kurt/0000-0001-5816-2676	departmental funds at University of North Carolina, Chapel Hill	departmental funds at University of North Carolina, Chapel Hill	This study was funded by departmental funds at University of North Carolina, Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H, 2012, J EXP SOC PSYCHOL, V48, P918, DOI 10.1016/j.jesp.2012.02.008; Apicella CL, 2007, PERCEPTION, V36, P1813, DOI 10.1068/p5601; Berger J, 2008, J PERS SOC PSYCHOL, V95, P593, DOI 10.1037/0022-3514.95.3.593; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Espinoza J, 2011, WALL STR J; FORSYTHE SM, 1990, J APPL SOC PSYCHOL, V20, P1579, DOI 10.1111/j.1559-1816.1990.tb01494.x; Hoult TF, 1954, AM SOCIOL REV, V19, P324, DOI 10.2307/2087765; Huron D.B., 2006, SWEET ANTICIPATION M; Kidd C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036399; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Patel N, 2013, WEAR TREND MONOCHROM	12	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102772	10.1371/journal.pone.0102772	http://dx.doi.org/10.1371/journal.pone.0102772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033079	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300090
J	Liang, Q; Han, Q; Huang, W; Nan, G; Xu, BQ; Jiang, JL; Chen, ZN				Liang, Qiang; Han, Qing; Huang, Wan; Nan, Gang; Xu, Bao-Qing; Jiang, Jian-Li; Chen, Zhi-Nan			HAb18G/CD147 Regulates Vinculin-Mediated Focal Adhesion and Cytoskeleton Organization in Cultured Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN HEPATOMA-CELLS; PROMOTES INVASION; LIVING CELLS; IN-VITRO; METASTASIS; PHOSPHORYLATION; RECRUITMENT; DYNAMICS; PAXILLIN; MOTILITY	Focal adhesions (FAs), integrin-mediated macromolecular complexes located at the cell membrane extracellular interface, have been shown to regulate cell adhesion and migration. Our previous studies have indicated that HAb18G/CD147 (CD147) is involved in cytoskeleton reorganization and FA formation in human hepatocellular carcinoma (HCC) cells. However, the precise mechanisms underlying these processes remain unclear. In the current study, we determined that CD147 was involved in vinculin-mediated FA focal adhesion formation in HCC cells. We also found that deletion of CD147 led to reduced vinculin-mediated FA areas (P<0.0001), length/width ratios (P<0.0001), and mean intensities (P<0.0001). CD147 promoted lamellipodia formation by localizing Arp2/3 to the leading edge of the cell. Deletion of CD147 significantly reduced the fluorescence (t(1/2)) recovery times (22.7 +/- 63.3 s) of vinculin-mediated focal adhesions (P<0.0001). In cell-spreading assays, CD147 was found to be essential for dynamic focal adhesion enlargement and disassembly. Furthermore, the current data showed that CD147 reduced tyrosine phosphorylation in vinculin-mediated focal adhesions, and enhanced the accumulation of the acidic phospholipid phosphatidylinositol-4, 5-bisphosphate (PIP2). Together, these results revealed that CD147 is involved in vinculin-mediated focal adhesion formation, which subsequently promotes cytoskeleton reorganization to facilitate invasion and migration of human HCC cells.	[Liang, Qiang; Huang, Wan; Nan, Gang; Xu, Bao-Qing; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Shaanxi, Peoples R China; [Liang, Qiang; Huang, Wan; Nan, Gang; Xu, Bao-Qing; Jiang, Jian-Li; Chen, Zhi-Nan] Fourth Mil Med Univ, Dept Cell Biol, State Key Discipline Cell Biol, Xian 710032, Shaanxi, Peoples R China; [Han, Qing] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jiang, JL (corresponding author), Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Shaanxi, Peoples R China.	jiangjl@fmmu.edu.cn; znchen@fmmu.edu.cn		Chen, Zhi-Nan/0000-0001-5512-4623	National ST Major Project [2011ZX09102-001-21, 2012ZX10002017-002, 2013ZX09301301]; National Natural Science Foundation of China [31101005, 31371405]; National High Technology Research and Development program of China [2012AA020302]	National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National S&T Major Project (2011ZX09102-001-21, 2012ZX10002017-002, 2013ZX09301301), the National Natural Science Foundation of China (31101005, 31371405), the National High Technology Research and Development program of China (2012AA020302). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Craig SW, 2003, CURR BIOL, V13, pR236, DOI 10.1016/S0960-9822(03)00160-X; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Huang W, 2013, BIOCHEM J, V449, P437, DOI 10.1042/BJ20120343; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Jiang JL, 2004, CELL MOL LIFE SCI, V61, P2083, DOI 10.1007/s00018-004-4146-4; Jiang JL, 2001, J BIOL CHEM, V276, P46870, DOI 10.1074/jbc.M108291200; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; McGrath JL, 2007, CURR BIOL, V17, pR357, DOI 10.1016/j.cub.2007.03.057; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x	39	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102496	10.1371/journal.pone.0102496	http://dx.doi.org/10.1371/journal.pone.0102496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033086	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300058
J	de Andrade, RCLP; Sayao, JM				Lima Pedroso de Andrade, Rafael Cesar; Sayao, Juliana Manso			Paleohistology and Lifestyle Inferences of a Dyrosaurid (Archosauria: Crocodylomorpha) from Paraiba Basin (Northeastern Brazil)	PLOS ONE			English	Article							BONE-HISTOLOGY; DETERMINATE GROWTH; AGE; REPTILIA; PALEOCENE; EVOLUTION	Among the few vertebrates that survived the mass extinction event documented at the Cretaceous-Paleocene boundary are dyrosaurid crocodylomorphs. Surprisingly, there is little information regarding the bone histology of dyrosaurids, despite their relatively common occurrence in the fossil record, and the potential to gain insight about their biology and lifestyle. We provide the first description of the long bone histology of the dyrosaurids. Specimens were collected from the Maria Farinha Formation, in the Paraiba Basin of northeast Brazil. Thin sections of a right femur and left tibia were made. In the left tibia, the cortex consists of lamellar-zonal bone with five lines of arrested growth (LAGs), spaced similar to 300 mu m apart. The tibia contains a small to medium-sized organized vascular network of both simple vascular canals and primary osteons that decrease in density periostially. The femur exhibits a similar histological pattern overall but has double-LAGs, and an EFS layer (the latter is rare in living crocodylians). Secondary osteons occur in the deep cortex near and inside the spongiosa as a result of remodeling in both bones. This tissue pattern is fairly common among slow-growing animals. These specimens were a sub-adult and a senescent. Patterns in the distribution of bone consistent with osteosclerosis suggest that these animals probably hada fast-swimming ecology. Although these results are consistent with the histology in anatomically convergent taxa, it will be necessary to make additional sections from the mid-diaphysis in order to assign their ecology.	[Lima Pedroso de Andrade, Rafael Cesar] Univ Fed Pernambuco, Grad Student Programa Posgrad CTG, Recife, PE, Brazil; [Sayao, Juliana Manso] Univ Fed Pernambuco, Ctr Acad Vitoria, Vitoria De Santo Antao, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	de Andrade, RCLP (corresponding author), Univ Fed Pernambuco, Grad Student Programa Posgrad CTG, Recife, PE, Brazil.	rafael-clpa1@hotmail.com	Sayao, Juliana M/H-5652-2013		Conselho Nacional Pq [401787/2010-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES fellowship)	Conselho Nacional Pq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES fellowship)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research is supported by Conselho Nacional Pq (Proc. N. 401787/2010-9 grant to J.M.S.) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES fellowship to R.C.L.P.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOLLO J, 1987, GEOBIOS-LYON, V20, P123, DOI 10.1016/S0016-6995(87)80061-X; Barbosa JA, 2008, P ROY SOC B-BIOL SCI, V275, P1385, DOI 10.1098/rspb.2008.0110; Bardet N, 2008, B SOC GEOL FR, V179, P605, DOI 10.2113/gssgfbull.179.6.605; BARTELS WS, 1984, J PALEONTOL, V58, P1347; Beurlen K., 1967, Boletim da Sociedade Brasileira de Geologia, V16, P73; Beurlen K., 1967, B SOC BRASILEIRA GEO, V16, P43; Bona P, 2007, AMEGHINIANA, V44, P435; Brochu CA, 2002, J PALEONTOL, V76, P1060, DOI 10.1666/0022-3360(2002)076<1060:ADCBFM>2.0.CO;2; BUFFETAUT E, 1990, TECTONOPHYSICS, V171, P337, DOI 10.1016/0040-1951(90)90108-K; Buffetaut E., 1982, ANN PALEONTOLOGIE, V68, P327; Buffetaut Eric, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P541; Caetano M. H., 1993, Amphibia-Reptilia, V14, P117, DOI 10.1163/156853893X00291; Castanet JFJ, 1977, B BIOL FR BELG, V3, P183; CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy A, 2009, ANAT REC, V292, P1462, DOI 10.1002/ar.20990; Cope ED, 1886, P AM PHILOS SOC, V23, P1; Cox, 1976, MORPHOLOGY BIOL REPT, P123; CURRIE P J, 1982, Annals of the South African Museum, V86, P247; de Buffrenil V., 1980, ARCHIVES DE ZOOLOGIE EXPERIMENTALE ET GENERALE, V121, P63; de Ricqles A., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P351; de Ricqles Armand, 2001, P289; DEBUFFRENIL V, 1988, J MORPHOL, V198, P149, DOI 10.1002/jmor.1051980203; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; Denton Robert K. Jr, 1997, P375, DOI 10.1016/B978-012155210-7/50020-X; Dumont M, 2013, J MORPHOL, V274, P570, DOI 10.1002/jmor.20122; Enlow D. H., 1957, Texas Journal of Science, V9, P186; FRANCILLONVIEILLOT H, 1990, J HERPETOL, V24, P13, DOI 10.2307/1564284; Gayet Mireille, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P393; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; Hastings A, 2007, J VERTEBR PALEONTOL, V27, p87A; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Houssaye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095637; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Kaiser HE, 1969, ACTA BIOTHEOR S9; Kellner AWA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081386; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Lee AH, 2013, J VERTEBR PALEONTOL, V33, P865, DOI 10.1080/02724634.2013.743898; Montefeltro FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021916; Nascimento-Silva M, 2011, J S AM EARTH SCI, P1; Owen R, 1849, Q J GEOL SOC LONDON, V5, P380, DOI DOI 10.1144/GSL.JGS.1849.005.01-02.43; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Pinheiro AEP, 2012, HIST BIOL, P1, DOI [10.1080/08912963.2012.705838, DOI 10.1080/08912963.2012.705838)]; Pol D, 2012, J VERTEBR PALEONTOL, V32, P328, DOI 10.1080/02724634.2012.646833; Ricqles A. de, 1998, J VERT PALEONT, V18, p72A; Rieppel Olivier, 1995, Palaeontologische Zeitschrift, V69, P289; Salgado L, 2007, AMEGHINIANA, V44, P1; Sayao Juliana M., 2003, Geological Society Special Publication, V217, P335, DOI 10.1144/GSL.SP.2003.217.01.21; Schwarz D, 2006, PALAEONTOLOGY, V49, P695, DOI 10.1111/j.1475-4983.2006.00563.x; Silva MC, 2007, ESTUD GEOL, V17, P85, DOI DOI 10.18190/1980-8208/ESTUD0SGE0L0GIC0S.V17N2P85-95; Stefano G, 1903, B SOC GEOL ITAL, V22, P51; Stein K., 2009, METHODS FOSSIL PREPA, P69; STORRS GW, 1993, AM J SCI, V293A, P63, DOI 10.2475/ajs.293.A.63; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Woodward HN, 2011, J HERPETOL, V45, P339	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102189	10.1371/journal.pone.0102189	http://dx.doi.org/10.1371/journal.pone.0102189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032965	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300041
J	Zeng, XX; Du, J; Zhuang, CQ; Zhang, JH; Jia, YL; Zheng, XF				Zeng, Xiang-Xing; Du, Juan; Zhuang, Chu-Qun; Zhang, Jun-Hua; Jia, Yan-Lei; Zheng, Xi-Fu			Unconditioned Stimulus Revaluation to Promote Conditioned Fear Extinction in the Memory Reconsolidation Window	PLOS ONE			English	Article							AMYGDALA; DISSOCIATION; MECHANISMS; EXPRESSION; RESPONSES; CIRCUITS; EMOTION	The retrieval-extinction paradigm, which disrupts the reconsolidation of fear memories in humans, is a non-invasive technique that can be used to prevent the return of fear in humans. In the present study, unconditioned stimulus revaluation was applied in the retrieval-extinction paradigm to investigate its promotion of conditioned fear extinction in the memory reconsolidation window after participants acquired conditioned fear. This experiment comprised three stages (acquisition, unconditioned stimulus revaluation, retrieval-extinction) and three methods for indexing fear (unconditioned stimulus expectancy, skin conductance response, conditioned stimulus pleasure rating). After the acquisition phase, we decreased the intensity of the unconditioned stimulus in one group (devaluation) and maintained constant for the other group (control). The results indicated that both groups exhibited similar levels of unconditioned stimulus expectancy, but the devaluation group had significantly smaller skin conductance responses and exhibited a growth in conditioned stimulus + pleasure. Thus, our findings indicate unconditioned stimulus revaluation effectively promoted the extinction of conditioned fear within the memory reconsolidation window.	[Zeng, Xiang-Xing; Du, Juan; Zhuang, Chu-Qun; Zhang, Jun-Hua; Jia, Yan-Lei; Zheng, Xi-Fu] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Zeng, Xiang-Xing; Du, Juan; Zhuang, Chu-Qun; Zhang, Jun-Hua; Jia, Yan-Lei; Zheng, Xi-Fu] S China Normal Univ, Hlth Serv Ctr Communities, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Zheng, XF (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	zhengxf@scnu.edu.cn			National Natural Science Foundation of China [31371057]; Guangzhou government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou government	This research was supported in part by grants from the National Natural Science Foundation of China (Nos. 31371057) and psychological services and counseling base for the Happy Guangzhou project, which received funding from the Guangzhou government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderston NL, 2010, LEARN MOTIV, V23, P200; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Costanzi M, 2011, LEARN MEMORY, V18, P508, DOI 10.1101/lm.2175811; Davis M, 2003, ANN NY ACAD SCI, V985, P218; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Effting M, 2007, BEHAV RES THER, V45, P2002, DOI 10.1016/j.brat.2007.02.011; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Jackson ED, 2006, BIOL PSYCHIAT, V59, P516, DOI 10.1016/j.biopsych.2005.08.002; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Kindt M, 2013, BIOL PSYCHOL, V92, P43, DOI 10.1016/j.biopsycho.2011.09.016; Klucken T, 2013, BEHAV NEUROSCI, V127, P380, DOI 10.1037/a0032331; Knight DC, 2003, P NATL ACAD SCI USA, V100, P15280, DOI 10.1073/pnas.2535780100; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; [刘涛生 LIU TaoSheng], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P709; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pavlov I, 1927, CONDTITIONAL REFEXES; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schreurs BG, 2011, AM J PSYCHIAT, V157, P255; Schultz DH, 2013, BEHAV NEUROSCI, V127, P357, DOI 10.1037/a0032742; Simon NM, 2008, J CLIN PSYCHIAT, V69, P400, DOI 10.4088/JCP.v69n0309; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; [孙楠 Sun Nan], 2012, [心理学报, Acta Psychologica Sinica], V44, P314; Walther E, 2009, COGNITION EMOTION, V23, P889, DOI 10.1080/02699930802212423; WHITE K, 1989, BEHAV RES THER, V27, P161, DOI 10.1016/0005-7967(89)90074-0; [吴韦玮 Wu Weiwei], 2012, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V20, P649; Zheng Y, 2013, ACTA PSYCHOL SINICA, V46, P396	36	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101589	10.1371/journal.pone.0101589	http://dx.doi.org/10.1371/journal.pone.0101589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033450	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300022
J	Edwards, T; Cox, EC; Buzzard, V; Wiese, C; Hillard, LS; Murphy, RW				Edwards, Taylor; Cox, Elizabeth Canty; Buzzard, Vanessa; Wiese, Christiane; Hillard, L. Scott; Murphy, Robert W.			Genetic Assessments and Parentage Analysis of Captive Bolson Tortoises (Gopherus flavomarginatus) Inform Their "Rewilding'' in New Mexico	PLOS ONE			English	Article							ALLELE FREQUENCY DATA; COMPUTER-PROGRAM; DESERT TORTOISE; MICROSATELLITE LOCI; CONSERVATION GENETICS; PAIRWISE RELATEDNESS; POPULATION-STRUCTURE; BREEDING PROGRAMS; MOLECULAR MARKERS; AGASSIZII	The Bolson tortoise (Gopherus flavomarginatus) is the first species of extirpated megafauna to be repatriated into the United States. In September 2006, 30 individuals were translocated from Arizona to New Mexico with the long-term objective of restoring wild populations via captive propagation. We evaluated mtDNA sequences and allelic diversity among 11 microsatellite loci from the captive population and archived samples collected from wild individuals in Durango, Mexico (n = 28). Both populations exhibited very low genetic diversity and the captive population captured roughly 97.5% of the total wild diversity, making it a promising founder population. Genetic screening of other captive animals (n = 26) potentially suitable for reintroduction uncovered multiple hybrid G. flavomarginatusxG. polyphemus, which were ineligible for repatriation; only three of these individuals were verified as purebred G. flavomarginatus. We used these genetic data to inform mate pairing, reduce the potential for inbreeding and to monitor the maintenance of genetic diversity in the captive population. After six years of successful propagation, we analyzed the parentage of 241 hatchlings to assess the maintenance of genetic diversity. Not all adults contributed equally to successive generations. Most yearly cohorts of hatchlings failed to capture the diversity of the parental population. However, overlapping generations of tortoises helped to alleviate genetic loss because the entire six-year cohort of hatchlings contained the allelic diversity of the parental population. Polyandry and sperm storage occurred in the captives and future management strategies must consider such events.	[Edwards, Taylor; Cox, Elizabeth Canty] Univ Arizona, Univ Arizona Genet Core, Tucson, AZ 85721 USA; [Buzzard, Vanessa] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Wiese, Christiane; Hillard, L. Scott] Ladder Ranch, Turner Endangered Species Fund, Caballo, NM USA; [Hillard, L. Scott] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	University of Arizona; University of Arizona; University of California System; University of California Los Angeles; Royal Ontario Museum	Edwards, T (corresponding author), Univ Arizona, Univ Arizona Genet Core, Tucson, AZ 85721 USA.	taylore@email.arizona.edu		Edwards, Taylor/0000-0002-7235-6175	Natural Sciences and Engineering Research Council (Canada) [3148]; Sundance Biology, Inc.; Tucson Herpetological Society; Arizona Research Laboratories	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sundance Biology, Inc.; Tucson Herpetological Society; Arizona Research Laboratories	This research was supported, in part, by the Natural Sciences and Engineering Research Council (Canada) Discovery Grant 3148. Additional funding was provided by Sundance Biology, Inc. biologists, M. Vaughn, the Tucson Herpetological Society and Arizona Research Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre Gustavo, 1997, P333; Urena-Aranda CA, 2012, AMPHIBIA-REPTILIA, V33, P45, DOI 10.1163/156853811X621508; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Banks MA, 2000, J HERED, V91, P87, DOI 10.1093/jhered/91.1.87; Britten HB, 1997, COPEIA, P523; Cornuet JM, 1996, GENETICS, V144, P2001; Davy CM, 2011, CONSERV GENET, V12, P1313, DOI 10.1007/s10592-011-0232-y; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Edwards T, 2004, CONSERV GENET, V5, P485, DOI 10.1023/B:COGE.0000041031.58192.7c; Edwards T, 2003, MOL ECOL NOTES, V3, P589, DOI 10.1046/j.1471-8286.2003.00521.x; Edwards T, 2011, CONSERV GENET RESOUR, V3, P365, DOI 10.1007/s12686-010-9363-6; Edwards T, 2003, THESIS U ARIZONA TUC; Edwards T, 2013, CONSERV GENET, V14, P649, DOI 10.1007/s10592-013-0458-y; Engstrom Tag N., 2007, Chelonian Research Monographs, V4, P124; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FITZSIMMONS NN, 1995, MOL BIOL EVOL, V12, P432; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fujii A, 2010, CHELONIAN CONSERV BI, V9, P61, DOI 10.2744/CCB-0786.1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; Ivy JA, 2009, J HERED, V100, P441, DOI 10.1093/jhered/esp019; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Lynch M, 1999, GENETICS, V152, P1753; MORAFKA DJ, 1994, CAN J ZOOL, V72, P1665, DOI 10.1139/z94-222; Morafka DJ, 1981, ECOLOGY CHIHUAHUAN D, P35; Morafka DJ, 1988, ANN CARNEGIE MUS, P47; Murphy RW, 2007, CHELONIAN CONSERV BI, V6, P229, DOI 10.2744/1071-8443(2007)6[229:AGAOTR]2.0.CO;2; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; de Cara MAR, 2013, MOL ECOL, V22, P6091, DOI 10.1111/mec.12560; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; TAJIMA F, 1983, GENETICS, V105, P437; Truett Joe, 2009, Ecological Restoration, V27, P144, DOI 10.3368/er.27.2.144; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; van Dijk PP, 2007, IUCN 2013 IUCN RED L; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2002, GENETICS, V160, P1203; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams DA, 2007, CHELONIAN CONSERV BI, V6, P302, DOI 10.2744/1071-8443(2007)6[302:GCFTCB]2.0.CO;2; Witzenberger KA, 2011, BIODIVERS CONSERV, V20, P1843, DOI 10.1007/s10531-011-0074-4	46	11	11	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102787	10.1371/journal.pone.0102787	http://dx.doi.org/10.1371/journal.pone.0102787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029369	Green Published, gold			2022-12-27	WOS:000341306600101
J	Deguchi, T; Takahashi, K; Takayasu, H; Takayasu, M				Deguchi, Tsuyoshi; Takahashi, Katsuhide; Takayasu, Hideki; Takayasu, Misako			Hubs and Authorities in the World Trade Network Using a Weighted HITS Algorithm	PLOS ONE			English	Article								We investigate the economic hubs and authorities of the world trade network (WTN) from 1992 to 2012, an era of rapid economic globalization. Using a well-defined weighted hyperlink-induced topic search (HITS) algorithm, we can calculate the values of the weighted HITS hub and authority for each country in a conjugate way. In the context of the WTN, authority values are large for countries with significant imports from large hub countries, and hub values are large for countries with significant exports to high-authority countries. The United States was the largest economic authority in the WTN from 1992 to 2012. The authority value of the United States has declined since 2001, and China has now become the largest hub in the WTN. At the same time, China's authority value has grown as China is transforming itself from the "factory of the world" to the "market of the world." European countries show a tendency to trade mostly within the European Union, which has decreased Europe's hub and authority values. Japan's authority value has increased slowly, while its hub value has declined. These changes are consistent with Japan's transition from being an export-driven economy in its high economic growth era in the latter half of the twentieth century to being a more mature, economically balanced nation.	[Deguchi, Tsuyoshi; Takahashi, Katsuhide; Takayasu, Misako] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 227, Japan; [Takahashi, Katsuhide] Kokugakuin Univ, Dept Econ, Shibuya Ku, Tokyo, Japan; [Takayasu, Hideki] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan; [Takayasu, Hideki] Meiji Univ, Grad Sch Adv Math Sci, Tokyo 101, Japan	Tokyo Institute of Technology	Takayasu, M (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 227, Japan.	takayasu@dis.titech.ac.jp	Takayasu, Hideki/B-9899-2015; Takayasu, Misako/H-9890-2014	Takayasu, Hideki/0000-0002-4452-5517; Takayasu, Misako/0000-0002-2467-614X	 [24540395]		This work was supported by the Grant-in-Aid for Scientific Research (C), Grant Nmber 24540395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PEARSON SERIES EC; Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Barigozzi M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046104; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Caldarelli G., 2007, SCALE FREE NETWORKS; De Benedictis L, 2011, WORLD ECON, V34, P1417, DOI 10.1111/j.1467-9701.2011.01360.x; Easley D, 2010, NETWORKS CROWDS MARK; Ermann L, 2011, ACTA PHYS POL A, V120, pA158; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Garlaschelli D, 2007, EUR PHYS J B, V57, P159, DOI 10.1140/epjb/e2007-00131-6; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; He JK, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.198701; Henzigner MR, 2001, IEEE INTERNET COMPUT, V5, P45, DOI 10.1109/4236.895141; Kawai M, 1998, EC DEV COOPERATION P, P251; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; League of Nations, 1942, WORLD TRAD NETW; Li X, 2003, PHYSICA A, V328, P287, DOI 10.1016/S0378-4371(03)00567-3; Ministry of Economy Trade and Industry of Japan, 2011, WHIT PAP INT EC TRAD; Miura W, 2012, EUR PHYS J-SPEC TOP, V212, P65, DOI 10.1140/epjst/e2012-01654-7; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; NOLAND M, 1995, WORLD ECON, V18, P237, DOI 10.1111/j.1467-9701.1995.tb00212.x; Ohnishi T, 2009, PROG THEOR PHYS SUPP, P157, DOI 10.1143/PTPS.179.157; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Squartini T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046118; Squartini T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046117; Takahashi K, 2010, BUS POLIT, V12, DOI 10.2202/1469-3569.1310; Wei W., 2012, INT PROC EC DEV RES, V28, P88, DOI [10.7763/IPEDR, DOI 10.7763/IPEDR]	30	41	41	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e100338	10.1371/journal.pone.0100338	http://dx.doi.org/10.1371/journal.pone.0100338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050940	gold, Green Submitted, Green Published			2022-12-27	WOS:000339551100004
J	Meng, J; Shi, L; Luan, YS				Meng, Jun; Shi, Lin; Luan, Yushi			Plant microRNA-Target Interaction Identification Model Based on the Integration of Prediction Tools and Support Vector Machine	PLOS ONE			English	Article							BINDING-SITES; MIRNA TARGETS; WEB SERVER; SIRNA; BIOGENESIS; MECHANISMS; SEQUENCE	Background: Confident identification of microRNA-target interactions is significant for studying the function of microRNA (miRNA). Although some computational miRNA target prediction methods have been proposed for plants, results of various methods tend to be inconsistent and usually lead to more false positive. To address these issues, we developed an integrated model for identifying plant miRNA-target interactions. Results: Three online miRNA target prediction toolkits and machine learning algorithms were integrated to identify and analyze Arabidopsis thaliana miRNA-target interactions. Principle component analysis (PCA) feature extraction and self-training technology were introduced to improve the performance. Results showed that the proposed model outperformed the previously existing methods. The results were validated by using degradome sequencing supported Arabidopsis thaliana miRNA-target interactions. The proposed model constructed on Arabidopsis thaliana was run over Oryza sativa and Vitis vinifera to demonstrate that our model is effective for other plant species. Conclusions: The integrated model of online predictors and local PCA-SVM classifier gained credible and high quality miRNA-target interactions. The supervised learning algorithm of PCA-SVM classifier was employed in plant miRNA target identification for the first time. Its performance can be substantially improved if more experimentally proved training samples are provided.	[Meng, Jun; Shi, Lin] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Luan, Yushi] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian University of Technology	Luan, YS (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Liaoning, Peoples R China.	luanyush@dlut.edu.cn			National Natural Science Foundation of China [31272167]; Natural Science Foundation of Liaoning Province of China [20130200029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province)	This work and the article processing charge were supported by grants from the National Natural Science Foundation of China (No. 31272167), the Natural Science Foundation of Liaoning Province of China (No. 20130200029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergauer T, 2009, OLIGONUCLEOTIDES, V19, P41, DOI 10.1089/oli.2008.0154; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; Ding JD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S3; Fahlgren N, 2010, METHODS MOL BIOL, V592, P51, DOI 10.1007/978-1-60327-005-2_4; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Jha A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-636; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li F, 2012, PLANT J, V70, P891, DOI 10.1111/j.1365-313X.2012.04922.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Poole Rebecca L., 2007, V406, P179; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rosenberg C, 2005, SEMI SUPERVISED SELF, P374; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020391; Vasquez-Rifo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033750; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383	49	15	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103181	10.1371/journal.pone.0103181	http://dx.doi.org/10.1371/journal.pone.0103181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051153	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100094
J	Cavallari, M; Ceccarelli, A; Wang, GY; Moscufo, N; Hannoun, S; Matulis, CR; Jackson, JS; Glanz, BI; Bakshi, R; Neema, M; Guttmann, CRG				Cavallari, Michele; Ceccarelli, Antonia; Wang, Guang-Yi; Moscufo, Nicola; Hannoun, Salem; Matulis, Christina R.; Jackson, Jonathan S.; Glanz, Bonnie I.; Bakshi, Rohit; Neema, Mohit; Guttmann, Charles R. G.			Microstructural Changes in the Striatum and Their Impact on Motor and Neuropsychological Performance in Patients with Multiple Sclerosis	PLOS ONE			English	Article							GRAY-MATTER ATROPHY; DIFFUSION TENSOR; COGNITIVE IMPAIRMENT; T2 HYPOINTENSITY; MRI; MS; DEGENERATION; REGISTRATION; INVOLVEMENT; VOLUMETRY	Grey matter (GM) damage is a clinically relevant feature of multiple sclerosis (MS) that has been previously assessed with diffusion tensor imaging (DTI). Fractional anisotropy (FA) of the basal ganglia and thalamus might be increased in MS patients, and correlates with disability scores. Despite the established role of the striatum and thalamus in motor control, mood and cognition, the impact of DTI changes within these structures on motor and neuropsychological performance has not yet been specifically addressed in MS. We investigated DTI metrics of deep GM nuclei and their potential association with mobility and neuropsychological function. DTI metrics from 3T MRI were assessed in the caudate, putamen, and thalamus of 30 MS patients and 10 controls. Sixteen of the patients underwent neuropsychological testing. FA of the caudate and putamen was higher in MS patients compared to controls. Caudate FA correlated with Expanded Disability Status Scale score, Ambulation Index, and severity of depressive symptomatology. Putamen and thalamus FA correlated with deficits in memory tests. In contrast, cerebral white matter (WM) lesion burden showed no significant correlation with any of the disability, mobility and psychometric parameters. Our findings support evidence of FA changes in the basal ganglia in MS patients, as well as deep GM involvement in disabling features of MS, including mobility and cognitive impairment. Deep GM FA appears to be a more sensitive correlate of disability than WM lesion burden.	[Cavallari, Michele; Wang, Guang-Yi; Moscufo, Nicola; Guttmann, Charles R. G.] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp,Ctr Neurol Imaging, Boston, MA 02115 USA; [Cavallari, Michele] Univ Roma La Sapienza, Dipartimento Neurosci Salute Mentale & Organi Sen, Rome, Italy; [Ceccarelli, Antonia; Matulis, Christina R.; Jackson, Jonathan S.; Glanz, Bonnie I.; Bakshi, Rohit; Neema, Mohit] Harvard Univ, Sch Med, Dept Neurol,Lab Neuroimaging Res, Brigham & Womens Hosp,Partners Multiple Sclerosis, Boston, MA 02115 USA; [Wang, Guang-Yi] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Hannoun, Salem] Univ Lyon 1, Ctr Rech Acquisit Traitement Image Sante CREATIS, CNRS, Unites Mixtes Rech UMR 5220, F-69365 Lyon, France; [Hannoun, Salem] Univ Lyon 1, INSERM, U1044, F-69365 Lyon, France; [Hannoun, Salem] Univ Lyon, Observ Francais Sclerose Plaques OFSEP, Lyon, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Sapienza University Rome; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Guttmann, CRG (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp,Ctr Neurol Imaging, Boston, MA 02115 USA.	guttmann@bwh.harvard.edu	ceccarelli, antonia/N-9563-2019; Guttmann, Charles RG/J-3093-2018; Hannoun, Salem/I-2761-2016	ceccarelli, antonia/0000-0002-1628-5667; Hannoun, Salem/0000-0002-5982-3242; Guttmann, Charles/0000-0002-7006-9762	National Institute on Aging [NIH 2R01AG22092-06A]; NATIONAL INSTITUTE ON AGING [R01AG022092] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Michele Cavallari, Nicola Moscufo, and Charles RG Guttmann acknowledge support from the National Institute on Aging (NIH 2R01AG22092-06A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Brass SD, 2006, MULT SCLER J, V12, P437, DOI 10.1191/135248506ms1301oa; Catalaa I, 1999, AM J NEURORADIOL, V20, P1613; Ceccarelli A, 2012, AM J NEURORADIOL, V33, P1579, DOI 10.3174/ajnr.A3083; Ceccarelli A, 2012, CURR OPIN NEUROL, V25, P402, DOI 10.1097/WCO.0b013e328354f63f; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Cohen JA, 2001, ARCH NEUROL-CHICAGO, V58, P961, DOI 10.1001/archneur.58.6.961; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Hasan KM, 2009, J MAGN RESON IMAGING, V29, P70, DOI 10.1002/jmri.21648; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056/NEJM198301273080401; Horakova D, 2008, J NEUROL NEUROSUR PS, V79, P407, DOI 10.1136/jnnp.2007.120378; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Nakamura K, 2009, NEUROIMAGE, V44, P769, DOI 10.1016/j.neuroimage.2008.09.059; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu BFG, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-11; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sander DM, 1898, MSCHR PSYCHIAT NEURO, V4, P427; Sastre-Garriga J, 2009, J NEUROL SCI, V282, P120, DOI 10.1016/j.jns.2008.12.019; Schmahmann JD, 2008, CORTEX, V44, P1037, DOI 10.1016/j.cortex.2008.04.004; Stankiewicz JM, 2011, J NEUROIMAGING, V21, pe50, DOI 10.1111/j.1552-6569.2009.00449.x; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564; Yu B, 2008, 2008 CONFERENCE ON LASERS AND ELECTRO-OPTICS & QUANTUM ELECTRONICS AND LASER SCIENCE CONFERENCE, VOLS 1-9, P947, DOI 10.1109/ISBI.2008.4541154	39	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101199	10.1371/journal.pone.0101199	http://dx.doi.org/10.1371/journal.pone.0101199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047083	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100007
J	Choi, JG; Mun, SH; Chahar, HS; Bharaj, P; Kang, OH; Kim, SG; Shin, DW; Kwon, DY				Choi, Jang-Gi; Mun, Su-Hyun; Chahar, Harendra S.; Bharaj, Preeti; Kang, Ok-Hwa; Kim, Se-Gun; Shin, Dong-Won; Kwon, Dong-Yeul			Methyl Gallate from Galla rhois Successfully Controls Clinical Isolates of Salmonella Infection in Both In Vitro and In Vivo Systems	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL DRUG-RESISTANCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL ACTIVITY; MICE; COMBINATION; ENTERICA; HOST; DISEASES	Galla rhois is a commonly used traditional medicine for the treatment of pathogenic bacteria in Korea as well as in other parts of Asia. Methyl gallate (MG), a major component of Galla Rhois, exhibits strong antibacterial activity, but its mechanism of action against Salmonella spp. is unclear. In the present study, we investigated the antibacterial actions of MG against Salmonella. The antibacterial activity determined by broth dilution method indicated that the antibacterial activity of MG against Salmonella strains ranged from 3.9 to 125 mu g/ml. In vitro bacterial viability test indicated that MG significantly decreased the viability of Salmonella over 40% when combined with ATPase inhibitors. The time-kill curves showed that a combined MG and ATPase inhibitors (DCCD and NaN3) treatment reduced the bacterial counts dramatically after 24 h. Oral administration of MG showed a strong anti-bacterial activity against WS-5 infected BALB/c mice. In contrast to the untreated Salmonella infected control animals, MG treated groups showed no clinical symptoms of the disease, such as lethargy and liver damage. It was observed that MG treatment significantly increased the survival of animals from Salmonella infection, while in untreated groups all animal succumbed to disease by the sixth day post infection. Thus, the present study demonstrates the therapeutic ability of MG against Salmonella infections.	[Choi, Jang-Gi; Kang, Ok-Hwa; Kim, Se-Gun; Kwon, Dong-Yeul] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Inst Biotechnol, Dept Oriental Pharm,Coll Pharm, Jeonbuk, South Korea; [Choi, Jang-Gi; Chahar, Harendra S.; Bharaj, Preeti] Texas Tech Univ, Ctr Excellence Infect Dis Res, Dept Biomed Sci, Paul L Foster Sch Med,Hlth Sci Ctr, El Paso, TX USA; [Mun, Su-Hyun] Wonkwang Univ, Profess Grad Sch Oriental Med, Plus Team BK21, Iksan, Jeonbuk, South Korea; [Shin, Dong-Won] Sunchon Natl Univ, Dept Oriental Med Resources, Jeonnam, South Korea	Wonkwang University; Texas Tech University System; Texas Tech University; Wonkwang University; Sunchon National University	Kwon, DY (corresponding author), Wonkwang Univ, Wonkwang Oriental Med Res Inst, Inst Biotechnol, Dept Oriental Pharm,Coll Pharm, Jeonbuk, South Korea.	sssimi@wku.ac.kr	Choi, Jang-gi/AAP-6339-2020; Bharaj, Preeti/AAX-7394-2020	Bharaj, Preeti/0000-0002-9411-9373	Wonkwang University	Wonkwang University	This research was supported by Wonkwang University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 1998, J APPL MICROBIOL, V84, P439, DOI 10.1046/j.1365-2672.1998.00363.x; Ali NAA, 2001, J ETHNOPHARMACOL, V74, P173, DOI 10.1016/S0378-8741(00)00364-0; Alvarez J, 2004, J CLIN MICROBIOL, V42, P1734, DOI 10.1128/JCM.42.4.1734-1738.2004; Aqil F, 2005, J BASIC MICROB, V45, P106, DOI 10.1002/jobm.200410355; Barrow PA, 2011, AVIAN PATHOL, V40, P1, DOI 10.1080/03079457.2010.542575; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Belley A, 2008, ANTIMICROB AGENTS CH, V52, P3820, DOI 10.1128/AAC.00361-08; Chen AP, 2003, J BIOL CHEM, V278, P23381, DOI 10.1074/jbc.M212042200; Choi JG, 2009, MOLECULES, V14, P1773, DOI 10.3390/molecules14051773; Choi JG, 2008, J MICROBIOL BIOTECHN, V18, P1848, DOI 10.4014/jmb.0800.025; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Falconer SB, 2011, NAT CHEM BIOL, V7, P416, DOI [10.1038/nchembio.590, 10.1038/NCHEMBIO.590]; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Gebreyes WA, 2004, J ANTIMICROB CHEMOTH, V53, P997, DOI 10.1093/jac/dkh247; Goncalves PP, 1999, MOL BRAIN RES, V71, P178, DOI 10.1016/S0169-328X(99)00183-7; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Hsieh TJ, 2004, FOOD CHEM TOXICOL, V42, P843, DOI 10.1016/j.fct.2004.01.008; IRVIN RT, 1981, J BACTERIOL, V145, P1397, DOI 10.1128/JB.145.3.1397-1403.1981; Jones RN, 2010, J CLIN MICROBIOL, V48, P972, DOI 10.1128/JCM.01829-09; Jung HJ, 2008, J MICROBIOL, V46, P462, DOI 10.1007/s12275-008-0138-7; Kim S, 2010, J KOREAN MED SCI, V25, P1893, DOI 10.3346/jkms.2010.25.12.1693; Kim SP, 2014, J AGR FOOD CHEM, V62, P2384, DOI 10.1021/jf405223q; Lee MH, 2006, INT J FOOD MICROBIOL, V111, P270, DOI 10.1016/j.ijfoodmicro.2006.06.004; LEIVE L, 1965, BIOCHEM BIOPH RES CO, V18, P13, DOI 10.1016/0006-291X(65)90874-0; Linnett P E, 1979, Methods Enzymol, V55, P472; Mascellino MT, 1998, DRUG EXP CLIN RES, V24, P139; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Meakins S, 2008, MICROB DRUG RESIST, V14, P31, DOI 10.1089/mdr.2008.0777; Mun SH, 2014, FOODBORNE PATHOG DIS, V11, P234, DOI 10.1089/fpd.2013.1627; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Perez-Capilla T, 2005, J BACTERIOL, V187, P1515, DOI 10.1128/JB.187.4.1515-1518.2005; Perron GG, 2008, FEMS MICROBIOL LETT, V281, P17, DOI 10.1111/j.1574-6968.2007.01045.x; Poppe C, 2002, MICROB DRUG RESIST, V8, P107, DOI 10.1089/107662902760190653; Pournaras S, 2011, INT J ANTIMICROB AG, V37, P244, DOI 10.1016/j.ijantimicag.2010.10.031; Sciuto AM, 2001, J APPL TOXICOL, V21, P33, DOI 10.1002/jat.729; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; Threlfall EJ, 2002, FEMS MICROBIOL REV, V26, P141, DOI 10.1016/S0168-6445(02)00092-X; Threlfall EJ, 2000, ACTA VET SCAND, P63; Trkov M, 2003, INT J FOOD MICROBIOL, V80, P67, DOI 10.1016/S0168-1605(02)00138-1; Vidaillac C, 2009, ANTIMICROB AGENTS CH, V53, P2360, DOI 10.1128/AAC.01452-08	41	37	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102697	10.1371/journal.pone.0102697	http://dx.doi.org/10.1371/journal.pone.0102697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048362	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100061
J	Christie, KS; Ruess, RW; Lindberg, MS; Mulder, CP				Christie, Katie S.; Ruess, Roger W.; Lindberg, Mark S.; Mulder, Christa P.			Herbivores Influence the Growth, Reproduction, and Morphology of a Widespread Arctic Willow	PLOS ONE			English	Article							PLANT COMMUNITY RESPONSES; TUNDRA VEGETATION; SHRUB EXPANSION; FELTLEAF WILLOW; SNOWSHOE HARE; GRAZING LAWNS; MOOSE; ALASKA; QUALITY; FLOODPLAIN	Shrubs have expanded in Arctic ecosystems over the past century, resulting in significant changes to albedo, ecosystem function, and plant community composition. Willow and rock ptarmigan (Lagopus lagopus, L. muta) and moose (Alces alces) extensively browse Arctic shrubs, and may influence their architecture, growth, and reproduction. Furthermore, these herbivores may alter forage plants in such a way as to increase the quantity and accessibility of their own food source. We estimated the effect of winter browsing by ptarmigan and moose on an abundant, early-successional willow (Salix alaxensis) in northern Alaska by comparing browsed to unbrowsed branches. Ptarmigan browsed 82-89% of willows and removed 30-39% of buds, depending on study area and year. Moose browsed 17-44% of willows and browsed 39-55% of shoots. Browsing inhibited apical dominance and activated axillary and adventitious buds to produce new vegetative shoots. Ptarmigan-and moose-browsed willow branches produced twice the volume of shoot growth but significantly fewer catkins the following summer compared with unbrowsed willow branches. Shoots on browsed willows were larger and produced 40-60% more buds compared to unbrowsed shoots. This process of shoot production at basal parts of the branch is the mechanism by which willows develop a highly complex "broomed'' architecture after several years of browsing. Broomed willows were shorter and more likely to be re-browsed by ptarmigan, but not moose. Ptarmigan likely benefit from the greater quantity and accessibility of buds on previously browsed willows and may increase the carrying capacity of their own habitat. Despite the observed tolerance of willows to browsing, their vertical growth and reproduction were strongly inhibited by moose and ptarmigan. Browsing by these herbivores therefore needs to be considered in future models of shrub expansion in the Arctic.	[Christie, Katie S.; Ruess, Roger W.; Lindberg, Mark S.; Mulder, Christa P.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Christie, KS (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	kschristie@alaska.edu			NSERC Canada [CGS D2-374218-2009]; National Park Service; UAF Institute of Arctic Biology; Alaska EPSCoR	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Park Service; UAF Institute of Arctic Biology; Alaska EPSCoR	NSERC Canada (CGS D2-374218-2009), The National Park Service, The UAF Institute of Arctic Biology, and Alaska EPSCoR provided financial support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER S, 1980, ARCTIC ALPINE RES, V12, P531, DOI 10.2307/1550499; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bowyer R. Terry, 2003, Alces, V39, P193; Bryant JP, 2003, OIKOS, V102, P25, DOI 10.1034/j.1600-0706.2003.12443.x; BRYANT JP, 1987, ECOLOGY, V68, P1319, DOI 10.2307/1939216; BRYANT JP, 1985, ECOLOGY, V66, P1564, DOI 10.2307/1938018; Butler LG, 2007, J BIOGEOGR, V34, P1622, DOI 10.1111/j.1365-2699.2007.01713.x; Caswell, 2000, MATRIX POPULATION MO; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Chapin FS, 1996, J VEG SCI, V7, P347, DOI 10.2307/3236278; Christie KS, 2014, POLAR BIOL, V37, P1111, DOI 10.1007/s00300-014-1504-z; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; DANELL K, 1994, J MAMMAL, V75, P833, DOI 10.2307/1382465; den Herder M, 2008, BASIC APPL ECOL, V9, P324, DOI 10.1016/j.baae.2007.03.005; DUTOIT JT, 1990, ECOLOGY, V71, P149; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; FOX JF, 1984, OECOLOGIA, V63, P128, DOI 10.1007/BF00379794; Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Hakkarainen H, 2007, POLAR BIOL, V30, P619, DOI 10.1007/s00300-006-0221-7; Harrison KA, 2008, ECOLOGY BROWSING GRA; HENRY GHR, 1991, ARCTIC, V44, P38; HIK DS, 1990, J ECOL, V78, P180, DOI 10.2307/2261044; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; IRVING L, 1967, ARCTIC, V20, P77; Makhabu SW, 2006, ACTA OECOL, V30, P136, DOI 10.1016/j.actao.2006.02.005; Masters M, 1980, MOOSE UTILIZATION RI; Mauer FJ, 1998, ALCES-N AM MOOSE CON, V34, P75; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; MOLVAR EM, 1993, OECOLOGIA, V94, P472, DOI 10.1007/BF00566961; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; NIEMELA P, 1988, J APPL ECOL, V25, P761, DOI 10.2307/2403744; Olofsson J, 2009, GLOBAL CHANGE BIOL, V15, P2681, DOI 10.1111/j.1365-2486.2009.01935.x; Pajunen A, 2012, OIKOS, V121, P1544, DOI 10.1111/j.1600-0706.2011.20115.x; Pajunen AM, 2009, ARCT ANTARCT ALP RES, V41, P478, DOI 10.1657/1938-4246-41.4.478; Person BT, 2003, OECOLOGIA, V135, P583, DOI 10.1007/s00442-003-1197-4; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Ravolainen VT, 2011, BASIC APPL ECOL, V12, P643, DOI 10.1016/j.baae.2011.09.009; Rea RV, 2012, CAN FIELD NAT, V126, P189; RISENHOOVER KL, 1989, J WILDLIFE MANAGE, V53, P568, DOI 10.2307/3809178; Schickhoff U, 2002, PHYTOCOENOLOGIA, V32, P145, DOI 10.1127/0340-269X/2002/0032-0145; Shipley LA, 1998, CAN J ZOOL, V76, P1722, DOI 10.1139/cjz-76-9-1722; Skarpe Christina, 2008, V195, P217, DOI 10.1007/978-3-540-72422-3_9; Stewart KM, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)167[1:HOBNAE]2.0.CO;2; Stolter C, 2008, ECOL MONOGR, V78, P167, DOI 10.1890/07-0401.1; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tape KD, 2010, ECOSCIENCE, V17, P186, DOI 10.2980/17-2-3323; Tolvanen A, 2001, EVOL ECOL, V15, P443, DOI 10.1023/A:1016049301905; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; WEEDEN RB, 1969, AUK, V86, P271, DOI 10.2307/4083500; Yu Q, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045505	54	21	21	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101716	10.1371/journal.pone.0101716	http://dx.doi.org/10.1371/journal.pone.0101716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047582	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100012
J	Boa, BCS; Souza, MDC; Leite, RD; Silva, SVD; Barja-Fidalgo, TC; Kraemer-Aguiar, LG; Bouskela, E				Boa, Beatriz C. S.; Souza, Maria das Gracas C.; Leite, Richard D.; da Silva, Simone V.; Barja-Fidalgo, Thereza Christina; Kraemer-Aguiar, Luiz Guilherme; Bouskela, Eliete			Chronic Aerobic Exercise Associated to Dietary Modification Improve Endothelial Function and eNOS Expression in High Fat Fed Hamsters	PLOS ONE			English	Article							INDUCED OBESE RATS; INSULIN-RESISTANCE; CHEEK POUCH; WEIGHT-LOSS; MICROVASCULAR DYSFUNCTION; SKELETAL-MUSCLE; MACROMOLECULAR PERMEABILITY; PHYSICAL-EXERCISE; SHEAR-STRESS; CHEST PAIN	Obesity is epidemic in the western world and central adipose tissue deposition points to increased cardiovascular morbidity and mortality, independently of any association between obesity and other cardiovascular risk factors. Physical exercise has been used as non-pharmacological treatment to significantly reverse/attenuate obesity comorbidities. In this study we have investigated effects of exercise and/or dietary modification on microcirculatory function, body composition, serum glucose, iNOS and eNOS expression on 120 male hamsters treated for 12 weeks with high fat chow (HF, n = 30) starting on the 21st day of birth. From week 12 to 20, animals were randomly separated in HF (no treatment change), return to standard chow (HFSC, n = 30), high fat chow associated to an aerobic exercise training program (AET) (HFEX, n = 30) and return to standard chow+AET (HFSCEX, n = 30). Microvascular reactivity in response to acetylcholine and sodium nitroprusside and macromolecular permeability increase induced by 30 minutes ischemia followed by reperfusion were assessed on the cheek pouch preparation. Total body fat and aorta eNOS and iNOS expression by immunoblotting assay were evaluated on the experimental day. Compared to HFSC and HFSCEX groups, HF and HFEX ones presented increased visceral fat [(mean +/- SEM) (HF) 4.9 +/- 1.5 g and (HFEX) 4.7 +/- 0.9 g vs. (HFSC)*3.0 +/- 0.7 g and (HFSCEX)*1.9 +/- 0.4 g/100 g BW]; impaired endothelial-dependent vasodilatation [Ach 10(-8) M (HF) 87.9 +/- 2.7%; (HFSC)*116.7 +/- 5.9%; (HFEX)*109.1 +/- 4.6%; (HFSCEX)*105 +/- 2.8%; Ach10(-6) M (HF) 95.3 +/- 3.1%; (HFSC)*126 +/- 6.2%; (HFEX)*122.5 +/- 2.8%; (HFSCEX)*118.1 +/- 4.3% and Ach10(-4) M (HF) 109.5 +/- 4.8%; (HFSC)*149.6 +/- 6.6%; (HFEX)*143.5 +/- 5.4% and (HFSCEX)* 139.4 +/- 5.2%], macromolecular permeability increase after ischemia/reperfusion [(HF) 40.5 +/- 4.2; (HFSC)*19.0 +/- 1.6; (HFEX)*18.6 +/- 2.1 and (HFSCEX)*21.5 +/- 3.7 leaks/cm(2)), decreased eNOS expression, increased leptin and glycaemic levels. Endothelial-independent microvascular reactivity was similar between groups, suggesting that only endothelial damage had occurred. Our results indicate that an aerobic routine and/or dietary modification may cause significant improvements to high fat fed animals, diminishing visceral depots, increasing eNOS expression and reducing microcirculatory dysfunction.	[Boa, Beatriz C. S.; Souza, Maria das Gracas C.; Leite, Richard D.; Kraemer-Aguiar, Luiz Guilherme; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil; [da Silva, Simone V.; Barja-Fidalgo, Thereza Christina] Univ Estado Rio De Janeiro, Biomed Ctr, Inst Biol Roberto Alcantara Gomes, Dept Cell Biol, Rio De Janeiro, RJ, Brazil; [Kraemer-Aguiar, Luiz Guilherme] Univ Estado Rio De Janeiro, Fac Med Sci, Biomed Ctr, Dept Internal Med, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Boa, BCS (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil.	beatrizcsb@gmail.com	Leite, Richard D/H-1060-2012; BOA, BEATRIZ/D-1158-2013	BOA, BEATRIZ/0000-0002-1015-7410; Kraemer-Aguiar, Luiz Guilherme/0000-0002-3528-5881	National Research Council [CNPq - 474116/2008-5]; Research Supporting Agency of Rio de Janeiro State [FAPERJ - E-26/111.732/2011]	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Research Supporting Agency of Rio de Janeiro State	This study was supported by grants from the National Research Council (CNPq - 474116/2008-5) and the Research Supporting Agency of Rio de Janeiro State (FAPERJ - E-26/111.732/2011). Further information concerning those agencies are founded on the following URLs: CNPq: http://www.cnpq.br/web/guest/geral;jsessionid=7C28AB306E0BE450036DAE00943FFEB0, FAPERJ: http://www.faperj.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 1999, J AM COLL CARDIOL, V34, P631, DOI 10.1016/S0735-1097(99)00259-4; Antonios TFT, 2001, EUR HEART J, V22, P1144, DOI 10.1053/euhj.2000.2442; Ay L, 2010, J THROMB HAEMOST, V8, P759, DOI 10.1111/j.1538-7836.2010.03766.x; Bays HE, 2011, J AM COLL CARDIOLOGY, V57; Beeton Christine, 2007, J Vis Exp, P266, DOI 10.3791/266; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bourgoin F, 2008, AM J PHYSIOL-HEART C, V295, pH1044, DOI 10.1152/ajpheart.00516.2008; BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478, DOI 10.1152/ajpheart.1992.262.2.H478; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Cho JK, 2011, INT J SPORTS MED; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Collier SR, 2015, J HUM HYPERTENS, V29, P53, DOI 10.1038/jhh.2014.33; Costa RRS, 2011, MICROVASC RES, V82, P416, DOI 10.1016/j.mvr.2011.08.007; de Jongh RT, 2006, J CLIN ENDOCR METAB, V91, P5100, DOI 10.1210/jc.2006-1103; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; Dias IBF, 2013, CLIN ENDOCRINOL, V79, P667, DOI 10.1111/cen.12195; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; DULING BR, 1973, MICROVASC RES, V5, P423, DOI 10.1016/0026-2862(73)90059-9; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gu Q, 2014, EXP GERONTOL; Hainer V, 2011, DIABETES CARE S2, V34; Heunks LMA, 2000, J APPL PHYSIOL, V88, P2054, DOI 10.1152/jappl.2000.88.6.2054; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; Jonk AM, 2007, PHYSIOLOGY, V22, P252, DOI 10.1152/physiol.00012.2007; Kowalska I, 1999, J PHYSIOL PHARMACOL, V50, P309; Kullo IJ, 2007, AM J HYPERTENS, V20, P735, DOI 10.1016/j.amjhyper.2007.01.015; Laughlin MH, 1996, HDB PHYSL 120; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; Mawatari K, 2004, ATHEROSCLEROSIS, V175, P203, DOI 10.1016/j.atherosclerosis.2003.10.015; Miyazawa-Hoshimoto S, 2005, AM J PHYSIOL-ENDOC M, V288, pE1128, DOI 10.1152/ajpendo.00003.2004; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; NUUTILA P, 1992, J CLIN INVEST, V89, P1767, DOI 10.1172/JCI115780; PERSSON NH, 1985, INT J MICROCIRC, V4, P257; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Pinheiro AR, 2007, NUTR METAB CARDIOVAS, V17, P365, DOI 10.1016/j.numecd.2006.01.009; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; SAX FL, 1987, NEW ENGL J MED, V317, P1366, DOI 10.1056/NEJM198711263172202; Singer G, 2007, MICROCIRCULATION, V14, P375, DOI 10.1080/10739680701283158; Smith AG, 2005, INT J BIOCHEM CELL B, V37, P2047, DOI 10.1016/j.biocel.2005.03.002; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; SVENSJO E, 1978, UPSALA J MED SCI, V83, P71, DOI 10.3109/03009737809179115; Traupe T, 2002, J HYPERTENS, V20, P2239, DOI 10.1097/00004872-200211000-00024; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Warboys CM, 2010, AM J PHYSIOL-HEART C, V298, pH1850, DOI 10.1152/ajpheart.00114.2010; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Zhang J, 2012, AM J PHYSIOL-HEART C, V302, pH983, DOI 10.1152/ajpheart.00168.2011; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102554	10.1371/journal.pone.0102554	http://dx.doi.org/10.1371/journal.pone.0102554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036223	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200068
J	Chuang, KH; Hsieh, YC; Chiang, IS; Chuang, CH; Kao, CH; Cheng, TC; Wang, YT; Lin, WW; Chen, BM; Roffler, SR; Huang, MY; Cheng, TL				Chuang, Kuo-Hsiang; Hsieh, Yuan-Chin; Chiang, I-Shiuan; Chuang, Chih-Hung; Kao, Chien-Han; Cheng, Ta-Chun; Wang, Yeng-Tseng; Lin, Wen-Wei; Chen, Bing-Mae; Roffler, Steve R.; Huang, Ming-Yii; Cheng, Tian-Lu			High-Throughput Sorting of the Highest Producing Cell via a Transiently Protein-Anchored System	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RECOMBINANT CHO-CELLS; FLOW-CYTOMETRY; HIGH-AFFINITY; ANTIBODY; EXPRESSION; SECRETION; SELECTION; DISPLAY; GENE	Developing a high-throughput method for the effecient selection of the highest producing cell is very important for the production of recombinant protein drugs. Here, we developed a novel transiently protein-anchored system coupled with fluorescence activated cell sorting (FACS) for the efficient selection of the highest producing cell. A furin cleavage peptide (RAKR) was used to join a human anti-epithelial growth factor antibody (alpha EGFR Ab) and the extracellular-transmembranecytosolic domains of the mouse B7-1 antigen (B7). The furin inhibitor can transiently switch secreted alpha EGFR Ab into a membrane-anchored form. After cell sorting, the level of membrane alpha EGFR Ab-RAKR-B7 is proportional to the amount of secreted alpha EGFR Ab in the medium. We further selected 23 alpha EGFR Ab expressing cells and demonstrated a high correlation (R-2 = 0.9165) between the secretion level and surface expression levels of alpha EGFR Ab. These results suggested that the novel transiently protein-anchored system can easily and efficiently select the highest producing cells, reducing the cost for the production of biopharmaceuticals.	[Chuang, Kuo-Hsiang; Cheng, Ta-Chun] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Hsieh, Yuan-Chin; Kao, Chien-Han] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chiang, I-Shiuan; Chuang, Chih-Hung; Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Wang, Yeng-Tseng] Kaohsiung Med Univ, Coll Med, Dept Biochem, Kaohsiung, Taiwan; [Lin, Wen-Wei] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chen, Bing-Mae; Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Dept Radiat Oncol, Kaohsiung, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chuang, Kuo-Hsiang] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan; [Chuang, Kuo-Hsiang] Taipei Med Univ, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Taipei Medical University	Huang, MY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Dept Radiat Oncol, Kaohsiung, Taiwan.	miyihu@gmail.com; tlcheng@kmu.edu.tw	Wang, Yeng-Tseng/AAZ-4252-2020; Huang, Ming-Yii/AAS-8132-2021; Roffler, Steve R/N-7791-2018; Wang, Yeng-Tseng/AAZ-7564-2020	Roffler, Steve R/0000-0003-2543-7295; Wang, Yeng-Tseng/0000-0002-7575-4953; Cheng, Tian-Lu/0000-0002-7263-2766; Hsieh, Yuan Chin/0000-0003-4005-5340; Wang, Yeng-Tseng/0000-0002-6159-2690	National Science Council, Taipei, Taiwan [NSC103-2325-B-037- 007, NSC102-2321-B-037-001, NSC 102-2320-B-038-043-MY2]; National Research Program for Biopharmaceuticals; National Health Research Institutes, Taiwan [NHRI-EX103-10238SC]; Ministry of Health and Welfare, Taiwan [MOHW103-TD-B-111-05]; 102NSYSU-KMU Joint Research Project [NSYSUKMU103 I-003]; Comprehensive Cancer Center of Taipei Medical University/Health and welfare surcharge of tobacco products [MOHW103-TD-B-111-01]; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Biopharmaceuticals; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Health and Welfare, Taiwan; 102NSYSU-KMU Joint Research Project; Comprehensive Cancer Center of Taipei Medical University/Health and welfare surcharge of tobacco products; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	This work was supported by grants from the National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan (NSC103-2325-B-037- 007, NSC102-2321-B-037-001, and NSC 102-2320-B-038-043-MY2), the National Health Research Institutes, Taiwan (NHRI-EX103-10238SC), the Ministry of Health and Welfare, Taiwan (MOHW103-TD-B-111-05), 102NSYSU-KMU Joint Research Project (NSYSUKMU103 I-003), Comprehensive Cancer Center of Taipei Medical University/Health and welfare surcharge of tobacco products (MOHW103-TD-B-111-01) and the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borth N, 2000, BIOTECHNOL BIOENG, V71, P266, DOI 10.1002/1097-0290(2000)71:4<266::AID-BIT1016>3.0.CO;2-2; Bowers PM, 2014, METHODS, V65, P44, DOI 10.1016/j.ymeth.2013.06.010; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; Chen CP, 2012, PROTEIN ENG DES SEL, V25, P367, DOI 10.1093/protein/gzs033; Chuang KH, 2010, J NUCL MED, V51, P933, DOI 10.2967/jnumed.109.071977; Chuang KH, 2010, ANAL CHEM, V82, P2355, DOI 10.1021/ac902548m; DeMaria CT, 2007, BIOTECHNOL PROGR, V23, P465, DOI 10.1021/bp060298i; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Hammill L, 2000, CYTOTECHNOLOGY, V34, P27, DOI 10.1023/A:1008186113245; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Holmes P, 1999, J IMMUNOL METHODS, V230, P141, DOI 10.1016/S0022-1759(99)00181-7; Jostock T, 2010, APPL MICROBIOL BIOT, V87, P1517, DOI 10.1007/s00253-010-2625-0; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lin YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075084; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; MEILHOC E, 1989, J IMMUNOL METHODS, V121, P167, DOI 10.1016/0022-1759(89)90157-9; Meng YG, 2000, GENE, V242, P201, DOI 10.1016/S0378-1119(99)00524-7; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Muller-Loennies S, 2000, GLYCOBIOLOGY, V10, P121, DOI 10.1093/glycob/10.2.121; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Potter PK, 1999, EUR J IMMUNOL, V29, P3936, DOI 10.1002/(SICI)1521-4141(199912)29:12<3936::AID-IMMU3936>3.3.CO;2-B; POWELL KT, 1990, BIO-TECHNOL, V8, P333, DOI 10.1038/nbt0490-333; PUCK TT, 1955, P NATL ACAD SCI USA, V41, P432, DOI 10.1073/pnas.41.7.432; Shi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091712; Shiryaev SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054290; Sunderji R, 1997, BIOTECHNOL BIOENG, V55, P136, DOI 10.1002/(SICI)1097-0290(19970705)55:1<136::AID-BIT14>3.0.CO;2-K; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Yoon SO, 2006, J BIOL CHEM, V281, P6985, DOI 10.1074/jbc.M511165200	32	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102569	10.1371/journal.pone.0102569	http://dx.doi.org/10.1371/journal.pone.0102569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036759	Green Submitted, gold, Green Published			2022-12-27	WOS:000339615200071
J	Halupka, K				Halupka, Konrad			Spreading Information in a Network of Interacting Neighbours	PLOS ONE			English	Article							SONG; EVOLUTION; BIRDS; SYNCHRONIZATION; DISCRIMINATION; BEHAVIOR; NOISE	Dispersed individuals can coordinate the onset of life history events, like reproduction or migration, on a large (population) spatial scale. However, the mechanism of this synchronisation has not yet been identified. In many species signals produced by one individual stimulate signalling activity of immediate neighbours. I propose that such local focuses of signalling could transform into waves propagating in space. This hypothesis predicts that signalling self-organizes into bursts, because neighbours tend to enter activity and refractory periods together. Temporal characteristics of such pulses should be more similar in locations proximate to one another than in distant ones. Finally, denser populations should produce relatively more complex wave patterns, since the number of propagating waves is proportional to the number of individuals. These predictions were tested in an analysis of time series of numbers of territorial songs in chaffinches, Fringilla coelebs, and the results supported the hypothesis. Time series of singing activity had memory of their past states: they were autoregressive processes with spectra in which low frequency oscillations predominated. The degree of similarity in two synchronously sampled time series, measured as a Euclidean distance between their spectra, decreased with the increasing physical distance of sampling spots and the number of signalling males. It is concluded that networks of interacting neighbours may integrate populations synchronising life cycles of dispersed individuals.	Univ Wroclaw, Dept Behav Ecol, PL-50138 Wroclaw, Poland	University of Wroclaw	Halupka, K (corresponding author), Univ Wroclaw, Dept Behav Ecol, PL-50138 Wroclaw, Poland.	konrad.halupka@uni.wroc.pl	Halupka, Konrad/E-2534-2018	Halupka, Konrad/0000-0001-5139-1134	University of Wroclaw [1069/S/KBEE/2012-2013]	University of Wroclaw	Research was funded by the University of Wroclaw (1069/S/KBEE/2012-2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RJ, 1962, ANN NY ACAD SCI, V102, P296, DOI 10.1111/j.1749-6632.1962.tb13648.x; Backwell P, 2006, ACTA ETHOL, V9, P22, DOI 10.1007/s10211-005-0009-8; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beauchamp G, 2011, ETHOLOGY, V117, P326, DOI 10.1111/j.1439-0310.2011.01875.x; Brooke PN, 2000, BEHAV ECOL SOCIOBIOL, V49, P79, DOI 10.1007/s002650000256; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, ANIM BEHAV, V77, P37, DOI 10.1016/j.anbehav.2008.09.009; Calabrese JM, 2004, AM NAT, V164, P25, DOI 10.1086/421443; Caro SP, 2007, BEHAV PROCESS, V75, P1, DOI 10.1016/j.beproc.2007.02.011; Catchpole CK, 1979, VOCAL COMMUNICATION; Chang C.-I., 2013, HYPERSPECTRAL DATA P, DOI [10.1002/9781118269787, DOI 10.1002/9781118269787]; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Cramp S.E., 1994, HDB BIRDS EUROPE MID; Darling F.F., 1938, BIRD FLOCKS BREEDING; Evans LE, 2009, ANIM BEHAV, V78, P671, DOI 10.1016/j.anbehav.2009.05.031; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; Hare JF, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2153; Hau M, 2008, ORNITOL NEOTROP, V19, P39; Helm B, 2006, ANIM BEHAV, V72, P245, DOI 10.1016/j.anbehav.2005.12.007; Henson SM, 2010, AUK, V127, P571, DOI 10.1525/auk.2010.09202; HUTCHINSON JMC, 1993, ANIM BEHAV, V45, P1153, DOI 10.1006/anbe.1993.1139; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Jovani R, 2008, P ROY SOC B-BIOL SCI, V275, P1557, DOI 10.1098/rspb.2008.0125; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Araujo SBL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057362; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Mathevon N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001580; McGregor PK, 2005, ANIMAL COMMUNICATION; Naguib M, 2000, ANIM BEHAV, V59, P715, DOI 10.1006/anbe.1999.1354; Naguib M, 2006, BEHAV ECOL SOCIOBIOL, V59, P419, DOI 10.1007/s00265-005-0066-z; Naguib Marc, 2005, P300, DOI 10.1017/CBO9780511610363.018; Porter TA, 2001, J ZOOL, V253, P383, DOI 10.1017/S0952836901000358; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SMITH DG, 1979, BEHAVIOUR, V68, P193, DOI 10.1163/156853979X00313; Trainor BC, 2006, GEN COMP ENDOCR, V148, P252, DOI 10.1016/j.ygcen.2006.03.006; Ward L. M., 2007, SCHOLARPEDIA, V2, P1537, DOI [DOI 10.4249/SCH0LARPEDIA.1537, 10.4249/scholarpedia.1537, DOI 10.4249/SCHOLARPEDIA.1537]; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; YOMTOV Y, 1975, AUK, V92, P778, DOI 10.2307/4084788; Ziegler TE, 2013, AM J PRIMATOL, V75, P202, DOI 10.1002/ajp.22061	42	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102801	10.1371/journal.pone.0102801	http://dx.doi.org/10.1371/journal.pone.0102801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036106	gold, Green Submitted, Green Published			2022-12-27	WOS:000339615200088
J	Schuck, S; Weinhold, A; Luu, VT; Baldwin, IT				Schuck, Stefan; Weinhold, Arne; Van Thi Luu; Baldwin, Ian T.			Isolating Fungal Pathogens from a Dynamic Disease Outbreak in a Native Plant Population to Establish Plant-Pathogen Bioassays for the Ecological Model Plant Nicotiana attenuata	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS; HERBIVORE INTERACTIONS; JASMONIC ACID; 1ST REPORT; RESISTANCE; SPECIFICITY; GENE; TIME; IDENTIFICATION; FLUCTUATIONS	The wild tobacco species Nicotiana attenuata has been intensively used as a model plant to study its interaction with insect herbivores and pollinators in nature, however very little is known about its native pathogen community. We describe a fungal disease outbreak in a native N. attenuata population comprising 873 plants growing in an area of about 1500 m(2). The population was divided into 14 subpopulations and disease symptom development in the subpopulations was monitored for 16 days, revealing a waxing and waning of visible disease symptoms with some diseased plants recovering fully. Native fungal N. attenuata pathogens were isolated from diseased plants, characterized genetically, chemotaxonomically and morphologically, revealing several isolates of the ascomycete genera Fusarium and Alternaria, that differed in the type and strength of the disease symptoms they caused in bioassays on either detached leaves or intact soil-grown plants. These isolates and the bioassays will empower the study of N. attenuata-pathogen interactions in a realistic ecological context.	[Schuck, Stefan; Weinhold, Arne; Van Thi Luu; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Weinhold, Arne/R-1739-2016; Schepler-Luu, Van/ABG-1804-2021	Weinhold, Arne/0000-0001-9999-7450; Schepler-Luu, Van/0000-0002-0709-2783; Baldwin, Ian/0000-0001-5371-2974; Schuck, Stefan/0000-0002-3959-4884	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahmooli IH, 2013, PLANT DIS, V97, P687, DOI 10.1094/PDIS-09-12-0828-PDN; Allen C, 2009, PLANT PHYSIOL, V150, P1631, DOI 10.1104/pp.109.140004; Andersen B, 2005, PHYTOPATHOLOGY, V95, P1021, DOI 10.1094/PHYTO-95-1021; Andersen B, 2004, J AGR FOOD CHEM, V52, P7507, DOI 10.1021/jf048727k; Andrew M, 2009, MYCOLOGIA, V101, P95, DOI 10.3852/08-135; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Barrett LG, 2009, NEW PHYTOL, V183, P513, DOI 10.1111/j.1469-8137.2009.02927.x; Belisario A, 2004, PLANT DIS, V88, P426, DOI 10.1094/PDIS.2004.88.4.426A; Belisario A, 2002, PLANT DIS, V86, P599, DOI [10.1094/PDIS.2002.86.6.599, 10.1094/PDIS.2002.86.1.74A]; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Bhattacharya S, 2012, PLANT J, V71, P587, DOI 10.1111/j.1365-313X.2012.05011.x; Bilgrami K S, 1994, Mycotoxin Res, V10, P56, DOI 10.1007/BF03192251; Bonaventure G, 2011, PLANT CELL ENVIRON, V34, P1507, DOI 10.1111/j.1365-3040.2011.02348.x; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; BURDON JJ, 1991, EVOLUTION, V45, P205, DOI [10.1111/j.1558-5646.1991.tb05278.x, 10.2307/2409494]; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DINOOR A, 1984, ANNU REV PHYTOPATHOL, V22, P443; Fourie P, 2013, PHYTOPATHOLOGY, V103, P281, DOI 10.1094/PHYTO-07-11-0194; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; GARDES M, 1991, CAN J BOT, V69, P180, DOI 10.1139/b91-026; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hadwiger LA, 2008, PHYTOPATHOLOGY, V98, P372, DOI 10.1094/PHYTO-98-4-0372; Hettenhausen C, 2012, PLANT PHYSIOL, V158, P759, DOI 10.1104/pp.111.190074; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Khan J, 2009, PHYTOPATHOLOGY, V99, P796, DOI 10.1094/PHYTO-99-7-0796; Kriss AB, 2010, PHYTOPATHOLOGY, V100, P784, DOI 10.1094/PHYTO-100-8-0784; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Lebeda A, 2008, EUR J PLANT PATHOL, V122, P127, DOI 10.1007/s10658-008-9291-4; LENNE JM, 1991, ANNU REV PHYTOPATHOL, V29, P35, DOI 10.1146/annurev.py.29.090191.000343; LEONARDSSCHIPPERS C, 1992, MOL GEN GENET, V233, P278, DOI 10.1007/BF00587589; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Nemri A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041366; Nielsen KF, 2003, J CHROMATOGR A, V1002, P111, DOI 10.1016/S0021-9673(03)00490-4; Ostry V, 2008, WORLD MYCOTOXIN J, V1, P175, DOI 10.3920/WMJ2008.x013; Pham GH, 2004, PLANT SURFACE MICROBIOLOGY, P237; Pulimood TB, 2007, J ALLERGY CLIN IMMUN, V120, P610, DOI 10.1016/j.jaci.2007.04.045; Rayapuram C, 2007, PLANT J, V52, P700, DOI 10.1111/j.1365-313X.2007.03267.x; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Schmidt SM, 2011, CURR OPIN PLANT BIOL, V14, P392, DOI 10.1016/j.pbi.2011.03.006; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Simmons EG, 1999, HOST SPECIFIC TOXIN; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Steppuhn A, 2008, MOL ECOL, V17, P3717, DOI 10.1111/j.1365-294X.2008.03862.x; Sun Y, 2012, MYCOL PROG, V11, P781, DOI 10.1007/s11557-011-0790-x; Tack AJM, 2012, J EVOLUTION BIOL, V25, P1918, DOI 10.1111/j.1420-9101.2012.02588.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; van der Does HC, 2007, MOL PLANT MICROBE IN, V20, P1175, DOI 10.1094/MPMI-20-10-1175; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; Wang L, 2013, J GENET GENOMICS, V40, P597, DOI 10.1016/j.jgg.2013.10.001; Weber RW, 2003, IMMUNOL ALLERGY CLIN, V23, P411, DOI 10.1016/S0889-8561(03)00062-6; Weidenborner M, 2001, CAN J MICROBIOL, V47, P460, DOI 10.1139/cjm-47-5-460; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WILLS RT, 1993, AUST J ECOL, V18, P145, DOI 10.1111/j.1442-9993.1993.tb00439.x; Wu JQ, 2008, PLANT PHYSIOL, V146, P927, DOI 10.1104/pp.107.114785; Xue AG, 2003, PHYTOPATHOLOGY, V93, P329, DOI 10.1094/PHYTO.2003.93.3.329	66	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102915	10.1371/journal.pone.0102915	http://dx.doi.org/10.1371/journal.pone.0102915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036191	Green Published, gold			2022-12-27	WOS:000339615200096
J	Datta, S; Roychoudhury, S; Ghosh, A; Dasgupta, D; Ghosh, A; Chakraborty, B; Roy, S; Gupta, S; Santra, AK; Datta, S; Das, K; Dhali, GK; Chowdhury, A; Banerjee, S				Datta, Somenath; Roychoudhury, Shrabasti; Ghosh, Alip; Dasgupta, Debanjali; Ghosh, Amit; Chakraborty, Bidhan; Roy, Sukanta; Gupta, Subash; Santra, Amal Kumar; Datta, Simanti; Das, Kausik; Dhali, Gopal Krishna; Chowdhury, Abhijit; Banerjee, Soma			Distinct Distribution Pattern of Hepatitis B Virus Genotype C and D in Liver Tissue and Serum of Dual Genotype Infected Liver Cirrhosis and Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; DISEASE PATIENTS; HBV GENOTYPES; DNA; INTEGRATION; RECOMBINATION; SUBGENOTYPES; MIXTURES	Aims: The impact of co-infection of several hepatitis B virus (HBV) genotypes on the clinical outcome remains controversial. This study has for the first time investigated the distribution of HBV genotypes in the serum and in the intrahepatic tissue of liver cirrhotic (LC) and hepatocellular carcinoma (HCC) patients from India. In addition, the genotype-genotype interplay and plausible mechanism of development of HCC has also been explored. Methods: The assessment of HBV genotypes was performed by nested PCR using either surface or HBx specific primers from both the circulating virus in the serum and replicative virus that includes covalently closed circular DNA (cccDNA) and relaxed circular DNA (rcDNA) of HBV from the intrahepatic tissue. The integrated virus within the host chromosome was genotyped by Alu-PCR method. Each PCR products were cloned and sequences of five randomly selected clones were subsequently analysed. Results: HBV/genotype D was detected in the serum of all LC and HCC patients whereas the sequences of the replicative HBV DNA (cccDNA and rcDNA) from the intrahepatic tissue of the same patients revealed the presence of both HBV/ genotype C and D. The sequences of the integrated viruses exhibited the solo presence of HBV/genotype C in the majority of LC and HCC tissues while both HBV/genotype C and D clones were found in few patients in which HBV/genotype C was predominated. Moreover, compared to HBV/genotype D, genotype C had higher propensity to generate double strand breaks, ER stress and reactive oxygen species and it had also showed higher cellular homologous-recombination efficiency that engendered more chromosomal rearrangements, which ultimately led to development of HCC. Conclusions: Our study highlights the necessity of routine analysis of HBV genotype from the liver tissue of each chronic HBV infected patient in clinical practice to understand the disease prognosis and also to select therapeutic strategy.	[Datta, Somenath; Roychoudhury, Shrabasti; Ghosh, Alip; Dasgupta, Debanjali; Ghosh, Amit; Chakraborty, Bidhan; Santra, Amal Kumar; Datta, Simanti; Banerjee, Soma] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Liver Res Ctr, Kolkata, India; [Roy, Sukanta] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Dept Gastrointestinal Surg, Kolkata, India; [Gupta, Subash] Indraprastha Apollo Hosp, Ctr Liver & Biliary Surg, New Delhi, India; [Das, Kausik; Chowdhury, Abhijit] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Dept Hepatol, Kolkata, India; [Dhali, Gopal Krishna] Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Dept Gastroenterol, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Banerjee, S (corresponding author), Postgrad Inst Med Educ & Res, Sch Digest & Liver Dis, Liver Res Ctr, Kolkata, India.	somabanerjee70@gmail.com	Dasgupta, Debanjali/AGT-9408-2022; Dhali, Gopal Krishna/AAE-5331-2022; Ghosh, Amit/AAB-3140-2019; Datta, Somenath/AAD-7752-2021	Dasgupta, Debanjali/0000-0001-8307-9719; Dhali, Gopal Krishna/0000-0002-6759-5067; Das, Kausik/0000-0001-6602-5516	West-Bengal State DST [75/ST/P/ST/9G-21/2012]	West-Bengal State DST	West-Bengal State DST has funded this study through the project no: 75/ST/P/S&T/9G-21/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, J ANTIMICROB CHEMOTH, V55, P139, DOI 10.1093/jac/dkh533; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Biswas A, 2009, HEPATOL RES, V39, P53, DOI 10.1111/j.1872-034X.2008.00403.x; Borkakoty BJ, 2008, INDIAN J MED RES, V127, P65; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chattopadhyay S, 2006, WORLD J GASTROENTERO, V12, P6702, DOI 10.3748/wjg.v12.i41.6702; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; COUROUCE AM, 1983, DEV BIOL STAND, V54, P527; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Fang ZL, 2004, WORLD J GASTROENTERO, V10, P3264, DOI 10.3748/wjg.v10.i22.3264; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Gerner PR, 1998, VIROLOGY, V245, P163, DOI 10.1006/viro.1998.9126; Ghosh S, 2012, CLIN MICROBIOL INFEC, V18, pE412, DOI 10.1111/j.1469-0691.2012.03975.x; Guerrero RB, 2005, J HEPATOL, V42, P760, DOI 10.1016/j.jhep.2005.02.005; Hannoun C, 2002, J INFECT DIS, V186, P752, DOI 10.1086/342599; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Henderson G, 1997, MOL CELL BIOL, V17, P3779, DOI 10.1128/MCB.17.7.3779; Hu XW, 2010, J HUAZHONG U SCI-MED, V30, P265, DOI 10.1007/s11596-010-0341-8; Ismail AM, 2014, INT J INFECT DIS, V20, P1, DOI 10.1016/j.ijid.2013.12.007; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2002, J CLIN MICROBIOL, V40, P22, DOI 10.1128/JCM.40.1.22-25.2002; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kao JH, 2003, GASTROENTEROLOGY, V125, P1916, DOI 10.1053/j.gastro.2003.05.014; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Kumar Kailash, 2011, Asian J Transfus Sci, V5, P144, DOI 10.4103/0973-6247.83240; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Liu CJ, 2005, J INFECT DIS, V192, P1308, DOI 10.1086/444470; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/BF00207507; Ma JC, 2007, HEPATOB PANCREAT DIS, V6, P166; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Nishikawa M, 2001, CANCER RES, V61, P1843; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Srisuttee R, 2011, INT J MOL MED, V28, P255, DOI 10.3892/ijmm.2011.699; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Thakur V, 2002, J GASTROEN HEPATOL, V17, P165, DOI 10.1046/j.1440-1746.2002.02605.x; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang ZH, 2007, HEPATOL RES, V37, pS36, DOI 10.1111/j.1872-034X.2007.00102.x; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301	47	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102573	10.1371/journal.pone.0102573	http://dx.doi.org/10.1371/journal.pone.0102573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032957	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300065
J	Ling, BH; Piatak, M; Rogers, L; Johnson, AM; Russell-Lodrigue, K; Hazuda, DJ; Lifson, JD; Veazey, RS				Ling, Binhua; Piatak, Michael, Jr.; Rogers, Linda; Johnson, Ann-Marie; Russell-Lodrigue, Kasi; Hazuda, Daria J.; Lifson, Jeffrey D.; Veazey, Ronald S.			Effects of Treatment with Suppressive Combination Antiretroviral Drug Therapy and the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid; (SAHA) on SIV-Infected Chinese Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; RALTEGRAVIR INTENSIFICATION; IMMUNE ACTIVATION; HIV-1 INFECTION; VALPROIC ACID; IN-VIVO; RESERVOIR; PATHOGENESIS; INDIVIDUALS; REPLICATION	Objectives: Viral reservoirs-persistent residual virus despite combination antiretroviral therapy (cART)-remain an obstacle to cure of HIV-1 infection. Difficulty studying reservoirs in patients underscores the need for animal models that mimics HIV infected humans on cART. We studied SIV-infected Chinese-origin rhesus macaques (Ch-RM) treated with intensive combination antiretroviral therapy (cART) and 3 weeks of treatment with the histone deacetyalse inhibitor, suberoylanilide hydroxamic acid (SAHA). Methods: SIVmac251 infected Ch-RM received reverse transcriptase inhibitors PMPA and FTC and integrase inhibitor L-870812 beginning 7 weeks post infection. Integrase inhibitor L-900564 and boosted protease inhibitor treatment with Darunavir and Ritonavir were added later. cART was continued for 45 weeks, with daily SAHA administered for the last 3 weeks, followed by euthanasia/necropsy. Plasma viral RNA and cell/tissue-associated SIV gag RNA and DNA were quantified by qRT-PCR/qPCR, with flow cytometry monitoring changes in immune cell populations. Results: Upon cART initiation, plasma viremia declined, remaining <30 SIV RNA copy Eq/ml during cART, with occasional blips. Decreased viral replication was associated with decreased immune activation and partial restoration of intestinal CD4+ T cells. SAHA was well tolerated but did not result in demonstrable treatment-associated changes in plasma or cell associated viral parameters. Conclusions: The ability to achieve and sustain virological suppression makes cART-suppressed, SIV-infected Ch-RM a potentially useful model to evaluate interventions targeting residual virus. However, despite intensive cART over one year, persistent viral DNA and RNA remained in tissues of all three animals. While well tolerated, three weeks of SAHA treatment did not demonstrably impact viral RNA levels in plasma or tissues; perhaps reflecting dosing, sampling and assay limitations.	[Ling, Binhua; Rogers, Linda; Johnson, Ann-Marie; Russell-Lodrigue, Kasi; Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Ling, Binhua] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Hazuda, Daria J.] Merck Res Labs, West Point, PA USA; [Veazey, Ronald S.] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA	Tulane University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Merck & Company; Tulane University	Ling, BH (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	bling@tulane.edu; rveazey@tulane.edu	Russell-Lodrigue, Kasi E/G-7084-2016	Russell-Lodrigue, Kasi E/0000-0003-3719-0779	NIAID [R01 AI093307-01A1]; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [OD011104-51]; CI/NIH [HHSN261200800001E]; National Center for Research Resources;  [R01 AI084793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093307, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; CI/NIH; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by R01 AI084793 (RSV), NIAID R01 AI093307-01A1 (BL) and the National Center for Research Resources, and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through grant no. OD011104-51, and in part with federal funds from CI/NIH Contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, J INFECT DIS; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cory TJ, 2013, CURR OPIN HIV AIDS; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Del Prete GQ, 2013, CURR OPIN HIV AIDS, V8, P262, DOI 10.1097/COH.0b013e328361cf40; Duvic M, 2007, BIOL-TARGETS THER, V1, P377; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lewin SR, 2011, AIDS, V25, P885, DOI 10.1097/QAD.0b013e3283467041; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Ling BH, 2013, AIDS RES HUM RETROV, V29, P1465, DOI [10.1089/aid.2012.0378, 10.1089/AID.2012.0378]; Ling BH, 2010, J INFECT DIS, V202, P1846, DOI 10.1086/657413; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; Plaeger SF, 2012, AIDS RES HUM RETROV, V28, P469, DOI [10.1089/aid.2011.0213, 10.1089/AID.2011.0213]; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Van Rompay KKA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-57; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102795	10.1371/journal.pone.0102795	http://dx.doi.org/10.1371/journal.pone.0102795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033210	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300091
J	Mao, XG; Egli, R; Petersen, N; Hanzlik, M; Liu, XM				Mao, Xuegang; Egli, Ramon; Petersen, Nikolai; Hanzlik, Marianne; Liu, Xiuming			Magneto-Chemotaxis in Sediment: First Insights	PLOS ONE			English	Article							BACTERIA; CULTIVATION; PROKARYOTES; HEMISPHERE	Magnetotactic bacteria (MTB) use passive alignment with the Earth magnetic field as a mean to increase their navigation efficiency in horizontally stratified environments through what is known as magneto-aerotaxis (M-A). Current M-A models have been derived from MTB observations in aqueous environments, where a >80% alignment with inclined magnetic field lines produces a one-dimensional search for optimal living conditions. However, the mean magnetic alignment of MTB in their most widespread living environment, i.e. sediment, has been recently found to be <1%, greatly reducing or even eliminating the magnetotactic advantage deduced for the case of MTB in water. In order to understand the role of magnetotaxis for MTB populations living in sediment, we performed first M-A observations with lake sediment microcosms. Microcosm experiments were based on different combinations of (1) MTB position with respect to their preferred living depth (i.e. above, at, and below), and (2) magnetic field configurations (i.e. correctly and incorrectly polarized vertical fields, horizontal fields, and zero fields). Results suggest that polar magnetotaxis is more complex than implied by previous experiments, and revealed unexpected differences between two types of MTB living in the same sediment. Our main findings are: (1) all investigated MTB benefit of a clear magnetotactic advantage when they need to migrate over macroscopic distances for reaching their optimal living depth, (2) magnetotaxis is not used by all MTB under stationary, undisturbed conditions, (3) some MTB can rely only on chemotaxis for macroscopic vertical displacements in sediment while other cannot, and (4) some MTB use a fixed polar M-A mechanisms, while other can switch their M-A polarity, performing what can be considered as a mixed polar-axial M-A. These observations demonstrate that sedimentary M-A is controlled by complex mechanical, chemical, and temporal factors that are poorly reproduced in aqueous environments.	[Mao, Xuegang; Liu, Xiuming] Fujian Normal Univ, Coll Geog Sci, Fuzhou, Peoples R China; [Egli, Ramon] Cent Inst Meteorol & Geodynam, Vienna, Austria; [Mao, Xuegang; Petersen, Nikolai] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Hanzlik, Marianne] Tech Univ Munich, Dept Chem, D-80290 Munich, Germany; [Liu, Xiuming] Macquarie Univ, Dept Geog & Environm, Sydney, NSW 2109, Australia	Fujian Normal University; University of Munich; Technical University of Munich; University of Munich; Macquarie University	Egli, R (corresponding author), Cent Inst Meteorol & Geodynam, Vienna, Austria.	ramon.egli@zamg.ac.at	Egli, Ramon/AAQ-3767-2020	Egli, Ramon/0000-0001-6825-4742	German Research Foundation [EG 294/1-1, EG 294/2-1]; China Scholarship Council; Natural Science Foundation of China (NSF) [41210002]	German Research Foundation(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council); Natural Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC))	EG 294/1-1 and EG 294/2-1, German Research Foundation (http://www.dfg.de/en/); XM was funded by the China Scholarship Council (en.csc.edu.cn/). Natural Science Foundation of China (NSF grant 41210002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245; BLAKEMORE RP, 1980, NATURE, V286, P384, DOI 10.1038/286384a0; Chen CF, 2011, APPL MICROBIOL BIOT, V90, P269, DOI 10.1007/s00253-010-3017-1; Cox BL, 2002, GEOMICROBIOL J, V19, P387, DOI 10.1080/01490450290098504; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Flies CB, 2005, FEMS MICROBIOL ECOL, V52, P185, DOI 10.1016/j.femsec.2004.11.006; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; Hanzlik M, 1996, EARTH PLANET SC LETT, V145, P125, DOI 10.1016/S0012-821X(96)00191-4; Jogler C, 2010, ENVIRON MICROBIOL, V12, P2466, DOI 10.1111/j.1462-2920.2010.02220.x; KIRSCHVINK JL, 1980, J EXP BIOL, V86, P345; Lin W, 2009, INT MICROBIOL, V12, P237, DOI 10.2436/20.1501.01.103; Mao XG, 2014, GEOCHEM GEOPHY GEOSY, V15, P255, DOI 10.1002/2013GC005034; Pan YX, 2005, EARTH PLANET SC LETT, V232, P109, DOI 10.1016/j.epsl.2005.01.006; PETERMANN H, 1993, EARTH PLANET SC LETT, V117, P223, DOI 10.1016/0012-821X(93)90128-V; Petersen N, 1989, GEOMAGNETISM PALEOMA, P231, DOI DOI 10.1007/978-94-009-0905-2_17; Shapiro OH, 2011, ENV MICROBIOL REP, V3, P233, DOI 10.1111/j.1758-2229.2010.00215.x; Simmons SL, 2006, SCIENCE, V311, P371, DOI 10.1126/science.1122843; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; SPORMANN AM, 1984, FEMS MICROBIOL LETT, V22, P171; SPRING S, 1993, APPL ENVIRON MICROB, V59, P2397, DOI 10.1128/AEM.59.8.2397-2403.1993; Spring S, 2000, FEMS MICROBIOL REV, V24, P573, DOI 10.1016/S0168-6445(00)00046-2; STEINBERGER B, 1994, J FLUID MECH, V273, P189, DOI 10.1017/S0022112094001904; Taktikos J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081936; Zhang WJ, 2010, ENV MICROBIOL REP, V2, P646, DOI 10.1111/j.1758-2229.2010.00150.x	27	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102810	10.1371/journal.pone.0102810	http://dx.doi.org/10.1371/journal.pone.0102810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032699	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300095
J	Ong, JJ; Read, TRH; Vodstrcil, LA; Walker, S; Chen, M; Bradshaw, CS; Garland, SM; Tabrizi, SN; Cornall, A; Grulich, A; Hocking, J; Fairley, CK				Ong, Jason J.; Read, Tim R. H.; Vodstrcil, Lenka A.; Walker, Sandra; Chen, Marcus; Bradshaw, Catriona S.; Garland, Suzanne M.; Tabrizi, Sepehr N.; Cornall, Alyssa; Grulich, Andrew; Hocking, Jane; Fairley, Christopher K.			Detection of Oral Human Papillomavirus in HIV-Positive Men Who Have Sex with Men 3 Years after Baseline: A Follow Up Cross-Sectional Study	PLOS ONE			English	Article							HPV INFECTION; PREVALENCE; AMPLIFICATION; CANCERS; MUCOSAL; HEAD	Background: Human papillomavirus (HPV) is a causative agent in oropharyngeal squamous cell carcinoma. The natural history of oral HPV in HIV-positive men who have sex with men (MSM) is unclear. Methods: Detection of oral human papillomavirus in 173 HIV-positive MSM using oral rinse samples 3 years apart was investigated. HPV DNA was detected by polymerase chain reaction, and genotyped by Roche Linear Array. Results: Of 173 men tested in 2010, 30 had at least one HPV genotype (17%, 95% CI: 12-23), 15 at least one hr-HPV (9%, 95% CI: 5-14) and 8 had HPV 16 (5%, 95% CI: 2-9) detected. In 2013, 33 had at least one HPV genotype (19%, 95% CI: 14-26), 20 had at least one hr-HPV (12%, 95% CI: 7-17) and 7 had HPV 16 (4%, 95% CI: 2-8) detected. Of 30 men at baseline (2010) with any HPV detected, 14 (47%, 95% CI: 28-66) had at least one persistent genotype. Of the 15 men in 2010 with high risk (hr-) HPV, 6 men (40%, 95% CI: 16-68) had at least one persistent hr-HPV genotype. The incidence rate of detection of at least one new HPV genotype was 4.8 per 100 person years (95% CI: 3.1-7.0), of at least one hr-HPV genotype was 3.2 per 100 person years (95% CI: 1.8-5.1) and of HPV 16 was 0.8 per 100 person years (95% CI: 0.2-2.0). The clearance rate was 14.9 per 100 person years (95% CI: 8.2-24.2) for any HPV, 18.2 per 100 person years (95% CI: 8.2-32.7) for hr-HPV and 17.4 per 100 person years (95% CI: 5.0-38.8) for HPV-16. Persistent HPV detection was associated with duration of HIV (OR 1.13 (per additional year), 95% CI: 1.00-1.26) and tonsillectomy (OR 8.17, 95% CI: 1.30-51.40). Conclusion: The same oral HPV genotype was detected again after 3 years in nearly half of HIV-positive men who have sex with men.	[Ong, Jason J.; Vodstrcil, Lenka A.; Hocking, Jane] Univ Melbourne Parkville, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Read, Tim R. H.; Vodstrcil, Lenka A.; Walker, Sandra; Chen, Marcus; Bradshaw, Catriona S.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Read, Tim R. H.; Chen, Marcus; Bradshaw, Catriona S.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Clayton, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.; Cornall, Alyssa] Royal Womens Hosp, Dept Microbiol & Infect Dis, Reg HPV Lab, Net Reference Lab, Parkville, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.; Cornall, Alyssa] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Grulich, Andrew] Univ New S Wales, Kirby Inst, Darlinghurst, NSW, Australia	University of Melbourne; Monash University; University of Melbourne; Murdoch Children's Research Institute; University of New South Wales Sydney; Kirby Institute	Ong, JJ (corresponding author), Univ Melbourne Parkville, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	j.ong@unimelb.edu.au	Hocking, Jane/AAD-5203-2021; Ong, Jason/AAB-3086-2019; Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019	Hocking, Jane/0000-0001-9329-8501; Ong, Jason/0000-0001-5784-7403; Vodstrcil, Lenka/0000-0003-3679-9195; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Health and Research Medical Council [568971]	National Health and Research Medical Council	National Health and Research Medical Council Program grant (568971) (https://www.nhmrc.gov.au/). CK received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachler DC, 2013, CURR OPIN ONCOL, V25, P503, DOI 10.1097/CCO.0b013e32836242b4; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; LaytonHenry J, 1996, INT J GYNECOL CANCER, V6, P193, DOI 10.1046/j.1525-1438.1996.06030193.x; Nasrin M, 2012, Bangladesh Med Res Counc Bull, V38, P59; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Tabrizi SN, 2005, AM J CLIN PATHOL, V123, P896, DOI 10.1309/MPERNJ0G62RECHCQ; Tugizov SM, 2013, VIROLOGY, V446, P378, DOI 10.1016/j.virol.2013.08.018; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Walline Heather M, 2013, JAMA Otolaryngol Head Neck Surg, V139, P1320, DOI 10.1001/jamaoto.2013.5460	19	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102138	10.1371/journal.pone.0102138	http://dx.doi.org/10.1371/journal.pone.0102138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033212	Green Published, gold			2022-12-27	WOS:000339418300035
J	Bainbridge, TW; DeAlmeida, VI; Izrael-Tomasevic, A; Chalouni, C; Pan, B; Goldsmith, J; Schoen, AP; Quinones, GA; Kelly, R; Lill, JR; Sandoval, W; Costa, M; Polakis, P; Arnott, D; Rubinfeld, B; Ernst, JA				Bainbridge, Travis W.; DeAlmeida, Venita I.; Izrael-Tomasevic, Anita; Chalouni, Cecile; Pan, Borlan; Goldsmith, Joshua; Schoen, Alia P.; Quinones, Gabriel A.; Kelly, Ryan; Lill, Jennie R.; Sandoval, Wendy; Costa, Mike; Polakis, Paul; Arnott, David; Rubinfeld, Bonnee; Ernst, James A.			Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-ASSOCIATED ANTIGEN; TOXOPLASMA-GONDII; CELL-MIGRATION; CRD DOMAIN; ACTIVATION; BINDING; GROWTH; COMPLEX	Receptor tyrosine kinase-like orphan receptors (ROR) 1 and 2 are atypical members of the receptor tyrosine kinase (RTK) family and have been associated with several human diseases. The vertebrate RORs contain an ATP binding domain that deviates from the consensus amino acid sequence, although the impact of this deviation on catalytic activity is not known and the kinase function of these receptors remains controversial. Recently, ROR2 was shown to signal through a Wnt responsive, beta-catenin independent pathway and suppress a canonical Wnt/beta-catenin signal. In this work we demonstrate that both ROR1 and ROR2 kinase domains are catalytically deficient while CAM-1, the C. elegans homolog of ROR, has an active tyrosine kinase domain, suggesting a divergence in the signaling processes of the ROR family during evolution. In addition, we show that substitution of the non-consensus residues from ROR1 or ROR2 into CAM-1 and MuSK markedly reduce kinase activity, while restoration of the consensus residues in ROR does not restore robust kinase function. We further demonstrate that the membrane-bound extracellular domain alone of either ROR1 or ROR2 is sufficient for suppression of canonical Wnt3a signaling, and that this domain can also enhance Wnt5a suppression of Wnt3a signaling. Based on these data, we conclude that human ROR1 and ROR2 are RTK-like pseudokinases.	[Bainbridge, Travis W.; Izrael-Tomasevic, Anita; Schoen, Alia P.; Quinones, Gabriel A.; Kelly, Ryan; Lill, Jennie R.; Sandoval, Wendy; Arnott, David; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [DeAlmeida, Venita I.; Goldsmith, Joshua; Costa, Mike; Polakis, Paul; Rubinfeld, Bonnee] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Chalouni, Cecile] Genentech Inc, Ctr Adv Light Microscopy, San Francisco, CA 94080 USA; [Pan, Borlan] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ernst, JA (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	ernst.james@gene.com		Kelly, Ryan/0000-0001-5003-9104; Rubinfeld, Bonnee/0000-0001-9861-6775				Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Henriquez JP, 2012, ACTA PHYSIOL, V204, P128, DOI 10.1111/j.1748-1716.2011.02295.x; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Rajakulendran T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3111pe8; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Shabani M, 2007, TUMOR BIOL, V28, P318, DOI 10.1159/000121405; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; WHITE MF, 1984, J BIOL CHEM, V259, P255; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Zhang XH, 2007, BBA-GEN SUBJECTS, V1770, P1490, DOI 10.1016/j.bbagen.2007.06.017	52	26	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102695	10.1371/journal.pone.0102695	http://dx.doi.org/10.1371/journal.pone.0102695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029443	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600093
J	McCracken, CB; Kiss, ZHT				McCracken, Clinton B.; Kiss, Zelma H. T.			Time and Frequency-Dependent Modulation of Local Field Potential Synchronization by Deep Brain Stimulation	PLOS ONE			English	Article							GLOBUS-PALLIDUS INTERNUS; SUBTHALAMIC NUCLEUS OSCILLATIONS; 20 HZ SLOWS; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; ENTOPEDUNCULAR NUCLEUS; BETA-OSCILLATIONS; GAMMA-ACTIVITY; POSTSYNAPTIC POTENTIALS; ELECTRICAL-STIMULATION	High-frequency electrical stimulation of specific brain structures, known as deep brain stimulation (DBS), is an effective treatment for movement disorders, but mechanisms of action remain unclear. We examined the time-dependent effects of DBS applied to the entopeduncular nucleus (EP), the rat homolog of the internal globus pallidus, a target used for treatment of both dystonia and Parkinson's disease (PD). We performed simultaneous multi-site local field potential (LFP) recordings in urethane-anesthetized rats to assess the effects of high-frequency (HF, 130 Hz; clinically effective), low-frequency (LF, 15 Hz; ineffective) and sham DBS delivered to EP. LFP activity was recorded from dorsal striatum (STR), ventroanterior thalamus (VA), primary motor cortex (M1), and the stimulation site in EP. Spontaneous and acute stimulation-induced LFP oscillation power and functional connectivity were assessed at baseline, and after 30, 60, and 90 minutes of stimulation. HF EP DBS produced widespread alterations in spontaneous and stimulus-induced LFP oscillations, with some effects similar across regions and others occurring in a region-and frequency band-specific manner. Many of these changes evolved over time. HF EP DBS produced an initial transient reduction in power in the low beta band in M1 and STR; however, phase synchronization between these regions in the low beta band was markedly suppressed at all time points. DBS also enhanced low gamma synchronization throughout the circuit. With sustained stimulation, there were significant reductions in low beta synchronization between M1-VA and STR-VA, and increases in power within regions in the faster frequency bands. HF DBS also suppressed the ability of acute EP stimulation to induce beta oscillations in all regions along the circuit. This dynamic pattern of synchronizing and desynchronizing effects of EP DBS suggests a complex modulation of activity along cortico-BG-thalamic circuits underlying the therapeutic effects of GPi DBS for conditions such as PD and dystonia.	[Kiss, Zelma H. T.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Kiss, ZHT (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	zkiss@ucalgary.ca	Kiss, Zelma/D-2342-2016	Kiss, Zelma/0000-0002-8656-2690	Canadian Institutes of Health Research; Parkinson Society Canada; Hotchkiss Brain Institute; Alberta Innovates [201200847] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada; Hotchkiss Brain Institute; Alberta Innovates	This work was supported by a grant from the Canadian Institutes of Health Research. Dr. Kiss is a Clinical Scholar of the Alberta Heritage Foundation for Medical Research. Dr. McCracken received fellowship support from Parkinson Society Canada and Hotchkiss Brain Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; Anderson TR, 2006, J NEUROSCI, V26, P841, DOI 10.1523/JNEUROSCI.3523-05.2006; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Bittar RG, 2005, J CLIN NEUROSCI, V12, P12, DOI 10.1016/j.jocn.2004.03.025; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brucke C, 2012, J NEUROSCI, V32, P1008, DOI 10.1523/JNEUROSCI.3860-11.2012; CARTER DA, 1978, J COMP NEUROL, V177, P113, DOI 10.1002/cne.901770108; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Chen CC, 2006, NEUROLOGY, V66, P418, DOI 10.1212/01.wnl.0000196470.00165.7d; Chen CC, 2007, EXP NEUROL, V205, P214, DOI 10.1016/j.expneurol.2007.01.027; Chen CC, 2006, EXP NEUROL, V202, P480, DOI 10.1016/j.expneurol.2006.07.011; Chen CC, 2011, EXP NEUROL, V231, P91, DOI 10.1016/j.expneurol.2011.05.018; Chiken S, 2013, J NEUROSCI, V33, P2268, DOI 10.1523/JNEUROSCI.4144-11.2013; Cleary DR, 2013, J NEUROPHYSIOL, V109, P978, DOI 10.1152/jn.00420.2012; Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189; Courtemanche R, 2003, J NEUROSCI, V23, P11741; Creed M, 2011, EUR NEUROPSYCHOPHARM, V21, P393, DOI 10.1016/j.euroneuro.2010.06.012; Creed MC, 2012, J NEUROSCI, V32, P9574, DOI 10.1523/JNEUROSCI.1196-12.2012; Creed MC, 2012, EUR NEUROPSYCHOPHARM, V22, P506, DOI 10.1016/j.euroneuro.2011.11.004; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Crowell AL, 2012, BRAIN, V135, P615, DOI 10.1093/brain/awr332; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Eusebio A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00047; Fakhar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058665; Florin E, 2008, CLIN NEUROPHYSIOL, V119, P2098, DOI 10.1016/j.clinph.2008.05.026; Foffani G, 2005, J PHYSIOL-LONDON, V568, P699, DOI 10.1113/jphysiol.2005.089722; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Hristova A, 2000, CLIN NEUROPHARMACOL, V23, P208, DOI 10.1097/00002826-200007000-00007; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Kempf F, 2007, EUR J NEUROSCI, V25, P3137, DOI 10.1111/j.1460-9568.2007.05536.x; Kempf F, 2009, EUR J NEUROSCI, V29, P943, DOI 10.1111/j.1460-9568.2009.06655.x; Kha HT, 2000, J COMP NEUROL, V426, P366; Kiss ZHT, 2007, BRAIN, V130, P2879, DOI 10.1093/brain/awm229; Kita H, 2001, NEUROSCIENCE, V105, P871, DOI 10.1016/S0306-4522(01)00231-7; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Kupsch A, 2003, J NEUROL, V250, P1201, DOI 10.1007/s00415-003-0179-0; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Lai HY, 2014, NEUROIMAGE, V84, P11, DOI 10.1016/j.neuroimage.2013.08.026; Leblois A, 2007, EUR J NEUROSCI, V26, P1701, DOI 10.1111/j.1460-9568.2007.05777.x; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Liu XG, 2002, MOVEMENT DISORD, V17, P346, DOI 10.1002/mds.10038; Liu XG, 2008, BRAIN, V131, P1562, DOI 10.1093/brain/awn083; Lopez-Azcarate J, 2010, J NEUROSCI, V30, P6667, DOI 10.1523/JNEUROSCI.5459-09.2010; Magarinos-Ascone CM, 2008, NEUROSCIENCE, V152, P558, DOI 10.1016/j.neuroscience.2008.01.001; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Marceglia S, 2006, J PHYSIOL-LONDON, V571, P579, DOI 10.1113/jphysiol.2005.100271; McCairn KW, 2012, NEUROREPORT, V23, P206, DOI 10.1097/WNR.0b013e32834fab9d; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Min HK, 2012, NEUROIMAGE, V63, P1408, DOI 10.1016/j.neuroimage.2012.08.006; Montgomery EB, 2006, CLIN NEUROPHYSIOL, V117, P2691, DOI 10.1016/j.clinph.2006.08.011; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; NAGY JI, 1978, BRAIN RES, V158, P15, DOI 10.1016/0006-8993(78)90003-3; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pogosyan A, 2006, EXP NEUROL, V202, P271, DOI 10.1016/j.expneurol.2006.06.014; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Ruge D, 2011, MOVEMENT DISORD, V26, P1913, DOI 10.1002/mds.23731; Sani S, 2009, EXP NEUROL, V216, P295, DOI 10.1016/j.expneurol.2008.12.006; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Sharott A, 2008, BRAIN, V131, P473, DOI 10.1093/brain/awm324; Shin DS, 2007, NEUROSCIENCE, V149, P68, DOI 10.1016/j.neuroscience.2007.06.055; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Silberstein P, 2003, BRAIN, V126, P2597, DOI 10.1093/brain/awg267; Tang JKH, 2007, J NEUROPHYSIOL, V98, P720, DOI 10.1152/jn.01107.2006; Tang JKH, 2007, EXP NEUROL, V204, P845, DOI 10.1016/j.expneurol.2007.01.010; Timmermann L, 2004, MOVEMENT DISORD, V19, P1328, DOI 10.1002/mds.20198; van der Meer MAA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00300; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Weinberger M, 2012, CLIN NEUROPHYSIOL, V123, P358, DOI 10.1016/j.clinph.2011.07.029; Weinberger M, 2009, EXP NEUROL, V219, P58, DOI 10.1016/j.expneurol.2009.05.014; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Wu YR, 2001, MOVEMENT DISORD, V16, P208, DOI 10.1002/mds.1046	98	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102576	10.1371/journal.pone.0102576	http://dx.doi.org/10.1371/journal.pone.0102576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029468	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600086
J	Kelsh, R; You, R; Horzempa, C; Zheng, MZ; McKeown-Longo, PJ				Kelsh, Rhiannon; You, Ran; Horzempa, Carol; Zheng, Mingzhe; McKeown-Longo, Paula J.			Regulation of the Innate Immune Response by Fibronectin: Synergism between the III-1 and EDA Domains	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; TOLL-LIKE RECEPTORS; EXTRA DOMAIN; EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; POSITIVE FEEDBACK; INTEGRIN-BINDING; A FIBRONECTIN; TENASCIN-C; INFLAMMATION	Fibronectin is a critical component of the extracellular matrix and alterations to its structure will influence cellular behavior. Matrix fibronectin is subjected to both mechanical and biochemical regulation. The Type III domains of fibronectin can be unfolded in response to increased cellular contractility, included or excluded from the molecule by alternative splicing mechanisms, or released from the matrix by proteolysis. Using Inflammatory Cytokine microarrays we found that the alternatively spliced fibronectin Type III domain, FnEDA, and the partially unfolded III-1 domain, FnIII-1c, induced the expression of a multitude of pro-inflammatory cytokines in human dermal fibroblasts, most notably CXCL1-3, IL-8 and TNF alpha. FnIII-1c, a peptide representing an unfolded intermediate structure of the first Type III domain has been shown to initiate the toll-like receptor-4 (TLR4)-NF kappa B-dependent release of cytokines from human dermal fibroblasts (You, et al., J. Biol. Chem., 2010). Here we demonstrate that FnIII-1c and the alternatively spliced FnEDA domain induce a TLR4 dependent activation of p38 MAP kinase and its downstream effector, MAPKAP Kinase-2 (MK-2), to regulate cytokine expression in fibroblasts. RT-qPCR analysis indicated that the p38-MK-2 pathway regulates IL-8 mRNA stability. Interestingly, addition of FnIII-1c and FnEDA synergistically enhanced TLR4-dependent IL-8 release. These data indicate that Fn contains two Type III domains which can activate TLR signaling to induce an inflammatory response in fibroblasts. Furthermore, our data identifies the NF-kappa B and p38/MK2 signaling pathways as transducers of signals initiated in response to structural changes in fibronectin.	[Kelsh, Rhiannon; You, Ran; Horzempa, Carol; Zheng, Mingzhe; McKeown-Longo, Paula J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	McKeown-Longo, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	mckeowp@mail.amc.edu			National Institutes of Health [R01 CA58626]; NATIONAL CANCER INSTITUTE [R01CA058626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA58626. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Arslan F, 2011, CIRC RES, V108, P582, DOI 10.1161/CIRCRESAHA.110.224428; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Booth AJ, 2012, J PATHOL, V226, P609, DOI 10.1002/path.3010; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Bradshaw M.J., 2013, ACTA BIOMATER; Bradshaw MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002845; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; BUSBY TF, 1995, J BIOL CHEM, V270, P18558, DOI 10.1074/jbc.270.31.18558; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; DENO DC, 1983, AM J PHYSIOL, V245, pR564, DOI 10.1152/ajpregu.1983.245.4.R564; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Feaver RE, 2010, CIRC RES, V106, P1703, DOI 10.1161/CIRCRESAHA.109.216283; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gee EPS, 2013, J BIOL CHEM, V288, P21329, DOI 10.1074/jbc.M113.462077; Gee EPS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002373; Gondokaryono SP, 2007, J LEUKOCYTE BIOL, V82, P657, DOI 10.1189/jlb.1206730; Hirshoren N, 2013, ANN ALLERG ASTHMA IM, V110, P322, DOI 10.1016/j.anai.2013.03.002; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hocking DC, 2008, CIRC RES, V102, P372, DOI 10.1161/CIRCRESAHA.107.158501; Homandberg GA, 1999, FRONT BIOSCI, V4, pD713; Kelsh Rhiannon M, 2013, Trends Cancer Res, V9, P1; Kendal-Wright CE, 2010, PLACENTA, V31, P665, DOI 10.1016/j.placenta.2010.06.007; Khan MM, 2012, STROKE, V43, P1376, DOI 10.1161/STROKEAHA.111.635516; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Knapinska AM, 2005, CURR GENOMICS, V6, P471, DOI 10.2174/138920205774482954; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Kumar P, 2003, BLOOD, V101, P3960, DOI 10.1182/blood-2002-04-1237; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; McFadden JP, 2011, CLIN DERMATOL, V29, P257, DOI 10.1016/j.clindermatol.2010.11.003; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Miura S, 2007, BIOL PHARM BULL, V30, P891, DOI 10.1248/bpb.30.891; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Mogami H, 2013, J BIOL CHEM, V288, P1953, DOI 10.1074/jbc.M112.424366; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; Muro AF, 1998, FEBS LETT, V437, P137, DOI 10.1016/S0014-5793(98)01201-0; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; OH E, 1981, P NATL ACAD SCI-BIOL, V78, P3218, DOI 10.1073/pnas.78.5.3218; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Peleg O, 2012, BIOPHYS J, V103, P1909, DOI 10.1016/j.bpj.2012.09.028; Piccinini AM, 2012, CELL REP, V2, P914, DOI 10.1016/j.celrep.2012.09.005; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Schedin P, 2000, J CELL SCI, V113, P795; Schor SL, 2001, BREAST CANCER RES, V3, P373, DOI 10.1186/bcr325; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sofat N, 2009, INT J EXP PATHOL, V90, P463, DOI 10.1111/j.1365-2613.2009.00676.x; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sweeney SE, 2006, ANN RHEUM DIS, V65, P83, DOI 10.1136/ard.2006.058388; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Terhorst D, 2010, AM J CLIN DERMATOL, V11, P1, DOI 10.2165/11311110-000000000-00000; THOMPSON C, 1989, J CLIN INVEST, V84, P1226, DOI 10.1172/JCI114289; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115, DOI 10.1615/CritRevImmunol.v31.i2.30; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; van der Straaten HM, 2004, J INVEST DERMATOL, V123, P1057, DOI 10.1111/j.0022-202X.2004.23474.x; Volz KS, 2012, VASC PHARMACOL, V56, P288, DOI 10.1016/j.vph.2012.02.010; Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; You R, 2010, J BIOL CHEM, V285, P36255, DOI 10.1074/jbc.C110.176990; You R, 2009, MATRIX BIOL, V28, P101, DOI 10.1016/j.matbio.2009.01.003; Zheng MZ, 2011, J CANCER, V2, P478, DOI 10.7150/jca.2.478; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	75	63	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102974	10.1371/journal.pone.0102974	http://dx.doi.org/10.1371/journal.pone.0102974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051083	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100072
J	Brenes, JC; Schwarting, RKW				Brenes, Juan C.; Schwarting, Rainer K. W.			Attribution and Expression of Incentive Salience Are Differentially Signaled by Ultrasonic Vocalizations in Rats	PLOS ONE			English	Article							FOOD-SEEKING; REWARD; REINFORCEMENT; COCAINE; BEHAVIOR; DEPRIVATION; AGGRESSION; EXTINCTION; MOTIVATION; AROUSAL	During Pavlovian incentive learning, the affective properties of rewards are thought to be transferred to their predicting cues. However, how rewards are represented emotionally in animals is widely unknown. This study sought to determine whether 50-kHz ultrasonic vocalizations (USVs) in rats may signal such a state of incentive motivation to natural, nutritional rewards. To this end, rats learned to anticipate food rewards and, across experiments, the current physiological state (deprived vs. sated), the type of learning mechanism recruited (Pavlovian vs. instrumental), the hedonic properties of UCS (low vs. high palatable food), and the availability of food reward (continued vs. discontinued) were manipulated. Overall, we found that reward-cues elicited 50-kHz calls as they were signaling a putative affective state indicative of incentive motivation in the rat. Attribution and expression of incentive salience, however, seemed not to be an unified process, and could be teased apart in two different ways: 1) under high motivational state (i.e., hunger), the attribution of incentive salience to cues occurred without being expressed at the USVs level, if reward expectations were higher than the outcome; 2) in all experiments when food rewards were devalued by satiation, reward cues were still able to elicit USVs and conditioned anticipatory activity although reward seeking and consumption were drastically weakened. Our results suggest that rats are capable of representing rewards emotionally beyond apparent, immediate physiological demands. These findings may have translational potential in uncovering mechanisms underlying aberrant and persistent motivation as observed in drug addiction, gambling, and eating disorders.	[Brenes, Juan C.] Univ Costa Rica, Inst Psychol Res, San Pedro, Costa Rica; [Brenes, Juan C.] Univ Costa Rica, Neurosci Res Ctr, San Pedro, Costa Rica; [Brenes, Juan C.; Schwarting, Rainer K. W.] Univ Marburg, Marburg, Germany	Universidad Costa Rica; Universidad Costa Rica; Philipps University Marburg	Brenes, JC (corresponding author), Univ Costa Rica, Inst Psychol Res, Rodrigo Facio Campus, San Pedro, Costa Rica.	brenesaenz@gmail.com	Schwarting, RAINER/AAJ-1516-2021	Schwarting, Rainer/0000-0002-4686-3974	Deutsche Forschungsgemeinschaft [Schw 559/10-1]; Deutscher Akademischer Austauschdienst (DAAD, Germany); University of Costa Rica	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD, Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Costa Rica	This work was supported by the grant Schw 559/10-1 from the Deutsche Forschungsgemeinschaft. JCB was funded by the Deutscher Akademischer Austauschdienst (DAAD, Germany), and the University of Costa Rica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL A, 1958, PSYCHOL BULL, V55, P102, DOI 10.1037/h0043125; AMSEL A, 1977, SCIENCE, V197, P786, DOI 10.1126/science.560717; AZRIN NH, 1966, J EXP ANAL BEHAV, V9, P191, DOI 10.1901/jeab.1966.9-191; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Baron A, 2005, BEHAV ANALYST, V28, P85, DOI 10.1007/BF03392107; Berridge KC, 2001, PSYCHOL LEARN MOTIV, V40, P223, DOI 10.1016/s0079-7421(00)80022-5; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; BINDRA D, 1978, BEHAV BRAIN SCI, V1, P41, DOI 10.1017/S0140525X00059380; Bolles RC, 1975, THEORY MOTIVATION, P330; Brandon SE, 2003, BEHAV PROCESS, V62, P5, DOI 10.1016/S0376-6357(03)00016-0; Browning JR, 2011, NEUROPHARMACOLOGY, V61, P268, DOI 10.1016/j.neuropharm.2011.04.012; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Coffey KR, 2013, BEHAV BRAIN RES, V237, P256, DOI 10.1016/j.bbr.2012.09.041; CORNELL CE, 1989, PHYSIOL BEHAV, V45, P695, DOI 10.1016/0031-9384(89)90281-3; Covington HE, 2003, EUR J PHARMACOL, V467, P1, DOI 10.1016/S0014-2999(03)01558-9; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Daly H.B., 1974, PSYCHOL LEARNING MOT, P187, DOI [10.1016/S0079-7421(08)60455-7, DOI 10.1016/S0079-7421(08)60455-7]; DANDREA T, 1971, J EXP ANAL BEHAV, V15, P319, DOI 10.1901/jeab.1971.15-319; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; FLAHERTY CF, 1985, ANIM LEARN BEHAV, V13, P309, DOI 10.3758/BF03200025; Hull C, 1952, BEHAV SYSTEM INTRO B, P151; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Konorski J, 1967, INTEGRATIVE ACTIVITY, P29; Meyer PJ, 2012, PSYCHOPHARMACOLOGY, V219, P999, DOI 10.1007/s00213-011-2429-7; Mowrer OH, 1960, LEARNING THEORY BEHA, DOI DOI 10.1037/10802-000; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Natusch C, 2010, PHARMACOL BIOCHEM BE, V96, P251, DOI 10.1016/j.pbb.2010.05.013; PANKSEPP J, 1992, PSYCHOL REV, V99, P554, DOI 10.1037/0033-295X.99.3.554; Papini M.R., 1997, REV GEN PSYCHOL, V1, P175, DOI [10.1037/1089-2680.1.2.175, DOI 10.1037/1089-2680.1.2.175]; Pecoraro NC, 1999, J EXP PSYCHOL ANIM B, V25, P153, DOI 10.1037/0097-7403.25.2.153; Petrovich GD, 2007, PHYSIOL BEHAV, V90, P362, DOI 10.1016/j.physbeh.2006.09.031; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; Robinson MJF, 2013, CURR BIOL, V23, P282, DOI 10.1016/j.cub.2013.01.016; SCHACHTER S, 1968, SCIENCE, V161, P751, DOI 10.1126/science.161.3843.751; Schwarting RKW, 2007, BEHAV BRAIN RES, V182, P208, DOI 10.1016/j.bbr.2007.01.029; Timberlake W, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P155; Toates FM, 1986, MOTIVATIONAL SYSTEMS, P121; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286; Willey AR, 2013, BEHAV BRAIN RES, V245, P107, DOI 10.1016/j.bbr.2013.02.020; Williams SN, 2010, J PHARMACOL EXP THER, V332, P463, DOI 10.1124/jpet.109.158535; Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; WONG PTP, 1979, ANIM LEARN BEHAV, V7, P111, DOI 10.3758/BF03209667	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102414	10.1371/journal.pone.0102414	http://dx.doi.org/10.1371/journal.pone.0102414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047234	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100029
J	Dougherty, K; Smith, BA; Moore, AF; Maitland, S; Fanger, C; Murillo, R; Baltrus, DA				Dougherty, Kevin; Smith, Brian A.; Moore, Autumn F.; Maitland, Shannon; Fanger, Chris; Murillo, Rachel; Baltrus, David A.			Multiple Phenotypic Changes Associated with Large-Scale Horizontal Gene Transfer	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; NATURAL TRANSFORMATION; H-NS; EXPRESSION; PROTEINS; COST; POPULATION; FITNESS	Horizontal gene transfer often leads to phenotypic changes within recipient organisms independent of any immediate evolutionary benefits. While secondary phenotypic effects of horizontal transfer (i.e., changes in growth rates) have been demonstrated and studied across a variety of systems using relatively small plasmids and phage, little is known about the magnitude or number of such costs after the transfer of larger regions. Here we describe numerous phenotypic changes that occur after a large-scale horizontal transfer event (similar to 1 Mb megaplasmid) within Pseudomonas stutzeri including sensitization to various stresses as well as changes in bacterial behavior. These results highlight the power of horizontal transfer to shift pleiotropic relationships and cellular networks within bacterial genomes. They also provide an important context for how secondary effects of transfer can bias evolutionary trajectories and interactions between species. Lastly, these results and system provide a foundation to investigate evolutionary consequences in real time as newly acquired regions are ameliorated and integrated into new genomic contexts.	[Dougherty, Kevin; Smith, Brian A.; Moore, Autumn F.; Maitland, Shannon; Fanger, Chris; Murillo, Rachel; Baltrus, David A.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA	University of Arizona	Baltrus, DA (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	Baltrus@email.arizona.edu		Baltrus, David/0000-0002-5166-9551	University of Arizona	University of Arizona	This research was funded through startup funds to DAB from the University of Arizona. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Baltrus DA, 2008, EVOLUTION, V62, P39, DOI 10.1111/j.1558-5646.2007.00271.x; Baltrus DA, 2013, TRENDS ECOL EVOL, V28, P489, DOI 10.1016/j.tree.2013.04.002; Baltrus DA, 2012, MOL PLANT MICROBE IN, V25, P877, DOI 10.1094/MPMI-08-11-0218; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Baynham PJ, 2006, J BACTERIOL, V188, P132, DOI 10.1128/JB.188.1.132-140.2006; Bergstrom CT, 2000, GENETICS, V155, P1505; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bragg JG, 2009, TRENDS GENET, V25, P5, DOI 10.1016/j.tig.2008.10.007; Busquets A, 2012, J BACTERIOL, V194, P5477, DOI 10.1128/JB.01257-12; Campos MA, 2006, ANTIMICROB AGENTS CH, V50, P2361, DOI 10.1128/AAC.01437-05; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Dahlberg C, 2003, GENETICS, V165, P1641; Dethlefsen L, 2007, J BACTERIOL, V189, P3237, DOI 10.1128/JB.01686-06; Dorman CJ, 2009, NUCLEIC ACIDS RES, V37, P672, DOI 10.1093/nar/gkn996; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Gaillard M, 2008, P NATL ACAD SCI USA, V105, P7058, DOI 10.1073/pnas.0801269105; Goncalves GAL, 2012, BIOTECHNOL J, V7, P251, DOI 10.1002/biot.201100062; Harrison PW, 2010, TRENDS MICROBIOL, V18, P141, DOI 10.1016/j.tim.2009.12.010; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Heuer H, 2007, FEMS MICROBIOL ECOL, V59, P738, DOI 10.1111/j.1574-6941.2006.00223.x; HIGGINS CF, 1988, CELL, V52, P569, DOI 10.1016/0092-8674(88)90470-9; Hockett KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059850; Inglis RF, 2012, BIOL LETT, V9, DOI [10.1038/nature00823, DOI 10.1038/NATURE00823]; Jurgen B, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-41; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lee MC, 2013, GENETICS, V193, P943, DOI 10.1534/genetics.112.148502; Lind PA, 2010, MOL MICROBIOL, V75, P1078, DOI 10.1111/j.1365-2958.2009.07030.x; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Park C, 2012, GENOME BIOL EVOL, V4, P523, DOI 10.1093/gbe/evs030; Paytubi S, 2014, ENVIRON MICROBIOL, V16, P950, DOI 10.1111/1462-2920.12244; Platt TG, 2012, P ROY SOC B-BIOL SCI, V279, P1691, DOI 10.1098/rspb.2011.2002; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rankin DJ, 2011, HEREDITY, V106, P1, DOI 10.1038/hdy.2010.24; Ricci JCD, 2000, CRIT REV BIOTECHNOL, V20, P79, DOI 10.1080/07388550008984167; Romanchuk A, 2014, PLASMID, V73, P16, DOI 10.1016/j.plasmid.2014.04.002; Sato T, 1998, MICROBIOL IMMUNOL, V42, P467, DOI 10.1111/j.1348-0421.1998.tb02310.x; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Shintani M, 2010, ENVIRON MICROBIOL, V12, P1413, DOI 10.1111/j.1462-2920.2009.02110.x; Sikorski J, 2002, APPL ENVIRON MICROB, V68, P865, DOI 10.1128/AEM.68.2.865-873.2002; Singh G, 2010, MICROB PATHOGENESIS, V49, P196, DOI 10.1016/j.micpath.2010.05.013; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Takeda T., 2011, INT J EVOL BIOL, DOI [10.1016/j.jmb.2006.12.032, DOI 10.1016/J.JMB.2006.12.032, 10.4061/2011/685015]; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	61	22	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102170	10.1371/journal.pone.0102170	http://dx.doi.org/10.1371/journal.pone.0102170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048697	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100023
J	Kim, JH; Jeon, M; Song, JS; Lee, JH; Choi, BJ; Jung, HS; Moon, SJ; DenBesten, PK; Kim, SO				Kim, Ji-Hee; Jeon, Mijeong; Song, Je-Seon; Lee, Jae-Ho; Choi, Byung-Jai; Jung, Han-Sung; Moon, Seok Jun; DenBesten, Pamela K.; Kim, Seong-Oh			Distinctive Genetic Activity Pattern of the Human Dental Pulp between Deciduous and Permanent Teeth	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; BONE SIALOPROTEIN; CDNA MICROARRAY; BINDING PROTEIN; MESSENGER-RNA; EXPRESSION; OSTEONECTIN; ODONTOBLASTS; TISSUE; PROGNOSIS	Human deciduous and permanent teeth exhibit different developmental processes, morphologies, histological characteristics and life cycles. In addition, their pulp tissues react differently to external stimuli, such as the pulp sensitivity test, dental trauma and pulp therapy materials. These suggest differences in gene expression and regulation, and in this study we compared gene-expression profiles of the human dental pulp from deciduous and permanent teeth. Pulp tissues from permanent premolars and deciduous molars aged 11-14 years were extirpated and mRNA was isolated for cDNA microarray analysis, and quantitative real-time PCR (qPCR). Other teeth were used for immunohistochemical analysis (IHC). Microarray analysis identified 263 genes with a twofold or greater difference in expression level between the two types of pulp tissue, 43 and 220 of which were more abundant in deciduous and permanent pulp tissues, respectively. qPCR analysis was conducted for eight randomly selected genes, and the findings were consistent with the cDNA microarray results. IHC confirmed that insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) was broadly expressed in deciduous dental pulp tissue, but minimally expressed in permanent dental pulp tissue. Immunohistochemical analysis showed that calbindin 1 (CALB1), leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), and gamma-aminobutyric acid A receptor beta 1 (GABRB1) were abundantly expressed in permanent predentin/odontoblasts, but only minimally expressed in deciduous dental pulp tissue. These results show that deciduous and permanent pulp tissues have different characteristics and gene expression, suggesting that they may have different functions and responses to therapies focused on pulp or dentin regeneration.	[Kim, Ji-Hee; Jeon, Mijeong; Song, Je-Seon; Lee, Jae-Ho; Choi, Byung-Jai; Kim, Seong-Oh] Yonsei Univ, Dept Pediat Dent, Coll Dent, Oral Sci Res Ctr, Seoul 120749, South Korea; [Jung, Han-Sung] Yonsei Univ, Dept Oral Biol, Coll Dent, Div Histol, Seoul 120749, South Korea; [Moon, Seok Jun] Yonsei Univ, Dept Oral Biol, Coll Dent, Div Pharmacol, Seoul 120749, South Korea; [DenBesten, Pamela K.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California San Francisco	Kim, SO (corresponding author), Yonsei Univ, Dept Pediat Dent, Coll Dent, Oral Sci Res Ctr, Seoul 120749, South Korea.	ksodds@yuhs.ac	Jung, Han-Sung/I-3848-2012	Moon, Seok Jun/0000-0001-7282-2888; Jung, Han-Sung/0000-0003-2795-531X; Kim, Seong Oh/0000-0002-8620-1377; Song, Je Seon/0000-0001-8620-5629; lee, jaeho/0000-0002-1556-3485	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2041910, 2011-0022160]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2041910, 2011-0022160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; BYERS MR, 1982, PAIN, V13, P221, DOI 10.1016/0304-3959(82)90012-4; CHEN JK, 1993, ARCH ORAL BIOL, V38, P241, DOI 10.1016/0003-9969(93)90034-J; Egan C A, 1999, Int J Paediatr Dent, V9, P57, DOI 10.1046/j.1365-263x.1999.00096.x; Fuks A B, 2000, Dent Clin North Am, V44, P571; Fuks AB, 2000, DENT CLIN N AM, V44, pvii; Garcia JMQ, 2003, INT ENDOD J, V36, P404, DOI 10.1046/j.1365-2591.2003.00669.x; Gu LJ, 2004, INT J ONCOL, V24, P671; Hamshere ML, 2009, BRIT J PSYCHIAT, V195, P23, DOI 10.1192/bjp.bp.108.061424; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Itota T, 2001, ARCH ORAL BIOL, V46, P829, DOI 10.1016/S0003-9969(01)00041-3; JACOBSEN I, 1978, ACTA ODONTOL SCAND, V36, P199, DOI 10.3109/00016357809004668; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007; Nakamura S, 2009, J ENDODONT, V35, P1536, DOI 10.1016/j.joen.2009.07.024; Paakkonen V, 2008, INT ENDOD J, V41, P117; Paakkonen V, 2005, EUR J ORAL SCI, V113, P369, DOI 10.1111/j.1600-0722.2005.00237.x; Paakkonen V, 2007, CYTOKINE, V40, P44, DOI 10.1016/j.cyto.2007.08.003; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; RAPP R, 1967, ANAT REC, V159, P89, DOI 10.1002/ar.1091590113; REICHERT T, 1992, CALCIFIED TISSUE INT, V50, P468, DOI 10.1007/BF00296779; Robertson A, 1996, J ENDODONT, V22, P557, DOI 10.1016/S0099-2399(96)80018-5; Shi S, 2001, BONE, V29, P532, DOI 10.1016/S8756-3282(01)00612-3; Shiba H, 2001, J DENT RES, V80, P1653, DOI 10.1177/00220345010800071101; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Staquet MJ, 2008, J DENT RES, V87, P256, DOI 10.1177/154405910808700304; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; WASSERMA.RH, 1966, SCIENCE, V152, P791, DOI 10.1126/science.152.3723.791; Wells MA, 2006, BIOCHEM J, V400, P501, DOI 10.1042/BJ20060721	32	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102893	10.1371/journal.pone.0102893	http://dx.doi.org/10.1371/journal.pone.0102893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047033	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100086
J	Liu, B; Tarigan, LH; Bromet, EJ; Kim, H				Liu, Bian; Tarigan, Lukman H.; Bromet, Evelyn J.; Kim, Hyun			World Trade Center Disaster Exposure-Related Probable Posttraumatic Stress Disorder among Responders and Civilians: A Meta-Analysis	PLOS ONE			English	Article							CENTER TERRORIST ATTACK; LOWER RESPIRATORY SYMPTOMS; OF-THE-LITERATURE; CENTER RESCUE; RECOVERY WORKERS; MENTAL-HEALTH; PTSD PREVALENCE; CLEANUP WORKERS; RISK-FACTORS; SEPTEMBER 11	The World Trade Center (WTC) disaster on September 11, 2001 was an unprecedented traumatic event with long-lasting health consequences among the affected populations in the New York metropolitan area. This meta-analysis aimed to estimate the risk of probable posttraumatic stress disorder (PTSD) associated with specific types of WTC exposures. Meta-analytical findings from 10 studies of 3,271 to 20,294 participants yielded 37 relevant associations. The pooled summary odds ratio (OR) was 2.05 (95% confidence interval (CI): 1.82, 2.32), with substantial heterogeneity linked to exposure classification, cohort type, data source, PTSD assessment instrument/criteria, and lapse time since 9/11. In general, responders (e. g. police, firefighters, rescue/recovery workers and volunteers) had a lower probable PTSD risk (OR = 1.61; 95% CI: 1.39, 1.87) compared to civilians (e. g. residents, office workers, and passersby; OR = 2.71, 95% CI: 2.35, 3.12). The differences in ORs between responders and civilians were larger for physical compared to psychosocial exposure types. We also found that injury, lost someone, and witnessed horror were the three (out of six) most pernicious exposures. These findings suggest that these three exposures should be a particular focus in psychological evaluation and treatment programs in WTC intervention and future emergency preparedness efforts.	[Liu, Bian; Kim, Hyun] Hofstra North Shore LIJ Sch Med, Dept Populat Hlth, Great Neck, NY 11021 USA; [Tarigan, Lukman H.] Univ Massachusetts, Dept Work Environm, Lowell, MA USA; [Bromet, Evelyn J.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	Hofstra University; Northwell Health; University of Massachusetts System; University of Massachusetts Lowell; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, B (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Populat Hlth, Great Neck, NY 11021 USA.	bliu@nshs.edu		Liu, Bian/0000-0001-9166-693X	Centers for Disease Control and Prevention (CDC) [1U01OH010399-01]; National Institute for Occupational Safety and Health (NIOSH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U01OH010399] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This research was supported by the grant (1U01OH010399-01) from the Centers for Disease Control and Prevention (CDC) and National Institute for Occupational Safety and Health (NIOSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berninger A, 2010, AM J IND MED, V53, P1177, DOI 10.1002/ajim.20894; Berninger A, 2010, PUBLIC HEALTH REP, V125, P556, DOI 10.1177/003335491012500411; Bills CB, 2008, MT SINAI J MED, V75, P115, DOI 10.1002/msj.20026; Bowler RM, 2010, AM J IND MED, V53, P1186, DOI 10.1002/ajim.20876; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Chiu S, 2011, ANN CLIN PSYCHIATRY, V23, P95; Corrigan Malachy, 2009, Am J Public Health, V99 Suppl 3, pS702, DOI 10.2105/AJPH.2008.151605; Debchoudhury I, 2011, PREV MED, V53, P359, DOI 10.1016/j.ypmed.2011.08.034; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; DiGrande L, 2011, AM J EPIDEMIOL, V173, P271, DOI 10.1093/aje/kwq372; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; First MB, 2002, STRUCTURED CLIN INTE; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoven Christina W, 2003, Curr Psychiatry Rep, V5, P101, DOI 10.1007/s11920-003-0026-0; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim H, 2012, AM J IND MED, V55, P44, DOI 10.1002/ajim.21025; Kotov R, 2014, POSTTRAUMAT IN PRESS; Lin S, 2010, INT J OCCUP ENV HEAL, V16, P44; Lucchini R G, 2012, G Ital Med Lav Ergon, V34, P529; Luft BJ, 2012, PSYCHOL MED, V42, P1069, DOI 10.1017/S003329171100256X; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P779, DOI 10.1001/jama.300.7.779; Moline JM, 2008, MT SINAI J MED, V75, P67, DOI 10.1002/msj.20022; Nair HP, 2012, AM J PUBLIC HEALTH, V102, P1964, DOI 10.2105/AJPH.2012.300690; Neria Y, 2011, AM PSYCHOL, V66, P429, DOI 10.1037/a0024791; Perlman SE, 2011, LANCET, V378, P925, DOI 10.1016/S0140-6736(11)60967-7; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Pietrzak RH, 2012, J PSYCHIATR RES, V46, P835, DOI 10.1016/j.jpsychires.2012.03.011; Reibman J, 2009, J OCCUP ENVIRON MED, V51, P534, DOI 10.1097/JOM.0b013e3181a0365b; Solan S, 2013, ENVIRON HEALTH PERSP, V121, P699, DOI 10.1289/ehp.1205894; Soo J, 2011, DISASTER MED PUBLIC, V5, pS197, DOI 10.1001/dmp.2011.48; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Webber MP, 2011, SLEEP BREATH, V15, P283, DOI 10.1007/s11325-010-0379-7; Webber MP, 2011, AM J IND MED, V54, P661, DOI 10.1002/ajim.20993; Wisnivesky JP, 2011, LANCET, V378, P888, DOI 10.1016/S0140-6736(11)61180-X	39	66	67	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101491	10.1371/journal.pone.0101491	http://dx.doi.org/10.1371/journal.pone.0101491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0SW	25047411	Green Published, gold			2022-12-27	WOS:000339558100010
J	Qin, JX; Liu, WZ; Zhu, J; Weng, W; Xu, JM; Ai, ZS				Qin, Jingxiang; Liu, Wuzhong; Zhu, Jun; Weng, Wei; Xu, Jiaming; Ai, Zisheng			Health Related Quality of Life and Influencing Factors among Welders	PLOS ONE			English	Article							MANGANESE; EXPOSURE; SF-36; PARKINSONISM; POPULATION; SYMPTOMS; CHINA; FUME	Background: Occupational exposure to welding fumes is a serious occupational health problem all over the world. Welders are exposed to many occupational hazards; these hazards might cause some occupational diseases. The aim of the study was to assess the health related quality of life (HRQL) of electric welders in Shanghai China and explore influencing factors to HRQL of welders. Methods: 301 male welders (without pneumoconiosis) and 305 non-dust male workers in Shanghai were enrolled in this study. Short Form-36 (SF-36) health survey questionnaires were applied in this cross-sectional study. Socio-demographic, working and health factors were also collected. Multiple stepwise regress analysis was used to identify significant factors related to the eight dimension scores. Results: Six dimensions including role-physical (RP), bodily pain (BP), general health (GH), validity (VT), social function (SF), and mental health (MH) were significantly worse in welders compared to non-dust workers. Multiple stepwise regress analysis results show that native place, monthly income, quantity of children, drinking, sleep time, welding type, use of personal protective equipment (PPE), great events in life, and some symptoms including dizziness, discomfort of cervical vertebra, low back pain, cough and insomnia may be influencing factors for HRQL of welders. Among these factors, only sleep time and the use of PPE were salutary. Conclusions: Some dimensions of HRQL of these welders have been affected. Enterprises which employ welders should take measures to protect the health of these people and improve their HRQL.	[Qin, Jingxiang; Liu, Wuzhong; Zhu, Jun; Weng, Wei] Baoshan Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Xu, Jiaming] Shanghai 6 Peoples Hosp, Shanghai, Peoples R China; [Ai, Zisheng] Shanghai Univ, Dept Prevent Med, Coll Med, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; Shanghai University	Ai, ZS (corresponding author), Shanghai Univ, Dept Prevent Med, Coll Med, Shanghai, Peoples R China.	azs1966@126.com		Ai, Zi-Sheng/0000-0001-8417-4160	Baoshan committee of science and technology of Shanghai [10-E-31]	Baoshan committee of science and technology of Shanghai	This study was funded by the Baoshan committee of science and technology of Shanghai (grant 10-E-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini JM, 2006, NEUROTOXICOLOGY, V27, P304, DOI 10.1016/j.neuro.2005.09.001; Balkhyour MA, 2010, INT J ENV RES PUB HE, V7, P2978, DOI 10.3390/ijerph7072978; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P327, DOI 10.1016/j.neuro.2005.10.011; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Bowler RM, 2011, NEUROTOXICOLOGY, V32, P596, DOI 10.1016/j.neuro.2011.06.004; Chang Y, 2013, NEUROTOXICOLOGY, V37, P182, DOI 10.1016/j.neuro.2013.05.003; Chang Y, 2009, NEUROTOXICOLOGY, V30, P555, DOI 10.1016/j.neuro.2009.04.002; Deeken M, 2002, OLHYDRAUL PNEUM, V46, P1; Demiral Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-247; Flynn MR, 2009, INT J HYG ENVIR HEAL, V212, P459, DOI 10.1016/j.ijheh.2008.12.003; Jin WZ, 2012, CHINESE HLTH RESOURC, V5, P265; Laohaudomchok W, 2011, NEUROTOXICOLOGY, V32, P171, DOI 10.1016/j.neuro.2010.12.014; Lim LLY, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-52; Pang SL, 2004, CHINESE J IND MED, V17, P255; Qin JingXiang, 2012, Occupation and Health, V28, P2211; Qin JX, 2012, OCCUP HLTH, V28, P2215; Racette BA, 2012, NEUROTOXICOLOGY, V33, P1356, DOI 10.1016/j.neuro.2012.08.011; Rachiotis G, 2006, Med Lav, V97, P44; Ross JAS, 2013, ANN OCCUP HYG, V57, P26, DOI 10.1093/annhyg/mes042; Wang R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-292; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Yu HM, 2008, J OCCUP HEALTH, V50, P505, DOI 10.1539/joh.L7167	22	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101982	10.1371/journal.pone.0101982	http://dx.doi.org/10.1371/journal.pone.0101982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048102	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100018
J	Berke, SK; Jablonski, D; Krug, AZ; Valentine, JW				Berke, Sarah K.; Jablonski, David; Krug, Andrew Z.; Valentine, James W.			Origination and Immigration Drive Latitudinal Gradients in Marine Functional Diversity	PLOS ONE			English	Article							BODY-SIZE; PATTERNS; EVOLUTIONARY; DYNAMICS; EXTINCTION; FIDELITY; TROPICS; IMPACT; RECORD	Global patterns in the functional attributes of organisms are critical to understanding biodiversity trends and predicting biotic responses to environmental change. In the first global marine analysis, we find a strong decrease in functional richness, but a strong increase in functional evenness, with increasing latitude using intertidal-to-outer-shelf bivalves as a model system (N = 5571 species). These patterns appear to be driven by the interplay between variation in origination rates among functional groups, and latitudinal patterns in origination and range expansion, as documented by the rich fossil record of the group. The data suggest that (i) accumulation of taxa in spatial bins and functional categories has not impeded continued diversification in the tropics, and (ii) extinctions will influence ecosystem function differentially across latitudes.	[Berke, Sarah K.] Siena Coll, Dept Biol, New York, NY 12211 USA; [Berke, Sarah K.; Jablonski, David; Krug, Andrew Z.] Siena Coll, Dept Biol, New York, NY 12211 USA; [Krug, Andrew Z.] Flint Hill Sch, Oakton, VA USA; [Valentine, James W.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berke, SK (corresponding author), Siena Coll, Dept Biol, New York, NY 12211 USA.	skberke@gmail.com			National Science Foundation [EAR-0922156, DEB-0919451]; NASA Exobiology Program [EXOB08-0089]	National Science Foundation(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA))	Funding provided by National Science Foundation EAR-0922156, DEB-0919451, nsf.gov and NASA Exobiology Program, EXOB08-0089, astrobiology.nasa.gov/exobiology/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Duffy JE, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P164; Foote M, 2001, PALEOBIOLOGY, V27, P602, DOI 10.1666/0094-8373(2001)027<0602:ITPOPO>2.0.CO;2; Freestone AL, 2011, ECOLOGY, V92, P208, DOI 10.1890/09-1841.1; Harper EM, 1998, ADEQUACY OF THE FOSSIL RECORD, P243; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Huber M., 2010, COMPENDIUM BIVALVES; Jablonski D, 2003, SCIENCE, V300, P1133, DOI 10.1126/science.1083246; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Kosnik MA, 2006, PALAIOS, V21, P588, DOI 10.2110/palo.2006.p06-012r; Krug AZ, 2007, P NATL ACAD SCI USA, V104, P18129, DOI 10.1073/pnas.0709202104; Krug AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015362; Krug AZ, 2009, SCIENCE, V323, P767, DOI 10.1126/science.1164905; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Markert A, 2010, BIOL INVASIONS, V12, P15, DOI 10.1007/s10530-009-9425-4; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Ohnishi S, 2006, FISHERIES SCI, V72, P787, DOI 10.1111/j.1444-2906.2006.01219.x; Pianka E. R., 1999, EVOLUTIONARY ECOLOGY; Rivadeneira MM, 2010, PALAIOS, V25, P40, DOI 10.2110/palo.2009.p09-035r; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; Steneck Robert S., 2001, P121; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056853; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Swenson NG, 2012, GLOBAL ECOL BIOGEOGR, V21, P798, DOI 10.1111/j.1466-8238.2011.00727.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Todd JA, 2012, NEOGENE MARINE BIOTA; Valentine James W., 2009, P3; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Volkenborn N, 2012, J MAR RES, V70, P794, DOI 10.1357/002224012806770955; Wilson B, 1998, MOLLUSCA SO SYNTHESI, V5, P827; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031	42	20	20	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101494	10.1371/journal.pone.0101494	http://dx.doi.org/10.1371/journal.pone.0101494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036112	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200018
J	Carr, DE; Roulston, TH; Hart, H				Carr, David E.; Roulston, T'ai H.; Hart, Haley			Inbreeding in Mimulus guttatus Reduces Visitation by Bumble Bee Pollinators	PLOS ONE			English	Article							FLORAL DISPLAY SIZE; ARTIFICIAL FLOWERS; SELF-FERTILIZATION; POTENTIAL MALE; 5 GENERATIONS; PLANT; DEPRESSION; POLLEN; EVOLUTION; HERBIVORY	Inbreeding in plants typically reduces individual fitness but may also alter ecological interactions. This study examined the effect of inbreeding in the mixed-mating annual Mimulus guttatus on visitation by pollinators (Bombus impatiens) in greenhouse experiments. Previous studies of M. guttatus have shown that inbreeding reduced corolla size, flower number, and pollen quantity and quality. Using controlled crosses, we produced inbred and outbred families from three different M. guttatus populations. We recorded the plant genotypes that bees visited and the number of flowers probed per visit. In our first experiment, bees were 31% more likely to visit outbred plants than those selfed for one generation and 43% more likely to visit outbred plants than those selfed for two generations. Inbreeding had only a small effect on the number of flowers probed once bees arrived at a genotype. These differences were explained partially by differences in mean floral display and mean flower size, but even when these variables were controlled statistically, the effect of inbreeding remained large and significant. In a second experiment we quantified pollen viability from inbred and self plants. Bees were 37-54% more likely to visit outbred plants, depending on the population, even when controlling for floral display size. Pollen viability proved to be as important as floral display in predicting pollinator visitation in one population, but the overall explanatory power of a multiple regression model was weak. Our data suggested that bees use cues in addition to display size, flower size, and pollen reward quality in their discrimination of inbred plants. Discrimination against inbred plants could have effects on plant fitness and thereby reinforce selection for outcrossing. Inbreeding in plant populations could also reduce resource quality for pollinators, potentially resulting in negative effects on pollinator populations.	[Carr, David E.; Roulston, T'ai H.] Univ Virginia, Blandy Expt Farm, Boyce, VA 22620 USA; [Hart, Haley] Southeastern High Sch, Detroit, MI USA	University of Virginia	Carr, DE (corresponding author), Univ Virginia, Blandy Expt Farm, Boyce, VA 22620 USA.	david.carr@virginia.edu	Roulston, Tai/AAI-4974-2020	Roulston, Tai/0000-0002-1220-1315	National Science Foundation [DEB-0614395, DBI-0453465]	National Science Foundation(National Science Foundation (NSF))	D.E.C. received funding from DEB-0614395, National Science Foundation, http://www.nsf.gov/. T.H.R. received funding from DBI-0453465, National Science Foundation, http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovics J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P426; Arathi HS, 2004, INT J PLANT SCI, V165, P1039, DOI 10.1086/423876; Arathi HS, 2002, INT J PLANT SCI, V163, P567, DOI 10.1086/340444; Ashman TL, 2005, ECOLOGY, V86, P2099, DOI 10.1890/04-1161; Bangert RK, 2005, CONSERV BIOL, V19, P379, DOI 10.1111/j.1523-1739.2005.00450.x; Beardsley PM, 2002, AM J BOT, V89, P1093, DOI 10.3732/ajb.89.7.1093; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Byers KJRP, 2014, J EXP BIOL, V217, P614, DOI 10.1242/jeb.092213; Campbell SA, 2013, ECOL LETT, V16, P252, DOI 10.1111/ele.12036; Carr DE, 2014, ANNU REV ENTOMOL, V59, P185, DOI 10.1146/annurev-ento-011613-162049; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; CARR DE, 1995, HEREDITY, V75, P437, DOI 10.1038/hdy.1995.159; Carr DE, 1997, EVOLUTION, V51, P1797, DOI 10.1111/j.1558-5646.1997.tb05103.x; Carr DE, 2003, EVOL ECOL, V17, P85, DOI 10.1023/A:1022439432213; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chittka L, 2002, ENTOMOL GEN, V26, P85; Church D, 2001, GREAT LAKES ENTOMOL, V34, P85; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Darwin C, 1878, EFFECTS CROSS SELF F; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; DOLE JA, 1992, AM J BOT, V79, P650, DOI 10.2307/2444881; Dudash MR, 1997, EVOLUTION, V51, P54, DOI [10.2307/2410960, 10.1111/j.1558-5646.1997.tb02388.x]; DUDASH MR, 1991, AM J BOT, V78, P1746, DOI 10.2307/2444854; Fenster CB, 1997, J EVOLUTION BIOL, V10, P641, DOI 10.1007/s000360050046; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; Gegear RJ, 2004, CAN J ZOOL, V82, P587, DOI 10.1139/Z04-029; Hayes CN, 2004, OECOLOGIA, V140, P601, DOI 10.1007/s00442-004-1623-2; Herlihy CR, 2004, EVOLUTION, V58, P2693, DOI 10.1111/j.0014-3820.2004.tb01622.x; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Ivey CT, 2005, AM J BOT, V92, P1641, DOI 10.3732/ajb.92.10.1641; Ivey CT, 2004, ECOLOGY, V85, P567, DOI 10.1890/02-0730; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kariyat RR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0020; Kariyat RR, 2012, ECOL LETT, V15, P301, DOI 10.1111/j.1461-0248.2011.01738.x; Karron JD, 2004, HEREDITY, V92, P242, DOI 10.1038/sj.hdy.6800402; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kelly JK, 2005, NEW PHYTOL, V165, P55, DOI 10.1111/j.1469-8137.2004.01184.x; Kelly JK, 2003, HEREDITY, V90, P77, DOI 10.1038/sj.hdy.6800181; KIANG YT, 1972, EVOLUTION, V26, P308, DOI [10.2307/2407041, 10.1111/j.1558-5646.1972.tb00197.x]; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Leimu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042326; Levin DA, 2013, ANN BOT, V109, P613; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MACNAIR MR, 1989, NEW PHYTOL, V112, P269, DOI 10.1111/j.1469-8137.1989.tb02383.x; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; Ouborg NJ, 2000, ECOLOGY, V81, P520, DOI 10.2307/177445; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; Plowright CMS, 1999, BEHAVIOUR, V136, P951, DOI 10.1163/156853999501667; Rae JM, 2013, PLANT SPEC BIOL, V28, P177, DOI 10.1111/j.1442-1984.2012.00375.x; RITLAND C, 1989, AM J BOT, V76, P1731, DOI 10.2307/2444472; RITLAND K, 1990, EVOLUTION, V44, P1230, DOI [10.2307/2409284, 10.1111/j.1558-5646.1990.tb05227.x]; ROBERTSON AW, 1995, OIKOS, V72, P106, DOI 10.2307/3546044; Robertson AW, 1999, ECOLOGY, V80, P2594, DOI 10.1890/0012-9658(1999)080[2594:BBSOMG]2.0.CO;2; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Simonds V, 2004, ANIM BEHAV, V67, P379, DOI 10.1016/j.anbehav.2003.03.020; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; Uyenoyama M.K., 1993, OXFORD SURVEYS EVOLU, V9, P327, DOI [DOI 10.1016/0040-5809(91)90046-I, 10.1016/0040-5809(91)90046-I]; Vickery RK, 1999, GREAT BASIN NAT, V59, P112; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wiegmann DD, 2003, PHYSIOL BEHAV, V79, P561, DOI 10.1016/S0031-9384(03)00122-7; Willis JH, 1999, HEREDITY, V83, P337, DOI 10.1038/sj.hdy.6885790; WILLIS JH, 1993, HEREDITY, V71, P145, DOI 10.1038/hdy.1993.118; WILLSON MF, 1977, EVOLUTION, V31, P495, DOI 10.1111/j.1558-5646.1977.tb01040.x; Wise MJ, 2011, INT J PLANT SCI, V172, P199, DOI 10.1086/657677; Yeamans RL, 2011, THESIS U VIRGINIA	67	16	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101463	10.1371/journal.pone.0101463	http://dx.doi.org/10.1371/journal.pone.0101463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036035	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200017
J	Chen, TH; Wo, HT; Chang, PC; Wang, CC; Wen, MS; Chou, CC				Chen, Tien-Hsing; Wo, Hung-Ta; Chang, Po-Cheng; Wang, Chun-Chieh; Wen, Ming-Shien; Chou, Chung-Chuan			A Meta-Analysis of Mortality in End-Stage Renal Disease Patients Receiving Implantable Cardioverter Defibrillators (ICDs)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SUDDEN CARDIAC DEATH; PRIMARY PREVENTION; DIALYSIS PATIENTS; MYOCARDIAL-INFARCTION; HEART-FAILURE; SURVIVAL; THERAPY; HEMODIALYSIS; RISK	Data on the effectiveness of implantable implantable cardioverter defibrillators (ICDs) with respect to reducing mortality in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) are lacking. The purpose of this meta-analysis was to compare the mortality of patients with ESRD who have received and not received an ICD. A search was conducted on January 31, 2013 of Medline, Cochrane, EMBASE, and Google Scholar. Studies were selected for inclusion based on the following criteria. 1) Randomized controlled trial. 2) ESRD patients with heart failure. 3) Device therapy (ICD, CRT-defibrillator [CRT-D]) used to treat heart failure. 4) Primary outcome is survival analysis. 5) Retrospective study if survival analysis was performed. The primary outcome was overall survival (OS), and the secondary outcome was 2-year survival. Odds ratios (ORs) with 95% confidence intervals (CI) were calculated, and a chi(2)-based test of homogeneity was performed. Three studies were included in the analysis. The combined OR for OS was 2.245 (95% CI 1.871 to 2.685, P<0.001), indicating that patients with an ICD had a significantly higher OS than those without an ICD. The combined OR for 2-year survival was 2.312 (95% CI 1.921 to 2.784, P<0.001), indicating that patients with an ICD had a significantly higher 2-year survival rate than those without an ICD. The use of ICD in patients with ESRD is associated with an increase in the OS and the 2-year survival rate.	[Chen, Tien-Hsing; Wo, Hung-Ta; Chang, Po-Cheng; Wang, Chun-Chieh; Wen, Ming-Shien; Chou, Chung-Chuan] Chang Gung Mem Hosp, Dept Cardiol, Linkou, Taiwan; [Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Cardiol, Xiamen, Peoples R China; [Chen, Tien-Hsing] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, TH (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, Linkou, Taiwan.	skyheart0826@gmail.com	Chou, Chung-Chuan/AAZ-9776-2021; Chang, Po-Cheng/ABA-4979-2020	Chang, Po-Cheng/0000-0002-6901-5951				Aggarwal A, 2009, HEART RHYTHM, V6, P1565, DOI 10.1016/j.hrthm.2009.08.006; Alsheikh-Ali AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.020; Amin MS, 2008, J CARDIOVASC ELECTR, V19, P1275, DOI 10.1111/j.1540-8167.2008.01258.x; [Anonymous], 2012, US REN DAT SYST 2012; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Berger AK, 2003, J AM COLL CARDIOL, V42, P201, DOI 10.1016/S0735-1097(03)00572-2; Bilchick KC, 2012, J AM COLL CARDIOL, V60, P1647, DOI 10.1016/j.jacc.2012.07.028; Cannizzaro LA, 2011, J AM COLL CARDIOL, V58, P889, DOI 10.1016/j.jacc.2011.05.024; Chen-Scarabelli C, 2007, PACE, V30, P371, DOI 10.1111/j.1540-8159.2007.00677.x; Cuculich PS, 2007, PACE, V30, P207, DOI 10.1111/j.1540-8159.2007.00651.x; Dasgupta A, 2007, AM J KIDNEY DIS, V49, P656, DOI 10.1053/j.ajkd.2007.02.272; de Bie MK, 2008, CURR MED RES OPIN, V24, P2151, DOI 10.1185/03007990802237343; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Goldenberg I, 2006, AM J CARDIOL, V98, P485, DOI 10.1016/j.amjcard.2006.03.025; Grothe Cibele, 2009, Nephrol Nurs J, V36, P613; Herzog CA, 2005, KIDNEY INT, V68, P818, DOI 10.1111/j.1523-1755.2005.00462.x; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Hiremath S, 2010, AM J NEPHROL, V32, P305, DOI 10.1159/000319461; Hreybe H, 2006, AM HEART J, V151, P852, DOI 10.1016/j.ahj.2005.06.042; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Khan F, 2010, J INTERV CARD ELECTR, V28, P117, DOI 10.1007/s10840-010-9484-6; Kidney disease outcomes quality initiative (KDOQI), KIDNEY DIS OUTCOMES, V39, pS46, DOI [10.1053/ajkd.2002.30943, DOI 10.1053/AJKD.2002.30943]; Korantzopoulos P, 2009, EUROPACE, V11, P1469, DOI 10.1093/europace/eup282; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; O'Shaughnessy MM, 2012, SEMIN DIALYSIS, V25, P272, DOI 10.1111/j.1525-139X.2012.01067.x; Oetgen WJ, 2013, J AM COLL CARDIOL, V61, P1318, DOI 10.1016/j.jacc.2012.12.017; Robin J, 2006, HEART RHYTHM, V3, P1196, DOI 10.1016/j.hrthm.2006.06.013; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Teruya TH, 2003, ANN VASC SURG, V17, P526, DOI 10.1007/s10016-003-0048-4; Thomson P, 2010, NEPHROL DIAL TRANSPL, V25, P1596, DOI 10.1093/ndt/gfp667; Tompkins C, 2011, J CARDIOVASC ELECTR, V22, P1099, DOI 10.1111/j.1540-8167.2011.02066.x; Turakhia MP, 2007, PACE, V30, P377, DOI 10.1111/j.1540-8159.2007.00678.x; Voigt A, 2004, J AM COLL CARDIOL, V44, P855, DOI 10.1016/j.jacc.2004.05.053; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wase A, 2004, J INTERV CARD ELECTR, V11, P199, DOI 10.1023/B:JICE.0000048570.43706.34; Williams ES, 2011, EUROPACE, V13, P1717, DOI 10.1093/europace/eur253	37	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99418	10.1371/journal.pone.0099418	http://dx.doi.org/10.1371/journal.pone.0099418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036181	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200005
J	Ji, ZW; Su, J; Liu, CL; Wang, HY; Huang, DS; Zhou, XB				Ji, Zhiwei; Su, Jing; Liu, Chenglin; Wang, Hongyan; Huang, Deshuang; Zhou, Xiaobo			Integrating Genomics and Proteomics Data to Predict Drug Effects Using Binary Linear Programming	PLOS ONE			English	Article							CANCER-CELLS; P38 MAPK; APOPTOSIS; EXPRESSION; P53; PHOSPHORYLATION; GENERATION; INDUCTION; CARCINOMA; PATHWAY	The Library of Integrated Network-Based Cellular Signatures (LINCS) project aims to create a network-based understanding of biology by cataloging changes in gene expression and signal transduction that occur when cells are exposed to a variety of perturbations. It is helpful for understanding cell pathways and facilitating drug discovery. Here, we developed a novel approach to infer cell-specific pathways and identify a compound's effects using gene expression and phosphoproteomics data under treatments with different compounds. Gene expression data were employed to infer potential targets of compounds and create a generic pathway map. Binary linear programming (BLP) was then developed to optimize the generic pathway topology based on the mid-stage signaling response of phosphorylation. To demonstrate effectiveness of this approach, we built a generic pathway map for the MCF7 breast cancer cell line and inferred the cell-specific pathways by BLP. The first group of 11 compounds was utilized to optimize the generic pathways, and then 4 compounds were used to identify effects based on the inferred cell-specific pathways. Cross-validation indicated that the cell-specific pathways reliably predicted a compound's effects. Finally, we applied BLP to re-optimize the cell-specific pathways to predict the effects of 4 compounds (trichostatin A, MS-275, staurosporine, and digoxigenin) according to compound-induced topological alterations. Trichostatin A and MS-275 (both HDAC inhibitors) inhibited the downstream pathway of HDAC1 and caused cell growth arrest via activation of p53 and p21; the effects of digoxigenin were totally opposite. Staurosporine blocked the cell cycle via p53 and p21, but also promoted cell growth via activated HDAC1 and its downstream pathway. Our approach was also applied to the PC3 prostate cancer cell line, and the cross-validation analysis showed very good accuracy in predicting effects of 4 compounds. In summary, our computational model can be used to elucidate potential mechanisms of a compound's efficacy.	[Ji, Zhiwei; Su, Jing; Liu, Chenglin; Wang, Hongyan; Zhou, Xiaobo] Ctr Bioinformat & Syst Biol, Wake Forest Sch Med, Div Radiol Sci, Winston Salem, NC 27103 USA; [Ji, Zhiwei; Huang, Deshuang] Tongji Univ, Sch Elect & Informat Engn, Shanghai, Peoples R China	Wake Forest University; Tongji University	Zhou, XB (corresponding author), Ctr Bioinformat & Syst Biol, Wake Forest Sch Med, Div Radiol Sci, Med Ctr Blvd, Winston Salem, NC 27103 USA.	xizhou@wakehealth.edu	shi, zhensheng/GXN-3967-2022	Su, Jing/0000-0003-4917-6173	NIH [U01HL111560-04, U01CA166886-03]; NSFC [61373105]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project is funded by NIH U01HL111560-04 (Zhou) and NIH U01CA166886-03 (Zhou). This work was also partially supported by NSFC No. 61373105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Arikuma T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S11; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chen SC, 2006, HYPERTENSION, V47, P252, DOI 10.1161/01.HYP.0000198424.93598.6b; Chen XP, 2013, J CELL BIOCHEM, V114, P1145, DOI 10.1002/jcb.24457; Coulonval K, 2003, J BIOL CHEM, V278, P52052, DOI 10.1074/jbc.M307012200; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Dimitrova ES, 2010, J COMPUT BIOL, V17, P853, DOI 10.1089/cmb.2008.0023; Gasparian AV, 2002, J CELL SCI, V115, P141; Giacinti L, 2012, J CELL PHYSIOL, V227, P3426, DOI 10.1002/jcp.24043; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Gu J, 2012, MOL BIOSYST, V8, P2041, DOI 10.1039/c2mb25065a; Hopfensitz M, 2012, IEEE ACM T COMPUT BI, V9, P487, DOI 10.1109/TCBB.2011.62; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Opiteck GJ, 2004, EXPERT REV PROTEOMIC, V1, P57, DOI 10.1586/14789450.1.1.57; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Rodriguez-Berriguete G, 2012, PROSTATE, V72, P40, DOI 10.1002/pros.21404; Rosato RR, 2003, CANCER RES, V63, P3637; Rubin E, 2001, ONCOGENE, V20, P3776, DOI 10.1038/sj.onc.1204518; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Su JS, 2012, NMR BIOMED, V25, P379, DOI 10.1002/nbm.1764; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Xue LY, 2003, EXP CELL RES, V283, P135, DOI 10.1016/S0014-4827(02)00032-0; Zhang BH, 2013, EUR REV MED PHARMACO, V17, P758; Zhao Guo-qin, 2013, Yingyong Shengtai Xuebao, V24, P2122	39	17	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102798	10.1371/journal.pone.0102798	http://dx.doi.org/10.1371/journal.pone.0102798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036040	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200087
J	Liu, Q; Hou, JF; Chen, XG; Liu, GT; Zhang, D; Sun, H; Zhang, JL				Liu, Qian; Hou, Jinfeng; Chen, Xiaoguang; Liu, Gengtao; Zhang, Dan; Sun, Hua; Zhang, Jinlan			P-Glycoprotein Mediated Efflux Limits the Transport of the Novel Anti-Parkinson's Disease Candidate Drug FLZ across the Physiological and PD Pathological In Vitro BBB Models	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MICROVASCULAR ENDOTHELIAL-CELLS; RAT-BRAIN; PRIMARY CULTURES; SH-SY5Y CELLS; PROTECTS; PERMEABILITY; ASTROCYTES; EXPRESSION; INDUCTION	FLZ, a novel anti-Parkinson's disease (PD) candidate drug, has shown poor blood-brain barrier (BBB) penetration based on the pharmacokinetic study using rat brain. P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) are two important transporters obstructing substrates entry into the CNS as well as in relation to PD neuropathology. However, it is unclear whether P-gp and BCRP are involved in low BBB permeability of FLZ and what the differences of FLZ brain penetration are between normal and Parkinson's conditions. For this purpose, in vitro BBB models mimicking physiological and PD pathological-related BBB properties were constructed by C6 astroglial cells co-cultured with primary normal or PD rat cerebral microvessel endothelial cells (rCMECs) and in vitro permeability experiments of FLZ were carried out. High transepithelial electrical resistance (TEER) and low permeability for sodium fluorescein (NaF) confirmed the BBB functionality of the two models. Significantly greater expressions of P-gp and BCRP were detected in PD rCMECs associated with the lower in vitro BBB permeability of FLZ in pathological BBB model compared with physiological model. In transport studies only P-gp blocker effectively inhibited the efflux of FLZ, which was consistent with the in vivo permeability data. This result was also confirmed by ATPase assays, suggesting FLZ is a substrate for P-gp but not BCRP. The present study first established in vitro BBB models reproducing PD-related changes of BBB functions in vivo and demonstrated that poor brain penetration of FLZ and low BBB permeability were due to the P-gp transport.	[Liu, Qian; Hou, Jinfeng; Chen, Xiaoguang; Liu, Gengtao; Zhang, Dan; Sun, Hua; Zhang, Jinlan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Substance & Funct Nat Med, Beijing, Peoples R China; [Liu, Qian; Hou, Jinfeng; Chen, Xiaoguang; Liu, Gengtao; Zhang, Dan; Sun, Hua; Zhang, Jinlan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Qian] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Neurosurgical Institute; Capital Medical University	Sun, H (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Dept Pharmacol, Beijing 100730, Peoples R China.	sunhua@imm.ac.cn; zhjl@imm.ac.cn			Beijing Municipal Natural Science Foundation [7122113]; China National Natural Science Foundation [81072697]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Beijing Municipal Natural Science Foundation (No. 7122113) as well as China National Natural Science Foundation (No. 81072697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Bao XQ, 2012, NEUROSCIENCE, V202, P396, DOI 10.1016/j.neuroscience.2011.11.036; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Colgan OC, 2008, BRAIN RES, V1193, P84, DOI 10.1016/j.brainres.2007.11.072; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deracinois B, 2013, PROTEOMICS; ElAli A, 2011, NEUROSCIENTIST, V17, P423, DOI 10.1177/1073858410391270; Feng WH, 2005, MOL NEUROBIOL, V31, P295, DOI 10.1385/MN:31:1-3:295; GORDON EL, 1991, IN VITRO CELL DEV B, V27, P312; GRABB PA, 1995, J NEUROSURG, V82, P1053, DOI 10.3171/jns.1995.82.6.1053; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Hou JF, 2012, J PHARMACEUT BIOMED, V66, P232, DOI 10.1016/j.jpba.2012.03.001; Kong XC, 2011, BRAIN RES, V1383, P99, DOI 10.1016/j.brainres.2011.01.093; Nagpal K, 2013, EXPERT OPIN DRUG DEL; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Ogunshola OO, 2011, CURR PHARM DESIGN, V17, P2755; PANULA P, 1978, EXPERIENTIA, V34, P95, DOI 10.1007/BF01921925; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Poller B, 2011, MOL PHARMACEUT, V8, P571, DOI 10.1021/mp1003898; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Tan KH, 2001, NEUROREPORT, V12, P1329, DOI 10.1097/00001756-200105250-00008; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Zhang D, 2007, EUR J PHARMACOL, V561, P1, DOI 10.1016/j.ejphar.2006.11.015; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	33	27	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102442	10.1371/journal.pone.0102442	http://dx.doi.org/10.1371/journal.pone.0102442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036090	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200060
J	Pedley, AM; Lill, MA; Davisson, VJ				Pedley, Anthony M.; Lill, Markus A.; Davisson, V. Jo			Flexibility of PCNA-Protein Interface Accommodates Differential Binding Partners	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; PHOSPHOINOSITIDE 3-KINASE BETA; SMALL-MOLECULE INHIBITORS; DOUBLE-STRAND BREAK; DNA-REPLICATION; FLAP ENDONUCLEASE-1; DRUG DISCOVERY; FLUORESCENCE POLARIZATION; REPAIR; DYNAMICS	The expanding roles of PCNA in functional assembly of DNA replication and repair complexes motivated investigation of the structural and dynamic properties guiding specificity of PCNA-protein interactions. A series of biochemical and computational analyses were combined to evaluate the PIP Box recognition features impacting complex formation. The results indicate subtle differences in topological and molecular descriptors distinguishing both affinity and stoichiometry of binding among PCNA-peptide complexes through cooperative effects. These features were validated using peptide mimics of p85 alpha and Akt, two previously unreported PCNA binding partners. This study characterizes for the first time a reverse PIP Box interaction with PCNA. Small molecule ligand binding at the PIP Box interaction site confirmed the adaptive nature of the protein in dictating overall shape and implicates allosterism in transmitting biological effects.	[Pedley, Anthony M.; Lill, Markus A.; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Davisson, VJ (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	davisson@purdue.edu	Lill, Markus A/E-5118-2017	Lill, Markus A/0000-0003-3023-5188; Pedley, Anthony/0000-0003-1034-5072	Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program [W81XWH-10-1-0105, W81XWH-11-1-0050]; Purdue Center for Cancer Research	Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program; Purdue Center for Cancer Research	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program under Award No. W81XWH-10-1-0105 (VJD) and No. W81XWH-11-1-0050 (AMP). The cost of publication was covered by the Purdue Center for Cancer Research. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis M, 2013, BIOORGAN MED CHEM, V21, P1972, DOI 10.1016/j.bmc.2013.01.022; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bohm HJ, 1996, ANGEW CHEM INT EDIT, V35, P2589; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Bozza WP, 2012, ANAL BIOCHEM, V427, P69, DOI 10.1016/j.ab.2012.04.018; Brath U, 2009, J MOL BIOL, V387, P233, DOI 10.1016/j.jmb.2009.01.047; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Case DA, 2012, AMBER 12; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; De Biasio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048390; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Fridman Y, 2013, PROTEINS, V81, P341, DOI 10.1002/prot.24190; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; He X, 2009, APOPTOSIS, V14, P268, DOI 10.1007/s10495-009-0313-2; Hlinkova V, 2008, ACTA CRYSTALLOGR D, V64, P941, DOI 10.1107/S0907444908021665; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoue A, 2014, J BIOL CHEM, V289, P7109, DOI 10.1074/jbc.M113.520429; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kumar A, 2010, P NATL ACAD SCI USA, V107, P7491, DOI 10.1073/pnas.0914242107; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lu ZL, 2007, J BIOL CHEM, V282, P17921, DOI 10.1074/jbc.M610413200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marques M, 2009, P NATL ACAD SCI USA, V106, P7525, DOI 10.1073/pnas.0812000106; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Robertson AD, 2002, TRENDS BIOCHEM SCI, V27, P521, DOI 10.1016/S0968-0004(02)02184-9; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schrodinger L., PYMOL MOL GRAPHICS S; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102481	10.1371/journal.pone.0102481	http://dx.doi.org/10.1371/journal.pone.0102481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036435	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200063
J	Sakkiah, S; Senese, S; Yang, QF; Lee, KW; Torres, JZ				Sakkiah, Sugunadevi; Senese, Silvia; Yang, Qianfan; Lee, Keun Woo; Torres, Jorge Z.			Dynamic and Multi-Pharmacophore Modeling for Designing Polo-Box Domain Inhibitors	PLOS ONE			English	Article							MOLECULAR-BASIS; KINASE 1; PLK1; POLO-LIKE-KINASE-1; LOCALIZATION; BINDING; PERMEABILITY; LIGANDS; DOCKING; MITOSIS	The polo-like kinase 1 (Plk1) is a critical regulator of cell division that is overexpressed in many types of tumors. Thus, a strategy in the treatment of cancer has been to target the kinase activity (ATPase domain) or substrate-binding domain (Polo-box Domain, PBD) of Plk1. However, only few synthetic small molecules have been identified that target the Plk1-PBD. Here, we have applied an integrative approach that combines pharmacophore modeling, molecular docking, virtual screening, and in vitro testing to discover novel Plk1-PBD inhibitors. Nine Plk1-PBD crystal structures were used to generate structure-based hypotheses. A common pharmacophore model (Hypo1) composed of five chemical features was selected from the 9 structure-based hypotheses and used for virtual screening of a drug-like database consisting of 159,757 compounds to identify novel Plk1-PBD inhibitors. The virtual screening technique revealed 9,327 compounds with a maximum fit value of 3 or greater, which were selected and subjected to molecular docking analyses. This approach yielded 93 compounds that made good interactions with critical residues within the Plk1-PBD active site. The testing of these 93 compounds in vitro for their ability to inhibit the Plk1-PBD, showed that many of these compounds had Plk1-PBD inhibitory activity and that compound Chemistry_28272 was the most potent Plk1-PBD inhibitor. Thus Chemistry_28272 and the other top compounds are novel Plk1-PBD inhibitors and could be used for the development of cancer therapeutics.	[Sakkiah, Sugunadevi; Senese, Silvia; Yang, Qianfan; Torres, Jorge Z.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lee, Keun Woo] GNU, RINS, PMBBRC, SSAC,Div Appl Life Sci,Program BK21, Jinju, South Korea; [Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Torres, Jorge Z.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	torres@chem.ucla.edu		Sakkiah, Suguna Devi/0000-0002-8337-9348; Torres, Jorge/0000-0002-2158-889X	National Science Foundation [NSF-MCB1243645]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Science Foundation Grant NSF-MCB1243645 to J.Z.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bayliss R, 2012, OPEN BIOL, V2; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Laufer S, 2012, CHEMBIOCHEM, V13, P2146; ledz P. S, 2011, ANGEW CHEM INT EDIT, V50, P4003; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Murugan RN, 2013, BIOORGAN MED CHEM, V21, P2623, DOI 10.1016/j.bmc.2013.02.020; Murugan RN, 2011, MOL CELLS, V32, P209, DOI 10.1007/s10059-011-0126-3; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Sakkiah S, 2011, EUR J MED CHEM, V46, P2937, DOI 10.1016/j.ejmech.2011.04.018; Sledz P, 2012, ANGEW CHEM INT EDIT, V51, P7680, DOI 10.1002/anie.201202660; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	27	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101405	10.1371/journal.pone.0101405	http://dx.doi.org/10.1371/journal.pone.0101405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036740	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200015
J	Wang, YY; Li, YD; Liu, JB; Ran, XX; Guo, YY; Ren, NN; Chen, X; Jiang, H; Li, YQ				Wang, Yue-Yue; Li, Yu-Dong; Liu, Jian-Bo; Ran, Xin-Xin; Guo, Yuan-Yang; Ren, Ni-Ni; Chen, Xin; Jiang, Hui; Li, Yong-Quan			Characterization and Evolutionary Implications of the Triad Asp-Xxx-Glu in Group II Phosphopantetheinyl Transferases	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; POLYKETIDE SYNTHASE; 4'-PHOSPHOPANTETHEINYL TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; NATAMYCIN PRODUCTION; MUTATIONAL ANALYSIS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; FATTY-ACID; PROTEIN	Phosphopantetheinyl transferases (PPTases), which play an essential role in both primary and secondary metabolism, are magnesium binding enzymes. In this study, we characterized the magnesium binding residues of all known group II PPTases by biochemical and evolutionary analysis. Our results suggested that group II PPTases could be classified into two subgroups, two-magnesium-binding-residue-PPTases containing the triad Asp-Xxx-Glu and three-magnesium-binding-residue-PPTases containing the triad Asp-Glu-Glu. Mutations of two three-magnesium-binding-residue-PPTases and one two-magnesium-binding-residue-PPTase indicate that the first and the third residues in the triads are essential to activities; the second residues in the triads are non-essential. Although variations of the second residues in the triad Asp-Xxx-Glu exist throughout the whole phylogenetic tree, the second residues are conserved in animals, plants, algae, and most prokaryotes, respectively. Evolutionary analysis suggests that: the animal group II PPTases may originate from one common ancestor; the plant two-magnesium-binding-residue-PPTases may originate from one common ancestor; the plant three-magnesium-binding-residue-PPTases may derive from horizontal gene transfer from prokaryotes.	[Wang, Yue-Yue; Liu, Jian-Bo; Ran, Xin-Xin; Guo, Yuan-Yang; Ren, Ni-Ni; Chen, Xin; Jiang, Hui; Li, Yong-Quan] Zhejiang Univ, Coll Sci, Zhengzhou, Peoples R China; [Li, Yu-Dong] Zhejiang Gongshang Univ, Dept Bioengn, Hangzhou, Zhejiang, Peoples R China; [Jiang, Hui; Li, Yong-Quan] Key Lab Microbial Biochem & Metab Engn Zhejiang P, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Gongshang University	Jiang, H (corresponding author), Zhejiang Univ, Coll Sci, Zhengzhou, Peoples R China.	jianghuisioc@zju.edu.cn; lyq@zju.edu.cn	Li, Yudong/GSN-4036-2022; li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022		National Basic Research Program of China (973 Program) [2012CB721005]; Zhejiang Provincial Natural Science Foundation of China [LZ12C01001]; National Natural Science Foundation of China [31200600]; National High Technology Research & Development Program of China (863 Program) [2012AA02A706]; National Key Technologies R & D Program of China [2011BAD23B05-2]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technologies R & D Program of China(National Key Technology R&D Program)	This work was supported by National Basic Research Program of China (973 Program) 2012CB721005, Zhejiang Provincial Natural Science Foundation of China LZ12C01001, National Natural Science Foundation of China 31200600, National High Technology Research & Development Program of China (863 Program) 2012AA02A706, National Key Technologies R & D Program of China 2011BAD23B05-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chirgadze NY, 2000, EMBO J, V19, P5281, DOI 10.1093/emboj/19.20.5281; Copp JN, 2007, J BACTERIOL, V189, P3133, DOI 10.1128/JB.01850-06; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; Dall'Aglio P, 2011, BIOCHEMISTRY-US, V50, P5704, DOI 10.1021/bi2003668; De Lay NR, 2006, MOL MICROBIOL, V61, P232, DOI 10.1111/j.1365-2958.2006.05222.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Du YL, 2011, APPL ENVIRON MICROB, V77, P8415, DOI 10.1128/AEM.05898-11; Du YL, 2011, MICROBIOL-SGM, V157, P1300, DOI 10.1099/mic.0.046607-0; Du YL, 2009, J MICROBIOL, V47, P506, DOI 10.1007/s12275-009-0014-0; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Guo SJ, 2003, FEMS MICROBIOL LETT, V224, P261, DOI 10.1016/S0378-1097(03)00455-5; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Huang Y, 2006, J BIOL CHEM, V281, P29660, DOI 10.1074/jbc.M604895200; Jiang H, 2013, APPL ENVIRON MICROB, V79, P3346, DOI 10.1128/AEM.00099-13; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lombo F, 2004, CHEMBIOCHEM, V5, P1181, DOI 10.1002/cbic.200400073; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Meiser P, 2008, CHEMBIOCHEM, V9, P1549, DOI 10.1002/cbic.200800077; Mofid MR, 2004, BIOCHEMISTRY-US, V43, P4128, DOI 10.1021/bi036013h; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Praphanphoj V, 2001, MOL GENET METAB, V72, P336, DOI 10.1006/mgme.2000.3138; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Roberts AA, 2009, CHEMBIOCHEM, V10, P1869, DOI 10.1002/cbic.200900095; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Sunbul M, 2009, METHOD ENZYMOL, V458, P255, DOI 10.1016/S0076-6879(09)04810-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Weissman KJ, 2004, CHEMBIOCHEM, V5, P116, DOI 10.1002/cbic.200300775; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zhou Z, 2011, CURR GENOMICS, V12, P404, DOI 10.2174/138920211797248556	44	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103031	10.1371/journal.pone.0103031	http://dx.doi.org/10.1371/journal.pone.0103031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036863	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200106
J	Zhao, W; Zou, K; Farasyn, T; Ho, WT; Zhao, ZZJ				Zhao, Wanke; Zou, Kang; Farasyn, Taleah; Ho, Wanting Tina; Zhao, Zhizhuang Joe			Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line	PLOS ONE			English	Article							TYROSINE KINASE JAK2; HEMATOPOIETIC STEM; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; MUTATION; EXPRESSION; JAK2V617F; JAK2(V617F); ERYTHROPOIETIN; MYELOFIBROSIS	The JAK2V617F mutation is found in the majority of patients with myeloproliferative neoplasms (MPNs). Transgenic expression of the mutant gene causes MPN-like phenotypes in mice. We have produced JAK2V617F mice with p53 null background. Some of these mice developed acute erythroleukemia. From one of these mice, we derived a cell line designated J53Z1. J53Z1 cells were stained positive for surface markers CD71 and CD117 but negative for Sca-1, TER-119, CD11b, Gr-1, F4/80, CD11c, CD317, CD4, CD8a, CD3e, B220, CD19, CD41, CD42d, NK-1.1, and FceR1. Real time PCR analyses demonstrated expressions of erythropoietin receptor EpoR, GATA1, and GATA2 in these cells. J53Z1 cells grew rapidly in suspension culture containing fetal bovine serum with a doubling time of similar to 18 hours. When transplanted into C57Bl/6 mice, J53Z1 cells induced acute erythroleukemia with massive infiltration of tumor cells in the spleen and liver. J53Z1 cells were responsive to stimulation with erythropoietin and stem cell factor and were selectively inhibited by JAK2 inhibitors which induced apoptosis of the cells. Together, J53Z1 cells belong to the erythroid lineage, and they may be useful for studying the role of JAK2V617F in proliferation and differentiation of erythroid cells and for identifying potential therapeutic drugs targeting JAK2.	[Zhao, Wanke; Farasyn, Taleah; Ho, Wanting Tina; Zhao, Zhizhuang Joe] Univ Oklahoma Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Zou, Kang] Oklahoma Sch Sci & Math, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhao, ZZJ (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA.				Stephenson Cancer Center of University of Oklahoma	Stephenson Cancer Center of University of Oklahoma	This work was supported by a pilot grant from the Stephenson Cancer Center of University of Oklahoma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Ferbeyre G, 2002, NATURE, V415, P26, DOI 10.1038/415026a; Guo Y, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-72; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084340; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Li Z, 2007, J BIOL CHEM, V282, P3428, DOI 10.1074/jbc.C600277200; Liu Y, 2009, CELL CYCLE, V8, P3120, DOI 10.4161/cc.8.19.9627; Marty C, 2010, BLOOD, V116, P783, DOI 10.1182/blood-2009-12-257063; Mesa RA, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-79; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Prasher JM, 2001, ONCOGENE, V20, P2946, DOI 10.1038/sj.onc.1204395; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; RUSCETTI SK, 1990, J VIROL, V64, P1057, DOI 10.1128/JVI.64.3.1057-1062.1990; Shi KY, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-25; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Sui XW, 1998, BLOOD, V92, P1142, DOI 10.1182/blood.V92.4.1142.416k42_1142_1149; Tefferi A, 2008, LEUKEMIA, V22, P3, DOI 10.1038/sj.leu.2404946; Tian CX, 2003, BLOOD, V101, P2235, DOI 10.1182/blood-2002-04-1217; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhao AH, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-40; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200; Zhao WK, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-15; Zhao WM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-4	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99017	10.1371/journal.pone.0099017	http://dx.doi.org/10.1371/journal.pone.0099017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036984	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200002
J	Zhou, C; He, JJ; Li, J; Fan, JH; Zhang, B; Yang, HJ; Xie, XM; Tang, ZH; Li, H; Li, JY; Wang, SL; Qiao, YL; Huang, R; Zhang, P				Zhou, Can; He, Jian Jun; Li, Jing; Fan, Jin Hu; Zhang, Bin; Yang, Hong Jian; Xie, Xiao Ming; Tang, Zhong Hua; Li, Hui; Li, Jia Yuan; Wang, Shu Lian; Qiao, You Lin; Huang, Rong; Zhang, Pin			A Nation-Wide Multicenter 10-Year (1999-2008) Retrospective Clinical Study of Endocrine Therapy for Chinese Females with Breast Cancer	PLOS ONE			English	Article							HORMONE-RECEPTOR STATUS; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; AROMATASE INHIBITORS; ADJUVANT TAMOXIFEN; ANASTROZOLE; CHEMOTHERAPY; LETROZOLE; COMBINATION	Endocrine therapy (ET) is one of the main systemic treatments for patients with breast cancer. To our knowledge, few studies have addressed the performance of ET or relevant influencing factors in cancer treatment in China. By retrospectively analyzing the clinicopathological data on breast cancer collected from representative hospitals of 7 traditional areas in China in one random month from each year between year 1999 and 2008, we found that: 1) The rate of the use of hormone receptor (HR) testing was 83.8% (3529/4211), with the estrogen receptor-positive (ER+) rate and/or the progesterone receptor-positive (PR+) rate being 67.9% (2395/3529), and the ER-PR rate being 32.1% (1134/3529). 2) Of the 1599 patients who had received ET, 999 patients (58.3%) were premenopausal while 600 (41.7%) were postmenopausal; 1598 patients received adjuvant hormonal therapy (AHT), whereas only 1 patient received palliative therapy. The medications mainly administered to patients were anti-estrogen agents (80.3% [1283/1598]), followed by AIs (15.5% [248/1598]). Of the 1598 patients receiving AHT, 1416 patients (88.6%) were positive for ER and/or PR, while 75 (4.7%) were negative for both and 108 patients (6.7%) had unknown HR status. The ratio of the use of endocrine therapy for breast cancer patients with ER+ and/or PR+ status was 60.0% (1416/2395). 3) Results from the logistic regression analysis revealed that geography, occupations, and history of chemotherapy and surgery were dependent factors affecting the application of ET in breast cancer treatment in China (P<0.001). In conclusion, the use of ET on Chinese women with breast cancer is increasingly and gradually accounted into the standardized process. Economic status, occupations, and history of chemotherapy and surgery were key factors affecting the application of ET. People residing in developed areas, engaging in mental labour, having history of chemotherapy and surgery are susceptible to accept ET.	[Zhou, Can; He, Jian Jun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Surg Oncol, Xian 710049, Shaanxi Provinc, Peoples R China; [Li, Jing; Fan, Jin Hu; Qiao, You Lin; Huang, Rong] Chinese Acad Med Sci, Dept Canc Epidemiol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Li, Jing; Fan, Jin Hu; Wang, Shu Lian; Qiao, You Lin; Huang, Rong; Zhang, Pin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Bin] Liaoning Canc Hosp, Dept Breast Surg, Shenyang, Liaoning Provin, Peoples R China; [Yang, Hong Jian] Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Zhejiang, Peoples R China; [Xie, Xiao Ming] Sun Yat Sen Univ, Dept Breast Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Zhong Hua] Cent South Univ, Xiangya Hosp 2, Dept Breast Thyroid Surg, Changsha, Hunan, Peoples R China; [Li, Hui] Second Peoples Hosp Sichuan Prov, Dept Breast Surg, Chengdu, Sichuan Provinc, Peoples R China; [Li, Jia Yuan] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Shu Lian] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Radiotherapy, Beijing 100730, Peoples R China; [Zhang, Pin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang Cancer Hospital; Sun Yat Sen University; Central South University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhang, P (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China.	zhang_pin@sina.com	li, jia/GVT-7587-2022; Qiao, You-Lin/B-4139-2012	Qiao, You-Lin/0000-0001-6380-0871	Chinese Cancer Foundation	Chinese Cancer Foundation	This study was financially supported. The review has sufficient funding support for initiation and management from The Chinese Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Baum M, 2002, LANCET, V359, P2131; Baum Michael, 2004, Cancer Control, V11, P217; Belfiglio M, 2005, CANCER-AM CANCER SOC, V104, P2334, DOI 10.1002/cncr.21474; Bowles EJA, 2012, J ONCOL PRACT, V8, P113, DOI 10.1200/JOP.2011.000417; Cardoso F, 2013, CANCER TREAT REV, V39, P457, DOI 10.1016/j.ctrv.2012.06.011; Cataliotti L, 2006, CANCER-AM CANCER SOC, V106, P2095, DOI 10.1002/cncr.21872; Colleoni M, 2012, ANN ONCOL, V23, P243, DOI 10.1093/annonc/mds305; Colleoni M, 2000, ANN ONCOL, V11, P1057, DOI 10.1023/A:1008334404825; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; CORDER MP, 1980, J IOWA MED SOC, V70, P105; Cuncins-Hearn AV, 2006, ANZ J SURG, V76, P745, DOI 10.1111/j.1445-2197.2006.03846.x; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Del Mastro L, 2007, CANCER TREAT REV, V33, P681, DOI 10.1016/j.ctrv.2007.07.014; Dickschen K, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00092; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Dowsett M, 2005, J CLIN ONCOL, V23, P7512, DOI 10.1200/JCO.2005.01.4829; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Dubsky PC, 2012, J CLIN ONCOL, V30, P722, DOI 10.1200/JCO.2011.36.8993; Eiermann W, 2001, ANN ONCOL, V12, P1527, DOI 10.1023/A:1013128213451; Eisen A, 2008, CANCER TREAT REV, V34, P157, DOI 10.1016/j.ctrv.2007.11.001; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Fink AK, 2004, J CLIN ONCOL, V22, P3309, DOI 10.1200/JCO.2004.11.064; Forbes JF, 2006, SEMIN ONCOL, V33, P2; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Gradishar W, 2006, CANCER-AM CANCER SOC, V106, P975, DOI 10.1002/cncr.21707; GRATTAROLA R, 1975, AM J OBSTET GYNECOL, V121, P169, DOI 10.1016/0002-9378(75)90633-X; HADFIELD J, 1958, Postgrad Med J, V34, P628; Hadji P, 2010, CRIT REV ONCOL HEMAT, V73, P156, DOI 10.1016/j.critrevonc.2009.02.001; Harlan LC, 2006, J CLIN ONCOL, V24, P872, DOI 10.1200/JCO.2005.03.5840; HARRIS AL, 1983, BRIT J CANCER, V47, P621, DOI 10.1038/bjc.1983.100; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hayward J, 1974, P ROY SOC MED, V67, P22; HUGGINS C, 1952, ANN SURG, V136, P595; Johnston SRD, 2010, CLIN CANCER RES, V16, P1979, DOI 10.1158/1078-0432.CCR-09-1823; Jordan VC, 2003, J NATL CANCER I, V95, P338, DOI 10.1093/jnci/95.5.338; JORDAN VC, 1977, BRIT MED J, V1, P1534, DOI 10.1136/bmj.1.6075.1534-d; JUNGI WF, 1978, SCHWEIZ MED WSCHR, V108, P1317; Kimmick G, 2009, J CLIN ONCOL, V27, P3445, DOI 10.1200/JCO.2008.19.2419; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; Li J, 2011, BMC CANCER, V11, P1; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087224; Lumachi F, 2013, CURR MED CHEM, V20, P596, DOI 10.2174/092986713804999303; Miaskowski C, 2008, CLIN J ONCOL NURS, V12, P213, DOI 10.1188/08.CJON.213-221; Myrick ME, 2012, ACTA ONCOL, V51, P247, DOI 10.3109/0284186X.2011.619567; Nguyen O, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/180574; NOMURA Y, 1992, CANCER, V69, P153, DOI 10.1002/1097-0142(19920101)69:1<153::AID-CNCR2820690127>3.0.CO;2-P; Padilha M, 2012, ACTA MEDICA PORT, V25, P422; PEARSON OH, 1982, CANCER RES, V42, P3424; Prowell TM, 2004, ONCOLOGIST, V9, P507, DOI 10.1634/theoncologist.9-5-507; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Ruddy K, 2009, CA-CANCER J CLIN, V59, P56, DOI 10.3322/caac.20004; Semiglazov VF, 2007, CANCER-AM CANCER SOC, V110, P244, DOI 10.1002/cncr.22789; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; STONESIFER GL, 1973, ANN SURG, V178, P563, DOI 10.1097/00000658-197311000-00001; Svahn TH, 2009, J NATL COMPR CANC NE, V7, P115, DOI 10.6004/jnccn.2009.0011; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Wang MP, 2013, PLOS ONE, V13; Weaver KE, 2013, AM J CLIN ONCOL-CANC, V36, P181, DOI 10.1097/COC.0b013e3182436ec1; Wong ZW, 2004, BRIT J CANCER, V90, P20, DOI 10.1038/sj.bjc.6601508	61	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e100159	10.1371/journal.pone.0100159	http://dx.doi.org/10.1371/journal.pone.0100159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036532	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200007
J	Bogler, C; Mehnert, J; Steinbrink, J; Haynes, JD				Bogler, Carsten; Mehnert, Jan; Steinbrink, Jens; Haynes, John-Dylan			Decoding Vigilance with NIRS	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BRAIN-COMPUTER-INTERFACE; DIFFUSE OPTICAL TOMOGRAPHY; CEREBRAL-BLOOD; SUSTAINED ATTENTION; PERFORMANCE; TALAIRACH; CORTEX; TASK; FMRI	Sustained, long-term cognitive workload is associated with variations and decrements in performance. Such fluctuations in vigilance can be a risk factor especially during dangerous attention demanding activities. Functional MRI studies have shown that attentional performance is correlated with BOLD-signals, especially in parietal and prefrontal cortical regions. An interesting question is whether these BOLD-signals could be measured in real-world scenarios, say to warn in a dangerous workplace whenever a subjects' vigilance is low. Because fMRI lacks the mobility needed for such applications, we tested whether the monitoring of vigilance might be possible using Near-Infrared Spectroscopy (NIRS). NIRS is a highly mobile technique that measures hemodynamics in the surface of the brain. We demonstrate that non-invasive NIRS signals correlate with vigilance. These signals carry enough information to decode subjects' reaction times at a single trial level.	[Bogler, Carsten; Haynes, John-Dylan] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany; [Bogler, Carsten; Haynes, John-Dylan] Charite, D-13353 Berlin, Germany; [Bogler, Carsten; Mehnert, Jan; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Bogler, Carsten; Haynes, John-Dylan] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Mehnert, Jan; Steinbrink, Jens] Charite, Berlin NeuroImaging Ctr, D-13353 Berlin, Germany; [Steinbrink, Jens] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Steinbrink, Jens] Berlin Inst Technol, Bernstein Focus Neurotechnol Berlin, Berlin, Germany; [Mehnert, Jan] Inst Technol, Dept Machine Learning, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin	Bogler, C (corresponding author), Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany.	carsten.bogler@bccn-berlin.de; haynes@bccn-berlin.de	Mehnert, Jan/AAX-8791-2020; Haynes, John-Dylan/Q-1148-2016	Mehnert, Jan/0000-0001-7088-740X; Haynes, John-Dylan/0000-0003-1786-6954; Bogler, Carsten/0000-0003-0162-6016	German Ministry for Research (BMBF) [01GQ1001C]; Bernstein Focus Neurotechnology Berlin [01GQ0850]; NIH [R42NS050007, R44NS049734]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS049734, R42NS050007] Funding Source: NIH RePORTER	German Ministry for Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bernstein Focus Neurotechnology Berlin; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by German Ministry for Research (BMBF 01GQ1001C), Bernstein Focus Neurotechnology Berlin (01GQ0850) and in part by NIH Grant nos. R42NS050007 and R44NS049734. The authors would like to thank the Max-Planck Institute for Human Cognitive and Brain Sciences (Leipzig, Germany) for providing the infrastructure and NIRx Medizintechnik GmbH (Berlin, Germany) for their support and technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; Davies DR, 1982, PSYCHOL VIGILANCE; De Joux N, 2013, BRAIN COGNITION, V81, P370, DOI 10.1016/j.bandc.2012.12.003; Derosiere G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00583; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Friston K., 1997, HUMAN BRAIN FUNCTION, P141; Gregg Nicholas M, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00014; Habermehl C, 2012, NEUROIMAGE, V59, P3201, DOI 10.1016/j.neuroimage.2011.11.062; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Haufe S, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056001; Helton WS, 2013, EXP BRAIN RES, V226, P357, DOI 10.1007/s00221-013-3441-4; Helton WS, 2010, NEUROPSYCHOLOGIA, V48, P1683, DOI 10.1016/j.neuropsychologia.2010.02.014; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Koch Stefan P, 2010, Front Neuroenergetics, V2, P12, DOI 10.3389/fnene.2010.00012; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee JH, 2009, NEUROSCI LETT, V450, P1, DOI 10.1016/j.neulet.2008.11.024; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Luck S.J., 2005, INTRO EVENT RELATED; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; MANGUN GRR, 1987, HUM FACTORS, V29, P195, DOI 10.1177/001872088702900207; Mouao-Miranda J, 2007, NEUROIMAGE, V36, P88, DOI 10.1016/j.neuroimage.2007.02.020; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Piper SK, 2014, NEUROIMAGE, V85, P64, DOI 10.1016/j.neuroimage.2013.06.062; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Sorger B, 2009, PROG BRAIN RES, V177, P275, DOI 10.1016/S0079-6123(09)17719-1; Stevenson H, 2011, BRAIN COGNITION, V77, P215, DOI 10.1016/j.bandc.2011.08.007; Tsubone T, 2007, P ANN INT IEEE EMBS, P5342, DOI 10.1109/IEMBS.2007.4353548; Warm J. S., 1984, SUSTAINED ATTENTION; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Zhang Y, 2008, J COGNITIVE NEUROSCI, V20, P1915, DOI 10.1162/jocn.2008.20132	52	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101729	10.1371/journal.pone.0101729	http://dx.doi.org/10.1371/journal.pone.0101729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032963	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300025
J	Chiu, CY; Huang, YL; Tsai, MH; Tu, YL; Hua, MC; Yao, TC; Yeh, KW; Huang, JL				Chiu, Chih-Yung; Huang, Yu-Lin; Tsai, Ming-Han; Tu, Yu-Ling; Hua, Man-Chin; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long			Sensitization to Food and Inhalant Allergens in Relation to Atopic Diseases in Early Childhood: A Birth Cohort Study	PLOS ONE			English	Article							SERUM IGE LEVELS; ASTHMA; ASSOCIATION; PREVALENCE; DISORDERS; EXPOSURE; INFANT; RISK; SKIN	Objectives: A correct interpretation of sensitization to common allergens is critical in determining susceptibility to allergic diseases. The aim of this study was to investigate the patterns of sensitization to food and inhalant allergens, and their relation to the development of atopic diseases in early childhood. Methods: Children aged 0 through 4 years from a birth cohort in the Prediction of Allergies in Taiwanese Children (PATCH) study were enrolled. Specific IgE antibody against food and inhalant allergens were measured and their association between total serum IgE levels and atopic diseases were assessed. Results: A total of 182 children were regular followed up at clinics for a four-year follow-up period. The prevalence of food allergen sensitization increased markedly after 6 months of age, reaching up to 47% at 1.5 years of age and then declined significantly to 10% in parallel with a considerable increase in the prevalence of sensitization to inhalant allergens up to 25% at age 4. Food allergen sensitization appeared to be mainly associated with the elevation of serum total IgE levels before age 2. A combined sensitization to food and inhalant allergens had an additive effect on serum IgE levels after age 2, and was significantly associated with the risk of developing atopic diseases at age 4. Conclusions: Sensitization to food occurs early in life, in parallel with the rising prevalence of sensitization to inhalant allergens at older age. A combined sensitization to food and inhalant allergens not only has an additive increase in serum IgE antibody production but also increases the risk of developing allergic respiratory diseases in early childhood.	[Chiu, Chih-Yung; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Chiu, Chih-Yung; Huang, Yu-Lin; Tsai, Ming-Han; Tu, Yu-Ling; Hua, Man-Chin; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chiu, Chih-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Div Pediat Pulmonol, Taoyuan, Taiwan; [Huang, Yu-Lin; Tu, Yu-Ling; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Huang, Yu-Lin; Tu, Yu-Ling; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Yeh, KW (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	kwyeh@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019; Chiu, CY/Q-4238-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG2B0050-52]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG2B0050-52 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247, DOI 10.1016/S1081-1206(10)61221-5; Bousquet J, 2002, ALLERGY, V57, P661, DOI 10.1034/j.1398-9995.2002.02002.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse W, 2005, CHEST, V127, P1312, DOI 10.1378/chest.127.4.1312; de Jong AB, 2011, PEDIAT ALLERG IMM-UK, V22, P166, DOI 10.1111/j.1399-3038.2010.00993.x; Downs SH, 2001, ARCH DIS CHILD, V84, P20, DOI 10.1136/adc.84.1.20; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Halvorsen R, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/460737; Hattevig G, 1993, Pediatr Allergy Immunol, V4, P182, DOI 10.1111/j.1399-3038.1993.tb00089.x; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Host A, 2003, ALLERGY, V58, P559, DOI 10.1034/j.1398-9995.2003.00238.x; Kulig M, 1998, PEDIAT ALLERG IMM-UK, V9, P61, DOI 10.1111/j.1399-3038.1998.tb00305.x; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Lee AJ, 2013, ASIA PAC ALLERGY, V3, P3, DOI 10.5415/apallergy.2013.3.1.3; Leung R, 1997, J ALLERGY CLIN IMMUN, V99, P594, DOI 10.1016/S0091-6749(97)70018-6; Martinez FD, 2002, PEDIATRICS, V109, P362; Martorell Aragones A, 2001, Allergol Immunopathol (Madr), V29, P72; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Satwani Hema, 2009, JPMA Journal of the Pakistan Medical Association, V59, P698; SEYMOUR JL, 1987, J AM ACAD DERMATOL, V17, P988, DOI 10.1016/S0190-9622(87)70288-6; Sun BQ, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-2; Sunyer J, 1996, EUR RESPIR J, V9, P1880, DOI 10.1183/09031936.96.09091880; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Togias Alkis G., 2000, Journal of Allergy and Clinical Immunology, V106, pS247; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Vance GHS, 2005, CLIN EXP ALLERGY, V35, P1318, DOI 10.1111/j.1365-2222.2005.02346.x; Worth A, 2010, CURR OPIN ALLERGY CL, V10, P226, DOI 10.1097/ACI.0b013e3283387fae; Yong SB, 2013, J MICROBIOL IMMUNOL, V46, P295, DOI 10.1016/j.jmii.2012.07.002; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	33	42	43	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102809	10.1371/journal.pone.0102809	http://dx.doi.org/10.1371/journal.pone.0102809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033453	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300094
J	Qie, LF; Jia, GQ; Zhang, WY; Schnable, J; Shang, ZL; Li, W; Liu, BH; Li, MZ; Chai, Y; Zhi, H; Diao, XM				Qie, Lufeng; Jia, Guanqing; Zhang, Wenying; Schnable, James; Shang, Zhonglin; Li, Wei; Liu, Binhui; Li, Mingzhe; Chai, Yang; Zhi, Hui; Diao, Xianmin			Mapping of Quantitative Trait Locus (QTLs) that Contribute to Germination and Early Seedling Drought Tolerance in the Interspecific Cross Setaria italicaxSetaria viridis	PLOS ONE			English	Article							FOXTAIL MILLET; COLEOPTILE LENGTH; TRANSGRESSIVE SEGREGATION; GENETIC-ANALYSIS; GRAIN-YIELD; ITALICA; STRESS; SEQUENCE; RESISTANCE; MARKERS	Drought tolerance is an important breeding target for enhancing the yields of grain crop species in arid and semi-arid regions of the world. Two species of Setaria, domesticated foxtail millet (S. italica) and its wild ancestor green foxtail (S. viridis) are becoming widely adopted as models for functional genomics studies in the Panicoid grasses. In this study, the genomic regions controlling germination and early seedling drought tolerance in Setaria were identified using 190 F-7 lines derived from a cross between Yugu1, a S. italica cultivar developed in China, and a wild S. viridis genotype collected from Uzbekistan. Quantitative trait loci were identified which contribute to a number of traits including promptness index, radical root length, coleoptile length and lateral root number at germinating stage and seedling survival rate was characterized by the ability of desiccated seedlings to revive after rehydration. A genetic map with 128 SSR markers which spans 1293.9 cM with an average of 14 markers per linkage group of the 9 linkage groups was constructed. A total of eighteen QTLs were detected which included nine that explained over 10% of the phenotypic variance for a given trait. Both the wild green foxtail genotype and the foxtail millet cultivar contributed the favorite alleles for traits detected in this trial, indicating that wild Setaria viridis populations may serve as a reservoir for novel stress tolerance alleles which could be employed in foxtail millet breeding.	[Qie, Lufeng; Jia, Guanqing; Schnable, James; Chai, Yang; Zhi, Hui; Diao, Xianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Li, Wei; Diao, Xianmin] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Shijiazhuang, Peoples R China; [Zhang, Wenying; Liu, Binhui; Li, Mingzhe] Hebei Acad Agr & Forestry Sci, Inst Dry Land Agr, Hengshui, Peoples R China; [Qie, Lufeng; Shang, Zhonglin; Diao, Xianmin] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Hebei Academy of Agricultural & Forestry Sciences; Hebei Academy of Agricultural & Forestry Sciences; Hebei Normal University	Zhi, H (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	diaoxianmin@caas.cn; zhihui@caas.cn		Schnable, James/0000-0001-6739-5527	Beijing Natural Science Foundation [6142019]; Fundamental Research Funds of ICS-CAAS [2013007]; Science and Technology Innovation Project of CAAS; National High Technology Research and Development Program of China (863 Program) [2013AA102603]; National Natural Science Foundation of China [31171560, 31301328, 31200910]; China Agricultural Research System [CARS07-12.5-A02]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds of ICS-CAAS; Science and Technology Innovation Project of CAAS; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System	This work was supported by Beijing Natural Science Foundation (6142019), Fundamental Research Funds of ICS-CAAS (Grant to Guanqing Jia, 2013007), Science and Technology Innovation Project of CAAS, National High Technology Research and Development Program of China (863 Program) (2013AA102603), the National Natural Science Foundation of China (31171560, 31301328, 31200910), and China Agricultural Research System (CARS07-12.5-A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bidinger FR, 2007, CROP SCI, V47, P969, DOI 10.2135/cropsci2006.07.0465; BLUM A, 1980, EUPHYTICA, V29, P727, DOI 10.1007/BF00023219; BOUSLAMA M, 1984, CROP SCI, V24, P933, DOI 10.2135/cropsci1984.0011183X002400050026x; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chen GX, 2010, GENET RESOUR CROP EV, V57, P85, DOI 10.1007/s10722-009-9453-z; DEVICENTE MC, 1993, GENETICS, V134, P585; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Dhanda SS, 2004, J AGRON CROP SCI, V190, P6, DOI 10.1111/j.1439-037X.2004.00592.x; Dias PMB, 2011, THEOR APPL GENET, V122, P429, DOI 10.1007/s00122-010-1458-7; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Foolad MR, 2003, GENOME, V46, P536, DOI [10.1139/g03-035, 10.1139/G03-035]; Grando S, 1995, EUPHYTICA, V86, P73, DOI 10.1007/BF00035941; Gu S., 1987, FOXTAIL MILLET CULTI, P63; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hu SP, 2007, RICE SCI, V14, P13, DOI 10.1016/S1672-6308(07)60003-1; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li YM, 1997, FOXTAIL MILLET BREED, P421; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Mauro-Herrera M, 2013, G3-GENES GENOM GENET, V3, P283, DOI 10.1534/g3.112.005207; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Monteros MJ, 2006, 11 BIENN C MOL CELL; Qi X, 2013, PLANT MOL BIOL, V83, P459, DOI 10.1007/s11103-013-0104-6; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; RICHARDS RA, 1979, EUPHYTICA, V28, P755, DOI 10.1007/BF00038945; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Salekdeh GH, 2009, TRENDS PLANT SCI, V14, P488, DOI 10.1016/j.tplants.2009.07.007; Sanchez AC, 2002, PLANT MOL BIOL, V48, P713, DOI 10.1023/A:1014894130270; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wang JK, 2009, THEOR APPL GENET, V119, P65, DOI 10.1007/s00122-009-1017-2; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang ZM, 1998, THEOR APPL GENET, V96, P31, DOI 10.1007/s001220050705; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yi F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-212; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang JP, 2007, GENOMICS, V90, P121, DOI 10.1016/j.ygeno.2007.03.016; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; [朱学海 ZHU Xuehai], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P62	56	38	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101868	10.1371/journal.pone.0101868	http://dx.doi.org/10.1371/journal.pone.0101868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033201	gold, Green Submitted, Green Published			2022-12-27	WOS:000339418300027
J	Talebpour, A; Maaskant, R; Khine, AA; Alavie, T				Talebpour, Abdossamad; Maaskant, Robert; Khine, Aye Aye; Alavie, Tino			Use of Surface Enhanced Blocking (SEB) Electrodes for Microbial Cell Lysis in Flow-Through Devices	PLOS ONE			English	Article							ESCHERICHIA-COLI; ELECTRICAL LYSIS; INACTIVATION	By simultaneously subjecting microbial cells to high amplitude pulsed electric fields and flash heating of the cell suspension fluid, effective release of intracellular contents was achieved. The synergistic effect of the applied electric field and elevated temperature on cell lysis in a flow-through device was demonstrated for Gram-negative and Gram-positive bacteria, and Mycobacterium species. The resulting lysate is suitable for downstream nucleic acid amplification and detection without requiring further preparation. The lysis chamber employs surface enhanced blocking electrodes which possess an etched micro-structured surface and a thin layer of dielectric metal oxide which provides a large effective area and blocks transmission of electrical current. The surface enhanced blocking electrodes enable simultaneous suppression of the rapid onset of electric field screening in the bulk of the cell suspension medium and avoidance of undesired electrochemical processes at the electrode-electrolyte interface. In addition the blocking layer ensures the robustness of the cell lysis device in applications involving prolonged flow-through processing of the microbial cells.	[Talebpour, Abdossamad; Maaskant, Robert; Khine, Aye Aye; Alavie, Tino] Qvella Inc, Richmond Hill, ON, Canada		Talebpour, A (corresponding author), Qvella Inc, Richmond Hill, ON, Canada.	samadt@qvella.com						Aronsson K, 2005, INT J FOOD MICROBIOL, V99, P19, DOI 10.1016/j.ijfoodmicro.2004.07.012; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII; Bazant MZ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021506; Beunis F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011502; Borukhov I, 1997, PHYS REV LETT, V79, P435, DOI 10.1103/PhysRevLett.79.435; Chazalviel JN, 1999, COULOMB SCREENING MO, P72; Cheng J, 1998, NAT BIOTECHNOL, V16, P541, DOI 10.1038/nbt0698-541; de la Rosa C, 2008, IEEE T BIO-MED ENG, V55, P2426, DOI 10.1109/TBME.2008.923148; DYER CK, 1978, ELECTROCHIM ACTA, V23, P347, DOI 10.1016/0013-4686(78)80073-5; Elias E, 2007, HEAT MASS TRANSFER, V43, P957, DOI 10.1007/s00231-006-0167-x; Geng T, 2013, LAB CHIP, V13, P3803, DOI 10.1039/c3lc50566a; Han ZJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077605; HULSHEGER H, 1983, RADIAT ENVIRON BIOPH, V22, P149, DOI 10.1007/BF01338893; Kanzaki N, 1981, U.S. Patent, Patent No. [4,276,129, 4276129]; Kilic MS, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021502; Lee SW, 1999, SENSOR ACTUAT A-PHYS, V73, P74, DOI 10.1016/S0924-4247(98)00257-X; McCleskey RB, 2011, J CHEM ENG DATA, V56, P317, DOI 10.1021/je101012n; Mitchell GJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0892; Morshed Bashir I., 2013, Critical Reviews in Biomedical Engineering, V41, P37; Packard MM, 2013, DIAGNOSTICS, V3, P105, DOI 10.3390/diagnostics3010105; Pavlin M, 2010, ADV PLANAR LIPID BIL, V6, P165; Persat A, 2009, LAB CHIP, V9, P2454, DOI 10.1039/b906468k; Sakaguchi H, 2010, PHYS REV E, V75; SARANG PG, 1986, J PHYS E SCI INSTRUM, V19, P1063, DOI 10.1088/0022-3735/19/12/018; Wang HY, 2006, BIOSENS BIOELECTRON, V22, P582, DOI 10.1016/j.bios.2006.01.032; Wu J, 2008, IET NANOBIOTECHNOL, V2, P14, DOI 10.1049/iet-nbt:20070023; ZEKOVIC LD, 1983, THIN SOLID FILMS, V109, P217, DOI 10.1016/0040-6090(83)90111-6; Zhong K, 2005, J FOOD PROCESS ENG, V28, P595, DOI 10.1111/j.1745-4530.2005.00041.x	28	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102707	10.1371/journal.pone.0102707	http://dx.doi.org/10.1371/journal.pone.0102707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033080	gold, Green Submitted, Green Published			2022-12-27	WOS:000339418300082
J	Kitsy, A; Carney, S; Vivar, JC; Knight, MS; Pointer, MA; Gwathmey, JK; Ghosh, S				Kitsy, Abderrazak; Carney, Skyla; Vivar, Juan C.; Knight, Megan S.; Pointer, Mildred A.; Gwathmey, Judith K.; Ghosh, Sujoy			Effects of Leucine Supplementation and Serum Withdrawal on Branched-Chain Amino Acid Pathway Gene and Protein Expression in Mouse Adipocytes	PLOS ONE			English	Article							INSULIN-RESISTANCE; SKELETAL-MUSCLE; WEIGHT-LOSS; DEHYDROGENASE KINASE; RAT-LIVER; METABOLISM; OBESITY; CATABOLISM; GLUCOSE; TISSUE	The essential branched-chain amino acids (BCAA), leucine, valine and isoleucine, are traditionally associated with skeletal muscle growth and maintenance, energy production, and generation of neurotransmitter and gluconeogenic precursors. Recent evidence from human and animal model studies has established an additional link between BCAA levels and obesity. However, details of the mechanism of regulation of BCAA metabolism during adipogenesis are largely unknown. We interrogated whether the expression of genes and proteins involved in BCAA metabolism are sensitive to the adipocyte differentiation process, and responsive to nutrient stress from starvation or BCAA excess. Murine 3T3-L1 preadipocytes were differentiated to adipocytes under control conditions and under conditions of L-leucine supplementation or serum withdrawal. RNA and proteins were isolated at days 0, 4 and 10 of differentiation to represent pre-differentiation, early differentiation and late differentiation stages. Expression of 16 BCAA metabolism genes was quantified by quantitative real-time PCR. Expression of the protein levels of branched-chain amino acid transaminase 2 (Bcat2) and branched-chain alpha keto acid dehydrogenase (Bckdha) was quantified by immunoblotting. Under control conditions, all genes displayed induction of gene expression during early adipogenesis (Day 4) compared to Day 0. Leucine supplementation resulted in an induction of Bcat2 and Bckdha genes during early and late differentiation. Western blot analysis demonstrated condition-specific concordance between gene and protein expression. Serum withdrawal resulted in undetectable Bcat2 and Bckdha protein levels at all timepoints. These results demonstrate that the expression of genes related to BCAA metabolism are regulated during adipocyte differentiation and influenced by nutrient levels. These results provide additional insights on how BCAA metabolism is associated with adipose tissue function and extends our understanding of the transcriptomic response of this pathway to variations in nutrient availability.	[Kitsy, Abderrazak; Carney, Skyla; Vivar, Juan C.; Knight, Megan S.; Pointer, Mildred A.; Ghosh, Sujoy] N Carolina Cent Univ, Biomed Biotechnol Res Inst, Div Cardiometab Disorders, Durham, NC 27707 USA; [Gwathmey, Judith K.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore, Singapore	University of North Carolina; North Carolina Central University; Boston University; National University of Singapore	Ghosh, S (corresponding author), N Carolina Cent Univ, Biomed Biotechnol Res Inst, Div Cardiometab Disorders, Durham, NC 27707 USA.	sujoy.ghosh@duke-nus.edu.sg	Ghosh, Sujoy/I-3729-2017	Ghosh, Sujoy/0000-0002-7601-165X	NCMHD [P20MD000175-09]; NIDDK [1R21DK088319-01]; American Heart Association [AHA10SDG4230068]; Duke-NUS grant [WBS R-913-200-076-263]; tuition scholarship from the Biomedical Biotechnology Research Institute, NCCU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088319] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000175] Funding Source: NIH RePORTER	NCMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); Duke-NUS grant; tuition scholarship from the Biomedical Biotechnology Research Institute, NCCU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was partly supported by NCMHD P20MD000175-09, NIDDK 1R21DK088319-01, American Heart Association grant AHA10SDG4230068, and Duke-NUS grant WBS R-913-200-076-263 to SG. AK was partly supported by a tuition scholarship from the Biomedical Biotechnology Research Institute, NCCU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Baum JI, 2005, AM J PHYSIOL-ENDOC M, V288, pE86, DOI 10.1152/ajpendo.00272.2004; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; CABALLERO B, 1988, METABOLISM, V37, P672, DOI 10.1016/0026-0495(88)90089-3; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Chan A, 2006, GENES IMMUN, V7, P169, DOI 10.1038/sj.gene.6364287; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FORLANI G, 1984, METABOLISM, V33, P147, DOI 10.1016/0026-0495(84)90127-6; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; HERAIEF E, 1983, J NEURAL TRANSM, V57, P187, DOI 10.1007/BF01245117; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Holecek M, 2001, PHYSIOL RES, V50, P19; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Kimball SR, 2001, CURR OPIN CLIN NUTR, V4, P39, DOI 10.1097/00075197-200101000-00008; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDHOLM K, 1981, CLIN SCI, V60, P319, DOI 10.1042/cs0600319; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Patterson BW, 2002, AM J PHYSIOL-ENDOC M, V282, pE931, DOI 10.1152/ajpendo.00359.2001; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; RANDLE PJ, 1963, LANCET, V1, P785; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; SANS RM, 1980, ARCH BIOCHEM BIOPHYS, V200, P336, DOI 10.1016/0003-9861(80)90363-X; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Thalacker-Mercer AE, 2014, DIABETES, V63, P791, DOI 10.2337/db13-0396; Tremblay F, 2001, J BIOL CHEM, V276, P38052; van Greevenbroek MMJ, 2012, J CLIN ENDOCR METAB, V97, P4742, DOI 10.1210/jc.2012-2539; Vassault A, 1984, METHODS ENZYM ANAL, V3, P118; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; WILLIAMSON JR, 1979, J BIOL CHEM, V254, P1511; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	47	17	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102615	10.1371/journal.pone.0102615	http://dx.doi.org/10.1371/journal.pone.0102615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050624	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100044
J	Matsuda, E; Hubert, J; Ikegami, T				Matsuda, Eiko; Hubert, Julien; Ikegami, Takashi			A Robotic Approach to Understanding the Role and the Mechanism of Vicarious Trial-And-Error in a T-Maze Task	PLOS ONE			English	Article							DECISION; LINK	Vicarious trial-and-error (VTE) is a behavior observed in rat experiments that seems to suggest self-conflict. This behavior is seen mainly when the rats are uncertain about making a decision. The presence of VTE is regarded as an indicator of a deliberative decision-making process, that is, searching, predicting, and evaluating outcomes. This process is slower than automated decision-making processes, such as reflex or habituation, but it allows for flexible and ongoing control of behavior. In this study, we propose for the first time a robotic model of VTE to see if VTE can emerge just from a body-environment interaction and to show the underlying mechanism responsible for the observation of VTE and the advantages provided by it. We tried several robots with different parameters, and we have found that they showed three different types of VTE: high numbers of VTE at the beginning of learning, decreasing numbers afterward (similar VTE pattern to experiments with rats), low during the whole learning period, and high numbers all the time. Therefore, we were able to reproduce the phenomenon of VTE in a model robot using only a simple dynamical neural network with Hebbian learning, which suggests that VTE is an emergent property of a plastic and embodied neural network. From a comparison of the three types of VTE, we demonstrated that 1) VTE is associated with chaotic activity of neurons in our model and 2) VTE-showing robots were robust to environmental perturbations. We suggest that the instability of neuronal activity found in VTE allows ongoing learning to rebuild its strategy continuously, which creates robust behavior. Based on these results, we suggest that VTE is caused by a similar mechanism in biology and leads to robust decision making in an analogous way.	[Matsuda, Eiko; Hubert, Julien; Ikegami, Takashi] Univ Tokyo, Dept Arts & Sci, Tokyo, Japan; [Matsuda, Eiko] Univ Sussex, Sch Informat & Engn, Brighton, E Sussex, England; [Matsuda, Eiko] Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; University of Sussex; Japan Society for the Promotion of Science	Matsuda, E (corresponding author), Univ Tokyo, Dept Arts & Sci, Tokyo, Japan.	eiko@sacral.c.u-tokyo.ac.jp	Matsuda, Eiko/GRO-5471-2022		Japan Society for the Promotion of Science [24120704]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research on Innovative Areas (#24120704 "The study on the neural dynamics for understanding communication in terms of complex hetero systems"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bovet S, 2005, 2005 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P841, DOI 10.1109/IROS.2005.1545085; Bovet SI, 2007, THESIS U ZURICH; Bovet S, 2006, INTELLIGENT AUTONOMOUS SYSTEMS 9, P525; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Caluwaerts K, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025009; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Harvey I, 1997, ROBOT AUTON SYST, V20, P205, DOI 10.1016/S0921-8890(96)00067-X; Holland J.H., 1975, ADAPTATION NATURAL A; HU D, 1995, P NATL ACAD SCI USA, V92, P5506, DOI 10.1073/pnas.92.12.5506; Iizuka H, 2008, LECT NOTES ARTIF INT, V5040, P1; Ikegami T, 2007, J CONSCIOUSNESS STUD, V14, P111; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Khamassi M, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00079; Mondada F., 2009, P 9 C AUT ROB SYST C, V1, P59; Muenzinger KF, 1931, J COMP PSYCHOL, V12, P195, DOI 10.1037/h0072238; Muenzinger KF, 1938, PEDAGOG SEMIN J GEN, V53, P75; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Pfeifer R., 2006, BODY SHAPES WAY WE T; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; ROSSLER OE, 1994, CHAOS SOLITON FRACT, V4, P125, DOI 10.1016/0960-0779(94)90022-1; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Scheier C, 1999, UNDERSTANDING INTELL; Schmidt B, 2013, LEARN MEMORY, V20, P130, DOI 10.1101/lm.028753.112; Tarsitano M, 2006, ANIM BEHAV, V72, P1437, DOI 10.1016/j.anbehav.2006.05.007; Tolman EC, 1939, PSYCHOL REV, V46, P318, DOI 10.1037/h0057054; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; van der Meer M, 2012, NEUROSCIENTIST, V18, P342, DOI 10.1177/1073858411435128; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; Voss JL, 2011, P NATL ACAD SCI USA, V108, pE402, DOI 10.1073/pnas.1100225108	33	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102708	10.1371/journal.pone.0102708	http://dx.doi.org/10.1371/journal.pone.0102708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050548	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100054
J	Nirmal, J; Tyagi, P; Chuang, YC; Lee, WC; Yoshimura, N; Huang, CC; Rajaganapathy, B; Chancellor, MB				Nirmal, Jayabalan; Tyagi, Pradeep; Chuang, Yao-Chi; Lee, Wei-Chia; Yoshimura, Naoki; Huang, Chao-Cheng; Rajaganapathy, Bharathi; Chancellor, Michael B.			Functional and Molecular Characterization of Hyposensitive Underactive Bladder Tissue and Urine in Streptozotocin-Induced Diabetic Rat	PLOS ONE			English	Article							NERVE-GROWTH-FACTOR; RECEPTOR ANTAGONIST; PROSTANOID RECEPTORS; OVERACTIVE BLADDER; OUTLET OBSTRUCTION; SMOOTH-MUSCLE; CYSTOPATHY; DYSFUNCTION; EXPRESSION; MODEL	Background: The functional and molecular alterations of nerve growth factor (NGF) and Prostaglandin E2 (PGE2) and its receptors were studied in bladder and urine in streptozotocin (STZ)-induced diabetic rats. Methodology/Principal Findings: Diabetes mellitus was induced with a single dose of 45 mg/kg STZ Intraperitoneally (i.p) in female Sprague-Dawley rats. Continuous cystometrogram were performed on control rats and STZ treated rats at week 4 or 12 under urethane anesthesia. Bladder was then harvested for histology, expression of EP receptors and NGF by western blotting, PGE2 levels by ELISA, and detection of apoptosis by TUNEL staining. In addition, 4-hr urine was collected from all groups for urine levels of PGE2, and NGF assay. DM induced progressive increase of bladder weight, urine production, intercontraction interval (ICI) and residual urine in a time dependent fashion. Upregulation of Prostaglandin E receptor (EP) 1 and EP3 receptors and downregulation of NGF expression, increase in urine NGF and decrease levels of urine PGE2 at week 12 was observed. The decrease in ICI by intravesical instillation of PGE2 was by 51% in control rats and 31.4% in DM group at week 12. Conclusions/Significance: DM induced hyposensitive underactive bladder which is characterized by increased inflammatory reaction, apoptosis, urine NGF levels, upregulation of EP1 and EP3 receptors and decreased bladder NGF and urine PGE2. The data suggest that EP3 receptor are potential targets in the treatment of diabetes induced underactive bladder.	[Chuang, Yao-Chi; Lee, Wei-Chia] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Tyagi, Pradeep; Yoshimura, Naoki] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA; [Huang, Chao-Cheng] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Nirmal, Jayabalan; Rajaganapathy, Bharathi; Chancellor, Michael B.] Oakland Univ, William Beaumont Sch Med, Dept Urol, Ctr Urol Res Excellence, Royal Oak, MI USA	Chang Gung Memorial Hospital; Chang Gung University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chang Gung Memorial Hospital; Chang Gung University; Oakland University	Chuang, YC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan.	chuang82@ms26.hinet.net	J, Nirmal/AAO-5138-2020	J, Nirmal/0000-0001-7864-6053; Lee, Wei-Chia/0000-0003-0701-2285; Chuang, Yao-Chi/0000-0002-1468-3792	National Science council Taiwan [101-2314-B-182A-017 -MY3 101-2314-B-182A-017 -MY3]	National Science council Taiwan(Ministry of Science and Technology, Taiwan)	This work is funded by the National Science council Taiwan 101-2314-B-182A-017 -MY3 101-2314-B-182A-017 -MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle S, 2005, MOL HUM REPROD, V11, P279, DOI 10.1093/molehr/gah158; Changolkar AK, 2005, J UROLOGY, V173, P309, DOI 10.1097/01.ju.0000141583.31183.7a; Chuang YC, 2010, BJU INT, V106, P1782, DOI 10.1111/j.1464-410X.2010.09260.x; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Daneshgari F, 2006, SEMIN NEPHROL, V26, P182, DOI 10.1016/j.semnephrol.2005.09.009; Daneshgari F, 2009, J UROLOGY, V182, pS18, DOI 10.1016/j.juro.2009.08.070; DVEKSLER G, 1989, PROSTAG LEUKOTR ESS, V36, P65, DOI 10.1016/0952-3278(89)90019-7; ELLENBERG M, 1980, ANN INTERN MED, V92, P321, DOI 10.7326/0003-4819-92-2-321; FRIMODTMOLLER C, 1980, ANN INTERN MED, V92, P327, DOI 10.7326/0003-4819-92-2-327; Ha US, 2013, NEUROUROL URODYNAM, V32, P493, DOI 10.1002/nau.22334; JEREMY JY, 1987, BRIT J UROL, V59, P36, DOI 10.1111/j.1464-410X.1987.tb04575.x; Khan MA, 1998, PROSTAG LEUKOTR ESS, V59, P415, DOI 10.1016/S0952-3278(98)90104-1; Lee T, 2008, NEUROUROL URODYNAM, V27, P88, DOI 10.1002/nau.20460; Lee T, 2007, J UROLOGY, V177, P1562, DOI 10.1016/j.juro.2006.11.070; Li Y, 2013, BJU INT, V112, pE143, DOI 10.1111/bju.12172; Li YZ, 2011, INT UROL NEPHROL, V43, P109, DOI 10.1007/s11255-010-9747-2; Liu RT, 2011, UROLOGY, V78, P1040, DOI 10.1016/j.urology.2011.05.017; MAGGI CA, 1988, EUR J PHARMACOL, V152, P273, DOI 10.1016/0014-2999(88)90722-4; MIKHAILIDIS DP, 1987, J UROLOGY, V137, P577, DOI 10.1016/S0022-5347(17)44109-7; Miyazato Minoru, 2013, Rev Urol, V15, P11; NEGISHI M, 1995, BBA-LIPID LIPID MET, V1259, P109, DOI 10.1016/0005-2760(95)00146-4; Philyppov IB, 2012, LIFE SCI, V91, P912, DOI 10.1016/j.lfs.2012.09.001; Pinna C, 2000, EUR J PHARMACOL, V388, P267, DOI 10.1016/S0014-2999(99)00833-X; Pittenger Gary, 2003, Exp Diabesity Res, V4, P271, DOI 10.1155/EDR.2003.271; Sasaki K, 2004, DIABETES, V53, P2723, DOI 10.2337/diabetes.53.10.2723; Sasaki K, 2002, J UROLOGY, V168, P1259, DOI 10.1016/S0022-5347(05)64636-8; SCHMID A, 1995, EUR J BIOCHEM, V228, P23, DOI 10.1111/j.1432-1033.1995.tb20223.x; Schnegelsberg B, 2010, AM J PHYSIOL-REG I, V298, pR534, DOI 10.1152/ajpregu.00367.2009; SCHUSSLER B, 1990, UROL RES, V18, P349, DOI 10.1007/BF00300786; Shakhmatova E I, 1997, Ross Fiziol Zh Im I M Sechenova, V83, P168; STEERS WD, 1991, J CLIN INVEST, V88, P1709, DOI 10.1172/JCI115488; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Terry KK, 2008, PROSTAG LEUKOTR ESS, V78, P3, DOI 10.1016/j.plefa.2007.10.003; Tong YC, 2005, BJU INT, V96, P1392, DOI 10.1111/j.1464-410X.2005.05854.x; Ueda T, 1997, J UROLOGY, V157, P580, DOI 10.1016/S0022-5347(01)65209-1; van Koeveringe GA, 2011, NEUROUROL URODYNAM, V30, P723, DOI 10.1002/nau.21097; Wada N, 2013, INT J UROL, V20, P235, DOI 10.1111/j.1442-2042.2012.03126.x; Yang ZG, 2010, AM J PHYSIOL-RENAL, V298, pF118, DOI 10.1152/ajprenal.00281.2009; Yoshimura N, 2005, BJU INT, V95, P733, DOI 10.1111/j.1464-410X.2005.05392.x; Yoshimura N, 1999, J NEUROSCI, V19, P4644	40	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102644	10.1371/journal.pone.0102644	http://dx.doi.org/10.1371/journal.pone.0102644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050870	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100047
J	Kwon, YD; Yoon, SS; Chang, H				Kwon, Young Dae; Yoon, Sung Sang; Chang, Hyejung			High Total Hospitalization Cost but Low Cost of Imaging Studies in Recurrent Acute Ischemic Stroke Patients	PLOS ONE			English	Article							CEREBRAL INFARCTION; COMMUNITY; EPIDEMIOLOGY; PREDICTORS; LENGTH; STAY; RISK	Background: Due to the high risk and severity of recurrence after stroke attack, recurrence is a major reason contributing to the disease burden. This study aims to determine whether recurrence is a significant contributor of hospitalization cost in items for ischemic stroke patients. Methods: This study assessed acute ischemic stroke patients admitted to an academic medical center in 2003 through 2009. The t-test and Chi-square tests were used to compare first-ever and recurrent ischemic stroke groups in terms of total and categorized hospitalization cost, and multiple regression was performed to assess the influence of stroke recurrence. Results: Recurrent ischemic strokes were associated with higher total cost, but examination cost showed no difference between the two groups. The recurrent stroke group showed higher laboratory but lower imaging cost. Of imaging studies, there was no significant difference in computed tomography scan cost while the first-ever stroke group spent more on magnetic resonance imaging and sonography. Controlling for other influential factors, recurrence was discovered to be a significant factor in lowering examination cost. Conclusions: The findings of stroke recurrence in lowering examination cost could be explained from two perspectives, different clinical patterns of healthcare utilization and patients' economic status in recurrent stroke.	[Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea; [Yoon, Sung Sang] Kyung Hee Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Chang, Hyejung] Kyung Hee Univ, Sch Management, Dept Hlth Serv Management, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Kyung Hee University; Kyung Hee University	Chang, H (corresponding author), Kyung Hee Univ, Sch Management, Dept Hlth Serv Management, Seoul, South Korea.	hjchang@khu.ac.kr	Kwon, Young Dae/T-1591-2017; Chang, Hyejung/K-5764-2013	Kwon, Young Dae/0000-0002-8781-6832; 	Kyung Hee University [KHU-2009554]	Kyung Hee University	This study was supported by a Faculty Research Grant from the Kyung Hee University in 2009 (KHU-2009554). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Chang Hyejung, 2011, [Journal of the Korean Neurological Association, 대한신경과학회지], V29, P9; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Fine MJ, 2000, AM J MED, V109, P378, DOI 10.1016/S0002-9343(00)00500-3; Gumbinger C, 2013, NEUROEPIDEMIOLOGY, V41, P161, DOI 10.1159/000354356; Hacke W, 2000, EUR J NEUROL, V7, P607, DOI 10.1046/j.1468-1331.2000.00137.x; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Jorgensen HS, 1997, NEUROLOGY, V48, P891; Keerthi MM, 2011, STROKE, V42, P1489; Leoo T, 2008, CEREBROVASC DIS, V25, P254, DOI 10.1159/000113864; Modrego PJ, 2000, NEUROL SCI, V21, P355, DOI 10.1007/s100720070050; Mohr JP, 2004, STROKE PATHOPHYSIOLO, P42; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; Paul AT, 2000, J AM COLL SURGEONS, V191, P123; Peltola M, 2013, CEREBROVASC DIS, V35, P113, DOI 10.1159/000346092; Ryglewicz D, 1997, NEUROL RES, V19, P377, DOI 10.1080/01616412.1997.11740828; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Schmidt EV, 1988, STROKE, V19, P942; Spieler JF, 2003, EUR J NEUROL, V10, P621, DOI 10.1046/j.1468-1331.2003.00665.x; YASAKA M, 1993, STROKE, V24, P1681, DOI 10.1161/01.STR.24.11.1681	22	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101360	10.1371/journal.pone.0101360	http://dx.doi.org/10.1371/journal.pone.0101360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047140	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100008
J	Yoshimura, S; Okamoto, Y; Yoshino, A; Kobayakawa, M; Machino, A; Yamawaki, S				Yoshimura, Shinpei; Okamoto, Yasumasa; Yoshino, Atsuo; Kobayakawa, Makoto; Machino, Akihiko; Yamawaki, Shigeto			Neural Basis of Anticipatory Anxiety Reappraisals	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; EMOTION REGULATION; ACTIVATION; MECHANISMS; PATHWAYS; PAIN; SUPPRESSION; EXPERIENCE; RESPONSES	Reappraisal is a well-known emotion regulation strategy. Recent neuroimaging studies suggest that reappraisal recruits both medial and lateral prefrontal brain regions. However, few studies have investigated neural representation of reappraisals associated with anticipatory anxiety, and the specific nature of the brain activity underlying this process remains unclear. We used functional magnetic resonance imaging (fMRI) to investigate neural activity associated with reappraisals of transient anticipatory anxiety. Although transient anxiety activated mainly subcortical regions, reappraisals targeting the anxiety were associated with increased activity in the medial and lateral prefrontal regions (including the orbitofrontal and anterior cingulate cortices). Reappraisal decreased fear circuit activity (including the amygdala and thalamus). Correlational analysis demonstrated that reductions in subjective anxiety associated with reappraisal were correlated with orbitofrontal and anterior cingulate cortex activation. Reappraisal recruits medial and lateral prefrontal regions; particularly the orbitofrontal and anterior cingulate cortices are associated with successful use of this emotion regulation strategy.	[Yoshimura, Shinpei] Otemon Gakuin Univ, Osaka, Japan; [Okamoto, Yasumasa; Yoshino, Atsuo; Kobayakawa, Makoto; Machino, Akihiko; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Div Frontier Grad Sch Biomed Sci, Minami Ku, Hiroshima, Japan	Hiroshima University	Yoshimura, S (corresponding author), Otemon Gakuin Univ, Osaka, Japan.	syoshimura1981@hotmail.co.jp	Yoshimura, Shinpei/AAG-5540-2019	Yoshimura, Shinpei/0000-0001-9957-7982; Yoshimura, Shimpei/0000-0001-6756-4829	Neurological and Psychiatric Disorders of NCNP, Japan [24-2]; MEXT, Japan; KAKENHI [24390284, 25780413]; MEXT; Grants-in-Aid for Scientific Research [25780413] Funding Source: KAKEN	Neurological and Psychiatric Disorders of NCNP, Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Intramural Research Grant (24-2) for Neurological and Psychiatric Disorders of NCNP, Japan; "Adolescent Mind & Self-Regulation'' Grant-in-Aid for Scientific Research on Innovative Areas, MEXT, Japan; KAKENHI Grant number 24390284 and 25780413; and a Grant-in-Aid for 'Integrated research on neuropsychiatric disorders' carried out under the Strategic Research Program for Brain Sciences by the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Carlson JM, 2010, BIOL PSYCHOL, V85, P383, DOI 10.1016/j.biopsycho.2010.08.010; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Grillon C, 2008, AM J PSYCHIAT, V165, P898, DOI 10.1176/appi.ajp.2007.07101581; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Haggard P, 2004, CONSCIOUS COGN, V13, P646, DOI 10.1016/j.concog.2004.06.001; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; Herwig U, 2007, NEUROIMAGE, V34, P848, DOI 10.1016/j.neuroimage.2006.09.035; Hofmann SG, 2009, BEHAV RES THER, V47, P389, DOI 10.1016/j.brat.2009.02.010; Inui K, 2006, CEREB CORTEX, V16, P355, DOI 10.1093/cercor.bhi114; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lam S, 2009, PSYCHONEUROENDOCRINO, V34, P1355, DOI 10.1016/j.psyneuen.2009.04.006; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Onoda K, 2008, NEUROPSYCHOLOGIA, V46, P102, DOI 10.1016/j.neuropsychologia.2007.08.006; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Schunck T, 2008, J MAGN RESON IMAGING, V27, P459, DOI 10.1002/jmri.21237; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Smoski MJ, 2011, PSYCHIAT RES-NEUROIM, V194, P263, DOI 10.1016/j.pscychresns.2011.06.012; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wagner GP, 2006, J EXP ZOOL PART A, V305A, P1, DOI 10.1002/jez.a.261; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303; Yoshino A, 2010, NEUROIMAGE, V50, P1194, DOI 10.1016/j.neuroimage.2009.11.079; Zeidan F, 2012, NEUROSCI LETT, V520, P165, DOI 10.1016/j.neulet.2012.03.082; Zeidan F., 2013, SOC COGN AFFECT NEUR	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102836	10.1371/journal.pone.0102836	http://dx.doi.org/10.1371/journal.pone.0102836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048028	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100078
J	Ortega-Roldan, B; Rodriguez-Ruiz, S; Perakakis, P; Fernandez-Santaella, MC; Vila, J				Ortega-Roldan, Blanca; Rodriguez-Ruiz, Sonia; Perakakis, Pandelis; Fernandez-Santaella, M. Carmen; Vila, Jaime			The Emotional and Attentional Impact of Exposure to One's Own Body in Bulimia Nervosa: A Physiological View	PLOS ONE			English	Article							CARDIAC DEFENSE; MIRROR CONFRONTATION; STIMULUS MODALITY; ANOREXIA-NERVOSA; EATING PATHOLOGY; CUE REACTIVITY; ANIMAL-MODELS; BIAS; DISSATISFACTION; RESPONSES	Background: Body dissatisfaction is the most relevant body image disturbance in bulimia nervosa (BN). Research has shown that viewing one's own body evokes negative thoughts and emotions in individuals with BN. However, the psychophysiological mechanisms involved in this negative reaction have not yet been clearly established. Our aim was to examine the emotional and attentional processes that are activated when patients with BN view their own bodies. Method: We examined the effects of viewing a video of one's own body on the physiological (eye-blink startle, cardiac defense, and skin conductance) and subjective (pleasure, arousal, and control ratings) responses elicited by a burst of 110 dB white noise of 500 ms duration. The participants were 30 women with BN and 30 healthy control women. The experimental task consisted of two consecutive and counterbalanced presentations of the auditory stimulus preceded, alternatively, by a video of the participant's own body versus no such video. Results: The results showed that, when viewing their own bodies, women with BN experienced (a) greater inhibition of the startle reflex, (b) greater cardiac acceleration in the first component of the defense reaction, (c) greater skin conductance response, and (d) less subjective pleasure and control combined with greater arousal, compared with the control participants. Conclusion: Our findings suggest that, for women with BN, peripheral-physiological responses to self-images are dominated by attentional processes, which provoke an immobility reaction caused by a dysfunctional negative response to their own body.	[Ortega-Roldan, Blanca; Rodriguez-Ruiz, Sonia; Perakakis, Pandelis; Fernandez-Santaella, M. Carmen; Vila, Jaime] Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain; [Perakakis, Pandelis] Univ Jaume 1, Dept Econ, Lab Expt Econ, Castellon de La Plana, Spain	University of Granada; Universitat Jaume I	Ortega-Roldan, B (corresponding author), Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain.	bortega@ugr.es	Fernández, María Carmen/H-5469-2011; Perakakis, Pandelis/Y-9230-2019; Perakakis, Pandelis/AFR-1800-2022; Perakakis, Pandelis/F-9038-2010; Vila, Jaime/F-9719-2010	Fernández, María Carmen/0000-0001-7094-1138; Perakakis, Pandelis/0000-0002-9130-3247; Perakakis, Pandelis/0000-0002-9130-3247; Vila, Jaime/0000-0002-1767-8606	Spanish Ministry of Economy and Competitiveness [PSI2009-08417, PSI2012-31395]; Spanish Ministry of Science and Innovation; University Jaume I [ECO2011-23634, P1-1B2012-27, JCI-2010-06790]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University Jaume I	The present research was supported by grants from the Spanish Ministry of Economy and Competitiveness [PSI2009-08417 and PSI2012-31395]. P.P. was supported by grants from the Spanish Ministry of Science and Innovation and University Jaume I [ECO2011-23634, P1-1B2012-27, and JCI-2010-06790]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beato-Fernandez L, 2009, PSYCHIAT RES-NEUROIM, V171, P129, DOI 10.1016/j.pscychresns.2008.01.001; Bond DD, 1943, AM J PHYSIOL, V138, P0468, DOI 10.1152/ajplegacy.1943.138.3.468; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Buck SM, 2004, MOTIV EMOTION, V28, P279, DOI 10.1023/B:MOEM.0000040155.79452.23; Cash TF., 2004, HDB EATING DISORDERS, P515; Coffey SF, 2002, DRUG ALCOHOL DEPEN, V65, P115, DOI 10.1016/S0376-8716(01)00157-0; COOPER MJ, 1992, BEHAV RES THER, V30, P501, DOI 10.1016/0005-7967(92)90034-E; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; DAVIS M, 1992, TRENDS PHARMACOL SCI, V13, P35, DOI 10.1016/0165-6147(92)90014-W; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; del Paso GAR, 1998, BIOL PSYCHOL, V48, P269, DOI 10.1016/S0301-0511(98)00039-8; Delinsky SS, 2010, COGN BEHAV PRACT, V17, P270, DOI 10.1016/j.cbpra.2010.02.004; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Fairburn CG, 2003, J CONSULT CLIN PSYCH, V71, P103, DOI 10.1037/0022-006X.71.1.103; FAIRBURN CG, 1993, J CONSULT CLIN PSYCH, V61, P696, DOI 10.1037/0022-006X.61.4.696; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Globisch J., 1993, PSYCHOPHYSIOLOGY, V30, pS30, DOI DOI 10.1111/J.1469-8986.1993.TB02377.X; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; HENDERSON M, 1987, BRIT J PSYCHIAT, V150, P18, DOI 10.1192/bjp.150.1.18; Hoebel BGRP, 1999, WELL BEING FDN HEDON, P558; Jansen A, 2006, BRIT J CLIN PSYCHOL, V45, P123, DOI 10.1348/014466505X50167; Jansen A, 2005, BEHAV RES THER, V43, P183, DOI 10.1016/j.brat.2004.01.003; Jones DC, 2004, DEV PSYCHOL, V40, P823, DOI 10.1037/0012-1649.40.5.823; Keil A, 2010, NEUROPSYCHOLOGIA, V48, P3580, DOI 10.1016/j.neuropsychologia.2010.08.007; LABERG JC, 1991, INT J EAT DISORDER, V10, P169, DOI 10.1002/1098-108X(199103)10:2&lt;169::AID-EAT2260100205&gt;3.0.CO;2-Y; Lamprea MR, 2002, BRAIN RES, V950, P186, DOI 10.1016/S0006-8993(02)03036-6; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lipp OV, 2003, BIOL PSYCHOL, V62, P115, DOI 10.1016/S0301-0511(02)00115-1; Mata JL, 2009, BIOL PSYCHOL, V81, P192, DOI 10.1016/j.biopsycho.2009.04.006; Maner JK, 2006, INT J EAT DISORDER, V39, P55, DOI 10.1002/eat.20222; McTeague LM, 2010, BIOL PSYCHIAT, V67, P346, DOI 10.1016/j.biopsych.2009.08.023; Moreno-Dominguez S, 2012, BODY IMAGE, V9, P285, DOI 10.1016/j.bodyim.2011.12.001; Moya T.R., 2004, BEHAV PSYCHOL, P447; NORRIS DL, 1984, PSYCHOL MED, V14, P835, DOI 10.1017/S0033291700019802; Overduin J, 1997, ADDICT BEHAV, V22, P395, DOI 10.1016/S0306-4603(97)80002-0; Paxton SJ, 2006, DEV PSYCHOL, V42, P888, DOI 10.1037/0012-1649.42.5.888; Perakakis P, 2010, COMPUT METH PROG BIO, V98, P83, DOI 10.1016/j.cmpb.2009.10.002; Posner MI, 1975, HDB PSYCHOBIOLOGY, P441, DOI DOI 10.1016/B978-0-12-278656-3.50019-3; Posner Michael I., 1995, P615; Raich R.M., 1996, CLIN SALUD, V7, P51; Ramirez I, 2005, PSYCHOPHYSIOLOGY, V42, P732, DOI 10.1111/j.1469-8986.2005.00362.x; Ramirez I, 2010, PSYCHOPHYSIOLOGY, V47, P879, DOI 10.1111/j.1469-8986.2010.01008.x; Reas DL, 2002, INT J EAT DISORDER, V31, P324, DOI 10.1002/eat.10012; Rosen JC, 1996, INT J EAT DISORDER, V20, P331, DOI 10.1002/(SICI)1098-108X(199612)20:4<331::AID-EAT1>3.0.CO;2-O; Ruiz-Padial E, 2007, BIOL PSYCHIAT, V61, P996, DOI 10.1016/j.biopsych.2006.08.046; Slaughter V, 2004, CURR DIR PSYCHOL SCI, V13, P219, DOI 10.1111/j.0963-7214.2004.00312.x; Smeets E, 2008, BEHAV RES THER, V46, P229, DOI 10.1016/j.brat.2007.12.003; Smeets E, 2011, INT J EAT DISORDER, V44, P50, DOI 10.1002/eat.20776; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Strauss H, 1929, J PSYCHOL NEUROL, V39, P111; Trentowska M, 2013, BEHAV RES THER, V51, P1, DOI 10.1016/j.brat.2012.03.012; Tuschen-Caffier B, 2003, BEHAV RES THER, V41, P573, DOI 10.1016/S0005-7967(02)00030-X; Tuschen-Caffier B, 2001, BEHAV RES THER, V39, P299, DOI 10.1016/S0005-7967(00)00004-8; Van Zomeren A.H., 1994, CLIN NEUROPSYCHOLOGY, V1st ed.; Viken RJ, 2002, J ABNORM PSYCHOL, V111, P598, DOI 10.1037//0021-843X.111.4.598; VILA J, 1992, J PSYCHOPHYSIOL, V6, P140; Vila J, 2007, INT J PSYCHOPHYSIOL, V66, P169, DOI 10.1016/j.ijpsycho.2007.07.004; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; WEBB RA, 1970, PSYCHOPHYSIOLOGY, V6, P389, DOI 10.1111/j.1469-8986.1970.tb01749.x; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5	67	9	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102595	10.1371/journal.pone.0102595	http://dx.doi.org/10.1371/journal.pone.0102595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036222	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200075
J	Stamova, B; Jickling, GC; Ander, BP; Zhan, XH; Liu, DZ; Turner, R; Ho, C; Khoury, JC; Bushnell, C; Pancioli, A; Jauch, EC; Broderick, JP; Sharp, FR				Stamova, Boryana; Jickling, Glen C.; Ander, Bradley P.; Zhan, Xinhua; Liu, Dazhi; Turner, Renee; Ho, Carolyn; Khoury, Jane C.; Bushnell, Cheryl; Pancioli, Arthur; Jauch, Edward C.; Broderick, Joseph P.; Sharp, Frank R.			Gene Expression in Peripheral Immune Cells following Cardioembolic Stroke Is Sexually Dimorphic	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACUTE ISCHEMIC-STROKE; SEX-DIFFERENCES; GENDER; BLOOD; THROMBOLYSIS; INFLAMMATION; NEUTROPHILS; CHROMOSOME; MECHANISMS	Aims: Epidemiological studies suggest that sex has a role in the pathogenesis of cardioembolic stroke. Since stroke is a vascular disease, identifying sexually dimorphic gene expression changes in blood leukocytes can inform on sex-specific risk factors, response and outcome biology. We aimed to examine the sexually dimorphic immune response following cardioembolic stroke by studying the differential gene expression in peripheral white blood cells. Methods and Results: Blood samples from patients with cardioembolic stroke were obtained at <= 3 hours (prior to treatment), 5 hours and 24 hours (after treatment) after stroke onset (n = 23; 69 samples) and compared with vascular risk factor controls without symptomatic vascular diseases (n = 23, 23 samples) (ANCOVA, false discovery rate p <= 0.05, vertical bar fold change vertical bar >= 1.2). mRNA levels were measured on whole-genome Affymetrix microarrays. There were more up-regulated than down-regulated genes in both sexes, and females had more differentially expressed genes than males following cardioembolic stroke. Female gene expression was associated with cell death and survival, cell-cell signaling and inflammation. Male gene expression was associated with cellular assembly, organization and compromise. Immune response pathways were over represented at <= 3, 5 and 24 h after stroke in female subjects but only at 24 h in males. Neutrophil-specific genes were differentially expressed at 3, 5 and 24 h in females but only at 5 h and 24 h in males. Conclusions: There are sexually dimorphic immune cell expression profiles following cardioembolic stroke. Future studies are needed to confirm the findings using qRT-PCR in an independent cohort, to determine how they relate to risk and outcome, and to compare to other causes of ischemic stroke.	[Stamova, Boryana; Jickling, Glen C.; Ander, Bradley P.; Zhan, Xinhua; Liu, Dazhi; Turner, Renee; Ho, Carolyn; Sharp, Frank R.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Stamova, Boryana; Jickling, Glen C.; Ander, Bradley P.; Zhan, Xinhua; Liu, Dazhi; Turner, Renee; Ho, Carolyn; Sharp, Frank R.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Khoury, Jane C.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Bushnell, Cheryl] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, Winston Salem, NC 27103 USA; [Pancioli, Arthur] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Jauch, Edward C.] Med Univ S Carolina, Div Emergency Med, Charleston, SC 29425 USA; [Broderick, Joseph P.] Univ Cincinnati, Inst Neurosci, Cincinnati, OH USA	University of California System; University of California Davis; University of California System; University of California Davis; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Wake Forest University; Wake Forest Baptist Medical Center; University System of Ohio; University of Cincinnati; Medical University of South Carolina; University System of Ohio; University of Cincinnati	Stamova, B (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.	boryana.stamova@ucdmc.ucdavis.edu	Jickling, Glen/J-8790-2019; Stamova, Boryana/ABA-2981-2020; Khoury, Jane/O-2068-2015	Jickling, Glen/0000-0003-3543-0820; Stamova, Boryana/0000-0002-5440-8816	National Institutes of Health [NS056302, NS075035, NS079153]; NINDS [1 P50 NS44283-01]; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079153, P50NS044283, R01NS056302, R01NS075035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NS056302, NS075035, NS079153, FRS), NINDS (1 P50 NS44283-01, JK) and an American Heart Association Fellow to Faculty Award (GJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolanle F, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-174; Caso V, 2010, WOMENS HEALTH, V6, P51, DOI [10.2217/whe.09.82, 10.2217/WHE.09.82]; Easton AS, 2013, INT IMMUNOPHARMACOL, V17, P1218, DOI 10.1016/j.intimp.2013.06.015; Forster A, 2009, STROKE, V40, P2428, DOI 10.1161/STROKEAHA.109.548750; Giralt D, 2012, ACTA NEUROL SCAND, V125, P83, DOI 10.1111/j.1600-0404.2011.01514.x; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; Kent DM, 2008, NEUROLOGY, V71, P1080, DOI 10.1212/01.wnl.0000316191.84334.bd; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Manwani B, 2011, WOMENS HEALTH, V7, P319, DOI [10.2217/whe.11.22, 10.2217/WHE.11.22]; McCombe PA, 2008, INT J STROKE, V3, P254, DOI 10.1111/j.1747-4949.2008.00222.x; Pham M, 2012, J MOL MED, V90, P119, DOI 10.1007/s00109-011-0812-9; Pancioli AM, 2008, STROKE, V39, P3268, DOI 10.1161/STROKEAHA.108.517656; Persky Rebecca W, 2010, Curr Cardiol Rep, V12, P6, DOI 10.1007/s11886-009-0080-2; Prince LR, 2011, CURR OPIN PHARMACOL, V11, P397, DOI 10.1016/j.coph.2011.06.007; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Reeves MJ, 2011, WOMENS HEALTH, V7, P383, DOI [10.2217/whe.11.31, 10.2217/WHE.11.31]; Ritzel RM, 2013, HORM BEHAV, V63, P238, DOI 10.1016/j.yhbeh.2012.04.007; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Siegel C, 2010, J NEUROSCI RES, V88, P2765, DOI 10.1002/jnr.22406; Stamova B, 2012, STROKE, V43, P326, DOI 10.1161/STROKEAHA.111.629337; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264; Tian YF, 2012, J CEREBR BLOOD F MET, V32, P780, DOI 10.1038/jcbfm.2011.179; Tian YF, 2012, GENDER MED, V9, P68, DOI 10.1016/j.genm.2012.01.005; Turner RJ, 2011, TRANSL STROKE RES, V2, P171, DOI 10.1007/s12975-011-0066-4; Turtzo LC, 2010, FUTUR NEUROL, V5, P47, DOI 10.2217/FNL.09.66; Ulm L, 2012, J NEUROL SCI, V319, P15, DOI 10.1016/j.jns.2012.05.042; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Xu HC, 2008, J CEREBR BLOOD F MET, V28, P1320, DOI 10.1038/jcbfm.2008.22	32	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102550	10.1371/journal.pone.0102550	http://dx.doi.org/10.1371/journal.pone.0102550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036109	gold, Green Submitted, Green Published			2022-12-27	WOS:000339615200067
J	Faller, EM; McVey, MJ; MacPherson, PA				Faller, Elliott M.; McVey, Mark J.; MacPherson, Paul A.			IL-7 Receptor Recovery on CD8 T-Cells Isolated from HIV plus Patients Is Inhibited by the HIV Tat Protein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PERIPHERAL-BLOOD; INTERLEUKIN-7 RECEPTOR; HIV-1-INFECTED INDIVIDUALS; ANTIRETROVIRAL THERAPY; CYNOMOLGUS MONKEYS; CD127 EXPRESSION; GROWTH-FACTOR; SELECTIVE EXPRESSION; DISEASE PROGRESSION	Expression of the IL-7 receptor alpha-chain (CD127) is decreased on CD8 T-cells in HIV infected patients and partially recovers in those receiving antiretroviral therapy with sustained viral suppression. We have shown that soluble HIV Tat protein down regulates CD127 expression on CD8 T-cells isolated from healthy HIV-negative individuals. Tat is taken up by CD8 T-cells via endocytosis, exits the endosome and then translocates to the inner leaflet of the cell membrane where it binds to the cytoplasmic tail of CD127 inducing receptor internalization and degradation by the proteasome. This down regulation of CD127 by Tat results in impaired CD8 T-cell function. Interestingly, suppression of CD127 by Tat is reversible and requires the continual presence of Tat in the culture media. We thus questioned whether the low IL-7 receptor expression evident on CD8 T-cells in HIV+ patients was similarly reversible and if suppression of the receptor could be maintained ex vivo by Tat protein alone. We show here that when CD8 T-cells isolated from HIV+ patients are incubated alone in fresh medium, low CD127 expression on the cell surface recovers to normal levels. This recovery of CD127, however, is completely inhibited by the addition of HIV Tat protein to the culture media. This study then provides evidence that soluble factor(s) are responsible for low CD127 expression on circulating CD8 T-cells in HIV+ individuals and further implicates Tat in suppressing this receptor essential to CD8 T-cell proliferation and function.	[Faller, Elliott M.; McVey, Mark J.; MacPherson, Paul A.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [MacPherson, Paul A.] Div Infect Dis, Ottawa, ON, Canada; [Faller, Elliott M.; MacPherson, Paul A.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	MacPherson, PA (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	pmacpherson@ottawahospital.on.ca		McVey, Mark/0000-0002-0918-7030	CIHR [200510lDB-162377-159103, 200509CNI-161294-HPA-ADYP-39720]; OHTN [ROGA240]	CIHR(Canadian Institutes of Health Research (CIHR)); OHTN	Elliott Faller was supported by a Doctoral research grant (200510lDB-162377-159103) from CIHR. P. MacPherson was supported by a New Investigator Award (200509CNI-161294-HPA-ADYP-39720) from CIHR (http://www.cihr-irsc.gc.ca). This Project was performed with grant funding from OHTN, grant number ROGA240 (www.ohtn.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1990, J EXP MED, V172, P577, DOI 10.1084/jem.172.2.577; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; ARMITAGE RJ, 1990, J IMMUNOL, V144, P938; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; BETTENS F, 1991, AIDS RES HUM RETROV, V7, P773, DOI 10.1089/aid.1991.7.773; Borsetti A, 2008, ARCH VIROL, V153, P463, DOI 10.1007/s00705-007-0009-2; Borsetti A, 2009, VIRAL IMMUNOL, V22, P117, DOI 10.1089/vim.2008.0082; Boutboul F, 2005, AIDS, V19, P1981, DOI 10.1097/01.aids.0000191919.24185.46; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2000, J MED PRIMATOL, V29, P193, DOI 10.1034/j.1600-0684.2000.290313.x; CARINI C, 1994, AIDS RES HUM RETROV, V10, P121, DOI 10.1089/aid.1994.10.121; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; CHIRMULE N, 1995, J VIROL, V69, P492, DOI 10.1128/JVI.69.1.492-498.1995; Cohen SS, 1999, P NATL ACAD SCI USA, V96, P10842, DOI 10.1073/pnas.96.19.10842; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Faller E, 2009, INT IMMUNOL, V21, P203, DOI 10.1093/intimm/dxn140; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; Faller EM, 2010, J IMMUNOL, V185, P2854, DOI 10.4049/jimmunol.0902207; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; FERRARI G, 1995, CLIN EXP IMMUNOL, V101, P239; Finke S, 1998, GENE THER, V5, P31, DOI 10.1038/sj.gt.3300560; Fittipaldi A, 2005, ADV DRUG DELIVER REV, V57, P597, DOI 10.1016/j.addr.2004.10.011; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Fry TJ, 2002, J HEMATOTH STEM CELL, V11, P803, DOI 10.1089/152581602760404603; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; FURLINI MCRG, 1995, J ACQ IMMUN DEF SYND, V10, P408, DOI 10.1097/00042560-199512000-00003; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; GERSTOFT J, 1985, SCAND J IMMUNOL, V22, P463, DOI 10.1111/j.1365-3083.1985.tb01904.x; Ghazawi FM, 2013, IMMUNOL CELL BIOL, V91, P149, DOI 10.1038/icb.2012.69; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Heintel T, 2002, AIDS, V16, P1497, DOI 10.1097/00002030-200207260-00006; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; JICHA DL, 1991, J EXP MED, V174, P1511, DOI 10.1084/jem.174.6.1511; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; KOS FJ, 1992, EUR J IMMUNOL, V22, P3183, DOI 10.1002/eji.1830221224; Lee SH, 1996, ONCOGENE, V13, P2131; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; LOTZE MT, 1981, CANCER RES, V41, P4420; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; Migueles SA, 2001, IMMUNOL LETT, V79, P141, DOI 10.1016/S0165-2478(01)00276-0; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Poggi A, 2004, BLOOD, V103, P2205, DOI 10.1182/blood-2003-08-2928; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Rowshani AT, 2004, EUR J IMMUNOL, V34, P882, DOI 10.1002/eji.200324821; Sasson SC, 2006, CURR DRUG TARGETS, V7, P1571, DOI 10.2174/138945006779025365; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; SHARMA B, 1985, CLIN EXP IMMUNOL, V62, P296; SMYTH MJ, 1991, CELL IMMUNOL, V138, P390, DOI 10.1016/0008-8749(91)90163-6; Soares MVD, 1998, J IMMUNOL, V161, P5909; Spiegel HML, 2000, J VIROL, V74, P1018, DOI 10.1128/JVI.74.2.1018-1022.2000; Swainson L, 2006, J IMMUNOL, V176, P6702, DOI 10.4049/jimmunol.176.11.6702; Talayev VY, 2005, CLIN EXP IMMUNOL, V141, P440, DOI 10.1111/j.1365-2249.2005.02863.x; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; VISCIDI RP, 1989, SCIENCE, V246, P1606, DOI 10.1126/science.2556795; WELCH PA, 1989, J IMMUNOL, V143, P3562; Westermann J, 1998, GENE THER, V5, P264, DOI 10.1038/sj.gt.3300568; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang OO, 2005, VIROLOGY, V332, P16, DOI 10.1016/j.virol.2004.11.028; Yezid H, 2009, J BIOL CHEM, V284, P22736, DOI 10.1074/jbc.M109.023705; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851; Zagury J F, 1998, J Hum Virol, V1, P282	84	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102677	10.1371/journal.pone.0102677	http://dx.doi.org/10.1371/journal.pone.0102677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033393	gold, Green Published			2022-12-27	WOS:000339418300077
J	Mohammed, YH; Yamada, M; Lin, LL; Grice, JE; Roberts, MS; Raphael, AP; Benson, HAE; Prow, TW				Mohammed, Yousuf H.; Yamada, Miko; Lin, Lynlee L.; Grice, Jeffrey E.; Roberts, Michael S.; Raphael, Anthony P.; Benson, Heather A. E.; Prow, Tarl W.			Microneedle Enhanced Delivery of Cosmeceutically Relevant Peptides in Human Skin	PLOS ONE			English	Article							IN-VIVO; TRANSDERMAL DELIVERY; DRUG-DELIVERY; PROTEINS	Peptides and proteins play an important role in skin health and well-being. They are also found to contribute to skin aging and melanogenesis. Microneedles have been shown to substantially enhance skin penetration and may offer an effective means of peptide delivery enhancement. The aim of this investigation was to assess the influence of microneedles on the skin penetration of peptides using fluorescence imaging to determine skin distribution. In particular the effect of peptide chain length (3, 4, 5 amino acid chain length) on passive and MN facilitated skin penetration was investigated. Confocal laser scanning microscopy was used to image fluorescence intensity and the area of penetration of fluorescently tagged peptides. Penetration studies were conducted on excised full thickness human skin in Franz type diffusion cells for 1 and 24 hours. A 2 to 22 fold signal improvement in microneedle enhanced delivery of melanostatin, rigin and pal-KTTKS was observed. To our knowledge this is the first description of microneedle enhanced skin permeation studies on these peptides.	[Mohammed, Yousuf H.; Yamada, Miko; Lin, Lynlee L.; Raphael, Anthony P.; Prow, Tarl W.] Univ Queensland, Sch Med, Translat Res Inst, Dermatol Res Ctr, Brisbane, Qld, Australia; [Mohammed, Yousuf H.; Benson, Heather A. E.] Curtin Univ, CHIRI Biosci, Sch Pharm, Perth, WA 6845, Australia; [Mohammed, Yousuf H.; Grice, Jeffrey E.; Roberts, Michael S.] Univ Queensland, Sch Med, Princess Alexandra Hosp, Therapeut Res Ctr, Brisbane, Qld, Australia	University of Queensland; Curtin University; University of Queensland	Prow, TW (corresponding author), Univ Queensland, Sch Med, Translat Res Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	t.prow@uq.edu.au	Grice, Jeffrey/F-6257-2010; Yamada, Miko/AAW-6136-2020; Roberts, Michael S/C-5247-2014; Prow, Tarl/AAB-8359-2019; Lin, Li/H-2348-2013; Prow, Tarl W/A-4764-2010; Raphael, Anthony/A-7173-2012	Grice, Jeffrey/0000-0002-8862-4461; Yamada, Miko/0000-0001-8795-4461; Roberts, Michael S/0000-0003-3894-5301; Prow, Tarl/0000-0003-2892-6238; Lin, Li/0000-0003-3100-9668; Prow, Tarl W/0000-0003-2892-6238; Raphael, Anthony/0000-0002-5870-9528; FCCN, Bogus/0000-0001-6282-8004; Mohammed, Yousuf/0000-0002-7825-7557; FCCN, Bogus/0000-0003-1034-3552	Australian National Health and Medical Research Council; University of Queensland; Australian Postgraduate	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); Australian Postgraduate	This project was funded by Australian National Health and Medical Research Council. APR acknowledges The University of Queensland Post-Doctoral Fellowship and Early Career Research Award for funding. YM acknowledges the Australian Postgraduate Award for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal SM, 2010, J CONTROL RELEASE, V147, P218, DOI 10.1016/j.jconrel.2010.07.104; Banks SL, 2011, PHARM RES-DORDR, V28, P1211, DOI 10.1007/s11095-011-0372-2; Banks SL, 2010, J PHARM SCI-US, V99, P3072, DOI 10.1002/jps.22083; Benson HAE, 2008, J PHARM SCI-US, V97, P3591, DOI 10.1002/jps.21277; Donald JE, 2009, NUCLEIC ACIDS RES, V37, pD191, DOI 10.1093/nar/gkn716; Gill HS, 2008, J PHYS CHEM SOLIDS, V69, P1537, DOI 10.1016/j.jpcs.2007.10.059; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Lintner K, 2000, USE PEPTIDES COSMETI; Martanto W, 2006, J CONTROL RELEASE, V112, P357, DOI 10.1016/j.jconrel.2006.02.017; Prausnitz MR, 2006, NAT BIOTECHNOL, V24, P416, DOI 10.1038/nbt0406-416; Sachdeva V, 2013, CURR PHARM BIOTECHNO, V14, P180; Sauermann K, 2002, SKIN RES TECHNOL, V8, P141, DOI 10.1034/j.1600-0846.2002.20345.x; Zhang LJ, 2009, CLIN DERMATOL, V27, P485, DOI 10.1016/j.clindermatol.2009.05.013; Zhang XD, 2009, BIOL PHARM BULL, V32, P86, DOI 10.1248/bpb.32.86	14	54	56	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101956	10.1371/journal.pone.0101956	http://dx.doi.org/10.1371/journal.pone.0101956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033398	Green Published, gold, Green Accepted			2022-12-27	WOS:000339418300029
J	Tavares, A; Nielsen, JB; Boye, K; Rohde, S; Paulo, AC; Westh, H; Schonning, K; de Lencastre, H; Miragaia, M				Tavares, Ana; Nielsen, Jesper B.; Boye, Kit; Rohde, Susanne; Paulo, Ana C.; Westh, Henrik; Schonning, Kristian; de Lencastre, Herminia; Miragaia, Maria			Insights into Alpha-Hemolysin (Hla) Evolution and Expression among Staphylococcus aureus Clones with Hospital and Community Origin	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; GENETIC BACKGROUNDS; METHICILLIN; VIRULENCE; TOXIN; INFECTION; EPIDEMIC; PORE; RESISTANCE; PORTUGAL	Background: Alpha-hemolysin (Hla) is a major virulence factor in the pathogenesis of Staphylococcus aureus infection, being active against a wide range of host cells. Although hla is ubiquitous in S. aureus, its genetic diversity and variation in expression in different genetic backgrounds is not known. We evaluated nucleotide sequence variation and gene expression profiles of hla among representatives of hospital (HA) and community-associated (CA) S. aureus clones. Methods: 51 methicillin-resistant S. aureus and 22 methicillin-susceptible S. aureus were characterized by PFGE, spa typing, MLST and SCCmec typing. The internal regions of hla and the hla promoter were sequenced and gene expression was assessed by RT-PCR. Results: Alpha-hemolysin encoding- and promoter sequences were diverse, with 12 and 23 different alleles, respectively. Based on phylogenetic analysis, we suggest that hla may have evolved together with the S. aureus genetic background, except for ST22, ST121, ST59 and ST93. Conversely, the promoter region showed lack of co-evolution with the genetic backgrounds. Four non-synonymous amino acid changes were identified close to important regions of hla activity. Amino acid changes in the RNAIII binding site were not associated to hla expression. Although expression rates of hla were in general strain-specific, we observed CA clones showed significantly higher hla expression (p = 0.003) when compared with HA clones. Conclusion: We propose that the hla gene has evolved together with the genetic background. Overall, CA genetic backgrounds showed higher levels of hla expression than HA, and a high strain-to-strain variation of gene expression was detected in closely related strains.	[Tavares, Ana; de Lencastre, Herminia; Miragaia, Maria] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Nielsen, Jesper B.; Boye, Kit; Rohde, Susanne; Westh, Henrik; Schonning, Kristian] Copenhagen Univ Hosp, Dept Clin Microbiol 445, Hvidovre, Denmark; [Paulo, Ana C.] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Westh, Henrik; Schonning, Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10021 USA; [Miragaia, Maria] Inst Tecnol Quim & Biol, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal	Universidade Nova de Lisboa; University of Copenhagen; University of Copenhagen; Rockefeller University	Miragaia, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	miragaia@itqb.unl.pt	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Westh, Henrik/0000-0001-5681-647X; Tavares, Ana/0000-0002-2221-4785; PAULO, Ana Cristina/0000-0002-9249-2609	Fundacao Calouste Gulbenkian [P-99911]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-MIC/3195/2012, PTDC/BIA-EVF/117507/2010]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [Pest-OE/EQB/LAO004/2011]; FCT [SFRH/BD/44220/2008]	Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by project Ref. P-99911 from Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/Institucional/pt/Homepage) and Project PTDC/BIA-MIC/3195/2012 from Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/) awarded to HdL; Project PTDC/BIA-EVF/117507/2010 from Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/) awarded to MM; and through grant Ref. Pest-OE/EQB/LAO004/2011 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. A. Tavares was supported by grant SFRH/BD/44220/2008 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Amorim ML, 2002, MICROB DRUG RESIST, V8, P301, DOI 10.1089/10766290260469561; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Ballal A, 2009, J BACTERIOL, V191, P1656, DOI 10.1128/JB.01555-08; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Lencastre H, 2000, MICROB DRUG RESIST, V6, P1, DOI 10.1089/mdr.2000.6.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Faria NA, 2005, J CLIN MICROBIOL, V43, P1836, DOI 10.1128/JCM.43.4.1836-1842.2005; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Liang XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018428; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Oliveira DC, 2006, J ANTIMICROB CHEMOTH, V58, P23, DOI 10.1093/jac/dkl208; Otto M., 2013, INT J MED MICROBIOL; RICHARDSON JF, 1993, J HOSP INFECT, V25, P45, DOI 10.1016/0195-6701(93)90007-M; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; SANCHES IS, 1995, J CLIN MICROBIOL, V33, P1243, DOI 10.1128/JCM.33.5.1243-1246.1995; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tavares A, 2013, EUR J CLIN MICROBIOL, V32, P1269, DOI 10.1007/s10096-013-1872-2; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wilson GJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002271; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	50	27	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e98634	10.1371/journal.pone.0098634	http://dx.doi.org/10.1371/journal.pone.0098634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033196	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300003
J	Wetter, A; Nensa, F; Schenck, M; Heusch, P; Poppel, T; Bockisch, A; Forsting, M; Schlosser, TW; Lauenstein, TC; Nagarajah, J				Wetter, Axel; Nensa, Felix; Schenck, Marcus; Heusch, Philipp; Poeppel, Thorsten; Bockisch, Andreas; Forsting, Michael; Schlosser, Thomas W.; Lauenstein, Thomas C.; Nagarajah, James			Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [F-18] Choline PET/MRI	PLOS ONE			English	Article							WHOLE-BODY; RESPONSE ASSESSMENT; THERAPY RESPONSE; CANCER; MRI; COEFFICIENT; RADIOTHERAPY; BIOPSY; KINASE; HEAD	Purpose: To characterize intermediate and high-risk prostate carcinomas with measurements of standardized uptake values (SUVs) and apparent diffusion coefficient (ADC) values by means of simultaneous [F-18] choline PET/MRI. Materials and Methods: 35 patients with primary prostate cancer underwent simultaneous [F-18] choline PET/MRI. From these, 21 patients with an intermediate and high risk constellation who were not under ongoing hormonal therapy were included. Altogether 32 tumor lesions with a focal uptake of [F-18] choline could be identified. Average ADC values (ADC(aver)) minimum ADC values (ADC(min)) as well as maximum and mean SUVs (SUVmax, SUVmean) of tumor lesions were assessed with volume-of-interest (VOI) and Region-of-interest (ROI) measurements. As a reference, also ADC(aver), ADC(min) and SUVmax and SUVmean of non-tumorous prostate tissue were measured. Statistical analysis comprised calculation of descriptive parameters and calculation of Pearson's product moment correlations between ADC values and SUVs of tumor lesions. Results: Mean ADC(aver) and ADC(min) of tumor lesions were 0.94 +/- 0.22 x 10(-3) mm(2)/s and 0.65 +/- 0.21 x 10(-3) mm(2)/s, respectively. Mean SUVmax and SUVmean of tumor lesions were 6.3 +/- 2.3 and 2.6 +/- 0.8, respectively. These values were in each case significantly different from the reference values (p<0.001). There was no significant correlation between the measured SUVs and ADC values (SUVmax vs. ADC(aver): R = -0.24, p = 0.179; SUVmax vs. ADC(min): R = -0.03, p = 0.877; SUVmean vs. ADC(aver): R = -0.27, p = 0.136; SUVmean vs. ADC(min): R = -0.08, p = 0.679). Conclusion: Both SUVs and ADC values differ significantly between tumor lesions and healthy tissue. However, there is no significant correlation between these two parameters. This might be explained by the fact that SUVs and ADC values characterize different parts of tumor biology.	[Wetter, Axel; Nensa, Felix; Forsting, Michael; Schlosser, Thomas W.; Lauenstein, Thomas C.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Schenck, Marcus] Univ Hosp Essen, Dept Urol & Paediat Urol, Essen, Germany; [Heusch, Philipp] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Poeppel, Thorsten; Bockisch, Andreas; Nagarajah, James] Univ Hosp Essen, Dept Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf; University of Duisburg Essen	Wetter, A (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	axel.wetter@uk-essen.de	Nagarajah, James/H-1472-2012; Nagarajah, James/X-5804-2019	Nagarajah, James/0000-0002-3555-0809; Nagarajah, James/0000-0002-3555-0809; Nensa, Felix/0000-0002-5811-7100				Bae H, 2014, INT UROL NEPHROL, V46, P555, DOI 10.1007/s11255-013-0557-1; Bains LJ, 2012, CANCER IMAGING, V12, P395, DOI 10.1102/1470-7330.2012.9047; Bauman G, 2012, PROSTATE CANCER P D, V15, P45, DOI 10.1038/pcan.2011.35; Beheshti M, 2010, RADIOLOGY, V254, P925, DOI 10.1148/radiol.09090413; Bonekamp S, 2012, J MAGN RESON IMAGING, V35, P257, DOI 10.1002/jmri.22786; Borren A, 2013, ACTA ONCOL, V52, P1629, DOI 10.3109/0284186X.2013.787164; Challapalli A, 2014, NUCL MED COMMUN, V35, P20, DOI 10.1097/MNM.0000000000000014; Choi SH, 2011, J NUCL MED, V52, P1056, DOI 10.2967/jnumed.111.089334; Contractor K, 2011, CLIN CANCER RES, V17, P7673, DOI 10.1158/1078-0432.CCR-11-2048; D'Amico AV, 2001, J UROLOGY, V166, P2185, DOI 10.1016/S0022-5347(05)65531-0; De Waele A, 2010, CLIN NUCL MED, V35, P701, DOI 10.1097/RLU.0b013e3181e9faf5; Giannarini G, 2012, EUR UROL, V61, P326, DOI 10.1016/j.eururo.2011.09.019; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Heijmen L, 2013, EUR RADIOL, V23, P748, DOI 10.1007/s00330-012-2654-4; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kitajima K, 2013, EUR J RADIOL, V82, P1219, DOI 10.1016/j.ejrad.2013.02.021; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Murphy G, 2013, AM J ROENTGENOL, V201, P1229, DOI 10.2214/AJR.12.10178; Nagel KNA, 2013, RADIOLOGY, V267, P164, DOI 10.1148/radiol.12111683; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Roe K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-65; Scher B, 2007, EUR J NUCL MED MOL I, V34, P45, DOI 10.1007/s00259-006-0190-7; Schwarzenbock S, 2013, NUKLEARMED-NUCL MED, V52, P141, DOI 10.3413/Nukmed-0521-12-07; Song I, 2010, AM J ROENTGENOL, V195, P534; Song I, 2010, AM J ROENTGENOL, V194, pW477, DOI 10.2214/AJR.09.3557; Souvatzoglou M, 2013, EUR J NUCL MED MOL I, V40, P1486, DOI 10.1007/s00259-013-2467-y; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; Wetter A, 2014, EUR J NUCL MED MOL I, V41, P79, DOI 10.1007/s00259-013-2560-2; Wetter A, 2013, INVEST RADIOL, V48, P256, DOI 10.1097/RLI.0b013e318282c654; Wu LM, 2012, ACAD RADIOL, V19, P1215, DOI 10.1016/j.acra.2012.05.016; Zhang J, 2013, ACAD RADIOL, V20, P1535, DOI 10.1016/j.acra.2013.09.007	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101571	10.1371/journal.pone.0101571	http://dx.doi.org/10.1371/journal.pone.0101571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033396	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300021
J	Low, E; Mathieson, SR; Stevenson, NJ; Livingstone, V; Ryan, CA; Bogue, CO; Rennie, JM; Boylan, GB				Low, Evonne; Mathieson, Sean R.; Stevenson, Nathan J.; Livingstone, Vicki; Ryan, C. Anthony; Bogue, Conor O.; Rennie, Janet M.; Boylan, Geraldine B.			Early Postnatal EEG Features of Perinatal Arterial Ischaemic Stroke with Seizures	PLOS ONE			English	Article							NEONATAL CEREBRAL INFARCTION; TERM INFANTS; PREDICTIVE-VALUE; ELECTROENCEPHALOGRAM; ENCEPHALOPATHY; NEWBORN; BURDEN	Background: Stroke is the second most common cause of seizures in term neonates and is associated with abnormal long-term neurodevelopmental outcome in some cases. Objective: To aid diagnosis earlier in the postnatal period, our aim was to describe the characteristic EEG patterns in term neonates with perinatal arterial ischaemic stroke (PAIS) seizures. Design: Retrospective observational study. Patients: Neonates >37 weeks born between 2003 and 2011 in two hospitals. Method: Continuous multichannel video-EEG was used to analyze the background patterns and characteristics of seizures. Each EEG was assessed for continuity, symmetry, characteristic features and sleep cycling; morphology of electrographic seizures was also examined. Each seizure was categorized as electrographic-only or electroclinical; the percentage of seizure events for each seizure type was also summarized. Results: Nine neonates with PAIS seizures and EEG monitoring were identified. While EEG continuity was present in all cases, the background pattern showed suppression over the infarcted side; this was quite marked (>50% amplitude reduction) when the lesion was large. Characteristic unilateral bursts of theta activity with sharp or spike waves intermixed were seen in all cases. Sleep cycling was generally present but was more disturbed over the infarcted side. Seizures demonstrated a characteristic pattern; focal sharp waves/spike-polyspikes were seen at frequency of 1-2 Hz and phase reversal over the central region was common. Electrographic-only seizure events were more frequent compared to electroclinical seizure events (78 vs 22%). Conclusions: Focal electrographic and electroclinical seizures with ipsilateral suppression of the background activity and focal sharp waves are strong indicators of PAIS. Approximately 80% of seizure events were the result of clinically unsuspected seizures in neonates with PAIS. Prolonged and continuous multichannel video-EEG monitoring is advocated for adequate seizure surveillance.	[Low, Evonne; Stevenson, Nathan J.; Livingstone, Vicki; Ryan, C. Anthony; Bogue, Conor O.; Boylan, Geraldine B.] Natl Univ Ireland Univ Coll Cork, Dept Paediat & Child Hlth, Irish Ctr Fetal & Neonatal Translat Res, Neonatal Brain Res Grp, Cork, Ireland; [Mathieson, Sean R.; Rennie, Janet M.] Univ Coll London Hosp, Elizabeth Garrett Anderson Inst Womens Hlth, London, England	University College Cork; University College London Hospitals NHS Foundation Trust; University of London; University College London	Boylan, GB (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Paediat & Child Hlth, Irish Ctr Fetal & Neonatal Translat Res, Neonatal Brain Res Grp, Cork, Ireland.	G.Boylan@ucc.ie		Boylan, Geraldine/0000-0003-0920-5291	Wellcome Trust Translational Award UK [85249/z/08/z]; Science Foundation Ireland [10/IN.1/B3036]; Department of National Institute for Health Research and Biomedical Research Centers	Wellcome Trust Translational Award UK(Wellcome Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of National Institute for Health Research and Biomedical Research Centers	E.L. was funded by a Wellcome Trust Translational Award UK (85249/z/08/z) and N.J.S. received funding from Science Foundation Ireland Principal Investigator Award (10/IN.1/B3036). This work was also partly undertaken at University London Hospitals/University College London, which received a proportion of funding from the Department of National Institute for Health Research and Biomedical Research Centers funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boylan GB, 2002, ARCH DIS CHILD-FETAL, V86, P165; Clancy RR, 2006, CLIN PERINATOL, V33, P649, DOI 10.1016/j.clp.2006.06.004; CLANCY RR, 1987, EPILEPSIA, V28, P537, DOI 10.1111/j.1528-1157.1987.tb03685.x; Cowan F, 2005, ARCH DIS CHILD-FETAL, V90, P252, DOI 10.1136/adc.2004.055558; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Estan J, 1997, ARCH DIS CHILD-FETAL, V76, pF88, DOI 10.1136/fn.76.2.F88; FUJIMOTO S, 1992, BRAIN DEV-JPN, V14, P48, DOI 10.1016/S0387-7604(12)80279-8; Glass HC, 2009, J CHILD NEUROL, V24, P591, DOI 10.1177/0883073808327832; Glykys J, 2009, NEURON, V63, P657, DOI 10.1016/j.neuron.2009.08.022; Golomb MR, 2007, J PEDIATR-US, V151, P409, DOI 10.1016/j.jpeds.2007.03.058; Govaert P, 2000, ARCH DIS CHILD-FETAL, V82, pF59, DOI 10.1136/fn.82.1.F59; Hoogstraate SR, 2009, EUR J PAEDIATR NEURO, V13, P356, DOI 10.1016/j.ejpn.2008.07.005; Kirton A, 2011, PEDIATRICS, V128, pE1402, DOI 10.1542/peds.2011-1148; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lamblin MD, 2013, NEUROPHYSIOL CLIN, V43, P267, DOI 10.1016/j.neucli.2013.07.001; Low E, 2012, ARCH DIS CHILD-FETAL, V97, pF267, DOI 10.1136/archdischild-2011-300716; Lynch JK, 2001, CURR OPIN PEDIATR, V13, P499, DOI 10.1097/00008480-200112000-00002; Lynch N, 2011, ARCH DIS CHILD, V96, pA39; Marks MP, 1999, STROKE, V30, P389, DOI 10.1161/01.STR.30.2.389; Mercuri E, 2001, Minerva Pediatr, V53, P305; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Miller V, 2000, Semin Pediatr Neurol, V7, P278, DOI 10.1053/spen.2000.20076; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Ortibus EL, 1996, ELECTROEN CLIN NEURO, V98, P175, DOI 10.1016/0013-4694(95)00245-6; Pinto LC, 2001, EPILEPTIC DISORD, V3, P125; Rafay MF, 2009, STROKE, V40, P2402, DOI 10.1161/STROKEAHA.109.547281; Ramaswamy V, 2004, NEUROLOGY, V62, P2088, DOI 10.1212/01.WNL.0000129909.77753.C4; Rando T, 2000, NEUROPEDIATRICS, V31, P202, DOI 10.1055/s-2000-7454; Rutherford MA, 2012, ARCH DIS CHILD-FETAL, V97, pF377, DOI 10.1136/fetalneonatal-2010-196451; Sreenan C, 2000, J PEDIATR-US, V137, P351, DOI 10.1067/mpd.2000.107845; van Rooij LGM, 2010, ARCH DIS CHILD-FETAL, V95, pF160, DOI 10.1136/adc.2008.156711; Vasiljevic B, 2012, VOJNOSANIT PREGL, V69, P492; Volpe JJ, 2008, NEUROLOGY NEWBORN, P203; Walsh BH, 2011, DEV MED CHILD NEUROL, V53, P89, DOI 10.1111/j.1469-8749.2010.03837.x; WEINER SP, 1991, PEDIATR NEUROL, V7, P363, DOI 10.1016/0887-8994(91)90067-U; Wusthoff CJ, 2011, J CHILD NEUROL, V26, P724, DOI 10.1177/0883073810390036	36	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e100973	10.1371/journal.pone.0100973	http://dx.doi.org/10.1371/journal.pone.0100973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051161	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100006
J	Raso, L; Sint, D; Rief, A; Kaufmann, R; Traugott, M				Raso, Lorna; Sint, Daniela; Rief, Alexander; Kaufmann, Ruediger; Traugott, Michael			Molecular Identification of Adult and Juvenile Linyphiid and Theridiid Spiders in Alpine Glacier Foreland Communities	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DNA; ARANEAE; INFECTIONS; CARDINIUM; WOLBACHIA; PREDATION	In glacier forelands spiders constitute a large proportion of the invertebrate community. Therefore, it is important to be able to determine the species that can be found in these areas. Linyphiid and theridiid spider identification is currently not possible in juvenile specimens using traditional morphological based methods, however, a large proportion of the population in these areas are usually juveniles. Molecular methods permit identification of species at different life stages, making juvenile identification possible. In this study we tested a molecular tool to identify the 10 most common species of Linyphiidae and Theridiidae found in three glacier foreland communities of the Austrian Alps. Two multiplex PCR systems were developed and over 90% of the 753 field-collected spiders were identified successfully. The species targeted were found to be common in all three valleys during the summer of 2010. A comparison between the molecular and morphological data showed that although there was a slight difference in the results, the overall outcome was the same independently of the identification method used. We believe the quick and reliable identification of the spiders via the multiplex PCR assays developed here will aid the study of these families in Alpine habitats.	[Raso, Lorna; Sint, Daniela; Rief, Alexander; Kaufmann, Ruediger; Traugott, Michael] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria	University of Innsbruck	Traugott, M (corresponding author), Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria.	Michael.Traugott@uibk.ac.at	Sint, Daniela/HCI-8508-2022	Sint, Daniela/0000-0003-3387-4284; Traugott, Michael/0000-0001-9719-5059	Austrian Science Fund FWF [P20859-B17]; Austrian Science Fund (FWF) [P 20859] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was funded by the Austrian Science Fund FWF project P20859-B17 'Invertebrate food webs in recently deglaciated alpine areas'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnedo MA, 2009, CLADISTICS, V25, P231, DOI 10.1111/j.1096-0031.2009.00249.x; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benefer CM, 2013, J PEST SCI, V86, P19, DOI 10.1007/s10340-012-0454-x; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Duron O, 2008, MOL ECOL, V17, P1427, DOI 10.1111/j.1365-294X.2008.03689.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Greenstone MH, 2011, MOL ECOL RESOUR, V11, P286, DOI 10.1111/j.1755-0998.2010.02922.x; GREENSTONE MH, 1987, J ARACHNOL, V15, P266; Hagvar S, 2010, EUR J ENTOMOL, V107, P281, DOI 10.14411/eje.2010.037; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haupt J, 2002, FUNGAL RICKETTSIAL I, P45; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hodkinson ID, 2001, OIKOS, V95, P349, DOI 10.1034/j.1600-0706.2001.950217.x; Hosseini R, 2007, BIOL CONTROL, V40, P128, DOI 10.1016/j.biocontrol.2006.10.007; Hosseini Reza, 2011, Zootaxa, V3009, P46; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; Knoflach B, 1998, KUGELSPINNEN VERWAND, P667; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Koponen S, 2005, J ARACHNOL, V33, P230, DOI 10.1636/CT04-112.1; Martin OY, 2009, J ARACHNOL, V37, P106, DOI 10.1636/SH08-05.1; McCune B, 2001, PC ORD MULTIVARIATE; Muster C, 2007, INVERTEBR SYST, V21, P39, DOI 10.1071/IS06014; NENTWIG W, 1985, J ARACHNOL, V13, P272; Nentwig W, KROPF C ARANEA SPIDE; Platnick N. I., 2014, WORLD SPIDER CATALOG; Reiskind J, 1965, PSYCHE, P279; Roberts M, 2001, COLLINS FIELD GUIDE; Roberts M.J., 1987, SPIDERS GREAT BRITAI, V2; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Staudacher K, 2011, B ENTOMOL RES, V101, P201, DOI 10.1017/S0007485310000337; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thaler Konrad, 1999, Veroeffentlichungen des Tiroler Landesmuseums Ferdinandeum, V79, P215; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vialle A, 2009, MOL ECOL RESOUR, V9, P99, DOI 10.1111/j.1755-0998.2009.02637.x; Wiehle H, 1960, SPINNENTIERE ODER AR, V28, p[i, 1]; Wiehle H, 1960, SPINNENTIERE ODER AR, VXI, p[i, 1]	49	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101755	10.1371/journal.pone.0101755	http://dx.doi.org/10.1371/journal.pone.0101755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050841	gold, Green Submitted, Green Published			2022-12-27	WOS:000339551100014
J	Yang, DW; Luo, T; Lin, T; Qiu, QY; Luo, YJ				Yang, Dewei; Luo, Tao; Lin, Tao; Qiu, Quanyi; Luo, Yunjian			Combining Aesthetic with Ecological Values for Landscape Sustainability	PLOS ONE			English	Article							ECOSYSTEM SERVICES; PREFERENCES; QUALITY; MANAGEMENT; PEOPLE; RIVER	Humans receive multiple benefits from various landscapes that foster ecological services and aesthetic attractiveness. In this study, a hybrid framework was proposed to evaluate ecological and aesthetic values of five landscape types in Houguanhu Region of central China. Data from the public aesthetic survey and professional ecological assessment were converted into a two-dimensional coordinate system and distribution maps of landscape values. Results showed that natural landscapes (i.e. water body and forest) contributed positively more to both aesthetic and ecological values than semi-natural and human-dominated landscapes (i.e. farmland and non-ecological land). The distribution maps of landscape values indicated that the aesthetic, ecological and integrated landscape values were significantly associated with landscape attributes and human activity intensity. To combine aesthetic preferences with ecological services, the methods (i.e. field survey, landscape value coefficients, normalized method, a two-dimensional coordinate system, and landscape value distribution maps) were employed in landscape assessment. Our results could facilitate to identify the underlying structure-function-value chain, and also improve the understanding of multiple functions in landscape planning. The situation context could also be emphasized to bring ecological and aesthetic goals into better alignment.	[Yang, Dewei; Luo, Tao; Lin, Tao; Qiu, Quanyi; Luo, Yunjian] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Yang, Dewei; Luo, Tao; Lin, Tao; Qiu, Quanyi; Luo, Yunjian] Xiamen Key Lab Urban Metab, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS	Luo, T (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	tluo@iue.ac.cn	Luo, Yunjian/C-5366-2019; CAS, KLUEH/T-5743-2019; YANG, Dewei/I-7155-2013; Lin, Tao/B-7256-2009	Luo, Yunjian/0000-0002-7358-5797; YANG, Dewei/0000-0003-3573-3717; Lin, Tao/0000-0002-7479-2333	National Natural Science Foundation of China [41371535, 41001098, 41371192, 40971111]; Fujian Provincial ST Programme [2013Y0083, 2011J01280]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial ST Programme	This study was supported by the National Natural Science Foundation of China (41371535, 41001098, 41371192 and 40971111) and the Fujian Provincial S&T Programme (2013Y0083 and 2011J01280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aretano R, 2013, LANDSCAPE URBAN PLAN, V112, P63, DOI 10.1016/j.landurbplan.2012.12.010; Bastian O, 2006, ECOL INDIC, V6, P215, DOI 10.1016/j.ecolind.2005.08.011; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dandy N, 2011, LANDSCAPE URBAN PLAN, V102, P43, DOI 10.1016/j.landurbplan.2011.03.008; Daniel TC, 2001, LANDSCAPE URBAN PLAN, V54, P267, DOI 10.1016/S0169-2046(01)00141-4; Forman RTT, 2008, LANDSCAPE ECOL, V23, P251, DOI 10.1007/s10980-008-9209-8; Frank S, 2013, ECOL INDIC, V32, P222, DOI 10.1016/j.ecolind.2013.03.026; Fry G, 2009, ECOL INDIC, V9, P933, DOI 10.1016/j.ecolind.2008.11.008; Gobster PH, 2007, LANDSCAPE ECOL, V22, P959, DOI 10.1007/s10980-007-9110-x; Gomez-Sal A, 2003, ECOL MODEL, V168, P319, DOI 10.1016/S0304-3800(03)00144-3; Hale BW, 2005, ENVIRON MANAGE, V35, P381, DOI 10.1007/s00267-003-3061-z; Hands DE, 2002, LANDSCAPE URBAN PLAN, V58, P57, DOI 10.1016/S0169-2046(01)00240-7; Joan Iverson Nassauer, 1997, PLACING NATURE CULTU; Junker B, 2008, LANDSCAPE URBAN PLAN, V85, P141, DOI 10.1016/j.landurbplan.2007.11.002; Klein L.R., 2013, QUANTIFYING RELATION, P70; Lothian A, 1999, LANDSCAPE URBAN PLAN, V44, P177, DOI 10.1016/S0169-2046(99)00019-5; [罗涛 Luo Tao], 2010, [环境科学研究, Research of Environmental Sciences], V23, P1320; Mikusinski G, 2013, LANDSCAPE RES, V38, P384, DOI 10.1080/01426397.2011.650629; Mozingo L.A., 1997, LANDSC J, V16, P46, DOI [10.3368/lj.16.1.46, DOI 10.3368/LJ.16.1.46]; Musacchio LR, 2009, LANDSCAPE ECOL, V24, P989, DOI 10.1007/s10980-009-9393-1; Nassauer JI, 2004, WETLANDS, V24, P756, DOI 10.1672/0277-5212(2004)024[0756:MTSOMW]2.0.CO;2; Naveh Z, 2007, LANDSCAPE ECOL, V22, P1437, DOI 10.1007/s10980-007-9171-x; Norton LR, 2012, LAND USE POLICY, V29, P449, DOI 10.1016/j.landusepol.2011.09.002; PARSONS R, 1995, LANDSCAPE URBAN PLAN, V32, P227, DOI 10.1016/0169-2046(95)07004-E; Porto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086001; Purcell AT, 1998, LANDSCAPE URBAN PLAN, V42, P57, DOI 10.1016/S0169-2046(98)00073-5; Roth M, 2012, LATVIAN ACAD SCI A, P129; Termorshuizen JW, 2009, LANDSCAPE ECOL, V24, P1037, DOI 10.1007/s10980-008-9314-8; Tress B, 2001, LANDSCAPE URBAN PLAN, V57, P137, DOI 10.1016/S0169-2046(01)00199-2; Tyrvainen Liisa, 2003, Urban Forestry & Urban Greening, V1, P135, DOI 10.1078/1618-8667-00014; Von Haaren C, 2004, LANDSCHAFTSPLANUNG, P245; Williams KJH, 2002, ENVIRON BEHAV, V34, P257, DOI 10.1177/0013916502034002006; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Wu JG, 2010, LANDSCAPE ECOL, V25, P1147, DOI 10.1007/s10980-010-9524-8; [谢高地 Xie Gaodi], 2003, [自然资源学报, Journal of Natural Resources], V18, P189; YANG BE, 1992, ENVIRON BEHAV, V24, P471, DOI 10.1177/0013916592244003; Yang DW, 2014, ECOL MODEL, V272, P40, DOI 10.1016/j.ecolmodel.2013.09.014; Yang DW, 2012, J MT SCI-ENGL, V9, P760, DOI 10.1007/s11629-012-2163-6; Yang ZhiYou, 2012, Environmental Science & Technology (China), V35, P187; Zhao JW, 2013, J ENVIRON ENG LANDSC, V21, P123, DOI 10.3846/16486897.2012.695738	40	9	9	6	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102437	10.1371/journal.pone.0102437	http://dx.doi.org/10.1371/journal.pone.0102437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0QO	25050886	Green Submitted, gold, Green Published			2022-12-27	WOS:000339551100036
J	Lipinski, RJ; Holloway, HT; O'Leary-Moore, SK; Ament, JJ; Pecevich, SJ; Cofer, GP; Budin, F; Everson, JL; Johnson, GA; Sulik, KK				Lipinski, Robert J.; Holloway, Hunter T.; O'Leary-Moore, Shonagh K.; Ament, Jacob J.; Pecevich, Stephen J.; Cofer, Gary P.; Budin, Francois; Everson, Joshua L.; Johnson, G. Allan; Sulik, Kathleen K.			Characterization of Subtle Brain Abnormalities in a Mouse Model of Hedgehog Pathway Antagonist-Induced Cleft Lip and Palate	PLOS ONE			English	Article							AND/OR PALATE; SONIC-HEDGEHOG; OROFACIAL CLEFTS; ADULT MALES; CHILDREN; DISABILITIES; INDIVIDUALS; MORPHOLOGY; FOREBRAIN; MUTATIONS	Subtle behavioral and cognitive deficits have been documented in patient cohorts with orofacial clefts (OFCs). Recent neuroimaging studies argue that these traits are associated with structural brain abnormalities but have been limited to adolescent and adult populations where brain plasticity during infancy and childhood may be a confounding factor. Here, we employed high resolution magnetic resonance microscopy to examine primary brain morphology in a mouse model of OFCs. Transient in utero exposure to the Hedgehog (Hh) signaling pathway antagonist cyclopamine resulted in a spectrum of facial dysmorphology, including unilateral and bilateral cleft lip and palate, cleft of the secondary palate only, and a non-cleft phenotype marked by midfacial hypoplasia. Relative to controls, cyclopamine-exposed fetuses exhibited volumetric differences in several brain regions, including hypoplasia of the pituitary gland and olfactory bulbs, hyperplasia of the forebrain septal region, and expansion of the third ventricle. However, in affected fetuses the corpus callosum was intact and normal division of the forebrain was observed. This argues that temporally-specific Hh signaling perturbation can result in typical appearing OFCs in the absence of holoprosencephaly-a condition classically associated with Hh pathway inhibition and frequently co-occurring with OFCs. Supporting the premise that some forms of OFCs co-occur with subtle brain malformations, these results provide a possible ontological basis for traits identified in clinical populations. They also argue in favor of future investigations into genetic and/or environmental modulation of the Hh pathway in the etiopathogenesis of orofacial clefting.	[Lipinski, Robert J.; Holloway, Hunter T.; O'Leary-Moore, Shonagh K.; Ament, Jacob J.; Pecevich, Stephen J.; Sulik, Kathleen K.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA; [Lipinski, Robert J.; Everson, Joshua L.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI USA; [O'Leary-Moore, Shonagh K.; Budin, Francois] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Cofer, Gary P.; Johnson, G. Allan] Duke Univ, Ctr In Vivo Microscopy, Durham, NC USA; [Sulik, Kathleen K.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Lipinski, RJ (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27514 USA.	rjlipinski@wisc.edu		Everson, Josh/0000-0002-2887-8574; Lipinski, Robert/0000-0002-1994-4090	National Institute on Alcohol Abuse and Alcoholism/NIH [U01-AA017124, U01-AA021651, P60-AA011605]; National Institute of Dental and Craniofacial Research/NIH [K99DE022101, R00DE022101]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE022101, R00DE022101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021651, U01AA017124, P60AA011605] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Dental and Craniofacial Research/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	It was funded by grant nos. U01-AA017124, U01-AA021651 and P60-AA011605 grants to KKS from the National Institute on Alcohol Abuse and Alcoholism/NIH and K99DE022101 and R00DE022101 grants to RJL from the National Institute of Dental and Craniofacial Research/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was conducted as part of the Carolina Institute for Developmental Disabilities. MR images were acquired at the Duke Center for In Vivo Microscopy, a National Institute of Biomedical Imaging and Bioengineering (NIBIB) National Resource (8P41EB015897).	Aerts A, 2014, AM J MED GENET A, V164, P655, DOI 10.1002/ajmg.a.36333; Anchlia S, 2011, J MAXILLOFAC ORAL SU, V10, P14, DOI 10.1007/s12663-010-0058-z; Broder HL, 1998, CLEFT PALATE-CRAN J, V35, P127, DOI 10.1597/1545-1569(1998)035<0127:LDSAAG>2.3.CO;2; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cobourne MT, 2012, FRONT ORAL BIOL, V16, P52, DOI 10.1159/000337543; Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295; Collett BR, 2007, ORTHOD CRANIOFAC RES, V10, P138, DOI 10.1111/j.1601-6343.2007.00394.x; Collett BR, 2010, J PEDIATR PSYCHOL, V35, P199, DOI 10.1093/jpepsy/jsp047; Conrad AL, 2009, CHILD NEUROPSYCHOL, P1; Endriga MC, 1999, CLEFT PALATE-CRAN J, V36, P3, DOI 10.1597/1545-1569(1999)036<0001:PIICCS>2.3.CO;2; Estes R E, 1970, Cleft Palate J, V7, P763; Hahn JS, 2010, AM J MED GENET C, V154C, P120, DOI 10.1002/ajmg.c.30238; Hovorakova M, 2006, J DENT RES, V85, P167, DOI 10.1177/154405910608500210; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jiang Y, 2011, NEUROIMAGE, V56, P1235, DOI 10.1016/j.neuroimage.2011.03.031; Jocelyn LJ, 1996, PEDIATRICS, V97, P529; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; KJAER I, 1995, ACTA ODONTOL SCAND, V53, P135, DOI 10.3109/00016359509005963; LARON Z, 1969, HELV PAEDIATR ACTA, V24, P576; Lipinski RJ, 2008, TOXICOL SCI, V104, P189, DOI 10.1093/toxsci/kfn076; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; Lipinski RJ, 2010, BIRTH DEFECTS RES A, V88, P232, DOI 10.1002/bdra.20656; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Muller M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003582; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nopoulos P, 2000, CLEFT PALATE-CRAN J, V37, P441, DOI 10.1597/1545-1569(2000)037<0441:ABMIPW>2.0.CO;2; Nopoulos P, 2002, NEUROPSYCHOLOGIA, V40, P2178, DOI 10.1016/S0028-3932(02)00043-X; Nopoulos P, 2002, GENET MED, V4, P1, DOI 10.1097/00125817-200201000-00001; Nopoulos P, 2001, J NEUROIMAGING, V11, P418, DOI 10.1111/j.1552-6569.2001.tb00072.x; Nopoulos P, 2007, ARCH PEDIAT ADOL MED, V161, P753, DOI 10.1001/archpedi.161.8.753; Oguz I, 2011, P SOC PHOTOOPTICAL I, V7962; Parnell SE, 2009, ALCOHOL CLIN EXP RES, V33, P1001, DOI 10.1111/j.1530-0277.2009.00921.x; Richieri-Costa A, 2010, AM J MED GENET C, V154C, P149, DOI 10.1002/ajmg.c.30247; RICHMAN LC, 1980, J SPEECH HEAR RES, V23, P447, DOI 10.1044/jshr.2302.447; RICHMAN LC, 1988, CLEFT PALATE J, V25, P21; Richman LC, 2003, CLEFT PALATE-CRAN J, V40, P154, DOI 10.1597/1545-1569(2003)040<0154:DTRDOC>2.0.CO;2; RICHMAN RA, 1988, PEDIATRICS, V82, P840; Robin NH, 2006, SOUTH MED J, V99, P1111, DOI 10.1097/01.smj.0000209093.78617.3a; ROITMAN A, 1978, ARCH DIS CHILD, V53, P952, DOI 10.1136/adc.53.12.952; RUDMAN D, 1978, J PEDIATR-US, V93, P378, DOI 10.1016/S0022-3476(78)81141-X; SAK RJ, 1982, J DEV BEHAV PEDIATR, V3, P7; Schimmel MS, 2006, PEDIATRICS, V117, pE928, DOI 10.1542/peds.2005-1788; Solomon BD, 2012, J MED GENET, V49, P473, DOI 10.1136/jmedgenet-2012-101008; Tsai TP, 1998, CLEFT PALATE-CRAN J, V35, P154, DOI 10.1597/1545-1569(1998)035<0154:DPOPAP>2.3.CO;2; van der Plas E, 2012, PEDIATR RES, V71, P612, DOI 10.1038/pr.2012.12; Waitzman N., 1996, COST BIRTH DEFECTS E; Wehby GL, 2014, PEDIATRICS; Weinberg SM, 2009, ORTHOD CRANIOFAC RES, V12, P271, DOI 10.1111/j.1601-6343.2009.01462.x; Weinberg SM, 2009, J ANAT, V214, P926, DOI 10.1111/j.1469-7580.2009.01084.x	50	18	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102603	10.1371/journal.pone.0102603	http://dx.doi.org/10.1371/journal.pone.0102603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047453	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100051
J	Owart, BR; Corbi, J; Burke, JM; Dechaine, JM				Owart, Birkin R.; Corbi, Jonathan; Burke, John M.; Dechaine, Jennifer M.			Selection on Crop-Derived Traits and QTL in Sunflower (Helianthus annuus) Crop-Wild Hybrids under Water Stress	PLOS ONE			English	Article							GENE FLOW; PHENOTYPIC SELECTION; DOMESTICATION TRAITS; ECOPHYSIOLOGICAL TRAITS; DROUGHT TOLERANCE; SEED PREDATION; FITNESS; POPULATIONS; EVOLUTION; GROWTH	Locally relevant conditions, such as water stress in irrigated agricultural regions, should be considered when assessing the risk of crop allele introgression into wild populations following hybridization. Although research in cultivars has suggested that domestication traits may reduce fecundity under water stress as compared to wild-like phenotypes, this has not been investigated in crop-wild hybrids. In this study, we examine phenotypic selection acting on, as well as the genetic architecture of vegetative, reproductive, and physiological characteristics in an experimental population of sunflower crop-wild hybrids grown under wild-like low water conditions. Crop-derived petiole length and head diameter were favored in low and control water environments. The direction of selection differed between environments for leaf size and leaf pressure potential. Interestingly, the additive effect of the crop-derived allele was in the direction favored by selection for approximately half the QTL detected in the low water environment. Selection favoring crop-derived traits and alleles in the low water environment suggests that a subset of these alleles would be likely to spread into wild populations under water stress. Furthermore, differences in selection between environments support the view that risk assessments should be conducted under multiple locally relevant conditions.	[Owart, Birkin R.; Dechaine, Jennifer M.] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA 98926 USA; [Corbi, Jonathan; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	Central Washington University; University System of Georgia; University of Georgia	Dechaine, JM (corresponding author), Cent Washington Univ, Dept Biol Sci, Ellensburg, WA 98926 USA.	dechaine@cwu.edu	Burke, John M/A-3502-2013	Burke, John M/0000-0002-1412-5539	United States Department of Agriculture Biotechnology Risk Assessment Program from United States Department of Agriculture National Institute of Food and Agriculture [2010-33522-21668]	United States Department of Agriculture Biotechnology Risk Assessment Program from United States Department of Agriculture National Institute of Food and Agriculture	This work was supported by the United States Department of Agriculture Biotechnology Risk Assessment Program competitive grant #2010-33522-21668 from the United States Department of Agriculture National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agele S. O., 2003, International Journal of Biotronics, V32, P17; Alexander HM, 2001, AM J BOT, V88, P623, DOI 10.2307/2657061; Argyris J, 2005, THEOR APPL GENET, V111, P1365, DOI 10.1007/s00122-005-0066-4; ARIAS DM, 1994, THEOR APPL GENET, V89, P655, DOI 10.1007/BF00223700; Ash M, 2012, SUNFLOWERSEED; Baack EJ, 2008, MOL ECOL, V17, P666, DOI 10.1111/j.1365-294X.2007.03596.x; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Bartlett MK, 2012, ECOL LETT, V15, P393, DOI 10.1111/j.1461-0248.2012.01751.x; Bates D, 2012, LME4 LINEAR MIXED EF; Beavis William D., 1998, P145; Becker R, 1988, COMPUTER SCI SERIES; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Burke JM, 2002, AM J BOT, V89, P1550, DOI 10.3732/ajb.89.9.1550; Burke JM, 2003, SCIENCE, V300, P1250, DOI 10.1126/science.1084960; Burke JM, 2002, GENETICS, V161, P1257; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; CHURCHILL GA, 1994, GENETICS, V138, P963; Cummings CL, 2002, OECOLOGIA, V130, P274, DOI 10.1007/s004420100806; Cummings CL, 1999, OECOLOGIA, V121, P330, DOI 10.1007/s004420050936; Davies WJ, 2011, J AGR SCI-CAMBRIDGE, V149, P123, DOI 10.1017/S0021859610001115; Dechaine JM, 2010, MOL ECOL, V19, P3477, DOI 10.1111/j.1365-294X.2010.04740.x; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; Donovan LA, 2009, NEW PHYTOL, V183, P868, DOI 10.1111/j.1469-8137.2009.02916.x; Donovan LA, 2007, OECOLOGIA, V152, P13, DOI 10.1007/s00442-006-0627-5; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; Geyer CJ, 2008, ASTER PACKAGE TUTORI; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; Hartman Y, 2013, EVOL APPL, V6, P569, DOI 10.1111/eva.12043; Hartman Y, 2013, GENET RESOUR CROP EV, V60, P1487, DOI 10.1007/s10722-012-9937-0; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; HEISER C. B. JUN., 1951, Proceedings of the American Philosophical Society, V95, P432; Hovick SM, 2012, AM NAT, V179, P192, DOI 10.1086/663684; JIANG CJ, 1995, GENETICS, V140, P1111; Kane NC, 2008, MOL ECOL, V17, P384, DOI 10.1111/j.1365-294X.2007.03467.x; Kim SC, 1999, GENETICS, V153, P965; Koziol L, 2012, EVOLUTION, V66, P3803, DOI 10.1111/j.1558-5646.2012.01718.x; Kuznetsova K, 2013, LMERTEST TESTS RANDO; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Laughlin KD, 2009, ECOL APPL, V19, P1091, DOI 10.1890/08-0105.1; Lenth R. V., 2013, LSMEANS LEAST SQUARE; Li JT, 2007, GENET MOL RES, V6, P1064; Liancourt P, 2005, ECOLOGY, V86, P1611, DOI 10.1890/04-1398; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; Mayrose M, 2011, MOL ECOL, V20, P4683, DOI 10.1111/j.1365-294X.2011.05301.x; Mercer KL, 2007, ECOL LETT, V10, P383, DOI 10.1111/j.1461-0248.2007.01029.x; Mercer KL, 2006, EVOLUTION, V60, P2044, DOI 10.1111/j.0014-3820.2006.tb01842.x; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Neter J., 1996, APPL LINEAR STAT MOD; NOBEL PS, 1999, PHYSIOCHEMICAL ENV P; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; R Core Team, 2021, R LANGUAGE ENV STAT; Reagon M, 2006, AM J BOT, V93, P127, DOI 10.3732/ajb.93.1.127; Rieseberg LH, 2001, TAXON, V50, P47, DOI 10.2307/1224511; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Ross-Ibarra J, 2005, GENETICA, V123, P197, DOI 10.1007/s10709-004-2744-6; Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022; SCHNEITER AA, 1981, CROP SCI, V21, P901, DOI 10.2135/cropsci1981.0011183X002100060024x; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; Shaw RG, 2010, EVOLUTION, V64, P2510, DOI 10.1111/j.1558-5646.2010.01010.x; Slate J, 2013, EVOLUTION, V67, P1251, DOI 10.1111/evo.12060; Snow AA, 2010, NEW PHYTOL, V186, P537, DOI 10.1111/j.1469-8137.2009.03172.x; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Stanton ML, 2000, EVOLUTION, V54, P93, DOI 10.1111/j.0014-3820.2000.tb00011.x; Stanton-Geddes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036015; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Turhan H., 2004, Helia, V27, P227, DOI 10.2298/HEL0440227T; US DEPARTMENT OF AGRICULTURE NATURAL RESOURCES CONSERVATION SERVICE, 2012, WEB SOIL SURV; Wang S, 2010, NCSU STAT GENETICS; Weinig C, 2000, EVOLUTION, V54, P124, DOI 10.1111/j.0014-3820.2000.tb00013.x; Whitton J, 1997, THEOR APPL GENET, V95, P33, DOI 10.1007/s001220050529; Yang X, 2011, EVOL APPL, V4, P672, DOI 10.1111/j.1752-4571.2011.00190.x; Zhang FZ, 2007, J EXP BOT, V58, P1433, DOI 10.1093/jxb/erm006; [No title captured]	84	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102717	10.1371/journal.pone.0102717	http://dx.doi.org/10.1371/journal.pone.0102717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048600	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100063
J	Simon-Delso, N; San Martin, G; Bruneau, E; Minsart, LA; Mouret, C; Hautier, L				Simon-Delso, Noa; San Martin, Gilles; Bruneau, Etienne; Minsart, Laure-Anne; Mouret, Coralie; Hautier, Louis			Honeybee Colony Disorder in Crop Areas: The Role of Pesticides and Viruses	PLOS ONE			English	Article							APIS-MELLIFERA L.; SEASONAL-VARIATIONS; COLLAPSE DISORDER; SPECIES RICHNESS; BEE; HYMENOPTERA; PREVALENCE; FUNGICIDES; RESIDUES; DECLINES	As in many other locations in the world, honeybee colony losses and disorders have increased in Belgium. Some of the symptoms observed rest unspecific and their causes remain unknown. The present study aims to determine the role of both pesticide exposure and virus load on the appraisal of unexplained honeybee colony disorders in field conditions. From July 2011 to May 2012, 330 colonies were monitored. Honeybees, wax, beebread and honey samples were collected. Morbidity and mortality information provided by beekeepers, colony clinical visits and availability of analytical matrix were used to form 2 groups: healthy colonies and colonies with disorders (n = 29, n = 25, respectively). Disorders included: (1) dead colonies or colonies in which part of the colony appeared dead, or had disappeared; (2) weak colonies; (3) queen loss; (4) problems linked to brood and not related to any known disease. Five common viruses and 99 pesticides (41 fungicides, 39 insecticides and synergist, 14 herbicides, 5 acaricides and metabolites) were quantified in the samples. The main symptoms observed in the group with disorders are linked to brood and queens. The viruses most frequently found are Black Queen Cell Virus, Sac Brood Virus, Deformed Wing Virus. No significant difference in virus load was observed between the two groups. Three acaricides, 5 insecticides and 13 fungicides were detected in the analysed samples. A significant correlation was found between the presence of fungicide residues and honeybee colony disorders. A significant positive link could also be established between the observation of disorder and the abundance of crop surface around the beehive. According to our results, the role of fungicides as a potential stressor for honeybee colonies should be further studied, either by their direct and/or indirect impacts on bees and bee colonies.	[Simon-Delso, Noa; Bruneau, Etienne; Minsart, Laure-Anne; Mouret, Coralie] Beekeeping Res & Informat Ctr, Louvain La Neuve, Belgium; [Simon-Delso, Noa] Univ Utrecht, Copernicus Inst, Utrecht, Netherlands; [San Martin, Gilles; Hautier, Louis] Walloon Agr Res Ctr, Dept Life Sci, Plant Protect & Ecotoxicol Unit, Gembloux, Belgium	Utrecht University	Simon-Delso, N (corresponding author), Beekeeping Res & Informat Ctr, Louvain La Neuve, Belgium.	simon@cari.be	San Martin, Gilles/B-7827-2015	San Martin, Gilles/0000-0002-0434-9416; Hautier, Louis/0000-0002-6390-300X	Walloon Region	Walloon Region	The Walloon Region was the only funder of this study. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Aubee C., 2010, ENV FATE ECOLOGICAL; Aubert M, 2008, ENQUETE PROSPECTIVE; Nguyen BK, 2011, J APICULT RES, V50, P195, DOI 10.3896/IBRA.1.50.3.03; BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; Bates Douglas, 2013, LINEAR MIXED MODEL I; BATRA LR, 1973, MYCOPATH MYCOL APPL, V49, P13, DOI 10.1007/BF02057445; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Belzunces LP, 1992, PHENOMENES AFFAIBLIS; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Bradber N, 1990, BEEKEEPING RURAL DEV; Brittain CA, 2010, BASIC APPL ECOL, V11, P106, DOI 10.1016/j.baae.2009.11.007; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRA-API, 2011, EFF COAT MAIZ SEED H; De Smet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047953; DeGrandi-Hoffman Gloria, 2013, Insects, V4, P71, DOI 10.3390/insects4010071; deM IRM IR, 2013, BIL CLIM ANN; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Farooqui T, 2013, NEUROCHEM INT, V62, P122, DOI 10.1016/j.neuint.2012.09.020; Fischer R, 2003, ACTIVE INGREDIENT CO; Fox J, 2002, COX PROPORTIONAL HAZ; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Jull AB, 2008, HONEY TOPICAL TREATM, P1; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Klein Alexandra-Maria, 2009, P195; Kluser S., 2007, GLOBAL POLLINATOR DE; Kubik M, 1999, APIDOLOGIE, V30, P521, DOI 10.1051/apido:19990607; Kubik M, 2000, APIDOLOGIE, V31, P531, DOI 10.1051/apido:2000144; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lefevbre M, 2004, ETAT LIEUX PHENOMENE; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2013, SEED DRESSING SYSTEM, P401; Meled M, 1998, ENVIRON TOXICOL CHEM, V17, P2517, DOI [10.1002/etc.5620171220, 10.1897/1551-5028(1998)017&lt;2517:SVISOA&gt;2.3.CO;2]; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mussen EC, 2004, ENVIRON ENTOMOL, V33, P1151, DOI 10.1603/0046-225X-33.5.1151; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nguyen BK, 2010, J APICULT RES, V49, P337, DOI 10.3896/IBRA.1.49.4.07; Oomen PA, 2001, COLLOQ INRA, P129; Pesticide Properties Database (PPDB), 2014, 100309 SN PPDB; Pesticide Properties Database (PPDB), 2014, BOSC; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2013, ROLE PESTICIDES QUEE; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Pinheiro J, 2001, MIXED EFFECTS MODELS; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rasmont P, 2005, SURVEY WILD BEES HYM; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Sartor RB, 2008, P NATL ACAD SCI USA, V105, P16413, DOI 10.1073/pnas.0809363105; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; STANDIFER LN, 1967, INSECT SOC, V14, P415, DOI 10.1007/BF02223687; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; UNEP, 2005, EC HUM WELL BEING OU; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Verhoeven B, 2014, PROJ PIL SURV MORT A; Vidau C, 2011, NEUROTOXICOLOGY, V32, P935, DOI 10.1016/j.neuro.2011.04.006; Wiest L, 2011, J CHROMATOGR A, V1218, P5743, DOI 10.1016/j.chroma.2011.06.079; Wu LM, 2009, J FOOD COMPOS ANAL, V22, P242, DOI 10.1016/j.jfca.2008.10.022; Yoder JA, 2013, J TOXICOL ENV HEAL A, V76, P587, DOI 10.1080/15287394.2013.798846; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	88	124	125	5	297	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103073	10.1371/journal.pone.0103073	http://dx.doi.org/10.1371/journal.pone.0103073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048715	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100104
J	Angel, N; Li, L; Dosdall, DJ				Angel, Nathan; Li, Li; Dosdall, Derek J.			His Bundle Activates Faster than Ventricular Myocardium during Prolonged Ventricular Fibrillation	PLOS ONE			English	Article							SUBENDOCARDIAL PURKINJE-FIBERS; SUDDEN CARDIAC DEATH; CONDUCTING SYSTEM; CANINE HEART; ARRHYTHMIAS; DOGS; PROPAGATION; PATTERNS; MODEL; ELECTROGRAMS	Background: The Purkinje fiber system has recently been implicated as an important driver of the rapid activation rate during long duration ventricular fibrillation (VF>2 minutes). The goal of this study is to determine whether this activity propagates to or occurs in the proximal specialized conduction system during VF as well. Methods and Results: An 8X8 array with 300 mm spaced electrodes was placed over the His bundles of isolated, perfused rabbit hearts (n = 12). Ventricular myocardial (VM) and His activations were differentiated by calculating Laplacian recordings from unipolar signals. Activation rates of the VM and His bundle were compared and the His bundle conduction velocity was measured during perfused VF followed by 8 minutes of unperfused VF. During perfused VF the average VM activation rate of 11.04 activations/sec was significantly higher than the His bundle activation rate of 6.88 activations/sec (p<0.05). However from 3-8 minutes of unperfused VF the His system activation rate (6.16, 5.53, 5.14, 5.22, 6.00, and 4.62 activations/sec significantly faster than the rate of the VM (4.67, 3.63, 2.94, 2.24, 3.45, and 2.31 activations/sec) (p<0.05). The conduction velocity of the His system immediately decreased to 94% of the sinus rate during perfused VF then gradually decreased to 67% of sinus rhythm conduction at 8 minutes of unperfused VF. Conclusion: During prolonged VF the activation rate of the His bundle is faster than that of the VM. This suggests that the proximal conduction system, like the distal Purkinje system, may be an important driver during long duration VF and may be a target for interventional therapy.	[Angel, Nathan; Li, Li] Univ Utah, Comprehens Arrhythmia Res & Management Ctr, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Angel, Nathan; Dosdall, Derek J.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Dosdall, Derek J.] Univ Utah, Ctr Engn Innovat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Dosdall, DJ (corresponding author), Univ Utah, Comprehens Arrhythmia Res & Management Ctr, Div Cardiovasc Med, Salt Lake City, UT 84112 USA.	derek.dosdall@utah.edu			National Heart, Lung, and Blood Institute of the National Institutes of Health [R00HL091138]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091138] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under the Award Number: R00HL091138. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTAR M, 1975, CIRCULATION, V52, P766, DOI 10.1161/01.CIR.52.5.766; BAGDONAS AA, 1961, AM HEART J, V61, P206, DOI 10.1016/0002-8703(61)90577-4; Behradfar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088000; BENHAIM SA, 1993, AM J PHYSIOL, V265, pH1588; Berenfeld O, 1998, CIRC RES, V82, P1063, DOI 10.1161/01.RES.82.10.1063; Bogun F, 2006, J AM COLL CARDIOL, V48, P2500, DOI 10.1016/j.jacc.2006.07.062; Camargo AFD, 2005, J ELECTROCARDIOL, V38, P226, DOI 10.1016/j.jelectrocard.2004.12.002; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUID CAR US LAB AN, VEighth; Coronel R, 2000, J CARDIOVASC ELECTR, V11, P1119, DOI 10.1111/j.1540-8167.2000.tb01758.x; Decker KF, 2009, AM J PHYSIOL-HEART C, V296, pH1017, DOI 10.1152/ajpheart.01216.2008; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Dosdall DJ, 2008, AM J PHYSIOL-HEART C, V295, pH883, DOI 10.1152/ajpheart.00466.2008; Dun W, 2008, J MOL CELL CARDIOL, V45, P617, DOI 10.1016/j.yjmcc.2008.08.001; Efimov I, 2006, HEART RHYTHM, V3, P1100, DOI 10.1016/j.hrthm.2006.03.005; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; FRIEDMAN PL, 1973, CIRC RES, V33, P612, DOI 10.1161/01.RES.33.5.612; FRIEDMAN PL, 1973, CIRC RES, V33, P597, DOI 10.1161/01.RES.33.5.597; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Huang J, 2014, IMPORTANCE PURKINIE; Huelsing DJ, 1999, AM J PHYSIOL-HEART C, V276, pH572, DOI 10.1152/ajpheart.1999.276.2.H572; Huselsing D, 1999, J BIOL SYST, V7, P491; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; MENDEZ C, 1970, CIRC RES, V26, P135, DOI 10.1161/01.RES.26.2.135; MYERBURG RJ, 1972, CIRC RES, V30, P217, DOI 10.1161/01.RES.30.2.217; Odening KE, 2010, ELECTROPHYSIOLOGICAL, P643; Oriente V, 2009, RESUSCITATION, V80, P1417, DOI 10.1016/j.resuscitation.2009.08.017; Punske BB, 2003, ANN BIOMED ENG, V31, P781, DOI 10.1114/1.1581877; Robichaux RP, 2010, J CARDIOVASC ELECTR, V21, P1266, DOI 10.1111/j.1540-8167.2010.01803.x; Scheinman MM, 2009, HEART RHYTHM, V6, P1050, DOI 10.1016/j.hrthm.2009.03.011; STEINHAUS BM, 1989, CIRC RES, V64, P449, DOI 10.1161/01.RES.64.3.449; Tabereaux PB, 2007, CIRCULATION, V116, P1113, DOI 10.1161/CIRCULATIONAHA.107.699264; Tovar OH, 2000, CIRCULATION, V102, P2886; Turakhia M, 2007, CURR PROB CARDIOLOGY, V32, P501, DOI 10.1016/j.cpcardiol.2007.05.002; van Rees JB, 2011, J AM COLL CARDIOL, V57, P556, DOI 10.1016/j.jacc.2010.06.059; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zipes DP, 1999, J CARDIOVASC ELECTR, V10, P267, DOI 10.1111/j.1540-8167.1999.tb00672.x	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e101666	10.1371/journal.pone.0101666	http://dx.doi.org/10.1371/journal.pone.0101666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036418	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200020
J	Granjeiro, EM; Marroni, SS; Martins Dias, DP; Heck Bonagamba, LG; Costa, KM; dos Santos, JC; Cortes Oliveira, JA; Machado, BH; Garcia-Cairasco, N				Granjeiro, Erica Maria; Marroni, Simone Saldanha; Martins Dias, Daniel Penteado; Heck Bonagamba, Leni Gomes; Costa, Kaue Machado; dos Santos, Jessica Cristina; Cortes Oliveira, Jose Antonio; Machado, Benedito H.; Garcia-Cairasco, Norberto			Behavioral and Cardiorespiratory Responses to Bilateral Microinjections of Oxytocin into the Central Nucleus of Amygdala of Wistar Rats, an Experimental Model of Compulsion	PLOS ONE			English	Article							DORSAL MOTOR NUCLEUS; BLOOD-PRESSURE; SPECTRAL-ANALYSIS; SOLITARY TRACT; BRAIN-STEM; HEART-RATE; CARDIOVASCULAR REGULATION; CONSCIOUS RATS; VAGUS NERVE; ADH RELEASE	Introduction: The central nucleus of amygdala plays an important role mediating fear and anxiety responses. It is known that oxytocin microinjections into the central nucleus of amygdala induce hypergrooming, an experimental model of compulsive behavior. We evaluated the behavioral and cardiorespiratory responses of conscious rats microinjected with oxytocin into the central nucleus of amygdala. Methods: Male Wistar rats were implanted with guide cannulae into the central nucleus of amygdala and microinjected with oxytocin (0.5 mu g, 1 mu g) or saline. After 24 h, rats had a catheter implanted into the femoral artery for pulsatile arterial pressure measurement. The pulsatile arterial pressure was recorded at baseline conditions and data used for cardiovascular variability and baroreflex sensitivity analysis. Respiratory and behavioral parameters were assessed during this data collection session. Results: Microinjections of oxytocin (0.5 mu g) into the central nucleus of amygdala produced hypergrooming behavior but did not change cardiorespiratory parameters. However, hypergrooming evoked by microinjections of oxytocin (1 mu g) into the central nucleus of amygdala was accompanied by increase in arterial pressure, heart rate and ventilation and augmented the power of low and high (respiratory-related) frequency bands of the systolic arterial pressure spectrum. No changes were observed in power of the low and high frequency bands of the pulse interval spectrum. Baroreflex sensitivity was found lower after oxytocin microinjections, demonstrating that the oxytocin-induced pressor response may involve an inhibition of baroreflex pathways and a consequent facilitation of sympathetic outflow to the cardiovascular system. Conclusions: The microinjection of oxytocin (1 mu g) into the central nucleus of amygdala not only induces hypergrooming but also changes cardiorespiratory parameters. Moreover, specific oxytocin receptor antagonism attenuated hypergrooming but did not affect pressor, tachycardic and ventilatory responses to oxytocin, suggesting the involvement of distinct neural pathways.	[Granjeiro, Erica Maria; Marroni, Simone Saldanha; Martins Dias, Daniel Penteado; Heck Bonagamba, Leni Gomes; Costa, Kaue Machado; dos Santos, Jessica Cristina; Cortes Oliveira, Jose Antonio; Machado, Benedito H.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Garcia-Cairasco, N (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil.	ngcairas@fmrp.usp.br	Costa, Kauê M/H-5574-2012; Dias, Daniel Penteado Martins/J-1783-2014; Machado, Benedito Honorio/B-5139-2013; Cairasco, Norberto Garcia/E-3250-2015	Costa, Kauê M/0000-0002-5562-6495; Cairasco, Norberto Garcia/0000-0001-8857-3775; dos Santos, Jessica Cristina/0000-0002-9671-7123	Fundacao de Amparo A Pesquisa do Estado de Sao Paulo [06/60768-6, 2007/50261-4, 05/56447-7, FAPESP-Cinapce 2005/56447-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil) [02417/09-0]	Fundacao de Amparo A Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo A Pesquisa do Estado de Sao Paulo Grants (06/60768-6; 2007/50261-4; 05/56447-7; FAPESP-Cinapce 2005/56447-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil; Grant (02417/09-0). BHM and NGC are established investigators by CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2009, RESP PHYSIOL NEUROBI, V168, P19, DOI 10.1016/j.resp.2009.06.011; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; BERNTSON GG, 1988, ANN NY ACAD SCI, V525, P350, DOI 10.1111/j.1749-6632.1988.tb38619.x; BERRIDGE KC, 1989, BEHAV BRAIN RES, V33, P241, DOI 10.1016/S0166-4328(89)80119-6; Braga DC, 2000, AM J PHYSIOL-REG I, V278, pR1474, DOI 10.1152/ajpregu.2000.278.6.R1474; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; CERUTTI C, 1991, ARCH MAL COEUR VAISS, V84, P1235; CHARPAK S, 1984, BRAIN RES, V300, P83, DOI 10.1016/0006-8993(84)91342-8; Coelho BEA, 2008, BRAZ J PROBAB STAT, V22, P183; DANIELSEN EH, 1989, BRAIN RES BULL, V22, P705, DOI 10.1016/0361-9230(89)90090-7; DRAGO F, 1981, BEHAV NEURAL BIOL, V33, P117, DOI 10.1016/S0163-1047(81)92293-7; Draper N.R., 1998, APPL REGRESSION ANAL, P79; FEUERSTEIN G, 1984, J PHARMACOL EXP THER, V228, P348; GALENO TM, 1983, AM J PHYSIOL, V245, pR281, DOI 10.1152/ajpregu.1983.245.2.R281; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; GISPEN WH, 1975, LIFE SCI, V17, P645, DOI 10.1016/0024-3205(75)90103-4; Granjeiro EM, 2009, AUTON NEUROSCI-BASIC, V151, P117, DOI 10.1016/j.autneu.2009.07.022; Granjeiro EM, 2009, RESP PHYSIOL NEUROBI, V166, P32, DOI 10.1016/j.resp.2009.01.003; Grippo AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1542, DOI 10.1016/j.psyneuen.2009.05.017; HILTON SM, 1963, J PHYSIOL-LONDON, V165, P160, DOI 10.1113/jphysiol.1963.sp007049; HOPKINS DA, 1978, EXP BRAIN RES, V32, P529; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; INOUE K, 1991, AM J PHYSIOL, V260, pH842, DOI 10.1152/ajpheart.1991.260.3.H842; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kuo TBJ, 2005, J CARDIOVASC ELECTR, V16, P864, DOI 10.1111/j.1540-8167.2005.40656.x; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Labuschagne I, 2010, NEUROPSYCHOPHARMACOL, V35, P2403, DOI 10.1038/npp.2010.123; Larsen BA, 2009, CARDIOVASCULAR PSYCH, V2009, DOI [10.1155/2009/791017, DOI 10.1155/2009/791017]; Mack SO, 2007, J APPL PHYSIOL, V102, P189, DOI 10.1152/japplphysiol.00522.2006; Marroni SS, 2007, MOL PSYCHIATR, V12, P1103, DOI 10.1038/sj.mp.4002015; Michelini LC, 2001, ANN NY ACAD SCI, V940, P206; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; MOOS FC, 1995, BRAIN RES, V669, P309, DOI 10.1016/0006-8993(94)01296-T; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nie L, 1992, Sheng Li Xue Bao, V44, P303; Nosaka S, 1996, JPN J PHYSIOL, V46, P271, DOI 10.2170/jjphysiol.46.271; Oliva WM, 2010, AUTON NEUROSCI-BASIC, V155, P73, DOI 10.1016/j.autneu.2010.01.013; Petersson M, 2007, PSYCHONEUROENDOCRINO, V32, P959, DOI 10.1016/j.psyneuen.2007.06.015; Pittig A, 2013, INT J PSYCHOPHYSIOL, V87, P19, DOI 10.1016/j.ijpsycho.2012.10.012; RICHARD P, 1991, PHYSIOL REV, V71, P331, DOI 10.1152/physrev.1991.71.2.331; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SACHS BD, 1988, ANN NY ACAD SCI, V525, P1, DOI 10.1111/j.1749-6632.1988.tb38591.x; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Saha S, 2000, NEUROSCIENCE, V99, P613, DOI 10.1016/S0306-4522(00)00240-2; SCHWABER JS, 1982, J NEUROSCI, V2, P1424, DOI 10.1523/jneurosci.02-10-01424.1982; SHARE L, 1976, CARDIOLOGY, V61, P51, DOI 10.1159/000169792; SHARE L, 1988, PHYSIOL REV, V68, P1248, DOI 10.1152/physrev.1988.68.4.1248; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; STOCK G, 1978, PFLUG ARCH EUR J PHY, V376, P177, DOI 10.1007/BF00581581; SVED AF, 1985, HYPERTENSION, V7, P262, DOI 10.1161/01.HYP.7.2.262; Terenzi MG, 2005, NEUROSCIENCE, V134, P345, DOI 10.1016/j.neuroscience.2005.04.004; THAMES MD, 1979, AM J PHYSIOL, V237, pH299, DOI 10.1152/ajpheart.1979.237.3.H299; Tokita K, 2010, NEUROSCIENCE, V171, P351, DOI 10.1016/j.neuroscience.2010.08.026; TRAN LD, 1982, BRIT J PHARMACOL, V77, P69, DOI 10.1111/j.1476-5381.1982.tb09270.x; VANDERKOOY D, 1984, J COMP NEUROL, V224, P1, DOI 10.1002/cne.902240102; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; WALLACE DM, 1992, BRAIN RES BULL, V28, P447, DOI 10.1016/0361-9230(92)90046-Z; Wsol A, 2014, STRESS, V17, P117, DOI 10.3109/10253890.2013.872620; Wsol A, 2008, J PHYSIOL PHARMACOL, V59, P123; YAMASHITA H, 1979, BRAIN RES, V170, P259, DOI 10.1016/0006-8993(79)90106-9; Yang CCH, 1996, AM J PHYSIOL-HEART C, V270, pH575, DOI 10.1152/ajpheart.1996.270.2.H575; YOSHIMURA R, 1993, ENDOCRINOLOGY, V133, P1239, DOI 10.1210/en.133.3.1239; ZHANG JX, 1986, BRAIN RES, V386, P136, DOI 10.1016/0006-8993(86)90150-2; Zoccal DB, 2010, RESP PHYSIOL NEUROBI, V174, P98, DOI 10.1016/j.resp.2010.08.011; Zoccal DB, 2009, CLIN EXP PHARMACOL P, V36, P1188, DOI 10.1111/j.1440-1681.2009.05202.x	66	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99284	10.1371/journal.pone.0099284	http://dx.doi.org/10.1371/journal.pone.0099284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036025	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200003
J	Le, MH; Cao, YR; Zhang, XC; Stacey, G				Le, Mi Ha; Cao, Yangrong; Zhang, Xue-Cheng; Stacey, Gary			LIK1, A CERK1-Interacting Kinase, Regulates Plant Immune Responses in Arabidopsis	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; INNATE IMMUNITY; CHITIN; DEFENSE; GENES; CERK1; EXPRESSION; THALIANA; COMPLEX; PROTEIN	Chitin, an integral component of the fungal cell wall, is one of the best-studied microbe-associated molecular patterns. Previous work identified a LysM receptor-like kinase (LysM-RLK1/CERK1) as the primary chitin receptor in Arabidopsis. In order to identify proteins that interact with CERK1, we conducted a yeast two-hybrid screen using the intracellular kinase domain of CERK1 as the bait. This screen identified 54 putative CERK1-interactors. Screening mutants defective in 43 of these interacting proteins identified only two, a calmodulin like protein (At3g10190) and a leucine-rich repeat receptor like kinase (At3g14840), which differed in their response to pathogen challenge. In the present work, we focused on characterizing the LRR-RLK gene where mutations altered responses to chitin elicitation. This LRR-RLK was named LysM RLK1-interacting kinase 1 (LIK1). The interaction between CERK1 and LIK1 was confirmed by co-immunoprecipitation using protoplasts and transgenic plants. In vitro experiments showed that LIK1 was directly phosphorylated by CERK1. In vivo phosphorylation assays showed that Col-0 wild-type plants have more phosphorylated LIK1 than cerk1 mutant plants, suggesting that LIK1 may be directly phosphorylated by CERK1. Lik1 mutant plants showed an enhanced response to both chitin and flagellin elicitors. In comparison to the wild-type plants, lik1 mutant plants were more resistant to the hemibiotrophic pathogen Pseudomonas syringae, but more susceptible to the necrotrophic pathogen Sclerotinia sclerotiorum. Consistent with the enhanced susceptibility to necrotrophs, lik1 mutants showed reduced expression of genes involved in jasmonic acid and ethylene signaling pathways. These data suggest that LIK1 directly interacts with CERK1 and regulates MAMP-triggered innate immunity.	[Le, Mi Ha; Cao, Yangrong; Zhang, Xue-Cheng; Stacey, Gary] Univ Missouri, C S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci & Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Stacey, G (corresponding author), Univ Missouri, C S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci & Biochem, Columbia, MO 65211 USA.	staceyg@missouri.edu	poinssot, benoit/B-2569-2009	poinssot, benoit/0000-0001-5890-4318	Vietnam Education Foundation; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]	Vietnam Education Foundation; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by a fellowship awarded to Mi Ha Le by the Vietnam Education Foundation and by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-FG02-08ER15309, to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DICKMAN MB, 1992, PHYSIOL MOL PLANT P, V41, P255, DOI 10.1016/0885-5765(92)90025-Q; Fan J, 2008, PLANT J, V53, P393, DOI 10.1111/j.1365-313X.2007.03303.x; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Narusaka Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25345; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shinya T, 2012, PLANT CELL PHYSIOL, V53, P1696, DOI 10.1093/pcp/pcs113; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Takahashi H, 2004, PLANT CELL PHYSIOL, V45, P803, DOI 10.1093/pcp/pch085; Tanaka K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22598; Wan J, 2010, BIOL PLANTE MICROBE; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wan JR, 2008, PLANT SIGNAL BEHAV, V3, P831, DOI 10.4161/psb.3.10.5916; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeng LR, 2012, PLANT J, V69, P92, DOI 10.1111/j.1365-313X.2011.04773.x; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183	48	45	46	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102245	10.1371/journal.pone.0102245	http://dx.doi.org/10.1371/journal.pone.0102245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036661	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200043
J	Legrand, N; Araud, T; Conne, B; Kuijpers, O; Jaquier-Gubler, P; Curran, J				Legrand, Noemie; Araud, Tanguy; Conne, Beatrice; Kuijpers, Odin; Jaquier-Gubler, Pascale; Curran, Joseph			An AUG Codon Conserved for Protein Function Rather than Translational Initiation: The Story of the Protein sElk1	PLOS ONE			English	Article							CONTROL REPORTER SYSTEM; ELK-1; EXPRESSION; COMPLEX; BRAIN; RNA	Elk1 belongs to the ternary complex (TCF) subfamily of the ETS-domain transcription factors. Several studies have implicated an important function for Elk1 in the CNS including synaptic plasticity and cell differentiation. Whilst studying ELK1 gene expression in rat brain a 54 aa N-terminally truncated isoform lacking the DBD was observed on immunoblots. A similar protein was also detected in NGF differentiated PC12 cells. It was proposed that this protein, referred to as sElk1, arose due to a de-novo initiation event at the second AUG codon on the Elk1 ORF. Transient over-expression of sElk1 potentiated neurite growth in the PC12 model and induced differentiation in the absence of NGF, leading to the proposition that it may have a specific function in the CNS. Here we report on the translational expression from the mouse and rat transcript and compare it with our earlier published work on human. Results demonstrate that the previously observed sElk1 protein is a non-specific band arising from the antibody employed. The tight conservation of the internal AUG reported to drive sElk1 expression is in fact coupled to Elk1 protein function, a result consistent with the Elk1-SRE crystal structure. It is also supported by the observed conservation of this methionine in the DBD of all ETS transcription factors independent of the N- or C-terminal positioning of this domain. Reporter assays demonstrate that elements both within the 5'UTR and downstream of the AUG(Elk1) serve to limit 40S access to the AUG(sElk1) codon.	[Legrand, Noemie; Araud, Tanguy; Conne, Beatrice; Kuijpers, Odin; Jaquier-Gubler, Pascale; Curran, Joseph] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Conne, Beatrice] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Curran, Joseph] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Curran, J (corresponding author), Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	Joseph.Curran@unige.ch			Swiss National Science Foundation [31003A_143772]; La Ligue Genevoise contre le Cancer	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); La Ligue Genevoise contre le Cancer	This study was supported by the Swiss National Science Foundation (Grant #31003A_143772) and La Ligue Genevoise contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araud T, 2007, NUCLEIC ACIDS RES, V35, P4649, DOI 10.1093/nar/gkm482; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Figueroa C, 2003, ONCOGENE, V22, P5554, DOI 10.1038/sj.onc.1206496; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lin H, 2007, TOXICOL SCI, V96, P83, DOI 10.1093/toxsci/kfl172; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Rahim G, 2012, MOL CELL BIOL, V32, P1745, DOI 10.1128/MCB.06751-11; Sgambato V, 1998, J NEUROSCI, V18, P214; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Szatmari EM, 2013, J NEUROSCI, V33, P5367, DOI 10.1523/JNEUROSCI.2641-12.2013; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; VANHOUTTE P, 2002, HAND CHEM N, V19, P287; Wang XQ, 2004, NUCLEIC ACIDS RES, V32, P1382, DOI 10.1093/nar/gkh305; Wiesenthal V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj029; Wiesenthal V, 2006, NAT PROTOC, V1, P1531, DOI 10.1038/nprot.2006.274	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102890	10.1371/journal.pone.0102890	http://dx.doi.org/10.1371/journal.pone.0102890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036748	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200092
J	Chakraborty, S; Nunez, D; Hu, SY; Domingo, MP; Pardo, J; Karmenyan, A; Galvez, EM; Chiou, A				Chakraborty, Sandeep; Nunez, David; Hu, Shih-Yang; Domingo, Maria Pilar; Pardo, Julian; Karmenyan, Artashes; Galvez, Eva Ma; Chiou, Arthur			FRET Based Quantification and Screening Technology Platform for the Interactions of Leukocyte Function-Associated Antigen-1 (LFA-1) with InterCellular Adhesion Molecule-1 (ICAM-1)	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; I-DOMAIN; PROTEIN INTERACTIONS; INTEGRIN REGULATION; CRYSTAL-STRUCTURE; COUNTER-RECEPTOR; STRUCTURAL BASIS; BINDING; SPECTROSCOPY; AFFINITY	The interaction between leukocyte function-associated antigen-1(LFA-1) and intercellular adhesion molecule-1 (ICAM-1) plays a pivotal role in cellular adhesion including the extravasation and inflammatory response of leukocytes, and also in the formation of immunological synapse. However, irregular expressions of LFA-1 or ICAM-1 or both may lead to autoimmune diseases, metastasis cancer, etc. Thus, the LFA-1/ICAM-1 interaction may serve as a potential therapeutic target for the treatment of these diseases. Here, we developed one simple 'in solution' steady state fluorescence resonance energy transfer (FRET) technique to obtain the dissociation constant (K-d) of the interaction between LFA-1 and ICAM-1. Moreover, we developed the assay into a screening platform to identify peptides and small molecules that inhibit the LFA-1/ICAM-1 interaction. For the FRET pair, we used Alexa Fluor 488-LFA-1 conjugate as donor and Alexa Fluor 555-human recombinant ICAM-1 (D1-D2-Fc) as acceptor. From our quantitative FRET analysis, the K-d between LFA-1 and D1-D2-Fc was determined to be 17.93 +/- 1.34 nM. Both the K-d determination and screening assay were performed in a 96-well plate platform, providing the opportunity to develop it into a high-throughput assay. This is the first reported work which applies FRET based technique to determine K-d as well as classifying inhibitors of the LFA-1/ICAM-1 interaction.	[Chakraborty, Sandeep; Hu, Shih-Yang; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Nunez, David; Domingo, Maria Pilar; Galvez, Eva Ma] CSIC, Inst Carboquim, Zaragoza, Spain; [Nunez, David; Domingo, Maria Pilar; Pardo, Julian; Galvez, Eva Ma] Biomed Res Ctr Aragon, Aragon Hlth Res Inst, Immune Effector Cells Grp, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Fac Ciencias, Dept Biochem & Mol & Cell Biol, E-50009 Zaragoza, Spain; [Pardo, Julian] Govt Aragon, Aragon I D Fdn, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Nanosci Inst Aragon, Aragon I D Fdn, Zaragoza, Spain; [Karmenyan, Artashes; Chiou, Arthur] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Carboquimica (ICB); University of Zaragoza; University of Zaragoza; National Yang Ming Chiao Tung University	Karmenyan, A (corresponding author), Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan.	artashes@ym.edu.tw; eva@icb.csic.es; aechiou@ym.edu.tw	Domingo, Pilar/D-6325-2014; Galvez, Eva M./K-6751-2014; Karmenyan, Artashes/U-3697-2019; Pardo, Julián/K-6764-2014	Domingo, Pilar/0000-0002-6829-8769; Galvez, Eva M./0000-0001-6928-5516; Pardo, Julián/0000-0003-0154-0730; Nunez Jurado, David/0000-0002-0360-5625	National Science Council, Taiwan, ROC (Spain-Taiwan Collaborative Research Project) [NSC99-2923- E-010-001-MY3]; Taiwan Ministry of Education - Spanish National Science Council (CSIC) [2009tw0034]; Spanish Ministry of Economy and Competitiveness [SAF2011-25390]	National Science Council, Taiwan, ROC (Spain-Taiwan Collaborative Research Project); Taiwan Ministry of Education - Spanish National Science Council (CSIC); Spanish Ministry of Economy and Competitiveness(Spanish Government)	SC SH AK AC were jointly supported by the National Science Council, Taiwan, ROC (Spain-Taiwan Collaborative Research Project, Project No. NSC99-2923- E-010-001-MY3), the Top University Project from Taiwan Ministry of Education while DN MPD JP EG were supported by the Spanish National Science Council (CSIC) (2009tw0034), SAF2011-25390 from Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2003, PEPTIDES, V24, P487, DOI 10.1016/S0196-9781(03)00083-4; Barbeau B, 1998, J VIROL, V72, P7125, DOI 10.1128/JVI.72.9.7125-7136.1998; Bernabeu M, 2012, CELL MICROBIOL, V14, P386, DOI 10.1111/j.1462-5822.2011.01726.x; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bojarski P, 2011, J PHYS CHEM B, V115, P10120, DOI 10.1021/jp202152m; Bossis G, 2005, METHOD ENZYMOL, V398, P20, DOI 10.1016/S0076-6879(05)98003-8; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Ciubotaru M, 2007, MOL CELL BIOL, V27, P4745, DOI 10.1128/MCB.00177-07; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Estecha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033313; Fairclough R H, 1978, Methods Enzymol, V48, P347; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fuchs R, 2010, REV MED VIROL, V20, P281, DOI 10.1002/rmv.654; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Gottlieb AB, 2002, ARCH DERMATOL, V138, P591, DOI 10.1001/archderm.138.5.591; Grunwald D, 2005, CURR PHARM BIOTECHNO, V6, P381, DOI 10.2174/138920105774370616; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ihanus E, 2003, EUR J BIOCHEM, V270, P1710, DOI 10.1046/j.1432-1033.2003.03528.x; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; KAVANAUGH AF, 1994, ARTHRITIS RHEUM, V37, P992, DOI 10.1002/art.1780370703; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lichlyter DJ, 2003, BIOSENS BIOELECTRON, V19, P219, DOI 10.1016/S0956-5663(03)00215-X; Liu L, 2008, BIOCONJUGATE CHEM, V19, P574, DOI 10.1021/bc700369q; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Lou JN, 1997, NEUROREPORT, V8, P629, DOI 10.1097/00001756-199702100-00010; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma XY, 2006, PROTEIN PEPTIDE LETT, V13, P397, DOI 10.2174/092986606775974429; Maliwal BP, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.011006; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961; Nunez D, 2013, PROCESS BIOCHEM, V48, P708, DOI 10.1016/j.procbio.2013.03.006; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song Y, 2012, BIOTECHNOL BIOENG, V109, P2875, DOI 10.1002/bit.24564; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stankovic-Valentin Nicolas, 2009, V497, P241, DOI 10.1007/978-1-59745-566-4_16; Steinman L, 1996, P NATL ACAD SCI USA, V93, P2253, DOI 10.1073/pnas.93.6.2253; Sun YS, 2013, CYTOM PART A, V83, P780, DOI 10.1002/cyto.a.22321; Tibbetts SA, 2000, PEPTIDES, V21, P1161, DOI 10.1016/S0196-9781(00)00255-2; Tominaga Y, 1998, J IMMUNOL, V161, P4016; Tsuganezawa K, 2013, J BIOMOL SCREEN, V18, P1103, DOI 10.1177/1087057113492200; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Wu SH, 2014, BIOSENS BIOELECTRON, V56, P159, DOI 10.1016/j.bios.2014.01.008; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Yang HP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/368938; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zheng Y, 2013, LEUKEMIA, V27, P702, DOI 10.1038/leu.2012.272; Zhou CL, 2011, PEPTIDES, V32, P408, DOI 10.1016/j.peptides.2010.10.019; Zhu XW, 2013, ASIAN PAC J CANCER P, V14, P1579, DOI 10.7314/APJCP.2013.14.3.1579	64	8	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102572	10.1371/journal.pone.0102572	http://dx.doi.org/10.1371/journal.pone.0102572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032811	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300064
J	Van Yperen, NW; Rietzschel, EF; De Jonge, KMM				Van Yperen, Nico W.; Rietzschel, Eric F.; De Jonge, Kiki M. M.			Blended Working: For Whom It May (Not) Work	PLOS ONE			English	Article							FAMILY CONFLICT; VIRTUAL OFFICE; MOTIVATION; CONSEQUENCES; ARRANGEMENTS; NEED; METAANALYSIS; FLEXIBILITY; PERSONALITY; ENVIRONMENT	Similarly to related developments such as blended learning and blended care, blended working is a pervasive and booming trend in modern societies. Blended working combines on-site and off-site working in an optimal way to improve workers' and organizations' outcomes. In this paper, we examine the degree to which workers feel that the two defining features of blended working (i.e., time-independent working and location-independent working) enhance their own functioning in their jobs. Blended working, enabled through the continuing advance and improvement of high-tech ICT software, devices, and infrastructure, may be considered beneficial for workers' perceived effectiveness because it increases their job autonomy. However, because blended working may have downsides as well, it is important to know for whom blended working may (not) work. As hypothesized, in a sample of 348 workers (51.7% women), representing a wide range of occupations and organizations, we found that the perceived personal effectiveness of blended working was contingent upon workers' psychological need strength. Specifically, the perceived effectiveness of both time-independent working and location-independent working was positively related to individuals' need for autonomy at work, and negatively related to their need for relatedness and need for structure at work.	[Van Yperen, Nico W.; Rietzschel, Eric F.; De Jonge, Kiki M. M.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen	Van Yperen, NW (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	N.van.Yperen@rug.nl	Van Yperen, Nico W./C-2341-2012	Van Yperen, Nico W./0000-0003-2116-8841				Allen TD, 2013, PERS PSYCHOL, V66, P345, DOI 10.1111/peps.12012; [Anonymous], JUGGLING REBALANCING; ASHFORD SJ, 1985, J OCCUP PSYCHOL, V58, P67, DOI 10.1111/j.2044-8325.1985.tb00181.x; Bartel CA, 2012, ORGAN SCI, V23, P743, DOI 10.1287/orsc.1110.0661; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Cooper CD, 2002, J ORGAN BEHAV, V23, P511, DOI 10.1002/job.145; Ehrhart MG, 2001, LEADERSHIP QUART, V12, P153, DOI 10.1016/S1048-9843(01)00074-1; Fonner KL, 2010, J APPL COMMUN RES, V38, P336, DOI 10.1080/00909882.2010.513998; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Gajendran RS, 2007, J APPL PSYCHOL, V92, P1524, DOI 10.1037/0021-9010.92.6.1524; Gajendran RS, PERSON PSYC IN PRESS, Vxx, pxxx; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Hill EJ, 2003, J VOCAT BEHAV, V63, P220, DOI 10.1016/S0001-8791(03)00042-3; Hill EJ, 1998, PERS PSYCHOL, V51, P667, DOI 10.1111/j.1744-6570.1998.tb00256.x; Karasek R, 1990, HLTH WORK STRESS PRO; Kelliher C, 2010, HUM RELAT, V63, P83, DOI 10.1177/0018726709349199; Kreiner GE, 2006, J ORGAN BEHAV, V27, P485, DOI 10.1002/job.386; Kristof-Brown AL, 2005, PERS PSYCHOL, V58, P281, DOI 10.1111/j.1744-6570.2005.00672.x; Lister K., 2011, STATE TELEWORK US IN; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Matusik SF, 2011, HUM RELAT, V64, P1001, DOI 10.1177/0018726711405552; McLennan KJ, 2008, VIRTUAL WORLD WORK G; Morgeson FP, 2013, PERS PSYCHOL, V66, P805, DOI 10.1111/peps.12055; O'Neill TA, 2014, COMPUT HUM BEHAV, V34, P291, DOI 10.1016/j.chb.2014.02.015; O'Neill TA, 2009, NEW TECH WORK EMPLOY, V24, P144, DOI 10.1111/j.1468-005X.2009.00225.x; Owston R, 2013, INTERNET HIGH EDUC, V18, P1, DOI 10.1016/j.iheduc.2013.03.002; Pedersen VB, 2012, WORK EMPLOY SOC, V26, P464, DOI 10.1177/0950017012438571; Ryan RM, 2000, PSYCHOL INQ, V11, P319, DOI 10.1207/S15327965PLI1104_03; Shockley KM, 2007, J VOCAT BEHAV, V71, P479, DOI 10.1016/j.jvb.2007.08.006; Slijkhuis JM, 2013, EUR J WORK ORGAN PSY, V22, P15, DOI 10.1080/1359432X.2011.626244; ten Brummelhuis LL, 2012, PSICOTHEMA, V24, P113; Thompson MM, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P19; Van den Broeck A, 2010, J OCCUP ORGAN PSYCH, V83, P981, DOI 10.1348/096317909X481382; Van Yperen NW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093594; Wilhelmsen M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-296; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843	36	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102921	10.1371/journal.pone.0102921	http://dx.doi.org/10.1371/journal.pone.0102921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033202	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300107
J	Zargarian, L; Tisne, C; Barraud, P; Xu, XQ; Morellet, N; Rene, B; Mely, Y; Fosse, P; Mauffret, O				Zargarian, Loussine; Tisne, Carine; Barraud, Pierre; Xu, Xiaoqian; Morellet, Nelly; Rene, Brigitte; Mely, Yves; Fosse, Philippe; Mauffret, Olivier			Dynamics of Linker Residues Modulate the Nucleic Acid Binding Properties of the HIV-1 Nucleocapsid Protein Zinc Fingers	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; BACKBONE DYNAMICS; NMR RELAXATION; CHAPERONE ACTIVITY; STRAND TRANSFER; CTAR DNA; STRUCTURAL DETERMINANTS; REVERSE TRANSCRIPTION	The HIV-1 nucleocapsid protein (NC) is a small basic protein containing two zinc fingers (ZF) separated by a short linker. It is involved in several steps of the replication cycle and acts as a nucleic acid chaperone protein in facilitating nucleic acid strand transfers occurring during reverse transcription. Recent analysis of three-dimensional structures of NC-nucleic acids complexes established a new property: the unpaired guanines targeted by NC are more often inserted in the C-terminal zinc finger (ZF2) than in the N-terminal zinc finger (ZF1). Although previous NMR dynamic studies were performed with NC, the dynamic behavior of the linker residues connecting the two ZF domains remains unclear. This prompted us to investigate the dynamic behavior of the linker residues. Here, we collected N-15 NMR relaxation data and used for the first time data at several fields to probe the protein dynamics. The analysis at two fields allows us to detect a slow motion occurring between the two domains around a hinge located in the linker at the G35 position. However, the amplitude of motion appears limited in our conditions. In addition, we showed that the neighboring linker residues R29, A30, P31, R32, K33 displayed restricted motion and numerous contacts with residues of ZF1. Our results are fully consistent with a model in which the ZF1-linker contacts prevent the ZF1 domain to interact with unpaired guanines, whereas the ZF2 domain is more accessible and competent to interact with unpaired guanines. In contrast, ZF1 with its large hydrophobic plateau is able to destabilize the double-stranded regions adjacent to the guanines bound by ZF2. The linker residues and the internal dynamics of NC regulate therefore the different functions of the two zinc fingers that are required for an optimal chaperone activity.	[Zargarian, Loussine; Xu, Xiaoqian; Rene, Brigitte; Fosse, Philippe; Mauffret, Olivier] CNRS, Unite Mixte Rech 8113, Ecole Normale Super Cachan, Lab Biol & Pharmacol Appl, Cachan, France; [Tisne, Carine; Barraud, Pierre] Univ Paris 05, Unite Mixte Rech 8015, CNRS, Lab Cristallog & RMN Biol, Paris, France; [Xu, Xiaoqian] E China Normal Univ, Dept Life Sci, Shanghai 200062, Peoples R China; [Morellet, Nelly] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, Gif Sur Yvette, France; [Mely, Yves] Univ Strasbourg, Fac Pharm, CNRS, Lab Biophoton & Pharmacol,Unite Mixte Rech 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; East China Normal University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mauffret, O (corresponding author), CNRS, Unite Mixte Rech 8113, Ecole Normale Super Cachan, Lab Biol & Pharmacol Appl, Cachan, France.	olivier.mauffret@lbpa.ens-cachan.fr	Barraud, Pierre/AAT-9884-2020	Barraud, Pierre/0000-0003-4460-8360; morellet, nelly/0000-0001-5076-8884; Tisne, Carine/0000-0001-5534-4650	ANRS; CNRS; TGIR-RMN-THC [Fr3050 CNRS]	ANRS(ANRSFrench National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); TGIR-RMN-THC	ANRS and CNRS supported the work. Financial support from the TGIR-RMN-THC Fr3050 CNRS for conducting the research is gratefully acknowledged. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Aduri R, 2013, NUCLEIC ACIDS RES, V41, P2565, DOI 10.1093/nar/gks1350; Akke M, 1997, RNA, V3, P702; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Avilov SV, 2008, NUCLEIC ACIDS RES, V36, P885, DOI 10.1093/nar/gkm1109; Avilov SV, 2009, BIOCHEMISTRY-US, V48, P2422, DOI 10.1021/bi8022366; Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; Barraud P, 2007, BIOCHIMIE, V89, P1204, DOI 10.1016/j.biochi.2007.01.016; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bazzi A, 2011, NUCLEIC ACIDS RES, V39, P3903, DOI 10.1093/nar/gkq1290; Beltz H, 2005, J MOL BIOL, V348, P1113, DOI 10.1016/j.jmb.2005.02.042; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Bourbigot S, 2008, J MOL BIOL, V383, P1112, DOI 10.1016/j.jmb.2008.08.046; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cristofari G, 2002, PROG NUCLEIC ACID RE, V72, P223, DOI 10.1016/S0079-6603(02)72071-0; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; DAMASCHUN G, 1993, BIOCHEMISTRY-US, V32, P7739, DOI 10.1021/bi00081a019; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fisher RJ, 2006, NUCLEIC ACIDS RES, V34, P472, DOI 10.1093/nar/gkj442; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Godet J, 2013, NUCLEIC ACIDS RES, V41, P5036, DOI 10.1093/nar/gkt164; Godet J, 2011, NUCLEIC ACIDS RES, V39, P6633, DOI 10.1093/nar/gkr274; Godet J, 2010, RNA BIOL, V7, P687, DOI 10.4161/rna.7.6.13616; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Guo JH, 2002, J VIROL, V76, P4370, DOI 10.1128/JVI.76.9.4370-4378.2002; Heath MJ, 2003, J BIOL CHEM, V278, P30755, DOI 10.1074/jbc.M303819200; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; Johnson PE, 2000, BIOCHEMISTRY-US, V39, P9084, DOI 10.1021/bi000841i; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Korzhnev DM, 1997, J MAGN RESON, V127, P184, DOI 10.1006/jmre.1997.1190; Korzhnev DM, 2000, J BIOMOL NMR, V17, P231, DOI 10.1023/A:1008348827208; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Lienin SF, 1998, J AM CHEM SOC, V120, P9870, DOI 10.1021/ja9810179; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Luginbuhl P, 2002, PROG NUCL MAG RES SP, V40, P199, DOI 10.1016/S0079-6565(01)00043-7; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MELY Y, 1994, BIOCHEMISTRY-US, V33, P12085, DOI 10.1021/bi00206a011; MELY Y, 1993, BIOPHYS J, V65, P1513, DOI 10.1016/S0006-3495(93)81222-0; Mirambeau G, 2006, J MOL BIOL, V364, P496, DOI 10.1016/j.jmb.2006.08.065; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; Musier-Forsyth K, 2010, RNA BIOL, V7, P632, DOI 10.4161/rna.7.6.14467; Oberstrass FC, 2008, J AM CHEM SOC, V130, P12007, DOI 10.1021/ja8023115; Ochsenbein F, 2001, J BIOMOL NMR, V19, P3, DOI 10.1023/A:1008390606077; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; OTTMANN M, 1995, J VIROL, V69, P1778, DOI 10.1128/JVI.69.3.1778-1784.1995; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PENG JW, 1991, J MAGN RESON, V95, P421, DOI 10.1016/0022-2364(91)90233-J; Ramalanjaona N, 2007, J MOL BIOL, V374, P1041, DOI 10.1016/j.jmb.2007.10.001; Ramboarina S, 2002, J MOL BIOL, V316, P611, DOI 10.1006/jmbi.2001.5379; Ravindranathan S, 2010, J MOL BIOL, V396, P732, DOI 10.1016/j.jmb.2009.12.004; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shajani Z, 2005, J MOL BIOL, V349, P699, DOI 10.1016/j.jmb.2005.04.012; Sleiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064700; Spriggs S, 2008, BIOCHEMISTRY-US, V47, P13064, DOI 10.1021/bi8014373; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Tisne C, 2005, CURR HIV RES, V3, P147, DOI 10.2174/1570162053506919; Tisne C, 2003, BIOCHIMIE, V85, P557, DOI 10.1016/S0300-9084(03)00034-8; Tisne C, 2001, J MOL BIOL, V306, P443, DOI 10.1006/jmbi.2000.4391; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Urbaneja MA, 1999, J MOL BIOL, V287, P59, DOI 10.1006/jmbi.1998.2521; Vuilleumier C, 1999, BIOCHEMISTRY-US, V38, P16816, DOI 10.1021/bi991145p; Webb JA, 2013, RNA, V19, P1078, DOI 10.1261/rna.038869.113; Williams MC, 2002, P NATL ACAD SCI USA, V99, P8614, DOI 10.1073/pnas.132128999; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Wu H, 2013, VIRUS RES, V42, P2525; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021	84	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102150	10.1371/journal.pone.0102150	http://dx.doi.org/10.1371/journal.pone.0102150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029439	Green Published, gold			2022-12-27	WOS:000341306600037
J	Brown, RWB; Collingridge, PW; Gull, K; Rigden, DJ; Ginger, ML				Brown, Robert W. B.; Collingridge, Peter W.; Gull, Keith; Rigden, Daniel J.; Ginger, Michael L.			Evidence for Loss of a Partial Flagellar Glycolytic Pathway during Trypanosomatid Evolution	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PARAFLAGELLAR ROD; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOGLYCERATE KINASE; FUNCTIONAL GENOMICS; RNA INTERFERENCE; ADENYLATE KINASE; PROTEIN; BRUCEI	Classically viewed as a cytosolic pathway, glycolysis is increasingly recognized as a metabolic pathway exhibiting surprisingly wide-ranging variations in compartmentalization within eukaryotic cells. Trypanosomatid parasites provide an extreme view of glycolytic enzyme compartmentalization as several glycolytic enzymes are found exclusively in peroxisomes. Here, we characterize Trypanosoma brucei flagellar proteins resembling glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and phosphoglycerate kinase (PGK): we show the latter associates with the axoneme and the former is a novel paraflagellar rod component. The paraflagellar rod is an essential extra-axonemal structure in trypanosomes and related protists, providing a platform into which metabolic activities can be built. Yet, bioinformatics interrogation and structural modelling indicate neither the trypanosome PGK-like nor the GAPDH-like protein is catalytically active. Orthologs are present in a free-living ancestor of the trypanosomatids, Bodo saltans: the PGK-like protein from B. saltans also lacks key catalytic residues, but its GAPDH-like protein is predicted to be catalytically competent. We discuss the likelihood that the trypanosome GAPDH-like and PGK-like proteins constitute molecular evidence for evolutionary loss of a flagellar glycolytic pathway, either as a consequence of niche adaptation or the re-localization of glycolytic enzymes to peroxisomes and the extensive changes to glycolytic flux regulation that accompanied this re-localization. Evidence indicating loss of localized ATP provision via glycolytic enzymes therefore provides a novel contribution to an emerging theme of hidden diversity with respect to compartmentalization of the ubiquitous glycolytic pathway in eukaryotes. A possibility that trypanosome GAPDH-like protein additionally represents a degenerate example of a moonlighting protein is also discussed.	[Brown, Robert W. B.; Ginger, Michael L.] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England; [Collingridge, Peter W.; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rigden, Daniel J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	Lancaster University; University of Oxford; University of Liverpool	Ginger, ML (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England.	m.ginger@lancaster.ac.uk		Ginger, Michael/0000-0002-9643-8482; gull, keith/0000-0001-6954-9569; Brown, Robert/0000-0003-4086-7699; Rigden, Daniel/0000-0002-7565-8937	Royal Society; Biotechnology and Biological Sciences Research Council; Wellcome Trust; Lancaster University; BBSRC [BB/F010931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F010931/1] Funding Source: researchfish	Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Lancaster University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society (http://royalsociety.org/) (to MLG), the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (through a studentship to PWC), The Wellcome Trust (http://www.wellcome.ac.uk/) (to KG) and a Lancaster University doctoral studentship to RWBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Attias M, 1996, CELL STRUCT FUNCT, V21, P297, DOI 10.1247/csf.21.297; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chambers JW, 2008, J BIOL CHEM, V283, P14963, DOI 10.1074/jbc.M802124200; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Davidge JA, 2006, J CELL SCI, V119, P3935, DOI 10.1242/jcs.03203; Didierjean C, 1997, J MOL BIOL, V268, P739, DOI 10.1006/jmbi.1997.0998; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Ginger ML, 2013, PROTIST, V164, P528, DOI 10.1016/j.protis.2013.05.002; Ginger ML, 2010, PHILOS T R SOC B, V365, P831, DOI 10.1098/rstb.2009.0259; Ginger ML, 2005, J BIOL CHEM, V280, P11781, DOI 10.1074/jbc.M413821200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Gualdron-Lopez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034530; Gualdron-Lopez M, 2012, INT J PARASITOL, V42, P1, DOI 10.1016/j.ijpara.2011.10.007; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; Joice AC, 2012, INT J PARASITOL, V42, P401, DOI 10.1016/j.ijpara.2012.02.008; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar R, 2010, MOL BIOCHEM PARASIT, V170, P41, DOI 10.1016/j.molbiopara.2009.11.002; Lacomble S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007685; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu W, 2010, MOL BIOCHEM PARASIT, V169, P20, DOI 10.1016/j.molbiopara.2009.09.004; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; MISSET O, 1987, EUR J BIOCHEM, V162, P501, DOI 10.1111/j.1432-1033.1987.tb10668.x; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; Miura N, 2013, EUKARYOT CELL, V12, P1106, DOI 10.1128/EC.00093-13; Moniot S, 2008, J BIOL CHEM, V283, P21693, DOI 10.1074/jbc.M802286200; Nakayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052340; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; OSINGA KA, 1985, EMBO J, V4, P3811, DOI 10.1002/j.1460-2075.1985.tb04152.x; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pomel S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000188; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Porcel BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004007; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Proudfoot C, 2005, NUCLEIC ACIDS RES, V33, P6906, DOI 10.1093/nar/gki996; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Rotureau B, 2014, CELL MICROBIOL, V16, P425, DOI 10.1111/cmi.12230; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Saito T, 2008, J BIOL CHEM, V283, P14041, DOI 10.1074/jbc.M709015200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weise F, 2000, J CELL SCI, V113, P4587; WIEMER EAC, 1995, J MOL EVOL, V40, P443, DOI 10.1007/BF00164030; Zhang WW, 2013, EUKARYOT CELL, V12, P70, DOI 10.1128/EC.00263-12	90	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103026	10.1371/journal.pone.0103026	http://dx.doi.org/10.1371/journal.pone.0103026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050549	Green Accepted, gold, Green Published			2022-12-27	WOS:000339551100076
J	Liu, FL; Yang, QS; Cong, WX; Wang, G				Liu, Fenglin; Yang, Qingsong; Cong, Wenxiang; Wang, Ge			Dynamic Bowtie Filter for Cone-Beam/Multi-Slice CT	PLOS ONE			English	Article							TUBE CURRENT MODULATION; DOSE REDUCTION; TIE FILTER; BEAM; OPTIMIZATION; QUALITY; NOISE; MODEL	A pre-patient attenuator ("bowtie filter" or "bowtie") is used to modulate an incoming x-ray beam as a function of the angle of the x-ray with respect to a patient to balance the photon flux on a detector array. While the current dynamic bowtie design is focused on fan-beam geometry, in this study we propose a methodology for dynamic bowtie design in multi-slice/cone-beam geometry. The proposed 3D dynamic bowtie is an extension of the 2D prior art. The 3D bowtie consists of a highly attenuating bowtie (HB) filled in with heavy liquid and a weakly attenuating bowtie (WB) immersed in the liquid of the HB. The HB targets a balanced flux distribution on a detector array when no object is in the field of view (FOV). The WB compensates for an object in the FOV, and hence is a scaled-down version of the object. The WB is rotated and translated in synchrony with the source rotation and patient translation so that the overall flux balance is maintained on the detector array. First, the mathematical models of different scanning modes are established for an elliptical water phantom. Then, a numerical simulation study is performed to compare the performance of the scanning modes in the cases of the water phantom and a patient cross-section without any bowtie and with a dynamic bowtie. The dynamic bowtie can equalize the numbers of detected photons in the case of the water phantom. In practical cases, the dynamic bowtie can effectively reduce the dynamic range of detected signals inside the FOV. Furthermore, the WB can be individualized using a 3D printing technique as the gold standard. We have extended the dynamic bowtie concept from 2D to 3D by using highly attenuating liquid and moving a scale-reduced negative copy of an object being scanned. Our methodology can be applied to reduce radiation dose and facilitate photon-counting detection.	[Liu, Fenglin] Chongqing Univ, Key Lab Optoelect Technol & Syst, Engn Res Ctr Ind Comp Tomog Nondestruct Testing, Minist Educ, Chongqing 630044, Peoples R China; [Liu, Fenglin; Yang, Qingsong; Cong, Wenxiang; Wang, Ge] Rensselaer Polytech Inst, Dept Biomed Engn, Biomed Imaging Ctr, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Chongqing University; Rensselaer Polytechnic Institute	Liu, FL (corresponding author), Chongqing Univ, Key Lab Optoelect Technol & Syst, Engn Res Ctr Ind Comp Tomog Nondestruct Testing, Minist Educ, Chongqing 630044, Peoples R China.	liufl@cqu.edu.cn	Liu, Fenglin/N-3010-2019; Wang, Ge/AAH-8592-2020	Liu, Fenglin/0000-0002-8952-311X; Wang, Ge/0000-0002-2656-7705	National Instrumentation Program [2013YQ030629]; Chongqing Science and Technology Research Plan in China [cstc2012gg-yyjs70016]; NIH [R01 EB011785]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Instrumentation Program; Chongqing Science and Technology Research Plan in China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the National Instrumentation Program (2013YQ030629), Chongqing Science and Technology Research Plan (cstc2012gg-yyjs70016) in China, and NIH R01 EB011785. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabriga R, 2011, NUCL INSTRUM METH A, V633, pS15, DOI 10.1016/j.nima.2010.06.108; Bartolac S, 2011, MED PHYS, V38, pS2, DOI 10.1118/1.3574885; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Blessing M, 2012, PHYS MEDICA, V28, P134, DOI 10.1016/j.ejmp.2011.04.001; Bogue R, 2013, ASSEMBLY AUTOM, V33, P307, DOI 10.1108/AA-06-2013-055; Boone JM, 2010, MED PHYS, V37, P40, DOI 10.1118/1.3264616; Gaisberger C, 2013, STRAHLENTHER ONKOL, V189, P887, DOI 10.1007/s00066-013-0358-6; Gies M, 1999, MED PHYS, V26, P2235, DOI 10.1118/1.598779; Hsieh J., 2009, COMPUTER TOMOGRAPHY, V2nd; Hsieh SS, 2013, MED PHYS, V40; Kak AC, 2001, CLASSICS APPL MATH, V33, P1; Kalender WA, 1999, MED PHYS, V26, P2248, DOI 10.1118/1.598738; Liu FL, 2013, J X-RAY SCI TECHNOL, V21, P579, DOI 10.3233/XST-130386; Mail N, 2009, MED PHYS, V36, P22, DOI 10.1118/1.3017470; Mavroidis C, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-1; McKenney SE, 2011, MED PHYS, V38, P1406, DOI 10.1118/1.3551990; Mutic S, 2003, MED PHYS, V30, P2762, DOI 10.1118/1.1609271; PEPPLER W, 1982, AM J ROENTGENOL, V139, P426; Roessl E, 2013, DYNAMIC BEAM SHAPER; Taguchi K, 2010, MED PHYS, V37, P3957, DOI 10.1118/1.3429056; Toth TL, 2005, P SOC PHOTO-OPT INS, V5745, P283, DOI 10.1117/12.595465; Wang W, 2013, ACM T GRAPHIC, V32; Zeng GSL, 2004, IEEE T MED IMAGING, V23, P690, DOI 10.1109/TMI.2004.826943	23	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103054	10.1371/journal.pone.0103054	http://dx.doi.org/10.1371/journal.pone.0103054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051067	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100082
J	Stratmann, M; Konrad, C; Kugel, H; Krug, A; Schoning, S; Ohrmann, P; Uhlmann, C; Postert, C; Suslow, T; Heindel, W; Arolt, V; Kircher, T; Dannlowski, U				Stratmann, Mirjam; Konrad, Carsten; Kugel, Harald; Krug, Axel; Schoening, Sonja; Ohrmann, Patricia; Uhlmann, Christina; Postert, Christian; Suslow, Thomas; Heindel, Walter; Arolt, Volker; Kircher, Tilo; Dannlowski, Udo			Insular and Hippocampal Gray Matter Volume Reductions in Patients with Major Depressive Disorder	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SEROTONIN TRANSPORTER GENE; COMORBIDITY SURVEY REPLICATION; AMYGDALA VOLUMES; MOOD DISORDERS; BRAIN VOLUME; UNIPOLAR DEPRESSION; ANTERIOR CINGULATE; STRUCTURAL-CHANGES; BIPOLAR-DISORDER	Background: Major depressive disorder is a serious psychiatric illness with a highly variable and heterogeneous clinical course. Due to the lack of consistent data from previous studies, the study of morphometric changes in major depressive disorder is still a major point of research requiring additional studies. The aim of the study presented here was to characterize and quantify regional gray matter abnormalities in a large sample of clinically well-characterized patients with major depressive disorder. Methods: For this study one-hundred thirty two patients with major depressive disorder and 132 age-and gender-matched healthy control participants were included, 35 with their first episode and 97 with recurrent depression. To analyse gray matter abnormalities, voxel-based morphometry (VBM8) was employed on T1 weighted MRI data. We performed whole-brain analyses as well as a region-of-interest approach on the hippocampal formation, anterior cingulate cortex and amygdala, correlating the number of depressive episodes. Results: Compared to healthy control persons, patients showed a strong gray-matter reduction in the right anterior insula. In addition, region-of-interest analyses revealed significant gray-matter reductions in the hippocampal formation. The observed alterations were more severe in patients with recurrent depressive episodes than in patients with a first episode. The number of depressive episodes was negatively correlated with gray-matter volume in the right hippocampus and right amygdala. Conclusions: The anterior insula gray matter structure appears to be strongly affected in major depressive disorder and might play an important role in the neurobiology of depression. The hippocampal and amygdala volume loss cumulating with the number of episodes might be explained either by repeated neurotoxic stress or alternatively by higher relapse rates in patients showing hippocampal atrophy.	[Stratmann, Mirjam; Konrad, Carsten; Krug, Axel; Kircher, Tilo; Dannlowski, Udo] Univ Marburg, Dept Psychiat, Marburg, Germany; [Schoening, Sonja; Ohrmann, Patricia; Uhlmann, Christina; Postert, Christian; Arolt, Volker; Dannlowski, Udo] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Kugel, Harald; Heindel, Walter] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany; [Postert, Christian] Univ Munster, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-48149 Munster, Germany; [Suslow, Thomas] Univ Leipzig, Dept Psychosomat Med & Psychotherapy, D-04109 Leipzig, Germany	Philipps University Marburg; University of Munster; University of Munster; University of Munster; Leipzig University	Konrad, C (corresponding author), Univ Marburg, Dept Psychiat, Marburg, Germany.	Carsten.Konrad@uk-gm.de	Postert, Christian/D-2253-2019; Kircher, Tilo/AAT-6480-2020; Krug, Axel/ABC-8530-2020	Postert, Christian/0000-0003-2578-5900; Kircher, Tilo/0000-0002-2514-2625; Krug, Axel/0000-0002-0564-2497; Suslow, Thomas/0000-0003-4560-0555; Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759	Innovative Medizinische Forschung (IMF) of the Medical Faculty of Munster [DA120309, DA111107, DA211012]; Rolf-Dierichs-Stiftung [ZUW80037]; Interdisciplinary Center for Clinical Research of the University of Munster, Germany [IZKF FG4]; Astra-Zeneca; Lundbeck; Wyeth	Innovative Medizinische Forschung (IMF) of the Medical Faculty of Munster; Rolf-Dierichs-Stiftung; Interdisciplinary Center for Clinical Research of the University of Munster, Germany; Astra-Zeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); Wyeth(Wyeth)	The study was supported by grants of Innovative Medizinische Forschung (IMF) of the Medical Faculty of Munster (DA120309 to UD, DA111107 to UD, and DA211012 to UD) and Rolf-Dierichs-Stiftung (ZUW80037 to UD) to Udo Dannlowski. Furthermore this work was supported by a grant to Carsten Konrad by the Interdisciplinary Center for Clinical Research (IZKF FG4) of the University of Munster, Germany. Financial Disclosures: Prof. Volker Arolt, MD, PhD is member of advisory boards and/or gave presentations for the following companies: Astra-Zeneca, Janssen-Organon, Eli Lilly, Lundbeck, Pfizer, Servier, and Wyeth. He also received grants from Astra-Zeneca, Lundbeck, and Wyeth. He chaired the committee for the "Wyeth Research Award Depression and Anxiety". Carsten Konrad has received a travel grant by Lundbeck. These co-operations have no relevance to the work covered in the manuscript. All other authors (Mirjam Stratmann, Harald Kugel, Axel Krug, Sonja Schoning, Patricia Ohrmann, Christina Uhlmann, Christian Postert, Thomas Suslow, Walter Heindel, Tilo Kircher, Udo Dannlowski) have no conflicts of interest to declare, financial or otherwise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Ahdidan J, 2011, ACTA PSYCHIAT SCAND, V123, P211, DOI 10.1111/j.1600-0447.2010.01644.x; Arnone D, 2013, MOL PSYCHIATR, V18, P1265, DOI 10.1038/mp.2012.150; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baare WFC, 2010, J PSYCHIATR RES, V44, P655, DOI 10.1016/j.jpsychires.2009.12.009; Baune BT, 2012, BIOL PSYCHIAT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belzer Kenneth, 2004, J Psychiatr Pract, V10, P296, DOI 10.1097/00131746-200409000-00003; Bielau H, 2005, EUR ARCH PSY CLIN N, V255, P401, DOI 10.1007/s00406-005-0581-y; Bora E, 2011, PSYCHOL MED, P1; Bora E, 2011, J AFFECT DISORD; Bremner JD, 2004, ANN NY ACAD SCI, V1032, P154, DOI 10.1196/annals.1314.012; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chen MC, 2010, ARCH GEN PSYCHIAT, V67, P270, DOI 10.1001/archgenpsychiatry.2009.202; Cheng YQ, 2010, NEUROSCI LETT, V480, P30, DOI 10.1016/j.neulet.2010.05.075; Cloutman LL, 2011, NEUROIMAGE; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; Cole J, 2010, J AFFECT DISORDERS, V126, P272, DOI 10.1016/j.jad.2010.03.004; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Eker C, 2010, EUR ARCH PSY CLIN N, V260, P527, DOI 10.1007/s00406-010-0110-5; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Frodl T, 2004, J CLIN PSYCHIAT, V65, P492; Frodl T, 2003, BIOL PSYCHIAT, V53, P338, DOI 10.1016/S0006-3223(02)01474-9; Frodl T, 2002, AM J PSYCHIAT, V159, P1112, DOI 10.1176/appi.ajp.159.7.1112; Frodl T, 2012, NEUROBIOL DIS; Frodl T, 2008, J PSYCHIATR NEUROSCI, V33, P423; Frodl T, 2006, J PSYCHIATR NEUROSCI, V31, P316; Frodl T, 2010, NEUROPSYCHOPHARMACOL, V35, P1383, DOI 10.1038/npp.2010.8; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Gerritsen L, 2011, BIOL PSYCHIAT, V70, P373, DOI 10.1016/j.biopsych.2011.01.029; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Harter M, 2010, NERVENARZT, V81, P1049, DOI 10.1007/s00115-010-3084-7; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Hickie IB, 2007, J AFFECT DISORDERS, V98, P137, DOI 10.1016/j.jad.2006.07.010; Hou ZH, 2012, BEHAV BRAIN RES, V227, P30, DOI 10.1016/j.bbr.2011.10.025; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Inkster B, 2011, J NEUROIMAGING, V21, P375, DOI 10.1111/j.1552-6569.2010.00515.x; Janssen J, 2004, BIOL PSYCHIAT, V56, P825, DOI 10.1016/j.biopsych.2004.09.011; Kaymak SU, 2010, EUR ARCH PSY CLIN N, V260, P217, DOI 10.1007/s00406-009-0045-x; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim AJ, 2008, PSYCHIAT RES-NEUROIM, V164, P114, DOI 10.1016/j.pscychresns.2007.12.020; Klein Hofmeijer-Sevink M, 2012, J AFFECT DISORD; Konrad C, 2009, NEUROIMAGE, V47, P1185, DOI 10.1016/j.neuroimage.2009.05.019; Koolschijn PCMP, 2010, EUR NEUROPSYCHOPHARM, V20, P398, DOI 10.1016/j.euroneuro.2010.02.010; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kronenberg G, 2009, J PSYCHIATR RES, V43, P1112, DOI 10.1016/j.jpsychires.2009.03.007; Kronmuller KT, 2009, PSYCHIAT RES-NEUROIM, V174, P62, DOI 10.1016/j.pscychresns.2008.08.001; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Kurth F, 2010, CEREB CORTEX, V20, P1448, DOI 10.1093/cercor/bhp208; Lai CH, 2013, PSYCHIAT RES-NEUROIM, V211, P37, DOI 10.1016/j.pscychresns.2012.06.006; Lai CH, 2010, EUR NEUROPSYCHOPHARM, V20, P676, DOI 10.1016/j.euroneuro.2010.06.002; Lange C, 2004, PSYCHOL MED, V34, P1059, DOI 10.1017/S0033291703001806; Lee HY, 2011, J AFFECT DISORDERS, V133, P128, DOI 10.1016/j.jad.2011.04.006; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Lorenzetti V, 2010, J AFFECT DISORDERS, V120, P112, DOI 10.1016/j.jad.2009.04.021; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; MacQueen GM, 2008, BIOL PSYCHIAT, V64, P880, DOI 10.1016/j.biopsych.2008.06.027; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Malykhin NV, 2012, J AFFECT DISORDERS, V136, P1104, DOI 10.1016/j.jad.2011.10.038; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Manji HK, 2000, BIOL PSYCHIAT, V48, P740, DOI 10.1016/S0006-3223(00)00979-3; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Mervaala E, 2000, PSYCHOL MED, V30, P117, DOI 10.1017/S0033291799001567; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Munn MA, 2007, BIOL PSYCHIAT, V62, P415, DOI 10.1016/j.biopsych.2006.11.031; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Nordanskog P, 2010, J ECT, V26, P62, DOI 10.1097/YCT.0b013e3181a95da8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel MX, 2013, SCHIZOPHR RES, V149, P141, DOI 10.1016/j.schres.2013.06.030; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Perico CD, 2011, BIPOLAR DISORD, V13, P28, DOI 10.1111/j.1399-5618.2011.00896.x; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Sacher J, 2011, J AFFECT DISORD; Sackeim HA, 2001, J CLIN PSYCHIAT, V62, pS10; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saylam C, 2006, SURG RADIOL ANAT, V28, P82, DOI 10.1007/s00276-005-0050-3; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Schindler S, 2012, PSYCHIAT RES-NEUROIM, V201, P1, DOI 10.1016/j.pscychresns.2011.06.005; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Sheline YI, 1999, J NEUROSCI, V19, P5034; Sheline YI, 2011, BIOL PSYCHIAT, V70, P308, DOI 10.1016/j.biopsych.2011.06.006; Shelley BP, 2004, WORLD J BIOL PSYCHIA, V5, P176, DOI 10.1080/15622970410029933; Sliz D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00323; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Sprengelmeyer R, 2011, J AFFECT DISORDERS, V133, P120, DOI 10.1016/j.jad.2011.04.004; Stephani C, 2011, BRAIN STRUCT FUNCT, V216, P137, DOI 10.1007/s00429-010-0296-3; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Takahashi T, 2010, J AFFECT DISORDERS, V121, P231, DOI 10.1016/j.jad.2009.06.003; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Treadway MT, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004887, 10.1371/journal.pone.0006598]; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vakili K, 2000, BIOL PSYCHIAT, V47, P1087, DOI 10.1016/S0006-3223(99)00296-6; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Vasic N, 2008, J AFFECT DISORDERS, V109, P107, DOI 10.1016/j.jad.2007.11.011; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Wagner G, 2011, NEUROIMAGE, V54, P1607, DOI 10.1016/j.neuroimage.2010.08.082; Weniger G, 2006, J AFFECT DISORDERS, V94, P219, DOI 10.1016/j.jad.2006.04.017; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; World Health Organization, 2008, GLOBAL BURDEN DIS; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang X, 2011, J AFFECT DISORD; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014	129	102	106	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102692	10.1371/journal.pone.0102692	http://dx.doi.org/10.1371/journal.pone.0102692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051163	gold, Green Published, Green Submitted			2022-12-27	WOS:000339551100050
J	Ariza, A; Kaartvedt, S; Rostad, A; Garijo, JC; Aristegui, J; Fraile-Nuez, E; Hernandez-Leon, S				Ariza, Alejandro; Kaartvedt, Stein; Rostad, Anders; Carlos Garijo, Juan; Aristegui, Javier; Fraile-Nuez, Eugenio; Hernandez-Leon, Santiago			The Submarine Volcano Eruption off El Hierro Island: Effects on the Scattering Migrant Biota and the Evolution of the Pelagic Communities	PLOS ONE			English	Article							DIEL VERTICAL MIGRATIONS; CANARY-ISLANDS; ZOOPLANKTON BIOMASS; OXYGEN-CONSUMPTION; MIDWATER FISHES; CARBON; ZONE; MESOZOOPLANKTON; MYCTOPHIDAE; MICRONEKTON	The submarine volcano eruption off El Hierro Island (Canary Islands) on 10 October 2011 promoted dramatic perturbation of the water column leading to changes in the distribution of pelagic fauna. To study the response of the scattering biota, we combined acoustic data with hydrographic profiles and concurrent sea surface turbidity indexes from satellite imagery. We also monitored changes in the plankton and nekton communities through the eruptive and post-eruptive phases. Decrease of oxygen, acidification, rising temperature and deposition of chemicals in shallow waters resulted in a reduction of epipelagic stocks and a disruption of diel vertical migration (nocturnal ascent) of mesopelagic organisms. Furthermore, decreased light levels at depth caused by extinction in the volcanic plume resulted in a significant shallowing of the deep acoustic scattering layer. Once the eruption ceased, the distribution and abundances of the pelagic biota returned to baseline levels. There was no evidence of a volcano-induced bloom in the plankton community.	[Ariza, Alejandro; Carlos Garijo, Juan; Aristegui, Javier; Hernandez-Leon, Santiago] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Las Palmas Gran Canaria, Canary Islands, Spain; [Kaartvedt, Stein; Rostad, Anders] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Makkah, Saudi Arabia; [Fraile-Nuez, Eugenio] Ctr Oceanog Canarias, Inst Espanol Oceanog, Santa Cruz De Tenerife, Canary Islands, Spain	Universidad de Las Palmas de Gran Canaria; King Abdullah University of Science & Technology; Spanish Institute of Oceanography	Ariza, A (corresponding author), Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Las Palmas Gran Canaria, Canary Islands, Spain.	avariza@ulpgc.es	Nuez, Eugenio Fraile/R-2258-2019; Fraile-Nuez, Eugenio/D-1521-2010; Ariza, Alejandro/O-6180-2016; Arístegui, Javier/D-5833-2013; Hernández-León, Santiago/M-2563-2014	Nuez, Eugenio Fraile/0000-0003-4250-4445; Fraile-Nuez, Eugenio/0000-0003-4250-4445; Arístegui, Javier/0000-0002-7526-7741; Ariza, Alejandro/0000-0001-7864-4381; Rostad, Anders/0000-0002-2512-9033; Hernandez-Leon, Santiago/0000-0002-3085-4969	Instituto de Oceanografia y Cambio Global (IOCAG); Instituto Espanol de Oceanografia (IEO); MAFIA [CTM2012-39587]; CETOBAPH [CGL2009-13112)]; Spanish Ministry of Science and Innovation [BES2009-028908]	Instituto de Oceanografia y Cambio Global (IOCAG); Instituto Espanol de Oceanografia (IEO); MAFIA; CETOBAPH; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was suported by the Instituto de Oceanografia y Cambio Global (IOCAG) and the Instituto Espanol de Oceanografia (IEO). This work was also funded by projects MAFIA (CTM2012-39587) and CETOBAPH (CGL2009-13112). A. Ariza was supported by a postgraduate grant from the Spanish Ministry of Science and Innovation (BES2009-028908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel MV, 2000, HYDROBIOLOGIA, V440, P161, DOI 10.1023/A:1004115010030; Aristegui J, 1997, DEEP-SEA RES PT I, V44, P71, DOI 10.1016/S0967-0637(96)00093-3; Aristegui J, 2001, SCI MAR, V65, P51, DOI 10.3989/scimar.2001.65s151; Arranz P, 2007, THESIS U LAS PALMAS; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; BALINO BM, 1993, MAR ECOL PROG SER, V102, P35, DOI 10.3354/meps102035; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Boden BP, 1967, S ZOOL SOC LOND, V19; Bordes F., 2009, CATALOGO ESPECIES ME; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CLARKE GL, 1956, DEEP-SEA RES, V4, P1; Claustre H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014056; Davenport R, 2002, DEEP-SEA RES PT II, V49, P3481, DOI 10.1016/S0967-0645(02)00095-4; Davison PC, 2013, PROG OCEANOGR, V116, P14, DOI 10.1016/j.pocean.2013.05.013; DIETZ RS, 1948, J MAR RES, V7, P430; DONNELLY J, 1988, MAR BIOL, V97, P483, DOI 10.1007/BF00391044; DOTY M. S., 1956, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V22, P33; Doxaran D, 2009, ESTUAR COAST SHELF S, V81, P321, DOI 10.1016/j.ecss.2008.11.013; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Foote K, 1987, 144 ICES; Fraile-Nuez E, 2012, SCI REPORTS, V2; Grosjean P, 2007, ZOO PHYTOIMAGE VERSI; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hamme RC, 2010, GEOPHYS RES LETT, V37; Hernandez-Leon S, 2004, MAR BIOL, V145, P1191, DOI 10.1007/s00227-004-1396-5; Hernandez-Leon S, 2007, PROG OCEANOGR, V74, P397, DOI 10.1016/j.pocean.2007.04.010; HERNANDEZLEON S, 1988, J PLANKTON RES, V10, P1141, DOI 10.1093/plankt/10.6.1141; Hidaka K, 2001, DEEP-SEA RES PT I, V48, P1923, DOI 10.1016/S0967-0637(01)00003-6; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Kaartvedt S, 1996, MAR ECOL PROG SER, V136, P51, DOI 10.3354/meps136051; Kaartvedt S, 2012, MAR ECOL PROG SER, V452, P1, DOI 10.3354/meps09688; Korneliussen RJ, 2000, ICES J MAR SCI, V57, P1204, DOI 10.1006/jmsc.2000.0806; Korneliussen RJ, 2009, ICES J MAR SCI, V66, P1111, DOI 10.1093/icesjms/fsp119; Lehette P, 2009, LIMNOL OCEANOGR-METH, V7, P304, DOI 10.4319/lom.2009.7.304; Lin II, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003758; Lopes AR, 2013, DEEP SEA RES 1; Love RH, 2004, DEEP-SEA RES PT I, V51, P1, DOI 10.1016/j.dsr.2003.09.004; MacLennan D.N., 1992, SPRINGER SCI BUS MED; Mantas VM, 2011, REMOTE SENS ENVIRON, V115, P1341, DOI 10.1016/j.rse.2011.01.014; Nechad B, 2010, REMOTE SENS ENVIRON, V114, P854, DOI 10.1016/j.rse.2009.11.022; NEILSON JD, 1990, ADV MAR BIOL, V26, P115, DOI 10.1016/S0065-2881(08)60200-X; Olgun N, 2013, MAR ECOL PROG SER, V488, P81, DOI 10.3354/meps10403; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; ROE HSJ, 1974, MAR BIOL, V28, P99, DOI 10.1007/BF00396301; ROE HSJ, 1983, MAR BIOL, V77, P287, DOI 10.1007/BF00395818; Santana-Casiano JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01140; Sassa C, 2010, MAR ECOL PROG SER, V407, P227, DOI 10.3354/meps08526; Schukat A, 2013, DEEP-SEA RES PT I, V75, P146, DOI 10.1016/j.dsr.2013.02.003; Simmonds J., 2005, FISHERIES ACOUSTICS; Staby A, 2011, MAR ECOL PROG SER, V422, P265, DOI 10.3354/meps08938; Stanton TK, 2000, ICES J MAR SCI, V57, P793, DOI 10.1006/jmsc.1999.0517; TORRES JJ, 1979, DEEP-SEA RES, V26, P185, DOI 10.1016/0198-0149(79)90075-X; Troupin C, 2012, OCEAN MODEL, V52-53, P90, DOI 10.1016/j.ocemod.2012.05.002; TUCKER GH, 1951, J MAR RES, V10, P215; Tuya F, 2006, CIENCIAS MARINAS, V32; UNESCO, 1994, TECHNICAL REPORT; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Wienerroither R, 2009, MAR BIOL RES, V5, P328, DOI 10.1080/17451000802478055	63	12	12	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102354	10.1371/journal.pone.0102354	http://dx.doi.org/10.1371/journal.pone.0102354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047077	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100027
J	Ishikawa, T; Abe, S; Inoue, R; Sugano, T; Watanabe, Y; Iwanaga, A; Seki, K; Honma, T; Nemoto, T; Takeda, K; Yoshida, T				Ishikawa, Toru; Abe, Satoshi; Inoue, Ryousuke; Sugano, Tomoyuki; Watanabe, Yuhsuke; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Nemoto, Takeo; Takeda, Keiko; Yoshida, Toshiaki			Predictive Factor of Local Recurrence after Balloon-Occluded TACE with Miriplatin (MPT) in Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL EMBOLIZATION; INFUSION CHEMOTHERAPY; LIPIODOL EMULSION; HEPATIC-ARTERY; MITOMYCIN-C; CHEMOEMBOLIZATION; EPIRUBICIN; ACCUMULATION; CIRRHOSIS; GROWTH	Background: Miriplatin (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC). However, rapid washout has been reported in some cases. Therefore, various methods of administration with MPT have been attempted to increase its therapeutic efficacy. One hopeful method is balloon-occluded TACE (B-TACE), but the therapeutic efficacy of B-TACE with MPT has not been evaluated. Aim: To investigate the treatment outcomes and factors involved in local recurrence after B-TACE with MPT in HCC. Methods: This study included 51 patients (55 nodules) with HCC lesions equal or less than 5 cm in diameter who underwent B-TACE with MPT between January 2012 and June 2013. Local recurrence after B-TACE with MPT and factors associated with local recurrence were evaluated. Results: The overall local recurrence rate was 11.1% at 6 months and 26.2% at 12 months. The local recurrence rate did differ significantly depending on CT values immediately after B-TACE with MPT. Multivariate analysis also showed that the CT value after B-TACE with MPT was the only factor related to local recurrence after B-TACE. Conclusions: B-TACE with MPT achieves relatively good local control of HCC. The plain CT value immediately after B-TACE with MPT is a predictive factor for local recurrence. In patients with unsatisfactory CT values, locoregional therapy or additional treatment is required.	[Ishikawa, Toru; Abe, Satoshi; Inoue, Ryousuke; Sugano, Tomoyuki; Watanabe, Yuhsuke; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Yoshida, Toshiaki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata, Japan; [Nemoto, Takeo; Takeda, Keiko] Saiseikai Niigata Daini Hosp, Dept Radiol, Niigata, Japan		Ishikawa, T (corresponding author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata, Japan.	toruishi@ngt.saiseikai.or.jp						AOYAMA K, 1992, CANCER CHEMOTH PHARM, V31, pS55, DOI 10.1007/BF00687106; COLLEONI M, 1994, ONCOL REP, V1, P1171; Hanada M, 2009, CANCER CHEMOTH PHARM, V64, P473, DOI 10.1007/s00280-008-0895-3; Hanada M, 2009, CANCER SCI, V100, P189, DOI 10.1111/j.1349-7006.2008.01010.x; ICHIDA T, 1992, CANCER CHEMOTH PHARM, V31, pS51, DOI 10.1007/BF00687105; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Ishikawa T, 2011, CANCER-AM CANCER SOC, V117, P4018, DOI 10.1002/cncr.25989; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Kishimoto S, 2003, BIOL PHARM BULL, V26, P683; MAEDA M, 1986, JPN J CANCER RES, V77, P523; MATSUI O, 1993, RADIOLOGY, V188, P79, DOI 10.1148/radiology.188.1.8390073; Miyayama S, 2012, JPN J RADIOL, V30, P263, DOI 10.1007/s11604-011-0043-6; OHNISHI K, 1984, RADIOLOGY, V152, P51, DOI 10.1148/radiology.152.1.6203138; Okita K, 2006, J GASTROENTEROL, V41, P100, DOI 10.1007/s00535-005-1763-0; Okusaka T, 2004, INVEST NEW DRUG, V22, P169, DOI 10.1023/B:DRUG.0000011793.72775.d1; SASAKI Y, 1987, CANCER, V60, P1194, DOI 10.1002/1097-0142(19870915)60:6<1194::AID-CNCR2820600607>3.0.CO;2-T; TAKAYASU K, 1987, RADIOLOGY, V163, P345, DOI 10.1148/radiology.163.2.3031724; Takayasu K, 2010, AM J ROENTGENOL, V194, P830, DOI 10.2214/AJR.09.3308; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Tohma T, 2005, RADIOLOGY, V237, P361, DOI 10.1148/radiol.2371040919; TOMMASINI M, 1986, AM J CLIN ONCOL-CANC, V9, P8, DOI 10.1097/00000421-198602000-00002; YAMADA R, 1983, RADIOLOGY, V148, P397, DOI 10.1148/radiology.148.2.6306721	22	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103009	10.1371/journal.pone.0103009	http://dx.doi.org/10.1371/journal.pone.0103009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047920	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100097
J	Matani, A; Nakayama, M; Watanabe, M; Furuyama, Y; Hotta, A; Hoshino, S				Matani, Ayumu; Nakayama, Masaaki; Watanabe, Mayumi; Furuyama, Yoshikazu; Hotta, Atsushi; Hoshino, Shotaro			Transcranial Extracellular Impedance Control (tEIC) Modulates Behavioral Performances	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; RANDOM NOISE STIMULATION; PRIMARY MOTOR CORTEX; PREFRONTAL CORTEX; ELECTRIC-FIELDS; WORKING-MEMORY; HD-TDCS; EXCITABILITY; FACILITATION; PERCEPTION	Electric brain stimulations such as transcranial direct current stimulation (tDCS), transcranial random noise stimulation (tRNS), and transcranial alternating current stimulation (tACS) electrophysiologically modulate brain activity and as a result sometimes modulate behavioral performances. These stimulations can be viewed from an engineering standpoint as involving an artificial electric source (DC, noise, or AC) attached to an impedance branch of a distributed parameter circuit. The distributed parameter circuit is an approximation of the brain and includes electric sources (neurons) and impedances (volume conductors). Such a brain model is linear, as is often the case with the electroencephalogram (EEG) forward model. Thus, the above-mentioned current stimulations change the current distribution in the brain depending on the locations of the electric sources in the brain. Now, if the attached artificial electric source were to be replaced with a resistor, or even a negative resistor, the resistor would also change the current distribution in the brain. In light of the superposition theorem, which holds for any linear electric circuit, attaching an electric source is different from attaching a resistor; the resistor affects each active electric source in the brain so as to increase (or decrease in some cases of a negative resistor) the current flowing out from each source. From an electrophysiological standpoint, the attached resistor can only control the extracellular impedance and never causes forced stimulation; we call this technique transcranial extracellular impedance control (tEIC). We conducted a behavioral experiment to evaluate tEIC and found evidence that it had real-time enhancement and depression effects on EEGs and a real-time facilitation effect on reaction times. Thus, tEIC could be another technique to modulate behavioral performance.	[Matani, Ayumu; Watanabe, Mayumi; Furuyama, Yoshikazu; Hotta, Atsushi; Hoshino, Shotaro] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Nakayama, Masaaki] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Matani, A (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan.	matani@isp.ac	Matani, Ayumu/AAB-3050-2019	Matani, Ayumu/0000-0001-5238-6898	Strategic Information and Communications R&D Promotion Programme (SCOPE); Human Frontier Science Program (HFSP)	Strategic Information and Communications R&D Promotion Programme (SCOPE); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	The research was supported by Strategic Information and Communications R&D Promotion Programme (SCOPE) and Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou CA, 2010, J NEUROSCI, V30, P1925, DOI 10.1523/JNEUROSCI.3635-09.2010; [Anonymous], [No title captured]; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00317; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Bastani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072254; Bedard C, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022709; Bikson M, 2013, FRONT NEUROSCI, P55; Bolognini N, 2011, NEUROPSYCHOLOGIA, V49, P231, DOI 10.1016/j.neuropsychologia.2010.11.015; Borckardt JJ, 2012, J PAIN, V13, P112, DOI 10.1016/j.jpain.2011.07.001; Brignani D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056589; Carter B., 2001, HDB OPERATIONAL AMPL; Chi RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016655; Chib VS, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.44; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dorf R. C., 2010, INTRO ELECT CIRCUITS, P162; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Francis JT, 2003, J NEUROSCI, V23, P7255; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jausovec N, 2014, ACTA PSYCHOL, V146, P1, DOI 10.1016/j.actpsy.2013.11.011; Jausovec N, 2014, BIOL PSYCHOL, V96, P42, DOI 10.1016/j.biopsycho.2013.11.006; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Ladeira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025399; Lafontaine MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081721; Mark Stitt R., 1990, BURR BROWN APPL B; Moliadze V, 2012, BRAIN STIMUL, V5, P505, DOI 10.1016/j.brs.2011.11.004; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Niedermeyer F., 2005, ELECTROENCEPHALOGRAP, P107; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nunez P.L., 2006, ELECT FIELDS BRAIN N, P147; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Purves D, 2013, PRINCIPLES COGNITIVE, P31; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; RICHARDSON TL, 1984, BRAIN RES, V294, P255, DOI 10.1016/0006-8993(84)91037-0; Speckmann E.-J., 2005, ELECTROENCEPHALOGRAP, P17; Struber D, 2014, BRAIN TOPOGR, V27, P158, DOI 10.1007/s10548-013-0294-x; TAYLOR CP, 1984, J NEUROPHYSIOL, V52, P126, DOI 10.1152/jn.1984.52.1.126; Terney D, 2008, J NEUROSCI, V28, P14147, DOI 10.1523/JNEUROSCI.4248-08.2008; Villamar MF, 2013, J PAIN, V14, P371, DOI 10.1016/j.jpain.2012.12.007; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	49	1	1	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102834	10.1371/journal.pone.0102834	http://dx.doi.org/10.1371/journal.pone.0102834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047913	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100077
J	Van Hemelrijck, M; Feller, A; Garmo, H; Valeri, F; Korol, D; Dehler, S; Rohrmann, S				Van Hemelrijck, Mieke; Feller, Anita; Garmo, Hans; Valeri, Fabio; Korol, Dimitri; Dehler, Silvia; Rohrmann, Sabine			Incidence of Second Malignancies for Prostate Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; RADICAL PROSTATECTOMY; RADIATION-THERAPY; PRIMARY TUMORS; RISK; BRACHYTHERAPY; ADENOCARCINOMA; DEATH	Introduction: There is a need to assess risk of second primary cancers in prostate cancer (PCa) patients, especially since PCa treatment may be associated with increased risk of second primary tumours. Methods: We calculated standardized incidence ratios (SIRs) for second primary tumours comparing men diagnosed with PCa between 1980 and 2010 in the Canton of Zurich, Switzerland (n = 20,559), and the general male population in the Canton. Results: A total of 1,718 men developed a second primary tumour after PCa diagnosis, with lung and colon cancer being the most common (15 and 13% respectively). The SIR for overall second primary cancer was 1.11 (95% CI: 1.06-1.17). Site-specific SIRs varied from 1.19 (1.05-1.34) to 2.89 (2.62-4.77) for lung and thyroid cancer, respectively. When stratified by treatment, the highest SIR was observed for thyroid cancer (3.57 (1.30-7.76)) when undergoing surgery, whereas liver cancer was common when treated with radiotherapy (3.21 (1.54-5.90)) and kidney bladder was most prevalent for those on hormonal treatment (3.15 (1.93-4.87)). Stratification by time since PCa diagnosis showed a lower risk of cancer for men with PCa compared to the general population for the first four years, but then a steep increase in risk was observed. Conclusion: In the Canton of Zurich, there was an increased risk of second primary cancers among men with PCa compared to the general population. Increased diagnostic activity after PCa diagnosis may partly explain increased risks within the first years of diagnosis, but time-stratified analyses indicated that increased risks remained and even increased over time.	[Van Hemelrijck, Mieke; Garmo, Hans] Kings Coll London, Sch Med, Canc Epidemiol Unit, Div Canc Studies, London WC2R 2LS, England; [Feller, Anita] Fdn Natl Inst Canc Epidemiol & Registrat NICER, Zurich, Switzerland; [Feller, Anita] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Valeri, Fabio; Korol, Dimitri; Dehler, Silvia] Canc Registry Zurich & Zug, Zurich, Switzerland; [Rohrmann, Sabine] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland	University of London; King's College London; University of Bern; University of Zurich	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Canc Epidemiol Unit, Div Canc Studies, London WC2R 2LS, England.	mieke.vanhemelrijck@kcl.ac.uk	Rohrmann, Sabine/D-2113-2012	Rohrmann, Sabine/0000-0002-2215-1200; Feller, Anita/0000-0002-3837-8477; Van Hemelrijck, Mieke/0000-0002-7317-0858				American Cancer Society, 2013, PROSTATE CANC; Braisch U, 2012, EUR J CANCER PREV, V21, P552, DOI 10.1097/CEJ.0b013e328351c748; Breslow NE., 1987, STAT METHODS CANC RE, P81; Dehler S, 2012, KREBSREGISTER KANTON; Eifler JB, 2012, J UROLOGY, V188, P798, DOI 10.1016/j.juro.2012.04.109; European Commission Eurostat, 2013, EUR SHORTL CAUS DEAT; Foundation National Institue for Cancer Epidemiology and Registrationm, 2014, CANC INC MORT SWITZ; Herrmann C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-287; Hinnen KA, 2011, J CLIN ONCOL, V29, P4510, DOI 10.1200/JCO.2011.35.0991; Levi F, 1999, CANCER, V86, P1567, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1567::AID-CNCR25>3.0.CO;2-Z; Margel D, 2011, ANN SURG, V254, P947, DOI 10.1097/SLA.0b013e3182382fd5; Moon K, 2006, CANCER-AM CANCER SOC, V107, P991, DOI 10.1002/cncr.22083; Murray L, 2014, RADIOTHER ONCOL; Nash GF, 2012, ANN ROY COLL SURG, V94, P456, DOI 10.1308/003588412X13373405384611; Pawlish KS, 1997, PROSTATE, V33, P75; Rapiti E, 2008, INT J CANCER, V123, P1141, DOI 10.1002/ijc.23601; Smith GD, 2000, BMJ-BRIT MED J, V321, P847, DOI 10.1136/bmj.321.7265.847; Van Hemelrijck M, 2012, CANCER-AM CANCER SOC, V118, P6207, DOI 10.1002/cncr.27672; Wallner LP, 2013, CANCER EPIDEM BIOMAR, V22, P313, DOI 10.1158/1055-9965.EPI-12-1137; Wu XF, 2004, CLIN CANCER RES, V10, P3988, DOI 10.1158/1078-0432.CCR-03-0762; Zar N, 2008, EUR J CANCER, V44, P718, DOI 10.1016/j.ejca.2007.12.003; Zelefsky MJ, 2012, BJU INT, V110, P1696, DOI 10.1111/j.1464-410X.2012.11385.x; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V83, P953, DOI 10.1016/j.ijrobp.2011.08.034	23	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102596	10.1371/journal.pone.0102596	http://dx.doi.org/10.1371/journal.pone.0102596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047238	gold, Green Published, Green Accepted			2022-12-27	WOS:000339558100049
J	Welvaert, M; Rosseel, Y				Welvaert, Marijke; Rosseel, Yves			A Review of fMRI Simulation Studies	PLOS ONE			English	Review							FUNCTIONAL MRI	Simulation studies that validate statistical techniques for fMRI data are challenging due to the complexity of the data. Therefore, it is not surprising that no common data generating process is available (i.e. several models can be found to model BOLD activation and noise). Based on a literature search, a database of simulation studies was compiled. The information in this database was analysed and critically evaluated focusing on the parameters in the simulation design, the adopted model to generate fMRI data, and on how the simulation studies are reported. Our literature analysis demonstrates that many fMRI simulation studies do not report a thorough experimental design and almost consistently ignore crucial knowledge on how fMRI data are acquired. Advice is provided on how the quality of fMRI simulation studies can be improved.	[Welvaert, Marijke; Rosseel, Yves] Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium	Ghent University	Welvaert, M (corresponding author), Univ Ghent, Dept Data Anal, B-9000 Ghent, Belgium.	Marijke.Welvaert@csiro.au	Welvaert, Marijke/K-8486-2013; Welvaert, Marijke/GOE-6151-2022	Welvaert, Marijke/0000-0002-0802-8134; Rosseel, Yves/0000-0002-4129-4477				Backfrieder W, 1996, PHYS MED BIOL, V41, P1425, DOI 10.1088/0031-9155/41/8/011; Bandettini PA, 2012, NEUROIMAGE, V62, P575, DOI 10.1016/j.neuroimage.2012.04.026; Bellec P, 2009, MAGN RESON IMAGING, V27, P1382, DOI 10.1016/j.mri.2009.05.034; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brosch JR, 2002, IEEE T BIO-MED ENG, V49, P700, DOI 10.1109/TBME.2002.1010854; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Erhardt EB, 2012, NEUROIMAGE, V59, P4160, DOI 10.1016/j.neuroimage.2011.11.088; Fadili MJ, 2001, MED IMAGE ANAL, V5, P55, DOI 10.1016/S1361-8415(00)00035-9; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Greve DN, 2013, PSYCHOMETRIKA, V78, P396, DOI [10.1007/S11336-012-9294-0, 10.1007/s11336-012-9294-0]; Handwerker DA, 2012, NEUROIMAGE, V62, P1017, DOI 10.1016/j.neuroimage.2012.02.015; Johnston LA, 2008, NEUROIMAGE, V40, P504, DOI 10.1016/j.neuroimage.2007.11.024; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Park J, 2012, NEUROIMAGE, V59, P1132, DOI 10.1016/j.neuroimage.2011.06.066; Penny WD, 2012, NEUROIMAGE, V59, P319, DOI 10.1016/j.neuroimage.2011.07.039; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Skrondal A, 2000, MULTIVAR BEHAV RES, V35, P137, DOI 10.1207/S15327906MBR3502_1; Sturzbecher MJ, 2009, PHYS MED BIOL, V54, P161, DOI 10.1088/0031-9155/54/1/011	25	27	28	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e101953	10.1371/journal.pone.0101953	http://dx.doi.org/10.1371/journal.pone.0101953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048024	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100017
J	Alvarez, GG; VanDyk, DD; Aaron, SD; Cameron, DW; Davies, N; Stephen, N; Mallick, R; Momoli, F; Moreau, K; Obed, N; Baikie, M; Osborne, G				Alvarez, Gonzalo G.; VanDyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Davies, Naomi; Stephen, Natasha; Mallick, Ranjeeta; Momoli, Franco; Moreau, Katherine; Obed, Natan; Baikie, Maureen; Osborne, Geraldine			TAIMA (Stop) TB: The Impact of a Multifaceted TB Awareness and Door-to-Door Campaign in Residential Areas of High Risk for TB in Iqaluit, Nunavut	PLOS ONE			English	Article							TUBERCULOSIS TRANSMISSION; METAANALYSIS; COMMUNITIES; MARIJUANA; SMOKING	Background: The incidence rate of active tuberculosis (TB) disease in the Canadian Territory of Nunavut has shown a rising trend over the past 10 years. In 2010 it was 60 times greater than the national incidence rate. The objective of the Taima (translates to "stop'' in Inuktitut) TB study was to implement and evaluate a public health campaign to enhance existing TB prevention efforts in Nunavut. Methods: A TB awareness campaign followed by a door-to-door screening campaign was carried out in Iqaluit, Nunavut. The aim of the campaign was to raise awareness about TB, and to provide in-home screening and treatment for people living in residential areas at high risk for TB. Screening was based on geographic location rather than on individual risk factors. Results: During the general awareness campaign an increase in the number of people who requested TB testing at the local public health clinic was observed. However, this increase was not sustained following cessation of the awareness campaign. Targeted TB screening in high risk residential areas in Iqaluit resulted in 224 individuals having TSTs read, and detection of 42 previously unidentified cases of latent TB, (overall yield of 18.8% or number needed to screen = 5.3). These cases of latent TB infection (LTBI) were extra cases that had not been picked up by traditional screening practices (34% relative increase within the community). This resulted in a 33% relative increase in the completion of LTBI treatment within the community. The program directly and indirectly identified 5/17 new cases of active TB disease in Iqaluit during the study period (29.5% of all incident cases). Conclusions: While contact tracing investigations remain a cornerstone of TB prevention, additional awareness, screening, and treatment programs like Taima TB may contribute to the successful control of TB in Aboriginal communities.	[Alvarez, Gonzalo G.; VanDyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Mallick, Ranjeeta; Momoli, Franco] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Aaron, Shawn D.; Cameron, D. William; Mallick, Ranjeeta; Momoli, Franco; Moreau, Katherine] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Aaron, Shawn D.; Cameron, D. William] Ottawa Hosp, Dept Med, Div Respirol, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Aaron, Shawn D.; Cameron, D. William] Ottawa Hosp, Dept Med, Div Infect Dis, Ottawa, ON, Canada; [Momoli, Franco; Moreau, Katherine] Childrens Hosp Eastern Ontario, Res Inst, Ctr Practice Changing Res, Ottawa, ON K1H 8L1, Canada; [Obed, Natan] Nunavut Tunngavik Inc, Dept Social & Cultural Dev, Iqaluit, NU, Canada; [Davies, Naomi; Stephen, Natasha; Baikie, Maureen; Osborne, Geraldine] Govt Nunavut, Dept Hlth, Iqaluit, NU, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Alvarez, GG (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	galvarez@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Aaron, Shawn/0000-0002-4762-3542; Alvarez, Gonzalo G/0000-0003-1562-5305	Public Health Agency of Canada; National Lung Health Framework	Public Health Agency of Canada; National Lung Health Framework	Funding was provided by the Public Health Agency of Canada, and the National Lung Health Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Boffa J, 2011, SOC SCI MED, V72, P733, DOI 10.1016/j.socscimed.2010.10.033; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; Cain KP, 2012, AM J RESP CRIT CARE, V186, P273, DOI 10.1164/rccm.201111-2076OC; Cegielski JP, 2014, AM J PUBLIC HEALTH, V104, pS225, DOI [10.2105/AJPH.2012.300781, 10.2105/AJPH.2012.300781r]; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; Cook VJ, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18643; Egeland GM, 2011, CAN MED ASSOC J, V183, P1022, DOI 10.1503/cmaj.101801; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Godoy P, 2013, INT J TUBERC LUNG D, V17, P771, DOI 10.5588/ijtld.12.0696; GRZYBOWSKI S, 1976, Bulletin of the International Union Against Tuberculosis, V51, P181; Halverson J EE, 2013, CANADIAN RESP J, V20, p3A; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2013, CANADIAN RESP J, V20; Moonan PK, 2006, AM J RESP CRIT CARE, V174, P599, DOI 10.1164/rccm.200512-1977OC; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; Public Health Agency of Canada, 2012, TUB CAN 2010 PRER; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Soborg B, 2010, EUR RESPIR J, V36, P878, DOI 10.1183/09031936.00015510; Statistics Canada, 2010, AN HOUS NEEDS NUN NU; Tait H, 2006, IN HLTH SOC COND; Tan WC, 2009, CAN MED ASSOC J, V180, P814, DOI 10.1503/cmaj.081040; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156	25	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100975	10.1371/journal.pone.0100975	http://dx.doi.org/10.1371/journal.pone.0100975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033320	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300012
J	Del Pino, F; Jara, C; Pino, L; Godoy-Herrera, R				Del Pino, Francisco; Jara, Claudia; Pino, Luis; Godoy-Herrera, Raul			The Neuro-Ecology of Drosophila Pupation Behavior	PLOS ONE			English	Article							LARVA; GENE	Many species of Drosophila form conspecific pupa aggregations across the breeding sites. These aggregations could result from species-specific larval odor recognition. To test this hypothesis we used larval odors of D. melanogaster and D. pavani, two species that coexist in the nature. When stimulated by those odors, wild type and vestigial (vg) third-instar larvae of D. melanogaster pupated on conspecific larval odors, but individuals deficient in the expression of the odor co-receptor Orco randomly pupated across the substrate, indicating that in this species, olfaction plays a role in pupation site selection. Larvae are unable to learn but can smell, the Syn(97CS) and rut strains of D. melanogaster, did not respond to conspecific odors or D. pavani larval cues, and they randomly pupated across the substrate, suggesting that larval odor-based learning could influence the pupation site selection. Thus, Orco, Syn(97CS) and rut loci participated in the pupation site selection. When stimulated by conspecific and D. melanogaster larval cues, D. pavani larvae also pupated on conspecific odors. The larvae of D. gaucha, a sibling species of D. pavani, did not respond to D. melanogaster larval cues, pupating randomly across the substrate. In nature, D. gaucha is isolated from D. melanogaster. Interspecific hybrids, which result from crossing pavani female with gaucha males clumped their pupae similarly to D. pavani, but the behavior of gaucha female x pavani male hybrids was similar to D. gaucha parent. The two sibling species show substantial evolutionary divergence in organization and functioning of larval nervous system. D. melanogaster and D. pavani larvae extracted information about odor identities and the spatial location of congener and alien larvae to select pupation sites. We hypothesize that larval recognition contributes to the cohabitation of species with similar ecologies, thus aiding the organization and persistence of Drosophila species guilds in the wild.	[Del Pino, Francisco; Jara, Claudia; Pino, Luis; Godoy-Herrera, Raul] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile	Universidad de Chile	Godoy-Herrera, R (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile.	raulgodoy.herrera@gmail.com	Corrêa, Marcio N Nunes/D-1034-2019	Corrêa, Marcio N Nunes/0000-0003-0855-2750	Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) [1100110]	Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The work was supported by Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) No 1100110. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Ashburner M, 2004, DROSOPHILA LAB HDB, P934; BARKER JSF, 1981, AUST J BIOL SCI, V34, P613, DOI 10.1071/BI9810613; Beltrami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039393; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Borenstein E, 2008, EVOLUTION, V62, P586, DOI 10.1111/j.1558-5646.2007.00313.x; BRNCIC D, 1957, EVOLUTION, V11, P300, DOI 10.2307/2405794; Brncic D, 1957, ESPECIES CHILENAS DR; BRNCIC D, 1970, ESSAYS EVOLUTION GEN, P401; Burdick A. B., 1954, DROSOPH INF SERV, V28, P170; Carson H.L., 1971, LYON ARBORETUM LECT, V2; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Dukas R, 1999, BEHAV ECOL SOCIOBIOL, V45, P195, DOI 10.1007/s002650050553; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; FOSTER JLM, 1993, APPL ENVIRON MICROB, V59, P1; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Godoy-Herrera R, 2005, GENETICA, V124, P33, DOI 10.1007/s10709-004-5913-8; GODOYHERRERA R, 1994, BEHAV GENET, V24, P427, DOI 10.1007/BF01076178; Hoare DJ, 2008, J NEUROSCI, V28, P9710, DOI 10.1523/JNEUROSCI.1955-08.2008; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Iyengar A, 2010, P NATL ACAD SCI USA, V107, P9855, DOI 10.1073/pnas.1003856107; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Labeur C, 2002, GENETICA, V114, P269, DOI 10.1023/A:1016223000650; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow Therese A., 2006, P235, DOI 10.1016/B978-012473052-6/50011-1; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Powell J. R., 1997, PROGR PROSPECTS EVOL; RodriguezGirones MA, 1997, THEOR POPUL BIOL, V52, P32, DOI 10.1006/tpbi.1997.1317; Saumweber T, 2011, CHEM SENSES, V36, P223, DOI 10.1093/chemse/bjq128; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9	38	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102159	10.1371/journal.pone.0102159	http://dx.doi.org/10.1371/journal.pone.0102159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033294	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300036
J	Ferrer, MF; Scharrig, E; Alberdi, L; Cedola, M; Pretre, G; Drut, R; Song, WC; Gomez, RM				Ferrer, Maria F.; Scharrig, Emilia; Alberdi, Lucrecia; Cedola, Maia; Pretre, Gabriela; Drut, Ricardo; Song, Wen-Chao; Gomez, Ricardo M.			Decay-Accelerating Factor 1 Deficiency Exacerbates Leptospiral-Induced Murine Chronic Nephritis and Renal Fibrosis	PLOS ONE			English	Article							T-CELL IMMUNITY; CHRONIC KIDNEY-DISEASE; NITRIC-OXIDE SYNTHASE; AUTOIMMUNE-DISEASE; MEMBRANE-PROTEINS; GENE-EXPRESSION; IN-VIVO; MICE; COMPLEMENT; INTERROGANS	Leptospirosis is a global zoonosis caused by pathogenic Leptospira, which can colonize the proximal renal tubules and persist for long periods in the kidneys of infected hosts. Here, we characterized the infection of C57BL/6J wild-type and Daf1(-/-) mice, which have an enhanced host response, with a virulent Leptospira interrogans strain at 14 days post-infection, its persistence in the kidney, and its link to kidney fibrosis at 90 days post-infection. We found that Leptospira interrogans can induce acute moderate nephritis in wild-type mice and is able to persist in some animals, inducing fibrosis in the absence of mortality. In contrast, Daf1(-/-) mice showed acute mortality, with a higher bacterial burden. At the chronic stage, Daf1(-/-) mice showed greater inflammation and fibrosis than at 14 days post-infection and higher levels at all times than the wild-type counterpart. Compared with uninfected mice, infected wild-type mice showed higher levels of IL-4, IL-10 and IL-13, with similar levels of alpha-smooth muscle actin, galectin-3, TGF-beta 1, IL-17, IFN-gamma, and lower IL-12 levels at 90 days post-infection. In contrast, fibrosis in Daf1(-/-) mice was accompanied by high expression of a-smooth muscle actin, galectin-3, IL10, IL-13, and IFN-gamma, similar levels of TGF-beta 1, IL-12, and IL-17 and lower IL-4 levels. This study demonstrates the link between Leptospira-induced murine chronic nephritis with renal fibrosis and shows a protective role of Daf1.	[Ferrer, Maria F.; Scharrig, Emilia; Alberdi, Lucrecia; Cedola, Maia; Pretre, Gabriela; Gomez, Ricardo M.] CONICET UNLP, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina; [Drut, Ricardo] UNLP, Fac Med, Catedra Patol A, La Plata, Buenos Aires, Argentina; [Song, Wen-Chao] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Pennsylvania; Pennsylvania Medicine	Gomez, RM (corresponding author), CONICET UNLP, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina.	rmg1426@gmail.com	Gomez, Ricardo M/AAG-9555-2019; alberdi, maria lucrecia/P-5916-2016	Gomez, Ricardo M/0000-0002-4001-519X; alberdi, maria lucrecia/0000-0001-9421-3311; PRETRE, GABRIELA/0000-0002-0428-1570; Scharrig, Emilia/0000-0003-2599-5297; Ferrer, Maria F/0000-0003-2171-2990	Universidad Nacional de La Plata [X592]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 07-00642, 07-00028, 12-0434]	Universidad Nacional de La Plata(National University of La Plata); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from Universidad Nacional de La Plata (X592), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) PICT 07-00642, 07-00028 and 12-0434 (RMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER B, 1976, INFECT IMMUN, V14, P703, DOI 10.1128/IAI.14.3.703-708.1976; An FQ, 2009, INVEST OPHTH VIS SCI, V50, P3778, DOI 10.1167/iovs.08-3264; Atasoyu EM, 2005, NEPHROL DIAL TRANSPL, V20, P2290, DOI 10.1093/ndt/gfi014; Athanazio DA, 2008, ACTA TROP, V105, P95, DOI 10.1016/j.actatropica.2007.09.004; Bandeira M, 2011, INFECT IMMUN, V79, P2936, DOI 10.1128/IAI.05099-11; Bani-Ahmad M, 2011, CLIN EXP IMMUNOL, V163, P199, DOI 10.1111/j.1365-2249.2010.04284.x; Bao LH, 2009, J CLIN INVEST, V119, P1264, DOI 10.1172/JCI36000; Cauvi DM, 2012, IMMUNOLOGY, V135, P333, DOI 10.1111/j.1365-2567.2011.03545.x; Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506; Conway B, 2012, QJM-INT J MED, V105, P611, DOI 10.1093/qjmed/hcr235; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fang CY, 2007, J IMMUNOL, V179, P3178, DOI 10.4049/jimmunol.179.5.3178; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612; GOMEZ RM, 1992, INT J EXP PATHOL, V73, P643; GOMEZ RM, 1991, J MED VIROL, V35, P71, DOI 10.1002/jmv.1890350202; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hung CC, 2006, NEPHROL DIAL TRANSPL, V21, P898, DOI 10.1093/ndt/gfi316; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Lesher AM, 2010, NEPHROLOGY, V15, P663, DOI 10.1111/j.1440-1797.2010.01373.x; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LIU FT, 1995, AM J PATHOL, V147, P1016; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154; Matsui M, 2011, INFECT IMMUN, V79, P4480, DOI 10.1128/IAI.05727-11; Miwa T, 2002, AM J PATHOL, V161, P1077, DOI 10.1016/S0002-9440(10)64268-X; Miwa T, 2007, AM J PATHOL, V170, P1258, DOI 10.2353/ajpath.2007.060601; Monahan AM, 2009, VET PATHOL, V46, P792, DOI 10.1354/vp.08-VP-0265-N-REV; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Noguchi H, 1918, J EXP MED, V28, P561, DOI 10.1084/jem.28.5.561; PENNA D, 1963, AM J TROP MED HYG, V12, P896, DOI 10.4269/ajtmh.1963.12.896; Pereira MM, 1998, EXP TOXICOL PATHOL, V50, P191, DOI 10.1016/S0940-2993(98)80083-3; Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6; Pretre G, 2013, MICROB PATHOGENESIS, V56, P21, DOI 10.1016/j.micpath.2012.10.002; Pretre G, 2011, MICROB PATHOGENESIS, V51, P203, DOI 10.1016/j.micpath.2011.03.011; Rana T, 2014, J INFECT DIS, V209, P1066, DOI 10.1093/infdis/jit619; Randall R, 1944, SCIENCE, V100, P133, DOI 10.1126/science.100.2589.133; Santos CS, 2010, J MED MICROBIOL, V59, P1101, DOI 10.1099/jmm.0.021089-0; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Solana ME, 2012, MUSCLE NERVE, V46, P582, DOI 10.1002/mus.23347; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Tian YC, 2006, J AM SOC NEPHROL, V17, P2792, DOI 10.1681/ASN.2006020159; Veninga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024431; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636	64	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102860	10.1371/journal.pone.0102860	http://dx.doi.org/10.1371/journal.pone.0102860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032961	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300105
J	Jordan, TR; Sheen, M; Abedipour, L; Paterson, KB				Jordan, Timothy R.; Sheen, Mercedes; Abedipour, Lily; Paterson, Kevin B.			Visual Speech Perception in Foveal and Extrafoveal Vision: Further Implications for Divisions in Hemispheric Projections	PLOS ONE			English	Article							LATERALIZED WORD RECOGNITION; SPLIT-FOVEA; INTERHEMISPHERIC COMMUNICATION; RETINAL ECCENTRICITY; NASOTEMPORAL OVERLAP; CEREBRAL ASYMMETRY; MOUTH ASYMMETRY; FIELD ADVANTAGE; MOVING FACES; REPRESENTATION	When observing a talking face, it has often been argued that visual speech to the left and right of fixation may produce differences in performance due to divided projections to the two cerebral hemispheres. However, while it seems likely that such a division in hemispheric projections exists for areas away from fixation, the nature and existence of a functional division in visual speech perception at the foveal midline remains to be determined. We investigated this issue by presenting visual speech in matched hemiface displays to the left and right of a central fixation point, either exactly abutting the foveal midline or else located away from the midline in extrafoveal vision. The location of displays relative to the foveal midline was controlled precisely using an automated, gaze-contingent eye-tracking procedure. Visual speech perception showed a clear right hemifield advantage when presented in extrafoveal locations but no hemifield advantage (left or right) when presented abutting the foveal midline. Thus, while visual speech observed in extrafoveal vision appears to benefit from unilateral projections to left-hemisphere processes, no evidence was obtained to indicate that a functional division exists when visual speech is observed around the point of fixation. Implications of these findings for understanding visual speech perception and the nature of functional divisions in hemispheric projection are discussed.	[Jordan, Timothy R.; Sheen, Mercedes] Zayed Univ, Dept Psychol, Dubai, U Arab Emirates; [Abedipour, Lily; Paterson, Kevin B.] Univ Leicester, Dept Psychol, Leicester LE1 7RH, Leics, England	Zayed University; University of Leicester	Jordan, TR (corresponding author), Zayed Univ, Dept Psychol, Dubai, U Arab Emirates.	Timothy.Jordan@zu.ac.ae		Paterson, Kevin/0000-0002-8150-8628	Ulverscroft Foundation; BA Mid-Career Fellowship; ERF Professorial Fellowship	Ulverscroft Foundation; BA Mid-Career Fellowship; ERF Professorial Fellowship	This research was funded by the Ulverscroft Foundation, an ERF Professorial Fellowship to Tim Jordan, and a BA Mid-Career Fellowship to Kevin Paterson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almabruk AAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018131; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; BENNETT HL, 1987, NEUROPSYCHOLOGIA, V25, P681, DOI 10.1016/0028-3932(87)90059-5; Bourne VJ, 2006, LATERALITY, V11, P373, DOI 10.1080/13576500600633982; Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; BRYSBAERT M, 1994, BEHAV BRAIN RES, V64, P151, DOI 10.1016/0166-4328(94)90127-9; Brysbaert M, 1996, NEUROPSYCHOLOGY, V10, P385, DOI 10.1037/0894-4105.10.3.385; BUNT AH, 1977, J COMP NEUROL, V171, P619, DOI 10.1002/cne.901710412; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CAMPBELL R, 1986, BRAIN COGNITION, V5, P1, DOI 10.1016/0278-2626(86)90059-X; CAMPBELL R, 1982, BRIT J PSYCHOL, V73, P95, DOI 10.1111/j.2044-8295.1982.tb01794.x; Carbary TJ, 1999, BRAIN COGNITION, V40, P71; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; DRASDO N, 1977, NATURE, V266, P554, DOI 10.1038/266554a0; Ellis AW, 2010, NEUROPSYCHOLOGIA, V48, P353, DOI 10.1016/j.neuropsychologia.2009.08.021; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; Fendrich R, 1996, NEUROPSYCHOLOGIA, V34, P637, DOI 10.1016/0028-3932(95)00155-7; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; GRAVES R, 1983, NEUROPSYCHOLOGIA, V21, P641, DOI 10.1016/0028-3932(83)90062-3; GRAVES R, 1982, NEUROPSYCHOLOGIA, V20, P371, DOI 10.1016/0028-3932(82)90037-9; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hunter ZR, 2007, J COGNITIVE NEUROSCI, V19, P1373, DOI 10.1162/jocn.2007.19.8.1373; Jordan TR, 2008, NEUROPSYCHOLOGY, V22, P738, DOI 10.1037/a0013140; Jordan TR, 2007, NEUROPSYCHOLOGY, V21, P721, DOI 10.1037/0894-4105.21.6.721; Jordan TR, 2011, ATTEN PERCEPT PSYCHO, V73, P2270, DOI 10.3758/s13414-011-0152-4; Jordan TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023957; Jordan TR, 2011, CORTEX, V47, P992, DOI 10.1016/j.cortex.2011.02.012; Jordan TR, 2010, NEUROPSYCHOLOGIA, V48, P2782, DOI 10.1016/j.neuropsychologia.2010.04.029; Jordan TR, 2010, CORTEX, V46, P298, DOI 10.1016/j.cortex.2009.01.008; Jordan TR, 2010, CORTEX, V46, P100, DOI 10.1016/j.cortex.2008.10.008; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2004, DOI 10.1016/j.neuropsychologia.2008.12.014; Jordan TR, 2009, CORTEX, V45, P495, DOI 10.1016/j.cortex.2007.07.007; Jordan TR, 2009, COGN AFFECT BEHAV NE, V9, P113, DOI 10.3758/CABN.9.1.113; Jordan TR, 2000, LANG SPEECH, V43, P107, DOI 10.1177/00238309000430010401; Jordan TR, 2000, PERCEPT PSYCHOPHYS, V62, P1394, DOI 10.3758/BF03212141; Jordan TR, 1998, Q J EXP PSYCHOL-A, V51, P371, DOI 10.1080/713755764; Jordan TR, 2006, NEUROPSYCHOLOGIA, V44, P686, DOI 10.1016/j.neuropsychologia.2005.08.008; Jordan TR, 2003, COGN NEUROPSYCHOL, V20, P81, DOI 10.1080/02643290244000202; Jordan TR, 2003, COGN NEUROPSYCHOL, V20, P49, DOI 10.1080/02643290244000185; Jordan TR, 2001, J EXP PSYCHOL HUMAN, V27, P1386, DOI 10.1037//0096-1523.27.6.1386; Jordan TR, 2000, J EXP PSYCHOL HUMAN, V26, P1192, DOI 10.1037/0096-1523.26.3.1192; Jordan TR, 1998, HEARING EYE 2, P155; Lavidor M, 2004, NAT REV NEUROSCI, V5, P729, DOI 10.1038/nrn1498; Lavidor M, 2001, COGNITIVE BRAIN RES, V12, P265, DOI 10.1016/S0926-6410(01)00056-8; LEVENTHAL AG, 1988, SCIENCE, V240, P66, DOI 10.1126/science.3353708; Lindell AK, 2003, CORTEX, V39, P111, DOI 10.1016/S0010-9452(08)70079-0; Lindzey G., 1952, J PERSONALTIY, V21, P687; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; MACLEOD A, 1990, British Journal of Audiology, V24, P29, DOI 10.3109/03005369009077840; MacSweeney M, 2001, P ROY SOC B-BIOL SCI, V268, P451, DOI 10.1098/rspb.2000.0393; MacSweeney M, 2000, NEUROREPORT, V11, P1729, DOI 10.1097/00001756-200006050-00026; MCCURDY HG, 1949, J ABNORM SOC PSYCH, V44, P553, DOI 10.1037/h0062519; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MIDDELWEERD MJ, 1987, J ACOUST SOC AM, V82, P2145, DOI 10.1121/1.395659; MISHKIN M, 1952, J EXP PSYCHOL, V43, P43, DOI 10.1037/h0061361; Monteiro A, 2004, BEHAV RES METH INS C, V36, P107, DOI 10.3758/BF03195556; Nicholls MER, 2006, BRAIN LANG, V97, P322, DOI 10.1016/j.bandl.2005.11.007; Nicholls MER, 2004, PSYCHOL SCI, V15, P138, DOI 10.1111/j.0963-7214.2004.01502011.x; Patching GR, 1998, BEHAV RES METH INS C, V30, P643, DOI 10.3758/BF03209482; Reinhard J, 2003, INVEST OPHTH VIS SCI, V44, P1568, DOI 10.1167/iovs.02-0313; Reisberg D., 1987, HEARING EYE PSYCHOL, P97; Seinen M, 1969, Ned Tijdschr Psychol, V24, P551; STONE J, 1973, J COMP NEUROL, V150, P333, DOI 10.1002/cne.901500306; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Thomas SM, 2004, J EXP PSYCHOL HUMAN, V30, P873, DOI 10.1037/0096-1523.30.5.873; Thomas SM, 2002, PERCEPT PSYCHOPHYS, V64, P932, DOI 10.3758/BF03196797; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Trauzettel-Klosinski S, 1998, INVEST OPHTH VIS SCI, V39, P2177; WOLF ME, 1987, NEUROPSYCHOLOGIA, V25, P375, DOI 10.1016/0028-3932(87)90026-1; Wolff W, 1933, CHARACT PERSON, V2, P168	74	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e98273	10.1371/journal.pone.0098273	http://dx.doi.org/10.1371/journal.pone.0098273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25032950	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300001
J	Rachlis, B; Cole, DC; van Lettow, M; Escobar, M; Muula, AS; Ahmad, F; Orbinski, J; Chan, AK				Rachlis, Beth; Cole, Donald C.; van Lettow, Monique; Escobar, Michael; Muula, Adamson S.; Ahmad, Farah; Orbinski, James; Chan, Adrienne K.			Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) Programme in Zomba, Malawi	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SOUTH-AFRICA; PATIENTS LOST; ADULT PATIENTS; PATIENT RETENTION; DRUG-RESISTANCE; UNITED-STATES; HIV/AIDS CARE; 1ST YEAR	Background: Identifying follow-up (FU) visit patterns, and exploring which factors influence them are likely to be useful in determining which patients on antiretroviral therapy (ART) may become Lost to Follow-Up (LTFU). Using an operation and implementation research approach, we sought 1) to describe the timing of FU visits amongst patients who have been on ART for shorter and longer periods of time; and 2) to determine the median time to late visits, and 3) to identify specific factors that may be associated with these patterns in Zomba, Malawi. Methods and Findings: Using routinely collected programme monitoring data from Zomba District, we performed descriptive analyses on all ART visits among patients who initiated ART between Jan. 1, 2007-June 30, 2010. Based on an expected FU date, each FU visit was classified as early (>= 4 day before an expected FU date), on time (3 days before an expected FU date/up to 6 days after an expected FU date), or late (>= 7 days after an expected FU date). In total, 7,815 patients with 76417 FU visits were included. Ninety-two percent of patients had >= 2 FU visits. At the majority of visits, patients were either on time or late. The median time to a first late visit among those with 2 or more visits was 216 days (IQR: 128-359). Various patient-and visit-level factors differed significantly across Early, On Time, and Late visit groups including ART adherence and frequency of, and type of side effects. Discussion: The majority of patients do not demonstrate consistent FU visit patterns. Individuals were generally on ART for at least 6 months before experiencing their first late visit. Our findings have implications for the development of effective interventions that meet patient needs when they present early and can reduce patient losses to follow-up when they are late. In particular, time-varying visit characteristics need further research.	[Rachlis, Beth; Cole, Donald C.; van Lettow, Monique; Escobar, Michael; Chan, Adrienne K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [van Lettow, Monique; Chan, Adrienne K.] Dignitas Int, Zomba, Malawi; [Muula, Adamson S.] Univ Malawi, Coll Med, Blantyre, Malawi; [Ahmad, Farah] York Univ, Sch Hlth Policy & Management, Toronto, ON M3J 2R7, Canada; [Orbinski, James] Ctr Int Governance Innovat, Waterloo, ON, Canada; [Chan, Adrienne K.] Sunnybrook Hlth Sci Ctr, Div Infect Dis, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Malawi; York University - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Rachlis, B (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	beth.rachlis@utoronto.ca	Ahmad, Farah/B-4261-2008; Muula, Adamson/AAF-1153-2020	Ahmad, Farah/0000-0001-9747-1148; Escobar, Michael/0000-0001-9055-4709	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alamo ST, 2012, JAIDS-J ACQ IMM DEF, V60, pE36, DOI 10.1097/FTD.0b013e3182526e6a; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2012, GLOB REP UNAIDS REP; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bastard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049091; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Bisson GP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000174; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Braitstein P, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-7; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brugha R, 2003, BRIT MED J, V326, P1382, DOI 10.1136/bmj.326.7403.1382; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Daniel O. J., 2008, African Journal of Biomedical Research, V11, P221; Davies MA, 2009, CLIN INFECT DIS, V49, P973, DOI 10.1086/605501; Eholie SP, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17334; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gilbert L, 2010, HEALTH SOC CARE COMM, V18, P139, DOI 10.1111/j.1365-2524.2009.00881.x; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Horberg MA, 2013, AIDS PATIENT CARE ST, V27, P442, DOI 10.1089/apc.2013.0073; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, GLOB REP UNAIDS REP; Joint United Nations Programme on HIV/AIDS Website (UNAIDS), 2012, REP GLOB AIDS PAND; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Malawi Ministry of Health, 2008, TREATM AIDS GUID US; Malawi National Statistical Office and MEASURE DHS, 2010, MAL DEM HLTH SURV 20; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ministry of Health Government of Malawi, 2012, INT HIV PROGR REP JU; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Mukora R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-205; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Mutevedzi PC, 2013, TROP MED INT HEALTH, V18, P934, DOI 10.1111/tmi.12135; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Norman A, 2007, AM J PUBLIC HEALTH, V97, P1775, DOI 10.2105/AJPH.2005.082511; O'Connor C, 2011, JAIDS-J ACQ IMM DEF, V58, P429, DOI 10.1097/QAI.0b013e318230d507; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Pinto AD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18055; Rachlis BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018948; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Remien RH, 2003, ADHERENCE MEDICATION; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schouten Erik J, 2011, J Int AIDS Soc, V14 Suppl 1, pS4, DOI 10.1186/1758-2652-14-S1-S4; Skiest DJ, 2007, J INFECT DIS, V195, P1426, DOI 10.1086/512681; Torpey KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002204; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Uzochukwu BSC, 2009, HEALTH POLICY PLANN, V24, P189, DOI 10.1093/heapol/czp006; van Oosterhout JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042029; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; World Health Organization Website, 2009, PRIOR INT HIV AIDS P; Yiannoustos CT, 2008, PLOS ONE, V3, pe38	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101875	10.1371/journal.pone.0101875	http://dx.doi.org/10.1371/journal.pone.0101875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25033285	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300028
J	Sede, MM; Moretti, FA; Laufer, NL; Jones, LR; Quarleri, JF				Sede, Mariano M.; Moretti, Franco A.; Laufer, Natalia L.; Jones, Leandro R.; Quarleri, Jorge F.			HIV-1 Tropism Dynamics and Phylogenetic Analysis from Longitudinal Ultra-Deep Sequencing Data of CCR5-and CXCR4-Using Variants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4 CELL COUNT; CORECEPTOR USAGE; MAXIMUM-LIKELIHOOD; ANTIRETROVIRAL TREATMENT; INFECTED PATIENTS; IMPACT; PREDICTION; MUTATIONS; TREE	Objective: Coreceptor switch from CCR5 to CXCR4 is associated with HIV disease progression. The molecular and evolutionary mechanisms underlying the CCR5 to CXCR4 switch are the focus of intense recent research. We studied the HIV-1 tropism dynamics in relation to coreceptor usage, the nature of quasispecies from ultra deep sequencing (UDPS) data and their phylogenetic relationships. Methods: Here, we characterized C2-V3-C3 sequences of HIV obtained from 19 patients followed up for 54 to 114 months using UDPS, with further genotyping and phylogenetic analysis for coreceptor usage. HIV quasispecies diversity and variability as well as HIV plasma viral load were measured longitudinally and their relationship with the HIV coreceptor usage was analyzed. The longitudinal UDPS data were submitted to phylogenetic analysis and sampling times and coreceptor usage were mapped onto the trees obtained. Results: Although a temporal viral genetic structuring was evident, the persistence of several viral lineages evolving independently along the infection was statistically supported, indicating a complex scenario for the evolution of viral quasispecies. HIV X4-using variants were present in most of our patients, exhibiting a dissimilar inter- and intra-patient predominance as the component of quasispecies even on antiretroviral therapy. The viral populations from some of the patients studied displayed evidences of the evolution of X4 variants through fitness valleys, whereas for other patients the data favored a gradual mode of emergence. Conclusions: CXCR4 usage can emerge independently, in multiple lineages, along the course of HIV infection. The mode of emergence, i.e. gradual or through fitness valleys seems to depend on both virus and patient factors. Furthermore, our analyses suggest that, besides becoming dominant after population-level switches, minor proportions of X4 viruses might exist along the infection, perhaps even at early stages of it. The fate of these minor variants might depend on both viral and host factors.	[Sede, Mariano M.; Moretti, Franco A.; Laufer, Natalia L.; Quarleri, Jorge F.] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina; [Sede, Mariano M.; Moretti, Franco A.; Laufer, Natalia L.; Jones, Leandro R.; Quarleri, Jorge F.] Consejo Nacl Invest Cient & Tecn, Consejo Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Jones, Leandro R.] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Lab Virol & Genet Mol, Chubut, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Quarleri, JF (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & Sida INBIRS, Buenos Aires, DF, Argentina.	quarleri@fmed.uba.ar	Laufer, Natalia/AAB-7472-2022; Quarleri, Jorge/AFR-0308-2022	Laufer, Natalia/0000-0002-5690-9454; Quarleri, Jorge/0000-0001-5110-8773; Jones, Leandro/0000-0002-5877-4194	National Agency of Scientific and Technological Promotion(ANPCYT) [0422]	National Agency of Scientific and Technological Promotion(ANPCYT)(ANPCyT)	This study has been funded by National Agency of Scientific and Technological Promotion(ANPCYT) grant 0422 [http://www.agencia.mincyt.gob.ar/ frontend/agencia/convocatoria/105]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; ALBERT J, 1990, J CLIN MICROBIOL, V28, P1560, DOI 10.1128/JCM.28.7.1560-1564.1990; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Briz V, 2008, J ANTIMICROB CHEMOTH, V61, P405, DOI 10.1093/jac/dkm469; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Chor B, 2006, J ACM, V53, P722, DOI 10.1145/1183907.1183909; Daumer M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-30; Delgado E, 2012, J ANTIMICROB CHEMOTH, V67, P25, DOI 10.1093/jac/dkr438; Delwart EL, 1997, J VIROL, V71, P7498, DOI 10.1128/JVI.71.10.7498-7508.1997; Dimonte S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-33; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Duran A, 2012, LATE DIAGNOSIS HIV I; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Felsenstein J., 2004, INFERRING PHYLOGENIE; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GRAHAM RL, 1982, MATH BIOSCI, V60, P133, DOI 10.1016/0025-5564(82)90125-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jones LR, 2010, CLADISTICS, V26, P213; Jones LR, 2007, DARWINIANA, V45, P30; Kagan RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046334; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Kijak GH, 2002, J VIROL, V76, P7000, DOI 10.1128/JVI.76.14.7000-7009.2002; Kumar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061437; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Monno L, 2011, ANTIMICROB AGENTS CH, V55, P5078, DOI 10.1128/AAC.00743-11; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Pou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067085; Poveda E, 2007, J MED VIROL, V79, P1040, DOI 10.1002/jmv.20900; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Raymond S, 2014, J ANTIMICROB CHEMOTH; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Sanchez V, 2010, J CLIN MICROBIOL, V48, P4135, DOI 10.1128/JCM.01204-10; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Savkovic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038755; Seclen E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; Shannon CE, 1997, M D COMPUT, V14, P306; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Skrabal K, 2003, AIDS, V17, P809, DOI 10.1097/00002030-200304110-00005; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Svicher V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053603; Swenson LC, 2012, CURR OPIN HIV AIDS; Thielen A, 2012, INTERVIROLOGY, V55, P113, DOI 10.1159/000332002; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06	60	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102857	10.1371/journal.pone.0102857	http://dx.doi.org/10.1371/journal.pone.0102857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032817	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300104
J	Gontis, V; Kononovicius, A				Gontis, Vygintas; Kononovicius, Aleksejus			Consentaneous Agent-Based and Stochastic Model of the Financial Markets	PLOS ONE			English	Article							DISTRIBUTIONS; ECONOPHYSICS; DYNAMICS; NEEDS; LAW	We are looking for the agent-based treatment of the financial markets considering necessity to build bridges between microscopic, agent based, and macroscopic, phenomenological modeling. The acknowledgment that agent-based modeling framework, which may provide qualitative and quantitative understanding of the financial markets, is very ambiguous emphasizes the exceptional value of well defined analytically tractable agent systems. Herding as one of the behavior peculiarities considered in the behavioral finance is the main property of the agent interactions we deal with in this contribution. Looking for the consentaneous agent-based and macroscopic approach we combine two origins of the noise: exogenous one, related to the information flow, and endogenous one, arising form the complex stochastic dynamics of agents. As a result we propose a three state agent-based herding model of the financial markets. From this agent-based model we derive a set of stochastic differential equations, which describes underlying macroscopic dynamics of agent population and log price in the financial markets. The obtained solution is then subjected to the exogenous noise, which shapes instantaneous return fluctuations. We test both Gaussian and q-Gaussian noise as a source of the short term fluctuations. The resulting model of the return in the financial markets with the same set of parameters reproduces empirical probability and spectral densities of absolute return observed in New York, Warsaw and NASDAQ OMX Vilnius Stock Exchanges. Our result confirms the prevalent idea in behavioral finance that herding interactions may be dominant over agent rationality and contribute towards bubble formation.	[Gontis, Vygintas; Kononovicius, Aleksejus] Vilnius State Univ, Inst Theoret Phys & Astron, Vilnius, Lithuania	Vilnius University	Gontis, V (corresponding author), Vilnius State Univ, Inst Theoret Phys & Astron, Vilnius, Lithuania.	vygintas@gontis.eu	Gontis, Vygintas/A-5134-2008; Kononovicius, Aleksejus/I-5629-2019	Gontis, Vygintas/0000-0002-1859-1318; Kononovicius, Aleksejus/0000-0001-6365-0252				Akerlof George, 2009, ANIMAL SPIRITS HUMAN; Alfarano S., 2005, Computational Economics, V26, P19, DOI 10.1007/s10614-005-6415-1; [Anonymous], 2007, RECONSTRUCTING MACRO; Ball P, 2012, WHY SOC IS COMPLEX M, V2012, DOI [10.1007/978-3-642-29000-8, DOI 10.1007/978-3-642-29000-8]; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Borland L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.098701; Borland L, 1998, PHYS REV E, V57, P6634, DOI 10.1103/PhysRevE.57.6634; Bouchaud JP, 2008, NATURE, V455, P1181, DOI 10.1038/4551181a; Campbell J., 1997, ECONOMETRICS FINANCI; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chakraborti A, 2011, QUANT FINANC, V11, P1013, DOI 10.1080/14697688.2010.539249; Cont R., 1997, SCALE INVARIANCE; Cristelli M, 2012, P INT SCH PHYS, V176, P235, DOI 10.3254/978-1-61499-071-0-235; Ding Z, 1993, J EMPIR FINANC, V1, P83, DOI [10.1016/0927-5398(93)90006-D, DOI 10.1016/0927-5398(93)90006-D]; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Farmer JD, 2012, EUR PHYS J-SPEC TOP, V214, P295, DOI 10.1140/epjst/e2012-01696-9; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Farmer JD, 2004, QUANT FINANC, V4, P383, DOI 10.1080/14697680400008627; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gabaix X, 2006, Q J ECON, V121, P461, DOI 10.1162/qjec.2006.121.2.461; Gekle S, 2005, EUR PHYS J B, V45, P569, DOI 10.1140/epjb/e2005-00215-3; Gontis Vygintas, 2010, Stochastic Control, P559; Gontis V, 2010, PHYSICA A, V389, P100, DOI 10.1016/j.physa.2009.09.011; Gontis V, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500713; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; Jeanblanc M, 2009, SPRINGER FINANC, P1, DOI 10.1007/978-1-84628-737-4; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Kloeden P.E., 1999, NUMERICAL SOLUTION S; Kononovicius A, 2014, PHYSICA A, V405, P80, DOI 10.1016/j.physa.2014.03.003; Kononovicius A, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/28001; Kononovicius A, 2012, PHYSICA A, V391, P1309, DOI 10.1016/j.physa.2011.08.061; Kononovicius A, 2012, INT J ADV INTELLIGEN, V5, P111; Lobato IN, 1998, J BUS ECON STAT, V16, P261, DOI 10.2307/1392497; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T., 1996, APPL FINANCIAL EC, V6, P463, DOI DOI 10.1080/096031096333917; Lux T., 2002, SCI DISASTERS, P372, DOI DOI 10.1007/978-3-642-56257-0_13; Lux T, 2009, NAT PHYS, V5, P2, DOI 10.1038/nphys1163; Lye R, 2012, PHYSICA A, V391, P5521, DOI 10.1016/j.physa.2012.06.014; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Pietronero L., 2008, EUROPHYSICS NEWS, V39, P6, DOI 10.1051/epn:2008603; Preis T, 2006, EUROPHYS LETT, V75, P510, DOI 10.1209/epl/i2006-10139-0; Rak R, 2013, ACTA PHYS POL B, V44, P2035, DOI 10.5506/APhysPolB.44.2035; Roehner BM, 2010, SCI CULTURE, V76, P305; Scalas E, 2009, ECONOMICS-KIEL, V3, P1; Schinckus C, 2013, CONTEMP PHYS, V54, P17, DOI 10.1080/00107514.2013.774528; Schmitt TA, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/38005; Shiller R. J., 2012, FINANCE GOOD SOC; Stauffer D, 2011, CORRABS11092475; Taylor S.J., 1994, MATH FINANC, V4, P183, DOI DOI 10.1111/J.1467-9965.1994.TB00057.X; Traulsen A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041901; Tsallis C, 1996, PHYS REV E, V54, pR2197, DOI 10.1103/PhysRevE.54.R2197; Tsallis C., 2009, SPRINGER; Vandewalle N, 1997, PHYSICA A, V246, P454, DOI 10.1016/S0378-4371(97)00366-X; Voit J., 2005, STAT MECH FINANCIAL	55	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102201	10.1371/journal.pone.0102201	http://dx.doi.org/10.1371/journal.pone.0102201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KM	25029364	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600045
J	Teruel-Montoya, R; Kong, XG; Abraham, S; Ma, L; Kunapuli, SP; Holinstat, M; Shaw, CA; McKenzie, SE; Edelstein, LC; Bray, PF				Teruel-Montoya, Raul; Kong, Xianguo; Abraham, Shaji; Ma, Lin; Kunapuli, Satya P.; Holinstat, Michael; Shaw, Chad A.; McKenzie, Steven E.; Edelstein, Leonard C.; Bray, Paul F.			MicroRNA Expression Differences in Human Hematopoietic Cell Lineages Enable Regulated Transgene Expression	PLOS ONE			English	Article							MESSENGER-RNA; CIRCULATING MICRORNAS; GENE-TRANSFER; STEM-CELL; FACTOR-IX; T-CELLS; PLATELETS; CANCER; IDENTIFICATION; DISEASES	Blood microRNA (miRNA) levels have been associated with and shown to participate in disease pathophysiology. However, the hematopoietic cell of origin of blood miRNAs and the individual blood cell miRNA profiles are poorly understood. We report the miRNA content of highly purified normal hematopoietic cells from the same individuals. Although T-cells, B-cells and granulocytes had the highest miRNA content per cell, erythrocytes contributed more cellular miRNA to the blood, followed by granulocytes and platelets. miRNA profiling revealed different patterns and different expression levels of miRNA specific for each lineage. miR-30c-5p was determined to be an appropriate reference normalizer for cross-cell qRT-PCR comparisons. miRNA profiling of 5 hematopoietic cell lines revealed differential expression of miR-125a-5p. We demonstrated endogenous levels of miR-125a-5p regulate reporter gene expression in Meg-01 and Jurkat cells by (1) constructs containing binding sites for miR-125a-5p or (2) over-expressing or inhibiting miR-125a-5p. This quantitative analysis of the miRNA profiles of peripheral blood cells identifies the circulating hematopoietic cellular miRNAs, supports the use of miRNA profiles for distinguishing different hematopoietic lineages and suggests that endogenously expressed miRNAs can be exploited to regulate transgene expression in a cell-specific manner.	[Teruel-Montoya, Raul; Kong, Xianguo; Abraham, Shaji; Ma, Lin; Holinstat, Michael; McKenzie, Steven E.; Edelstein, Leonard C.; Bray, Paul F.] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Teruel-Montoya, Raul; Kong, Xianguo; Abraham, Shaji; Ma, Lin; Holinstat, Michael; McKenzie, Steven E.; Edelstein, Leonard C.; Bray, Paul F.] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Shaw, Chad A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shaw, Chad A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Shaw, Chad A.] Rice Univ, Dept Stat, Houston, TX 77251 USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine; Baylor College of Medicine; Rice University	Bray, PF (corresponding author), Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA.	paul.bray@jefferson.edu	Teruel-Montoya, Raúl/H-9012-2017	Teruel-Montoya, Raúl/0000-0002-6741-9725; McKenzie, Steven/0000-0003-2654-8560; Edelstein, Leonard/0000-0002-8976-6410	National Heart, Lung and Blood Institute [R01HL102482, R01MD007880]; National Institute on Minority Health and Health Disparities of the National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102482, R01HL116713] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007880] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded by R01HL102482 and R01MD007880 from the National Heart, Lung and Blood Institute and National Institute on Minority Health and Health Disparities of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bisset LR, 2004, EUR J HAEMATOL, V72, P203, DOI 10.1046/j.0902-4441.2003.00199.x; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Diehl P, CARDIOVASCULAR RES, V93, P633; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Edelstein LC, 2013, J THROMB HAEMOST, V11, P340, DOI 10.1111/jth.12214; Edelstein LC, NAT MED; Edelstein LC, 2013, NAT MED; Eikmans M, 2013, BLOOD, V121, pE81, DOI 10.1182/blood-2012-06-438887; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GEORGE JN, 1982, BLOOD, V60, P834; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Guo G, CELL STEM CELL, V13, P492; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Khetawat G, 2000, BLOOD, V95, P2289, DOI 10.1182/blood.V95.7.2289.007k03_2289_2296; Klusmann JH, 2010, GENE DEV, V24, P478, DOI 10.1101/gad.1856210; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Ricicova M, 2003, FEMS YEAST RES, V4, P119, DOI 10.1016/S1567-1356(03)00145-4; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stratz C, 2012, THROMB HAEMOSTASIS, V107, P634, DOI 10.1160/TH11-10-0742; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Ward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015810; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; WICKI AN, 1989, THROMB HAEMOSTASIS, V61, P448; Willeit P, 2013, CIRCULATION RES; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang QZ, 2013, CURR OPIN HEMATOL, V20, P265, DOI 10.1097/MOH.0b013e3283612628	64	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102259	10.1371/journal.pone.0102259	http://dx.doi.org/10.1371/journal.pone.0102259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029370	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600053
J	Urban, K; Tangherlini, TR; Vijunas, A; Broadwell, PM				Urban, Kryztof; Tangherlini, Timothy R.; Vijunas, Aurelijus; Broadwell, Peter M.			Semi-Supervised Morphosyntactic Classification of Old Icelandic	PLOS ONE			English	Article								We present IceMorph, a semi-supervised morphosyntactic analyzer of Old Icelandic. In addition to machine-read corpora and dictionaries, it applies a small set of declension prototypes to map corpus words to dictionary entries. A web-based GUI allows expert users to modify and augment data through an online process. A machine learning module incorporates prototype data, edit-distance metrics, and expert feedback to continuously update part-of-speech and morphosyntactic classification. An advantage of the analyzer is its ability to achieve competitive classification accuracy with minimum training data.	[Urban, Kryztof; Tangherlini, Timothy R.] Univ Calif Los Angeles, Scandinavian Sect, Los Angeles, CA 90095 USA; [Vijunas, Aurelijus] Natl Kaohsiung Normal Univ, Dept English, Kaohsiung, Taiwan; [Broadwell, Peter M.] Univ Calif Los Angeles, Univ Lib, Los Angeles, CA USA	University of California System; University of California Los Angeles; National Kaohsiung Normal University; University of California System; University of California Los Angeles	Tangherlini, TR (corresponding author), Univ Calif Los Angeles, Scandinavian Sect, Los Angeles, CA 90095 USA.	tango@humnet.ucla.edu	Tangherlini, Timothy R/AAG-9820-2020	Tangherlini, Timothy/0000-0002-1775-2052; Broadwell, Peter/0000-0003-4371-9472	National Science Foundation (NSF) [BCS-0921123]; NSF [IIS-0122491/EU IST2001-32745]; UCLA's Center for Medieval and Renaissance Studies; UCLA Council on Research; UCLA Office of the Vice Chancellor for Research	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); UCLA's Center for Medieval and Renaissance Studies; UCLA Council on Research; UCLA Office of the Vice Chancellor for Research	Funding for this project was provided through National Science Foundation (NSF) #BCS-0921123; NSF #IIS-0122491/EU IST2001-32745; with additional support from UCLA's Center for Medieval and Renaissance Studies; the UCLA Council on Research; and the UCLA Office of the Vice Chancellor for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borin Lars, 2008, LREC 2008 WORKSH LAN, P9; Brill E, 1992, AAAI FALL S PROB APP, P10; Chatzis SP, 2013, IEEE T PATTERN ANAL, V35, P1523, DOI 10.1109/TPAMI.2012.208; Clark S, 2003, P 7 C NAT LANG LEARN, V4, P49, DOI DOI 10.3115/1119176.1119183; Cleasby R, 1874, ICELANDIC ENGLISH DI; Cucerzan S, 2002, P CONLL 2002, V2002, P132; Feldman A, 2009, RESOURCE LIGHT APPRO; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Forsberg M, 2004, ACM SIGPLAN NOTICES, V39, P213, DOI 10.1145/1016848.1016879; Fritzner Johan, 1867, ORDBOG GAMLE NORSKE; Gordon E, 1938, INTRO OLD NORSE; Griffiths Tom, 2007, P 45 ANN M ASS COMP, P744; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Liu P, 2005, QUANTITATIVE STUDY E, DOI [10.1109/CIT.2005.41, DOI 10.1109/CIT.2005.41]; Loftsson H, 2011, P REC ADV NAT LANG P, P49; Loftsson H, 2008, NORD J LINGUIST, V31, P47, DOI 10.1017/S0332586508001820; Manning C, 2003, FDN STAT NATURAL LAN, P23; Rabiner L., 1986, ASSP MAGAZINE IEEE, V3, P4; Ranta A, 2004, J FUNCT PROGRAM, V14, P145, DOI 10.1017/S0956796803004738; Ratnaparkhi Adwait, 1996, C EMP METH NAT LANG; Renooij S, 2008, INT J APPROX REASON, V49, P398, DOI 10.1016/j.ijar.2008.02.008; Ringger E., 2007, P LING ANN WORKSH AC, P101; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41; Rognvaldsson E, 2011, THEOR APPL NAT LANG, P63, DOI 10.1007/978-3-642-20227-8_4; Schmid H., 1994, P INT C NEW METH LAN, P44; Tataru Paula, 2013, Biology (Basel), V2, P1282, DOI 10.3390/biology2041282; Toutanova K, 2008, ADV NEURAL INFORM PR, V20, P1521; WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; Zhang H., 2004, P 17 INT FLOR ART IN; Zoega G. T., 1910, CONCISE DICT OLD ICE	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102366	10.1371/journal.pone.0102366	http://dx.doi.org/10.1371/journal.pone.0102366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029462	Green Published, gold			2022-12-27	WOS:000341306600070
J	Enarson, PM; Gie, RP; Mwansambo, CC; Maganga, ER; Lombard, CJ; Enarson, DA; Graham, SM				Enarson, Penelope M.; Gie, Robert P.; Mwansambo, Charles C.; Maganga, Ellubey R.; Lombard, Carl J.; Enarson, Donald A.; Graham, Stephen M.			Reducing Deaths from Severe Pneumonia in Children in Malawi by Improving Delivery of Pneumonia Case Management	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CHILDHOOD PNEUMONIA; AFRICAN CHILDREN; DISEASE; TUBERCULOSIS; MORTALITY; INFECTION; ETIOLOGY; MALARIA	Objective: To evaluate the pneumonia specific case fatality rate over time following the implementation of a Child Lung Health Programme (CLHP) within the existing government health services in Malawi to improve delivery of pneumonia case management. Methods: A prospective, nationwide public health intervention was studied to evaluate the impact on pneumonia specific case fatality rate (CFR) in infants and young children (0 to 59 months of age) following the implementation of the CLHP. The implementation was step-wise from October 1st 2000 until 31st December 2005 within paediatric inpatient wards in 24 of 25 district hospitals in Malawi. Data analysis compared recorded outcomes in the first three months of the intervention (the control period) to the period after that, looking at trend over time and variation by calendar month, age group, severity of disease and region of the country. The analysis was repeated standardizing the follow-up period by using only the first 15 months after implementation at each district hospital. Findings: Following implementation, 47,228 children were admitted to hospital for severe/very severe pneumonia with an overall CFR of 9N8%. In both analyses, the highest CFR was in the children 2 to 11 months, and those with very severe pneumonia. The majority (64%) of cases, 2-59 months, had severe pneumonia. In this group there was a significant effect of the intervention Odds Ratio (OR) 0N70 (95% CI: 0.50-0.98); p = 0.036), while in the same age group children treated for very severe pneumonia there was no interventional benefit (OR 0.97 (95% CI: 0.72-1.30); p = 0.8). No benefit was observed for neonates (OR 0.83 (95% CI: 0.56-1.22); p = 0.335). Conclusions: The nationwide implementation of the CLHP significantly reduced CFR in Malawian infants and children (2-59 months) treated for severe pneumonia. Reasons for the lack of benefit for neonates, infants and children with very severe pneumonia requires further research.	[Enarson, Penelope M.; Enarson, Donald A.; Graham, Stephen M.] Int Union TB & Lung Dis, Child Lung Hlth Div, Paris, France; [Enarson, Penelope M.; Enarson, Donald A.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Gie, Robert P.] Univ Stellenbosch, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Mwansambo, Charles C.] Minist Hlth, Lilongwe, Malawi; [Maganga, Ellubey R.] UNICEF Malawi, Lilongwe, Malawi; [Lombard, Carl J.] South Africa Med Res Council MRC, Biostat Unit, Cape Town, South Africa; [Graham, Stephen M.] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Stellenbosch University; Stellenbosch University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Enarson, PM (corresponding author), Int Union TB & Lung Dis, Child Lung Hlth Div, Paris, France.	penarson@theunion.org		Lombard, Carl/0000-0002-2136-6533; Graham, Stephen/0000-0003-3525-2294	MoH of Malawi; Bill and Melinda Gates Foundation [413]	MoH of Malawi; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The CLHP was primarly funded by the MoH of Malawi, who contributed 69% of the running costs comprising facilities and human resources that are part of the existing health system. The Bill and Melinda Gates Foundation funded the remaining 31% of the costs, 21% of which was investment and 79% operating costs. The Bill & Melinda Gates Foundation grant ID#: 413 http://www.gatesfoundation.org/Pages/home.aspx). The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, HOSP CAR CHILDR GUID; Ayieko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047622; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Bukhman G, 2008, AM J PUBLIC HEALTH, V98, P44, DOI 10.2105/AJPH.2007.110841; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Ellis J, 2007, ANN TROP PAEDIATR, V27, P261, DOI 10.1179/146532807X245643; ENARSON DA, 1995, TUBERCLE LUNG DIS, V76, P95, DOI 10.1016/0962-8479(95)90548-0; Enarson P, 2000, INTEGRATED CHILD LUN; Enarson PM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000137; Enarson P, 2008, B WORLD HEALTH ORGAN, V86, P344, DOI 10.2471/BLT.07.048017; Enarson Penny M, 2010, Expert Rev Respir Med, V4, P211, DOI 10.1586/ers.10.14; Enarson PM, 2005, GUIDE LOW INCOME COU; Everett DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044250; Gonani A, 2005, IMPACT HIV AIDS HLTH; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Government of Malawi, 2001, MAL DEM HLTH SURV 20; Government of Malawi, 1999, MAL 4 NATL HLTH PLAN; Government of Malawi, 2005, INT HOUS SURV 2004 2; Government of Malawi, 2011, MAL DEM HLTH SURV 20; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Graham SM, 2011, PEDIATR INFECT DIS J, V30, P33, DOI 10.1097/INF.0b013e3181fcabe4; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Nantongo JM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-16; National AIDS Control Commission Malawi, 2001, EST NAT HIV PREV MAL; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; ONeil M, 2010, EVALUATION MALAWIS E; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Roca-Feltrer A, 2012, EMERG INFECT DIS, V18, P272, DOI 10.3201/eid1802.111008; Rogerson SR, 2004, T ROY SOC TROP MED H, V98, P544, DOI 10.1016/j.trstmh.2003.12.011; SHANN F, 1984, B WORLD HEALTH ORGAN, V62, P749; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; UNICEF, 2012, STAT WORLDS CHILDR 2; UNICEF, 2002, SENT SURV REP; United Nations Childrens Fund, 2007, STAT WORLDS CHILDR 2; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2013, POCK BOOK HOSP CAR C; World Health Organization UNICEF, 2000, MAN CHILD SER INF SE	42	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102955	10.1371/journal.pone.0102955	http://dx.doi.org/10.1371/journal.pone.0102955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050894	Green Published, gold			2022-12-27	WOS:000339551100070
J	Franz, S; Ciatipis, M; Pfeifer, K; Kierdorf, B; Sandner, B; Bogdahn, U; Blesch, A; Winner, B; Weidner, N				Franz, Steffen; Ciatipis, Mareva; Pfeifer, Kathrin; Kierdorf, Birthe; Sandner, Beatrice; Bogdahn, Ulrich; Blesch, Armin; Winner, Beate; Weidner, Norbert			Thoracic Rat Spinal Cord Contusion Injury Induces Remote Spinal Gliogenesis but Not Neurogenesis or Gliogenesis in the Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOCOMOTOR RECOVERY; CORTICOSPINAL TRACT; ADULT BRAIN; CELLS; NEURONS; PROLIFERATION; PLASTICITY; TRANSECTION; APOPTOSIS	After spinal cord injury, transected axons fail to regenerate, yet significant, spontaneous functional improvement can be observed over time. Distinct central nervous system regions retain the capacity to generate new neurons and glia from an endogenous pool of progenitor cells and to compensate neural cell loss following certain lesions. The aim of the present study was to investigate whether endogenous cell replacement (neurogenesis or gliogenesis) in the brain (subventricular zone, SVZ; corpus callosum, CC; hippocampus, HC; and motor cortex, MC) or cervical spinal cord might represent a structural correlate for spontaneous locomotor recovery after a thoracic spinal cord injury. Adult Fischer 344 rats received severe contusion injuries (200 kDyn) of the mid-thoracic spinal cord using an Infinite Horizon Impactor. Uninjured rats served as controls. From 4 to 14 days post-injury, both groups received injections of bromodeoxyuridine (BrdU) to label dividing cells. Over the course of six weeks post-injury, spontaneous recovery of locomotor function occurred. Survival of newly generated cells was unaltered in the SVZ, HC, CC, and the MC. Neurogenesis, as determined by identification and quantification of doublecortin immunoreactive neuroblasts or BrdU/neuronal nuclear antigen double positive newly generated neurons, was not present in non-neurogenic regions (MC, CC, and cervical spinal cord) and unaltered in neurogenic regions (dentate gyrus and SVZ) of the brain. The lack of neuronal replacement in the brain and spinal cord after spinal cord injury precludes any relevance for spontaneous recovery of locomotor function. Gliogenesis was increased in the cervical spinal cord remote from the injury site, however, is unlikely to contribute to functional improvement.	[Franz, Steffen; Ciatipis, Mareva; Sandner, Beatrice; Blesch, Armin; Weidner, Norbert] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, Heidelberg, Germany; [Pfeifer, Kathrin; Kierdorf, Birthe; Bogdahn, Ulrich] Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany; [Winner, Beate] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, IZKF Jr Grp 3, D-91054 Erlangen, Germany; [Winner, Beate] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, BMBF Res Grp Neurosci, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Regensburg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Weidner, N (corresponding author), Univ Heidelberg Hosp, Spinal Cord Injury Ctr, Heidelberg, Germany.	norbert.weidner@med.uni-heidelberg.de	Winner, Beate/K-3730-2012; Winner, Beate/O-8213-2019	Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564; Blesch, Armin/0000-0003-1133-1174	German Federal Ministry of Education and Research (BMBF) [01GQ113]; Bavarian Ministry of Education and Culture, Sciences and the Arts in the framework of the Bavarian Molecular Biosystems Research Network; Interdisciplinary Center for Clinical Research (University Hospital of Erlangen); Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Bavarian Ministry of Education and Culture, Sciences and the Arts in the framework of the Bavarian Molecular Biosystems Research Network; Interdisciplinary Center for Clinical Research (University Hospital of Erlangen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Additional financial support came from the German Federal Ministry of Education and Research (BMBF, 01GQ113), the Bavarian Ministry of Education and Culture, Sciences and the Arts in the framework of the Bavarian Molecular Biosystems Research Network, and the Interdisciplinary Center for Clinical Research (University Hospital of Erlangen). The authors acknowledge financial support by "Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg" within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Boncoraglio GB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007231.pub2; Cajal S., 1928, DEGENERATION REGENER; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Freund P, 2013, LANCET NEUROL; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; Hillen BK, 2013, ANN NY ACAD SCI, V1279, P164, DOI 10.1111/nyas.12061; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807; Lacroix S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085916; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; McTigue DM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt48; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Muir GD, 1999, BEHAV BRAIN RES, V103, P45, DOI 10.1016/S0166-4328(99)00018-2; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nielson JL, 2011, J COMP NEUROL, V519, P2852, DOI 10.1002/cne.22661; Nielson JL, 2010, J NEUROSCI, V30, P11516, DOI 10.1523/JNEUROSCI.1433-10.2010; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Siegenthaler MM, 2007, J NEUROTRAUM, V24, P1631, DOI 10.1089/neu.2007.0302; Small SL, 2013, NAT REV NEUROL, V9, P698, DOI 10.1038/nrneurol.2013.222; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Spiess MR, 2009, J NEUROTRAUM, V26, P2027, DOI 10.1089/neu.2008-0760; Swash M, 1998, OUTCOMES NEUROLOGICA; Vroemen M, 2006, AM J NEURORADIOL, V27, P598; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WINNER B, 2007, NEUROBIOL AGING; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Yoo S, 2007, DEV NEUROBIOL, V67, P860, DOI 10.1002/dneu.20369; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102896	10.1371/journal.pone.0102896	http://dx.doi.org/10.1371/journal.pone.0102896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050623	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100066
J	Yan, HJ; Zhang, M; Zhao, JK; Huan, XP; Ding, JP; Wu, SS; Wang, CC; Xu, YY; Liu, L; Xu, F; Yang, HT				Yan, Hongjing; Zhang, Min; Zhao, Jinkou; Huan, Xiping; Ding, Jianping; Wu, Susu; Wang, Chenchen; Xu, Yuanyuan; Liu, Li; Xu, Fei; Yang, Haitao			The Increased Effectiveness of HIV Preventive Intervention among Men Who Have Sex with Men and of Follow-Up Care for People Living with HIV after 'Task-Shifting' to Community-Based Organizations: A 'Cash on Service Delivery' Model in China	PLOS ONE			English	Article								Background: A large number of men who have sex with men (MSM) and people living with HIV/AIDS (PLHA) are underserved despite increased service availability from government facilities while many community based organizations (CBOs) are not involved. We aimed to assess the feasibility and effectiveness of the task shifting from government facilities to CBOs in China. Methods: HIV preventive intervention for MSM and follow-up care for PLHA were shifted from government facilities to CBOs. Based on 'cash on service delivery' model, 10 USD per MSM tested for HIV with results notified, 82 USD per newly HIV cases diagnosed, and 50 USD per PLHA received a defined package of follow-up care services, were paid to the CBOs. Cash payments were made biannually based on the verified results in the national web-based HIV/AIDS information system. Findings: After task shifting, CBOs gradually assumed preventive intervention for MSM and follow-up care for PLHA from 2008 to 2012. HIV testing coverage among MSM increased from 4.1% in 2008 to 22.7% in 2012. The baseline median CD4 counts of newly diagnosed HIV positive MSM increased from 309 to 397 cells/mu L. HIV tests among MSM by CBOs accounted for less than 1% of the total HIV tests in Nanjing but the share of HIV cases detected by CBOs was 12.4% in 2008 and 43.6% in 2012. Unit cost per HIV case detected by CBOs was 47 times lower than that by government facilities. The coverage of CD4 tests and antiretroviral therapy increased from 71.1% and 78.6% in 2008 to 86.0% and 90.1% in 2012, respectively. Conclusion: It is feasible to shift essential HIV services from government facilities to CBOs, and to verify independently service results to adopt 'cash on service delivery' model. Services provided by CBOs are cost-effective, as compared with that by government facilities.	[Yan, Hongjing; Zhao, Jinkou; Huan, Xiping; Ding, Jianping; Yang, Haitao] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhang, Min; Wu, Susu; Wang, Chenchen; Xu, Yuanyuan; Liu, Li; Xu, Fei] Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Huan, Xiping; Ding, Jianping] Jiangsu Prov Prevent Med Assoc, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Zhao, JK (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	jinkouzhao@hotmail.com; yht@jscdc.cn		Zhao, Jinkou/0000-0001-9184-3385	Bill & Melinda Gates Foundation; Outstanding Medical Academic Leader Program of Jiangsu Provincial government; Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Outstanding Medical Academic Leader Program of Jiangsu Provincial government; Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention	The present study was funded by The Bill & Melinda Gates Foundation; Outstanding Medical Academic Leader Program of Jiangsu Provincial government and Outstanding Medical Academic Leader Program of Jiangsu Provincial Center for Diseases Control and Prevention. The Bill & Melinda Gates Foundation Beijing Representative Office participated in the study design. The other study sponsors had no role in the study design. All study sponsors had no role in data collection, data analysis, data interpretation, or writing of this report.	[Anonymous], 2008, CHINA 2010 UNGASS CO; [Anonymous], 2009, BBC NEWS; [Anonymous], 2012, STAT YB NANJ MUN 201; Broadhead RS, 1999, PUBLIC HEALTH, V113, P42; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Du J, 2012, INT J INFECT DIS, V16, pE498, DOI 10.1016/j.ijid.2012.02.013; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Jain V, 2014, JAIDS-J ACQ IMM DEF, V65, P327, DOI 10.1097/QAI.0000000000000021; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP UN REP GLOB; Li H, 2010, INT J EPIDEMIOL, V39, pII65, DOI 10.1093/ije/dyq223; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; Mahgoub A., 2010, CASH DELIVERY NEW AP; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; National Centre for AIDS/STD Control and Prevention Chinese Centre for Diseases Control and Prevention, 2012, NATL TECHN HDB HIV R; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Settle E, 2003, AIDS CHINA ANNOTED C; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Vassall A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001567; Wang Y, 2011, AIDS BEHAV, V15, P702, DOI 10.1007/s10461-010-9703-2; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wen Y, 2011, AIDS CARE, V23, P1226, DOI 10.1080/09540121.2011.555748; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2010, INT J EPIDEMIOL, V39, pII1, DOI 10.1093/ije/dyq220; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Yan H, 2010, CHIN J AIDS STD, VTD16, P29; Yan HJ, 2012, JAIDS-J ACQ IMM DEF, V59, P177, DOI 10.1097/QAI.0b013e318239c947; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019; Zhang F, 2012, CHINESE NATL FREE AN; [张津萍 Zhang Jinping], 2004, [中华皮肤科杂志, Chinese Journa of Dermatology], V37, P546	34	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103146	10.1371/journal.pone.0103146	http://dx.doi.org/10.1371/journal.pone.0103146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0QO	25050797	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100090
J	Caminiti, F; De Salvo, S; De Cola, MC; Russo, M; Bramanti, P; Marino, S; Ciurleo, R				Caminiti, Fabrizia; De Salvo, Simona; De Cola, Maria Cristina; Russo, Margherita; Bramanti, Placido; Marino, Silvia; Ciurleo, Rosella			Detection of Olfactory Dysfunction Using Olfactory Event Related Potentials in Young Patients with Multiple Sclerosis	PLOS ONE			English	Article							SMELL IDENTIFICATION TEST; ODOR IDENTIFICATION; PARKINSONS-DISEASE; GUSTATORY FUNCTION; TESTS; DISCRIMINATION; THRESHOLDS; ATROPHY	Background: Several studies reported olfactory dysfunction in patients with multiple sclerosis. The estimate of the incidence of olfactory deficits in multiple sclerosis is uncertain; this may arise from different testing methods that may be influenced by patients' response bias and clinical, demographic and cognitive features. Aims: To evaluate objectively the olfactory function using Olfactory Event Related Potentials. Materials and Methods: We tested the olfactory function of 30 patients with relapsing remitting multiple sclerosis (mean age of 36.03 +/- 6.96 years) and of 30 age, sex and smoking-habit matched healthy controls by using olfactory potentials. A selective and controlled stimulation of the olfactory system to elicit the olfactory event related potentials was achieved by a computer-controlled olfactometer linked directly with electroencephalograph. Relationships between olfactory potential results and patients' clinical characteristics, such as gender, disability status score, disease-modifying therapy, and disease duration, were evaluated. Results: Seven of 30 patients did not show olfactory event related potentials. Sixteen of remaining 23 patients had a mean value of amplitude significantly lower than control group (p<0.01). The presence/absence of olfactory event related potentials was associated with dichotomous expanded disability status scale (p = 0.0433), as well as inversely correlated with the disease duration (r = -0.3641, p = 0.0479). Conclusion: Unbiased olfactory dysfunction of different severity found in multiple sclerosis patients suggests an organic impairment which could be related to neuroinflammatory and/or neurodegenerative processes of olfactory networks, supporting the recent findings on neurophysiopathology of disease.	[Caminiti, Fabrizia; De Salvo, Simona; De Cola, Maria Cristina; Russo, Margherita; Bramanti, Placido; Marino, Silvia; Ciurleo, Rosella] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Marino, Silvia] Univ Messina, Dept Biomed Sci & Morphol & Funct Imaging, Messina, Italy	IRCCS Bonino Pulejo; University of Messina	Caminiti, F (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	fabriziacaminiti@tiscali.it	De Cola, Maria C/B-7714-2017; Marino, Silvia/T-5118-2019; Caminiti, Fabrizia/B-9458-2017; Ciurleo, Rosella/T-4590-2019; De Salvo, Simona/K-3180-2016; Bramanti, Placido/K-5117-2016	De Cola, Maria C/0000-0002-7509-3833; Marino, Silvia/0000-0002-1088-6808; Caminiti, Fabrizia/0000-0002-2527-8063; De Salvo, Simona/0000-0001-9501-3258; Ciurleo, Rosella/0000-0003-0709-5914				Amato MP, 2010, NEUROLOGY, V75, P1134, DOI 10.1212/WNL.0b013e3181f4d821; Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Bahar-Fuchs A, 2011, INT PSYCHOGERIATR, V23, P1097, DOI 10.1017/S1041610210002371; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Dahlslett SB, 2012, EUR ARCH OTO-RHINO-L, V269, P1163, DOI 10.1007/s00405-011-1812-7; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; Doty RL, 1999, NEUROLOGY, V53, P880, DOI 10.1212/WNL.53.4.880; Doty RL, 1998, ANN NY ACAD SCI, V855, P781, DOI 10.1111/j.1749-6632.1998.tb10658.x; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Doty RL, 1997, NEW ENGL J MED, V336, P1918, DOI 10.1056/NEJM199706263362617; Fleiner F, 2010, AM J RHINOL ALLERGY, V24, pE93, DOI 10.2500/ajra.2010.24.3506; Giessel AJ, 2014, CURR OPIN NEUROBIOL, V24, P120, DOI 10.1016/j.conb.2013.09.010; Haehner A, 2009, EXPERT REV NEUROTHER, V9, P1773, DOI [10.1586/ern.09.115, 10.1586/ERN.09.115]; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V63, P145, DOI 10.1136/jnnp.63.2.145; Hawkes CH, 1998, ANN NY ACAD SCI, V855, P608, DOI 10.1111/j.1749-6632.1998.tb10631.x; Heberhold C, 1975, ARCH OTOHINOLARYNGOL, V210, P67; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Kjelvik G, 2007, INT J GERIATR PSYCH, V22, P1020, DOI 10.1002/gps.1783; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Lumsden CE, 1983, HDB CLIN NEUROLOGY, V9, P217; Lutterotti A, 2011, MULT SCLER J, V17, P964, DOI 10.1177/1352458511399798; MCDONALD WI, 1986, J NEUROL NEUROSUR PS, V49, P113, DOI 10.1136/jnnp.49.2.113; MOBERG PJ, 1987, J CLIN EXP NEUROPSYC, V9, P650, DOI 10.1080/01688638708405208; Olofsson JK, 2004, CHEM SENSES, V29, P629, DOI 10.1093/chemse/bjh066; Pause BM, 1996, PSYCHOPHYSIOLOGY, V33, P376, DOI 10.1111/j.1469-8986.1996.tb01062.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Racke MK, 2009, ANN INDIAN ACAD NEUR, V12, P215, DOI 10.4103/0972-2327.58274; Rolet A, 2013, EUR NEUROL, V69, P166, DOI 10.1159/000345482; Rombaux P, 2006, NEUROPHYSIOL CLIN, V36, P53, DOI 10.1016/j.neucli.2006.03.005; Silva AM, 2012, MULT SCLER J, V18, P616, DOI 10.1177/1352458511427156; Singh S, 2009, ARCH NEUROL-CHICAGO, V66, P805, DOI 10.1001/archneurol.2009.87; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Wattendorf E, 2009, J NEUROSCI, V29, P15410, DOI 10.1523/JNEUROSCI.1909-09.2009; Zivadinov R, 1999, J NEUROL SCI, V168, P127, DOI 10.1016/S0022-510X(99)00189-6; Zorzon M, 2000, MULT SCLER J, V6, P386, DOI 10.1191/135245800701566368	38	26	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103151	10.1371/journal.pone.0103151	http://dx.doi.org/10.1371/journal.pone.0103151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047369	Green Submitted, gold, Green Published			2022-12-27	WOS:000339558100110
J	Ishida, K; Taguchi, K; Matsumoto, T; Kobayashi, T				Ishida, Keiko; Taguchi, Kumiko; Matsumoto, Takayuki; Kobayashi, Tsuneo			Activated Platelets from Diabetic Rats Cause Endothelial Dysfunction by Decreasing Akt/Endothelial NO Synthase Signaling Pathway	PLOS ONE			English	Article							TREATMENT-INDUCED IMPROVEMENT; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; DEPENDENT RELAXATION; VASCULAR-DISEASE; HEART-FAILURE; MECHANISMS; COMPLICATIONS; INVOLVEMENT; BLOCKADE	Diabetes is associated with endothelial dysfunction and platelet activation, both of which may contribute to increased cardiovascular risk. The purpose of this study was to characterize circulating platelets in diabetes and clarify their effects on endothelial function. Male Wistar rats were injected with streptozotocin (STZ) to induce diabetes. Each experiment was performed by incubating carotid arterial rings with platelets (1.65x10(7) cells/mL; 30 min) isolated from STZ or control rats. Thereafter, the vascular function was characterized in isolated carotid arterial rings in organ bath chambers, and each expression and activation of enzymes involved in nitric oxide and oxidative stress levels were analyzed. Endothelium-dependent relaxation induced by acetylcholine was significantly attenuated in carotid arteries treated with platelets isolated from STZ rats. Similarly, treatment with platelets isolated from STZ rats significantly reduced ACh-induced Akt/endothelial NO synthase signaling/NO production and enhanced TXB2 (metabolite of TXA(2)), while CD61 (platelet marker) and CD62P (activated platelet marker) were increased in carotid arteries treated with platelets isolated from STZ rats. Furthermore, the platelets isolated from STZ rats decreased total eNOS protein and eNOS dimerization, and increased oxidative stress. These data provide direct evidence that circulating platelets isolated from diabetic rats cause dysfunction of the endothelium by decreasing NO production (via Akt/endothelial NO synthase signaling pathway) and increasing TXA(2). Moreover, activated platelets disrupt the carotid artery by increasing oxidative stress.	[Ishida, Keiko; Taguchi, Kumiko; Matsumoto, Takayuki; Kobayashi, Tsuneo] Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Tokyo 142, Japan	Hoshi University	Kobayashi, T (corresponding author), Hoshi Univ, Inst Med Chem, Dept Physiol & Morphol, Shinagawa Ku, Ebara 2-4-41, Tokyo 142, Japan.	tkoba@hoshi.ac.jp		Ishida, Keiko/0000-0002-0344-6193; Matsumoto, Takayuki/0000-0001-9177-8384	Ministry of Education, Culture, Sports, Science and Technology, Japan [25870258, 24590127]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology, Japan (25870258 and 24590127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colas R, 2011, DIABETOLOGIA, V54, P2931, DOI 10.1007/s00125-011-2272-8; Colwell JA, 2003, DIABETES CARE, V26, P2181, DOI 10.2337/diacare.26.7.2181; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Guerci B, 2001, DIABETES METAB, V27, P436; Hadas K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074401; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Heitzer T, 2003, CIRCULATION, V108, P536, DOI 10.1161/01.cir.0000081774.31064.62; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Kamata K, 2000, N-S ARCH PHARMACOL, V362, P52, DOI 10.1007/s002100000248; Kobayashi T, 2000, BRIT J PHARMACOL, V131, P231, DOI 10.1038/sj.bjp.0703572; Kobayashi T, 2012, CLIN SCI, V123, P375, DOI 10.1042/CS20110621; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Littleton-Kearney MT, 2005, BIOL RES NURS, V7, P135, DOI 10.1177/1099800405276832; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Matsumoto T, 2007, FREE RADICAL BIO MED, V42, P993, DOI 10.1016/j.freeradbiomed.2006.12.028; Matsumoto T, 2014, PFLUG ARCH EUR J PHY, V466, P331, DOI 10.1007/s00424-013-1330-0; Matsumoto T, 2009, ATHEROSCLEROSIS, V205, P87, DOI 10.1016/j.atherosclerosis.2008.11.015; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Natarajan A, 2008, DIABETES VASC DIS RE, V5, P138, DOI 10.3132/dvdr.2008.023; NIMPF J, 1986, BASIC RES CARDIOL, V81, P437, DOI 10.1007/BF01907750; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Romano MR, 2009, EUR J PHARMACOL, V608, P48, DOI 10.1016/j.ejphar.2009.02.034; Schafer A, 2004, THROMB HAEMOSTASIS, V92, P97, DOI 10.1160/th04-02-0118; Schafer A, 2003, THROMB HAEMOSTASIS, V89, P1024, DOI 10.1055/s-0037-1613404; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Sowers JR, 2013, HYPERTENSION, V61, P943, DOI 10.1161/HYPERTENSIONAHA.111.00612; Sudhahar V, 2013, DIABETES, V62, P3839, DOI 10.2337/db12-1228; Taguchi K, 2012, DIABETES, V61, P1978, DOI 10.2337/db11-1729; Tschoepe D, 1997, DIABETOLOGIA, V40, P573, DOI 10.1007/s001250050717; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; Vaidya D, 2009, METAB SYNDR RELAT D, V7, P289, DOI 10.1089/met.2008.0083; Vericel E, 2004, DIABETES, V53, P1046, DOI 10.2337/diabetes.53.4.1046; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wang XW, 2012, CIRCULATION, V125, P3117, DOI 10.1161/CIRCULATIONAHA.111.030312; Zhang X, 2013, J THROMB TH IN PRESS	40	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102310	10.1371/journal.pone.0102310	http://dx.doi.org/10.1371/journal.pone.0102310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047034	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100026
J	Vriens, B; Ammann, AA; Hagendorfer, H; Lenz, M; Berg, M; Winkel, LHE				Vriens, Bas; Ammann, Adrian A.; Hagendorfer, Harald; Lenz, Markus; Berg, Michael; Winkel, Lenny H. E.			Quantification of Methylated Selenium, Sulfur, and Arsenic in the Environment	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; GAS-CHROMATOGRAPHY; SPECIATION ANALYSIS; VOLATILE SELENIUM; NATURAL-WATERS; ICP-MS; SPECTROMETRY; SE; GROUNDWATER; ELEMENTS	Biomethylation and volatilization of trace elements may contribute to their redistribution in the environment. However, quantification of volatile, methylated species in the environment is complicated by a lack of straightforward and field-deployable air sampling methods that preserve element speciation. This paper presents a robust and versatile gas trapping method for the simultaneous preconcentration of volatile selenium (Se), sulfur (S), and arsenic (As) species. Using HPLC-HR-ICP- MS and ESI-MS/MS analyses, we demonstrate that volatile Se and S species efficiently transform into specific non-volatile compounds during trapping, which enables the deduction of the original gaseous speciation. With minor adaptations, the presented HPLC-HR-ICP-MS method also allows for the quantification of 13 non-volatile methylated species and oxyanions of Se, S, and As in natural waters. Application of these methods in a peatland indicated that, at the selected sites, fluxes varied between 190-210 ng Se.m(-2).d(-1), 90-270 ng As.m(-2).d(-1), and 4-14 mu g S.m(-2).d(-1), and contained at least 70% methylated Se and S species. In the surface water, methylated species were particularly abundant for As (> 50% of total As). Our results indicate that methylation plays a significant role in the biogeochemical cycles of these elements.	[Vriens, Bas; Berg, Michael; Winkel, Lenny H. E.] Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, Dubendorf, Switzerland; [Vriens, Bas; Winkel, Lenny H. E.] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Ammann, Adrian A.] Swiss Fed Inst Aquat Sci & Technol, Dept Environm Toxicol, Dubendorf, Switzerland; [Hagendorfer, Harald] Swiss Fed Inst Mat Sci & Technol, Dept Thin Films & Photovolta, Dubendorf, Switzerland; [Lenz, Markus] Univ Appl Sci & Arts Northwestern Switzerland, Inst Ecopreneurship, Sch Life Sci, Muttenz, Switzerland; [Lenz, Markus] Wageningen Univ, Dept Environm Technol, NL-6700 AP Wageningen, Netherlands	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); FHNW University of Applied Sciences & Arts Northwestern Switzerland; Wageningen University & Research	Winkel, LHE (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, Dubendorf, Switzerland.	lenny.winkel@eawag.ch	Berg, Michael/C-3738-2012; Lenz, Markus/AAN-7142-2020	Berg, Michael/0000-0002-7342-4061; Lenz, Markus/0000-0001-6832-3218; Vriens, Bas/0000-0001-8444-3383; Winkel, Lenny/0000-0001-7586-7256	Swiss National Science Foundation [SNF PP00P2_133619, 200020_138210]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (http://www.snf.ch) (SNF PP00P2_133619 and 200020_138210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann AA., 2011, AM J ANAL CHEM, V2, P27, DOI DOI 10.4236/AJAC.2011.21004; Ammann AA, 2010, J CHROMATOGR A, V1217, P2111, DOI 10.1016/j.chroma.2010.01.086; Amouroux D, 2001, EARTH PLANET SC LETT, V189, P277, DOI 10.1016/S0012-821X(01)00370-3; Amouroux D, 1998, ANAL CHIM ACTA, V377, P241, DOI 10.1016/S0003-2670(98)00425-5; ANDERSON LCD, 1991, ENVIRON SCI TECHNOL, V25, P420, DOI 10.1021/es00015a007; B'Hymer C, 2006, J CHROMATOGR A, V1114, P1, DOI 10.1016/j.chroma.2006.02.063; Bednar AJ, 2004, WATER RES, V38, P355, DOI 10.1016/j.watres.2003.09.034; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bentley R, 2002, MICROBIOL MOL BIOL R, V66, P250, DOI 10.1128/MMBR.66.2.250-271.2002; Cai Y, 2000, TRAC-TREND ANAL CHEM, V19, P62, DOI 10.1016/S0165-9936(99)00180-6; Chasteen TG, 2003, CHEM REV, V103, P1, DOI 10.1021/cr010210+; Chen BB, 2013, J ANAL ATOM SPECTROM, V28, P334, DOI 10.1039/c2ja30280b; Chen YW, 2010, ANAL CHIM ACTA, V671, P9, DOI 10.1016/j.aca.2010.05.011; D'Ulivo A, 2007, ANAL CHEM, V79, P3008, DOI 10.1021/ac061962c; Fernandez-Martinez Alejandro, 2009, Reviews in Environmental Science and Bio/Technology, V8, P81, DOI 10.1007/s11157-009-9145-3; Francesconi KA, 2002, BOOK SOIL P, P51; Latorre CH, 2013, ANAL CHIM ACTA, V804, P37, DOI 10.1016/j.aca.2013.09.054; Jain CK, 2000, WATER RES, V34, P4304, DOI 10.1016/S0043-1354(00)00182-2; JIANG S, 1983, ATMOS ENVIRON, V17, P111, DOI 10.1016/0004-6981(83)90014-8; Juresa D, 2006, ANAL CHEM, V78, P8569, DOI 10.1021/ac061496r; Langner P, 2012, NAT GEOSCI, V5, P66, DOI [10.1038/NGEO1329, 10.1038/ngeo1329]; Lenz M, 2012, ENVIRON SCI TECHNOL, V46, P11988, DOI 10.1021/es302550b; Li KC, 2004, INT J ENVIRON AN CH, V84, P749, DOI 10.1080/03067310410001729619; Lomans BP, 2002, CELL MOL LIFE SCI, V59, P575, DOI 10.1007/s00018-002-8450-6; Martinez-Bravo Y, 2001, J CHROMATOGR A, V926, P265, DOI 10.1016/S0021-9673(01)01062-7; Meija J, 2002, ANAL CHEM, V74, P5837, DOI 10.1021/ac020285t; Mestrot A, 2011, ENVIRON SCI TECHNOL, V45, P1798, DOI 10.1021/es103463d; Mestrot A, 2009, ENVIRON SCI TECHNOL, V43, P8270, DOI 10.1021/es9018755; MESZAROS E, 1978, ATMOS ENVIRON, V12, P699, DOI 10.1016/0004-6981(78)90250-0; Niedzielski P, 2005, ANAL CHIM ACTA, V551, P199, DOI 10.1016/j.aca.2005.06.073; Pandey SK, 2009, ENVIRON SCI TECHNOL, V43, P3020, DOI 10.1021/es803272f; Pantsar-Kallio M, 2000, ANAL CHIM ACTA, V410, P65, DOI 10.1016/S0003-2670(99)00892-2; Pecheyran C, 1998, ANAL CHEM, V70, P2639, DOI 10.1021/ac9709615; Pecheyran C, 1998, J ANAL ATOM SPECTROM, V13, P615, DOI 10.1039/a802246a; Planer-Friedrich B, 2002, ANAL BIOANAL CHEM, V374, P1191, DOI 10.1007/s00216-002-1636-9; Planer-Friedrich B, 2007, ENVIRON SCI TECHNOL, V41, P5245, DOI 10.1021/es070273v; Plant JA, 2005, TREATISE ON GEOCHEMISTRY, VOL 9: ENVIRONMENTAL GEOCHEMISTRY, P17; Pyrzynska K, 2002, MICROCHIM ACTA, V140, P55, DOI 10.1007/s00604-001-0899-8; Thayer JS, 2002, APPL ORGANOMET CHEM, V16, P677, DOI 10.1002/aoc.375; Tonietto GB, 2010, ANAL BIOANAL CHEM, V397, P1755, DOI 10.1007/s00216-010-3764-y; Vriens B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4035; Wardencki W, 1998, J CHROMATOGR A, V793, P1, DOI 10.1016/S0021-9673(97)00997-7; Wen HJ, 2007, ATMOS ENVIRON, V41, P7151, DOI 10.1016/j.atmosenv.2007.07.035; Winkel L, 2008, NAT GEOSCI, V1, P536, DOI 10.1038/ngeo254; Winkel L, 2010, ENVIRON SCI TECHNOL, V44, P382, DOI 10.1021/es902345m; Winkel LHE, 2012, ENVIRON SCI TECHNOL, V46, P571, DOI 10.1021/es203434d; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Yang GS, 2012, CHEMOSPHERE, V87, P845, DOI 10.1016/j.chemosphere.2012.01.023	49	22	22	7	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102906	10.1371/journal.pone.0102906	http://dx.doi.org/10.1371/journal.pone.0102906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047128	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100088
J	Apaijai, N; Chinda, K; Palee, S; Chattipakorn, S; Chattipakorn, N				Apaijai, Nattayaporn; Chinda, Kroekkiat; Palee, Siripong; Chattipakorn, Siriporn; Chattipakorn, Nipon			Combined Vildagliptin and Metformin Exert Better Cardioprotection than Monotherapy against Ischemia-Reperfusion Injury in Obese-Insulin Resistant Rats	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; PROTEIN-KINASE; ISCHEMIA/REPERFUSION; MITOCHONDRIA; MODEL; CONNEXIN-43; INHIBITION; ARRHYTHMIA	Background: Obese-insulin resistance caused by long-term high-fat diet (HFD) consumption is associated with left ventricular (LV) dysfunction and increased risk of myocardial infarction. Metformin and vildagliptin have been shown to exert cardioprotective effects. However, the effect of these drugs on the hearts under obese-insulin resistance with ischemia-reperfusion (I/R) injury is unclear. We hypothesized that combined vildagliptin and metformin provide better protective effects against I/R injury than monotherapy in obese-insulin resistant rats. Methodology: Male Wistar rats were fed either HFD or normal diet. Rats in each diet group were divided into 4 subgroups to receive vildagliptin, metformin, combined vildagliptin and metformin, or saline for 21 days. Ischemia due to left anterior descending artery ligation was allowed for 30-min, followed by 120-min reperfusion. Metabolic parameters, heart rate variability (HRV), LV function, infarct size, mitochondrial function, calcium transient, Bax and Bcl-2, and Connexin 43 (Cx43) were determined. Rats developed insulin resistance after 12 weeks of HFD consumption. Vildagliptin, metformin, and combined drugs improved metabolic parameters, HRV, and LV function. During I/R, all treatments improved LV function, reduced infarct size and Bax, increased Bcl-2, and improved mitochondrial function in HFD rats. However, only combined drugs delayed the time to the first VT/VF onset, reduced arrhythmia score and mortality rate, and increased p-Cx43 in HFD rats. Conclusion: Although both vildagliptin and metformin improved insulin resistance and attenuate myocardial injury caused by I/R, combined drugs provided better outcomes than single therapy by reducing arrhythmia score and mortality rate.	[Apaijai, Nattayaporn; Chinda, Kroekkiat; Palee, Siripong; Chattipakorn, Siriporn; Chattipakorn, Nipon] Chiang Mai Univ, Fac Med, Cardiac Elect Res & Training Ctr, Chiang Mai 50000, Thailand; [Apaijai, Nattayaporn; Chinda, Kroekkiat; Chattipakorn, Nipon] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50000, Thailand; [Chattipakorn, Siriporn] Chiang Mai Univ, Fac Med, Dept Oral Biol & Diagnost Sci, Chiang Mai 50000, Thailand; [Chattipakorn, Nipon] Chiang Mai Univ, Ctr Biomed Engn, Chiang Mai 50000, Thailand; [Palee, Siripong] Mae Fahluang Univ, Sch Med, Chiang Rai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Fac Med, Cardiac Elect Res & Training Ctr, Chiang Mai 50000, Thailand.	nchattip@gmail.com	Chattipakorn, Nipon/AAJ-4049-2021; Chinda, Kroekkiat/GNW-2626-2022; PALEE, SIRIPONG/ABD-8607-2021	Chattipakorn, Nipon/0000-0003-3026-718X	Thailand Research Fund [RTA5580006]; BRG; Thailand Research Fund Royal Golden Jubilee Program; Chiang Mai University Excellent Center Award	Thailand Research Fund(Thailand Research Fund (TRF)); BRG; Thailand Research Fund Royal Golden Jubilee Program(Thailand Research Fund (TRF)); Chiang Mai University Excellent Center Award	This work was supported by the Thailand Research Fund RTA5580006 (NC), BRG (SC), the Thailand Research Fund Royal Golden Jubilee Program (NC and NA), and the Chiang Mai University Excellent Center Award (NC). Vildagliptin was kindly provided by Novartis (Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apaijai N, 2013, BRIT J PHARMACOL, V169, P1048, DOI 10.1111/bph.12176; Apaijai N, 2012, ENDOCRINOLOGY, V153, P3878, DOI 10.1210/en.2012-1262; Avila DD, 2013, ARCH MED RES, V44, P194, DOI 10.1016/j.arcmed.2013.03.004; Barreto-Torres G, 2012, INT J MOL SCI, V13, P7694, DOI 10.3390/ijms13067694; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Bikman BT, 2010, J OBES, V2010, DOI 10.1155/2010/970865; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Chinda K, 2013, INT J CARDIOL, V167, P451, DOI 10.1016/j.ijcard.2012.01.011; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; Danik SB, 2008, FASEB J, V22, P1204, DOI 10.1096/fj.07-8974com; Derosa G, 2013, PHARMACOL RES, V73, P20, DOI 10.1016/j.phrs.2013.04.005; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; du Toit EF, 2008, AM J PHYSIOL-HEART C, V294, pH2336, DOI 10.1152/ajpheart.00481.2007; Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Jackson PEM, 2008, ACTA PHYSIOL, V194, P23, DOI 10.1111/j.1748-1716.2008.01858.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Mari A, 2005, J CLIN ENDOCR METAB, V90, P4888, DOI 10.1210/jc.2004-2460; Palee S, 2013, EXP PHYSIOL, V98, P1028, DOI 10.1113/expphysiol.2012.070433; Pavithran P, 2008, CLIN EXP HYPERTENS, V30, P486, DOI 10.1080/10641960802251875; Pintana H, 2012, LIFE SCI, V91, P409, DOI 10.1016/j.lfs.2012.08.017; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Pratchayasakul W, 2011, LIFE SCI, V88, P619, DOI 10.1016/j.lfs.2011.02.003; Riess Matthias L., 2009, Journal of Pharmacological and Toxicological Methods, V60, P275, DOI 10.1016/j.vascn.2009.05.012; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Srisakuldee W, 2006, CELL COMMUN ADHES, V13, P13, DOI 10.1080/15419060600631326; Supakul L, 2013, EUR J NUTR IN PRESS; Surinkaew S, 2013, J CARDIOVASC PHARM, V61, P133, DOI 10.1097/FJC.0b013e318279b7b1; Thummasorn S, 2011, MITOCHONDRION, V11, P457, DOI 10.1016/j.mito.2011.01.008; Wensley I, 2013, EXP PHYSL IN PRESS; Whittington HJ, 2013, CARDIOVASC DRUG THER, V27, P5, DOI 10.1007/s10557-012-6425-x; Wongcharoen W, 2006, CARDIOVASC RES, V70, P497, DOI 10.1016/j.cardiores.2006.02.026; Zhang YY, 2010, J BIOL CHEM, V285, P4025, DOI 10.1074/jbc.M109.065664	39	68	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102374	10.1371/journal.pone.0102374	http://dx.doi.org/10.1371/journal.pone.0102374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036861	Green Published, gold, Green Submitted			2022-12-27	WOS:000339615200051
J	Huang, JL; Lin, YJ; Hung, YW; Hsieh, YC; Cheng, CM; Wang, KY				Huang, Jin-Long; Lin, Yenn-Jiang; Hung, Yi-Wen; Hsieh, Yu-Cheng; Cheng, Chien-Ming; Wang, Kuo-Yang			Preventing Phrenic Nerve Stimulation by a Patch Insulation in an Intact Swine Heart Model	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; VENTRICULAR PACING THRESHOLDS; LEAD; MANAGEMENT; OVERCOME	Introduction: Phrenic nerve stimulation (PNS) could be prevented by a silastic patch over the epicardial lead. We studied the effects in preventing PNS by placing a silastic patch directly over an epicardial lead or placing a graft around the phrenic nerve (PN). Methods and Results: Fourteen Lanyu swine were enrolled. A bipolar lead was placed epicardially on the left ventricle (LV) inferior to the PN. An implantable cardioverter-defibrillator (ICD) lead was placed into the right ventricle (RV). The maximal influential distance (MID) was measured under 3 pacing configurations to express the influential electrical field on the PN. The threshold of the LV and PN were evaluated epicardially. Then, PTFE patches of different sizes (10x10 mm, 20x20 mm and 30x30 mm) were placed between the LV lead and PN to study the rise in PN threshold in 7 swine. On the other hand, the PN were surrounded by a PTFE graft of different lengths (10 mm, 20 mm, and 30 mm) in the remaining 7 swine. LV-bipolar pacing showed the shortest MID when compared to the other 2 unipolar pacing configurations at pacing voltage of 10 V. The patch was most effective in preventing PNS during LV-bipolar pacing. PNS was prevented under all circumstances with a larger PTFE patch (30x30 mm) or long graft (30 mm). Conclusions: PNS was avoided by placing a PTFE patch over the LV lead or a graft around the PN despite pacing configurations. Hence if PNS persisted during CRT implantation, a PTFE patch on the LV lead or a graft around the PN could be considered.	[Huang, Jin-Long; Hsieh, Yu-Cheng; Wang, Kuo-Yang] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Huang, Jin-Long; Lin, Yenn-Jiang; Hsieh, Yu-Cheng] Natl Yang Ming Univ, Sch Med, Dept Med, Inst Clin Med, Taipei 112, Taiwan; [Huang, Jin-Long; Lin, Yenn-Jiang; Hsieh, Yu-Cheng] Natl Yang Ming Univ, Sch Med, Dept Med, Cardiovasc Res Inst, Taipei 112, Taiwan; [Huang, Jin-Long; Wang, Kuo-Yang] Chung Shan Med Univ, Sch Med, Dept Med, Taichung, Taiwan; [Lin, Yenn-Jiang] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Hung, Yi-Wen] Natl Chung Hsing Univ, Coll Vet Med, Dept Vet Med, Taichung Vet Gen Hosp,Dept Educ & Res, Taichung 40227, Taiwan; [Cheng, Chien-Ming] Minist Hlth & Welf, Feng Yuan Hosp, Dept Med, Div Cardiol, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taipei Veterans General Hospital; National Chung Hsing University; Taichung Veterans General Hospital	Huang, JL (corresponding author), Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan.	golden@vghtc.gov.tw			National Science Council [NSC 100-2314-B-075A-005-MY3]; Taichung Veterans General Hospital [1003105C, 1013105C, 1023105C]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital	Supported in part by grants from the National Science Council (NSC 100-2314-B-075A-005-MY3); Taichung Veterans General Hospital (1003105C, 1013105C, and 1023105C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Sham'a R, 2011, EUROPACE, V13, P997, DOI 10.1093/europace/eur076; Anderson SE, 2010, J ELECTROCARDIOL, V43, P136, DOI 10.1016/j.jelectrocard.2009.08.002; Biffi M, 2012, CIRC-ARRHYTHMIA ELEC, V5, P815, DOI 10.1161/CIRCEP.112.971317; Biffi M, 2011, CURR OPIN CARDIOL, V26, P12, DOI 10.1097/HCO.0b013e3283413838; Biffi M, 2009, CIRC-ARRHYTHMIA ELEC, V2, P402, DOI 10.1161/CIRCEP.108.836254; Champagne J, 2011, EUROPACE, V13, P409, DOI 10.1093/europace/euq499; Dendy Khalin F, 2011, Indian Pacing Electrophysiol J, V11, P64; Gurevitz O, 2005, PACE, V28, P1255, DOI 10.1111/j.1540-8159.2005.00265.x; James DS, 1963, CIRCULATION, V28, P114; Kirubakaran S, 2012, EUROPACE, V14, P608, DOI 10.1093/europace/eur355; Mediratta N, 2012, EUROPACE, V14, P1049, DOI 10.1093/europace/eur396; Oh S, 2011, HEART RHYTHM, V8, P1637, DOI 10.1016/j.hrthm.2011.05.002; Rickard J, 2011, AM J CARDIOL, V108, P1576, DOI 10.1016/j.amjcard.2011.07.017; Rickard J, 2011, J INTERV CARD ELECTR, V31, P61, DOI 10.1007/s10840-011-9555-3; Selvaraj Raja, 2011, Indian Pacing Electrophysiol J, V11, P61; Thibault B, 2010, EUROPACE, V12, P751, DOI 10.1093/europace/eup435; van Steenberghe M, 2011, INT J CARDIOL, V147, P328, DOI 10.1016/j.ijcard.2010.12.087; Wells WJ, 2003, ANN THORAC SURG, V76, P1757, DOI 10.1016/S0003-4975(03)00557-5	18	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102608	10.1371/journal.pone.0102608	http://dx.doi.org/10.1371/journal.pone.0102608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033271	Green Submitted, Green Published, gold			2022-12-27	WOS:000339418300068
J	van de Kamp, T; Rolo, TD; Vagovic, P; Baumbach, T; Riedel, A				van de Kamp, Thomas; Rolo, Tomy dos Santos; Vagovic, Patrik; Baumbach, Tilo; Riedel, Alexander			Three-Dimensional Reconstructions Come to Life - Interactive 3D PDF Animations in Functional Morphology	PLOS ONE			English	Article							HAWKMOTH MANDUCA-SEXTA; NEW-GUINEA; MECHANICS; CURCULIONIDAE; COLEOPTERA; SPECIMENS; SCIENCE; INSECT; MODELS; FLIGHT	Digital surface mesh models based on segmented datasets have become an integral part of studies on animal anatomy and functional morphology; usually, they are published as static images, movies or as interactive PDF files. We demonstrate the use of animated 3D models embedded in PDF documents, which combine the advantages of both movie and interactivity, based on the example of preserved Trigonopterus weevils. The method is particularly suitable to simulate joints with largely deterministic movements due to precise form closure. We illustrate the function of an individual screw-and-nut type hip joint and proceed to the complex movements of the entire insect attaining a defence position. This posture is achieved by a specific cascade of movements: Head and legs interlock mutually and with specific features of thorax and the first abdominal ventrite, presumably to increase the mechanical stability of the beetle and to maintain the defence position with minimal muscle activity. The deterministic interaction of accurately fitting body parts follows a defined sequence, which resembles a piece of engineering.	[van de Kamp, Thomas; Rolo, Tomy dos Santos; Vagovic, Patrik; Baumbach, Tilo] KIT, ANKA Inst Photon Sci & Synchrotron Radiat, Eggenstein Leopoldshafen, Germany; [van de Kamp, Thomas; Riedel, Alexander] State Museum Nat Hist SMNK, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	van de Kamp, T (corresponding author), KIT, ANKA Inst Photon Sci & Synchrotron Radiat, Eggenstein Leopoldshafen, Germany.	thomas.vandekamp@kit.edu	Baumbach, Tilo Gerd/K-5355-2013; dos Santos Rolo, Tomy/F-5511-2016; Riedel, Alexander/V-2608-2019; van de Kamp, Thomas/G-1440-2016	dos Santos Rolo, Tomy/0000-0002-9771-3511; Riedel, Alexander/0000-0002-8291-4425; van de Kamp, Thomas/0000-0001-7390-1318	Deutsche Forschungsgemeinschaft, DFG [RI 1817/3-1, RI 1817/3-3]; German Federal Ministry of Education and Research [05K10CKB, 05K12CK2]; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	This work was partly funded by Deutsche Forschungsgemeinschaft, DFG (www.dfg.de; RI 1817/3-1, 3-3) and the German Federal Ministry of Education and Research (www.bmbf.de; grants 05K10CKB and 05K12CK2). The authors' acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumler N, 2008, ZOOSYMPOSIA, V1, P101, DOI 10.11646/zoosymposia.1.1.9; Baier DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063982; Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; BLEICH OTTO ERNST, 1928, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPHOL U OKOL TIERE, V10, P1, DOI 10.1007/BF00419278; Bogelsack G, 2000, THEOR BIOSCI, V119, P104, DOI 10.1078/1431-7613-00008; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; FULL RJ, 1991, J EXP BIOL, V156, P215; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; Handschuh S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-44; HOMBERGER DG, 1988, AM ZOOL, V28, P217; Lauridsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017879; Murienne J, 2008, NATURE, V453, P450, DOI 10.1038/453450d; Riedel A, 2010, ZOOTAXA, P59; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x; Rolo TD, 2014, P NATL ACAD SCI USA, V111, P3921, DOI 10.1073/pnas.1308650111; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Sahara W, 2006, J ORTHOP RES, V24, P1823, DOI 10.1002/jor.20208; Spence AJ, 2010, J EXP BIOL, V213, P1907, DOI 10.1242/jeb.042515; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; van de Kamp T, 2011, SCIENCE, V333, P52, DOI 10.1126/science.1204245; Weide D, 2014, ACTA ZOOL-STOCKHOLM, V95, P84, DOI 10.1111/azo.12011; Weitkamp T, 2011, J SYNCHROTRON RADIAT, V18, P617, DOI 10.1107/S0909049511002895; Westneat MW, 2008, ANNU REV PHYSIOL, V70, P119, DOI 10.1146/annurev.physiol.70.113006.100434; Willmott AP, 1997, J EXP BIOL, V200, P2705; Willmott AP, 1997, J EXP BIOL, V200, P2723; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Zill S, 2000, MICROSC RES TECHNIQ, V48, P367, DOI 10.1002/(SICI)1097-0029(20000315)48:6<367::AID-JEMT7>3.3.CO;2-P	30	47	48	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102355	10.1371/journal.pone.0102355	http://dx.doi.org/10.1371/journal.pone.0102355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029366	Green Published, Green Submitted, gold			2022-12-27	WOS:000341306600069
J	DeNiro, M; Al-Mohanna, FA				DeNiro, Michael; Al-Mohanna, Futwan A.			Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; RETINAL NEOVASCULARIZATION; DIABETIC-RETINOPATHY; INTRAVITREAL BEVACIZUMAB; UP-REGULATION; ACTIVATION; EXPRESSION; CANCER; MODEL	Retinal ischemia promotes the upregulation of VEGF expression and accounts for most pathological features of retinal neovascularization (NV). Paradoxically, VEGF remains the pivotal stimulator of ocular NV, despite the absence of ischemia. Therefore, the central question arises as to how the various molecular mechanisms interplay in ischemia-independent NV. It's been suggested that NF kappa B plays a crucial role in the pathogenesis of diabetic vasculopathies. Here, we dissected the molecular mechanism of ocular NV in the rho/VEGF transgenic mouse model, which develops subretinal NV in ischemia-independent microenvironment. Furthermore, we examined whether intravitreal administration of YC-1, a HIF-1 inhibitor, can modulate the activation of NF kappa B and its downstream angiogenic signaling in the mouse retina. We demonstrated that YC-1 inhibited retinal NF kappa B/p65 DNA binding activity and downregulated NF kappa B/p65, FAK, alpha 5 beta 1, EPO, ET-1, and MMP-9 expression at the message and the protein levels. In addition, YC-1 significantly inhibited subretinal NV by reducing the number of neovascular lesions, the area of each lesion and the total area of NV per retina. We further investigated the influence of VEGF signaling pathway on HIF-1 alpha transcriptional activity to substantiate that this mouse model develops subretinal NV in an ischemia-independent microenvironment. Our data demonstrated that VEGF overexpression didn't have any impact on HIF-1 alpha transcriptional activity, whereas treatment with YC-1 significantly inhibited endogenous HIF-1 activity. Our study suggests that retinal NF kappa B transcriptional activity is pivotal to ischemia-independent mechanisms, which lead to the local activation of angiogenic cascades. Our data also indicate that the nexus between VEGF and NF kappa B is implicated in triggering the angiogenic cascade that promotes retinal NV. Hence, targeting the VEGF/NF kappa B axis may act in a negative feedback loop to suppress ocular NV. This study suggests that inhibition of NF kappa B activation may be a means of turning off a "master switch" responsible for initiating and perpetuating these ocular pathologies.	[DeNiro, Michael; Al-Mohanna, Futwan A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia; [Al-Mohanna, Futwan A.] Al Faisal Univ, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Alfaisal University	DeNiro, M (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia.	mdeniro@kfshrc.edu.sa			King Khaled Eye Specialist Hospital Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia	King Khaled Eye Specialist Hospital Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia	This research study was funded by King Khaled Eye Specialist Hospital Riyadh, Saudi Arabia, and King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Berglin L, 2003, INVEST OPHTH VIS SCI, V44, P403, DOI 10.1167/iovs.02-0180; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; DeNiro M, 2010, MOL PHARMACOL, V77, P348, DOI 10.1124/mol.109.061366; DeNiro M, 2009, EXP EYE RES, V89, P700, DOI 10.1016/j.exer.2009.06.013; DeNiro M, 2011, OPEN DIABETES J, V4, P75; DeNiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059021; DeNiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022244; Dikov MM, 2001, CANCER RES, V61, P2015; Fontanilla F, 2006, RETINAL VACUITIES; Forte R, 2010, EYE, V24, P1325, DOI 10.1038/eye.2010.23; GAUDRIC A, 1984, J FR OPHTALMOL, V7, P291; Hayreh SS, 2012, RETINA-J RET VIT DIS, V32, P1553, DOI 10.1097/IAE.0b013e318246912c; He H, 2010, J HUAZHONG U SCI-MED, V30, P659, DOI 10.1007/s11596-010-0560-z; Huang YT, 2005, MOL CANCER THER, V4, P1628, DOI 10.1158/1535-7163.MCT-05-0090; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keunen JEE, 2002, RETINA-J RET VIT DIS, V22, P371, DOI 10.1097/00006982-200206000-00023; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; Kornberg LJ, 2004, INVEST OPHTH VIS SCI, V45, P4463, DOI 10.1167/iovs.03-1201; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Majka M, 2000, BLOOD, V96, P4142, DOI 10.1182/blood.V96.13.4142.h8004142_4142_4151; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Mitry D, 2013, COCHRANE DB SYST REV, V1; Moses MA, 1997, STEM CELLS, V15, P180, DOI 10.1002/stem.150180; Muqit MMK, 2012, ACTA OPHTHALMOL, V90, P155, DOI 10.1111/j.1755-3768.2009.01854.x; Nezi L, 2002, BIOL CHEM, V383, P167, DOI 10.1515/BC.2002.017; Ohno-Matsui K, 2002, AM J PATHOL, V160, P711, DOI 10.1016/S0002-9440(10)64891-2; Okamoto N, 1997, AM J PATHOL, V151, P281; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Pan SL, 2005, THROMB HAEMOSTASIS, V93, P940, DOI 10.1160/TH04-03-0195; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Pe'er J, 1998, OPHTHALMOLOGY, V105, P412, DOI 10.1016/S0161-6420(98)93020-2; Quarnstrom F, 1994, Quintessence Int, V25, P713; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Saati S, 2010, GRAEF ARCH CLIN EXP, V248, P457, DOI 10.1007/s00417-009-1153-z; Santos AM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036243, 10.1371/journal.pone.0048332]; SELAM JL, 1986, DIABETIC MED, V3, P60, DOI 10.1111/j.1464-5491.1986.tb00709.x; Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje; Stitt Alan W., 2000, Molecular Cell Biology Research Communications, V3, P380, DOI 10.1006/mcbr.2000.0243; Stone RA, 2001, INVEST OPHTH VIS SCI, V42, P557; THIEME H, 1995, DIABETES, V44, P98, DOI 10.2337/diabetes.44.1.98; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Turpaev KT, 2002, BIOCHEMISTRY-MOSCOW+, V67, P281, DOI 10.1023/A:1014819832003; Vinores SA, 1997, HISTOL HISTOPATHOL, V12, P99; Wang VYF, 2012, CELL REP, V2, P824, DOI 10.1016/j.celrep.2012.08.042; ZALUSKI S, 1985, J FR OPHTALMOL, V8, P449	51	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101602	10.1371/journal.pone.0101602	http://dx.doi.org/10.1371/journal.pone.0101602			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050547	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100010
J	Sung, KH; Song, HK				Sung, Kwang Hoon; Song, Hyun Kyu			Insights into the Molecular Evolution of HslU ATPase through Biochemical and Mutational Analyses	PLOS ONE			English	Article							CELL-DIVISION INHIBITOR; LOCUS V HSLV; ESCHERICHIA-COLI; DEPENDENT PROTEASE; CRYSTAL-STRUCTURE; PROTEOLYTIC ACTIVITY; PEPTIDASE; COMPLEX; BINDING; PURIFICATION	The ATP-dependent HslVU complexes are found in all three biological kingdoms. A single HslV protease exists in each species of prokaryotes, archaea, and eukaryotes, but two HslUs (HslU1 and HslU2) are present in the mitochondria of eukaryotes. Previously, a tyrosine residue at the C-terminal tail of HslU2 has been identified as a key determinant of HslV activation in Trypanosoma brucei and a phenylalanine at the equivalent position to E. coli HslU is found in T. brucei HslU1. Unexpectedly, we found that an F441Y mutation in HslU enhanced the peptidase and caseinolytic activity of HslV in E. coli but it showed partially reduced ATPase and SulA degradation activity. Previously, only the C-terminal tail of HslU has been the focus of HslV activation studies. However, the Pro315 residue interacting with Phe441 in free HslU has also been found to be critical for HslV activation. Hence, our current biochemical analyses explore the importance of the loop region just before Pro315 for HslVU complex functionality. The proline and phenylalanine pair in prokaryotic HslU was replaced with the threonine and tyrosine pair from the functional eukaryotic HslU2. Sequence comparisons between multiple HslUs from three different biological kingdoms in combination with biochemical analysis of E. coli mutants have uncovered important new insights into the molecular evolutionary pathway of HslU.	[Sung, Kwang Hoon; Song, Hyun Kyu] Korea Univ, Dept Life Sci, Seoul, South Korea	Korea University	Song, HK (corresponding author), Korea Univ, Dept Life Sci, Seoul, South Korea.	hksong@korea.ac.kr	Song, Hyun Kyu/D-6763-2016; Sood, Anoop Kumar/A-7344-2013	Song, Hyun Kyu/0000-0001-5684-4059; Sood, Anoop Kumar/0000-0001-5702-4108	National Research Foundation of Korea (NRF) - Korean government [NRF-2011-0028168, NRF-2013R1A1A2020177]	National Research Foundation of Korea (NRF) - Korean government	This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (NRF-2011-0028168 and NRF-2013R1A1A2020177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barboza NR, 2012, EXP PARASITOL, V130, P171, DOI 10.1016/j.exppara.2011.10.011; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chrobak M, 2012, INT J PARASITOL, V42, P329, DOI 10.1016/j.ijpara.2012.01.008; Couvreur B, 2002, MOL BIOL EVOL, V19, P2110, DOI 10.1093/oxfordjournals.molbev.a004036; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gille C, 2003, J MOL BIOL, V326, P1437, DOI 10.1016/S0022-2836(02)01470-5; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Higashitani A, 1997, MOL GEN GENET, V254, P351, DOI 10.1007/s004380050426; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; KANAOKA Y, 1985, CHEM PHARM BULL, V33, P1721; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000048; Park E, 2008, J BIOL CHEM, V283, P33258, DOI 10.1074/jbc.M805411200; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Ruiz-Gonzalez MX, 2006, J MOL EVOL, V63, P504, DOI 10.1007/s00239-005-0282-1; SCHICKANEDER E, 1988, FRESEN Z ANAL CHEM, V330, P360, DOI 10.1007/BF00469282; Seong IS, 2000, FEBS LETT, V477, P224, DOI 10.1016/S0014-5793(00)01808-1; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Shi LC, 2014, P NATL ACAD SCI USA, V111, P2140, DOI 10.1073/pnas.1318476111; SONEZAKI S, 1994, APPL MICROBIOL BIOT, V42, P313; SONEZAKI S, 1995, APPL MICROBIOL BIOT, V43, P304; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Song HK, 2003, BIOPHYS CHEM, V100, P437, DOI 10.1016/S0301-4622(02)00297-1; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Sung KH, 2013, J BIOL CHEM, V288, P23234, DOI 10.1074/jbc.M113.484832; Tschan S, 2010, INT J PARASITOL, V40, P1517, DOI 10.1016/j.ijpara.2010.05.006; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	48	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103027	10.1371/journal.pone.0103027	http://dx.doi.org/10.1371/journal.pone.0103027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050622	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100077
J	Sutcliffe, JS; Beaumont, V; Watson, JM; Chew, CS; Beconi, M; Hutcheson, DM; Dominguez, C; Munoz-Sanjuan, I				Sutcliffe, Jane S.; Beaumont, Vahri; Watson, James M.; Chew, Chang Sing; Beconi, Maria; Hutcheson, Daniel M.; Dominguez, Celia; Munoz-Sanjuan, Ignacio			Efficacy of Selective PDE4D Negative Allosteric Modulators in the Object Retrieval Task in Female Cynomolgus Monkeys (Macaca fascicularis)	PLOS ONE			English	Article							QUINOLINIC ACID MODEL; CREB-BINDING-PROTEIN; R6/2 MOUSE MODEL; HUNTINGTONS-DISEASE; PREFRONTAL CORTEX; INHIBITOR ROLIPRAM; MOTOR DEFICITS; PHOSPHODIESTERASE INHIBITORS; DARPP-32 PHOSPHORYLATION; STRIATAL EXCITOTOXICITY	Cyclic adenosine monophosphate (cAMP) signalling plays an important role in synaptic plasticity and information processing in the hippocampal and basal ganglia systems. The augmentation of cAMP signalling through the selective inhibition of phosphodiesterases represents a viable strategy to treat disorders associated with dysfunction of these circuits. The phosphodiesterase (PDE) type 4 inhibitor rolipram has shown significant pro-cognitive effects in neurological disease models, both in rodents and primates. However, competitive non-isoform selective PDE4 inhibitors have a low therapeutic index which has stalled their clinical development. Here, we demonstrate the pro-cognitive effects of selective negative allosteric modulators (NAMs) of PDE4D, D159687 and D159797 in female Cynomolgous macaques, in the object retrieval detour task. The efficacy displayed by these NAMs in a primate cognitive task which engages the corticostriatal circuitry, together with their suitable pharmacokinetic properties and safety profiles, suggests that clinical development of these allosteric modulators should be considered for the treatment of a variety of brain disorders associated with cognitive decline.	[Sutcliffe, Jane S.; Watson, James M.; Chew, Chang Sing; Hutcheson, Daniel M.] Maccine Pte Ltd, Dept Neurosci & CNS Safety Pharmacol, Singapore, Singapore; [Beaumont, Vahri; Beconi, Maria; Dominguez, Celia; Munoz-Sanjuan, Ignacio] CHDI Management Inc, CHDI Fdn, Los Angeles, CA 90045 USA		Munoz-Sanjuan, I (corresponding author), CHDI Management Inc, CHDI Fdn, Los Angeles, CA 90045 USA.	ignacio.munoz@chdifoundation.org		Beaumont, Vahri/0000-0002-6488-2175	CHDI Foundation	CHDI Foundation	CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organization Maccine Pte Ltd. under a fee-for-service agreement. The authors listed all contributed to the conception, study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'uthor contributions' section.	ASANUMA M, 1993, ARCH GERONTOL GERIAT, V16, P191, DOI 10.1016/0167-4943(93)90009-7; Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; BERTOLINO A, 1988, INT CLIN PSYCHOPHARM, V3, P245, DOI 10.1097/00004850-198807000-00006; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Chiang MC, 2005, J BIOL CHEM, V280, P14331, DOI 10.1074/jbc.M413279200; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; Di L, 2013, J MED CHEM, V56, P2, DOI 10.1021/jm301297f; DIAMOND A, 1989, BEHAV NEUROSCI, V103, P526, DOI 10.1037/0735-7044.103.3.526; Dias R, 1996, BEHAV NEUROSCI, V110, P872, DOI 10.1037/0735-7044.110.5.872; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friden M, 2009, J MED CHEM, V52, P6233, DOI 10.1021/jm901036q; Giampa C, 2009, NEUROBIOL DIS, V34, P450, DOI 10.1016/j.nbd.2009.02.014; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gray RA, 2006, AIDS RES HUM RETROV, V22, P1031, DOI 10.1089/aid.2006.22.1031; Hebb ALO, 2007, CURR OPIN PHARMACOL, V7, P86, DOI 10.1016/j.coph.2006.08.014; HEBENSTREIT GF, 1989, PHARMACOPSYCHIATRY, V22, P156, DOI 10.1055/s-2007-1014599; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huang Z, 2007, BIOCHEM PHARMACOL, V73, P1971, DOI 10.1016/j.bcp.2007.03.010; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jentsch JD, 1997, SCIENCE, V277, P953, DOI 10.1126/science.277.5328.953; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kleiman RJ, 2011, J PHARMACOL EXP THER, V336, P64, DOI 10.1124/jpet.110.173294; Kobayashi M, 2011, INT IMMUNOPHARMACOL, V11, P732, DOI 10.1016/j.intimp.2011.01.023; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kuroiwa M, 2011, PSYCHOPHARMACOLOGY B; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Li YF, 2009, NEUROPSYCHOPHARMACOL, V34, P2404, DOI 10.1038/npp.2009.66; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marte A, 2008, J NEUROSCI RES, V86, P3338, DOI 10.1002/jnr.21788; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Navakkode S, 2004, J NEUROSCI, V24, P7740, DOI 10.1523/JNEUROSCI.1796-04.2004; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Obrietan K, 2004, J NEUROSCI, V24, P791, DOI 10.1523/JNEUROSCI.3493-03.2004; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Palfi SP, 1996, J NEUROSCI, V16, P3019; Puerta E, 2010, NEUROBIOL DIS, V38, P237, DOI 10.1016/j.nbd.2010.01.013; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Robichaud A, 1999, NEUROPHARMACOLOGY, V38, P289, DOI 10.1016/S0028-3908(98)00190-7; Rodefer JS, 2011, NEUROPHARMACOLOGY; Roitberg BZ, 2002, NEUROSURGERY, V50, P137, DOI 10.1097/00006123-200201000-00022; Rosas HD, 2011, MOVEMENT DISORD, V26, P1691, DOI 10.1002/mds.23762; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Rose GM, 2005, CURR PHARM DESIGN, V11, P3329, DOI 10.2174/138161205774370799; Rutten K, 2008, PSYCHOPHARMACOLOGY, V196, P643, DOI 10.1007/s00213-007-0999-1; Rutten K, 2007, PSYCHOPHARMACOLOGY, V192, P275, DOI 10.1007/s00213-006-0697-4; Rutten K, 2006, NEUROBIOL LEARN MEM, V85, P132, DOI 10.1016/j.nlm.2005.09.002; Sanderson TM, 2013, NEUROPHARMACOLOGY, V74, P86, DOI 10.1016/j.neuropharm.2013.01.011; Scahill RI, 2011, HUM BRAIN MAPP; Sharma S, 2013, EUR J PHARMACOL, V714, P486, DOI 10.1016/j.ejphar.2013.06.038; Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; TAYLOR JR, 1990, BRAIN, V113, P617, DOI 10.1093/brain/113.3.617; Threlfell S, 2009, J PHARMACOL EXP THER, V328, P785, DOI 10.1124/jpet.108.146332; Tinsley M, 2007, COGNITION ENHANCING; Walker SC, 2006, EUR J NEUROSCI, V23, P3119, DOI 10.1111/j.1460-9568.2006.04826.x; Wang HC, 2007, BIOCHEM J, V408, P193, DOI 10.1042/BJ20070970; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005	72	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102449	10.1371/journal.pone.0102449	http://dx.doi.org/10.1371/journal.pone.0102449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050979	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100037
J	Canovas, A; Reverter, A; DeAtley, KL; Ashley, RL; Colgrave, ML; Fortes, MRS; Islas-Trejo, A; Lehnert, S; Porto-Neto, L; Rincon, G; Silver, GA; Snelling, WM; Medrano, JF; Thomas, MG				Canovas, Angela; Reverter, Antonio; DeAtley, Kasey L.; Ashley, Ryan L.; Colgrave, Michelle L.; Fortes, Marina R. S.; Islas-Trejo, Alma; Lehnert, Sigrid; Porto-Neto, Laercio; Rincon, Gonzalo; Silver, Gail A.; Snelling, Warren M.; Medrano, Juan F.; Thomas, Milton G.			Multi-Tissue Omics Analyses Reveal Molecular Regulatory Networks for Puberty in Composite Beef Cattle	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; GENOME-WIDE ASSOCIATION; 1ST SERVICE CONCEPTION; SKELETAL-MUSCLE; CANDIDATE GENES; ADIPOSE-TISSUE; PROTEIN; GROWTH; POLYMORPHISM; RECEPTOR	Puberty is a complex physiological event by which animals mature into an adult capable of sexual reproduction. In order to enhance our understanding of the genes and regulatory pathways and networks involved in puberty, we characterized the transcriptome of five reproductive tissues (i.e. hypothalamus, pituitary gland, ovary, uterus, and endometrium) as well as tissues known to be relevant to growth and metabolism needed to achieve puberty (i.e., longissimus dorsi muscle, adipose, and liver). These tissues were collected from pre- and post-pubertal Brangus heifers (3/8 Brahman; Bos indicus x 5/8 Angus; Bos taurus) derived from a population of cattle used to identify quantitative trait loci associated with fertility traits (i.e., age of first observed corpus luteum (ACL), first service conception (FSC), and heifer pregnancy (HPG)). In order to exploit the power of complementary omics analyses, pre- and post-puberty co-expression gene networks were constructed by combining the results from genome-wide association studies (GWAS), RNA-Seq, and bovine transcription factors. Eight tissues among pre-pubertal and post-pubertal Brangus heifers revealed 1,515 differentially expressed and 943 tissue-specific genes within the 17,832 genes confirmed by RNA-Seq analysis. The hypothalamus experienced the most notable up-regulation of genes via puberty (i.e., 204 out of 275 genes). Combining the results of GWAS and RNA-Seq, we identified 25 loci containing a single nucleotide polymorphism (SNP) associated with ACL, FSC, and (or) HPG. Seventeen of these SNP were within a gene and 13 of the genes were expressed in uterus or endometrium. Multi-tissue omics analyses revealed 2,450 co-expressed genes relative to puberty. The pre-pubertal network had 372,861 connections whereas the postpubertal network had 328,357 connections. A sub-network from this process revealed key transcriptional regulators (i.e., PITX2, FOXA1, DACH2, PROP1, SIX6, etc.). Results from these multi-tissue omics analyses improve understanding of the number of genes and their complex interactions for puberty in cattle.	[Canovas, Angela; Islas-Trejo, Alma; Rincon, Gonzalo; Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Reverter, Antonio; Colgrave, Michelle L.; Lehnert, Sigrid; Porto-Neto, Laercio] CSIRO, Food Futures Flagship, St Lucia, Qld, Australia; [Reverter, Antonio; Colgrave, Michelle L.; Lehnert, Sigrid; Porto-Neto, Laercio] Queensland Biosci Precinct, Div Anim Food & Hlth Sci, St Lucia, Qld, Australia; [DeAtley, Kasey L.; Ashley, Ryan L.; Silver, Gail A.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA; [Fortes, Marina R. S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Anim Sci, Gatton, Qld, Australia; [Snelling, Warren M.] USDA, Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Thomas, Milton G.] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA	University of California System; University of California Davis; Commonwealth Scientific & Industrial Research Organisation (CSIRO); New Mexico State University; University of Queensland; United States Department of Agriculture (USDA); Colorado State University	Thomas, MG (corresponding author), Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA.	milt.thomas@colostate.edu	Lehnert, Sigrid A/A-3676-2013; Porto-Neto, Laercio R/D-2594-2012; Reverter, Antonio/C-9699-2013; Colgrave, Michelle/A-5710-2012; Fortes, Marina/AAN-6815-2020; Cánovas, Angela/AAG-6282-2020; Fortes, Marina R S/G-2302-2012	Lehnert, Sigrid A/0000-0003-4891-9094; Porto-Neto, Laercio R/0000-0002-3536-8265; Reverter, Antonio/0000-0002-4681-9404; Colgrave, Michelle/0000-0001-8463-805X; Fortes, Marina/0000-0002-7254-1960; Fortes, Marina R S/0000-0002-7254-1960	USDA-AFRI [2008-35205-18751]; McMaster Fellowship program of CSIRO-Australia; Gerald Thomas Chair Endowment of New Mexico State University; New Mexico Agricultural Experiment Station Project (Hatch) [216391]; John E. Rouse Chair Endowment of Colorado State University; Cooperative Research Centre for Beef Genetic Technologies in Australia; ME/Fulbright scholarship program; ARS [ARS-0424177] Funding Source: Federal RePORTER	USDA-AFRI(United States Department of Agriculture (USDA)); McMaster Fellowship program of CSIRO-Australia; Gerald Thomas Chair Endowment of New Mexico State University; New Mexico Agricultural Experiment Station Project (Hatch); John E. Rouse Chair Endowment of Colorado State University; Cooperative Research Centre for Beef Genetic Technologies in Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); ME/Fulbright scholarship program; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-AFRI (Grant no. 2008-35205-18751), McMaster Fellowship program of CSIRO-Australia, Gerald Thomas Chair Endowment of New Mexico State University, New Mexico Agricultural Experiment Station Project (Hatch #216391), John E. Rouse Chair Endowment of Colorado State University, and the Cooperative Research Centre for Beef Genetic Technologies in Australia. AC was supported by the ME/Fulbright scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almawi WY, 2013, REPRODUCTION, V146, pR73, DOI 10.1530/REP-13-0072; Amstalden Marcel, 2011, Front Endocrinol (Lausanne), V2, P109, DOI 10.3389/fendo.2011.00109; Bafunno V, 2011, THROMB RES, V128, P508, DOI 10.1016/j.thromres.2011.08.007; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bione S, 2004, HUM REPROD, V19, P2759, DOI 10.1093/humrep/deh502; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Burns BM, 2010, ANIM REPROD SCI, V122, P1, DOI 10.1016/j.anireprosci.2010.04.010; Buske FA, 2010, BIOINFORMATICS, V26, P860, DOI 10.1093/bioinformatics/btq049; Canovas A, 2013, J DAIRY SCI, V96, P2637, DOI 10.3168/jds.2012-6213; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Chazenbalk G, 2012, J CLIN ENDOCR METAB, V97, pE765, DOI 10.1210/jc.2011-2377; Chen NN, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.111.098335; Connell MT, 2013, J GENET SYNDR GENE T, V4; D'Elia AV, 2001, HUM MUTAT, V18, P361, DOI 10.1002/humu.1207; Day M. L., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0027; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Dorn LD, 2011, J RES ADOLESCENCE, V21, P180, DOI 10.1111/j.1532-7795.2010.00722.x; Dupre Aude, 2011, J Signal Transduct, V2011, P350412, DOI 10.1155/2011/350412; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Fortes MRS, 2012, J ANIM SCI, V90, P2894, DOI 10.2527/jas.2011-4601; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gabbay-Benziv R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037015; Garrett AJ, 2008, J ANIM SCI, V86, P3315, DOI 10.2527/jas.2008-0990; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; Gu B, 2012, STEM CELLS DEV, V21, P2878, DOI 10.1089/scd.2012.0097; Gu QA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-23; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Kogata N, 2013, J MAMMARY GLAND BIOL, V18, P149, DOI 10.1007/s10911-013-9286-4; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Larder R, 2011, J NEUROSCI, V31, P426, DOI 10.1523/JNEUROSCI.1688-10.2011; Lee SH, 2010, ANIM GENET, V41, P442, DOI 10.1111/j.1365-2052.2010.02024.x; Lomniczi A, 2013, HORM BEHAV, V64, P175, DOI 10.1016/j.yhbeh.2012.09.013; Lopez R., 2006, PROFESSIONAL ANIMAL, V22, P273, DOI [10.15232/S1080-7446(15)31104-9, DOI 10.15232/S1080-7446(15)31104-9]; Luna-Nevarez P, 2011, J ANIM SCI, V89, P926, DOI 10.2527/jas.2010-3483; Luna-Nevarez P, 2010, J ANIM SCI, V88, P1891, DOI 10.2527/jas.2009-2541; Markholt S, 2012, MOL HUM REPROD, V18, P96, DOI 10.1093/molehr/gar083; Martinez-Giner M, 2011, J ANIM BREED GENET, V128, P344, DOI 10.1111/j.1439-0388.2011.00925.x; Matorras R, 2011, FERTIL STERIL, V95, P1937, DOI 10.1016/j.fertnstert.2011.02.030; McLachlan GJ, 2006, BIOINFORMATICS, V22, P1608, DOI 10.1093/bioinformatics/btl148; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; Medrano JF, 2010, P 9 WORLD C APPL LIV; Moreno-Sanchez N, 2012, FUNCT INTEGR GENOMIC, V12, P93, DOI 10.1007/s10142-011-0249-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narro LA, 2003, DOMEST ANIM ENDOCRIN, V24, P243, DOI 10.1016/S0739-7240(02)00239-4; Narukami T, 2011, ANIM SCI J, V82, P406, DOI 10.1111/j.1740-0929.2010.00855.x; Nogueira GP, 2004, ANIM REPROD SCI, V82-3, P361, DOI 10.1016/j.anireprosci.2004.04.007; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Ojeda SR, 2010, MOL CELL ENDOCRINOL, V324, P3, DOI 10.1016/j.mce.2009.12.003; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ounzain S, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2809; Peters SO, 2013, J ANIM SCI, V91, P605, DOI 10.2527/jas.2012-5580; Peters SO, 2012, J ANIM SCI, V90, P3398, DOI [10.2527/jas.2011-4507, 10.2527/jas.2012-4507]; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Raetzman LT, 2002, DEVELOPMENT, V129, P4229; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Reverter A, 2005, BIOINFORMATICS, V21, P1112, DOI 10.1093/bioinformatics/bti124; Reverter A, 2013, J ANIM SCI, V91, P530, DOI 10.2527/jas.2012-5780; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Rodrigues HD, 2002, BIOL REPROD, V66, P603, DOI 10.1095/biolreprod66.3.603; Rogers RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013150; Roth CL, 2007, ENDOCRINOLOGY, V148, P5147, DOI 10.1210/en.2007-0634; Satchell L, 2013, ENDOCRINOLOGY, V154, P1897, DOI 10.1210/en.2012-2232; Schneider F. A., 1996, Sheep & Goat Research Journal, V12, P33; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirley K.L., 2006, PROF ANIM SCI, V22, DOI [10.15232/S1080-7446(15)31060-3, DOI 10.15232/S1080-7446(15)31060-3]; Snelling WM, 2013, J ANIM SCI, V91, P537, DOI 10.2527/jas.2012-5784; Subiran N, 2011, MOL MED, V17, P846, DOI 10.2119/molmed.2010.00268; Sugihara Y, 2013, GENE, V521, P91, DOI 10.1016/j.gene.2013.02.040; Sun Wei, 2012, BMC Res Notes, V5, P632, DOI 10.1186/1756-0500-5-632; Suzumori N, 2007, CURR MED CHEM, V14, P353, DOI 10.2174/092986707779941087; Tabandeh MR, 2010, THERIOGENOLOGY, V73, P659, DOI 10.1016/j.theriogenology.2009.11.006; Tan O, 2013, REPROD SCI, V20, P16, DOI 10.1177/1933719112459244; Tang KQ, 2011, MOL BIOL REP, V38, P17, DOI 10.1007/s11033-010-0072-8; Thackray VG, 2014, MOL CELL ENDOCRINOL, V385, P62, DOI 10.1016/j.mce.2013.09.034; Torricelli M, 2012, AM J REPROD IMMUNOL, V68, P392, DOI 10.1111/j.1600-0897.2012.01180.x; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; Ulbrich SE, 2009, BIOL REPROD, V81, P795, DOI 10.1095/biolreprod.108.075184; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zieba DA, 2005, DOMEST ANIM ENDOCRIN, V29, P166, DOI 10.1016/j.domaniend.2005.02.019	97	83	83	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102551	10.1371/journal.pone.0102551	http://dx.doi.org/10.1371/journal.pone.0102551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048735	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100044
J	Madhu, V; Li, CJ; Dighe, AS; Balian, G; Cui, QJ				Madhu, Vedavathi; Li, Ching-Ju; Dighe, Abhijit S.; Balian, Gary; Cui, Quanjun			BMP-Non-Responsive Sca1(+)CD73(+)CD44(+) Mouse Bone Marrow Derived Osteoprogenitor Cells Respond to Combination of VEGF and BMP-6 to Display Enhanced Osteoblastic Differentiation and Ectopic Bone Formation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; MORPHOGENETIC PROTEIN-2; OSTEOGENIC DIFFERENTIATION; REPAIR; FRACTURES; DELIVERY	Clinical trials on fracture repair have challenged the effectiveness of bone morphogenetic proteins (BMPs) but suggest that delivery of mesenchymal stem cells (MSCs) might be beneficial. It has also been reported that BMPs could not increase mineralization in several MSCs populations, which adds ambiguity to the use of BMPs. However, an exogenous supply of MSCs combined with vascular endothelial growth factor (VEGF) and BMPs is reported to synergistically enhance fracture repair in animal models. To elucidate the mechanism of this synergy, we investigated the osteoblastic differentiation of cloned mouse bone marrow derived MSCs (D1 cells) in vitro in response to human recombinant proteins of VEGF, BMPs (-2, -4, -6, -9) and the combination of VEGF with BMP-6 (most potent BMP). We further investigated ectopic bone formation induced by MSCs pre-conditioned with VEGF, BMP-6 or both. No significant increase in mineralization, phosphorylation of Smads 1/5/8 and expression of the ALP, COL1A1 and osterix genes was observed upon addition of VEGF or BMPs alone to the cells in culture. The lack of CD105, Alk1 and Alk6 expression in D1 cells correlated with poor response to BMPs indicating that a greater care in the selection of MSCs is necessary. Interestingly, the combination of VEGF and BMP-6 significantly increased the expression of ALP, COL1A1 and osterix genes and D1 cells pre-conditioned with VEGF and BMP-6 induced greater bone formation in vivo than the non-conditioned control cells or the cells pre-conditioned with either VEGF or BMP-6 alone. This enhanced bone formation by MSCs correlated with higher CADM1 expression and OPG/RANKL ratio in the implants. Thus, combined action of VEGF and BMP on MSCs enhances osteoblastic differentiation of MSCs and increases their bone forming ability, which cannot be achieved through use of BMPs alone. This strategy can be effectively used for bone repair.	[Madhu, Vedavathi; Li, Ching-Ju; Dighe, Abhijit S.; Balian, Gary; Cui, Quanjun] Univ Virginia, Dept Orthopaed Surg, Orthopaed Res Labs, Charlottesville, VA 22903 USA	University of Virginia	Cui, QJ (corresponding author), Univ Virginia, Dept Orthopaed Surg, Orthopaed Res Labs, Charlottesville, VA 22903 USA.	QC4Q@hscmail.mcc.virginia.edu			Orthopaedic Research and Education Foundation (OREF); Musculoskeletal Transplant Foundation (MTF); Orthopaedic Trauma Association (OTA); NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER	Orthopaedic Research and Education Foundation (OREF); Musculoskeletal Transplant Foundation (MTF); Orthopaedic Trauma Association (OTA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Orthopaedic Research and Education Foundation (OREF) http://www.oref.org/site/PageServer, the Musculoskeletal Transplant Foundation (MTF) https://www.mtf.org/ and the Orthopaedic Trauma Association (OTA) http://ota.org/ to QC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Bajada S, 2009, BONE, V45, P726, DOI 10.1016/j.bone.2009.06.015; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Chou YF, 2011, CONNECT TISSUE RES, V52, P109, DOI 10.3109/03008207.2010.484514; Cui FA, 2010, GROWTH FACTORS, V28, P306, DOI 10.3109/08977194.2010.484423; Cui QJ, 2013, CURR PHARM DESIGN, V19, P3374, DOI 10.2174/1381612811319190004; Delimar D, 2012, INT ORTHOP, V36, P683, DOI 10.1007/s00264-011-1397-1; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825; Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005; Dighe AS, 2013, J ORTHOP RES, V31, P227, DOI 10.1002/jor.22212; Fajardo M, 2009, CLIN ORTHOP RELAT R, V467, P3071, DOI 10.1007/s11999-009-0981-9; Garrison KR, 2010, COCHRANE DB SYST REV, V6, P1; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kloen P, 2012, BONE, V51, P59, DOI 10.1016/j.bone.2012.03.032; Kyllonen L, 2013, GROWTH FACTORS, V31, P141, DOI 10.3109/08977194.2013.817404; Li GH, 2009, TISSUE ENG PT A, V15, P2123, DOI 10.1089/ten.tea.2008.0214; Li JZ, 2003, GENE THER, V10, P1735, DOI 10.1038/sj.gt.3302075; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Mathieu M, 2013, BONE, V53, P391, DOI 10.1016/j.bone.2013.01.005; Mentink A, 2013, BIOMATERIALS, V34, P4592, DOI 10.1016/j.biomaterials.2013.03.001; Mizuno D, 2010, GROWTH FACTORS, V28, P34, DOI 10.3109/08977190903326362; Nauth A, 2009, INJURY, V40, P27; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Osyczka AM, 2004, CELLS TISSUES ORGANS, V176, P109, DOI 10.1159/000075032; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O; Reed AAC, 2002, J ORTHOP RES, V20, P593, DOI 10.1016/S0736-0266(01)00142-5; Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003; Sarahrudi K, 2009, J ORTHOP RES, V27, P1293, DOI 10.1002/jor.20906; Seamon J, 2013, BONE MARROW RES, DOI 10.1155/2013/737580; Song KN, 2010, J BIOL CHEM, V285, P12169, DOI 10.1074/jbc.M109.087197; Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; TAKAGI K, 1982, CLIN ORTHOP RELAT R, P224; Waese EYL, 2008, SKELETAL RADIOL, V37, P601, DOI 10.1007/s00256-007-0438-8; Wang XL, 2011, GROWTH FACTORS, V29, P36, DOI 10.3109/08977194.2010.544656; Zhang Y, 2012, GROWTH FACTORS, V30, P333, DOI 10.3109/08977194.2012.720574; Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515	43	10	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e103060	10.1371/journal.pone.0103060	http://dx.doi.org/10.1371/journal.pone.0103060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048464	gold, Green Published, Green Submitted			2022-12-27	WOS:000339558100102
J	Bao, T; Zhang, X; Rao, ZM; Zhao, XJ; Zhang, RZ; Yang, TW; Xu, ZH; Yang, ST				Bao, Teng; Zhang, Xian; Rao, Zhiming; Zhao, Xiaojing; Zhang, Rongzhen; Yang, Taowei; Xu, Zhenghong; Yang, Shangtian			Efficient Whole-Cell Biocatalyst for Acetoin Production with NAD(+) Regeneration System through Homologous Co-Expression of 2,3-Butanediol Dehydrogenase and NADH Oxidase in Engineered Bacillus subtilis	PLOS ONE			English	Article							SERRATIA-MARCESCENS H32; SACCHAROMYCES-CEREVISIAE; STATISTICAL OPTIMIZATION; MODERATE-EXPRESSION; MEDIUM COMPONENTS; ESCHERICHIA-COLI; REDUCTASE GENE; GLUCOSE; FERMENTATION; PURIFICATION	Acetoin (3-hydroxy-2-butanone), an extensively-used food spice and bio-based platform chemical, is usually produced by chemical synthesis methods. With increasingly requirement of food security and environmental protection, bio-fermentation of acetoin by microorganisms has a great promising market. However, through metabolic engineering strategies, the mixed acid-butanediol fermentation metabolizes a certain portion of substrate to the by-products of organic acids such as lactic acid and acetic acid, which causes energy cost and increases the difficulty of product purification in downstream processes. In this work, due to the high efficiency of enzymatic reaction and excellent selectivity, a strategy for efficiently converting 2,3-butandiol to acetoin using whole-cell biocatalyst by engineered Bacillus subtilis is proposed. In this process, NAD(+) plays a significant role on 2,3-butanediol and acetoin distribution, so the NADH oxidase and 2,3-butanediol dehydrogenase both from B. subtilis are co-expressed in B. subtilis 168 to construct an NAD(+) regeneration system, which forces dramatic decrease of the intracellular NADH concentration (1.6 fold) and NADH/NAD(+) ratio (2.2 fold). By optimization of the enzymatic reaction and applying repeated batch conversion, the whole-cell biocatalyst efficiently produced 91.8 g/L acetoin with a productivity of 2.30 g/(L.h), which was the highest record ever reported by biocatalysis. This work indicated that manipulation of the intracellular cofactor levels was more effective than the strategy of enhancing enzyme activity, and the bioprocess for NAD(+) regeneration may also be a useful way for improving the productivity of NAD(+)-dependent chemistry-based products.	[Bao, Teng; Zhang, Xian; Rao, Zhiming; Zhao, Xiaojing; Yang, Taowei] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Zhang, Rongzhen] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Xu, Zhenghong] Jiangnan Univ, Sch Med & Pharmaceut, Wuxi, Jiangsu, Peoples R China; [Yang, Shangtian] Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA	Jiangnan University; Jiangnan University; Jiangnan University; University System of Ohio; Ohio State University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.	raozhm@jiangnan.edu.cn	Yang, Shang-Tian/A-7892-2009		Program for New Century Excellent Talents in University [NCET-10-0459]; National Basic Research Program of China (973 Program) [2012CB725202]; National Natural Science Foundation of China [21276110]; Chinese Ministry of Education [113033A]; Fundamental Research Funds for the Central Universities [JUSRP51306A, JUSRP21121]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institution	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by the Program for New Century Excellent Talents in University (NCET-10-0459), the National Basic Research Program of China (973 Program) (2012CB725202), the National Natural Science Foundation of China (21276110), the Research Project of Chinese Ministry of Education. (No. 113033A), the Fundamental Research Funds for the Central Universities (JUSRP51306A and JUSRP21121), the 111 Project (111-2-06) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen T, 2013, J BIOTECHNOL, V168, P499, DOI 10.1016/j.jbiotec.2013.09.020; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; CROW VL, 1990, APPL ENVIRON MICROB, V56, P1656, DOI 10.1128/AEM.56.6.1656-1665.1990; DARTOIS V, 1994, APPL ENVIRON MICROB, V60, P1670, DOI 10.1128/AEM.60.5.1670-1673.1994; de Felipe FL, 2001, INT DAIRY J, V11, P37, DOI 10.1016/S0958-6946(01)00031-0; Gao C, 2013, BIORESOURCE TECHNOL, V137, P111, DOI 10.1016/j.biortech.2013.02.115; Gao J, 2013, LETT APPL MICROBIOL, V57, P274, DOI 10.1111/lam.12107; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; Gong Y, 2004, DESALINATION, V161, P169, DOI 10.1016/S0011-9164(04)90052-5; Gonzalez E, 2001, CHEM-BIOL INTERACT, V130, P425, DOI 10.1016/S0009-2797(00)00282-9; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; HEIDLAS J, 1990, ARCH MICROBIOL, V154, P267, DOI 10.1007/BF00248966; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; HOHNBENTZ H, 1978, ARCH MICROBIOL, V116, P197, DOI 10.1007/BF00406037; Ji XJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-7; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; KANEKO T, 1990, APPL ENVIRON MICROB, V56, P2644, DOI 10.1128/AEM.56.9.2644-2649.1990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li LX, 2012, BIORESOURCE TECHNOL, V115, P111, DOI 10.1016/j.biortech.2011.08.097; Liu YF, 2011, PROCESS BIOCHEM, V46, P390, DOI 10.1016/j.procbio.2010.07.024; Liu Z, 2011, BIORESOURCE TECHNOL, V102, P10741, DOI 10.1016/j.biortech.2011.08.110; Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006; O'Donnell JM, 2004, AM J PHYSIOL-HEART C, V286, pH2237, DOI 10.1152/ajpheart.01113.2003; Perkins JB, 1999, J IND MICROBIOL BIOT, V22, P8, DOI 10.1038/sj.jim.2900587; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sun JA, 2012, BIORESOURCE TECHNOL, V119, P94, DOI 10.1016/j.biortech.2012.05.108; Sun JN, 2012, BIOTECHNOL BIOPROC E, V17, P598, DOI 10.1007/s12257-011-0587-4; TODA F, 1989, J CHEM SOC PERK T 1, P1555, DOI 10.1039/p19890001555; Wang M, 2012, BIOTECHNOL LETT, V34, P1877, DOI 10.1007/s10529-012-0981-9; Wang XQ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-155; Wang Z, 2013, APPL MICROBIOL BIOTE; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Zhang LY, 2012, J CHEM TECHNOL BIOT, V87, P1551, DOI 10.1002/jctb.3791; Zhang X, 2014, METAB ENG, V23, P34, DOI 10.1016/j.ymben.2014.02.002; Zhang X, 2013, WORLD J MICROB BIOT, V29, P1783, DOI 10.1007/s11274-013-1339-8; Zhang X, 2013, J IND MICROBIOL BIOT, V40, P1067, DOI 10.1007/s10295-013-1303-5; Zhang X, 2011, WORLD J MICROB BIOT, V27, P2785, DOI 10.1007/s11274-011-0754-y; Zhang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087788; Zhang YJ, 2013, BIORESOURCE TECHNOL, V130, P256, DOI 10.1016/j.biortech.2012.10.036; Zhou YJJ, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-103	44	34	36	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102951	10.1371/journal.pone.0102951	http://dx.doi.org/10.1371/journal.pone.0102951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036158	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200102
J	Du, JK; Li, L; Dou, YH; Li, PP; Chen, R; Liu, HL				Du, Jikun; Li, Li; Dou, Yuhong; Li, Peipei; Chen, Rui; Liu, Helu			Diagnostic Utility of Neutrophil CD64 as a Marker for Early-Onset Sepsis in Preterm Neonates	PLOS ONE			English	Article							BACTERIAL-INFECTION; EXPRESSION; PROCALCITONIN; BIOMARKER; ACCURACY; INDEXES; TERM	Introduction: Neutrophil CD64 has been proposed as an early marker of sepsis. This study aims to evaluate the diagnostic utility of neutrophil CD64 for identification of early-onset sepsis in preterm neonates. Methods: The prospective study was conducted in a neonatal intensive care unit between November 2010 and June 2011. Preterm neonates in whom infection was suspected when they were <12 hours of age were enrolled. Complete blood count with differential, blood culture, neutrophil CD11b and CD64 measurement were performed. Receiver operating characteristic curve analysis was performed to evaluate the performance of neutrophil CD64 as biomarker of sepsis. Results: A total of 158 preterm neonates was enrolled, 88 of whom were suspected infection. The suspected sepsis group was of lesser gestational age (P<0.001) and lower birth weight (P<0.001), compared with controls. The hematologic profiles of the suspected sepsis group were characterized by higher white blood cell count, neutrophil counts and C-reactive protein. The suspected sepsis neonates had significantly higher neutrophil CD64 expression compared with controls. Neutrophil CD64 had an area value under the curve of 0.869 with an optimal cutoff values of 1010 phycoerythrin molecules bound/cell and it had a high sensitivity (81.82%) and negative predictive value (77.4%). The level of neutrophil CD64 was independent of antibiotic therapy within 24 hours after the onset of sepsis in preterm neonates. Conclusions: Neutrophil CD64 is a highly sensitive marker for suspected early-onset sepsis in preterm neonates. Our study suggests that neutrophil CD64 may be incorporated as a valuable marker to diagnose infection.	[Du, Jikun; Dou, Yuhong; Li, Peipei; Liu, Helu] Guangzhou Med Univ, Shenzhen Shajing Hosp, Dept Clin Lab, Shenzhen, Peoples R China; [Li, Li] Guangdong Med Coll, Dept Pharmacol, Dongguan, Peoples R China; [Chen, Rui] Shenzhen Baoan Maternal & Child Hlth Hosp, Shenzhen, Peoples R China	Guangzhou Medical University; Guangdong Medical University	Chen, R (corresponding author), Shenzhen Baoan Maternal & Child Hlth Hosp, Shenzhen, Peoples R China.	110665707@qq.com; liuhelu@21cn.com	du, jikun/G-3990-2013		Baoan Key Medical Subject Construction Program	Baoan Key Medical Subject Construction Program	This work was supported by the Baoan Key Medical Subject Construction Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Chirico G, 2011, PEDIATRIC REP, V3, P1, DOI 10.4081/pr.2011.e1; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; DASILVA O, 1995, PEDIATR INFECT DIS J, V14, P362; Fjaertoft G, 2005, ACTA PAEDIATR, V94, P295, DOI 10.1111/j.1651-2227.2005.tb03072.x; Fjaertoft G, 1999, PEDIATR RES, V45, P871, DOI 10.1203/00006450-199906000-00016; Ganatra HA, 2010, CLIN PERINATOL, V37, P501, DOI 10.1016/j.clp.2010.02.004; GERDES JS, 1991, CLIN PERINATOL, V18, P361, DOI 10.1016/S0095-5108(18)30528-1; Gonzalez BE, 2003, J PERINAT MED, V31, P60, DOI 10.1515/JPM.2003.009; Gros A, 2012, INTENS CARE MED, V38, P445, DOI 10.1007/s00134-012-2483-6; Icardi M, 2009, J CLIN MICROBIOL, V47, P3914, DOI 10.1128/JCM.00628-09; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MESSARITAKIS J, 1990, ARCH DIS CHILD-FETAL, V65, P380, DOI 10.1136/adc.65.4_Spec_No.380; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, pF229, DOI 10.1136/adc.2002.023838; Ng PC, 2002, PEDIATR RES, V51, P296, DOI 10.1203/00006450-200203000-00006; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; Onal EE, 1999, LANCET, V353, P239, DOI 10.1016/S0140-6736(05)77250-0; OZDEMIR A, 1994, AM J PERINAT, V11, P282, DOI 10.1055/s-2007-994592; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; Roussel M, 2012, AM J RESP CRIT CARE, V186, P1058, DOI 10.1164/ajrccm.186.10.1058; Soni S, 2013, PEDIATR INFECT DIS J, V32, pE33, DOI 10.1097/INF.0b013e31826faede; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Streimish I, 2012, PEDIATR INFECT DIS J, V31, P777, DOI 10.1097/INF.0b013e318256fb07; Streimish I, 2014, AM J PERINAT, V31, P21, DOI 10.1055/s-0033-1334453; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Umlauf VN, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/763191; van der Meer W, 2007, J ENDOTOXIN RES, V13, P94, DOI 10.1177/0968051907079101; Weinschenk NP, 2000, J PEDIATR-US, V137, P345, DOI 10.1067/mpd.2000.107846; Weirich E, 1998, J PEDIATR-US, V132, P445, DOI 10.1016/S0022-3476(98)70018-6; Zeitoun AAH, 2010, SCAND J INFECT DIS, V42, P299, DOI 10.3109/00365540903449832	38	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102647	10.1371/journal.pone.0102647	http://dx.doi.org/10.1371/journal.pone.0102647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033045	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300074
J	Hurt, RA; Robeson, MS; Shakya, M; Moberly, JG; Vishnivetskaya, TA; Gu, BH; Elias, DA				Hurt, Richard A., Jr.; Robeson, Michael S., II; Shakya, Migun; Moberly, James G.; Vishnivetskaya, Tatiana A.; Gu, Baohua; Elias, Dwayne A.			Improved Yield of High Molecular Weight DNA Coincides with Increased Microbial Diversity Access from Iron Oxide Cemented Sub-Surface Clay Environments	PLOS ONE			English	Article							MEDIATED FENTON REACTIONS; ORGANIC-MATTER; COMPETITIVE ADSORPTION; MINERAL PARTICLES; HUMIC ACIDS; RNA; SOILS; EXTRACTION; RECOVERY; SEQUENCES	Despite over three decades of progress, extraction of high molecular weight (HMW) DNA from high clay soils or iron oxide cemented clay has remained challenging. HMW DNA is desirable for next generation sequencing as it yields the most comprehensive coverage. Several DNA extraction procedures were compared from samples that exhibit strong nucleic acid adsorption. pH manipulation or use of alternative ion solutions offered no improvement in nucleic acid recovery. Lysis by liquid N-2 grinding in concentrated guanidine followed by concentrated sodium phosphate extraction supported HMW DNA recovery from clays high in iron oxides. DNA recovered using 1 M sodium phosphate buffer (PB) as a competitive desorptive wash was 15.22 +/- 2.33 mu g DNA/g clay, with most DNA consisting of >20 Kb fragments, compared to 2.46 +/- 0.25 mu g DNA/g clay with the Powerlyzer system (MoBio). Increasing PB concentration in the lysis reagent coincided with increasing DNA fragment length during initial extraction. Rarefaction plots of 16S rRNA (V1-V3 region) pyrosequencing from A-horizon and clay soils showed an similar to 80% and similar to 400% larger accessed diversity compared to the Powerlyzer soil DNA system, respectively. The observed diversity from the Firmicutes showed the strongest increase with >3-fold more operational taxonomic units (OTU) recovered.	[Hurt, Richard A., Jr.; Robeson, Michael S., II; Moberly, James G.; Elias, Dwayne A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Shakya, Migun; Vishnivetskaya, Tatiana A.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Gu, Baohua] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Elias, DA (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.	eliasda@ornl.gov	Elias, Dwayne/GZL-8202-2022; Gu, Baohua/B-9511-2012; Vishnivetskaya, Tatiana/A-4488-2008; Robeson, Michael Scott/J-5211-2019	Gu, Baohua/0000-0002-7299-2956; Vishnivetskaya, Tatiana/0000-0002-0660-023X; Robeson, Michael Scott/0000-0001-7119-6301; , ENIGMA/0000-0002-0894-2831; Shakya, Migun/0000-0003-3876-691X; Moberly, James/0000-0003-0950-0952	U.S. Department of Energy, Office of Science, Biological and Environmental Research [DE-AC05-00OR22725, DE-AC02-05CH11231]; U.S. Department of Energy [DEAC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted by the Oak Ridge National Laboratory Mercury Subsurface Science Focus Area and ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies (http://enigma.lbl.gov), a Scientific Focus Area Program at Lawrence Berkeley National Laboratory. Support was provided by the U.S. Department of Energy, Office of Science, Biological and Environmental Research under Contract No. DE-AC05-00OR22725 for ORNL and DE-AC02-05CH11231 for LBNL. ORNL is managed by UT-Battelle LLC for the U.S. Department of Energy under contract DEAC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm E, 1996, MOL MICROBIAL ECOLOG; Andeer P, 2012, APPL ENVIRON MICROB, V78, P163, DOI 10.1128/AEM.05973-11; Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439; Avena MJ, 1998, ENVIRON SCI TECHNOL, V32, P2572, DOI 10.1021/es980112e; Bertrand H, 2005, J MICROBIOL METH, V62, P1, DOI 10.1016/j.mimet.2005.01.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cleaves HJ, 2011, CHEMOSPHERE, V83, P1560, DOI 10.1016/j.chemosphere.2011.01.023; Cohn CA, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-3; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cullen DW, 1998, SOIL BIOL BIOCHEM, V30, P983, DOI 10.1016/S0038-0717(98)00001-7; DeAngelis KM, 2011, APPL ENVIRON MICROB, V77, P6313, DOI 10.1128/AEM.05262-11; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Direito SOL, 2012, FEMS MICROBIOL ECOL, V81, P111, DOI 10.1111/j.1574-6941.2012.01325.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; GREAVES M. P., 1969, Soil Biology and Biochemistry, V1, P317, DOI 10.1016/0038-0717(69)90014-5; Gu BH, 1996, GEOCHIM COSMOCHIM AC, V60, P2977, DOI 10.1016/0016-7037(96)00157-3; Gu BH, 1996, GEOCHIM COSMOCHIM AC, V60, P1943, DOI 10.1016/0016-7037(96)00059-2; GU BH, 1994, ENVIRON SCI TECHNOL, V28, P38, DOI 10.1021/es00050a007; Hazen TC, 2013, CURR OPIN BIOTECH, V24, P526, DOI 10.1016/j.copbio.2012.10.020; Hurt RA, 2001, APPL ENVIRON MICROB, V67, P4495, DOI 10.1128/AEM.67.10.4495-4503.2001; Hwang C, 2006, APPL MICROBIOL BIOT, V71, P748, DOI 10.1007/s00253-005-0189-1; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Liles MR, 2008, APPL ENVIRON MICROB, V74, P3302, DOI 10.1128/AEM.02630-07; Liu AG, 1999, J COLLOID INTERF SCI, V218, P225, DOI 10.1006/jcis.1999.6419; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Luo WS, 2011, ENVIRON SCI TECHNOL, V45, P2994, DOI 10.1021/es103073u; Luo YZ, 1996, J BIOL CHEM, V271, P21167, DOI 10.1074/jbc.271.35.21167; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; OGRAM A, 1988, ENVIRON SCI TECHNOL, V22, P982, DOI 10.1021/es00173a020; OGRAM AV, 1994, APPL ENVIRON MICROB, V60, P393, DOI 10.1128/AEM.60.2.393-396.1994; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raskin L, 1997, ECOLOGY PHYSL GASTRO, V2; Robertson RM, 2006, P NATL ACAD SCI USA, V103, P7310, DOI 10.1073/pnas.0601903103; Sanchez-Martin MJ, 2008, J HAZARD MATER, V150, P115, DOI 10.1016/j.jhazmat.2007.04.093; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Tanaka T, 2009, LANGMUIR, V25, P2956, DOI 10.1021/la8032397; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; VARADACHARI C, 1994, SOIL BIOL BIOCHEM, V26, P1145, DOI 10.1016/0038-0717(94)90136-8; Vermeer AWP, 1998, LANGMUIR, V14, P4210, DOI 10.1021/la970836o; Vermeer AWP, 1998, LANGMUIR, V14, P2810, DOI 10.1021/la970624r; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wong D, 2004, MICROB ECOL, V47, P80, DOI 10.1007/s00248-003-1021-z; Yankson KK, 2009, APPL ENV MICROBIOL, V75; Zhou J, 2011, ISME J          0224, V24, P1; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	55	18	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102826	10.1371/journal.pone.0102826	http://dx.doi.org/10.1371/journal.pone.0102826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033199	gold, Green Submitted, Green Published			2022-12-27	WOS:000339418300099
J	Sengupta, M; Cheema, A; Kaminski, HJ; Kusner, LL				Sengupta, Manjistha; Cheema, Amrita; Kaminski, Henry J.; Kusner, Linda L.		Muscle Study Grp	Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment	PLOS ONE			English	Article							PHOSPHATIDYLCHOLINE METABOLISM; ACID; GLUCOCORTICOIDS; CORTICOSTEROIDS; BIOMARKERS; PATHWAYS; REVEALS; DISEASE	Prednisone is often used for the treatment of autoimmune and inflammatory diseases but they suffer from variable therapeutic responses and significant adverse effects. Serum biological markers that are modulated by chronic corticosteroid use have not been identified. Myasthenia gravis is an autoimmune neuromuscular disorder caused by antibodies directed against proteins present at the post-synaptic surface of neuromuscular junction resulting in weakness. The patients with myasthenia gravis are primarily treated with prednisone. We analyzed the metabolomic profile of serum collected from patients prior to and after 12 weeks of prednisone treatment during a clinical trial. Our aim was to identify metabolites that may be treatment responsive and be evaluated in future studies as potential biomarkers of efficacy or adverse effects. Ultra-performance liquid chromatography coupled with electro-spray quadrupole time of flight mass spectrometry was used to obtain comparative metabolomic and lipidomic profile. Untargeted metabolic profiling of serum showed a clear distinction between pre- and post-treatment groups. Chronic prednisone treatment caused upregulation of membrane associated glycerophospholipids: phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, 1, 2-diacyl-sn glycerol 3 phosphate and 1-Acyl-sn-glycero-3-phosphocholine. Arachidonic acid (AA) and AA derived proinflammatory eicosanoids such as 18-carboxy dinor leukotriene B4 and 15 hydroxyeicosatetraenoic acids were reduced. Perturbations in amino acid, carbohydrate, vitamin and lipid metabolism were observed. Chronic prednisone treatment caused increase in membrane associated glycerophospholipids, which may be associated with certain adverse effects. Decrease of AA and AA derived pro-inflammatory eicosanoids demonstrate that immunosuppression by corticosteroid is via suppression of pro-inflammatory pathways. The study identified metabolomic fingerprints that can now be validated as prednisone responsive biomarkers for the improvement in diagnostic accuracy and prediction of therapeutic outcome.	[Sengupta, Manjistha; Kaminski, Henry J.] George Washington Univ, Dept Neurol, Washington, DC USA; [Cheema, Amrita] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Kusner, Linda L.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA	George Washington University; Georgetown University; George Washington University	Kusner, LL (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	lkusner@gwu.edu		Kaminski, Henry/0000-0002-8195-0141; Kusner, Linda/0000-0002-5530-2140	Roswell Park Cancer Institute, Cancer Center [NIH-CCSG-CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute, Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Roswell Park Cancer Institute, Cancer Center Support Grant; NIH-CCSG-CA016056. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY JM, 1991, BIOFACTORS, V3, P97; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bye A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042330; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; Ciappio ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084583; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Exton JH, 2000, ANN NY ACAD SCI, V905, P61; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Gensler LS, 2013, NEUROHOSPITALIST, V3, P92, DOI 10.1177/1941874412458678; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hasselgren PO, 2010, CURR OPIN CLIN NUTR, V13, P423, DOI 10.1097/MCO.0b013e32833a5107; Ho WE, 2013, AM J RESP CELL MOL, V48, P204, DOI 10.1165/rcmb.2012-0246OC; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Li F, 2012, J LIPID RES, V53, P1625, DOI 10.1194/jlr.M027433; Lu YH, 2012, METABOLOMICS, V8, P704, DOI 10.1007/s11306-011-0364-6; Malcher-Lopes R, 2008, EUR J PHARMACOL, V583, P322, DOI 10.1016/j.ejphar.2007.12.033; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Myhr KM, 2009, ACTA NEUROL SCAND, V120, P73, DOI 10.1111/j.1600-0404.2009.01213.x; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885; Pereira SP, 1996, CLIN SCI, V91, P509, DOI 10.1042/cs0910509; POST M, 1986, J BIOL CHEM, V261, P2179; Ried JS, 2013, ALLERGY, V68, P629, DOI 10.1111/all.12110; Sanders DB, 2008, NEUROLOGY, V71, P394, DOI 10.1212/01.wnl.0000312373.67493.7f; Sanders DB, 2010, AUTOIMMUNITY, V43, P428, DOI 10.3109/08916930903518107; Scheider-Gold C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002828.pub2; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tahan G, 2011, CAN J SURG, V54, P333, DOI 10.1503/cjs.013610; Team RDC, 2010, LANG ENV STAT COMP V; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; van Hall G, 2012, CURR OPIN CLIN NUTR, V15, P85, DOI 10.1097/MCO.0b013e32834e6ea2; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]	41	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102635	10.1371/journal.pone.0102635	http://dx.doi.org/10.1371/journal.pone.0102635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032816	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300072
J	Hubert, D; Soubeiran, L; Gourmelon, F; Grenet, D; Serreau, R; Perrodeau, E; Zegarra-Parodi, R; Boutron, I				Hubert, Dominique; Soubeiran, Lucile; Gourmelon, Fabrice; Grenet, Dominique; Serreau, Raphael; Perrodeau, Elodie; Zegarra-Parodi, Rafael; Boutron, Isabelle			Impact of Osteopathic Treatment on Pain in Adult Patients with Cystic Fibrosis - A Pilot Randomized Controlled Study	PLOS ONE			English	Article							LOW-BACK-PAIN; MANIPULATIVE TREATMENT; ALTERNATIVE MEDICINE; QUALITY	Background: Pain is a common complication in patients with cystic fibrosis (CF) and is associated with shorter survival. We evaluated the impact of osteopathic manipulative treatment (OMT) on pain in adults with CF. Methods: A pilot multicenter randomized controlled trial was conducted with three parallel arms: OMT (group A, 16 patients), sham OMT (sham treatment, group B, 8 patients) and no treatment (group C, 8 patients). Medical investigators and patients were double-blind to treatment for groups A and B, who received OMT or sham OMT monthly for 6 months. Pain was rated as a composite of its intensity and duration over the previous month. The evolution of chest/back pain after 6 months was compared between group A and groups B+C combined (control group). The evolution of cervical pain, headache and quality of life (QOL) were similarly evaluated. Results: There was no statistically significant difference between the treatment and control groups in the decrease of chest/back pain (difference = -2.20 IC95% [-4.81; 0.42], p = 0.098); also, group A did not differ from group B. However, chest/back pain decreased more in groups A (p = 0.002) and B (p = 0.006) than in group C. Cervical pain, headache and QOL scores did not differ between the treatment and control groups. Conclusion: This pilot study demonstrated the feasibility of evaluating the efficacy of OMT to treat the pain of patients with CF. The lack of difference between the group treated with OMT and the control group may be due to the small number of patients included in this trial, which also precludes any definitive conclusion about the greater decrease of pain in patients receiving OMT or sham OMT than in those with no intervention.	[Hubert, Dominique] Hop Cochin, APHP, Adult CF Ctr, F-75674 Paris, France; [Hubert, Dominique] Hop Cochin, APHP, Dept Pulmonol, F-75674 Paris, France; [Hubert, Dominique; Boutron, Isabelle] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Soubeiran, Lucile; Gourmelon, Fabrice; Serreau, Raphael] Hop Cochin, APHP, Dept Clin Res, F-75674 Paris, France; [Grenet, Dominique] Hop Foch, Adult CF Ctr, Suresnes, France; [Grenet, Dominique] Hop Foch, Dept Pulmonol, Suresnes, France; [Perrodeau, Elodie; Boutron, Isabelle] Hop Hotel Dieu, APHP, Clin Epidemiol Ctr, F-75181 Paris, France; [Zegarra-Parodi, Rafael] AT Still Univ, AT Still Res Inst, Kirksville, MO USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; A.T. Still University of Health Sciences	Hubert, D (corresponding author), Hop Cochin, APHP, Adult CF Ctr, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	dominique.hubert@cch.aphp.fr	Serreau, Raphael/ABC-7602-2021	Serreau, Raphael/0000-0003-4430-2046; Boutron, Isabelle/0000-0002-5263-6241; Zegarra-Parodi, Rafael/0000-0002-2418-8592	Vaincre la Mucoviscidose and Fondation de France, Paris, France	Vaincre la Mucoviscidose and Fondation de France, Paris, France	This work was supported by Vaincre la Mucoviscidose and Fondation de France, Paris, France, who had no role in the design of the study, the collection or analysis of the data, or the preparation of the manuscript.	Abbott J, 2009, AM J RESP CRIT CARE, V179, P54, DOI 10.1164/rccm.200802-220OC; Agrario L, 2006, J CYST FIBROS S1, V5, pS90; American Academy of Osteopathy, 2002, OUTP OST SOAP NOT FO; American Association of Colleges of Osteopathic Medicine, AUTH OST THES; Andersson GBJ, 1999, NEW ENGL J MED, V341, P1426, DOI 10.1056/NEJM199911043411903; Cystic Fibrosis Foundation, 2012, CYST FIBR FDN PAT RE; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Degenhardt BF, 2014, J AM OSTEOPATH ASSOC, V114, P154, DOI 10.7556/jaoa.2014.033; Festini Filippo, 2004, J Cyst Fibros, V3, P51, DOI 10.1016/j.jcf.2003.12.001; Flume PA, 2009, J CYST FIBROS, V8, P321, DOI 10.1016/j.jcf.2009.07.004; Havermans T, 2013, J CYST FIBROS, V12, P423, DOI 10.1016/j.jcf.2013.04.001; Hayes M, 2011, CHEST, V140, P1598, DOI 10.1378/chest.11-0132; Henry B, 2003, QUAL LIFE RES, V12, P63, DOI 10.1023/A:1022037320039; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jakel A, 2012, COMPLEMENT THER MED, V20, P456, DOI 10.1016/j.ctim.2012.07.009; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kelemen L, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.524; Lee A, 2009, J CYST FIBROS, V8, P79, DOI 10.1016/j.jcf.2008.07.002; Licciardone JC, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-43; Licciardone JC, 2003, SPINE, V28, P1355, DOI 10.1097/00007632-200307010-00002; Licciardone JC, 2006, J AM OSTEOPATH ASSOC, V106, P457; Moulson A, 2006, MANUAL THER, V11, P214, DOI 10.1016/j.math.2006.04.003; Noll Donald R, 2010, Osteopath Med Prim Care, V4, P2, DOI 10.1186/1750-4732-4-2; Noll DR, 2008, J AM OSTEOPATH ASSOC, V108, P508; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; R Core Team, 2021, R LANGUAGE ENV STAT; Ravilly S, 1996, PEDIATRICS, V98, P741; Sergueef N, 2002, ALTERN THER HEALTH M, V8, P74; Sermet-Gaudelus I, 2009, J PAIN SYMPTOM MANAG, V38, P281, DOI 10.1016/j.jpainsymman.2008.08.009; Soubeiran L., 2011, J PHYS THER, V4, P18; Staud R, 2011, RHEUM DIS CLIN N AM, V37, P9, DOI 10.1016/j.rdc.2010.11.009; Stenekes SI, 2009, J PAIN SYMPTOM MANAG, V38, P387; STERN RC, 1992, J ADOLESCENT HEALTH, V13, P612, DOI 10.1016/1054-139X(92)90376-M; Sweezey NB, 2014, PEDIATR PULM, V49, P309, DOI 10.1002/ppul.22967; Tanase A, 2008, J ALTERN COMPLEM MED, V14, P1271, DOI 10.1089/acm.2008.0185; Vaincre la Mucoviscidose INED, 2013, REG FRANC MUC BIL DO; VANBUSKIRK RL, 1990, J AM OSTEOPATH ASSOC, V90, P792; WHO, 2010, BENCHM TRAIN TRAD CO	38	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102465	10.1371/journal.pone.0102465	http://dx.doi.org/10.1371/journal.pone.0102465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029347	Green Published, gold, Green Submitted			2022-12-27	WOS:000341306600076
J	Boers, A; Slagter-Menkema, L; van Hemel, BM; Belinson, JL; Ruitenbeek, T; Buikema, HJ; Klip, H; Ghyssaert, H; van der Zee, AGJ; de Bock, GH; Wisman, GBA; Schuuring, E				Boers, Aniek; Slagter-Menkema, Lorian; van Hemel, Bettien M.; Belinson, Jerome L.; Ruitenbeek, Teus; Buikema, Henk J.; Klip, Harry; Ghyssaert, Hilde; van der Zee, Ate G. J.; de Bock, Geertruida H.; Wisman, G. Bea A.; Schuuring, Ed			Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off	PLOS ONE			English	Article							HIGH-RISK HPV; HUMAN-PAPILLOMAVIRUS DNA; CERVICAL-CANCER; WOMEN; CYTOLOGY; PERFORMANCE; VALIDATION; PREVENTION; GUIDELINES; EXPERIENCE	The diagnostic performance of the widely-used Cervista HPV HR test was compared to the Hybrid Capture 2 (HC2) test in a Dutch population-based cervical cancer screening program. In 900 scrapings of women with normal cytomorphology, specificity was 90% (95% CI: 87.84-91.87) for the Cervista HPV HR test and 96% (95% CI: 94.76-97.37) for the HC2 test with 93% agreement between both tests (kappa = 0.5, p<0.001). The sensitivity for CIN2+ using 65 scrapings of women with histological-confirmed CIN2+ was 91% (95% CI: 80.97-96.51) for the Cervista HPV HR test and 92% (95% CI: 82.94-97.43) for the HC2 test with 95% agreement between both tests (kappa = 0.7, p<0.001). Fifty-seven of 60 HC2 negative/Cervista positive cases tested HPV-negative with PCR-based HPV assays; of these cases 56% were defined as Cervista triple-positive with FOZ values in all 3 mixes higher than the second cut-off of 1.93 (as set by manufacturer). By setting this cut-off at 5.0, specificity improved significantly without affecting sensitivity. External validation of this new cut-off at 5.0 in triple-positive scrapings of women selected from the SHENCCASTII database revealed that 22/24 histological normal cases now tested HPV-negative in the Cervista HPV HR test, while CIN2+ lesions remained HPV-positive. The intra-laboratory reproducibility of the Cervista HPV HR test (n = 510) showed a concordance of 92% and 93% for cut-off 1.93 and 5.0 (kappa = 0.83 and kappa = 0.84, p<0.001) and inter-laboratory agreement of the Cervista HPV HR test was 90% and 93% for cut-off 1.93 and 5.0 (kappa = 0.80 and kappa = 0.85, p<0.001). In conclusion, the specificity of the Cervista HPV HR test could be improved significantly by increasing the second cut-off from 1.93 to 5.0, without affecting the sensitivity of the test in a population-based screening setting.	[Boers, Aniek; Klip, Harry; van der Zee, Ate G. J.; Wisman, G. Bea A.] Univ Groningen, Univ Med Ctr Groningen, Div Gynecol Oncol, Dept Obstet & Gynecol, Groningen, Netherlands; [Slagter-Menkema, Lorian; van Hemel, Bettien M.; Ruitenbeek, Teus; Buikema, Henk J.; Schuuring, Ed] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Belinson, Jerome L.] Prevent Oncol Int Inc, Cleveland Hts, OH USA; [Belinson, Jerome L.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Ghyssaert, Hilde] AZ St Jan Brugge Oostende, Dept Pathol, Brugge, Belgium; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; Case Western Reserve University; Cleveland Clinic Foundation; University of Groningen	Schuuring, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	e.schuuring@umcg.nl	de Bock, Geertruida Hendrika/F-6529-2014	de Bock, Geertruida Hendrika/0000-0003-3104-4471	Dutch Cancer Society [RUG-NKB2009-4577]	Dutch Cancer Society(KWF Kankerbestrijding)	AB is supported by the Dutch Cancer Society (RUG-NKB2009-4577). The Cervista HPV HR test reagents were kindly provided by Hologic Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ALP, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-262; [Anonymous], 2009, GUIDELINES CERVICAL; [Anonymous], 2008, CERV HPV HR PACK INS; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Belinson JL, 2011, AM J CLIN PATHOL, V135, P790, DOI 10.1309/AJCPKA6ATAPBZ6JQ; Bory JP, 2002, INT J CANCER, V102, P519, DOI 10.1002/ijc.10735; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Day SP, 2009, J CLIN VIROL, V45, pS63, DOI 10.1016/S1386-6532(09)70010-1; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Du Chateau BK, 2013, J CLIN MICROBIOL, V51, P1057, DOI 10.1128/JCM.02836-12; Einstein MH, 2010, GYNECOL ONCOL, V118, P116, DOI 10.1016/j.ygyno.2010.04.013; Else EA, 2011, J CLIN MICROBIOL, V49, P1907, DOI 10.1128/JCM.00236-10; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Ginocchio CC, 2008, J CLIN MICROBIOL, V46, P1641, DOI 10.1128/JCM.01824-07; Gold MA, 2013, J LOW GENIT TRACT DI, V17, P51, DOI 10.1097/LGT.0b013e31824ddbe0; Kinney W, 2010, AM J CLIN PATHOL, V134, P193, DOI 10.1309/AJCPRI8XPQUEAA3K; Kurian EM, 2011, AM J CLIN PATHOL, V136, P808, DOI 10.1309/AJCPCQD7B7DPVHLH; Meijer CJLM, 2009, J CLIN VIROL, V46, pS1, DOI 10.1016/S1386-6532(09)00540-X; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Poljak M, 2010, EXPERT REV ANTI-INFE, V8, P1139, DOI [10.1586/eri.10.104, 10.1586/ERI.10.104]; Quigley NB, 2011, J CLIN VIROL, V52, P23, DOI 10.1016/j.jcv.2011.05.014; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Wisman GBA, 2006, INT J CANCER, V119, P1908, DOI 10.1002/ijc.22060; Youens KE, 2011, J MOL DIAGN, V13, P160, DOI 10.1016/j.jmoldx.2010.11.016; Zhao J, 2012, J LOW GENIT TRACT DI, V16, P358, DOI 10.1097/LGT.0b013e31824b9bf9	28	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e101930	10.1371/journal.pone.0101930	http://dx.doi.org/10.1371/journal.pone.0101930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051098	Green Published, Green Submitted, gold			2022-12-27	WOS:000339551100017
J	Otto, B; Koenig, AM; Tolstonog, GV; Jeschke, A; Klaetschke, K; Vashist, YK; Wicklein, D; Wagener, C; Izbicki, JR; Streichert, T				Otto, Benjamin; Koenig, Alexandra M.; Tolstonog, Genrich V.; Jeschke, Anke; Klaetschke, Kristin; Vashist, Yogesh K.; Wicklein, Daniel; Wagener, Christoph; Izbicki, Jakob R.; Streichert, Thomas			Molecular Changes in Pre-Metastatic Lymph Nodes of Esophageal Cancer Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MULTIPLE-MYELOMA; BETA-CATENIN/TCF; BREAST-CANCER; EXPRESSION; DICKKOPF-1; TUMOR; DKK1; ADENOCARCINOMA; SURVIVAL	Lymph node metastasis indicates poor prognosis in esophageal cancer. To understand the underlying mechanisms, most studies so far focused on investigating the tumors themselves and/or invaded lymph nodes. However they neglected the potential events within the metastatic niche, which precede invasion. Here we report the first description of these regulations in patients on transcription level. We determined transcriptomic profiles of still metastasis-free regional lymph nodes for two patient groups: patients classified as pN1 (n = 9, metastatic nodes exist) or pN0 (n = 5, no metastatic nodes exist). All investigated lymph nodes, also those from pN1 patients, were still metastasis-free. The results show that regional lymph nodes of pN1 patients differ decisively from those of pN0 patients - even before metastasis has taken place. In the pN0 group distinct immune response patterns were observed. In contrast, lymph nodes of the pN1 group exhibited a clear profile of reduced immune response and reduced proliferation, but increased apoptosis, enhanced hypoplasia and morphological conversion processes. DKK1 was the most significant gene associated with the molecular mechanisms taking place in lymph nodes of patients suffering from metastasis (pN1). We assume that the two molecular profiles observed constitute different stages of a progressive disease. Finally we suggest that DKK1 might play an important role within the mechanisms leading to lymph node metastasis.	[Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Ctr Internal Med, Hamburg, Germany; [Otto, Benjamin; Klaetschke, Kristin; Wagener, Christoph; Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Ctr Diagnost, Hamburg, Germany; [Koenig, Alexandra M.; Vashist, Yogesh K.; Izbicki, Jakob R.] Univ Med Ctr Hamburg Eppendorf, Surg Sci Ctr, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Tolstonog, Genrich V.] Univ Lausanne, Dept Otolaryngol Head & Neck Surg, CHUV, Lausanne, Switzerland; [Jeschke, Anke] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Ctr Med Expt, Hamburg, Germany; [Wicklein, Daniel] Univ Med Ctr Hamburg Eppendorf, Dept Anat & Expt Morphol, Ctr Med Expt, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Otto, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Ctr Internal Med, Hamburg, Germany.	b.otto@uke.de	Vashist, Yogesh/AAF-3529-2022; Vashist, Yogesh/ABE-4001-2020; Vashist, Yogesh/AFH-9205-2022		Stiftung fur Pathobiochemie und Molekulare Diagnostik, Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin e.V	Stiftung fur Pathobiochemie und Molekulare Diagnostik, Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin e.V	This work was funded by the Stiftung fur Pathobiochemie und Molekulare Diagnostik, Deutsche Vereinte Gesellschaft fur Klinische Chemie und Laboratoriumsmedizin e.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Baldus SE, 1998, INT J CANCER, V79, P133, DOI 10.1002/(SICI)1097-0215(19980417)79:2<133::AID-IJC6>3.0.CO;2-U; Barbolina MV, 2013, J BIOL CHEM, V288, P141, DOI 10.1074/jbc.M112.431411; CASSON AG, 1994, ANN THORAC SURG, V58, P1569, DOI 10.1016/0003-4975(94)91986-0; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-157; Clezardin P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2835; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Garmy-Susini B, 2013, P NATL ACAD SCI USA, V110, P9042, DOI 10.1073/pnas.1219603110; Gertler R, 2014, ANN SURG, V259, P96, DOI 10.1097/SLA.0000000000000239; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gyobu K, 2011, ANN SURG ONCOL, V18, P1185, DOI 10.1245/s10434-010-1393-5; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jiang T, 2013, INT J BIOL MARKER, V28, P221, DOI 10.5301/jbm.5000005; Jones D, 2009, AGENDA, V44, P39; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Koenig AM, 2009, ANN SURG ONCOL, V16, P454, DOI 10.1245/s10434-008-0169-7; Lin TY, 2005, BIOCHEM BIOPH RES CO, V337, P330, DOI 10.1016/j.bbrc.2005.09.056; Lindberg P, 2006, INT J CANCER, V118, P2948, DOI 10.1002/ijc.21568; Magnusson M, 2007, BLOOD, V109, P3687, DOI 10.1182/blood-2006-10-054676; Makino T, 2009, ANN SURG ONCOL, V16, P2058, DOI 10.1245/s10434-009-0476-7; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; MOMBURG F, 1987, CANCER RES, V47, P2883; Moreau M, 2011, INT J CANCER, V128, P1280, DOI 10.1002/ijc.25455; Nakamura Y, 2009, ONCOTHERAPY SCI; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Qian JF, 2007, BLOOD, V110, P1587, DOI 10.1182/blood-2007-03-082529; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rawnaq T, 2009, ANTICANCER RES, V29, P1195; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Revet I, 2010, CANCER LETT, V289, P195, DOI 10.1016/j.canlet.2009.08.019; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shi RY, 2013, CANCER-AM CANCER SOC, V119, P993, DOI 10.1002/cncr.27788; SHURBAJI MS, 1991, AM J CLIN PATHOL, V96, P238, DOI 10.1093/ajcp/96.2.238; Takahashi N, 2010, INT J CANCER, V126, P1611, DOI 10.1002/ijc.24865; Tamoto E, 2004, CLIN CANCER RES, V10, P3629, DOI 10.1158/1078-0432.CCR-04-0048; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Uchikado Y, 2006, INT J ONCOL, V29, P1337; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zanaruddin SNS, 2013, HUM PATHOL, V44, P417, DOI 10.1016/j.humpath.2012.06.007	59	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102552	10.1371/journal.pone.0102552	http://dx.doi.org/10.1371/journal.pone.0102552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048826	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100045
J	Wang, YL; Wang, JZ; Zou, YB; Bao, JR; Sun, K; Zhu, L; Tian, T; Shen, H; Zhou, XL; Ahmad, F; Hui, RT; Song, L				Wang, Yilu; Wang, Jizheng; Zou, Yubao; Bao, Jingru; Sun, Kai; Zhu, Ling; Tian, Tao; Shen, Hu; Zhou, Xianliang; Ahmad, Ferhaan; Hui, Rutai; Song, Lei			Female Sex Is Associated with Worse Prognosis in Patients with Hypertrophic Cardiomyopathy in China	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; SUDDEN CARDIAC DEATH; HEART-FAILURE; RISK STRATIFICATION; TASK-FORCE; DYSFUNCTION; DIAGNOSIS; DISEASE	Background: Sex plays an important role in the clinical expression and prognosis of various cardiovascular diseases. This study was designed to observe the effects of sex on hypertrophic cardiomyopathy (HCM). Methods and Results: A total of 621 unrelated patients with HCM without heart failure (460 males) were enrolled from 1999 to 2011. Compared to male patients, at baseline female patients were older at diagnosis (49.6 +/- 17.2 years vs. 46.7 +/- 14.4 years, P = 0.033), and had greater frequency of left ventricular outflow tract obstruction (72/161, 44.7% vs. 149/460, 32.4%, P = 0.005). During the average four year follow-up period (range 2-7 years), survival analysis showed that the incidences of mortality from all causes, cardiovascular death and progression to chronic heart failure were greater in women than in men (P = 0.031, 0.040 and 0.012, respectively). After adjustment for multiple factors that may confound survival and cardiac function, female sex remained an independent risk factor for all-cause mortality, cardiovascular death, and chronic heart failure [hazard ratio (HR) 2.19, 95% confidence interval (CI) 1.21-3.95, P = 0.010; HR 2.19, 95% CI 1.17-4.09, P = 0.014; HR 1.73, 95% CI 1.12-2.69, P = 0.014, respectively] in HCM patients. Subgroup analysis revealed that female sex as a risk factor was identified only in patients younger than 50 years old (P = 0.011, 0.011 and 0.009, respectively), but not for those 50 years or older. Conclusion: Our results suggest that female sex is associated with worse survival and heart failure in HCM patients. Further studies are required to determine whether female hormones modify the clinical expression and prognosis of HCM.	[Wang, Yilu] China Meitan Gen Hosp, Dept ICU, Beijing, Peoples R China; [Wang, Jizheng; Sun, Kai; Hui, Rutai; Song, Lei] Chinese Acad Med Sci, Sinogerman Lab Mol Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Wang, Jizheng; Sun, Kai; Zhou, Xianliang; Hui, Rutai; Song, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zou, Yubao; Tian, Tao; Hui, Rutai; Song, Lei] Chinese Acad Med Sci, Dept Cardiovasc Internal Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Bao, Jingru] PLA Navy Gen Hosp, Ctr Cardiovasc Dis, Beijing, Peoples R China; [Zhu, Ling; Shen, Hu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Cardiovasc Med, Xian 710049, Shanxi Prov, Peoples R China; [Zhou, Xianliang; Hui, Rutai; Song, Lei] Chinese Acad Med Sci, Hypertens Ctr, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Ahmad, Ferhaan] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Sixth Medical Center of Chinese PLA General Hospital; Xi'an Jiaotong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Iowa	Hui, RT (corresponding author), Chinese Acad Med Sci, Sinogerman Lab Mol Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	huirutai@gmail.com; lsongqd@yahoo.com	Sun, Kai/GQG-9680-2022	Ahmad, Ferhaan/0000-0003-2877-4641	Ministry of Science & Technology of China [2009DFB30050, 2010CB732601]; National Natural Science Foundation of China [30971233, 81070100]; Doris Duke Charitable Foundation	Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This research was supported by the Ministry of Science & Technology of China (grant numbers: 2009DFB30050 and 2010CB732601) and by the National Natural Science Foundation of China (grant numbers: 30971233 and 81070100), and the Doris Duke Charitable Foundation Clinical Scientist Development Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandsaeter B, 2011, INT J CARDIOL, V146, P354, DOI 10.1016/j.ijcard.2009.07.014; Christiaans I, 2010, EUROPACE, V12, P313, DOI 10.1093/europace/eup431; Collins P, 2002, CARDIOVASC RES, V53, P535, DOI 10.1016/S0008-6363(02)00224-9; Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Dimitrow PP, 2010, EUR HEART J, V31, P3084, DOI 10.1093/eurheartj/ehq308; Gardner JD, 2002, J CARD FAIL, V8, P101, DOI 10.1054/jcaf.2002.32195; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Haines CD, 2012, ENDOCRINOLOGY, V153, P4470, DOI 10.1210/en.2012-1391; Heidecker B, 2010, EUR HEART J, V31, P1188, DOI 10.1093/eurheartj/ehp549; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Jeevanantham V, 2010, AM J CARDIOL, V105, P1317, DOI 10.1016/j.amjcard.2009.12.046; Kawarai H, 2011, J CARD FAIL, V17, P459, DOI 10.1016/j.cardfail.2011.01.015; Kostkiewicz M, 1999, INT J CARDIOL, V71, P57, DOI 10.1016/S0167-5273(99)00114-X; Lee CH, 2007, CLIN CARDIOL, V30, P177, DOI 10.1002/clc.20057; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2003, J AM COLL CARDIOL, V41, P974, DOI 10.1016/S0735-1097(02)02976-5; Martinez-Selles M, 2003, EUR HEART J, V24, P2046, DOI 10.1016/j.ehj.2003.07.007; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; Mosca L, 2004, CIRCULATION, V109, P573, DOI 10.1161/01.CIR.0000115222.69428.C9; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Pacileo G, 2013, J CARDIOVASC MED, V14, P319, DOI 10.2459/JCM.0b013e328357739e; Phillips GB, 1997, ARTERIOSCL THROM VAS, V17, P695, DOI 10.1161/01.ATV.17.4.695; Regitz-Zagrosek V, 2007, PROG CARDIOVASC DIS, V49, P241, DOI 10.1016/j.pcad.2006.08.011; Santangeli P, 2010, HEART RHYTHM, V7, P876, DOI 10.1016/j.hrthm.2010.03.042; Saura D, 2009, INT J CLIN PRACT, V63, P1465, DOI 10.1111/j.1742-1241.2009.02127.x; Schulz-Menger J, 2008, EUR J HEART FAIL, V10, P850, DOI 10.1016/j.ejheart.2008.06.021; Sherazi S, 2011, CARDIOL J, V18, P222; Zou YB, 2004, AM J MED, V116, P14, DOI 10.1016/j.amjmed.2003.05.009	30	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102969	10.1371/journal.pone.0102969	http://dx.doi.org/10.1371/journal.pone.0102969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25047602	Green Published, gold, Green Submitted			2022-12-27	WOS:000339558100093
J	Wilson, JM; Severson, R; Beman, JM				Wilson, Jesse M.; Severson, Rodney; Beman, J. Michael			Ocean-Scale Patterns in Community Respiration Rates along Continuous Transects across the Pacific Ocean	PLOS ONE			English	Article							GAS-EXCHANGE; OLIGOTROPHIC OCEAN; METABOLIC BALANCE; PLANKTON RESPIRATION; ATLANTIC-OCEAN; CARBON BUDGET; WIND-SPEED; SEA; NET; OXYGEN	Community respiration (CR) of organic material to carbon dioxide plays a fundamental role in ecosystems and ocean biogeochemical cycles, as it dictates the amount of production available to higher trophic levels and for export to the deep ocean. Yet how CR varies across large oceanographic gradients is not well-known: CR is measured infrequently and cannot be easily sensed from space. We used continuous oxygen measurements collected by autonomous gliders to quantify surface CR rates across the Pacific Ocean. CR rates were calculated from changes in apparent oxygen utilization and six different estimates of oxygen flux based on wind speed. CR showed substantial spatial variation: rates were lowest in ocean gyres (mean of 6.93 mmol m(-3) d(-1) +/- 8.0 mmol m(-3) d(-1) standard deviation in the North Pacific Subtropical Gyre) and were more rapid and more variable near the equator (8.69 mmol m(-3) d(-1)+/- 7.32 mmol m(-3) d(-1) between 10 degrees N and 10 degrees S) and near shore (e.g., 5.62 mmol m(-3) d(-1)+/- 45.6 mmol m(-3) d(-1) between the coast of California and 124 degrees W, and 17.0 mmol m(-3) d(-1)+/- 13.9 mmol m(-3) d(-1) between 156 degrees E and the Australian coast). We examined how CR varied with coincident measurements of temperature, turbidity, and chlorophyll concentrations (a proxy for phytoplankton biomass), and found that CR was weakly related to different explanatory variables across the Pacific, but more strongly related to particular variables in different biogeographical areas. Our results indicate that CR is not a simple linear function of chlorophyll or temperature, and that at the scale of the Pacific, the coupling between primary production, ocean warming, and CR is complex and variable. We suggest that this stems from substantial spatial variation in CR captured by high-resolution autonomous measurements.	[Wilson, Jesse M.] Univ Calif Merced, Merced, CA 95343 USA; Univ Calif Merced, Sierra Nevada Res Inst, Merced, CA USA	University of California System; University of California Merced; University of California System; University of California Merced	Wilson, JM (corresponding author), Univ Calif Merced, Merced, CA 95343 USA.	jwilson34@ucmerced.edu		Wilson, Jesse/0000-0003-2837-2060				Breitburg DL, 2010, INTEGR COMP BIOL, V50, P188, DOI 10.1093/icb/icq051; BREITBURG DL, 2009, MAR SCI, V1, P349; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Crusius J, 2003, LIMNOL OCEANOGR, V48, P1010, DOI 10.4319/lo.2003.48.3.1010; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Donelan M., 1990, SEA VOLUME 9 OCEAN E, V9, P239; Duarte CM, 2013, ANNU REV MAR SCI, V5, P551, DOI 10.1146/annurev-marine-121211-172337; Duarte CM, 1999, SCIENCE, V284, P1735, DOI DOI 10.1126/SCIENCE.284.5421.1735B; Engle D, 2000, BIOGEOCHEMISTRY, V51, P71, DOI 10.1023/A:1006389124823; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gonzalez N, 2002, MAR ECOL PROG SER, V233, P21, DOI 10.3354/meps233021; Hamme RC, 2006, J MAR RES, V64, P73, DOI 10.1357/002224006776412322; HOLMEN K, 1984, TELLUS B, V36, P92, DOI 10.1111/j.1600-0889.1984.tb00231.x; Hopkinson Charles S. Jr, 2005, P122, DOI 10.1093/acprof:oso/9780198527084.003.0008; Jahne B, 1989, TELLUS B, V41, P177, DOI 10.1111/j.1600-0889.1989.tb00135.x; JAHNE B, 1987, J GEOPHYS RES-OCEANS, V92, P1937, DOI 10.1029/JC092iC02p01937; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; LISS PS, 1974, NATURE, V247, P181, DOI 10.1038/247181a0; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Luz B, 2009, AQUAT MICROB ECOL, V56, P133, DOI 10.3354/ame01296; MacIntyre S., 1995, BIOGENIC TRACE GASES, P52; Maranon E, 2007, AQUAT MICROB ECOL, V48, P261, DOI 10.3354/ame048261; NEEDOBA JA, 2012, ANONYMOUS MOL BIOL T, P73; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; ODUM HT, 1956, LIMNOL OCEANOGR, V1, P102, DOI 10.4319/lo.1956.1.2.0102; Perez V, 2005, DEEP-SEA RES PT I, V52, P861, DOI 10.1016/j.dsr.2005.01.002; POMEROY LR, 1986, SCIENCE, V233, P359, DOI 10.1126/science.233.4761.359; Quay P, 2003, DEEP-SEA RES PT I, V50, P1045, DOI 10.1016/S0967-0637(03)00116-X; Quay PD, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003665; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; Regaudie-de-Gioux A, 2013, LIMNOL OCEANOGR, V58, P977, DOI 10.4319/lo.2013.58.3.0977; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Robinson C, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P147, DOI 10.1093/acprof:oso/9780198527084.003.0009; Robinson C, 2002, DEEP-SEA RES PT I, V49, P787, DOI 10.1016/S0967-0637(01)00083-8; ROBOTICS L, 2012, PACX; Schlitzer R., 2013, OCEAN DATA VIEW; Serret P, 2002, ECOLOGY, V83, P3225, DOI 10.2307/3071855; SPITZER WS, 1989, J MAR RES, V47, P169, DOI 10.1357/002224089785076370; Stanley RHR, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003651; STAUFFER RE, 1980, LIMNOL OCEANOGR, V25, P513, DOI 10.4319/lo.1980.25.3.0513; Sverdrup H. U, 1946, OCEANS THEIR PHYS CH; Teira E, 2010, AQUAT MICROB ECOL, V61, P31, DOI 10.3354/ame01438; Villareal TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092280; Viviani DA, 2011, AQUAT MICROB ECOL, V62, P1, DOI 10.3354/ame01451; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; WANNINKHOF R, 2009, MARINE SCI, V1; Westberry TK, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004094; Williams PJL, 2013, ANNU REV MAR SCI, V5, P535, DOI 10.1146/annurev-marine-121211-172335; WILLIAMS PJ, 1999, SCIENCE, V284, P1735, DOI DOI 10.1126/SCIENCE.284.5421.1735B; WILLIAMS PJB, 1991, DEEP-SEA RES, V38, P891, DOI 10.1016/0198-0149(91)90024-A; Williams PJL, 2004, DEEP-SEA RES PT I, V51, P1563, DOI 10.1016/j.dsr.2004.07.001; Wohlers J, 2009, P NATL ACAD SCI USA, V106, P7067, DOI 10.1073/pnas.0812743106; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778	59	6	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e99821	10.1371/journal.pone.0099821	http://dx.doi.org/10.1371/journal.pone.0099821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048960	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100004
J	Cachay, ER; Hill, L; Wyles, D; Colwell, B; Ballard, C; Torriani, F; Mathews, WC				Cachay, Edward R.; Hill, Lucas; Wyles, David; Colwell, Bradford; Ballard, Craig; Torriani, Francesca; Mathews, William C.			The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care	PLOS ONE			English	Article							VIRUS HCV; USE DRUGS; PEOPLE; COINFECTION; OUTPATIENT; MANAGEMENT; UPDATE	Background: The aims were to investigate the hepatitis C (HCV) cascade of care among HIV-infected patients and to identify reasons for not referring for and not initiating HCV therapy after completion of HCV treatment staging. Design and Methods: Retrospective cohort analysis of HIV-infected patients under care at the University of California, San Diego (UCSD). We identified patients screened for and diagnosed with active HCV infection. Logistic regression analyses were used to identify factors associated with lack of referral for HCV therapy. Electronic medical records were reviewed to ascertain reasons for not initiating HCV therapy. Results: Between 2008 and 2012, 4725 HIV-infected patients received care at the UCSD Owen clinic. Most patients [4534 (96%)] were screened for HCV, 748 (16%) patients had reactive serum HCV antibodies but only 542 patients had active HCV infection. Lack of engagement in care was the most important predictor of non-referral for HCV therapy [odds ratio (OR): 5.08, 95% confidence interval 3.24-6.97, p<0.00001]. Other significant predictors included unstable housing (OR: 2.26), AIDS (OR: 1.83), having a detectable HIV viral load (OR: 1.98) and being non-white (OR: 1.67). The most common reason (40%) for not initiating or deferring HCV therapy was the presence of ongoing barriers to care. Conclusions: Screening for HCV in HIV-infected patients linked to care is high but almost half of patients diagnosed with HCV are not referred for HCV therapy. Despite improvements in HCV therapy the benefits will not be realized unless effective measures for dealing with barriers to care are implemented.	[Cachay, Edward R.; Wyles, David; Torriani, Francesca; Mathews, William C.] Univ Calif San Diego, Dept Med, Owen Clin, San Diego, CA 92103 USA; [Cachay, Edward R.; Wyles, David; Torriani, Francesca] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; [Hill, Lucas; Colwell, Bradford; Ballard, Craig] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cachay, ER (corresponding author), Univ Calif San Diego, Dept Med, Owen Clin, San Diego, CA 92103 USA.	ecachay@ucsd.edu	Trajman, Anete/C-7679-2016; Mathews, William C/E-4451-2010; Torriani, Francesca/HGE-5175-2022	Trajman, Anete/0000-0002-4000-4984; Mathews, William C/0000-0002-2352-0725; 	Clinical Investigation Core of the University of California San Diego Center for AIDS Research [AI036214]; CFAR Network of Integrated Clinical Systems (CNICS) [R24 AI067039-01A1]; Pacific AIDS Education and Training Center (PAETC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R24AI067039] Funding Source: NIH RePORTER	Clinical Investigation Core of the University of California San Diego Center for AIDS Research; CFAR Network of Integrated Clinical Systems (CNICS); Pacific AIDS Education and Training Center (PAETC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Clinical Investigation Core of the University of California San Diego Center for AIDS Research [AI036214], the CFAR Network of Integrated Clinical Systems (CNICS) [R24 AI067039-01A1], and the Pacific AIDS Education and Training Center (PAETC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Adeyemi OM ES, 2014, 21 C RETR OPP INF BO; Astell-Burt T, 2012, SOC SCI MED, V75, P240, DOI 10.1016/j.socscimed.2012.02.046; Barreiro P, 2014, ANTIVIR RES, V105, P1, DOI 10.1016/j.antiviral.2014.02.004; Brener L, 2013, SEX HEALTH, V10, P268, DOI 10.1071/SH12179; Cachay ER, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-9; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Freimman JM, 2014, CLIN INFEC IN PRESS; Grebely J, 2013, J INFECT DIS, V207, pS19, DOI 10.1093/infdis/jis928; Grint D, 2013, HIV MED, V14, P614, DOI 10.1111/hiv.12068; Haubitz S SV, 2014, 21 C RETR OPP INF BO; Higgs P, 2011, HEPAT MON, V11, P513; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kresina TF, 2005, CLIN INFECT DIS, V41, pS83, DOI 10.1086/429502; Lekas HM, 2012, QUAL HEALTH RES, V22, P54, DOI 10.1177/1049732311418248; Meyer JP, 2013, CLIN INFECT DIS, V57, P1309, DOI 10.1093/cid/cit427; Meyer PA, 2013, MMWR-MORBID MORTAL W, V62, P184; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Norton BL, 2012, AIDS PATIENT CARE ST, V26, P541, DOI 10.1089/apc.2012.0170; Olsen Y, 2014, JAMA-J AM MED ASSOC, V311, P1393, DOI 10.1001/jama.2014.2147; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Soriano V, 2013, CURR HIV-AIDS REP, V10, P226, DOI 10.1007/s11904-013-0169-5; Stepanova M, 2011, HEPATOLOGY, V53, P737, DOI 10.1002/hep.24131; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Vellozzi C, 2011, J VIRAL HEPATITIS, V18, P316, DOI 10.1111/j.1365-2893.2010.01299.x; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	28	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102883	10.1371/journal.pone.0102883	http://dx.doi.org/10.1371/journal.pone.0102883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036553	Green Published, gold			2022-12-27	WOS:000339615200091
J	Gao, YH; Guan, WJ; Xu, G; Lin, ZY; Tang, Y; Lin, ZM; Li, HM; Gao, Y; Luo, Q; Zhong, NS; Chen, RC				Gao, Yonghua; Guan, Weijie; Xu, Gang; Lin, Zhiya; Tang, Yan; Lin, Zhimin; Li, Huimin; Gao, Yang; Luo, Qun; Zhong, Nanshan; Chen, Rongchang			Sleep Disturbances and Health-Related Quality of Life in Adults with Steady-State Bronchiectasis	PLOS ONE			English	Article							CHINESE VERSION; RESPIRATORY QUESTIONNAIRE; DAYTIME SLEEPINESS; HOSPITAL ANXIETY; VALIDATION; DEPRESSION; COMPLAINTS; SYMPTOMS; COUGH; INDEX	Background: Sleep disturbances are common in patients with chronic lung diseases, but little is known about the prevalence in patients with bronchiectasis. A cross sectional study was conducted to investigate the prevalence and determinants associated with sleep disturbances, and the correlation between sleep disturbances and quality of life (QoL) in adults with steady-state bronchiectasis. Methods: One hundred and forty-four bronchiectasis patients and eighty healthy subjects were enrolled. Sleep disturbances, daytime sleepiness, and QoL were measured by utilizing the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS) and St. George Respiratory Questionnaire (SGRQ), respectively. Demographic, clinical indices, radiology, spirometry, bacteriology, anxiety and depression were also assessed. Results: Adults with steady-state bronchiectasis had a higher prevalence of sleep disturbances (PSQI>5) (57% vs. 29%, P<0.001), but not daytime sleepiness (ESS >= 10) (32% vs. 30%, P = 0.76), compared with healthy subjects. In the multivariate model, determinants associated with sleep disturbances in bronchiectasis patients included depression (OR, 10.09; 95% CI, 3.46-29.37; P<0.001), nocturnal cough (OR, 1.89; 95% CI, 1.13-3.18; P = 0.016), aging (OR, 1.04; 95% CI, 1.01-1.07; P = 0.009) and increased 24-hour sputum volume (OR, 2.01; 95% CI, 1.22-3.33; P = 0.006). Patients with sleep disturbances had more significantly impaired QoL affecting all domains than those without. Only 6.2% of patients reported using a sleep medication at least weekly. Conclusions: In adults with steady-state bronchiectasis, sleep disturbances are more common than in healthy subjects and are related to poorer QoL. Determinants associated with sleep disturbances include depression, aging, nighttime cough and increased sputum volume. Assessment and intervention of sleep disturbances are warranted and may improve QoL.	[Gao, Yonghua; Guan, Weijie; Xu, Gang; Lin, Zhiya; Tang, Yan; Lin, Zhimin; Li, Huimin; Gao, Yang; Luo, Qun; Zhong, Nanshan; Chen, Rongchang] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Dis,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	ChenRC@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The work was supported by Changjiang Scholars and Innovative Research Team in University ITR0961 (Dr. N. Zhong and R. Chen), which was endowed by the Ministry of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER AF, 1988, AM REV RESPIR DIS, V137, P969, DOI 10.1164/ajrccm/137.4.969; Batal O, 2011, LUNG, V189, P141, DOI 10.1007/s00408-010-9277-9; Bouka A, 2012, RESP MED, V106, P1244, DOI 10.1016/j.rmed.2012.06.010; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chan KKY, 2010, EUR RESPIR J, V35, P368, DOI 10.1183/09031936.00110409; Chan SL, 2002, CHEST, V122, P2030, DOI 10.1378/chest.122.6.2030; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Da Costa D, 2005, ARTHRIT RHEUM-ARTHR, V53, P272, DOI 10.1002/art.21069; De Soyza A, 2013, THORAX, V68, P695, DOI 10.1136/thoraxjnl-2012-202893; Erdem E, 2011, PEDIATR PULM, V46, P919, DOI 10.1002/ppul.21454; Fokkens W, 2007, RHINOLOGY, V45, P97; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Havlikova E, 2011, J NEUROL, V258, P2222, DOI 10.1007/s00415-011-6098-6; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; Jankelowitz L, 2005, CHEST, V127, P1593, DOI 10.1378/chest.127.5.1593; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; King PT, 2006, RESP MED, V100, P2183, DOI 10.1016/j.rmed.2006.03.012; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Krishnan V, 2008, CHEST, V134, P693, DOI 10.1378/chest.08-0173; Leung CM, 1999, ACTA PSYCHIAT SCAND, V100, P456, DOI 10.1111/j.1600-0447.1999.tb10897.x; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Maggi S, 1998, J AM GERIATR SOC, V46, P161, DOI 10.1111/j.1532-5415.1998.tb02533.x; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; Milross Maree A, 2002, Sleep Med, V3, P205, DOI 10.1016/S1389-9457(01)00157-5; Nunes DM, 2009, LUNG, V187, P159, DOI 10.1007/s00408-009-9147-5; O'Leary CJ, 2002, RESP MED, V96, P686, DOI 10.1053/rmed.2002.1330; Olveira C, 2013, QUAL LIFE RES, V22, P597, DOI 10.1007/s11136-012-0188-5; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Scharf SM, 2011, INT J CHRONIC OBSTR, V6, P1, DOI 10.2147/COPD.S15666; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tsang KW, 2009, RESPIROLOGY, V14, P637, DOI 10.1111/j.1440-1843.2009.01569.x; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102970	10.1371/journal.pone.0102970	http://dx.doi.org/10.1371/journal.pone.0102970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036723	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200105
J	Gough, AH; Chen, N; Shun, TY; Lezon, TR; Boltz, RC; Reese, CE; Wagner, J; Vernetti, LA; Grandis, JR; Lee, AV; Stern, AM; Schurdak, ME; Taylor, DL				Gough, Albert H.; Chen, Ning; Shun, Tong Ying; Lezon, Timothy R.; Boltz, Robert C.; Reese, Celeste E.; Wagner, Jacob; Vernetti, Lawrence A.; Grandis, Jennifer R.; Lee, Adrian V.; Stern, Andrew M.; Schurdak, Mark E.; Taylor, D. Lansing			Identifying and Quantifying Heterogeneity in High Content Analysis: Application of Heterogeneity Indices to Drug Discovery	PLOS ONE			English	Article							KOLMOGOROV-SMIRNOV TEST; INDIVIDUAL CANCER-CELLS; TUMOR HETEROGENEITY; NONGENETIC HETEROGENEITY; CELLULAR HETEROGENEITY; GENETIC-HETEROGENEITY; DYNAMIC PROTEOMICS; STAT3; RESISTANCE; EVOLUTION	One of the greatest challenges in biomedical research, drug discovery and diagnostics is understanding how seemingly identical cells can respond differently to perturbagens including drugs for disease treatment. Although heterogeneity has become an accepted characteristic of a population of cells, in drug discovery it is not routinely evaluated or reported. The standard practice for cell-based, high content assays has been to assume a normal distribution and to report a well-to-well average value with a standard deviation. To address this important issue we sought to define a method that could be readily implemented to identify, quantify and characterize heterogeneity in cellular and small organism assays to guide decisions during drug discovery and experimental cell/tissue profiling. Our study revealed that heterogeneity can be effectively identified and quantified with three indices that indicate diversity, non-normality and percent outliers. The indices were evaluated using the induction and inhibition of STAT3 activation in five cell lines where the systems response including sample preparation and instrument performance were well characterized and controlled. These heterogeneity indices provide a standardized method that can easily be integrated into small and large scale screening or profiling projects to guide interpretation of the biology, as well as the development of therapeutics and diagnostics. Understanding the heterogeneity in the response to perturbagens will become a critical factor in designing strategies for the development of therapeutics including targeted polypharmacology.	[Gough, Albert H.; Chen, Ning; Shun, Tong Ying; Lezon, Timothy R.; Boltz, Robert C.; Reese, Celeste E.; Wagner, Jacob; Vernetti, Lawrence A.; Stern, Andrew M.; Schurdak, Mark E.; Taylor, D. Lansing] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15260 USA; [Gough, Albert H.; Lezon, Timothy R.; Boltz, Robert C.; Vernetti, Lawrence A.; Stern, Andrew M.; Schurdak, Mark E.; Taylor, D. Lansing] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Grandis, Jennifer R.; Lee, Adrian V.; Schurdak, Mark E.; Taylor, D. Lansing] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Grandis, Jennifer R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Grandis, Jennifer R.; Lee, Adrian V.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gough, AH (corresponding author), Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15260 USA.	gough@pitt.edu	Gough, Albert/K-2490-2019	Gough, Albert/0000-0001-6456-0195; Taylor, D. Lansing/0000-0001-6947-1343; Stern, Andrew/0000-0002-8437-2957; Lezon, Timothy/0000-0001-9802-3961; Lee, Adrian/0000-0001-9917-514X; Schurdak, Mark/0000-0002-1146-3268; Vernetti, Lawrence/0000-0003-4861-3167	NIH-National Cancer Institute;  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000503] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012269] Funding Source: NIH RePORTER	NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project used the University of Pittsburgh Cancer Institute (UPCI) Chemical Biology Facility that is supported in part by award P30CA047904, an NIH-National Cancer Institute, Cancer Center Support Grant to the UPCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Y, 2014, J BIOMOL SCREEN; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azegrouz H, 2013, J BIOMOL SCREEN; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer VL, 2010, GENES-BASEL, V1, P388, DOI 10.3390/genes1030388; Beckman RA, 2012, P NATL ACAD SCI USA, V109, P14586, DOI 10.1073/pnas.1203559109; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bray M., 2012, ASSAY GUIDANCE MANUA; BRIGHT GR, 1989, J CELL PHYSIOL, V141, P410, DOI 10.1002/jcp.1041410223; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chakravarty A, 2007, DEV ROBUST HIGH CONT, P85; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Critchley-Thorne RJ, 2009, COMB CHEM HIGH T SCR, V12, P860, DOI 10.2174/138620709789383222; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Fang CG, 2013, J CANCER, V4, P402, DOI 10.7150/jca.6780; Fedele C, 2014, CANCER DISCOV, V4, P146, DOI 10.1158/2159-8290.CD-13-1042; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Giuliano KA, 2004, J BIOMOL SCREEN, V9, P557, DOI 10.1177/1087057104265387; Giuliano KA, 2005, ASSAY DRUG DEV TECHN, V3, P501, DOI 10.1089/adt.2005.3.501; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Gough A, 2014, MOL BASIS CANC; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haney S.A., 2014, J BIOMOL SCREEN; Haney S.A., 2008, HIGH CONTENT SCREENI; Hasenauer J, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-4; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Huang SG, 2010, J COMPUT BIOL, V17, P879, DOI 10.1089/cmb.2009.0071; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Inglese J, 2006, METHOD ENZYMOL, V414, P1; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnston PA, 2013, ASSAY DRUG DEV TECHN; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Li RX, 2009, EXPERT REV PROTEOMIC, V6, P19, DOI 10.1586/14789450.6.1.19; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Ng AYJ, 2010, J BIOMOL SCREEN, V15, P858, DOI 10.1177/1087057110372256; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; ONG LDY, 1968, HEALTH PHYS, V14, P376; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Potts SJ, 2012, LAB INVEST, V92, P1342, DOI 10.1038/labinvest.2012.91; Pritchard JR, 2013, P NATL ACAD SCI USA, V110, pE170, DOI 10.1073/pnas.1210419110; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Razali NM, 2011, J STAT MODEL ANAL, V2, P13; RUBIN H, 1990, CANCER METAST REV, V9, P1, DOI 10.1007/BF00047585; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sexton Jonathan Z, 2010, Int J High Throughput Screen, V2010, P127; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Taylor DL, 2007, METH MOL B, V356, P3; Taylor DL, 2007, HIGH CONTENT SCREENI, Vxiii; Team RC, 2012, LANG ENV STAT COMP; Thomas N, 2010, J BIOMOL SCREEN, V15, P1, DOI 10.1177/1087057109353790; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Vogt PK, 2011, CANCER DISCOV, V1, P481, DOI 10.1158/2159-8290.CD-11-0218; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Wang Y-l, 1988, FLOURESCENCE MICRO A; Wang Y-l, 1989, FLOURESCENCE MICRO B; Wood KC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002612; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zhao BY, 2014, CANCER DISCOV, V4, P166, DOI 10.1158/2159-8290.CD-13-0465	91	46	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102678	10.1371/journal.pone.0102678	http://dx.doi.org/10.1371/journal.pone.0102678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036749	Green Published, gold, Green Accepted			2022-12-27	WOS:000339615200078
J	Hofree, G; Ruvolo, P; Bartlett, MS; Winkielman, P				Hofree, Galit; Ruvolo, Paul; Bartlett, Marian Stewart; Winkielman, Piotr			Bridging the Mechanical and the Human Mind: Spontaneous Mimicry of a Physically Present Android	PLOS ONE			English	Article							FACIAL REACTIONS; RECOGNITION; MODULATION; EMOTION; EMPATHY; SMILES; ROBOT; FACE	The spontaneous mimicry of others' emotional facial expressions constitutes a rudimentary form of empathy and facilitates social understanding. Here, we show that human participants spontaneously match facial expressions of an android physically present in the room with them. This mimicry occurs even though these participants find the android unsettling and are fully aware that it lacks intentionality. Interestingly, a video of that same android elicits weaker mimicry reactions, occurring only in participants who find the android "humanlike." These findings suggest that spontaneous mimicry depends on the salience of humanlike features highlighted by face-to-face contact, emphasizing the role of presence in human-robot interaction. Further, the findings suggest that mimicry of androids can dissociate from knowledge of artificiality and experienced emotional unease. These findings have implications for theoretical debates about the mechanisms of imitation. They also inform creation of future robots that effectively build rapport and engagement with their human users.	[Hofree, Galit; Winkielman, Piotr] Univ Calif San Diego, Dept Psychol, San Diego, CA 92103 USA; [Ruvolo, Paul] Olin Coll Engn, Needham, MA USA; [Bartlett, Marian Stewart] Univ Calif San Diego, Inst Neural Computat, San Diego, CA 92103 USA; [Bartlett, Marian Stewart] Emotient Inc, San Diego, CA USA	University of California System; University of California San Diego; Franklin W. Olin College of Engineering; University of California System; University of California San Diego	Hofree, G (corresponding author), Univ Calif San Diego, Dept Psychol, San Diego, CA 92103 USA.	ghofree@ucsd.edu; pwinkielman@ucsd.edu	Winkielman, Piotr/AAT-6275-2020	Winkielman, Piotr/0000-0003-2330-1802	NSF [IIS-0808767, SMA-1041755]	NSF(National Science Foundation (NSF))	This work was supported in part by NSF grants IIS-0808767 and SMA-1041755. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chouchourelou A., 2013, PEOPLE WATCHING SOCI, P63; Cook R, 2014, BEHAV BRAIN SCI, V37, P177, DOI 10.1017/S0140525X13000903; Coradeschi S, 2006, IEEE INTELL SYST, V21, P74, DOI 10.1109/MIS.2006.72; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; Freud S, 1919, GW, V12, P229; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Goldman AI, 2006, SIMULATING MINDS; GRATCH J, 2006, LECT NOTES ARTIF INT, P14; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hatfield E., 1992, EMOTION SOCIAL BEHAV, P151; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Kiesler S, 2008, SOC COGNITION, V26, P169, DOI 10.1521/soco.2008.26.2.169; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Nadel J., 2006, P 6 INT WORKSH EP RO, P79; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Orfanidis S.J., 1988, OPTIMUM SIGNAL PROCE; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Riek LD, 2010, J MULTIMODAL USER IN, V3, P99, DOI 10.1007/s12193-009-0028-2; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x; Tanaka F, 2007, P NATL ACAD SCI USA, V104, P17954, DOI 10.1073/pnas.0707769104; Tassinary L. G., 2000, HDB PSYCHOPHYSIOLOGY, P163; Tomasello M, 1999, ANNU REV ANTHROPOL, V28, P509, DOI 10.1146/annurev.anthro.28.1.509; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006; Waytz A, 2010, PERSPECT PSYCHOL SCI, V5, P219, DOI 10.1177/1745691610369336; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Weyers P, 2009, PSYCHOPHYSIOLOGY, V46, P328, DOI 10.1111/j.1469-8986.2008.00771.x; WINKIELMAN P, 2013, HDB COGNITION EMOTIO, P212; Wu T, 2009, PROCEEDINGS OF 2009 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS TECHNOLOGY AND APPLICATIONS, P101, DOI 10.1109/ICCOMTA.2009.5349228	45	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99934	10.1371/journal.pone.0099934	http://dx.doi.org/10.1371/journal.pone.0099934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	25036365	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200006
J	Ibrahim, OMA; Dogru, M; Matsumoto, Y; Igarashi, A; Kojima, T; Wakamatsu, TH; Inaba, T; Shimizu, T; Shimazaki, J; Tsubota, K				Ibrahim, Osama M. A.; Dogru, Murat; Matsumoto, Yukihiro; Igarashi, Ayako; Kojima, Takashi; Wakamatsu, Tais Hitomi; Inaba, Takaaki; Shimizu, Takahiko; Shimazaki, Jun; Tsubota, Kazuo			Oxidative Stress Induced Age Dependent Meibomian Gland Dysfunction in Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DRY EYE DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; SJOGRENS-SYNDROME; LACRIMAL GLAND; MUSCLE ATROPHY; CYTOCHROME-C; MITOCHONDRIAL; DAMAGE	Purpose: The purpose of our study was to investigate alterations in the meibomian gland (MG) in Cu, Zn-Superoxide Dismutase-1 knockout (Sod1(-/-)) mouse. Methods: Tear function tests [Break up time (BUT) and cotton thread] and ocular vital staining test were performed on Sod1(-/-) male mice (n = 24) aged 10 and 50 weeks, and age and sex matched wild-type (+/+) mice (n = 25). Tear and serum samples were collected at sacrifice for inflammatory cytokine assays. MG specimens underwent Hematoxylin and Eosin staining, Mallory staining for fibrosis, Oil Red O lipid staining, TUNEL staining, immunohistochemistry stainings for 4HNE, 8-OHdG and CD45. Transmission electron microscopic examination (TEM) was also performed. Results: Corneal vital staining scores in the Sod1(-/-) mice were significantly higher compared with the wild type mice throughout the follow-up. Tear and serum IL-6 and TNF-alpha levels also showed significant elevations in the 10 to 50 week Sod1(-/-) mice. Oil Red O staining showed an accumulation of large lipid droplets in the Sod1(-/-) mice at 50 weeks. Immunohistochemistry revealed both increased TUNEL and oxidative stress marker stainings of the MG acinar epithelium in the Sod1(-/-) mice compared to the wild type mice. Immunohistochemistry staining for CD45 showed increasing inflammatory cell infiltrates from 10 to 50 weeks in the Sod1(-/-) mice compared to the wild type mice. TEM revealed prominent mitochondrial changes in 50 week Sod1(-/-) mice. Conclusions: Our results suggest that reactive oxygen species might play a vital role in the pathogensis of meibomian gland dysfunction. The Sod1(-/-) mouse appears to be a promising model for the study of reactive oxygen species associated MG alterations.	[Ibrahim, Osama M. A.; Dogru, Murat; Matsumoto, Yukihiro; Kojima, Takashi; Wakamatsu, Tais Hitomi; Inaba, Takaaki; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Dogru, Murat; Igarashi, Ayako; Shimizu, Takahiko] Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan; [Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chiba, Japan	Keio University; Tokyo Dental College; Chiba University	Dogru, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	muratodooru2012@yahoo.com	Wakamatsu, Tais/E-9300-2012; Jun, Shimazaki/K-5976-2019		Japan Society for the Promotion of Science [22791694]; Johnson and Johnson Vision Care Company	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Johnson and Johnson Vision Care Company	This work was supported by funds from Japan Society for the Promotion of Science (Grant No. 22791694) (http://www.jsps.go.jp/english/e-grants/) and Johnson and Johnson Vision Care Company (http://www.jnj.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIO JL, 1995, CORNEA, V14, P175; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; BHUYAN KC, 1986, LIFE SCI, V38, P1463, DOI 10.1016/0024-3205(86)90559-X; Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x; Bruunsgaard H, 2004, J AM GERIATR SOC, V52, P1361, DOI 10.1111/j.1532-5415.2004.52369.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P153, DOI 10.4161/oxim.3.2.11758; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Den S, 2006, CORNEA, V25, P651, DOI 10.1097/01.ico.0000227889.11500.6f; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dotti G, 2001, EXP HEMATOL, V29, P952, DOI 10.1016/S0301-472X(01)00668-3; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FOX RI, 1994, J IMMUNOL, V152, P5532; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; Fujimura M, 2000, J NEUROSCI, V20, P2817; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GRITZ DC, 1991, CURR EYE RES, V10, P927, DOI 10.3109/02713689109020328; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; HOM MM, 1990, OPTOMETRY VISION SCI, V67, P710, DOI 10.1097/00006324-199009000-00010; HYKIN PG, 1992, CORNEA, V11, P334, DOI 10.1097/00003226-199207000-00012; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jenny NS, 2002, ARTERIOSCL THROM VAS, V22, P2066, DOI 10.1161/01.ATV.0000040224.49362.60; JESTER JV, 1989, INVEST OPHTH VIS SCI, V30, P927; Kim GW, 2003, J NEUROSCI, V23, P8733; Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kuwahara H, 2010, FREE RADICAL BIO MED, V48, P1252, DOI 10.1016/j.freeradbiomed.2010.02.011; Li Q, 2009, MOL CELL BIOCHEM, V322, P151, DOI 10.1007/s11010-008-9952-9; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Murakami K, 2009, BIOCHEM BIOPH RES CO, V382, P457, DOI 10.1016/j.bbrc.2009.03.053; Narayanan S, 2006, INVEST OPHTH VIS SCI, V47, P2445, DOI 10.1167/iovs.05-1364; Nava F, 2001, NEUROSCI LETT, V307, P57, DOI 10.1016/S0304-3940(01)01930-9; Nien CJ, 2011, ARCH OPHTHALMOL-CHIC, V129, P462, DOI 10.1001/archophthalmol.2011.69; Nien CJ, 2009, EXP EYE RES, V89, P1021, DOI 10.1016/j.exer.2009.08.013; Noda Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092999; Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Nunomura A, 1999, J NEUROSCI, V19, P1959; Obata H, 2002, CORNEA, V21, pS70, DOI 10.1097/01.ico.0000263122.45898.09; OHNISHI Y, 1979, INVEST OPHTH VIS SCI, V18, P981; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; PULIDO R, 1988, J IMMUNOL, V140, P3851; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodriguez-Iturbe B, 2003, HYPERTENSION, V41, P341, DOI 10.1161/01.HYP.0000052833.20759.64; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Stern Michael E, 2004, Ocul Surf, V2, P124; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Sullivan BD, 2006, ARCH OPHTHALMOL-CHIC, V124, P1286, DOI 10.1001/archopht.124.9.1286; Tishler M, 1998, OPHTHALMOLOGY, V105, P2327, DOI 10.1016/S0161-6420(98)91236-2; TOYOKUNI S, 1995, FEBS LETT, V359, P189, DOI 10.1016/0014-5793(95)00033-6; Toyokuni S, 1997, LAB INVEST, V76, P365; Tsubota K, 2010, OPHTHALMIC RES, V44, P146, DOI 10.1159/000316594; Uchino M, 2006, OPTOMETRY VISION SCI, V83, P797, DOI 10.1097/01.opx.0000232814.39651.fa; Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Ying W, 2010, CURR MED CHEM, V17, P2152, DOI 10.2174/092986710791299911; Zoukhri D, 2006, EXP EYE RES, V82, P885, DOI 10.1016/j.exer.2005.10.018	71	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e99328	10.1371/journal.pone.0099328	http://dx.doi.org/10.1371/journal.pone.0099328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036096	Green Submitted, Green Published, gold			2022-12-27	WOS:000339615200004
J	Wang, K; Shrestha, R; Wyatt, AW; Reddy, A; Lehar, J; Wang, YZ; Lapuk, A; Collins, CC				Wang, Kendric; Shrestha, Raunak; Wyatt, Alexander W.; Reddy, Anupama; Lehar, Joseph; Wang, Yuzhou; Lapuk, Anna; Collins, Colin C.			A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; INHIBITORS; IDENTIFICATION; CHEMOTHERAPY; COLLECTION; ACTIVATION; MUTATIONS; PHENOTYPE; RADIATION; PATHWAYS	Understanding the heterogeneous drug response of cancer patients is essential to precision oncology. Pioneering genomic analyses of individual cancer subtypes have begun to identify key determinants of resistance, including up-regulation of multi-drug resistance (MDR) genes and mutational alterations of drug targets. However, these alterations are sufficient to explain only a minority of the population, and additional mechanisms of drug resistance or sensitivity are required to explain the remaining spectrum of patient responses to ultimately achieve the goal of precision oncology. We hypothesized that a pan-cancer analysis of in vitro drug sensitivities across numerous cancer lineages will improve the detection of statistical associations and yield more robust and, importantly, recurrent determinants of response. In this study, we developed a statistical framework based on the meta-analysis of expression profiles to identify pan-cancer markers and mechanisms of drug response. Using the Cancer Cell Line Encyclopaedia (CCLE), a large panel of several hundred cancer cell lines from numerous distinct lineages, we characterized both known and novel mechanisms of response to cytotoxic drugs including inhibitors of Topoisomerase 1 (TOP1; Topotecan, Irinotecan) and targeted therapies including inhibitors of histone deacetylases (HDAC; Panobinostat) and MAP/ERK kinases (MEK; PD-0325901, AZD6244). Notably, our analysis implicated reduced replication and transcriptional rates, as well as deficiency in DNA damage repair genes in resistance to TOP1 inhibitors. The constitutive activation of several signaling pathways including the interferon/STAT-1 pathway was implicated in resistance to the pan-HDAC inhibitor. Finally, a number of dysregulations upstream of MEK were identified as compensatory mechanisms of resistance to the MEK inhibitors. In comparison to alternative pan-cancer analysis strategies, our approach can better elucidate relevant drug response mechanisms. Moreover, the compendium of putative markers and mechanisms identified through our analysis can serve as a foundation for future studies into these drugs.	[Wang, Kendric; Shrestha, Raunak; Wyatt, Alexander W.; Wang, Yuzhou; Lapuk, Anna; Collins, Colin C.] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Shrestha, Raunak] Univ British Columbia, CIHR MSHFR Bioinformat Training Program, Vancouver, BC, Canada; [Wang, Yuzhou; Collins, Colin C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada; [Reddy, Anupama; Lehar, Joseph] Novartis Pharmaceut, Div Oncol, Basel, Switzerland	University of British Columbia; University of British Columbia; University of British Columbia; Novartis	Collins, CC (corresponding author), Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada.	ccollins@prostatecentre.com		Wang, Yuzhuo/0000-0002-9749-8591; Shrestha, Raunak/0000-0002-1144-1413				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bianco R, 2005, ENDOCR-RELAT CANCER, V12, pS159, DOI 10.1677/erc.1.00999; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gillet J, 2010, MULTIDRUG RESISTANCE, V596; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Khodarev NN, 2012, CLIN CANCER RES, V18, P3015, DOI 10.1158/1078-0432.CCR-11-3225; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Krynetskaia NF, 2009, MOL CANCER THER, V8, P864, DOI 10.1158/1535-7163.MCT-08-0695; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McCubrey JA, 2010, EXPERT OPIN EMERG DR, V15, P203, DOI 10.1517/14728210903282760; Minna JD, 2007, J CLIN ONCOL, V25, P4329, DOI 10.1200/JCO.2007.12.3968; Mo QX, 2013, P NATL ACAD SCI USA, V110, P4245, DOI 10.1073/pnas.1208949110; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Sullivan C, 2013, TRENDS PHARMACOL SCI, V34, P401, DOI 10.1016/j.tips.2013.05.002; Owen AB, 2009, ANN STAT, V37, P3867, DOI 10.1214/09-AOS697; Pitroda SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008291; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rhodes D, 2004, IEEE IND APPL MAG, V10, P5; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robey RW, 2011, MOL PHARMACEUT, V8, P2021, DOI 10.1021/mp200329f; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Sebolt-Leopold JS, 2008, CLIN CANCER RES, V14, P3651, DOI 10.1158/1078-0432.CCR-08-0333; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Thiele CJ, 2009, CLIN CANCER RES, V15, P5962, DOI 10.1158/1078-0432.CCR-08-0651; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vilasco M, 2011, BREAST CANCER RES TR, V130, P1, DOI 10.1007/s10549-011-1689-6; Watanabe-Takano H, 2010, EXP CELL RES, V316, P477, DOI 10.1016/j.yexcr.2009.09.028; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zoppoli G, 2012, PROC, V11, P2	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e103050	10.1371/journal.pone.0103050	http://dx.doi.org/10.1371/journal.pone.0103050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036042	gold, Green Published, Green Submitted			2022-12-27	WOS:000339615200108
J	Kant, R; Rintahaka, J; Yu, X; Sigvart-Mattila, P; Paulin, L; Mecklin, JP; Saarela, M; Palva, A; von Ossowski, I				Kant, Ravi; Rintahaka, Johanna; Yu, Xia; Sigvart-Mattila, Pia; Paulin, Lars; Mecklin, Jukka-Pekka; Saarela, Maria; Palva, Airi; von Ossowski, Ingemar			A Comparative Pan-Genome Perspective of Niche-Adaptable Cell-Surface Protein Phenotypes in Lactobacillus rhamnosus	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FUNCTIONAL-ANALYSIS; GASTROINTESTINAL-TRACT; ADHESION PROPERTIES; PROBIOTIC BACTERIA; SOLUBLE-PROTEIN; GG; CASEI; STRAINS; HEALTH	Lactobacillus rhamnosus is a ubiquitously adaptable Gram-positive bacterium and as a typical commensal can be recovered from various microbe-accessible bodily orifices and cavities. Then again, other isolates are food-borne, with some of these having been long associated with naturally fermented cheeses and yogurts. Additionally, because of perceived health benefits to humans and animals, numerous L. rhamnosus strains have been selected for use as so-called probiotics and are often taken in the form of dietary supplements and functional foods. At the genome level, it is anticipated that certain genetic variances will have provided the niche-related phenotypes that augment the flexible adaptiveness of this species, thus enabling its strains to grow and survive in their respective host environments. For this present study, we considered it functionally informative to examine and catalogue the genotype-phenotype variation existing at the cell surface between different L. rhamnosus strains, with the presumption that this might be relatable to habitat preferences and ecological adaptability. Here, we conducted a pan-genomic study involving 13 genomes from L. rhamnosus isolates with various origins. In using a benchmark strain (gut-adapted L. rhamnosus GG) for our pan-genome comparison, we had focused our efforts on a detailed examination and description of gene products for certain functionally relevant surface-exposed proteins, each of which in effect might also play a part in niche adaptability among the other strains. Perhaps most significantly of the surface protein loci we had analyzed, it would appear that the spaCBA operon (known to encode SpaCBA-called pili having a mucoadhesive phenotype) is a genomic rarity and an uncommon occurrence in L. rhamnosus. However, for any of the so-piliated L. rhamnosus strains, they will likely possess an increased niche-specific fitness, which functionally might presumably be manifested by a protracted transient colonization of the gut mucosa or some similar microhabitat.	[Kant, Ravi; Rintahaka, Johanna; Yu, Xia; Palva, Airi; von Ossowski, Ingemar] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Sigvart-Mattila, Pia] MTT Agrifood Res Finland, Jokioinen, Finland; [Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Mecklin, Jukka-Pekka] Univ Eastern Finland, Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland; [Mecklin, Jukka-Pekka] Univ Eastern Finland, Inst Clin Med, Jyvaskyla, Finland; [Saarela, Maria] VTT Tech Res Ctr Finland, Espoo, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); University of Helsinki; Central Finland Central Hospital; University of Eastern Finland; University of Eastern Finland; VTT Technical Research Center Finland	Palva, A (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	airi.palva@helsinki.fi; ingemar.von.ossowski@helsinki.fi	Mecklin, Jukka-Pekka/AAB-5378-2020; Mecklin, Jukka-Pekka/AAC-9650-2019; Kant, Ravi/AAF-8495-2021; Saarela, Maria/AAY-5918-2020	Mecklin, Jukka-Pekka/0000-0003-4895-2249; Kant, Ravi/0000-0003-3878-9775; Saarela, Maria/0000-0001-8842-7292; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program [141140]; University of Helsinki Applied Bioscience (ABS) Graduate School	Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program; University of Helsinki Applied Bioscience (ABS) Graduate School	Financial support for this study was through the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (Grant No. 141140) (http://www.aka.fi). The University of Helsinki Applied Bioscience (ABS) Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm) provided additional salary funding to Ravi Kant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 2005, MICROBES INFECT, V7, P1256, DOI 10.1016/j.micinf.2005.04.011; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Bernardeau M, 2008, INT J FOOD MICROBIOL, V126, P278, DOI 10.1016/j.ijfoodmicro.2007.08.015; Black BF, 1998, SCI BREASTFEEDING, V3; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; Chen ZL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00073-12; Claes IJJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-161; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Douillard FP, 2013, APPL ENVIRON MICROB, V79, P1923, DOI 10.1128/AEM.03467-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Haakensen M, 2009, INT J FOOD MICROBIOL, V130, P56, DOI 10.1016/j.ijfoodmicro.2009.01.001; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; Kontula P, 1999, J DAIRY SCI, V82, P249, DOI 10.3168/jds.S0022-0302(99)75230-6; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Manganelli R, 1999, INFECT IMMUN, V67, P50, DOI 10.1128/IAI.67.1.50-56.1999; Martin R, 2007, J APPL MICROBIOL, V103, P2638, DOI 10.1111/j.1365-2672.2007.03497.x; Morita H, 2009, J BACTERIOL, V191, P7630, DOI 10.1128/JB.01287-09; Munoz-Provencio D, 2010, J APPL MICROBIOL, V108, P1050, DOI 10.1111/j.1365-2672.2009.04508.x; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Newburg DS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P771, DOI 10.1134/S0006297913070092; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pittet V, 2012, J BACTERIOL, V194, P726, DOI 10.1128/JB.06430-11; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Salminen S, 2010, CURR OPIN BIOTECH, V21, P157, DOI 10.1016/j.copbio.2010.03.016; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tannock GW, 2004, APPL ENVIRON MICROB, V70, P3189, DOI 10.1128/AEM.70.6.3189-3194.2004; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Tompkins TA, 2012, J BACTERIOL, V194, P902, DOI 10.1128/JB.06584-11; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Tuomola EM, 2000, INT J FOOD MICROBIOL, V60, P75, DOI 10.1016/S0168-1605(00)00319-6; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Walter J, 2005, PROBIOTICS AND PREBIOTICS: SCIENTIFIC ASPECTS, P51; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004	70	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102762	10.1371/journal.pone.0102762	http://dx.doi.org/10.1371/journal.pone.0102762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032833	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300088
J	Pittet, F; Houdelier, C; Le Bot, O; Leterrier, C; Lumineau, S				Pittet, Florent; Houdelier, Cecilia; Le Bot, Oceane; Leterrier, Christine; Lumineau, Sophie			Fearfulness Affects Quail Maternal Care and Subsequent Offspring Development	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; SOCIAL REINSTATEMENT BEHAVIOR; JAPANESE-QUAIL; TONIC IMMOBILITY; EMOTIONAL REACTIVITY; INDIVIDUAL-DIFFERENCES; PRECOCIAL BIRD; GENE-EXPRESSION; RHESUS MACAQUES; DOMESTIC QUAIL	Our study investigated relationships between a precocial bird's fearfulness and maternal care, and the implication of maternal care as a vector for non-genomic transmission of fearfulness to chicks. We compared care given to chicks between two sets of female Japanese quail selected to present either high (LTI) or low fearfulness (STI). Chicks, from a broiler line, were adopted by these females following a sensitization procedure. Chicks' fearfulness after separation from their mother was assessed by well-established procedures. LTIs took longer to present maternal responses, pecked chicks more during the first days post-hatch, presented impaired maternal vocal behaviour and were globally less active than STI females. Chicks mothered by LTIs presented more fearful reactions than did chicks mothered by STIs, supporting the hypothesis of a non-genetic maternal transmission of fearfulness. We suggest that the longer latencies required by LTIs to become maternal are a consequence of their greater fear of chicks, and that their lower general and vocal activity could be components of a heightened antipredatory strategy. We discuss the transmission of maternal fearfulness to fostered chicks, taking into account the possible implication of several well-known mechanisms underlying maternal effects.	[Pittet, Florent; Houdelier, Cecilia; Le Bot, Oceane; Lumineau, Sophie] Univ Rennes 1, CNRS, Unite Mixte Rech Ethos 6552, Rennes, France; [Leterrier, Christine] INRA, Unite Mixte Rech Physiol Reprod & Comportements 8, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; INRAE	Lumineau, S (corresponding author), Univ Rennes 1, CNRS, Unite Mixte Rech Ethos 6552, Rennes, France.	sophie.lumineau@univ-rennes1.fr	Pittet, Florent/Q-2100-2015; Leterrier, Christine/AAY-7201-2020	Lumineau, Sophie/0000-0002-2076-9947				Ainsworth M., 1978, PATTERNS ATTACHMENT; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; Archer J, 1976, PERSPECTIVES ETHOLOG, P231; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Boissy A, 1995, APPL ANIM BEHAV SCI, V46, P17, DOI 10.1016/0168-1591(95)00633-8; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Calatayud F, 2001, PHYSIOL BEHAV, V74, P355, DOI 10.1016/S0031-9384(01)00566-2; Caldji C, 2004, NEUROPSYCHOPHARMACOL, V29, P1344, DOI 10.1038/sj.npp.1300436; Calkins SD, 1999, SOC DEV, V8, P310, DOI 10.1111/1467-9507.00098; Champagne F, 2001, Prog Brain Res, V133, P287; Cook CJ, 1999, PHYSIOL BEHAV, V67, P803, DOI 10.1016/S0031-9384(99)00107-9; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; DAVIS SR, 1979, J DAIRY RES, V46, P613, DOI 10.1017/S0022029900020677; de Margerie E, 2013, DEV PSYCHOBIOL, V55, P256, DOI 10.1002/dev.21019; Dwyer CM, 2008, SMALL RUMINANT RES, V76, P31, DOI 10.1016/j.smallrumres.2007.12.011; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019074; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Gerull FC, 2002, BEHAV RES THER, V40, P279, DOI 10.1016/S0005-7967(01)00013-4; Grandinson K, 2005, LIVEST PROD SCI, V93, P43, DOI 10.1016/j.livprodsci.2004.11.005; Harlow H. F., 1969, DETERMINANTS INFANT, V4, P15; HARLOW HF, 1971, P NATL ACAD SCI USA, V68, P1534, DOI 10.1073/pnas.68.7.1534; Harris MJ, 2003, CAN J ANIM SCI, V83, P435, DOI 10.4141/A02-001; Hazard D, 2008, GEN COMP ENDOCR, V155, P288, DOI 10.1016/j.ygcen.2007.05.009; Hazard D, 2008, HORM BEHAV, V54, P645, DOI 10.1016/j.yhbeh.2008.07.002; Hinde K., 2013, BUILDING BABIES PRIM, P187; Houdelier C., 2013, NONGENETIC INHERITAN, V1, DOI [10.2478/ngi-2013-0007, DOI 10.2478/NGI-2013-0007]; Houdelier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014604; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; LAUNAY F, 1993, BEHAV PROCESS, V29, P1, DOI 10.1016/0376-6357(93)90023-K; LICKLITER R, 1992, Developmental Psychobiology, V25, P17, DOI 10.1002/dev.420250103; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MAESTRIPIERI D, 1993, ETHOLOGY, V95, P32; Maestripieri D, 2007, DEV PSYCHOBIOL, V49, P165, DOI 10.1002/dev.20200; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Mills AD, 2000, APPL ANIM BEHAV SCI, V69, P125, DOI 10.1016/S0168-1591(00)00126-X; MURPHY LB, 1978, ANIM BEHAV, V26, P422, DOI 10.1016/0003-3472(78)90059-3; Murphy P., 1998, P 32 C INT SOC APPL; Nowak R, 2011, J NEUROENDOCRINOL, V23, P1042, DOI 10.1111/j.1365-2826.2011.02205.x; Numan M, 2009, FRONT NEUROENDOCRIN, V30, P46, DOI 10.1016/j.yfrne.2008.10.002; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; ORCUTT FS, 1976, AUK, V93, P135; Pittet F, 2014, J EXP ZOOL PART A, V321, P265, DOI 10.1002/jez.1858; Pittet F, 2014, DEV PSYCHOBIOL, V56, P622, DOI 10.1002/dev.21129; Pittet F, 2014, ANIM BEHAV, V87, P31, DOI 10.1016/j.anbehav.2013.10.025; Pittet F, 2013, ANIM BEHAV, V85, P797, DOI 10.1016/j.anbehav.2013.01.026; Pittet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036835; Plush KJ, 2011, APPL ANIM BEHAV SCI, V134, P130, DOI 10.1016/j.applanim.2011.07.009; PUGESEK BH, 1990, BEHAV ECOL SOCIOBIOL, V27, P211; Rehling A, 2008, ANIM BEHAV, V75, P1455, DOI 10.1016/j.anbehav.2007.09.019; Richard S, 2008, PROD ANIM, V21, P71; Richard S, 2010, BEHAV PROCESS, V85, P18, DOI 10.1016/j.beproc.2010.05.009; Richard-Yris M. A., 1994, COMPORTEMENT ADAPTAT, P61; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; SEEGAL RF, 1974, PHYSIOL BEHAV, V13, P339, DOI 10.1016/0031-9384(74)90056-0; TENCATE C, 1989, ETHOLOGY, V82, P287; van der Staay FJ, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-50; Warren SL, 1997, J AM ACAD CHILD PSY, V36, P637, DOI 10.1097/00004583-199705000-00014; Zeanah CH, 2003, ANN NY ACAD SCI, V1008, P22, DOI 10.1196/annals.1301.003	68	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102800	10.1371/journal.pone.0102800	http://dx.doi.org/10.1371/journal.pone.0102800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033292	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300092
J	Teirila, L; Karvala, K; Ahonen, N; Riska, H; Pietinalho, A; Tuominen, P; Piirila, P; Puustinen, A; Wolff, H				Teirila, Laura; Karvala, Kirsi; Ahonen, Niina; Riska, Henrik; Pietinalho, Anne; Tuominen, Paivi; Piirila, Paivi; Puustinen, Anne; Wolff, Henrik			Proteomic Changes of Alveolar Lining Fluid in Illnesses Associated with Exposure to Inhaled Non-Infectious Microbial Particles	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; HUMAN SEMINAL PLASMA; IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL LUNG-DISEASES; HYPERSENSITIVITY PNEUMONITIS; ALPHA-1-ANTITRYPSIN DEFICIENCY; BRONCHIAL HYPERRESPONSIVENESS; AIRWAY INFLAMMATION; SYSTEMIC-SCLEROSIS; NLRP3 INFLAMMASOME	Background: Hyperresponsiveness to inhaled non-infectious microbial particles (NIMPs) has been associated with illnesses in the airways. Hypersensitivity pneumonitis (HP) is considered to be the prototype for these NIMPs-related diseases; however, there is no consensus on the definitions or diagnostic criteria for HP and the spectrum of related illnesses. Methods and Findings: In order to identify the possible diagnostic markers for illnesses associated with NIMPs in alveolar lining fluid, we performed a proteomic analysis using a two-dimensional difference gel electrophoresis on bronchoalveolar lavage (BAL) fluid from patients with exposure to NIMPs in the context of damp building-related illness (DBRI) or conditions on the borderline to acute HP, designated here as agricultural type of microbial exposure (AME). Samples from patients with HP and sarcoidosis (SARC) were included for reference. Results were compared to results of healthy subjects (CTR). Western blot was used for validation of potential marker proteins from BAL fluid and plasma. Protein expression patterns suggest a close similarity between AME and HP, while DBRI was similar to CTR. However, in DBRI the levels of the inflammation associated molecules galectin-3 and alpha-1-antitrypsin were increased. A novel finding emerging from this study was the increases of semenogelin levels in BAL fluid from patients with AME, HP and SARC. Histone 4 levels were increased in AME, HP and SARC. Elevated plasma levels of histone 2B were detected in HP and SARC, suggesting it to be a potential blood indicator for inflammatory diseases of the lungs. Conclusions: In this study, the proteomic changes in bronchoalveolar lavage of DBRI patients were distinct from other NIMP exposure associated lung diseases, while changes in AME overlapped those observed for HP patient samples. Some of the proteins identified in this study, semenogelin and histone 4, could function as diagnostic markers for differential diagnosis between DBRI and HP-like conditions.	[Teirila, Laura; Karvala, Kirsi; Ahonen, Niina; Tuominen, Paivi; Puustinen, Anne; Wolff, Henrik] Finnish Inst Occupat Hlth, Helsinki, Finland; [Riska, Henrik] Univ Helsinki, Cent Hosp, Dept Pulmonol, Helsinki, Finland; [Pietinalho, Anne] Raasepori Hlth Care Ctr, Raasepori, Finland; [Piirila, Paivi] Univ Helsinki, Cent Hosp, Med Imaging Ctr, Unit Clin Physiol,Dept Clin Physiol & Nucl Med, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Wolff, H (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	henrik.wolff@ttl.fi	Piirilä, Päivi/H-2291-2018	Piirilä, Päivi/0000-0002-2535-4409; Puustinen, Anne/0000-0002-0262-9975	Nummela Foundation; Finnish Medical Society (Finska lakaresallskapet); Graduate School in Environmental Health 'SYTYKE'; Finnish Work Environment Fund (Tyosuojelurahasto)	Nummela Foundation; Finnish Medical Society (Finska lakaresallskapet); Graduate School in Environmental Health 'SYTYKE'; Finnish Work Environment Fund (Tyosuojelurahasto)	This work was supported by grants from the Nummela Foundation, the Finnish Medical Society (Finska lakaresallskapet), Graduate School in Environmental Health 'SYTYKE' and The Finnish Work Environment Fund (Tyosuojelurahasto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpinar-Elci M, 2008, INDOOR AIR, V18, P125, DOI 10.1111/j.1600-0668.2007.00514.x; [Anonymous], 1990, Eur Respir J, V3, P937; Bao SY, 2006, AM J PHYSIOL-LUNG C, V290, pL433, DOI 10.1152/ajplung.00341.2005; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Benson LM, 2009, J SEP SCI, V32, P44, DOI 10.1002/jssc.200800474; Bornehag CG, 2004, INDOOR AIR, V14, P243, DOI 10.1111/j.1600-0668.2004.00240.x; Bourgeon F, 2004, BIOL REPROD, V70, P768, DOI 10.1095/biolreprod.103.022533; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Canacci AM, 2011, PROSTATE, V71, P1108, DOI 10.1002/pros.21323; Canesin G, 2010, TUMOR BIOL, V31, P277, DOI 10.1007/s13277-010-0033-9; Carter JE, 2002, BIOCHEM BIOPH RES CO, V297, P1062, DOI 10.1016/S0006-291X(02)02292-1; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Congote LF, 2006, BIOCHEM BIOPH RES CO, V343, P617, DOI 10.1016/j.bbrc.2006.02.190; CORMIER Y, 1984, AM REV RESPIR DIS, V130, P1046; Costabel U, 2001, Curr Opin Pulm Med, V7, P255, DOI 10.1097/00063198-200109000-00002; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; Dhami R, 1999, J MOL MED-JMM, V77, P377, DOI 10.1007/s001090050364; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; FRIGERI LG, 1993, BIOCHEMISTRY-US, V32, P7644, DOI 10.1021/bi00081a007; Frol'ova L, 2009, INFLAMM RES, V58, P503, DOI 10.1007/s00011-009-0016-8; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Girard M, 2009, ALLERGY, V64, P322, DOI 10.1111/j.1398-9995.2009.01949.x; GOMZI M, 1989, Medicina del Lavoro, V80, P301; Greene CM, 2008, J INHERIT METAB DIS, V31, P21, DOI 10.1007/s10545-007-0748-y; Hacker S, 2009, J CLIN LAB ANAL, V23, P372, DOI 10.1002/jcla.20348; Health Canada, 2022, GUID GUID IND AIR CO; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hendrick DJ., 2002, OCCUPATIONAL DISORDE; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holdenrieder S, 2009, CRIT REV CL LAB SCI, V46, P1, DOI [10.1080/10408360802485875 , 10.1080/10408360802485875]; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Jacobs RL, 2005, ANN ALLERG ASTHMA IM, V95, P115, DOI 10.1016/S1081-1206(10)61200-8; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kankkunen P, 2014, HUM IMMUNOL, V75, P134, DOI 10.1016/j.humimm.2013.11.010; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Karvala K, 2012, INT ARCH OCC ENV HEA, V87, P1; Karvala K, 2013, SCAND J WORK ENV HEA, V39, P96, DOI 10.5271/sjweh.3289; Klech H, 1989, EUR RESPIR J, V2, P2; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kriegova E, 2006, AM J RESP CRIT CARE, V173, P1145, DOI 10.1164/rccm.200507-1126OC; Kumar V, 2008, MOL REPROD DEV, V75, P1767, DOI 10.1002/mrd.20910; Landi C, 2013, J PROTEOMICS, V83, P60, DOI 10.1016/j.jprot.2013.03.006; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Lundwall A, 2002, MOL HUM REPROD, V8, P805, DOI 10.1093/molehr/8.9.805; Magi B, 2002, ELECTROPHORESIS, V23, P3434, DOI 10.1002/1522-2683(200210)23:19<3434::AID-ELPS3434>3.0.CO;2-R; Magi B, 2006, PROTEOMICS, V6, P6354, DOI 10.1002/pmic.200600303; Matsuda Y, 2008, HEPATOL RES, V38, P1098, DOI 10.1111/j.1872-034X.2008.00387.x; McSharry C, 2002, CLIN EXP IMMUNOL, V128, P3, DOI 10.1046/j.1365-2249.2002.01849.x; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Meyer KC, 2011, EUR RESPIR J, V38, P761, DOI 10.1183/09031936.00069509; Mitchell BL, 2005, CANCER INFORM, V1, P98; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Okamoto T, 2012, ALLERGOL INT, V61, P83, DOI 10.2332/allergolint.11-OA-0315; Patel AM, 2001, J ALLERGY CLIN IMMUN, V108, P661; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Pietinalho A, 1993, 4 INT C BRONCH LAV U, p[P28, P76]; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rodrigues RG, 2001, CLIN CANCER RES, V7, P854; Rottoli P, 2005, PROTEOMICS, V5, P1423, DOI 10.1002/pmic.200301007; Sallenave JM, 2002, BIOCHEM SOC T, V30, P111, DOI 10.1042/BST0300111; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Sigsgaard T, 2000, EUR RESPIR J, V16, P50, DOI 10.1034/j.1399-3003.2000.16a09.x; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Straus DC, 2003, ARCH ENVIRON HEALTH, V58, P475, DOI 10.3200/AEOH.58.8.475-478; TASKINEN EI, 1994, PATHOL ANNU, V29, P121; TERHO EO, 1986, AM J IND MED, V10, P329, DOI 10.1002/ajim.4700100333; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Wattiez R, 2000, ELECTROPHORESIS, V21, P2703, DOI 10.1002/1522-2683(20000701)21:13<2703::AID-ELPS2703>3.3.CO;2-N; Wolff CHJ, 2011, INT J BIOL SCI, V7, P261, DOI 10.7150/ijbs.7.261; Wolff H, 2003, SCAND J CLIN LAB INV, V63, P27, DOI 10.1080/00365510310000466; Wolff H, 2009, SCAND J CLIN LAB INV, V69, P537, DOI 10.1080/00365510902770061; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Zhang YN, 2003, J IMMUNOTHER, V26, P461, DOI 10.1097/00002371-200311000-00001; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	87	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102624	10.1371/journal.pone.0102624	http://dx.doi.org/10.1371/journal.pone.0102624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033447	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300070
J	Kang, LJ; Cheung, PY; Pichler, G; O'Reilly, M; Aziz, K; Schmolzer, GM				Kang, Liane J.; Cheung, Po-Yin; Pichler, Gerhard; O'Reilly, Megan; Aziz, Khalid; Schmoelzer, Georg M.			Monitoring Lung Aeration during Respiratory Support in Preterm Infants at Birth	PLOS ONE			English	Article							PULMONARY GAS-EXCHANGE; MASK VENTILATION; NEONATAL RESUSCITATION; CARBON-DIOXIDE	Background: If infants fail to initiate spontaneous breathing, resuscitation guidelines recommend respiratory support with positive pressure ventilation (PPV). The purpose of PPV is to establish functional residual capacity and deliver an adequate tidal volume (V-T) to achieve gas exchange. Objective: The aim of our pilot study was to measure changes in exhaled carbon dioxide (ECO2), V-T, and rate of carbon dioxide elimination (VCO2) to assess lung aeration in preterm infants requiring respiratory support immediately after birth. Method: A prospective observational study was performed between March and July 2013. Infants born at <37 weeks gestational age who received continuous positive airway pressure (CPAP) or PPV immediately after birth had V-T delivery and ECO2 continuously recorded using a sensor attached to the facemask. Results: Fifty-one preterm infants (mean (SD) gestational age 29 (3) weeks and birth weight 1425 (592 g)) receiving respiratory support in the delivery room were included. Infants in the CPAP group (n = 31) had higher ECO2 values during the first 10 min after birth compared to infants receiving PPV (n = 20) (ranging between 18-30 vs. 13-18 mmHg, p<0.05, respectively). At 10 min no significant difference in ECO2 values was observed. V-T was lower in the CPAP group compared to the PPV group over the first 10 min ranging between 5.2-6.6 vs. and 7.2-11.3 mL/kg (p<0.05), respectively. Conclusions: Immediately after birth, spontaneously breathing preterm infants supported via CPAP achieved better lung aeration compared to infants requiring PPV. PPV guided by V-T and ECO2 potentially optimize lung aeration without excessive V-T administered.	[Kang, Liane J.; Cheung, Po-Yin; Pichler, Gerhard; O'Reilly, Megan; Aziz, Khalid; Schmoelzer, Georg M.] Univ Alberta, Dept Pediat, Div Neonatol, Edmonton, AB, Canada; [Kang, Liane J.; Cheung, Po-Yin; Pichler, Gerhard; O'Reilly, Megan; Aziz, Khalid; Schmoelzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Alberta Hlth Serv, Edmonton, AB, Canada; [Pichler, Gerhard; Schmoelzer, Georg M.] Med Univ, Div Neonatol, Dept Pediat, Graz, Austria	University of Alberta; Alberta Health Services (AHS); Royal Alexandra Hospital; Medical University of Graz	Schmolzer, GM (corresponding author), Univ Alberta, Dept Pediat, Div Neonatol, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schmölzer, Georg M/E-7883-2010; Cheung, Po-Yin/C-2804-2013; Aziz, Khalid/ABG-3331-2020	Schmölzer, Georg M/0000-0001-9798-2415; Cheung, Po-Yin/0000-0002-7141-1523; Aziz, Khalid/0000-0001-8054-9113; Kang, Liane/0000-0002-2499-7840; Pichler, Gerhard/0000-0003-2405-7143	Faculty of Medicine and Dentistry, University of Alberta; Neonatal Research Fund, Alberta Health Services	Faculty of Medicine and Dentistry, University of Alberta(University of Alberta); Neonatal Research Fund, Alberta Health Services	LK is a recipient of the summer studentship from the Faculty of Medicine and Dentistry, University of Alberta and Neonatal Research Fund, Alberta Health Services. GMS is a recipient of a Banting Postdoctoral Fellowship, Canadian Institutes of Health Research and an Alberta Innovates - Health Solutions Clinical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliwalas LLD, 2004, J PERINATOL, V25, P26; Binder C, 2014, ARCH DIS CHILD-FETAL, V99, pF120, DOI 10.1136/archdischild-2013-304311; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Finer NN, 2009, PEDIATRICS, V123, P865, DOI 10.1542/peds.2008-0560; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Hooper SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070895; Kattwinkel J, 2011, NEON RES PROGR; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Kaufman J, 2013, ARCH DIS CHILD-FETAL, V98, pF405, DOI 10.1136/archdischild-2012-303313; Kong JY, 2013, J PEDIATR-US, V163, P104, DOI 10.1016/j.jpeds.2012.12.016; Murthy V, 2012, EARLY HUM DEV, V88, P783, DOI 10.1016/j.earlhumdev.2012.05.003; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; PALMEKILANDER C, 1993, ARCH DIS CHILD-FETAL, V68, P11, DOI 10.1136/adc.68.1_Spec_No.11; PALMEKILANDER C, 1993, ARCH DIS CHILD-FETAL, V68, P6, DOI 10.1136/adc.68.1_Spec_No.6; PALMEKILANDER C, 1993, MED BIOL ENG COMPUT, V31, P67, DOI 10.1007/BF02446896; Pas ABT, 2008, PEDIATR RES, V64, P281, DOI 10.1203/PDR.0b013e31817d9c35; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Schmolzer GM, 2012, J PEDIATR-US, V160, P377, DOI 10.1016/j.jpeds.2011.09.017; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF393, DOI 10.1136/adc.2009.174003; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Te Pas AB, 2008, J PEDIATR-US, V152, P607, DOI 10.1016/j.jpeds.2007.10.041; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; TUNELL R, 1969, ACTA OBSTET GYN SCAN, VS 48, P90, DOI 10.3109/00016346909157719; Vento M, 2008, PEDIATRICS, V122, P1113, DOI 10.1542/peds.2008-1422; Wu CH, 2003, PEDIATR PULM, V35, P292, DOI 10.1002/ppul.10260; Yam CH, 2011, ARCH DIS CHILD-FETAL, V96, pF102, DOI 10.1136/adc.2009.180950	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102729	10.1371/journal.pone.0102729	http://dx.doi.org/10.1371/journal.pone.0102729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029553	gold, Green Submitted, Green Published			2022-12-27	WOS:000341306600095
J	Leonard, CE; Razzaghi, H; Freeman, CP; Roy, JA; Newcomb, CW; Hennessy, S				Leonard, Charles E.; Razzaghi, Hanieh; Freeman, Cristin P.; Roy, Jason A.; Newcomb, Craig W.; Hennessy, Sean			Empiric Potassium Supplementation and Increased Survival in Users of Loop Diuretics	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; SUDDEN CARDIAC DEATH; RENAL-INSUFFICIENCY; SERUM POTASSIUM; RISK; VALIDATION; ARRHYTHMIA; MORTALITY; THERAPY; TRIALS	Background: The effectiveness of the clinical strategy of empiric potassium supplementation in reducing the frequency of adverse clinical outcomes in patients receiving loop diuretics is unknown. We sought to examine the association between empiric potassium supplementation and 1) all-cause death and 2) outpatient-originating sudden cardiac death (SD) and ventricular arrhythmia (VA) among new starters of loop diuretics, stratified on initial loop diuretic dose. Methods: We conducted a one-to-one propensity score-matched cohort study using 1999-2007 US Medicaid claims from five states. Empiric potassium supplementation was defined as a potassium prescription on the day of or the day after the initial loop diuretic prescription. Death, the primary outcome, was ascertained from the Social Security Administration Death Master File; SD/VA, the secondary outcome, from incident, first-listed emergency department or principal inpatient SD/VA discharge diagnoses (positive predictive value = 85%). Results: We identified 654,060 persons who met eligibility criteria and initiated therapy with a loop diuretic, 27% of whom received empiric potassium supplementation (N = 179,436) and 73% of whom did not (N = 474,624). The matched hazard ratio for empiric potassium supplementation was 0.93 (95% confidence interval, 0.89-0.98, p = 0.003) for all-cause death. Stratifying on initial furosemide dose, hazard ratios for empiric potassium supplementation with furosemide <40 and >= 40 milligrams/day were 0.93 (0.86-1.00, p = 0.050) and 0.84 (0.79-0.89, p<0.0001). The matched hazard ratio for empiric potassium supplementation was 1.02 (0.83-1.24, p = 0.879) for SD/VA. Conclusions: Empiric potassium supplementation upon initiation of a loop diuretic appears to be associated with improved survival, with a greater apparent benefit seen with higher diuretic dose. If confirmed, these findings support the use of empiric potassium supplementation upon initiation of a loop diuretic.	[Leonard, Charles E.; Razzaghi, Hanieh; Freeman, Cristin P.; Roy, Jason A.; Newcomb, Craig W.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Leonard, Charles E.; Razzaghi, Hanieh; Freeman, Cristin P.; Roy, Jason A.; Hennessy, Sean] Univ Penn, Perelman Sch Med, Ctr Pharmacoepidemiol Res & Training, Philadelphia, PA 19104 USA; [Hennessy, Sean] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Leonard, CE (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	celeonar@upenn.edu	Leonard, Charles/AAN-4463-2020		US Department of Health & Human Services (DHHS) National Institute on Aging [RC1AG035751, R01AG025152]; US DHHS National Institute of Diabetes and Kidney Diseases [R01DK102694]; US DHHS National Center for Advancing Translational Sciences [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025152, RC1AG035751] Funding Source: NIH RePORTER	US Department of Health & Human Services (DHHS) National Institute on Aging; US DHHS National Institute of Diabetes and Kidney Diseases; US DHHS National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by RC1AG035751 and R01AG025152 from the US Department of Health & Human Services (DHHS) National Institute on Aging, R01DK102694 from the US DHHS National Institute of Diabetes and Kidney Diseases, and UL1TR000003 from the US DHHS National Center for Advancing Translational Sciences. The National Institutes of Health had no role in the design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Abildstrom S. Z., 1999, CARDIAC ELECTROPHYSI, V3, P177, DOI DOI 10.1023/A:1009971104937; Ahmed MI, 2010, INT J CARDIOL, V144, P383, DOI 10.1016/j.ijcard.2009.04.041; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Ekundayo OJ, 2010, INT J CARDIOL, V141, P167, DOI 10.1016/j.ijcard.2008.11.195; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Green DM, 2002, NEUROLOGY, V59, P314, DOI 10.1212/WNL.59.3.314; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; Henz S, 2008, NEPHROL DIAL TRANSPL, V23, P3939, DOI 10.1093/ndt/gfn380; Holahan J, 2005, KAIS FAM FDN PUBL, V7346, P1; Holahan J, 2009, KAIS FAM FDN PUBL, V7846, P1; HOLLAND OB, 1981, AM J MED, V70, P762, DOI 10.1016/0002-9343(81)90530-1; Kaiser Family Foundation, 2011, KAIS FAM FDN PUBL; Leonard CE, 2010, PHARMACOEPIDEM DR S, V19, P576, DOI 10.1002/pds.1956; MACMAHON S, 1989, AM J CARDIOL, V63, P202, DOI 10.1016/0002-9149(89)90286-5; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Rose BD, 2012, DIURETIC INDUCED HYP; Rousseau D, 2010, KAIS FAM FDN PUBL, V7846-02, P1; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sica Doemnic A, 2004, J Clin Hypertens (Greenwich), V6, P532, DOI 10.1111/j.1524-6175.2004.03789.x; Sica DA, 2011, J CLIN HYPERTENS, V13, P639, DOI 10.1111/j.1751-7176.2011.00512.x; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V267, P1083, DOI 10.1001/jama.267.8.1083; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P1; van Kraaij DJW, 1998, EUR J CLIN PHARMACOL, V54, P323, DOI 10.1007/s002280050467; YUSUF S, 1990, AM J CARDIOL, V66, P315	30	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2014	9	7							e102279	10.1371/journal.pone.0102279	http://dx.doi.org/10.1371/journal.pone.0102279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KM	25029519	Green Submitted, Green Published, gold			2022-12-27	WOS:000341306600055
J	Guo, T; Qin, YY; Jiao, X; Li, GY; Simpson, JL; Chen, ZJ				Guo, Ting; Qin, Yingying; Jiao, Xue; Li, Guangyu; Simpson, Joe Leigh; Chen, Zi-Jiang			FMR1 Premutation Is an Uncommon Explanation for Premature Ovarian Failure in Han Chinese	PLOS ONE			English	Article							FRAGILE-X PREMUTATION; TRIPLE CGG REPEATS; GENE; WOMEN; INSUFFICIENCY; ASSOCIATION; INTERMEDIATE; DYSFUNCTION; RESERVE; DONORS	Background: In premature ovarian failure (POF), cessation of menstruation occurs before the expected age of menopause. Approximately 1% of women are affected. FMR1 premutation was reported to be responsible for up to 3.3%-6.7% of sporadic POF and 13% of familial cases in Caucasians, while the data was absent in Chinese population. Therefore, the impact of FMR1 CGG repeat on ovarian reserve is needed to be investigated in large Chinese cohort. Methods: The number of FMR1 CGG repeat was determined in 379 Han Chinese women with well-defined 46, XX non-syndromic sporadic POF and 402 controls. The age of menopause onset in respect to CGG repeats was further analyzed. Results: The frequency of FMR1 premutation in Han Chinese POF was only 0.5% (2/379), although it was higher than that in matched controls (0%, 0/402), it was much lower than that reported in Caucasian with POF (3.3%-6.7%). The prevalence of intermediate FMR1 (41-54) was not increased significantly in sporadic POF than that in controls (2.9% vs. 1.7%, P = 0.343). However, POF patients more often carried a single additional CGG repeat in a single allele than did fertile women (allele-1: 29.7 vs. 28.8, P<0.001; allele-2: 32.6 vs. 31.5, P<0.001). POF patients with both alleles of CGG repeats outside (below or above) the normal range (26-34) showed an earlier age of cessation of menses than those with two alleles within normal range (hom-high/high vs. norm: 20.4 +/- 4.8 vs. 24.7 +/- 6.4, P<0.01; hom-low/high vs. norm: 18.7 +/- 1.7 vs. 24.7 +/- 6.4, P<0.01). Conclusions: FMR1 premutation seems to be an uncommon explanation for POF in Han Chinese. However, having both alleles with CGG repeats outside the normal range might still adversely affect ovarian aging.	[Guo, Ting; Qin, Yingying; Jiao, Xue; Li, Guangyu; Chen, Zi-Jiang] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Shandong Prov Key Lab Reprod Med,Minist Educ, Ctr Reprod Med,Shandong Prov Hosp,Key Lab Reprod, Jinan 250100, Peoples R China; [Simpson, Joe Leigh] Res & Global Programs March Dimes Fdn, White Plains, NY USA; [Simpson, Joe Leigh] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; State University System of Florida; Florida International University; Shanghai Jiao Tong University	Chen, ZJ (corresponding author), Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Shandong Prov Key Lab Reprod Med,Minist Educ, Ctr Reprod Med,Shandong Prov Hosp,Key Lab Reprod, Jinan 250100, Peoples R China.	chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022; Li, Yuan/GXV-1310-2022	JIAO, XUE/0000-0002-2936-2166; Chen, Zi-Jiang/0000-0001-6637-6631	National Basic Research Program of China (973 program) [2012CB944700]; National Natural Science Foundation of China [81270662]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201078]; Independent Innovation Foundation of Shandong University, IIFSDU [2012TS130]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Independent Innovation Foundation of Shandong University, IIFSDU	This work was supported by the National Basic Research Program of China (973 program-2012CB944700); the National Natural Science Foundation of China (81270662); Foundation for the Author of National Excellent Doctoral Dissertation of China (201078); and Independent Innovation Foundation of Shandong University, IIFSDU (2012TS130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasoain M, 2013, GENE, V521, P145, DOI 10.1016/j.gene.2013.03.032; Bennett CE, 2010, HUM REPROD, V25, P1335, DOI 10.1093/humrep/deq058; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Broadie K, 2005, MOL CELL, V17, P757, DOI 10.1016/j.molcel.2005.03.004; Ceylaner G, 2010, INT J GYNECOL OBSTET, V110, P122, DOI 10.1016/j.ijgo.2010.03.023; Chatterjee S, 2009, REPROD BIOMED ONLINE, V19, P281, DOI 10.1016/S1472-6483(10)60086-7; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; Dorsey ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029522; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gersak K, 2003, HUM REPROD, V18, P1637, DOI 10.1093/humrep/deg327; Gleicher N, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-80; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, REPROD SCI, V16, P462, DOI 10.1177/1933719108328617; Gleicher N, 2009, FERTIL STERIL, V91, P1700, DOI 10.1016/j.fertnstert.2008.01.098; Ishizuka B, 2011, FERTIL STERIL, V96, P1170, DOI 10.1016/j.fertnstert.2011.08.028; Khaniani MS, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-5; Lledo B, 2012, HUM REPROD, V27, P609, DOI 10.1093/humrep/der415; Lo T. K., 2005, Hong Kong Medical Journal, V11, P243; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Machuca-Tzili L, 2005, MUSCLE NERVE, V32, P1, DOI 10.1002/mus.20301; Marozzi A, 2000, HUM REPROD, V15, P197, DOI 10.1093/humrep/15.1.197; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; Murray A, 2014, GENET MED, V16, P19, DOI 10.1038/gim.2013.64; Rajkiewicz M, 2011, EUR J OBSTET GYN R B, V155, P176, DOI 10.1016/j.ejogrb.2010.12.031; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tanaka F, 1996, HUM MOL GENET, V5, P1253, DOI 10.1093/hmg/5.9.1253; Tosh D, 2014, ARCH GYNECOL OBSTET, V289, P1255, DOI 10.1007/s00404-014-3145-4; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	31	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103316	10.1371/journal.pone.0103316	http://dx.doi.org/10.1371/journal.pone.0103316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050920	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100103
J	Iniguez, G; Castro, JJ; Garcia, M; Kakarieka, E; Johnson, MC; Cassorla, F; Mericq, V				Iniguez, German; Jose Castro, Juan; Garcia, Mirna; Kakarieka, Elena; Cecilia Johnson, M.; Cassorla, Fernando; Mericq, Veronica			IGF-IR Signal Transduction Protein Content and Its Activation by IGF-I in Human Placentas: Relationship with Gestational Age and Birth Weight	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; BINDING-PROTEINS; INSULIN; EXPRESSION; RECEPTOR; FETAL; PHOSPHORYLATION; NEWBORNS; PATHWAY; SYSTEM	Introduction: The human placenta expresses the IGF-I and IGF-IR proteins and their intracellular signal components (IRS-1, AKT and mTOR). The aim of this study was to assess the IGF-IR content and activation of downstream signaling molecules in placentas from newborns who were classified by gestational age and birth weight. We studied placentas from 25 term appropriate (T-AGA), 26 term small (T-SGA), 22 preterm AGA (PT-AGA), and 20 preterm SGA (PT-SGA) newborns. The total and phosphorylated IGF-IR, IRS-1, AKT, and mTOR contents were determined by Western Blot and normalized by actin or with their respective total content. The effect of IGF-I was determined by stimulating placental explants with recombinant IGF-I 10(-8) mol/L for 15, 30, and 60 minutes. Results: The IGF-IR content was higher in T-SGA compared to T-AGA placentas, and the IRS-1 content was higher in PT-placentas compared with their respective T-placentas. The effect of IGF-I on the phosphorylated forms of IGF-IR was increased in T-SGA (150%) and PT-SGA (300%) compared with their respective AGA placentas. In addition, AKT serine phosphorylation was higher in PT-SGA compared to PT-AGA and T-SGA placentas (90% and 390% respectively). Conclusion: The higher protein content and response to IGF-I of IGF-IR, IRS-1, and AKT observed in SGA placentas may represent a compensatory mechanism in response to fetal growth restriction.	[Iniguez, German; Jose Castro, Juan; Cecilia Johnson, M.; Cassorla, Fernando; Mericq, Veronica] Univ Chile, Inst Maternal & Child Res, Santiago, Chile; [Garcia, Mirna; Kakarieka, Elena] Univ Chile, Hosp Clin San Borja Arriaran, Santiago, Chile	Universidad de Chile; Universidad de Chile	Iniguez, G (corresponding author), Univ Chile, Inst Maternal & Child Res, Santiago, Chile.	giniguez@med.uchile.cl		Mericq, Veronica/0000-0003-2287-0181	FONDECYT [111 0240]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by FONDECYT Grant 111 0240. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero SN, 1998, MOL REPROD DEV, V49, P229, DOI 10.1002/(SICI)1098-2795(199803)49:3<229::AID-MRD2>3.0.CO;2-Q; Aye ILMH, 2013, MOL CELL ENDOCRINOL, V381, P46, DOI 10.1016/j.mce.2013.07.013; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barker DJP, 2004, PHILOS T R SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518; Behrman RE, 2007, PRETERM BIRT CAUSES; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Ge WJ, 2013, PEDIATRICS, V132, pE876, DOI 10.1542/peds.2013-0702; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; Harlan SM, 2013, CELL METAB, V17, P599, DOI 10.1016/j.cmet.2013.02.017; Harris LK, 2011, BIOL REPROD, V84, P440, DOI 10.1095/biolreprod.110.088195; Hasson SP, 2013, BREAST CARE, V8, P248, DOI 10.1159/000354757; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Iniguez G, 2010, HORM RES PAEDIAT, V73, P320, DOI 10.1159/000308163; Iniguez G, 2011, J CLIN ENDOCR METAB, V96, P187, DOI 10.1210/jc.2010-0244; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; KRAMER MS, 1990, PEDIATRICS, V86, P707; Laviola L, 2005, ENDOCRINOLOGY, V146, P1498, DOI 10.1210/en.2004-1332; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LOW JA, 1992, AM J OBSTET GYNECOL, V167, P11, DOI 10.1016/S0002-9378(11)91616-0; Ma Y, 2011, PLACENTA, V32, P255, DOI 10.1016/j.placenta.2011.01.007; Milad M, 2010, REV CHIL PEDIATR-CHI, V81, P264; Peres SB, 2005, J APPL PHYSIOL, V98, P1037, DOI 10.1152/japplphysiol.00536.2004; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Street ME, 2011, EUR J ENDOCRINOL, V164, P45, DOI 10.1530/EJE-10-0752; Wang CCL, 2013, METABOLISM, V62, P595, DOI 10.1016/j.metabol.2012.10.010; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102252	10.1371/journal.pone.0102252	http://dx.doi.org/10.1371/journal.pone.0102252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25050889	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100025
J	Yang, CW; Chou, WC; Chen, KH; Cheng, AL; Mao, IF; Chao, HR; Chuang, CY				Yang, Chung-Wei; Chou, Wei-Chun; Chen, Kuan-Hsueh; Cheng, An-Lin; Mao, I-Fang; Chao, How-Ran; Chuang, Chun-Yu			Visualized Gene Network Reveals the Novel Target Transcripts Sox2 and Pax6 of Neuronal Development in Trans-Placental Exposure to Bisphenol A	PLOS ONE			English	Article							NEURAL STEM-CELLS; PERINATAL EXPOSURE; CONSTITUTIVE ACTIVATION; PRENATAL EXPOSURE; DNA METHYLATION; EXPRESSION; GROWTH; PROLIFERATION; PROTEIN; NOTCH	Background: Bisphenol A (BPA) is a ubiquitous endocrine disrupting chemical in our daily life, and its health effect in response to prenatal exposure is still controversial. Early-life BPA exposure may impact brain development and contribute to childhood neurological disorders. The aim of the present study was to investigate molecular target genes of neuronal development in trans-placental exposure to BPA. Methodology: A meta-analysis of three public microarray datasets was performed to screen for differentially expressed genes (DEGs) in exposure to BPA. The candidate genes of neuronal development were identified from gene ontology analysis in a reconstructed neuronal sub-network, and their gene expressions were determined using real-time PCR in 20 umbilical cord blood samples dichotomized into high and low BPA level groups upon the median 16.8 nM. Principal Findings: Among 36 neuronal transcripts sorted from DAVID ontology clusters of 457 DEGs using the analysis of Bioconductor limma package, we found two neuronal genes, sex determining region Y-box 2 (Sox2) and paired box 6 (Pax6), had preferentially down-regulated expression (Bonferroni correction p-value <10(-4) and log2-transformed fold change <=-1.2) in response to BPA exposure. Fetal cord blood samples had the obviously attenuated gene expression of Sox2 and Pax6 in high BPA group referred to low BPA group. Visualized gene network of Cytoscape analysis showed that Sox2 and Pax6 which were contributed to neural precursor cell proliferation and neuronal differentiation might be down-regulated through sonic hedgehog (Shh), vascular endothelial growth factor A (VEGFA) and Notch signaling. Conclusions: These results indicated that trans-placental BPA exposure down-regulated gene expression of Sox2 and Pax6 potentially underlying the adverse effect on childhood neuronal development.	[Yang, Chung-Wei; Chou, Wei-Chun; Chen, Kuan-Hsueh; Chuang, Chun-Yu] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Cheng, An-Lin] Univ Missouri Kansas City, Sch Nursing, Kansas City, KS USA; [Cheng, An-Lin] Univ Missouri Kansas City, Sch Hlth Studies, Kansas City, KS USA; [Mao, I-Fang] Chung Shan Med Univ, Sch Occupat Safety & Hlth, Taichung, Taiwan; [Chao, How-Ran] Natl Pingtung Univ Sci & Technol, Dept Environm Sci & Engn, Emerging Cpds Res Ctr, Neipu City, Pingtung County, Taiwan	National Tsing Hua University; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Chung Shan Medical University; National Pingtung University Science & Technology	Chuang, CY (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cychuang@mx.nthu.edu.tw	Chou, Wei-Chun/AAO-6532-2020	Chou, Wei-Chun/0000-0003-3355-6921; Chao, How-Ran/0000-0001-6492-6417	Taiwan National Science Council [NSC 100-2621-M-007-002, NSC 102-2918-I-007 -011]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was funded from Taiwan National Science Council grants NSC 100-2621-M-007-002 and NSC 102-2918-I-007 -011 (http://web1.nsc.gov.tw/). "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alatzoglou KS, 2009, EARLY HUM DEV, V85, P705, DOI 10.1016/j.earlhumdev.2009.08.057; Angle BM, 2013, REPROD TOXICOL; Baba K, 2009, TOXICOL SCI, V108, P344, DOI 10.1093/toxsci/kfp025; Bamiou DE, 2007, INT J AUDIOL, V46, P196, DOI 10.1080/14992020601175952; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bonini SA, 2013, NEURODEGENER DIS; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Byrne AB, 2014, NEURON; Cain JT, 2014, DEV NEUROBIOL, V74, P63, DOI 10.1002/dneu.22130; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Du WZ, 2013, CNS NEUROSCI THER, V19, P926, DOI 10.1111/cns.12163; Fujimoto T, 2013, J TOXICOL SCI, V38, P539, DOI 10.2131/jts.38.539; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Ha TJ, 2012, EUR J NEUROSCI, V36, P2888, DOI 10.1111/j.1460-9568.2012.08221.x; Harley KG, 2013, ENV RES; Heffernan AL, 2013, J TOXICOL ENV HEAL A, V76, P1039, DOI 10.1080/15287394.2013.834856; Hernandez SL, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-17; Hong EJ, 2005, J REPROD DEVELOP, V51, P499, DOI 10.1262/jrd.17012; Hong SB, 2013, J CHILD PSYCHOL PSYC, V54, P890, DOI 10.1111/jcpp.12050; Horstman KA, 2012, BIRTH DEFECTS RES B, V95, P318, DOI 10.1002/bdrb.21020; Hwang Kyung-A, 2011, Lab Anim Res, V27, P99, DOI 10.5625/lar.2011.27.2.99; Imaoka S, 2007, BIOL PHARM BULL, V30, P371, DOI 10.1248/bpb.30.371; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Itoh K, 2012, NEUROPATHOLOGY, V32, P447, DOI 10.1111/j.1440-1789.2011.01287.x; Jedeon K, 2013, AM J PATHOL, V183, P108, DOI 10.1016/j.ajpath.2013.04.004; Khalil N, 2014, SCI TOTAL ENVIRON, V470, P726, DOI 10.1016/j.scitotenv.2013.09.088; Kotasova H, 2014, CELL MOL NEUROBIOL, V34, P1, DOI 10.1007/s10571-013-9996-6; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Lee BE, 2013, INT J HYG ENV HLTH; Lei QB, 2004, DEVELOPMENT, V131, P3593, DOI 10.1242/dev.01230; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Ma XX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-119; Maekawa M, 2009, NEUROSCI LETT, V462, P267, DOI 10.1016/j.neulet.2009.07.021; Malik S, 2013, J NEUROSCI, V33, P411, DOI 10.1523/JNEUROSCI.4445-12.2013; Masuo Y, 2011, J TOXICOL ENV HEAL B, V14, P346, DOI 10.1080/10937404.2011.578557; Matsuda S, 2013, HORM BEHAV, V63, P709, DOI 10.1016/j.yhbeh.2013.03.016; Matthews J, 2000, J STEROID BIOCHEM, V74, P223, DOI 10.1016/S0960-0760(00)00126-6; Miyagawa Kazuya, 2007, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V27, P69; Miyatake M, 2006, J NEUROENDOCRINOL, V18, P434, DOI 10.1111/j.1365-2826.2006.01434.x; Nicolucci C, 2013, ANAL BIOANAL CHEM, V405, P9139, DOI 10.1007/s00216-013-7342-y; Nishimura Y, 2014, NEUROSCI LETT, V570, P1, DOI 10.1016/j.neulet.2014.04.014; Petrova R, 2013, J NEUROSCI, V33, P17490, DOI 10.1523/JNEUROSCI.2042-13.2013; Poschl J, 2013, DEV BIOL, V374, P319, DOI 10.1016/j.ydbio.2012.12.001; Poimenova A, 2010, NEUROSCIENCE, V167, P741, DOI 10.1016/j.neuroscience.2010.02.051; Quinn JC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-26; Rajatileka S, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-105; Rankouhi TR, 2004, TOXICOL SCI, V81, P90, DOI 10.1093/toxsci/kfh176; Rudy J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-467; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Saint-Geniez M, 2009, INVEST OPHTH VIS SCI, V50, P311, DOI 10.1167/iovs.08-2461; Schneider A, 2009, AM J MED GENET A, V149A, P2706, DOI 10.1002/ajmg.a.33098; Schneider L, 2012, NUCLEIC ACIDS RES, V40, P5332, DOI 10.1093/nar/gks207; Seki S, 2011, CHEM-BIOL INTERACT, V194, P23, DOI 10.1016/j.cbi.2011.08.001; Sha L, 2013, MOL NEUROBIOL; Snijder CA, 2013, ENVIRON HEALTH PERSP, V121, P393, DOI 10.1289/ehp.1205296; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Suzuki A, 2002, REPROD TOXICOL, V16, P107, DOI 10.1016/S0890-6238(02)00005-9; Tainaka H, 2012, J TOXICOL SCI, V37, P539; Wang C, 2014, TOXICOLOGY; Wang TG, 2013, EPIDEMIOLOGY, V24, P295, DOI 10.1097/EDE.0b013e318280e02f; Wen JH, 2008, NEUROREPORT, V19, P413, DOI 10.1097/WNR.0b013e3282f64377; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084617; Yang LQ, 2013, TOXICOL LETT, V218, P187, DOI 10.1016/j.toxlet.2013.01.026; Yeo M, 2013, P NATL ACAD SCI USA, V110, P4315, DOI 10.1073/pnas.1300959110; Yokosuka M, 2008, TOXICOL IN VITRO, V22, P1, DOI 10.1016/j.tiv.2007.07.003; Zhang ZD, 2013, J BIOMED RES, V27, P486, DOI 10.7555/JBR.27.20130010; Zhou FC, 2011, ALCOHOL CLIN EXP RES, V35, P735, DOI 10.1111/j.1530-0277.2010.01391.x; Zhou R, 2011, NEUROPHARMACOLOGY, V60, P789, DOI 10.1016/j.neuropharm.2011.01.031	73	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e100576	10.1371/journal.pone.0100576	http://dx.doi.org/10.1371/journal.pone.0100576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	25051057	Green Published, gold, Green Submitted			2022-12-27	WOS:000339551100005
J	Chen, JJ; Xu, J; Liu, BH; Yao, XF; Li, YB				Chen, Jingjing; Xu, Jun; Liu, Bohan; Yao, Xuefeng; Li, Yibing			Quantity Effect of Radial Cracks on the Cracking Propagation Behavior and the Crack Morphology	PLOS ONE			English	Article							DYNAMIC CRACK; WINDSHIELD CRACKING; PEDESTRIAN HEAD; RESISTANCE; FRACTURE; SUBJECT	In this letter, the quantity effect of radial cracks on the cracking propagation behavior as well as the circular crack generation on the impacted glass plate within the sandwiched glass sheets are experimentally investigated via high-speed photography system. Results show that the radial crack velocity on the backing glass layer decreases with the crack number under the same impact conditions during large quantities of repeated experiments. Thus, the "energy conversion factor'' is suggested to elucidate the physical relation between the cracking number and the crack propagation speed. Besides, the number of radial crack also takes the determinative effect in the crack morphology of the impacted glass plate. This study may shed lights on understanding the cracking and propagation mechanism in laminated glass structures and provide useful tool to explore the impact information on the cracking debris.	[Chen, Jingjing; Xu, Jun; Liu, Bohan; Li, Yibing] Tsinghua Univ, Dept Automot Engn, State Key Lab Automot Safety & Energy, Beijing 100084, Peoples R China; [Yao, Xuefeng] Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Chen, JJ (corresponding author), Tsinghua Univ, Dept Automot Engn, State Key Lab Automot Safety & Energy, Beijing 100084, Peoples R China.	cjjmonica@163.com; xujun06@mails.tsinghua.edu.cn	Xu, Jun/B-2260-2016	Xu, Jun/0000-0002-8619-8737	National Natural Science Foundation of China [11102099, 11372164]; International joint research project - Tsinghua University [20121080050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International joint research project - Tsinghua University	The work is financially supported by National Natural Science Foundation of China ( No. 11102099, No. 11372164) and International joint research project sponsored by Tsinghua University (20121080050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa K, 2007, EXP MECH, V47, P609, DOI 10.1007/s11340-006-9020-x; Astrom J, 1997, PHYS REV LETT, V79, P3684, DOI 10.1103/PhysRevLett.79.3684; Beery I, 2003, J APPL PHYS, V93, P2429, DOI 10.1063/1.1540736; Campione G, 2013, ENG STRUCT, V49, P664, DOI 10.1016/j.engstruct.2012.12.027; Chen JJ, 2013, ENG FRACT MECH, V112, P26, DOI 10.1016/j.engfracmech.2013.09.010; Cortet PP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.205502; Cramer T, 2000, PHYS REV LETT, V85, P788, DOI 10.1103/PhysRevLett.85.788; dos Santos FPM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026115; Hooper PA, 2012, INT J SOLIDS STRUCT, V49, P899, DOI 10.1016/j.ijsolstr.2011.12.008; Kadono T, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035107; Konka HP, 2012, J ENG MATER-T ASME, V134, DOI 10.1115/1.4005349; Lee JJW, 2007, ACTA MATER, V55, P5859, DOI 10.1016/j.actamat.2007.06.038; Liu BH, 2012, POLYM ENG SCI, V52, P1137, DOI 10.1002/pen.22175; Liu YX, 2009, POLYM TEST, V28, P599, DOI 10.1016/j.polymertesting.2009.04.008; Pauly S, 2009, J APPL PHYS, V106, DOI 10.1063/1.3259418; Sun X, 2005, P I MECH ENG D-J AUT, V219, P1059, DOI 10.1243/095440705X34784; Vandenberghe N, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.174302; Xu J, 2011, INT J AUTO TECH-KOR, V12, P687, DOI 10.1007/s12239-011-0080-2; Xu J, 2011, ENG FAIL ANAL, V18, P1605, DOI 10.1016/j.engfailanal.2011.05.004; Xu J, 2010, CMC-COMPUT MATER CON, V18, P183; Xu J, 2010, COMP MATER SCI, V48, P582, DOI 10.1016/j.commatsci.2010.02.026; Xu J, 2009, INT J CRASHWORTHINES, V14, P63, DOI 10.1080/13588260802462427; Xu J, 2009, INT J IMPACT ENG, V36, P783, DOI 10.1016/j.ijimpeng.2008.11.008; Yao XF, 2008, COMPOS SCI TECHNOL, V68, P953, DOI 10.1016/j.compscitech.2007.08.007	24	9	9	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e98196	10.1371/journal.pone.0098196	http://dx.doi.org/10.1371/journal.pone.0098196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048684	Green Submitted, Green Published, gold			2022-12-27	WOS:000339558100002
J	Ivask, A; Kurvet, I; Kasemets, K; Blinova, I; Aruoja, V; Suppi, S; Vija, H; Kakinen, A; Titma, T; Heinlaan, M; Visnapuu, M; Koller, D; Kisand, V; Kahru, A				Ivask, Angela; Kurvet, Imbi; Kasemets, Kaja; Blinova, Irina; Aruoja, Villem; Suppi, Sandra; Vija, Heiki; Kaekinen, Aleksandr; Titma, Tiina; Heinlaan, Margit; Visnapuu, Meeri; Koller, Dagmar; Kisand, Vambola; Kahru, Anne			Size-Dependent Toxicity of Silver Nanoparticles to Bacteria, Yeast, Algae, Crustaceans and Mammalian Cells In Vitro	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; DAPHNIA-MAGNA; PARTICLE-SIZE; SOILS; CADMIUM; MODEL; BIOAVAILABILITY; CYTOTOXICITY; DISSOLUTION	The concept of nanotechnologies is based on size-dependent properties of particles in the 1-100 nm range. However, the relation between the particle size and biological effects is still unclear. The aim of the current paper was to generate and analyse a homogenous set of experimental toxicity data on Ag nanoparticles (Ag NPs) of similar coating (citrate) but of 5 different primary sizes (10, 20, 40, 60 and 80 nm) to different types of organisms/cells commonly used in toxicity assays: bacterial, yeast and algal cells, crustaceans and mammalian cells in vitro. When possible, the assays were conducted in ultrapure water to minimise the effect of medium components on silver speciation. The toxic effects of NPs to different organisms varied about two orders of magnitude, being the lowest (similar to 0.1 mg Ag/L) for crustaceans and algae and the highest (similar to 26 mg Ag/L) for mammalian cells. To quantify the role of Ag ions in the toxicity of Ag NPs, we normalized the EC50 values to Ag ions that dissolved from the NPs. The analysis showed that the toxicity of 20-80 nm Ag NPs could fully be explained by released Ag ions whereas 10 nm Ag NPs proved more toxic than predicted. Using E. coli Ag-biosensor, we demonstrated that 10 nm Ag NPs were more bioavailable to E. coli than silver salt (AgNO3). Thus, one may infer that 10 nm Ag NPs had more efficient cell-particle contact resulting in higher intracellular bioavailability of silver than in case of bigger NPs. Although the latter conclusion is initially based on one test organism, it may lead to an explanation for "sizedependent`` biological effects of silver NPs. This study, for the first time, investigated the size-dependent toxic effects of a well-characterized library of Ag NPs to several microbial species, protozoans, algae, crustaceans and mammalian cells in vitro.	[Ivask, Angela; Kurvet, Imbi; Kasemets, Kaja; Blinova, Irina; Aruoja, Villem; Suppi, Sandra; Vija, Heiki; Kaekinen, Aleksandr; Titma, Tiina; Heinlaan, Margit; Visnapuu, Meeri; Kahru, Anne] NICPB, Lab Environm Toxicol, Tallinn, Estonia; [Visnapuu, Meeri; Kisand, Vambola] Univ Tartu, Fac Sci & Technol, Inst Phys, EE-50090 Tartu, Estonia; [Koller, Dagmar] Med Res Council Human Nutr Res, Biomineral Res Grp, Cambridge, England	National Institute of Chemical Physics & Biophysics (NICPB); University of Tartu; University of Tartu Institute of Physics; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Ivask, A (corresponding author), NICPB, Lab Environm Toxicol, Tallinn, Estonia.	angela.ivask@kbfi.ee; anne.kahru@kbfi.ee	heinlaan, margit/F-8431-2011; Visnapuu, Meeri/AAJ-4545-2021; Kisand, Vambola/AAA-2539-2021; Ivask, Angela/G-5180-2011; Kahru, Anne/C-4927-2008; Aruoja, Villem/G-8415-2016; Kasemets, Kaja/B-9802-2016; Titma, Tiina/Q-6971-2019; Kisand, Vambola/A-6822-2008; Kakinen, Aleksandr/J-8417-2017; Ivask, Angela/AAH-5777-2021	heinlaan, margit/0000-0003-1528-2461; Kisand, Vambola/0000-0001-9765-055X; Ivask, Angela/0000-0003-3451-7211; Kahru, Anne/0000-0002-4944-4900; Kasemets, Kaja/0000-0001-6413-3660; Titma, Tiina/0000-0002-4935-8914; Kisand, Vambola/0000-0001-9765-055X; Kakinen, Aleksandr/0000-0003-1547-2855; Visnapuu, Meeri/0000-0003-0028-7083	Estonian Targeted Funding projects [SF0690063s08, IUT23-5]; Estonian Science Foundation projects [ETF9001, ETF9347, ETF8561]; European Regional Development Fund project TERIKVANT; EU [263147, 309314]; United Kingdom Medical Research Council, Unit [U105960399]; Medical Research Council [MC_U105960399] Funding Source: researchfish; MRC [MC_U105960399] Funding Source: UKRI	Estonian Targeted Funding projects; Estonian Science Foundation projects; European Regional Development Fund project TERIKVANT; EU(European Commission); United Kingdom Medical Research Council, Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Estonian Targeted Funding projects SF0690063s08 (authors from NICPB), IUT23-5 (authors from NICPB), Estonian Science Foundation projects ETF9001 (KK, SS), ETF9347 (MH, IB, AK), ETF8561 (AI, AK, Anne K), by the European Regional Development Fund project TERIKVANT (AI, IB, Anne K), EU FP7 grant NanoValid under Grant Agreement No. 263147 (AI, MH, Anne K), EU FP7 Project MODERN under Grant Agreement No. 309314 (VA, Anne K) and by the United Kingdom Medical Research Council, Unit Programme no. U105960399 (DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081; Aruoja V, 2004, ENVIRON TOXICOL, V19, P396, DOI 10.1002/tox.20046; Badwaik VD, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-623; Bai YC, 2014, ENVIRON SCI TECHNOL, V48, P3098, DOI 10.1021/es500365k; Blinova I, 2013, ENVIRON SCI POLLUT R, V20, P3456, DOI 10.1007/s11356-012-1290-5; Bondarenko O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064060; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Bowman CR, 2012, ENVIRON TOXICOL CHEM, V31, P1793, DOI 10.1002/etc.1881; Burello E, 2011, WIRES NANOMED NANOBI, V3, P298, DOI 10.1002/wnan.137; Chen CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021865; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Commission, 2011, OFFICIAL J EUROPEA L, VL275/38; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Ivask A, 2004, CHEMOSPHERE, V55, P147, DOI 10.1016/j.chemosphere.2003.10.064; Ivask A, 2002, SOIL BIOL BIOCHEM, V34, P1439, DOI 10.1016/S0038-0717(02)00088-3; Ivask A, NANOTOXICOLOGY; Ivask A., 2012, NANO ANTIMICROBIALS, P253; Ivask A, 2007, BIOSENS BIOELECTRON, V22, P1396, DOI 10.1016/j.bios.2006.06.019; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Ivask A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-41; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Kakinen A, 2011, SENSORS-BASEL, V11, P10502, DOI 10.3390/s111110502; Kahru A, 2013, ACCOUNTS CHEM RES, V46, P823, DOI 10.1021/ar3000212; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Lopes S, 2014, ENVIRON TOXICOL CHEM, V33, P190, DOI 10.1002/etc.2413; Lu Z, 2013, J MATER SCI-MATER M, V24, P1465, DOI 10.1007/s10856-013-4894-5; Ma R, 2012, ENVIRON SCI TECHNOL, V46, P752, DOI 10.1021/es201686j; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Peltola P, 2005, SCI TOTAL ENVIRON, V350, P194, DOI 10.1016/j.scitotenv.2005.01.029; Peters R, 2014, ASHGATE RESEARCH COMPANION TO ISLAMIC LAW, P1; Piccinno F, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1109-9; Priester JH, 2009, ENVIRON SCI TECHNOL, V43, P2589, DOI 10.1021/es802806n; Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]; Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311; Sarand I, 2000, FEMS MICROBIOL ECOL, V31, P127, DOI 10.1111/j.1574-6941.2000.tb00678.x; Silva T, 2014, SCI TOTAL ENVIRON, V468, P968, DOI 10.1016/j.scitotenv.2013.09.006; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tsao TM, 2009, SOIL SCI SOC AM J, V73, P1808, DOI 10.2136/sssaj2008.0376; Wang X, 2014, SMALL, V10, P385, DOI 10.1002/smll.201301597; Wehling J, 2013, ENVIRON POLLUT, V176, P292, DOI 10.1016/j.envpol.2013.02.001; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w	48	382	390	11	233	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102108	10.1371/journal.pone.0102108	http://dx.doi.org/10.1371/journal.pone.0102108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048192	gold, Green Submitted, Green Published			2022-12-27	WOS:000339558100019
J	Zhang, YP; Chu, RX; Liu, H				Zhang, Yun-Ping; Chu, Rui-Xue; Liu, Hui			Vitamin A Intake and Risk of Melanoma: A Meta-Analysis	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; BETA-CAROTENE; SUN EXPOSURE; DIET; CANCER; RETINOIDS; CHEMOPREVENTION; CARCINOGENESIS; PREVENTION	Background: Mounting evidence from experimental and animal studies suggests that vitamin A may have a protective effect on melanoma, but the findings on the association of vitamin A intake with risk of melanoma have been inconsistently reported in epidemiologic studies. We attempted to elucidate the association by performing a meta-analysis. Methods: Eligible studies were identified by searching PubMed and EMBASE databases, as well as by reviewing the references of retrieved publications. Summary odds ratios (OR) with corresponding 95% confidence interval (CI) were computed with a random-effects model. Study-specific ORs and 95% CIs for the highest vs. lowest categories of vitamin A intake were pooled. Results: A total of 8 case-control studies and 2 prospective studies comprising 3,328 melanoma cases and 233,295 non-case subjects were included. The summary OR for the highest compared with the lowest intake of total vitamin A, retinol and beta-carotene was 0.86 (95% CI = 0.59-1.25), 0.80 (95% CI = 0.69-0.92) and 0.87 (95% CI = 0.62-1.20), respectively. Significant heterogeneity was observed among studies on vitamin A and beta-carotene intake, but not among studies on retinol intake. Subgroup and sensitivity analyses confirmed these findings. There was no indication of publication bias. Conclusion: Findings from this meta-analysis suggest that intake of retinol, rather than of total vitamin A or beta-carotene, is significantly associated with reduced risk of melanoma.	[Zhang, Yun-Ping] Liaocheng Peoples Hosp, Dept Dermatol, Liaocheng, Peoples R China; [Chu, Rui-Xue] Liaocheng Peoples Hosp, Dept Clin Lab, Liaocheng, Peoples R China; [Liu, Hui] Liaocheng Peoples Hosp, Dept Obstet & Gynaecol, Liaocheng, Peoples R China		Chu, RX (corresponding author), Liaocheng Peoples Hosp, Dept Clin Lab, Liaocheng, Peoples R China.	churx0635@126.com						Asgari MM, 2012, J INVEST DERMATOL, V132, P1573, DOI 10.1038/jid.2012.21; Bain C, 1993, Ann Epidemiol, V3, P235, DOI 10.1016/1047-2797(93)90024-X; de Vries E, 2004, EUR J CANCER, V40, P2355, DOI 10.1016/j.ejca.2004.06.003; Dennis LK, 1999, ARCH DERMATOL, V135, P275, DOI 10.1001/archderm.135.3.275; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Druesne-Pecollo N, 2010, INT J CANCER, V127, P172, DOI 10.1002/ijc.25008; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feskanich D, 2003, BRIT J CANCER, V88, P1381, DOI 10.1038/sj.bjc.6600882; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holman C D, 1986, Recent Results Cancer Res, V102, P18; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Khuri FR, 2000, SEMIN SURG ONCOL, V18, P100, DOI 10.1002/(SICI)1098-2388(200003)18:2<100::AID-SSU3>3.3.CO;2-0; KIRKPATRICK CS, 1994, AM J EPIDEMIOL, V139, P869, DOI 10.1093/oxfordjournals.aje.a117093; Le Marchand L, 2006, AM J EPIDEMIOL, V164, P232, DOI 10.1093/aje/kwj115; LOTAN R, 1978, J NATL CANCER I, V60, P1035, DOI 10.1093/jnci/60.5.1035; LOTAN R, 1980, CANCER RES, V40, P1097; Millen AE, 2004, CANCER EPIDEM BIOMAR, V13, P1042; Naldi L, 2004, EUR J CANCER PREV, V13, P503, DOI 10.1097/00008469-200412000-00007; Niles RM, 2000, NUTRITION, V16, P1084, DOI 10.1016/S0899-9007(00)00436-6; OIKARINEN A, 1991, ANN MED, V23, P497, DOI 10.3109/07853899109150509; SANTAMARIA L, 1988, ANN NY ACAD SCI, V534, P584, DOI 10.1111/j.1749-6632.1988.tb30149.x; STRYKER WS, 1990, AM J EPIDEMIOL, V131, P597, DOI 10.1093/oxfordjournals.aje.a115544; van Berkel TJC, 2009, J LIPID RES, V50, P2337, DOI 10.1194/jlr.E002659; Vinceti M, 2005, PUBLIC HEALTH NUTR, V8, P1307, DOI 10.1079/PHN2005754	27	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e102527	10.1371/journal.pone.0102527	http://dx.doi.org/10.1371/journal.pone.0102527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25048246	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100040
J	Fang, ZM; Zhou, P; Chang, F; Yin, Q; Fang, W; Yuan, J; Zhang, XC; Xiao, YZ				Fang, Zemin; Zhou, Peng; Chang, Fei; Yin, Qiang; Fang, Wei; Yuan, Jing; Zhang, Xuecheng; Xiao, Yazhong			Structure-Based Rational Design to Enhance the Solubility and Thermostability of a Bacterial Laccase Lac15	PLOS ONE			English	Article							BIOCHEMICAL FUNDAMENTALS; COMMERCIAL SYSTEMS; FUNGAL LACCASES; STABILITY; PURIFICATION; EXPRESSION; PROLINE	Bacterial laccases are ideal alternatives of fungal laccases for specific industrial applications due to specific characteristics such as alkalescence dependence and high chloride tolerance. However, some bacterial laccases presented as inclusion bodies when expressing in Escherichia coli and showed thermal instability. In this study, rational design was employed to enhance the solubility and the thermostablity of the bacterial laccase Lac15-His(6) based on the crystal structure obtained previously. After deletion of His-tag and residues(323-332), the obtained Lac15D was completely expressed in soluble form even at a higher temperature of 28 degrees C, compared to only 50% of Lac15-His6 expressed solubly at 16 degrees C. It showed a two-time higher activity at temperatures lower than 35 degrees C and a half-life increasing from 72 min to 150 min at 45 degrees C. When used in chromogenic reactions, Lac15D showed constant activity toward dye precursors and their combinations under alkaline conditions, demonstrating its application potential in hair coloring biotechnology.	[Fang, Zemin; Zhou, Peng; Chang, Fei; Yin, Qiang; Fang, Wei; Yuan, Jing; Zhang, Xuecheng; Xiao, Yazhong] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Fang, Zemin; Zhou, Peng; Chang, Fei; Yin, Qiang; Fang, Wei; Yuan, Jing; Zhang, Xuecheng; Xiao, Yazhong] Anhui Prov Engn Technol Res Ctr Microorganisma &, Hefei, Peoples R China	Anhui University	Xiao, YZ (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China.	turenzh@ahu.edu.cn; yzxiao@ahu.edu.cn			National High Technology Research and Development Program of China [2011AA09070305]; National Natural Science Foundation of China [31370114]; Scientific Research Foundation for Returned Scholars; Ministry of Education of China; Natural Science Foundation of Anhui Province [1208085QC63]; Introduction Program of Academic and Technology Leaders [32030066]; Innovative Research Team Program of 211 Project in Anhui University	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Introduction Program of Academic and Technology Leaders; Innovative Research Team Program of 211 Project in Anhui University	This work was funded by the National High Technology Research and Development Program of China (2011AA09070305 to YX); the National Natural Science Foundation of China (31370114 to YX); the Scientific Research Foundation for Returned Scholars, the Ministry of Education of China (to YX); the Natural Science Foundation of Anhui Province (1208085QC63 to JY); the Introduction Program of Academic and Technology Leaders (32030066 to ZF); and the Innovative Research Team Program of 211 Project in Anhui University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; AMES BN, 1975, P NATL ACAD SCI USA, V72, P2423, DOI 10.1073/pnas.72.6.2423; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Chen CY, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-49; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Galai S, 2009, APPL BIOCHEM BIOTECH, V158, P416, DOI 10.1007/s12010-008-8369-y; Gatti-Lafranconi P, 2011, FEBS J, V278, P2408, DOI 10.1111/j.1742-4658.2011.08163.x; Ge HH, 2011, ACTA CRYSTALLOGR F, V67, P956, DOI 10.1107/S1744309111024912; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Li BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046881; Lu L, 2012, BIORESOURCE TECHNOL, V115, P35, DOI 10.1016/j.biortech.2011.07.111; Lu XY, 2013, APPL MICROBIOL BIOT, V97, P9419, DOI 10.1007/s00253-013-4751-y; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Saito K, 2012, J BIOSCI BIOENG, V113, P575, DOI 10.1016/j.jbiosc.2012.01.001; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Xiao YZ, 2003, APPL MICROBIOL BIOT, V60, P700, DOI 10.1007/s00253-002-1169-3; Xu F., 2005, IND BIOTECHNOL, V1, P38, DOI DOI 10.1089/IND.2005.1.38; Zheng BS, 2012, J BIOL CHEM, V287, P8336, DOI 10.1074/jbc.M111.266346; Zhou C, 2010, J BIOSCI BIOENG, V110, P12, DOI 10.1016/j.jbiosc.2009.12.002; Zhu GP, 1999, PROTEIN ENG, V12, P635, DOI 10.1093/protein/12.8.635; Zhu SZ, 2013, APPL MICROBIOL BIOT, V97, P837, DOI 10.1007/s00253-012-4630-y	30	13	16	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102423	10.1371/journal.pone.0102423	http://dx.doi.org/10.1371/journal.pone.0102423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1OC	25036001	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200059
J	Biffi, G; Tannahill, D; Miller, J; Howat, WJ; Balasubramanian, S				Biffi, Giulia; Tannahill, David; Miller, Jodi; Howat, William J.; Balasubramanian, Shankar			Elevated Levels of G-Quadruplex Formation in Human Stomach and Liver Cancer Tissues	PLOS ONE			English	Article							SMALL-MOLECULE; BREAKPOINT REGION; LIGAND RHPS4; IN-VITRO; DNA; INSTABILITY; MOTIFS; TRANSLOCATION; EXPRESSION; CONSISTENT	Four-stranded G-quadruplex DNA secondary structures have recently been visualized in the nuclei of human cultured cells. Here, we show that BG4, a G-quadruplex-specific antibody, can be used to stain DNA G-quadruplex structures in patient-derived tissues using immunohistochemistry. We observe a significantly elevated number of G-quadruplex-positive nuclei in human cancers of the liver and stomach as compared to background non-neoplastic tissue. Our results suggest that G-quadruplex formation can be detected and measured in patient-derived material and that elevated G-quadruplex formation may be a characteristic of some cancers.	[Biffi, Giulia; Tannahill, David; Miller, Jodi; Howat, William J.; Balasubramanian, Shankar] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009	Tannahill, David/0000-0002-3811-6864; Miller, Jodi/0000-0001-6870-204X; Balasubramanian, Shankar/0000-0002-0281-5815; Biffi, Giulia/0000-0003-4592-0970	Cancer Research UK [C9681/A11961]; Cancer Research UK [22310, 12488] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The authors thank Cancer Research UK for programme grant (C9681/A11961) and core institutional funding to the Balasubramanian lab, and for a PhD studentship for GB (http://www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Bejugam M, 2010, ACS MED CHEM LETT, V1, P306, DOI 10.1021/ml100062z; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gomez D, 2006, CANCER RES, V66, P6908, DOI 10.1158/0008-5472.CAN-06-1581; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Katapadi VK, 2012, GENOMICS, V100, P72, DOI 10.1016/j.ygeno.2012.05.008; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Marinoni I, 2014, GASTROENTEROLOGY, V146, P453, DOI 10.1053/j.gastro.2013.10.020; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Phatak P, 2007, BRIT J CANCER, V96, P1223, DOI 10.1038/sj.bjc.6603691; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x	34	114	118	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102711	10.1371/journal.pone.0102711	http://dx.doi.org/10.1371/journal.pone.0102711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033211	Green Published, gold, Green Submitted			2022-12-27	WOS:000339418300083
J	Douglass, LL; Turner, J; Grantham, HS; Kaiser, S; Constable, A; Nicoll, R; Raymond, B; Post, A; Brandt, A; Beaver, D				Douglass, Lucinda L.; Turner, Joel; Grantham, Hedley S.; Kaiser, Stefanie; Constable, Andrew; Nicoll, Rob; Raymond, Ben; Post, Alexandra; Brandt, Angelika; Beaver, Daniel			A Hierarchical Classification of Benthic Biodiversity and Assessment of Protected Areas in the Southern Ocean	PLOS ONE			English	Article							ANTARCTIC POLAR FRONT; DEEP-WATER; PROMACHOCRINUS-KERGUELENSIS; CRYPTIC SPECIATION; LARVAL DISPERSAL; ATLANTIC SECTOR; MARINE; BIOGEOGRAPHY; SHELF; ICE	An international effort is underway to establish a representative system of marine protected areas (MPAs) in the Southern Ocean to help provide for the long-term conservation of marine biodiversity in the region. Important to this undertaking is knowledge of the distribution of benthic assemblages. Here, our aim is to identify the areas where benthic marine assemblages are likely to differ from each other in the Southern Ocean including near-shore Antarctica. We achieve this by using a hierarchical spatial classification of ecoregions, bathomes and environmental types. Ecoregions are defined according to available data on biogeographic patterns and environmental drivers on dispersal. Bathomes are identified according to depth strata defined by species distributions. Environmental types are uniquely classified according to the geomorphic features found within the bathomes in each ecoregion. We identified 23 ecoregions and nine bathomes. From a set of 28 types of geomorphic features of the seabed, 562 unique environmental types were classified for the Southern Ocean. We applied the environmental types as surrogates of different assemblages of biodiversity to assess the representativeness of existing MPAs. We found that 12 ecoregions are not represented in MPAs and that no ecoregion has their full range of environmental types represented in MPAs. Current MPA planning processes, if implemented, will substantially increase the representation of environmental types particularly within 8 ecoregions. To meet internationally agreed conservation goals, additional MPAs will be needed. To assist with this process, we identified 107 spatially restricted environmental types, which should be considered for inclusion in future MPAs. Detailed supplementary data including a spatial dataset are provided.	[Douglass, Lucinda L.; Grantham, Hedley S.; Beaver, Daniel] Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Douglass, Lucinda L.; Turner, Joel; Beaver, Daniel] Ctr Conservat Geog, Sydney, NSW, Australia; [Grantham, Hedley S.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Kaiser, Stefanie; Brandt, Angelika] Univ Hamburg, Bioctr Grindel & Zool Museum, Hamburg, Germany; [Kaiser, Stefanie] German Ctr Marine Biodivers Res, Wilhelmshaven, Germany; [Constable, Andrew; Raymond, Ben] Australian Govt, Dept Environm, Australian Antarctic Div, Kingston, Tas, Australia; [Constable, Andrew; Raymond, Ben] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Nicoll, Rob] WWF Australia, Ultimo, NSW, Australia; [Post, Alexandra] Geosci Australia, Marine & Coastal Environm Grp, Canberra, ACT, Australia	University of Queensland; Conservation International; University of Hamburg; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; World Wildlife Fund; Geoscience Australia	Douglass, LL (corresponding author), Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	douglass.lucinda@gmail.com	Brandt, Angelika/C-1630-2018	Kaiser, Stefanie/0000-0003-2026-4663; Post, Alexandra/0000-0002-6287-3283	WWF	WWF	Research funding was provided by WWF (wwf.panda.org). The funders had no role in data collection and analysis or decision to publish the manuscript.	Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Ainley DG, 2010, ROSS SEA BIOREGION 1; Aldea C, 2008, DEEP-SEA RES PT I, V55, P350, DOI 10.1016/j.dsr.2007.12.002; Allcock AL, 2011, DEEP-SEA RES PT II, V58, P242, DOI 10.1016/j.dsr2.2010.05.016; Allcock AL, 2005, ZOOL J LINN SOC-LOND, V143, P75, DOI 10.1111/j.1096-3642.2004.00146.x; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Baines PG, 2007, ENCY ANTARCTIC, P1146; Barnes DKA, 2008, GLOBAL ECOL BIOGEOGR, V17, P84, DOI 10.1111/j.1466-8238.2007.00342.x; Barnes DKA, 2010, J BIOGEOGR, V37, P1648, DOI 10.1111/j.1365-2699.2010.02320.x; BARNES DKA, 1995, POLAR BIOL, V15, P335; Barry J.P., 1991, Ecological Studies, P270; Barry James P., 2003, Antarctic Research Series, V78, P327; BARRY JP, 1988, POLAR BIOL, V8, P367, DOI 10.1007/BF00442028; Beaman RJ, 2005, CONT SHELF RES, V25, P1657, DOI 10.1016/j.csr.2005.04.013; Bowden DA, 2011, DEEP-SEA RES PT II, V58, P119, DOI 10.1016/j.dsr2.2010.09.006; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; BRANDT A, 1992, MAR BIOL, V113, P415, DOI 10.1007/BF00349167; Brandt A, 2011, DEEP-SEA RES PT II, V58, P1962, DOI 10.1016/j.dsr2.2011.01.008; Brandt A, 2007, DEEP-SEA RES PT II, V54, P1760, DOI 10.1016/j.dsr2.2007.07.015; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Brandt A, 2009, DEEP-SEA RES PT I, V56, P2013, DOI 10.1016/j.dsr.2009.06.007; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Brockington S, 2001, MAR BIOL, V139, P127; Cantero ALP, 2004, POLAR BIOL, V27, P767, DOI 10.1007/s00300-004-0654-9; CCAMLR, 2010, CONS MEAS 22 07 INT; CCAMLR, 2012, CONS MEAS 22 06 BOTT; CCAMLR, 2012, CONS MEAS 91 02 PROT; CCAMLR, 2009, CONS MEAS 91 03 2009; CCAMLR Secretariat, 2013, VULN MAR EC REG; Christiansen S, 2010, SID EV 12 UNEP GLOB; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke A, 2006, DEEP-SEA RES PT II, V53, P803, DOI 10.1016/j.dsr2.2006.05.001; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Danis B, 2009, NATURE, V458, P830, DOI 10.1038/458830b; David B, 2003, ANTARCTIC ECHINOIDS; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Delegations of Australia and France, 2011, PROP REPR SYST UNPUB; Diaz A, 2011, DEEP-SEA RES PT II, V58, P205, DOI 10.1016/j.dsr2.2010.10.012; Duhamel G, 2009, CCAMLR SCI, V16, P1; ERA, 2011, ANT PROT AR; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Feldman GC, 2010, SEAWIFS REPROCESSING; Fichefet T, 1999, GEOPHYS RES LETT, V26, P1015, DOI 10.1029/1999GL900159; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Fukamachi Y, 2010, NAT GEOSCI, V3, P327, DOI 10.1038/NGEO842; Gili JM, 2006, MAR ECOL PROG SER, V322, P43, DOI 10.3354/meps322043; Gjerde Kristina M., 2006, UNEP Regional Seas Reports and Studies, V178, P1; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; Grant S, 2006, BIOR SO OC REP EXP W; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Gutt J, 2013, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.4.4499; Hall S, 2011, POLAR BIOL, V34, P363, DOI 10.1007/s00300-010-0890-0; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Harris PT, 2011, MAR GEOL, V285, P69, DOI 10.1016/j.margeo.2011.05.008; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Harris PT, 2012, ELSEV INSIGHT, P1; Havermans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074218; Held C, 2005, SCI MAR, V69, P175, DOI 10.3989/scimar.2005.69s2175; Held C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P135; Hemery LG, 2012, MOL ECOL, V21, P2502, DOI 10.1111/j.1365-294X.2012.05512.x; Hoffman JI, 2011, J HERED, V102, P55, DOI 10.1093/jhered/esq094; Huang Z, 2011, CONT SHELF RES, V31, pS4, DOI 10.1016/j.csr.2010.03.012; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Kaiser S, 2013, MAR BIOL, V160, P2295, DOI 10.1007/s00227-013-2232-6; Kaiser S, 2011, DEEP-SEA RES PT II, V58, P91, DOI 10.1016/j.dsr2.2010.05.017; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Knox G. A., 2007, BIOL SO OCEAN; Kock KH, 2007, ANTARCT SCI, V19, P231, DOI 10.1017/S0954102007000302; Koubbi P, 2011, DEEP-SEA RES PT II, V58, P170, DOI 10.1016/j.dsr2.2010.09.007; Koubbi P, 2010, POLAR SCI, V4, P115, DOI 10.1016/j.polar.2010.04.012; Kruse S, 2009, POLAR BIOL, V32, P1359, DOI 10.1007/s00300-009-0632-3; Last PR, 2010, BIOL CONSERV, V143, P1675, DOI 10.1016/j.biocon.2010.04.008; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Leon TM, 2001, POLAR BIOL, V24, P941, DOI 10.1007/s003000100305; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Locarnini R. A., 2006, WORLD OCEAN ATLAS 20, V1; Lombard AT, 2007, ANTARCT SCI, V19, P39, DOI 10.1017/S0954102007000077; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Martin S, 2001, ENCY OCEAN SCI, P2241, DOI DOI 10.1006/RWOS.2001.0007; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McCartney MS, 2007, PROG OCEANOGR, V75, P675, DOI 10.1016/j.pocean.2007.02.008; McLeod DJ, 2010, POLAR SCI, V4, P353, DOI 10.1016/j.polar.2010.03.004; Meijers AJS, 2010, DEEP-SEA RES PT II, V57, P723, DOI 10.1016/j.dsr2.2009.04.019; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; N.Z and U.S, 2012, REV 1 CONSERVATION M; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Njaastad B, 2011, COMMUNICATION; O'Brien PE, 2009, SCI COMM COMM ANT MA; O'Brien PE, 1997, ANTARCT RES SER, V2, P109; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Penhale P, 2007, COMM CONS ANT MAR LI; Post AL, 2011, DEEP-SEA RES PT II, V58, P105, DOI 10.1016/j.dsr2.2010.05.020; Post AL, 2010, ANTARCT SCI, V22, P371, DOI 10.1017/S0954102010000180; Potthoff M, 2006, POLAR BIOL, V29, P543, DOI 10.1007/s00300-005-0086-1; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Robertson R, 2002, DEEP-SEA RES PT II, V49, P4791, DOI 10.1016/S0967-0645(02)00159-5; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; SC-CAMLR, 2010, PRER VERS REP 29 M S; SC-CAMLR, 2009, SCI COMM CONS ANT MA; SC-CAMLR, 2005, REP SCI COMM WORKSH; SC-CAMLR, 2009, REP JOINT SC CAMLR C; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; Schnack-Schiel SB, 2005, SCI MARINA, V69; SCOTT J M, 1993, WILDLIFE MONOGR, V123, P3, DOI DOI 10.1016/0006-3207(94)90022-1; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith W, 2010, MEASURED ESTIMATED S; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spreen G, 2008, J GEOPHYS RES, V113, P3481; Suhr SB, 2006, DEEP-SEA RES PT II, V53, P895, DOI 10.1016/j.dsr2.2006.02.002; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; UQEC, 2009, SCI PRINC DES MAR PR; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wiencke C, 2006, J ECOL, V94, P455, DOI 10.1111/j.1365-2745.2006.01102.x; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; Williams R., 1995, CCAMLR Science, V2, P1; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301	139	42	43	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100551	10.1371/journal.pone.0100551	http://dx.doi.org/10.1371/journal.pone.0100551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032993	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300009
J	Sadamura-Takenaka, Y; Ito, T; Noma, S; Oyama, Y; Yamada, S; Kawahara, K; Inoue, H; Maruyama, I				Sadamura-Takenaka, Yukari; Ito, Takashi; Noma, Satoshi; Oyama, Yoko; Yamada, Shingo; Kawahara, Ko-ichi; Inoue, Hiromasa; Maruyama, Ikuro			HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats	PLOS ONE			English	Article							CHROMATIN PROTEIN HMGB1; SMOOTH-MUSCLE-CELLS; GROUP BOX PROTEIN; ATHEROSCLEROTIC PLAQUES; INFLAMMATION; EXPRESSION; THERAPY; SIGNAL; HMG-1	Rationale: Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary vascular resistance leading to right ventricular failure and death. Recent studies have suggested that chronic inflammatory processes are involved in the pathogenesis of PAH. However, the molecular and cellular mechanisms driving inflammation have not been fully elucidated. Objectives: To elucidate the roles of high mobility group box 1 protein (HMGB1), a ubiquitous DNA-binding protein with extracellular pro-inflammatory activity, in a rat model of PAH. Methods: Male Sprague-Dawley rats were administered monocrotaline (MCT). Concentrations of HMGB1 in bronchoalveolar lavage fluid (BALF) and serum, and localization of HMGB1 in the lung were examined over time. The protective effects of anti-HMGB1 neutralizing antibody against MCT-induced PAH were tested. Results: HMGB1 levels in BALF were elevated 1 week after MCT injection, and this elevation preceded increases of other pro-inflammatory cytokines, such as TNF-alpha, and the development of PAH. In contrast, serum HMGB1 levels were elevated 4 weeks after MCT injection, at which time the rats began to die. Immunohistochemical analyses indicated that HMGB1 was translocated to the extranuclear space in periarterial infiltrating cells, alveolar macrophages, and bronchial epithelial cells of MCT-injected rats. Anti-HMGB1 neutralizing antibody protected rats against MCT-induced lung inflammation, thickening of the pulmonary artery wall, and elevation of right ventricular systolic pressure, and significantly improved the survival of the MCT-induced PAH rats. Conclusions: Our results identify extracellular HMGB1 as a promoting factor for MCT-induced PAH. The blockade of HMGB1 activity improved survival of MCT-induced PAH rats, and thus might be a promising therapy for the treatment of PAH.	[Sadamura-Takenaka, Yukari; Noma, Satoshi; Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima 890, Japan; [Sadamura-Takenaka, Yukari; Ito, Takashi; Noma, Satoshi; Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan; [Oyama, Yoko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan; [Yamada, Shingo] Shinotest Corp, Sagamihara, Kanagawa, Japan; [Kawahara, Ko-ichi] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Osaka Institute of Technology	Maruyama, I (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan.	maruyama@m2.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science [25293192, 24390402, 23390412]; Grants-in-Aid for Scientific Research [25293192] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Japan Society for the Promotion of Science (Grant-in-Aid 25293192, 24390402, and 23390412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bauer EM, 2012, MOL MED, V18, P1509, DOI 10.2119/molmed.2012.00283; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; de Souza AWS, 2012, AUTOIMMUN REV, V11, P909, DOI 10.1016/j.autrev.2012.03.007; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Ikeda Y, 2002, AM J PHYSIOL-HEART C, V283, pH2021, DOI 10.1152/ajpheart.00919.2001; Ito T, 2007, NBER E A EC, V16, P1; Itoh T, 2006, RESPIROLOGY, V11, P158, DOI 10.1111/j.1440-1843.2006.00821.x; Itoh T, 2004, AM J RESP CRIT CARE, V170, P1204, DOI 10.1164/rccm.200404-455OC; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Kuang TG, 2010, PULM PHARMACOL THER, V23, P456, DOI 10.1016/j.pupt.2010.02.003; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mathew R, 2010, CARDIOL REV, V18, P67, DOI 10.1097/CRD.0b013e3181cd612f; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Moreno JA, 2013, ARTERIOSCL THROM VAS, V33, P612, DOI 10.1161/ATVBAHA.112.300874; Oyama Y, 2010, LAB INVEST, V90, P853, DOI 10.1038/labinvest.2010.64; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Pullamsetti SS, 2011, CLIN MICROBIOL INFEC, V17, P7, DOI 10.1111/j.1469-0691.2010.03285.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tang D, ANTIOXID REDOX SIGNA, V14, P1315; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Umar S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/702836; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Q, 2013, VASC PHARMACOL, V58, P71, DOI 10.1016/j.vph.2012.07.006; Wang W, 2011, MOL BIOL REP, V38, P3277, DOI 10.1007/s11033-010-0390-x; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6	40	46	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102482	10.1371/journal.pone.0102482	http://dx.doi.org/10.1371/journal.pone.0102482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032709	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300055
J	Toth, AE; Walter, FR; Bocsik, A; Santha, P; Veszelka, S; Nagy, L; Puskas, LG; Couraud, PO; Takata, F; Dohgu, S; Kataoka, Y; Deli, MA				Toth, Andrea E.; Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Veszelka, Szilvia; Nagy, Lajos; Puskas, Laszlo G.; Couraud, Pierre-Olivier; Takata, Fuyuko; Dohgu, Shinya; Kataoka, Yasufumi; Deli, Maria A.			Edaravone Protects against Methylglyoxal-Induced Barrier Damage in Human Brain Endothelial Cells	PLOS ONE			English	Article							FREE-RADICAL GENERATION; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; IN-VITRO; CARBONYL STRESS; DIABETIC COMPLICATIONS; ALZHEIMERS-DISEASE; ISCHEMIC-STROKE; GLYOXALASE-I; PERMEABILITY	Background: Elevated level of reactive carbonyl species, such as methylglyoxal, triggers carbonyl stress and activates a series of inflammatory responses leading to accelerated vascular damage. Edaravone is the active substance of a Japanese medicine, which aids neurological recovery following acute brain ischemia and subsequent cerebral infarction. Our aim was to test whether edaravone can exert a protective effect on the barrier properties of human brain endothelial cells (hCMEC/D3 cell line) treated with methylglyoxal. Methodology: Cell viability was monitored in real-time by impedance-based cell electronic sensing. The barrier function of the monolayer was characterized by measurement of resistance and flux of permeability markers, and visualized by immunohistochemistry for claudin-5 and beta-catenin. Cell morphology was also examined by holographic phase imaging. Principal Findings: Methylglyoxal exerted a time- and dose-dependent toxicity on cultured human brain endothelial cells: a concentration of 600 mu M resulted in about 50% toxicity, significantly reduced the integrity and increased the permeability of the barrier. The cell morphology also changed dramatically: the area of cells decreased, their optical height significantly increased. Edaravone (3 mM) provided a complete protection against the toxic effect of methylglyoxal. Co-administration of edaravone restored cell viability, barrier integrity and functions of brain endothelial cells. Similar protection was obtained by the well-known antiglycating molecule, aminoguanidine, our reference compound. Conclusion: These results indicate for the first time that edaravone is protective in carbonyl stress induced barrier damage. Our data may contribute to the development of compounds to treat brain endothelial dysfunction in carbonyl stress related diseases.	[Toth, Andrea E.; Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Veszelka, Szilvia; Deli, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Nagy, Lajos; Puskas, Laszlo G.] Avidin Ltd, Szeged, Hungary; [Couraud, Pierre-Olivier] Inst Cochin, INSERM, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Takata, Fuyuko; Dohgu, Shinya; Kataoka, Yasufumi] Fukuoka Univ, Dept Pharmaceut Care & Hlth Sci, Fukuoka 81401, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Fukuoka University	Deli, MA (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary.	deli.maria@brc.mta.hu	Toth, Andrea E. E/T-1226-2018; Dohgu, Shinya/AAK-9992-2020; Deli, Mária A./I-2885-2019	Toth, Andrea E. E/0000-0001-6122-919X; Deli, Mária A./0000-0001-6084-6524; Veszelka, Szilvia/0000-0001-8864-1184	European Union; State of Hungary - European Social Fund in the framework of "National Excellence Program'' [TAMOP-4.2.4. A/2-11-1-2012-0001, TAMOP-4.2.2.A-11/1/KONV-2012-0052]; Rollin D. Hotchkiss Foundation	European Union(European Commission); State of Hungary - European Social Fund in the framework of "National Excellence Program''; Rollin D. Hotchkiss Foundation	This research was supported by grants from the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4. A/2-11-1-2012-0001 "National Excellence Program'' and TAMOP-4.2.2.A-11/1/KONV-2012-0052, and the Dr. Rollin D. Hotchkiss Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; Beeri MS, 2011, MECH AGEING DEV, V132, P583, DOI 10.1016/j.mad.2011.10.007; Bruno A, 2010, CURR TREAT OPTION NE, V12, P492, DOI 10.1007/s11940-010-0093-6; Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; del Zoppo GJ, 2006, BIOCHEM SOC T, V34, P1261, DOI 10.1042/BST0341261; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Dukic-Stefanovic S, 2001, BIOGERONTOLOGY, V2, P19, DOI 10.1023/A:1010052800347; EDELSTEIN D, 1992, DIABETES, V41, P26, DOI 10.2337/diabetes.41.1.26; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Kalapos MP, 2013, DIABETES RES CLIN PR, V99, P260, DOI 10.1016/j.diabres.2012.11.003; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Kaur S, 2013, ARCH DERMATOL RES, V305, P489, DOI 10.1007/s00403-013-1362-5; Kiss L, 2013, J PHARM SCI-US, V102, P1173, DOI 10.1002/jps.23458; Kono S, 2013, J STROKE CEREBROVASC, V22, P1175, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.010; Kurti L, 2013, EUR J PHARM SCI, V50, P86, DOI 10.1016/j.ejps.2013.03.012; Kurti L, 2013, CYTOTECHNOLOGY, V65, P395, DOI 10.1007/s10616-012-9493-7; Kuhla B, 2005, ANN NY ACAD SCI, V1043, P211, DOI 10.1196/annals.1333.026; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; Li W, 2013, FREE RADICAL BIO MED, V54, P51, DOI 10.1016/j.freeradbiomed.2012.10.552; Li WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076025; Li WL, 2013, NEUROSCI LETT, V549, P146, DOI 10.1016/j.neulet.2013.06.007; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lukic-Panin V, 2010, CURR NEUROVASC RES, V7, P319, DOI 10.2174/156720210793180747; Madacsi R, 2013, MED CHEM, V9, P911, DOI 10.2174/1573406411309070004; Mangalmurti NS, 2010, TRANSFUSION, V50, P2353, DOI 10.1111/j.1537-2995.2010.02689.x; Matafome P, 2013, ENDOCRINE, V43, P472, DOI 10.1007/s12020-012-9795-8; Moheimani F, 2010, BBA-MOL BASIS DIS, V1802, P561, DOI 10.1016/j.bbadis.2010.02.007; Munch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y; Mukohda M, 2012, J PHARMACOL SCI, V118, P303, DOI 10.1254/jphs.11R12CP; Munch G, 2003, BIOCHEM SOC T, V31, P1397; Murata-Kamiya N, 2001, NUCLEIC ACIDS RES, V29, P3433, DOI 10.1093/nar/29.16.3433; Nemet I, 2006, MOL NUTR FOOD RES, V50, P1105, DOI 10.1002/mnfr.200600065; Okouchi M, 2009, CURR NEUROVASC RES, V6, P267, DOI 10.2174/156720209789630348; Omori K, 2007, AM J PHYSIOL-CELL PH, V293, pC1523, DOI 10.1152/ajpcell.00524.2006; Onodera H, 2013, BRAIN RES, V1534, P87, DOI 10.1016/j.brainres.2013.08.019; Ozsvari B, 2010, INT J MOL MED, V25, P525, DOI 10.3892/ijmm_00000373; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Rabbani N, 2011, DIABETES, V60, P1973, DOI 10.2337/db11-0085; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; Rouhiainen Ari, 2013, Methods Mol Biol, V963, P239, DOI 10.1007/978-1-62703-230-8_15; Sena CM, 2012, PHARMACOL RES, V65, P497, DOI 10.1016/j.phrs.2012.03.004; Srikanth V, 2013, J GERONTOL A-BIOL, V68, P68, DOI 10.1093/gerona/gls100; Stitt AW, 2002, EXPERT OPIN INV DRUG, V11, P1205, DOI 10.1517/13543784.11.9.1205; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Turk Z, 2010, PHYSIOL RES, V59, P147, DOI 10.33549/physiolres.931585; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Wang CX, 2007, PROG NEUROBIOL, V83, P140, DOI 10.1016/j.pneurobio.2007.07.006; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yamawaki H, 2008, AM J PHYSIOL-CELL PH, V295, pC1510, DOI 10.1152/ajpcell.00252.2008; Yao DC, 2006, CELL, V124, P275, DOI 10.1016/j.cell.2005.11.024; YIM HS, 1995, J BIOL CHEM, V270, P28228; Youdim KA, 2003, DRUG DISCOV TODAY, V8, P997, DOI 10.1016/S1359-6446(03)02873-3	68	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100152	10.1371/journal.pone.0100152	http://dx.doi.org/10.1371/journal.pone.0100152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25033388	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300005
J	Wildhagen, KCAA; Schrijver, R; Beckers, L; ten Cate, H; Reutelingsperger, CPM; Lutgens, E; Nicolaes, GAF				Wildhagen, Karin C. A. A.; Schrijver, Roy; Beckers, Linda; ten Cate, Hugo; Reutelingsperger, Chris P. M.; Lutgens, Esther; Nicolaes, Gerry A. F.			Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; REDUCED ANTICOAGULANT ACTIVITY; ENDOTHELIAL-CELLS; MYOCARDIAL-ISCHEMIA; FACTOR-V; LIPID-PEROXIDATION; THROMBOTIC DISEASE; DEFICIENT MICE; STROKE MODEL; INTERLEUKIN-6	Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotective properties. The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C receptor (EPCR) dependent and likely underlie protective effects of APC in animal models of sepsis, myocardial infarction and ischemic stroke. S360A-(A) PC, a variant (A) PC that has no catalytic activity, binds EPCR and shifts pro-inflammatory signaling of the thrombin-PAR-1 complex to anti-inflammatory signaling. In this study we investigated effects of human (h) wt-PC, hS360A-PC, hwt-APC and hS360A-APC in acute (mouse model of acute myocardial ischemia/reperfusion (I/R) injury) and chronic inflammation (apoE(-/-) mouse model of atherosclerosis). All h(A) PC variants significantly reduced myocardial infarct area (p<0.05) following I/R injury. IL-6 levels in heart homogenates did not differ significantly between sham, placebo and treatment groups in I/R injury. None of the h(A) PC variants decreased number and size of atherosclerotic plaques in apoE(-/-) mice. Only hS360A-APC slightly affected phenotype of plaques. IL-6 levels in plasma were significantly (p<0.001) decreased in hwt-APC and hS360A-PC treated mice. In the last group levels of monocyte chemotactic protein 1 (MCP-1) were significantly increased (p<0.05). In this study we show that both hwt and hS360A-(A)PC protect against acute myocardial I/R injury, which implies that protection from I/R injury is independent of the proteolytic activity of APC. However, in the chronic atherosclerosis model hwt and hS360-(A)PC had only minor effects. When the dose, species and mode of (A) PC administration will be adjusted, we believe that (A)PC will have potential to influence development of chronic inflammation as occurring during atherosclerosis as well.	[Wildhagen, Karin C. A. A.; Schrijver, Roy; ten Cate, Hugo; Reutelingsperger, Chris P. M.; Nicolaes, Gerry A. F.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Beckers, Linda; Lutgens, Esther] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [ten Cate, Hugo] Maastricht Univ, Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Haemostasis, Dept Internal Med, Maastricht, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	g.nicolaes@maastrichtuniversity.nl	Nicolaes, Gerry A.F./A-8421-2016; Cate, Hugo ten/AAM-4000-2021; Lutgens, Esther/E-2919-2010	Nicolaes, Gerry A.F./0000-0002-2482-0412; Lutgens, Esther/0000-0002-2609-5744	Netherlands Thrombosis Foundation [125/2008/OPI]; Cardiovascular Research Institute Maastricht	Netherlands Thrombosis Foundation; Cardiovascular Research Institute Maastricht	The authors would like to acknowledge the financial support by the Netherlands Thrombosis Foundation (project grant 125/2008/OPI, to HtC and GN) and grants from the Cardiovascular Research Institute Maastricht (to GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2008, J THROMB HAEMOST, V6, P954, DOI 10.1111/j.1538-7836.2008.02924.x; Bae JS, 2008, THROMB HAEMOSTASIS, V100, P101, DOI 10.1160/TH08-02-0127; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bae JS, 2009, THROMB HAEMOSTASIS, V101, P513, DOI 10.1160/TH08-09-0568; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Bock F, 2014, THROMB HAEMOSTASIS, V111, P610, DOI 10.1160/TH13-11-0967; BOISCLAIR MD, 1993, THROMB HAEMOSTASIS, V70, P253; Borissoff JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055784; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; Brueckner M, 2013, NEUROSCI LETT, V551, P28, DOI 10.1016/j.neulet.2013.06.055; Chen CM, 2006, CRIT CARE MED, V34, P1960, DOI 10.1097/01.CCM.0000224231.01533.B1; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Ding JW, 2010, J KOREAN MED SCI, V25, P1609, DOI 10.3346/jkms.2010.25.11.1609; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; FRIEDRICH U, 1994, THROMB HAEMOSTASIS, V72, P567; Gale AJ, 1997, PROTEIN SCI, V6, P132; Galley HF, 2008, BRIT J ANAESTH, V100, P815, DOI 10.1093/bja/aen079; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Guo H, 2009, J NEUROCHEM, V109, P116, DOI 10.1111/j.1471-4159.2009.05921.x; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hirose K, 2000, ANN SURG, V232, P272, DOI 10.1097/00000658-200008000-00018; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Iqbal K, 2002, AM J CARDIOL, V89, P334, DOI 10.1016/S0002-9149(01)02237-8; Jong WMC, 2003, COMPARATIVE MED, V53, P522; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Keidar S, 2001, ARTERIOSCL THROM VAS, V21, P1464, DOI 10.1161/hq0901.095547; Krisinger MJ, 2009, FEBS J, V276, P6586, DOI 10.1111/j.1742-4658.2009.07371.x; Lay WN, 2012, INT J CARDIOL, V159, P246, DOI 10.1016/j.ijcard.2012.05.087; Libby P, 2010, ARTERIOSCLER THROMB, V32, P2045; Lin XJ, 2009, SHOCK, V32, P524, DOI 10.1097/SHK.0b013e3181a1a75d; Loubele S, 2009, THESIS MAASTRICHT U, P91; Loubele STBG, 2009, ARTERIOSCL THROM VAS, V29, P1087, DOI 10.1161/ATVBAHA.109.188656; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Maehata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038738; MARLAR RA, 1989, J PEDIATR-US, V114, P528, DOI 10.1016/S0022-3476(89)80688-2; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Murakami K, 1996, BLOOD, V87, P642, DOI 10.1182/blood.V87.2.642.bloodjournal872642; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nicolaes GAF, 2003, HEMATOL ONCOL CLIN N, V17, P37, DOI 10.1016/S0889-8588(02)00097-7; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Nicolaes GAF, 2010, J BIOL CHEM, V285, P22888, DOI 10.1074/jbc.M110.131029; Park SW, 2009, KIDNEY INT, V76, P739, DOI 10.1038/ki.2009.255; Petaja J, 1999, J THORAC CARDIOV SUR, V118, P422, DOI 10.1016/S0022-5223(99)70178-9; Pirat B, 2007, CORONARY ARTERY DIS, V18, P61, DOI 10.1097/MCA.0b013e328010a44a; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Song L, 2004, ATHEROSCLEROSIS, V177, P43, DOI 10.1016/j.atherosclerosis.2004.06.018; Sopel MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045663; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Sun YH, 2003, BLOOD, V101, P2277, DOI 10.1182/blood-2002-06-1691; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Teschendorf P, 2008, RESUSCITATION, V79, P316, DOI 10.1016/j.resuscitation.2008.05.005; Teschendorf P, 2009, RESUSCITATION, V80, P940, DOI 10.1016/j.resuscitation.2009.04.029; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Van Lenten BJ, 2001, J BIOL CHEM, V276, P1923, DOI 10.1074/jbc.M004074200; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang J, 2011, J THROMB HAEMOST, V9, P1308, DOI 10.1111/j.1538-7836.2011.04331.x; Wang YM, 2013, BLOOD CELL MOL DIS, V51, P104, DOI 10.1016/j.bcmd.2013.02.009; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Yamaji K, 2005, THROMB RES, V115, P319, DOI 10.1016/j.thromres.2004.09.011; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2005, ANN NEUROL, V58, P474, DOI 10.1002/ana.20602	74	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e101446	10.1371/journal.pone.0101446	http://dx.doi.org/10.1371/journal.pone.0101446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032959	gold, Green Published, Green Submitted			2022-12-27	WOS:000339418300017
J	Zhao, J; Ozawa, K; Kyotani, Y; Nagayama, K; Ito, S; Komatsubara, AT; Tsuji, Y; Yoshizumi, M				Zhao, Jing; Ozawa, Kentaro; Kyotani, Yoji; Nagayama, Kosuke; Ito, Satoyasu; Komatsubara, Akira T.; Tsuji, Yuichi; Yoshizumi, Masanori			Azelnidipine Inhibits Cultured Rat Aortic Smooth Muscle Cell Death Induced by Cyclic Mechanical Stretch	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; ANGIOTENSIN-II; CHANNEL BLOCKER; CALCIUM BLOCKER; P38; JNK; ATHEROSCLEROSIS; AMLODIPINE; PATHWAYS	Acute aortic dissection is the most common life-threatening vascular disease, with sudden onset of severe pain and a high fatality rate. Clarifying the detailed mechanism for aortic dissection is of great significance for establishing effective pharmacotherapy for this high mortality disease. In the present study, we evaluated the influence of biomechanical stretch, which mimics an acute rise in blood pressure using an experimental apparatus of stretching loads in vitro, on rat aortic smooth muscle cell (RASMC) death. Then, we examined the effects of azelnidipine and mitogen-activated protein kinase inhibitors on mechanical stretch-induced RASMC death. The major findings of the present study are as follows: (1) cyclic mechanical stretch on RASMC caused cell death in a time-dependent manner up to 4 h; (2) cyclic mechanical stretch on RASMC induced c-Jun N-terminal kinase (JNK) and p38 activation with peaks at 10 min; (3) azelnidipine inhibited RASMC death in a concentration-dependent manner as well as inhibited JNK and p38 activation by mechanical stretch; and (4) SP600125 (a JNK inhibitor) and SB203580 (a p38 inhibitor) protected against stretch-induced RASMC death; (5) Antioxidants, diphenylene iodonium and tempol failed to inhibit stretch-induced RASMC death. On the basis of the above findings, we propose a possible mechanism where an acute rise in blood pressure increases biomechanical stress on the arterial walls, which induces RASMC death, and thus, may lead to aortic dissection. Azelnidipine may be used as a pharmacotherapeutic agent for prevention of aortic dissection independent of its blood pressure lowering effect.	[Zhao, Jing; Ozawa, Kentaro; Kyotani, Yoji; Nagayama, Kosuke; Ito, Satoyasu; Komatsubara, Akira T.; Tsuji, Yuichi; Yoshizumi, Masanori] Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan	Nara Medical University	Yoshizumi, M (corresponding author), Nara Med Univ, Dept Pharmacol, Sch Med, Kashihara, Nara 634, Japan.	yoshizu@naramed-u.ac.jp	Kyotani, Yoji/AAR-3830-2020	Kyotani, Yoji/0000-0002-7771-6889	JSPS KAKENHI [23590306, 26460345]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by JSPS KAKENHI Grants, number 23590306 and 26460345, to MY. (http://www.e-rad.go.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chahine MN, 2012, CAN J PHYSIOL PHARM, V90, P1559, DOI 10.1139/y2012-141; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Collins MJ, 2007, CLIN PATHOL, V61, P519; Cornelissen J, 2004, ARTERIOSCL THROM VAS, V24, P451, DOI 10.1161/01.ATV.0000116690.17017.8b; Costopouzos C, 2008, BIOCHEM PHARMACOL, V75, P1251, DOI 10.1016/j.bcp.2007.10.006; Eguchi K, 2007, J CARDIOVASC PHARM, V49, P394, DOI 10.1097/FJC.0b013e31804d1cf1; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Fujimoto S, 2009, NEPHROL DIAL TRANSPL, V24, P3651, DOI 10.1093/ndt/gfp407; GUILMET D, 1993, J CARDIOVASC SURG, V34, P23; Hamada K, 1998, J BIOL CHEM, V273, P6334, DOI 10.1074/jbc.273.11.6334; Hipper A, 2000, PFLUG ARCH EUR J PHY, V440, P19, DOI 10.1007/s004240000246; Huh JE, 2004, BIOCHEM PHARMACOL, V67, P1811, DOI 10.1016/j.bcp.2003.12.025; Iryo Y, 2000, BIOCHEM PHARMACOL, V60, P1875, DOI 10.1016/S0006-2952(00)00510-4; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kondo N, 2006, J PHARMACOL EXP THER, V316, P1047, DOI 10.1124/jpet.105.095331; Kurobe H, 2013, J THORAC CARDIOV SUR, V146, P1501, DOI 10.1016/j.jtcvs.2013.02.073; Kyaw M, 2001, HYPERTENS RES, V24, P251, DOI 10.1291/hypres.24.251; Nakayama H, 2009, CLIN EXP PHARMACOL P, V36, P1183, DOI 10.1111/j.1440-1681.2009.05224.x; Ohyama T, 2012, BRIT J PHARMACOL, V165, P1173, DOI 10.1111/j.1476-5381.2011.01599.x; OIZUMI K, 1990, JPN J PHARMACOL, V54, P1, DOI 10.1254/jjp.54.1; OIZUMI K, 1989, JPN J PHARMACOL, V51, P57, DOI 10.1254/jjp.51.57; Satoh K, 1998, JPN J PHARMACOL, V76, P369, DOI 10.1254/jjp.76.369; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Su BY, 2006, J VASC RES, V43, P229, DOI 10.1159/000091102; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Yoshimura K, 2006, ANN NY ACAD SCI, V1085, P74, DOI 10.1196/annals.1383.031; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Zhao XL, 2010, CLIN EXP HYPERTENS, V32, P372, DOI 10.3109/10641961003628510	29	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e102813	10.1371/journal.pone.0102813	http://dx.doi.org/10.1371/journal.pone.0102813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8VR	25032824	Green Submitted, gold, Green Published			2022-12-27	WOS:000339418300096
J	Shinko, A; Agari, T; Kameda, M; Yasuhara, T; Kondo, A; Tayra, JT; Sato, K; Sasaki, T; Sasada, S; Takeuchi, H; Wakamori, T; Borlongan, CV; Date, I				Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Borlongan, Cesario V.; Date, Isao			Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; SUBTHALAMIC NUCLEUS STIMULATION; DORSAL COLUMN STIMULATION; ELECTRICAL-STIMULATION; SUBARACHNOID HEMORRHAGE; DOPAMINERGIC-NEURONS; RAT MODEL; IN-VITRO; PAIN	In clinical practice, deep brain stimulation (DBS) is effective for treatment of motor symptoms in Parkinson's disease (PD). However, the mechanisms have not been understood completely. There are some reports that electrical stimulation exerts neuroprotective effects on the central nervous system diseases including cerebral ischemia, head trauma, epilepsy and PD, although there are a few reports on neuroprotective effects of spinal cord stimulation (SCS). We investigated the neuroprotective effects of high cervical SCS on PD model of rats. Adult female Sprague-Dawley rats received hour-long SCS (2, 50 or 200 Hz) with an epidural electrode at C1-2 level for 16 consecutive days. At 2 days after initial SCS, 6-hydroxydopamine (6-OHDA) was injected into the right striatum of rats. Behavioral evaluations of PD symptoms were employed, including cylinder test and amphetamine-induced rotation test performed at 1 and 2 weeks after 6-OHDA injection. Animals were subsequently euthanized for immunohistochemical investigations. In order to explore neurotrophic and growth factor upregulation induced by SCS, another cohort of rats that received 50 Hz SCS was euthanized at 1 and 2 weeks after lesion for protein assays. Behavioral tests revealed that the number of amphetamine-induced rotations decreased in SCS groups. Immunohistochemically, tyrosine hydroxylase (TH)-positive fibers in the striatum were significantly preserved in SCS groups. TH-positive neurons in the substantia nigra pars compacta were significantly preserved in 50 Hz SCS group. The level of vascular endothelial growth factor (VEGF) was upregulated by SCS at 1 week after the lesion. These results suggest that high cervical SCS exerts neuroprotection in PD model of rats, at least partially by upregulation of VEGF. SCS is supposed to suppress or delay PD progression and might become a less invasive option for PD patients, although further preclinical and clinical investigations are needed to confirm the effectiveness and safety.	[Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Date, Isao] Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan; [Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA	Okayama University; State University System of Florida; University of South Florida	Agari, T (corresponding author), Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan.	agarit@cc.okayama-u.ac.jp	Yasuhara, Takao/AEU-1075-2022; Borlongan, Cesar/I-5696-2012; Kondo, Akihiko/A-2130-2015; Sheshukova, Ekaterina/O-1365-2013	Borlongan, Cesar/0000-0002-2966-9782; Shindyapina, Anastasia/0000-0002-7336-3086; Sheshukova, Ekaterina/0000-0002-0934-3902				Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; CHANDLER MJ, 1993, EUR HEART J, V14, P96, DOI 10.1093/eurheartj/14.1.96; Cui JG, 1996, PAIN, V66, P287, DOI 10.1016/0304-3959(96)03069-2; Cui JG, 1997, PAIN, V73, P87, DOI 10.1016/S0304-3959(97)00077-8; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; EDVINSSON L, 1989, J CEREBR BLOOD F MET, V9, P212, DOI 10.1038/jcbfm.1989.31; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Goksel HM, 2001, ACTA NEUROCHIR, V143, P383, DOI 10.1007/s007010170094; Gurelik M, 2005, NEUROSCIENCE, V134, P827, DOI 10.1016/j.neuroscience.2005.04.062; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; HOSOBUCHI Y, 1991, PACE, V14, P122, DOI 10.1111/j.1540-8159.1991.tb04056.x; HOSOBUCHI Y, 1985, APPL NEUROPHYSIOL, V48, P372, DOI 10.1159/000101161; Isono M, 1995, STEREOT FUNCT NEUROS, V64, P40, DOI 10.1159/000098732; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Lee JY, 2008, J NEUROSURG, V109, P1148, DOI 10.3171/JNS.2008.109.12.1148; LEVIN BE, 1980, NEUROLOGY, V30, P65, DOI 10.1212/WNL.30.1.65; LINDEROTH B, 1995, NEUROSURGERY, V37, P266, DOI 10.1227/00006123-199508000-00011; LINDEROTH B, 1992, NEUROSURGERY, V31, P289, DOI 10.1227/00006123-199208000-00014; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Maher J, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01237.x; Maher J, 2009, NEUROGASTROENT MOTIL, V21, pe633; MEGLIO M, 1991, PACE, V14, P127, DOI 10.1111/j.1540-8159.1991.tb04057.x; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Patel S, 2004, NEUROSURGERY, V55, P201, DOI 10.1227/01.NEU.0000126949.28912.71; Patel S, 2003, J NEUROSURG, V99, P754, DOI 10.3171/jns.2003.99.4.0754; Paxions G, 1998, RAT BRAIN STEREOTAXI; Pitzer MR, 2003, EXP NEUROL, V182, P435, DOI 10.1016/S0014-4886(03)00100-6; Rajput AH, 2004, PARKINSONISM RELAT D, V10, P221, DOI 10.1016/j.parkreldis.2004.01.004; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sagher O, 2003, J NEUROSURG, V99, P131, DOI 10.3171/jns.2003.99.1.0131; Sagher Oren, 2006, Neurosurg Focus, V21, pE2; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schechtmann G, 2008, PAIN, V139, P136, DOI 10.1016/j.pain.2008.03.023; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Song ZY, 2008, NEUROSCI LETT, V436, P7, DOI 10.1016/j.neulet.2008.02.044; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Stiller CO, 1996, NEUROSURGERY, V39, P367, DOI 10.1097/00006123-199608000-00026; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; Thevathasan W, 2010, NEUROLOGY, V74, P1325, DOI 10.1212/WNL.0b013e3181d9ed58; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P262, DOI 10.1159/000066729; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P269, DOI 10.1159/000066730; Visocchi M, 2001, ACTA NEUROCHIR, V143, P177; Yadav AP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03839; Yakhnitsa V, 1999, PAIN, V79, P223, DOI 10.1016/S0304-3959(98)00169-9; Yang X, 2008, NEUROSCIENCE, V152, P950, DOI 10.1016/j.neuroscience.2008.01.009; Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhong J, 2004, ACTA NEUROCHIR, V146, P1227, DOI 10.1007/s00701-004-0364-7	55	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101468	10.1371/journal.pone.0101468	http://dx.doi.org/10.1371/journal.pone.0101468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009993	Green Submitted, Green Published, gold			2022-12-27	WOS:000338763800025
J	Ward, ME; McMahon, G; St Pourcain, B; Evans, DM; Rietveld, CA; Benjamin, DJ; Koellinger, PD; Cesarini, D; Smith, GD; Timpson, NJ				Ward, Mary E.; McMahon, George; St Pourcain, Beate; Evans, David M.; Rietveld, Cornelius A.; Benjamin, Daniel J.; Koellinger, Philipp D.; Cesarini, David; Smith, George Davey; Timpson, Nicholas J.		Social Sci Genetic Assoc Consortiu	Genetic Variation Associated with Differential Educational Attainment in Adults Has Anticipated Associations with School Performance in Children	PLOS ONE			English	Article							HERITABILITY	Genome-wide association study results have yielded evidence for the association of common genetic variants with crude measures of completed educational attainment in adults. Whilst informative, these results do not inform as to the mechanism of these effects or their presence at earlier ages and where educational performance is more routinely and more precisely assessed. Single nucleotide polymorphisms exhibiting genome-wide significant associations with adult educational attainment were combined to derive an unweighted allele score in 5,979 and 6,145 young participants from the Avon Longitudinal Study of Parents and Children with key stage 3 national curriculum test results (SATS results) available at age 13 to 14 years in English and mathematics respectively. Standardised (z-scored) results for English and mathematics showed an expected relationship with sex, with girls exhibiting an advantage over boys in English (0.433 SD (95%CI 0.395, 0.470), p<10(-10)) with more similar results (though in the opposite direction) in mathematics (0.042 SD (95%CI 0.004, 0.080), p = 0.030). Each additional adult educational attainment increasing allele was associated with 0.041 SD (95%CI 0.020, 0.063), p = 1.79 x 10(-04) and 0.028 SD (95%CI 0.007, 0.050), p = 0.01 increases in standardised SATS score for English and mathematics respectively. Educational attainment is a complex multifactorial behavioural trait which has not had heritable contributions to it fully characterised. We were able to apply the results from a large study of adult educational attainment to a study of child exam performance marking events in the process of learning rather than realised adult end product. Our results support evidence for common, small genetic contributions to educational attainment, but also emphasise the likely lifecourse nature of this genetic effect. Results here also, by an alternative route, suggest that existing methods for child examination are able to recognise early life variation likely to be related to ultimate educational attainment.	[Ward, Mary E.; McMahon, George; St Pourcain, Beate; Evans, David M.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Rietveld, Cornelius A.; Koellinger, Philipp D.] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [Rietveld, Cornelius A.; Koellinger, Philipp D.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Benjamin, Daniel J.] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Koellinger, Philipp D.] Univ Amsterdam, Amsterdam Business Sch, Amsterdam, Netherlands; [Cesarini, David] NYU, Dept Econ, Ctr Expt Social Sci, New York, NY 10003 USA; [Cesarini, David] New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates; [Cesarini, David] Res Inst Ind Econ, Stockholm, Sweden	University of Bristol; University of Bristol; University of Bristol; University of Queensland; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Cornell University; University of Amsterdam; New York University; Research Institute of Industrial Economics (IFN)	Timpson, NJ (corresponding author), Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol, Avon, England.	n.j.timpson@bris.ac.uk	Evans, David M/H-6325-2013; Fox, Laura J/C-6249-2016; Davey Smith, George/A-7407-2013; Attrill, Lauren/V-1688-2018; St Pourcain, Beate/K-8004-2017; Timpson, Nicholas John/O-7548-2015	Evans, David M/0000-0003-0663-4621; Davey Smith, George/0000-0002-1407-8314; St Pourcain, Beate/0000-0002-4680-3517; Timpson, Nicholas John/0000-0002-7141-9189; Koellinger, Philipp/0000-0001-7413-0412; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Cesarini, David/0000-0002-0043-009X; Munafo, Marcus/0000-0002-4049-993X; s, hema/0000-0002-3440-9475	Wellcome Trust PhD studentship award [099873/Z/12/Z]; Wellcome Trust [092731]; MRC [MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/3] Funding Source: UKRI; Medical Research Council [MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/3, MC_PC_15018] Funding Source: researchfish	Wellcome Trust PhD studentship award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MEW is funded through a Wellcome Trust PhD studentship award (grant ref. 099873/Z/12/Z) (http://www.wellcome.ac.uk/). NJT, DME and GDS work in the UK Medical Research Council and University of Bristol Integrative Epidemiology Unit. The UK Medical Research Council (http://www.mrc.ac.uk/) and the Wellcome Trust (grant ref: 092731) and the University of Bristol (http://www.bristol.ac.uk/) provide core support for ALSPAC. The authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Branigan AR, 2013, SOC FORCES, V92, P109, DOI 10.1093/sf/sot076; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson W, 2011, AM J EPIDEMIOL, V173, P55, DOI 10.1093/aje/kwq333; Levacic R, 2005, RR679 DFES DEP ED SK; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Miller P, 2001, ECON EDUC REV, V20, P211, DOI 10.1016/S0272-7757(00)00018-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Shakeshaft NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080341; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; TAUBMAN P, 1976, AM ECON REV, V66, P858; UNESCO, 2006, INT STAND CLASS ED; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	25	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100248	10.1371/journal.pone.0100248	http://dx.doi.org/10.1371/journal.pone.0100248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25032841	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300008
J	Zhang, BB; Shimada, Y; Kuroyanagi, J; Umemoto, N; Nishimura, Y; Tanaka, T				Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio			Quantitative wPhenotyping-Based In Vivo Chemical Screening in a Zebrafish Model of Leukemia Stem Cell Xenotransplantation	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KAPPA-B PATHWAY; APOPTOSIS; MECHANISMS; QUIESCENT; CML; PROLIFERATION; XENOGRAFTS; DISCOVERY; IMATINIB	Zebrafish-based chemical screening has recently emerged as a rapid and efficient method to identify important compounds that modulate specific biological processes and to test the therapeutic efficacy in disease models, including cancer. In leukemia, the ablation of leukemia stem cells (LSCs) is necessary to permanently eradicate the leukemia cell population. However, because of the very small number of LSCs in leukemia cell populations, their use in xenotransplantation studies (in vivo) and the difficulties in functionally and pathophysiologically replicating clinical conditions in cell culture experiments (in vitro), the progress of drug discovery for LSC inhibitors has been painfully slow. In this study, we developed a novel phenotype-based in vivo screening method using LSCs xenotransplanted into zebrafish. Aldehyde dehydrogenase-positive (ALDH+) cells were purified from chronic myelogenous leukemia K562 cells tagged with a fluorescent protein (Kusabira-orange) and then implanted in young zebrafish at 48 hours post-fertilization. Twenty-four hours after transplantation, the animals were treated with one of eight different therapeutic agents (imatinib, dasatinib, parthenolide, TDZD-8, arsenic trioxide, niclosamide, salinomycin, and thioridazine). Cancer cell proliferation, and cell migration were determined by high-content imaging. Of the eight compounds that were tested, all except imatinib and dasatinib selectively inhibited ALDH+ cell proliferation in zebrafish. In addition, these anti-LSC agents suppressed tumor cell migration in LSC-xenotransplants. Our approach offers a simple, rapid, and reliable in vivo screening system that facilitates the phenotype-driven discovery of drugs effective in suppressing LSCs.	[Zhang, Beibei; Shimada, Yasuhito; Kuroyanagi, Junya; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Med Zebrafish Res Ctr, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Life Sci Res Ctr, Dept Bioinformat, Tsu, Mie 514, Japan; [Shimada, Yasuhito; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ Ind Technol Innovat, Dept Om Med, Tsu, Mie, Japan; [Shimada, Yasuhito; Umemoto, Noriko; Nishimura, Yuhei; Tanaka, Toshio] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie 514, Japan	Mie University; Mie University; Mie University; Mie University	Tanaka, T (corresponding author), Mie Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol Pharmacogen & Pharm, Tsu, Mie 514, Japan.	tanaka@doc.medic.mie-u.ac.jp	Shimada, Yasuhito/H-2916-2019	Shimada, Yasuhito/0000-0002-4111-8262; Zhang, Bin/0000-0002-7347-0367; Ichino, Noriko/0000-0002-7009-8299; Nishimura, Yuhei/0000-0003-1901-8799	Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the Japan Science and Technology Agency, KAKENHI of Grants-in-Aid for Scientific Research, and the New Energy and Industrial Technology Development Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2010, J EXP MED, V207, P677, DOI 10.1084/jem.20100523; Angstreich GR, 2005, BRIT J HAEMATOL, V130, P373, DOI 10.1111/j.1365-2141.2005.05606.x; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Delvecchio C, 2011, ASSAY DRUG DEV TECHN, V9, P354, DOI 10.1089/adt.2010.0346; Fleischman AG, 2012, BLOOD, V119, P3376, DOI 10.1182/blood-2012-02-406751; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Gerber JM, 2011, AM J HEMATOL, V86, P31, DOI 10.1002/ajh.21915; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Koyama-Nasu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053710; Liu L, 2011, MED ONCOL, V28, P835, DOI 10.1007/s12032-010-9529-9; Liu ZB, 2012, BIOCHEM BIOPH RES CO, V427, P223, DOI 10.1016/j.bbrc.2012.09.064; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Miller WH, 2002, CANCER RES, V62, P3893; Moreb JS, 2012, CHEM-BIOL INTERACT, V195, P52, DOI 10.1016/j.cbi.2011.10.007; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nakamura S, 2012, INT J CANCER, V130, P1046, DOI 10.1002/ijc.26065; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Peal DS, 2010, J CARDIOVASC TRANSL, V3, P454, DOI 10.1007/s12265-010-9212-8; Pei SS, 2012, BEST PRACT RES CL HA, V25, P415, DOI 10.1016/j.beha.2012.10.003; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Rice KN, 2010, INT J HEMATOL, V91, P748, DOI 10.1007/s12185-010-0615-8; Rodrigues T, 2002, BRIT J PHARMACOL, V136, P136, DOI 10.1038/sj.bjp.0704672; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Smithen DA, 2013, ORG BIOMOL CHEM, V11, P62, DOI 10.1039/c2ob26535d; Snaar-Jagalska BE, 2009, ZEBRAFISH, V6, P441, DOI 10.1089/zeb.2009.0614; Stuart SA, 2009, CELL CYCLE, V8, P1338, DOI 10.4161/cc.8.9.8209; Szabo AZ, 2013, STEM CELLS, V31, P786, DOI 10.1002/stem.1329; Takeuchi Y, 2004, J NEUROCHEM, V88, P41, DOI 10.1046/j.1471-4159.2003.02129.x; Thomas Xavier, 2012, World J Stem Cells, V4, P44; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang IH, 2008, IEEE ENG MED BIO, P1837, DOI 10.1109/IEMBS.2008.4649537; Yong ASM, 2008, LEUKEMIA, V22, P1721, DOI 10.1038/leu.2008.161; Yuan Lin-Bo, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P191; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zhen XC, 2001, MOL PHARMACOL, V60, P857; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	54	71	73	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85439	10.1371/journal.pone.0085439	http://dx.doi.org/10.1371/journal.pone.0085439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	25036550	gold, Green Submitted, Green Published			2022-12-27	WOS:000330235100085
J	Zhang, SB; Sun, M; Cao, KF; Hu, H; Zhang, JL				Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang; Hu, Hong; Zhang, Jiao-Lin			Leaf Photosynthetic Rate of Tropical Ferns Is Evolutionarily Linked to Water Transport Capacity	PLOS ONE			English	Article							GENOME SIZE; HYDRAULIC CAPACITY; STOMATAL DENSITY; CELL-SIZE; VENATION; DIVERSIFICATION; XYLEM; ARCHITECTURE; CONDUCTANCE; SPOROPHYTES	Ferns usually have relatively lower photosynthetic potential than angiosperms. However, it is unclear whether low photosynthetic potential of ferns is linked to leaf water supply. We hypothesized that there is an evolutionary association of leaf water transport capacity with photosynthesis and stomatal density in ferns. In the present study, a series of functional traits relating to leaf anatomy, hydraulics and physiology were assessed in 19 terrestrial and 11 epiphytic ferns in a common garden, and analyzed by a comparative phylogenetics method. Compared with epiphytic ferns, terrestrial ferns had higher vein density (D-vein), stomatal density (SD), stomatal conductance (g(s)), and photosynthetic capacity (A(max)), but lower values for lower epidermal thickness (LET) and leaf thickness (LT). Across species, all traits varied significantly, but only stomatal length (SL) showed strong phylogenetic conservatism. A(max) was positively correlated with D-vein and g(s) with and without phylogenetic corrections. SD correlated positively with A(max), D-vein and g(s), with the correlation between SD and Dvein being significant after phylogenetic correction. Leaf water content showed significant correlations with LET, LT, and mesophyll thickness. Our results provide evidence that A(max) of the studied ferns is linked to leaf water transport capacity, and there was an evolutionary association between water supply and demand in ferns. These findings add new insights into the evolutionary correlations among traits involving carbon and water economy in ferns.	[Zhang, Shi-Bao; Hu, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Kunming, Yunnan, Peoples R China; [Zhang, Shi-Bao; Sun, Mei; Cao, Kun-Fang; Zhang, Jiao-Lin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Sun, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JL (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	zjl@xtbg.org.cn	Cao, Kun-Fang/D-2157-2009	Cao, Kun-Fang/0000-0002-2253-7189; Xia, Ningshao/0000-0003-0179-5266; Ge, Shengxiang/0000-0002-7165-3004	National Natural Science Foundation of China [31170315, 30900174, 31270453, 31370362]; West Light Foundation of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work is financially supported by the National Natural Science Foundation of China (31170315, 30900174, 31270453, 31370362) and the West Light Foundation of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasamaa K, 2001, AUST J PLANT PHYSIOL, V28, P765, DOI 10.1071/PP00157; Ackerly DD, 1998, AM NAT, V152, P767, DOI 10.1086/286208; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brodersen CR, 2012, PLANT CELL ENVIRON, V35, P1898, DOI 10.1111/j.1365-3040.2012.02524.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2013, NEW PHYTOL, V199, P559, DOI 10.1111/nph.12300; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Brodribb TJ, 2005, NEW PHYTOL, V165, P839, DOI 10.1111/j.1469-8137.2004.01259.x; Brodribb TJ, 2004, NEW PHYTOL, V162, P663, DOI 10.1111/j.1469-8137.2004.01060.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Carlquist S, 2001, AM J BOT, V88, P1, DOI 10.2307/2657121; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Feild TS, 2013, NEW PHYTOL, V199, P720, DOI 10.1111/nph.12311; Feild TS, 2011, P NATL ACAD SCI USA, V108, P8363, DOI 10.1073/pnas.1014456108; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2012, PHILOS T R SOC B, V367, P537, DOI 10.1098/rstb.2011.0270; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hietz P, 1998, OECOLOGIA, V114, P305, DOI 10.1007/s004420050452; HIETZ P., 2010, FERN ECOLOGY, P140, DOI DOI 10.1017/CB09780511844898; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; Laube S, 2003, FUNCT ECOL, V17, P598, DOI 10.1046/j.1365-2435.2003.00760.x; Lo Gullo MA, 2010, FUNCT PLANT BIOL, V37, P566, DOI 10.1071/FP09303; Lomax BH, 2009, NEW PHYTOL, V181, P311, DOI 10.1111/j.1469-8137.2008.02700.x; McAdam SAM, 2013, NEW PHYTOL, V198, P429, DOI 10.1111/nph.12190; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; McElwain JC, 2011, NEW PHYTOL, V192, P307, DOI 10.1111/j.1469-8137.2011.03865.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Ogburn RM, 2012, PLANT CELL ENVIRON, V35, P1533, DOI 10.1111/j.1365-3040.2012.02503.x; Page CN, 2002, REV PALAEOBOT PALYNO, V119, P1, DOI 10.1016/S0034-6667(01)00127-0; Pittermann J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00285; Pittermann J, 2011, NEW PHYTOL, V192, P449, DOI 10.1111/j.1469-8137.2011.03817.x; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Schneider H, 2004, MOL PHYLOGENET EVOL, V31, P1041, DOI 10.1016/j.ympev.2003.09.018; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Torre S, 2003, J AM SOC HORTIC SCI, V128, P598, DOI 10.21273/JASHS.128.4.0598; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Wang J-H, 2012, PHYSIOL PLANTARUM, V147, P283; Watkins JE, 2012, INT J PLANT SCI, V173, P695, DOI 10.1086/665974; Watkins JE, 2010, AM J BOT, V97, P2007, DOI 10.3732/ajb.1000124; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080	55	35	41	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e84682	10.1371/journal.pone.0084682	http://dx.doi.org/10.1371/journal.pone.0084682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	25029500	Green Published, gold, Green Submitted			2022-12-27	WOS:000329866300036
J	Wu, CH; Chen, LS; Yen, MF; Chiu, YH; Fann, CY; Chen, HH; Pan, SL				Wu, Chueh-Hung; Chen, Li-Sheng; Yen, Ming-Fang; Chiu, Yueh-Hsia; Fann, Ching-Yuan; Chen, Hsiu-Hsi; Pan, Shin-Liang			Does Non-Central Nervous System Tuberculosis Increase the Risk of Ischemic Stroke? A Population-Based Propensity Score-Matched Follow-Up Study	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; CHRONIC INFECTIONS; CIGARETTE-SMOKING; HEALTH-INSURANCE; PREVALENCE; TAIWAN; SEX; AGE	Background: Previous studies on the association between tuberculosis and the risk of developing ischemic stroke have generated inconsistent results. We therefore performed a population-based, propensity score-matched longitudinal follow-up study to investigate whether contracting non-central nervous system (CNS) tuberculosis leads to an increased risk of ischemic stroke. Methods: We used a logistic regression model that includes age, sex, pre-existing comorbidities and socioeconomic status as covariates to compute the propensity score. A total of 5804 persons with at least three ambulatory visits in 2001 with the principal diagnosis of non-CNS tuberculosis were enrolled in the tuberculosis group. The non-tuberculosis group consisted of 5804, propensity score-matched subjects without tuberculosis. The three-year ischemic stroke-free survival rates for these 2 groups were estimated using the Kaplan-Meier method. The stratified Cox proportional hazards regression was used to estimate the effect of tuberculosis on the occurrence of ischemic stroke. Results: During three-year follow-up, 176 subjects in the tuberculosis group (3.0%) and 207 in the non-tuberculosis group (3.6%) had ischemic stroke. The hazard ratio for developing ischemic stroke in the tuberculosis group was 0.92 compared to the non-tuberculosis group (95% confidence interval: 0.73-1.14, P = 0.4299). Conclusions: Non-CNS tuberculosis does not increase the risk of subsequent ischemic stroke.	[Wu, Chueh-Hung; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wu, Chueh-Hung; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Li-Sheng; Yen, Ming-Fang] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Taoyuan, Taiwan; [Fann, Ching-Yuan] Kainan Univ, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Ctr Biostat Consultat, Taipei 10764, Taiwan; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Div Biostat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Chang Gung University; Nan Kai University Technology; National Taiwan University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		Chen, Hsiu-Hsi/0000-0002-5799-6705; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; PAN, SHIN-LIANG/0000-0001-6451-4666; WU, CHUEH-HUNG/0000-0002-3979-3541	Department of Health, Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health, Executive Yuan, Republic of China	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health, Executive Yuan, Republic of China. This study used the complete National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health. The interpretation and conclusions contained in this study do not necessarily represent those of the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Asplund K, 2009, STROKE, V40, P2319, DOI 10.1161/STROKEAHA.109.547869; Byberg S, 2012, EUR RESPIR J, V40, P1289, DOI 10.1183/09031936.00039612; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAVIS PH, 1987, ANN NEUROL, V22, P319, DOI 10.1002/ana.410220307; De Silva DA, 2009, J NEUROL SCI, V285, P118, DOI 10.1016/j.jns.2009.06.013; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Elkind MSV, 2006, STROKE, V37, P790, DOI 10.1161/01.STR.0000202624.89869.e9; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Espinola-Klein C, 2002, STROKE, V33, P2581, DOI 10.1161/01.STR.0000034789.82859.A4; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Giral P, 2007, ATHEROSCLEROSIS, V190, P150, DOI 10.1016/j.atherosclerosis.2006.01.008; Hagiwara Noriko, 2007, J Stroke Cerebrovasc Dis, V16, P145, DOI 10.1016/j.jstrokecerebrovasdis.2007.02.001; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068314; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 2002, STROKE, V33, P2170, DOI 10.1161/01.STR.0000027209.59821.98; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Mori T, 2010, INFECT DIS CLIN N AM, V24, P751, DOI 10.1016/j.idc.2010.04.011; Parsons L.S., 2004, PERFORMING 1 N CASE; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; WHO, 2009, GLOB TUB CONTR EP ST, P6; WOLF PA, 1985, STROKE, V16, P359, DOI 10.1161/01.STR.16.3.359; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	38	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2014	9	7							e98158	10.1371/journal.pone.0098158	http://dx.doi.org/10.1371/journal.pone.0098158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0SW	25133789	Green Published, Green Submitted, gold			2022-12-27	WOS:000339558100001
J	Harvey, AE; Lashinger, LM; Hays, D; Harrison, LM; Lewis, K; Fischer, SM; Hursting, SD				Harvey, Alison E.; Lashinger, Laura M.; Hays, Drew; Harrison, Lauren M.; Lewis, Kimberly; Fischer, Susan M.; Hursting, Stephen D.			Calorie Restriction Decreases Murine and Human Pancreatic Tumor Cell Growth, Nuclear Factor-kB Activation, and Inflammation-Related Gene Expression in an Insulin-like Growth Factor-1-Dependent Manner	PLOS ONE			English	Article							FACTOR-KAPPA-B; ENERGY-BALANCE; FACTOR-I; DIETARY MODULATION; CANCER; OBESITY; CARCINOGENESIS; PROGRESSION; SERUM; INDUCTION	Calorie restriction (CR) prevents obesity and has potent anticancer effects that may be mediated through its ability to reduce serum growth and inflammatory factors, particularly insulin-like growth factor (IGF)-1 and protumorigenic cytokines. IGF-1 is a nutrient-responsive growth factor that activates the inflammatory regulator nuclear factor (NF)-kB, which is linked to many types of cancers, including pancreatic cancer. We hypothesized that CR would inhibit pancreatic tumor growth through modulation of IGF-1-stimulated NF-kB activation and protumorigenic gene expression. To test this, 30 male C57BL/ 6 mice were randomized to either a control diet consumed ad libitum or a 30% CR diet administered in daily aliquots for 21 weeks, then were subcutaneously injected with syngeneic mouse pancreatic cancer cells (Panc02) and tumor growth was monitored for 5 weeks. Relative to controls, CR mice weighed less and had decreased serum IGF-1 levels and smaller tumors. Also, CR tumors demonstrated a 70% decrease in the expression of genes encoding the pro-inflammatory factors S100a9 and F4/80, and a 56% decrease in the macrophage chemoattractant, Ccl2. Similar CR effects on tumor growth and NF-kB-related gene expression were observed in a separate study of transplanted MiaPaCa-2 human pancreatic tumor cell growth in nude mice. In vitro analyses in Panc02 cells showed that IGF-1 treatment promoted NF-kB nuclear localization, increased DNA-binding of p65 and transcriptional activation, and increased expression of NF-kB downstream genes. Finally, the IGF-1-induced increase in expression of genes downstream of NF-kB (Ccdn1, Vegf, Birc5, and Ptgs2) was decreased significantly in the context of silenced p65. These findings suggest that the inhibitory effects of CR on Panc02 pancreatic tumor growth are associated with reduced IGF-1-dependent NF-kB activation.	[Harvey, Alison E.; Lashinger, Laura M.; Hays, Drew; Harrison, Lauren M.; Lewis, Kimberly; Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Fischer, Susan M.; Hursting, Stephen D.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Hursting, SD (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.	shursting@austin.utexas.edu		Callan, Mitchell/0000-0002-6737-8281; Lewis, Kimberly/0000-0002-2590-8627	National Institutes of Health (NIH) [R01 CA135386]; NIH-sponsored postdoctoral fellowship [R25T CA57730, T32 CA135386]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA135386, R25CA057730] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-sponsored postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health (NIH) grant, R01 CA135386, awarded to S. D. Hursting and S. M. Fischer and NIH-sponsored postdoctoral fellowship grants, R25T CA57730 and T32 CA135386, awarded to L. M. Lashinger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2010, WORLD J GASTROENTERO, V16, P5779, DOI 10.3748/wjg.v16.i46.5779; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Bhattacharya A, 2006, BIOCHEM BIOPH RES CO, V349, P925, DOI 10.1016/j.bbrc.2006.08.093; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; CORBETT TH, 1984, CANCER RES, V44, P717; CRAVENGILES T, 1994, CANCER RES, V54, pS1964; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Ford NA, 2013, ENDOCR-RELAT CANCER, V20, P39, DOI 10.1530/ERC-12-0329; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harvey AE, 2012, MOL CARCINOGENESIS; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hursting SD, 2012, ANN NY ACAD SCI, V1271, P82, DOI 10.1111/j.1749-6632.2012.06737.x; Hursting SD, 2010, J CLIN ONCOL, V28, P4058, DOI 10.1200/JCO.2010.27.9935; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; Karna E, 2002, INT J EXP PATHOL, V83, P239, DOI 10.1046/j.1365-2613.2002.00237.x; Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6; Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0; Kokawa A, 2001, CANCER, V91, P333, DOI 10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N; Lashinger LM, 2014, J NUTR, V144, P109, DOI 10.3945/jn.113.178533; Lashinger LM, 2013, CANCER PREV RES, V6, P1046, DOI 10.1158/1940-6207.CAPR-13-0185; Lashinger LM, 2011, CANCER PREV RES, V4, P1041, DOI 10.1158/1940-6207.CAPR-11-0023; Lashinger LM, 2011, CANCER PREV RES, V4, P1030, DOI 10.1158/1940-6207.CAPR-11-0027; Lin YS, 2004, INT J CANCER, V110, P584, DOI 10.1002/ijc.20147; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Luedde T, 2006, J GASTROEN HEPATOL, V21, pS43, DOI 10.1111/j.1440-1746.2006.04588.x; Ma JC, 2010, J SURG RES, V160, P90, DOI 10.1016/j.jss.2008.08.016; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mancino A, 2010, CLIN CANCER RES, V16, P784, DOI 10.1158/1078-0432.CCR-09-1015; Monti P, 2003, CANCER RES, V63, P7451; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Olivo-Marston SE, 2009, MOL CARCINOGEN, V48, P1071, DOI 10.1002/mc.20577; ROEBUCK BD, 1993, CANCER RES, V53, P46; ROEBUCK BD, 1981, CANCER RES, V41, P888; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Shaib YH, 2006, ALIMENT PHARM THER, V24, P87, DOI 10.1111/j.1365-2036.2006.02961.x; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Xiong Henry Q, 2004, Surg Oncol Clin N Am, V13, P737, DOI 10.1016/j.soc.2004.06.010; YEBRA M, 1995, MOL BIOL CELL, V6, P841, DOI 10.1091/mbc.6.7.841	47	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94151	10.1371/journal.pone.0094151	http://dx.doi.org/10.1371/journal.pone.0094151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	25036011	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900009
J	Gong, YH; Han, TG; Chen, W; Dib, HH; Yang, GA; Zhuang, RS; Chen, YQ; Tong, XY; Yin, XX; Lu, ZX				Gong, Yanhong; Han, Tieguang; Chen, Wei; Dib, Hassan H.; Yang, Guoan; Zhuang, Runsen; Chen, Yuqi; Tong, Xinyue; Yin, Xiaoxv; Lu, Zuxun			Prevalence of Anxiety and Depressive Symptoms and Related Risk Factors among Physicians in China: A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; WORK HOURS; BURNOUT; SLEEP; CARE; PERCEPTIONS; WORKPLACE; DOCTORS; STRESS	Background: Physicians' poor mental health not only hinders their professional performance and affects the quality of healthcare provided but also adversely affects patients' health outcomes. Few studies in China have evaluated the mental health of physicians. The purposes of this study are to quantify Chinese physicians' anxiety and depressive symptoms as well as evaluate associated risk factors. Methods: In our study, 2641 physicians working in public hospitals in Shenzhen in southern China were recruited and interviewed by using a structured questionnaire along with validated scales testing anxiety and depressive symptoms. Multivariable logistic regression models were used to identify risk factors for anxiety and depressive symptoms. Results: An estimated 25.67% of physicians had anxiety symptoms, 28.13% had depressive symptoms, and 19.01% had both anxiety and depressive symptoms. More than 10% of the participants often experienced workplace violence and 63.17% sometimes encountered it. Among our study population, anxiety and depressive symptoms were associated with poor self-reported physical health, frequent workplace violence, lengthy working hours (more than 60 hours a week), frequent night shifts (twice or more per week), and lack of regular physical exercise. Conclusions: Our study demonstrates that anxiety and depressive symptoms are common among physicians in China, and the doctor-patient relationship issue is particularly stressful. Interventions implemented to minimize workload, improve doctor-patient relationships, and assist physicians in developing healthier lifestyles are essential to combat anxiety and depressive symptoms among physicians, which may improve their professional performance.	[Gong, Yanhong; Tong, Xinyue; Yin, Xiaoxv; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China; [Han, Tieguang; Yang, Guoan; Zhuang, Runsen; Chen, Yuqi] Shenzhen Hlth Educ & Promot Ctr, Shenzhen, Guangdong, Peoples R China; [Chen, Wei] Laiwu Municipal Ctr Dis Control & Prevent, Dept Occupat Hlth, Laiwu, Guangdong, Peoples R China; [Dib, Hassan H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Yin, XX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China.	hnyinxiaoxv@126.com; zuxunlu@yahoo.com	Dib, Hassan/M-7694-2015; Tian, Hua/GPP-4477-2022	Dib, Hassan/0000-0002-9508-0909; Gong, Yufeng/0000-0002-1396-527X	Shenzhen Health Education and Promotion Center	Shenzhen Health Education and Promotion Center	This project was funded by the Shenzhen Health Education and Promotion Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Little Y, 2007, BRIT MED J, V334, P777, DOI 10.1136/bmj.39154.516667.BE; Amaddeo F, 2007, EPIDEMIOL PSICHIAT S, V16, P16, DOI 10.1017/S1121189X00004565; Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Averina M, 2005, SOC PSYCH PSYCH EPID, V40, P511, DOI 10.1007/s00127-005-0918-x; Aytac S, 2012, WORK, V41, P3026, DOI 10.3233/WOR-2012-0559-3026; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Coomber S, 2002, BRIT J ANAESTH, V89, P873, DOI 10.1093/bja/aef273; Costa G, 2003, THEOR ISS ERGON SCI, V4, P263, DOI DOI 10.1080/14639220210158880; Devi S, 2011, LANCET, V377, P454, DOI 10.1016/S0140-6736(11)60145-1; Donisi Valeria, 2013, Psychiatry Res, V209, P691, DOI 10.1016/j.psychres.2013.02.031; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; General Administration of Sport of China, 2008, B STAT PHYS EX CHIN; GLASS DC, 1993, J CONSULT CLIN PSYCH, V61, P147, DOI 10.1037/0022-006X.61.1.147; Harma M, 1996, APPL ERGON, V27, P25, DOI 10.1016/0003-6870(95)00046-1; Henwood T, 2012, J CLIN NURS, V21, P1746, DOI 10.1111/j.1365-2702.2011.03994.x; Iacovides A, 2003, J AFFECT DISORDERS, V75, P209, DOI 10.1016/S0165-0327(02)00101-5; Kong LP, 2013, J CLIN NURS, V22, P1163, DOI 10.1111/jocn.12090; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Li JA, 2006, SOC SCI MED, V62, P1066, DOI 10.1016/j.socscimed.2005.07.011; Liu Y, 2013, J CLIN NURS, V22, P80, DOI 10.1111/jocn.12010; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lloyd S, 1994, J Emerg Med, V12, P559; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; MCKNIGHT JD, 1995, J CONSULT CLIN PSYCH, V63, P490, DOI 10.1037/0022-006X.63.3.490; Merecz D, 2009, INT J OCCUP MED ENV, V22, P243, DOI 10.2478/v10001-009-0027-2; National Health and Family Planning Commission of the People's Republic of China, 2012, STAT B DEV HLTH SERV; Ofili AN, 2004, OCCUP MED-OXFORD, V54, P400, DOI 10.1093/occmed/kqh081; Osborn DPJ, 2003, INT J GERIATR PSYCH, V18, P623, DOI 10.1002/gps.896; POMERLEAU OF, 1990, CIBA F SYMP, V152, P225; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ruitenburg MM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-292; RUSSELL GFM, 1983, BRIT J CLIN PHARMACO, V15, pS147, DOI 10.1111/j.1365-2125.1983.tb05859.x; Schwenk TL, 2008, J CLIN PSYCHIAT, V69, P617, DOI 10.4088/JCP.v69n0414; Shen LL, 2012, INT J PSYCHIAT MED, V44, P257, DOI 10.2190/PM.44.3.f; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Sun W, 2012, J OCCUP HEALTH, V54, P1, DOI 10.1539/joh.11-0169-OA; Takahashi M, 2012, J OCCUP ENVIRON MED, V54, P1078, DOI 10.1097/JOM.0b013e31826230b7; Tsai YC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-199; Vaglum P, 1999, J AFFECT DISORDERS, V52, P153, DOI 10.1016/S0165-0327(98)00081-0; Virtanen M, 2012, EXPERT REV NEUROTHER, V12, P497, DOI [10.1586/ERN.12.29, 10.1586/ern.12.29]; Wada K, 2011, INT J BEHAV MED, V18, P384, DOI 10.1007/s12529-010-9132-7; Wallace JE, 2012, HEALTH-LONDON, V16, P3, DOI 10.1177/1363459310371080; Wang Fang P, 2012, MED SOC, V25, P74; Wang JN, 2010, INT ARCH OCC ENV HEA, V83, P905, DOI 10.1007/s00420-010-0508-4; Wang ZY, 1984, SHANGHAI ARCH PSYCHI, P71; Zhao M, 2011, MED LAW, V30, P401; Zhengyu W., 1984, SHANGHAI ARCH PSYCHI, P73; [朱大方 Zhu Dafang], 2010, [中国公共卫生, China Public Health], V26, P429; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	50	156	164	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103242	10.1371/journal.pone.0103242	http://dx.doi.org/10.1371/journal.pone.0103242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0QO	24743634	Green Submitted, Green Published, gold			2022-12-27	WOS:000339551100099
J	Gong, YF; Tian, H; Wang, LJ; Yu, SP; Ru, SG				Gong, Yufeng; Tian, Hua; Wang, Lijia; Yu, Suping; Ru, Shaoguo			An Integrated Approach Combining Chemical Analysis and an In Vivo Bioassay to Assess the Estrogenic Potency of a Municipal Solid Waste Landfill Leachate in Qingdao	PLOS ONE			English	Article							GOLDFISH CARASSIUS-AURATUS; ENDOCRINE-DISRUPTING CHEMICALS; EELPOUT ZOARCES-VIVIPARUS; PERCH PERCA-FLUVIATILIS; YEAST 2-HYBRID ASSAY; PUBLIC REFUSE DUMP; WATER TREATMENT; TREATMENT-PLANT; BISPHENOL-A; CONTAMINATED SEDIMENTS	Various adverse effects related to landfill leachate have made leachates an important issue in past decades, and it has been demonstrated that landfill leachate is an important source of environmental estrogens. In this study, we employed chemical analysis of some already evaluated estrogenic substances, in combination with a bioassay using several specific biomarkers (e.g., plasma vitellogenin and sex steroids, enzyme activity of gonad gamma-glutamyl transpeptidase, and gonadosomatic index) to evaluate the estrogenic activities in outlets from different stages of the leachate treatment process. The results indicated that 5 environmental estrogens (4-t-octylphenol, bisphenol A, di-ethyl phthalate, di-n-butyl phthalate, and diethylhexyl phthalate) were detected by a gas chromatography-mass spectrometry, and the concentrations in leachate samples were 6153 ng/L, 3642 ng/L, 2139 ng/L, 5900 ng/L, and 9422 ng/L, respectively. Leachate (1:200 diluted) induced the synthesis of plasma vitellogenin and led to decreased enzyme activity of gonad gamma-glutamyl transpeptidase and gonadosomatic index in male goldfish (Carassius auratus) after a 28-day exposure, while increased circulating 17b-estradiol level was also observed in males exposed to treated effluent. Although the target EEs were partially removed with removal rates varying from 87.2% to 99.77% by the "membrane bioreactor+ reverse osmosis+ aeration zeolite biofilter'' treatment process, the treated effluent is still estrogenic to fish. The method combined chemical techniques with the responses of test organisms allowing us to identify the group of estrogen-like chemicals so that we were able to evaluate the overall estrogenic effects of a complex mixture, avoiding false negative assessments.	[Gong, Yufeng; Tian, Hua; Yu, Suping; Ru, Shaoguo] Ocean Univ China, Marine Life Sci Coll, Qingdao, Peoples R China; [Wang, Lijia] Qingdao Chengtou Xiaojianxi Leachate Treatment Co, Qingdao, Peoples R China	Ocean University of China	Ru, SG (corresponding author), Ocean Univ China, Marine Life Sci Coll, Qingdao, Peoples R China.	rusg@ouc.edu.cn	Dib, Hassan/M-7694-2015; Tian, Hua/GPP-4477-2022	Dib, Hassan/0000-0002-9508-0909; Gong, Yufeng/0000-0002-1396-527X	Natural Science Foundation of China [31170322]; Natural Science Foundation of Jiangsu Province [BK2011165]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by Natural Science Foundation of China (31170322), www.nsfc.gov.cn and Natural Science Foundation of Jiangsu Province (BK2011165), www.jsnsf.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1; Asakura H, 2004, WASTE MANAGE, V24, P613, DOI 10.1016/j.wasman.2004.02.004; Asakura H, 2009, WASTE MANAGE, V29, P1852, DOI 10.1016/j.wasman.2008.11.030; Asakura Hiroshi, 2007, Environmental Sciences, V14, P79; Baderna D, 2011, ENVIRON RES, V111, P603, DOI 10.1016/j.envres.2011.01.015; Behnisch PA, 2001, CHEMOSPHERE, V43, P977, DOI 10.1016/S0045-6535(00)00458-6; Blankvoort BMG, 2005, ENVIRON TOXICOL PHAR, V19, P263, DOI 10.1016/j.etap.2004.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardinali M, 2004, REPROD TOXICOL, V18, P597, DOI 10.1016/j.reprotox.2004.03.001; CARNEVALI O, 1993, J ENDOCRINOL, V137, P383, DOI 10.1677/joe.0.1370383; CARNEVALI O, 1992, GEN COMP ENDOCR, V88, P406, DOI 10.1016/0016-6480(92)90235-C; Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046; Christiansen LB, 1998, MAR ENVIRON RES, V46, P137, DOI 10.1016/S0141-1136(97)00047-0; Coors A, 2003, ENVIRON SCI TECHNOL, V37, P3430, DOI 10.1021/es0300158; Diniz MS, 2009, ECOTOXICOLOGY, V18, P1011, DOI 10.1007/s10646-009-0392-4; Dinizi MS, 2010, J ENVIRON SCI, V22, P1613, DOI 10.1016/S1001-0742(09)60297-7; Dizer H, 2002, ENVIRON TOXICOL, V17, P105, DOI 10.1002/tox.10038; Folmar LC, 2002, AQUAT TOXICOL, V60, P101, DOI 10.1016/S0166-445X(01)00276-4; Furhacker M, 2000, CHEMOSPHERE, V41, P751, DOI 10.1016/S0045-6535(99)00466-X; GERBERHUBER S, 1987, NUCLEIC ACIDS RES, V15, P4737, DOI 10.1093/nar/15.12.4737; Giam C.S., 1984, Handbook of Environmental Chemistry, V3C, P67; Gunnarsson L, 2009, SCI TOTAL ENVIRON, V407, P5235, DOI 10.1016/j.scitotenv.2009.06.018; He PJ, 2009, SCI TOTAL ENVIRON, V407, P4928, DOI 10.1016/j.scitotenv.2009.05.036; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; Jobling S, 1998, IDENTIFICATION OESTR; Jonsson S, 2003, WATER RES, V37, P609, DOI 10.1016/S0043-1354(02)00304-4; Joseph L, 2011, WATER RES, V45, P4056, DOI 10.1016/j.watres.2011.05.015; Kawagoshi Y, 2003, J ENVIRON MONITOR, V5, P269, DOI 10.1039/b210962j; Kawagoshi Y, 2002, J ENVIRON MONITOR, V4, P1040, DOI 10.1039/b206161a; Kime DE, 1999, AQUACULTURE, V177, P345, DOI 10.1016/S0044-8486(99)00097-6; Kjeldsen P, 2002, CRIT REV ENV SCI TEC, V32, P297, DOI 10.1080/10643380290813462; Klauck CR, 2013, WASTE MANAGE RES, V31, P1148, DOI 10.1177/0734242X13502388; KOMEN J, 1989, AQUACULTURE, V78, P349, DOI 10.1016/0044-8486(89)90111-7; Korner W, 2000, CHEMOSPHERE, V40, P1131, DOI 10.1016/S0045-6535(99)00362-8; Kurata Y, 2008, J MATER CYCLES WASTE, V10, P144, DOI 10.1007/s10163-008-0200-x; Lei L, 2006, JPN J ENV TOXICOL, V9, P11; Leusch FDL, 2006, ECOTOX ENVIRON SAFE, V65, P403, DOI 10.1016/j.ecoenv.2005.07.020; Li CR, 2009, ENVIRON MONIT ASSESS, V150, P397, DOI 10.1007/s10661-008-0238-1; Liu ZH, 2009, SCI TOTAL ENVIRON, V407, P731, DOI 10.1016/j.scitotenv.2008.08.039; Lu GH, 2010, CHEMOSPHERE, V80, P982, DOI 10.1016/j.chemosphere.2010.05.038; Lu GH, 2011, ECOTOXICOLOGY, V20, P974, DOI 10.1007/s10646-011-0660-y; Marin MG, 2004, MAR POLLUT BULL, V48, P835, DOI 10.1016/j.marpolbul.2004.02.037; Ministry of Environmental Protection of The People's Republic of China, 2011, CHIN ENV STAT ANN BO; MIURA T, 1991, ZOOL SCI, V8, P63; Muller M, 2008, ENVIRON TOXICOL CHEM, V27, P1649, DOI [10.1897/07-519.1, 10.1897/07-519]; Nakamura D, 2010, TOXICOL LETT, V194, P16, DOI 10.1016/j.toxlet.2010.02.002; Noaksson E, 2005, AQUAT TOXICOL, V75, P162, DOI 10.1016/j.aquatox.2005.07.011; Noaksson E, 2003, SCI TOTAL ENVIRON, V305, P87, DOI 10.1016/S0048-9697(02)00503-X; Noaksson E, 2001, TOXICOL APPL PHARM, V174, P160, DOI 10.1006/taap.2001.9194; Pan ZB, 2012, J KOREAN SOC APPL BI, V55, P219, DOI 10.1007/s13765-012-1014-z; Pivato A, 2006, WASTE MANAGE, V26, P1148, DOI 10.1016/j.wasman.2005.10.008; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Rasmussen TH, 2005, AQUAT TOXICOL, V72, P177, DOI 10.1016/j.aquatox.2004.12.003; Rasmussen TH, 2004, COMP BIOCHEM PHYS C, V139, P1, DOI 10.1016/j.cca.2004.08.016; Ribecco C, 2012, AQUAT TOXICOL, V109, P133, DOI 10.1016/j.aquatox.2011.12.002; Ribecco C, 2011, AQUAT TOXICOL, V104, P308, DOI 10.1016/j.aquatox.2011.05.005; Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sisinno CLS, 2000, B ENVIRON CONTAM TOX, V64, P107, DOI 10.1007/s001289910017; Sole M, 2003, COMP BIOCHEM PHYS C, V136, P145, DOI 10.1016/S1532-0456(03)00192-3; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Svenson A, 2004, J ENVIRON SCI HEAL A, V39, P2817, DOI [10.1081/LESA-200033857, 10.1081/ESE-200033857]; ter Veld MGR, 2006, J AGR FOOD CHEM, V54, P4407, DOI 10.1021/jf052864f; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; Tian H, 2010, COMP BIOCHEM PHYS C, V152, P107, DOI 10.1016/j.cbpc.2010.03.004; Tian H, 2010, AQUAT TOXICOL, V98, P67, DOI 10.1016/j.aquatox.2010.01.011; Tian H, 2009, COMP BIOCHEM PHYS C, V150, P231, DOI 10.1016/j.cbpc.2009.04.014; Toft G, 2001, ECOTOX ENVIRON SAFE, V48, P76, DOI 10.1006/eesa.2000.1985; Tyler CR, 1999, ENVIRON TOXICOL CHEM, V18, P337, DOI 10.1002/etc.5620180234; WALLACE RA, 1985, J BIOL CHEM, V260, P1268; Wang RM, 2013, ENVIRON SCI POLLUT R, V20, P8612, DOI 10.1007/s11356-013-1817-4; Wen RS, 2013, AQUAT TOXICOL, V132, P165, DOI 10.1016/j.aquatox.2013.02.010; Yasuhara A, 1999, WASTE MANAGE RES, V17, P186, DOI 10.1177/0734242X9901700304; Yasuhara A, 1997, J CHROMATOGR A, V774, P321, DOI 10.1016/S0021-9673(97)00078-2; Zhang XN, 2013, GEN COMP ENDOCR, V193, P158, DOI 10.1016/j.ygcen.2013.08.003; Zheng G, 2004, CHIN J IND MED, V17, P273	77	156	164	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95597	10.1371/journal.pone.0095597	http://dx.doi.org/10.1371/journal.pone.0095597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743634	Green Published, gold, Green Submitted			2022-12-27	WOS:000335309100144
J	Liu, MX; Chen, X; Chen, G; Cui, QH; Yan, GY				Liu, Ming-Xi; Chen, Xing; Chen, Geng; Cui, Qing-Hua; Yan, Gui-Ying			A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DATABASE; GENOME; PROTEIN; INHIBITOR; MOUSE; OVEREXPRESSION; SUSCEPTIBILITY; IDENTIFICATION	As a major class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been implicated in various critical biological processes. Accumulating researches have linked dysregulations and mutations of lncRNAs to a variety of human disorders and diseases. However, to date, only a few human lncRNAs have been associated with diseases. Therefore, it is very important to develop a computational method to globally predict potential associated diseases for human lncRNAs. In this paper, we developed a computational framework to accomplish this by combining human lncRNA expression profiles, gene expression profiles, and human disease-associated gene data. Applying this framework to available human long intergenic noncoding RNAs (lincRNAs) expression data, we showed that the framework has reliable accuracy. As a result, for non-tissue-specific lincRNAs, the AUC of our algorithm is 0.7645, and the prediction accuracy is about 89%. This study will be helpful for identifying novel lncRNAs for human diseases, which will help in understanding the roles of lncRNAs in human diseases and facilitate treatment. The corresponding codes for our method and the predicted results are all available at http://asdcd.amss.ac.cn/MingXiLiu/lncRNA-disease.html.	[Liu, Ming-Xi; Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Geng; Cui, Qing-Hua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Peking University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342; Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China [10531070, 10721101, 11301517, 11371355, KJCX-YW-S7]; National Center for Mathematics and Interdisciplinary Sciences, CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 10531070, 10721101, 11301517, 11371355, KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haruta N, 2011, P JPN ACAD B-PHYS, V87, P641, DOI 10.2183/pjab.87.641; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li P, 2011, NAT PROD COMMUN, V6, P1801; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mattingly CJ, 2006, J EXP ZOOL PART A, V305A, P689, DOI 10.1002/jez.a.307; Mitsui Sachiko, 2011, Neural Syst Circuits, V1, P5, DOI 10.1186/2042-1001-1-5; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Sakuma Y, 2012, LAB INVEST, V92, P371, DOI 10.1038/labinvest.2011.187; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoshihara C, 2012, ONCOL LETT, V3, P387, DOI 10.3892/ol.2011.467; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yoshihara Eiji, 2011, Japanese Journal of Alcohol Studies & Drug Dependence, V46, P570; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	51	195	205	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84408	10.1371/journal.pone.0084408	http://dx.doi.org/10.1371/journal.pone.0084408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	25244184	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100056
J	Fan, YT; Cheng, YW				Fan, Yang-Teng; Cheng, Yawei			Atypical Mismatch Negativity in Response to Emotional Voices in People with Autism Spectrum Conditions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ASPERGER-SYNDROME; CHILDREN; SPEECH; BRAIN; PERCEPTION; ATTENTION; DISCRIMINATION; LANGUAGE; DISORDER	Autism Spectrum Conditions (ASC) are characterized by heterogeneous impairments of social reciprocity and sensory processing. Voices, similar to faces, convey socially relevant information. Whether voice processing is selectively impaired remains undetermined. This study involved recording mismatch negativity (MMN) while presenting emotionally spoken syllables dada and acoustically matched nonvocal sounds to 20 subjects with ASC and 20 healthy matched controls. The people with ASC exhibited no MMN response to emotional syllables and reduced MMN to nonvocal sounds, indicating general impairments of affective voice and acoustic discrimination. Weaker angry MMN amplitudes were associated with more autistic traits. Receiver operator characteristic analysis revealed that angry MMN amplitudes yielded a value of 0.88 (p<.001). The results suggest that people with ASC may process emotional voices in an atypical fashion already at the automatic stage. This processing abnormality can facilitate diagnosing ASC and enable social deficits in people with ASC to be predicted.	[Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Fan, Yang-Teng; Cheng, Yawei] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Rehabil, Yilan, Taiwan; [Cheng, Yawei] Taipei City Hosp, Dept Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Cheng, YW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	ywcheng2@ym.edu.tw			Ministry of Science and Technology [MOST 103-2401-H-010-003-MY3]; National Yang-Ming University Hospital [RD2014-003]; Health Department of Taipei City Government [10301-62-009]; Ministry of Education (Aim for the Top University Plan)	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Yang-Ming University Hospital; Health Department of Taipei City Government; Ministry of Education (Aim for the Top University Plan)(Ministry of Education, Taiwan)	The study was funded by the Ministry of Science and Technology (MOST 103-2401-H-010-003-MY3), National Yang-Ming University Hospital (RD2014-003), Health Department of Taipei City Government (10301-62-009), and Ministry of Education (Aim for the Top University Plan). The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Boersma Paul, 2002, GLOT INT, V5, P341; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cheng YW, 2012, J COGNITIVE NEUROSCI, V24, P1411, DOI 10.1162/jocn_a_00214; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Fan YT, 2013, NEUROREPORT, V24, P457, DOI 10.1097/WNR.0b013e32836169b9; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; Griffin R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-61; Grossmann T, 2012, SOC NEUROSCI-UK, V7, P369, DOI 10.1080/17470919.2011.628758; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; HOBSON RP, 1989, BRIT J DEV PSYCHOL, V7, P237, DOI 10.1111/j.2044-835X.1989.tb00803.x; Hung AY, 2014, NEUROREPORT, V25, P464, DOI 10.1097/WNR.0000000000000115; Hung AY, 2013, J CHILD PSYCHOL PSYC, V54, P1016, DOI 10.1111/jcpp.12076; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jansson-Verkasalo E, 2003, NEUROSCI LETT, V338, P197, DOI 10.1016/S0304-3940(02)01405-2; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; LINCOLN AJ, 1993, J AUTISM DEV DISORD, V23, P37, DOI 10.1007/BF01066417; Locke J.L., 1993, CHILDS PATH SPOKEN L; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maestro S, 2002, J AM ACAD CHILD PSY, V41, P1239, DOI 10.1097/00004583-200210000-00014; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NICHOLSON C, 1973, IEEE T BIO-MED ENG, VBM20, P278, DOI 10.1109/TBME.1973.324192; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Roberts TPL, 2011, BIOL PSYCHIAT, V70, P263, DOI 10.1016/j.biopsych.2011.01.015; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schirmer A, 2008, NEUROIMAGE, V40, P1402, DOI 10.1016/j.neuroimage.2008.01.018; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; Seri S, 1999, CLIN NEUROPHYSIOL, V110, P1825, DOI 10.1016/S1388-2457(99)00137-6; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Sussman ES, 2013, BRAIN TOPOGR; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winer B.J., 1991, STAT PRINCIPLES EXPT	67	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2014	9	7							e102471	10.1371/journal.pone.0102471	http://dx.doi.org/10.1371/journal.pone.0102471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1OC	24475058	Green Published, Green Submitted, gold			2022-12-27	WOS:000339615200061
J	Zhu, LL; Fan, Y; Zou, QH; Wang, J; Gao, JH; Niu, ZD				Zhu, Linlin; Fan, Yang; Zou, Qihong; Wang, Jue; Gao, Jia-Hong; Niu, Zhendong			Temporal Reliability and Lateralization of the Resting-State Language Network	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; TEST-RETEST RELIABILITY; HUMAN BRAIN; CORTICAL ORGANIZATION; ALZHEIMERS-DISEASE; COMPONENT ANALYSIS; CINGULATE CORTEX; FMRI; SCHIZOPHRENIA; ASYMMETRIES	The neural processing loop of language is complex but highly associated with Broca's and Wernicke's areas. The left dominance of these two areas was the earliest observation of brain asymmetry. It was demonstrated that the language network and its functional asymmetry during resting state were reproducible across institutions. However, the temporal reliability of resting-state language network and its functional asymmetry are still short of knowledge. In this study, we established a seed-based resting-state functional connectivity analysis of language network with seed regions located at Broca's and Wernicke's areas, and investigated temporal reliability of language network and its functional asymmetry. The language network was found to be temporally reliable in both short-and long-term. In the aspect of functional asymmetry, the Broca's area was found to be left lateralized, while the Wernicke's area is mainly right lateralized. Functional asymmetry of these two areas revealed high short-and long-term reliability as well. In addition, the impact of global signal regression (GSR) on reliability of the resting-state language network was investigated, and our results demonstrated that GSR had negligible effect on the temporal reliability of the resting-state language network. Our study provided methodology basis for future cross-culture and clinical researches of resting-state language network and suggested priority of adopting seed-based functional connectivity for its high reliability.	[Zhu, Linlin; Niu, Zhendong] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing 100081, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China; [Fan, Yang; Zou, Qihong; Gao, Jia-Hong] Peking Univ, Sch Phys, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Wang, Jue] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China; [Gao, Jia-Hong] Peking Univ, McGovern Inst Brain Res, Beijing 100871, Peoples R China	Beijing Institute of Technology; Peking University; Peking University; Hangzhou Normal University; Peking University	Zou, QH (corresponding author), Peking Univ, Sch Phys, Ctr MRI Res, Beijing 100871, Peoples R China.	zouqihong@pku.edu.cn; zniu@bit.edu.cn			China's National Strategic Basic Research Program (973) [2012CB720700]; National Key Technology R D Program [2011BAI12B01]; Natural Science Foundation of China [81201142, 81227003]	China's National Strategic Basic Research Program (973); National Key Technology R D Program(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by China's National Strategic Basic Research Program (973) (2012CB720700), the National Key Technology R& D Program (2011BAI12B01), and the Natural Science Foundation of China (81201142, 81227003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2013, NEUROIMAGE; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chen G, 2012, MAGN RESON MED, V68, P1828, DOI 10.1002/mrm.24201; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; Dollfus S, 2005, BIOL PSYCHIAT, V57, P1020, DOI 10.1016/j.biopsych.2005.01.009; Dronkers NF, 2011, NEUROLOGY, V76, pA162; Egidi G, 2013, NEUROIMAGE, V71, P59, DOI 10.1016/j.neuroimage.2013.01.003; Fiecas M, 2013, NEUROIMAGE, V65, P231, DOI 10.1016/j.neuroimage.2012.09.052; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GALABURDA AM, 1978, SCIENCE, V199, P852, DOI 10.1126/science.341314; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HEILMAN KM, 1976, CORTEX, V12, P258, DOI 10.1016/S0010-9452(76)80007-X; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2007, LATERALITY, V12, P87, DOI 10.1080/13576500600959247; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Jung WH, 2012, PLOS ONE, V7; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; KERTESZ A, 1986, CORTEX, V22, P117, DOI 10.1016/S0010-9452(86)80036-3; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Kollndorfer K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00095; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; LEMAY M, 1978, J COMPUT ASSIST TOMO, V2, P471; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narr KL, 2001, AM J PSYCHIAT, V158, P244, DOI 10.1176/appi.ajp.158.2.244; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Petridou N, 2009, MAGN RESON IMAGING, V27, P1046, DOI 10.1016/j.mri.2009.02.006; Posthuma D, 2002, NAT NEUROSCI, V5, P83, DOI 10.1038/nn0202-83; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; PREVIC FH, 1991, PSYCHOL REV, V98, P299, DOI 10.1037/0033-295X.98.3.299; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Proverbio AM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-116; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel M, 2008, PLOS ONE, P3; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zuo X-N, 2012, NEUROIMAGE; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	90	164	168	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e85880	10.1371/journal.pone.0085880	http://dx.doi.org/10.1371/journal.pone.0085880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24475058	gold, Green Submitted, Green Published			2022-12-27	WOS:000330339800018
J	Yang, YC; Huang, YT; Hsieh, CW; Yang, PM; Wung, BS				Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Yang, Po-Min; Wung, Being-Sun			Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM-STRESS; CO-RELEASING MOLECULES; THERAPEUTIC APPLICATIONS; GENE-EXPRESSION; UP-REGULATION; JNK PATHWAY; PHOSPHORYLATION; INHIBITION; APOPTOSIS	IL-6/STAT3 pathway is involved in a variety of biological responses, including cell proliferation, differentiation, apoptosis, and inflammation. In our present study, we found that CO releasing molecules (CORMs) suppress IL-6-induced STAT3 phosphorylation, nuclear translocation and transactivity in endothelial cells (ECs). CO is a byproduct of heme degradation mediated by heme oxygenase (HO-1). However, CORMs can induce HO-1 expression and then inhibit STAT3 phosphorylation. CO has been found to increase a low level ROS and which may induce protein glutathionylation. We hypothesized that CORMs increases protein glutathionylation and inhibits STAT3 activation. We found that CORMs increase the intracellular GSSG level and induce the glutathionylation of multiple proteins including STAT3. GSSG can inhibit STAT3 phosphorylation and increase STAT3 glutathionylation whereas the antioxidant enzyme catalase can suppress the glutathionylation. Furthermore, catalase blocks the inhibition of STAT3 phosphorylation by CORMs treatment. The inhibition of glutathione synthesis by BSO was also found to attenuate STAT3 glutathionylation and its inhibition of STAT3 phosphorylation. We further found that HO-1 increases STAT3 glutathionylation and that HO-1 siRNA attenuates CORM-induced STAT3 glutathionylation. Hence, the inhibition of STAT3 activation is likely to occur via a CO-mediated increase in the GSSG level, which augments protein glutathionylation, and CO-induced HO-1 expression, which may enhance and maintain its effects in IL-6-treated ECs.	[Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Wung, Being-Sun] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Yang, Po-Min] Chiayi Christian Hosp, Dept Ophthalmol, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital	Wung, BS (corresponding author), Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	bswung@mail.ncyu.edu.tw	; Herrup, Karl/C-5313-2014	Chen, Ji-hua/0000-0002-1151-0693; wung, being sun/0000-0002-9378-2798; Hsieh, Chia-Wen/0000-0003-1188-1934; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	National Science Council, Taiwan [102-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (102-2320-B-415-002-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh PY, 2014, FREE RADICAL BIO MED, V70, P1, DOI 10.1016/j.freeradbiomed.2014.01.042; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	112	121	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100677	10.1371/journal.pone.0100677	http://dx.doi.org/10.1371/journal.pone.0100677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	24498369	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600004
